Citrus Sinensis ID: 004660

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------74
Protein Sequence
MQESGKAGNFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDLASLFRKPESSGHGFESPEGRPHRGSTNQTAKGSAGFLSHFHKGDSQVLNIESVKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEVCPQCHAGTFNCATASRHSSCSTFGVHISLSTSNSHNFSPSSRNMPLGAVNNHPCAPLRSQGQEISHI
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccEEccccccEEEEEEEcccccEEEEEEEEccccccccHHHHHHHHHHHHHHccccccccEEEEEEEEEccEEEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEcccccEEEccccccccccccccccccccccccccHHHHcccccccccccccccccHHHHHHHHHHHHcccccccccccHHHHHHcccccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccEcccccccEEcHHHccccccccccHcccccccccccccccccccccccHHHHHHccccccccccccccccccccccccccccccccccccccHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHEEEEEEcccccHHEEEEEEcccHHHHHHHHHHHcHHccccHHHHHHHHHHHHHHcccccccEccEEEEccccccccEEEEcccccEHHHHHcccHccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEccccccccEccHHHcccccccHHHccHHHHHHHcccccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccHHHHHHHHHHHcccHHccccHHHHHccHHHHcccccHccccccccccccccccccEEEHccccccHHHHHHcccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mqesgkagnffknrvqsssfnnrkltrvrklrhvpddelgllmtdracspsaspdsarmspspgtsdhwsssavpkplplpdlaslfrkpessghgfespegrphrgstnqtakgsagflshfhkgdsqvlniesvkndlrpsvpvrstptslssshavspqrsnlqnptplhnpksistrrrgfshdlniecanyssradiipksaptsvfsspavspqssktgnvfssfwapkeiqdwstaevpdlgrfvgctspvspfkrnvysadhsplpspprqssqsnlrsprkvyfplrhkslpqnSKELLESnnhlnahplplppgalsppkssvtsavmphimekpsaspkksqwqkgkligrgtfgsvyigtnretgascaikevdiipddpksAECIKQLEQEIKVLGHLKHENIVQyygsevvddHLYIYLEYvhpgsinryVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLvdasgvvkladfgmakhlTGLSYelslkgspnwmaPEVIKAVMQkdgnpklaLAVDIWSLGCTVIemltgkppwsefegpqamfkvlnrtppipemlssegkDFLLRCFlrnpverpsavellehpfirnanyqnlsvpmrvfsrinlgdkshDQVERAtrkteslpdspetrvrnrklpcnsevcpqchagtfncatasrhsscstfGVHISlstsnshnfspssrnmplgavnnhpcaplrsqgqeishi
Flexible Loop (DISEMBL)
mqesgkagnffknrvqsssfnnrkltrvrklrhvpddelgllmTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDLASLFRKPESSghgfespegrphRGSTNQTAKGSAGFLSHFHKGDSQVLNIESVKNDLRPSVPVRStptslssshavspqrsnlqnptplhnpksistrrrgFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSadhsplpspprqssqsnlrsPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMekpsaspkksqwqkGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINlgdkshdqveratrkteslpdspetrvrnrklpcnsevcpqCHAGTFNCATASRHSSCSTFGVHISLSTSNSHNFSPSSRNMPLGAVNNHPCaplrsqgqeishi
Low Complexity Region (SEG)
MQESGKAGNFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDLASLFRKPESSGHGFESPEGRPHRGSTNQTAKGSAGFLSHFHKGDSQVLNIESVKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSADHsplpspprqssqsnlrsprKVYFPLRHKSLPQNSKELLEsnnhlnahplplppgalsppKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEVCPQCHAGTFNCATASRHSSCSTFGVHIslstsnshnfspssrnMPLGAVNNHPCAPLRSQGQEISHI
Disordered region (IsUnstruct)
********************************************************************************************************************************************************************************************LNIECANY******************************VFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVS*************************************************************************************************GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR***********GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINL********************************CNSEVCPQCHAGTFNCATASRHSSCSTFGVHI****************************************
Disordered Region (DISOPRED)
******************************************************************************************************************************************************************************************************************************************************************************************************************************************************************QKGKLIGRGTFGSVYIGTNRETGASCAIKEVD****************QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR***************************************************************************************************************************
Disordered Region (DISEMBL)
********NFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRA**************************VPKPLPLPDLASLFRK************************KGSAGFLSHFHKGDSQVLNIESVKNDLRPS***********************QNPTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAP****************GNVFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYS********************PRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGAL********SAVMPHIM*************KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDK************************NRKLPCNSEVCPQCHAGTFNCATASRHSSCSTFGVHISLSTSNSHNFSPSSRNMPLGAVNNHPCAPLR*********
Disordered Region (DISPRO)
***************QSSSFNNRKLTRVRKLRH**************************************************************************************************************************************************************************************************************************************************************************************************************************SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEVCP*****************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MQESGKAGNFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDLASLFRKPESSGHGFESPEGRPHRGSTNQTAKGSAGFLSHFHKGDSQVLNIESVKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEVCPQCHAGTFNCATASRHSSCSTFGVHISLSTSNSHNFSPSSRNMPLGAVNNHPCAPLRSQGQEISHI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	739	2.2.26 [Sep-21-2011]
Q39008	608	Mitogen-activated protein	no	no	0.355	0.432	0.496	3e-66
O22040	666	Mitogen-activated protein	no	no	0.412	0.457	0.424	2e-63
Q9FZ36	651	Mitogen-activated protein	no	no	0.408	0.463	0.415	5e-63
Q54R82	942	Mitogen-activated protein	no	no	0.358	0.281	0.435	6e-63
Q99759	626	Mitogen-activated protein	yes	no	0.336	0.397	0.448	6e-61
Q61084	626	Mitogen-activated protein	yes	no	0.336	0.397	0.448	1e-60
O22042	651	Mitogen-activated protein	no	no	0.345	0.391	0.459	9e-60
Q9SZ67	1895	Probable WRKY transcripti	no	no	0.336	0.131	0.464	2e-59
Q9Y2U5	619	Mitogen-activated protein	no	no	0.350	0.418	0.441	2e-58
Q10407	1116	MAP kinase kinase kinase	yes	no	0.347	0.230	0.437	3e-57

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  253 bits (647), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 136/274 (49%), Positives = 185/274 (67%), Gaps = 11/274 (4%)

Query: 345 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           P      + WQKG+L+GRG+FGSVY G + + G   A+KEV ++    ++ ECI+QLE E
Sbjct: 324 PDGGAIITSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGE 382

Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRH 463
           IK+L  L+H+NIV+Y G+     +LYI+LE V  GS+ + Y R   RD   S+V  +TR 
Sbjct: 383 IKLLSQLQHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRD---SVVSLYTRQ 439

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 523
           IL+GL YLH    IHRDIK AN+LVDA+G VKLADFG+AK ++  +   S KG+P WMAP
Sbjct: 440 ILDGLKYLHDKGFIHRDIKCANILVDANGAVKLADFGLAK-VSKFNDIKSCKGTPFWMAP 498

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI    +KD +   + A DIWSLGCTV+EM TG+ P+S+ E  QA+F++   T P +P+
Sbjct: 499 EVIN---RKDSDGYGSPA-DIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPD 554

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
            LS + + F+L+C   NP ERP+A ELL HPF+R
Sbjct: 555 TLSLDARLFILKCLKVNPEERPTAAELLNHPFVR 588

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  244 bits (623), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 144/339 (42%), Positives = 198/339 (58%), Gaps = 34/339 (10%)

Query: 309 ESNNHLNAHPLPLPPGALSPPKSSVTSAVMP-HIMEKPSASPKK----------SQWQKG 357
           + +N  N  P P   G L+     +TS +    I  KPS SP              W+KG
Sbjct: 19  DDDNQENQPPFP---GVLA---DKITSCIRKSKIFIKPSFSPPPPANTVDMAPPISWRKG 72

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLGHLKHE 414
           +LIGRG FG+VY+G N ++G   A+K+V I  +     K+   I++LE+E+K+L +L H 
Sbjct: 73  QLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKNLSHP 132

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NIV+Y G+   DD L I LE+V  GSI+  + E      ES+VR +TR +L GL YLH+ 
Sbjct: 133 NIVRYLGTVREDDTLNILLEFVPGGSISSLL-EKFGPFPESVVRTYTRQLLLGLEYLHNH 191

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGLSYELSLKGSPNWMAPEVIKAVMQ 531
             +HRDIKGAN+LVD  G +KLADFG +K    L  ++   S+KG+P WMAPEVI     
Sbjct: 192 AIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVILQTGH 251

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSSEG 588
                  + + DIWS+GCTVIEM+TGK PWS+     A    +  T   PPIP+ LSS+ 
Sbjct: 252 -------SFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDA 304

Query: 589 KDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 627
           KDFLL+C    P  RP+A ELL+HPF+   + ++ S  +
Sbjct: 305 KDFLLKCLQEVPNLRPTASELLKHPFVMGKHKESASTDL 343

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  243 bits (619), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 138/332 (41%), Positives = 197/332 (59%), Gaps = 30/332 (9%)

Query: 317 HPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKS---------QWQKGKLIGRGTFGS 367
           HP P P    S     +TS +   ++   S SP  +         +W+KG+LIGRG FG+
Sbjct: 26  HPPPFP----SLLADKITSCIRKSMVFAKSQSPPNNSTVQIKPPIRWRKGQLIGRGAFGT 81

Query: 368 VYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 424
           VY+G N ++G   A+K+V I  +     K+   I++LE+E+K+L +L H NIV+Y G+  
Sbjct: 82  VYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKNLSHPNIVRYLGTVR 141

Query: 425 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 484
            D+ L I LE+V  GSI+  + E      ES+VR +T  +L GL YLH+   +HRDIKGA
Sbjct: 142 EDETLNILLEFVPGGSISSLL-EKFGAFPESVVRTYTNQLLLGLEYLHNHAIMHRDIKGA 200

Query: 485 NLLVDASGVVKLADFGMAKH---LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 541
           N+LVD  G +KLADFG +K    L  +S   S+KG+P WMAPEVI            + +
Sbjct: 201 NILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVILQTGH-------SFS 253

Query: 542 VDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKV--LNRTPPIPEMLSSEGKDFLLRCFLR 598
            DIWS+GCTVIEM+TGK PWS +++   A+F +      PPIP+ +SS+  DFLL+C  +
Sbjct: 254 ADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDANDFLLKCLQQ 313

Query: 599 NPVERPSAVELLEHPFIRNANYQNLSVPMRVF 630
            P  RP+A ELL+HPF+     ++ S  +  F
Sbjct: 314 EPNLRPTASELLKHPFVTGKQKESASKDLTSF 345

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  243 bits (619), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 122/280 (43%), Positives = 186/280 (66%), Gaps = 15/280 (5%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGH 410
           +WQKG+++GRG +GSVY+G N++TG   A+K+++I  I  DPK    I    +EI+V+  
Sbjct: 169 KWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRS 228

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L+H+NIV+Y G+ +    L ++LEY+  GSI+  + +     +E++++ +T+ IL GL++
Sbjct: 229 LRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGA-FSENVIKVYTKQILQGLSF 287

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAV 529
           LH+ + IHRDIKGAN+L+D  G+VKL+DFG +K  +G+  +  S++G+P WMAPEVIK  
Sbjct: 288 LHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIK-- 345

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVL--NRTPPIPEMLSS 586
             + G+ +   + DIWSLGC ++EM T +PPWS   E    M+ +   N  P IP  +S 
Sbjct: 346 --QTGHGR---SSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQ 400

Query: 587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
           E  DFL  CF R+P ERP A +LL+HPFI N +  N+ +P
Sbjct: 401 EAFDFLNLCFKRDPKERPDANQLLKHPFIMNLD-DNIQLP 439

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2

 Score =  236 bits (602), Expect = 6e-61,   Method: Compositional matrix adjust.
 Identities = 122/272 (44%), Positives = 176/272 (64%), Gaps = 23/272 (8%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W++GKL+G+G FG VY+  + +TG   A K+V   PD P++++ +  LE EI++L +L+H
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQH 421

Query: 414 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           E IVQYYG   +  +  L I++EY+  GS+   ++ +   +TES+ R +TR IL G++YL
Sbjct: 422 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL 480

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPE 524
           HS   +HRDIKGAN+L D++G VKL DFG +K L       TG+    S+ G+P WM+PE
Sbjct: 481 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMR---SVTGTPYWMSPE 537

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE 582
           VI      +G  + A   D+WSLGCTV+EMLT KPPW+E+E   A+FK+  +   P +P 
Sbjct: 538 VISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 590

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
            +S  G+DFL R F+    +RPSA ELL H F
Sbjct: 591 HISEHGRDFLRRIFV-EARQRPSAEELLTHHF 621

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1

 Score =  235 bits (599), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 122/272 (44%), Positives = 176/272 (64%), Gaps = 23/272 (8%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W++GKL+G+G FG VY+  + +TG   A K+V   PD P++++ +  LE EI++L +L+H
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQH 421

Query: 414 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           E IVQYYG   +  +  L I++EY+  GS+   ++ +   +TES+ R +TR IL G++YL
Sbjct: 422 ERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL 480

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPE 524
           HS   +HRDIKGAN+L D++G VKL DFG +K L       TG+    S+ G+P WM+PE
Sbjct: 481 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR---SVTGTPYWMSPE 537

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE 582
           VI      +G  + A   D+WSLGCTV+EMLT KPPW+E+E   A+FK+  +   P +P 
Sbjct: 538 VISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 590

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
            +S  G+DFL R F+    +RPSA ELL H F
Sbjct: 591 HISEHGRDFLRRIFV-EARQRPSAEELLTHHF 621

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  232 bits (591), Expect = 9e-60,   Method: Compositional matrix adjust.
 Identities = 125/272 (45%), Positives = 170/272 (62%), Gaps = 17/272 (6%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQEIKVLG 409
           +W+KG+LIG G FG VY+G N ++G   AIK+V I P      K+   I++LE+E+++L 
Sbjct: 67  RWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLK 126

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
           +L H NIV+Y G+    D L I +E+V  GSI+  + E      E ++  +T+ +L GL 
Sbjct: 127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLL-EKFGSFPEPVIIMYTKQLLLGLE 185

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVI 526
           YLH+   +HRDIKGAN+LVD  G ++LADFG +K +  L+      S+KG+P WMAPEVI
Sbjct: 186 YLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI 245

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEM 583
                       + + DIWS+GCTVIEM TGKPPWSE     A    + RT   PPIPE 
Sbjct: 246 LQTGH-------SFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPED 298

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           LS E KDFL++C  + P  R SA ELL+HPF+
Sbjct: 299 LSPEAKDFLMKCLHKEPSLRLSATELLQHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1

 Score =  231 bits (589), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 123/265 (46%), Positives = 172/265 (64%), Gaps = 16/265 (6%)

Query: 354  WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
            WQKG+L+GRG+ GSVY G + + G   A KEV ++    ++ E I+Q+E  I +L  L+H
Sbjct: 1626 WQKGQLLGRGSLGSVYEGISAD-GDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQH 1684

Query: 414  ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            +NIV+Y G+   + +LYI+LE V  GS+ +  + +   + +S+V  +TR IL+GL YLH 
Sbjct: 1685 QNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRN--QLGDSVVSLYTRQILDGLKYLHD 1742

Query: 474  TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP--NWMAPEVIKAVMQ 531
               IHR+IK AN+LVDA+G VKLADFG+AK        +SL  +P  NWMAPEVI     
Sbjct: 1743 KGFIHRNIKCANVLVDANGTVKLADFGLAK-------VMSLWRTPYWNWMAPEVILNPKD 1795

Query: 532  KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKD 590
             DG        DIWSLGCTV+EMLTG+ P+S+ E   A++ +   + P IP++LS + +D
Sbjct: 1796 YDG---YGTPADIWSLGCTVLEMLTGQIPYSDLEIGTALYNIGTGKLPKIPDILSLDARD 1852

Query: 591  FLLRCFLRNPVERPSAVELLEHPFI 615
            F+L C   NP ERP+A ELL HPF+
Sbjct: 1853 FILTCLKVNPEERPTAAELLNHPFV 1877

Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

>sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2

 Score =  228 bits (580), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 125/283 (44%), Positives = 179/283 (63%), Gaps = 24/283 (8%)

Query: 345 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 403
           PS SP+  + W+ GKL+G+G FG VY+  + +TG   A+K+V   PD P++++ +  LE 
Sbjct: 346 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALEC 405

Query: 404 EIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 461
           EI++L +L HE IVQYYG   +  +  L I++EY+  GSI   ++ +   +TE++ R +T
Sbjct: 406 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 464

Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSL 514
           R IL G+ YLHS   +HRDIKGAN+L D++G VKL DFG +K L       TG+    S+
Sbjct: 465 RQILEGVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMK---SV 521

Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            G+P WM+PEVI      +G  + A   DIWS+ CTV+EMLT KPPW+EFE   A+FK+ 
Sbjct: 522 TGTPYWMSPEVISG----EGYGRKA---DIWSVACTVVEMLTEKPPWAEFEAMAAIFKIA 574

Query: 575 NR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
            +   P +P  +S   +DFL R F+   + RPSA ELL H F+
Sbjct: 575 TQPTNPKLPPHVSDYTRDFLKRIFVEAKL-RPSADELLRHMFV 616

Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q10407|MKH1_SCHPO MAP kinase kinase kinase mkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mkh1 PE=3 SV=1

 Score =  224 bits (570), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 122/279 (43%), Positives = 162/279 (58%), Gaps = 22/279 (7%)

Query: 353  QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD------DPKSAECIKQLEQEIK 406
            +W KG+LIG GT+G V++  N  TG   A+K+V+I P       D    + +  +  EI 
Sbjct: 824  KWMKGELIGNGTYGKVFLAMNINTGELIAVKQVEI-PQTINGRHDQLRKDIVDSINAEIS 882

Query: 407  VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
            ++  L H NIVQY G E  +  + I+LEYV  GSI R +R +     E +VR  +R +L 
Sbjct: 883  MIADLDHLNIVQYLGFEKTETDISIFLEYVSGGSIGRCLRNYG-PFEEQLVRFVSRQVLY 941

Query: 467  GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELSLKGSPNWMAP 523
            GL+YLHS   IHRD+K  NLL+D  GV K++DFG++KH   +      LS++GS  WMAP
Sbjct: 942  GLSYLHSKGIIHRDLKADNLLIDFDGVCKISDFGISKHSDNVYDNDANLSMQGSIFWMAP 1001

Query: 524  EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV--LNRTPPIP 581
            EVI    Q       +  VD+WSLGC V+EML G+ PWS  E  QAMFK+    + PPIP
Sbjct: 1002 EVIHNDHQ-----GYSAKVDVWSLGCVVLEMLAGRRPWSTDEAIQAMFKLGTEKKAPPIP 1056

Query: 582  EMLSS----EGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
              L S    E   FL  CF  N   RP+A ELL HPF++
Sbjct: 1057 SELVSQVSPEAIQFLNACFTVNADVRPTAEELLNHPFMK 1095

May regulate cell morphology, cell wall integrity, salt resistance, cell cycle reentry from stationary-phase arrest, and filamentous growth in response to stress. Activates the MAP kinase kinase skh1/pek1 by phosphorylation.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	739
255538424	692	conserved hypothetical protein [Ricinus	0.791	0.845	0.576	1e-168
225470467	707	PREDICTED: uncharacterized protein LOC10	0.867	0.906	0.5	1e-162
449470172	709	PREDICTED: uncharacterized protein LOC10	0.840	0.875	0.517	1e-154
225458499	782	PREDICTED: uncharacterized protein LOC10	0.603	0.570	0.623	1e-153
449448516	760	PREDICTED: uncharacterized protein LOC10	0.880	0.856	0.444	1e-144
255562635	709	conserved hypothetical protein [Ricinus	0.596	0.622	0.598	1e-143
449521088	604	PREDICTED: uncharacterized protein LOC10	0.668	0.817	0.531	1e-141
356565641	637	PREDICTED: uncharacterized protein LOC10	0.565	0.656	0.586	1e-140
357465415	700	Mitogen-activated protein kinase kinase	0.732	0.772	0.471	1e-137
356514005	634	PREDICTED: mitogen-activated protein kin	0.437	0.509	0.686	1e-135

>gi|255538424|ref|XP_002510277.1| conserved hypothetical protein [Ricinus communis] gi|223550978|gb|EEF52464.1| conserved hypothetical protein [Ricinus communis]

 Score =  600 bits (1546), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 360/625 (57%), Positives = 425/625 (68%), Gaps = 40/625 (6%)

Query: 21  NNRKLTRVRKLRHVPDDELGLLMT-DRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLP 79
           N ++LTR RK+RH    +LGL  + DR  SP ASPDSAR   SP  S   SS A+P+PLP
Sbjct: 21  NTKRLTRQRKIRHETQQDLGLQFSQDRLNSPPASPDSARKPRSPPCSSSSSSPALPQPLP 80

Query: 80  LPDLASLFRKPES----SGHGF-ESPEGRP----HRGSTNQ----TAKGSAGFLSHFHKG 126
           LP+ +   R+ E      GH    SPE RP     R S +Q    +A GS+ F   F   
Sbjct: 81  LPE-SHFTRRLEPFGFIPGHAVPASPEERPIYLLRRNSADQVDINSATGSSNFQWRFSPQ 139

Query: 127 DSQVLNIESVKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNP----KSISTRR 182
           D    N+++  + LR ++  RS P    SS  VSP+RSN    +   N     K   T  
Sbjct: 140 DP---NVDTANHGLRLNIAPRSAP----SSPLVSPRRSNAGEFSTTFNAADSTKCSKTCC 192

Query: 183 RGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 242
           +G  +DLNIEC NY       P+SAPTS FSSP VSPQ S T +   SF A         
Sbjct: 193 KGQLNDLNIECVNYKLSWIDSPRSAPTSGFSSPNVSPQRSYTIDFLPSFVA--------- 243

Query: 243 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQ 302
            EVPDLGR  G TS  S  K      D S +  P +QS   N + P K  F L +K    
Sbjct: 244 REVPDLGRHAGHTSRKSLVKTG-NGLDRSAI-YPSQQSPTPNKKPPHKFSFQLHNKMFVG 301

Query: 303 NSKELLESNNHLNAHPLPLPPGALSPPKSSVTS--AVMPHIMEKPSASPKKSQWQKGKLI 360
            SKE  E+N+  +AHPLPLPPGA SP +S + S  A++ H +EKP+ S +K+QW KGKLI
Sbjct: 302 KSKEWPETNSQFSAHPLPLPPGAASP-QSFIPSPPAILHHTIEKPNVSLRKTQWLKGKLI 360

Query: 361 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 420
           GRGT+GSVY+GTNRETGA CA+KEVDIIP D KS ECIKQLEQEI++L HL+H NIVQYY
Sbjct: 361 GRGTYGSVYVGTNRETGALCAMKEVDIIPGDSKSVECIKQLEQEIRLLQHLEHPNIVQYY 420

Query: 421 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 480
             E+VDDH YIYLEYV+PGSI++YVREHC  +TESIVRNFTRHIL+GLAYLHS  TIHRD
Sbjct: 421 SCEIVDDHFYIYLEYVYPGSISKYVREHCGAMTESIVRNFTRHILSGLAYLHSKKTIHRD 480

Query: 481 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 540
           IKGANLLV++SG+VKLADFGMAKHL+GLSYELSLKGSP+WMAPEVI+AVMQ + NP LAL
Sbjct: 481 IKGANLLVNSSGIVKLADFGMAKHLSGLSYELSLKGSPHWMAPEVIQAVMQNNANPDLAL 540

Query: 541 AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNP 600
           AVDIWSLGCT+IEM TGKPPW E EGPQAMFK LN+TPPIPE +S E KDFL  C  RNP
Sbjct: 541 AVDIWSLGCTIIEMFTGKPPWGELEGPQAMFKALNKTPPIPEAMSPEAKDFLCCCLRRNP 600

Query: 601 VERPSAVELLEHPFIRNANYQNLSV 625
            ERPSA  LLEHPF+RN++  NLS 
Sbjct: 601 AERPSASMLLEHPFLRNSSELNLST 625

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225470467|ref|XP_002263088.1| PREDICTED: uncharacterized protein LOC100245919 [Vitis vinifera] gi|296084711|emb|CBI25853.3| unnamed protein product [Vitis vinifera]

 Score =  578 bits (1491), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 344/688 (50%), Positives = 428/688 (62%), Gaps = 47/688 (6%)

Query: 25  LTRVRKLRHVPDDELGLLMTDRACS-PSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDL 83
           LTR RKLRHV  + +  L+  R+ + P         S S   S    SS VP PLP P+L
Sbjct: 25  LTRARKLRHVRGNHIDALVRSRSSAEPKDLLPLPSSSSSFDHSSERLSSVVPHPLPRPEL 84

Query: 84  ASLFRKPESSGHGF--ESPEGRPHRGSTNQTAKGSAGFLSHFHKGDSQVLNIESVKNDLR 141
           A LFR+   S      + P   P  G        S GF     KG+S V        D  
Sbjct: 85  ALLFRRNGGSNSNLNCDRPLPSPKEGL-------SRGFEDR-DKGNSFV-------GDGN 129

Query: 142 PSVPVRSTPTSLSSSHAVSPQRSNLQNPTPL------HNPKSISTRRRGFSHDLNIECAN 195
             V V ST T   S    +  R +++    L          S+   R  F          
Sbjct: 130 GEVAVSSTATG--SKVGYNEARKSMEQFDTLSSRYLPQGQNSVKNNRVNF---------- 177

Query: 196 YSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVF-SSFWAPKEIQDWSTAEVPDLGRFVGC 254
              + D+  +SAPTS  SSPAVSPQ +  GN+F S   +P+  Q WS  E+P      G 
Sbjct: 178 ---KLDVPTRSAPTSSLSSPAVSPQRTSPGNLFLSQNVSPQVFQGWSAPEMPVFDMVTGF 234

Query: 255 TSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHL 314
           T  +SP ++ ++S D+SPL SP  +S   N RSP     PL  K   + S    E+N+H 
Sbjct: 235 TPQMSP-EQTMFSTDNSPLHSPTVKSPHVNPRSPSGPASPLHPKISLETSTARRENNSHA 293

Query: 315 NAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR 374
           N H LPLPPG ++PP++S   ++ P ++ K  + P  +QWQKGKLIGRGTFGSVY+ TNR
Sbjct: 294 NVHRLPLPPGVVAPPQAS---SIHP-VIAKTESFPMTTQWQKGKLIGRGTFGSVYVATNR 349

Query: 375 ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 434
           ETGA CA+KEV+++PDDPKSAE IKQLEQEIK+L  LKH NIVQY+GSE V+D LYIYLE
Sbjct: 350 ETGALCAMKEVELLPDDPKSAESIKQLEQEIKILSQLKHPNIVQYFGSETVEDRLYIYLE 409

Query: 435 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 494
           YVHPGSIN+YVREHC  ITES+VRNFTRHIL+GLAYLHST TIHRDIKGANLLVDASGVV
Sbjct: 410 YVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSTKTIHRDIKGANLLVDASGVV 469

Query: 495 KLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           KLADFGM+KHLTG + +LSLKGSP WMAPE+++AVMQKD +  LA AVDIWSLGCT+IEM
Sbjct: 470 KLADFGMSKHLTGAAADLSLKGSPYWMAPELMQAVMQKDHSSDLAFAVDIWSLGCTIIEM 529

Query: 555 LTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
           L GKPPWSE+EG  AMFKV+  +PPIP+ LSSEGKDFL  CF RNP ERP A++LLEH F
Sbjct: 530 LNGKPPWSEYEGAAAMFKVMRESPPIPKTLSSEGKDFLRCCFRRNPAERPPAIKLLEHRF 589

Query: 615 IRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEVCP 674
           ++N+   ++ +  + FS + L DK++   E++  + + +P SP  R +  K    S    
Sbjct: 590 LKNSTQLDVPLLTQAFSGMKLPDKANKSREKSNDRVDPVPISP--RKKTSKGKKASGTGQ 647

Query: 675 QCHAGTFNCATASRHSSCSTFGVHISLS 702
           Q H  T +   AS HS  ST     SLS
Sbjct: 648 QSHRETSDLTVASHHSPRSTLEALPSLS 675

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449470172|ref|XP_004152792.1| PREDICTED: uncharacterized protein LOC101219854 [Cucumis sativus]

 Score =  552 bits (1423), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 347/670 (51%), Positives = 426/670 (63%), Gaps = 49/670 (7%)

Query: 20  FNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSP----GTSDHWSSSAVP 75
           F  R+LTR RKLRH+ D ++G         P + PDS  +S  P    G S+ WSSS  P
Sbjct: 38  FIQRRLTRQRKLRHLTDQDVGFEH------PRSLPDSPDISAKPKSPLGGSERWSSSPSP 91

Query: 76  KPLPLPDLASLFRKPESSGHGFESPEGRPHRGSTNQTAKGSAGFLS----HFHKGDSQVL 131
           +PLPLP+L  + R PE   +  +   G P   S  + +  +   +S    H  +  +  L
Sbjct: 92  QPLPLPELFPV-RSPEFGSNYGQGRVGSPVETSVRKCSDHATTNVSRSFGHNQRRVATDL 150

Query: 132 NIESVKNDLRPSVPVRSTPTSLSS-SHAVSPQRSNL---QNPTPLHNPKSISTRRRGFSH 187
            +E V  + R      ++P SLS+ S  ++P +  L    + TP       + + RG   
Sbjct: 151 TLEVVDGNSRTGATAFTSPQSLSANSGKLNPNKEFLFGCSDQTP-------NNKGRGSPT 203

Query: 188 DLNIECANYSSRADIIPK-----SAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 242
             + E  NY    ++ PK     SAPTS+  SP VSP+ S  GN F    +  E Q+  +
Sbjct: 204 HPSAERGNY----NLTPKKSSSKSAPTSILPSPVVSPRKSYNGNHFVPGLSHHEHQESPS 259

Query: 243 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQ 302
                        SP  P  +   S+   PL SP  +SS SN RS   + FPL  K    
Sbjct: 260 N-----------NSPKVPPLKTALSSQPFPLHSPTARSSISNSRSHNDMTFPLHTKLQKD 308

Query: 303 NSKELLESNNHLNAHPLPLPPGALSPPKSSVTS--AVMPHIMEKPSASPKKSQWQKGKLI 360
           NS +  ES+ H+NAHPLPLPP  ++  ++S  S  + + H++EKP  S  K QWQKGKLI
Sbjct: 309 NSIDRSESHAHVNAHPLPLPPPLVASSQASAQSLPSNVHHVIEKPFISSMKGQWQKGKLI 368

Query: 361 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 420
           GRGTFGSVY+ TNRETGA CA+KEVD+IPDDPKSAECIKQLEQEI+VL HLKH NIVQYY
Sbjct: 369 GRGTFGSVYLATNRETGALCAMKEVDLIPDDPKSAECIKQLEQEIEVLSHLKHPNIVQYY 428

Query: 421 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 480
           GSE++ D  YIYLEYV+PGSIN+YVRE C  ITESIVRNFTRHIL+GLAYLHST TIHRD
Sbjct: 429 GSEIIGDCFYIYLEYVYPGSINKYVRERCGAITESIVRNFTRHILSGLAYLHSTKTIHRD 488

Query: 481 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 540
           IKGANLLVD+SGVVKLADFGMAKHLTG  Y+LSLKGSP WMAPEVIKA M KD NP LAL
Sbjct: 489 IKGANLLVDSSGVVKLADFGMAKHLTG-QYDLSLKGSPYWMAPEVIKAAMLKDANPDLAL 547

Query: 541 AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNP 600
           AVDIWSLGCT+IEML GKPPW EFEG Q MFKVLN+TPPIPE LS EGKDFL  CF RNP
Sbjct: 548 AVDIWSLGCTIIEMLNGKPPWCEFEGHQVMFKVLNKTPPIPEKLSPEGKDFLQCCFQRNP 607

Query: 601 VERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETR 660
            +RP+A+ LL+HPF+R+++  N S+P   FS +NL +K     +    K +   +S  T 
Sbjct: 608 ADRPTAMVLLDHPFLRSSSDSNASIPTSAFSTMNLLEKLLSPKDPLNPKGDQAQNSSGTL 667

Query: 661 VRNRKLPCNS 670
             N  L C S
Sbjct: 668 TSNDYLSCRS 677

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225458499|ref|XP_002282240.1| PREDICTED: uncharacterized protein LOC100257467 [Vitis vinifera]

 Score =  550 bits (1417), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 290/465 (62%), Positives = 342/465 (73%), Gaps = 19/465 (4%)

Query: 183 RGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 242
           RGFS DLN E   Y+ R +I  +SAPTS FSSPA+SPQ    G    S +A   IQD+ +
Sbjct: 228 RGFSQDLNDEACPYNLRVNIPARSAPTSGFSSPALSPQRFSPGERLPSSYA--AIQDFQS 285

Query: 243 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNL----RSPRKVYFPLRHK 298
              P   R  GC+S +SP K   ++ D+SPL SP  QS   +     +SP  + F L  K
Sbjct: 286 ---PGFDRLPGCSSQMSPLK-TPHTPDYSPLHSPTVQSPCISPCLSPKSPTGIAFSLYPK 341

Query: 299 SLPQNSKELLESNNHLNAHPLPLPPGALSP-----PKSSVT---SAVMPHIMEKPSASPK 350
            LP +     E N H+  HPLPLPP AL P     P  ++T   SA+  H  EKP+    
Sbjct: 342 LLPGSHVTWPEKNGHVTVHPLPLPPIALMPSELPLPPKALTPSESAISHHTAEKPNVPSM 401

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           KSQWQKGKLIGRGTFGSVY+ TNRETGA CA+KEVDIIPDDPKS+ECIKQLEQEIKVL H
Sbjct: 402 KSQWQKGKLIGRGTFGSVYVATNRETGALCAMKEVDIIPDDPKSSECIKQLEQEIKVLHH 461

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           LKH NIVQYYGSE+VDDH YIYLEYVHPGSIN+YV +H   +TE++VRNFTRHIL+GLAY
Sbjct: 462 LKHPNIVQYYGSEIVDDHFYIYLEYVHPGSINKYV-DHFGAMTENVVRNFTRHILSGLAY 520

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
           LHST TIHRDIKGANLLVD+ GVVKLADFG+AK LTG + +LSLKGSP+WMAPEV++AV+
Sbjct: 521 LHSTKTIHRDIKGANLLVDSFGVVKLADFGLAKFLTGQACDLSLKGSPHWMAPEVMQAVL 580

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
           +KD NP LA AVDIWSLGCT+IEML G+PPWSEF  P AMFKVL+ +PP+PE LSSEGKD
Sbjct: 581 RKDANPDLAFAVDIWSLGCTIIEMLNGRPPWSEFAAPAAMFKVLHESPPLPETLSSEGKD 640

Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINL 635
           FL  CF RNP ERPSA  LL+H F+R++  QN+S   + FS + L
Sbjct: 641 FLQHCFRRNPAERPSAAMLLDHSFVRSSQDQNVSGFSQAFSGMQL 685

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449448516|ref|XP_004142012.1| PREDICTED: uncharacterized protein LOC101219486 [Cucumis sativus]

 Score =  519 bits (1336), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 323/726 (44%), Positives = 423/726 (58%), Gaps = 75/726 (10%)

Query: 5   GKAGNFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSPG 64
           G A N ++  V    F   + +R RKLR++   E   + +  A     +P+   +S SP 
Sbjct: 36  GSAENNYRGIVWR--FGASRYSRHRKLRNLSGREH--VDSSLAKWSDTAPEPVSLSRSPS 91

Query: 65  TSDHWSSSAVPKPLPLPDLASLFRKPE------SSGHGFESPEGRPHRGSTNQTAKGSAG 118
           TSDH    AVP  LPLP+++ LF+  E      S+G   + P   P         KGS G
Sbjct: 92  TSDH---PAVP--LPLPEVSPLFQPRERISTSNSAGGEGDCPLPSP---------KGSRG 137

Query: 119 FLSHFHKGDSQVLNI------ESVKNDLRPSVPVRSTPTSLSSSHA----VSPQRSNLQN 168
                  GD + ++       + +   + P+  ++S   S+   H     +  + S   N
Sbjct: 138 -----RAGDERDVDRDRNAPPQKIGGGISPNASIKSVSDSVGERHKKEGQIEARLSGRAN 192

Query: 169 PTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVF 228
                 P++    R GF               D+  +SAPTS ++SP  SPQ + +GN+ 
Sbjct: 193 QDARRYPEN---SRNGF-------------WIDVPSRSAPTSPYTSPTPSPQRNISGNIS 236

Query: 229 S-SFWAPKEIQDWSTAEVPD-------LGRFVGCTS--PVSPFKRNV---------YSAD 269
           +  + +P   Q WS  E+P+       +G  V      P S   R V          S +
Sbjct: 237 NFHYMSPVGNQGWSAPELPNFPCVAAPVGNHVWSAPELPSSAMMRGVPPAFFDCSTLSTE 296

Query: 270 HSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPP 329
            SP+ SP  +S   + RSP     PL  K   +      E + H++ HPLPLPPG   P 
Sbjct: 297 SSPMHSPRGKSPHLDPRSPTGPTSPLHAKISHETHAMRREGSGHVSVHPLPLPPGVPMPS 356

Query: 330 KSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 389
            SS ++ +     +  S S  K+QWQKGKLIGRGTFGSVY+ +NR+ GA CA+KEV++  
Sbjct: 357 ASSPSTPISQANTKSESIS-MKNQWQKGKLIGRGTFGSVYVASNRQNGALCAMKEVELFH 415

Query: 390 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 449
           DDPKSAE IKQLEQEIK+L  LKH NIVQYYGS+++DD LYIYLEYVHPGSIN+YVREHC
Sbjct: 416 DDPKSAESIKQLEQEIKLLSQLKHPNIVQYYGSDIIDDRLYIYLEYVHPGSINKYVREHC 475

Query: 450 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
             +TES+VRNFTRHIL+GLAYLHST TIHRDIKGANLLVD+ GVVKLADFGMAKHLTG  
Sbjct: 476 GAMTESVVRNFTRHILSGLAYLHSTKTIHRDIKGANLLVDSCGVVKLADFGMAKHLTGQV 535

Query: 510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA 569
            +LSLKGSP WMAPE++ +VMQKD  P LALAVDIWSLGCT+IEM TGKPPWSE+EG  A
Sbjct: 536 ADLSLKGSPYWMAPELLLSVMQKDNTPDLALAVDIWSLGCTIIEMFTGKPPWSEYEGAAA 595

Query: 570 MFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRV 629
           MFKV+  TPP+PE LS E +DFL  CF RNP ERP+A  LLEHPF++N  Y + S   +V
Sbjct: 596 MFKVMKDTPPMPESLSYEARDFLKCCFQRNPAERPTAAMLLEHPFMKNLQYTDASSCSQV 655

Query: 630 FSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEVCPQCHAGTFNCATASRH 689
            +  +L DK +   ++ + K++     P  +    KL  ++ + P  H  T +    SR+
Sbjct: 656 VAGASLMDKCYSPSKQYSSKSDQSSMLPSPQNSKGKLAADNVIGPLSHHETSDLTVMSRY 715

Query: 690 SSCSTF 695
           S  ST 
Sbjct: 716 SPRSTL 721

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255562635|ref|XP_002522323.1| conserved hypothetical protein [Ricinus communis] gi|223538401|gb|EEF40007.1| conserved hypothetical protein [Ricinus communis]

 Score =  515 bits (1326), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 273/456 (59%), Positives = 324/456 (71%), Gaps = 15/456 (3%)

Query: 188 DLNIE-CANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWA--PKEIQDWSTAE 244
           D +++ CA+YS R +   +SAPTS FSSP    Q   T   F  ++    K  Q WS  E
Sbjct: 216 DFSVDHCADYS-RINAPIRSAPTSPFSSP----QKLTTAADFLPYYQMIAKGNQVWSAPE 270

Query: 245 VPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNS 304
           +  L   +    P + F    +S D SPL SPP +S + N +SP      L  +   + S
Sbjct: 271 MATLD--IPGLPPPAFFDYTAFSTDTSPLHSPPSRSPRRNPKSPTGGPASLNARLSIETS 328

Query: 305 KELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGT 364
           +E    N +L  HPLPLPPGA S       S+ +P ++ K  + P KSQWQKGKLIGRGT
Sbjct: 329 REC---NANLEVHPLPLPPGASS--SRPSISSSVPQVISKAESIPLKSQWQKGKLIGRGT 383

Query: 365 FGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 424
           FGSVY+ +NRETGA CA+KEVD+ PDDPKSAE IKQLEQEIKVL HLKH NIVQYYGSE+
Sbjct: 384 FGSVYVASNRETGALCAMKEVDMFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI 443

Query: 425 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 484
           V DH YIYLEYVHPGSIN+YVREHC  ITE++VR+F+RHIL+GLAYLHS  TIHRDIKGA
Sbjct: 444 VGDHFYIYLEYVHPGSINKYVREHCGAITENVVRSFSRHILSGLAYLHSMKTIHRDIKGA 503

Query: 485 NLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 544
           NLLVDASGVVKLADFGM+KHLTG + ELSLKGSP WMAPE+++AVMQKD +  LALAVDI
Sbjct: 504 NLLVDASGVVKLADFGMSKHLTGQAAELSLKGSPYWMAPELMQAVMQKDTSSDLALAVDI 563

Query: 545 WSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERP 604
           WSLGCT+IEM TGKPPWS++EG  AMFKVL   PPIPE LS EGKDFL  CF RNP +RP
Sbjct: 564 WSLGCTIIEMFTGKPPWSDYEGAAAMFKVLRDIPPIPETLSPEGKDFLHCCFQRNPADRP 623

Query: 605 SAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSH 640
           SA  LLEH ++RN+   +     R  + I L D +H
Sbjct: 624 SASMLLEHRWLRNSQQLDFPSSTRSINGIKLMDLTH 659

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449521088|ref|XP_004167563.1| PREDICTED: uncharacterized protein LOC101228290 [Cucumis sativus]

 Score =  510 bits (1313), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 273/514 (53%), Positives = 342/514 (66%), Gaps = 20/514 (3%)

Query: 201 DIIPKSAPTSVFSSPAVSPQSSKTGNVFS-SFWAPKEIQDWSTAEVPD-------LGRFV 252
           D+  +SAPTS ++SP  SPQ + +GN+ +  + +P   Q WS  E+P+       +G  V
Sbjct: 53  DVPSRSAPTSPYTSPTPSPQRNISGNISNFHYMSPVGNQGWSAPELPNFPCVAAPVGNHV 112

Query: 253 GCTS--PVSPFKRNV---------YSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLP 301
                 P S   R V          S + SP+ SP  +S   + RSP     PL  K   
Sbjct: 113 WSAPELPSSAMMRGVPPAFFDCSTLSTESSPMHSPRGKSPHLDPRSPTGPTSPLHAKISH 172

Query: 302 QNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIG 361
           +      E + H++ HPLPLPPG   P  SS ++ +     +  S S  K+QWQKGKLIG
Sbjct: 173 ETHAMRREGSGHVSVHPLPLPPGVPMPSASSPSTPISQANTKSESIS-MKNQWQKGKLIG 231

Query: 362 RGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG 421
           RGTFGSVY+ +NR+ GA CA+KEV++  DDPKSAE IKQLEQEIK+L  LKH NIVQYYG
Sbjct: 232 RGTFGSVYVASNRQNGALCAMKEVELFHDDPKSAESIKQLEQEIKLLSQLKHPNIVQYYG 291

Query: 422 SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 481
           S+++DD LYIYLEYVHPGSIN+YVREHC  +TES+VRNFTRHIL+GLAYLHST TIHRDI
Sbjct: 292 SDIIDDRLYIYLEYVHPGSINKYVREHCGAMTESVVRNFTRHILSGLAYLHSTKTIHRDI 351

Query: 482 KGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 541
           KGANLLVD+ GVVKLADFGMAKHLTG   +LSLKGSP WMAPE++ +VMQKD  P LALA
Sbjct: 352 KGANLLVDSCGVVKLADFGMAKHLTGQVADLSLKGSPYWMAPELLLSVMQKDNTPDLALA 411

Query: 542 VDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPV 601
           VDIWSLGCT+IEM TGKPPWSE+EG  AMFKV+  TPP+PE LS E +DFL  CF RNP 
Sbjct: 412 VDIWSLGCTIIEMFTGKPPWSEYEGAAAMFKVMKDTPPMPESLSYEARDFLKCCFQRNPA 471

Query: 602 ERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRV 661
           ERP+A  LLEHPF++N  Y + S   +V +  +L DK +   ++ + K++     P  + 
Sbjct: 472 ERPTAAMLLEHPFMKNLQYTDASSCSQVVAGASLMDKCYSPSKQYSSKSDQSSMLPSPQN 531

Query: 662 RNRKLPCNSEVCPQCHAGTFNCATASRHSSCSTF 695
              KL  ++ + P  H  T +    SR+S  ST 
Sbjct: 532 SKGKLAADNVIGPLSHHETSDLTVMSRYSPRSTL 565

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356565641|ref|XP_003551047.1| PREDICTED: uncharacterized protein LOC100790701 [Glycine max]

 Score =  505 bits (1301), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 261/445 (58%), Positives = 317/445 (71%), Gaps = 27/445 (6%)

Query: 210 SVFSSPAVSPQSSKTGNVFSSFWA-PKEIQDWSTAEVP--DLGRFVGCTSPVSPFKRNVY 266
           S+  SP++SPQ ++ G+    ++A PK  Q WST E+P  D G       P + F  +  
Sbjct: 161 SISGSPSMSPQKTRNGDFVPYYYACPKGNQFWSTPEMPTCDAGLL-----PPAFFDLSAL 215

Query: 267 SADHSPLP----SPPRQSSQSNLRS---PRKVYFPLRHKSLPQNSKELLESNNH--LNAH 317
           S + S  P    SP R+S Q + R+   P     P+    +P    E    NN   +  H
Sbjct: 216 STETSLSPNSHQSPQRKSPQKHTRTFSGPPSPIHPMLSLEIPTVRHE----NNAPPVAVH 271

Query: 318 PLPLPP--GALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRE 375
           PLPLPP  G  SPP     +A   H M K  + P KSQW+KGKLIGRGTFGSVY+ TNRE
Sbjct: 272 PLPLPPRAGLTSPP----AAATFSHAMVKSESLPMKSQWKKGKLIGRGTFGSVYVATNRE 327

Query: 376 TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 435
           TGA CA+KEV++ PDDPKSAECIKQLEQEIKVL +LKH NIVQYYGSE+V+D  YIYLEY
Sbjct: 328 TGALCAMKEVELFPDDPKSAECIKQLEQEIKVLSNLKHSNIVQYYGSEIVEDRFYIYLEY 387

Query: 436 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 495
           VHPGSIN+YVR+HC  ITES++RNFTRHIL+GLAYLHS  TIHRDIKGANLLVD++GVVK
Sbjct: 388 VHPGSINKYVRDHCGAITESVIRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDSAGVVK 447

Query: 496 LADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 555
           LADFGMAKHLTG    LSL+GSP WMAPE+++AV+QKD +P LA A+DIWSLGCT+IEM 
Sbjct: 448 LADFGMAKHLTGFEANLSLRGSPYWMAPELLQAVIQKDNSPDLAFAIDIWSLGCTIIEMF 507

Query: 556 TGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           TGKPPWSE+EG  A+FKV+  TPPIPE LSSEGKDFL  CF RNP ERP+A  LLEH F+
Sbjct: 508 TGKPPWSEYEGAAALFKVMKETPPIPETLSSEGKDFLRCCFKRNPAERPTAAVLLEHRFL 567

Query: 616 RNANYQNLSVPMRVFSRINLGDKSH 640
           +N+   +   P ++++  +  DK H
Sbjct: 568 KNSQQPDAISPTQLYNGTSFMDKPH 592

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357465415|ref|XP_003602992.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355492040|gb|AES73243.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula]

 Score =  494 bits (1273), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 293/621 (47%), Positives = 377/621 (60%), Gaps = 80/621 (12%)

Query: 20  FNNRKLTRVRKLRHVPDDELG--LLMTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKP 77
              R+LTR ++L +  D ++G     TD A S S        SP   +SDHWS+SAVP+P
Sbjct: 23  IQQRRLTRQKRLCYPNDQDVGESFHSTDVAVSFSLP-----TSPYRTSSDHWSTSAVPQP 77

Query: 78  LPLPDLASLFRKPESSGHGFESPEGRPHRG-STNQTAKGSAGFLSHFHKGDSQVLNIESV 136
           LPLP+     R+P+   H    P  R      T ++ + S+    HF    +      + 
Sbjct: 78  LPLPESPLTTRRPDH--HAAALPFSRKSADHDTVRSLRSSSNLGRHFFNTVTG-----NA 130

Query: 137 KNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNPKSISTRRRGFSHDLNIECANY 196
           K+DLR ++P               P R        L +  S     R  SHD + E  + 
Sbjct: 131 KSDLRVNIP---------------PTRG-------LVSSNSSCKDTRKHSHDNDCEGIS- 167

Query: 197 SSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFS-SFWAPKEIQDW------STAEVPDLG 249
           +S+     KSAP S+FSSP  SP+   + ++   S   P++  D        TA  PDL 
Sbjct: 168 NSKLQFAAKSAPNSIFSSPVTSPRRLSSVDLLDPSIILPQDFNDMFRVLPAKTAHSPDLS 227

Query: 250 --RFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKEL 307
             R  G  SP +  +  +               SQ + +   +V+               
Sbjct: 228 PRRSFGNHSPANHHRHTIQGG------------SQQHSKFCTRVW--------------- 260

Query: 308 LESNNHLNAHPLPLPPGALSPPKSS---VTSAVMPHIMEKPSASPKKSQWQKGKLIGRGT 364
              NNHL+AHPLPLPP A   P+ S    +S  M H  E   +   K  WQKGKLIGRG+
Sbjct: 261 -PENNHLDAHPLPLPPRASPQPQQSPAHQSSVTMNHSTENIHS--MKGHWQKGKLIGRGS 317

Query: 365 FGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 424
           FGSVY  TN ETGASCA+KEVD++PDDPKS +CIKQL+QEI++LG L H NIV+YYGSEV
Sbjct: 318 FGSVYHATNLETGASCALKEVDLVPDDPKSTDCIKQLDQEIRILGQLHHPNIVEYYGSEV 377

Query: 425 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 484
           V D L IY+EYVHPGS+ +++++HC  +TES+VRNFTRHIL+GLAYLHST TIHRDIKGA
Sbjct: 378 VGDRLCIYMEYVHPGSLQKFMQDHCGVMTESVVRNFTRHILSGLAYLHSTKTIHRDIKGA 437

Query: 485 NLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 544
           NLLVDASG+VKLADFG++K LT  SYELSLKGSP WMAPE++ A M+ + NP +A+AVDI
Sbjct: 438 NLLVDASGIVKLADFGVSKILTEKSYELSLKGSPYWMAPELMMAAMKNETNPTVAMAVDI 497

Query: 545 WSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERP 604
           WSLGCT+IEMLTGKPPWSEF G QAMFKVL+R+P IP+ LS EG+DFL +CF RNP +RP
Sbjct: 498 WSLGCTIIEMLTGKPPWSEFPGHQAMFKVLHRSPDIPKTLSPEGQDFLEQCFQRNPADRP 557

Query: 605 SAVELLEHPFIRNANYQNLSV 625
           SA  LL HPF++N + Q++ V
Sbjct: 558 SAAVLLTHPFVQNLHEQDVIV 578

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356514005|ref|XP_003525698.1| PREDICTED: mitogen-activated protein kinase kinase kinase 3-like [Glycine max]

 Score =  489 bits (1259), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 226/329 (68%), Positives = 266/329 (80%), Gaps = 6/329 (1%)

Query: 314 LNAHPLPLPPGA--LSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIG 371
           +  HPLPLPPGA   SPP     +A   H + K  + P KSQW+KGKLIGRGTFGSVY+ 
Sbjct: 265 VGVHPLPLPPGAALTSPP----AAATFSHAVAKSESFPMKSQWKKGKLIGRGTFGSVYVA 320

Query: 372 TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 431
           TNRETGA CA+KEV++ PDDPKSAECIKQLEQEIKVL +LKH NIVQYYGSE+V+D  YI
Sbjct: 321 TNRETGALCAMKEVELFPDDPKSAECIKQLEQEIKVLSNLKHSNIVQYYGSEIVEDRFYI 380

Query: 432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 491
           YLEYVHPGSIN+YVREHC  ITES++RNFTRHIL+GLAYLHS  TIHRDIKGANLLVD++
Sbjct: 381 YLEYVHPGSINKYVREHCGAITESVIRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDSA 440

Query: 492 GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 551
           GVVKLADFGMAKHLTG    LSL+GSP WMAPE+++AV+QKD +P LA A+DIWSLGCT+
Sbjct: 441 GVVKLADFGMAKHLTGFEANLSLRGSPYWMAPELLQAVIQKDNSPDLAFAIDIWSLGCTI 500

Query: 552 IEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
           IEM TGKPPWSE+EG  A+FKV+  TPPIPE LSSEGKDFL  CF RNP ERP+A  LLE
Sbjct: 501 IEMFTGKPPWSEYEGAAALFKVMKETPPIPETLSSEGKDFLRCCFKRNPAERPTAAVLLE 560

Query: 612 HPFIRNANYQNLSVPMRVFSRINLGDKSH 640
           H F++N+   ++    ++++  +  DK H
Sbjct: 561 HRFLKNSQLLDVLSSTQLYNETSFMDKPH 589

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	739
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.435	0.449	0.655	3.3e-130
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.378	0.317	0.575	1.9e-91
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.362	0.440	0.571	1.2e-85
TAIR|locus:2133559	608	MEKK1 "MAPK/ERK kinase kinase	0.346	0.421	0.505	2e-63
TAIR|locus:2133529	560	MEKK3 "MAPK/ERK kinase kinase	0.349	0.460	0.464	6.9e-63
ZFIN|ZDB-GENE-120215-96	623	si:dkey-32h20.5 "si:dkey-32h20	0.369	0.438	0.423	7.7e-62
DICTYBASE|DDB_G0283265	1267	mkkA "octicosapeptide/Phox/Bem	0.358	0.209	0.432	6.2e-60
UNIPROTKB|F1MH06	626	MAP3K3 "Uncharacterized protei	0.353	0.416	0.440	2e-59
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.392	0.435	0.448	9.3e-59
UNIPROTKB|E2RN16	620	MAP3K2 "Uncharacterized protei	0.354	0.422	0.442	1.1e-58

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1130 (402.8 bits), Expect = 3.3e-130, Sum P(2) = 3.3e-130
 Identities = 215/328 (65%), Positives = 259/328 (78%)

Query:   331 SSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 390
             SS  S   P    K  + P  SQW+KGKLIGRGTFGSVY+ +N ETGA CA+KEV++ PD
Sbjct:   323 SSAASVPSPQAPLKLDSFPMNSQWKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPD 382

Query:   391 DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR 450
             DPKSAECIKQLEQEIK+L +L+H NIVQY+GSE V+D  +IYLEYVHPGSIN+Y+R+HC 
Sbjct:   383 DPKSAECIKQLEQEIKLLSNLQHPNIVQYFGSETVEDRFFIYLEYVHPGSINKYIRDHCG 442

Query:   451 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 510
              +TES+VRNFTRHIL+GLAYLH+  T+HRDIKGANLLVDASGVVKLADFGMAKHLTG   
Sbjct:   443 TMTESVVRNFTRHILSGLAYLHNKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQRA 502

Query:   511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM 570
             +LSLKGSP WMAPE+++AVMQKD NP LA AVDIWSLGCT+IEM TGKPPWSEFEG  AM
Sbjct:   503 DLSLKGSPYWMAPELMQAVMQKDSNPDLAFAVDIWSLGCTIIEMFTGKPPWSEFEGAAAM 562

Query:   571 FKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA----NYQNLSVP 626
             FKV+  +PPIPE +S EGKDFL  CF RNP ERP+A  LLEH F++N+    +  N  V 
Sbjct:   563 FKVMRDSPPIPESMSPEGKDFLRLCFQRNPAERPTASMLLEHRFLKNSLQPTSPSNSDVS 622

Query:   627 MRVFSRINLGDKSHDQVERATRKTESLP 654
              ++F+ +N+ + S  + E+   K + +P
Sbjct:   623 -QLFNGMNITEPSSRR-EKPNFKLDQVP 648

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 844 (302.2 bits), Expect = 1.9e-91, Sum P(2) = 1.9e-91
 Identities = 167/290 (57%), Positives = 211/290 (72%)

Query:   331 SSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 389
             S+ TS  +P    +  A+    S+W+KG+L+G G+FG VY+G N E+G  CA+KEV +  
Sbjct:   376 SAATSPSVPRSPARAEATVSPGSRWKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCS 435

Query:   390 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 449
             DDPKS E  +QL QEI VL  L+H+NIVQYYGSE VDD LYIYLEYV  GSI + ++E+ 
Sbjct:   436 DDPKSRESAQQLGQEISVLSRLRHQNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYG 495

Query:   450 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
             +   E+ +RN+T+ IL+GLAYLH+ NT+HRDIKGAN+LVD  G VK+ADFGMAKH+T  S
Sbjct:   496 Q-FGENAIRNYTQQILSGLAYLHAKNTVHRDIKGANILVDPHGRVKVADFGMAKHITAQS 554

Query:   510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA 569
               LS KGSP WMAPEVIK     +G+    LAVDIWSLGCTV+EM T KPPWS++EG  A
Sbjct:   555 GPLSFKGSPYWMAPEVIK---NSNGSN---LAVDIWSLGCTVLEMATTKPPWSQYEGVPA 608

Query:   570 MFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
             MFK+ N    P IP+ LS EGKDF+ +C  RNP  RP+A +LL+H F+RN
Sbjct:   609 MFKIGNSKELPDIPDHLSEEGKDFVRKCLQRNPANRPTAAQLLDHAFVRN 658

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 817 (292.7 bits), Expect = 1.2e-85, Sum P(2) = 1.2e-85
 Identities = 159/278 (57%), Positives = 201/278 (72%)

Query:   352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
             S W+KGK +G GTFG VY+G N E G  CAIKEV +I DD  S EC+KQL QEI +L  L
Sbjct:   212 STWKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQL 271

Query:   412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
              H NIVQYYGSE+ ++ L +YLEYV  GSI++ ++++    TE +++N+TR IL GLAYL
Sbjct:   272 CHPNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDY-GSFTEPVIQNYTRQILAGLAYL 330

Query:   472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
             H  NT+HRDIKGAN+LVD +G +KLADFGMAKH+T  S  LS KGSP WMAPEV   VM 
Sbjct:   331 HGRNTVHRDIKGANILVDPNGEIKLADFGMAKHVTAFSTMLSFKGSPYWMAPEV---VMS 387

Query:   532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGK 589
             ++G      AVDIWSLGCT++EM T KPPWS+FEG  A+FK+ N   TP IP+ LS++ K
Sbjct:   388 QNGYTH---AVDIWSLGCTILEMATSKPPWSQFEGVAAIFKIGNSKDTPEIPDHLSNDAK 444

Query:   590 DFLLRCFLRNPVERPSAVELLEHPFIRNAN-YQNLSVP 626
             +F+  C  RNP  RP+A +LLEHPF+RN     + S+P
Sbjct:   445 NFIRLCLQRNPTVRPTASQLLEHPFLRNTTRVASTSLP 482

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 628 (226.1 bits), Expect = 2.0e-63, Sum P(2) = 2.0e-63
 Identities = 135/267 (50%), Positives = 181/267 (67%)

Query:   352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
             + WQKG+L+GRG+FGSVY G + + G   A+KEV ++    ++ ECI+QLE EIK+L  L
Sbjct:   331 TSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQL 389

Query:   412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRHILNGLAY 470
             +H+NIV+Y G+     +LYI+LE V  GS+ + Y R   RD   S+V  +TR IL+GL Y
Sbjct:   390 QHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRD---SVVSLYTRQILDGLKY 446

Query:   471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
             LH    IHRDIK AN+LVDA+G VKLADFG+AK ++  +   S KG+P WMAPEVI    
Sbjct:   447 LHDKGFIHRDIKCANILVDANGAVKLADFGLAK-VSKFNDIKSCKGTPFWMAPEVINR-K 504

Query:   531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGK 589
               DG    A   DIWSLGCTV+EM TG+ P+S+ E  QA+F++   T P +P+ LS + +
Sbjct:   505 DSDGYGSPA---DIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPDTLSLDAR 561

Query:   590 DFLLRCFLRNPVERPSAVELLEHPFIR 616
              F+L+C   NP ERP+A ELL HPF+R
Sbjct:   562 LFILKCLKVNPEERPTAAELLNHPFVR 588

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IGI

GO:0006970 "response to osmotic stress" evidence=IGI;IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009611 "response to wounding" evidence=RCA;IDA

GO:0003677 "DNA binding" evidence=IDA

GO:0019900 "kinase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IMP;RCA;IPI

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 576 (207.8 bits), Expect = 6.9e-63, Sum P(3) = 6.9e-63
 Identities = 124/267 (46%), Positives = 172/267 (64%)

Query:   352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
             + W KG+L+GRG++ SVY   + E G   A+KEV ++    ++ ECI+QLE EI +L  L
Sbjct:   301 TSWLKGQLLGRGSYASVYEAIS-EDGDFFAVKEVSLLDKGIQAQECIQQLEGEIALLSQL 359

Query:   412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
             +H+NIV+Y G+      LYI+LE V  GS+ +    +   ++ ++V  +TR IL GL YL
Sbjct:   360 QHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERY--QLSYTVVSLYTRQILAGLNYL 417

Query:   472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
             H    +HRDIK AN+LVDA+G VKLADFG+A+  +  +  +S KG+  WMAPEVI     
Sbjct:   418 HDKGFVHRDIKCANMLVDANGTVKLADFGLAE-ASKFNDIMSCKGTLFWMAPEVINR-KD 475

Query:   532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKD 590
              DGN   A   DIWSLGCTV+EM TG+ P+S+ +  QA FK+   T P +P+ LS + + 
Sbjct:   476 SDGNGSPA---DIWSLGCTVLEMCTGQIPYSDLKPIQAAFKIGRGTLPDVPDTLSLDARH 532

Query:   591 FLLRCFLRNPVERPSAVELLEHPFIRN 617
             F+L C   NP ERP+A ELL HPF+ N
Sbjct:   533 FILTCLKVNPEERPTAAELLHHPFVIN 559

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

ZFIN|ZDB-GENE-120215-96 si:dkey-32h20.5 "si:dkey-32h20.5" [Danio rerio (taxid:7955)]

 Score = 573 (206.8 bits), Expect = 7.7e-62, Sum P(3) = 7.7e-62
 Identities = 125/295 (42%), Positives = 186/295 (63%)

Query:   331 SSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 389
             S+ T +VM   +  PS SP+  + W+ GKL+G+G FG V++  + +TG   A+K+V   P
Sbjct:   340 SNPTLSVMD--ISPPSRSPRAPTNWRLGKLLGQGAFGRVFLCYDADTGRELAVKQVQFDP 397

Query:   390 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH---LYIYLEYVHPGSINRYVR 446
             D P++++ +  LE EI++L +L HE IVQYYG  + D H   L I++EY+  GSI   ++
Sbjct:   398 DSPETSKEVSALECEIQLLKNLFHERIVQYYGC-LRDTHEKTLSIFMEYMPGGSIKDQLK 456

Query:   447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
              +   +TE++ R +TR IL G+ YLHS   +HRDIKGAN+L D++G VKL DFG ++ L 
Sbjct:   457 SYGA-LTENVTRKYTRQILEGVCYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASRRLQ 515

Query:   507 GLSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 562
              +        S+ G+P WM+PEVI      +G  + A   DIWS+GCTV+EMLT +PPW+
Sbjct:   516 TICLSGTGIKSVTGTPYWMSPEVISG----EGYGRKA---DIWSIGCTVVEMLTQRPPWA 568

Query:   563 EFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
             EFE   A+FK+  +   P +P  +S   +DFL R F+    +RP+A +LL H F+
Sbjct:   569 EFEAMAAIFKIATQPTNPTLPPHVSDHCRDFLKRIFVETK-QRPAAEDLLRHTFV 622

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)]

 Score = 614 (221.2 bits), Expect = 6.2e-60, Sum P(2) = 6.2e-60
 Identities = 121/280 (43%), Positives = 186/280 (66%)

Query:   353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPKSAECIKQLEQEIKVLGH 410
             +WQKG+++GRG +GSVY+G N++TG   A+K+++I+    DPK    I    +EI+V+  
Sbjct:   494 KWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRS 553

Query:   411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
             L+H+NIV+Y G+ +    L ++LEY+  GSI+  + +     +E++++ +T+ IL GL++
Sbjct:   554 LRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGA-FSENVIKVYTKQILQGLSF 612

Query:   471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAV 529
             LH+ + IHRDIKGAN+L+D  G+VKL+DFG +K  +G+  +  S++G+P WMAPEVIK  
Sbjct:   613 LHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIK-- 670

Query:   530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVL--NRTPPIPEMLSS 586
               + G+ + +   DIWSLGC ++EM T +PPWS   E    M+ +   N  P IP  +S 
Sbjct:   671 --QTGHGRSS---DIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQ 725

Query:   587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
             E  DFL  CF R+P ERP A +LL+HPFI N +  N+ +P
Sbjct:   726 EAFDFLNLCFKRDPKERPDANQLLKHPFIMNLD-DNIQLP 764

GO:0030587 "sorocarp development" evidence=IMP

GO:0009653 "anatomical structure morphogenesis" evidence=IMP

GO:0005938 "cell cortex" evidence=IDA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA;ISS

GO:0000186 "activation of MAPKK activity" evidence=IEA;ISS

GO:0000165 "MAPK cascade" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|F1MH06 MAP3K3 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 581 (209.6 bits), Expect = 2.0e-59, Sum P(2) = 2.0e-59
 Identities = 123/279 (44%), Positives = 178/279 (63%)

Query:   345 PSASPKKS-QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 403
             P+ SP     W++GKL+G+G FG VY+  + +TG   A K+V   PD P++++ +  LE 
Sbjct:   352 PTKSPSAPINWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALEC 411

Query:   404 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 461
             EI++L +L+HE IVQYYG   +  +  L I++EY+  GS+   ++ +   +TES+ R +T
Sbjct:   412 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYT 470

Query:   462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGS 517
             R IL G++YLHS   +HRDIKGAN+L D++G VKL DFG +K L  +        S+ G+
Sbjct:   471 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGT 530

Query:   518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR- 576
             P WM+PEVI      +G  + A   D+WSLGCTV+EMLT KPPW+E+E   A+FK+  + 
Sbjct:   531 PYWMSPEVISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP 583

Query:   577 -TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
               P +P  +S  G+DFL R F+    +RPSA ELL H F
Sbjct:   584 TNPQLPSHISEHGRDFLRRIFVEAR-QRPSAEELLTHHF 621

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043123 "positive regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA

GO:0007243 "intracellular protein kinase cascade" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 603 (217.3 bits), Expect = 9.3e-59, P = 9.3e-59
 Identities = 140/312 (44%), Positives = 196/312 (62%)

Query:   354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLGH 410
             W+KG+LIGRG FG+VY+G N ++G   A+K+V I  +     K+   I++LE+E+K+L +
Sbjct:    69 WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128

Query:   411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
             L H NIV+Y G+   DD L I LE+V  GSI+  + E      ES+VR +TR +L GL Y
Sbjct:   129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLL-EKFGPFPESVVRTYTRQLLLGLEY 187

Query:   471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
             LH+   +HRDIKGAN+LVD  G +KLADFG +K +  L+      S+KG+P WMAPEVI 
Sbjct:   188 LHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI- 246

Query:   528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGPQAMFKV--LNRTPPIPEML 584
               +Q  G+   + + DIWS+GCTVIEM+TGK PWS+ ++   A+F +      PPIP+ L
Sbjct:   247 --LQT-GH---SFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTL 300

Query:   585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVE 644
             SS+ KDFLL+C    P  RP+A ELL+HPF+   + ++ S  +      NL      Q+ 
Sbjct:   301 SSDAKDFLLKCLQEVPNLRPTASELLKHPFVMGKHKESASTDLGSVLN-NLSTPLPLQIN 359

Query:   645 RATRKTESLPDS 656
                  T+S PDS
Sbjct:   360 N----TKSTPDS 367

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

UNIPROTKB|E2RN16 MAP3K2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 572 (206.4 bits), Expect = 1.1e-58, Sum P(2) = 1.1e-58
 Identities = 124/280 (44%), Positives = 178/280 (63%)

Query:   345 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 403
             PS SP+  + W+ GKL+G+G FG VY+  + +TG   A+K+V   PD P++++ +  LE 
Sbjct:   347 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALEC 406

Query:   404 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 461
             EI++L +L HE IVQYYG   +  +  L I++EY+  GSI   ++ +   +TE++ R +T
Sbjct:   407 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 465

Query:   462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGS 517
             R IL G+ YLHS   +HRDIKGAN+L D++G VKL DFG +K L  +        S+ G+
Sbjct:   466 RQILEGVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMKSVTGT 525

Query:   518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR- 576
             P WM+PEVI      +G  + A   DIWS+GCTV+EMLT KPPW+EFE   A+FK+  + 
Sbjct:   526 PYWMSPEVISG----EGYGRKA---DIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP 578

Query:   577 -TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
               P +P  +S   +DFL R F+   + RPSA ELL H F+
Sbjct:   579 TNPKLPPHVSDYTRDFLKRIFIEAKL-RPSADELLRHMFV 617

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00009700001 SubName- Full=Chromosome undetermined scaffold_245, whole genome shotgun sequence; (592 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	739
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-128
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-118
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-96
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-93
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-90
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-87
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-85
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-82
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-81
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-78
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-76
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-76
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-74
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-70
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-69
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-67
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-66
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-66
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-66
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-64
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-63
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-63
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-61
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-61
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-59
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-58
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-54
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-52
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-52
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-51
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-51
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-50
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-50
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-50
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-49
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-48
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-48
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-47
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-46
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-46
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-45
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-45
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-45
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-45
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-44
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-44
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-44
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-44
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-43
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-43
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-43
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-43
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-42
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-41
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-41
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-41
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-41
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-41
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-40
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-40
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-40
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-40
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-40
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-40
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-40
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-40
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-39
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-39
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-39
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-39
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-38
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-38
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-38
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-38
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-38
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-38
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-37
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-37
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-37
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-36
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-36
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-36
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-36
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-36
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-35
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-35
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-34
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-34
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-34
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-33
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-33
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-33
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-33
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-33
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-33
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-32
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-32
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-32
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-32
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-32
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-32
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-31
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-31
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-31
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-31
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-31
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-30
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-30
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-30
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-30
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-30
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-30
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-29
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-29
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-29
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-29
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-28
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-28
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-28
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-28
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-28
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-27
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-27
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-27
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-27
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-27
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-27
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-27
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-27
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-27
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-27
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-27
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-26
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-26
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-26
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-26
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-26
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-26
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-26
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-26
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-26
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-26
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-25
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-25
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-25
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-25
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-25
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-25
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-24
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-24
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-24
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-24
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-24
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-24
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-24
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-24
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-23
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-23
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-23
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-23
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-23
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-23
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-23
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-22
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-22
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-22
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-22
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-22
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-22
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-22
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-21
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-21
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-21
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-21
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-21
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-21
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-21
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-21
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-21
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-21
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-21
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-21
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-21
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-21
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-21
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-21
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-21
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-20
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-20
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-20
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-20
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-20
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-20
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-20
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-19
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-19
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-19
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-19
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-19
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-19
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-19
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-19
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-19
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-18
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-17
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-17
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-17
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-16
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-15
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-14
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-14
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	5e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-12
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	9e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-11
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	4e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-09
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	6e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.001
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.001

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  381 bits (981), Expect = e-128
 Identities = 146/264 (55%), Positives = 185/264 (70%), Gaps = 9/264 (3%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W+KG+L+G G+FGSVY G N + G   A+KEV +  D     E +KQLEQEI +L  L+H
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIVQY G+E  +D+LYI+LE V  GS+ + ++++     E ++R +TR IL GL YLH 
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHD 120

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
            NT+HRDIKGAN+LVD +GVVKLADFGMAK +   S+  S KGSP WMAPEVI    Q+ 
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVI---AQQG 177

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDF 591
           G     LA DIWSLGCTV+EM TGKPPWS+ EG  A+FK+      PPIP+ LS E KDF
Sbjct: 178 GY---GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234

Query: 592 LLRCFLRNPVERPSAVELLEHPFI 615
           +L+C  R+P  RP+A ELLEHPF+
Sbjct: 235 ILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  356 bits (916), Expect = e-118
 Identities = 135/271 (49%), Positives = 182/271 (67%), Gaps = 19/271 (7%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +W +G+L+GRG+FGSVY+  +++TG   A+K V++  D  +  E    LE+EI++L  L+
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE---ALEREIRILSSLQ 57

Query: 413 HENIVQYYGSEV--VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           H NIV+YYGSE     + L I+LEYV  GS+   + +    + E ++R +TR IL GLAY
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIRKYTRQILEGLAY 116

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LHS   +HRDIKGAN+LVD+ GVVKLADFG AK L  +       S++G+P WMAPEVI+
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRT--PPIPEML 584
              ++ G      A DIWSLGCTVIEM TGKPPWSE   P  A++K+ +    P IPE L
Sbjct: 177 G--EEYG-----RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHL 229

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           S E KDFL +C  R+P +RP+A ELL+HPF+
Sbjct: 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  298 bits (766), Expect = 2e-96
 Identities = 126/265 (47%), Positives = 168/265 (63%), Gaps = 13/265 (4%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
            +Q G LIGRG FG VY G N ETG   AIK++ +     + A  +K + QEI +L +LK
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEA--LKSIMQEIDLLKNLK 57

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H NIV+Y GS    D LYI LEY   GS+ + +++      ES+V  +   +L GLAYLH
Sbjct: 58  HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP-FPESLVAVYVYQVLQGLAYLH 116

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQ 531
               IHRDIK AN+L    GVVKLADFG+A  L  +S  + S+ G+P WMAPEVI    +
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI----E 172

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKD 590
             G    + A DIWSLGCTVIE+LTG PP+ +     A+F+ V +  PP+PE +S E KD
Sbjct: 173 MSG---ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD 229

Query: 591 FLLRCFLRNPVERPSAVELLEHPFI 615
           FL++CF ++P  RP+A +LL+HP+I
Sbjct: 230 FLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  289 bits (743), Expect = 6e-93
 Identities = 95/266 (35%), Positives = 147/266 (55%), Gaps = 16/266 (6%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++  + +G G+FG VY+  +++TG   AIK +             +++ +EIK+L  LKH
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD----RERILREIKILKKLKH 56

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+ Y     +D LY+ +EY   G +   +++  R ++E   R + R IL+ L YLHS
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLHS 115

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
              +HRD+K  N+L+D  G VKLADFG+A+ L       +  G+P +MAPEV+       
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL------ 169

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRTPPIPE---MLSSEGK 589
                  AVDIWSLG  + E+LTGKPP+   +    +FK +    PP P     +S E K
Sbjct: 170 -GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAK 228

Query: 590 DFLLRCFLRNPVERPSAVELLEHPFI 615
           D + +  +++P +R +A E L+HPF 
Sbjct: 229 DLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  281 bits (722), Expect = 9e-90
 Identities = 130/272 (47%), Positives = 169/272 (62%), Gaps = 17/272 (6%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +WQ+G  IG GTFG VY   N +TG   A+KE+ I  +DPK+   IK++  E+KVL  LK
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT---IKEIADEMKVLELLK 57

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H N+V+YYG EV  + +YI++EY   G++   + EH R + E ++R +T  +L GLAYLH
Sbjct: 58  HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLH 116

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-----TGLSYELSLKGSPNWMAPEVIK 527
           S   +HRDIK AN+ +D +GV+KL DFG A  L     T      SL G+P +MAPEVI 
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKV-LNRTPPIPE--M 583
                        A DIWSLGC V+EM TGK PWSE +   Q MF V     PPIP+   
Sbjct: 177 ----GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ 232

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           LS EGKDFL RC   +P +RP+A ELL+HPF+
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  275 bits (704), Expect = 3e-87
 Identities = 121/271 (44%), Positives = 176/271 (64%), Gaps = 20/271 (7%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W++GKL+G+G FG VY+  + +TG   A+K+V   PD P++ + +  LE EI++L +L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           E IVQYYG    D+ L I++EY+  GS+   ++ +   +TE++ R +TR IL G+ YLHS
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHS 122

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPEVI 526
              +HRDIKGAN+L D++G VKL DFG +K L       TG+    S+ G+P WM+PEVI
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK---SVTGTPYWMSPEVI 179

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEML 584
                 +G  + A   D+WS+GCTV+EMLT KPPW+EFE   A+FK+      P +P  +
Sbjct: 180 SG----EGYGRKA---DVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV 232

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           S + ++FL R F+ N  +RPSA ELL H F+
Sbjct: 233 SPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  271 bits (695), Expect = 1e-85
 Identities = 127/276 (46%), Positives = 166/276 (60%), Gaps = 20/276 (7%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-----DDPKSAECIKQLEQEIKVL 408
           W KG+LIG+GT+G VY+  N  TG   A+K+V++        D +  + +K L  EI+ L
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             L H NIVQY G E  +++L I+LEYV  GSI   +R + R   E +VR FT  +L GL
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRFFTEQVLEGL 121

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGLSYELSLKGSPNWMAPEV 525
           AYLHS   +HRD+K  NLLVDA G+ K++DFG++K    +      +S++GS  WMAPEV
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPE- 582
           I +  Q       +  VDIWSLGC V+EM  G+ PWS+ E   AMFK+ N    PPIP  
Sbjct: 182 IHSYSQ-----GYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236

Query: 583 ---MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
               LS    DFL  CF  NP  RP+A ELL+HPFI
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  262 bits (672), Expect = 1e-82
 Identities = 109/264 (41%), Positives = 157/264 (59%), Gaps = 15/264 (5%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++  + IG+G FG VY   ++ TG   AIK + +     +S E  +++  EI++L   KH
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIINEIQILKKCKH 56

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+YYGS +  D L+I +E+   GS+   ++   + +TES +    + +L GL YLHS
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
              IHRDIK AN+L+ + G VKL DFG++  L+      ++ G+P WMAPEVI     K 
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN---GKP 173

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGKD 590
            + K     DIWSLG T IE+  GKPP+SE    +A+FK+    PP    PE  S E KD
Sbjct: 174 YDYK----ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229

Query: 591 FLLRCFLRNPVERPSAVELLEHPF 614
           FL +C  +NP +RP+A +LL+HPF
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  259 bits (663), Expect = 3e-81
 Identities = 95/270 (35%), Positives = 143/270 (52%), Gaps = 18/270 (6%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++  + +G G+FG+VY   ++ TG   A+K +       KS +      +EI++L  L H
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK--RSEKSKKDQTAR-REIRILRRLSH 57

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+   +    DHLY+ +EY   G +  Y+      ++E   +     IL GL YLHS
Sbjct: 58  PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLHS 116

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQK 532
              IHRD+K  N+L+D +GVVK+ADFG+AK L   S  L +  G+P +MAPEV+      
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL----- 171

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-------MLS 585
            G       VD+WSLG  + E+LTGKPP+S       +  +     P  E         S
Sbjct: 172 -GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS 230

Query: 586 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
            E KD + +C  ++P +RP+A E+L+HP+ 
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  250 bits (640), Expect = 8e-78
 Identities = 105/261 (40%), Positives = 153/261 (58%), Gaps = 18/261 (6%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
            +G G++GSVY   ++ETG   AIK V +  D       ++++ +EI +L       IV+
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-------LQEIIKEISILKQCDSPYIVK 62

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           YYGS   +  L+I +EY   GS++  ++   + +TE  +       L GL YLHS   IH
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           RDIK  N+L++  G  KLADFG++  LT  ++   ++ G+P WMAPEVI    +   N K
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYNNK 179

Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGKDFLLR 594
                DIWSLG T IEM  GKPP+S+    +A+F + N+ PP    PE  S E  DF+ +
Sbjct: 180 ----ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235

Query: 595 CFLRNPVERPSAVELLEHPFI 615
           C +++P ERPSA++LL+HPFI
Sbjct: 236 CLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  246 bits (631), Expect = 2e-76
 Identities = 103/274 (37%), Positives = 146/274 (53%), Gaps = 24/274 (8%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
             +   + IG+G+FG VY   ++ T    AIK +D+     ++ + I+ ++QEI+ L   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL----EEAEDEIEDIQQEIQFLSQC 56

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           +   I +YYGS +    L+I +EY   GS    ++     + E+ +    R +L GL YL
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYL 114

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMAPEVI 526
           H    IHRDIK AN+L+   G VKLADFG++  LT        K     G+P WMAPEVI
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT----STMSKRNTFVGTPFWMAPEVI 170

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE--ML 584
           K   Q   + K     DIWSLG T IE+  G+PP S+    + +F +    PP  E    
Sbjct: 171 K---QSGYDEK----ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKF 223

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           S   KDF+  C  ++P ERPSA ELL+H FI+ A
Sbjct: 224 SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  245 bits (627), Expect = 6e-76
 Identities = 126/275 (45%), Positives = 168/275 (61%), Gaps = 20/275 (7%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI----IPDDPKSAECIKQLEQEIKVL 408
           +W KG LIG G+FGSVY+G N  +G   A+K+V++         +    +  L +EI +L
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             L+HENIVQY GS +  DHL I+LEYV  GS+   +  +     E++VRNF R IL GL
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGL 119

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-------SLKGSPNWM 521
            YLH+   IHRDIKGAN+LVD  G +K++DFG++K L   S          SL+GS  WM
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI 580
           APEV+K         K     DIWSLGC V+EMLTGK P+ +    QA+FK+  N +P I
Sbjct: 180 APEVVKQTSY---TRK----ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI 232

Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           P  +SSE  DFL + F  +  +RP+A ELL+HPF+
Sbjct: 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  241 bits (618), Expect = 3e-74
 Identities = 114/269 (42%), Positives = 155/269 (57%), Gaps = 20/269 (7%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
            +K   IG G  G VY  T+R TG   AIK++ +   + +       +  EI ++   KH
Sbjct: 24  LEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL------IINEILIMKDCKH 74

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV YY S +V D L++ +EY+  GS+   + ++   + E  +    R +L GL YLHS
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQK 532
            N IHRDIK  N+L+   G VKLADFG A  LT   S   S+ G+P WMAPEVIK   +K
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK---RK 191

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI--PEMLSSEGK 589
           D  PK    VDIWSLG   IEM  G+PP+      +A+F +     PP+  PE  S E K
Sbjct: 192 DYGPK----VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247

Query: 590 DFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           DFL +C +++P +RPSA ELL+HPF++ A
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  230 bits (587), Expect = 4e-70
 Identities = 121/274 (44%), Positives = 173/274 (63%), Gaps = 27/274 (9%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W++GKL+G+G FG VY+  + +TG   A K+V   P+ P++++ +  LE EI++L +L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 414 ENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
           E IVQYYG   + D     L I++EY+  GS+   ++ +   +TES+ R +TR IL G++
Sbjct: 64  ERIVQYYG--CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMS 120

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMA 522
           YLHS   +HRDIKGAN+L D++G VKL DFG +K L       TG+    S+ G+P WM+
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR---SVTGTPYWMS 177

Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPI 580
           PEVI      +G  + A   D+WSLGCTV+EMLT KPPW+E+E   A+FK+  +   P +
Sbjct: 178 PEVISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL 230

Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
           P  +S   +DF L C       RPSA ELL HPF
Sbjct: 231 PSHISEHARDF-LGCIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  227 bits (579), Expect = 6e-69
 Identities = 112/264 (42%), Positives = 159/264 (60%), Gaps = 17/264 (6%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           ++G+GT+G VY   +  T    AIKE+       + +  ++ L +EI +  +LKH NIVQ
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT--ESIVRNFTRHILNGLAYLHSTNT 476
           Y GS+  +    I++E V  GS++  +R     +   E  +  +T+ IL GL YLH    
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 477 IHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDG 534
           +HRDIKG N+LV+  SGVVK++DFG +K L G++    +  G+  +MAPEVI    +  G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189

Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKV--LNRTPPIPEMLSSEGKDF 591
            P      DIWSLGCT++EM TGKPP+ E   PQA MFKV      P IPE LS+E K+F
Sbjct: 190 AP-----ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244

Query: 592 LLRCFLRNPVERPSAVELLEHPFI 615
           +LRCF  +P +R SA +LL+ PF+
Sbjct: 245 ILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  221 bits (565), Expect = 5e-67
 Identities = 118/272 (43%), Positives = 174/272 (63%), Gaps = 17/272 (6%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           + W+ GKL+G+G FG VY+  + +TG   A+K+V   P+ P++++ +  LE EI++L +L
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 412 KHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            HE IVQYYG   + ++  L I++E++  GSI   ++ +   +TE++ R +TR IL G++
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVS 120

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPEV 525
           YLHS   +HRDIKGAN+L D+ G VKL DFG +K L  +        S+ G+P WM+PEV
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEM 583
           I      +G  + A   DIWS+GCTV+EMLT KPPW+EFE   A+FK+  +   P +P  
Sbjct: 181 ISG----EGYGRKA---DIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           +S   +DFL R F+   + RPSA ELL H F+
Sbjct: 234 VSDHCRDFLKRIFVEAKL-RPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  220 bits (561), Expect = 2e-66
 Identities = 105/275 (38%), Positives = 166/275 (60%), Gaps = 22/275 (8%)

Query: 353 QWQKGKLIGRGTFGSVYIG-TNRETGASCAIKEVDIIPDDPKSAEC-IKQLEQEIKVLGH 410
           +W KG+++G+G +G+VY G TN   G   A+K+V++   +  +AE   ++L++E+ +L  
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           LKH NIVQY G+ + D+ + I++E+V  GSI+  +      + E +   +T+ IL+G+AY
Sbjct: 59  LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAY 117

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-------SLKGSPNWMAP 523
           LH+   +HRDIKG N+++  +G++KL DFG A+ L  +           S+ G+P WMAP
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPI 580
           EVI     + G  + +   DIWS+GCTV EM TGKPP +  +   AMF +       P +
Sbjct: 178 EVIN----ESGYGRKS---DIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL 230

Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           P+  S+   DF+  C  R+  ERPSA++LL H F+
Sbjct: 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  219 bits (560), Expect = 4e-66
 Identities = 102/262 (38%), Positives = 148/262 (56%), Gaps = 17/262 (6%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG GT+G VY   +  TG   AIK + + P D       + ++QEI +L   +H NIV Y
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDD-----FEIIQQEISMLKECRHPNIVAY 65

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           +GS +  D L+I +EY   GS+    +     ++E  +    R  L GLAYLH T  IHR
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIKGAN+L+   G VKLADFG++  LT  ++   S  G+P WMAPEV  AV +K G    
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-AVERKGGYDGK 184

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK------DFL 592
               DIW+LG T IE+   +PP  +    +A+F +++++   P  L  + K      DF+
Sbjct: 185 C---DIWALGITAIELAELQPPMFDLHPMRALF-LISKSNFPPPKLKDKEKWSPVFHDFI 240

Query: 593 LRCFLRNPVERPSAVELLEHPF 614
            +C  ++P +RP+A +LL+HPF
Sbjct: 241 KKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  218 bits (557), Expect = 8e-66
 Identities = 115/273 (42%), Positives = 174/273 (63%), Gaps = 23/273 (8%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W+ GKL+GRG FG VY+  + +TG   A+K+V   PD  ++++ +  LE EI++L +L+H
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 414 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           + IVQYYG   +  +  L I++EY+  GSI   ++ +   +TE++ R +TR IL G++YL
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYL 122

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPE 524
           HS   +HRDIKGAN+L D++G VKL DFG +K +       TG+    S+ G+P WM+PE
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK---SVTGTPYWMSPE 179

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE 582
           VI      +G  + A   D+WS+ CTV+EMLT KPPW+E+E   A+FK+  +   P +P+
Sbjct: 180 VISG----EGYGRKA---DVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD 232

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
            +S   +DFL + F+     RP+A  LL HPF+
Sbjct: 233 GVSDACRDFLKQIFVEEKR-RPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  212 bits (543), Expect = 2e-64
 Identities = 87/256 (33%), Positives = 134/256 (52%), Gaps = 43/256 (16%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G FG+VY+  +++TG   AIK +        S+  +++L +EI++L  L H NIV+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           YG    ++HLY+ +EY   GS+   ++E+   ++E  +      IL GL YLHS   IHR
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 480 DIKGANLLVDA-SGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPK 537
           D+K  N+L+D+ +G VKLADFG++K LT     L ++ G+P +MAPEV+       G   
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL------GKGY 170

Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 597
            +   DIWSLG  + E+                                E KD + +   
Sbjct: 171 YSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQ 199

Query: 598 RNPVERPSAVELLEHP 613
           ++P +RPSA E+LEH 
Sbjct: 200 KDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  211 bits (538), Expect = 5e-63
 Identities = 96/276 (34%), Positives = 157/276 (56%), Gaps = 20/276 (7%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLGHL 411
           +W KG+ +G G F S Y   + +TG   A+K+V  + +     E + + L +EI+++  L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
            H +I++  G+   D H  +++E++  GS++  + ++     E+++ N+T  +L GL+YL
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYL 119

Query: 472 HSTNTIHRDIKGANLLVDASG-VVKLADFG----MAKHLTGLS-YELSLKGSPNWMAPEV 525
           H    IHRD+KGANLL+D++G  +++ADFG    +A   TG   ++  L G+  +MAPEV
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKV--LNRTPPI 580
           ++      G      + D+WS+GC +IEM T KPPW+  +       +FK+      P I
Sbjct: 180 LR------GEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232

Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
           PE LS   +D  LRC    P +RP + ELL+HP  R
Sbjct: 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  210 bits (536), Expect = 9e-63
 Identities = 88/270 (32%), Positives = 144/270 (53%), Gaps = 29/270 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K IG+G+FG VY+   +  G    +KE+D+     K     +    E+K+L  L H NI+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK---EREDALNEVKILKKLNHPNII 62

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLHST 474
           +YY S      L I +EY   G +++ +++  ++     E  + ++   +   L YLHS 
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQK 532
             +HRDIK  N+ + ++G+VKL DFG++K L+  + +L  ++ G+P +++PE+ +     
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-TVDLAKTVVGTPYYLSPELCQ----- 176

Query: 533 DGNP---KLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMFKVLNRT-PPIPEMLS 585
              P   K     DIWSLGC + E+ T K P   FEG    +   K+L    PPIP   S
Sbjct: 177 -NKPYNYK----SDIWSLGCVLYELCTLKHP---FEGENLLELALKILKGQYPPIPSQYS 228

Query: 586 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           SE ++ +     ++P ERPS  ++L+ PFI
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  207 bits (530), Expect = 1e-61
 Identities = 100/276 (36%), Positives = 146/276 (52%), Gaps = 22/276 (7%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-K 412
           ++  ++IG GT+G VY   +++TG   AIK +DII D+       +++++E  +L     
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE------EEEIKEEYNILRKYSN 61

Query: 413 HENIVQYYG------SEVVDDHLYIYLEYVHPGSINRYV---REHCRDITESIVRNFTRH 463
           H NI  +YG          DD L++ +E    GS+   V   R+  + + E  +    R 
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMA 522
            L GLAYLH    IHRDIKG N+L+  +  VKL DFG++  L        +  G+P WMA
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181

Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI-- 580
           PEVI A  ++  +       D+WSLG T IE+  GKPP  +    +A+FK+    PP   
Sbjct: 182 PEVI-ACDEQP-DASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK 239

Query: 581 -PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
            PE  S +  DF+  C ++N  +RP   ELLEHPFI
Sbjct: 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  205 bits (523), Expect = 8e-61
 Identities = 95/275 (34%), Positives = 151/275 (54%), Gaps = 19/275 (6%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S  ++ K++G+G+ G VY   ++ TG   A+K++  +  D    E  KQL +E+K L   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDE---EFRKQLLRELKTLRSC 56

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           +   +V+ YG+   +  + I LEY+  GS+   +++    I E ++    R IL GL YL
Sbjct: 57  ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL 115

Query: 472 HST-NTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAV 529
           H+  + IHRDIK +NLL+++ G VK+ADFG++K L   L    +  G+  +M+PE I+  
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG- 174

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ--AMFKVLNRTPPI---PEML 584
            +           DIWSLG T++E   GK P+     P    + + +   PP     E  
Sbjct: 175 -ESYSYAA-----DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           S E +DF+  C  ++P +RPSA ELL+HPFI+ A+
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  201 bits (514), Expect = 2e-59
 Identities = 101/289 (34%), Positives = 152/289 (52%), Gaps = 18/289 (6%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S +Q+ +LIGRG +G+VY G +  TG   A+K +++   D   ++    +++E+ +L  L
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD----IQREVALLSQL 56

Query: 412 KH---ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
           +     NI +YYGS +    L+I +EY   GS+   ++     I E  +    R +L  L
Sbjct: 57  RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVAL 114

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIK 527
            Y+H    IHRDIK AN+LV  +G VKL DFG+A  L    S   +  G+P WMAPEVI 
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IPE-MLS 585
                D         DIWSLG T+ EM TG PP+S+ +  +AM  +    PP + +   S
Sbjct: 175 EGKYYD------TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYS 228

Query: 586 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 634
              ++F+  C    P ER SA ELL+  +I+  +   +S+   + SR  
Sbjct: 229 KLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKELISRYQ 277

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  199 bits (508), Expect = 2e-58
 Identities = 103/269 (38%), Positives = 149/269 (55%), Gaps = 11/269 (4%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W+    +G G FG VY   ++ETG   A K + I     +S E ++    EI +L   KH
Sbjct: 7   WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSECKH 61

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV  Y +   ++ L+I +E+   G+++  + E  R +TE  +R   R +L  L +LHS
Sbjct: 62  PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
              IHRD+K  N+L+   G VKLADFG+ AK+ + L    +  G+P WMAPEV+     K
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGK 589
           D NP    A DIWSLG T+IE+   +PP  E    + + K+L   PP    P   SS   
Sbjct: 182 D-NPYDYKA-DIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239

Query: 590 DFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           DFL  C +++P +RP+A ELL+HPF+ + 
Sbjct: 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  186 bits (474), Expect = 7e-54
 Identities = 77/267 (28%), Positives = 124/267 (46%), Gaps = 20/267 (7%)

Query: 355 QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           + GK +G G FG VY GT       T    A+K +     + +  E      +E  ++  
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE----FLEEASIMKK 57

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H NIV+  G     + LYI  EY+  G +  ++R+H   +T   +      I  G+ Y
Sbjct: 58  LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIK 527
           L S N +HRD+   N LV  + VVK++DFG+++ +    Y     G      WMAPE +K
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT-PPIPEMLS 585
                  + K     D+WS G  + E+ T G+ P+      + +  + +    P PE   
Sbjct: 178 -------DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCP 230

Query: 586 SEGKDFLLRCFLRNPVERPSAVELLEH 612
            E  + +L+C+  +P +RP+  EL+E 
Sbjct: 231 DELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  182 bits (464), Expect = 1e-52
 Identities = 79/269 (29%), Positives = 131/269 (48%), Gaps = 27/269 (10%)

Query: 355 QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
             GK +G G FG VY G       +     A+K +     +  S + I++  +E +++  
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK----EDASEQQIEEFLREARIMRK 57

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H N+V+  G    ++ LYI +EY+  G +  Y+R++   ++ S + +F   I  G+ Y
Sbjct: 58  LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----WMAPEVI 526
           L S N IHRD+   N LV  + VVK++DFG+++ L     +   K        WMAPE +
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY--DDDYYRKRGGKLPIRWMAPESL 175

Query: 527 KAVMQKDG--NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE 582
                K+G    K     D+WS G  + E+ T G+ P+      + +  + N    P P 
Sbjct: 176 -----KEGKFTSK----SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPP 226

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLE 611
               E  D +L+C+  +P +RP+  EL+E
Sbjct: 227 NCPPELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  180 bits (460), Expect = 6e-52
 Identities = 80/267 (29%), Positives = 131/267 (49%), Gaps = 24/267 (8%)

Query: 356 KGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            GK +G G FG VY GT            A+K +     +  S + I++  +E +++  L
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK----EDASEQQIEEFLREARIMRKL 58

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAY 470
            H NIV+  G    ++ L I +EY+  G +  Y+R++  ++++ S + +F   I  G+ Y
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SP-NWMAPEVIKA 528
           L S N IHRD+   N LV  + VVK++DFG+++ L    Y     G  P  WMAPE +  
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL-- 176

Query: 529 VMQKDG--NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML 584
              K+G    K     D+WS G  + E+ T G+ P+      + +  +      P P   
Sbjct: 177 ---KEGKFTSK----SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC 229

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLE 611
             E    +L+C+  +P +RP+  EL+E
Sbjct: 230 PPELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  180 bits (458), Expect = 1e-51
 Identities = 90/270 (33%), Positives = 134/270 (49%), Gaps = 25/270 (9%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G    VY           AIK +D+     K    + +L +E++ +    H N+V+Y
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHSTNTI 477
           Y S VV D L++ + Y+  GS+   ++       + E+I+    + +L GL YLHS   I
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLK---GSPNWMAPEVIKAVMQK 532
           HRDIK  N+L+   G VK+ADFG++  L   G       K   G+P WMAPEV++   Q 
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME---QV 181

Query: 533 DG-NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM------LS 585
            G + K     DIWS G T IE+ TG  P+S++   + +   L   PP  E        S
Sbjct: 182 HGYDFK----ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237

Query: 586 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
              +  +  C  ++P +RP+A ELL+H F 
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  180 bits (458), Expect = 2e-51
 Identities = 110/274 (40%), Positives = 152/274 (55%), Gaps = 19/274 (6%)

Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           PKK ++ + + IG+G  G+VY   +  TG   AIK++++    PK    I     EI V+
Sbjct: 17  PKK-KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELII----NEILVM 70

Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
              KH NIV Y  S +V D L++ +EY+  GS+   V E C D  E  +    R  L  L
Sbjct: 71  RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQAL 128

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIK 527
            +LHS   IHRDIK  N+L+   G VKL DFG    +T   S   ++ G+P WMAPEV  
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-- 186

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI--PEML 584
            V +K   PK    VDIWSLG   IEM+ G+PP+      +A++ +  N TP +  PE L
Sbjct: 187 -VTRKAYGPK----VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           S+  +DFL RC   +  +R SA ELL+HPF++ A
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  178 bits (452), Expect = 1e-50
 Identities = 101/270 (37%), Positives = 143/270 (52%), Gaps = 11/270 (4%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W+    +G G FG VY   N+ETGA  A K ++      KS E ++    EI++L    H
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILATCNH 68

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             IV+  G+   D  L+I +E+   G+++  + E  R +TE  ++   R +L  L YLHS
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
              IHRD+K  N+L+   G +KLADFG+ AK++  L    S  G+P WMAPEV+     K
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGK 589
           D         DIWSLG T+IEM   +PP  E    + + K+    PP    P   S E +
Sbjct: 189 DT--PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246

Query: 590 DFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           DFL     ++P  RPSA +LLEHPF+ +  
Sbjct: 247 DFLKTALDKHPETRPSAAQLLEHPFVSSVT 276

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  177 bits (451), Expect = 2e-50
 Identities = 96/277 (34%), Positives = 147/277 (53%), Gaps = 28/277 (10%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----LEQEIKVLGHLKHE 414
           IG G+ G V I T++ TG   A+K++D+           KQ     L  E+ ++   +H 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLR----------KQQRRELLFNEVVIMRDYQHP 76

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NIV+ Y S +V D L++ +E++  G++   V  H R + E  +      +L  L++LH+ 
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLAVLKALSFLHAQ 134

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKD 533
             IHRDIK  ++L+ + G VKL+DFG    ++  +    SL G+P WMAPEVI  +    
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL---- 190

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKD 590
                   VDIWSLG  VIEM+ G+PP+      QAM ++ +  PP       +S   + 
Sbjct: 191 ---PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRS 247

Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 627
           FL R  +R+P +R +A ELL HPF+  A   +  VP+
Sbjct: 248 FLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVPL 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  175 bits (445), Expect = 8e-50
 Identities = 91/269 (33%), Positives = 143/269 (53%), Gaps = 20/269 (7%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G  G V    +R TG   A+K    I  +   A   KQ+ +E+ +L       IV +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVK---TIRLEINEAI-QKQILRELDILHKCNSPYIVGF 64

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIH 478
           YG+   +  + I +EY+  GS+++ ++E    I E I+      +L GL YLH     IH
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           RD+K +N+LV++ G +KL DFG++  L   S   +  G+ ++MAPE I+           
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVN-SLAKTFVGTSSYMAPERIQG-------NDY 176

Query: 539 ALAVDIWSLGCTVIEMLTGK-PPWSEFEGPQAMF----KVLNRTPP-IP-EMLSSEGKDF 591
           ++  DIWSLG ++IE+ TG+ P   E + P  +F     ++N  PP +P    S + +DF
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236

Query: 592 LLRCFLRNPVERPSAVELLEHPFIRNANY 620
           +  C +++P ERPS  ELLEHPFI+    
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIKKYES 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  174 bits (443), Expect = 3e-49
 Identities = 88/301 (29%), Positives = 151/301 (50%), Gaps = 60/301 (19%)

Query: 355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHL 411
           +K + +G GT+G VY   +++TG   A+K++ +  ++   P +   ++    EI +L  L
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPST--ALR----EISLLKEL 55

Query: 412 KHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
           KH NIV+    +V+  +  LY+  EY     + +Y+ +    ++ +++++    +L GLA
Sbjct: 56  KHPNIVKLL--DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM------AP 523
           Y HS   +HRD+K  N+L++  GV+KLADFG+A+     ++ + L+   + +      AP
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAP 167

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL------ 574
           E++       G+   + AVDIWS+GC   EM+TGKP +   SE +    +F++L      
Sbjct: 168 EILL------GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEE 221

Query: 575 ------------NRTPPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
                          P  P          L  EG D L +    NP +R SA E L+HP+
Sbjct: 222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Query: 615 I 615
            
Sbjct: 282 F 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  171 bits (435), Expect = 2e-48
 Identities = 87/276 (31%), Positives = 125/276 (45%), Gaps = 34/276 (12%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           + IG+G+FG+V     +  G     KE+D      K  E  +QL  E+ +L  LKH NIV
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK--EK-QQLVSEVNILRELKHPNIV 62

Query: 418 QYYGSEVVDDH--LYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGLAYL 471
           +YY   +   +  LYI +EY   G     I +  +E    I E  +      +L  L   
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLALYEC 121

Query: 472 H-----STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEV 525
           H         +HRD+K AN+ +DA+  VKL DFG+AK L    S+  +  G+P +M+PE 
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN------RTPP 579
           +        + K     DIWSLGC + E+    PP   F         L       +   
Sbjct: 182 L---NHMSYDEK----SDIWSLGCLIYELCALSPP---FTA--RNQLQLASKIKEGKFRR 229

Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           IP   SSE  + +      +P +RPS  ELL+ P I
Sbjct: 230 IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  169 bits (431), Expect = 7e-48
 Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 27/271 (9%)

Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           K +G G FG VY G            A+K +     + +     K   +E +V+  L H 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE----RKDFLKEARVMKKLGHP 56

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--------ITESIVRNFTRHILN 466
           N+V+  G    ++ LY+ LEY+  G +  Y+R+            ++   + +F   I  
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAP 523
           G+ YL S   +HRD+   N LV    VVK++DFG+++ +    Y     G      WMAP
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT-PPIP 581
           E +K       +       D+WS G  + E+ T G  P+      + +  +      P P
Sbjct: 177 ESLK-------DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP 229

Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           E    E  + +L C+  +P +RP+  EL+E 
Sbjct: 230 EYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  167 bits (425), Expect = 5e-47
 Identities = 101/258 (39%), Positives = 141/258 (54%), Gaps = 15/258 (5%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG+G+FG VY G +  T    AIK +D+     ++ + I+ ++QEI VL       I +Y
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYITRY 67

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           YGS +    L+I +EY+  GS    ++     + E+ +    R IL GL YLHS   IHR
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERKIHR 125

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK AN+L+   G VKLADFG+A  LT    +  +  G+P WMAPEVIK           
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK-------QSAY 178

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-MLSSEGKDFLLRCFL 597
               DIWSLG T IE+  G+PP S+    + +F +   +PP  E   S   K+F+  C  
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238

Query: 598 RNPVERPSAVELLEHPFI 615
           ++P  RP+A ELL+H FI
Sbjct: 239 KDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  166 bits (421), Expect = 2e-46
 Identities = 106/262 (40%), Positives = 144/262 (54%), Gaps = 16/262 (6%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG+G+FG V+ G +  T    AIK +D+     ++ + I+ ++QEI VL       + +Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           YGS + D  L+I +EY+  GS    +     D  E+ +    R IL GL YLHS   IHR
Sbjct: 68  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHR 125

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK AN+L+   G VKLADFG+A  LT    + +   G+P WMAPEVIK   Q   + K 
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDSK- 181

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-MLSSEGKDFLLRCFL 597
               DIWSLG T IE+  G+PP SE    + +F +    PP  E   S   K+F+  C  
Sbjct: 182 ---ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238

Query: 598 RNPVERPSAVELLEHPFI-RNA 618
           + P  RP+A ELL+H FI R A
Sbjct: 239 KEPSFRPTAKELLKHKFIVRFA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  164 bits (417), Expect = 9e-46
 Identities = 96/266 (36%), Positives = 138/266 (51%), Gaps = 11/266 (4%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W+    +G G FG VY   N+ETG   A K +D      KS E ++    EI +L    H
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT-----KSEEELEDYMVEIDILASCDH 61

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+   +   +++L+I +E+   G+++  + E  R +TE  +R   +  L  L YLH 
Sbjct: 62  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
              IHRD+K  N+L    G +KLADFG+ AK+   +    S  G+P WMAPEV+     K
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGK 589
           D         D+WSLG T+IEM   +PP  E    + + K+    PP    P   SSE K
Sbjct: 182 D--RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239

Query: 590 DFLLRCFLRNPVERPSAVELLEHPFI 615
           DFL +C  +N   R +  +LL+HPF+
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  164 bits (415), Expect = 2e-45
 Identities = 110/286 (38%), Positives = 156/286 (54%), Gaps = 22/286 (7%)

Query: 341 IMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 396
           IMEK     S    K ++ + + IG+G  G+V+   +  TG   AIK++++    PK   
Sbjct: 4   IMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKEL 62

Query: 397 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 456
            I     EI V+  LK+ NIV +  S +V D L++ +EY+  GS+   V E C D  E+ 
Sbjct: 63  II----NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD--EAQ 116

Query: 457 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLK 515
           +    R  L  L +LH+   IHRDIK  N+L+   G VKL DFG    +T   S   ++ 
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176

Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-L 574
           G+P WMAPEV   V +K   PK    VDIWSLG   IEM+ G+PP+      +A++ +  
Sbjct: 177 GTPYWMAPEV---VTRKAYGPK----VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229

Query: 575 NRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           N TP +  PE LS   +DFL RC   +  +R SA ELL+HPF++ A
Sbjct: 230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  163 bits (413), Expect = 3e-45
 Identities = 100/258 (38%), Positives = 142/258 (55%), Gaps = 15/258 (5%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG+G+FG V+ G +  T    AIK +D+     ++ + I+ ++QEI VL       + +Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           YGS +    L+I +EY+  GS    +R    D  E  +    + IL GL YLHS   IHR
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD--EFQIATMLKEILKGLDYLHSEKKIHR 125

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK AN+L+   G VKLADFG+A  LT    +  +  G+P WMAPEVI+   Q   + K 
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ---QSAYDSK- 181

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IPEMLSSEGKDFLLRCFL 597
               DIWSLG T IE+  G+PP S+    + +F +    PP +    S   K+F+  C  
Sbjct: 182 ---ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238

Query: 598 RNPVERPSAVELLEHPFI 615
           ++P  RP+A ELL+H FI
Sbjct: 239 KDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  163 bits (413), Expect = 4e-45
 Identities = 110/298 (36%), Positives = 159/298 (53%), Gaps = 18/298 (6%)

Query: 346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           S    K ++ + + IG+G  G+VY   +  TG   AIK++++    PK    I     EI
Sbjct: 13  SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNL-QQQPKKELII----NEI 67

Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E  +    R  L
Sbjct: 68  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECL 125

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPE 524
             L +LHS   IHRDIK  N+L+   G VKL DFG    +T   S   ++ G+P WMAPE
Sbjct: 126 QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI--P 581
           V   V +K   PK    VDIWSLG   IEM+ G+PP+      +A++ +  N TP +  P
Sbjct: 186 V---VTRKAYGPK----VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238

Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKS 639
           E LS+  +DFL RC   +   R SA ELL+HPF++ A   +   P+ + ++  + + S
Sbjct: 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAAKEAIKNSS 296

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  163 bits (413), Expect = 7e-45
 Identities = 92/261 (35%), Positives = 135/261 (51%), Gaps = 16/261 (6%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+FG+VY   +  T    AIK++       +S E  + + +E++ L  L+H N ++Y
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
            G  + +   ++ +EY   GS +  +  H + + E  +       L GLAYLHS   IHR
Sbjct: 81  KGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR 139

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 537
           DIK  N+L+   G VKLADFG A   + +S   S  G+P WMAPEVI A+   Q DG   
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSA---SLVSPANSFVGTPYWMAPEVILAMDEGQYDGK-- 194

Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRC 595
               VD+WSLG T IE+   KPP        A++ +     P       S   ++F+  C
Sbjct: 195 ----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC 250

Query: 596 FLRNPVERPSAVELLEHPFIR 616
             + P +RPS+ ELL+H F+ 
Sbjct: 251 LQKIPQDRPSSEELLKHRFVL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  160 bits (407), Expect = 1e-44
 Identities = 85/266 (31%), Positives = 134/266 (50%), Gaps = 28/266 (10%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVLGHLKHEN 415
           +G+G+FG V +   ++TG   A+K +       K     ++  +    E  +L  + H  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK------KKKIIKRKEVEHTLTERNILSRINHPF 54

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           IV+ + +   ++ LY+ LEY   G +  ++ +     +E   R +   I+  L YLHS  
Sbjct: 55  IVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG 113

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
            I+RD+K  N+L+DA G +KL DFG+AK L +  S   +  G+P ++APEV+     K  
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL---GKGY 170

Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEMLSSEGKDF 591
                 AVD WSLG  + EMLTGKPP   F     + ++ K+L      PE LS E +D 
Sbjct: 171 GK----AVDWWSLGVLLYEMLTGKPP---FYAEDRKEIYEKILKDPLRFPEFLSPEARDL 223

Query: 592 LLRCFLRNPVER---PSAVELLEHPF 614
           +     ++P +R     A E+  HPF
Sbjct: 224 ISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  164 bits (415), Expect = 1e-44
 Identities = 87/287 (30%), Positives = 136/287 (47%), Gaps = 33/287 (11%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++  + +G G+FG VY+  +R+     A+K +    +        ++  +EI++L  L H
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEV--ERFLREIQILASLNH 56

Query: 414 E-NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAY 470
             NIV+ Y     +  LY+ +EYV  GS+   +++      ++ES        IL+ L Y
Sbjct: 57  PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 471 LHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYEL-------SLKGSPNWMA 522
           LHS   IHRDIK  N+L+D  G VVKL DFG+AK L              +  G+P +MA
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-------- 574
           PEV+  +     +       DIWSLG T+ E+LTG PP+   +   A  + L        
Sbjct: 177 PEVLLGLSLAYASSS----SDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232

Query: 575 -----NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
                  +P  PE++S    D L +   ++P  R S+   L H  + 
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279

Length = 384

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  161 bits (408), Expect = 2e-44
 Identities = 96/275 (34%), Positives = 146/275 (53%), Gaps = 21/275 (7%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK- 412
           W+  + IG+GT+G V+   N++ G+  A+K +D I D        +++E E  +L  L  
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD------IDEEIEAEYNILKALSD 73

Query: 413 HENIVQYYG-----SEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHI 464
           H N+V++YG          D L++ LE  + GS+   V+   +    + E I+       
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAP 523
           L GL +LH   TIHRD+KG N+L+   G VKL DFG++  LT      +   G+P WMAP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--- 580
           EVI    Q D         D+WSLG T IE+  G PP ++    +A+FK+    PP    
Sbjct: 194 EVIACEQQLDST--YDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ 251

Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           PE+ S+E  DF+ +C  ++  +RP+  +LL+H FI
Sbjct: 252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  159 bits (404), Expect = 7e-44
 Identities = 106/277 (38%), Positives = 150/277 (54%), Gaps = 18/277 (6%)

Query: 346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           S    K ++ + + IG+G  G+VY   +  TG   AI+++++    PK    I     EI
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELII----NEI 68

Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E  +    R  L
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECL 126

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPE 524
             L +LHS   IHRDIK  N+L+   G VKL DFG    +T    + S + G+P WMAPE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI--P 581
           V   V +K   PK    VDIWSLG   IEM+ G+PP+      +A++ +  N TP +  P
Sbjct: 187 V---VTRKAYGPK----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239

Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           E LS+  +DFL RC   +  +R SA ELL+H F++ A
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  158 bits (402), Expect = 2e-43
 Identities = 86/297 (28%), Positives = 132/297 (44%), Gaps = 58/297 (19%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           ++G G +G V    N+ TG   AIK+     DD    +   +   E+KVL  L+HENIV 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVN 64

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
              +      LY+  EYV   ++   +      +    VR++   +L  +AY HS N IH
Sbjct: 65  LKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN--------WM-APEVIKAV 529
           RDIK  N+LV  SGV+KL DFG A+ L         + +          W  APE++   
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRA-------RPASPLTDYVATRWYRAPELLV-- 174

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFE---------GP--QAMFKVLN 575
               G+      VD+W++GC + E+L G+P +   S+ +         GP   +  ++ +
Sbjct: 175 ----GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230

Query: 576 --------RTPPIPEMLSSEGK----------DFLLRCFLRNPVERPSAVELLEHPF 614
                     P   +  S E +          DFL  C   +P ER +  ELL+HP+
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  158 bits (400), Expect = 2e-43
 Identities = 95/276 (34%), Positives = 142/276 (51%), Gaps = 21/276 (7%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-K 412
           W+  + IG+GT+G VY  TN++ G+  A+K +D I D        +++E E  +L  L  
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD------VDEEIEAEYNILQSLPN 77

Query: 413 HENIVQYYGSEVVDDH-----LYIYLEYVHPGSINRYVREHCR---DITESIVRNFTRHI 464
           H N+V++YG     D      L++ LE  + GS+   V+        + E+++       
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAP 523
           L GL +LH+   IHRD+KG N+L+   G VKL DFG++  LT      +   G+P WMAP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--- 580
           EVI    Q D +       D+WSLG T IE+  G PP  +    + +FK+    PP    
Sbjct: 198 EVIACEQQYDYS--YDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH 255

Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
           PE        F+ +C +++   RPS   LLEHPFI+
Sbjct: 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  157 bits (397), Expect = 3e-43
 Identities = 99/262 (37%), Positives = 147/262 (56%), Gaps = 18/262 (6%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG GT+G VY   N  TG   AIK + + P      E    ++QEI ++   KH NIV Y
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           +GS +  D L+I +E+   GS+   +      ++ES +   +R  L GL YLHS   +HR
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIKGAN+L+  +G VKLADFG++  +T  ++   S  G+P WMAPEV  AV +K G  +L
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV-AAVERKGGYNQL 189

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK------DFL 592
               DIW++G T IE+   +PP  +    +A+F ++ ++   P  L  + K       F+
Sbjct: 190 C---DIWAVGITAIELAELQPPMFDLHPMRALF-LMTKSNFQPPKLKDKMKWSNSFHHFV 245

Query: 593 LRCFLRNPVERPSAVELLEHPF 614
                +NP +RP+A +LL+HPF
Sbjct: 246 KMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  157 bits (397), Expect = 4e-43
 Identities = 100/273 (36%), Positives = 149/273 (54%), Gaps = 27/273 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG-HLKHENI 416
           +++G GT+G VY G + +TG   AIK +D+  D+ +      +++ EI +L  +  H NI
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE------EIKLEINMLKKYSHHRNI 75

Query: 417 VQYYGSEVV------DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLA 469
             YYG+ +       DD L++ +E+   GS+   V+      + E  +    R IL GLA
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKA 528
           +LH+   IHRDIKG N+L+  +  VKL DFG++  L   +    +  G+P WMAPEVI  
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 529 VMQKDGNPKLALAV--DIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSS 586
               D NP        DIWSLG T IEM  G PP  +    +A+F ++ R PP P++ S 
Sbjct: 196 ----DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPP-PKLKSK 249

Query: 587 EGK----DFLLRCFLRNPVERPSAVELLEHPFI 615
           +      DF+  C ++N + RPS  +LL+HPFI
Sbjct: 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  157 bits (397), Expect = 1e-42
 Identities = 105/290 (36%), Positives = 149/290 (51%), Gaps = 28/290 (9%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+FG+VY  TN  T    A+K++       ++ E  + + +E+K L  LKH N ++Y
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSY--SGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
            G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAYLHS N IHR
Sbjct: 87  KGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 537
           DIK  N+L+   G VKLADFG A   +  +   S  G+P WMAPEVI A+   Q DG   
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYDGK-- 200

Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD----FLL 593
               VD+WSLG T IE+   KPP        A++ +     P   + S+E  D    F+ 
Sbjct: 201 ----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT--LQSNEWTDSFRGFVD 254

Query: 594 RCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQV 643
            C  + P ERP++ ELL H F+R         P RV   I+L  ++ D V
Sbjct: 255 YCLQKIPQERPASAELLRHDFVRRDR------PARVL--IDLIQRTKDAV 296

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  153 bits (388), Expect = 1e-41
 Identities = 84/297 (28%), Positives = 131/297 (44%), Gaps = 57/297 (19%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG GT+G VY   N++TG   A+K+  I  ++ K    I  +  EIK+L  L+H NIV+ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKK--IRMENEKEGFPITAIR-EIKLLQKLRHPNIVRL 63

Query: 420 YGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
              E+V       +Y+  EY+    +   +       TES ++ + + +L GL YLHS  
Sbjct: 64  K--EIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----WM-APEVIKAVM 530
            +HRDIKG+N+L++  GV+KLADFG+A+  T      S   +      W   PE++    
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTK---RNSADYTNRVITLWYRPPELLL--- 174

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPP------------------------WSEFEG 566
              G  +    VD+WS+GC + E+  GKP                         W     
Sbjct: 175 ---GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231

Query: 567 PQAMFKVLNRTPPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
               F+ L    P           ++     D L +    +P +R SA + L+H + 
Sbjct: 232 LP-WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  152 bits (385), Expect = 2e-41
 Identities = 93/271 (34%), Positives = 145/271 (53%), Gaps = 23/271 (8%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG-HLKHENI 416
           +L+G GT+G VY G + +TG   AIK +D+  D+ +      +++QEI +L  +  H NI
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE------EIKQEINMLKKYSHHRNI 65

Query: 417 VQYYGSEV------VDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLA 469
             YYG+ +      +DD L++ +E+   GS+   ++      + E  +    R IL GL+
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKA 528
           +LH    IHRDIKG N+L+  +  VKL DFG++  L   +    +  G+P WMAPEVI  
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 529 VMQKDGNPKLA--LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP--IPEML 584
               D NP        D+WSLG T IEM  G PP  +    +A+F +     P    +  
Sbjct: 186 ----DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 241

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           S + + F+  C ++N  +RP+  +L++HPFI
Sbjct: 242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  153 bits (387), Expect = 2e-41
 Identities = 91/272 (33%), Positives = 141/272 (51%), Gaps = 18/272 (6%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+ G V I   + +G   A+K +D+     +  +  + L  E+ ++   +H+N+V+ 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHQNVVEM 83

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y S +V + L++ +E++  G++   V +    + E  +      +L  L YLHS   IHR
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHR 141

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK  ++L+   G VKL+DFG    ++  +    SL G+P WMAPEVI            
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-------Y 194

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE---MLSSEGKDFLLRC 595
              VDIWSLG  VIEM+ G+PP+      QAM ++ +  PP  +    +S   +DFL R 
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254

Query: 596 FLRNPVERPSAVELLEHPFIRNANYQNLSVPM 627
             R P ER +A ELL+HPF+         VP+
Sbjct: 255 LTREPQERATAQELLDHPFLLQTGLPECLVPL 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  151 bits (383), Expect = 3e-41
 Identities = 98/261 (37%), Positives = 143/261 (54%), Gaps = 16/261 (6%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G GT+G VY   N  TG   A+K + + P D  S      ++QEI ++   KH NIV Y
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-----IQQEIFMVKECKHCNIVAY 71

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           +GS +  + L+I +EY   GS+   +      ++E  +    R  L GLAYLHS   +HR
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIKGAN+L+  +G VKLADFG+A  +T  ++   S  G+P WMAPEV  AV +  G  +L
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV-AAVEKNGGYNQL 189

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF---KVLNRTPPIPEML--SSEGKDFLL 593
               DIW++G T IE+   +PP  +    +A+F   K   + P + +    SS   +F+ 
Sbjct: 190 C---DIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVK 246

Query: 594 RCFLRNPVERPSAVELLEHPF 614
               +NP +RP+A  LL H F
Sbjct: 247 ISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  153 bits (389), Expect = 3e-41
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 63/303 (20%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K IG G +G V    ++ TG   AIK++  + DD   A   K++ +EIK+L HL+HENI+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA---KRILREIKLLRHLRHENII 62

Query: 418 Q-----YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
                    S    + +YI  E +    +++ ++   + +T+  ++ F   IL GL YLH
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLH 120

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------A 522
           S N IHRD+K +N+LV+++  +K+ DFG+A+ +     E        ++          A
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE------KGFLTEYVVTRWYRA 174

Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWS 562
           PE++ +  +         A+DIWS+GC   E+LT KP                    P  
Sbjct: 175 PELLLSSSRYT------KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228

Query: 563 E----FEGPQAMFKVLNRTP----PIPEML---SSEGKDFLLRCFLRNPVERPSAVELLE 611
           E        +A   + +       P+ ++    S E  D L +  + +P +R +A E L 
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288

Query: 612 HPF 614
           HP+
Sbjct: 289 HPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  149 bits (377), Expect = 1e-40
 Identities = 79/258 (30%), Positives = 133/258 (51%), Gaps = 15/258 (5%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQ 418
           IG+G+FG V+    +      A+K++D+   + +   E I     E +VL  L    I++
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKLDSSYIIR 63

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTI 477
           YY S +    L I +EY   G +++ ++    R + E  V  F   IL GLA+LHS   +
Sbjct: 64  YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           HRDIK  NL +DA   VK+ D G+AK L    ++  ++ G+P +++PE+ +    K  N 
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE---DKPYNE 180

Query: 537 KLALAVDIWSLGCTVIEMLTGKPPW-SEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 595
           K     D+W+LG  + E  TGK P+ +  +G   +  +    PP+ +M S +    + +C
Sbjct: 181 K----SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236

Query: 596 FLRNPVERPSAVELLEHP 613
             ++  +RP   +LL +P
Sbjct: 237 LTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  149 bits (379), Expect = 2e-40
 Identities = 89/284 (31%), Positives = 142/284 (50%), Gaps = 47/284 (16%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G  GSV     + TG   A+K +   P+     +  KQ+ +E+++    K   IV+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNP----DLQKQILRELEINKSCKSPYIVKY 64

Query: 420 YGSEVVDDH---LYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHS 473
           YG+  +D+    + I +EY   GS++     V++    I E ++      +L GL+YLHS
Sbjct: 65  YGA-FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFG--------MAKHLTGLSYELSLKGSPNWMAPEV 525
              IHRDIK +N+L+   G VKL DFG        +A   TG S+         +MAPE 
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF---------YMAPER 174

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-SEFEGPQAMFKVLNR--TPPIPE 582
           I+      G P  ++  D+WSLG T++E+   + P+  E E P    ++L+     P PE
Sbjct: 175 IQ------GKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227

Query: 583 MLSSEG---------KDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           +    G         KDF+ +C  ++P  RP+  ++LEHP+I+ 
Sbjct: 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  149 bits (378), Expect = 2e-40
 Identities = 94/272 (34%), Positives = 149/272 (54%), Gaps = 18/272 (6%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+ G V I T + TG   A+K++D+     +  +  + L  E+ ++    HEN+V  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVDM 84

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+YLH+   IHR
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLSVLRALSYLHNQGVIHR 142

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK  ++L+ + G +KL+DFG    ++  +    SL G+P WMAPEVI  +         
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL-------PY 195

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IPEM--LSSEGKDFLLRC 595
              VDIWSLG  VIEM+ G+PP+      QAM ++ +  PP + +   +SS  + FL   
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255

Query: 596 FLRNPVERPSAVELLEHPFIRNANYQNLSVPM 627
            +R P +R +A ELL+HPF++ A   +  VP+
Sbjct: 256 LVREPSQRATAQELLQHPFLKLAGPPSCIVPL 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  148 bits (377), Expect = 2e-40
 Identities = 83/277 (29%), Positives = 137/277 (49%), Gaps = 28/277 (10%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQEIKVLGHLKHENIVQ 418
           I +G +G V++   + TG   AIK   +I       +  + Q+  E  +L   +   +V+
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIK---VIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
            Y S     +LY+ +EY+  G +   + E+   + E + R +   I+  L YLHS   IH
Sbjct: 58  LYYSFQGKKNLYLVMEYLPGGDLAS-LLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116

Query: 479 RDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLK--------GSPNWMAPEVIKAV 529
           RD+K  N+L+D++G +KL DFG++K  L      L+          G+P+++APEVI   
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG- 175

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPE--MLSS 586
             +  +      VD WSLGC + E L G PP+   E P+ +F  +LN     PE   +S 
Sbjct: 176 --QGHSK----TVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSD 228

Query: 587 EGKDFLLRCFLRNPVERP---SAVELLEHPFIRNANY 620
           E  D + +  + +P +R    S  E+  HPF +  ++
Sbjct: 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  148 bits (377), Expect = 3e-40
 Identities = 87/289 (30%), Positives = 135/289 (46%), Gaps = 46/289 (15%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENIVQ 418
           IG G  G V+   +RETG + A+K+V +     +    I  Q  +EIK L   +H  +V+
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVAL----RRLEGGIPNQALREIKALQACQHPYVVK 63

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
                       + +EY+ P  ++  +R+  R + E+ V+++ R +L G+AY+H+   +H
Sbjct: 64  LLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH 122

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNW-MAPEVIKAVMQKDGNP 536
           RD+K ANLL+ A GV+K+ADFG+A+          S + +  W  APE++       G  
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY------GAR 176

Query: 537 KLALAVDIWSLGCTVIEMLTGKP--------------------P----WSEFEG-PQAMF 571
           K    VD+W++GC   E+L G P                    P    W      P    
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236

Query: 572 KVLNRTPPIP--EML---SSEGKDFLLRCFLR-NPVERPSAVELLEHPF 614
                + PIP  E+    S E  D LL+  L  +P +R SA E L HP+
Sbjct: 237 ITFPESKPIPLEEIFPDASPEALD-LLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  148 bits (375), Expect = 7e-40
 Identities = 91/303 (30%), Positives = 143/303 (47%), Gaps = 71/303 (23%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA-----ECIKQLEQEIKVLGHLK 412
           K +G GTFGSVY+  N+ETG   AIK++       K       EC+    +E+K L  L 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMN--LREVKSLRKLN 55

Query: 413 -HENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGL 468
            H NIV+    EV   +D LY   EY+  G++ + +++   +  +ES++R+    IL GL
Sbjct: 56  EHPNIVKLK--EVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL------TGLSYELSLKGSPNWM- 521
           A++H     HRD+K  NLLV    VVK+ADFG+A+ +      T   Y      S  W  
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT--DYV-----STRWYR 165

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP---------------------- 559
           APE++        +   +  VDIW+LGC + E+ T +P                      
Sbjct: 166 APEILLR------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPT 219

Query: 560 --PWSE-FEGPQAM-FKVLNRTP-PIPEML---SSEGKDFLLRCFLRNPVERPSAVELLE 611
              W E ++    + F+     P  + +++   S E  D +      +P +RP+A + L+
Sbjct: 220 KQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279

Query: 612 HPF 614
           HP+
Sbjct: 280 HPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  147 bits (374), Expect = 8e-40
 Identities = 89/297 (29%), Positives = 133/297 (44%), Gaps = 62/297 (20%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV--------- 407
           GK+IG G+F +V +   +ET    AIK +D            +QL +E KV         
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDK-----------RQLIKEKKVKYVKIEKEV 54

Query: 408 LGHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHIL 465
           L  L  H  I++ Y +   +++LY  LEY   G + +Y+R++   D  E   R +   IL
Sbjct: 55  LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD--EKCTRFYAAEIL 112

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---------- 515
             L YLHS   IHRD+K  N+L+D    +K+ DFG AK L   S   S K          
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 516 -----------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 564
                      G+  +++PE++    +K        + D+W+LGC + +MLTGKPP   F
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLN---EKPAGK----SSDLWALGCIIYQMLTGKPP---F 222

Query: 565 EGP---QAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERP----SAVELLEHPF 614
            G        K+L      P     + KD + +  + +P +R        EL  HPF
Sbjct: 223 RGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  146 bits (371), Expect = 9e-40
 Identities = 82/274 (29%), Positives = 134/274 (48%), Gaps = 27/274 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHE-- 414
           K I +G FGSVY+   R TG   AIK   ++   D  +   +  ++ E  ++  ++ E  
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIK---VLKKSDMIAKNQVTNVKAERAIM-MIQGESP 57

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            + + Y S    D+LY+ +EY++ G     ++     + E   + +   ++ G+  LH  
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQR 116

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
             IHRDIK  NLL+D +G +KL DFG+++   GL  +    G+P+++APE I   +    
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSR--NGLENK-KFVGTPDYLAPETI---LGVGD 170

Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-----VLNRTPPIPEMLSSEGK 589
           +       D WSLGC + E L G PP+   E P A+F       +N    + E  S E  
Sbjct: 171 DK----MSDWWSLGCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAV 225

Query: 590 DFLLRCFLRNPVERPSA---VELLEHPFIRNANY 620
           D + R    +P +R  A    E+  HPF ++ N+
Sbjct: 226 DLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  146 bits (371), Expect = 2e-39
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 27/275 (9%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQEIKVLGHLKHEN 415
           +G G FG V +   +    + A+K V       K         + +  E ++L    H  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCV------KKRHIVETGQQEHIFSEKEILEECNHPF 54

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           IV+ Y +     ++Y+ +EY   G +   +R+      E   R +   ++    YLH+  
Sbjct: 55  IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLHNRG 113

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
            I+RD+K  NLL+D++G VKL DFG AK L       +  G+P ++APE+I     K  +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL---NKGYD 170

Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFK-VLNRTPPI--PEMLSSEGKDF 591
                +VD WSLG  + E+LTG+PP+ E  E P  ++  +L     +  P  +    KD 
Sbjct: 171 ----FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226

Query: 592 LLRCFLRNPVER-----PSAVELLEHPFIRNANYQ 621
           + +   RNP ER         ++ +H +    +++
Sbjct: 227 IKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  146 bits (371), Expect = 3e-39
 Identities = 84/275 (30%), Positives = 141/275 (51%), Gaps = 25/275 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 414
           K +G G+FG V +  ++ +G   A+K    I    K  + +KQ+E    E ++L  ++H 
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALK----ILSKAKIVK-LKQVEHVLNEKRILQSIRHP 61

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +V  YGS   D +LY+ +EYV  G +  ++R+      E + R +   ++  L YLHS 
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSL 120

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           + ++RD+K  NLL+D+ G +K+ DFG AK + G +Y L   G+P ++APE+I       G
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--GTPEYLAPEII----LSKG 174

Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLL 593
             K   AVD W+LG  + EML G PP+ + + P  ++ K+L      P   S + KD + 
Sbjct: 175 YGK---AVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEGKVRFPSFFSPDAKDLIR 230

Query: 594 RCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
                +  +R         ++  HP+    ++  L
Sbjct: 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 8e-39
 Identities = 83/296 (28%), Positives = 140/296 (47%), Gaps = 47/296 (15%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK   IG GT+G VY   ++ TG   AIK++ +  +        K   +EIK+L  L H
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP---KTALREIKLLKELNH 57

Query: 414 ENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
            NI++    +V      LY+  E++    + + +++  R + ES+++++   +L GLA+ 
Sbjct: 58  PNIIKLL--DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVM 530
           HS   +HRD+K  NLL++  GV+KLADFG+A+         +      W  APE++    
Sbjct: 115 HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP--------- 578
                      VDIWS+GC   E+L+ +P +   SE +    +F+ L  TP         
Sbjct: 175 GYSTP------VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLG-TPDPEVWPKFT 227

Query: 579 ----------------PIPEM---LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
                           P+P++    S +  D L +    +P +R +A + L HP+ 
Sbjct: 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  144 bits (366), Expect = 9e-39
 Identities = 91/276 (32%), Positives = 151/276 (54%), Gaps = 17/276 (6%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G +GSVY   +R TG + A+KE+ +  D+ K  + I +L+    +L       IV +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD----ILHKAVSPYIVDF 64

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHST-NT 476
           YG+  ++  +Y+ +EY+  GS+++          I E ++R  T  ++ GL +L    N 
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           IHRD+K  N+LV+ +G VKL DFG++ +L   S   +  G  ++MAPE IK     + NP
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-SLAKTNIGCQSYMAPERIK-SGGPNQNP 182

Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPP-IPEMLSSEGKDF 591
              +  D+WSLG +++EM  G+ P+   E    +F  L+      PP +P   S + +DF
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDF 241

Query: 592 LLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 627
           + +C  + P  RP+  +LLEHP++    Y+N  V M
Sbjct: 242 VAKCLNKIPNRRPTYAQLLEHPWLV--KYKNADVDM 275

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  144 bits (364), Expect = 2e-38
 Identities = 93/272 (34%), Positives = 147/272 (54%), Gaps = 18/272 (6%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+ G V I T + +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 82

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLKALSVLHAQGVIHR 140

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK  ++L+   G VKL+DFG    ++  +    SL G+P WMAPE+I  +         
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-------PY 193

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML---SSEGKDFLLRC 595
              VDIWSLG  VIEM+ G+PP+      +AM  + +  PP  + L   S   K FL R 
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL 253

Query: 596 FLRNPVERPSAVELLEHPFIRNANYQNLSVPM 627
            +R+P +R +A ELL+HPF+  A   +  VP+
Sbjct: 254 LVRDPAQRATAAELLKHPFLAKAGPPSCIVPL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  143 bits (364), Expect = 3e-38
 Identities = 89/312 (28%), Positives = 143/312 (45%), Gaps = 70/312 (22%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC------IKQLEQEIK 406
           +++KGK +G GT+  VY   ++ETG   AIK+  I   + K A+       ++    EIK
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKK--IKLGERKEAKDGINFTALR----EIK 54

Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +L  LKH NI+          ++ +  E++    + + +++    +T + ++++    L 
Sbjct: 55  LLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR 113

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPEV 525
           GL YLHS   +HRD+K  NLL+ + GV+KLADFG+A+     S+     GSPN  M  +V
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-----SF-----GSPNRKMTHQV 163

Query: 526 I----KAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF 571
           +    +A       P+L          VD+WS+GC   E+L   P     S+ +    +F
Sbjct: 164 VTRWYRA-------PELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF 216

Query: 572 KVL--------------------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSA 606
           + L                       PP P        S +  D L R    NP +R +A
Sbjct: 217 EALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA 276

Query: 607 VELLEHPFIRNA 618
            + LEHP+  N 
Sbjct: 277 RQALEHPYFSND 288

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  142 bits (361), Expect = 3e-38
 Identities = 84/267 (31%), Positives = 136/267 (50%), Gaps = 27/267 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAE-CIKQLEQEIKVLGHLKHEN 415
           K IG+G F  VY       G   A+K+V I    D K+ + C+K    EI +L  L H N
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK----EIDLLKQLDHPN 63

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINR---YVREHCRDITESIVRNFTRHILNGLAYLH 472
           +++Y  S + ++ L I LE    G ++R   + ++  R I E  +  +   + + L ++H
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQ 531
           S   +HRDIK AN+ + A+GVVKL D G+ +  +  +    SL G+P +M+PE I     
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI----H 179

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKVLNRT-----PPIP-EML 584
           ++G        DIWSLGC + EM   + P   F G +  ++ +  +      PP+P +  
Sbjct: 180 ENG---YNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEKCDYPPLPADHY 233

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLE 611
           S E +D + RC   +P +RP    +L+
Sbjct: 234 SEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  141 bits (358), Expect = 5e-38
 Identities = 82/264 (31%), Positives = 133/264 (50%), Gaps = 23/264 (8%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           K +G+G++GSVY           A+KEVD+      +  + +     EI++L  + H NI
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV----NEIRILASVNHPNI 61

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHS 473
           + Y  + +  + L I +EY   G +++ + +     + I E  +      +L GL  LH 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
              +HRD+K AN+L+ A+ +VK+ D G++K L     +  + G+P++MAPEV K      
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWK------ 174

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM---FKVLN-RTPPIPEMLSSEGK 589
           G P  +   DIWSLGC + EM T  PP   FE        +KV   + PPIP + S + +
Sbjct: 175 GRP-YSYKSDIWSLGCLLYEMATFAPP---FEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230

Query: 590 DFLLRCFLRNPVERPSAVELLEHP 613
           +F+       P  RP+  ++L  P
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  143 bits (362), Expect = 7e-38
 Identities = 91/314 (28%), Positives = 133/314 (42%), Gaps = 73/314 (23%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           GKL G GTFG VY     +TG   A+K+  I+  + K    I  L +EIK+L  LKH N+
Sbjct: 14  GKL-GEGTFGEVYKARQIKTGRVVALKK--ILMHNEKDGFPITAL-REIKILKKLKHPNV 69

Query: 417 VQY------YGSEVVDDHLYIYLEYVHP-------GSI-NRYVREHCRDITESIVRNFTR 462
           V           +       +Y+  V P       G + N  V+     +TES ++ +  
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYM--VTPYMDHDLSGLLENPSVK-----LTESQIKCYML 122

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN--- 519
            +L G+ YLH  + +HRDIK AN+L+D  G++K+ADFG+A+   G        G      
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182

Query: 520 --------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----------- 559
                   W   PE++       G  +   AVDIW +GC   EM T +P           
Sbjct: 183 YTNLVVTRWYRPPELLL------GERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236

Query: 560 ---------P-------WSEFEGPQAMFKVLNRTPPIPEM---LSSEGKDFLLRCFLRNP 600
                    P       W    G + +    N    + E    L  EG D L +    +P
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296

Query: 601 VERPSAVELLEHPF 614
            +R +A + LEHP+
Sbjct: 297 YKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  143 bits (361), Expect = 9e-38
 Identities = 95/262 (36%), Positives = 138/262 (52%), Gaps = 20/262 (7%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+FG+VY   +  T    AIK++       +S E  + + +E+K L  +KH N ++Y
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
            G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAYLHS N IHR
Sbjct: 91  KGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 537
           DIK  N+L+   G VKLADFG A   +  +   S  G+P WMAPEVI A+   Q DG   
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMDEGQYDGK-- 204

Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD----FLL 593
               VD+WSLG T IE+   KPP        A++ +     P   + S+E  D    F+ 
Sbjct: 205 ----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWSDYFRNFVD 258

Query: 594 RCFLRNPVERPSAVELLEHPFI 615
            C  + P +RP++ ELL+H F+
Sbjct: 259 SCLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  142 bits (359), Expect = 2e-37
 Identities = 81/272 (29%), Positives = 140/272 (51%), Gaps = 19/272 (6%)

Query: 358 KLIGRGTFGSVYI----GTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           K++G+G+FG V +    GTN         K+V +  DD    EC   +E+ +  L   +H
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD---VEC-TMVERRVLALA-WEH 55

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             +   + +    +HL+  +EY++ G +  +++       E+  R +   I+ GL +LH 
Sbjct: 56  PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHK 114

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
              I+RD+K  N+L+D  G +K+ADFGM K ++ G     +  G+P+++APE++K     
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ--- 171

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 592
               K   +VD WS G  + EML G+ P+   +  +    +LN  P  P  +S E KD L
Sbjct: 172 ----KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCL 227

Query: 593 LRCFLRNPVER-PSAVELLEHPFIRNANYQNL 623
            + F R+P +R     ++ +HPF R  +++ L
Sbjct: 228 SKLFERDPTKRLGVDGDIRQHPFFRGIDWERL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  141 bits (358), Expect = 5e-37
 Identities = 112/356 (31%), Positives = 177/356 (49%), Gaps = 41/356 (11%)

Query: 271 SPLPSPPRQSSQSNLRS-PRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPP 329
            P   P   +++   +S PR+   P     LPQ    L        A PLPLPP + S  
Sbjct: 6   PPPGVPLPSTARHTTKSRPRRR--PDLTLPLPQRDPSL--------AVPLPLPPPSSSSS 55

Query: 330 KSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 389
            SS +SA        PSA+   S+ ++   IG G  G+VY   +R TG   A+K +    
Sbjct: 56  SSSSSSA----SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111

Query: 390 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 449
           +D       +Q+ +EI++L  + H N+V+ +     +  + + LE++  GS+     E  
Sbjct: 112 ED----TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-----EGT 162

Query: 450 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GL 508
               E  + +  R IL+G+AYLH  + +HRDIK +NLL++++  VK+ADFG+++ L   +
Sbjct: 163 HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222

Query: 509 SYELSLKGSPNWMAPEVIKAVMQK---DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 565
               S  G+  +M+PE I   +     DG      A DIWSLG +++E   G+ P+    
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYDG-----YAGDIWSLGVSILEFYLGRFPFG--V 275

Query: 566 GPQAMFKVL------NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           G Q  +  L      ++ P  P   S E + F+  C  R P +R SA++LL+HPFI
Sbjct: 276 GRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  140 bits (353), Expect = 9e-37
 Identities = 91/277 (32%), Positives = 140/277 (50%), Gaps = 18/277 (6%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+FG+VY   +       AIK++       +S E  + + +E++ L  L+H N +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
            G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAYLHS N IHR
Sbjct: 81  RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 537
           D+K  N+L+   G+VKL DFG A  +   +      G+P WMAPEVI A+   Q DG   
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGK-- 194

Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE--MLSSEGKDFLLRC 595
               VD+WSLG T IE+   KPP        A++ +     P  +    S   ++F+  C
Sbjct: 195 ----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250

Query: 596 FLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSR 632
             + P +RP++  LL+H F+     +  +V M +  R
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLRE--RPPTVIMDLIQR 285

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  138 bits (348), Expect = 1e-36
 Identities = 84/268 (31%), Positives = 140/268 (52%), Gaps = 17/268 (6%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++ K K IG G+FG   +  ++E G    IKE++I    PK  E   +  +E+ VL ++K
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMK 57

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAY 470
           H NIVQY  S   + +LYI ++Y   G + + +    R +   E  + ++   I   L +
Sbjct: 58  HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKH 116

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK--GSPNWMAPEVIKA 528
           +H    +HRDIK  N+ +   G +KL DFG+A+ L   + EL+    G+P +++PE+ + 
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-TVELARTCIGTPYYLSPEICE- 174

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSE 587
              +  N K     DIW+LGC + EM T K  +        + K++  + PP+    S +
Sbjct: 175 --NRPYNNK----SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYD 228

Query: 588 GKDFLLRCFLRNPVERPSAVELLEHPFI 615
            ++ + + F RNP +RPS   +LE  FI
Sbjct: 229 LRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  137 bits (347), Expect = 2e-36
 Identities = 77/262 (29%), Positives = 139/262 (53%), Gaps = 15/262 (5%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +++G+G FG   +    E  +    KEV++     K     +    EI +L  L+H NI+
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER---RDALNEIVILSLLQHPNII 62

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
            YY   + D+ L I +EY + G++ ++ VR+  +   E +V  +   I++ ++Y+H    
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
           +HRDIK  N+ +  +G++KL DFG++K L +  S   ++ G+P +M+PE+ + V      
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV------ 176

Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLL 593
            K     DIW+LGC + E+LT K  +        + K++  N T P+  + SSE    + 
Sbjct: 177 -KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVYSSELISLVH 234

Query: 594 RCFLRNPVERPSAVELLEHPFI 615
               ++P +RP+A E+L+ P +
Sbjct: 235 SLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  136 bits (344), Expect = 6e-36
 Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 25/266 (9%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKE---VDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           IG+G FG V I   R+T    A+K       +         ++ +  E ++L  L H  +
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-----EKGSVRNVLNERRILQELNHPFL 62

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V  + S   ++++Y+ ++ +  G + RY        +E  V+ +   I+  L YLHS   
Sbjct: 63  VNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           IHRDIK  N+L+D  G V + DF +A  +T  +   S  G+P +MAPEV+    Q     
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR--QGYS-- 177

Query: 537 KLALAVDIWSLGCTVIEMLTGKPPW-----SEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 591
              +AVD WSLG T  E L GK P+     +  +  +A  +        P   S+E  D 
Sbjct: 178 ---VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE--TADVLYPATWSTEAIDA 232

Query: 592 LLRCFLRNPVERPSAV--ELLEHPFI 615
           + +   R+P +R      +L  HP+ 
Sbjct: 233 INKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  137 bits (347), Expect = 7e-36
 Identities = 81/278 (29%), Positives = 135/278 (48%), Gaps = 27/278 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           K++G+G+FG V +   + T    A+K +    I+ DD    EC    E+ +  L   KH 
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDD--DVECT-MTEKRVLALAG-KHP 56

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            + Q +      D L+  +EYV+ G +  +++       E   R +   I+ GL +LH  
Sbjct: 57  FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQ 531
             I+RD+K  N+L+D+ G +K+ADFGM K   G+   ++     G+P+++APE++     
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKE--GILGGVTTSTFCGTPDYIAPEILSYQ-- 171

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKD 590
                    AVD W+LG  + EML G+ P+ E +    +F+ +L      P  LS E K 
Sbjct: 172 -----PYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKS 225

Query: 591 FLLRCFLRNPVERPSAV-----ELLEHPFIRNANYQNL 623
            L     +NP +R   +     ++  HPF R  ++  L
Sbjct: 226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKL 263

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  136 bits (345), Expect = 8e-36
 Identities = 94/290 (32%), Positives = 138/290 (47%), Gaps = 46/290 (15%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           L+G G++G V    ++ETG   AIK      +        K   +EI++L  L+HEN+V 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64

Query: 419 YYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
               EV      LY+  E+V    ++  + ++   + ES VR +   IL G+ + HS N 
Sbjct: 65  LI--EVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSHNI 121

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGN 535
           IHRDIK  N+LV  SGVVKL DFG A+ L       +   +  W  APE++       G+
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV------GD 175

Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL-----------NRTPP-- 579
            K   AVDIW++GC V EMLTG+P +   S+ +    + K L            + P   
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235

Query: 580 ---IPEM------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
              +PE+            LS    D   +C   +P +RPS+ +LL H F
Sbjct: 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  133 bits (337), Expect = 3e-35
 Identities = 76/266 (28%), Positives = 141/266 (53%), Gaps = 13/266 (4%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++K +++GRG FG V++   +       IK+   IP +  + +     + E +VL  L 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQ---IPVEQMTKDERLAAQNECQVLKLLS 57

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYL 471
           H NI++YY + + D  L I +EY   G++  Y+++ C   + E  + +F   IL  L ++
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 472 HSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
           H+   +HRD+K  N+L+D    VVK+ DFG++K L+  S   ++ G+P +++PE+ +   
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-- 175

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGK 589
            K  N K     DIW+LGC + E+ + K  +     P  + K+++ T  PI +  S + +
Sbjct: 176 -KPYNQK----SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLR 230

Query: 590 DFLLRCFLRNPVERPSAVELLEHPFI 615
             +L     +P +RP   +++  P  
Sbjct: 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  134 bits (339), Expect = 5e-35
 Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 12/210 (5%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
              ++ K +G GTFG V++  +R +    A+K + I   +    +  + +  E +VL  +
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI--PEVIRLKQEQHVHNEKRVLKEV 58

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
            H  I++ + +E     LY+ +EYV  G +  Y+R      + S    +   I+  L YL
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYL 117

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           HS   ++RD+K  N+L+D  G +KL DFG AK L   ++  +L G+P ++APEVI    Q
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW--TLCGTPEYLAPEVI----Q 171

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 561
             G+ K   AVD W+LG  + EML G PP+
Sbjct: 172 SKGHNK---AVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  134 bits (338), Expect = 1e-34
 Identities = 100/340 (29%), Positives = 160/340 (47%), Gaps = 49/340 (14%)

Query: 342 MEKPSASP-KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-- 398
             KP  S  K S ++ G+ +G G+FG V I  ++ TG   AIK +       K  E +  
Sbjct: 7   FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCL-------KKREILKM 59

Query: 399 KQLE---QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 455
           KQ++   QE  +L  L H  IV    S   ++ +Y  LE+V  G +  ++R+  R     
Sbjct: 60  KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-FPND 118

Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           + + +   ++    YLHS + I+RD+K  NLL+D  G VK+ DFG AK +   ++  +L 
Sbjct: 119 VAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF--TLC 176

Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVL 574
           G+P ++APEVI    Q  G+ K   AVD W++G  + E + G PP+ + + P  ++ K+L
Sbjct: 177 GTPEYLAPEVI----QSKGHGK---AVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKIL 228

Query: 575 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV-----ELLEHPFIRNANYQNL------ 623
                 P       +D +      +  +R   +     ++  HP+   AN+  L      
Sbjct: 229 AGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYP 288

Query: 624 -SVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVR 662
             +P+RV S    GD         T   E  PDSP  R+ 
Sbjct: 289 APIPVRVKSP---GD---------TSNFEKYPDSPVDRLP 316

Length = 329

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  132 bits (333), Expect = 3e-34
 Identities = 92/290 (31%), Positives = 131/290 (45%), Gaps = 48/290 (16%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGHLKHENIVQ 418
           IG G++G V+   NRETG   AIK+     DDP     IK++  +EI++L  LKH N+V 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV----IKKIALREIRMLKQLKHPNLVN 64

Query: 419 YYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
               EV      L++  EY     +N   + + R + E +++      L  + + H  N 
Sbjct: 65  LI--EVFRRKRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGN 535
           IHRD+K  N+L+   G +KL DFG A+ LTG   + +   +  W  APE++    Q  G 
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY-GP 180

Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPW------------------------SEFEGPQAMF 571
           P     VD+W++GC   E+LTG+P W                          F   Q   
Sbjct: 181 P-----VDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235

Query: 572 KVLNRTPPIPEML-------SSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
            +    P   E L       SS    FL  C   +P ER S  ELLEHP+
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 7e-34
 Identities = 83/279 (29%), Positives = 136/279 (48%), Gaps = 34/279 (12%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQEIKVLGHLKHEN 415
           +G+G +G V++   ++TG   A+K +       KS       ++ +  E  +L   K E 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMK------KSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           +V+   +   D++LY+ +EYV PG   R +  +   ++E   R +   +   +  LH   
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYV-PGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
            IHRD+K  N L+DASG +KL DFG++K    ++Y  S+ GSP++MAPEV++        
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVLRG------- 172

Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-------KVLNR---TPPIPEMLS 585
                 VD WSLGC + E L G PP+S    P   +       + L R     P    LS
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFN-LS 230

Query: 586 SEGKDFLLRCFLRNPVERPSAVE-LLEHPFIRNANYQNL 623
            E  D + +  + +P  R  ++E +  HPF +  ++  L
Sbjct: 231 DEAWDLITKL-INDPSRRFGSLEDIKNHPFFKEVDWNEL 268

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 1e-33
 Identities = 84/307 (27%), Positives = 136/307 (44%), Gaps = 67/307 (21%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGH 410
           +++   IG G +G+VY   +  TG   A+K+V +   +   P S        +EI +L  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS------TLREIALLKQ 54

Query: 411 LK---HENIVQYYG-SEVVDDH----LYIYLEYVHPGSINRYVREHC--RDITESIVRNF 460
           L+   H NIV+               L +  E+V    +  Y+   C    +    +++ 
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPETIKDL 112

Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN- 519
            R +L G+ +LHS   +HRD+K  N+LV + G VK+ADFG+A+     S+E++L  +   
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMAL--TSVV 167

Query: 520 ---WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFK 572
              W  APEV+   +Q       A  VD+WS+GC   E+   +P +   SE +    +F 
Sbjct: 168 VTLWYRAPEVL---LQS----SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD 220

Query: 573 VLNRTP-------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAV 607
           V+                              +PE+   EG D L +    NP +R SA 
Sbjct: 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEI-CEEGLDLLKKMLTFNPHKRISAF 279

Query: 608 ELLEHPF 614
           E L+HP+
Sbjct: 280 EALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  130 bits (329), Expect = 1e-33
 Identities = 90/279 (32%), Positives = 136/279 (48%), Gaps = 44/279 (15%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--AECIKQLEQEIKVLGHLKHE-- 414
            IG GT G VY    ++TG   A+K++       ++   E  K++  ++ V+    H+  
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQM------RRTGNKEENKRILMDLDVV-LKSHDCP 74

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------ITESIVRNFTRHIL 465
            IV+ YG  + D  ++I +E          +   C D         I E I+   T  I+
Sbjct: 75  YIVKCYGYFITDSDVFICME----------LMSTCLDKLLKRIQGPIPEDILGKMTVAIV 124

Query: 466 NGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
             L YL      IHRD+K +N+L+DASG VKL DFG++  L     +    G   +MAPE
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE 184

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNRTPPI 580
            I      D NPK  +  D+WSLG +++E+ TG+ P+    +EFE    + K+L   PP 
Sbjct: 185 RIDP---PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE---VLTKILQEEPPS 238

Query: 581 P---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
               E  S +   F+  C  ++  +RP   ELL+HPFIR
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  129 bits (325), Expect = 1e-33
 Identities = 83/263 (31%), Positives = 135/263 (51%), Gaps = 16/263 (6%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K IG G+FG +Y+   +     C IKE+D+     K  E  K   +E+ +L  +KH NIV
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMKHPNIV 62

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
            ++ S   +  L+I +EY   G +  R  R+     +E  + ++   I  GL ++H    
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122

Query: 477 IHRDIKGANLLVDASGVV-KLADFGMAKHLTGLSYELSLK--GSPNWMAPEVIKAVMQKD 533
           +HRDIK  N+ +  +G+V KL DFG+A+ L   S EL+    G+P +++PE+ +    + 
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTPYYLSPEICQ---NRP 178

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFL 592
            N K     DIWSLGC + E+ T K P+      Q + K+      PI    S + +  +
Sbjct: 179 YNNK----TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI 234

Query: 593 LRCFLRNPVERPSAVELLEHPFI 615
            + F  +P +RPS   +L+ PF+
Sbjct: 235 SQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 2e-33
 Identities = 90/318 (28%), Positives = 146/318 (45%), Gaps = 68/318 (21%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-------LEQE 404
             ++  K+IGRG FG V++  +++TG   A+K +       + ++ IK+        E++
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-------RKSDMIKRNQIAHVRAERD 53

Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGS--INRYVREHCRDITESIVRNFTR 462
           I          IV+ Y S   ++HLY+ +EY+ PG   +N  +R+      E   R +  
Sbjct: 54  ILA--DADSPWIVKLYYSFQDEEHLYLVMEYM-PGGDLMNLLIRKDV--FPEETARFYIA 108

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLK--- 515
            ++  L  +H    IHRDIK  N+L+DA G +KLADFG+ K +        Y        
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 516 -----------------------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 552
                                  G+P+++APEV++            L  D WSLG  + 
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-------PYGLECDWWSLGVILY 221

Query: 553 EMLTGKPPWSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSA 606
           EML G PP+   +  Q  + K++N     R PP P  +S E  D + R  L +P +R  +
Sbjct: 222 EMLYGFPPFYS-DTLQETYNKIINWKESLRFPPDPP-VSPEAIDLICR-LLCDPEDRLGS 278

Query: 607 VE-LLEHPFIRNANYQNL 623
            E +  HPF +  +++NL
Sbjct: 279 FEEIKSHPFFKGIDWENL 296

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  129 bits (326), Expect = 3e-33
 Identities = 84/303 (27%), Positives = 149/303 (49%), Gaps = 63/303 (20%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGH 410
           +QK + IG GT+G VY   ++ TG   A+K++ +  +D   P +A  I+    EI +L  
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IR----EISLLKE 54

Query: 411 LKHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNG 467
           L H NIV+    +VV  ++ LY+  E++    + +Y+       +   +++++   +L G
Sbjct: 55  LNHPNIVRLL--DVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WM- 521
           +AY HS   +HRD+K  NLL+D  G +KLADFG+A+     ++ + ++   +     W  
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-----AFGVPVRTYTHEVVTLWYR 166

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL---- 574
           APE++       G+ + +  VDIWS+GC   EM+  +P +   SE +    +F+ L    
Sbjct: 167 APEILL------GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPD 220

Query: 575 -----------------------NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
                                  + +  +P  L  +G D L +  + +P +R SA   L+
Sbjct: 221 EDVWPGVTSLPDYKPTFPKWARQDLSKVVPN-LDEDGLDLLSKMLVYDPAKRISAKAALQ 279

Query: 612 HPF 614
           HP+
Sbjct: 280 HPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  128 bits (323), Expect = 6e-33
 Identities = 88/276 (31%), Positives = 141/276 (51%), Gaps = 18/276 (6%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQ 418
           +GRG +G V    +  TG   A+K    I     S E  K+L  ++ +          V 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKR---IRATVNSQE-QKRLLMDLDISMRSVDCPYTVT 64

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHST- 474
           +YG+   +  ++I +E V   S++++   V +    I E I+      I+  L YLHS  
Sbjct: 65  FYGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           + IHRD+K +N+L++ +G VKL DFG++ +L     +    G   +MAPE I      + 
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINP----EL 179

Query: 535 NPK-LALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPP-IP-EMLSSEGKD 590
           N K   +  D+WSLG T+IE+ TG+ P+  ++ P Q + +V+    P +P E  S E +D
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD 239

Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
           F+ +C  +N  ERP+  ELL+HPF      +N  V 
Sbjct: 240 FVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVA 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  126 bits (319), Expect = 2e-32
 Identities = 85/298 (28%), Positives = 143/298 (47%), Gaps = 53/298 (17%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 58

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLH 472
            NIV+       ++ LY+  E++H   + +++       I   +++++   +L GLA+ H
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------WMAPEVI 526
           S   +HRD+K  NLL++  G +KLADFG+A+     ++ + ++   +      + APE++
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEVVTLWYRAPEIL 172

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVLNRTP----- 578
                  G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L  TP     
Sbjct: 173 L------GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG-TPDEVVW 225

Query: 579 ----PIPE------------------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
                +P+                   L  +G+D L +    +P +R SA   L HPF
Sbjct: 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  126 bits (317), Expect = 3e-32
 Identities = 84/282 (29%), Positives = 140/282 (49%), Gaps = 26/282 (9%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
             Q  +++G G  G+VY   +  T    A+K   +IP D  + E  KQ+  E+++L    
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVK---VIPLD-ITVELQKQIMSELEILYKCD 57

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
              I+ +YG+  V++ + I  E++  GS++ Y     R I E ++      ++ GL YL 
Sbjct: 58  SPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLW 112

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
           S   +HRD+K +N+LV+  G VKL DFG++  L   S   +  G+  +MAPE I      
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-SIAKTYVGTNAYMAPERISG---- 167

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-------VLNRTPPI-PEML 584
               +  +  D+WSLG + +E+  G+ P+ + +  Q           +++  PP+ P   
Sbjct: 168 ---EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224

Query: 585 SSEG-KDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSV 625
            SE    F+ +C  + P ERP+   L++HPFI   N  N  V
Sbjct: 225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV 266

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  126 bits (318), Expect = 4e-32
 Identities = 83/290 (28%), Positives = 133/290 (45%), Gaps = 43/290 (14%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIV 417
            IGRG FG+V    ++ +G   A+K +    D+ K     K+L  ++ V+        IV
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQ---KRLLMDLDVVMRSSDCPYIV 66

Query: 418 QYYGS-----------EVVD---DHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTR 462
           ++YG+           E++D   D  Y            +YV E  +  I E I+     
Sbjct: 67  KFYGALFREGDCWICMELMDISLDKFY------------KYVYEVLKSVIPEEILGKIAV 114

Query: 463 HILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             +  L YL      IHRD+K +N+L+D +G +KL DFG++  L     +    G   +M
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYM 174

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI 580
           APE I             +  D+WSLG T+ E+ TGK P+ ++      + +V+   PPI
Sbjct: 175 APERI----DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPI 230

Query: 581 -----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSV 625
                    S    +F+  C +++  +RP   ELLEHPFI++   +N+ V
Sbjct: 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDV 280

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  125 bits (316), Expect = 5e-32
 Identities = 87/301 (28%), Positives = 142/301 (47%), Gaps = 70/301 (23%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLKHENI 416
           IG GT+G VY G N++TG   A+K++ +  ++   P +A       +EI +L  L+H NI
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI------REISLLKELQHPNI 61

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHST 474
           V      + +  LY+  E++    + +Y+    +   +   +V+++   IL G+ + HS 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAK-----------HLTGLSYELSLKGSPNWMAP 523
             +HRD+K  NLL+D  GV+KLADFG+A+            +  L Y           AP
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR----------AP 170

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP-- 578
           EV+       G+P+ +  VDIWS+G    EM T KP +   SE +    +F++L  TP  
Sbjct: 171 EVLL------GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG-TPTE 223

Query: 579 -------PIPEM------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHP 613
                   +P+                   L  +G D L +  + +P +R SA + L HP
Sbjct: 224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283

Query: 614 F 614
           +
Sbjct: 284 Y 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  125 bits (316), Expect = 7e-32
 Identities = 93/309 (30%), Positives = 140/309 (45%), Gaps = 81/309 (26%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           I  GT+G VY   +++TG   A+K++ +  +  K    I  L +EI +L  L+H NIV  
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSL-REINILLKLQHPNIVTV 69

Query: 420 YGSEVV----DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFT--------RHILN 466
              EVV     D +Y+ +EYV          EH  + + E++ + F           +L+
Sbjct: 70  --KEVVVGSNLDKIYMVMEYV----------EHDLKSLMETMKQPFLQSEVKCLMLQLLS 117

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA-------KHLTGLSYELSLKGSPN 519
           G+A+LH    +HRD+K +NLL++  G++K+ DFG+A       K  T L   L       
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL------- 170

Query: 520 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------------------- 559
           W  APE++       G  + + A+D+WS+GC   E+LT KP                   
Sbjct: 171 WYRAPELLL------GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG 224

Query: 560 -P----WSEF-EGPQAMFKVLNRTPP------IPE-MLSSEGKDFLLRCFLRNPVERPSA 606
            P    W  F E P A  K   + P        P   LS  G D L R    +P +R SA
Sbjct: 225 TPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA 284

Query: 607 VELLEHPFI 615
            + L+HP+ 
Sbjct: 285 EDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  124 bits (314), Expect = 9e-32
 Identities = 97/300 (32%), Positives = 144/300 (48%), Gaps = 55/300 (18%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 409
           +++K + IG GT+G+V+   NRET    A+K V +  DD   P SA       +EI +L 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLK 54

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGL 468
            LKH+NIV+ Y     D  L +  EY     + +Y  + C  DI   IV++F   +L GL
Sbjct: 55  ELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYF-DSCNGDIDPEIVKSFMFQLLKGL 112

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIK 527
           A+ HS N +HRD+K  NLL++ +G +KLADFG+A+         S +    W   P+V+ 
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 172

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP------QAMFKVLNR----- 576
                 G    + ++D+WS GC   E+     P   F G       + +F++L       
Sbjct: 173 ------GAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEES 224

Query: 577 ------------TPPIPEM---------LSSEGKDFLLRCFLR-NPVERPSAVELLEHPF 614
                        P  P           L+S G+D LL+  L  NPV+R SA E L+HP+
Sbjct: 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRD-LLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  125 bits (314), Expect = 2e-31
 Identities = 82/275 (29%), Positives = 143/275 (52%), Gaps = 25/275 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           K++G+G+FG V +   +  G   A+K    +V +I DD    EC      E +VL  L  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD---VECTMV---EKRVLA-LAW 53

Query: 414 EN--IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAY 470
           EN  +   Y +    +HL+  +E+++ G +  ++++  R D+  +    +   I+ GL +
Sbjct: 54  ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF--YAAEIVCGLQF 111

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAV 529
           LHS   I+RD+K  N+++D  G +K+ADFGM K ++ G +   +  G+P+++APE+++ +
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 589
                  K   +VD WS G  + EML G+ P+   +  +    +   TP  P  ++ E K
Sbjct: 172 -------KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESK 224

Query: 590 DFLLRCFLRNPVERPSAV-ELLEHPFIRNANYQNL 623
           D L + F R+P  R   V  +  HPF +  N+  L
Sbjct: 225 DILEKLFERDPTRRLGVVGNIRGHPFFKTINWTAL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  124 bits (312), Expect = 3e-31
 Identities = 81/274 (29%), Positives = 146/274 (53%), Gaps = 23/274 (8%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           K++G+G+FG V++   + T    AIK    +V ++ DD    EC   +E+ +  L   +H
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD---VEC-TMVEKRVLSLA-WEH 55

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLH 472
             +   Y +    ++L+  +EY++ G +  +++  H  D+  +    +   I+ GL +LH
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLH 113

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           S   ++RD+K  N+L+D  G +K+ADFGM K ++ G +   +  G+P+++APE++  + Q
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL--LGQ 171

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 591
           K        +VD WS G  + EML G+ P+   +  +    +    P  P  L+ E KD 
Sbjct: 172 KYNT-----SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDI 226

Query: 592 LLRCFLRNPVERPSAV--ELLEHPFIRNANYQNL 623
           L++ F+R P ER   V  ++ +HPF R  ++  L
Sbjct: 227 LVKLFVREP-ERRLGVKGDIRQHPFFREIDWSAL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  122 bits (306), Expect = 5e-31
 Identities = 76/256 (29%), Positives = 131/256 (51%), Gaps = 14/256 (5%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +++G G+FG   +  +  +    A+KE+ +    PKS+  ++   +E  +L  +KH NIV
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNT 476
            +  S   D HLYI +EY   G + + ++ +  +   E  +  +   +  G+ ++H    
Sbjct: 62  AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGN 535
           +HRDIK  N+ +  +G VKL DFG A+ LT   +Y  +  G+P ++ PE+ + +   + +
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKS 181

Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLR 594
                  DIWSLGC + E+ T K P+        + KV   +  P+P   S E +  + +
Sbjct: 182 -------DIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234

Query: 595 CFLRNPVERPSAVELL 610
            F RNP  RPSA  +L
Sbjct: 235 MFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  122 bits (307), Expect = 7e-31
 Identities = 79/271 (29%), Positives = 139/271 (51%), Gaps = 28/271 (10%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G  GSV    +  TG   A K V I     KS    KQ+ +E++++   +   IV +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHI---GAKS-SVRKQILRELQIMHECRSPYIVSF 68

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI-H 478
           YG+ + ++++ + +E++  GS++R  ++    I   I+      ++ GL YL++ + I H
Sbjct: 69  YGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           RDIK +N+LV++ G +KL DFG++  L   S   +  G+  +M+PE I+         K 
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELIN-SIADTFVGTSTYMSPERIQG-------GKY 179

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFE-------GPQAMFKVLNR-----TPPIP-EMLS 585
            +  D+WSLG ++IE+  GK P++           P  +  +L +      P +P     
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239

Query: 586 SEGKDFLLRCFLRNPVERPSAVELLE-HPFI 615
            + +DF+  C L++P ERP+  +L    PFI
Sbjct: 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  121 bits (305), Expect = 8e-31
 Identities = 88/260 (33%), Positives = 131/260 (50%), Gaps = 27/260 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           K IGRG F  VY  T    G   A+K+V I  + D    A+CIK    EI +L  L H N
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLLKQLNHPN 63

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLH 472
           +++YY S + D+ L I LE    G ++R ++   +  R I E  V  +   + + L ++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQ 531
           S   +HRDIK AN+ + A+GVVKL D G+ +  +  +    SL G+P +M+PE I     
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI----H 179

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------PPIP-EML 584
           ++G        DIWSLGC + EM   + P   F G +     L +       PP+P +  
Sbjct: 180 ENG---YNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQCDYPPLPSDHY 233

Query: 585 SSEGKDFLLRCFLRNPVERP 604
           S E +  +  C   +P +RP
Sbjct: 234 SEELRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  121 bits (306), Expect = 1e-30
 Identities = 91/287 (31%), Positives = 135/287 (47%), Gaps = 47/287 (16%)

Query: 355 QKGKLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----QEIK 406
           +K +++G G FG V    Y   N  TG   A+K +          EC +Q      +EI 
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--------KRECGQQNTSGWKKEIN 58

Query: 407 VLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +L  L HENIV+Y G  SE     L + +EYV  GS+  Y+ +H  ++ + ++  F + I
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--FAQQI 116

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TG-LSYELSLKG-SPN-W 520
             G+AYLHS + IHRD+   N+L+D   +VK+ DFG+AK +  G   Y +   G SP  W
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176

Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEFE---GP-QAMFK 572
            A E +K         K + A D+WS G T+ E+LT     + P  +FE   GP Q    
Sbjct: 177 YAVECLKEN-------KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229

Query: 573 VLNRTP--------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
           V+            P P+    E    +  C+      RP+   L+ 
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  122 bits (308), Expect = 1e-30
 Identities = 82/278 (29%), Positives = 136/278 (48%), Gaps = 28/278 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           KL+G+GTFG V +   + TG   A+K    EV I  D+      +     E +VL + +H
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE------VAHTLTESRVLQNTRH 54

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             +     S    D L   +EY + G +  ++    R  +E   R +   I++ L YLHS
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALGYLHS 113

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 530
            + ++RD+K  NL++D  G +K+ DFG+ K   G+S   ++K   G+P ++APEV++   
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLE--- 168

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
               +     AVD W LG  + EM+ G+ P+   +  +    +L      P  LS E K 
Sbjct: 169 ----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKS 224

Query: 591 FLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
            L     ++P +R       A E++EH F  + N+Q++
Sbjct: 225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV 262

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  122 bits (307), Expect = 2e-30
 Identities = 82/319 (25%), Positives = 133/319 (41%), Gaps = 76/319 (23%)

Query: 359 LIGRGTFG--SVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           LIG+       V++  ++ T    A+K++++   D  S E +K L+QEI     L+H NI
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 475
           + Y  S +VD  LY+    +  GS    ++ H  + + E  +    + +LN L Y+HS  
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL----------KGSP------- 518
            IHR +K +++L+   G V          L+GL Y +S+             P       
Sbjct: 122 FIHRSVKASHILLSGDGKV---------VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172

Query: 519 NWMAPEVIKAVMQKDG-NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 577
            W++PEV++  +Q  G N K     DI+S+G T  E+  G  P+ +    Q + + +  T
Sbjct: 173 PWLSPEVLQQNLQ--GYNEK----SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT 226

Query: 578 PP-------IPEMLSSEGKD---------------------------FLLRCFLRNPVER 603
            P        P    S  +                            F+  C  R+P  R
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286

Query: 604 PSAVELLEHPF---IRNAN 619
           PSA +LL H F    +  N
Sbjct: 287 PSASQLLNHSFFKQCKRRN 305

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  121 bits (306), Expect = 3e-30
 Identities = 82/274 (29%), Positives = 129/274 (47%), Gaps = 22/274 (8%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEV---DIIP-DDPKSAECIKQLEQEIKVLGHLKHEN 415
           +GRG FG V +   ++TG   AIK +   DII  D+ +S  C K++    +     +H  
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRI---FETANSERHPF 63

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           +V  +     +DH+   +EY   G +  ++  H    +E     +   ++ GL YLH   
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAACVVLGLQYLHENK 121

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKDG 534
            ++RD+K  NLL+D  G VK+ADFG+ K   G     S   G+P ++APEV+        
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT------- 174

Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLR 594
                 AVD W LG  + EML G+ P+   +  +    ++N     P  LS E    + R
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR 234

Query: 595 CFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
              RNP  R       A ++ + PF R+ N+ +L
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  120 bits (302), Expect = 3e-30
 Identities = 76/273 (27%), Positives = 125/273 (45%), Gaps = 30/273 (10%)

Query: 360 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G   + E      +  V  +  +  S +  K  E+E ++L + +HENIV
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNFQHENIV 71

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-------------ITESIVRNFTRHI 464
           ++YG     D   +  EY+  G +N+++R H  D             +T S +      I
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----NW 520
            +G+ YL S + +HRD+   N LV    VVK+ DFGM++ +    Y   + G       W
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY-YRVGGHTMLPIRW 190

Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPP 579
           M PE   ++M +    K     D+WS G  + E+ T GK PW      + +  +      
Sbjct: 191 MPPE---SIMYR----KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243

Query: 580 I-PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
             P    SE  D +L C+ R+P +R +  ++ E
Sbjct: 244 QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 4e-30
 Identities = 76/267 (28%), Positives = 117/267 (43%), Gaps = 34/267 (12%)

Query: 355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           + G  IG+G FG V +G  R  G   A+K    + DD  +A+       E  V+  L+H 
Sbjct: 9   KLGATIGKGEFGDVMLGDYR--GQKVAVKC---LKDDSTAAQ---AFLAEASVMTTLRHP 60

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHS 473
           N+VQ  G  +  + LYI  EY+  GS+  Y+R   R  IT +    F   +  G+ YL  
Sbjct: 61  NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVM 530
            N +HRD+   N+LV    V K++DFG+AK                   W APE ++   
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALR--- 172

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG- 588
                 K +   D+WS G  + E+ + G+ P+     P     V+        M + EG 
Sbjct: 173 ----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLK--DVVPHVEKGYRMEAPEGC 224

Query: 589 ----KDFLLRCFLRNPVERPSAVELLE 611
                  +  C+  +P +RP+  +L E
Sbjct: 225 PPEVYKVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  118 bits (298), Expect = 7e-30
 Identities = 82/265 (30%), Positives = 132/265 (49%), Gaps = 25/265 (9%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPKSAECIKQLEQEIKVLG 409
           + +Q  K IGRG F  VY  T        A+K+V I    D     +C+K    EI +L 
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK----EIDLLK 57

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSIN---RYVREHCRDITESIVRNFTRHILN 466
            L H N+++Y  S + D+ L I LE    G ++   +Y ++  R I E  V  +   + +
Sbjct: 58  QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEV 525
            + ++HS   +HRDIK AN+ + A+GVVKL D G+ +  +  +    SL G+P +M+PE 
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPI 580
           I     ++G        DIWSLGC + EM   + P+  +     +F +  +      PP+
Sbjct: 178 I----HENG---YNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDYPPL 228

Query: 581 P-EMLSSEGKDFLLRCFLRNPVERP 604
           P E  S + ++ +  C   +P +RP
Sbjct: 229 PTEHYSEKLRELVSMCIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  118 bits (297), Expect = 2e-29
 Identities = 89/284 (31%), Positives = 144/284 (50%), Gaps = 30/284 (10%)

Query: 358 KLIGRGTFGSVYI---GTNRETGASCAIKEVD--IIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++G G +G V++       + G   A+K +    I    K+AE  +    E +VL  ++
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT---ERQVLEAVR 62

Query: 413 HEN-IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLA 469
               +V  + +   D  L++ L+YV+ G +  + Y REH    TES VR +   I+  L 
Sbjct: 63  RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALD 119

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIK 527
           +LH    I+RDIK  N+L+D+ G V L DFG++K       E   S  G+  +MAPEVI+
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-----VLNRTPPIPE 582
                 G+     AVD WSLG    E+LTG  P++  +G Q         +L   PP P+
Sbjct: 180 G-----GSGGHDKAVDWWSLGVLTFELLTGASPFT-VDGEQNSQSEISRRILKSKPPFPK 233

Query: 583 MLSSEGKDFLLRCFLRNPVER---PSAVELLEHPFIRNANYQNL 623
            +S+E +DF+ +   ++P +R     A E+  HPF +  ++ +L
Sbjct: 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL 277

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  117 bits (296), Expect = 2e-29
 Identities = 85/281 (30%), Positives = 132/281 (46%), Gaps = 39/281 (13%)

Query: 358 KLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           K +G G FG V +         TG   A+K ++   ++   ++     E+EI++L  L H
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD----FEREIEILRTLDH 65

Query: 414 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           ENIV+Y G   +     L + +EY+  GS+  Y++ H   I    +  F+  I  G+ YL
Sbjct: 66  ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT---GLSYELSLKGSP-NWMAPEVIK 527
            S   IHRD+   N+LV++  +VK++DFG+AK L       Y      SP  W APE ++
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP---PWSEF-------EGPQAMFKVLN- 575
                    K + A D+WS G T+ E+ T G P   P +EF       +G   + ++L  
Sbjct: 186 -------TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238

Query: 576 -----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
                R P  P     E  D +  C+   P +RPS  +L+ 
Sbjct: 239 LKEGERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  117 bits (296), Expect = 3e-29
 Identities = 83/294 (28%), Positives = 140/294 (47%), Gaps = 43/294 (14%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
            +++ + +G GT+ +VY G NR TG   A+KE+ +  ++   +  I+    EI ++  LK
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELK 56

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAY 470
           HENIV+ +     ++ L +  EY+    + +Y+        +  + V++FT  +L G+A+
Sbjct: 57  HENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAV 529
            H    +HRD+K  NLL++  G +KLADFG+A+         S +    W  AP+V+   
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL-- 173

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPP-------- 579
               G+   + ++DIWS+GC + EM+TG+P +        + K+     TP         
Sbjct: 174 ----GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229

Query: 580 -IPEM------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
            +PE                       G D L R    NP  R SA + L+HP+
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  118 bits (299), Expect = 3e-29
 Identities = 83/303 (27%), Positives = 135/303 (44%), Gaps = 65/303 (21%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +  +G   AIK++    D P  A   K+  +E+K+L H KH+NI+  
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA---KRTLRELKILRHFKHDNIIAI 69

Query: 418 -QYYGSEVVD-DHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHST 474
                    D   +Y+ ++ +    ++  +  H    +TE  +R F   +L GL Y+HS 
Sbjct: 70  RDILRPPGADFKDVYVVMDLME-SDLHHII--HSDQPLTEEHIRYFLYQLLRGLKYIHSA 126

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------APE 524
           N IHRD+K +NLLV+    +++ DFGMA+ L+    E        +M          APE
Sbjct: 127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-----YFMTEYVATRWYRAPE 181

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEML---------------------TGKPPWSE 563
           ++ ++      P+   A+D+WS+GC   EML                      G P   E
Sbjct: 182 LLLSL------PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS-EE 234

Query: 564 F------EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEH 612
                  +  +   + L R  P+P  ++    S E  D L +    +P ER +  + L+H
Sbjct: 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294

Query: 613 PFI 615
           PF+
Sbjct: 295 PFL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  115 bits (290), Expect = 6e-29
 Identities = 75/263 (28%), Positives = 135/263 (51%), Gaps = 16/263 (6%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +++G+G++G V +  +R  G    IK++++      S    K  EQE ++L  LKH NIV
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNL---RNASRRERKAAEQEAQLLSQLKHPNIV 62

Query: 418 QYYGS-EVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN 475
            Y  S E  D  LYI + +   G +   ++E   + + E+ V  +   I   L YLH  +
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKD 533
            +HRD+K  N+ +  + ++K+ D G+A+ L     ++  +L G+P +M+PE+        
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLIGTPYYMSPELFS------ 175

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFL 592
            N       D+W+LGC V EM T K  ++  +    +++++  + PP+P+  S E  + +
Sbjct: 176 -NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELI 234

Query: 593 LRCFLRNPVERPSAVELLEHPFI 615
                + P +RPS   +L  P+I
Sbjct: 235 ATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  116 bits (292), Expect = 1e-28
 Identities = 87/279 (31%), Positives = 140/279 (50%), Gaps = 30/279 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           KL+G+GTFG V +   + TG   A+K    EV I  D+      +     E +VL + +H
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 54

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 472
             +     +    D L   +EY + G +  ++ RE  R  TE   R +   I++ L YLH
Sbjct: 55  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 112

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAV 529
           S + ++RDIK  NL++D  G +K+ DFG+ K   G+S   ++K   G+P ++APEV++  
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLE-- 168

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 589
                +     AVD W LG  + EM+ G+ P+   +  +    +L      P  LS E K
Sbjct: 169 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 223

Query: 590 DFLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNL 623
             L     ++P +R    PS A E++EH F  + N+Q++
Sbjct: 224 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 262

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  116 bits (291), Expect = 2e-28
 Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 25/278 (8%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           K++G+G+FG V +   + T    AIK +    I+ DD    +C    E+ I  L   KH 
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDD--DVDC-TMTEKRILALAA-KHP 56

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +   +      D L+  +EYV+ G +  +  +  R   E   R +   +   L +LH  
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
             I+RD+K  N+L+DA G  KLADFGM K  +       +  G+P+++APE+++ +    
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL---- 171

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFL 592
              +   +VD W+LG  + EM+ G+PP+ E +    +F+ +L+     P  LS E    L
Sbjct: 172 ---EYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSIL 227

Query: 593 LRCFLRNPVERPSAV-------ELLEHPFIRNANYQNL 623
                +NP +R   V        + +HPF +  ++  L
Sbjct: 228 KAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL 265

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  113 bits (285), Expect = 4e-28
 Identities = 77/266 (28%), Positives = 122/266 (45%), Gaps = 25/266 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G+FG V  G    +G       V  +  D K ++ +    +E  ++  L HEN++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSD-KLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE-SIVRNFTRHILNGLAYLHSTNT 476
           + YG  V+   L +  E    GS+   +R+        S + ++   I NG+ YL S   
Sbjct: 60  RLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSY--ELSLKGSPNWMAPEVIKAVMQK 532
           IHRD+   N+L+ +   VK+ DFG+ + L      Y  E  LK    W APE ++     
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR--- 175

Query: 533 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV------LNRTPPIPEMLS 585
                 + A D+W  G T+ EM T G+ PW+   G Q + K+      L R    PE   
Sbjct: 176 ----TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER----PEACP 227

Query: 586 SEGKDFLLRCFLRNPVERPSAVELLE 611
            +  + +L+C+  NP +RP+   L E
Sbjct: 228 QDIYNVMLQCWAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  114 bits (287), Expect = 6e-28
 Identities = 82/277 (29%), Positives = 139/277 (50%), Gaps = 24/277 (8%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +++G+G+FG V +   +E+G   A+K  + D+I  D    EC    E+ I  L    H  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-DDVEC-TMTEKRILSLAR-NHPF 57

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           + Q Y      D L+  +E+V+ G +  ++++  R   E+  R +   I + L +LH   
Sbjct: 58  LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKG 116

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
            I+RD+K  N+L+D  G  KLADFGM K     G +   +  G+P+++APE+++ ++   
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS-TFCGTPDYIAPEILQEML--- 172

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFL 592
                  +VD W++G  + EML G  P+ E E    +F+ +LN     P  LS +  D L
Sbjct: 173 ----YGPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDIL 227

Query: 593 LRCFLRNPVERPSAVEL------LEHPFIRNANYQNL 623
                +NP  R  ++ L      L HPF +  +++ L
Sbjct: 228 KAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  114 bits (288), Expect = 7e-28
 Identities = 94/319 (29%), Positives = 148/319 (46%), Gaps = 50/319 (15%)

Query: 346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP---DDPKSAECIKQ-- 400
           S S  +   QKG  +G GT+G V    +  TG   AIK+V II    D  K  + +    
Sbjct: 3   SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62

Query: 401 ----LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 456
                 +E+K++  +KHENI+      V  D + + ++ +    + + V    R +TES 
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR-LTESQ 120

Query: 457 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG 516
           V+     ILNGL  LH    +HRD+  AN+ +++ G+ K+ADFG+A+      Y  +L  
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 517 SPNW-----MAPEVI----KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEF 564
                    M  +V+    +A     G  K   AVD+WS+GC   E+LTGKP +   +E 
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240

Query: 565 EGPQAMFKVLNRTP---PIPEMLS---------SEGKDF-------------LLRCFLR- 598
           +    +F++L  TP     P+             + KD              LL+  L+ 
Sbjct: 241 DQLGRIFELLG-TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299

Query: 599 NPVERPSAVELLEHPFIRN 617
           NP+ER SA E L+H + ++
Sbjct: 300 NPLERISAKEALKHEYFKS 318

Length = 335

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  113 bits (285), Expect = 1e-27
 Identities = 92/305 (30%), Positives = 146/305 (47%), Gaps = 56/305 (18%)

Query: 355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +K   +G G  G V    +R +G   A K +  +I P          Q+ +E+KVL    
Sbjct: 4   EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP------AIRNQIIRELKVLHECN 57

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
              IV +YG+   D  + I +E++  GS+++ +++  R I E+I+   +  +L GL YL 
Sbjct: 58  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPENILGKISIAVLRGLTYLR 116

Query: 473 STNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
             + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++M+PE ++    
Sbjct: 117 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ---- 171

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGK----------------PPWSEFEG--------- 566
             G     +  DIWSLG +++EM  G+                 P SE E          
Sbjct: 172 --GT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228

Query: 567 -------PQAMFKVL----NRTPPIPE--MLSSEGKDFLLRCFLRNPVERPSAVELLEHP 613
                  P A+F++L    N  PP       S E +DF+ +C  +NP ER    EL +HP
Sbjct: 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288

Query: 614 FIRNA 618
           FI+ A
Sbjct: 289 FIKRA 293

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  113 bits (283), Expect = 1e-27
 Identities = 80/285 (28%), Positives = 151/285 (52%), Gaps = 28/285 (9%)

Query: 358 KLIGRGTFGSVYIG---TNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           K++G G +G V++    +  ++G   A   +K+  I+    + A+  +    E +VL H+
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV----QKAKTTEHTRTERQVLEHI 61

Query: 412 KHEN-IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           +    +V  + +   D  L++ L+Y++ G +  ++ +  R   E  V+ ++  I+  L +
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER-FKEQEVQIYSGEIVLALEH 120

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIKA 528
           LH    I+RDIK  N+L+D++G V L DFG++K       E   S  G+  +MAP++++ 
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS----EFEGPQAMFKVLNRTPPIPEML 584
                G+ K   AVD WS+G  + E+LTG  P++    +    +   ++L   PP P+ +
Sbjct: 181 --GDGGHDK---AVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 235

Query: 585 SSEGKDFLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNLS 624
           S+  KD + R  +++P +R    PS A E+ +HPF +  N+ +L+
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  114 bits (285), Expect = 1e-27
 Identities = 79/278 (28%), Positives = 136/278 (48%), Gaps = 28/278 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           KL+G+GTFG V +   + +G   A+K    EV I  D+      +     E +VL + +H
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE------VAHTLTESRVLKNTRH 54

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             +     S    D L   +EYV+ G +  ++    R  +E   R +   I++ L YLHS
Sbjct: 55  PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHS 113

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 530
              ++RD+K  NL++D  G +K+ DFG+ K   G++   ++K   G+P ++APEV++   
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLE--- 168

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
               +     AVD W LG  + EM+ G+ P+   +  +    +L      P  LS++ K 
Sbjct: 169 ----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKS 224

Query: 591 FLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
            L    +++P +R       A E++ H F    N+Q++
Sbjct: 225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDV 262

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  113 bits (285), Expect = 1e-27
 Identities = 85/286 (29%), Positives = 134/286 (46%), Gaps = 32/286 (11%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQEIKVLGHLKHE 414
           L+GRG FG V +   + TG   A+K +       KS     E +   E+E  +L      
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMK------KSVLLAQETVSFFEEERDILSISNSP 61

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGS-----INRYVREHCRDITESIVRNFTRHILNGLA 469
            I Q   +    D+LY+ +EY  PG      +NRY  +      E + + +   ++  + 
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEY-QPGGDLLSLLNRYEDQ----FDEDMAQFYLAELVLAIH 116

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIK 527
            +H    +HRDIK  N+L+D +G +KLADFG A  LT   +       G+P+++APEV+ 
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-----RTPPIPE 582
             M  DG     +  D WSLG    EM+ G+ P+ E    +    ++N     + P  P+
Sbjct: 177 T-MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK 235

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL--SVP 626
            +SS+  D L++  L    ER     L  HPF    ++ N+  S+P
Sbjct: 236 -VSSDFLD-LIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLP 279

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 1e-27
 Identities = 72/267 (26%), Positives = 115/267 (43%), Gaps = 38/267 (14%)

Query: 360 IGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEI----KVLGHLK 412
           +G G FGSV  G            A+K +          E I   ++E      V+  L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--------KQEHIAAGKKEFLREASVMAQLD 54

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H  IV+  G     + L + +E    G + +Y+++  R+I  S ++     +  G+AYL 
Sbjct: 55  HPCIVRLIGV-CKGEPLMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLE 112

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGS--P-NWMAPEVIKA 528
           S + +HRD+   N+L+      K++DFGM++ L  G  Y  +      P  W APE I  
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPE 582
                   K +   D+WS G T+ E  + G  P+ E +G + +  +     L R    PE
Sbjct: 173 G-------KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR----PE 221

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVEL 609
               E    +L C+   P +RP+  EL
Sbjct: 222 ECPQEIYSIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  114 bits (287), Expect = 2e-27
 Identities = 97/335 (28%), Positives = 159/335 (47%), Gaps = 46/335 (13%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLK 412
           K+IGRG FG V +  ++ +    A+K +          E IK+ +     +E  ++ H  
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLS-------KFEMIKRSDSAFFWEERDIMAHAN 101

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
            E IVQ + +   D +LY+ +EY+  G +   +  +  DI E   R +T  ++  L  +H
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH 159

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
           S   IHRD+K  N+L+D SG +KLADFG  M     G+    +  G+P++++PEV+K+  
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS-- 217

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPEMLS 585
            + G+       D WS+G  + EML G  P+          K+++       P   E+ S
Sbjct: 218 -QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI-S 275

Query: 586 SEGKDFLLRCFL--------RNPVERPSAVELLEHPFIRNA--NYQNL--SVPMRVFSRI 633
            + KD L+  FL        RN V+     E+  HPF +N    + N+  +V   V    
Sbjct: 276 KQAKD-LICAFLTDREVRLGRNGVD-----EIKSHPFFKNDQWTFDNIRETVAPVVPELS 329

Query: 634 NLGDKSH-DQVERATRKTESLPDSPETRVRNRKLP 667
           +  D S+ D +E   +  E+ P  P+    N +LP
Sbjct: 330 SDIDTSNFDDIEDDDKNEETFP-LPKAFAGN-QLP 362

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  112 bits (283), Expect = 2e-27
 Identities = 72/233 (30%), Positives = 112/233 (48%), Gaps = 47/233 (20%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S+++K   IG+GTFG V+   +++T    A+K+  ++ ++ K    I  L +EIK+L  L
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKK--VLMENEKEGFPITAL-REIKILQLL 68

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY------VREHCR------------DIT 453
           KHEN+V          +L I +        NRY      V E C               T
Sbjct: 69  KHENVV----------NL-IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT 117

Query: 454 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 513
            S ++   + +LNGL Y+H    +HRD+K AN+L+   G++KLADFG+A+     ++ LS
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR-----AFSLS 172

Query: 514 LKGSPNWMAPEVIKAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 559
               PN     V+    +    P+L L        +D+W  GC + EM T  P
Sbjct: 173 KNSKPNRYTNRVVTLWYRP---PELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  111 bits (279), Expect = 2e-27
 Identities = 80/266 (30%), Positives = 136/266 (51%), Gaps = 23/266 (8%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           +G+G+FG+VY+  +++  A   +K +  IP  +    E + Q  QE ++L  L H  IV+
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV-QANQEAQLLSKLDHPAIVK 66

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLHSTN 475
           ++ S +  D   I  EY     ++  + E       ++E+ V  +   +L G+ Y+H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKD 533
            +HRD+K  N+ +  + ++K+ DFG+++ L G S +L  +  G+P +M+PE +K    + 
Sbjct: 127 ILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMG-SCDLATTFTGTPYYMSPEALK---HQG 181

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN----RTPPIPEMLSSEGK 589
            + K     DIWSLGC + EM         FEG   +  VL      TP +PE  S +  
Sbjct: 182 YDSK----SDIWSLGCILYEMCCLA---HAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN 234

Query: 590 DFLLRCFLRNPVERPSAVELLEHPFI 615
             +     ++P  RPSA E+L +PFI
Sbjct: 235 SIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  113 bits (285), Expect = 2e-27
 Identities = 91/314 (28%), Positives = 151/314 (48%), Gaps = 65/314 (20%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S++   + +G G+ G V+   + +     A+K+  I+  DP+S   +K   +EIK++  L
Sbjct: 5   SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKK--IVLTDPQS---VKHALREIKIIRRL 59

Query: 412 KHENIVQYY------GSEVVDDH--------LYIYLEYVHPGSINRYVREHCRDITESIV 457
            H+NIV+ Y      GS++ +D         +YI  EY+        V E    ++E   
Sbjct: 60  DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDL--ANVLEQGP-LSEEHA 116

Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAK----HLTGLSYEL 512
           R F   +L GL Y+HS N +HRD+K AN+ ++    V+K+ DFG+A+    H +   Y L
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY-L 175

Query: 513 SLKGSPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS---EFEGPQ 568
           S      W  +P +   ++  +   K   A+D+W+ GC   EMLTGKP ++   E E  Q
Sbjct: 176 SEGLVTKWYRSPRL---LLSPNNYTK---AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229

Query: 569 AMFK------------VLNRTP------------PIPEML---SSEGKDFLLRCFLRNPV 601
            + +            +LN  P            P+ ++L   + E  DFL +    NP+
Sbjct: 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM 289

Query: 602 ERPSAVELLEHPFI 615
           +R +A E L HP++
Sbjct: 290 DRLTAEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 4e-27
 Identities = 78/262 (29%), Positives = 120/262 (45%), Gaps = 23/262 (8%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           + IG+G FG VY G  +      A+K     + PD        K L QE ++L    H N
Sbjct: 1   EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLK-----RKFL-QEAEILKQYDHPN 53

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           IV+  G  V    +YI +E V  GS+  ++R+    +T   +   +     G+ YL S N
Sbjct: 54  IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQK 532
            IHRD+   N LV  + V+K++DFGM++   G  Y +S  LK  P  W APE +      
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY---- 169

Query: 533 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGK 589
               +     D+WS G  + E  + G  P+      Q   ++ +  R P  P++   E  
Sbjct: 170 ---GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA-PQLCPEEIY 225

Query: 590 DFLLRCFLRNPVERPSAVELLE 611
             +L+C+  +P  RPS  E+  
Sbjct: 226 RLMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  112 bits (281), Expect = 5e-27
 Identities = 95/316 (30%), Positives = 154/316 (48%), Gaps = 29/316 (9%)

Query: 358 KLIGRGTFGSVYI---GTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           K++G+G +G V+     T  +TG   A+K   +  I+ +   +A      + E  +L  +
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTA----HTKAERNILEAV 57

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAY 470
           KH  IV    +      LY+ LEY+  G +  ++ RE      E     +   I   L +
Sbjct: 58  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLSEISLALEH 115

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAV 529
           LH    I+RD+K  N+L+DA G VKL DFG+ K  +   +   +  G+  +MAPE++   
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL--- 172

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 589
             + G+ K   AVD WSLG  + +MLTG PP++     + + K+L     +P  L+ E +
Sbjct: 173 -MRSGHGK---AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEAR 228

Query: 590 DFLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVE 644
           D L +   RNP  R    P  A E+  HPF R+ N+ +L +  +V        +S + V 
Sbjct: 229 DLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL-LARKVEPPFKPLLQSEEDVS 287

Query: 645 R-ATRKTESLP-DSPE 658
           +  ++ T   P DSP+
Sbjct: 288 QFDSKFTRQTPVDSPD 303

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  111 bits (279), Expect = 7e-27
 Identities = 85/301 (28%), Positives = 144/301 (47%), Gaps = 58/301 (19%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK-QLEQ---EIKVLGHLKH 413
           KLI  G +G+VY+  ++ET    A+K+++      K    ++ Q++Q   E  +L   ++
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKIN------KQNLILRNQIQQVFVERDILTFAEN 60

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI-------VRNFTRHILN 466
             +V  + S     HL + +EYV  G         C  + ++I        R +    + 
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGD--------CATLLKNIGALPVDMARMYFAETVL 112

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK----HLTGLSYELSLK------- 515
            L YLH+   +HRD+K  NLL+ + G +KL DFG++K     LT   YE  ++       
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 516 -----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQA 569
                G+P ++APEVI  + Q  G P     VD W++G  + E L G  P+  F + P+ 
Sbjct: 173 DKQVCGTPEYIAPEVI--LRQGYGKP-----VDWWAMGIILYEFLVGCVPF--FGDTPEE 223

Query: 570 MF-KVLNRT---PPIPEMLSSEGKDFLLRCFLRNPVER---PSAVELLEHPFIRNANYQN 622
           +F +V++     P   E L ++ +D + R   +NP+ER     A E+ +H F    ++  
Sbjct: 224 LFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283

Query: 623 L 623
           L
Sbjct: 284 L 284

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 7e-27
 Identities = 99/334 (29%), Positives = 143/334 (42%), Gaps = 105/334 (31%)

Query: 360 IGRGTFGSVY--IGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGHLKHENI 416
           IGRGT+G VY     N + G   AIK+      D +    I Q   +EI +L  LKHEN+
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENV 64

Query: 417 VQYYGSEVVDDH----LYIYLEYV-HP-GSINRYVREHCRD-ITESIVRNFTRHILNGLA 469
           V     EV  +H    +Y+  +Y  H    I ++ R+  R  I  S+V++    ILNG+ 
Sbjct: 65  VSL--VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122

Query: 470 YLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
           YLHS   +HRD+K AN+LV       GVVK+ D G+A+                + AP  
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL---------------FNAP-- 165

Query: 526 IKAVMQKDG--------NPKLAL-------AVDIWSLGCTVIEMLTGKPPWSEFEGPQA- 569
           +K +   D          P+L L       A+DIW++GC   E+LT +P    F+G +A 
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI---FKGREAK 222

Query: 570 --------------MFKVLNRTPP---------IPEM----------------------- 583
                         +F+VL  TP          +PE                        
Sbjct: 223 IKKSNPFQRDQLERIFEVLG-TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEK 281

Query: 584 ---LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
                S+G D L +    +P +R +A E LEHP+
Sbjct: 282 HKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  110 bits (278), Expect = 1e-26
 Identities = 87/306 (28%), Positives = 139/306 (45%), Gaps = 59/306 (19%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           ++++K   IG GT+G VY   +  +G   A+K+V +  D+ +    I  L +EI +L +L
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM--DNERDGIPISSL-REITLLLNL 63

Query: 412 KHENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
           +H NIV+    EVV     D +++ +EY     +   +       +ES V+     +L G
Sbjct: 64  RHPNIVEL--KEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SPN----WM- 521
           L YLH    IHRD+K +NLL+   G +K+ADFG+A+     +Y L  K  +P     W  
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR-----TYGLPAKPMTPKVVTLWYR 175

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL---- 574
           APE++       G      A+D+W++GC + E+L  KP     SE E    + ++L    
Sbjct: 176 APELLL------GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN 229

Query: 575 ------------------------NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
                                   N     P  LS  G   L    + +P +R +A E L
Sbjct: 230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKKRATAEEAL 288

Query: 611 EHPFIR 616
           E  + +
Sbjct: 289 ESSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  110 bits (276), Expect = 1e-26
 Identities = 83/307 (27%), Positives = 139/307 (45%), Gaps = 62/307 (20%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA----ECIKQLEQEIK 406
           ++K + IG GT+G VY   ++ TG   A+K+  +  D+   P +A      ++ L + I 
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62

Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRH 463
           ++  L  E++ +  G       LY+  EY+       ++   R   R +    +++F   
Sbjct: 63  IVRLLDVEHVEEKNGKPS----LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSPN--- 519
           +L G+A+ H    +HRD+K  NLLVD   G++K+AD G+ +  +     + +K   +   
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-----IPVKSYTHEIV 173

Query: 520 ---WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKV 573
              + APEV+       G+   +  VDIWS+GC   EM   +P +   SE +    +FK+
Sbjct: 174 TLWYRAPEVLL------GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL 227

Query: 574 LNRTP-----------------PI--PEMLSS-------EGKDFLLRCFLRNPVERPSAV 607
           L  TP                 P   P+ LS        EG D L +    +P +R SA 
Sbjct: 228 LG-TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK 286

Query: 608 ELLEHPF 614
             L HP+
Sbjct: 287 AALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  111 bits (278), Expect = 1e-26
 Identities = 81/276 (29%), Positives = 138/276 (50%), Gaps = 23/276 (8%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 414
            ++G+G+FG V +   + T    AIK +    II DD    EC   +E+ +  L   K  
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDD--DVECT-MVEKRVLALPG-KPP 61

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            + Q +      D LY  +EYV+ G +  ++++  +   E     +   I  GL +LHS 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSK 120

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
             I+RD+K  N+++DA G +K+ADFGM K ++ G     +  G+P+++APE+I    Q  
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII--AYQPY 178

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFL 592
           G      +VD W+ G  + EML G+PP+ + E    +F+ ++      P+ LS E     
Sbjct: 179 GK-----SVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLSKEAVSIC 232

Query: 593 LRCFLRNPVER----PSAV-ELLEHPFIRNANYQNL 623
                ++P +R    P+   ++ EH F R  +++ L
Sbjct: 233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL 268

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  109 bits (274), Expect = 2e-26
 Identities = 72/278 (25%), Positives = 126/278 (45%), Gaps = 19/278 (6%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V     + TG   A K++D      +  E +   E++I      +   IV  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIH 478
             +    D L + +  ++ G +  ++         E+    +   I+ GL +LH    ++
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           RD+K  N+L+D  G V+++D G+A  L G        G+P +MAPEV++           
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ-------GEVY 171

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEF----EGPQAMFKVLNRTPPIPEMLSSEGKDFLLR 594
             +VD ++LGCT+ EM+ G+ P+ +     E  +   + L      P+  S E KD    
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA 231

Query: 595 CFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 627
              ++P +R      SA E+ EHP  ++ N++ L   M
Sbjct: 232 LLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGM 269

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  110 bits (277), Expect = 2e-26
 Identities = 85/288 (29%), Positives = 148/288 (51%), Gaps = 35/288 (12%)

Query: 358 KLIGRGTFGSVYI---GTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           K++G G +G V++    T  +TG   A+K   +  ++    + A+ ++    E  VL H+
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV----QKAKTVEHTRTERNVLEHV 61

Query: 412 KHEN-IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGL 468
           +    +V  + +   +  L++ L+YV  G +  + Y R++    +E  VR ++  I+  L
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILAL 118

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVI 526
            +LH    ++RDIK  N+L+D+ G V L DFG++K       E   S  G+  +MAPE+I
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-----PQAMFKVLNRTPPIP 581
           +    K G+ K   AVD WSLG  + E+LTG  P++  EG      +   ++L   PP P
Sbjct: 179 RG---KGGHGK---AVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRILKCDPPFP 231

Query: 582 EMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLS 624
             +  E +D L +   ++P +R       A E+ EHPF +  +++ L+
Sbjct: 232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  108 bits (272), Expect = 5e-26
 Identities = 84/307 (27%), Positives = 139/307 (45%), Gaps = 60/307 (19%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 409
           Q++K + IG GT+G VY   +R T  + A+K++ +  +D   P +A       +EI +L 
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI------REISLLK 56

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYV------HPGSINRYVREHCRDITESIVRNFTRH 463
            ++H NIV+       +  LY+  EY+      H  S   + +         +++ +   
Sbjct: 57  EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP------RLIKTYLYQ 110

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWM- 521
           IL G+AY HS   +HRD+K  NLL+D     +KLADFG+A+         + +    W  
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP 578
           APE++       G+   +  VDIWS+GC   EM+  KP +   SE +    +F++L  TP
Sbjct: 171 APEILL------GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG-TP 223

Query: 579 ---------PIPEM------------------LSSEGKDFLLRCFLRNPVERPSAVELLE 611
                     +P+                   L   G D L +    +P +R +A   LE
Sbjct: 224 NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283

Query: 612 HPFIRNA 618
           H + ++ 
Sbjct: 284 HEYFKDL 290

Length = 294

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  109 bits (275), Expect = 5e-26
 Identities = 79/304 (25%), Positives = 139/304 (45%), Gaps = 57/304 (18%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHL 411
           ++Q    +G G +G V    + +TG   AIK++      P +SA   K+  +E+++L H+
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKHM 71

Query: 412 KHENIVQ----YYGSEVVDDHLYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRHI 464
            HEN++     +  +  ++D   +YL  V       +N  V+  C+ +++  ++     I
Sbjct: 72  DHENVIGLLDVFTPASSLEDFQDVYL--VTHLMGADLNNIVK--CQKLSDDHIQFLVYQI 127

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAP 523
           L GL Y+HS   IHRD+K +N+ V+    +K+ DFG+A+H      E++   +  W  AP
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEMTGYVATRWYRAP 184

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSE 563
           E++   M  +        VDIWS+GC + E+LTGK                     P  E
Sbjct: 185 EIMLNWMHYNQ------TVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238

Query: 564 F------EGPQAMFKVLNRTP-----PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
                  E  +   + L + P      +    +    D L +  + +P +R +A E L H
Sbjct: 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298

Query: 613 PFIR 616
           P++ 
Sbjct: 299 PYLA 302

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  108 bits (273), Expect = 7e-26
 Identities = 88/301 (29%), Positives = 139/301 (46%), Gaps = 62/301 (20%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLK-HENIV 417
           +G+G +G V+   +R T    A+K++ D   +   +    +    EI  L  L  H NIV
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR----EIMFLQELGDHPNIV 70

Query: 418 QYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNF-TRHILNGLAYLHST 474
           +       ++   IYL  EY+    ++  +R    +I E + + +    +L  L Y+HS 
Sbjct: 71  KLLNVIKAENDKDIYLVFEYMET-DLHAVIR---ANILEDVHKRYIMYQLLKALKYIHSG 126

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP--------NWM-APEV 525
           N IHRD+K +N+L+++   VKLADFG+A+ L+ L        +P         W  APE+
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP---ENPVLTDYVATRWYRAPEI 183

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWS----------EFEGP------ 567
           +       G+ +    VD+WS+GC + EML GKP  P +          E  GP      
Sbjct: 184 LL------GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237

Query: 568 --------QAMFKVLNRTP--PIPEML---SSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
                     M   L   P  P+ E+L   S +  D L +  + NP +R +A E LEHP+
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297

Query: 615 I 615
           +
Sbjct: 298 V 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  109 bits (273), Expect = 8e-26
 Identities = 86/314 (27%), Positives = 143/314 (45%), Gaps = 72/314 (22%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           ++  K +G+G +G V    N ET    + AIK++  +    K     + L +E+K+L H 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRAL-RELKLLRHF 58

Query: 412 K-HENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           + H+NI   Y  ++V     + LY+Y E +    +++ +R     +T++  ++F   IL 
Sbjct: 59  RGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQP-LTDAHFQSFIYQILC 116

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----- 521
           GL Y+HS N +HRD+K  NLLV+A   +K+ DFG+A+      +  +   +  +M     
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-----GFSENPGENAGFMTEYVA 171

Query: 522 -----APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKV 573
                APE++ +            A+D+WS+GC + E+L  KP    F+G      + ++
Sbjct: 172 TRWYRAPEIMLS------FQSYTKAIDVWSVGCILAELLGRKP---VFKGKDYVDQLNQI 222

Query: 574 LNR--TPPIPEMLSS----------------EGKDF-------------LLRCFLR-NPV 601
           L    TP   E LS                   K F             LL   L  +P 
Sbjct: 223 LQVLGTPD-EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPT 281

Query: 602 ERPSAVELLEHPFI 615
           +R S  E LEHP++
Sbjct: 282 KRISVEEALEHPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  106 bits (267), Expect = 9e-26
 Identities = 74/262 (28%), Positives = 122/262 (46%), Gaps = 26/262 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V++G  R      AIK ++      + A   +   +E KV+  L H  +V
Sbjct: 10  KELGSGQFGVVHLGKWRAQ-IKVAIKAIN------EGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG       LYI  E++  G +  Y+R+    +++ ++ +  + +  G+ YL   + I
Sbjct: 63  QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGN 535
           HRD+   N LV ++GVVK++DFGM +++    Y  S   K    W  PEV          
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF------- 175

Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEMLSSEGK 589
            K +   D+WS G  + E+ T GK P+ +    + +  +     L R    P++ S    
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----PKLASMTVY 231

Query: 590 DFLLRCFLRNPVERPSAVELLE 611
           + +  C+   P  RP+  ELL 
Sbjct: 232 EVMYSCWHEKPEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  106 bits (267), Expect = 9e-26
 Identities = 80/263 (30%), Positives = 120/263 (45%), Gaps = 30/263 (11%)

Query: 358 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           K +G G FG V  G  R     A   IKE  +  D+           +E KV+  L HE 
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE---------FIEEAKVMMKLSHEK 60

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           +VQ YG       +YI  EY+  G +  Y+REH +    S +    + +  G+AYL S  
Sbjct: 61  LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVMQKD 533
            IHRD+   N LVD  G VK++DFG+++++    Y  S+  K    W  PEV+       
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS---- 176

Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEMLSSE 587
              K +   D+W+ G  + E+ + GK P+  F   + + KV     L R    P + S +
Sbjct: 177 ---KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR----PHLASEK 229

Query: 588 GKDFLLRCFLRNPVERPSAVELL 610
               +  C+     ERP+  +LL
Sbjct: 230 VYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  106 bits (266), Expect = 2e-25
 Identities = 80/279 (28%), Positives = 133/279 (47%), Gaps = 39/279 (13%)

Query: 358 KLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           + +G+G FGSV    Y      TG   A+K++        +AE ++  E+EI++L  L+H
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-----HSTAEHLRDFEREIEILKSLQH 64

Query: 414 ENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           +NIV+Y G        +L + +EY+  GS+  Y+++H   +    +  +   I  G+ YL
Sbjct: 65  DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKG-SP-NWMAPEVIK 527
            S   +HRD+   N+LV++   VK+ DFG+ K L      Y++   G SP  W APE + 
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL- 574
                    K ++A D+WS G  + E+ T       P +EF        +G   ++ ++ 
Sbjct: 185 -------ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237

Query: 575 ----NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
               N   P P    +E    +  C+  +P +RPS  EL
Sbjct: 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 2e-25
 Identities = 89/327 (27%), Positives = 146/327 (44%), Gaps = 87/327 (26%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-- 415
           K+IGRG FG V +   ++TG   A+K++       + +E +++ EQ    + H++ E   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEK-EQ----VAHVRAERDI 54

Query: 416 --------IVQYYGSEVVDDHLYIYLEYVHPGS--INRYVREHCRDI-TESIVRNFTRHI 464
                   +V+ Y S   +++LY+ +EY+ PG   +   ++   +D  TE   R +    
Sbjct: 55  LAEADNPWVVKLYYSFQDENYLYLIMEYL-PGGDMMTLLMK---KDTFTEEETRFYIAET 110

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-----HLT------------- 506
           +  +  +H    IHRDIK  NLL+DA G +KL+DFG+       H T             
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 507 -----------------------GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 543
                                   L+Y  S  G+P+++APEV    +Q   N       D
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAY--STVGTPDYIAPEVF---LQTGYNK----ECD 221

Query: 544 IWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLN--RTPPIPE--MLSSEGKDFLLR--CF 596
            WSLG  + EML G PP+   + PQ  + K++N   T   P+   LS E KD + R  C 
Sbjct: 222 WWSLGVIMYEMLVGYPPFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCE 280

Query: 597 LRNPVERPSAVELLEHPFIRNANYQNL 623
               +      E+  HPF +  +++++
Sbjct: 281 AERRLGNNGVNEIKSHPFFKGVDWEHI 307

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 2e-25
 Identities = 89/279 (31%), Positives = 137/279 (49%), Gaps = 28/279 (10%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVD--IIPDDPKSAECIKQLEQEIKVLGHLKHEN-I 416
           IG+GTFG VY    ++T    A+K +    I    + A  I   E+ I V   L     I
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIG--ERNILVRTLLDESPFI 58

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V    S   D  LY+  +Y+  G +  ++++  R  +E   + +   ++  L +LH  + 
Sbjct: 59  VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR-FSEDRAKFYIAELVLALEHLHKYDI 117

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
           ++RD+K  N+L+DA+G + L DFG++K +LT      +  G+  ++APEV+   + + G 
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL---LDEKGY 174

Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMFKVLN----RTPPIPEMLSSEGK 589
            K    VD WSLG  V EM  G   WS F     Q M++ +     R P    +LS EG+
Sbjct: 175 TKH---VDFWSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGKVRFP--KNVLSDEGR 226

Query: 590 DFLLRCFLRNPVER----PSAVELLEHPFIRNANYQNLS 624
            F+     RNP  R      AVEL EHPF  + ++  LS
Sbjct: 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLS 265

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 2e-25
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 28/264 (10%)

Query: 357 GKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
            K +G G FG V++G    +   A   I+E  +  DD           +E KV+  L H 
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD---------FIEEAKVMMKLSHP 59

Query: 415 NIVQYYGSEVVDDH--LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           N+VQ YG  V      ++I  EY+  G +  Y+RE    +    + +    +   + YL 
Sbjct: 60  NLVQLYG--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVM 530
           S   IHRD+   N LV    VVK++DFG+A+++    Y  S   K    W  PEV     
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD--- 174

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSE 587
                 + +   D+WS G  + E+ + GK P+  F   + +  V    R    P++  +E
Sbjct: 175 ----YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR-PKLAPTE 229

Query: 588 GKDFLLRCFLRNPVERPSAVELLE 611
               +  C+   P +RP+  +LL 
Sbjct: 230 VYTIMYSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  107 bits (269), Expect = 2e-25
 Identities = 81/277 (29%), Positives = 134/277 (48%), Gaps = 28/277 (10%)

Query: 358 KLIGRGTFGSVYIGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHL 411
           + +G G+FG V + T + E     AIK  +        ++ IKQ +      E K+L ++
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFE-------KSKIIKQKQVDHVFSERKILNYI 88

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
            H   V  YGS   + +LY+ LE+V  G    ++R + R     +   +   I+    YL
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYL 147

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
            S N ++RD+K  NLL+D  G +K+ DFG AK +   +Y  +L G+P ++APE++  V  
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY--TLCGTPEYIAPEILLNV-- 203

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 591
             G+ K   A D W+LG  + E+L G PP+   E      K+L      P+ L +  K  
Sbjct: 204 --GHGK---AADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258

Query: 592 LLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
           + +    +  +R       A  + EHP+  N ++ +L
Sbjct: 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295

Length = 340

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 3e-25
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)

Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQE 404
            K+++ +K K++G G FG+VY G     G       AIK +     +  S +  K++  E
Sbjct: 4   LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR----EETSPKANKEILDE 59

Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
             V+  + H ++V+  G  +      I  + +  G +  YVR H  +I    + N+   I
Sbjct: 60  AYVMASVDHPHVVRLLGICLSSQVQLI-TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI 118

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWM 521
             G++YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WM
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 561
           A E I        +       D+WS G TV E++T G  P+
Sbjct: 179 ALESIL-------HRIYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  106 bits (265), Expect = 4e-25
 Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 36/219 (16%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG GT+G VY   +++TG   A+K+V +  D+ K    I  + +EIK+L  L H NIV  
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAI-REIKILRQLNHRNIVNL 71

Query: 420 YGSEVVDDH------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
              E+V D              Y+  EY+    +   +       +E  +++F + +L G
Sbjct: 72  K--EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG-LLESGLVHFSEDHIKSFMKQLLEG 128

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           L Y H  N +HRDIK +N+L++  G +KLADFG+A+        L           +VI 
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR--------LYNSEESRPYTNKVIT 180

Query: 528 AVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 559
              +    P+L L       A+D+WS GC + E+ T KP
Sbjct: 181 LWYRP---PELLLGEERYGPAIDVWSCGCILGELFTKKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  105 bits (264), Expect = 8e-25
 Identities = 81/277 (29%), Positives = 135/277 (48%), Gaps = 26/277 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-----VLGHLK 412
           K+IG+G+FG V +  ++  G   A+K +       K A   K+ ++ I      +L ++K
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQ------KKAILKKKEQKHIMAERNVLLKNVK 54

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYL 471
           H  +V  + S    D LY  L+YV+ G +  ++ RE  R   E   R +   I + L YL
Sbjct: 55  HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYL 112

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVM 530
           HS N I+RD+K  N+L+D+ G V L DFG+ K  +       +  G+P ++APEV++   
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR--- 169

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
            K    +    VD W LG  + EML G PP+   +  +    +LN+   +   +S   + 
Sbjct: 170 -KQPYDR---TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARH 225

Query: 591 FLLRCFLRNPVERPSA----VELLEHPFIRNANYQNL 623
            L     ++  +R  A    +E+  H F  + N+ +L
Sbjct: 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDL 262

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  105 bits (262), Expect = 1e-24
 Identities = 80/274 (29%), Positives = 130/274 (47%), Gaps = 26/274 (9%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLKHE 414
           IG+G+FG V     R+T    A+K +       + A  + + E      E  VL  +   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTI-------RKAHIVSRSEVTHTLAERTVLAQVNCP 53

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLHS 473
            IV    S    + LY+ L +++ G +  ++ RE   D++ +  R +T  +L  L  LH 
Sbjct: 54  FIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA--RFYTAELLCALENLHK 111

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
            N I+RD+K  N+L+D  G + L DFG+ K ++       +  G+P ++APE++      
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH--- 168

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 592
            G  K   AVD W+LG  + EMLTG PP+ +    +   K+L      P+    + KD L
Sbjct: 169 -GYTK---AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLL 224

Query: 593 LRCFLRNPVER---PSAVELLEHPFIRNANYQNL 623
           +    R+P  R     A E+  HPF    +++ L
Sbjct: 225 IGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKL 258

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 1e-24
 Identities = 79/309 (25%), Positives = 137/309 (44%), Gaps = 62/309 (20%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           KL+G+G  G V++   + TG   A+K +D   +I  +      +K++  E ++L  L H 
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-----VKRVLTEQEILATLDHP 61

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYL 471
            +   Y S   + +L + ++Y   G + R ++     C  ++E + R +   +L  L YL
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC--LSEEVARFYAAEVLLALEYL 119

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPN--------- 519
           H    ++RD+K  N+L+  SG + L+DF ++K          +   KGS           
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179

Query: 520 ------------------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 561
                             ++APEVI      DG+     AVD W+LG  + EML G  P 
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISG----DGH---GSAVDWWTLGILLYEMLYGTTP- 231

Query: 562 SEFEGP---QAMFKVLNRTPPIPEM--LSSEGKDFLLRCFLRNPVER----PSAVELLEH 612
             F+G    +    +L +    P    +SS  +D + +  +++P +R      A E+ +H
Sbjct: 232 --FKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289

Query: 613 PFIRNANYQ 621
           PF R  N+ 
Sbjct: 290 PFFRGVNWA 298

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  105 bits (262), Expect = 2e-24
 Identities = 81/289 (28%), Positives = 138/289 (47%), Gaps = 37/289 (12%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLG 409
             +++  K +G G +G+V    +R TGA  AIK++      P  +E   K+  +E+++L 
Sbjct: 14  PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLK 69

Query: 410 HLKHENIVQ----YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
           H+KHEN++     +     +D     YL     G+    + +H + ++E  ++     +L
Sbjct: 70  HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK-LSEDRIQFLVYQML 128

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APE 524
            GL Y+H+   IHRD+K  NL V+    +K+ DFG+A+       E++      W  APE
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS---EMTGYVVTRWYRAPE 185

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPP--- 579
           VI   M           VDIWS+GC + EMLTGKP +   +    + +++    TP    
Sbjct: 186 VILNWMH------YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239

Query: 580 IPEMLSSEGKDFL----------LRCFLRNPVERPSAVELLEHPFIRNA 618
           + ++ S + K+++           R  L N    P AV +LE   + +A
Sbjct: 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNA--NPLAVNVLEKMLVLDA 286

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  102 bits (257), Expect = 3e-24
 Identities = 70/260 (26%), Positives = 117/260 (45%), Gaps = 19/260 (7%)

Query: 357 GKLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           G+ IG G FG VY G          + A+K        P   E   +  QE  ++    H
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKN-CTSPSVRE---KFLQEAYIMRQFDH 66

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            +IV+  G  + ++ ++I +E    G +  Y++ +   +  + +  ++  +   LAYL S
Sbjct: 67  PHIVKLIGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQ 531
              +HRDI   N+LV +   VKL DFG++++L   SY  + KG  P  WMAPE I     
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF--- 182

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGK 589
                +   A D+W  G  + E+L  G  P+   +    + ++ N    P+P        
Sbjct: 183 ----RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238

Query: 590 DFLLRCFLRNPVERPSAVEL 609
             + +C+  +P +RP   EL
Sbjct: 239 SLMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 3e-24
 Identities = 82/312 (26%), Positives = 136/312 (43%), Gaps = 69/312 (22%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            ++Q    IG G +G V   T++ TG   AIK+  I P +     C + L +EIK+L   
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--ISPFE-HQTFCQRTL-REIKILRRF 60

Query: 412 KHENIVQYYGSEVVDD-----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           KHENI+                +YI  E +    + + ++   + ++   ++ F   IL 
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKT--QHLSNDHIQYFLYQILR 117

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------- 519
           GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        ++     +       
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR--------IADPEHDHTGFLTEY 169

Query: 520 ----WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------- 559
               W  APE++   +   G  K   A+DIWS+GC + EML+ +P               
Sbjct: 170 VATRWYRAPEIM---LNSKGYTK---AIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL 223

Query: 560 -----PWSE----FEGPQAM--FKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVER 603
                P  E        +A    K L   P +P  ++      +  D L +    NP +R
Sbjct: 224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR 283

Query: 604 PSAVELLEHPFI 615
            +  E L HP++
Sbjct: 284 ITVEEALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  103 bits (257), Expect = 3e-24
 Identities = 74/268 (27%), Positives = 124/268 (46%), Gaps = 35/268 (13%)

Query: 360 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++    N        +  V  + D   +A   K  ++E ++L +L+HE+IV
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------------ITESIVRNFTR 462
           ++YG     D L +  EY+  G +N+++R H  D               +  S + +   
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---- 518
            I +G+ YL S + +HRD+   N LV A+ +VK+ DFGM++ +    Y   + G      
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPI 189

Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-- 575
            WM PE   ++M +    K     D+WS G  + E+ T GK PW +      + + +   
Sbjct: 190 RWMPPE---SIMYR----KFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIECITQG 241

Query: 576 RTPPIPEMLSSEGKDFLLRCFLRNPVER 603
           R    P +   E  D +L C+ R P +R
Sbjct: 242 RVLERPRVCPKEVYDIMLGCWQREPQQR 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  102 bits (256), Expect = 4e-24
 Identities = 80/279 (28%), Positives = 128/279 (45%), Gaps = 39/279 (13%)

Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAEC-IKQLEQEIKVLGHLKHE 414
           +G G FG V    Y      TG   A+K +      P+S    I  L++EI++L +L HE
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 66

Query: 415 NIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           NIV+Y G  +E   + + + +E++  GS+  Y+  +   I       +   I  G+ YL 
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPN-WMAPEVIKA 528
           S   +HRD+   N+LV++   VK+ DFG+ K +       ++K    SP  W APE +  
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL-- 184

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEFE---GPQA-------MFKVL 574
            +Q     K  +A D+WS G T+ E+LT       P + F    GP         + +VL
Sbjct: 185 -IQS----KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239

Query: 575 N--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
              +  P P     E    + +C+   P +R +   L+E
Sbjct: 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  102 bits (255), Expect = 5e-24
 Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 44/271 (16%)

Query: 360 IGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           +G G FG V++         +     A+K +    D+ +     K   +E ++L +L+HE
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR-----KDFHREAELLTNLQHE 67

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------------ITESIVRNFTR 462
           +IV++YG  V  D L +  EY+  G +N+++R H  D            +T+S + +  +
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---- 518
            I  G+ YL S + +HRD+   N LV  + +VK+ DFGM++ +    Y   + G      
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPI 186

Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM-----FK 572
            WM PE   ++M +    K     D+WSLG  + E+ T GK PW +    + +      +
Sbjct: 187 RWMPPE---SIMYR----KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239

Query: 573 VLNRTPPIPEMLSSEGKDFLLRCFLRNPVER 603
           VL R    P     E  D +L C+ R P  R
Sbjct: 240 VLQR----PRTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  102 bits (257), Expect = 9e-24
 Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 51/225 (22%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K IGRG +G V    N ET    AIK++    D+   A   K+  +EIK+L HL HEN++
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA---KRTLREIKLLRHLDHENVI 67

Query: 418 Q----------------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 461
                            Y   E++D  L+  +      S      +HC+         F 
Sbjct: 68  AIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLS-----DDHCQ--------YFL 114

Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             +L GL Y+HS N +HRD+K +NLL++A+  +K+ DFG+A+         +     ++M
Sbjct: 115 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---------TTSEKGDFM 165

Query: 522 APEVIKAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 559
              V   V +    P+L L       A+D+WS+GC   E+L  KP
Sbjct: 166 TEYV---VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  101 bits (254), Expect = 9e-24
 Identities = 80/295 (27%), Positives = 124/295 (42%), Gaps = 53/295 (17%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           + +G G++ +VY G +R  G   A+K + +  ++      I+    E  +L  LKH NIV
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANIV 66

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
             +      + L    EY+H   + +Y+ +H   +    VR F   +L GLAY+H  + +
Sbjct: 67  LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           HRD+K  NLL+   G +KLADFG+A+  +  S   S +    W  P     ++   G   
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPP--DVLL---GATD 180

Query: 538 LALAVDIWSLGCTVIEMLTG--------------------------------------KP 559
            + A+DIW  GC  IEML G                                      KP
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240

Query: 560 PWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
            W     PQ +  V  R    P     + +D   +  +  P +R SA + L HP+
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPP-----KAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  101 bits (252), Expect = 1e-23
 Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 22/265 (8%)

Query: 356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLK 412
           K K+IG G FG V+ G  +  G     KEV +     K     KQ +    E  ++G   
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGR----KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H NI++  G         I  EY+  G++++Y+R+H  + +   +    R I  G+ YL 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELSLKGSP-NWMAPEVIKA 528
             N +HRD+   N+LV+++   K++DFG+++ L      +Y  S    P  W APE I  
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI-- 182

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT--PPIPEMLS 585
                   K   A D+WS G  + E+++ G+ P+ +    + M K +N     P P    
Sbjct: 183 -----AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-KAINDGFRLPAPMDCP 236

Query: 586 SEGKDFLLRCFLRNPVERPSAVELL 610
           S     +L+C+ ++   RP  V+++
Sbjct: 237 SAVYQLMLQCWQQDRARRPRFVDIV 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  101 bits (253), Expect = 1e-23
 Identities = 72/275 (26%), Positives = 119/275 (43%), Gaps = 50/275 (18%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-----------EQEIKVL 408
           +G G FG V++       A C     +++P+  K    +K L           ++E ++L
Sbjct: 13  LGEGAFGKVFL-------AECH----NLLPEQDKMLVAVKALKEASESARQDFQREAELL 61

Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH--------------CRDITE 454
             L+H++IV++YG       L +  EY+  G +NR++R H                 +T 
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 455 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 514
             +      I +G+ YL S + +HRD+   N LV    VVK+ DFGM++ +    Y   +
Sbjct: 122 GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-YRV 180

Query: 515 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 569
            G       WM PE   +++ +    K     DIWS G  + E+ T GK PW +    +A
Sbjct: 181 GGRTMLPIRWMPPE---SILYR----KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233

Query: 570 MFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVER 603
           +  +   R    P     E    +  C+ R P +R
Sbjct: 234 IECITQGRELERPRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  102 bits (254), Expect = 2e-23
 Identities = 79/279 (28%), Positives = 133/279 (47%), Gaps = 29/279 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           KL+G+GTFG V +   + TG   A+K    EV +  D+      +     E +VL + +H
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRVLQNSRH 54

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             +     S    D L   +EY + G +  ++    R  +E   R +   I++ L YLHS
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHS 113

Query: 474 T-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAV 529
             N ++RD+K  NL++D  G +K+ DFG+ K   G+    ++K   G+P ++APEV++  
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLE-- 169

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 589
                +     AVD W LG  + EM+ G+ P+   +  +    +L      P  LS E K
Sbjct: 170 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAK 224

Query: 590 DFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
             L     ++P +R       A E+++H F     +Q++
Sbjct: 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDV 263

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 42/277 (15%)

Query: 360 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           +G+G+FG VY G  +     E     AIK V+   ++    E I+ L  E  V+      
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFL-NEASVMKEFNCH 69

Query: 415 NIVQYYGSEVVDD--HLYIYLEYVHPGSINRYVREHCRD---------ITESIVRNFTRH 463
           ++V+  G  VV       + +E +  G +  Y+R    +          T          
Sbjct: 70  HVVRLLG--VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGS-P-NW 520
           I +G+AYL +   +HRD+   N +V     VK+ DFGM + +     Y    KG  P  W
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM-F----KVL 574
           MAPE +     KDG        D+WS G  + EM T  + P+      + + F      L
Sbjct: 188 MAPESL-----KDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240

Query: 575 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
           +     PE    +  + +  C+  NP  RP+ +E++ 
Sbjct: 241 DL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 70/261 (26%), Positives = 122/261 (46%), Gaps = 21/261 (8%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLG 409
           +   +  + +G G FG V++GT   T    A+K +       K      +   QE +++ 
Sbjct: 5   RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTL-------KPGTMSPEAFLQEAQIMK 56

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGL 468
            L+H+ +VQ Y     ++ +YI  EY+  GS+  +++    + +    + +    I  G+
Sbjct: 57  KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVI 526
           AYL S N IHRD+   N+LV  + V K+ADFG+A+ +    Y      K    W APE  
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEML 584
                     +  +  D+WS G  + E++T G+ P+      + + +V      P P   
Sbjct: 177 NY-------GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNC 229

Query: 585 SSEGKDFLLRCFLRNPVERPS 605
             E  D +L+C+ ++P ERP+
Sbjct: 230 PEELYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 2e-23
 Identities = 89/324 (27%), Positives = 154/324 (47%), Gaps = 20/324 (6%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE--CIKQLEQEIKVLGHLKHEN 415
           K+IGRG FG V +   + TG   A+K ++   +  K AE  C ++ E+++ V G  +   
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKW-EMLKRAETACFRE-ERDVLVNGDRRWIT 64

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
            + Y   +  +++LY+ ++Y   G +   + +    + E + R +   ++  +  +H   
Sbjct: 65  NLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKD 533
            +HRDIK  N+L+D +G ++LADFG    L   G        G+P++++PE+++A+  +D
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM--ED 180

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPEMLSSEG 588
           G  +     D WSLG  + EML G+ P+      +   K++N       PP    +S E 
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240

Query: 589 KDFLLR--CFLRNPVERPSAVELLEHPFIRNANYQNL--SVPMRVFSRINLGDKSH-DQV 643
           KD + R  C     + R    +  +HPF    ++ N+  S    V    +  D S+ D  
Sbjct: 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFDVD 300

Query: 644 ERATRKTESLPDSPETRVRNRKLP 667
           +   R TESLP S         LP
Sbjct: 301 DDDLRNTESLPPSSHGAFSGNHLP 324

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 3e-23
 Identities = 83/300 (27%), Positives = 135/300 (45%), Gaps = 47/300 (15%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G++ +VY G ++ TG   A+KE+ +  ++      I+    E  +L 
Sbjct: 3   KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLK 58

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            LKH NIV  +        L +  EY+    + +Y+ +    ++   VR F   +L GLA
Sbjct: 59  DLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKA 528
           Y H    +HRD+K  NLL+   G +KLADFG+A+  +  S   S +    W   P+V+  
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL- 176

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWSEFEGPQ--AMFKVLNRTP------ 578
                G+ + + ++D+W +GC   EM TG+P  P S     Q   +F+VL  TP      
Sbjct: 177 -----GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLG-TPTEETWP 230

Query: 579 ---------------PIPEML---------SSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
                            P  L            G++  L+     P +R SA E ++HP+
Sbjct: 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 99.4 bits (247), Expect = 4e-23
 Identities = 79/263 (30%), Positives = 133/263 (50%), Gaps = 23/263 (8%)

Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++S   + KL G+G FG V++GT   T    AIK +      P++        QE +V+
Sbjct: 4   PRESLRLEVKL-GQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVM 55

Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNG 467
             L+HE +VQ Y + V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G
Sbjct: 56  KKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 114

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEV 525
           +AY+   N +HRD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE 
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE- 173

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPE 582
             A +      +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE
Sbjct: 174 --AALYG----RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 227

Query: 583 MLSSEGKDFLLRCFLRNPVERPS 605
              S   D + +C+ + P ERP+
Sbjct: 228 CPESL-HDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 4e-23
 Identities = 69/255 (27%), Positives = 120/255 (47%), Gaps = 23/255 (9%)

Query: 358 KLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           + +G G FG V+ G  N  T    A+K +     DPK          E +++  L+H  +
Sbjct: 12  RKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPK------DFLAEAQIMKKLRHPKL 63

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTN 475
           +Q Y    +++ +YI  E +  GS+  Y++    R +    + +    + +G+AYL + N
Sbjct: 64  IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIKAVMQKD 533
            IHRD+   N+LV  + + K+ADFG+A+ +    YE     K    W APE         
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY----- 178

Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 590
              + ++  D+WS G  + E++T G+ P+      + + +V    R P  P     E  D
Sbjct: 179 --NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-PPGCPKELYD 235

Query: 591 FLLRCFLRNPVERPS 605
            +L C+  +P +RP+
Sbjct: 236 IMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  100 bits (250), Expect = 5e-23
 Identities = 80/279 (28%), Positives = 136/279 (48%), Gaps = 28/279 (10%)

Query: 358 KLIGRGTFGSVYIG---TNRETGASCAIKEVDIIPDDPKSAECIK---QLEQEIKVLGHL 411
           K++G+G+FG V++    T  + G   A+K +       K+   ++   + + E  +L  +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLK------KATLKVRDRVRTKMERDILAEV 55

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAY 470
            H  IV+ + +   +  LY+ L+++  G +  R  +E     TE  V+ +   +   L +
Sbjct: 56  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDH 113

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAV 529
           LHS   I+RD+K  N+L+D  G +KL DFG++K  +       S  G+  +MAPEV+   
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV--- 170

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 589
             + G+     + D WS G  + EMLTG  P+   +  + M  +L     +P+ LS E +
Sbjct: 171 -NRRGH---TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 226

Query: 590 DFLLRCFLRNPVER----PSAVELLE-HPFIRNANYQNL 623
             L   F RNP  R    P  VE ++ HPF    ++  L
Sbjct: 227 SLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL 265

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 98.1 bits (244), Expect = 9e-23
 Identities = 73/260 (28%), Positives = 121/260 (46%), Gaps = 30/260 (11%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG+G FG V +G  R  G   A+K    I +D  +   +     E  V+  L+H N+VQ 
Sbjct: 14  IGKGEFGDVMLGDYR--GNKVAVK---CIKNDATAQAFLA----EASVMTQLRHSNLVQL 64

Query: 420 YGSEVVDD-HLYIYLEYVHPGSINRYVREHCRDITE-SIVRNFTRHILNGLAYLHSTNTI 477
            G  V +   LYI  EY+  GS+  Y+R   R +     +  F+  +   + YL + N +
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           HRD+   N+LV    V K++DFG+ K  +  S + + K    W APE ++         K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALR-------EKK 175

Query: 538 LALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG-----KDF 591
            +   D+WS G  + E+ + G+ P+        +  V+ R     +M + +G      D 
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVEKGYKMDAPDGCPPVVYDV 231

Query: 592 LLRCFLRNPVERPSAVELLE 611
           + +C+  +   RPS ++L E
Sbjct: 232 MKQCWHLDAATRPSFLQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  100 bits (250), Expect = 9e-23
 Identities = 93/342 (27%), Positives = 158/342 (46%), Gaps = 44/342 (12%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QE 404
           K   ++  K+IGRG FG V +  ++ T    A+K +          E IK+ +     +E
Sbjct: 41  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-------SKFEMIKRSDSAFFWEE 93

Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
             ++       +VQ + +   D +LY+ +EY+  G +   +  +  D+ E   R +T  +
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEV 151

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMA 522
           +  L  +HS   IHRD+K  N+L+D SG +KLADFG  M  +  G+    +  G+P++++
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211

Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TP 578
           PEV+K+   + G+       D WS+G  + EML G  P+          K++N     T 
Sbjct: 212 PEVLKS---QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF 268

Query: 579 PIPEMLSSEGKDFLLRCFL--------RNPVERPSAVELLEHPFIRN-----ANYQNLSV 625
           P    +S E K+ L+  FL        RN VE     E+  H F +N        ++   
Sbjct: 269 PDDNDISKEAKN-LICAFLTDREVRLGRNGVE-----EIKRHLFFKNDQWAWETLRDTVA 322

Query: 626 PMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLP 667
           P+      ++   + D +E    + E+ P  P+  V N +LP
Sbjct: 323 PVVPDLSSDIDTSNFDDIEEDKGEEETFP-IPKAFVGN-QLP 362

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =   99 bits (249), Expect = 1e-22
 Identities = 89/300 (29%), Positives = 134/300 (44%), Gaps = 64/300 (21%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENI 416
           K +G G +GSV    ++ TG   AIK++      P  +E   K+  +E+ +L H++HEN+
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLS----RPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 417 V---QYYGSEVVDDHLY-IYLEYVHPGSINRYVREHCRDI-----TESIVRNFTRHILNG 467
           +     + S V  D     YL  V P     Y++   + I     +E  V+     +L G
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYL--VMP-----YMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVI 526
           L Y+HS   IHRD+K  NL V+    +K+ DFG+A+H      E++      W  APEVI
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVI 186

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF-- 564
              M  +        VDIWS+GC + EMLTGK                     P  EF  
Sbjct: 187 LNWMHYNQ------TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240

Query: 565 ----EGPQAMFKVLNRTPP------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
               +  ++  K L + P        P+  S +  D L +    +  +R +A E LEHP+
Sbjct: 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKA-SPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 99.5 bits (248), Expect = 1e-22
 Identities = 80/303 (26%), Positives = 130/303 (42%), Gaps = 76/303 (25%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ- 418
           +G G FG V    ++ TG + AIK+   I     +    K+  +E+K+L HL+HENI+  
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKK---IMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74

Query: 419 -----------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
                      Y+ +E++   L+  L                R + +  ++ F   IL G
Sbjct: 75  SDIFISPLEDIYFVTELLGTDLHRLLT--------------SRPLEKQFIQYFLYQILRG 120

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK----HLTGLSYELSLKGSPNWMAP 523
           L Y+HS   +HRD+K +N+L++ +  +K+ DFG+A+     +TG         +  + AP
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV------STRYYRAP 174

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSE 563
           E++    QK       + VDIWS GC   EML GKP                    P  +
Sbjct: 175 EIM-LTWQKYD-----VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228

Query: 564 F------EGPQAMFKVLNRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
                  E      + L +  P+P     +       D L +  + +P +R SA E L H
Sbjct: 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288

Query: 613 PFI 615
           P++
Sbjct: 289 PYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  100 bits (251), Expect = 1e-22
 Identities = 83/315 (26%), Positives = 128/315 (40%), Gaps = 88/315 (27%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G FG V+  T+   G   A+K++  +  +  S    K++ +E+K+L   KH+N++  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS---CKRVFRELKMLCFFKHDNVLSA 64

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE--------SIVRN----------FT 461
                        L+ + P  I+ +  E    +TE         IV            F 
Sbjct: 65  -------------LDILQPPHIDPF--EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFL 109

Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA--------KHLTGLSYELS 513
             IL GL YLHS   +HRDIK  NLLV+++ V+K+ DFG+A        KH+T    E+ 
Sbjct: 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT---QEVV 166

Query: 514 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK--------------- 558
              +  + APE++       G+     AVDIWS+GC   E+L  +               
Sbjct: 167 ---TQYYRAPEILM------GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217

Query: 559 ------PPWSEFEGP-QAMFKVLNRTPPIPEMLSS----------EGKDFLLRCFLRNPV 601
                 P         +     + R P  P  L            E    L R  + +P 
Sbjct: 218 TDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD 277

Query: 602 ERPSAVELLEHPFIR 616
           +R SA + L HP++ 
Sbjct: 278 KRISAADALAHPYLD 292

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)

Query: 359 LIGRGTFGSVYIGTNRETGAS-CAIKEVDII-PDDPKSA----ECIKQLEQEIKVLG-HL 411
            +G G FG VY    +  G +  A+KE+++  P   K      + I  +  E+ ++   L
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 468
           +H NIV+YY + + +D LYI ++ +    +  +   ++E  +  TE  + N    ++  L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 469 AYLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
            YLH    I HRD+   N+++     V + DFG+AK     S   S+ G+  +  PE++K
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVK 186

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMFKVLNRTPPIPEMLSS 586
                  N       D+W+ GC + +M T +PP +S      A   V     P+PE + S
Sbjct: 187 -------NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239

Query: 587 EGKDFLL-RCFLRNPVERPSAVEL 609
           E    ++  C   +   RP  +++
Sbjct: 240 EDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 73/301 (24%), Positives = 127/301 (42%), Gaps = 54/301 (17%)

Query: 357 GKLIGRGTFGSVYIGTN-RETGASCAIKEVDIIPDDPK-----------SAECIKQLEQE 404
            + +G G FG V++         S      +   D P            S    +   +E
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69

Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH----------CRDITE 454
           +K+L  L   NI +  G   VD  L + +EY+  G +N+++++H           + ++ 
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 455 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 514
           S +      I +G+ YL S N +HRD+   N LV  +  +K+ADFGM+++L    Y   +
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY-YRV 188

Query: 515 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWSE----- 563
           +G       WMA E   +V+      K     D+W+ G T+ E+LT   + P+       
Sbjct: 189 QGRAPLPIRWMAWE---SVLLG----KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241

Query: 564 -------FEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
                  F         L R P  P+ +     + +L C+ R+  +RP+  E+  H F++
Sbjct: 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIY----ELMLECWRRDEEDRPTFREI--HLFLQ 295

Query: 617 N 617
            
Sbjct: 296 R 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 96.3 bits (240), Expect = 4e-22
 Identities = 70/261 (26%), Positives = 122/261 (46%), Gaps = 21/261 (8%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--LEQEIKVL 408
           + ++   + +G G FG V+ G  +      AIK   I+    KS + +KQ   ++E++ L
Sbjct: 5   REEFTLERKLGSGYFGEVWEGLWKNR-VRVAIK---IL----KSDDLLKQQDFQKEVQAL 56

Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNG 467
             L+H++++  +    V + +YI  E +  GS+  ++R    + +  + + +    +  G
Sbjct: 57  KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP-NWMAPEVI 526
           +AYL   N+IHRD+   N+LV    V K+ADFG+A+ +    Y  S K  P  W APE  
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEML 584
                   +   +   D+WS G  + EM T G+ P+      +   ++      P P   
Sbjct: 177 -------SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKC 229

Query: 585 SSEGKDFLLRCFLRNPVERPS 605
             E    +L C+   P +RPS
Sbjct: 230 PQEIYKIMLECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 99.0 bits (246), Expect = 7e-22
 Identities = 71/227 (31%), Positives = 119/227 (52%), Gaps = 29/227 (12%)

Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
           SP KS ++ G +IG G+FG VY     +T    AIK+V     DP+         +E+ +
Sbjct: 63  SPNKS-YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV---LQDPQYKN------RELLI 112

Query: 408 LGHLKHENIV---QYYGSEVVDDH-----LYIYLEYVHPGSINRYVREHCRD---ITESI 456
           + +L H NI+    YY +E    +     L + +E++ P ++++Y++ + R+   +   +
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI-PQTVHKYMKHYARNNHALPLFL 171

Query: 457 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLK 515
           V+ ++  +   LAY+HS    HRD+K  NLL+D  +  +KL DFG AK+L      +S  
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI 231

Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 562
            S  + APE++       G       +D+WSLGC + EM+ G P +S
Sbjct: 232 CSRFYRAPELML------GATNYTTHIDLWSLGCIIAEMILGYPIFS 272

Length = 440

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 95.3 bits (237), Expect = 8e-22
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 28/257 (10%)

Query: 358 KLIGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           K +G G FG V++G        A  ++K+  + P+             E  ++  L+H  
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---------AFLAEANLMKQLQHPR 62

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHST 474
           +V+ Y + V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   
Sbjct: 63  LVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQ 531
           N IHRD++ AN+LV  +   K+ADFG+A+ +    Y  + +G+     W APE I     
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINY--- 177

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEG 588
                   +  D+WS G  + E++T G+ P+     P+ + + L R    P P+    E 
Sbjct: 178 ----GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-QNLERGYRMPRPDNCPEEL 232

Query: 589 KDFLLRCFLRNPVERPS 605
            + +  C+   P ERP+
Sbjct: 233 YELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 95.1 bits (236), Expect = 9e-22
 Identities = 75/257 (29%), Positives = 116/257 (45%), Gaps = 18/257 (7%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           +L+G+G FG V+ GT ++     A+K   + +P + K    IK L  E ++L    H NI
Sbjct: 1   ELLGKGNFGEVFKGTLKDK-TPVAVKTCKEDLPQELK----IKFL-SEARILKQYDHPNI 54

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V+  G       +YI +E V  G    ++R+   ++    +  F      G+AYL S N 
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSP-NWMAPEVIKAVMQKDG 534
           IHRD+   N LV  + V+K++DFGM++      Y  S LK  P  W APE +        
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY------ 168

Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKDFL 592
             + +   D+WS G  + E  + G  P+      QA  +V        P+    +    +
Sbjct: 169 -GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVM 227

Query: 593 LRCFLRNPVERPSAVEL 609
            RC+   P  RP   EL
Sbjct: 228 QRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 97.4 bits (242), Expect = 9e-22
 Identities = 81/287 (28%), Positives = 139/287 (48%), Gaps = 39/287 (13%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLK 412
           K+IGRG FG V +  ++ +    A+K +          E IK+ +     +E  ++    
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLL-------SKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
              +VQ + +   D +LY+ +EY+  G +   +  +  D+ E   + +T  ++  L  +H
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH 159

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
           S   IHRD+K  N+L+D  G +KLADFG  M    TG+    +  G+P++++PEV+K+  
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS-- 217

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--PE--MLSS 586
            + G+       D WS+G  + EML G  P+          K+++    +  PE   +S 
Sbjct: 218 -QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276

Query: 587 EGKDFLLRCFL--------RNPVERPSAVELLEHPFIRNA--NYQNL 623
             K+ L+  FL        RN VE     E+ +HPF +N   N+ N+
Sbjct: 277 HAKN-LICAFLTDREVRLGRNGVE-----EIKQHPFFKNDQWNWDNI 317

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 95.9 bits (239), Expect = 9e-22
 Identities = 72/293 (24%), Positives = 130/293 (44%), Gaps = 47/293 (16%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
            + +   GK +G G FG V         N    ++ A+K +     +   ++ + ++E  
Sbjct: 10  PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEM- 68

Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-----------CRDIT 453
           +K++G  KH+NI+   G    +  LY+ +EY   G++  ++R              R   
Sbjct: 69  MKMIG--KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126

Query: 454 ESI----VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
           E++    + +F   +  G+ +L S   IHRD+   N+LV    V+K+ADFG+A+ +  + 
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 510 Y-------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 561
           Y        L +K    WMAPE +   +            D+WS G  + E+ T G  P+
Sbjct: 187 YYRKTTNGRLPVK----WMAPEALFDRV-------YTHQSDVWSFGVLLWEIFTLGGSPY 235

Query: 562 SEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
                 + +FK+L    R    P+  + E    +  C+   P +RP+  +L+E
Sbjct: 236 PGIPVEE-LFKLLKEGYRMEK-PQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 96.2 bits (239), Expect = 1e-21
 Identities = 81/310 (26%), Positives = 139/310 (44%), Gaps = 40/310 (12%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   + K + +G GT+ +V+ G ++ T    A+KE+ +  ++      I+    E+ +L 
Sbjct: 4   KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLK 59

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            LKH NIV  +     D  L +  EY+    + +Y+ +    ++   V+ F   IL GLA
Sbjct: 60  DLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLA 118

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           Y H    +HRD+K  NLL++  G +KLADFG+A+  +  +   S +    W  P  +   
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL- 177

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWSEFEGPQAMFKVLNRTP--------- 578
               G+ + +  +D+W +GC   EM +G+P  P S  E    +   L  TP         
Sbjct: 178 ----GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233

Query: 579 --------------PIPEM-----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
                         P P +     L +EG + L +       +R SA E ++H + R+  
Sbjct: 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293

Query: 620 YQNLSVPMRV 629
            +  S+P  +
Sbjct: 294 TRIHSLPESI 303

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 96.2 bits (239), Expect = 1e-21
 Identities = 82/280 (29%), Positives = 134/280 (47%), Gaps = 32/280 (11%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-----EIKVL-GHL 411
           K+IG+G+FG V +   +  G+  A+K +       +    +K+ EQ     E  VL  +L
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVL-------QKKTILKKKEQNHIMAERNVLLKNL 53

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAY 470
           KH  +V  + S    + LY  L+YV+ G +  ++ RE C    E   R +   + + + Y
Sbjct: 54  KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIGY 111

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIK 527
           LHS N I+RD+K  N+L+D+ G V L DFG+ K   G+  E +     G+P ++APEV++
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLR 169

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                         VD W LG  + EML G PP+   +  Q    +L++   +P   +  
Sbjct: 170 -------KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVA 222

Query: 588 GKDFLLRCFLRNPVERPSA----VELLEHPFIRNANYQNL 623
             D L+    ++   R  A    +E+  H F    N+ +L
Sbjct: 223 ACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDL 262

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 96.2 bits (239), Expect = 1e-21
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 23/276 (8%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHL-KHE 414
           ++G+G+FG V +   + T    AIK +    +I DD    EC      E +VL    K  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD--DVECTMV---EKRVLALQDKPP 61

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            + Q +      D LY  +EYV+ G +  ++++  +   E     +   I  GL +LH  
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHRR 120

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
             I+RD+K  N+++D+ G +K+ADFGM K H+       +  G+P+++APE+I    Q  
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII--AYQPY 178

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 593
           G      +VD W+ G  + EML G+PP+   +  +    ++      P+ LS E      
Sbjct: 179 G-----KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICK 233

Query: 594 RCFLRNPVER-----PSAVELLEHPFIRNANYQNLS 624
               ++P +R         ++ EH F R  ++  L 
Sbjct: 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE 269

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 96.3 bits (239), Expect = 1e-21
 Identities = 89/337 (26%), Positives = 159/337 (47%), Gaps = 60/337 (17%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G  G V+  +++ +G   A K   +I  + K A    Q+ +E++VL 
Sbjct: 3   KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARK---LIHLEIKPA-IRNQIIRELQVLH 58

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 117

Query: 470 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL   + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++M+PE ++ 
Sbjct: 118 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 176

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGK-----PPWSEFE------------------ 565
                     ++  DIWS+G +++EM  G+     P   E E                  
Sbjct: 177 T-------HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP 229

Query: 566 -----------------GPQAMFKVL----NRTPP-IPE-MLSSEGKDFLLRCFLRNPVE 602
                             P A+F++L    N  PP +P  +  +E +DF+ +C ++NP E
Sbjct: 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAE 289

Query: 603 RPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKS 639
           R    +L+ H FI+ +  + +     + S I L   S
Sbjct: 290 RADLKQLMVHAFIKRSEAEEVDFAGWLCSTIGLNQPS 326

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 34/273 (12%)

Query: 356 KGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           K KL G G +G VY G  ++   + A+K +  D +         +++  +E  V+  +KH
Sbjct: 11  KHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--------VEEFLKEAAVMKEIKH 61

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF-TRHILNGLAYLH 472
            N+VQ  G    +   YI  E++  G++  Y+RE  R    ++V  +    I + + YL 
Sbjct: 62  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVM 530
             N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K    W APE +    
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL---- 177

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEML 584
                 K ++  D+W+ G  + E+ T G  P+   +  Q    +     + R    P   
Sbjct: 178 ---AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP-- 232

Query: 585 SSEGKDFLLRCFLRNPVERPSAVEL---LEHPF 614
             +  + +  C+  NP +RPS  E+    E  F
Sbjct: 233 --KVYELMRACWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 95.8 bits (238), Expect = 2e-21
 Identities = 80/274 (29%), Positives = 132/274 (48%), Gaps = 20/274 (7%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLEQEIKVL-GHLKHE 414
           K+IG+G+FG V +   +  G   A+K  +  I+ +  +     K +  E  VL  ++KH 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ----KHIMAERNVLLKNVKHP 56

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +V  + S    + LY  L++V+ G +  +++   R   E   R +   I + L YLHS 
Sbjct: 57  FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSI 115

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKD 533
           N ++RD+K  N+L+D+ G V L DFG+ K     S    +  G+P ++APEVI+   Q  
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK--QPY 173

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA----MFKVLNRTPPIPEMLSSEGK 589
            N      VD W LG  + EML G PP+   +  +     + K L   P       S  +
Sbjct: 174 DN-----TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228

Query: 590 DFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 623
           + L +   R    +   +E+ EHPF  + ++ +L
Sbjct: 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDL 262

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 96.3 bits (239), Expect = 2e-21
 Identities = 81/280 (28%), Positives = 140/280 (50%), Gaps = 37/280 (13%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHL 411
           ++Q    +G G +GSV    + +TG   A+K++      P +S    K+  +E+++L H+
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS----RPFQSIIHAKRTYRELRLLKHM 73

Query: 412 KHENIVQ----YYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           KHEN++     +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL 
Sbjct: 74  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 131

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEV 525
           GL Y+HS + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE+
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEI 188

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWSEFEGPQAMFKVLNRTPPIPEM 583
           +   M  +        VDIWS+GC + E+LTG+   P ++      +   L  TP   E+
Sbjct: 189 MLNWMHYN------QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AEL 241

Query: 584 L---SSEGKDFLLRCFLRNPV---------ERPSAVELLE 611
           L   SSE     ++   + P            P AV+LLE
Sbjct: 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 281

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 95.9 bits (238), Expect = 2e-21
 Identities = 77/282 (27%), Positives = 134/282 (47%), Gaps = 31/282 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHL-KHE 414
           ++IGRG++  V +   ++T    A+K V  +++ DD    E I  ++ E  V      H 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 56

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +V  +     +  L+  +EYV+ G +  +++   R + E   R ++  I   L YLH  
Sbjct: 57  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER 115

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
             I+RD+K  N+L+D+ G +KL D+GM K  L       +  G+PN++APE+++      
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG----- 170

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWS---EFEGPQA-----MFKV-LNRTPPIPEML 584
                  +VD W+LG  + EM+ G+ P+      + P       +F+V L +   IP  L
Sbjct: 171 --EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 585 SSEGKDFLLRCFLRNPVERPSAV------ELLEHPFIRNANY 620
           S +    L     ++P ER          ++  HPF RN ++
Sbjct: 229 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 69/253 (27%), Positives = 125/253 (49%), Gaps = 20/253 (7%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V++GT        A+K +      P+S        +E +++  L+H+ +V
Sbjct: 12  KKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTMSPES------FLEEAQIMKKLRHDKLV 64

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           Q Y + V ++ +YI  EY+  GS+  ++++   R +    + +    +  G+AY+   N 
Sbjct: 65  QLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV    V K+ADFG+A+ +    Y      K    W APE   A +    
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYG-- 178

Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKDFL 592
             +  +  D+WS G  + E++T G+ P+      + + +V      P P+       + +
Sbjct: 179 --RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236

Query: 593 LRCFLRNPVERPS 605
           L+C+ ++P ERP+
Sbjct: 237 LQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 81/300 (27%), Positives = 131/300 (43%), Gaps = 51/300 (17%)

Query: 349 PKKSQWQKGKLIGRGTFGSVYI----GTNRETGASCAIKEVDIIPDDPKSAECIKQLE-- 402
           P+K    K KL G G FG V++    G  +      +   +D+  + P     +K L   
Sbjct: 3   PRKRLTFKEKL-GEGQFGEVHLCEAEGMEKFMDKDFS---LDVSGNQPVLV-AVKMLRED 57

Query: 403 ----------QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH---- 448
                     +EIK++  LK  NI++     +  D L +  EY+  G +N+++  H    
Sbjct: 58  ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117

Query: 449 ------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 502
                    I+ S +      I +G+ YL S N +HRD+   N LV  +  +K+ADFGM+
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Query: 503 KHL-TGLSYELSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--G 557
           ++L +G  Y +  +      WM+ E I          K   A D+W+ G T+ E+LT   
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILL-------GKFTTASDVWAFGVTLWEILTLCK 230

Query: 558 KPPWSEFEGPQAM------FKVLNRTP--PIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + P+S+    Q +      F+   R    P P +        +L C+ RN  ERPS  E+
Sbjct: 231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 95.1 bits (236), Expect = 2e-21
 Identities = 80/298 (26%), Positives = 132/298 (44%), Gaps = 42/298 (14%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G GT+ +VY G ++ T    A+KE+ +  ++      I+    E+ +L  LKH NIV  
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 69

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           +     +  L +  EY+    + +Y+ +    I    V+ F   +L GL Y H    +HR
Sbjct: 70  HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 539
           D+K  NLL++  G +KLADFG+A+  +  +   S +    W  P  I       G+   +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL-----GSTDYS 183

Query: 540 LAVDIWSLGCTVIEMLTGKP--PWSEFEGP-QAMFKVLNRTP---PIPEMLSSE------ 587
             +D+W +GC   EM TG+P  P S  E     +F++L  TP     P +LS+E      
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG-TPTEETWPGILSNEEFKSYN 242

Query: 588 -------------------GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
                              G + L +       +R SA E ++HP+      +   +P
Sbjct: 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLP 300

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 95.5 bits (237), Expect = 2e-21
 Identities = 76/277 (27%), Positives = 131/277 (47%), Gaps = 26/277 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-----VLGHLK 412
           K+IG+G+FG V +  ++      A+K +       K A   K+ E+ I      +L ++K
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQ------KKAILKKKEEKHIMSERNVLLKNVK 54

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYL 471
           H  +V  + S    D LY  L+Y++ G +  ++ RE C    E   R +   I + L YL
Sbjct: 55  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYL 112

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVM 530
           HS N ++RD+K  N+L+D+ G + L DFG+ K ++       +  G+P ++APEV+    
Sbjct: 113 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH--- 169

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
                      VD W LG  + EML G PP+      +    +LN+   +   +++  + 
Sbjct: 170 ----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARH 225

Query: 591 FLLRCFLRNPVERPSA----VELLEHPFIRNANYQNL 623
            L     ++  +R  A    +E+  H F    N+ +L
Sbjct: 226 LLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDL 262

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 97.4 bits (242), Expect = 3e-21
 Identities = 77/290 (26%), Positives = 137/290 (47%), Gaps = 25/290 (8%)

Query: 338 MPHIMEKP-SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 396
           +P   E P S +P++  +    L+GR    + ++ T         + +  ++ D+ ++A 
Sbjct: 52  LPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAY 111

Query: 397 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---IT 453
                  E+  L    H  IV+++     DD L + +EY   G +N+ +++  ++     
Sbjct: 112 A----RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ 167

Query: 454 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT---GLSY 510
           E  V      I+  L  +HS   +HRD+K AN+ +  +G++KL DFG +K  +    L  
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227

Query: 511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--- 567
             S  G+P ++APE+ +         + +   D+WSLG  + E+LT   P   F+GP   
Sbjct: 228 ASSFCGTPYYLAPELWE-------RKRYSKKADMWSLGVILYELLTLHRP---FKGPSQR 277

Query: 568 QAMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
           + M +VL  +  P P  +SS  K  L     +NP  RP+  +LL   F++
Sbjct: 278 EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 95.1 bits (236), Expect = 3e-21
 Identities = 78/277 (28%), Positives = 135/277 (48%), Gaps = 25/277 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 414
            ++G+G+FG V +   + T    AIK +    +I DD    EC   +E+ +  L   K  
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD--DVEC-TMVEKRVLALSG-KPP 61

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            + Q +      D LY  +EYV+ G +   +++  R   E     +   I  GL +LHS 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSK 120

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWMAPEVIKAVMQK 532
             I+RD+K  N+++D+ G +K+ADFGM K     G++ + +  G+P+++APE+I    Q 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-TFCGTPDYIAPEIIA--YQP 177

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDF 591
            G      +VD W+ G  + EML G+ P+ E E    +F+ ++      P+ +S E    
Sbjct: 178 YGK-----SVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAI 231

Query: 592 LLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
                 ++P +R         ++ EH F R  +++ L
Sbjct: 232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 74/275 (26%), Positives = 116/275 (42%), Gaps = 43/275 (15%)

Query: 358 KLIGRGTFGSVYIGTNRE-----TGAS-CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
             +G G FG VY GT  +     +G    A+K +     D +  E +K    E  ++ + 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK----EAHLMSNF 56

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR------HIL 465
            H NIV+  G  ++++  YI +E +  G +  Y+R+   +     +            + 
Sbjct: 57  NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 466 NGLAYLHSTNTIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGLSY---ELSLKGS 517
            G  YL   + IHRD+   N LV     DA  VVK+ DFG+A+ +    Y   E      
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN- 575
             WMAPE +      DG  K     D+WS G  + E+LT G+ P+          +VL  
Sbjct: 177 VRWMAPESL-----LDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQH 225

Query: 576 -----RTPPIPEMLSSEGKDFLLRCFLRNPVERPS 605
                R    PE    +    +  C+ ++P ERP+
Sbjct: 226 VTAGGRLQK-PENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 75/267 (28%), Positives = 124/267 (46%), Gaps = 27/267 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASC---AIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHL 411
           K+IG G FG V  G  +  G      AIK +       K+    KQ      E  ++G  
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-------KAGSSDKQRLDFLTEASIMGQF 62

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
            H NI++  G       + I  EY+  GS+++++RE+    T   +    R I +G+ YL
Sbjct: 63  DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG--SP-NWMAPEVIKA 528
              N +HRD+   N+LV+++ V K++DFG+++ L       + KG   P  W APE I  
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI-- 180

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 585
                   K   A D+WS G  + E+++ G+ P+ +      +  V +  R PP P    
Sbjct: 181 -----AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP-PMDCP 234

Query: 586 SEGKDFLLRCFLRNPVERPSAVELLEH 612
           S     +L C+ ++  ERP+  +++  
Sbjct: 235 SALYQLMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 94.9 bits (236), Expect = 4e-21
 Identities = 77/286 (26%), Positives = 136/286 (47%), Gaps = 33/286 (11%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHL-KHE 414
           ++IGRG++  V +   ++T    A+K +  +++ DD    E I  ++ E  V      H 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD----EDIDWVQTEKHVFETASNHP 56

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +V  +     +  L+  +E+V  G +  +++   R + E   R ++  I   L +LH  
Sbjct: 57  FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHER 115

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKD 533
             I+RD+K  N+L+DA G +KL D+GM K         S   G+PN++APE+++      
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG----- 170

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPW--------SEFEGPQAMFKV-LNRTPPIPEML 584
                  +VD W+LG  + EM+ G+ P+         +      +F+V L +   IP  L
Sbjct: 171 --EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 585 SSEGKDFLLRCFL-RNPVER------PSAVELLEHPFIRNANYQNL 623
           S +    +L+ FL ++P ER          ++  HPF RN ++  L
Sbjct: 229 SVKASS-VLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLL 273

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 93.9 bits (233), Expect = 4e-21
 Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 50/290 (17%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G GT+ +V+ G ++ T    A+KE+ +  ++      I+    E+ +L +LKH NIV  
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHSTNTIH 478
           +     +  L +  EY+    + +Y+ ++C ++ +   V+ F   +L GL+Y H    +H
Sbjct: 69  HDIIHTERCLTLVFEYLD-SDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           RD+K  NLL++  G +KLADFG+A+  +  +   S +    W  P  +       G+ + 
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL-----GSTEY 181

Query: 539 ALAVDIWSLGCTVIEMLTGKP------------------------PW------SEFEG-- 566
           +  +D+W +GC + EM TG+P                         W       EF    
Sbjct: 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241

Query: 567 -PQAMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
            PQ   + L N  P     L ++G D L    L     R SA   L H +
Sbjct: 242 FPQYRAQPLINHAP----RLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 92.8 bits (230), Expect = 7e-21
 Identities = 72/259 (27%), Positives = 129/259 (49%), Gaps = 32/259 (12%)

Query: 358 KLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           K +G G FG V++ T N+ T    A+K +      P S   ++    E  V+  L+H+ +
Sbjct: 12  KKLGAGQFGEVWMATYNKHT--KVAVKTMK-----PGSMS-VEAFLAEANVMKTLQHDKL 63

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTN 475
           V+ + + V  + +YI  E++  GS+  +++ +         + +F+  I  G+A++   N
Sbjct: 64  VKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQK 532
            IHRD++ AN+LV AS V K+ADFG+A+ +    Y  + +G+     W APE I      
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINF---- 177

Query: 533 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEMLSS 586
                  +  D+WS G  ++E++T G+ P+     P+ +  +     + R    PE L  
Sbjct: 178 ---GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY- 233

Query: 587 EGKDFLLRCFLRNPVERPS 605
              + ++RC+   P ERP+
Sbjct: 234 ---NIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 93.5 bits (232), Expect = 7e-21
 Identities = 87/309 (28%), Positives = 136/309 (44%), Gaps = 58/309 (18%)

Query: 349 PKKSQWQKGKLIGRGTFGSVYI------------GTNRETGASCAIKEVDIIPDDPKSAE 396
           P++    K KL G G FG V++            G     G    +    +  D  K+A 
Sbjct: 3   PRQQLRLKEKL-GEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR 61

Query: 397 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--RE------H 448
                 +EIK++  LK+ NI++  G  V DD L +  EY+  G +N+++  RE      H
Sbjct: 62  --NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 449 CRDITESIVRNF---TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 505
             +I    + N       I +G+ YL S N +HRD+   N LV     +K+ADFGM+++L
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Query: 506 TGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM--LTGKP 559
               Y   ++G       WMA E I          K   A D+W+ G T+ EM  L  + 
Sbjct: 180 YSGDY-YRIQGRAVLPIRWMAWESILL-------GKFTTASDVWAFGVTLWEMFTLCKEQ 231

Query: 560 PWS------------EFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 607
           P+S            EF   Q     L++TP  P  +       ++RC+ R+  +RP+  
Sbjct: 232 PYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVF----KLMMRCWSRDIKDRPTFN 287

Query: 608 ELLEHPFIR 616
           ++  H F+R
Sbjct: 288 KI--HHFLR 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 93.6 bits (232), Expect = 8e-21
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 10/208 (4%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K + +G G++ +VY G ++  G   A+K + +  ++      I+    E  +L 
Sbjct: 3   KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR----EASLLK 58

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            LKH NIV  +      + L +  EYVH   + +Y+ +H   +    V+ F   +L GL+
Sbjct: 59  GLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           Y+H    +HRD+K  NLL+  +G +KLADFG+A+  +  S+  S +    W  P  +   
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL- 176

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTG 557
               G+ + +  +D+W +GC  +EM+ G
Sbjct: 177 ----GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 93.1 bits (231), Expect = 9e-21
 Identities = 84/303 (27%), Positives = 126/303 (41%), Gaps = 69/303 (22%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G +G+VY   +  +G   A+K V +  ++        +    +K L    H NIV+ 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 420 YGS----------------EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                              E VD  L  YL+ V P  +               +++  R 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGL-----------PAETIKDLMRQ 116

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG---SPNW 520
            L GL +LH+   +HRD+K  N+LV + G VKLADFG+A+     S +++L     +  +
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWY 173

Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLN-- 575
            APEV+   +Q       A  VD+WS+GC   EM   KP +   SE +    +F ++   
Sbjct: 174 RAPEVL---LQS----TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 226

Query: 576 ------------------RTP-PI----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
                             R P P+    PE+    G   LL     NP +R SA   L+H
Sbjct: 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEI-EESGAQLLLEMLTFNPHKRISAFRALQH 285

Query: 613 PFI 615
           PF 
Sbjct: 286 PFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 70/255 (27%), Positives = 119/255 (46%), Gaps = 23/255 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V++G    +    A+K +      P +   ++   +E  ++  L+H+ +V
Sbjct: 12  KKLGAGQFGEVWMGYYNNS-TKVAVKTLK-----PGTMS-VQAFLEEANLMKTLQHDKLV 64

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTN 475
           + Y     ++ +YI  EY+  GS+  +++  E  + +   ++ +F+  I  G+AY+   N
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKN 123

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKD 533
            IHRD++ AN+LV  S + K+ADFG+A+ +    Y      K    W APE I       
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF----- 178

Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKD 590
                 +  D+WS G  + E++T GK P+        M   L R    P  E    E  D
Sbjct: 179 --GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM-SALQRGYRMPRMENCPDELYD 235

Query: 591 FLLRCFLRNPVERPS 605
            +  C+     ERP+
Sbjct: 236 IMKTCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 74/267 (27%), Positives = 129/267 (48%), Gaps = 30/267 (11%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            +   G++IG G FG+V  G    TG   A+K +       K     +   +E  V+  L
Sbjct: 6   QKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNI-------KCDVTAQAFLEETAVMTKL 56

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI-VRNFTRHILNGLAY 470
            H+N+V+  G  ++ + LYI +E +  G++  ++R   R +   I +  F+  +  G+ Y
Sbjct: 57  HHKNLVRLLGV-ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGL-SYELSLKGSPNWMAPEVIKA 528
           L S   +HRD+   N+LV   GV K++DFG+A+    G+ + +L +K    W APE +K 
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALK- 170

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF---EGPQAMFKVLNRTPPIPEML 584
                 + K +   D+WS G  + E+ + G+ P+ +    E  + + K     P  PE  
Sbjct: 171 ------HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP--PEGC 222

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLE 611
            ++    +  C+   P +RPS  +L E
Sbjct: 223 PADVYVLMTSCWETEPKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 72/260 (27%), Positives = 114/260 (43%), Gaps = 28/260 (10%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G FG V++G   E     AIK +       + A   +   +E +V+  L H  +VQ 
Sbjct: 12  IGSGQFGLVWLGYWLEK-RKVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQL 64

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           YG       + +  E++  G ++ Y+R      ++  +      +  G+AYL S+N IHR
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124

Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGNPK 537
           D+   N LV  + VVK++DFGM + +    Y  S   K    W +PEV           K
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-------SK 177

Query: 538 LALAVDIWSLGCTVIEMLT-GKPPWSE------FEGPQAMFKVLNRTPPIPEMLSSEGKD 590
            +   D+WS G  + E+ + GK P+         E   A F++       P + S    +
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK-----PRLASQSVYE 232

Query: 591 FLLRCFLRNPVERPSAVELL 610
            +  C+   P +RPS   LL
Sbjct: 233 LMQHCWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 71/274 (25%), Positives = 122/274 (44%), Gaps = 44/274 (16%)

Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK---VLGHL 411
           ++IG+G FG VY GT   +      CA+K ++ I D       ++++EQ +K   ++   
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-------LEEVEQFLKEGIIMKDF 53

Query: 412 KHENIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
            H N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ Y
Sbjct: 54  SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---------ELSLKGSPNWM 521
           L S   +HRD+   N ++D S  VK+ADFG+A+ +    Y         +L +K    WM
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WM 169

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN----- 575
           A E ++         K     D+WS G  + E++T G PP+ + +     F +       
Sbjct: 170 ALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----FDITVYLLQG 218

Query: 576 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           R    PE       + +L C+   P  RP+  EL
Sbjct: 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 90.9 bits (225), Expect = 6e-20
 Identities = 78/300 (26%), Positives = 136/300 (45%), Gaps = 45/300 (15%)

Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 6   EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS 65

Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 66  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 122

Query: 449 CRDITE--------SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI            + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 182

Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 183 LARDVNNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 232

Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P  RP+  +L+E
Sbjct: 233 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 90.0 bits (224), Expect = 7e-20
 Identities = 84/294 (28%), Positives = 127/294 (43%), Gaps = 58/294 (19%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQ 418
           IG GTF  V    +R+TG   AIK    +    KS E +  L +EI+ L  L  H NI++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKC---MKKHFKSLEQVNNL-REIQALRRLSPHPNILR 62

Query: 419 YYGSEVVDDHLYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
               EV+ D     L  V      ++   ++   R + E  V+++   +L  L ++H   
Sbjct: 63  LI--EVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWM-APEVIKAVMQKD 533
             HRDIK  N+L+    ++KLADFG  + +     Y   +  S  W  APE     +  D
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYI--STRWYRAPE----CLLTD 173

Query: 534 G--NPKLALAVDIWSLGCTVIEMLTGKP--PWS-EFEGPQAMFKVLNRTPP--------- 579
           G   PK    +DIW++GC   E+L+  P  P + E +    +  VL  TP          
Sbjct: 174 GYYGPK----MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG-TPDAEVLKKFRK 228

Query: 580 -------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
                              +P   S+EG D L +    +P ER +A + L HP+
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNA-SAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 90.0 bits (223), Expect = 8e-20
 Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 19/280 (6%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +++G+G FG V     R TG   A K ++      +  E +   E++I  L  +  + +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVNSQFVV 63

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNT 476
               +    D L + L  ++ G +  ++         E     +   IL GL  LH  NT
Sbjct: 64  NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           ++RD+K  N+L+D  G ++++D G+A  +          G+  +MAPEV+        N 
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN-------NQ 176

Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSS----EGKDFL 592
           +  L+ D W LGC + EM+ G+ P+   +      +V  R     E+ S+    E K   
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236

Query: 593 LRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 627
                ++P +R       A E+  HPF RN N++ L   M
Sbjct: 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGM 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 90.3 bits (224), Expect = 8e-20
 Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 29/285 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +++G+G FG V     R TG   A K+++      +  E +   E++I  L  +    +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVV 63

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNT 476
               +    D L + L  ++ G +  ++         E     +   I  GL  LH    
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           ++RD+K  N+L+D  G ++++D G+A  +          G+  +MAPEV+K       N 
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK-------NE 176

Query: 537 KLALAVDIWSLGCTVIEMLTGKPP---------WSEFEGPQAMFKVLNRTPPIPEMLSSE 587
           +   + D W LGC + EM+ GK P           E E      +V        E  S  
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-----RVKEDQEEYSEKFSEA 231

Query: 588 GKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 627
            +    +   ++P  R       A E+  HPF R AN++ L   M
Sbjct: 232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGM 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 90.2 bits (224), Expect = 9e-20
 Identities = 75/278 (26%), Positives = 127/278 (45%), Gaps = 25/278 (8%)

Query: 345 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 397
           P+  P   +W         GK +G G FG V   T      S A+ +V +    P +   
Sbjct: 21  PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS 80

Query: 398 IKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITE 454
            ++ L  E+K++ HL  HENIV   G+  +   + +  EY   G +  ++R      +T 
Sbjct: 81  EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140

Query: 455 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 514
             + +F+  +  G+A+L S N IHRD+   N+L+    +VK+ DFG+A+ +   S  +  
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV- 199

Query: 515 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 569
           KG+      WMAPE I        N       D+WS G  + E+ + G  P+        
Sbjct: 200 KGNARLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK 252

Query: 570 MFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS 605
            +K++     +  PE   +E  D +  C+  +P++RP+
Sbjct: 253 FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPT 290

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 90.8 bits (225), Expect = 9e-20
 Identities = 71/277 (25%), Positives = 135/277 (48%), Gaps = 17/277 (6%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE--CIKQLEQEIKVLGHLKHEN 415
           K+IGRG FG V +   + T    A+K ++   +  K AE  C ++ E+ + V G  +   
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKW-EMLKRAETACFRE-ERNVLVNGDCQWIT 64

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
            + Y   +  +++LY+ ++Y   G +   + +    + E + R +   ++  +  +H  +
Sbjct: 65  TLHYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKD 533
            +HRDIK  N+L+D +G ++LADFG    +   G        G+P++++PE+++A+  +D
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM--ED 180

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPEMLSSEG 588
           G  K     D WSLG  + EML G+ P+      +   K++N       P     +S E 
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240

Query: 589 KDFLLR--CFLRNPVERPSAVELLEHPFIRNANYQNL 623
           KD + R  C     + +    +  +H F    +++N+
Sbjct: 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI 277

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 90.9 bits (225), Expect = 9e-20
 Identities = 74/283 (26%), Positives = 131/283 (46%), Gaps = 29/283 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           ++IGRG++  V +   ++     A+K V  +++ DD    E I  ++ E  V        
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD----EDIDWVQTEKHVFEQASSNP 56

Query: 416 -IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +V  +        L++ +EYV+ G +  +++   R + E   R +   I   L +LH  
Sbjct: 57  FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHER 115

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKD 533
             I+RD+K  N+L+DA G +KL D+GM K   G     S   G+PN++APE+++      
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG----- 170

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWS------EFEGPQAMFKVLNRTP-PIPEMLSS 586
              +   +VD W+LG  + EM+ G+ P+       +      +F+V+   P  IP  LS 
Sbjct: 171 --EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSV 228

Query: 587 EGKDFLLRCFLRNPVERPSA------VELLEHPFIRNANYQNL 623
           +    L     ++P ER          ++  H F R+ ++  L
Sbjct: 229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 90.9 bits (225), Expect = 9e-20
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 58/273 (21%)

Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 459
           Q+ +E++VL       IV +YG+   D  + I +E++  GS+++ ++E  + I E I+  
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGK 107

Query: 460 FTRHILNGLAYLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +  +L GLAYL   + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ 
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTR 166

Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG--------------------- 557
           ++M+PE ++           ++  DIWS+G +++E+  G                     
Sbjct: 167 SYMSPERLQGT-------HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVV 219

Query: 558 --------------KPPWSEFEG-------PQAMFKVL----NRTPP-IPE-MLSSEGKD 590
                         +PP     G         A+F++L    N  PP +P  + + + ++
Sbjct: 220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQE 279

Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 623
           F+ +C ++NP ER     L+ H FI+ +  + +
Sbjct: 280 FVNKCLIKNPAERADLKMLMNHTFIKRSEVEEV 312

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 89.0 bits (220), Expect = 1e-19
 Identities = 68/251 (27%), Positives = 125/251 (49%), Gaps = 20/251 (7%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +++  L+H+ +V  
Sbjct: 14  LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEA------FLQEAQIMKKLRHDKLVPL 66

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y + V ++ +YI  E++  GS+  +++E   + +    + +    I +G+AY+   N IH
Sbjct: 67  Y-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE   A +      
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYG---- 178

Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKDFLLR 594
           +  +  D+WS G  + E++T G+ P+      + + +V      P P+       + +  
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL 238

Query: 595 CFLRNPVERPS 605
           C+ ++P ERP+
Sbjct: 239 CWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 89.6 bits (222), Expect = 2e-19
 Identities = 77/263 (29%), Positives = 123/263 (46%), Gaps = 52/263 (19%)

Query: 389 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 448
           PD  K+A       +E+K+L  LK  NI++  G  V +D L +  EY+  G +N+++  H
Sbjct: 56  PDANKNAR--NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH 113

Query: 449 CRD------------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 490
             D                  I+ S + +    I +G+ YL S N +HRD+   N LV  
Sbjct: 114 HLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE 173

Query: 491 SGVVKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWS 546
           +  +K+ADFGM+++L    Y   ++G       WMA E I  +M      K   A D+W+
Sbjct: 174 NLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECI--LMG-----KFTTASDVWA 225

Query: 547 LGCTVIEMLT--GKPPWSEFEGPQAM------FK------VLNRTPPIPEMLSSEGKDFL 592
            G T+ E+L    + P+ E    Q +      F+       L R PP P+ L     + +
Sbjct: 226 FGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLY----ELM 281

Query: 593 LRCFLRNPVERPSAVELLEHPFI 615
           L+C+ R+  ERPS  ++  H F+
Sbjct: 282 LQCWSRDCRERPSFSDI--HAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 70/253 (27%), Positives = 110/253 (43%), Gaps = 20/253 (7%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           IGRG FG V+ G  R      A+K   + +P D K+     +  QE ++L    H NIV+
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-----KFLQEARILKQYSHPNIVR 57

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
             G       +YI +E V  G    ++R     +    +     +   G+ YL S + IH
Sbjct: 58  LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQKDGN 535
           RD+   N LV    V+K++DFGM++      Y  +  +K  P  W APE +         
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY------- 170

Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFL 592
            + +   D+WS G  + E  + G  P++     Q    +    R P  PE+        +
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC-PELCPDAVYRLM 229

Query: 593 LRCFLRNPVERPS 605
            RC+  +P +RPS
Sbjct: 230 ERCWEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 89.4 bits (221), Expect = 3e-19
 Identities = 71/277 (25%), Positives = 136/277 (49%), Gaps = 17/277 (6%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE--CIKQLEQEIKVLGHLKHEN 415
           K+IGRG FG V +   +      A+K ++   +  K AE  C ++ E+++ V G  +   
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKW-EMLKRAETACFRE-ERDVLVNGDNQWIT 64

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
            + Y   +  +++LY+ ++Y   G +   + +    + E + R +   ++  +  +H  +
Sbjct: 65  TLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKD 533
            +HRDIK  N+L+D +G ++LADFG    L   G        G+P++++PE+++A+  +D
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM--ED 180

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPEMLSSEG 588
           G  K     D WSLG  + EML G+ P+      +   K++N       P     +S + 
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240

Query: 589 KDFLLR--CFLRNPVERPSAVELLEHPFIRNANYQNL 623
           KD + R  C   + + +    +  +HPF    ++ N+
Sbjct: 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI 277

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 16/226 (7%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           ++G G +G V    ++ET    AIK+     D  ++ E  +   +E+K+L  LK ENIV+
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKK---FKDSEENEEVKETTLRELKMLRTLKQENIVE 64

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
              +      LY+  EYV    +   + E    +    VR++   ++  + + H  + +H
Sbjct: 65  LKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWM-APEVIKAVMQKDGNP 536
           RDIK  NLL+  + V+KL DFG A++L+ G +   +   +  W  +PE++       G P
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL------GAP 177

Query: 537 KLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP 579
               AVD+WS+GC + E+  G+P +   SE +    + KVL   P 
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 92.5 bits (229), Expect = 4e-19
 Identities = 77/292 (26%), Positives = 139/292 (47%), Gaps = 42/292 (14%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           K IG G FG V++  ++ T      K +    + +  KS     QL  E+ V+  LKH+N
Sbjct: 19  KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-----QLVIEVNVMRELKHKN 73

Query: 416 IVQYYGSEV--VDDHLYIYLEYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAY 470
           IV+Y    +   +  LYI +E+   G ++R +++  +    I E  + + TR +L+ LAY
Sbjct: 74  IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133

Query: 471 LHS-------TNTIHRDIKGANLLV-----------------DASGVVKLADFGMAKHLT 506
            H+          +HRD+K  N+ +                 +   + K+ DFG++K++ 
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193

Query: 507 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 566
             S   S  G+P + +PE++    +   +       D+W+LGC + E+ +GK P+ +   
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKS-----DMWALGCIIYELCSGKTPFHKANN 248

Query: 567 PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR-NPVERPSAVELLEHPFIRN 617
              +   L R P +P    S+  + L++  L  +  ERPSA++ L +  I+N
Sbjct: 249 FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300

Length = 1021

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 89.1 bits (221), Expect = 4e-19
 Identities = 80/310 (25%), Positives = 134/310 (43%), Gaps = 70/310 (22%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           ++IG+G++G V    +  TG   AIK+++ + +    A  I +   EIK+L  L+H +IV
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR---EIKLLRLLRHPDIV 62

Query: 418 QYYG-------SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           +           E  D  +Y+  E +   S    V +   D+T    + F   +L  L Y
Sbjct: 63  EIKHIMLPPSRREFKD--IYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----------- 519
           +H+ N  HRD+K  N+L +A   +K+ DFG+A+        ++   +P            
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLAR--------VAFNDTPTAIFWTDYVATR 170

Query: 520 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW------------SEFEG 566
            + APE+  +   K        A+DIWS+GC   E+LTGKP +            ++  G
Sbjct: 171 WYRAPELCGSFFSK-----YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG 225

Query: 567 ---PQAMFKVLN-----------RTPPIPEMLSSEGKDFLLRCFLR-----NPVERPSAV 607
              P+ + +V N           +  P+P        D L    L      +P +RP+A 
Sbjct: 226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAE 285

Query: 608 ELLEHPFIRN 617
           E L  P+ + 
Sbjct: 286 EALADPYFKG 295

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 87.4 bits (216), Expect = 7e-19
 Identities = 87/317 (27%), Positives = 130/317 (41%), Gaps = 84/317 (26%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGAS-CAIKEVDIIPDD---PKSAECIKQLEQEIKVL 408
           Q++    IG G +G V+   + + G    A+K V +   +   P S        +E+ VL
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI------REVAVL 55

Query: 409 GHLK---HENIVQYYGS----------------EVVDDHLYIYLEYV-HPGSINRYVREH 448
            HL+   H N+V+ +                  E VD  L  YL+ V  PG         
Sbjct: 56  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--------- 106

Query: 449 CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 508
              +    +++    +L GL +LHS   +HRD+K  N+LV +SG +KLADFG+A+  +  
Sbjct: 107 ---VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 163

Query: 509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------- 559
               S+  +  + APEV+   +Q       A  VD+WS+GC   EM   KP         
Sbjct: 164 MALTSVVVTLWYRAPEVL---LQS----SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216

Query: 560 ---------------PWSEFEG-PQAMFK------VLNRTPPIPEMLSSEGKDFLLRCFL 597
                           W      P+  F       +      I E+    GKD LL+C  
Sbjct: 217 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL----GKDLLLKCLT 272

Query: 598 RNPVERPSAVELLEHPF 614
            NP +R SA   L HP+
Sbjct: 273 FNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 87.8 bits (217), Expect = 7e-19
 Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 21/269 (7%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K+++ ++ K++G G FG+VY G     G +  I     I ++    +   +   E  ++ 
Sbjct: 5   KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 64

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            + H ++V+  G   +   + +  + +  G +  YV EH  +I   ++ N+   I  G+ 
Sbjct: 65  SMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 526
           YL     +HRD+   N+LV +   VK+ DFG+A+ L G   E +  G      WMA E I
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP----PWSEFEGPQAMFKVLNRTPPI 580
                     K     D+WS G T+ E++T  GKP    P  E   P  + K      P 
Sbjct: 184 HY-------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI--PDLLEK--GERLPQ 232

Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           P + + +    +++C++ +   RP   EL
Sbjct: 233 PPICTIDVYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 88.7 bits (220), Expect = 8e-19
 Identities = 87/335 (25%), Positives = 136/335 (40%), Gaps = 86/335 (25%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----LEQEIK 406
           S + K K IG G FG V +    +T A  A+K +       + A+ + +     ++ E  
Sbjct: 1   SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTL-------RKADVLMRNQAAHVKAERD 53

Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGS------INRYVREHCRDITESIVRNF 460
           +L    +E +V+ Y S    D+LY  ++Y+ PG       I   + E      E + R +
Sbjct: 54  ILAEADNEWVVKLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRLGIFE------EDLARFY 106

Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM---------------AKHL 505
              +   +  +H    IHRDIK  N+L+D  G +KL DFG+                 H 
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166

Query: 506 TGLSYEL-----------------------------SLKGSPNWMAPEVIKAVMQKDGNP 536
              S E                              SL G+PN++APEV+     + G  
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL----LRTGYT 222

Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-----RTPPIPEMLSSEGKDF 591
           +L    D WS+G  + EML G+PP+      +   KV+N       P   + LS E  D 
Sbjct: 223 QLC---DWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK-LSREASDL 278

Query: 592 LLRCFLRNPVER---PSAVELLEHPFIRNANYQNL 623
           +LR       +R     A E+  HPF +  ++ +L
Sbjct: 279 ILR-LCCGAEDRLGKNGADEIKAHPFFKGIDFASL 312

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 86.9 bits (215), Expect = 9e-19
 Identities = 72/275 (26%), Positives = 129/275 (46%), Gaps = 21/275 (7%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V     + TG   A K++D      KS E +  LE+EI  L  +    IV  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
             +     HL + +  ++ G +  ++     R +    V +++  I  G+ +LHS + ++
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           RD+K  N+L+D  G  +L+D G+A  L          G+  +MAPE++K           
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK-------EEPY 171

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP-----EMLSSEGKDFLL 593
           +  VD +++GC++ EM+ G+ P+ + +   A  ++  RT         +  + E KD + 
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKD-IC 230

Query: 594 RCFL-RNPVERPSAVEL----LEHPFIRNANYQNL 623
           R FL + P +R  + E      +H F +  N+  L
Sbjct: 231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 87.8 bits (217), Expect = 9e-19
 Identities = 84/325 (25%), Positives = 145/325 (44%), Gaps = 54/325 (16%)

Query: 347 ASPK----KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           A PK    +++   GK +G G FG V     IG +++         V ++ DD      +
Sbjct: 3   ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS 62

Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--------- 446
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R         
Sbjct: 63  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119

Query: 447 --EHCRDITESI----VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             + C+   E +    + +    +  G+ YL S   IHRD+   N+LV    V+K+ADFG
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG 179

Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 180 LARDVHNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLLWEI 229

Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   + E    +  C+   P +RP+  +L+E
Sbjct: 230 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Query: 612 H-----PFIRNANYQNLSVPMRVFS 631
                        Y +LSVP   +S
Sbjct: 289 DLDRVLTVTSTDEYLDLSVPFEQYS 313

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 87.8 bits (217), Expect = 1e-18
 Identities = 86/311 (27%), Positives = 135/311 (43%), Gaps = 58/311 (18%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K+IGRG FG V +   ++TG   A+K +     D    E +  +  E  +L       +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILR--KADMLEKEQVAHIRAERDILVEADGAWVV 64

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           + + S     +LY+ +E++ PG     +      ++E   + +    +  +  +H    I
Sbjct: 65  KMFYSFQDKRNLYLIMEFL-PGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFI 123

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHL-----------------TGLSYE--------- 511
           HRDIK  NLL+DA G VKL+DFG+   L                 +  S++         
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183

Query: 512 ----------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 561
                      S  G+P+++APEV    MQ  G  KL    D WSLG  + EML G PP+
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVF---MQT-GYNKLC---DWWSLGVIMYEMLIGYPPF 236

Query: 562 SEFEGPQAMF-KVLNRT------PPIPEMLSSEGKDFLLRCFL--RNPVERPSAVELLEH 612
              E PQ  + KV+N        P +P  +S + KD +LR      N +      E+  H
Sbjct: 237 CS-ETPQETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSNGVEEIKSH 293

Query: 613 PFIRNANYQNL 623
           PF    ++ ++
Sbjct: 294 PFFEGVDWGHI 304

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 68/281 (24%), Positives = 123/281 (43%), Gaps = 21/281 (7%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +++G+G FG V     R TG   A K+++      +  E +   E++I  L  +    +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVNSRFVV 63

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHSTN 475
               +    D L + L  ++ G +  ++  H  +    E     +   I  GL  LH   
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
            ++RD+K  N+L+D  G ++++D G+A H+          G+  +MAPEV+K       N
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-------N 175

Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSS----EGKDF 591
            +   + D W+LGC + EM+ G+ P+ + +      +V      + E  S     + +  
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235

Query: 592 LLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 627
                 ++P ER       A E+ EHP  +  N++ L   M
Sbjct: 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGM 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 79/301 (26%), Positives = 136/301 (45%), Gaps = 52/301 (17%)

Query: 349 PKKSQWQK-------GKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS--- 394
           P+  +W+        GK +G G FG V     IG ++E         V ++  D      
Sbjct: 8   PEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDL 67

Query: 395 AECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------E 447
           ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E
Sbjct: 68  SDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 124

Query: 448 HCRDITESIVRNFT--------RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 499
           +C + T+      +          +  G+ YL S   IHRD+   N+LV    V+K+ADF
Sbjct: 125 YCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 184

Query: 500 GMAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE 553
           G+A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E
Sbjct: 185 GLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLWE 234

Query: 554 MLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           + T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+
Sbjct: 235 IFTLGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293

Query: 611 E 611
           E
Sbjct: 294 E 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 70/290 (24%), Positives = 125/290 (43%), Gaps = 48/290 (16%)

Query: 355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLK 412
             GK +G G FG V   T            V +  + ++  S+E ++ L  E  +L  + 
Sbjct: 3   VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQVN 61

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-----------------------C 449
           H ++++ YG+   D  L + +EY   GS+  ++RE                         
Sbjct: 62  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121

Query: 450 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
           R +T   + +F   I  G+ YL     +HRD+   N+LV     +K++DFG+++ +    
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV---- 177

Query: 510 YELS--LKGSPN-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 561
           YE    +K S       WMA E +   +    +       D+WS G  + E++T G  P+
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVLLWEIVTLGGNPY 230

Query: 562 SEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
                P+ +F +L     +  PE  S E  + +L C+ + P +RP+  ++
Sbjct: 231 PGI-APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 85.9 bits (212), Expect = 5e-18
 Identities = 85/311 (27%), Positives = 137/311 (44%), Gaps = 58/311 (18%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K+IGRG FG V +   ++TG   A+K +     D    E +  +  E  +L       +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILR--KADMLEKEQVGHIRAERDILVEADSLWVV 64

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           + + S     +LY+ +E++ PG     +      +TE   + +    +  +  +H    I
Sbjct: 65  KMFYSFQDKLNLYLIMEFL-PGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI 123

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLT---------GLSYEL---------------- 512
           HRDIK  NLL+D+ G VKL+DFG+   L           L++ L                
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183

Query: 513 -----------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 561
                      S  G+P+++APE    V  + G  KL    D WSLG  + EML G PP+
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPE----VFMQTGYNKLC---DWWSLGVIMYEMLIGYPPF 236

Query: 562 SEFEGPQAMF-KVLNRT------PPIPEMLSSEGKDFLLR--CFLRNPVERPSAVELLEH 612
              E PQ  + KV+N        P +P  +S + KD +LR  C   + +  P   E+  +
Sbjct: 237 CS-ETPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293

Query: 613 PFIRNANYQNL 623
           PF    +++++
Sbjct: 294 PFFEGVDWEHI 304

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 85.0 bits (210), Expect = 6e-18
 Identities = 81/310 (26%), Positives = 137/310 (44%), Gaps = 49/310 (15%)

Query: 357 GKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLG 409
           GK +G G FG V      G ++          V ++ D   D   A+ I ++E  +K++G
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMEL-MKLIG 75

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EHCRDITESIVRNFT- 461
             KH+NI+   G    +  LY+ +EY   G++  ++R       ++  DIT+      + 
Sbjct: 76  --KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133

Query: 462 -------RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 514
                    +  G+ YL S   IHRD+   N+LV    V+K+ADFG+A+ +  + Y    
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY---Y 190

Query: 515 KGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP 567
           K + N      WMAPE +   +    +       D+WS G  + E+ T G  P+      
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGILMWEIFTLGGSPYPGIP-V 242

Query: 568 QAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA----NYQ 621
           + +FK+L     +  P   + E    +  C+   P +RP+  +L+E      A     Y 
Sbjct: 243 EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL 302

Query: 622 NLSVPMRVFS 631
           +LS+P   +S
Sbjct: 303 DLSMPFEQYS 312

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 86.8 bits (215), Expect = 8e-18
 Identities = 76/291 (26%), Positives = 136/291 (46%), Gaps = 36/291 (12%)

Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE 402
           E  +    K  W   +++G G  G+V        G   A+K VD+   +  S     + +
Sbjct: 24  EATAKEQAKKYWIS-RVLGSGATGTVLCAKRVSDGEPFAVKVVDM---EGMSEADKNRAQ 79

Query: 403 QEIKVLGHLKHENIVQYYGSEVVDDH--------LYIYLEYVHPGSINRYVREHCRDITE 454
            E+  L +    +IV+ +      D         + + L+Y + G + + ++   +    
Sbjct: 80  AEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK---- 135

Query: 455 SIVRNFTRH--------ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
              R F  H        +L  + ++HS + IHRDIK AN+L+ ++G+VKL DFG +K   
Sbjct: 136 -TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194

Query: 507 G-LSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
             +S ++  +  G+P ++APE+ +   +K  + K     D++SLG  + E+LT K P+  
Sbjct: 195 ATVSDDVGRTFCGTPYYVAPEIWR---RKPYSKK----ADMFSLGVLLYELLTLKRPFDG 247

Query: 564 FEGPQAMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHP 613
               + M K L  R  P+P  +S E ++ +      +P  RPS+ +LL  P
Sbjct: 248 ENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 75/283 (26%), Positives = 129/283 (45%), Gaps = 26/283 (9%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V     R TG   A K+++      K  +  +    E ++L  +    IV  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLN--KKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 420 -YGSEVVDDHLYIYLEYVHPGSINRY----VREHCRDITESIVRNFTRHILNGLAYLHST 474
            Y  +   D L + +  ++ G + RY    V E      E     +T  I++GL +LH  
Sbjct: 59  AYAFQTKTD-LCLVMTIMNGGDL-RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKD 533
             I+RD+K  N+L+D  G V+++D G+A  L  G S      G+P +MAPE+++      
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ------ 170

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNRTPPIPEMLSSEGK 589
              +   +VD ++LG T+ EM+  + P+     + E  +   ++LN +   P+  S   K
Sbjct: 171 -GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASK 229

Query: 590 DFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 627
            F      ++P +R      +   L  HP  R+ N++ L   M
Sbjct: 230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGM 272

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 84.3 bits (208), Expect = 2e-17
 Identities = 82/326 (25%), Positives = 132/326 (40%), Gaps = 66/326 (20%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S + K K +G G FG V +    +T A  A+K +     D      +  ++ E  +L   
Sbjct: 1   SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR--KKDVLLRNQVAHVKAERDILAEA 58

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
            +E +V+ Y S    D+LY  ++Y+ PG     +        E + R +   +   +  +
Sbjct: 59  DNEWVVRLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGM---------------AKHLTGLSYEL---- 512
           H    IHRDIK  N+L+D  G +KL DFG+                 H+   S +     
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 513 -----------------------------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 543
                                        SL G+PN++APE    V+ + G  +L    D
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE----VLLRTGYTQLC---D 230

Query: 544 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----PIPEMLSSEGKDFLLRCFLRN 599
            WS+G  + EML G+PP+      +   KV+N       P    LS E  D +++   R 
Sbjct: 231 WWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRG 289

Query: 600 PVER---PSAVELLEHPFIRNANYQN 622
           P +R     A E+  HPF +  ++ +
Sbjct: 290 PEDRLGKNGADEIKAHPFFKTIDFSS 315

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 63/283 (22%), Positives = 114/283 (40%), Gaps = 46/283 (16%)

Query: 360 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           IG+G FG V+              +  V ++ ++  SA+     ++E  ++    H NIV
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIV 71

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR--------------- 462
           +  G   V   + +  EY+  G +N ++R        S+  + +                
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 463 ------HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG 516
                  +  G+AYL     +HRD+   N LV  + VVK+ADFG+++++    Y    K 
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY---YKA 188

Query: 517 SPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 569
           S N      WM PE I          +     D+W+ G  + E+ + G  P+      + 
Sbjct: 189 SENDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241

Query: 570 MFKVLNRTPPI---PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           ++ V  R   +   P+    E  + +  C+ + P +RPS   +
Sbjct: 242 IYYV--RDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 82.7 bits (204), Expect = 4e-17
 Identities = 71/272 (26%), Positives = 122/272 (44%), Gaps = 25/272 (9%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K+++++K K++G G FG+VY G     G    I        +  S +  K++  E  V+ 
Sbjct: 5   KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I  G+ 
Sbjct: 65  SVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 526
           YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA E I
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP----PWSEFEGPQAMFKVLNRTP-- 578
              +    +       D+WS G TV E++T   KP    P SE         +L +    
Sbjct: 184 LHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASEISS------ILEKGERL 230

Query: 579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           P P + + +    +++C++ +   RP   EL+
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 82.8 bits (204), Expect = 6e-17
 Identities = 72/300 (24%), Positives = 139/300 (46%), Gaps = 53/300 (17%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHL 411
           ++Q    +G G +GSV    +       A+K++      P +S    ++  +E+++L H+
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS----RPFQSLIHARRTYRELRLLKHM 71

Query: 412 KHENIVQ----YYGSEVVDDHLYIYLEYVHPGS-INRYVREHCRDITESIVRNFTRHILN 466
           KHEN++     +  +  +++   +YL     G+ +N  V+  C+ +++  V+     +L 
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLR 129

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEV 525
           GL Y+HS   IHRD+K +N+ V+    +++ DFG+A+       E++   +  W  APE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYVATRWYRAPEI 186

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWSEF-------------EGPQAM 570
           +   M  +        VDIWS+GC + E+L GK   P +++               P+ +
Sbjct: 187 MLNWMHYNQ------TVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240

Query: 571 FKV--------LNRTPPIPEMLSSE--------GKDFLLRCFLRNPVERPSAVELLEHPF 614
            K+        +   P +P+    +          D L +  + +  +R SA E L HP+
Sbjct: 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 81.5 bits (201), Expect = 6e-17
 Identities = 72/272 (26%), Positives = 130/272 (47%), Gaps = 17/272 (6%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-EIKVLGHLKHENIV 417
           +IGRG FG VY     +TG   A+K +D      K  E +   E+  + ++       IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
               +    D L   L+ ++ G ++ ++ +H    +E+ +R +   I+ GL ++H+   +
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFVV 119

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           +RD+K AN+L+D  G V+++D G+A   +      S+ G+  +MAPEV++  +  D    
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDS--- 175

Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM---FKVLNRTPPIPEMLSSEGKDFLLR 594
              + D +SLGC + ++L G  P+ + +           L     +P+  S E +  L  
Sbjct: 176 ---SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 232

Query: 595 CFLRNPVER-----PSAVELLEHPFIRNANYQ 621
              R+   R       A E+ EHPF R+ ++Q
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 68/259 (26%), Positives = 118/259 (45%), Gaps = 24/259 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 414
           ++IG G FG V  G  +  G     +E+ +     KS    KQ      E  ++G   H 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NI+   G       + I  E++  G+++ ++R++    T   +    R I  G+ YL   
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGS-P-NWMAPEVIKA 528
           N +HRD+   N+LV+++ V K++DFG+++ L    +  +Y  SL G  P  W APE I  
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 585
                   K   A D+WS G  + E+++ G+ P+ +      +  +    R PP  +   
Sbjct: 186 -------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMD-CP 237

Query: 586 SEGKDFLLRCFLRNPVERP 604
           +     +L C+ ++   RP
Sbjct: 238 TALHQLMLDCWQKDRNARP 256

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 82.8 bits (204), Expect = 8e-17
 Identities = 84/325 (25%), Positives = 132/325 (40%), Gaps = 64/325 (19%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S + K K +G G FG V +    +T A  A+K +     D  +   +  ++ E  +L   
Sbjct: 1   SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLR--KKDVLNRNQVAHVKAERDILAEA 58

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
            +E +V+ Y S    D+LY  ++Y+ PG     +        E + R +   +   +  +
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGM---------------AKHLTGLSYE----- 511
           H    IHRDIK  N+L+D  G +KL DFG+                 H+   S E     
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177

Query: 512 ----------------------------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 543
                                        SL G+PN++APE    V+ + G  +L    D
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE----VLLRKGYTQLC---D 230

Query: 544 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEM--LSSEGKDFL--LRCFL 597
            WS+G  + EML G+PP+      +   KV+N   T  IP    LS E  D +  L C  
Sbjct: 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSA 290

Query: 598 RNPVERPSAVELLEHPFIRNANYQN 622
              + R  A ++  HPF    ++ +
Sbjct: 291 EERLGRNGADDIKAHPFFSEVDFSS 315

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 71/290 (24%), Positives = 111/290 (38%), Gaps = 56/290 (19%)

Query: 355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLK 412
              + +G G FG VY G  R         +V +  +P+     +    L  E  ++    
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMSKFN 67

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-------ITESIVRNFTRHIL 465
           H+NIV+  G        +I LE +  G +  ++RE  R        +T   +    R + 
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRE-NRPRPERPSSLTMKDLLFCARDVA 126

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYE-------LSLK 515
            G  YL   + IHRDI   N L+   G   V K+ADFGMA+ +   SY        L +K
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186

Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 574
               WM PE   A +      K     D+WS G  + E+ + G  P+      + M    
Sbjct: 187 ----WMPPE---AFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---- 231

Query: 575 NRTPPIPEMLSSEGK------------DFLLRCFLRNPVERPSAVELLEH 612
                  E ++  G+              +  C+   P +RP+   +LE 
Sbjct: 232 -------EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 15/266 (5%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K+++ +K KL+G G FG+V+ G     G S  I        D    +  +++   +  +G
Sbjct: 5   KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG 64

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            L H  IV+  G       L +  +    GS+  +VR+H   +    + N+   I  G+ 
Sbjct: 65  SLDHAYIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVI 526
           YL     +HR++   N+L+ +  +V++ADFG+A  L     +      K    WMA E I
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP--PIPEM 583
                     +     D+WS G TV EM++ G  P++    P  +  +L +      P++
Sbjct: 184 LF-------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-PHEVPDLLEKGERLAQPQI 235

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVEL 609
            + +    +++C++ +   RP+  EL
Sbjct: 236 CTIDVYMVMVKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 66/280 (23%), Positives = 116/280 (41%), Gaps = 19/280 (6%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +++G+G FG V     R TG   A K+++      +  E +   E+ I  L  +    +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI--LEKVNSRFVV 63

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNT 476
               +    D L + L  ++ G +  ++         E     +   +  GL  L     
Sbjct: 64  SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           ++RD+K  N+L+D  G ++++D G+A  +          G+  +MAPEVI        N 
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN-------NE 176

Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPEMLSSEGKDFL 592
           K   + D W LGC + EM+ G+ P+ + +      +   +V        E  S + K   
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236

Query: 593 LRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 627
                +NP ER       A  + +HP  +N N++ L   M
Sbjct: 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANM 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 71/258 (27%), Positives = 116/258 (44%), Gaps = 24/258 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 414
           K+IG G FG V  G  +  G     +E+ +     K+    KQ      E  ++G   H 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGK----REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NI+   G       + I  EY+  GS++ ++R+H    T   +    R I +G+ YL   
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG---LSYELSLKGSP-NWMAPEVIKAVM 530
             +HRD+   N+LV+++ V K++DFG+++ L      +Y       P  W APE I    
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-- 183

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RTPPIPEMLSS 586
                 K   A D+WS G  + E+++ G+ P+ E    Q + K +    R P  P    +
Sbjct: 184 -----RKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPA-PMDCPA 236

Query: 587 EGKDFLLRCFLRNPVERP 604
                +L C+ ++  ERP
Sbjct: 237 ALHQLMLDCWQKDRNERP 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 78.1 bits (192), Expect = 9e-16
 Identities = 71/274 (25%), Positives = 129/274 (47%), Gaps = 17/274 (6%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-EIKVLGHLKHENIV 417
           +IGRG FG VY     +TG   A+K +D      K  E +   E+  + ++       IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
               +    D L   L+ ++ G ++ ++ +H    +E  +R +   I+ GL ++H+   +
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRFVV 119

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           +RD+K AN+L+D  G V+++D G+A   +      S+ G+  +MAPEV++     D    
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAYDS--- 175

Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVLNRTPPIPEMLSSEGKDFLLR 594
              + D +SLGC + ++L G  P+ + +     +     L     +P+  S E K  L  
Sbjct: 176 ---SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG 232

Query: 595 CFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
              R+  +R       A E+ EH F +  ++Q +
Sbjct: 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 18/276 (6%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K+++ +K K++G G FG+VY G     G +  I     +  +  S +  K++  E  V+ 
Sbjct: 5   KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMA 64

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            +    + +  G   +   + +  + +  G +  YVRE+   I    + N+   I  G++
Sbjct: 65  GVGSPYVCRLLGI-CLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 526
           YL     +HRD+   N+LV +   VK+ DFG+A+ L     E    G      WMA E I
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF---EGPQAMFKVLNRTPPIPE 582
                   + +     D+WS G TV E++T G  P+      E P  + K      P P 
Sbjct: 184 L-------HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK--GERLPQPP 234

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           + + +    +++C++ +   RP   EL+   F R A
Sbjct: 235 ICTIDVYMIMVKCWMIDSECRPRFRELV-DEFSRMA 269

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 78.0 bits (192), Expect = 3e-15
 Identities = 83/331 (25%), Positives = 138/331 (41%), Gaps = 86/331 (25%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-- 415
           K+IG+G FG V +   ++TG   A+K +         +E  K+ +Q    L H+K E   
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTL-------LKSEMFKK-DQ----LAHVKAERDV 54

Query: 416 --------IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
                   +V  Y S     +LY+ +E++  G +   + ++    +E + R +    +  
Sbjct: 55  LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLA 113

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA-------------KHLTG------- 507
           +  +H    IHRDIK  N+L+D  G +KL+DFG++             K L G       
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173

Query: 508 ----------LSYELSLK------------------GSPNWMAPEVIKAVMQKDGNPKLA 539
                     ++  +S K                  G+P+++APE+   + Q  G     
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF--LQQGYGQ---- 227

Query: 540 LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLN--RTPPIPE--MLSSEGKDFLLR 594
              D WSLG  + E L G PP+   E     + K++N   T   P+   LS E +D + R
Sbjct: 228 -ECDWWSLGAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR 285

Query: 595 --CFLRNPVERPSAVELLEHPFIRNANYQNL 623
                 N + R  A E+  HPF R  ++  +
Sbjct: 286 LITNAENRLGRGGAHEIKSHPFFRGVDWDTI 316

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 66/261 (25%), Positives = 118/261 (45%), Gaps = 24/261 (9%)

Query: 360 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG+V  G    +++  + A+K   I+ +D        +L +E  V+  L +  IV
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVK---ILKNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +  G     +   + +E    G +N++++++ + +TE  +      +  G+ YL  TN +
Sbjct: 60  RMIGI-CEAESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFV 117

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWMAPEVIKAVMQKD 533
           HRD+   N+L+      K++DFG++K L      Y+    G  P  W APE +       
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY---- 173

Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKD 590
              K +   D+WS G  + E  + G+ P+   +G +   M +   R    P+    E  D
Sbjct: 174 ---KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM-ECPQRCPPEMYD 229

Query: 591 FLLRCFLRNPVERP--SAVEL 609
            +  C+     ERP  + VEL
Sbjct: 230 LMKLCWTYGVDERPGFAVVEL 250

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 68/282 (24%), Positives = 119/282 (42%), Gaps = 37/282 (13%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGAS-----CAIKEVDIIPDDPKSAECIKQLEQEI 405
           +S  Q+   +GRG FG V++   +            +K +    D+        +  +E+
Sbjct: 4   RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE----NLQSEFRREL 59

Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF-TRHI 464
            +   L H+N+V+  G     +  Y+ LEY   G + +++R       +       T+  
Sbjct: 60  DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119

Query: 465 LN-------GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLK 515
           +        G+ +L +   +HRD+   N LV +   VK++   ++K +    Y    +  
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179

Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 574
               W+APE   AV + D + K     D+WS G  + E+ T G+ P+      +    VL
Sbjct: 180 IPLRWLAPE---AVQEDDFSTK----SDVWSFGVLMWEVFTQGELPFYGLSDEE----VL 228

Query: 575 NRTP------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           NR        P+PE   S     + RC+  NP +RPS  EL+
Sbjct: 229 NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 30/275 (10%)

Query: 360 IGRGTFGSVYIGTNRETGASCA---IKEVDIIPDDPKSAECIKQLE--QEIKVLGHLKHE 414
           IG G FG V +G     G S A   +KE+        SA   +QL   QE++    L H 
Sbjct: 3   IGNGWFGKVLLG-EAHRGMSKARVVVKELR------ASATPDEQLLFLQEVQPYRELNHP 55

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRH-ILNGLAY 470
           N++Q  G  +      + LE+   G +  Y+R        + +  V       + +GL +
Sbjct: 56  NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIK 527
           LH  + IH D+   N  + A   VK+ D+G+A       Y ++      P  W+APE+++
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR------TPPI 580
              Q           +IWSLG T+ E+ T    P+ +    Q + +V+         P +
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235

Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVE---LLEH 612
               S    + +  C+L +P  RP+A E   LL +
Sbjct: 236 DLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 78.0 bits (192), Expect = 1e-14
 Identities = 65/254 (25%), Positives = 104/254 (40%), Gaps = 24/254 (9%)

Query: 375 ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS-EVVDDHLYIYL 433
            TG   AIK +    D P+      +  +E  +   L H NIV    S E     L+   
Sbjct: 1   MTGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVF 58

Query: 434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 493
           EYV PG   R V      +           +L+ LA  H+   +HRD+K  N++V  +GV
Sbjct: 59  EYV-PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117

Query: 494 ---VKLADFGMAKHLTG--------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 542
               K+ DFG+   L G        L+    + G+P + APE      Q  G P      
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE------QLRGEPVTP-NS 170

Query: 543 DIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEMLSSEGKDFLLRCFLR-NP 600
           D+++ G   +E LTG+         + +++ L+     +P  ++      +LR  L  +P
Sbjct: 171 DLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDP 230

Query: 601 VERPSAVELLEHPF 614
            +R ++   L   F
Sbjct: 231 RQRAASAPALAERF 244

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 64/258 (24%), Positives = 122/258 (47%), Gaps = 22/258 (8%)

Query: 360 IGRGTFGSVYIGTNRETGASCAI---KEVDIIPDDPKSAECIKQLEQE-IKVLGHLKHEN 415
           +G+GTF ++Y G  R       +   +EV ++     S         E   ++  L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           +V+ YG  V D+++ +  EYV  G ++ ++     +++     +  + + + L YL    
Sbjct: 63  LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121

Query: 476 TIHRDIKGANLLVDASGV-------VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            +H ++ G N+LV   G+       +KL+D G+   +T LS E  ++  P W+APE I  
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREERVERIP-WIAPECI-- 176

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
              ++G   L +A D WS G T++E+ + G+ P S         +       +P    +E
Sbjct: 177 ---RNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQHRLPMPDCAE 232

Query: 588 GKDFLLRCFLRNPVERPS 605
             + + +C+  +P +RPS
Sbjct: 233 LANLINQCWTYDPTKRPS 250

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 40/272 (14%)

Query: 360 IGRGTFGSVYIG-----TNRETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 412
           +G G FG VY G       R +  S AIK +       ++AE   Q E  QE +++  L+
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLK------ENAEPKVQQEFRQEAELMSDLQ 66

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILN---- 466
           H NIV   G    +    +  EY+  G ++ ++  +    D+         +  L+    
Sbjct: 67  HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 467 ---------GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 517
                    G+ YL S + +HRD+   N LV     VK++DFG+++ +    Y      S
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 518 P---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 573
                WM PE   A++      K     DIWS G  + E+ + G  P+  F   + +  +
Sbjct: 187 LLPVRWMPPE---AILYG----KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239

Query: 574 LNRTP-PIPEMLSSEGKDFLLRCFLRNPVERP 604
            +R   P PE   +     ++ C+   P  RP
Sbjct: 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.6 bits (178), Expect = 4e-14
 Identities = 65/258 (25%), Positives = 117/258 (45%), Gaps = 23/258 (8%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G+GTF  ++ G  RE G    + + +++    D       +   +   ++  L H+++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
             YG  V  D   +  EYV  GS++ Y++++   I  S      + +   L +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122

Query: 478 HRDIKGANLLV-----DASG---VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           H ++   N+L+       +G    +KL+D G++  +T L  E+ L+  P W+ PE I+  
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIP-WVPPECIE-- 177

Query: 530 MQKDGNPK-LALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                NP+ L+LA D WS G T+ E+ +G   P S  +  Q   +       +P    +E
Sbjct: 178 -----NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKKLQFYEDRHQLPAPKWTE 231

Query: 588 GKDFLLRCFLRNPVERPS 605
             + + +C    P  RPS
Sbjct: 232 LANLINQCMDYEPDFRPS 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 73.4 bits (180), Expect = 5e-14
 Identities = 74/316 (23%), Positives = 127/316 (40%), Gaps = 67/316 (21%)

Query: 359 LIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           +IGRG     +V +   + TG    ++ +++   +  + E +  L+ E+ V     H NI
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINL---EACTNEMVTFLQGELHVSKLFNHPNI 61

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 475
           V Y  + + D+ L++   ++  GS    +  H  D ++E  +    + +L  L Y+H   
Sbjct: 62  VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG 121

Query: 476 TIHRDIKGANLLVDASGVVKL----ADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVI 526
            +HR +K +++L+   G V L    ++  M  H   L       + S+K  P W++PEV+
Sbjct: 122 YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVL 180

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP------- 579
           +  +Q           DI+S+G T  E+  G  P+ +    Q + + LN T P       
Sbjct: 181 QQNLQGYDAKS-----DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235

Query: 580 IP---------------------------------------EMLSSEGKDFLLRCFLRNP 600
           IP                                          S     F+ +C  RNP
Sbjct: 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNP 295

Query: 601 VERPSAVELLEHPFIR 616
             RPSA  LL H F +
Sbjct: 296 DARPSASTLLNHSFFK 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 68/273 (24%), Positives = 123/273 (45%), Gaps = 36/273 (13%)

Query: 359 LIGRGTFGSVYIGT--NRETGASCA--IKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           L+  GTFG ++ G   + + G      +K V     D  S   +  L QE  +L  L H+
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK----DHASEIQVTLLLQESCLLYGLSHQ 68

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHP--GSINRYVREHCRDITESIVRNFTRH--------I 464
           NI+       ++D    ++ Y +   G++  ++++ CR    +  +  +          I
Sbjct: 69  NILPILHV-CIEDGEPPFVLYPYMNWGNLKLFLQQ-CRLGEANNPQALSTQQLVHMAIQI 126

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----W 520
             G++YLH    IH+DI   N ++D    VK+ D  +++ L  + Y   L  + N    W
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-CLGDNENRPVKW 185

Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPP 579
           MA E +        N + + A D+WS G  + E++T G+ P+ E + P  M   L     
Sbjct: 186 MALESLV-------NKEYSSASDVWSFGVLLWELMTLGQTPYVEID-PFEMAAYLKDGYR 237

Query: 580 IPEMLSSEGKDF--LLRCFLRNPVERPSAVELL 610
           + + ++   + F  +  C+  +P ERPS  +L+
Sbjct: 238 LAQPINCPDELFAVMACCWALDPEERPSFSQLV 270

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 46/278 (16%)

Query: 360 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 412
           +G+G+FG VY G  +     E     AIK V+      ++A   +++E   E  V+    
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN------EAASMRERIEFLNEASVMKEFN 67

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR---------NFTRH 463
             ++V+  G         + +E +  G +  Y+R    ++  + V+              
Sbjct: 68  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 519
           I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG       
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPV 185

Query: 520 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 573
            WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  V    
Sbjct: 186 RWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238

Query: 574 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 239 LLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 73/279 (26%), Positives = 121/279 (43%), Gaps = 40/279 (14%)

Query: 357 GKLIGRGTFGSVYIG--TNRETGASCAIKEVDI-------IPDDPKSAECIKQLEQE--I 405
           GK +G G FGSV  G     ++    A+K + I       + D    A C+K+ +    +
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 406 KVLGHLKHENIVQYYGSEVV------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 459
           +++G        + Y S VV         L+ +L Y   G   +Y+       T+ +V+ 
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLP------TQMLVK- 116

Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS---LKG 516
           F   I +G+ YL S + IHRD+   N +++ +  V +ADFG++K +    Y       K 
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL- 574
              W+A E +        +       D+WS G T+ E+ T G+ P+   E  + ++  L 
Sbjct: 177 PVKWIAIESL-------ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLR 228

Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
             NR    P+ L       +  C+L NP +RPS   L  
Sbjct: 229 QGNRLKQPPDCLDGL-YSLMSSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 69/321 (21%), Positives = 132/321 (41%), Gaps = 68/321 (21%)

Query: 360 IGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           IGRG     SVY+  +  TG    ++  D+   +  + E +K L+ E+ +    +H NI+
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDL---ENCTEEHLKALQNEVVLSHFFRHPNIM 62

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNT 476
             +        L++   ++  GS N  ++ +  + ++E+++ N     L GL YLH    
Sbjct: 63  TSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY 122

Query: 477 IHRDIKGANLLVDASGVVKLAD----FGMAKH--LTGLSYE---LSLKGSPNWMAPEVIK 527
           IHR+IK +++L+   G+V L+     + + ++     + Y+    S    P W++PE+++
Sbjct: 123 IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPELLR 181

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------- 578
             +         +  DI+S+G T  E+ TG+ P+ +    Q + + L   P         
Sbjct: 182 QDLY-----GYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236

Query: 579 --------------------------------------PIPEMLSSEGKDFLLRCFLRNP 600
                                                 P  +  S   ++ +  C  ++P
Sbjct: 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDP 296

Query: 601 VERPSAVELLEHPFIRNANYQ 621
            +RPSA  LL H F +    Q
Sbjct: 297 EKRPSASSLLSHAFFKQVKEQ 317

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 46/230 (20%)

Query: 356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE---------QEIK 406
           +G  +GRGT+G VY    R+ G            DD   A  +KQ+E         +EI 
Sbjct: 5   EGCKVGRGTYGHVY-KAKRKDGK-----------DDRDYA--LKQIEGTGISMSACREIA 50

Query: 407 VLGHLKHENIV--QYYGSEVVDDHLYIYLEYV-----HPGSINRYVREHCRDIT--ESIV 457
           +L  LKH N++  Q       D  +++  +Y      H    +R  + + + +     +V
Sbjct: 51  LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 110

Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELS 513
           ++    IL+G+ YLH+   +HRD+K AN+LV   G     VK+AD G A+        L+
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170

Query: 514 ----LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
               +  +  + APE++       G      A+DIW++GC   E+LT +P
Sbjct: 171 DLDPVVVTFWYRAPELLL------GARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 66/281 (23%), Positives = 117/281 (41%), Gaps = 34/281 (12%)

Query: 353 QWQKGK---LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
           +W   K   +IG G FG V     ++ G     AIK +     +  S +  +    E++V
Sbjct: 5   EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFAGELEV 60

Query: 408 LGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH---------------CRD 451
           L  L  H NI+   G+     +LY+ +EY   G++  ++R+                   
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 452 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 511
           ++   + +F   +  G+ YL     IHRD+   N+LV  + V K+ADFG+++       +
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180

Query: 512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 570
              +    WMA E +   +    +       D+WS G  + E+++ G  P+      +  
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAELY 233

Query: 571 FKV-LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            K+        P     E  D + +C+   P ERPS  ++L
Sbjct: 234 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 71/285 (24%), Positives = 130/285 (45%), Gaps = 49/285 (17%)

Query: 357 GKLIGRGTFGSVYIGT-NRETGAS--CAIK--EVDI-----IPDDPKSAECIKQLEQE-- 404
           GK++G G FGSV  G  +++ G+    A+K  ++DI     I +    A C+K  +    
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 405 IKVLGHLKHENIVQYYGSEVV------DDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           +K++G     + +Q     +V         L+ +L Y   G +   +        +++++
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLP------LQTLLK 117

Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-------E 511
            F   I  G+ YL + N IHRD+   N ++     V +ADFG++K +    Y       +
Sbjct: 118 -FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 570
           + +K    W+A   I+++  +    K     D+W+ G T+ E+ T G+ P+   E  + +
Sbjct: 177 MPVK----WIA---IESLADRVYTSK----SDVWAFGVTMWEIATRGQTPYPGVENHE-I 224

Query: 571 FKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +  L   NR    PE    E  D +  C+  +P +RP+  +L E 
Sbjct: 225 YDYLRHGNRLKQ-PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 46/230 (20%)

Query: 356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE---------QEIK 406
           +G  +GRGT+G VY    R+ G            D+ + A  +KQ+E         +EI 
Sbjct: 5   EGCKVGRGTYGHVY-KAKRKDGK-----------DEKEYA--LKQIEGTGISMSACREIA 50

Query: 407 VLGHLKHENIV--QYYGSEVVDDHLYIYLEYV-----HPGSINRYVREHCR--DITESIV 457
           +L  LKH N++  Q       D  +++  +Y      H    +R  + + +   +  S+V
Sbjct: 51  LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMV 110

Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELS 513
           ++    IL+G+ YLH+   +HRD+K AN+LV   G     VK+AD G A+        L+
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170

Query: 514 ----LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
               +  +  + APE++       G      A+DIW++GC   E+LT +P
Sbjct: 171 DLDPVVVTFWYRAPELLL------GARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 62/254 (24%), Positives = 109/254 (42%), Gaps = 22/254 (8%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGHLKHENI 416
           +G G FG V  G  +        K++D+     K+        ++ +E +++  L +  I
Sbjct: 3   LGSGNFGCVKKGVYKMRK-----KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V+  G     + L + +E    G +N+++     +IT S V      +  G+ YL   N 
Sbjct: 58  VRMIGV-CEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSP---NWMAPEVIKAVMQK 532
           +HRD+   N+L+      K++DFG++K L    SY  +         W APE I      
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF---- 172

Query: 533 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM-FKVLNRTPPIPEMLSSEGKD 590
               K +   D+WS G T+ E  + G+ P+ + +GP+ M F    +    P     E   
Sbjct: 173 ---RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA 229

Query: 591 FLLRCFLRNPVERP 604
            +  C++    +RP
Sbjct: 230 LMKDCWIYKWEDRP 243

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 66.1 bits (161), Expect = 8e-12
 Identities = 79/284 (27%), Positives = 127/284 (44%), Gaps = 53/284 (18%)

Query: 358 KLIGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLKH 413
           K IG G FG V +G   +  T A   +KE+ +      SA   +Q++  +E +    L+H
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRV------SASVQEQMKFLEEAQPYRSLQH 54

Query: 414 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI------VRNFTRHIL 465
            N++Q  G  +EV      + +E+   G +  Y+R  CR   E +      ++     I 
Sbjct: 55  SNLLQCLGQCTEVTP--YLLVMEFCPLGDLKGYLRS-CR-KAELMTPDPTTLQRMACEIA 110

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------ 519
            GL +LH  N IH D+   N L+ A   VK+ D+G++       Y+     +P+      
Sbjct: 111 LGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSH----NKYKEDYYVTPDQLWVPL 166

Query: 520 -WMAPEVIKAVMQKDGNPKLALAVD------IWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
            W+APE++  V    GN    L VD      +WSLG T+ E+   G  P+      Q + 
Sbjct: 167 RWIAPELVDEV---HGN---LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT 220

Query: 572 KVLNRTP---PIPEM---LSSEGKDFLLRCFLRNPVERPSAVEL 609
             +       P P +   LS    + +  C+L+ P +RPSA E+
Sbjct: 221 YTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.1 bits (161), Expect = 8e-12
 Identities = 65/278 (23%), Positives = 126/278 (45%), Gaps = 41/278 (14%)

Query: 357 GKLIGRGTFGSV---YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           G+++G+G FGSV    + +   +    A+K   ++  D  S+  I++  +E   +    H
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVAVK---MLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 414 ENIVQYYGSEV---VDDHLYI---YLEYVHPGSINRY-----VREHCRDITESIVRNFTR 462
            N+++  G  +       L I    L ++  G ++ +     + E    +    +  F  
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLK 515
            I +G+ YL S N IHRD+   N +++ +  V +ADFG++K +        G + +L +K
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 574
               W+A E +        +       D+W+ G T+ E++T G+ P++  E  + ++  L
Sbjct: 181 ----WLALESL-------ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYNYL 228

Query: 575 ---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
              NR    P+ L  +  + + +C+   P  RPS   L
Sbjct: 229 IKGNRLKQPPDCL-EDVYELMCQCWSPEPKCRPSFQHL 265

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 68.3 bits (167), Expect = 9e-12
 Identities = 68/292 (23%), Positives = 120/292 (41%), Gaps = 55/292 (18%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +LIG+G  G VY+  +       A+K+  I  D  ++    K+  +E K+   L H  IV
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKK--IREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 418 QYYGSEVVDDHLYIYLEYVHP---GSINRYVRE--------HCRDITESIVRNFTRHILN 466
             Y      D +Y  + Y+      S+ + V +          +    + +  F + I  
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK-ICA 124

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS------------- 513
            + Y+HS   +HRD+K  N+L+   G V + D+G A        +L              
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 514 ------LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 567
                 + G+P++MAPE +       G P  + + DI++LG  + +MLT   P+   +G 
Sbjct: 185 MTIPGKIVGTPDYMAPERLL------GVPA-SESTDIYALGVILYQMLTLSFPYRRKKGR 237

Query: 568 QAMFKVLNRTPP---------IPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  ++  +             IP  LS       ++    +P ER S+V+ L
Sbjct: 238 KISYR--DVILSPIEVAPYREIPPFLSQ----IAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 66.7 bits (163), Expect = 9e-12
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 60/201 (29%)

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 519
           +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ +    +P     
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM----TPYVVTR 181

Query: 520 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-------------------- 558
            + APEVI  +  K+        VDIWS+GC + EM+ G                     
Sbjct: 182 YYRAPEVILGMGYKEN-------VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234

Query: 559 PPWSEFE---GPQAMFKVLNRT--PPIP-EML-----------------SSEGKDFLLRC 595
            P  EF     P     V NR        E L                 +S+ +D L + 
Sbjct: 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKM 294

Query: 596 FLRNPVERPSAVELLEHPFIR 616
            + +P +R S  + L+HP+I 
Sbjct: 295 LVIDPEKRISVDDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 31/266 (11%)

Query: 359 LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           +IG G FG V     ++ G   + AIK +     +    +   +LE   K LGH  H NI
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCK-LGH--HPNI 65

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------------EH--CRDITESIVRNFT 461
           +   G+     +LYI +EY   G++  ++R             EH     +T   +  F 
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             +  G+ YL     IHRD+   N+LV  +   K+ADFG+++       +   +    WM
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWM 185

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI 580
           A E +   +    +       D+WS G  + E+++ G  P+      + +++ L +   +
Sbjct: 186 AIESLNYSVYTTKS-------DVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRM 237

Query: 581 --PEMLSSEGKDFLLRCFLRNPVERP 604
             P     E  + + +C+   P ERP
Sbjct: 238 EKPRNCDDEVYELMRQCWRDRPYERP 263

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 62/273 (22%), Positives = 106/273 (38%), Gaps = 42/273 (15%)

Query: 360 IGRGTFGSVYIG----TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G   FG +Y G       +     AIK +     D  + +   + +QE  ++  L H N
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK----DINNPQQWGEFQQEASLMAELHHPN 68

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYV---REH----CRDITESIVRNFTRH----- 463
           IV   G    +  + +  EY++ G ++ ++     H    C    +  V++   H     
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 464 ----ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN 519
               I  G+ YL S   +H+D+   N+L+     VK++D G+++ +    Y    +  P 
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY---YRVQPK 185

Query: 520 ------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM PE I          K +   DIWS G  + E+ + G  P+  F   + +  
Sbjct: 186 SLLPIRWMPPEAIMY-------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238

Query: 573 VLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERP 604
           V  R   P  E         +  C+   P  RP
Sbjct: 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 50/202 (24%), Positives = 73/202 (36%), Gaps = 55/202 (27%)

Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
           + IL GL YLH+   IHRD+K  N+ ++    V + D G A+        L L G+    
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA------------ 569
           APEV+          K     DIWS G  + EML    P + FE P +            
Sbjct: 224 APEVL-------ARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDPPSTPEEYVKSCHSH 274

Query: 570 MFKVLNRTPPIPEMLSSEGKDFLLRCFLR------------------------------- 598
           + K+++     PE    +    L+R F+                                
Sbjct: 275 LLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKM 334

Query: 599 ---NPVERPSAVELLEHPFIRN 617
              +   RPSA E+L +P    
Sbjct: 335 LTFDAAMRPSAEEILNYPMFAQ 356

Length = 357

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 69/279 (24%), Positives = 118/279 (42%), Gaps = 46/279 (16%)

Query: 360 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 412
           +G+G+FG VY G  R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 67

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR---------NFTRH 463
             ++V+  G         + +E +  G +  Y+R    +   +  R              
Sbjct: 68  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----- 518
           I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG       
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPV 185

Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 573
            WMAPE +     KDG      + D+WS G  + E+ +  + P+      Q +  V    
Sbjct: 186 RWMAPESL-----KDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238

Query: 574 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            L++    PE ++    D +  C+  NP  RP+ +E++ 
Sbjct: 239 YLDQPDNCPERVT----DLMRMCWQFNPKMRPTFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 13/207 (6%)

Query: 404 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
           E   LG   H NIV+  G     + + I  EY+  G+++ ++R+H   +    +      
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWM 521
           + +G+ YL     +H+ +    +LV++  V K++ F   +      +   +S K    W 
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTP 578
           APE I+           + A D+WS G  + E+++ G+ P+ +  G   +  V +  R P
Sbjct: 176 APEAIQY-------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP 228

Query: 579 PIPEMLSSEGKDFLLRCFLRNPVERPS 605
             P    +     +L C+ +   ERP 
Sbjct: 229 A-PRNCPNLLHQLMLDCWQKERGERPR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 62.0 bits (151), Expect = 4e-11
 Identities = 40/169 (23%), Positives = 56/169 (33%), Gaps = 29/169 (17%)

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
           L  L  LH        +   + L+   G V                    +  P +MAPE
Sbjct: 27  LGALRELHRQAKSGNILLTWDGLLKLDGSV------------AFKTPEQSRPDPYFMAPE 74

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKVLNRTPPIPEM 583
           VI+               DI+SLG T+ E L  + P++ E E    +  +LN  P     
Sbjct: 75  VIQGQSY-------TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR 127

Query: 584 LSSEG---------KDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 623
             S           +DF+  C  R P  R +A   L H     A    L
Sbjct: 128 DRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.6 bits (154), Expect = 6e-11
 Identities = 63/271 (23%), Positives = 113/271 (41%), Gaps = 31/271 (11%)

Query: 359 LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           +IG G FG V     ++ G     AIK +          +   +LE   K LGH  H NI
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LGH--HPNI 58

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSI-------------NRYVREH--CRDITESIVRNFT 461
           +   G+     +LY+ +EY   G++               +   +     ++   + +F 
Sbjct: 59  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             +  G+ YL     IHRD+   N+LV  + V K+ADFG+++       +   +    WM
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 178

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI 580
           A E +   +    +       D+WS G  + E+++ G  P+      + +++ L +   +
Sbjct: 179 AIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRL 230

Query: 581 --PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             P     E  D + +C+   P ERPS  ++
Sbjct: 231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 63.3 bits (155), Expect = 6e-11
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 20/186 (10%)

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           YY    +  H+ I ++Y+  G +   +++    ++E+ V+   R ++  L  LH  N IH
Sbjct: 75  YYSVTTLKGHVLI-MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIH 132

Query: 479 RDIKGANLLVD-ASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
            DIK  N+L D A   + L D+G+ K + T   Y+    G+ ++ +PE IK         
Sbjct: 133 NDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD----GTLDYFSPEKIK----GHNY- 183

Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPEMLSSEGKDFL 592
              ++ D W++G    E+LTGK P+ E E      +++ K   +  P  + +S    DF 
Sbjct: 184 --DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDF- 240

Query: 593 LRCFLR 598
           ++  L+
Sbjct: 241 VQSMLK 246

Length = 267

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 63.8 bits (155), Expect = 1e-10
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 18/163 (11%)

Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +F+  +  G+++L S N IHRD+   N+L+    + K+ DFG+A+ +   S    +KG+ 
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS-NYVVKGNA 276

Query: 519 ----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 573
                WMAPE I        N       D+WS G  + E+ + G  P+         +K+
Sbjct: 277 RLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329

Query: 574 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS---AVELLE 611
           +     +  PE   SE  D +  C+  +P++RP+    V+L+E
Sbjct: 330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 63.9 bits (155), Expect = 1e-10
 Identities = 76/314 (24%), Positives = 129/314 (41%), Gaps = 68/314 (21%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q+ K IG G  G V    +   G + A+K++     +   A   K+  +E+ +L  + 
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLKCVN 78

Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   +     +H R      +      +
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER------MSYLLYQM 132

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+             +  + APE
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK--------------------PPWSEF 564
           VI  +  K+        VDIWS+GC + E++ G                      P +EF
Sbjct: 193 VILGMGYKEN-------VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245

Query: 565 EG---PQAMFKVLNRTPPIP--------------------EMLSSEGKDFLLRCFLRNPV 601
                P     V NR P  P                    ++ +S+ +D L +  + +P 
Sbjct: 246 MNRLQPTVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD 304

Query: 602 ERPSAVELLEHPFI 615
           +R S  E L HP+I
Sbjct: 305 KRISVDEALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 15/158 (9%)

Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP- 518
           F+  + NG+ +L S N +HRD+   N+L+    +VK+ DFG+A+ +   S  +S KGS  
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS-KGSTF 302

Query: 519 ---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 574
               WMAPE I        N       D+WS G  + E+ T G  P+ E    +  +  +
Sbjct: 303 LPLKWMAPESIF-------NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355

Query: 575 NRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            R   +  P   S E  + + +C+      RP   +L+
Sbjct: 356 KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 21/163 (12%)

Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGLSYEL 512
           ++  +  G+ +L S   IHRD+   N+L+  + VVK+ DFG+A+       ++      L
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
            LK    WMAPE I        +    +  D+WS G  + E+ + G  P+   +  +   
Sbjct: 244 PLK----WMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292

Query: 572 KVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           + L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 61.3 bits (148), Expect = 6e-10
 Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 51/196 (26%)

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWM 521
            +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + 
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 185

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK--------------------PPW 561
           APEVI  +  K+        VDIWS+GC + EM+  K                     P 
Sbjct: 186 APEVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 562 SEFEG---PQAMFKVLNR------TPP--IPEML-----------SSEGKDFLLRCFLRN 599
            EF     P     V NR      T P   P+ L           +S+ +D L +  + +
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 600 PVERPSAVELLEHPFI 615
           P +R S  E L+HP+I
Sbjct: 299 PAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 61.2 bits (148), Expect = 7e-10
 Identities = 54/196 (27%), Positives = 86/196 (43%), Gaps = 51/196 (26%)

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM- 521
            +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++      +  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 192

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK--------------------PPW 561
           APEVI  +  K+        VDIWS+GC + EM+ G                      P 
Sbjct: 193 APEVILGMGYKEN-------VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245

Query: 562 SEFEG---PQAMFKVLNR--------TPPIPEML-----------SSEGKDFLLRCFLRN 599
            EF     P     V NR            P++L           +S+ +D L +  + +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305

Query: 600 PVERPSAVELLEHPFI 615
             +R S  E L+HP+I
Sbjct: 306 ASKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 60.6 bits (147), Expect = 9e-10
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 25/158 (15%)

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGLSYELSLKGSPN 519
           G+ +L S   IHRD+   N+L+  + VVK+ DFG+A+       ++      L LK    
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK---- 240

Query: 520 WMAPEVI--KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR 576
           WMAPE I  K    +          D+WS G  + E+ + G  P+   +  +   + L  
Sbjct: 241 WMAPESIFDKVYTTQS---------DVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE 291

Query: 577 TPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
              +  PE  + E    +L C+  NP +RP+  EL+E 
Sbjct: 292 GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 25/164 (15%)

Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGLSYEL 512
           ++  +  G+ +L S   IHRD+   N+L+  + VVK+ DFG+A+       ++   S  L
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 513 SLKGSPNWMAPEVI--KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 569
            LK    WMAPE I  K    +          D+WS G  + E+ + G  P+   +  + 
Sbjct: 239 PLK----WMAPESIFDKVYTTQS---------DVWSFGVLLWEIFSLGASPYPGVQINEE 285

Query: 570 MFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
             + L     +  PE  + E    +L C+  +P ERP+   L+E
Sbjct: 286 FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 15/153 (9%)

Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP- 518
           F+  +  G+ +L S N IHRD+   N+L+    V K+ DFG+A+ +   S    +KG+  
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-NYVVKGNAR 275

Query: 519 ---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 574
               WMAPE I   +         +  D+WS G  + E+ + GK P+         +K++
Sbjct: 276 LPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328

Query: 575 NRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS 605
            R   +  P+    E    +  C+   P ERP+
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPT 361

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 27/209 (12%)

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           N+V  +   V +D +++ L++   G +  ++ +    I E  V+ +   ++  L  LH  
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN-IPEECVKRWAAEMVVALDALHRE 104

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG---SPNWMAPEVIKAVMQ 531
             + RD+   N+L+D  G ++L  F     +     E S  G      + APEV      
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEV-----EDSCDGEAVENMYCAPEV------ 153

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKP-PWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
             G  +   A D WSLG  + E+LTGK        G        + T  IPE +S E + 
Sbjct: 154 -GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT-----HTTLNIPEWVSEEARS 207

Query: 591 FLLRCFLRNPVERPSA-----VELLEHPF 614
            L +    NP ER  A      ++  HPF
Sbjct: 208 LLQQLLQFNPTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 59.7 bits (144), Expect = 3e-09
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 15/160 (9%)

Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +FT  +  G+ +L S N +HRD+   N+L+    +VK+ DFG+A+ +   S  +S KGS 
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS-KGST 299

Query: 519 ----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 573
                WMAPE I        N    L+ D+WS G  + E+ + G  P+         +  
Sbjct: 300 FLPVKWMAPESIF------DNLYTTLS-DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352

Query: 574 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
           +     +  P+  + E  D +++C+   P +RPS + L +
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.9 bits (145), Expect = 3e-09
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 13/151 (8%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-----KQLEQEIKVLGHLK 412
           K I RG FG VY+G  +      A+K V       K A+ I      Q++ E   L   K
Sbjct: 10  KPISRGAFGKVYLGRKKNNSKLYAVKVV-------KKADMINKNMVHQVQAERDALALSK 62

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
              IV  Y S    +++Y+ +EY+  G +   +  +     E +   +   +   L YLH
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH 121

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAK 503
               IHRD+K  N+L+   G +KL DFG++K
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 53/226 (23%), Positives = 103/226 (45%), Gaps = 27/226 (11%)

Query: 398 IKQLEQEIKVLGHLKHENIVQYYG--SEVVDD--HLYIYLEYVHPGSINRYVREHCRDIT 453
           I   E EIK L  +   NI++ YG   ++VDD   L + LEY   G +   + +  +D++
Sbjct: 62  IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLS 120

Query: 454 ESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 512
                +       GL  L+  TN  ++++   + LV  +  +K+   G+ K L+   ++ 
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK- 179

Query: 513 SLKGSPNWMA---PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--P 567
               + N+M     +++  +  +       +  DI+SLG  + E+ TGK P   FE    
Sbjct: 180 ----NVNFMVYFSYKMLNDIFSE-----YTIKDDIYSLGVVLWEIFTGKIP---FENLTT 227

Query: 568 QAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           + ++ ++   N +  +P     E K  +  C   + ++RP+  E+L
Sbjct: 228 KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 54/239 (22%), Positives = 98/239 (41%), Gaps = 24/239 (10%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSAECIK----------Q 400
           +W+  KLIG G FG VY           + A+ +++ + ++    E +            
Sbjct: 13  EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIA 72

Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESI 456
           L + I  + HL    I +YYG          + +I LE +   +   + R  C++  + +
Sbjct: 73  LWKNIHNIDHL---GIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKN--KKL 127

Query: 457 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSL 514
           ++N  + +L  L Y+H     H DIK  N++VD +    + D+G+A H  + G   E S 
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS- 186

Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV 573
           K   +     +  A +       +    D+ SLG  +++    K PW  F     +   
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245

Length = 294

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 63/268 (23%), Positives = 114/268 (42%), Gaps = 41/268 (15%)

Query: 360 IGRGTFGSVYIGT-----NRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLK 412
           +GRGT   +Y G      + E       KE+ +I    DP   +      +   ++  + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H++IV  YG  V D    +  E+V  G ++ ++      +T        + + + L+YL 
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122

Query: 473 STNTIHRDIKGANLLVDASGV-------VKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
             + +H ++   N+L+   G+       +KL+D G+   +T LS +  ++  P W+APE 
Sbjct: 123 DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERIP-WIAPEC 179

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEM-LTGKPPWSE--------FEGPQAMFKVLNR 576
           ++       +  L++A D WS G T+ E+   G+ P  +        F   Q M      
Sbjct: 180 VE------DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLV---- 229

Query: 577 TPPIPEMLSSEGKDFLLRCFLRNPVERP 604
           TP   E+      D +  C   +P +RP
Sbjct: 230 TPSCKEL-----ADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 57.2 bits (138), Expect = 2e-08
 Identities = 39/112 (34%), Positives = 63/112 (56%), Gaps = 12/112 (10%)

Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VL 574
           G+P+++APE++   + K   P    AVD W+LG  + E LTG PP+++ E PQ +F+ +L
Sbjct: 542 GTPDYLAPELL---LGKPHGP----AVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNIL 593

Query: 575 NRTPPIP---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 623
           NR  P P   E LS   ++ +      +P +R    EL +HP     +++NL
Sbjct: 594 NRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENL 645

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 26/268 (9%)

Query: 360 IGRGTFGSV-----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           IG G FG V     Y  T     A   +KE+       +  E ++Q +        L+H 
Sbjct: 3   IGNGWFGKVLLSEIYTDT---GVARVVVKELKANASSKEQNEFLQQGDPYRI----LQHP 55

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYL 471
           NI+Q  G  V      +  EY   G +  Y+     H R+    +++     I  G+ ++
Sbjct: 56  NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKA 528
           H  N +H D+   N  + +   VK+ D+G+        Y   E        W+APE++  
Sbjct: 116 HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEFEGPQAMFKVLNR------TPPIP 581
                   +     ++W+LG T+ E+      P+S     + +  V+         P + 
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235

Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVEL 609
              S    + L  C+L +P +R +A E+
Sbjct: 236 LPYSERWYEVLQFCWL-SPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.6 bits (136), Expect = 3e-08
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)

Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY-LEYVHPGSINRYVREHCRDITESIVR 458
           QLE EI  LG L HENI++    E++      Y +   +   +  ++ +   D  +  + 
Sbjct: 209 QLENEILALGRLNHENILKI--EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266

Query: 459 NFTRHILNGL----AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYEL 512
             TR I+  L     Y+H    IHRDIK  N+ ++  G + L DFG A        +++ 
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326

Query: 513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
              G+    +PE    ++  DG  ++    DIWS G  +++ML+
Sbjct: 327 GWVGTVATNSPE----ILAGDGYCEIT---DIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 38/271 (14%)

Query: 360 IGRGTFGSVYIG-----TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           +G   FG VY G        E   + AIK +     D       ++ + E  +   L+H 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK----DKAEGPLREEFKHEAMMRSRLQHP 68

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDI----TESIVRN--------- 459
           NIV   G    +  L +   Y     ++ ++  R    D+     +  V++         
Sbjct: 69  NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128

Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP- 518
               I  G+ +L S + +H+D+   N+LV     VK++D G+ + +    Y   L G+  
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY-YKLMGNSL 187

Query: 519 ---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 574
               WM+PE   A+M      K ++  DIWS G  + E+ + G  P+  +     +  + 
Sbjct: 188 LPIRWMSPE---AIMYG----KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240

Query: 575 NR-TPPIPEMLSSEGKDFLLRCFLRNPVERP 604
           NR   P P+   +     +L C+   P  RP
Sbjct: 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 35/107 (32%), Positives = 47/107 (43%), Gaps = 9/107 (8%)

Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPN 519
           R +L  + YLH    IHRDIK  N+ ++  G V L DFG A     ++        G+  
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248

Query: 520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 566
             APE++              AVDIWS G  + EM T      E +G
Sbjct: 249 TNAPELL-------ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288

Length = 391

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 18/180 (10%)

Query: 434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 493
           E+V  G ++  +R+    +  +      + + + L+YL   N +H ++   N+L+   G+
Sbjct: 96  EFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155

Query: 494 -------VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 546
                  +KL+D G++   T LS E  ++  P W+APE +       GN  L+ A D WS
Sbjct: 156 AEGTSPFIKLSDPGVS--FTALSREERVERIP-WIAPECV-----PGGN-SLSTAADKWS 206

Query: 547 LGCTVIEM-LTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPS 605
            G T++E+   G+ P  E   P    +   +   +PE    E    + +C    P +RPS
Sbjct: 207 FGTTLLEICFDGEVPLKE-RTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPS 265

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 52.4 bits (125), Expect = 7e-07
 Identities = 32/78 (41%), Positives = 44/78 (56%), Gaps = 6/78 (7%)

Query: 450 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGL 508
           RDI  ++++   R +L GL  LH    +HRDIK  NLLV   G VK+ DFG A  + TG+
Sbjct: 306 RDI--NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI 363

Query: 509 SYELSLKG--SPNWMAPE 524
           ++   L G   P +  PE
Sbjct: 364 NFN-PLYGMLDPRYSPPE 380

Length = 507

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 44/178 (24%), Positives = 63/178 (35%), Gaps = 38/178 (21%)

Query: 399 KQLEQEIKVLGHLKHENIVQY-----YGSEV--VDDH----LYIYLEYVHPGSINRYVRE 447
           K   +EI +L  + H  I+       + S V  V       L+ Y++   P  + + +  
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI-- 188

Query: 448 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 507
                         R +L  LAYLH    IHRD+K  N+ +D      L DFG A  L  
Sbjct: 189 -----------TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237

Query: 508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL-----AVDIWSLGCTVIEMLTGKPP 560
                   G   W         ++ +    LAL       DIWS G  + EM      
Sbjct: 238 HPDTPQCYG---WS------GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 50.2 bits (120), Expect = 3e-06
 Identities = 37/119 (31%), Positives = 51/119 (42%), Gaps = 22/119 (18%)

Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHL-TGLSY--- 510
           I++   R IL  L  LHST  +HRD+K  N++    SG  K+ D G A  L  G++Y   
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK 315

Query: 511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV---------------DIWSLGCTVIEM 554
           E  L   P + APE      Q    P   +A                DI+S G   ++M
Sbjct: 316 EFLL--DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372

Length = 566

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.4 bits (115), Expect = 1e-05
 Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 10/113 (8%)

Query: 444 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 503
           Y+    R +  + V    R +L+ + Y+H    IHRDIK  N+LV+    + L DFG A 
Sbjct: 249 YLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC 308

Query: 504 HLTG---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE 553
              G     +   + G+ +  APEV+       G+P    +VDIWS G  + E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAPEVLA------GDP-YTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 9/118 (7%)

Query: 340 HIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP 392
           +I   P   P  S+W+        G+++G G FG V  GT      S  + +V +    P
Sbjct: 18  YIYVDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKP 77

Query: 393 KSAECIKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 448
            +    KQ L  E+K++ HL  H NIV   G+      +YI  EY   G +  Y+ ++
Sbjct: 78  TARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKN 135

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 40.7 bits (96), Expect = 0.001
 Identities = 21/86 (24%), Positives = 34/86 (39%), Gaps = 20/86 (23%)

Query: 425 VDDHLY-IYLEYVHPG-----SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           VD     I +EY+  G      I     E  R+I   + +            LH    +H
Sbjct: 67  VDPDNKTIVMEYIE-GKPLKDVIEEGNDELLREIGRLVGK------------LHKAGIVH 113

Query: 479 RDIKGANLLVDASGVVKLADFGMAKH 504
            D+  +N++V    +  L DFG+ K+
Sbjct: 114 GDLTTSNIIVRDDKLY-LIDFGLGKY 138

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.8 bits (99), Expect = 0.001
 Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 10/74 (13%)

Query: 431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 490
           I +EY+  G   + V E        +VR     +    A LH    +H D+  +N +V  
Sbjct: 413 IVMEYIG-GKDLKDVLEG----NPELVRKVGEIV----AKLHKAGIVHGDLTTSNFIVRD 463

Query: 491 SGVVKLADFGMAKH 504
             +  L DFG+ K+
Sbjct: 464 DRLY-LIDFGLGKY 476

Length = 535

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	739
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
PRK10345	210	hypothetical protein; Provisional	99.83
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.83
smart00090	237	RIO RIO-like kinase.	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.52
KOG1243	690	consensus Protein kinase [General function predict	99.49
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.15
KOG3087	229	consensus Serine/threonine protein kinase [General	99.15
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.14
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.06
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.97
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.82
COG4248	637	Uncharacterized protein with protein kinase and he	98.77
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.72
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.58
PRK09902	216	hypothetical protein; Provisional	98.58
PF01636	239	APH: Phosphotransferase enzyme family This family	98.48
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.47
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.45
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.4
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.39
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.34
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.15
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.09
PLN02876	822	acyl-CoA dehydrogenase	98.06
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.02
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.02
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.94
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.85
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.84
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.72
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.64
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.61
PRK10593	297	hypothetical protein; Provisional	97.61
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.61
KOG2270	520	consensus Serine/threonine protein kinase involved	97.58
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.54
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.47
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.47
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.39
PRK05231	319	homoserine kinase; Provisional	97.35
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.04
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.85
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.81
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.59
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.4
PLN02236	344	choline kinase	96.37
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.24
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.23
PRK12396	409	5-methylribose kinase; Reviewed	95.95
PLN02756	418	S-methyl-5-thioribose kinase	95.9
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.81
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.74
PTZ00384	383	choline kinase; Provisional	95.45
COG2334	331	Putative homoserine kinase type II (protein kinase	95.32
PRK06148	1013	hypothetical protein; Provisional	95.2
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.13
PRK11768	325	serine/threonine protein kinase; Provisional	94.71
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.34
KOG1236	565	consensus Predicted unusual protein kinase [Genera	93.77
PTZ00296	442	choline kinase; Provisional	93.77

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-56  Score=475.68  Aligned_cols=266  Identities=32%  Similarity=0.504  Sum_probs=235.3

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccH--HHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA--ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~--~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ..+.|.+.+.||+|+||.|.+|..+.||+.||||++...+......  .-...+.+|++||++|+|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            5678999999999999999999999999999999998655444322  12234679999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC---CcEEEeecccchh
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKH  504 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~---g~vKL~DFGlA~~  504 (739)
                      ..||||||++||+|++++..+ +.+.|..-+.+++||+.||.|||++||+||||||+|||+..+   -.+||+|||+|+.
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            999999999999999999876 679999999999999999999999999999999999999766   6899999999999


Q ss_pred             ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchH-HHHHHhhcCC----C
Q 004660          505 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKVLNRTP----P  579 (739)
Q Consensus       505 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~-~~~~i~~~~~----~  579 (739)
                      ......+.++|||+.|.|||++.+    .|...+..++||||||||||-+|+|.+||.+..... ....|..+..    .
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~----kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~  404 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLAS----KGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL  404 (475)
T ss_pred             cccceehhhhcCCccccChhheec----CCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence            988889999999999999999975    234455669999999999999999999998876666 6677766654    3


Q ss_pred             CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       580 iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      .+..+++++.+||.+||..||++|+|+.|+|+||||+....
T Consensus       405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence            44578999999999999999999999999999999987653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-54  Score=480.17  Aligned_cols=257  Identities=36%  Similarity=0.621  Sum_probs=238.6

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ..+|.++++||+|||++||.+++..+|+.||+|+|.+...  ......+.+.+||+|.+.|+|||||++|++|++.+.+|
T Consensus        17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l--~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY   94 (592)
T KOG0575|consen   17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL--KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY   94 (592)
T ss_pred             cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh--cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence            3689999999999999999999999999999999974221  22344577899999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-c
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~-~  509 (739)
                      ||+|+|..++|..+++. .+.++|.+++.|++||+.||.|||+++|+|||||..||||+++.+|||+|||||..+..+ .
T Consensus        95 ivLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   95 IVLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            99999999999999984 478999999999999999999999999999999999999999999999999999998754 7


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK  589 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~  589 (739)
                      ...+.||||.|+|||++.       ...++..+||||+|||||-||.|++||...+-.+.+.+|......+|..++.+++
T Consensus       174 rk~TlCGTPNYIAPEVl~-------k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~  246 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLN-------KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAK  246 (592)
T ss_pred             ccceecCCCcccChhHhc-------cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHH
Confidence            778999999999999998       3567889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          590 DFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                      +||.+||..||.+|||++++|.|+||+.
T Consensus       247 dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  247 DLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             HHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence            9999999999999999999999999954

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-53  Score=450.55  Aligned_cols=265  Identities=32%  Similarity=0.529  Sum_probs=239.8

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ....+|+++++||+|+||+||+++.+.|++.||+|++++...-.  ....+....|..||..++||+||+++..|++.+.
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~--~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k   99 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE--KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK   99 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh--hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence            44568999999999999999999999999999999987533222  2345778899999999999999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-C
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-G  507 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~-~  507 (739)
                      +|||+||+.||+|+.+|++. +.++|..++.|+..|+.||.|||++|||||||||+|||||.+|+++|+||||++... .
T Consensus       100 LylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            99999999999999999876 679999999999999999999999999999999999999999999999999998654 4


Q ss_pred             cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-CCCCccCCH
Q 004660          508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSS  586 (739)
Q Consensus       508 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~  586 (739)
                      .....+++||+.|||||++.+       ..|+.++|+|||||+|||||+|.+||.+.+..+.+.+|.... ...|..++.
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~-------~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~  251 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLG-------KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSE  251 (357)
T ss_pred             CCccccccCCccccChHHHhc-------CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCH
Confidence            456667899999999999984       478889999999999999999999999999999999999887 666777999


Q ss_pred             HHHHHHHHhcccCCCCCC----CHHHHHcCccccccccCCC
Q 004660          587 EGKDFLLRCFLRNPVERP----SAVELLEHPFIRNANYQNL  623 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRp----Ta~elLqHpwf~~~~~~~~  623 (739)
                      ++++||+++|.+||++|.    .+.+|-+||||...++..+
T Consensus       252 ~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l  292 (357)
T KOG0598|consen  252 EARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL  292 (357)
T ss_pred             HHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence            999999999999999996    6999999999998877543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-53  Score=449.70  Aligned_cols=263  Identities=32%  Similarity=0.570  Sum_probs=237.2

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc-
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-  427 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~-  427 (739)
                      ....+.+.++.||+|..|+||+++++.|++.+|+|+|..    ..+....+++.+|+++++.++||+||.+|++|..++ 
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~----~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL----NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc----cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence            344578899999999999999999999999999999853    244666789999999999999999999999999999 


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      .++|+||||+||+|.++++.. +.++|..+..++.+|++||.|||+ ++||||||||+||||+..|+|||||||.++.+.
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            599999999999999999775 679999999999999999999995 999999999999999999999999999999886


Q ss_pred             CcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCC-----CchHHHHHHhh-cCCCC
Q 004660          507 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-----EGPQAMFKVLN-RTPPI  580 (739)
Q Consensus       507 ~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~-----~~~~~~~~i~~-~~~~i  580 (739)
                      .. ...+++||..|||||.+.+       ..|+.++||||||++++||.+|+.||...     ...+.+..|.. ..+.+
T Consensus       231 nS-~a~tfvGT~~YMsPERi~g-------~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l  302 (364)
T KOG0581|consen  231 NS-IANTFVGTSAYMSPERISG-------ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL  302 (364)
T ss_pred             hh-hcccccccccccChhhhcC-------CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC
Confidence            65 6678999999999999984       57888999999999999999999999874     55677888887 45677


Q ss_pred             Ccc-CCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccccCCCC
Q 004660          581 PEM-LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLS  624 (739)
Q Consensus       581 P~~-ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~~~~~  624 (739)
                      |.. +++++++||..||++||.+|+++.|+|+|||++.....++.
T Consensus       303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd  347 (364)
T KOG0581|consen  303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVD  347 (364)
T ss_pred             CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccccc
Confidence            886 99999999999999999999999999999999877655543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-51  Score=452.58  Aligned_cols=263  Identities=30%  Similarity=0.539  Sum_probs=239.0

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecc
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD  427 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~  427 (739)
                      ...+.|.+++.||+|+||+|++|.+..+|..||+|+++............+.+.+|+.+|+.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567899999999999999999999999999999977653222111234567779999999999 999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEeecccchhc-
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHL-  505 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~-g~vKL~DFGlA~~~-  505 (739)
                      .+|||||||.||+|+++|.+ .+.+.|.+++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++... 
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            99999999999999999988 5789999999999999999999999999999999999999999 99999999999988 


Q ss_pred             cCcccccccCCCCCCCChHHHHHhhhcCCCC-CCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccC
Q 004660          506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP-KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML  584 (739)
Q Consensus       506 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~-~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~l  584 (739)
                      .......+.+||+.|+|||++.+      .. +.+.++||||||||||.|++|+.||.+.+...+..+|..+...+|..+
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~------~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~  246 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSG------KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYL  246 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCC------CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCc
Confidence            45667778999999999999985      23 446899999999999999999999999888889999999999999999


Q ss_pred             -CHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          585 -SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       585 -s~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                       +.++++||.+||..||.+|+|+.++++|+||+..
T Consensus       247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence             9999999999999999999999999999999974

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-52  Score=457.73  Aligned_cols=264  Identities=29%  Similarity=0.563  Sum_probs=238.7

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecce
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  428 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~  428 (739)
                      ...+|..++.||+|+|++|++|+++.+++.||||++.+..  -....-++.+.+|-.+|.+| .||.||+||-.|+++..
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~--Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY--IIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHH--HHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3468999999999999999999999999999999986311  11122235677788899999 79999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      +|+|+||+++|+|.++|.+. +.|+|..++.|+.||+.||+|||++|||||||||+|||||.+|++||+|||.|+.+...
T Consensus       149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999999886 78999999999999999999999999999999999999999999999999999877432


Q ss_pred             cc--------------ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHh
Q 004660          509 SY--------------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL  574 (739)
Q Consensus       509 ~~--------------~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~  574 (739)
                      ..              ..+++||..|.+||+|.       +...+..+|||+||||||+|+.|++||.+.++..++++|+
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-------~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~  300 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-------DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ  300 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhc-------CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence            11              14589999999999997       4677889999999999999999999999999999999999


Q ss_pred             hcCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccccCCC
Q 004660          575 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL  623 (739)
Q Consensus       575 ~~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~~~~  623 (739)
                      .....+|+.+++.++|||+++|.+||.+|+|++||.+||||...+|.++
T Consensus       301 ~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl  349 (604)
T KOG0592|consen  301 ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL  349 (604)
T ss_pred             HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence            9999999999999999999999999999999999999999999888764

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.1e-52  Score=428.23  Aligned_cols=257  Identities=28%  Similarity=0.500  Sum_probs=223.3

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      +.|+.+.++|+|+||+||+|+++.||+.||||++.-.   +.+....+-..+||++|++|+|+|+|.++++|..+..++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es---edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES---EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC---CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence            3689999999999999999999999999999987632   3335556677899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-Cccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSY  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~-~~~~  510 (739)
                      |+|||+..-|. .+......+++..++.|+.|++.|+.|||++++|||||||+||||+..|.+||||||+|+.+. ....
T Consensus        79 VFE~~dhTvL~-eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   79 VFEYCDHTVLH-ELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             EeeecchHHHH-HHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence            99999855444 455556779999999999999999999999999999999999999999999999999999987 4555


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC------------
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------------  578 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~------------  578 (739)
                      .+.++.|+||+|||.+.|      +..|+..+||||+||++.||++|.+.|.+....+.+..|.....            
T Consensus       158 YTDYVATRWYRaPELLvG------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVG------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             hhhhhhhhhccChhhhcc------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence            567889999999999985      67899999999999999999999999999888877776642110            


Q ss_pred             -------CCC------------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          579 -------PIP------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       579 -------~iP------------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                             .+|            ..++.-+.||+++||..||++|++.+|+|.|+||...
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence                   111            1256788999999999999999999999999999643

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-50  Score=431.31  Aligned_cols=259  Identities=33%  Similarity=0.605  Sum_probs=233.8

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...+|.+.+.||+|+||+||+|+++.++..||||.|....   ...+..+.+..||+||+.|+|||||+++++...++.+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~---l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK---LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc---cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence            4568999999999999999999999999999999987532   2455667788999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC------CcEEEeecccch
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS------GVVKLADFGMAK  503 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~------g~vKL~DFGlA~  503 (739)
                      |||||||.||||.+||+.+ +.++|..++.++.||+.||++||+++||||||||+||||+..      -.+||+|||+|+
T Consensus        85 ~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            9999999999999999886 579999999999999999999999999999999999999764      369999999999


Q ss_pred             hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc---CCCC
Q 004660          504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPI  580 (739)
Q Consensus       504 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~---~~~i  580 (739)
                      .+.......+.+|++.|||||+++.       ..|+.|+|+||+|+|||+|++|+.||......+.+..+..+   .+.+
T Consensus       164 ~L~~~~~a~tlcGSplYMAPEV~~~-------~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~  236 (429)
T KOG0595|consen  164 FLQPGSMAETLCGSPLYMAPEVIMS-------QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVL  236 (429)
T ss_pred             hCCchhHHHHhhCCccccCHHHHHh-------ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCch
Confidence            9998888889999999999999973       56888999999999999999999999998888877766543   3445


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      +..++..+.+|+...|++|+.+|.+..+.+.|+++....
T Consensus       237 ~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  237 PAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            667888899999999999999999999999999987654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-51  Score=458.80  Aligned_cols=261  Identities=33%  Similarity=0.532  Sum_probs=242.5

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .+-|++++-||.|+-|.|.+|++..||+.+|||+|.+..  .........+++||-||+.|.||||+++|++++.+.++|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly   88 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY   88 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeecccc--ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence            345999999999999999999999999999999987532  122233467889999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~  510 (739)
                      +|+||++||.|++++..+ +.++|.++..+++||+.||.|||..+|+||||||+|+|||..+++||+|||+|..-.++..
T Consensus        89 lvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             EEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence            999999999999999887 6799999999999999999999999999999999999999999999999999998888888


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD  590 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~d  590 (739)
                      ..+-||++.|.+||++.|      .++.+.++||||+|||||.||+|++||++.+...++.++..+...+|..++.++++
T Consensus       168 LeTSCGSPHYA~PEIV~G------~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQd  241 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSG------RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQD  241 (786)
T ss_pred             ccccCCCcccCCchhhcC------CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHH
Confidence            889999999999999985      67778899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          591 FLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       591 LI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      ||.+||..||++|+|.+||++|||+.....
T Consensus       242 LLr~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  242 LLRRMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             HHHHHhccCccccccHHHHhhCchhhcCCC
Confidence            999999999999999999999999986543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-50  Score=419.12  Aligned_cols=261  Identities=31%  Similarity=0.557  Sum_probs=240.3

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...+|++++.||.|+||+|.+++.+.+|..||+|++++.  +-.....++...+|..+|+.+.||++|++++.|.+.+.+
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~--~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQ--KVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHH--HHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence            456799999999999999999999999999999998742  223344567788999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      ||||||+.||.|+.++++. +.++|..++.|+.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+.+.+. 
T Consensus       120 ymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            9999999999999999875 67999999999999999999999999999999999999999999999999999998776 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK  589 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~  589 (739)
                       +.+.||||.|+|||+++       ...|+.++|+|||||++|||+.|.+||.+.+..++..+|+.+...+|..++.+++
T Consensus       198 -T~TlCGTPeYLAPEii~-------sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~k  269 (355)
T KOG0616|consen  198 -TWTLCGTPEYLAPEIIQ-------SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAK  269 (355)
T ss_pred             -EEEecCCccccChHHhh-------cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHH
Confidence             45789999999999998       3678889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHHcCccccccccCC
Q 004660          590 DFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQN  622 (739)
Q Consensus       590 dLI~kcL~~DP~kRp-----Ta~elLqHpwf~~~~~~~  622 (739)
                      +||+++|+.|-.+|.     ...+|..||||+...+..
T Consensus       270 dLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  270 DLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             HHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence            999999999999994     578999999999877643

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-51  Score=442.64  Aligned_cols=260  Identities=29%  Similarity=0.477  Sum_probs=229.8

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecc-
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD-  427 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~-  427 (739)
                      ...+|.++++||.|+||.||+|+.+.+|+.||||.++.....  -.+  -.-.||++.|++|. |||||++.+++.+.+ 
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--~ee--~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--WEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--HHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            346899999999999999999999999999999988742221  122  23468999999998 999999999999888 


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+|+|||||+ ..|+++++++.+.++|..++.|+.||++||+|+|++|++||||||+||||.....|||+|||+|+.+..
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence            9999999997 789999999888999999999999999999999999999999999999999999999999999999988


Q ss_pred             cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc--C--------
Q 004660          508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--T--------  577 (739)
Q Consensus       508 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~--------  577 (739)
                      ....+.++.|+||+|||+|..      ...|+.++||||+|||++|+.+-++.|.+.++.+.+.+|..-  .        
T Consensus       163 kpPYTeYVSTRWYRAPEvLLr------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLR------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             CCCcchhhhcccccchHHhhh------ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            777778899999999999985      578999999999999999999999999999988888877431  0        


Q ss_pred             ---------CCCC-----------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          578 ---------PPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       578 ---------~~iP-----------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                               ..+|           ..++.++.+||.+||.+||++||||.|+|+||||+....
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence                     0111           126789999999999999999999999999999986543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-50  Score=429.42  Aligned_cols=259  Identities=51%  Similarity=0.908  Sum_probs=225.1

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc--e
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--H  428 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~--~  428 (739)
                      ...|..++.||+|+||+||++.++.+|..+|||.+....     ....+.+++|+.+|.+|+|||||+++|.....+  .
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~-----~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED-----SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc-----chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            456999999999999999999999999999999987541     111677899999999999999999999755554  6


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC-CCcEEEeecccchhccC
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTG  507 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~-~g~vKL~DFGlA~~~~~  507 (739)
                      ++|+|||+.+|+|.+++...++.++|..++.+++||++||+|||++|||||||||+||||+. ++.+||+|||+++....
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999999999887657999999999999999999999999999999999999999 79999999999987763


Q ss_pred             ----cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCC-CCchHHHHHHhhc--CCCC
Q 004660          508 ----LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGPQAMFKVLNR--TPPI  580 (739)
Q Consensus       508 ----~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~-~~~~~~~~~i~~~--~~~i  580 (739)
                          ........||+.|||||++..      ....+.++|||||||++.||+||+.||.. ....+.+..+...  .+.+
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~i  244 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRN------GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEI  244 (313)
T ss_pred             ccccccccccccCCccccCchhhcC------CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCC
Confidence                223446789999999999973      11223589999999999999999999998 5556666666543  4789


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      |..++.++++||.+||.+||++||||.++|+|||.+....
T Consensus       245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999999999999976543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-50  Score=436.00  Aligned_cols=260  Identities=28%  Similarity=0.496  Sum_probs=227.1

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec--
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--  426 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~--  426 (739)
                      .....|+.+++||+|+||.||+|++..||+.||+|+|+....+   .+......+||.||++|+|||||+|.+...+.  
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~---~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~  190 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK---EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS  190 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC---CcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence            3456799999999999999999999999999999999864433   34456677899999999999999999987766  


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      ..+|||+|||+ -||..++......|++.+++.||+||+.||+|||.+||+|||||..|||||.+|++||+|||||+.+.
T Consensus       191 ~siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  191 GSIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             ceEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            68999999997 78888888777789999999999999999999999999999999999999999999999999999776


Q ss_pred             Ccc--cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc--C-----
Q 004660          507 GLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--T-----  577 (739)
Q Consensus       507 ~~~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~-----  577 (739)
                      ...  ..+..+.|.||+|||+|.|      ...|+.++|+||+||||.||+.|++.|.+..+.+.+.+|+..  .     
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG------~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLG------ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcC------CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence            543  3456778999999999996      578899999999999999999999999999888888877541  0     


Q ss_pred             ---CCCC-------------------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          578 ---PPIP-------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       578 ---~~iP-------------------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                         ..+|                   ..+++.+.+|+..||..||.+|.||.++|+++||...
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence               0112                   2367889999999999999999999999999999543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-49  Score=405.97  Aligned_cols=258  Identities=27%  Similarity=0.458  Sum_probs=225.5

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      .+|...++||+|.||+||+|++..+|+.||||+|+......   .......+||++|+.++|+|||.++++|-..+.+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd---Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD---GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc---CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence            47999999999999999999999999999999998643221   112456789999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      |+||++ .+|+..|++....++..+++.|+.|+++||+|||.+.|+||||||+|+||+.+|.+||+|||+|+.+......
T Consensus        79 VfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   79 VFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            999997 8999999998889999999999999999999999999999999999999999999999999999988654433


Q ss_pred             c-ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-----CCC----
Q 004660          512 L-SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----PIP----  581 (739)
Q Consensus       512 ~-s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-----~iP----  581 (739)
                      . ..+.|+||+|||++.|      ...|+..+||||.|||+.||+.|.+.|.+.+..+.+..|+.-..     .+|    
T Consensus       158 ~~~~V~TRWYRAPELLfG------sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFG------SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             cccceeeeeccChHHhcc------chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            2 3478999999999996      46678899999999999999999999999888888777754210     111    


Q ss_pred             -------------------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          582 -------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       582 -------------------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                         ...+.++.|||.+||..||.+|+++.|+|+|+||+...
T Consensus       232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                               12467889999999999999999999999999998643

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-49  Score=442.27  Aligned_cols=264  Identities=28%  Similarity=0.495  Sum_probs=239.9

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeec
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD  426 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~  426 (739)
                      .....+|.++++||+|.||+|+++..+.+++.||||++++  +.-...+.++.+..|.+|+.... ||.+++++..|+.+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK--~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKK--GDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeec--cceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            4556789999999999999999999999999999999874  23334445677888999988885 99999999999999


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      +++|+||||+.||++..+++.  +.++|..++.|+..|+.||.|||++||||||||.+|||||.+|++||+||||++...
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence            999999999999996555443  679999999999999999999999999999999999999999999999999999765


Q ss_pred             -CcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCC
Q 004660          507 -GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLS  585 (739)
Q Consensus       507 -~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls  585 (739)
                       ....+.+++||+.|||||++.+       ..|+.++|+|+|||+|||||.|..||.+.++++....|++..+.+|..++
T Consensus       520 ~~g~~TsTfCGTpey~aPEil~e-------~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls  592 (694)
T KOG0694|consen  520 GQGDRTSTFCGTPEFLAPEVLTE-------QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS  592 (694)
T ss_pred             CCCCccccccCChhhcChhhhcc-------CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence             5667778999999999999984       67899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----HHHHHcCccccccccCC
Q 004660          586 SEGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQN  622 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpT-----a~elLqHpwf~~~~~~~  622 (739)
                      .++.++|+++|.+||++|..     +++|.+||||+..++..
T Consensus       593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~  634 (694)
T KOG0694|consen  593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD  634 (694)
T ss_pred             HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence            99999999999999999975     68999999999887753

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.2e-49  Score=435.56  Aligned_cols=267  Identities=30%  Similarity=0.523  Sum_probs=234.9

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ....++|+++++||+|+||.||+|+.+.||..||||++++.  +....+.++.+..|-.||...+++.||+||..|++.+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS--~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS--EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHH--HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            44567899999999999999999999999999999998753  2233455678889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+||||||++|||+..+|... +.|+|..++.|+.+++.||+.||+.|+|||||||+|+|||..|++||.||||+.-+..
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            999999999999999999876 6799999999999999999999999999999999999999999999999999842210


Q ss_pred             ----------------------cc--------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCC
Q 004660          508 ----------------------LS--------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLA  539 (739)
Q Consensus       508 ----------------------~~--------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s  539 (739)
                                            ..                          ...+.+|||.|||||++.+       ..|+
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-------kgY~  366 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-------KGYG  366 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-------CCCC
Confidence                                  00                          0113679999999999984       4688


Q ss_pred             cchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--CCCCc--cCCHHHHHHHHHhcccCCCCCCC---HHHHHcC
Q 004660          540 LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE--MLSSEGKDFLLRCFLRNPVERPS---AVELLEH  612 (739)
Q Consensus       540 ~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~--~ls~el~dLI~kcL~~DP~kRpT---a~elLqH  612 (739)
                      ..+|+|||||||||||.|.+||...+..+...+|++..  ..+|.  .++.+++|||.+||. ||++|..   ++||.+|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence            99999999999999999999999999999999998754  44443  578999999999999 9999974   9999999


Q ss_pred             ccccccccCCCCC
Q 004660          613 PFIRNANYQNLSV  625 (739)
Q Consensus       613 pwf~~~~~~~~~~  625 (739)
                      |||+..+|..+..
T Consensus       446 PfF~~v~W~~l~~  458 (550)
T KOG0605|consen  446 PFFKGVDWDHLRE  458 (550)
T ss_pred             CccccCCcchhhc
Confidence            9999999877654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-50  Score=411.02  Aligned_cols=246  Identities=33%  Similarity=0.551  Sum_probs=218.6

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeecc-ceeecce-
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG-SEVVDDH-  428 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~-~~~~~~~-  428 (739)
                      ...|++.++||+|+||+||++++..+|..||.|.|..   +..+......+..|+.+|++|+|||||++|+ .|..+.. 
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f---~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev   94 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF---GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV   94 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch---hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence            3469999999999999999999999999999998763   3344555678889999999999999999999 5555554 


Q ss_pred             EEEEEeecCCCCcchhhhh---ccccccHHHHHHHHHhHHHHHHHHHh--CC--eecccCCCcceEecCCCcEEEeeccc
Q 004660          429 LYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHS--TN--TIHRDIKGANLLVDASGVVKLADFGM  501 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs--~G--IvHRDIKP~NILLd~~g~vKL~DFGl  501 (739)
                      ++||||||.+|||..+|+.   ..+.++|..+|.++.||+.||..||.  ..  |+||||||.||+|+.+|.|||+||||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL  174 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL  174 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence            9999999999999999853   45679999999999999999999998  44  99999999999999999999999999


Q ss_pred             chhccCc-ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-C
Q 004660          502 AKHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-P  579 (739)
Q Consensus       502 A~~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-~  579 (739)
                      ++.+... ....+++|||+||+||++.+       ..|..++|||||||++|||+.-+.||.+.+-.+...+|.++.. +
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~-------~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~  247 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHE-------SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP  247 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhc-------CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC
Confidence            9988653 45567899999999999984       5789999999999999999999999999988888888877654 4


Q ss_pred             CC-ccCCHHHHHHHHHhcccCCCCCCCH
Q 004660          580 IP-EMLSSEGKDFLLRCFLRNPVERPSA  606 (739)
Q Consensus       580 iP-~~ls~el~dLI~kcL~~DP~kRpTa  606 (739)
                      +| +.+|.++..||..|+..|++.||+.
T Consensus       248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  248 LPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            77 7899999999999999999999985

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.6e-49  Score=432.42  Aligned_cols=255  Identities=33%  Similarity=0.570  Sum_probs=235.5

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|.+.+.||+|+||+||+|+.+.|.+.||||.+.+..   .....++.+.+|++|++.|+|||||.++++|+...++|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g---r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG---RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC---CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence            47999999999999999999999999999999987543   334557789999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      |+|||.| +|+.+|.+. +.++|+.++.|+.|++.||.|||+++|+|||+||.||||+..|.+||+|||+|+.+..+. .
T Consensus        79 Vte~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             Eehhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence            9999986 999999775 679999999999999999999999999999999999999999999999999999886543 3


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD  590 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~d  590 (739)
                      ...+.|||.|||||++.+       ..|+..+|+||||||+|||+.|++||......+....|......+|...+..+++
T Consensus       157 ltsikGtPlYmAPElv~e-------~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~n  229 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEE-------QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVN  229 (808)
T ss_pred             eeeccCcccccCHHHHcC-------CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHH
Confidence            346789999999999973       5788999999999999999999999999888899999999999999999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          591 FLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       591 LI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      ||+.+|.+||.+|+|..+++.|||++..
T Consensus       230 fl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  230 FLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHHHhhcChhhcccHHHHhcChHHhhh
Confidence            9999999999999999999999999864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-48  Score=406.26  Aligned_cols=257  Identities=30%  Similarity=0.490  Sum_probs=228.4

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|+||+||+|.++.+|+.||||++....  .........+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE--VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH--HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence            36999999999999999999999999999999986421  1122334668899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      ||||+.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......  
T Consensus        79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--  155 (291)
T cd05612          79 LMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--  155 (291)
T ss_pred             EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence            99999999999999765 569999999999999999999999999999999999999999999999999998765432  


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHH
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF  591 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dL  591 (739)
                      ....||+.|+|||++.+       ..++.++|||||||++|||++|+.||......+....+......++..++..+++|
T Consensus       156 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  228 (291)
T cd05612         156 WTLCGTPEYLAPEVIQS-------KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDL  228 (291)
T ss_pred             ccccCChhhcCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHH
Confidence            24579999999999863       35678999999999999999999999988888888888888888888899999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHHcCcccccccc
Q 004660          592 LLRCFLRNPVERPS-----AVELLEHPFIRNANY  620 (739)
Q Consensus       592 I~kcL~~DP~kRpT-----a~elLqHpwf~~~~~  620 (739)
                      |++||..||.+|++     +.++++|+||+...+
T Consensus       229 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             HHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            99999999999995     999999999976543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=422.80  Aligned_cols=256  Identities=39%  Similarity=0.663  Sum_probs=229.8

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      .....|...+.||+|+.|.||.|+...+++.||||.+.+.....     .+.+.+|+.+|+..+|+|||++++.|..++.
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-----keLilnEi~Vm~~~~H~NiVnfl~Sylv~de  344 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-----KELLLNEILVMRDLHHPNIVNFLDSYLVGDE  344 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-----hhhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence            44567999999999999999999999999999999998644322     2567899999999999999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      +|+||||++||+|.+.+...  .++|.++..|++++++||+|||.+||+|||||.+|||++.+|.|||+|||++..+...
T Consensus       345 LWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  345 LWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             eEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            99999999999999999764  4999999999999999999999999999999999999999999999999999887654


Q ss_pred             c-cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh-cCC--CCCccC
Q 004660          509 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTP--PIPEML  584 (739)
Q Consensus       509 ~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-~~~--~iP~~l  584 (739)
                      . ...+.+||++|||||++.       ...|+.++||||||++++||+-|.+||-..+....++.|.. +.+  ..++.+
T Consensus       423 ~~KR~TmVGTPYWMAPEVvt-------rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~kl  495 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVT-------RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKL  495 (550)
T ss_pred             cCccccccCCCCccchhhhh-------hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcccc
Confidence            4 455788999999999998       46789999999999999999999999998777777777754 333  457789


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      +++++|||.+||+.|+++|++|.|||+||||+..
T Consensus       496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  496 SPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             CHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            9999999999999999999999999999999544

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9e-48  Score=413.02  Aligned_cols=259  Identities=29%  Similarity=0.494  Sum_probs=229.9

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ....+|++.+.||+|+||+||+|+++.+|+.||||++....  .......+.+.+|+.+|+.++|||||++++++..++.
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   92 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE--ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR   92 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence            34578999999999999999999999999999999987421  1122335678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      +|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999999999765 56899999999999999999999999999999999999999999999999999876443


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHH
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG  588 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el  588 (739)
                      .  ....||+.|+|||++.+       ..++.++|||||||++|||++|+.||.+....+....+......+|..++..+
T Consensus       172 ~--~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~  242 (329)
T PTZ00263        172 T--FTLCGTPEYLAPEVIQS-------KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRA  242 (329)
T ss_pred             c--ceecCChhhcCHHHHcC-------CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHH
Confidence            2  24579999999999873       35678999999999999999999999988777788888888888899999999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHHcCccccccc
Q 004660          589 KDFLLRCFLRNPVERPS-----AVELLEHPFIRNAN  619 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpT-----a~elLqHpwf~~~~  619 (739)
                      ++||++||..||.+|++     +++++.||||....
T Consensus       243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence            99999999999999997     79999999998644

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.3e-48  Score=411.87  Aligned_cols=253  Identities=29%  Similarity=0.475  Sum_probs=222.8

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecC
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  437 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~  437 (739)
                      ++||+|+||+||+|+++.+|+.||||+++....  ........+.+|+.+|+.++||||+++++++..++.+||||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            479999999999999999999999999874211  122344567889999999999999999999999999999999999


Q ss_pred             CCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccCC
Q 004660          438 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKG  516 (739)
Q Consensus       438 gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~G  516 (739)
                      +|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus        79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  157 (323)
T cd05571          79 GGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence            99999998765 5789999999999999999999999999999999999999999999999999976432 223335679


Q ss_pred             CCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHhc
Q 004660          517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF  596 (739)
Q Consensus       517 T~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kcL  596 (739)
                      |+.|+|||++.+       ..++.++|||||||++|||++|+.||...+.......+......+|..++.++.+||++||
T Consensus       158 t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05571         158 TPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             CccccChhhhcC-------CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence            999999999863       4577899999999999999999999988877777777777778889999999999999999


Q ss_pred             ccCCCCCC-----CHHHHHcCcccccccc
Q 004660          597 LRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       597 ~~DP~kRp-----Ta~elLqHpwf~~~~~  620 (739)
                      ..||++|+     ++.++++|+||....+
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999999     8999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-49  Score=400.26  Aligned_cols=261  Identities=27%  Similarity=0.437  Sum_probs=234.4

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ....++|++.++||+|.|+.||++.++.+|+.+|+|+|...+-...   ..+.+++|+.|.+.|+|||||++++.+..++
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~---~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQEES   83 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc---cHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence            4556789999999999999999999999999999999875433222   3467899999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC---CCcEEEeecccchh
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKH  504 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~---~g~vKL~DFGlA~~  504 (739)
                      ..|||+|++.|++|..-|.++ ..++|..+..+++||+.||.|||.+||||||+||+|+|+..   ..-|||+|||+|..
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999999999998888665 56899999999999999999999999999999999999953   34699999999999


Q ss_pred             ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCC----
Q 004660          505 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI----  580 (739)
Q Consensus       505 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~i----  580 (739)
                      +.+......+.|||.|||||+++       ...|+..+|||+.|||||.||.|.+||.+.+...++..|+.+...+    
T Consensus       163 l~~g~~~~G~~GtP~fmaPEvvr-------kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~  235 (355)
T KOG0033|consen  163 VNDGEAWHGFAGTPGYLSPEVLK-------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE  235 (355)
T ss_pred             eCCccccccccCCCcccCHHHhh-------cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc
Confidence            98777777899999999999998       3578899999999999999999999999988889999998776544    


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      +..+++++++||++||..||.+|+|+.|+|+|||+.+..
T Consensus       236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  236 WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            457899999999999999999999999999999998643

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-48  Score=417.41  Aligned_cols=269  Identities=28%  Similarity=0.449  Sum_probs=230.3

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc---------ccHHHHHHHHHHHHHHhhcCCCCeEe
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---------KSAECIKQLEQEIKVLGHLKHENIVQ  418 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~---------~~~~~~k~l~~Ei~iL~~L~HPNIVk  418 (739)
                      ....++|++++.||+|.||+|.+|++..+++.||||++.+.+...         ....-++++.+||.||++|+|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            344578999999999999999999999999999999996433211         11112457889999999999999999


Q ss_pred             eccceeec--ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEE
Q 004660          419 YYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL  496 (739)
Q Consensus       419 l~~~~~~~--~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL  496 (739)
                      |+++..+.  +.+|||+|||..|.+...-.. ...+++.+++.|+++++.||+|||.+|||||||||.|+||+.+|+|||
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence            99987654  679999999999988765433 233999999999999999999999999999999999999999999999


Q ss_pred             eecccchhccC------cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHH
Q 004660          497 ADFGMAKHLTG------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM  570 (739)
Q Consensus       497 ~DFGlA~~~~~------~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~  570 (739)
                      +|||.+..+..      .......+|||.|||||...+..   ...+.+.+.|||||||+||.|+.|+.||-+....+..
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~---~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN---SFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC---CccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            99999987622      22333478999999999987521   1346678999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCcc--CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          571 FKVLNRTPPIPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       571 ~~i~~~~~~iP~~--ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      .+|++....+|..  +.++++|||++||.+||++|+++.+|..|||......
T Consensus       329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            9999998888876  7999999999999999999999999999999986533

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9e-47  Score=395.70  Aligned_cols=259  Identities=24%  Similarity=0.384  Sum_probs=220.0

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .|++.+.||+|+||+||+|.++.+|+.||||.+......  .......+.+|+.+|+.++|+||+++++++..++.+++|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence            388999999999999999999999999999988642211  122234577899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          433 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      |||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV  158 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence            9999999999888543 246899999999999999999999999999999999999999999999999999876544444


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchH----HHHHHhhcCCCCCccCCHH
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ----AMFKVLNRTPPIPEMLSSE  587 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~----~~~~i~~~~~~iP~~ls~e  587 (739)
                      ....||..|+|||++.+       ..++.++|||||||++|||++|+.||.......    ....+......++..++.+
T Consensus       159 ~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (285)
T cd05631         159 RGRVGTVGYMAPEVINN-------EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSED  231 (285)
T ss_pred             cCCCCCCCccCHhhhcC-------CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHH
Confidence            45679999999999863       467789999999999999999999998654422    2222334445677789999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHcCcccccccc
Q 004660          588 GKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANY  620 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpT-----a~elLqHpwf~~~~~  620 (739)
                      +.+||++||..||++|++     ++++++||||...++
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         232 AKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             HHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence            999999999999999997     899999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-47  Score=401.24  Aligned_cols=260  Identities=28%  Similarity=0.435  Sum_probs=224.3

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee--cc
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DD  427 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~--~~  427 (739)
                      ..++|++++.|++|+||.||+|+++.|++.||+|+++..+....-.   -.-.+||.+|.+++|||||.+-++.+-  -+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP---ItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP---ITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc---chhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            3457999999999999999999999999999999998654332222   235679999999999999999987654  35


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+|||||||+ -||..++......+...+++.++.|+++||+|||.+.|+|||||++|+|++..|.+||+|||||+.+..
T Consensus       151 ~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  151 KIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            6999999997 789999988877899999999999999999999999999999999999999999999999999999876


Q ss_pred             cc-cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC--------
Q 004660          508 LS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------  578 (739)
Q Consensus       508 ~~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~--------  578 (739)
                      .. ..+..+.|.||+|||+|.+      ...|+.++||||+||||.||+++++.|.+..+.+.+.+|+....        
T Consensus       230 p~k~~T~lVVTLWYRaPELLLG------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  230 PLKPYTPLVVTLWYRAPELLLG------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             CcccCcceEEEeeecCHHHhcC------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence            43 3445678999999999996      57889999999999999999999999999888888777754110        


Q ss_pred             ---C--------------------CCcc-CCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          579 ---P--------------------IPEM-LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       579 ---~--------------------iP~~-ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                         .                    ++.. +++...+|+..+|..||++|.||.|.|+|.||.+..
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence               0                    1111 568999999999999999999999999999998754

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=7.7e-46  Score=401.39  Aligned_cols=261  Identities=31%  Similarity=0.493  Sum_probs=215.5

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      .....+|+++++||+|+||+||+|+++.+|+.||||++...    ......+.+.+|+++|+.++|+|||++++++..++
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  145 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG  145 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC----CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence            34456799999999999999999999999999999998632    22344567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+|+||||+.+|+|....     ...+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus       146 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             eEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            999999999999987542     356788889999999999999999999999999999999999999999999987643


Q ss_pred             cc-cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchH---HHHHH-hhcCCCCCc
Q 004660          508 LS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ---AMFKV-LNRTPPIPE  582 (739)
Q Consensus       508 ~~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~---~~~~i-~~~~~~iP~  582 (739)
                      .. ......||..|+|||++.....  .....+.++|||||||+||||++|+.||......+   ....+ .......+.
T Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
T PLN00034        221 TMDPCNSSVGTIAYMSPERINTDLN--HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPA  298 (353)
T ss_pred             ccccccccccCccccCccccccccc--cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCC
Confidence            22 2234579999999998753211  12345678999999999999999999997433222   22222 233445667


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      .++.++++||.+||..||++|||+.|+|+|+||....
T Consensus       299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        299 TASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            7899999999999999999999999999999998653

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-46  Score=406.70  Aligned_cols=260  Identities=28%  Similarity=0.464  Sum_probs=228.7

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCC-cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg-~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ....+|++.+.||+|+||.||+|.++.++ ..||+|++.....  ........+.+|+.+|+.++|||||++++++..++
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            44568999999999999999999977655 6899998864211  12233567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+||||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+..
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999999999765 5699999999999999999999999999999999999999999999999999986643


Q ss_pred             cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHH
Q 004660          508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE  587 (739)
Q Consensus       508 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~e  587 (739)
                      .  .....||+.|||||++.+       ..++.++|||||||++|||++|+.||...+.......+......+|..++.+
T Consensus       184 ~--~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  254 (340)
T PTZ00426        184 R--TYTLCGTPEYIAPEILLN-------VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNN  254 (340)
T ss_pred             C--cceecCChhhcCHHHHhC-------CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence            2  235679999999999973       3567899999999999999999999998887777888888888889999999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 004660          588 GKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRp-----Ta~elLqHpwf~~~~~  620 (739)
                      ++++|++||..||++|+     +++++++||||.+..+
T Consensus       255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             HHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999999999999995     8999999999987554

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-46  Score=404.49  Aligned_cols=253  Identities=28%  Similarity=0.479  Sum_probs=222.2

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecC
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  437 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~  437 (739)
                      ++||+|+||+||+|+++.+|+.||||++.....  ........+.+|+.+|+.++||||+++++++..++.+||||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            479999999999999999999999999874211  123345678889999999999999999999999999999999999


Q ss_pred             CCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccCC
Q 004660          438 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKG  516 (739)
Q Consensus       438 gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~G  516 (739)
                      +|+|..++... ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ........|
T Consensus        79 ~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  157 (328)
T cd05593          79 GGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG  157 (328)
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence            99999988664 5699999999999999999999999999999999999999999999999999876432 222334679


Q ss_pred             CCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHhc
Q 004660          517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF  596 (739)
Q Consensus       517 T~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kcL  596 (739)
                      |+.|+|||++.+       ..++.++|||||||+||||++|+.||...+..+....+......+|..++.++.+||.+||
T Consensus       158 t~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (328)
T cd05593         158 TPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLL  230 (328)
T ss_pred             CcCccChhhhcC-------CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHc
Confidence            999999999863       4567899999999999999999999988777777777777777888999999999999999


Q ss_pred             ccCCCCCC-----CHHHHHcCcccccccc
Q 004660          597 LRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       597 ~~DP~kRp-----Ta~elLqHpwf~~~~~  620 (739)
                      .+||++|+     ++.|+++|+||....+
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99999997     8999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-46  Score=400.22  Aligned_cols=250  Identities=30%  Similarity=0.457  Sum_probs=220.5

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecCCC
Q 004660          360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  439 (739)
Q Consensus       360 LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~gG  439 (739)
                      ||+|+||+||+|+++.+++.||+|++....  .........+.+|+.+|++++|||||++++++..++.+|+||||+.+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH--IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            799999999999999999999999986321  112334567788999999999999999999999999999999999999


Q ss_pred             CcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccCCCC
Q 004660          440 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSP  518 (739)
Q Consensus       440 sL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~GT~  518 (739)
                      +|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ........||+
T Consensus        79 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  157 (312)
T cd05585          79 ELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP  157 (312)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence            999999764 5699999999999999999999999999999999999999999999999999976432 22233467999


Q ss_pred             CCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHhccc
Q 004660          519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR  598 (739)
Q Consensus       519 ~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kcL~~  598 (739)
                      .|+|||++.+       ..++.++|||||||++|||++|+.||......+....++.....++..++.++++||.+||..
T Consensus       158 ~y~aPE~~~~-------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  230 (312)
T cd05585         158 EYLAPELLLG-------HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             ccCCHHHHcC-------CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCC
Confidence            9999999863       457789999999999999999999999888888888888888888999999999999999999


Q ss_pred             CCCCCC---CHHHHHcCccccccc
Q 004660          599 NPVERP---SAVELLEHPFIRNAN  619 (739)
Q Consensus       599 DP~kRp---Ta~elLqHpwf~~~~  619 (739)
                      ||++|+   ++.|+|+||||....
T Consensus       231 dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         231 DPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             CHHHcCCCCCHHHHHcCCCcCCCC
Confidence            999997   589999999998643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.4e-46  Score=407.15  Aligned_cols=259  Identities=29%  Similarity=0.460  Sum_probs=219.8

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++++.||+|+||+||+|+++.+++.||||++....  ....+....+.+|+.++..++|+||+++++.+.+++.+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD--MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            36999999999999999999999999999999986421  1223345678889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~--  509 (739)
                      ||||++||+|.+++.+. +.+++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+....  
T Consensus        79 v~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          79 IMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            99999999999999765 579999999999999999999999999999999999999999999999999987543210  


Q ss_pred             ----------------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHh
Q 004660          510 ----------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML  555 (739)
Q Consensus       510 ----------------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELL  555 (739)
                                                        .....+||+.|+|||++.+       ..++.++|||||||+||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-------TGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-------CCCCCchhhhhhHHHHHHHH
Confidence                                              0124579999999999863       45778999999999999999


Q ss_pred             hCCCCCCCCCchHHHHHHhhc--CCCCCc--cCCHHHHHHHHHhcccCCC---CCCCHHHHHcCccccccccC
Q 004660          556 TGKPPWSEFEGPQAMFKVLNR--TPPIPE--MLSSEGKDFLLRCFLRNPV---ERPSAVELLEHPFIRNANYQ  621 (739)
Q Consensus       556 tGk~PF~~~~~~~~~~~i~~~--~~~iP~--~ls~el~dLI~kcL~~DP~---kRpTa~elLqHpwf~~~~~~  621 (739)
                      +|+.||......+...+++..  ...+|.  .+++++++||.+|+. +|+   .||+++|+++||||+..++.
T Consensus       231 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~  302 (363)
T cd05628         231 IGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE  302 (363)
T ss_pred             hCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence            999999988777777777653  233443  468999999999875 454   45899999999999876654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-46  Score=407.58  Aligned_cols=259  Identities=30%  Similarity=0.500  Sum_probs=221.2

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.....  ........+.+|+.+|+.++|+||+++++++.+++.+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM--LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence            369999999999999999999999999999999874211  123345678889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~--  509 (739)
                      ||||+.||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+....  
T Consensus        79 v~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          79 IMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             EECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            99999999999999765 569999999999999999999999999999999999999999999999999987542211  


Q ss_pred             -------------------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHH
Q 004660          510 -------------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI  552 (739)
Q Consensus       510 -------------------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLy  552 (739)
                                                           .....+||+.|+|||++.+       ..++.++|||||||++|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~  230 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-------TGYNKECDWWSLGVIMY  230 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-------CCCCCeeeeecchhHHH
Confidence                                                 0113469999999999863       45778999999999999


Q ss_pred             HHhhCCCCCCCCCchHHHHHHhhcC--CCCCc--cCCHHHHHHHHHhcccCCCCCCC---HHHHHcCccccccccC
Q 004660          553 EMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE--MLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANYQ  621 (739)
Q Consensus       553 ELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~--~ls~el~dLI~kcL~~DP~kRpT---a~elLqHpwf~~~~~~  621 (739)
                      ||++|..||......+....++...  ..+|.  .+++++++||.+||. +|.+|++   +.|+|+||||+...+.
T Consensus       231 el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         231 EMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             HhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            9999999999887777776666432  23333  468999999999996 9999998   9999999999876543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.3e-46  Score=389.26  Aligned_cols=253  Identities=26%  Similarity=0.432  Sum_probs=211.1

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.....   .....+.+.+|+.+++.++|+||+++++++..++.+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE---NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc---cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence            369999999999999999999999999999999874322   12334567889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~--  509 (739)
                      ||||+.++.|..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....  
T Consensus        78 v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          78 VFEYVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            999999887765543 34569999999999999999999999999999999999999999999999999998764322  


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCC----------
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP----------  579 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~----------  579 (739)
                      ......||+.|+|||++.+       ..++.++|||||||++|||++|+.||......+....+.....+          
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         157 NYTEYVATRWYRSPELLLG-------APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccccccccCCcHHHcC-------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            2223568999999999863       34678999999999999999999999876554443332211000          


Q ss_pred             ----------------------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          580 ----------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       580 ----------------------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                                            ....++.++++||++||..||++|||++|+|+||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                                  012367889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-46  Score=402.63  Aligned_cols=266  Identities=30%  Similarity=0.559  Sum_probs=233.3

Q ss_pred             CCCCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       346 ~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      .+....+.|.+.++||.|.-++||+|+...+++.||||++.+.+.    ...++.+.+|+..|..++|||||+++..|..
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc----~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv   95 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC----NNDLDALRKEVQTMSLIDHPNIVTYHCSFVV   95 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh----hhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence            567778899999999999999999999999999999999986332    2236788999999999999999999999999


Q ss_pred             cceEEEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          426 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      +..+|+||.||.+|++.++++.. ...+.|..|..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+-.
T Consensus        96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen   96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSAS  175 (516)
T ss_pred             cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeee
Confidence            99999999999999999999764 34599999999999999999999999999999999999999999999999998755


Q ss_pred             ccCc-c---cc-cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCC
Q 004660          505 LTGL-S---YE-LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP  579 (739)
Q Consensus       505 ~~~~-~---~~-~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~  579 (739)
                      +... .   .. .+++||++|||||++...     ...|+.|+||||||++..||.+|..||..+...+++...+++.++
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~-----~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp  250 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQ-----LHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP  250 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhhhc-----ccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence            4321 1   11 467899999999997532     346889999999999999999999999999999888877777665


Q ss_pred             CC----------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          580 IP----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       580 iP----------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      .+          ..++..++++|..||++||.+||||+++|+|+||+....
T Consensus       251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            32          236778999999999999999999999999999987654

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.9e-46  Score=390.68  Aligned_cols=254  Identities=26%  Similarity=0.435  Sum_probs=213.0

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ..+|++.++||.|+||+||+|+++.++..||+|+++......    ....+.+|+.+|+.++|+||+++++++..++..|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKNLKHANIVTLHDIIHTERCLT   79 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC----cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            457999999999999999999999999999999986432221    1235678999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      +||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        80 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          80 LVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            9999998 48999887665668999999999999999999999999999999999999999999999999997653322 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-----------
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----------  578 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-----------  578 (739)
                      ......||+.|+|||++.+      ...++.++|||||||++|||++|+.||.+....+.+..+.....           
T Consensus       159 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLG------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             cccCceecccccChHHhcC------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            2234568999999999863      34577899999999999999999999988766555544332100           


Q ss_pred             --------CC-----------CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          579 --------PI-----------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       579 --------~i-----------P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                              .+           ...++.++++||.+||..||.+|+|++|+|+||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                    01           12467899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-47  Score=406.32  Aligned_cols=257  Identities=25%  Similarity=0.493  Sum_probs=235.2

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ..+-+|++.+.||.|+||+|.+|+....|+.||||.|++.+  -+....+-.+.+||+||..|+||||+++|++|+..+.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk--IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK--IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK  127 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh--cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence            34568999999999999999999999999999999887533  2344556779999999999999999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      +.|||||..+|+|++||.+. +.|+|.+++.|++||+.|+.|||+++++|||||.+|||||.++++||+||||+..+...
T Consensus       128 IvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            99999999999999999875 77999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHH
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG  588 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el  588 (739)
                      .+..++||++-|.+||+++|      .++-+..+|-|||||+||.|+.|..||++.+...++.+|-.+...-|+ .+.++
T Consensus       207 kfLqTFCGSPLYASPEIvNG------~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA  279 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNG------TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDA  279 (668)
T ss_pred             cHHHHhcCCcccCCccccCC------CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchH
Confidence            99999999999999999985      677788999999999999999999999999998888888877665555 45677


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      .-||+.||..||++|.|+++|..|=|+
T Consensus       280 ~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  280 SGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             HHHHHHHHhcCcccchhHHHHhhhhee
Confidence            899999999999999999999999665

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.7e-46  Score=392.49  Aligned_cols=258  Identities=25%  Similarity=0.442  Sum_probs=211.4

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ..+|++.+.||+|+||+||+|+++.+++.||||++........    ...+.+|+.+|+.++||||+++++++..++..|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT----PFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc----chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence            4679999999999999999999999999999999874322211    234667999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-c
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~-~  509 (739)
                      +||||+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            9999996 6788888766667999999999999999999999999999999999999999999999999998754322 2


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchH-HHHHHh---hcCC-------
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKVL---NRTP-------  578 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~-~~~~i~---~~~~-------  578 (739)
                      ......||+.|+|||++.+      ...++.++|||||||++|||++|+.||.+..... .+..+.   ....       
T Consensus       159 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLG------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             cCCCCcccCCCCChHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence            2234568999999999863      3457789999999999999999999998754432 222221   1000       


Q ss_pred             -C------------CC---------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          579 -P------------IP---------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       579 -~------------iP---------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                       .            .+         ..++.++++||.+||+.||++|+|+.|+|+||||+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence             0            00         01356889999999999999999999999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=411.64  Aligned_cols=261  Identities=29%  Similarity=0.492  Sum_probs=234.5

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeec
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD  426 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~  426 (739)
                      ......|++++.||+|.||.||+|+.+.+|+.||+|++.+.....  ......+.+|+.||++|. |||||+++++|++.
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~--~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG--KEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc--cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            445668999999999999999999999999999999997543322  224567889999999998 99999999999999


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC----CcEEEeecccc
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----GVVKLADFGMA  502 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~----g~vKL~DFGlA  502 (739)
                      +.+|+|||+|.||+|++.|...  .++|.++..+++||+.|+.|||+.||+||||||+|||+...    +.+||+|||++
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            9999999999999999999876  39999999999999999999999999999999999999643    47999999999


Q ss_pred             hhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCC---
Q 004660          503 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---  579 (739)
Q Consensus       503 ~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~---  579 (739)
                      ............+||+.|+|||++.       ...|+..+||||+|+++|.|++|..||.+........++..+...   
T Consensus       187 ~~~~~~~~~~~~~Gtp~y~APEvl~-------~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~  259 (382)
T KOG0032|consen  187 KFIKPGERLHTIVGTPEYVAPEVLG-------GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS  259 (382)
T ss_pred             eEccCCceEeeecCCccccCchhhc-------CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC
Confidence            9988866777899999999999997       357889999999999999999999999999988888888877544   


Q ss_pred             -CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          580 -IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       580 -iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                       .+..++..+++||.+||..||.+|+|+.++|+|||++...
T Consensus       260 ~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  260 EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence             3456899999999999999999999999999999998753

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-46  Score=402.87  Aligned_cols=258  Identities=31%  Similarity=0.525  Sum_probs=223.8

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++++.||+|+||+||+|++..+|+.||||++.....  ........+.+|+++|..++|+||+++++++.+++.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            369999999999999999999999999999999874211  112345678889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~--  509 (739)
                      ||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....  
T Consensus        79 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          79 VMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            99999999999999775 679999999999999999999999999999999999999999999999999997664432  


Q ss_pred             ----------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCC
Q 004660          510 ----------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW  561 (739)
Q Consensus       510 ----------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF  561 (739)
                                                  ......||+.|+|||++.+       ..++.++||||||||||||++|+.||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-------TPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCceeeEecchhhhhhccCCCCC
Confidence                                        2234569999999999874       36788999999999999999999999


Q ss_pred             CCCCchHHHHHHhh--cCCCCCc--cCCHHHHHHHHHhcccCCCCCCC-HHHHHcCcccccccc
Q 004660          562 SEFEGPQAMFKVLN--RTPPIPE--MLSSEGKDFLLRCFLRNPVERPS-AVELLEHPFIRNANY  620 (739)
Q Consensus       562 ~~~~~~~~~~~i~~--~~~~iP~--~ls~el~dLI~kcL~~DP~kRpT-a~elLqHpwf~~~~~  620 (739)
                      ......+...++..  ....+|.  .+++++.+||.+||. ||.+|++ +.++|+||||+...+
T Consensus       231 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~  293 (350)
T cd05573         231 YSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW  293 (350)
T ss_pred             CCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence            98887777777765  3334443  359999999999997 9999999 999999999987554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.7e-46  Score=402.21  Aligned_cols=253  Identities=30%  Similarity=0.472  Sum_probs=221.9

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecC
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  437 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~  437 (739)
                      ++||+|+||+||+++++.+|..||+|+++....  ........+.+|+++|+.++||||+++++++..++.+||||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            479999999999999999999999999874211  122345667789999999999999999999999999999999999


Q ss_pred             CCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccCC
Q 004660          438 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKG  516 (739)
Q Consensus       438 gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~G  516 (739)
                      +|+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ........|
T Consensus        79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  157 (323)
T cd05595          79 GGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence            99999888664 5689999999999999999999999999999999999999999999999999876432 222234679


Q ss_pred             CCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHhc
Q 004660          517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF  596 (739)
Q Consensus       517 T~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kcL  596 (739)
                      |+.|+|||++.+       ..++.++|||||||++|||++|+.||...+.......+......+|..+++++.+||.+||
T Consensus       158 t~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05595         158 TPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             CcCcCCcccccC-------CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence            999999999863       4567899999999999999999999988877777777777777888899999999999999


Q ss_pred             ccCCCCCC-----CHHHHHcCcccccccc
Q 004660          597 LRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       597 ~~DP~kRp-----Ta~elLqHpwf~~~~~  620 (739)
                      ..||++|+     ++.++++|+||....+
T Consensus       231 ~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         231 KKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             cCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999998     8999999999987554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-47  Score=411.19  Aligned_cols=262  Identities=27%  Similarity=0.483  Sum_probs=244.6

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...-|.+.+.||+|-|++|.+|++--||+.||||+|++.+.+...   ..++..|++.|+.++|||||++|++......+
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s---t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS---TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh---hhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence            345799999999999999999999999999999999876655433   35788899999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEec-CCCcEEEeecccchhccCc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd-~~g~vKL~DFGlA~~~~~~  508 (739)
                      |||+|+-++|+|++||-++...+.|..++.|+.||+.|+.|||...||||||||+|+++- .-|.|||.|||++..+...
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999999999999999888999999999999999999999999999999999998764 5699999999999999888


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHH
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG  588 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el  588 (739)
                      ....+.+|+..|-|||+|.|      +.+..+++||||||||||.|++|++||...+..+.+-.|+.-...+|..++.++
T Consensus       173 ~kL~TsCGSLAYSAPEILLG------DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eC  246 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLG------DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKEC  246 (864)
T ss_pred             chhhcccchhhccCchhhhc------CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHH
Confidence            88889999999999999995      667778999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      +|||..||.+||++|.+.++|..++|++..+.
T Consensus       247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            99999999999999999999999999997654

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.5e-46  Score=398.21  Aligned_cols=255  Identities=29%  Similarity=0.502  Sum_probs=221.1

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHH---hhcCCCCeEeeccceeecceEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL---GHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL---~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      |++.++||+|+||+||+|.++.+|+.||||+++....  ......+.+.+|++++   +.++||||+++++++...+.+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            7889999999999999999999999999999874211  1122334566666554   5678999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LS  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~  509 (739)
                      +||||+.||+|..++..  ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ..
T Consensus        79 lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          79 FVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence            99999999999988865  4699999999999999999999999999999999999999999999999999875432 22


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK  589 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~  589 (739)
                      ......||+.|||||++.+       ..++.++|||||||++|||++|+.||.+.+..+.+..+......+|..++.++.
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  229 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTE-------TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI  229 (324)
T ss_pred             cccccccCccccCHhHhcC-------CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            3335679999999999863       456789999999999999999999999888888888888887888889999999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHHcCccccccc
Q 004660          590 DFLLRCFLRNPVERP-----SAVELLEHPFIRNAN  619 (739)
Q Consensus       590 dLI~kcL~~DP~kRp-----Ta~elLqHpwf~~~~  619 (739)
                      +||.+||..||.+||     ++.++++|+||+...
T Consensus       230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             HHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            999999999999999     799999999997654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7e-46  Score=406.42  Aligned_cols=257  Identities=29%  Similarity=0.475  Sum_probs=216.7

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .|++++.||+|+||+||+|+++.+++.||||++....  .........+.+|+++|+.++|+|||++++++.+++.+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD--VLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence            6899999999999999999999999999999986421  12234456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc----
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL----  508 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~----  508 (739)
                      |||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...    
T Consensus        80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          80 MDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            9999999999999765 56899999999999999999999999999999999999999999999999997543100    


Q ss_pred             --------------------------------------------ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhh
Q 004660          509 --------------------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI  544 (739)
Q Consensus       509 --------------------------------------------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDI  544 (739)
                                                                  ......+||+.|+|||++.+       ..++.++||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~Di  231 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-------KGYTQLCDW  231 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-------CCCCCccce
Confidence                                                        01123579999999999863       457789999


Q ss_pred             hHHHHHHHHHhhCCCCCCCCCchHHHHHHhh--cCCCCCc--cCCHHHHHHHHHhcc--cCCCCCCCHHHHHcCcccccc
Q 004660          545 WSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPE--MLSSEGKDFLLRCFL--RNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       545 WSLGvVLyELLtGk~PF~~~~~~~~~~~i~~--~~~~iP~--~ls~el~dLI~kcL~--~DP~kRpTa~elLqHpwf~~~  618 (739)
                      |||||++|||++|+.||......+...+++.  ....+|.  .+++++++||.+||.  .++..|+++.++++||||+..
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            9999999999999999988776666666653  2334443  579999999999665  455569999999999999765


Q ss_pred             c
Q 004660          619 N  619 (739)
Q Consensus       619 ~  619 (739)
                      .
T Consensus       312 ~  312 (381)
T cd05626         312 D  312 (381)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.1e-46  Score=400.90  Aligned_cols=253  Identities=29%  Similarity=0.461  Sum_probs=221.3

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecC
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  437 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~  437 (739)
                      ++||+|+||+||+|+++.+|+.||+|++.....  ........+.+|+++++.++||||+++++++..++.+||||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            479999999999999999999999999874211  122334567789999999999999999999999999999999999


Q ss_pred             CCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004660          438 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK  515 (739)
Q Consensus       438 gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~  515 (739)
                      +|+|..++... ..+++..++.|+.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++.... ........
T Consensus        79 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (325)
T cd05594          79 GGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC  157 (325)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence            99999988664 569999999999999999999997 8999999999999999999999999999875432 22333467


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHh
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kc  595 (739)
                      ||+.|+|||++.+       ..++.++|||||||+||||++|+.||...+.......+......+|..++.++.+||.+|
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  230 (325)
T cd05594         158 GTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGL  230 (325)
T ss_pred             CCcccCCHHHHcc-------CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            9999999999863       456789999999999999999999998887777777777777888899999999999999


Q ss_pred             cccCCCCCC-----CHHHHHcCcccccccc
Q 004660          596 FLRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       596 L~~DP~kRp-----Ta~elLqHpwf~~~~~  620 (739)
                      |+.||++|+     ++.++|+|+||....+
T Consensus       231 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             hhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999997     9999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.1e-46  Score=397.13  Aligned_cols=259  Identities=29%  Similarity=0.502  Sum_probs=219.0

Q ss_pred             CceEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecce
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH  428 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k---~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~  428 (739)
                      +|++++.||+|+||+||+|++.   .+++.||+|++...... ......+.+.+|+.+|+.++ |+||+++++++..++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence            4899999999999999999864   47899999998642111 12233466788999999995 9999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      +|+||||+.+|+|.+++... ..+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            99999999999999999765 56999999999999999999999999999999999999999999999999999865332


Q ss_pred             c--cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC----chHHHHHHhhcCCCCCc
Q 004660          509 S--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE----GPQAMFKVLNRTPPIPE  582 (739)
Q Consensus       509 ~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~----~~~~~~~i~~~~~~iP~  582 (739)
                      .  ......||..|||||++.+      ...++.++||||||||||||++|+.||....    .......+......++.
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRG------KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS  232 (332)
T ss_pred             CCCccccccCCccccCHHHhcC------CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence            2  2234679999999999863      2346779999999999999999999996432    22344455666677888


Q ss_pred             cCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccccc
Q 004660          583 MLSSEGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNAN  619 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRp-----Ta~elLqHpwf~~~~  619 (739)
                      .++..+++||.+||..||++|+     +++++++||||+...
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            8999999999999999999999     889999999998654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.8e-46  Score=398.14  Aligned_cols=253  Identities=28%  Similarity=0.477  Sum_probs=220.7

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      ++||+|+||+||+|+++.+++.||||++.....  ......+.+..|+.++..+ +||||+++++++...+.+||||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            479999999999999999999999999863211  1122345667788888876 6999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~  515 (739)
                      .||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ........
T Consensus        79 ~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          79 NGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             CCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence            999999998765 5699999999999999999999999999999999999999999999999999875432 22333467


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHh
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kc  595 (739)
                      ||+.|+|||++.+       ..++.++|||||||++|||++|+.||...+..+.+..+......++..++.++++||.+|
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (320)
T cd05590         158 GTPDYIAPEILQE-------MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF  230 (320)
T ss_pred             cCccccCHHHHcC-------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            9999999999863       456789999999999999999999999988888888888888888889999999999999


Q ss_pred             cccCCCCCCCH------HHHHcCcccccccc
Q 004660          596 FLRNPVERPSA------VELLEHPFIRNANY  620 (739)
Q Consensus       596 L~~DP~kRpTa------~elLqHpwf~~~~~  620 (739)
                      |.+||++|+++      +++++||||+...+
T Consensus       231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             cccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999999998      99999999986543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.1e-46  Score=398.66  Aligned_cols=266  Identities=27%  Similarity=0.431  Sum_probs=226.3

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|.+.+.||+|+||+||+|+++.+|+.||||+++...  ....+..+.+.+|+.+++.++|+||+++++++..++.+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV--LLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence            36999999999999999999999999999999987421  1123345678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~-  510 (739)
                      ||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+..... 
T Consensus        79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            9999999999999987656799999999999999999999999999999999999999999999999999987643322 


Q ss_pred             -ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--CCCCc--cCC
Q 004660          511 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE--MLS  585 (739)
Q Consensus       511 -~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~--~ls  585 (739)
                       .....||+.|+|||++...... +...++.++|||||||++|||++|+.||........+.+++...  ..+|.  .++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGD-GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS  237 (330)
T ss_pred             eeecccCCccccCHHHhcccccc-ccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence             2234699999999998743211 23467789999999999999999999998877777777766432  23333  578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCccccccccC
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ  621 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~~  621 (739)
                      .++.+||.+||. ||.+|+|+.++++||||+...+.
T Consensus       238 ~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         238 SDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             HHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence            999999999998 99999999999999999876543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-46  Score=405.72  Aligned_cols=258  Identities=28%  Similarity=0.477  Sum_probs=218.0

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|+++++||+|+||+||+|+++.+|+.||||++....  ....+.++.+.+|+++|+.++|||||++++++.+++.+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE--MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            36999999999999999999999999999999986321  1123345678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~--  509 (739)
                      ||||+.||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....  
T Consensus        79 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          79 IMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            99999999999999764 569999999999999999999999999999999999999999999999999996432100  


Q ss_pred             ----------------------------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchh
Q 004660          510 ----------------------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD  543 (739)
Q Consensus       510 ----------------------------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asD  543 (739)
                                                                    .....+||+.|+|||++.+       ..++.++|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~D  230 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-------QGYGQECD  230 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-------CCCCCcee
Confidence                                                          0012469999999999863       45788999


Q ss_pred             hhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc--CCCCCc--cCCHHHHHHHHHhcccCCCCC---CCHHHHHcCcccc
Q 004660          544 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE--MLSSEGKDFLLRCFLRNPVER---PSAVELLEHPFIR  616 (739)
Q Consensus       544 IWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP~--~ls~el~dLI~kcL~~DP~kR---pTa~elLqHpwf~  616 (739)
                      |||||||||||++|..||......+.+..+...  ...+|.  .++.++++||.+||. +|.+|   +++.|+|+||||+
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~  309 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFR  309 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcC
Confidence            999999999999999999887776666666542  234444  478999999999997 77765   5999999999998


Q ss_pred             cccc
Q 004660          617 NANY  620 (739)
Q Consensus       617 ~~~~  620 (739)
                      ...+
T Consensus       310 ~~~~  313 (377)
T cd05629         310 GVDW  313 (377)
T ss_pred             CCCH
Confidence            6554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1e-45  Score=395.46  Aligned_cols=258  Identities=27%  Similarity=0.442  Sum_probs=224.6

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC-CCeEeeccceeecceEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~H-PNIVkl~~~~~~~~~l~L  431 (739)
                      +|++++.||+|+||.||+|+++.+++.||||++.....  ......+.+..|++++..+.| ++|+++++++..++.+|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            58999999999999999999999999999999874211  122334567789999999976 568899999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-Cccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSY  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~-~~~~  510 (739)
                      ||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.... ....
T Consensus        79 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          79 VMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence            99999999999999765 568999999999999999999999999999999999999999999999999987532 2223


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD  590 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~d  590 (739)
                      .....||+.|+|||++.+       ..++.++|||||||++|||++|+.||.+....+.+..+......+|..++.++.+
T Consensus       158 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS  230 (324)
T ss_pred             eeeecCCccccChhhhcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            334679999999999863       3567899999999999999999999998888888888888888888999999999


Q ss_pred             HHHHhcccCCCCCCCH-----HHHHcCcccccccc
Q 004660          591 FLLRCFLRNPVERPSA-----VELLEHPFIRNANY  620 (739)
Q Consensus       591 LI~kcL~~DP~kRpTa-----~elLqHpwf~~~~~  620 (739)
                      ||.+||.+||.+|+++     +++++||||+..++
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            9999999999999976     89999999987544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.6e-46  Score=396.44  Aligned_cols=252  Identities=28%  Similarity=0.451  Sum_probs=220.4

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      ++||+|+||+||+|+++.+++.||||++.....  ...+....+..|++++..+ +||||+++++++..++.+||||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            469999999999999999999999999864211  1223345667788888866 7999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~  515 (739)
                      ++|+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ........
T Consensus        79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          79 NGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence            999999998765 5699999999999999999999999999999999999999999999999999875432 22233467


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHh
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kc  595 (739)
                      ||+.|+|||++.+       ..++.++|||||||++|||++|+.||...+..+.+..+......+|..++.++.+||.+|
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~  230 (321)
T cd05591         158 GTPDYIAPEILQE-------LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAF  230 (321)
T ss_pred             cCccccCHHHHcC-------CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            9999999999863       457789999999999999999999999988888888888888888888999999999999


Q ss_pred             cccCCCCCC-------CHHHHHcCccccccc
Q 004660          596 FLRNPVERP-------SAVELLEHPFIRNAN  619 (739)
Q Consensus       596 L~~DP~kRp-------Ta~elLqHpwf~~~~  619 (739)
                      |.+||++|+       ++.++++||||....
T Consensus       231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             hccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence            999999999       999999999997644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.8e-46  Score=405.06  Aligned_cols=256  Identities=30%  Similarity=0.499  Sum_probs=217.7

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .|+++++||+|+||+||+|+++.+++.||||++...  ..........+.+|+++|++++|+|||++++++.+++.+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK--DVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHH--HhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            699999999999999999999999999999998632  112234456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc----
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL----  508 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~----  508 (739)
                      ||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+...    
T Consensus        80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          80 MDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            9999999999999765 56899999999999999999999999999999999999999999999999997533100    


Q ss_pred             --------------------------------------------ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhh
Q 004660          509 --------------------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI  544 (739)
Q Consensus       509 --------------------------------------------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDI  544 (739)
                                                                  ......+||+.|+|||++.+       ..++.++||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~Di  231 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-------TGYTQLCDW  231 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-------CCCCCeeeE
Confidence                                                        00123569999999999863       457789999


Q ss_pred             hHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--CCCC--ccCCHHHHHHHHHhcccCCCCCCC---HHHHHcCccccc
Q 004660          545 WSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP--EMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRN  617 (739)
Q Consensus       545 WSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP--~~ls~el~dLI~kcL~~DP~kRpT---a~elLqHpwf~~  617 (739)
                      |||||+||||++|+.||...+..+...++....  ..+|  ..+++++++||.+|+ .+|++|++   +.++++||||+.
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  310 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT  310 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence            999999999999999999877766666665432  2333  457999999999976 59999997   999999999986


Q ss_pred             cc
Q 004660          618 AN  619 (739)
Q Consensus       618 ~~  619 (739)
                      ..
T Consensus       311 ~~  312 (382)
T cd05625         311 ID  312 (382)
T ss_pred             cC
Confidence            54

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-46  Score=396.98  Aligned_cols=257  Identities=29%  Similarity=0.489  Sum_probs=221.2

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++++.||+|+||.||+|+++.+++.||||+++....  ........+.+|+++|..++||||+++++++..++.+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence            469999999999999999999999999999999874211  122345678889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      ||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....  ..
T Consensus        79 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~  155 (333)
T cd05600          79 AMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YA  155 (333)
T ss_pred             EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--cc
Confidence            99999999999999764 5689999999999999999999999999999999999999999999999999976644  23


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--CCCCc------c
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE------M  583 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~------~  583 (739)
                      ....||+.|+|||++.+       ..++.++|||||||+||||++|..||......+....+....  ...|.      .
T Consensus       156 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  228 (333)
T cd05600         156 NSVVGSPDYMAPEVLRG-------KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN  228 (333)
T ss_pred             CCcccCccccChhHhcC-------CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccc
Confidence            35679999999999873       367789999999999999999999998877666655554321  11121      4


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      ++.++.+||.+||..+|.+|+++.++++|+||....+
T Consensus       229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         229 LSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             cCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence            5899999999999999999999999999999987544

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-46  Score=401.41  Aligned_cols=267  Identities=27%  Similarity=0.452  Sum_probs=235.8

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ......|++++.||.|.-|+||+|+.+.++..+|||++++...  ....-+.+++.|-+||+.++||.++.||..|+.++
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l--~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL--ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH--hhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            4455679999999999999999999999999999999974221  22444677888999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          428 HLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      ..|++||||.||+|+.+++++ .+.+++..++.|+..++.||+|||-+|||+|||||+||||.++|+|.|.||.|+....
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            999999999999999999775 5679999999999999999999999999999999999999999999999999873210


Q ss_pred             ----------------------------------C-c----------------------ccccccCCCCCCCChHHHHHh
Q 004660          507 ----------------------------------G-L----------------------SYELSLKGSPNWMAPEVIKAV  529 (739)
Q Consensus       507 ----------------------------------~-~----------------------~~~~s~~GT~~Y~APEvl~~~  529 (739)
                                                        . .                      ....+++||-.|+|||++.| 
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-  309 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-  309 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence                                              0 0                      11124779999999999985 


Q ss_pred             hhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCc--cCCHHHHHHHHHhcccCCCCCCC--
Q 004660          530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE--MLSSEGKDFLLRCFLRNPVERPS--  605 (739)
Q Consensus       530 ~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~--~ls~el~dLI~kcL~~DP~kRpT--  605 (739)
                            ...+.++|+|+|||+|||||.|..||.+.+..+.+.+|+.....+|+  .++..++|||+++|.+||.+|+.  
T Consensus       310 ------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~  383 (459)
T KOG0610|consen  310 ------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK  383 (459)
T ss_pred             ------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc
Confidence                  35677999999999999999999999999999999999999888876  46799999999999999999998  


Q ss_pred             --HHHHHcCccccccccCCC
Q 004660          606 --AVELLEHPFIRNANYQNL  623 (739)
Q Consensus       606 --a~elLqHpwf~~~~~~~~  623 (739)
                        |.||-+||||+..+|.-+
T Consensus       384 rGA~eIK~HpFF~gVnWaLi  403 (459)
T KOG0610|consen  384 RGAAEIKRHPFFEGVNWALI  403 (459)
T ss_pred             cchHHhhcCccccCCChhhe
Confidence              999999999999988643

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-46  Score=405.00  Aligned_cols=255  Identities=32%  Similarity=0.564  Sum_probs=220.9

Q ss_pred             CCCCCCCceEeeEEeecCCeEEEEEEECCCCcE-EEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS-CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       347 ~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~-VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      .........+.+.||+|+||+||+|.++  |.. ||||++.....+   .+..+.|.+|+.+|.+|+|||||+++|++..
T Consensus        36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~---~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFD---DESRKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcC---hHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            3444556677788999999999999998  455 999988643222   2227889999999999999999999999988


Q ss_pred             cc-eEEEEEeecCCCCcchhhhh-ccccccHHHHHHHHHhHHHHHHHHHhCC-eecccCCCcceEecCCC-cEEEeeccc
Q 004660          426 DD-HLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTN-TIHRDIKGANLLVDASG-VVKLADFGM  501 (739)
Q Consensus       426 ~~-~l~LVmEy~~gGsL~~~L~~-~~~~lse~~i~~i~~QLl~aL~yLHs~G-IvHRDIKP~NILLd~~g-~vKL~DFGl  501 (739)
                      .. .++|||||+++|+|.+++.. ....++...+..|+.||++||+|||+++ |||||||++||||+.++ ++||+|||+
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            87 79999999999999999987 3678999999999999999999999999 99999999999999998 999999999


Q ss_pred             chhccCc-ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHh--hcCC
Q 004660          502 AKHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTP  578 (739)
Q Consensus       502 A~~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~--~~~~  578 (739)
                      ++..... .......||+.|||||++.+.     ...|+.++||||||+|||||+||+.||.+....+....+.  +..+
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~-----~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp  265 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGE-----KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP  265 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCC-----CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            9877553 233336899999999999842     3578999999999999999999999999988877666664  4567


Q ss_pred             CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       579 ~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .+|..+++.+..||++||..||.+||++.+++.
T Consensus       266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            788889999999999999999999999999885

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-45  Score=390.30  Aligned_cols=258  Identities=26%  Similarity=0.473  Sum_probs=208.8

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec-----c
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-----D  427 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~-----~  427 (739)
                      +|++.++||+|+||.||+|+++.+|..||||++.....   .......+.+|+++|+.++||||+++++++...     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   77 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK   77 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc---cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence            59999999999999999999999999999998863211   122235678899999999999999999987543     3


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        78 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          78 DIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             eEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            5899999995 7898888664 5699999999999999999999999999999999999999999999999999976532


Q ss_pred             cc----cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh--------
Q 004660          508 LS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--------  575 (739)
Q Consensus       508 ~~----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~--------  575 (739)
                      ..    ......||+.|+|||++.+.     ...++.++|||||||++|||++|+.||.+.+....+..+..        
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE  230 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhcc-----ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            21    12345799999999998631     24577899999999999999999999977554332221110        


Q ss_pred             ------------------cCCCC-----CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          576 ------------------RTPPI-----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       576 ------------------~~~~i-----P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                                        .....     ...+++++.+||.+||..||++|||++|+|+||||+....
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                              00000     1236788999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.4e-46  Score=396.01  Aligned_cols=254  Identities=31%  Similarity=0.475  Sum_probs=220.5

Q ss_pred             eeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          357 GKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k---~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      +++||+|+||+||+|++.   .+++.||||+++..... ........+.+|+.+|+.++||||+++++++..++.+|+||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH-hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence            368999999999999864   47899999998742111 11223456788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-ccccc
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYEL  512 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~  512 (739)
                      ||+.||+|.+++... +.+.+..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... .....
T Consensus        80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          80 EYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             eCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence            999999999999765 5688999999999999999999999999999999999999999999999999875432 23333


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHH
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL  592 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI  592 (739)
                      ...||+.|+|||++.+       ..++.++|||||||+||||++|+.||...+....+..+......+|..++.++.+||
T Consensus       159 ~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  231 (323)
T cd05584         159 TFCGTIEYMAPEILMR-------SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLL  231 (323)
T ss_pred             ccCCCccccChhhccC-------CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            4679999999999863       346779999999999999999999999888888888888888888999999999999


Q ss_pred             HHhcccCCCCCC-----CHHHHHcCccccccc
Q 004660          593 LRCFLRNPVERP-----SAVELLEHPFIRNAN  619 (739)
Q Consensus       593 ~kcL~~DP~kRp-----Ta~elLqHpwf~~~~  619 (739)
                      .+||.+||++|+     +++++++||||....
T Consensus       232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             HHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence            999999999999     899999999998654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-45  Score=393.30  Aligned_cols=258  Identities=26%  Similarity=0.411  Sum_probs=224.8

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecceEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~l~L  431 (739)
                      +|++++.||+|+||+||+|+++.+++.||||++....  .........+..|..++..+ +|++|+++++++...+.+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            4899999999999999999999999999999987421  11223345567788888877 48999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-ccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSY  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~  510 (739)
                      ||||+.+|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ...
T Consensus        79 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          79 VMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence            99999999999998765 5699999999999999999999999999999999999999999999999999975432 223


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD  590 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~d  590 (739)
                      .....||+.|+|||++.+       ..++.++|||||||++|||++|+.||.+.+..+.+..+......+|..++.++.+
T Consensus       158 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  230 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  230 (323)
T ss_pred             cccCCCChhhcCHHHhcC-------CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence            335679999999999863       4578899999999999999999999999888888888888888888999999999


Q ss_pred             HHHHhcccCCCCCCC-----HHHHHcCcccccccc
Q 004660          591 FLLRCFLRNPVERPS-----AVELLEHPFIRNANY  620 (739)
Q Consensus       591 LI~kcL~~DP~kRpT-----a~elLqHpwf~~~~~  620 (739)
                      ||.+||++||.+|++     ..++++|+||+..++
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999999999997     489999999986553

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-45  Score=395.85  Aligned_cols=253  Identities=27%  Similarity=0.477  Sum_probs=215.8

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      ++||+|+||+||+|+++.+++.||||+++...  ....+..+.+.+|+.++..+ +||||+++++++..++.+||||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL--VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            47999999999999999999999999987421  12233456688899999988 6999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-CcccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~-~~~~~~s~~  515 (739)
                      +||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++... .........
T Consensus        79 ~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          79 SGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence            999999988665 579999999999999999999999999999999999999999999999999987532 223334567


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC---------chHHHHHHhhcCCCCCccCCH
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---------GPQAMFKVLNRTPPIPEMLSS  586 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~---------~~~~~~~i~~~~~~iP~~ls~  586 (739)
                      ||+.|+|||++.+       ..++.++|||||||++|||++|+.||....         .......+......+|..++.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~  230 (329)
T cd05588         158 GTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSV  230 (329)
T ss_pred             CCccccCHHHHcC-------CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999863       457789999999999999999999996321         122344556667788889999


Q ss_pred             HHHHHHHHhcccCCCCCCC------HHHHHcCcccccccc
Q 004660          587 EGKDFLLRCFLRNPVERPS------AVELLEHPFIRNANY  620 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpT------a~elLqHpwf~~~~~  620 (739)
                      ++.+||.+||+.||.+|++      ++++++||||....+
T Consensus       231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            9999999999999999987      799999999976543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.4e-46  Score=404.00  Aligned_cols=257  Identities=30%  Similarity=0.475  Sum_probs=216.7

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++++.||+|+||+||+|+++.+++.||||++....  .........+.+|+++|+.++|+||+++++.+..++.+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD--VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH--HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence            36999999999999999999999999999999886321  1112334668899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc---
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---  508 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~---  508 (739)
                      ||||++||+|.+++.+. +.+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+...   
T Consensus        79 v~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          79 VMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            99999999999999775 56899999999999999999999999999999999999999999999999997533100   


Q ss_pred             -----------------------------------------ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHH
Q 004660          509 -----------------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL  547 (739)
Q Consensus       509 -----------------------------------------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSL  547 (739)
                                                               ......+||+.|||||++.+       ..++.++|||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSl  230 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-------TGYTQLCDWWSV  230 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-------CCCCcceeeeec
Confidence                                                     00113579999999999863       457789999999


Q ss_pred             HHHHHHHhhCCCCCCCCCchHHHHHHhhcC--CCCC--ccCCHHHHHHHHHhcccCCCCCC---CHHHHHcCccccccc
Q 004660          548 GCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP--EMLSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRNAN  619 (739)
Q Consensus       548 GvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP--~~ls~el~dLI~kcL~~DP~kRp---Ta~elLqHpwf~~~~  619 (739)
                      |||||||++|+.||......+....+....  ..++  ..++.++.+||.+|+ .+|.+|+   ++.|+++||||+...
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            999999999999999877766666655432  2222  357899999999976 5999999   999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=394.99  Aligned_cols=259  Identities=30%  Similarity=0.490  Sum_probs=221.1

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee----
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----  425 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~----  425 (739)
                      ....|...+.||+|+||.|+.|.++.+|+.||||++...   ....-..++..+|+++|++++|+|||.+++++..    
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~---F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP---FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh---hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            345677789999999999999999999999999987622   2334456788999999999999999999998865    


Q ss_pred             -cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          426 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 -~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                       -..+|+|+|+| +.+|...|+.. ..+++..++.++.||++||+|+|+.+|+||||||.|||++.+..+||+|||+|+.
T Consensus        97 ~f~DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   97 KFNDVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             ccceeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence             24699999999 58999999774 5599999999999999999999999999999999999999999999999999998


Q ss_pred             ccC---cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC----
Q 004660          505 LTG---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----  577 (739)
Q Consensus       505 ~~~---~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~----  577 (739)
                      ...   ....+..+.|+||+|||++..      ...|+.++||||+||||.|||+|++.|.+.+....+..|+.-.    
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLN------SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhc------cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            853   344456778999999999974      4578899999999999999999999999887776666554311    


Q ss_pred             -------------------CCC--------CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          578 -------------------PPI--------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       578 -------------------~~i--------P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                         +..        -...++.+.|||++||..||.+|+|++|+|+|||+....
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence                               111        124789999999999999999999999999999998643

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-45  Score=391.93  Aligned_cols=260  Identities=30%  Similarity=0.562  Sum_probs=223.3

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCC-eEeeccceeecc--
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDD--  427 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPN-IVkl~~~~~~~~--  427 (739)
                      ...|+.+++||+|+||+||+|+.+.+|+.||+|+++....++..   -....+|+.+|+.|+|+| ||.+++++..++  
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~---P~taiREisllk~L~~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGV---PSTAIREISLLKRLSHANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCC---CchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence            34588899999999999999999999999999999876553222   244677999999999999 999999998877  


Q ss_pred             ----eEEEEEeecCCCCcchhhhhcc---ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecc
Q 004660          428 ----HLYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG  500 (739)
Q Consensus       428 ----~l~LVmEy~~gGsL~~~L~~~~---~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFG  500 (739)
                          .++||+||++ -+|.+++....   ..++...++.+++||+.||+|||++||+||||||+||||+..|.+||+|||
T Consensus        87 ~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             cccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence                8999999997 89999997754   358889999999999999999999999999999999999999999999999


Q ss_pred             cchhcc-CcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--
Q 004660          501 MAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--  577 (739)
Q Consensus       501 lA~~~~-~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--  577 (739)
                      +|+.+. ........++|.+|+|||++.+      ...|+..+||||+|||++||++++..|.+..+.+.+..|....  
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlG------s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt  239 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLG------STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT  239 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcC------CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence            999876 3333556789999999999985      4578889999999999999999999999998888888775421  


Q ss_pred             C----------------CCC------------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          578 P----------------PIP------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       578 ~----------------~iP------------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      +                .++            ...+.++.+++.+||+.+|.+|.++..+|.|+||.....
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            0                011            112358899999999999999999999999999987643

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4e-45  Score=381.64  Aligned_cols=253  Identities=30%  Similarity=0.503  Sum_probs=206.7

Q ss_pred             CCceEeeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc---CCCCeEeecccee---
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEV---  424 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~-tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L---~HPNIVkl~~~~~---  424 (739)
                      .+|++.+.||+|+||+||+|++.. +|..||||+++.........   ..+.+|+.+++.+   +||||+++++++.   
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~   77 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   77 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch---HHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence            379999999999999999999864 56889999987543322221   2344566666655   6999999999875   


Q ss_pred             --ecceEEEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004660          425 --VDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM  501 (739)
Q Consensus       425 --~~~~l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGl  501 (739)
                        ....+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence              2456999999997 6888888653 24589999999999999999999999999999999999999999999999999


Q ss_pred             chhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC---
Q 004660          502 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---  578 (739)
Q Consensus       502 A~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~---  578 (739)
                      ++............||..|+|||++.+       ..++.++|||||||++|||++|++||.+....+.+.+++....   
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~  229 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQ-------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  229 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhC-------CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            987654444445678999999999863       3567799999999999999999999998777666666643210   


Q ss_pred             --C----------------------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          579 --P----------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       579 --~----------------------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                        .                      +...++..+++||.+||+.||++|||+.|+|+||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence              0                      112467888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-46  Score=379.91  Aligned_cols=258  Identities=29%  Similarity=0.542  Sum_probs=235.6

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ..++|.+++.||+|-||.||+|+.+.++-.||+|++.+..  -.......++.+|++|...|+||||+++|++|.++..+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            3467999999999999999999999999999999987432  22334457899999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          430 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      ||++||...|+|+..|++. ...++|.....|++|++.||.|||.++|+||||||+|+|++..|.+||+|||-+.... .
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~  176 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-S  176 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-C
Confidence            9999999999999999843 4569999999999999999999999999999999999999999999999999987665 5


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHH
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG  588 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el  588 (739)
                      ....+.+||..|.+||+..+       ..++..+|+|++|++.||++.|.+||......+.+.+|..-...+|..++.++
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~-------~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a  249 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEG-------RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGA  249 (281)
T ss_pred             CCceeeecccccCCHhhcCC-------CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhH
Confidence            55668899999999999874       46677999999999999999999999998899999999999999999999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                      +|||.+||.++|.+|.+..|+++|||+..
T Consensus       250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  250 ADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            99999999999999999999999999864

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.1e-45  Score=392.53  Aligned_cols=253  Identities=27%  Similarity=0.501  Sum_probs=217.4

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      ++||+|+||+||+|+++.+|+.||||+++.....  .......+..|+.++..+ +|+||+++++++..++.+||||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            5799999999999999999999999998742110  112234566788887754 8999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-CcccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~-~~~~~~s~~  515 (739)
                      .||+|..++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .........
T Consensus        79 ~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          79 NGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence            999999998764 568999999999999999999999999999999999999999999999999987532 222334567


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHh
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kc  595 (739)
                      ||+.|+|||++.+       ..++.++|||||||++|||++|+.||...+..+....+....+.+|..++.++++||.+|
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  230 (316)
T cd05620         158 GTPDYIAPEILQG-------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKL  230 (316)
T ss_pred             CCcCccCHHHHcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            9999999999873       457789999999999999999999999887777777777777788888999999999999


Q ss_pred             cccCCCCCCCH-HHHHcCcccccccc
Q 004660          596 FLRNPVERPSA-VELLEHPFIRNANY  620 (739)
Q Consensus       596 L~~DP~kRpTa-~elLqHpwf~~~~~  620 (739)
                      |..||++|+++ +++++||||+...+
T Consensus       231 l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         231 FERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             ccCCHHHcCCChHHHHcCCCcCCCCH
Confidence            99999999997 58999999987543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2e-45  Score=399.14  Aligned_cols=260  Identities=29%  Similarity=0.476  Sum_probs=221.2

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|+||+||+|+++.+++.||||++....  ....+....+.+|+.+|..++|+||+++++.+..++.+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD--MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            36999999999999999999999999999999987321  1223345678889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~--  509 (739)
                      ||||+.||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+....  
T Consensus        79 v~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          79 IMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             EEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            99999999999999765 569999999999999999999999999999999999999999999999999987542210  


Q ss_pred             ----------------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHh
Q 004660          510 ----------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML  555 (739)
Q Consensus       510 ----------------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELL  555 (739)
                                                        .....+||+.|+|||++.+       ..++.++|||||||+||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-------TGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-------CCCCCcceeccccceeeecc
Confidence                                              0123579999999999863       45778999999999999999


Q ss_pred             hCCCCCCCCCchHHHHHHhhc--CCCCCc--cCCHHHHHHHHHhcccCCCCCC---CHHHHHcCccccccccCC
Q 004660          556 TGKPPWSEFEGPQAMFKVLNR--TPPIPE--MLSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRNANYQN  622 (739)
Q Consensus       556 tGk~PF~~~~~~~~~~~i~~~--~~~iP~--~ls~el~dLI~kcL~~DP~kRp---Ta~elLqHpwf~~~~~~~  622 (739)
                      +|+.||......+...+++..  ...+|.  .++.++++||.+|+. ||.+|+   ++.|+++||||+..++..
T Consensus       231 tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         231 IGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence            999999988777777777653  233443  378999999999874 999998   589999999999876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-45  Score=393.29  Aligned_cols=252  Identities=30%  Similarity=0.483  Sum_probs=216.5

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHH-HHhhcCCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-VLGHLKHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~-iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      ++||+|+||+||+|+++.+|+.||||++.....  ......+.+..|.. +++.++|||||++++++..++.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI--LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            479999999999999999999999999864211  11122234445544 568899999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~  515 (739)
                      .+|+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ........
T Consensus        79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (323)
T cd05575          79 NGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC  157 (323)
T ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence            999999998764 5699999999999999999999999999999999999999999999999999876432 22333467


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHh
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kc  595 (739)
                      ||+.|+|||++.+       ..++.++|||||||++|||++|+.||...+..+....++.....++..++.++.+||++|
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (323)
T cd05575         158 GTPEYLAPEVLRK-------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGL  230 (323)
T ss_pred             CChhhcChhhhcC-------CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            9999999999863       457789999999999999999999999887777888888887788888999999999999


Q ss_pred             cccCCCCCCCH----HHHHcCccccccc
Q 004660          596 FLRNPVERPSA----VELLEHPFIRNAN  619 (739)
Q Consensus       596 L~~DP~kRpTa----~elLqHpwf~~~~  619 (739)
                      |+.||.+|+++    .++++||||....
T Consensus       231 l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         231 LQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             hhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            99999999987    6999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.2e-45  Score=391.14  Aligned_cols=252  Identities=30%  Similarity=0.526  Sum_probs=216.5

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      ++||+|+||+||+|+++.+++.||||+++.....  .....+.+..|..++..+ +||||+++++++..++.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL--EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4799999999999999999999999998742111  112234455666776654 7999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~  515 (739)
                      .||+|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ........
T Consensus        79 ~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          79 NGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence            999999998765 5699999999999999999999999999999999999999999999999999976432 22333567


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHh
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kc  595 (739)
                      ||+.|+|||++.+       ..++.++|||||||++|||++|+.||.+.+..+.+..+....+.+|..++.++.+||.+|
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~  230 (316)
T cd05592         158 GTPDYIAPEILKG-------QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL  230 (316)
T ss_pred             CCccccCHHHHcC-------CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            9999999999863       357789999999999999999999999888877888888777888889999999999999


Q ss_pred             cccCCCCCCCH-HHHHcCccccccc
Q 004660          596 FLRNPVERPSA-VELLEHPFIRNAN  619 (739)
Q Consensus       596 L~~DP~kRpTa-~elLqHpwf~~~~  619 (739)
                      |..||.+|+++ .++++|+||....
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         231 FERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             ccCCHHHcCCChHHHHcCcccCCCC
Confidence            99999999986 5899999997654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.1e-45  Score=399.80  Aligned_cols=265  Identities=28%  Similarity=0.440  Sum_probs=225.1

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ....+|++.++||+|+||+||+|+++.+++.||||++.....  ......+.+.+|+.+|+.++||||+++++++.+++.
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM--IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            445689999999999999999999999999999999863211  112233557789999999999999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      +||||||+.||+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999999999865  35899999999999999999999999999999999999999999999999999766432


Q ss_pred             c--cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--CCCCc--
Q 004660          509 S--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE--  582 (739)
Q Consensus       509 ~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~--  582 (739)
                      .  ......||+.|+|||++.+..   ....++.++|||||||+||||++|+.||........+.+++...  ..+|.  
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI  272 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCC---CCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence            2  223457999999999987421   12357889999999999999999999999887777777776543  33444  


Q ss_pred             cCCHHHHHHHHHhcccCCCC--CCCHHHHHcCcccccccc
Q 004660          583 MLSSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANY  620 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~k--RpTa~elLqHpwf~~~~~  620 (739)
                      .++.++++||.+||..+|++  |+++.|+++||||+...+
T Consensus       273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence            57999999999999999988  999999999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.5e-45  Score=390.75  Aligned_cols=253  Identities=29%  Similarity=0.477  Sum_probs=220.8

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      ++||+|+||+||+|+++.+++.||||+++....  ........+.+|+++++.+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            479999999999999999999999999874211  1123345677899999888 6999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~  515 (739)
                      .||+|..++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... .......+
T Consensus        79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          79 NGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence            999999998765 5699999999999999999999999999999999999999999999999999875322 22233457


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHh
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kc  595 (739)
                      ||+.|+|||++.+       ..++.++|||||||++|||++|+.||...+.......+......+|..++.++.+||++|
T Consensus       158 g~~~y~aPE~~~~-------~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (318)
T cd05570         158 GTPDYIAPEILSY-------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSF  230 (318)
T ss_pred             cCccccCHHHhcC-------CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHH
Confidence            9999999999863       457789999999999999999999999888777777888877888888999999999999


Q ss_pred             cccCCCCCCCH-----HHHHcCcccccccc
Q 004660          596 FLRNPVERPSA-----VELLEHPFIRNANY  620 (739)
Q Consensus       596 L~~DP~kRpTa-----~elLqHpwf~~~~~  620 (739)
                      |..||.+||++     .++++||||+...+
T Consensus       231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             ccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99999999999     99999999987543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-45  Score=392.39  Aligned_cols=252  Identities=29%  Similarity=0.469  Sum_probs=220.0

Q ss_pred             eeEEeecCCeEEEEEEE---CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          357 GKLIGRGTFGSVYIGTN---RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~---k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      ++.||+|+||+||++++   +.+|+.||+|++.....   .......+.+|+++|++++||||+++++++..++.+|+||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL   77 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence            36899999999999986   45789999999874221   1222345778999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-cccc
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYEL  512 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~-~~~~  512 (739)
                      ||+.+|+|.+++.+. ..+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ....
T Consensus        78 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          78 DFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence            999999999999664 56999999999999999999999999999999999999999999999999999765433 2334


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHH
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL  592 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI  592 (739)
                      ...||+.|+|||++.+       ..++.++|||||||++|||++|+.||...+..+.+..+......+|..++.++.+||
T Consensus       157 ~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  229 (318)
T cd05582         157 SFCGTVEYMAPEVVNR-------RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL  229 (318)
T ss_pred             cccCChhhcCHHHHcC-------CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            5679999999999863       356779999999999999999999999888878888888777788889999999999


Q ss_pred             HHhcccCCCCCCC-----HHHHHcCccccccc
Q 004660          593 LRCFLRNPVERPS-----AVELLEHPFIRNAN  619 (739)
Q Consensus       593 ~kcL~~DP~kRpT-----a~elLqHpwf~~~~  619 (739)
                      ++||+.||++||+     +.++++|+||....
T Consensus       230 ~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         230 RALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            9999999999999     78899999998643

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.3e-45  Score=391.94  Aligned_cols=253  Identities=28%  Similarity=0.488  Sum_probs=214.9

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      ++||+|+||+||+|+++.+++.||+|+++....  ........+.+|+.++.++ +|||||++++++..++.+||||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh--cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            479999999999999999999999999874321  2233456678899988776 7999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~  515 (739)
                      .+|+|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ........
T Consensus        79 ~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          79 NGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence            999999888664 5699999999999999999999999999999999999999999999999999975422 22333567


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC---------chHHHHHHhhcCCCCCccCCH
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---------GPQAMFKVLNRTPPIPEMLSS  586 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~---------~~~~~~~i~~~~~~iP~~ls~  586 (739)
                      ||..|+|||++.+       ..++.++|||||||++|||++|+.||....         .......+......+|..++.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~  230 (329)
T cd05618         158 GTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV  230 (329)
T ss_pred             CCccccCHHHHcC-------CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCH
Confidence            9999999999863       456789999999999999999999995311         122334456667788899999


Q ss_pred             HHHHHHHHhcccCCCCCCC------HHHHHcCcccccccc
Q 004660          587 EGKDFLLRCFLRNPVERPS------AVELLEHPFIRNANY  620 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpT------a~elLqHpwf~~~~~  620 (739)
                      ++++||.+||..||++|++      +.++++||||+..++
T Consensus       231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            9999999999999999998      589999999987544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-45  Score=380.66  Aligned_cols=259  Identities=25%  Similarity=0.394  Sum_probs=219.9

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .|++.++||+|+||+||++.+..+++.||||++.....  ........+.+|+.+++.++|+||+++++.+..++.+|+|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh--hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            38899999999999999999999999999999863211  1122345677899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          433 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      |||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++.........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            9999999999888653 346899999999999999999999999999999999999999999999999999876544433


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHH----HHHhhcCCCCCccCCHH
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM----FKVLNRTPPIPEMLSSE  587 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~----~~i~~~~~~iP~~ls~e  587 (739)
                      ....|+..|+|||++.+       ..++.++|||||||++|||++|+.||.+.......    ..+......++..++..
T Consensus       159 ~~~~~~~~y~aPE~~~~-------~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd05605         159 RGRVGTVGYMAPEVVKN-------ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEA  231 (285)
T ss_pred             ccccCCCCccCcHHhcC-------CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHH
Confidence            45679999999999863       45778999999999999999999999875543322    22334445667778999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 004660          588 GKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRp-----Ta~elLqHpwf~~~~~  620 (739)
                      +.+||.+||..||++|+     +++++++|+||...++
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05605         232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF  269 (285)
T ss_pred             HHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence            99999999999999999     8999999999986554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-47  Score=407.58  Aligned_cols=257  Identities=41%  Similarity=0.661  Sum_probs=228.0

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ....|...++||+|.||.||+|.+..+++.||||++++..    ..+.+..+++|+.+|.+++++||.++|+.|..+..+
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~----~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE----AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL   86 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhh----cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence            3456888899999999999999999999999999998632    234567888999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      +++||||.||++.++++-. ..+.|.++..++++++.||.|||.++.+|||||+.||||..+|.|||+|||++..+....
T Consensus        87 wiiMey~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHHHhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            9999999999999999663 456999999999999999999999999999999999999999999999999998876543


Q ss_pred             c-ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCccCCHH
Q 004660          510 Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE  587 (739)
Q Consensus       510 ~-~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~e  587 (739)
                      . ..+++||++|||||++++       ..|+.++||||||++.|||++|.+||.....+..++.|-.. .+.+...+++.
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~-------~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~  238 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQ-------SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPP  238 (467)
T ss_pred             hccccccccccccchhhhcc-------ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHH
Confidence            3 368999999999999983       46788999999999999999999999998886665555433 33445578999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          588 GKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      +++||..||.+||+.||+|.++|+|+|++..
T Consensus       239 ~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  239 FKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            9999999999999999999999999999874

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-46  Score=384.35  Aligned_cols=268  Identities=26%  Similarity=0.447  Sum_probs=239.8

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc---cHHHHHHHHHHHHHHhhcC-CCCeEeeccceee
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHLK-HENIVQYYGSEVV  425 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~---~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~  425 (739)
                      ....|.--++||+|..++|.+|..+.+|+.+|+|+|........   ..+.++.-.+|+.||+++. ||+|+++.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            34567788999999999999999999999999999986543322   2344556678999999995 9999999999999


Q ss_pred             cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                      +..+++|+|+|+.|.|++++... ..++|.+.+.||+||+.|+.|||.++||||||||+|||++++-++||.|||+|+.+
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence            99999999999999999999775 67999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCC----C
Q 004660          506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI----P  581 (739)
Q Consensus       506 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~i----P  581 (739)
                      .........||||+|+|||.+... -+++.+.|+..+|+|++|||||-||.|.+||..-.+.-++..|+.+...+    +
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~-m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCS-MYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW  252 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeee-cccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence            988888889999999999999743 34567889999999999999999999999999888888888888876654    3


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      ..++...+|||.+||+.||.+|+|++|+|.||||....
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~  290 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA  290 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence            56899999999999999999999999999999996543

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.2e-44  Score=386.75  Aligned_cols=256  Identities=27%  Similarity=0.539  Sum_probs=216.0

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ..++|++++.||+|+||.||+|+++.+|..||+|++...    ........+.+|+++|++++||||+++++++..++.+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   78 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            457899999999999999999999999999999988642    2234456789999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhC-CeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~-GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      ++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus        79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            9999999999999999764 5689999999999999999999986 6999999999999999999999999999766432


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh-------------
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-------------  575 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-------------  575 (739)
                       ......||..|+|||++.+       ..++.++|||||||+||||++|+.||...+..+.. .+++             
T Consensus       158 -~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  228 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AIFGRPVVDGEEGEPHS  228 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhcccccccccCCccc
Confidence             2334579999999999863       45778999999999999999999999764433221 1111             


Q ss_pred             ----------------------------------c-CCCCC-ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          576 ----------------------------------R-TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       576 ----------------------------------~-~~~iP-~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                                        . .+..+ ..++.++++||.+||.+||++|||+.|+|+|+||+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                              0 11111 23678999999999999999999999999999997644

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-44  Score=397.21  Aligned_cols=265  Identities=26%  Similarity=0.440  Sum_probs=222.7

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ....+|++.++||+|+||.||+|+++.+++.||+|++.....  ........+.+|+.+++.++||||+++++++..++.
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            345689999999999999999999999999999999863211  112233567789999999999999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      +|+||||+.||+|.+++...  .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999999999653  5899999999999999999999999999999999999999999999999999876432


Q ss_pred             c--cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--CCCCc--
Q 004660          509 S--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE--  582 (739)
Q Consensus       509 ~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~--  582 (739)
                      .  ......||+.|||||++.+.   .+...++.++|||||||+||||++|+.||........+.+++...  ..+|.  
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  272 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQ---GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV  272 (370)
T ss_pred             CceecccCCCCcccCCHHHHhcc---CCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence            2  12356799999999999742   112347789999999999999999999999887777777776532  34444  


Q ss_pred             cCCHHHHHHHHHhcccCCCC--CCCHHHHHcCcccccccc
Q 004660          583 MLSSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANY  620 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~k--RpTa~elLqHpwf~~~~~  620 (739)
                      .++..++++|.+||..++.+  |+++.|+++||||+...+
T Consensus       273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence            46999999999999855543  899999999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.9e-46  Score=392.53  Aligned_cols=258  Identities=33%  Similarity=0.507  Sum_probs=221.1

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec--c--
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--D--  427 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~--~--  427 (739)
                      -.|...+++|.|+||+||.|...++++.||||++-..+.         .-.+|+.+|+.++|||||+++-+|...  .  
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            358899999999999999999999999999998753211         123599999999999999999887643  1  


Q ss_pred             -eEEEEEeecCCCCcchhhhh---ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEeecccc
Q 004660          428 -HLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMA  502 (739)
Q Consensus       428 -~l~LVmEy~~gGsL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~-g~vKL~DFGlA  502 (739)
                       .+.+||||++ .+|.++++.   .+..++.-.++-++.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|
T Consensus        95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence             4678999996 889998874   24679999999999999999999999999999999999999977 99999999999


Q ss_pred             hhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-----
Q 004660          503 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----  577 (739)
Q Consensus       503 ~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-----  577 (739)
                      +.+..+....+...|++|+|||.+.|      ...|+.+.||||.||||.||+.|++.|.+.+..+++..|++-.     
T Consensus       174 K~L~~~epniSYicSRyYRaPELifg------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~  247 (364)
T KOG0658|consen  174 KVLVKGEPNISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR  247 (364)
T ss_pred             eeeccCCCceeEEEeccccCHHHHcC------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence            99988888888999999999999996      4678899999999999999999999999988777666554310     


Q ss_pred             -------C-----C------------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccccCCCCC
Q 004660          578 -------P-----P------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSV  625 (739)
Q Consensus       578 -------~-----~------------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~~~~~~  625 (739)
                             +     .            +....++++.+|+.++|..+|.+|.++.|+|.||||......+...
T Consensus       248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l  319 (364)
T KOG0658|consen  248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKL  319 (364)
T ss_pred             HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccC
Confidence                   0     0            2234689999999999999999999999999999998776554443

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.1e-44  Score=403.84  Aligned_cols=255  Identities=27%  Similarity=0.490  Sum_probs=210.6

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec---
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~---  426 (739)
                      ...+|+++++||+|+||+||+|.+..+++.||||++....         ....+|+.+|+.++|+|||++++++...   
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~  134 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFK  134 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence            3467999999999999999999999999999999875311         1234699999999999999998876432   


Q ss_pred             -----ceEEEEEeecCCCCcchhhhh---ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC-cEEEe
Q 004660          427 -----DHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLA  497 (739)
Q Consensus       427 -----~~l~LVmEy~~gGsL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g-~vKL~  497 (739)
                           ..+++||||+.+ +|.+++..   ....+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus       135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence                 247899999974 67666542   345699999999999999999999999999999999999998665 79999


Q ss_pred             ecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC
Q 004660          498 DFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT  577 (739)
Q Consensus       498 DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~  577 (739)
                      |||+|+.+..........||+.|+|||++.+      ...++.++|||||||+||||++|.+||.+....+.+.+++...
T Consensus       214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  287 (440)
T PTZ00036        214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLG------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL  287 (440)
T ss_pred             ccccchhccCCCCcccCCCCcCccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            9999988765555556789999999999863      3467889999999999999999999998876655554443210


Q ss_pred             -----------------------------CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          578 -----------------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       578 -----------------------------~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                                                   ..+|...+.++++||.+||.+||.+|+|+.|+|+||||.....
T Consensus       288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                                         0133456889999999999999999999999999999986543

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.2e-44  Score=381.49  Aligned_cols=258  Identities=26%  Similarity=0.440  Sum_probs=214.8

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ..+|++++.||+|+||+||+|+++.+++.||+|+++.......    ...+.+|+.+++.++|+||+++++++..++..|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA----PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc----chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            3579999999999999999999999999999999875332211    234667999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      +||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... 
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          81 LVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             EEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            9999997 48888887665668999999999999999999999999999999999999999999999999997653322 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC------------
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------  577 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------------  577 (739)
                      ......+|..|+|||++.+      ...++.++|||||||++|||++|+.||.+.+..+.+..++...            
T Consensus       160 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLG------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             ccccccccccccCCHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            2223468999999999863      3457789999999999999999999998766554444332210            


Q ss_pred             -------CC-----------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          578 -------PP-----------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       578 -------~~-----------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                             ..           ....++.++++||.+||..||.+|+|+.|+|+||||+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                   00           1124688999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.7e-44  Score=374.50  Aligned_cols=252  Identities=28%  Similarity=0.485  Sum_probs=205.3

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc---CCCCeEeeccceee----
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV----  425 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L---~HPNIVkl~~~~~~----  425 (739)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.++.........   ..+.+|+.+++.+   +||||+++++++..    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP---LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD   77 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc---hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence            5899999999999999999999999999999987533222111   2344566666554   79999999998764    


Q ss_pred             -cceEEEEEeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004660          426 -DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       426 -~~~l~LVmEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                       ...+++||||+. ++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence             345899999998 58888886532 358999999999999999999999999999999999999999999999999998


Q ss_pred             hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC------
Q 004660          504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------  577 (739)
Q Consensus       504 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------  577 (739)
                      ............||..|+|||++.+       ..++.++|||||||++|||++|++||........+.++....      
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQ-------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  229 (288)
T ss_pred             cccCcccCCCccccccccCchHhhC-------CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence            7654443345678999999999863       357789999999999999999999998776655555543210      


Q ss_pred             -----C----------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 -----P----------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 -----~----------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                           .                .+...++.++.+||.+||+.||++|||+.|+|+||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                 0                0112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-44  Score=388.03  Aligned_cols=265  Identities=25%  Similarity=0.416  Sum_probs=220.3

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++++.||+|+||+||+++++.+++.||||++....  .......+.+.+|+.++..++|+||+++++++..++.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE--MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            47999999999999999999999999999999986321  1122234567889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~-  510 (739)
                      ||||+.||+|.+++.+....+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+..... 
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            9999999999999977556799999999999999999999999999999999999999999999999999876543222 


Q ss_pred             -ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--CCCC---ccC
Q 004660          511 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP---EML  584 (739)
Q Consensus       511 -~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP---~~l  584 (739)
                       .....||+.|||||++.....  +...++.++|||||||++|||++|+.||......+....++...  ..++   ..+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  236 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMED--GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV  236 (331)
T ss_pred             cccceeccccccCHHHHhhccc--cccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence             122469999999999974211  12457789999999999999999999998877766666665432  2222   347


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHHcCcccccccc
Q 004660          585 SSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANY  620 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~k--RpTa~elLqHpwf~~~~~  620 (739)
                      +.++++||++||..++++  |+++.++|+||||....+
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence            899999999999764443  789999999999976543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1e-44  Score=387.65  Aligned_cols=253  Identities=28%  Similarity=0.526  Sum_probs=216.5

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhh-cCCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~-L~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      +.||+|+||+||+|+++.+++.||||+++.....  .......+..|..++.. ++||||+++++++..++.+||||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            4799999999999999999999999998742110  11223455667777776 48999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-CcccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~-~~~~~~s~~  515 (739)
                      .||+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .........
T Consensus        79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          79 NGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence            999999999764 568999999999999999999999999999999999999999999999999987542 222333567


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHh
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kc  595 (739)
                      ||..|+|||++.+       ..++.++|||||||++|||++|+.||...+..+.+..+......++..++.++++||.+|
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (316)
T cd05619         158 GTPDYIAPEILLG-------QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL  230 (316)
T ss_pred             CCccccCHHHHcC-------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            9999999999863       457789999999999999999999998877777777776666677888999999999999


Q ss_pred             cccCCCCCCCHH-HHHcCcccccccc
Q 004660          596 FLRNPVERPSAV-ELLEHPFIRNANY  620 (739)
Q Consensus       596 L~~DP~kRpTa~-elLqHpwf~~~~~  620 (739)
                      |..||++|+++. ++++||||+...+
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         231 FVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             hccCHhhcCCChHHHHcCcccCCCCH
Confidence            999999999996 9999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.9e-45  Score=388.19  Aligned_cols=253  Identities=29%  Similarity=0.468  Sum_probs=215.8

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHH-HHHhhcCCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI-KVLGHLKHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei-~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      ++||+|+||+||+|+++.+|+.||+|++.....  ........+..|+ .+++.++|||||++++++...+.+||||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI--LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            479999999999999999999999999864211  1112233444554 4678899999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~  515 (739)
                      +||+|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... ........
T Consensus        79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05603          79 NGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC  157 (321)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence            999999888654 5689999999999999999999999999999999999999999999999999875422 22333467


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHh
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kc  595 (739)
                      ||+.|+|||++.+       ..++.++|||||||++|||++|+.||...+..+....+......++...+.++.++|.+|
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (321)
T cd05603         158 GTPEYLAPEVLRK-------EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGL  230 (321)
T ss_pred             CCcccCCHHHhcC-------CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            9999999999863       457789999999999999999999999887777777888777788888999999999999


Q ss_pred             cccCCCCCCCH----HHHHcCcccccccc
Q 004660          596 FLRNPVERPSA----VELLEHPFIRNANY  620 (739)
Q Consensus       596 L~~DP~kRpTa----~elLqHpwf~~~~~  620 (739)
                      |++||.+|+++    .++++|+||....+
T Consensus       231 l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         231 LHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             ccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence            99999999875    59999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-45  Score=404.19  Aligned_cols=257  Identities=31%  Similarity=0.518  Sum_probs=236.2

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce-E
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-L  429 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~-l  429 (739)
                      ...|..+++||+|+||.+++++++.++..|++|.|........   ..+...+|+.++.+++|||||.+++.|+.++. +
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~---~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP---ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch---hhHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence            3579999999999999999999999999999999986443322   23467789999999999999999999999998 9


Q ss_pred             EEEEeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          430 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      +|||+||+||+|.+.|.+.. ..++|+.+..|+.||+.||.|||++.|+|||||+.|||++.++.|||+|||+|+.+...
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999999997754 67999999999999999999999999999999999999999999999999999999876


Q ss_pred             c-cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-CCCCccCCH
Q 004660          509 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSS  586 (739)
Q Consensus       509 ~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~  586 (739)
                      . ...+.+||+.||.||++.       +..|+.++|||||||++|||++-+++|.+.+-...+.+|.... .++|..++.
T Consensus       160 ~~~a~tvvGTp~YmcPEil~-------d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~  232 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILS-------DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSS  232 (426)
T ss_pred             hhhhheecCCCcccCHHHhC-------CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccH
Confidence            6 777889999999999998       4688999999999999999999999999999999999998766 788999999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                      +++.||+.||..+|+.||++.++|.+|.+..
T Consensus       233 el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  233 ELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            9999999999999999999999999988764

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.9e-45  Score=389.24  Aligned_cols=253  Identities=28%  Similarity=0.452  Sum_probs=215.4

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHH-HHHhhcCCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI-KVLGHLKHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei-~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      +.||+|+||+||+|+++.+++.||+|++......  .......+..|. .+++.++|+||+++++++..++.+|+||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH--hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            4799999999999999999999999998742111  111223344444 4578899999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~  515 (739)
                      .||+|.+++... ..+.+..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ........
T Consensus        79 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~  157 (325)
T cd05602          79 NGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC  157 (325)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence            999999999764 5688999999999999999999999999999999999999999999999999976432 22334567


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHh
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kc  595 (739)
                      ||+.|+|||++.+       ..++.++|||||||++|||++|+.||...+..+.+..+......++..++.++.++|++|
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (325)
T cd05602         158 GTPEYLAPEVLHK-------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL  230 (325)
T ss_pred             CCccccCHHHHcC-------CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHH
Confidence            9999999999863       457789999999999999999999999888777778887777777778999999999999


Q ss_pred             cccCCCCCCCHH----HHHcCcccccccc
Q 004660          596 FLRNPVERPSAV----ELLEHPFIRNANY  620 (739)
Q Consensus       596 L~~DP~kRpTa~----elLqHpwf~~~~~  620 (739)
                      |++||.+|+++.    ++++|+||....+
T Consensus       231 l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         231 LQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             cccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence            999999999865    8999999976544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.9e-44  Score=386.34  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=223.8

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecceEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~l~L  431 (739)
                      .|+..+.||+|+||+||+|+++.+|+.||||++.....  ......+.+..|+.++..+. |++|+++++++..++.+|+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            47889999999999999999999999999999874211  11233456777888988886 5778889999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-cc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SY  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~-~~  510 (739)
                      ||||++||+|.+++... ..+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus        79 v~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          79 VMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence            99999999999998765 56999999999999999999999999999999999999999999999999998764322 22


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD  590 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~d  590 (739)
                      .....||+.|+|||++.+       ..++.++|||||||++|||++|+.||...........++.....+|..++.++.+
T Consensus       158 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  230 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAY-------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS  230 (323)
T ss_pred             ccCccCCccccCHHHHcC-------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence            334569999999999863       3577899999999999999999999998888888888888888888899999999


Q ss_pred             HHHHhcccCCCCCCC-----HHHHHcCcccccccc
Q 004660          591 FLLRCFLRNPVERPS-----AVELLEHPFIRNANY  620 (739)
Q Consensus       591 LI~kcL~~DP~kRpT-----a~elLqHpwf~~~~~  620 (739)
                      ||.+||.+||.+|++     .+++++|+||+...+
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence            999999999999997     579999999987553

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-44  Score=368.33  Aligned_cols=256  Identities=46%  Similarity=0.859  Sum_probs=221.3

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ..|++++.||+|+||.||+|.+..+++.||+|++.............+.+.+|++++++++||||+++++++..++.+|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            35999999999999999999999999999999987543333333445678999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      ||||+.+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus        82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            99999999999999765 56899999999999999999999999999999999999999999999999999765432211


Q ss_pred             ----cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh--cCCCCCccCC
Q 004660          512 ----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLS  585 (739)
Q Consensus       512 ----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~--~~~~iP~~ls  585 (739)
                          ....|+..|+|||++.+       ..++.++||||||+++|||++|+.||...+.......+..  ....++..++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISG-------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVS  233 (263)
T ss_pred             cccccCCCcCccccCcceecc-------CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCC
Confidence                23457899999999873       3477899999999999999999999988766665555443  3445777899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      .++.++|.+||..+|.+|||+.|+|+|+||
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         234 PDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.5e-44  Score=377.89  Aligned_cols=252  Identities=25%  Similarity=0.418  Sum_probs=212.2

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecCCC
Q 004660          360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  439 (739)
Q Consensus       360 LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~gG  439 (739)
                      ||+|+||+||+|.++.+|+.||+|++.....  ......+.+..|+++|+.++|+||+++++++..++.+|+||||++||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL--KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHH--hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            7999999999999999999999998864211  12223456778999999999999999999999999999999999999


Q ss_pred             Ccchhhhh---ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cccccC
Q 004660          440 SINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK  515 (739)
Q Consensus       440 sL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~~~s~~  515 (739)
                      +|..++..   ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ......
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence            99887743   23568999999999999999999999999999999999999999999999999997654322 223457


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch----HHHHHHhhcCCCCCccCCHHHHHH
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----QAMFKVLNRTPPIPEMLSSEGKDF  591 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~----~~~~~i~~~~~~iP~~ls~el~dL  591 (739)
                      ||+.|+|||++.+       ..++.++|||||||++|||++|+.||......    .....+......++..++.++.+|
T Consensus       159 g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  231 (280)
T cd05608         159 GTPGFMAPELLQG-------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSF  231 (280)
T ss_pred             CCcCccCHHHhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHH
Confidence            8999999999873       35678999999999999999999999765332    233334445556677899999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 004660          592 LLRCFLRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       592 I~kcL~~DP~kRp-----Ta~elLqHpwf~~~~~  620 (739)
                      |.+||+.||++|+     +++++++||||+...+
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             HHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence            9999999999999     8899999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.3e-45  Score=389.55  Aligned_cols=252  Identities=29%  Similarity=0.458  Sum_probs=215.4

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHH-HHhhcCCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-VLGHLKHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~-iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      ++||+|+||+||+|+++.+|+.||||++.....  ........+..|.. +++.++||||+++++++..++.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV--LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            479999999999999999999999999864211  11222344555554 577899999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~  515 (739)
                      .||+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.... ........
T Consensus        79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (325)
T cd05604          79 NGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC  157 (325)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence            999999988764 5799999999999999999999999999999999999999999999999999875432 23334567


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHh
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kc  595 (739)
                      ||+.|+|||++.+       ..++.++|||||||++|||++|+.||...+..+....++.....++..++..+.++|.+|
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~l  230 (325)
T cd05604         158 GTPEYLAPEVIRK-------QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEEL  230 (325)
T ss_pred             CChhhCCHHHHcC-------CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHH
Confidence            9999999999863       456779999999999999999999999887777778887777777778999999999999


Q ss_pred             cccCCCCCCCH----HHHHcCccccccc
Q 004660          596 FLRNPVERPSA----VELLEHPFIRNAN  619 (739)
Q Consensus       596 L~~DP~kRpTa----~elLqHpwf~~~~  619 (739)
                      |.+||.+|+++    .++++||||....
T Consensus       231 l~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         231 LEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             hccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            99999999876    5999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.4e-44  Score=386.52  Aligned_cols=265  Identities=24%  Similarity=0.400  Sum_probs=221.8

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.++||+|+||+||+++++.+++.||+|++....  .........+.+|+.++..++|+||+++++++..++.+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH--HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            36999999999999999999999999999999986311  1122233457889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~-  510 (739)
                      ||||+.+|+|.+++.+....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... 
T Consensus        79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            9999999999999987556799999999999999999999999999999999999999999999999999976533221 


Q ss_pred             -ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--CCCC---ccC
Q 004660          511 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP---EML  584 (739)
Q Consensus       511 -~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP---~~l  584 (739)
                       .....||+.|+|||++.+...  +...++.++|||||||+||||++|+.||...+..+.+.++....  ..+|   ..+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMED--GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV  236 (332)
T ss_pred             eecccccCccccCHHHHhcccc--CCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence             223579999999999974321  23457889999999999999999999999888777777776543  2233   357


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHHcCcccccccc
Q 004660          585 SSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANY  620 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~k--RpTa~elLqHpwf~~~~~  620 (739)
                      +.++++||.+||..++.+  |++++|+++||||....+
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence            999999999999765444  689999999999987654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3e-44  Score=385.38  Aligned_cols=253  Identities=26%  Similarity=0.470  Sum_probs=215.1

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      ++||+|+||+||+|+++.+++.||+|+++...  ....+..+.+.+|+.++.++ +|+||+++++++...+.+||||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL--VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            47999999999999999999999999987421  12233456788899999888 5999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-CcccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~-~~~~~~s~~  515 (739)
                      .||+|..++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++... ........+
T Consensus        79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          79 NGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence            999999988664 569999999999999999999999999999999999999999999999999997532 223334567


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCC------Cch-HHHHHHhhcCCCCCccCCHHH
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF------EGP-QAMFKVLNRTPPIPEMLSSEG  588 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~------~~~-~~~~~i~~~~~~iP~~ls~el  588 (739)
                      ||+.|+|||++.+       ..++.++|||||||+||||++|+.||...      ... .....+......+|..++..+
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  230 (327)
T cd05617         158 GTPNYIAPEILRG-------EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKA  230 (327)
T ss_pred             CCcccCCHHHHCC-------CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999863       45778999999999999999999999532      122 233444556667888899999


Q ss_pred             HHHHHHhcccCCCCCCC------HHHHHcCcccccccc
Q 004660          589 KDFLLRCFLRNPVERPS------AVELLEHPFIRNANY  620 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpT------a~elLqHpwf~~~~~  620 (739)
                      .++|.+||..||++|++      +.++++|+||....+
T Consensus       231 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             HHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence            99999999999999997      579999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.5e-43  Score=395.87  Aligned_cols=252  Identities=19%  Similarity=0.356  Sum_probs=201.3

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC------CCeEeeccce
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH------ENIVQYYGSE  423 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~H------PNIVkl~~~~  423 (739)
                      ...+|+++++||+|+||+||+|.+..+++.||||+++...      .....+..|+.+++.++|      .+|+++++++
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch------hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            3578999999999999999999999999999999986321      222345567777766654      4588999888


Q ss_pred             eec-ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCC---------
Q 004660          424 VVD-DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASG---------  492 (739)
Q Consensus       424 ~~~-~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g---------  492 (739)
                      ..+ +.+|||||++ |++|.+++.+. +.+++..++.|+.||+.||+|||+ .|||||||||+||||+.++         
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence            764 5799999998 68888888765 569999999999999999999997 5999999999999998765         


Q ss_pred             -------cEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC
Q 004660          493 -------VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE  565 (739)
Q Consensus       493 -------~vKL~DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~  565 (739)
                             .+||+|||++.....  .....+||+.|||||++.+       ..++.++|||||||+||||++|++||...+
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~-------~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG-------LGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhc-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                   499999998864322  2335679999999999974       457889999999999999999999998766


Q ss_pred             chHHHHHHhhcCCCCCc------------------------------------------cCCHHHHHHHHHhcccCCCCC
Q 004660          566 GPQAMFKVLNRTPPIPE------------------------------------------MLSSEGKDFLLRCFLRNPVER  603 (739)
Q Consensus       566 ~~~~~~~i~~~~~~iP~------------------------------------------~ls~el~dLI~kcL~~DP~kR  603 (739)
                      ..+.+..+......+|.                                          ..++.+.|||.+||++||++|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            55443332211111000                                          113567799999999999999


Q ss_pred             CCHHHHHcCcccccc
Q 004660          604 PSAVELLEHPFIRNA  618 (739)
Q Consensus       604 pTa~elLqHpwf~~~  618 (739)
                      +|++|+|+||||...
T Consensus       430 ~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        430 LNARQMTTHPYVLKY  444 (467)
T ss_pred             CCHHHHhcCcccccc
Confidence            999999999999864

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-45  Score=389.47  Aligned_cols=251  Identities=29%  Similarity=0.439  Sum_probs=212.6

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc---CCCCeEeeccceeecceEEEEEeec
Q 004660          360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       360 LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L---~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      ||+|+||+||+|+++.+|+.||||++.....  ........+..|..++..+   .||||+++++++...+.+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHH--hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            7999999999999999999999999863211  1122234455667776655   6999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK  515 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~~~~~s~~  515 (739)
                      .+|+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..... .......+
T Consensus        79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          79 SGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             CCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            999999998764 5699999999999999999999999999999999999999999999999999876432 23334567


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCc-cCCHHHHHHHHH
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-MLSSEGKDFLLR  594 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~-~ls~el~dLI~k  594 (739)
                      ||..|+|||++.+      ...++.++|||||||++|||++|+.||...+..+.+..+......++. .++.++++||++
T Consensus       158 gt~~y~aPE~~~~------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  231 (330)
T cd05586         158 GTTEYLAPEVLLD------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG  231 (330)
T ss_pred             CCccccCHHHHcC------CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence            9999999999863      335678999999999999999999999887777777777666666654 479999999999


Q ss_pred             hcccCCCCCC----CHHHHHcCccccccc
Q 004660          595 CFLRNPVERP----SAVELLEHPFIRNAN  619 (739)
Q Consensus       595 cL~~DP~kRp----Ta~elLqHpwf~~~~  619 (739)
                      ||..||++|+    ++.++++||||....
T Consensus       232 ~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         232 LLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             HcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            9999999998    799999999997643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7e-44  Score=386.57  Aligned_cols=254  Identities=25%  Similarity=0.398  Sum_probs=207.8

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc--
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--  427 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~--  427 (739)
                      ...+|++.+.||+|+||+||+|.++.+|..||||++....   ........+.+|+.+++.++||||+++++++...+  
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF---QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc---cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            4568999999999999999999999999999999886422   22333456778999999999999999999886543  


Q ss_pred             ----eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004660          428 ----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       428 ----~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                          .+|+||||+.+ +|.+.+..   .+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence                57999999975 55555532   48899999999999999999999999999999999999999999999999998


Q ss_pred             hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh--------
Q 004660          504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--------  575 (739)
Q Consensus       504 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~--------  575 (739)
                      ............||+.|+|||++.+       ..++.++|||||||++|+|++|+.||.+.+....+..++.        
T Consensus       172 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         172 TACTNFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             ccccCccCCCCcccCCCCCchhccC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence            7655444445678999999999863       4577799999999999999999999987654433222211        


Q ss_pred             --------------cCCC--------------------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          576 --------------RTPP--------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       576 --------------~~~~--------------------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                                    ....                    .....+.++++||.+||..||++|||+.|+|+||||..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                          1111                    11124678899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.4e-44  Score=390.81  Aligned_cols=265  Identities=27%  Similarity=0.422  Sum_probs=222.0

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      .....+|++.+.||+|+||.||+|+++.+++.||+|++.....  ......+.+.+|+.+++.++||||+++++++..++
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            3445789999999999999999999999999999999864211  11223456778999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+|+||||+.||+|.+++...  .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            999999999999999998663  589999999999999999999999999999999999999999999999999987643


Q ss_pred             cc--cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--CCCC--
Q 004660          508 LS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP--  581 (739)
Q Consensus       508 ~~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP--  581 (739)
                      ..  ......||+.|||||++.+.   .+...++.++|||||||+||||++|+.||...+......+++...  ..+|  
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  271 (371)
T cd05622         195 EGMVRCDTAVGTPDYISPEVLKSQ---GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD  271 (371)
T ss_pred             CCcccccCcccCccccCHHHHhcc---CCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCc
Confidence            22  22346799999999999742   112347889999999999999999999999887777777776543  3333  


Q ss_pred             ccCCHHHHHHHHHhcccCCCC--CCCHHHHHcCccccccc
Q 004660          582 EMLSSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNAN  619 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~k--RpTa~elLqHpwf~~~~  619 (739)
                      ..++.++++||.+||..++.+  |++++++++|+||++..
T Consensus       272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            358999999999999844433  78999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.4e-44  Score=389.01  Aligned_cols=256  Identities=27%  Similarity=0.444  Sum_probs=212.5

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc-----
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-----  427 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~-----  427 (739)
                      +|++++.||+|+||+||+|.+..+|+.||||++....   ......+.+.+|+++|+.++|+||+++++++...+     
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   77 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE   77 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc---cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence            4789999999999999999999999999999875321   22334467889999999999999999999998776     


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          78 EIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             eEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            7999999996 6788877554 5699999999999999999999999999999999999999999999999999976533


Q ss_pred             cc--cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh----------
Q 004660          508 LS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN----------  575 (739)
Q Consensus       508 ~~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~----------  575 (739)
                      ..  ......+|+.|+|||++.+      ...++.++||||||||+|||++|+.||.+....+.+..+..          
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~  229 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMG------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM  229 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcC------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            21  2223468999999999874      34567899999999999999999999987665544443321          


Q ss_pred             -------------cCC---------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          576 -------------RTP---------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       576 -------------~~~---------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                   ...         .+....++++.+||.+||..||++|||+.|+|+||||+...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                         000         12234678999999999999999999999999999998743

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6e-44  Score=383.72  Aligned_cols=265  Identities=24%  Similarity=0.380  Sum_probs=220.8

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|+||+||+++++.+++.||+|++....  .........+.+|+.++..++|+||+++++++..++.+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE--MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH--HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            47999999999999999999999999999999986321  1112234557789999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      ||||+.||+|.+++.+....+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus        79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            99999999999999875567999999999999999999999999999999999999999999999999999766433221


Q ss_pred             --cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--CCCCc---cC
Q 004660          512 --LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE---ML  584 (739)
Q Consensus       512 --~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~---~l  584 (739)
                        ....||+.|+|||++.+...  +...++.++|||||||+||||++|+.||...+..+.+.++....  .++|.   .+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMED--GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             eeccccCCcccCCHHHHhcccc--CCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence              23569999999999874211  11356789999999999999999999998877777777766532  23333   46


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHHcCcccccccc
Q 004660          585 SSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANY  620 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~k--RpTa~elLqHpwf~~~~~  620 (739)
                      +.++++||.+||..++++  |++++++++|+||+...+
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence            899999999999876554  579999999999986544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-44  Score=394.15  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=205.5

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ....+|++++.||+|+||.||+|+++.+++.||||+...           ..+.+|+++|+.|+|||||++++++..++.
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~  157 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKF  157 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence            445689999999999999999999999999999996431           346789999999999999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      .++||||+. ++|..++... ..+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus       158 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        158 TCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             eEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            999999995 7888888664 56899999999999999999999999999999999999999999999999999754321


Q ss_pred             --ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc-------hHHHHHHhhc---
Q 004660          509 --SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-------PQAMFKVLNR---  576 (739)
Q Consensus       509 --~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~-------~~~~~~i~~~---  576 (739)
                        .......||+.|+|||++.+       ..++.++||||||||||||++|+.||.....       ...+..++..   
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~  308 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLAR-------DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT  308 (391)
T ss_pred             cccccccccCccCCCChhhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence              22234679999999999863       4578899999999999999999987743211       1111111110   


Q ss_pred             -----------------------CCCCC---------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          577 -----------------------TPPIP---------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       577 -----------------------~~~iP---------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                                             ....+         ..++.++.+||.+||..||++|||+.|+|+||||+..
T Consensus       309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                                   00000         1246688999999999999999999999999999764

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-43  Score=400.54  Aligned_cols=256  Identities=27%  Similarity=0.430  Sum_probs=221.8

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCC-CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~t-g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...|.+.++||+|+||.||+|.+..+ +..||+|.+..     ........+.+|+.+|+.++|||||++++++..++.+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-----~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~  140 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-----NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL  140 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence            44599999999999999999998887 78899997643     1233345678899999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhc---cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          430 YIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~---~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      ||||||+.||+|.+++...   ...+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            9999999999999988542   3458999999999999999999999999999999999999999999999999998764


Q ss_pred             Ccc---cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-CCCCc
Q 004660          507 GLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE  582 (739)
Q Consensus       507 ~~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~  582 (739)
                      ...   .....+||+.|+|||++.+       ..++.++|||||||++|||++|+.||......+.+..++.+. .+++.
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  293 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWER-------KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPC  293 (478)
T ss_pred             CccccccccccCCCccccCHhHhCC-------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            432   2335679999999999863       457889999999999999999999999887777777776543 35677


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      .++.++++||.+||..||++||++.++|.|+|++..
T Consensus       294 ~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            889999999999999999999999999999998753

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.6e-43  Score=384.53  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=209.7

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec---
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~---  426 (739)
                      ..++|++++.||+|+||.||+|.+..+++.||||++....   ........+.+|+.+++.++|+||+++++++...   
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc---cCchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence            4568999999999999999999999999999999886422   1223345677899999999999999999987543   


Q ss_pred             ---ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004660          427 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       427 ---~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                         ..+|+||||+.+ +|.+++..   .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus        99 ~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875          99 EEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             cccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence               357999999974 66666643   47889999999999999999999999999999999999999999999999998


Q ss_pred             hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC------
Q 004660          504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------  577 (739)
Q Consensus       504 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------  577 (739)
                      ............||..|+|||++.+       ..++.++|||||||+||||++|+.||.+.+..+.+.+++...      
T Consensus       175 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         175 TAGTSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             ccCCCCcccCCcccCCcCCHHHHhC-------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            7655444445679999999999973       457789999999999999999999998776655554443211      


Q ss_pred             ----------------CC--------------------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          578 ----------------PP--------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       578 ----------------~~--------------------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                                      +.                    .....+.++++||.+||..||.+|||+.|+|+||||..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                            00                    01113467899999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=377.49  Aligned_cols=262  Identities=28%  Similarity=0.449  Sum_probs=238.1

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      -++|..+++||+|+||+|.+|+.+.+|+.||||++++.-  -...+.+..-..|-++|+..+||.+..+...|+..+.+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev--iiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV--IIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhh--eeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            357899999999999999999999999999999886321  123344566778999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc-cCcc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLS  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~-~~~~  509 (739)
                      +||||+.||+|+.+|.. .+.++|...+.+-..|+.||.|||+++||.||||.+|+|+|.+|++||+||||++.- ....
T Consensus       245 FVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~  323 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD  323 (516)
T ss_pred             EEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence            99999999999999965 467999999999999999999999999999999999999999999999999999864 4455


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK  589 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~  589 (739)
                      ...++||||.|+|||++.       +..|+.++|+|.+|||||||++|++||.+.+....+..|+-....+|..++++++
T Consensus       324 t~kTFCGTPEYLAPEVle-------DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAk  396 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLE-------DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAK  396 (516)
T ss_pred             eeccccCChhhcCchhhc-------cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHH
Confidence            667899999999999997       5689999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHHcCccccccccCC
Q 004660          590 DFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQN  622 (739)
Q Consensus       590 dLI~kcL~~DP~kRp-----Ta~elLqHpwf~~~~~~~  622 (739)
                      .||..+|.+||.+|.     .+.||.+|+||...+++.
T Consensus       397 tLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  397 TLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             HHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence            999999999999996     489999999999888754

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-43  Score=383.41  Aligned_cols=254  Identities=25%  Similarity=0.387  Sum_probs=208.4

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec---
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~---  426 (739)
                      ..++|++++.||+|+||+||+|.+..+++.||||++....   ........+.+|+.+|+.++|+||+++++++...   
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc---cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            4568999999999999999999999999999999886422   2233456778899999999999999999987643   


Q ss_pred             ---ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004660          427 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       427 ---~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                         ...|+||||+++ +|.+++..   .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence               357999999975 56666543   48899999999999999999999999999999999999999999999999998


Q ss_pred             hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-------
Q 004660          504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-------  576 (739)
Q Consensus       504 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-------  576 (739)
                      ............||+.|+|||++.+       ..++.++|||||||++|||++|+.||.+.+..+.+..++..       
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         168 TAGTSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             cCCCccccCCccccCCccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            7655444445679999999999863       45778999999999999999999999876544333322110       


Q ss_pred             ---------------CC--------------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          577 ---------------TP--------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       577 ---------------~~--------------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                                     .+                    ..+...+.++++||.+||..||++|||+.|+|+||||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence                           00                    011224567899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.9e-44  Score=364.16  Aligned_cols=252  Identities=37%  Similarity=0.601  Sum_probs=210.5

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      |++++.||+|+||+||+|++..+++.||+|++....   ..........+|+.++++++|+||+++++++..++.+++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE---IEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT---HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc---ccccccchhhhhhhccccccccccccccccccccccccccc
Confidence            899999999999999999999999999999987421   22222234456999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc-cCccccc
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYEL  512 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~-~~~~~~~  512 (739)
                      ||+.+++|.+++... ..+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++... .......
T Consensus        78 ~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             EEETTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred             ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999843 67999999999999999999999999999999999999999999999999998753 2223334


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC---chHHHHHHhhcCC----CCCccCC
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---GPQAMFKVLNRTP----PIPEMLS  585 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~---~~~~~~~i~~~~~----~iP~~ls  585 (739)
                      ...++..|+|||++..      ...++.++||||||+++|+|++|..||....   ....+.+......    .......
T Consensus       157 ~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQ------GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKS  230 (260)
T ss_dssp             SSSSSGGGSCHHHHTT------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSH
T ss_pred             cccccccccccccccc------cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhH
Confidence            5678999999999861      3467789999999999999999999998873   3333333332211    1111224


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      .++.++|.+||..||++||++.++++||||
T Consensus       231 ~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  231 EELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            899999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.6e-43  Score=369.50  Aligned_cols=257  Identities=29%  Similarity=0.539  Sum_probs=227.6

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|+||.||++.+..+++.||+|++....  .......+.+.+|+++|+.++||||+++++++..++.+|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAK--IVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence            36999999999999999999999999999999886421  1223345678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      ||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||+|.||||+.++.+||+|||++......  .
T Consensus        79 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~  155 (290)
T cd05580          79 VMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--T  155 (290)
T ss_pred             EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--C
Confidence            99999999999999775 57999999999999999999999999999999999999999999999999999876544  3


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHH
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF  591 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dL  591 (739)
                      ....|++.|+|||.+.+       ..++.++||||||+++|+|++|+.||...+..+....+......++..++..++++
T Consensus       156 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  228 (290)
T cd05580         156 YTLCGTPEYLAPEIILS-------KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDL  228 (290)
T ss_pred             CCCCCCccccChhhhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHH
Confidence            34568999999998863       34567899999999999999999999887766677777777778888899999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 004660          592 LLRCFLRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       592 I~kcL~~DP~kRp-----Ta~elLqHpwf~~~~~  620 (739)
                      |.+||..||.+|+     +++|+++||||+...+
T Consensus       229 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  262 (290)
T cd05580         229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW  262 (290)
T ss_pred             HHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence            9999999999999     9999999999976543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.2e-43  Score=370.67  Aligned_cols=260  Identities=26%  Similarity=0.429  Sum_probs=216.0

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ..++|++.+.||.|+||.||+|.++.+++.||+|.++......    ....+.+|+.+++.++|+||+++++++..++.+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            4567999999999999999999999999999999987533221    123466799999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      |+||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            99999997 68888887765678999999999999999999999999999999999999999999999999997653322


Q ss_pred             -cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-----------
Q 004660          510 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----------  577 (739)
Q Consensus       510 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-----------  577 (739)
                       ......++..|+|||++.+      ...++.++|||||||++|||++|++||...+..+.+..+....           
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI  232 (301)
T ss_pred             CcccccceeecccCcHHHhC------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence             2223457899999999863      3456779999999999999999999998766554443322110           


Q ss_pred             --------CCC-----------CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          578 --------PPI-----------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       578 --------~~i-----------P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                              ..+           ...++.++++||.+||..||.+|||+.|+|+|+||+....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                    011           1246889999999999999999999999999999987654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.9e-44  Score=402.56  Aligned_cols=254  Identities=29%  Similarity=0.497  Sum_probs=219.3

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-C-----CCeEeeccce
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-H-----ENIVQYYGSE  423 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-H-----PNIVkl~~~~  423 (739)
                      ...+|.++++||+|+||.|.+|.+..|++.||||+|+      .......+...|++||..|+ |     -|||+++++|
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiK------N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIK------NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeec------cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            3448999999999999999999999999999999987      34556677888999999997 5     3899999999


Q ss_pred             eecceEEEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC--CcEEEeecc
Q 004660          424 VVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--GVVKLADFG  500 (739)
Q Consensus       424 ~~~~~l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~--g~vKL~DFG  500 (739)
                      ...+++|||+|++. .+|.++|+.+ ...++...++.|+.||+.||.+||+.||||+|||||||||...  ..|||+|||
T Consensus       258 ~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  258 YFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence            99999999999995 8999999774 4569999999999999999999999999999999999999654  479999999


Q ss_pred             cchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCC-
Q 004660          501 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-  579 (739)
Q Consensus       501 lA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~-  579 (739)
                      .++......+  +.+.++.|+|||++.|       -.|+.+.||||||||++||++|.+.|.+.++.+.+..|++-... 
T Consensus       337 SSc~~~q~vy--tYiQSRfYRAPEVILG-------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P  407 (586)
T KOG0667|consen  337 SSCFESQRVY--TYIQSRFYRAPEVILG-------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP  407 (586)
T ss_pred             cccccCCcce--eeeeccccccchhhcc-------CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence            9998766555  6789999999999995       57888999999999999999999999998887777665431000 


Q ss_pred             ---------------------------------------------------CC-c----------cCCHHHHHHHHHhcc
Q 004660          580 ---------------------------------------------------IP-E----------MLSSEGKDFLLRCFL  597 (739)
Q Consensus       580 ---------------------------------------------------iP-~----------~ls~el~dLI~kcL~  597 (739)
                                                                         .| .          .-...+.|||++||.
T Consensus       408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~  487 (586)
T KOG0667|consen  408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE  487 (586)
T ss_pred             CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence                                                               11 0          112567899999999


Q ss_pred             cCCCCCCCHHHHHcCccccccc
Q 004660          598 RNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       598 ~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      +||.+|+|+.|+|+||||....
T Consensus       488 ~dP~~R~tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  488 WDPAERITPAQALNHPFLTGTS  509 (586)
T ss_pred             cCchhcCCHHHHhcCccccccc
Confidence            9999999999999999998544

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.5e-43  Score=370.09  Aligned_cols=258  Identities=24%  Similarity=0.408  Sum_probs=216.2

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .|++.++||+|+||+||+|.++.+++.||||.+.....  ........+.+|+.+|+.++|+||+.+++.+..++.+|+|
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc--cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence            37889999999999999999999999999998864221  1223345677899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          433 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      |||+.|++|.+++... ...+++.++..|+.||+.||.|||++||+||||||+|||++.++.++|+|||++.........
T Consensus        79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence            9999999999988543 235899999999999999999999999999999999999999999999999999765443333


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch---HHHHHHh-hcCCCCCccCCHH
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVL-NRTPPIPEMLSSE  587 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~---~~~~~i~-~~~~~iP~~ls~e  587 (739)
                      ....|+..|+|||++.+       ..++.++|||||||++|||++|+.||......   .....+. .....++..++.+
T Consensus       159 ~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd05630         159 KGRVGTVGYMAPEVVKN-------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPD  231 (285)
T ss_pred             cCCCCCccccChHHHcC-------CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHH
Confidence            34579999999999863       45778999999999999999999999865432   1222222 1223456678999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHcCccccccc
Q 004660          588 GKDFLLRCFLRNPVERPS-----AVELLEHPFIRNAN  619 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpT-----a~elLqHpwf~~~~  619 (739)
                      +.+||.+||+.||++|+|     ++|+++||||+...
T Consensus       232 ~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05630         232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN  268 (285)
T ss_pred             HHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence            999999999999999999     99999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.9e-43  Score=379.09  Aligned_cols=257  Identities=28%  Similarity=0.549  Sum_probs=214.0

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ..++|++.+.||+|+||.||+|.++.+|..+|+|.+...    ........+.+|+++|+.++|+|||++++++..++.+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   78 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence            456899999999999999999999999999999988642    1233456788999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhC-CeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~-GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      ||||||+.+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus        79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            9999999999999999764 5689999999999999999999975 7999999999999999999999999999765432


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHH----------------
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK----------------  572 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~----------------  572 (739)
                       ......||..|+|||++.+       ..++.++|||||||++|||++|+.||......+....                
T Consensus       158 -~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP  229 (333)
T ss_pred             -ccccCCCCccccCHHHhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence             2234578999999999863       3577899999999999999999999975433222110                


Q ss_pred             ----------------------------Hhhc-CCCCC-ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          573 ----------------------------VLNR-TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       573 ----------------------------i~~~-~~~iP-~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                                  +... .+.++ ..++.++++||.+||++||++|||+.|+|+|+||+...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                                        1111 11111 13578899999999999999999999999999997543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.1e-43  Score=368.76  Aligned_cols=251  Identities=24%  Similarity=0.391  Sum_probs=207.3

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecCCC
Q 004660          360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  439 (739)
Q Consensus       360 LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~gG  439 (739)
                      ||+|+||+||+++++.+|+.||+|++......  .....+.+..|+++|++++||||+++++++..+..+|+||||+.|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK--KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh--cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            79999999999999999999999998632111  1112234567999999999999999999999999999999999999


Q ss_pred             Ccchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCCC
Q 004660          440 SINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP  518 (739)
Q Consensus       440 sL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s~~GT~  518 (739)
                      +|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..........|+.
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence            999888553 2358899999999999999999999999999999999999999999999999998765544434567999


Q ss_pred             CCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch----HHHHHHhhcCCCC-CccCCHHHHHHHH
Q 004660          519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----QAMFKVLNRTPPI-PEMLSSEGKDFLL  593 (739)
Q Consensus       519 ~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~----~~~~~i~~~~~~i-P~~ls~el~dLI~  593 (739)
                      .|+|||++.+       ..++.++|||||||++|||++|+.||......    +....+....... ...++.++++||.
T Consensus       159 ~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  231 (277)
T cd05607         159 GYMAPEILKE-------EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICR  231 (277)
T ss_pred             CccCHHHHcc-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHH
Confidence            9999999863       34778999999999999999999999764332    2223333332222 2457899999999


Q ss_pred             HhcccCCCCCCCH----HHHHcCccccccc
Q 004660          594 RCFLRNPVERPSA----VELLEHPFIRNAN  619 (739)
Q Consensus       594 kcL~~DP~kRpTa----~elLqHpwf~~~~  619 (739)
                      +||+.||++||++    ++++.|+||+..+
T Consensus       232 ~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         232 LFLAKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             HHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence            9999999999999    6788999997644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-43  Score=378.84  Aligned_cols=253  Identities=26%  Similarity=0.471  Sum_probs=205.9

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG  421 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~-----k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~  421 (739)
                      ....++|+++++||+|+||+||+|.+     +.++..||||+++..    ......+.+.+|+.+|..+ +|||||++++
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~~   78 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG----ATASEHKALMSELKILIHIGNHLNVVNLLG   78 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc----cchHHHHHHHHHHHHHHHhccCcceeeEEe
Confidence            34567899999999999999999975     235678999987531    2233446788999999999 8999999999


Q ss_pred             ceeec-ceEEEEEeecCCCCcchhhhhcc---------------------------------------------------
Q 004660          422 SEVVD-DHLYIYLEYVHPGSINRYVREHC---------------------------------------------------  449 (739)
Q Consensus       422 ~~~~~-~~l~LVmEy~~gGsL~~~L~~~~---------------------------------------------------  449 (739)
                      ++... +.+|+||||+++|+|.+++....                                                   
T Consensus        79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (338)
T cd05102          79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN  158 (338)
T ss_pred             EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence            87654 46899999999999999986421                                                   


Q ss_pred             ----------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc---ccccCC
Q 004660          450 ----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKG  516 (739)
Q Consensus       450 ----------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~---~~s~~G  516 (739)
                                ..+++.++..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......   .....+
T Consensus       159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                      2377888999999999999999999999999999999999999999999999986533221   112345


Q ss_pred             CCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHh-h-cCCCCCccCCHHHHHHHH
Q 004660          517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-N-RTPPIPEMLSSEGKDFLL  593 (739)
Q Consensus       517 T~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~-~-~~~~iP~~ls~el~dLI~  593 (739)
                      +..|+|||++.+       ..++.++|||||||+||||++ |..||......+.+...+ . .....+..+++++.+||.
T Consensus       239 ~~~y~aPE~~~~-------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  311 (338)
T cd05102         239 PLKWMAPESIFD-------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIML  311 (338)
T ss_pred             CccccCcHHhhc-------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            788999999863       457789999999999999997 999998765444433333 2 234456778999999999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q 004660          594 RCFLRNPVERPSAVELLE  611 (739)
Q Consensus       594 kcL~~DP~kRpTa~elLq  611 (739)
                      +||..||++|||+.|+++
T Consensus       312 ~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         312 ACWQGDPKERPTFSALVE  329 (338)
T ss_pred             HHccCChhhCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-43  Score=379.78  Aligned_cols=255  Identities=24%  Similarity=0.436  Sum_probs=210.3

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec----
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  426 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~----  426 (739)
                      ..+|++++.||+|+||+||+|.+..+++.||||++....   ......+.+.+|+++|+.++|+||+++++++...    
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            467999999999999999999999999999999876321   1223345677899999999999999999987543    


Q ss_pred             --ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          427 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       427 --~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                        ..+|++||++ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence              3579999998 7889888754  4699999999999999999999999999999999999999999999999999986


Q ss_pred             ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-------
Q 004660          505 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------  577 (739)
Q Consensus       505 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-------  577 (739)
                      ....  .....||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+.+..+.+..+....       
T Consensus       168 ~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         168 ADDE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             cCCC--cCCccccccccCchHhcC------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6432  234579999999999863      3457789999999999999999999998765554444332210       


Q ss_pred             ----------------CCCC--------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          578 ----------------PPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       578 ----------------~~iP--------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                      ...+        ...++.+.+||.+||..||.+|||+.|+|+||||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence                            0011        23466789999999999999999999999999998643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.2e-43  Score=367.28  Aligned_cols=259  Identities=26%  Similarity=0.415  Sum_probs=219.1

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .|+..++||.|+||+||+|.+..+++.||+|.+.....  ........+.+|+++|+.++|+||+.+++.+..++.+|+|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence            37889999999999999999999999999998864221  1222335577899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          433 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      |||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence            9999999999888653 246999999999999999999999999999999999999999999999999999765443333


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHH----hhcCCCCCccCCHH
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV----LNRTPPIPEMLSSE  587 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i----~~~~~~iP~~ls~e  587 (739)
                      ....|+..|+|||++.+       ..++.++|||||||++|||++|+.||...........+    ......++..++.+
T Consensus       159 ~~~~g~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd05632         159 RGRVGTVGYMAPEVLNN-------QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEE  231 (285)
T ss_pred             cCCCCCcCccChHHhcC-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHH
Confidence            45679999999999863       45778999999999999999999999876544333322    33344566778999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHcCcccccccc
Q 004660          588 GKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANY  620 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpT-----a~elLqHpwf~~~~~  620 (739)
                      +.+||.+||..||++||+     +.++++|+||....+
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             HHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence            999999999999999999     899999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.8e-43  Score=355.49  Aligned_cols=256  Identities=56%  Similarity=0.991  Sum_probs=222.7

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++.+.||+|+||+||+|.++.++..|++|++..........+..+.+.+|+.+++.++|+||+++++++..++.+|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            58889999999999999999999999999999876444444456678899999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL  512 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~  512 (739)
                      |||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK  159 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence            9999999999999765 468999999999999999999999999999999999999999999999999987765444344


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh--cCCCCCccCCHHHHH
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD  590 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~--~~~~iP~~ls~el~d  590 (739)
                      ...|+..|++||.+..      ...++.++|||||||++|+|++|+.||......+...++..  ....++..++.++++
T Consensus       160 ~~~~~~~y~~pe~~~~------~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (258)
T cd06632         160 SFKGSPYWMAPEVIAQ------QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD  233 (258)
T ss_pred             ccCCCcceeCHHHhcC------CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence            5678999999999863      11367899999999999999999999987765554444433  344567778999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCccc
Q 004660          591 FLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       591 LI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ||.+||..+|.+||++.++|+|||+
T Consensus       234 li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         234 FILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHhhcCcccCcCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.1e-43  Score=358.90  Aligned_cols=255  Identities=49%  Similarity=0.828  Sum_probs=219.7

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc----cHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~----~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      +|.+++.||.|+||.||+|.+..+++.||+|.+........    ..+..+.+.+|+.+++.++|+||+++++++..++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            48899999999999999999999999999998864332211    23345778899999999999999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      .++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            99999999999999999765 56899999999999999999999999999999999999999999999999999876532


Q ss_pred             c-------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCC
Q 004660          509 S-------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPI  580 (739)
Q Consensus       509 ~-------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~i  580 (739)
                      .       ......|+..|+|||.+.+       ..++.++|||||||++|+|++|+.||........+.++... ...+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQ-------TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI  232 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhcc-------CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcC
Confidence            1       1123458899999999863       35677899999999999999999999887666665555443 4466


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      +..++.++.++|.+||+.||.+||++.|+++|+||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            77889999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.6e-43  Score=362.48  Aligned_cols=253  Identities=30%  Similarity=0.537  Sum_probs=208.9

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|.+.+.||+|+||+||+|+++.+++.||||++.....+   ....+.+.+|+.+++.++|+||+++++++..++.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence            489999999999999999999999999999998643222   12235677899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc--cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          433 LEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~--~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      |||+. ++|.+++...  ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... 
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            99997 6888887543  2568999999999999999999999999999999999999999999999999987653222 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC------------
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------  577 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------------  577 (739)
                      ......++..|+|||++.+      ...++.++|||||||++|||++|+.||.+.........+....            
T Consensus       157 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLG------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT  230 (285)
T ss_pred             cccCCcccccccChHHhcC------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence            1223457899999999863      3456779999999999999999999998765544333322100            


Q ss_pred             -----------------CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 -----------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 -----------------~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                                       ......++.++++||.+||..||++|||+.++|.|+||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                             00123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.9e-43  Score=397.62  Aligned_cols=261  Identities=26%  Similarity=0.414  Sum_probs=223.7

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      .....+|++.++||+|+||+||+|++..+|+.||||++....   ........+.+|+.+|..++|+||+++++.+...+
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG---MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc---CCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            344579999999999999999999999999999999987432   23344567889999999999999999988765432


Q ss_pred             --------eEEEEEeecCCCCcchhhhhc---cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEE
Q 004660          428 --------HLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL  496 (739)
Q Consensus       428 --------~l~LVmEy~~gGsL~~~L~~~---~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL  496 (739)
                              .+++||||+.+|+|.++|...   ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence                    378999999999999998653   346899999999999999999999999999999999999999999999


Q ss_pred             eecccchhccCc---ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHH
Q 004660          497 ADFGMAKHLTGL---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV  573 (739)
Q Consensus       497 ~DFGlA~~~~~~---~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i  573 (739)
                      +|||+++.+...   .......||+.|+|||++.+       ..++.++|||||||+||||++|+.||......+.+..+
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~  257 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-------KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT  257 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999999765432   22234679999999999863       45788999999999999999999999987777777766


Q ss_pred             hhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          574 LNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       574 ~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      +.. ..+++..+++++.+||.+||..||.+||++.++|+|||++..
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        258 LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            654 345778899999999999999999999999999999998753

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.2e-43  Score=364.06  Aligned_cols=253  Identities=33%  Similarity=0.535  Sum_probs=207.5

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.+......   ......+.+|+++++.++|+||+++++++.+.+.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc---ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence            589999999999999999999999999999998753221   12234577899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~~  511 (739)
                      |||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.... ..
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          78 FEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence            99997 57888776655679999999999999999999999999999999999999999999999999998654322 12


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCC-CCCchHHHHHHhhcC-------------
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKVLNRT-------------  577 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~-~~~~~~~~~~i~~~~-------------  577 (739)
                      ....++..|+|||++.+      ...++.++|||||||++|||++|..||. ..+..+.+..+....             
T Consensus       157 ~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         157 SAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCccccCCcChHHHhC------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            23467899999999864      3456789999999999999999988864 333333332221100             


Q ss_pred             -------C---------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 -------P---------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 -------~---------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                             .         .....++.++++||.+||..||.+|||++|+|+||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                   0         0112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-43  Score=364.17  Aligned_cols=260  Identities=36%  Similarity=0.639  Sum_probs=223.4

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||.|+||+||+|.++.++..||+|.+...     .....+.+.+|+++++.++|+||+++++++..++.+|+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            4699999999999999999999999999999998642     23344678889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      ||||+.+++|.+++.+....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            999999999999998766679999999999999999999999999999999999999999999999999987653322 2


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC---CCCccCCHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSE  587 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~---~iP~~ls~e  587 (739)
                      .....|+..|+|||++.....  ....++.++|||||||++|||++|+.||...+....+.++.....   ..+..++.+
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~--~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETF--KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS  237 (280)
T ss_pred             cceeecchhhcCHHHHhhccc--CCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence            233568999999999864211  123567799999999999999999999988777666666654432   335678899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          588 GKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      +.++|.+||..||.+||++.++|+|+||...
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=368.12  Aligned_cols=264  Identities=28%  Similarity=0.497  Sum_probs=226.2

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      .+|++.+.||+|+||+||+|.+..+++.||||.+...  ........+.+.+|+++|+.++|+||+++++.+...+..|+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   78 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKK--EMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL   78 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecc--ccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence            3699999999999999999999999999999998642  22223355778899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          432 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      ||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||++....... 
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999999998753 3568999999999999999999999999999999999999999999999999986542211 


Q ss_pred             -----------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCC
Q 004660          510 -----------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP  560 (739)
Q Consensus       510 -----------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~P  560 (739)
                                                   ......||..|+|||++.+       ..++.++||||||+++|+|++|+.|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-------DGHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-------CCCCchHHHHHHHHHHHHHhhCCCC
Confidence                                         1112468899999999863       3467799999999999999999999


Q ss_pred             CCCCCchHHHHHHhhcCCCCCcc--CCHHHHHHHHHhcccCCCCCCC----HHHHHcCccccccccCCCC
Q 004660          561 WSEFEGPQAMFKVLNRTPPIPEM--LSSEGKDFLLRCFLRNPVERPS----AVELLEHPFIRNANYQNLS  624 (739)
Q Consensus       561 F~~~~~~~~~~~i~~~~~~iP~~--ls~el~dLI~kcL~~DP~kRpT----a~elLqHpwf~~~~~~~~~  624 (739)
                      |...+....+.++......++..  ++.+++++|.+||..||++||+    ++|+|+|+||+...+..+.
T Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~  301 (316)
T cd05574         232 FKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR  301 (316)
T ss_pred             CCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence            98888777777777665555544  6899999999999999999999    9999999999876654443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.1e-42  Score=353.32  Aligned_cols=253  Identities=29%  Similarity=0.543  Sum_probs=216.2

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee-cceEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDHLYI  431 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~-~~~l~L  431 (739)
                      .|++++.||+|+||.||++.++.+++.||+|++....   ......+.+.+|+++++.++|+||+++++.+.. +..+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN---ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh---cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            4899999999999999999999999999999986422   223345668889999999999999999998764 446899


Q ss_pred             EEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-c
Q 004660          432 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~-~  509 (739)
                      ||||+.+++|.+++... ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999999999763 345899999999999999999999999999999999999999999999999999766432 2


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-CCCCccCCHHH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEG  588 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~el  588 (739)
                      ......|++.|+|||++.+       ..++.++|||||||++|+|++|+.||...+.......+.... ..++..++.++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (257)
T cd08223         158 MASTLIGTPYYMSPELFSN-------KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPEL  230 (257)
T ss_pred             ccccccCCcCccChhHhcC-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHH
Confidence            2234568999999999863       456779999999999999999999998776666555555443 35567789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      .+||.+||+.||++||++.++++||||
T Consensus       231 ~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         231 GELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-45  Score=400.39  Aligned_cols=263  Identities=35%  Similarity=0.619  Sum_probs=235.6

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .+.|.|+..||.|+||+||+|.++.++...|.|+|..     +..+.++.+.-||+||..++||+||+|++.|..++.+|
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            3568999999999999999999999999999999874     45666788889999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-Ccc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLS  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~-~~~  509 (739)
                      |+.|||.||-...++.+.+..|++.+|..+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+.... ...
T Consensus       106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence            9999999999999998888999999999999999999999999999999999999999999999999999875443 233


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCC---CCccCCH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSS  586 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~---iP~~ls~  586 (739)
                      ...++.|||+|||||+.......  +..|+.++||||||++|+||..+.+|-...+....+.+|....++   .|..++.
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~K--D~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFK--DQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR  263 (1187)
T ss_pred             hhccccCCcccccchheeecccc--CCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence            34478999999999998743322  468899999999999999999999999999999998888765543   4678899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      .+.|||++||.+||..||++.|+|+||||++...
T Consensus       264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             HHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence            9999999999999999999999999999987653

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-42  Score=352.18  Aligned_cols=253  Identities=29%  Similarity=0.534  Sum_probs=219.9

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|.+.+.||+|+||.||+|.++.+|+.|++|.+.....   .......+.+|+++++.++|+||+++++++..++..|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM---NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC---CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            48899999999999999999999999999998864322   233456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          433 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      |||+.|++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.+.... .
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999999764 4568999999999999999999999999999999999999999999999999988664432 2


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCccCCHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK  589 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~  589 (739)
                      .....|+..|+|||++.+       ..++.++|||||||++|+|++|+.||......+....+... ...++..++.++.
T Consensus       158 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd08529         158 ANTIVGTPYYLSPELCED-------KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLA  230 (256)
T ss_pred             hhccccCccccCHHHhcC-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHH
Confidence            234568999999999863       34677999999999999999999999887766666666544 3455667899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          590 DFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ++|.+||+.+|++||++.++++|||+
T Consensus       231 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         231 QLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHHccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.6e-42  Score=355.79  Aligned_cols=256  Identities=45%  Similarity=0.814  Sum_probs=216.4

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec--ceE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL  429 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~--~~l  429 (739)
                      ..|.++++||+|+||.||+|.++.+|..||||.+.............+.+.+|+.+++.++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            469999999999999999999999999999998864333333344567889999999999999999999987663  568


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      |+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            8999999999999998765 458999999999999999999999999999999999999999999999999997654211


Q ss_pred             ----cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc--CCCCCcc
Q 004660          510 ----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEM  583 (739)
Q Consensus       510 ----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP~~  583 (739)
                          ......|+..|+|||.+.+       ..++.++|||||||++|||++|+.||........+.++...  ...+|..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISG-------EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH  233 (265)
T ss_pred             ccccccccCCCCccccChhhhcC-------CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchh
Confidence                1223568999999998863       35677999999999999999999999877655555554432  3446677


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR  616 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~  616 (739)
                      ++..+.++|.+||. +|++||+++|+++|+|+.
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            88999999999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.7e-43  Score=369.21  Aligned_cols=245  Identities=25%  Similarity=0.459  Sum_probs=192.3

Q ss_pred             eeEEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee--cceEEEE
Q 004660          357 GKLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIY  432 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k--~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~--~~~l~LV  432 (739)
                      +++||+|+||+||+|+++  .+++.||+|.+....   .    ...+.+|+.+|+.++|||||++++++..  +..+|+|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---I----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---C----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            578999999999999976  467899999886321   1    1346689999999999999999998854  4568999


Q ss_pred             EeecCCCCcchhhhhc--------cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEe----cCCCcEEEeecc
Q 004660          433 LEYVHPGSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFG  500 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~--------~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILL----d~~g~vKL~DFG  500 (739)
                      |||+. ++|.+++...        ...+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            99986 5787776432        1358999999999999999999999999999999999999    456799999999


Q ss_pred             cchhccCcc----cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc---------h
Q 004660          501 MAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---------P  567 (739)
Q Consensus       501 lA~~~~~~~----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~---------~  567 (739)
                      +++.+....    ......||+.|+|||++.+      ...++.++|||||||++|||++|++||.....         .
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~  231 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  231 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcC------CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccH
Confidence            998764321    2234578999999999874      34577899999999999999999999964322         1


Q ss_pred             HHHHHHhhcC-----------CCC---------------------------CccCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004660          568 QAMFKVLNRT-----------PPI---------------------------PEMLSSEGKDFLLRCFLRNPVERPSAVEL  609 (739)
Q Consensus       568 ~~~~~i~~~~-----------~~i---------------------------P~~ls~el~dLI~kcL~~DP~kRpTa~el  609 (739)
                      ..+..++...           ..+                           ....+.++.+||.+||..||++|+|++|+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~  311 (317)
T cd07868         232 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  311 (317)
T ss_pred             HHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHH
Confidence            1111111100           000                           01235678999999999999999999999


Q ss_pred             HcCccc
Q 004660          610 LEHPFI  615 (739)
Q Consensus       610 LqHpwf  615 (739)
                      |+||||
T Consensus       312 l~hp~f  317 (317)
T cd07868         312 MQDPYF  317 (317)
T ss_pred             hcCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.6e-42  Score=358.12  Aligned_cols=254  Identities=32%  Similarity=0.543  Sum_probs=212.1

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++......   ....+.+.+|+.+++.++|+||+++++++...+.+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC---ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            3699999999999999999999999999999988643221   1223457789999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      ||||++++.|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... .
T Consensus        78 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          78 VFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            99999999888877553 469999999999999999999999999999999999999999999999999998765433 2


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-------------
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------------  577 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-------------  577 (739)
                      .....++..|+|||.+.+      ...++.++|||||||++|||++|+.||.+....+....+....             
T Consensus       157 ~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         157 YTDYVATRWYRAPELLVG------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             ccCcccccccCCHHHHhC------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence            233457899999999863      3456779999999999999999999998766554444332100             


Q ss_pred             ------CCC------------CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 ------PPI------------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 ------~~i------------P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                            ...            -..++..+.+||.+||..||++||++.|+|.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                  000            12357889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1e-42  Score=372.49  Aligned_cols=255  Identities=25%  Similarity=0.464  Sum_probs=207.6

Q ss_pred             EeeEEeec--CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          356 KGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       356 i~~~LG~G--~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      ++++||+|  +|++||++.++.+|+.||||.++...   ...+..+.+.+|+.+++.++|||||++++++..++.+|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA---CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhh---ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            57889999  78999999999999999999886422   12344567888999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc---
Q 004660          434 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---  509 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~---  509 (739)
                      ||+.+|+|.+++..+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.......   
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999999654 3458999999999999999999999999999999999999999999999998764432111   


Q ss_pred             -----cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC------
Q 004660          510 -----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------  578 (739)
Q Consensus       510 -----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~------  578 (739)
                           ......++..|+|||++.+.     ...++.++|||||||++|||++|+.||.................      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQN-----LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  233 (327)
T ss_pred             cccccccccccceecccChHHhhcc-----cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence                 11123467889999998741     13577899999999999999999999986544433333222110      


Q ss_pred             ----------------------------------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          579 ----------------------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       579 ----------------------------------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                                                              +....+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                                    0112356789999999999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.4e-42  Score=355.61  Aligned_cols=254  Identities=39%  Similarity=0.768  Sum_probs=216.1

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC-cccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~-~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      +|++++.||.|+||+||+|.. .+|+.+|+|.++..... .........+.+|+.+|+.++|+||+++++++...+.+|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            589999999999999999986 47899999998753322 1223445678999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC----
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG----  507 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~----  507 (739)
                      ||||+.|++|.+++.+. ..+++..+..++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++.....    
T Consensus        80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            99999999999999765 4689999999999999999999999999999999999999999999999999876532    


Q ss_pred             ---cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc---CCCCC
Q 004660          508 ---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIP  581 (739)
Q Consensus       508 ---~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~---~~~iP  581 (739)
                         ........|+..|+|||.+.+       ..++.++|||||||++|+|++|+.||...+.......+...   ...++
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINE-------SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP  231 (265)
T ss_pred             ccccccccccCCCccccChhhhcC-------CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCC
Confidence               111223568999999999863       34677999999999999999999999876655544444332   34567


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ..++.++.++|.+||..+|.+||++.|+|+||||
T Consensus       232 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            7789999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.4e-42  Score=363.92  Aligned_cols=263  Identities=37%  Similarity=0.605  Sum_probs=222.2

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .+.|+++++||.|+||.||+|++..++..||+|.+..     ...+..+.+.+|+.+++.++|+||+++++.+..++.+|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence            4679999999999999999999999999999998863     23444677888999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      +||||+.+++|..++.+....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            9999999999998887655679999999999999999999999999999999999999999999999999987543321 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC---CCCccCCH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSS  586 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~---~iP~~ls~  586 (739)
                      ......++..|+|||.+.+....  ...++.++|||||||++|||++|..||...+......++.....   ..+..++.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMK--DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM  243 (292)
T ss_pred             ccceecCCccccCceeecccccc--CCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence            22345688999999988532111  23467899999999999999999999987766555555543322   23456788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      ++.++|.+||..||++||++.++|+||||.....
T Consensus       244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            9999999999999999999999999999976543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.3e-42  Score=360.28  Aligned_cols=254  Identities=30%  Similarity=0.505  Sum_probs=214.9

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++++.||+|+||.||+|.+..+|..||+|++......   ......+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence            589999999999999999999999999999998753221   23346788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--c
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--Y  510 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~--~  510 (739)
                      |||+ +++|.+++......+++.+++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......  .
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9999 999999997765779999999999999999999999999999999999999999999999999998765432  1


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC------------
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------------  578 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~------------  578 (739)
                      .....|+..|+|||.+.+      ...++.++|||||||++|||++|.++|........+..++....            
T Consensus       157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         157 YSHQVATRWYRAPELLYG------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             cccccCcccccCceeeec------cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            234568999999998753      34567899999999999999999998977665554444332100            


Q ss_pred             ------------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 004660          579 ------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR  616 (739)
Q Consensus       579 ------------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~  616 (739)
                                        .+...++.++.+||++||..||.+||+++++|+||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                              01124578999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=393.90  Aligned_cols=251  Identities=45%  Similarity=0.829  Sum_probs=223.8

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecCC
Q 004660          359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHP  438 (739)
Q Consensus       359 ~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~g  438 (739)
                      +||+|+||+||.|+++.|....|||.|..     +......-+..||.+.++|+|.|||+++|.+..++.+-|+||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe-----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE-----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccc-----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            79999999999999999999999998863     2334456688899999999999999999999999999999999999


Q ss_pred             CCcchhhhhccccc--cHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC-CCcEEEeecccchhccCc-cccccc
Q 004660          439 GSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGL-SYELSL  514 (739)
Q Consensus       439 GsL~~~L~~~~~~l--se~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~-~g~vKL~DFGlA~~~~~~-~~~~s~  514 (739)
                      |+|..+++..-+.+  .|..+..|.+||++||+|||++.|||||||-+|+||+. .|.+||.|||-++.+.+- ..+.++
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            99999998876777  89999999999999999999999999999999999974 599999999999988763 445678


Q ss_pred             CCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHH-HHHH--hhcCCCCCccCCHHHHHH
Q 004660          515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKV--LNRTPPIPEMLSSEGKDF  591 (739)
Q Consensus       515 ~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~-~~~i--~~~~~~iP~~ls~el~dL  591 (739)
                      .||..|||||++..     |-..|+.++|||||||++.||.||++||......+. ++++  +..-+++|+.++.+++.|
T Consensus       737 TGTLQYMAPEvIDq-----G~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~F  811 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQ-----GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNF  811 (1226)
T ss_pred             ccchhhhChHhhcc-----CCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHH
Confidence            99999999999974     456789999999999999999999999987765543 3333  345689999999999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          592 LLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       592 I~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      |.+|+..||.+||+|.++|+.||++..+
T Consensus       812 ilrcFepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  812 ILRCFEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             HHHHcCCCcccCccHHHhccCcccccCC
Confidence            9999999999999999999999998763

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=379.46  Aligned_cols=254  Identities=39%  Similarity=0.695  Sum_probs=226.1

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      -|.++++||+|+||.||+|.++++|+.+|||.+.+   +.    .+..+.+||.||++++.++||++||.|.....+|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence            48899999999999999999999999999998764   21    245677799999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-ccc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYE  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~-~~~  511 (739)
                      ||||..|++.+.++.+.+.++|.++..+++..+.||+|||...-+|||||..||||+.+|..||+|||.|..+.+. ...
T Consensus       107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence            9999999999999988899999999999999999999999999999999999999999999999999999877542 233


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC---CCCccCCHHH
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEG  588 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~---~iP~~ls~el  588 (739)
                      .+..||+.|||||+++..       .|..++||||||++..||..|++||.+......++.|-...+   .-|+.++.++
T Consensus       187 NTVIGTPFWMAPEVI~EI-------GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F  259 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEI-------GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEF  259 (502)
T ss_pred             CccccCcccccHHHHHHh-------ccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHH
Confidence            467899999999999853       466799999999999999999999999887766665544332   3467789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      .|||++||.++|++|-||.++++|+|+++...
T Consensus       260 ~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  260 NDFIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             HHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence            99999999999999999999999999998654

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.9e-42  Score=356.17  Aligned_cols=255  Identities=45%  Similarity=0.858  Sum_probs=215.8

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee--cceEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLY  430 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~--~~~l~  430 (739)
                      .|++++.||+|+||.||+|.+..++..||+|++...............+.+|+.+++.++|+||+++++.+..  .+.++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            5899999999999999999999999999999987544333344456778999999999999999999998765  36789


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc--
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL--  508 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~--  508 (739)
                      ++|||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...  
T Consensus        83 l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            999999999999999764 45899999999999999999999999999999999999999999999999998765321  


Q ss_pred             --ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh--cCCCCCccC
Q 004660          509 --SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEML  584 (739)
Q Consensus       509 --~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~--~~~~iP~~l  584 (739)
                        .......++..|+|||.+.+       ..++.++|||||||++|||++|+.||......+.+.++..  ..+.++..+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISG-------EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHI  234 (266)
T ss_pred             cCCccccCCccccccCHHHhCC-------CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhc
Confidence              11123458899999998863       3567799999999999999999999988766655554433  234566778


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIR  616 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLqHpwf~  616 (739)
                      +..++++| +||..+|++||+++|+++||||+
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            89999999 67778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-45  Score=429.26  Aligned_cols=259  Identities=44%  Similarity=0.780  Sum_probs=228.4

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      -+|+.+..||.|.||.||-|.+..+|+..|+|.|++...+   ....+.+.+|+++|..|+|||||++||+..+.+.+||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            4789999999999999999999999999999999875544   4456778899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      +||||+||+|.++++. ++..+|...+.+..|++.||.|||++|||||||||+||||+.+|.+|++|||.|..+......
T Consensus      1312 FMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            9999999999999854 567889999999999999999999999999999999999999999999999999887665322


Q ss_pred             -----cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch-HHHHHH-hhcCCCCCccC
Q 004660          512 -----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKV-LNRTPPIPEML  584 (739)
Q Consensus       512 -----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~-~~~~~i-~~~~~~iP~~l  584 (739)
                           ....||+.|||||++.+...    ...+.++||||||||+.||+||+.||...+.. ++++++ ++..+.+|+.+
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~----kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~l 1466 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKG----KGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERL 1466 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhccccc----CCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhh
Confidence                 24679999999999986421    23445999999999999999999999877665 444554 45678999999


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      +.+.+|||.+||..||++|+++.|+|+|.|-+..
T Consensus      1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             hHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            9999999999999999999999999999987643

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-42  Score=356.25  Aligned_cols=253  Identities=29%  Similarity=0.477  Sum_probs=220.9

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....  .......+.+.+|++++++++||||+++++.+..++..|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK--CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh--hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            4899999999999999999999999999999987422  12234467889999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL  512 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~  512 (739)
                      |||+.|++|.+++... ..+++..+..|+.||++||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus        79 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  157 (258)
T cd05578          79 VDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT  157 (258)
T ss_pred             EeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence            9999999999999775 579999999999999999999999999999999999999999999999999998765544444


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc--hHHHHHHhh-cCCCCCccCCHHHH
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLN-RTPPIPEMLSSEGK  589 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~--~~~~~~i~~-~~~~iP~~ls~el~  589 (739)
                      ...|+..|+|||.+.+       ..++.++||||||+++|+|++|+.||.....  ...+.+... ....++..++.++.
T Consensus       158 ~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (258)
T cd05578         158 STSGTPGYMAPEVLCR-------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAI  230 (258)
T ss_pred             ccCCChhhcCHHHHcc-------cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHH
Confidence            5668999999999863       3467799999999999999999999987664  333333333 55677888999999


Q ss_pred             HHHHHhcccCCCCCCCH--HHHHcCccc
Q 004660          590 DFLLRCFLRNPVERPSA--VELLEHPFI  615 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa--~elLqHpwf  615 (739)
                      ++|.+||..||.+|+++  .|+++||||
T Consensus       231 ~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         231 DAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            99999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=352.94  Aligned_cols=255  Identities=38%  Similarity=0.624  Sum_probs=217.3

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|++....     .+..+.+.+|+.+++.++||||+++++++..++.+|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW   76 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence            457999999999999999999999999999999987432     224567889999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      ++|||+.+++|.+++......+++.+++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+.... 
T Consensus        77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            9999999999999997765679999999999999999999999999999999999999999999999999997764422 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-----CCCccC
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----PIPEML  584 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-----~iP~~l  584 (739)
                      ......++..|+|||.+.+..    ...++.++|||||||++|||++|+.||...........+.....     ..+..+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~----~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVER----KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW  232 (262)
T ss_pred             ccccccCCccccCchhhcccc----cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhh
Confidence            223456899999999986311    12567799999999999999999999988765555544433311     123345


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLEHPF  614 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLqHpw  614 (739)
                      +.++.+||++||..||.+|||+.+++.|+|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         233 SPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.2e-42  Score=351.86  Aligned_cols=254  Identities=33%  Similarity=0.623  Sum_probs=217.6

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++++.||.|+||+||+|....++..+|+|++.....    ......+.+|+++|+.++|+||+++++.+..++..|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC----QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc----chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            469999999999999999999999999999998863221    2245778999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhc--cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          432 YLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~--~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      ||||+.+++|.+++...  ...+++..++.++.||+.||.|||++||+||||||+||++++++.+||+|||++..+....
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999999999764  2468999999999999999999999999999999999999999999999999997765432


Q ss_pred             cc-----cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCC-CC--
Q 004660          510 YE-----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IP--  581 (739)
Q Consensus       510 ~~-----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~-iP--  581 (739)
                      ..     ....|+..|+|||.+..      ...++.++|||||||++|+|++|+.||......+.+.++...... ++  
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  230 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQ------VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETG  230 (267)
T ss_pred             cccccccccccCChhhcChHHHcc------ccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCc
Confidence            22     34568999999999874      235677999999999999999999999887766666655544321 11  


Q ss_pred             ---ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          582 ---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       582 ---~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                         ..++.++.++|.+||..||++||++.++++||||
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence               2567899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.5e-42  Score=361.93  Aligned_cols=260  Identities=29%  Similarity=0.464  Sum_probs=216.8

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++.+.||+|+||.||+|.++.+|+.||||.++..............+..|+++++.++|+||+++++++..++.+|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            48999999999999999999999999999999875433222233445677899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~~  511 (739)
                      |||+ +|+|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 899999997754469999999999999999999999999999999999999999999999999997764432 22


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-------------
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-------------  578 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-------------  578 (739)
                      ....++..|+|||.+.+      ...++.++|||||||++|||++|.++|......+.+.++.....             
T Consensus       160 ~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         160 THQVVTRWYRAPELLFG------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             cccccceeeeCHHHHhC------CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence            23457889999998853      34567899999999999999999888887665554444432100             


Q ss_pred             ---------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          579 ---------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       579 ---------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                     .+...++.++.+||.+||..||++|||+.|+|+|+||++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence                           01133578899999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.3e-42  Score=359.96  Aligned_cols=259  Identities=35%  Similarity=0.579  Sum_probs=219.9

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .|++.+.||.|+||.||+|.+..++..+++|.+..     ......+.+.+|+++++.++|+||+++++++..++..|+|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT-----KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC-----CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            47899999999999999999999999999998753     1233456788899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~~  511 (739)
                      |||+.+++|..++......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            99999999999886655679999999999999999999999999999999999999999999999999987653321 22


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC---CCCCccCCHHH
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSSEG  588 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---~~iP~~ls~el  588 (739)
                      ....|+..|+|||++.....  ....++.++|||||||++|||++|+.||......+....+....   ...+..++.++
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETS--KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF  238 (282)
T ss_pred             ccccccccccCHhhccccCC--CCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHH
Confidence            34568999999999853211  12456779999999999999999999998877666665554432   23455688999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      ++||.+||..||.+||++.++++||||...
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            999999999999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.5e-42  Score=353.85  Aligned_cols=256  Identities=37%  Similarity=0.757  Sum_probs=215.8

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc-ccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~-~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      .|+.+++||+|+||.||+|.++.+++.||+|++....... ......+.+.+|+++|+.++|+||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4889999999999999999999999999999987433222 223456789999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC-cEEEeecccchhccCcc-
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g-~vKL~DFGlA~~~~~~~-  509 (739)
                      ||||+.|++|.+++.+. ..+++..++.|+.||+.||.|||++||+|+||||+||+++.++ .+||+|||++....... 
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            99999999999999764 5689999999999999999999999999999999999998776 69999999987664321 


Q ss_pred             ----cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchH---HHHHHh--hcCCCC
Q 004660          510 ----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ---AMFKVL--NRTPPI  580 (739)
Q Consensus       510 ----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~---~~~~i~--~~~~~i  580 (739)
                          ......|+..|+|||.+.+       ..++.++|||||||++|+|++|..||.......   .+..+.  .....+
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  232 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRG-------EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI  232 (268)
T ss_pred             cCCccccccccccceeCHhHhcc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCC
Confidence                1123468899999999863       356779999999999999999999997544322   222221  234556


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR  616 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~  616 (739)
                      +..++.++.++|.+||..||.+||++.++|+||||+
T Consensus       233 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             chhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            777899999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.9e-42  Score=351.46  Aligned_cols=250  Identities=40%  Similarity=0.700  Sum_probs=217.0

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||.|+||.||+|..+.++..|++|.+...       .....+.+|+++++.++|+||+++++.+..++.+|+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            5799999999999999999999999999999988631       115678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      +|||+.+++|.+++......+++..++.++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++....... .
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            999999999999997766779999999999999999999999999999999999999999999999999998765433 2


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC---CCCCccCCHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSSE  587 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---~~iP~~ls~e  587 (739)
                      .....|+..|+|||++.+       ..++.++||||||+++|+|++|+.||...........+....   ...+..++.+
T Consensus       156 ~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQE-------IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPE  228 (256)
T ss_pred             cccccCCccccCHHHHhc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHH
Confidence            233458899999999873       356789999999999999999999998766554444433321   2234567889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          588 GKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      +.++|.+||..||++|||+.|+|+|+||
T Consensus       229 ~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         229 FNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=387.22  Aligned_cols=251  Identities=29%  Similarity=0.515  Sum_probs=220.8

Q ss_pred             CCCCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       346 ~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      .+......+.+++.||+|-||.||+|.++. ...||+|.++....   .   ...+.+|+++|++|+|+|||++|+++..
T Consensus       200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m---~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~  272 (468)
T KOG0197|consen  200 PWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM---S---PEAFLREAQIMKKLRHEKLVKLYGVCTK  272 (468)
T ss_pred             CeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc---C---hhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence            455566678889999999999999999974 35899999874321   1   2456789999999999999999999999


Q ss_pred             cceEEEEEeecCCCCcchhhhh-ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          426 DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~-~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      ++.+||||||+..|+|.++|+. .+..+...+...++.||++||+||.++++|||||...||||++++.+||+|||||+.
T Consensus       273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence            8899999999999999999987 567799999999999999999999999999999999999999999999999999996


Q ss_pred             ccCcccccccCC--CCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh-cCCCC
Q 004660          505 LTGLSYELSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPI  580 (739)
Q Consensus       505 ~~~~~~~~s~~G--T~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~i  580 (739)
                      +.++.+.....+  -..|.|||.+.       ...++.++|||||||+||||+| |+.||.+....+.+..+.. .+.+-
T Consensus       353 ~~d~~Y~~~~~~kfPIkWtAPEa~~-------~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~  425 (468)
T KOG0197|consen  353 IGDDEYTASEGGKFPIKWTAPEALN-------YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR  425 (468)
T ss_pred             cCCCceeecCCCCCCceecCHHHHh-------hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC
Confidence            666555444333  45799999998       3578899999999999999999 9999999999999888865 46788


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELL  610 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~elL  610 (739)
                      |..+++++.++|+.||..+|++|||++.+.
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            899999999999999999999999998665

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.1e-42  Score=356.39  Aligned_cols=254  Identities=36%  Similarity=0.594  Sum_probs=212.4

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ..+|++.+.||+|+||.||+|++..+++.||+|+++...     ......+.+|+.+++.++||||+++++++...+.+|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            457999999999999999999999999999999987421     122345778999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      +||||+.+++|.+++... +.+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.... 
T Consensus        83 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             EEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            999999999999998765 569999999999999999999999999999999999999999999999999987654321 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCC-----CccC
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI-----PEML  584 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~i-----P~~l  584 (739)
                      ......|+..|+|||++...    ....++.++|||||||++|||++|+.||...................     ...+
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVE----RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW  237 (267)
T ss_pred             ccccccCcccccChhhhccc----cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence            22345689999999997521    12346779999999999999999999997665544443332222111     1246


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLEHPF  614 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLqHpw  614 (739)
                      +..+.+||.+||..||++||++.++|+|||
T Consensus       238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.9e-42  Score=353.47  Aligned_cols=251  Identities=29%  Similarity=0.481  Sum_probs=218.3

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecCCC
Q 004660          360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  439 (739)
Q Consensus       360 LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~gG  439 (739)
                      ||.|+||.||+|++..+++.||+|++.....  ......+.+.+|+++++.++|+||+++++.+..++.+|+||||++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcc--hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            6999999999999999999999999874321  22334567899999999999999999999999999999999999999


Q ss_pred             CcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCCCC
Q 004660          440 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN  519 (739)
Q Consensus       440 sL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s~~GT~~  519 (739)
                      +|.+++.+. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.............|+..
T Consensus        79 ~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  157 (262)
T cd05572          79 ELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE  157 (262)
T ss_pred             cHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence            999999765 4589999999999999999999999999999999999999999999999999987765433344578999


Q ss_pred             CCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC--chHHHHHHh--hcCCCCCccCCHHHHHHHHHh
Q 004660          520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE--GPQAMFKVL--NRTPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       520 Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~--~~~~~~~i~--~~~~~iP~~ls~el~dLI~kc  595 (739)
                      |++||.+.+       ..++.++||||||+++|+|++|..||....  ..+...++.  .....+|..++.++.++|.+|
T Consensus       158 ~~~PE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  230 (262)
T cd05572         158 YVAPEIILN-------KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL  230 (262)
T ss_pred             ccChhHhcC-------CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHH
Confidence            999998763       356778999999999999999999998766  555566665  445667777899999999999


Q ss_pred             cccCCCCCCC-----HHHHHcCcccccccc
Q 004660          596 FLRNPVERPS-----AVELLEHPFIRNANY  620 (739)
Q Consensus       596 L~~DP~kRpT-----a~elLqHpwf~~~~~  620 (739)
                      |..||++|++     +.|+++||||+...+
T Consensus       231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         231 LRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             ccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence            9999999999     999999999986543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.3e-42  Score=356.11  Aligned_cols=255  Identities=36%  Similarity=0.570  Sum_probs=212.0

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...+|++++.||+|+||.||+|+++.+++.||+|++....     ......+.+|+.+++.++|+||+++++++..++.+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            3457999999999999999999999999999999986422     12234678899999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      |+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999999999998664 568999999999999999999999999999999999999999999999999998664322


Q ss_pred             -cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCC-----CCcc
Q 004660          510 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-----IPEM  583 (739)
Q Consensus       510 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~-----iP~~  583 (739)
                       ......|+..|+|||.+...    ....++.++|||||||++|||++|+.||...........+......     ....
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVE----KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK  236 (267)
T ss_pred             cccCccccCccccCHhHcccc----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccc
Confidence             22345689999999987531    1234677999999999999999999999765443333322222111     1234


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPF  614 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLqHpw  614 (739)
                      ++..+.+||.+||..||++||+++++|+|.|
T Consensus       237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         237 WSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             cCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            6889999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-43  Score=386.03  Aligned_cols=267  Identities=27%  Similarity=0.468  Sum_probs=220.3

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeec
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD  426 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~  426 (739)
                      .+...+|+++++||+||.+.||++.... ...||+|++...   ..+...+.-+.+||++|.+|+ |.+||+||++...+
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~---~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL---EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh---hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            4556789999999999999999998654 466777765432   233556778999999999996 99999999999999


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      +.+||||||=+ .||..+|++....+....++.|.+||+.||+++|.+||||.||||.|+|| -.|.+||+|||+|..+.
T Consensus       433 ~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  433 GYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQ  510 (677)
T ss_pred             ceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccC
Confidence            99999999864 79999998876667767999999999999999999999999999999999 67899999999999886


Q ss_pred             Cccc---ccccCCCCCCCChHHHHHhhhcCC----CCCCCcchhhhHHHHHHHHHhhCCCCCCCCC-chHHHHHHhhcCC
Q 004660          507 GLSY---ELSLKGSPNWMAPEVIKAVMQKDG----NPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-GPQAMFKVLNRTP  578 (739)
Q Consensus       507 ~~~~---~~s~~GT~~Y~APEvl~~~~~~~g----~~~~s~asDIWSLGvVLyELLtGk~PF~~~~-~~~~~~~i~~~~~  578 (739)
                      .+..   ..+.+||..||+||.+........    .-..++++||||||||||+|+.|+.||..+. ....+..|++...
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH  590 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence            6443   346789999999999985432211    2247889999999999999999999998775 4445555665433


Q ss_pred             --CCCccCCHH-HHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          579 --PIPEMLSSE-GKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       579 --~iP~~ls~e-l~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                        ++|..-... +.++++.||.+||++||++.++|+|||++....
T Consensus       591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i  635 (677)
T KOG0596|consen  591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI  635 (677)
T ss_pred             cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence              455544433 999999999999999999999999999986443

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-42  Score=378.59  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=202.3

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ...|++++.||+|+||+||+|++..++..||+|+...           .....|+.+|+.++|+|||++++++...+..|
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            3579999999999999999999999999999996432           12345899999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~  510 (739)
                      +||||+. ++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus       134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  212 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA  212 (357)
T ss_pred             EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence            9999995 688888876667799999999999999999999999999999999999999999999999999976544444


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCC-CCCCCch---------HHHHHHhhc----
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGP---------QAMFKVLNR----  576 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~P-F~~~~~~---------~~~~~i~~~----  576 (739)
                      .....||..|+|||++.+       ..++.++|||||||+||||+++..+ |......         ..+..++..    
T Consensus       213 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~  285 (357)
T PHA03209        213 FLGLAGTVETNAPEVLAR-------DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH  285 (357)
T ss_pred             cccccccccccCCeecCC-------CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence            445679999999999863       4577899999999999999985444 4332111         111111110    


Q ss_pred             CCCCC------------------------------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          577 TPPIP------------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       577 ~~~iP------------------------------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                      ...++                              ..++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            00111                              134667788999999999999999999999999975

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.8e-42  Score=363.60  Aligned_cols=253  Identities=31%  Similarity=0.542  Sum_probs=212.2

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|+||.||++.+..++..||+|.+...    ...+...++.+|++++++++||||+++++++..++.+|+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE----IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence            3699999999999999999999999999999987632    123445678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~  510 (739)
                      ||||++|++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++...... .
T Consensus        77 v~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~  154 (308)
T cd06615          77 CMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  154 (308)
T ss_pred             EeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-c
Confidence            99999999999999765 668999999999999999999997 69999999999999999999999999998765332 2


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc--------------
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--------------  576 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--------------  576 (739)
                      .....|+..|+|||.+.+       ..++.++|||||||++|||++|+.||...+.... ..++..              
T Consensus       155 ~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         155 ANSFVGTRSYMSPERLQG-------THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             cccCCCCcCccChhHhcC-------CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccc
Confidence            234678999999998853       3467799999999999999999999965442222 111110              


Q ss_pred             ------------------------CCCCC-ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          577 ------------------------TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       577 ------------------------~~~iP-~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                                              .+.+| ..++.++++||.+||..||++|||+.|+++||||...
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                                    01111 1367889999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.2e-42  Score=348.57  Aligned_cols=253  Identities=27%  Similarity=0.518  Sum_probs=219.8

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++.+.||+|+||.||+|.+..+++.||||.+.....   ..+..+.+.+|+.+|+.++|+||+++++.+..++..++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM---TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc---ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence            58999999999999999999999999999999874322   233457788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEeecccchhccCccc
Q 004660          433 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~-g~vKL~DFGlA~~~~~~~~  510 (739)
                      |||+.+++|.+++.+. ...+++..+..++.||+.||+|||++||+|+||||+|||++.+ +.+||+|||++........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999999764 3458999999999999999999999999999999999999865 4689999999987755444


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCccCCHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK  589 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~  589 (739)
                      .....|+..|+|||.+.+       ..++.++||||||+++|+|++|+.||...+.......+... ...++..++.+++
T Consensus       158 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  230 (256)
T cd08220         158 AYTVVGTPCYISPELCEG-------KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLR  230 (256)
T ss_pred             ccccccCCcccCchhccC-------CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHH
Confidence            445678999999999863       34677999999999999999999999887766666665543 3456777899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          590 DFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ++|.+||..||.+|||+.|+|+||||
T Consensus       231 ~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         231 QLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=355.92  Aligned_cols=256  Identities=39%  Similarity=0.656  Sum_probs=220.7

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++....    .......+.+|+.+++.++|+||+++++++..+..+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI   76 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence            36899999999999999999999999999999886421    12334567889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-cc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SY  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~-~~  510 (739)
                      |+||+.+++|.+++...  .+++..++.++.||+.||.|||++||+||||+|+|||++.++.++|+|||+++.+... ..
T Consensus        77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  154 (274)
T cd06609          77 IMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK  154 (274)
T ss_pred             EEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence            99999999999999764  6899999999999999999999999999999999999999999999999999877543 22


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCcc-CCHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEM-LSSEG  588 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~-ls~el  588 (739)
                      .....|+..|+|||.+.+       ..++.++|||||||++|+|++|+.||...+.......+... ...++.. ++.++
T Consensus       155 ~~~~~~~~~y~~PE~~~~-------~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQ-------SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF  227 (274)
T ss_pred             cccccCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHH
Confidence            334568999999999873       34778999999999999999999999877665555555443 2334444 78999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      .++|.+||..||++|||++++++|+||.....
T Consensus       228 ~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         228 KDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence            99999999999999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.8e-42  Score=354.83  Aligned_cols=258  Identities=34%  Similarity=0.634  Sum_probs=212.6

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeec--
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD--  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~--  426 (739)
                      ..+.|++.+.||+|+||+||+|.++.+++.||+|++.....      ....+.+|+.+++.+ +|+||+++++++...  
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   77 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence            34579999999999999999999999999999999874321      124577899999998 699999999988653  


Q ss_pred             ----ceEEEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004660          427 ----DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM  501 (739)
Q Consensus       427 ----~~l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGl  501 (739)
                          ..+|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence                4689999999999999998764 34689999999999999999999999999999999999999999999999999


Q ss_pred             chhccCc-ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--C
Q 004660          502 AKHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--P  578 (739)
Q Consensus       502 A~~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~  578 (739)
                      +...... .......|+..|+|||++.+...  .+..++.++|||||||++|||++|+.||...........+....  .
T Consensus       158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06637         158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDEN--PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  235 (272)
T ss_pred             ceecccccccCCcccccccccCHhHhccccC--cCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence            9765432 22334668999999999863211  13457789999999999999999999997765544444333221  1


Q ss_pred             CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       579 ~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ..+..++.++.+||.+||..||.+|||+.++++||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            2234578899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-42  Score=358.74  Aligned_cols=263  Identities=30%  Similarity=0.584  Sum_probs=219.0

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++++.||+|+||+||+|.+..+|..||+|.+...    ........+.+|+.++++++|+||+++++.+..++.+|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE----LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence            3689999999999999999999999999999988642    123334678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhc--cccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          432 YLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~--~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      ||||+++++|..++...  ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++..+...
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999999988653  2368999999999999999999996 59999999999999999999999999999766432


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHH---HHhh-cCCCCCccC
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF---KVLN-RTPPIPEML  584 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~---~i~~-~~~~iP~~l  584 (739)
                       ......|+..|+|||.+.+.... ....++.++|||||||++|||++|+.||..........   .+.. ....++..+
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPN-QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY  234 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCC-ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence             22334688999999998642111 23456789999999999999999999997654433222   2332 234566778


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      +.++.+||.+||..+|++||++.++++|+||.....
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            999999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.6e-42  Score=356.45  Aligned_cols=252  Identities=30%  Similarity=0.554  Sum_probs=210.1

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      .+|++.++||+|+||+||+|++..+++.||||++...    ...+....+.+|+++|++++||||+++++.+..++..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD----ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI   76 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC----CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence            3688999999999999999999999999999988642    123344678889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      ||||+++++|..+     ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+... ..
T Consensus        77 v~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~  150 (279)
T cd06619          77 CTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IA  150 (279)
T ss_pred             EEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cc
Confidence            9999999998654     24788899999999999999999999999999999999999999999999999766433 23


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch-------HHHHHHhhcC-CCC-Cc
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-------QAMFKVLNRT-PPI-PE  582 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~-------~~~~~i~~~~-~~i-P~  582 (739)
                      ....||..|+|||.+.+       ..++.++|||||||++|+|++|+.||......       .....+.... ... ..
T Consensus       151 ~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (279)
T cd06619         151 KTYVGTNAYMAPERISG-------EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG  223 (279)
T ss_pred             cCCCCChhhcCceeecC-------CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC
Confidence            34579999999998863       35678999999999999999999999653221       1222222222 122 23


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      .++.++.+||.+||..||++||+++|+++|+||...+.
T Consensus       224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            47889999999999999999999999999999976644

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.4e-42  Score=360.43  Aligned_cols=255  Identities=36%  Similarity=0.599  Sum_probs=216.6

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...+|++.+.||+|+||.||+|+++.+++.||+|.+.....     .....+.+|+.+++.++|+||+++++.+..++..
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~   92 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence            34689999999999999999999999999999998874221     1235678899999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      |+||||+.+++|.+++.+  ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        93 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             EEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            999999999999999865  358899999999999999999999999999999999999999999999999987654332


Q ss_pred             -cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh-cC--CCCCccCC
Q 004660          510 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RT--PPIPEMLS  585 (739)
Q Consensus       510 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-~~--~~iP~~ls  585 (739)
                       ......|++.|+|||.+.+       ..++.++|||||||++|+|++|+.||........+..+.. ..  ...+..++
T Consensus       171 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T cd06654         171 SKRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS  243 (296)
T ss_pred             cccCcccCCccccCHHHHcC-------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccC
Confidence             2223568999999998863       3467799999999999999999999987665444333332 21  22356688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      ..+.+||.+||..||++||++.++++|+||...
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            999999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.5e-41  Score=402.16  Aligned_cols=265  Identities=28%  Similarity=0.492  Sum_probs=221.8

Q ss_pred             CCCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec
Q 004660          347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  426 (739)
Q Consensus       347 ~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~  426 (739)
                      ......+|++++.||+|+||+||+|+++.++..||+|++....   ........+..|+.+|+.|+|||||+++++|...
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~---l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG---LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc---cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            3445678999999999999999999999999999999987432   2233456788999999999999999999988653


Q ss_pred             --ceEEEEEeecCCCCcchhhhhc---cccccHHHHHHHHHhHHHHHHHHHhC-------CeecccCCCcceEecC----
Q 004660          427 --DHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHST-------NTIHRDIKGANLLVDA----  490 (739)
Q Consensus       427 --~~l~LVmEy~~gGsL~~~L~~~---~~~lse~~i~~i~~QLl~aL~yLHs~-------GIvHRDIKP~NILLd~----  490 (739)
                        ..+||||||+.+|+|.++|...   ...+++..++.|+.||+.||.|||+.       +||||||||+||||+.    
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence              5699999999999999999653   35699999999999999999999984       4999999999999964    


Q ss_pred             -------------CCcEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhC
Q 004660          491 -------------SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG  557 (739)
Q Consensus       491 -------------~g~vKL~DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtG  557 (739)
                                   .+.+||+|||++..+..........||+.|+|||++.+.     ...++.++||||||||||||++|
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge-----~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE-----TKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc-----CCCCCchhHHHHHHHHHHHHHHC
Confidence                         345999999999877555444556799999999998641     23577899999999999999999


Q ss_pred             CCCCCCCCchHHHHHHhhcCCCCC-ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          558 KPPWSEFEGPQAMFKVLNRTPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       558 k~PF~~~~~~~~~~~i~~~~~~iP-~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      +.||........+...+...+.++ ...+.++.+||..||..+|.+||++.|+|+|+|++...
T Consensus       240 k~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        240 KTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             CCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            999987666655555554444443 35789999999999999999999999999999998553

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.7e-42  Score=354.03  Aligned_cols=251  Identities=22%  Similarity=0.405  Sum_probs=211.8

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k---~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~  426 (739)
                      ...+|++.+.||+|+||.||+|.++   ..+..||+|.++..    ........+.+|+.+|++++||||+++++++..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   78 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG----CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG   78 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence            3457999999999999999999875   34678999987642    2233346788999999999999999999999999


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      +..||||||+.+|+|.+++......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999999999997765678999999999999999999999999999999999999999999999999876543


Q ss_pred             Cccccc--ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCc
Q 004660          507 GLSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE  582 (739)
Q Consensus       507 ~~~~~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~  582 (739)
                      ......  ...++..|+|||.+.+       ..++.++|||||||++|||++ |+.||......+.+..+... ..+.+.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  231 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQY-------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPR  231 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhh-------CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC
Confidence            222111  2335678999999863       457789999999999999775 99999887776666665543 345677


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .++..+.++|.+||+.+|.+||++.||++
T Consensus       232 ~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         232 NCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            88999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-41  Score=346.83  Aligned_cols=253  Identities=32%  Similarity=0.514  Sum_probs=217.4

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee--cceEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLY  430 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~--~~~l~  430 (739)
                      +|++.+.||.|+||.||+|.+..+|..||+|++....   ......+++.+|+.+++.++|+||+++++.+..  +..+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc---CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence            5899999999999999999999999999999886422   223445678899999999999999999997754  45689


Q ss_pred             EEEeecCCCCcchhhhhc---cccccHHHHHHHHHhHHHHHHHHH-----hCCeecccCCCcceEecCCCcEEEeecccc
Q 004660          431 IYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLH-----STNTIHRDIKGANLLVDASGVVKLADFGMA  502 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~---~~~lse~~i~~i~~QLl~aL~yLH-----s~GIvHRDIKP~NILLd~~g~vKL~DFGlA  502 (739)
                      ++|||+.+++|.+++...   ...+++..++.++.||+.||.|||     +.+|+|+||||+|||++.++.+||+|||++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999998653   456899999999999999999999     999999999999999999999999999999


Q ss_pred             hhccCccc-ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-CCC
Q 004660          503 KHLTGLSY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPI  580 (739)
Q Consensus       503 ~~~~~~~~-~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~i  580 (739)
                      ........ .....|+..|+|||.+.+       ..++.++||||||+++|+|++|+.||...+.......+.... ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNH-------MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI  230 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcC-------CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC
Confidence            87755433 334578999999999863       346778999999999999999999998877555555554443 356


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      +..++.++.++|.+||..+|++||++.++|+|||+
T Consensus       231 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            77889999999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.9e-42  Score=353.76  Aligned_cols=250  Identities=26%  Similarity=0.388  Sum_probs=206.5

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeec--ceEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD--DHLY  430 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~--~~l~  430 (739)
                      |++.+.||+|+||.||+|.++.++..||+|+++......   .. ....+|+.+++++. |+||+++++++.++  +.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            678999999999999999999999999999876432221   11 23346888888885 99999999999887  8899


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~  510 (739)
                      +||||+. |+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++..+.....
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          77 LVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             EEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            9999997 5788888765567899999999999999999999999999999999999999 9999999999987754444


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-------------
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------------  577 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-------------  577 (739)
                      .....++..|+|||.+..      ...++.++|||||||++|||++|..||...+..+.+..+....             
T Consensus       155 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         155 YTEYISTRWYRAPECLLT------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             cCCCCCCcccCChhHhhc------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence            344568999999998753      2456779999999999999999999998766554444332110             


Q ss_pred             -----CCC-----------CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 -----PPI-----------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 -----~~i-----------P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                           ..+           ...++.++++||.+||..||++||++.++|+||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                 011           12467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1e-41  Score=360.51  Aligned_cols=259  Identities=27%  Similarity=0.440  Sum_probs=213.4

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec--ce
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DH  428 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~--~~  428 (739)
                      ..+|++.+.||+|+||.||+|.++.+|+.||+|+++......   .....+.+|+.+|++++|+||+++++++...  +.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence            457999999999999999999999999999999987432221   1122456799999999999999999988755  56


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      +|+||||+. ++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            899999997 5788888765567999999999999999999999999999999999999999999999999999876543


Q ss_pred             c-cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC---------
Q 004660          509 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---------  578 (739)
Q Consensus       509 ~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~---------  578 (739)
                      . ......++..|+|||++.+      ...++.++|||||||++|||++|+.||...+..+.+..+.....         
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLG------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             cCCCCcccccccccChhhhcC------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence            2 1222346888999999863      34567899999999999999999999988777666655543110         


Q ss_pred             ----------CCC-----------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          579 ----------PIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       579 ----------~iP-----------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                .++           ..++.++.+||.+||..||++|||+.|+|.|+||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence                      011           12578899999999999999999999999999998544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-41  Score=360.05  Aligned_cols=256  Identities=36%  Similarity=0.609  Sum_probs=219.5

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...+|++.+.||.|+||+||+|.+..+|+.||+|.+.....     ...+.+.+|+.+++.++|+||+++++.+..++.+
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-----PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-----chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence            44679999999999999999999999999999998864221     1235678899999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      |+||||+.+++|..++..  ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        92 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             EEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            999999999999999865  358999999999999999999999999999999999999999999999999988764432


Q ss_pred             c-ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc---CCCCCccCC
Q 004660          510 Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLS  585 (739)
Q Consensus       510 ~-~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~---~~~iP~~ls  585 (739)
                      . .....|+..|+|||.+.+       ..++.++|||||||++|+|++|+.||...+....+..+...   ....+..++
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS  242 (296)
T ss_pred             ccCCCcCCCccccCcchhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCC
Confidence            2 223568999999998863       45677999999999999999999999887665555444332   223456788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      ..+.+||.+||..||.+||++.++++|+||+...
T Consensus       243 ~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            9999999999999999999999999999998644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.6e-41  Score=347.19  Aligned_cols=253  Identities=30%  Similarity=0.525  Sum_probs=219.0

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++.+.||+|+||+||++.+..+|+.||+|.+......   ....+.+.+|+.+++.++|+||+++++++..++..|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence            589999999999999999999999999999998743221   22345788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004660          433 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-  510 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~-  510 (739)
                      |||+.+++|.+++... ...+++.++..|+.||+.||.|||++|++|+||+|+|||++.++.++|+|||++........ 
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            9999999999998664 23588999999999999999999999999999999999999999999999999976644322 


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCccCCHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK  589 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~  589 (739)
                      .....|+..|+|||++.+       ..++.++|||||||++|+|++|+.||...+..+....++.+ ....+..++.++.
T Consensus       158 ~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd08218         158 ARTCIGTPYYLSPEICEN-------RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLR  230 (256)
T ss_pred             hhhccCCccccCHHHhCC-------CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHH
Confidence            123458899999999863       34667899999999999999999999887776666666544 3456778899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          590 DFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ++|.+||..+|.+||++.++|+|+||
T Consensus       231 ~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         231 NLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-42  Score=350.89  Aligned_cols=258  Identities=37%  Similarity=0.657  Sum_probs=214.6

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecc-
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD-  427 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~-  427 (739)
                      ..++|++.+.||+|+||+||+|.++.+++.|++|++....      .....+.+|+.+++.+ .|+||+++++++.... 
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP   77 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence            3468999999999999999999999999999999886421      1235688999999999 6999999999986544 


Q ss_pred             -----eEEEEEeecCCCCcchhhhhc---cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004660          428 -----HLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF  499 (739)
Q Consensus       428 -----~l~LVmEy~~gGsL~~~L~~~---~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DF  499 (739)
                           .+|+||||+.+++|.+++...   ...+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence                 489999999999999988653   357899999999999999999999999999999999999999999999999


Q ss_pred             ccchhccCcc-cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC
Q 004660          500 GMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP  578 (739)
Q Consensus       500 GlA~~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~  578 (739)
                      |++....... ......|+..|+|||++.....  ....++.++|||||||+||+|++|+.||........+..+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  235 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQ--PDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP  235 (275)
T ss_pred             ccceecccchhhhcCccccccccCHhHhccccc--ccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence            9987654322 2224568999999999864222  134577899999999999999999999987666555555544322


Q ss_pred             ---CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          579 ---PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       579 ---~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                         ..+..++.++++||.+||..||++|||+.|+++|||+
T Consensus       236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence               1223467899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.3e-41  Score=345.97  Aligned_cols=253  Identities=28%  Similarity=0.518  Sum_probs=219.5

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|+..++||.|+||.||.+++..+++.+++|.+.....   .....+.+.+|+.+|++++|+||+++++++.+++.++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL---SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc---chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence            58999999999999999999999999999999864322   233456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          433 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      |||+.+|+|.+++... ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... .
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            9999999999999764 3568999999999999999999999999999999999999999999999999997664433 2


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-CCCCccCCHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGK  589 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~el~  589 (739)
                      .....|+..|+|||.+.+       ..++.++||||||+++|||++|..||......+....+..+. ...+..++.++.
T Consensus       158 ~~~~~~~~~y~ape~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd08221         158 AETVVGTPYYMSPELCQG-------VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELI  230 (256)
T ss_pred             ccccCCCccccCHhhcCC-------CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHH
Confidence            234568999999998863       345678999999999999999999998877777666665443 334566789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          590 DFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ++|.+||..||++||++.++|+|+|+
T Consensus       231 ~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         231 SLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHHcccCcccCCCHHHHhhCcCC
Confidence            99999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-42  Score=388.03  Aligned_cols=264  Identities=27%  Similarity=0.441  Sum_probs=241.7

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ......|.+.+.||+|.|++|.+|++..+|..||||.|++...   ....+..+.+|+++|..|+|||||+++.+.+.+.
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l---n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL---NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc---ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            3455679999999999999999999999999999998875433   3344455899999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+|+||||+.+|++++++.++ +.+.+.+++.++.|+++||+|||+++|||||||.+||||+.+.++||+|||++..+..
T Consensus       129 ~lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999999999987 4577799999999999999999999999999999999999999999999999999998


Q ss_pred             cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHH
Q 004660          508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE  587 (739)
Q Consensus       508 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~e  587 (739)
                      .....+++|++.|.|||++.+      ..+.++.+|+|++|+|||-|+.|.+||++....+.....+.+...+|..++.+
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g------~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~d  281 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNG------KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCD  281 (596)
T ss_pred             cccccccCCCCCccChHhhcC------cccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeech
Confidence            888889999999999999985      45677899999999999999999999999888888888888889999999999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCccccccccC
Q 004660          588 GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ  621 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~~  621 (739)
                      +.+||+++|.++|.+|++++++++|.|.......
T Consensus       282 ce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  282 CEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             hHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            9999999999999999999999999998765443

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-41  Score=353.74  Aligned_cols=260  Identities=35%  Similarity=0.630  Sum_probs=212.7

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeecccee--
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEV--  424 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~--  424 (739)
                      .....+|++.+.||+|+||+||+|.++.+++.||+|++....      .....+.+|+.+++.+ +|+||+++++++.  
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            345678999999999999999999999999999999875311      1124577899999999 6999999999874  


Q ss_pred             ---ecceEEEEEeecCCCCcchhhhh---ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEee
Q 004660          425 ---VDDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD  498 (739)
Q Consensus       425 ---~~~~l~LVmEy~~gGsL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~D  498 (739)
                         .++.+|+||||++|++|.+++..   ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence               34579999999999999998753   234688999999999999999999999999999999999999999999999


Q ss_pred             cccchhccCcc-cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC
Q 004660          499 FGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT  577 (739)
Q Consensus       499 FGlA~~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~  577 (739)
                      ||++....... ......|+..|+|||++......  ...++.++|||||||++|||++|+.||........+.++....
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~  245 (286)
T cd06638         168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL--DSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP  245 (286)
T ss_pred             CCceeecccCCCccccccCCCcccChhhhchhhhc--cccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence            99987664322 22234689999999998642111  2346789999999999999999999998766555444433221


Q ss_pred             ---CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 ---PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 ---~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                         ...+..++.++.+||.+||..||++|||+.|+|+|+||
T Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence               12345578899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=378.78  Aligned_cols=267  Identities=26%  Similarity=0.412  Sum_probs=235.4

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ....+.|..-++||+||||.||-|+.+.||+.||+|.+.+........  .....+|-.||.+++.+.||.+-.+|+..+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~g--e~maLnEk~iL~kV~s~FiVslaYAfeTkd  258 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKG--ETMALNEKQILEKVSSPFIVSLAYAFETKD  258 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhh--hHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence            445667899999999999999999999999999999886433222222  244567889999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          428 HLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      .+++||..|.||+|..+|.+.+ ..++|..++.|+.+|+.||++||+.+||+|||||+|||||+.|+|+|.|+|||..+.
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            9999999999999999998764 469999999999999999999999999999999999999999999999999999998


Q ss_pred             CcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc----hHHHHHHhhcCCCCCc
Q 004660          507 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPE  582 (739)
Q Consensus       507 ~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~----~~~~~~i~~~~~~iP~  582 (739)
                      ........+||.+|||||+++       +..|+...|+|+|||+||||+.|+.||.....    .++-..++....++++
T Consensus       339 ~g~~~~~rvGT~GYMAPEvl~-------ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~  411 (591)
T KOG0986|consen  339 EGKPIRGRVGTVGYMAPEVLQ-------NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD  411 (591)
T ss_pred             CCCccccccCcccccCHHHHc-------CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc
Confidence            888877889999999999998       35699999999999999999999999975432    3455566777788999


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccccccCCC
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL  623 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpT-----a~elLqHpwf~~~~~~~~  623 (739)
                      .+++++++|.+.+|.+||.+|..     ++++.+||||+..+++.+
T Consensus       412 kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl  457 (591)
T KOG0986|consen  412 KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL  457 (591)
T ss_pred             ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence            99999999999999999999974     679999999999887655

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-41  Score=346.40  Aligned_cols=249  Identities=30%  Similarity=0.531  Sum_probs=215.1

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++.+.||+|+||.||++.++.+++.||+|.++...    .....+.+.+|+.+++.++|+||+++++.+..++.+|+|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK----SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc----chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            5899999999999999999999999999999986432    123346778899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          433 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      |||+++|+|.+++... ...+++..++.|+.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            9999999999988653 3458999999999999999999999999999999999999999999999999997664322 2


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCccCCHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK  589 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~  589 (739)
                      .....|+..|+|||++.+       ..++.++||||||+++|+|++|..||...+.......+... ...++..++..+.
T Consensus       157 ~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (255)
T cd08219         157 ACTYVGTPYYVPPEIWEN-------MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR  229 (255)
T ss_pred             cccccCCccccCHHHHcc-------CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHH
Confidence            234568999999999863       35677999999999999999999999887666665555444 3456778899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcC
Q 004660          590 DFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      +||.+||..||++||++.++|.-
T Consensus       230 ~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         230 SLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.1e-41  Score=357.40  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=204.0

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECC----------------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRE----------------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH  413 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~----------------tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~H  413 (739)
                      ...+|++.++||+|+||.||+|.+..                ++..||+|++...    ........+.+|+++|..++|
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h   78 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD----ANKNARNDFLKEVKILSRLKD   78 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC----CCHHHHHHHHHHHHHHhhcCC
Confidence            35689999999999999999998643                3457999987632    223445678899999999999


Q ss_pred             CCeEeeccceeecceEEEEEeecCCCCcchhhhhcc------------------ccccHHHHHHHHHhHHHHHHHHHhCC
Q 004660          414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC------------------RDITESIVRNFTRHILNGLAYLHSTN  475 (739)
Q Consensus       414 PNIVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~------------------~~lse~~i~~i~~QLl~aL~yLHs~G  475 (739)
                      ||||++++++...+..+|||||+.+|+|.+++....                  ..+++..+..++.||+.||.|||++|
T Consensus        79 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~  158 (304)
T cd05096          79 PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN  158 (304)
T ss_pred             CCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999999999999885421                  23677889999999999999999999


Q ss_pred             eecccCCCcceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHH
Q 004660          476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI  552 (739)
Q Consensus       476 IvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLy  552 (739)
                      |+||||||+||||+.++.+||+|||+++.+.....   .....++..|||||++.+       ..++.++|||||||++|
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~  231 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-------GKFTTASDVWAFGVTLW  231 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-------CCCCchhhhHHHHHHHH
Confidence            99999999999999999999999999976543221   122345789999999863       35778999999999999


Q ss_pred             HHhh--CCCCCCCCCchHHHHHHhh--------cCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          553 EMLT--GKPPWSEFEGPQAMFKVLN--------RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       553 ELLt--Gk~PF~~~~~~~~~~~i~~--------~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ||++  +..||......+.+..+..        .....+..++..+.+||.+||..||++|||+.|+.+
T Consensus       232 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         232 EILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             HHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            9986  6788887665554443321        112234567899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3e-41  Score=348.50  Aligned_cols=252  Identities=43%  Similarity=0.768  Sum_probs=210.6

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      ......||+|+||.||+|.+..++..||+|.+..     ......+.+.+|+++++.++|+||+++++++..++..++||
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecC-----CCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            3344689999999999999999999999998763     22334567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhhccccc--cHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC-CCcEEEeecccchhccCcc-
Q 004660          434 EYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~l--se~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~-~g~vKL~DFGlA~~~~~~~-  509 (739)
                      ||+.+++|.+++......+  ++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....... 
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            9999999999997654445  88899999999999999999999999999999999976 6799999999987654322 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHH-HHH--HhhcCCCCCccCCH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFK--VLNRTPPIPEMLSS  586 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~-~~~--i~~~~~~iP~~ls~  586 (739)
                      ......|+..|+|||.+.+.     ...++.++||||||+++|+|++|+.||........ ...  .......++..+++
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~-----~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKG-----PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA  239 (268)
T ss_pred             ccccCCCCccccChhhhccc-----cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence            22234689999999998531     23467799999999999999999999976543222 211  22344567778999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ++++||.+||..+|.+|||+.|+++||||
T Consensus       240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         240 EAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.8e-41  Score=356.77  Aligned_cols=242  Identities=21%  Similarity=0.313  Sum_probs=207.3

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee----cceEEEEE
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHLYIYL  433 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~----~~~l~LVm  433 (739)
                      ..||+|++|.||+|.+  +|+.||||+++..  ........+.+.+|+.+|++++|||||++++++.+    ...+++||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKF--HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEecccc--ccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            6799999999999987  5899999988643  22334446788899999999999999999998876    34689999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCccccc
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL  512 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~  512 (739)
                      ||+.||+|.+++.+. ..+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......  .
T Consensus       102 Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~  178 (283)
T PHA02988        102 EYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--F  178 (283)
T ss_pred             EeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--c
Confidence            999999999999775 568999999999999999999998 599999999999999999999999999998764322  2


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc--CCCCCccCCHHHHH
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKD  590 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP~~ls~el~d  590 (739)
                      ...||..|+|||++.+.     ...++.++|||||||++|||++|+.||.+....+....+...  ...++..++.++++
T Consensus       179 ~~~~~~~y~aPE~~~~~-----~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~  253 (283)
T PHA02988        179 KNVNFMVYFSYKMLNDI-----FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKC  253 (283)
T ss_pred             cccCcccccCHHHhhhc-----cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence            45689999999998742     246788999999999999999999999988777766666433  44566678999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHc
Q 004660          591 FLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       591 LI~kcL~~DP~kRpTa~elLq  611 (739)
                      ||.+||+.||++|||+.|+++
T Consensus       254 li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        254 IVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHhcCCcccCcCHHHHHH
Confidence            999999999999999999985

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.2e-41  Score=359.51  Aligned_cols=257  Identities=37%  Similarity=0.603  Sum_probs=217.3

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|.+.....     ...+.+.+|+.+++.++|+||+++++++..++.
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDE   90 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence            345789999999999999999999999999999999864221     123557889999999999999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      .|+||||+++++|.+++.+  ..+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++......
T Consensus        91 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             EEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            9999999999999999865  35889999999999999999999999999999999999999999999999998765433


Q ss_pred             cc-ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh-cC--CCCCccC
Q 004660          509 SY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RT--PPIPEML  584 (739)
Q Consensus       509 ~~-~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-~~--~~iP~~l  584 (739)
                      .. .....|++.|+|||.+.+       ..++.++|||||||++|+|++|+.||...+....+..+.. ..  ...+..+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (297)
T cd06656         169 QSKRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL  241 (297)
T ss_pred             ccCcCcccCCccccCHHHHcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcccc
Confidence            22 223468999999999863       4567899999999999999999999977654433332222 11  2245668


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      +..+++||.+||..||++||++.++|+||||+...
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            89999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.2e-41  Score=352.88  Aligned_cols=259  Identities=35%  Similarity=0.623  Sum_probs=214.7

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeec--
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD--  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~--  426 (739)
                      ..++|.+.+.||+|+||.||+|.++.+++.||+|++...      ......+.+|+.+++.+ +|+||+++++++...  
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~------~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI------SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc------ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            457799999999999999999999999999999988632      11234577899999999 799999999988653  


Q ss_pred             ---ceEEEEEeecCCCCcchhhhh---ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecc
Q 004660          427 ---DHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG  500 (739)
Q Consensus       427 ---~~l~LVmEy~~gGsL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFG  500 (739)
                         +..|+||||+.+|+|.+++..   ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg  173 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG  173 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence               358999999999999998853   23568999999999999999999999999999999999999999999999999


Q ss_pred             cchhccCcc-cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-
Q 004660          501 MAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-  578 (739)
Q Consensus       501 lA~~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-  578 (739)
                      ++....... ......|+..|+|||.+.....  .+..++.++|||||||++|||++|+.||........+..+..... 
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  251 (291)
T cd06639         174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ--YDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP  251 (291)
T ss_pred             cchhcccccccccCccCCccccChhhhcCCCC--cccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence            998764322 2223568999999999864211  122467899999999999999999999988766665555543322 


Q ss_pred             --CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 004660          579 --PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR  616 (739)
Q Consensus       579 --~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~  616 (739)
                        ..+..+...+.+||.+||..||++||++.|+|+||||+
T Consensus       252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence              23456778999999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1e-41  Score=354.63  Aligned_cols=252  Identities=28%  Similarity=0.446  Sum_probs=213.2

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecCCC
Q 004660          360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  439 (739)
Q Consensus       360 LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~gG  439 (739)
                      ||+|+||+||+|.++.+|+.||+|++.....  ........+.+|+++|+.++||||+++++++...+.+|+||||++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL--KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhh--hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            6999999999999999999999999864221  12223455678999999999999999999999999999999999999


Q ss_pred             Ccchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCCC
Q 004660          440 SINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP  518 (739)
Q Consensus       440 sL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s~~GT~  518 (739)
                      +|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............++.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence            9999987643 368999999999999999999999999999999999999999999999999998765443334456889


Q ss_pred             CCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc----hHHHHHHhhcCCCCCccCCHHHHHHHHH
Q 004660          519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPEMLSSEGKDFLLR  594 (739)
Q Consensus       519 ~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~----~~~~~~i~~~~~~iP~~ls~el~dLI~k  594 (739)
                      .|+|||.+.+       ..++.++|||||||++|+|++|+.||.....    .+....+......++..+++++.++|.+
T Consensus       159 ~y~~PE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  231 (277)
T cd05577         159 GYMAPEVLQG-------EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA  231 (277)
T ss_pred             CcCCHHHhcC-------CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHH
Confidence            9999999863       2367799999999999999999999976543    2233333444556677789999999999


Q ss_pred             hcccCCCCCC-----CHHHHHcCcccccccc
Q 004660          595 CFLRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       595 cL~~DP~kRp-----Ta~elLqHpwf~~~~~  620 (739)
                      ||+.||.+||     ++.++++||||...++
T Consensus       232 ~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         232 LLQKDPEKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             HccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence            9999999999     8999999999986554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.1e-41  Score=353.97  Aligned_cols=254  Identities=34%  Similarity=0.535  Sum_probs=211.3

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.++||+|+||.||+|.++.+++.||+|++......   ....+.+.+|+++|+.++|+||+++++++..++..|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc---chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence            3699999999999999999999999999999987542221   2334567889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      ||||++++.|..++... ..+++.+++.++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++..+.... .
T Consensus        78 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          78 VFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            99999999998877553 458999999999999999999999999999999999999999999999999997664322 2


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-------------
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------------  577 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-------------  577 (739)
                      .....++..|+|||++.+      ...++.++|||||||++|||++|++||......+....+....             
T Consensus       157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07846         157 YTDYVATRWYRAPELLVG------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK  230 (286)
T ss_pred             cCcccceeeccCcHHhcc------ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence            223568899999999863      3456778999999999999999999997665444333322100             


Q ss_pred             ------CC------------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 ------PP------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 ------~~------------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                            ..            ....++..+++||.+||..||++||++.++|+|+||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                  00            123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.6e-42  Score=375.73  Aligned_cols=254  Identities=21%  Similarity=0.292  Sum_probs=206.5

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~--tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ...+|.+++.||+|+||+||+|....  ++..||+|.+...          +.+.+|+++|+.|+|+|||++++++..++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~  159 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKS  159 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence            34689999999999999999998653  5678999977521          23457999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+|+||||+. ++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus       160 ~~~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             EEEEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            9999999996 688888844 36799999999999999999999999999999999999999999999999999976643


Q ss_pred             ccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc---hHHHHHHhhc-----
Q 004660          508 LSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMFKVLNR-----  576 (739)
Q Consensus       508 ~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~---~~~~~~i~~~-----  576 (739)
                      ...   .....||+.|+|||++.+       ..++.++|||||||+||||++|+.||.+...   ...+..++..     
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~  310 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLAL-------DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP  310 (392)
T ss_pred             ccccccccccccccCccCHhHhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence            222   224579999999999863       4577899999999999999999999965432   1122221110     


Q ss_pred             ----------------------C--CCCC-----ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccccCC
Q 004660          577 ----------------------T--PPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN  622 (739)
Q Consensus       577 ----------------------~--~~iP-----~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~~~  622 (739)
                                            .  ..++     ..++.++.+||.+||..||++|||+.|+|.||||.....+.
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~  385 (392)
T PHA03207        311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL  385 (392)
T ss_pred             cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence                                  0  0111     13467889999999999999999999999999998765443

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.3e-41  Score=349.59  Aligned_cols=257  Identities=48%  Similarity=0.842  Sum_probs=215.6

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC-----cccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~-----~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|.++.....     .......+.+.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            589999999999999999999999999999988642211     112334567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            999999999999999999776 5689999999999999999999999999999999999999999999999999976543


Q ss_pred             cc---cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc--CCCCCc
Q 004660          508 LS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE  582 (739)
Q Consensus       508 ~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP~  582 (739)
                      ..   ......|+..|+|||.+...     ...++.++||||||+++|||++|..||...+..+.+.++...  ...++.
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSY-----SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP  235 (272)
T ss_pred             cccccccccccCCccccCHHHhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence            21   12345689999999998641     124677999999999999999999999776665555544322  222332


Q ss_pred             ----cCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          583 ----MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       583 ----~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                          .++.++.++|.+||..||.+||++.++|+||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                458899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=352.71  Aligned_cols=254  Identities=28%  Similarity=0.482  Sum_probs=206.6

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .++|++.+.||+|+||+||+|.++.+++.||||.+........    ...+.+|+++++.++|+||+++++++..++..|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA----PFTAIREASLLKDLKHANIVTLHDIIHTKKTLT   79 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC----chhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence            4679999999999999999999999999999999874322211    134567999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      +||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        80 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          80 LVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             EEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            9999998 58999887765678999999999999999999999999999999999999999999999999987543211 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc-hHHHHHHhh---cC--------
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLN---RT--------  577 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~-~~~~~~i~~---~~--------  577 (739)
                      ......++..|+|||++.+      ...++.++|||||||++|||++|+.||..... .+.+..+..   ..        
T Consensus       159 ~~~~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLG------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             cccccccccccCCcHHhhc------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence            1122346889999999863      24467799999999999999999999976542 222222111   00        


Q ss_pred             ----------------C---CCCccCC--HHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 ----------------P---PIPEMLS--SEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 ----------------~---~iP~~ls--~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                                      .   .....++  .++.++|.+||..||++|||+.|+|+|+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                            0   0001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-41  Score=384.61  Aligned_cols=248  Identities=23%  Similarity=0.378  Sum_probs=203.2

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....           ..+.+|+++|++|+|+|||++++++..++..|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            4579999999999999999999999999999995321           23567999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      |||||+. ++|..++......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.... 
T Consensus       237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            9999995 78888887655679999999999999999999999999999999999999999999999999998664322 


Q ss_pred             --cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC-c------hHHHHHHhhc-C--
Q 004660          510 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-G------PQAMFKVLNR-T--  577 (739)
Q Consensus       510 --~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~-~------~~~~~~i~~~-~--  577 (739)
                        ......||..|||||++.+       ..++.++||||||||||||++|..++.... .      ...+.+++.. .  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~-------~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~  388 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAG-------DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH  388 (461)
T ss_pred             cccccccCCCcCCcCHHHHcC-------CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence              1224569999999999863       357789999999999999999876543211 1      1122222111 0  


Q ss_pred             -CCCC-------------------------------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          578 -PPIP-------------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       578 -~~iP-------------------------------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                       ..++                               ..++.++.+||.+||..||.+|||+.|+|+|+||+.
T Consensus       389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence             0011                               024568899999999999999999999999999964

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.8e-42  Score=357.46  Aligned_cols=254  Identities=30%  Similarity=0.500  Sum_probs=212.2

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec--ceE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL  429 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~--~~l  429 (739)
                      .+|++.+.||.|+||.||+|.++.+++.||+|.++.....   ......+.+|+.+++.++||||+++++++...  +..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            4699999999999999999999999999999998743222   22234567899999999999999999998877  889


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~-  508 (739)
                      ||||||+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+... 
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99999997 5898888765556999999999999999999999999999999999999999999999999999876543 


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-----------
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----------  577 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-----------  577 (739)
                      .......++..|+|||.+.+      ...++.++||||||+++|||++|..||......+.+.++....           
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLG------AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             cccccccccccccCchhhcC------CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence            22223457899999999863      2346779999999999999999999998766655544432210           


Q ss_pred             --------------------CCCCcc-CCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 --------------------PPIPEM-LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 --------------------~~iP~~-ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                                          ..++.. ++..+.+||++||+.||++|||+.|+|+|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                                112222 58889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1e-41  Score=349.78  Aligned_cols=254  Identities=33%  Similarity=0.579  Sum_probs=216.3

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+.....    .+..+.+.+|+++++.++|+||+++++.+..++.+|+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI   76 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence            368889999999999999999999999999998874321    2445678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~  510 (739)
                      +|||+.+++|.+++......+++..+..++.||+.||+|||+ .||+|+||||+|||++.++.+||+|||++........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            999999999999997755679999999999999999999999 9999999999999999999999999999876643222


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC-----chHHHHHHhhc-CCCCCcc-
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-----GPQAMFKVLNR-TPPIPEM-  583 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~-----~~~~~~~i~~~-~~~iP~~-  583 (739)
                      . ...|+..|+|||.+.+       ..++.++||||||+++|+|++|+.||....     ..+.+..+... .+.++.. 
T Consensus       157 ~-~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (265)
T cd06605         157 K-TFVGTSSYMAPERIQG-------NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGK  228 (265)
T ss_pred             h-cccCChhccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhh
Confidence            2 2678999999999864       357789999999999999999999997542     22333333332 2334444 


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                      ++.++.++|.+||..||++|||+.+++.||||+.
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            8899999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.3e-41  Score=353.63  Aligned_cols=254  Identities=27%  Similarity=0.415  Sum_probs=208.1

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHH-HHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecC
Q 004660          359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  437 (739)
Q Consensus       359 ~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~-~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~  437 (739)
                      +||+|+||+||+|.+..+++.||||.+..........+ .......++.+++...|+||+.+++++..++.+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999999999999999874322211111 11122223445556689999999999999999999999999


Q ss_pred             CCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCC
Q 004660          438 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS  517 (739)
Q Consensus       438 gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s~~GT  517 (739)
                      ||+|.+++... ..+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+.... .....|+
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~  158 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT  158 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCC
Confidence            99999988664 569999999999999999999999999999999999999999999999999997664322 2345799


Q ss_pred             CCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC---chHHHHHHhhcCCCCCccCCHHHHHHHHH
Q 004660          518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---GPQAMFKVLNRTPPIPEMLSSEGKDFLLR  594 (739)
Q Consensus       518 ~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~---~~~~~~~i~~~~~~iP~~ls~el~dLI~k  594 (739)
                      ..|+|||.+.+      ...++.++||||+||++|||++|+.||....   .......+......++..++.++.++|.+
T Consensus       159 ~~y~aPE~~~~------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (278)
T cd05606         159 HGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG  232 (278)
T ss_pred             cCCcCcHHhcC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHH
Confidence            99999999863      2346778999999999999999999998652   22333334444566777789999999999


Q ss_pred             hcccCCCCCC-----CHHHHHcCcccccccc
Q 004660          595 CFLRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       595 cL~~DP~kRp-----Ta~elLqHpwf~~~~~  620 (739)
                      ||..||.+|+     ++.++++||||+...+
T Consensus       233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             HhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence            9999999999     9999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=352.42  Aligned_cols=254  Identities=32%  Similarity=0.539  Sum_probs=213.0

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|+||.||+|.++.+++.||||+++....   .....+.+.+|+++|+.++|+||+++++++..++..|+
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence            369999999999999999999999999999998764222   23344678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~--  509 (739)
                      ||||+.++.|..++... ..+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus        78 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          78 VFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             EEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            99999987777666543 568999999999999999999999999999999999999999999999999998765443  


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC------------
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------  577 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------------  577 (739)
                      ......++..|+|||++.+      ...++.++||||||+++|+|++|+.||......+.+..+....            
T Consensus       157 ~~~~~~~~~~~~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         157 PLTDYVATRWYRAPELLVG------DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             cccCcccccCCcCCchhcC------CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence            2234568899999999874      2367789999999999999999999998765544433321100            


Q ss_pred             --------------------CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 --------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 --------------------~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                                          ..++..++.++++||++||..||++||+++++++|+||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                                01233458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.8e-41  Score=357.03  Aligned_cols=259  Identities=27%  Similarity=0.454  Sum_probs=218.2

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      .+|++.+.||+|+||.||++.++.+++.||+|.+....  .........+.+|+.+++.++|+||+++++.+..++.+|+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN--LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM   78 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh--hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence            36999999999999999999999999999999886421  1122344678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc---
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---  508 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~---  508 (739)
                      ||||+.|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....   
T Consensus        79 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          79 VMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            99999999999999765 56899999999999999999999999999999999999999999999999998642100   


Q ss_pred             -------------ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh
Q 004660          509 -------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN  575 (739)
Q Consensus       509 -------------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~  575 (739)
                                   .......|+..|+|||.+.+       ..++.++|||||||++|||++|..||.+....+....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~  230 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  230 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence                         01112457889999998762       4567899999999999999999999988776666666655


Q ss_pred             cCCCCC---ccCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcccccccc
Q 004660          576 RTPPIP---EMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANY  620 (739)
Q Consensus       576 ~~~~iP---~~ls~el~dLI~kcL~~DP~kRpT---a~elLqHpwf~~~~~  620 (739)
                      .....+   ..++.++.++|.+||..||++||+   +.++|+||||....+
T Consensus       231 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         231 DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             cccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            433333   257899999999999999999998   799999999976443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.2e-41  Score=352.11  Aligned_cols=258  Identities=36%  Similarity=0.650  Sum_probs=212.4

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceee---
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV---  425 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~---  425 (739)
                      ..+.|++.+.||.|+||.||+|.++.+++.||+|++...      ......+..|+.+++.+ +|+||+++++++..   
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            346799999999999999999999999999999987642      12235678899999988 69999999998853   


Q ss_pred             ---cceEEEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004660          426 ---DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM  501 (739)
Q Consensus       426 ---~~~l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGl  501 (739)
                         .+.+|++|||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||+
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~  167 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV  167 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence               46789999999999999999763 34588899999999999999999999999999999999999999999999999


Q ss_pred             chhccCc-ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC--
Q 004660          502 AKHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--  578 (739)
Q Consensus       502 A~~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~--  578 (739)
                      +...... .......|+..|+|||.+...  ......++.++|||||||++|||++|+.||........+..+.....  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  245 (282)
T cd06636         168 SAQLDRTVGRRNTFIGTPYWMAPEVIACD--ENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK  245 (282)
T ss_pred             hhhhhccccCCCcccccccccCHhhcCcc--cCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence            8765432 222345689999999987531  11234577899999999999999999999987665444444333221  


Q ss_pred             CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       579 ~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      .....++.++.+||.+||..||.+|||+.|+|+||||
T Consensus       246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            1233578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=377.92  Aligned_cols=255  Identities=28%  Similarity=0.435  Sum_probs=216.6

Q ss_pred             CCCCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       346 ~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      .++...++..+++.||+|.||+||+|++..   .||||+++..   .-..+.++.|++|+.+|++-+|.||+-+.|++..
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~---~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVD---DPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccCHHHhhccceeccccccceeeccccc---ceEEEEEecC---CCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            456667788999999999999999999874   5999998753   3345578899999999999999999999999987


Q ss_pred             cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                      ... .||+.+|+|-+|+.+|+.....|.....+.|++||++||.|||.++|||||||.+||||.+++.|||+||||+...
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence            776 9999999999999999887778999999999999999999999999999999999999999999999999999654


Q ss_pred             c---CcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-----
Q 004660          506 T---GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----  577 (739)
Q Consensus       506 ~---~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-----  577 (739)
                      .   +........|...|||||+++.  +.  ...|++.+||||||||+|||++|.+||.....+++++.+-.+.     
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRm--qd--~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~  614 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRM--QD--DNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL  614 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhh--cc--cCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence            2   2333334568889999999983  22  5689999999999999999999999999555555555443331     


Q ss_pred             CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       578 ~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ..+-..++.++++|+..||..++++||.+.+||.
T Consensus       615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            1233456789999999999999999999999985

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-43  Score=385.94  Aligned_cols=239  Identities=33%  Similarity=0.592  Sum_probs=217.1

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      ....++-||.|+.|.||+|+.+  ++.||||+++.            .-+.+|+-|++|+|+|||.+.|++...-.+|||
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIi  190 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCII  190 (904)
T ss_pred             HhhhhhhhccCcccceeeeecc--CceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence            3445677999999999999877  68999998752            234689999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL  512 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~  512 (739)
                      ||||..|-|...|+.. ..++...+..|.++|+.||.|||.+.|||||||.-||||+.+..|||+|||-++........+
T Consensus       191 MEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM  269 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM  269 (904)
T ss_pred             eeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhh
Confidence            9999999999999775 679999999999999999999999999999999999999999999999999999998888888


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc--CCCCCccCCHHHHH
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKD  590 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP~~ls~el~d  590 (739)
                      +++||..|||||+++       +..+..++|||||||||||||||..||.+.+...++.-+-..  ..++|..+++.++-
T Consensus       270 SFaGTVaWMAPEvIr-------nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfkl  342 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIR-------NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKL  342 (904)
T ss_pred             hhhhhHhhhCHHHhh-------cCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHH
Confidence            999999999999998       578899999999999999999999999998887776655433  35678999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCc
Q 004660          591 FLLRCFLRNPVERPSAVELLEHP  613 (739)
Q Consensus       591 LI~kcL~~DP~kRpTa~elLqHp  613 (739)
                      ||++||.-.|..||++.+||.|-
T Consensus       343 L~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  343 LLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             HHHHHHhcCCCCCccHHHHHHHH
Confidence            99999999999999999999983

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.6e-41  Score=358.84  Aligned_cols=246  Identities=26%  Similarity=0.449  Sum_probs=191.2

Q ss_pred             EeeEEeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee--cceEEE
Q 004660          356 KGKLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYI  431 (739)
Q Consensus       356 i~~~LG~G~fGtVy~a~~k~--tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~--~~~l~L  431 (739)
                      .+.+||+|+||+||+|+.+.  ++..||+|.+....   .    ...+.+|+++|+.++|||||++++++..  +..+|+
T Consensus         5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07867           5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---I----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL   77 (317)
T ss_pred             eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---C----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence            45789999999999999764  66889999876321   1    1346789999999999999999998754  467899


Q ss_pred             EEeecCCCCcchhhhhc--------cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEe----cCCCcEEEeec
Q 004660          432 YLEYVHPGSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADF  499 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~--------~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILL----d~~g~vKL~DF  499 (739)
                      ||||+. ++|.+++...        ...+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+||
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            999987 5777766421        1348899999999999999999999999999999999999    56679999999


Q ss_pred             ccchhccCcc----cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch--------
Q 004660          500 GMAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--------  567 (739)
Q Consensus       500 GlA~~~~~~~----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~--------  567 (739)
                      |+++.+....    ......||..|+|||++.+      ...++.++|||||||++|||++|++||......        
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~  230 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFH  230 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcC------CCccCcHHHHHhHHHHHHHHHhCCCCccccccccccccccc
Confidence            9998764322    1224568999999999863      345778999999999999999999999643211        


Q ss_pred             -HHHHHHhhc--------------CC------------------------CCCccCCHHHHHHHHHhcccCCCCCCCHHH
Q 004660          568 -QAMFKVLNR--------------TP------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVE  608 (739)
Q Consensus       568 -~~~~~i~~~--------------~~------------------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~e  608 (739)
                       ..+..+...              ..                        ......+..+.+||.+||..||.+|||+.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e  310 (317)
T cd07867         231 HDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ  310 (317)
T ss_pred             HHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHH
Confidence             111111100              00                        001123567889999999999999999999


Q ss_pred             HHcCccc
Q 004660          609 LLEHPFI  615 (739)
Q Consensus       609 lLqHpwf  615 (739)
                      +|+||||
T Consensus       311 ~l~hp~f  317 (317)
T cd07867         311 ALQDPYF  317 (317)
T ss_pred             HhcCCCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.3e-41  Score=338.66  Aligned_cols=252  Identities=53%  Similarity=0.967  Sum_probs=219.7

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec--ceEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLY  430 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~--~~l~  430 (739)
                      +|++.+.||+|++|.||+|.+..++..|++|++......   ....+.+.+|+.++++++|+||+++++.+...  +.++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            488999999999999999999999999999998743221   34567889999999999999999999999888  8899


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~  510 (739)
                      +||||+.+++|.+++... ..+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus        78 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            999999999999999775 3799999999999999999999999999999999999999999999999999987765443


Q ss_pred             ---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC-chHHHHHHh--hcCCCCCccC
Q 004660          511 ---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-GPQAMFKVL--NRTPPIPEML  584 (739)
Q Consensus       511 ---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~-~~~~~~~i~--~~~~~iP~~l  584 (739)
                         .....++..|++||.+.+       ..++.++||||||+++|+|++|..||.... .......+.  .....++..+
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRG-------EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHL  229 (260)
T ss_pred             cccccCCCCCccccCHhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCccc
Confidence               344678999999998863       336779999999999999999999998765 233333333  2455677888


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      +.++.+||.+||..||.+||++.++|+||||
T Consensus       230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-41  Score=344.76  Aligned_cols=250  Identities=30%  Similarity=0.543  Sum_probs=215.9

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecCCC
Q 004660          360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  439 (739)
Q Consensus       360 LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~gG  439 (739)
                      ||.|+||.||+|++..+|+.||+|++....  .......+.+.+|+.+++.++|+||+++++.+..++..|+||||+.++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD--MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchh--hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            689999999999999999999999886321  222345677889999999999999999999999999999999999999


Q ss_pred             CcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc---------c
Q 004660          440 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---------Y  510 (739)
Q Consensus       440 sL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~---------~  510 (739)
                      +|.+++... ..+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|||++.......         .
T Consensus        79 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          79 DLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence            999999775 479999999999999999999999999999999999999999999999999987653321         1


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccC--CHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML--SSEG  588 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~l--s~el  588 (739)
                      .....++..|++||.+..       ..++.++||||||+++|||++|..||......+....+.......+...  +..+
T Consensus       158 ~~~~~~~~~~~~Pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (265)
T cd05579         158 DKRIVGTPDYIAPEVILG-------QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEA  230 (265)
T ss_pred             ccCcccCccccCHHHhcC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHH
Confidence            223457889999999863       3367799999999999999999999988777777767666555666555  8999


Q ss_pred             HHHHHHhcccCCCCCCCH---HHHHcCccccccc
Q 004660          589 KDFLLRCFLRNPVERPSA---VELLEHPFIRNAN  619 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa---~elLqHpwf~~~~  619 (739)
                      .+||.+||+.+|++|||+   .++|+||||...+
T Consensus       231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             HHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence            999999999999999999   9999999997644

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.3e-41  Score=349.84  Aligned_cols=262  Identities=30%  Similarity=0.536  Sum_probs=210.9

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHH-HhhcCCCCeEeeccceeecceEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV-LGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~i-L~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ++|++.+.||+|+||.||+|+++.+|+.||||.++.....   .. ...+..|+.+ ++.++|+|||++++++..++.+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---QE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---HH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence            3699999999999999999999999999999988643211   11 2334456554 66678999999999999999999


Q ss_pred             EEEeecCCCCcchhhhh---ccccccHHHHHHHHHhHHHHHHHHHhC-CeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          431 IYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs~-GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      +||||++ |+|.+++..   ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+.
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9999997 677777654   234689999999999999999999997 99999999999999999999999999998765


Q ss_pred             CcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC-chHHHHHHhhc-CCCCC-cc
Q 004660          507 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-GPQAMFKVLNR-TPPIP-EM  583 (739)
Q Consensus       507 ~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~-~~~~~~~i~~~-~~~iP-~~  583 (739)
                      .........|+..|+|||.+.+...   ...++.++|||||||++|||++|+.||.... ..+.+..+... ...++ ..
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELN---QKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK  232 (283)
T ss_pred             cccccccccCCccccChhhcCCccc---ccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence            4333333568999999998864211   1346779999999999999999999997543 33344444433 23333 35


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccccC
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ  621 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~~  621 (739)
                      ++.++.+||.+||..+|++||++.++++|+||+....+
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            78999999999999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.1e-41  Score=353.95  Aligned_cols=256  Identities=26%  Similarity=0.436  Sum_probs=204.8

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc--
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--  427 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~--  427 (739)
                      ..++|++.+.||+|+||.||+|.++.+++.||||++......   ......+.+|+++++.++||||+++++++...+  
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   86 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKATP   86 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc---CCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence            445799999999999999999999999999999988643221   112234567999999999999999999876543  


Q ss_pred             ------eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004660          428 ------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM  501 (739)
Q Consensus       428 ------~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGl  501 (739)
                            ..|+||||+. ++|.+++......+++.+++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence                  4699999996 578888766555799999999999999999999999999999999999999999999999999


Q ss_pred             chhccCccc-----ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh-
Q 004660          502 AKHLTGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-  575 (739)
Q Consensus       502 A~~~~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-  575 (739)
                      +..+.....     .....++..|+|||.+.+      ...++.++||||||+++|||++|+.||...+.......+.. 
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~  239 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL  239 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcC------CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            976643221     123457889999998863      33466789999999999999999999987654433222211 


Q ss_pred             --cCC----------------CCC-------------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          576 --RTP----------------PIP-------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       576 --~~~----------------~iP-------------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                        ...                .++             ...+..+.+||.+||..||.+|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence              000                001             1135678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4e-41  Score=351.80  Aligned_cols=255  Identities=29%  Similarity=0.488  Sum_probs=208.3

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecce--
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH--  428 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~--  428 (739)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++......   ......+.+|+.+++.+. |+||+++++++...+.  
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE---EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc---cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            3699999999999999999999999999999987643221   122346778999999995 6999999998887665  


Q ss_pred             ---EEEEEeecCCCCcchhhhhc----cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC-CCcEEEeecc
Q 004660          429 ---LYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFG  500 (739)
Q Consensus       429 ---l~LVmEy~~gGsL~~~L~~~----~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~-~g~vKL~DFG  500 (739)
                         +|+||||+.+ +|.+++...    ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus        78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence               8999999985 788887543    235899999999999999999999999999999999999998 8999999999


Q ss_pred             cchhccCcc-cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-
Q 004660          501 MAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-  578 (739)
Q Consensus       501 lA~~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-  578 (739)
                      ++..+.... ......+++.|+|||++.+      ...++.++||||||+++|+|++|..||...+..+...+++.... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~  230 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLG------STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT  230 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhC------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence            987653321 1122357889999999863      34567899999999999999999999988766655554432100 


Q ss_pred             -------------------C--------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 004660          579 -------------------P--------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR  616 (739)
Q Consensus       579 -------------------~--------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~  616 (739)
                                         .        ....++.++.+||.+||..||.+||++.|+|.||||+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                               0        0124788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-41  Score=353.66  Aligned_cols=253  Identities=30%  Similarity=0.532  Sum_probs=209.4

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .|++.+.||.|+||.||+|+++.+|+.||||++.....   .......+.+|++++++++||||+++++++..++..|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc---ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            38899999999999999999999999999998864221   122335678899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          433 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      |||+. ++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.... .
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            99996 6788887543 3568999999999999999999999999999999999999999999999999987654322 1


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC------------
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------------  578 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~------------  578 (739)
                      .....++..|+|||.+.+      ...++.++|||||||++|||++|+.||...+......++.....            
T Consensus       157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         157 YTHEVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             cccccccccccCCeEEec------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence            223457889999998753      33467789999999999999999999987665554444332100            


Q ss_pred             -----------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          579 -----------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       579 -----------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                                       .+...++.+++++|.+||..||.+|||++++|+||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                             0122467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2e-41  Score=357.32  Aligned_cols=258  Identities=34%  Similarity=0.578  Sum_probs=217.2

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ...|.....||.|+||.||++.+..++..||||++..     ......+.+.+|+.+++.++|+||+++++.+...+..|
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW   95 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec-----chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence            3456667889999999999999999999999998763     12334566889999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      +||||+.+++|.+++..  ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        96 lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658          96 VVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             EEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            99999999999998854  458999999999999999999999999999999999999999999999999987654322 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC---CCCCccCCH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSS  586 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---~~iP~~ls~  586 (739)
                      ......|+..|+|||.+.+       ..++.++||||||+++|||++|+.||........+..+....   ......++.
T Consensus       174 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISR-------LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSS  246 (292)
T ss_pred             cCceeecCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCH
Confidence            2233568999999999863       356779999999999999999999998766655554443322   222335788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccccccccCC
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN  622 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~~~  622 (739)
                      .+.++|.+||..||.+|||++|+|+|+||+......
T Consensus       247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            999999999999999999999999999998765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=350.90  Aligned_cols=255  Identities=37%  Similarity=0.650  Sum_probs=215.5

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC---CCCeEeeccceeecceE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHL  429 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~---HPNIVkl~~~~~~~~~l  429 (739)
                      .|++.+.||+|+||.||+|.+..++..||+|.+....    .......+.+|+.+++.++   |+||+++++++..+...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            4888999999999999999999999999999886421    2233456888999999996   99999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      |+||||+.|++|.+++..  ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999999999865  368999999999999999999999999999999999999999999999999997765432


Q ss_pred             -cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCc-cCCH
Q 004660          510 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPE-MLSS  586 (739)
Q Consensus       510 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~-~ls~  586 (739)
                       ......|+..|+|||.+.+      ...++.++|||||||++|+|++|..||...........+... ...++. .++.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITE------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSK  229 (277)
T ss_pred             cccccccCCcceeCHHHhcc------CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCH
Confidence             2234568999999999863      345677999999999999999999999876655444333222 223333 3788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      ++.++|.+||..||++||++.++++|+||+...
T Consensus       230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            999999999999999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.8e-41  Score=348.14  Aligned_cols=254  Identities=32%  Similarity=0.562  Sum_probs=223.1

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecceEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~l~  430 (739)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++.....  ......+.+.+|+++++.+. |+||+++++++..++..+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL--IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc--cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            479999999999999999999999999999998864221  12233467888999999998 999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      +||||+.+++|.+++.+. ..+++..++.|+.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... 
T Consensus        79 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          79 FVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            999999999999999775 469999999999999999999999999999999999999999999999999997654322 


Q ss_pred             --------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHH
Q 004660          510 --------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA  569 (739)
Q Consensus       510 --------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~  569 (739)
                                          ......|+..|+|||++.+       ..++.++||||||+++|+|++|+.||........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-------KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT  230 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCC-------CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence                                1123457899999998763       3467799999999999999999999998877777


Q ss_pred             HHHHhhcCCCCCccCCHHHHHHHHHhcccCCCCCCCH----HHHHcCccc
Q 004660          570 MFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSA----VELLEHPFI  615 (739)
Q Consensus       570 ~~~i~~~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa----~elLqHpwf  615 (739)
                      +..+......++..+++.+.+||.+||..||.+||++    +++|+||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         231 FQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            7777777778888899999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6e-41  Score=343.36  Aligned_cols=255  Identities=49%  Similarity=0.869  Sum_probs=215.5

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++.....   ....+.+.+|+.+++.++|+||+++++.+...+.+++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence            599999999999999999999999999999998753322   45668899999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc-
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~-  511 (739)
                      +||+.+++|.+++... ..+++..++.|+.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... 
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          78 MEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             EecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            9999999999999764 45899999999999999999999999999999999999999999999999999876543221 


Q ss_pred             ----cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHH-HHHHhh-cCCCCCcc--
Q 004660          512 ----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKVLN-RTPPIPEM--  583 (739)
Q Consensus       512 ----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~-~~~i~~-~~~~iP~~--  583 (739)
                          ....++..|+|||.+.+..    ...++.++||||||+++|||++|+.||...+.... ...+.. ....+|..  
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~----~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGK----GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ  232 (264)
T ss_pred             cccccCCcCCcCccChhhccCCC----CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccc
Confidence                1245789999999986421    12367899999999999999999999976543332 222222 23344544  


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ++..+.+||.+||+.||.+||++.+++.|||+
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            48999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-43  Score=406.89  Aligned_cols=272  Identities=27%  Similarity=0.407  Sum_probs=236.9

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      .....+|.++++||+|+||.|.+++.+.+++.||||++.+..  ......-..|..|-.||..-+.+=||+++.+|+++.
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e--MlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE--MLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHH--HhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            345678999999999999999999999999999999886411  111112246778889999889999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      ++||||||+.||||..++.+.. .++|..++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-.+..
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            9999999999999999998875 899999999999999999999999999999999999999999999999998876653


Q ss_pred             c--ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc--CCCCC--
Q 004660          508 L--SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIP--  581 (739)
Q Consensus       508 ~--~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP--  581 (739)
                      +  ......+|||.|++||+|+...  ++...|+..+|+||+||++||||.|..||......+.+-+|++.  ...+|  
T Consensus       228 dG~V~s~~aVGTPDYISPEvLqs~~--~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~  305 (1317)
T KOG0612|consen  228 DGTVRSSVAVGTPDYISPEVLQSQG--DGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE  305 (1317)
T ss_pred             CCcEEeccccCCCCccCHHHHHhhc--CCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc
Confidence            3  2334578999999999998643  33468999999999999999999999999999999999999875  45566  


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCC---HHHHHcCccccccccCCCCC
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANYQNLSV  625 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpT---a~elLqHpwf~~~~~~~~~~  625 (739)
                      ..+|.++++||.++|. +|+.|..   ++++-.||||.+.+|.++..
T Consensus       306 ~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~  351 (1317)
T KOG0612|consen  306 TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRE  351 (1317)
T ss_pred             cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhh
Confidence            4689999999999776 8899988   99999999999999876643

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-41  Score=372.03  Aligned_cols=254  Identities=26%  Similarity=0.454  Sum_probs=208.8

Q ss_pred             CCCCCCCceEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeec
Q 004660          347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY  420 (739)
Q Consensus       347 ~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~t-----g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~  420 (739)
                      +....++|++++.||+|+||.||+|++..+     +..||||+++...    ..+....+.+|+.+|+.+ +|+|||+++
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA----HTDEREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC----CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence            344566899999999999999999986544     3579999886321    223356788999999999 899999999


Q ss_pred             cceeecceEEEEEeecCCCCcchhhhhcc---------------------------------------------------
Q 004660          421 GSEVVDDHLYIYLEYVHPGSINRYVREHC---------------------------------------------------  449 (739)
Q Consensus       421 ~~~~~~~~l~LVmEy~~gGsL~~~L~~~~---------------------------------------------------  449 (739)
                      +++...+.+|+||||+.+|+|.+++....                                                   
T Consensus       109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence            99999999999999999999999885421                                                   


Q ss_pred             ------------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          450 ------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       450 ------------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                                        ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                              23678889999999999999999999999999999999999999999999999765432211


Q ss_pred             ---cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc--CCCCCccCC
Q 004660          512 ---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLS  585 (739)
Q Consensus       512 ---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~--~~~iP~~ls  585 (739)
                         ....++..|||||++.       ...++.++|||||||++|||++ |+.||........+.+++..  ....+..++
T Consensus       269 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (374)
T cd05106         269 VVKGNARLPVKWMAPESIF-------DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAP  341 (374)
T ss_pred             eeccCCCCccceeCHHHhc-------CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCC
Confidence               1223567899999986       2457889999999999999997 99999876655544444433  334566788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .+++++|.+||+.||++|||+.++++
T Consensus       342 ~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         342 PEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.8e-41  Score=352.51  Aligned_cols=252  Identities=27%  Similarity=0.418  Sum_probs=204.4

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHH---HHhhcCCCCeEeeccceeecceEEEEEee
Q 004660          359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK---VLGHLKHENIVQYYGSEVVDDHLYIYLEY  435 (739)
Q Consensus       359 ~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~---iL~~L~HPNIVkl~~~~~~~~~l~LVmEy  435 (739)
                      +||+|+||.||++.+..+++.||+|.+..........+  ....+|..   ++...+|+||+.+++.+..++..|+||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE--TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH--HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            48999999999999999999999998864332212111  22333433   34445799999999999999999999999


Q ss_pred             cCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccC
Q 004660          436 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK  515 (739)
Q Consensus       436 ~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s~~  515 (739)
                      +.+|+|.+++..+ ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus        79 ~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          79 MNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcC
Confidence            9999999998765 569999999999999999999999999999999999999999999999999987554322 22356


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch--HHHH-HHhhcCCCCCccCCHHHHHHH
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEMLSSEGKDFL  592 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~--~~~~-~i~~~~~~iP~~ls~el~dLI  592 (739)
                      ||..|+|||.+.+      ...++.++|||||||++|||++|..||......  ..+. ........++..++.++.++|
T Consensus       157 ~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  230 (279)
T cd05633         157 GTHGYMAPEVLQK------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLL  230 (279)
T ss_pred             CCcCccCHHHhcC------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHH
Confidence            8999999998752      235678999999999999999999999754322  2222 222334567778999999999


Q ss_pred             HHhcccCCCCCC-----CHHHHHcCcccccccc
Q 004660          593 LRCFLRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       593 ~kcL~~DP~kRp-----Ta~elLqHpwf~~~~~  620 (739)
                      .+||..||.+|+     ++.|+++||||+..++
T Consensus       231 ~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~  263 (279)
T cd05633         231 EGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW  263 (279)
T ss_pred             HHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence            999999999999     6999999999987553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-41  Score=344.50  Aligned_cols=255  Identities=44%  Similarity=0.815  Sum_probs=216.8

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec--ceE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL  429 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~--~~l  429 (739)
                      ..|++++.||+|+||.||+|.++.++..||+|.+...............+.+|++++++++|+||+++++.+.+.  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            469999999999999999999999999999998754322223344567889999999999999999999988654  468


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~-  508 (739)
                      ++||||+.+++|.+++... ..+++..++.|+.||+.||.|||++||+|+||||+|||++.++.++|+|||+++..... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            9999999999999999765 45899999999999999999999999999999999999999999999999999865321 


Q ss_pred             ---ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc--CCCCCcc
Q 004660          509 ---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEM  583 (739)
Q Consensus       509 ---~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP~~  583 (739)
                         .......|+..|+|||.+.+       ..++.++|||||||++|||++|+.||......+.+.++...  ...+|..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~  233 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISG-------EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG  233 (264)
T ss_pred             ccCccccccCCcccccCHhhhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcc
Confidence               11123568999999998863       34667899999999999999999999887766666665533  3457888


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ++.++.++|.+||. ++.+||++.++|.|||+
T Consensus       234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         234 VSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             cCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.3e-41  Score=342.58  Aligned_cols=254  Identities=37%  Similarity=0.621  Sum_probs=218.7

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++.+.||.|++|.||+|.++.+++.||||++.....    ......+.+|+.++..++|+||+++++++...+..++|
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD----EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            68999999999999999999999999999998864221    14457788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      |||+.+++|.+++... ..+++..++.++.||+.||.|||+ +|++||||+|+||+++.++.++|+|||++.........
T Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          78 LEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             EEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999999765 679999999999999999999999 99999999999999999999999999999876543332


Q ss_pred             c-ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC---chHHHHHHhhc-CCCCCcc-CC
Q 004660          512 L-SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---GPQAMFKVLNR-TPPIPEM-LS  585 (739)
Q Consensus       512 ~-s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~---~~~~~~~i~~~-~~~iP~~-ls  585 (739)
                      . ...++..|+|||.+.+       ..++.++||||||+++|+|++|+.||....   ..+....+... ...++.. ++
T Consensus       157 ~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (264)
T cd06623         157 CNTFVGTVTYMSPERIQG-------ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFS  229 (264)
T ss_pred             ccceeecccccCHhhhCC-------CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCC
Confidence            2 4568899999998763       367789999999999999999999998764   33334444332 3344555 78


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      ..+.++|.+||..+|++||++.|+|+|||++..
T Consensus       230 ~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.3e-41  Score=347.44  Aligned_cols=252  Identities=31%  Similarity=0.551  Sum_probs=210.0

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++.+.||.|++|+||+|+++.+|..||||+++.....    .....+.+|+.++++++|+||+++++++...+..+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc----cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            489999999999999999999999999999998753222    1124566799999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhcc--ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          433 LEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~--~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      |||+. ++|.+++....  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... 
T Consensus        77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          77 FEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             EecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            99998 48888886543  458999999999999999999999999999999999999999999999999997654322 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC------------
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------  577 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------------  577 (739)
                      ......++..|++||.+.+      ...++.++|||||||++|+|++|+.||.+.+..+...+++...            
T Consensus       156 ~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLG------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             ccccccccccccChHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence            1123457899999999863      3456779999999999999999999998776655544433210            


Q ss_pred             ------CC-----------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 ------PP-----------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 ------~~-----------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                            ..           +...++.+++++|.+||+.||.+||++.|+++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                  00           112457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.2e-41  Score=363.99  Aligned_cols=253  Identities=25%  Similarity=0.414  Sum_probs=207.8

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec---
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~---  426 (739)
                      ...+|++.+.||+|+||+||+|.+..+|+.||||++....   ........+.+|+.+++.++|+||+++++++...   
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc---cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            3568999999999999999999999999999999875321   2233345677899999999999999999987644   


Q ss_pred             ---ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004660          427 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       427 ---~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                         ...|+||||+. ++|.+++...   +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          91 EEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             cccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence               35799999996 5788777543   8999999999999999999999999999999999999999999999999998


Q ss_pred             hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC------
Q 004660          504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------  577 (739)
Q Consensus       504 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------  577 (739)
                      ............|+..|+|||.+.+       ..++.++|||||||++|+|++|+.||...+....+.+++...      
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         167 TAGTSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             eCCCCCCCCCCcccccccCHHHHhC-------CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            7655444445568999999999863       457789999999999999999999998765544333332110      


Q ss_pred             ----------------CC--------------C-------CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 004660          578 ----------------PP--------------I-------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR  616 (739)
Q Consensus       578 ----------------~~--------------i-------P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~  616 (739)
                                      ..              +       +...+.++++||.+||..||++|||+.|+|+||||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence                            00              0       112456789999999999999999999999999886

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-42  Score=354.18  Aligned_cols=252  Identities=27%  Similarity=0.414  Sum_probs=216.7

Q ss_pred             CCCceEe-eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceee---
Q 004660          351 KSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV---  425 (739)
Q Consensus       351 ~~~Y~i~-~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~---  425 (739)
                      ..+|.+- ++||-|-.|+|..|..+.||+.+|+|++.-      .    ....+|+++.-.. .|||||.++++|+.   
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD------S----PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc------C----HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            4456664 689999999999999999999999998752      1    2345688776555 49999999998864   


Q ss_pred             -cceEEEEEeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC---CCcEEEeecc
Q 004660          426 -DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFG  500 (739)
Q Consensus       426 -~~~l~LVmEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~---~g~vKL~DFG  500 (739)
                       ...+.||||.++||+|+..|++++ ..++|.++..|++||..||.|||+.+|.||||||+|+|++.   +..+||+|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence             356899999999999999998863 45999999999999999999999999999999999999964   4579999999


Q ss_pred             cchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc----hHHHHHHhhc
Q 004660          501 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNR  576 (739)
Q Consensus       501 lA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~----~~~~~~i~~~  576 (739)
                      +|+.-.......+.+.|++|.|||++.       ...|+...|+||+||+||.||+|.+||....+    ..+..+|..+
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg-------~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g  282 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLG-------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG  282 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhC-------chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence            999887777777889999999999985       45688899999999999999999999976543    3456677777


Q ss_pred             CCCCCc----cCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          577 TPPIPE----MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       577 ~~~iP~----~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      ...+|.    .+|++.+|+|+++|..+|.+|.|++|+++|||+....
T Consensus       283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            777764    5899999999999999999999999999999997643

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.2e-41  Score=350.45  Aligned_cols=250  Identities=25%  Similarity=0.450  Sum_probs=211.9

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCC-----cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  426 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg-----~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~  426 (739)
                      .+|++.+.||+|+||.||+|.....+     ..||+|.++..    ........+.+|+.+|+.++||||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN----AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC----CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            46899999999999999999876554     67999987532    2234456788999999999999999999999998


Q ss_pred             ceEEEEEeecCCCCcchhhhhcc---------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC
Q 004660          427 DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS  491 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~---------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~  491 (739)
                      +..|++|||+.+|+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            99999999999999999996531               457889999999999999999999999999999999999999


Q ss_pred             CcEEEeecccchhccCcc---cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCch
Q 004660          492 GVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP  567 (739)
Q Consensus       492 g~vKL~DFGlA~~~~~~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~  567 (739)
                      +.+||+|||++.......   ......++..|+|||.+.+       ..++.++|||||||++|||++ |..||.+....
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-------GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ  233 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-------CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999997653322   1223456889999998863       457789999999999999998 99999887777


Q ss_pred             HHHHHHhhcC-CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          568 QAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       568 ~~~~~i~~~~-~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      +....+..+. ...+..++.++.+|+.+||+.||++||++.|++++
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         234 EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7666665443 45677889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.9e-41  Score=349.58  Aligned_cols=255  Identities=38%  Similarity=0.643  Sum_probs=218.5

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ..|+..+.||.|+||.||+|.++.++..||||++....    .......+.+|+++++.+.|+||+++++++..+...|+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            45888999999999999999999999999999887421    12345678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      ||||+.||+|.+++..  ..+++..+..++.||+.||+|||+++++|+||+|+|||++.++.++|+|||++..+.... .
T Consensus        80 v~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          80 IMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence            9999999999999865  468999999999999999999999999999999999999999999999999997664432 2


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCccCCHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK  589 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~  589 (739)
                      .....++..|+|||.+.+       ..++.++|||||||++|||++|+.||...........+... ...++..++..+.
T Consensus       158 ~~~~~~~~~y~apE~~~~-------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQ-------SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFK  230 (277)
T ss_pred             cccccCcccccCHhHhcc-------CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHH
Confidence            223468899999999863       34677999999999999999999999877655544444322 3445566788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          590 DFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      ++|.+||..+|++||++.++++|+||....
T Consensus       231 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         231 EFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             HHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence            999999999999999999999999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.1e-40  Score=337.91  Aligned_cols=253  Identities=32%  Similarity=0.597  Sum_probs=220.5

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++.+.||+|+||.||++.+..++..||+|++.....   ..+....+.+|+++++.++|+||+++++.+..++..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM---SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC---ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence            58999999999999999999999999999999874322   234456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc---cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          433 LEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~---~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      |||+++++|.+++...   ...+++.++..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999999764   3679999999999999999999999999999999999999999999999999997764433


Q ss_pred             -cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCccCCHH
Q 004660          510 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE  587 (739)
Q Consensus       510 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~e  587 (739)
                       ......|++.|+|||.+.+       ..++.++||||||+++|+|++|+.||...+..+....+... ...++..++.+
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQN-------KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE  230 (258)
T ss_pred             ceecceeeeecccChhHhcc-------CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHH
Confidence             2234568999999998763       34677899999999999999999999887766655555443 44566788999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          588 GKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      +.++|.+||..+|++|||+.++|+||||
T Consensus       231 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         231 LRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-42  Score=356.09  Aligned_cols=260  Identities=25%  Similarity=0.453  Sum_probs=222.8

Q ss_pred             ceE-eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecceEEE
Q 004660          354 WQK-GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       354 Y~i-~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~l~L  431 (739)
                      |++ .++||+|+||.|--|....+|..||||+|++++.     ....++.+|++++.+++ |+||++++++|++++.+||
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-----HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL  153 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-----HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL  153 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc-----hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence            444 4789999999999999999999999999986532     33578899999999996 9999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC---cEEEeecccchhccC-
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTG-  507 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g---~vKL~DFGlA~~~~~-  507 (739)
                      |||.+.||.|...|+++ ..++|.++..+.++|+.||.|||.+||.||||||+|||...-+   -||||||.|+..+.- 
T Consensus       154 VfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~  232 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN  232 (463)
T ss_pred             EEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence            99999999999999886 6799999999999999999999999999999999999996554   599999999865421 


Q ss_pred             -------cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC---------------
Q 004660          508 -------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---------------  565 (739)
Q Consensus       508 -------~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~---------------  565 (739)
                             .....+.+|+..|||||+..-...  ....|+.+.|.||||+|||.||.|.+||.+.-               
T Consensus       233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~--qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C  310 (463)
T KOG0607|consen  233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVD--QATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC  310 (463)
T ss_pred             CCCCCCCCccccCcccchhhcchhHHhhhcc--ccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence                   122345779999999999874322  24678899999999999999999999996532               


Q ss_pred             chHHHHHHhhcCCCCCc----cCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccccC
Q 004660          566 GPQAMFKVLNRTPPIPE----MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ  621 (739)
Q Consensus       566 ~~~~~~~i~~~~~~iP~----~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~~  621 (739)
                      +...+..|..+..++|+    .++.+.+|||..+|.+|+.+|.++.++|+|||++.....
T Consensus       311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            23455667788888886    489999999999999999999999999999999876543

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.5e-41  Score=343.60  Aligned_cols=243  Identities=26%  Similarity=0.470  Sum_probs=204.5

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecC
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  437 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~  437 (739)
                      +.||+|+||+||+|+++.+++.||+|.+...    ...+....+.+|+++|+.++|+||+++++++..++..|+||||+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            4699999999999999999999999987521    224445678899999999999999999999999999999999999


Q ss_pred             CCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc---cc
Q 004660          438 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SL  514 (739)
Q Consensus       438 gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~---s~  514 (739)
                      +++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........   ..
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            999999997665668999999999999999999999999999999999999999999999999987654322111   11


Q ss_pred             CCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh-cCCCCCccCCHHHHHHH
Q 004660          515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFL  592 (739)
Q Consensus       515 ~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~iP~~ls~el~dLI  592 (739)
                      .++..|+|||.+.+       ..++.++|||||||++|||++ |..||...........+.. .....+..++..+.+||
T Consensus       157 ~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  229 (252)
T cd05084         157 QIPVKWTAPEALNY-------GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLM  229 (252)
T ss_pred             CCceeecCchhhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHH
Confidence            22456999998863       346779999999999999997 9999987665554444433 23456677899999999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q 004660          593 LRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       593 ~kcL~~DP~kRpTa~elLq  611 (739)
                      .+||..||++|||+.++++
T Consensus       230 ~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         230 ERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-40  Score=334.23  Aligned_cols=250  Identities=41%  Similarity=0.733  Sum_probs=215.5

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|.+.+.||+|++|.||++.+..+++.|++|++.....     ...+.+.+|+++++.++|+||+++++.+..++..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            48899999999999999999999999999998864221     3456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL  512 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~  512 (739)
                      |||+.+++|.+++......+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++..........
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence            99999999999997765679999999999999999999999999999999999999999999999999998775543234


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh-cCCCCCc--cCCHHHH
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPE--MLSSEGK  589 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-~~~~iP~--~ls~el~  589 (739)
                      ...|+..|++||.+.+       ..++.++||||||+++|+|++|+.||...+.......+.. ....++.  .++.++.
T Consensus       156 ~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (253)
T cd05122         156 TMVGTPYWMAPEVING-------KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK  228 (253)
T ss_pred             ceecCCcccCHHHHcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHH
Confidence            5678999999999863       2367799999999999999999999987755554444432 2222332  2488999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCcc
Q 004660          590 DFLLRCFLRNPVERPSAVELLEHPF  614 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~elLqHpw  614 (739)
                      ++|.+||..||++|||+.|+|+|||
T Consensus       229 ~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         229 DFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHccCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.5e-41  Score=344.70  Aligned_cols=250  Identities=27%  Similarity=0.491  Sum_probs=212.6

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...+|++.+.||+|+||.||+|.++.++..||+|++..   +   ......+.+|+++|+.++|+||+++++++..++.+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~---~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---D---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecC---C---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            45579999999999999999999999999999998752   1   12245678899999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          430 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      ++||||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            9999999999999999653 345889999999999999999999999999999999999999999999999999876543


Q ss_pred             cccc--ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccC
Q 004660          509 SYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML  584 (739)
Q Consensus       509 ~~~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~l  584 (739)
                      ....  ...++..|+|||.+.+       ..++.++|||||||++|||++ |..||......+....+... ....+..+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  230 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGC  230 (263)
T ss_pred             eeeccCCCCCccccCCHHHhcc-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence            2221  1234668999998863       456779999999999999998 99999887666655555443 45567788


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      +.++.++|.+||..||++||++.++++.
T Consensus       231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         231 PPKVYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence            9999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.2e-41  Score=369.80  Aligned_cols=253  Identities=26%  Similarity=0.457  Sum_probs=207.5

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccc
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGS  422 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~-----k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~  422 (739)
                      ....+|++++.||+|+||+||+|++     ..++..||||+++...    .....+.+.+|+.+|+.+ +|||||+++++
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc----CcHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            3456799999999999999999974     3456789999886321    122345688899999999 79999999999


Q ss_pred             eeecceEEEEEeecCCCCcchhhhhcc-----------------------------------------------------
Q 004660          423 EVVDDHLYIYLEYVHPGSINRYVREHC-----------------------------------------------------  449 (739)
Q Consensus       423 ~~~~~~l~LVmEy~~gGsL~~~L~~~~-----------------------------------------------------  449 (739)
                      +...+..|+|||||.||+|.+++....                                                     
T Consensus       108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            999999999999999999999986431                                                     


Q ss_pred             ---------------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          450 ---------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       450 ---------------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                                           ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                                 14678889999999999999999999999999999999999999999999999766432


Q ss_pred             ccc---cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc--CCCCCc
Q 004660          509 SYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPE  582 (739)
Q Consensus       509 ~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~--~~~iP~  582 (739)
                      ...   ....++..|+|||++.+       ..++.++|||||||++|||++ |..||........+.+.+..  ....+.
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPE  340 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcC-------CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCC
Confidence            211   12234667999999863       457789999999999999998 89999876555444444432  234456


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ..+.++++||.+||..||++||++.|+++.
T Consensus       341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-42  Score=379.44  Aligned_cols=259  Identities=34%  Similarity=0.603  Sum_probs=227.4

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ...|.-++.||.|+||.||.|++..+.+.||||++.....  ...+-..++.+|+++|++|+|||+|.+-++|..+...|
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK--Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW  102 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW  102 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeecccccc--ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence            3468888999999999999999999999999999874332  23445678999999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~  510 (739)
                      ||||||- |+-.|++.-+.+.+-|-+|..|+.+.+.||.|||+++.||||||..||||++.|.|||+|||.|.....   
T Consensus       103 LVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  103 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            9999996 788888877778899999999999999999999999999999999999999999999999999987644   


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-CCCC-ccCCHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIP-EMLSSEG  588 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP-~~ls~el  588 (739)
                      ..+++|||+|||||++....    ...|+-++|||||||+.+||...++|+-+.+....++.|.... +.++ ..++..+
T Consensus       179 AnsFvGTPywMAPEVILAMD----EGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F  254 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF  254 (948)
T ss_pred             hhcccCCccccchhHheecc----ccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHH
Confidence            34689999999999998542    2356669999999999999999999999999988888886543 3333 4588999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      +.||..||++-|.+|||.+++|.|+|+....
T Consensus       255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  255 RNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             HHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence            9999999999999999999999999987543

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-40  Score=348.57  Aligned_cols=254  Identities=29%  Similarity=0.477  Sum_probs=204.5

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ...|++.+.||+|+||.||+|.++.+|..||||++.......    ....+.+|+.+|+.++|+||+++++++..++..|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   79 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence            367999999999999999999999999999999986432221    1234567999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      +||||+. ++|.+++......+.+..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++...... 
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9999996 67776665544568888999999999999999999999999999999999999999999999987643221 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch-HHHHHHhhc------------
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR------------  576 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~-~~~~~i~~~------------  576 (739)
                      ......++..|+|||.+.+      ...++.++|||||||++|||++|+.||...... +.+.++...            
T Consensus       159 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLG------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CCCCccccccccCCceeec------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhh
Confidence            1223457899999998763      234667899999999999999999999765432 222222110            


Q ss_pred             --CCC---------CC-------c--cCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          577 --TPP---------IP-------E--MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       577 --~~~---------iP-------~--~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                        .+.         .+       .  ..+.++.++|.+||..||.+|||+.|+|.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence              000         00       0  125688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=338.85  Aligned_cols=244  Identities=30%  Similarity=0.521  Sum_probs=211.7

Q ss_pred             eEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEe
Q 004660          358 KLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE  434 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~t---g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmE  434 (739)
                      +.||+|+||.||+|.+...   +..||+|.+.....    ....+.+.+|+++++.++|+||+++++++..++.+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS----EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc----hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            4799999999999999866   89999998864222    1145778899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhhc--------cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          435 YVHPGSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       435 y~~gGsL~~~L~~~--------~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      |+.+++|.+++...        ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999999875        4679999999999999999999999999999999999999999999999999998775


Q ss_pred             Ccc---cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh-cCCCCC
Q 004660          507 GLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIP  581 (739)
Q Consensus       507 ~~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~iP  581 (739)
                      ...   ......++..|+|||.+..       ..++.++|||||||++|||++ |..||......+....+.. .....+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  229 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKD-------GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP  229 (262)
T ss_pred             cccccccccCCCcCccccCHHHhcc-------CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            432   2234557889999998863       357789999999999999999 6999998877666666654 344567


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ..++.++.++|.+||..||.+||++.|++++
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         230 EYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            7889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5e-42  Score=334.28  Aligned_cols=256  Identities=31%  Similarity=0.523  Sum_probs=221.5

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .|..+++||+|+||+||+|+++.+++.||+|.++...+++.-.   ....+||.+|+.|+|.|||+++++...+..+-+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp---ssalreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc---HHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            5888999999999999999999999999999998755554333   4567899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~~  511 (739)
                      +|||+ .+|..+....++.++.+.++.++.|+++||.|||+++++||||||.|+||+.+|++||+|||+++.+.-.. ..
T Consensus        80 fe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   80 FEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            99996 78888888777889999999999999999999999999999999999999999999999999999886443 23


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhcC-----------CC
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT-----------PP  579 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~~-----------~~  579 (739)
                      ...+.|.+|++|.++.|      ..-|+...|+||.|||+.||.. |++.|.+.+-.+.+.+|+...           ..
T Consensus       159 saevvtlwyrppdvlfg------akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             eceeeeeeccCcceeee------eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            34567999999999986      4567889999999999999987 888899988888777775311           01


Q ss_pred             CC------------------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          580 IP------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       580 iP------------------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      +|                  ..+....+||++++|..+|.+|++++++|+||||.+.
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            11                  1244677899999999999999999999999999754

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.2e-41  Score=343.40  Aligned_cols=246  Identities=29%  Similarity=0.496  Sum_probs=209.1

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|+||.||++..+. +..+|+|.+....   ..   ...+.+|+.+|+.++||||+++++++..++..|+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~---~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA---MS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC---cc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            569999999999999999998764 5689999865211   11   2467789999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      ||||+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999999999999765456899999999999999999999999999999999999999999999999999765432222


Q ss_pred             c--ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccCCHH
Q 004660          512 L--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE  587 (739)
Q Consensus       512 ~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~e  587 (739)
                      .  ...++..|+|||.+.+       ..++.++||||||+++|||++ |+.||......+.+..+... ....+...+.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  229 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNF-------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMT  229 (256)
T ss_pred             ccCCCCCchhhCChhhccc-------CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            1  2235668999999862       356779999999999999999 99999888777777776654 33456678899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHc
Q 004660          588 GKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      +.++|.+||..||++||++.++++
T Consensus       230 ~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         230 VYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.9e-41  Score=350.73  Aligned_cols=254  Identities=39%  Similarity=0.662  Sum_probs=216.4

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ..|++.+.||.|+||.||+|.+..++..||+|.+....    .....+.+.+|+++++.++|+||+++++++..++..|+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            45888899999999999999999999999999876321    22345678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      ||||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..+.... .
T Consensus        80 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          80 IMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence            9999999999998865  468999999999999999999999999999999999999999999999999997764432 2


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCccCCHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK  589 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~  589 (739)
                      .....|+..|+|||.+.+       ..++.++|||||||++|||++|+.||...........+... ...++..++.++.
T Consensus       158 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQ-------SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFK  230 (277)
T ss_pred             hhcccCcccccCHHHhCc-------CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHH
Confidence            223468899999999863       35677999999999999999999999876554444433322 3344556788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          590 DFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      ++|.+||..+|++||++.++|+|+||...
T Consensus       231 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         231 EFVEACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             HHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence            99999999999999999999999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.5e-40  Score=339.10  Aligned_cols=253  Identities=29%  Similarity=0.551  Sum_probs=214.9

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|.+.+.||+|+||.||++.++.+|..||+|.+......   ....+.+.+|+.+++.++|+||+++++.+...+..|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP---VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc---chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            589999999999999999999999999999998753221   12235678899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC-cEEEeecccchhccCccc
Q 004660          433 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g-~vKL~DFGlA~~~~~~~~  510 (739)
                      |||+.+++|.+++.... ..+++..+..|+.||+.||.|||+++|+|+||||+|||++.++ .+||+|||++........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999999986642 3579999999999999999999999999999999999999886 569999999977644322


Q ss_pred             -ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCccCCHHH
Q 004660          511 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG  588 (739)
Q Consensus       511 -~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el  588 (739)
                       .....|+..|+|||.+.+       ..++.++||||||+++|||++|..||......+....+... ..+++..++.++
T Consensus       158 ~~~~~~~~~~~~ape~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQN-------RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDL  230 (257)
T ss_pred             cccccCCCccccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHH
Confidence             123458999999998863       35677999999999999999999999876665555554433 334556688999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      .++|.+||..+|++|||+.++++|+||
T Consensus       231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         231 RSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.6e-41  Score=346.62  Aligned_cols=250  Identities=30%  Similarity=0.530  Sum_probs=211.6

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~-----tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      ..+|.+.+.||+|+||.||+|.+..     ++..||||.++..    ...+..+.+.+|+++|+.++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET----ASNDARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc----CCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            4579999999999999999998753     4678999987632    223345678899999999999999999999999


Q ss_pred             cceEEEEEeecCCCCcchhhhhcc-------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHC-------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG  492 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~-------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g  492 (739)
                      .+..|+||||+.+++|.+++....             ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence            999999999999999999996532             3478899999999999999999999999999999999999999


Q ss_pred             cEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchH
Q 004660          493 VVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ  568 (739)
Q Consensus       493 ~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~  568 (739)
                      .+||+|||++........   .....++..|+|||++.+       ..++.++|||||||++|||++ |..||......+
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~  232 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE  232 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhcc-------CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999976533221   123345788999999863       457789999999999999998 999998877777


Q ss_pred             HHHHHhhcCC-CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          569 AMFKVLNRTP-PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       569 ~~~~i~~~~~-~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ....+..+.. ..+..++..++++|.+||..||++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         233 VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            7666665433 445678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-40  Score=348.06  Aligned_cols=258  Identities=28%  Similarity=0.482  Sum_probs=211.1

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|++|+||+|.++.+|+.||||.+......   ....+.+.+|+++++.++|+||+++++++..++..|+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc---ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence            4699999999999999999999999999999987643221   2233567789999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC-CCcEEEeecccchhccCcc
Q 004660          432 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~-~g~vKL~DFGlA~~~~~~~  509 (739)
                      ||||+. ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus        79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            999996 5777777543 233688899999999999999999999999999999999985 5679999999997653321


Q ss_pred             -cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC----------
Q 004660          510 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----------  578 (739)
Q Consensus       510 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~----------  578 (739)
                       ......++..|+|||.+.+      ...++.++|||||||++|+|++|+.||...+..+.+.+++....          
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLG------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             cccccCceeecccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence             1223457899999999863      34567799999999999999999999987766655555432100          


Q ss_pred             -----------C--------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          579 -----------P--------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       579 -----------~--------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                 .        ....++.++.++|.+||..||++||++.++|+|+||.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                       0        1124678899999999999999999999999999998754

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.9e-41  Score=348.81  Aligned_cols=256  Identities=28%  Similarity=0.515  Sum_probs=215.0

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...+|++.+.||+|+||+||+|.+..+|+.||+|++...    ......+.+.+|+++++.++|+||+++++++...+.+
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG----AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI   78 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec----CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence            346799999999999999999999999999999988642    1233456788999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      |+||||+++++|.+++.+. +.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++|+|||++......
T Consensus        79 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999999999998764 568999999999999999999997 69999999999999999999999999998655332


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch-----------HHHHHHhhc-
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-----------QAMFKVLNR-  576 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~-----------~~~~~i~~~-  576 (739)
                       ......|+..|+|||++.+       ..++.++|||||||++|+|++|+.||......           +.+..+... 
T Consensus       158 -~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQG-------GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP  229 (284)
T ss_pred             -ccCccccCcccCCHHHHcc-------CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence             2234578999999999863       35677999999999999999999999764431           222233322 


Q ss_pred             CCCCCcc-CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          577 TPPIPEM-LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       577 ~~~iP~~-ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      ...++.. ++.++.+||.+||..||++|||+.|+++|+||...
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            2233333 77899999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=355.27  Aligned_cols=256  Identities=27%  Similarity=0.479  Sum_probs=206.9

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec----
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  426 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~----  426 (739)
                      .++|++.++||+|+||+||+|+++.+|+.||||++....    .......+.+|+.+|+.++|+||+++++++...    
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence            468999999999999999999999999999999886321    122345677899999999999999999876543    


Q ss_pred             -ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          427 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       427 -~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                       ..+|+||||+. ++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence             35899999997 578777754  46999999999999999999999999999999999999999999999999998765


Q ss_pred             cCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-----
Q 004660          506 TGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-----  576 (739)
Q Consensus       506 ~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-----  576 (739)
                      .....    .....||..|+|||.+.+      ...++.++|||||||++|+|++|+.||.+.+....+..+...     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~  230 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS  230 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            43221    123468999999998753      345678999999999999999999999765433322221110     


Q ss_pred             ---------------------CCC-----CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          577 ---------------------TPP-----IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       577 ---------------------~~~-----iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                           ...     ....++.++.+||.+||..||++|||+.|+++||||....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                                 000     0123578899999999999999999999999999998653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=342.33  Aligned_cols=251  Identities=27%  Similarity=0.460  Sum_probs=212.5

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~t---g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      .++|.+.+.||+|+||+||+|.++.+   ...||||.++..    ........+.+|+.+++.++|+||+++++.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG----SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR   78 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC----CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence            35699999999999999999998654   457999987532    22334466888999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      ..|+||||+.+++|.+++......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            99999999999999999987666799999999999999999999999999999999999999999999999999987752


Q ss_pred             cccc---cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCc
Q 004660          508 LSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE  582 (739)
Q Consensus       508 ~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~  582 (739)
                      ....   ....++..|+|||.+.+       ..++.++||||||+++|||++ |..||......+....+... ..+.+.
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  231 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAY-------RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPM  231 (266)
T ss_pred             cccceeccCCCCCccccChhhhcc-------CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            1111   12234678999998863       456789999999999999998 99999877766666666543 335566


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      .++..+.+||.+||+.+|++||++.|++++
T Consensus       232 ~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         232 DCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.2e-40  Score=344.67  Aligned_cols=254  Identities=39%  Similarity=0.659  Sum_probs=217.3

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      .-|++.+.||.|+||.||+|.++.++..||||++...    ......+.+.+|+.+++.++|+||+++++++..++..|+
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   79 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   79 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc----cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence            3588999999999999999999999999999987532    122344678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      ||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+|+||||.|||++.++.++|+|||++..+.... .
T Consensus        80 v~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          80 IMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            9999999999999865  458999999999999999999999999999999999999999999999999987654322 1


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCccCCHHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK  589 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~  589 (739)
                      .....|+..|+|||.+.+       ..++.++|||||||++|+|++|..||...........+... ...++..++.++.
T Consensus       158 ~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQ-------SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLK  230 (277)
T ss_pred             hccccCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHH
Confidence            223468899999998863       34567899999999999999999999876655555554433 3345667889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          590 DFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      ++|.+||..+|.+||++.++++|+||...
T Consensus       231 ~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         231 EFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            99999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-40  Score=352.24  Aligned_cols=255  Identities=35%  Similarity=0.605  Sum_probs=215.5

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ...|.....||+|+||.||+|.+..+++.||||++.....     ...+.+.+|+.+++.++||||+++++.+..++..|
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   94 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELW   94 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEE
Confidence            3456667789999999999999999999999999864221     12356788999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-  509 (739)
                      +||||+++++|..++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... 
T Consensus        95 iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          95 VLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             EEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            99999999999998755  458999999999999999999999999999999999999999999999999997654322 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC---CCCccCCH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSS  586 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~---~iP~~ls~  586 (739)
                      ......|+..|+|||++.+       ..++.++|||||||++|||++|+.||......+.+..+.....   ..+..++.
T Consensus       173 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISR-------TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISP  245 (297)
T ss_pred             cccceecCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCH
Confidence            2234568999999999863       3567899999999999999999999987666555554433222   22345788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      ++.++|.+||..+|++||++.++++|+||....
T Consensus       246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         246 VLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence            999999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=351.12  Aligned_cols=254  Identities=31%  Similarity=0.510  Sum_probs=203.3

Q ss_pred             CceEeeEEeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec--ce
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DH  428 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~--tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~--~~  428 (739)
                      +|++.++||+|+||.||+|.++.  ++..||||.+.....  ........+.+|+.+++.++||||+++++++...  +.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            58999999999999999999988  899999999875321  1122235567899999999999999999999888  78


Q ss_pred             EEEEEeecCCCCcchhhhhc----cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC----CCcEEEeecc
Q 004660          429 LYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA----SGVVKLADFG  500 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~----~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~----~g~vKL~DFG  500 (739)
                      +|+||||+.+ +|.+++...    ...+++..++.++.||+.||.|||++||+||||||+|||++.    ++.+||+|||
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999999974 666666432    236899999999999999999999999999999999999999    8999999999


Q ss_pred             cchhccCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchH--------
Q 004660          501 MAKHLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ--------  568 (739)
Q Consensus       501 lA~~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~--------  568 (739)
                      ++..+.....    .....++..|+|||++.+      ...++.++|||||||+||+|++|+.||.......        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~  231 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR  231 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence            9986643222    223467899999998863      3456779999999999999999999997544321        


Q ss_pred             -HHHHHhh--------------------------cCCCCC-----------ccCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004660          569 -AMFKVLN--------------------------RTPPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELL  610 (739)
Q Consensus       569 -~~~~i~~--------------------------~~~~iP-----------~~ls~el~dLI~kcL~~DP~kRpTa~elL  610 (739)
                       .+..++.                          ....++           ...+.++.++|.+||..||++|||+.|++
T Consensus       232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil  311 (316)
T cd07842         232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL  311 (316)
T ss_pred             HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence             1111100                          001111           14667899999999999999999999999


Q ss_pred             cCccc
Q 004660          611 EHPFI  615 (739)
Q Consensus       611 qHpwf  615 (739)
                      +||||
T Consensus       312 ~~~~f  316 (316)
T cd07842         312 EHPYF  316 (316)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.4e-40  Score=346.66  Aligned_cols=261  Identities=24%  Similarity=0.413  Sum_probs=213.0

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS  422 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~-----tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~  422 (739)
                      .....+|++.++||+|+||.||+|..+.     .+..||+|.+...    ........+.+|+.+++.++|+||++++++
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   77 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----ASLRERIEFLNEASVMKGFTCHHVVRLLGV   77 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            3456789999999999999999997652     3557999976521    112223457789999999999999999999


Q ss_pred             eeecceEEEEEeecCCCCcchhhhhcc---------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCc
Q 004660          423 EVVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV  493 (739)
Q Consensus       423 ~~~~~~l~LVmEy~~gGsL~~~L~~~~---------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~  493 (739)
                      +...+..|+||||+.+|+|.+++....         ..++...+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~  157 (288)
T cd05061          78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc
Confidence            999999999999999999999996531         22456788899999999999999999999999999999999999


Q ss_pred             EEEeecccchhccCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHH
Q 004660          494 VKLADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA  569 (739)
Q Consensus       494 vKL~DFGlA~~~~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~  569 (739)
                      +||+|||+++........   ....++..|+|||.+.+       ..++.++|||||||++|||++ |..||......+.
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~  230 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-------GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV  230 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhcc-------CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999765432211   12235678999999863       356789999999999999998 8999988776666


Q ss_pred             HHHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc------Cccccccc
Q 004660          570 MFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE------HPFIRNAN  619 (739)
Q Consensus       570 ~~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq------Hpwf~~~~  619 (739)
                      ...+... ....+..++..+.++|.+||+.||++|||+.++++      ||||....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         231 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            5555533 44566778899999999999999999999999987      88887654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=340.91  Aligned_cols=250  Identities=30%  Similarity=0.518  Sum_probs=207.3

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHH-hhcCCCCeEeeccceeecceEEEEEeec
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL-~~L~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      +.||.|+||.||+|.++.+|+.||||++.....  ........+..|..++ ..++|+||+++++++..++.+|+||||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM--IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh--hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            679999999999999999999999998763211  1122233444555444 4558999999999999999999999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCC
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG  516 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s~~G  516 (739)
                      .+++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++.....   .....|
T Consensus        80 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          80 NGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCC
Confidence            999999999764 5689999999999999999999999999999999999999999999999999876533   224568


Q ss_pred             CCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCC----CCccCCHHHHHHH
Q 004660          517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP----IPEMLSSEGKDFL  592 (739)
Q Consensus       517 T~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~----iP~~ls~el~dLI  592 (739)
                      +..|+|||.+.+       ..++.++||||||+++|||++|..||...+..+....+......    ....++.++.++|
T Consensus       156 ~~~y~~pe~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  228 (260)
T cd05611         156 TPDYLAPETILG-------VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI  228 (260)
T ss_pred             CcCccChhhhcC-------CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHH
Confidence            999999999863       23678999999999999999999999887776666665544322    3345789999999


Q ss_pred             HHhcccCCCCCC---CHHHHHcCcccccccc
Q 004660          593 LRCFLRNPVERP---SAVELLEHPFIRNANY  620 (739)
Q Consensus       593 ~kcL~~DP~kRp---Ta~elLqHpwf~~~~~  620 (739)
                      .+||..||++||   +++|+|.||||...++
T Consensus       229 ~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         229 NRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             HHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            999999999999   5589999999986553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.8e-40  Score=339.08  Aligned_cols=252  Identities=31%  Similarity=0.502  Sum_probs=209.3

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|+||.||+|+++.+++.||||.+.....  ........+.+|+++++.++||||+++++++...+..++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM--MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc--CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence            479999999999999999999999999999998764322  234445678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhh---ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          432 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      ||||+++|+|.+++..   ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999999988853   2345899999999999999999999999999999999999999999999999998766432


Q ss_pred             cc-ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc--hHHHHHHhh-cCCCC-Ccc
Q 004660          509 SY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLN-RTPPI-PEM  583 (739)
Q Consensus       509 ~~-~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~--~~~~~~i~~-~~~~i-P~~  583 (739)
                      .. .....|+..|+|||.+.+       ..++.++||||||+++|||++|+.||.....  ......+.. ..++. +..
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEH  232 (267)
T ss_pred             hHHHhcCCCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhh
Confidence            22 223568899999999863       3466789999999999999999999965432  233333322 12222 245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ++..+.++|.+||..+|++||++.++|+.
T Consensus       233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         233 YSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             cCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            77899999999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.2e-40  Score=344.19  Aligned_cols=253  Identities=23%  Similarity=0.401  Sum_probs=209.0

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  423 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~-----tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~  423 (739)
                      ...++|++.+.||+|+||+||+|.++.     ++..||||++...    ........+.+|+.+++.++|+||+++++++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~   78 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            456789999999999999999998652     4567999987531    1122345688999999999999999999999


Q ss_pred             eecceEEEEEeecCCCCcchhhhhcc---------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcE
Q 004660          424 VVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV  494 (739)
Q Consensus       424 ~~~~~l~LVmEy~~gGsL~~~L~~~~---------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~v  494 (739)
                      ..++..++||||+.+|+|.+++....         ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence            99999999999999999999986532         125677889999999999999999999999999999999999999


Q ss_pred             EEeecccchhccCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHH
Q 004660          495 KLADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM  570 (739)
Q Consensus       495 KL~DFGlA~~~~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~  570 (739)
                      ||+|||+++.+......   ....++..|||||++.+       ..++.++|||||||++|||++ |..||.+....+.+
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~  231 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL  231 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999998765432211   12345778999999863       456789999999999999998 78999887766655


Q ss_pred             HHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          571 FKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       571 ~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ..+... ...++..++..+.++|.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         232 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            555443 345677789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-40  Score=333.68  Aligned_cols=252  Identities=49%  Similarity=0.864  Sum_probs=219.5

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|.+.+.||+|++|.||++.++.+++.||+|.+....   ........+.+|++++++++|+||+++++++..++..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK---IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc---cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence            5889999999999999999999999999999986432   2234567899999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-c
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-E  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~-~  511 (739)
                      |||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ .
T Consensus        78 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          78 LEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             EecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence            9999999999999765 5799999999999999999999999999999999999999999999999999987654332 2


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHh-hcCCCCCccCCHHHHH
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEGKD  590 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~-~~~~~iP~~ls~el~d  590 (739)
                      ....++..|+|||.+.+       ..++.++|||+||+++|+|++|+.||..........++. .....++..++.++.+
T Consensus       157 ~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (254)
T cd06627         157 ASVVGTPYWMAPEVIEM-------SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD  229 (254)
T ss_pred             cccccchhhcCHhhhcC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence            34568999999998863       236779999999999999999999998766555444443 4455677788999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCccc
Q 004660          591 FLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       591 LI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      +|.+||..+|++||++.+++.|+||
T Consensus       230 ~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         230 FLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.3e-40  Score=346.93  Aligned_cols=250  Identities=30%  Similarity=0.539  Sum_probs=211.2

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeecccee
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  424 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k-----~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~  424 (739)
                      .+..|.+.+.||+|+||+||++...     .++..||+|.+..     ........+.+|+.+|++++|+||+++++++.
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVCV   77 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC-----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            4567999999999999999999853     3456789997753     22334567889999999999999999999999


Q ss_pred             ecceEEEEEeecCCCCcchhhhhcc------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC
Q 004660          425 VDDHLYIYLEYVHPGSINRYVREHC------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG  492 (739)
Q Consensus       425 ~~~~l~LVmEy~~gGsL~~~L~~~~------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g  492 (739)
                      ..+.+|+||||+.+++|.+++....            ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            9999999999999999999996542            2489999999999999999999999999999999999999999


Q ss_pred             cEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchH
Q 004660          493 VVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ  568 (739)
Q Consensus       493 ~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~  568 (739)
                      .+||+|||+++.......   .....++..|+|||.+.+       ..++.++|||||||++|||++ |..||......+
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~  230 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE  230 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999976543221   112335778999998863       457789999999999999998 999998877777


Q ss_pred             HHHHHhhcC-CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          569 AMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       569 ~~~~i~~~~-~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .+..+..+. ...+..++.++.+||.+||+.||.+|||+.++++
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         231 VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            777766544 3456678899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.9e-40  Score=349.48  Aligned_cols=250  Identities=25%  Similarity=0.424  Sum_probs=207.7

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCc--EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecce
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  428 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~--~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~  428 (739)
                      ++|++.++||+|+||.||+|+++.++.  .+++|.++..    ......+.+.+|+.++.++ +||||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF----ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc----CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            579999999999999999999988775  4688876531    1223346788899999999 69999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhcc---------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCc
Q 004660          429 LYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV  493 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~---------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~  493 (739)
                      +|+||||+++|+|.+++.+..               ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence            999999999999999996531               24888999999999999999999999999999999999999999


Q ss_pred             EEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHH
Q 004660          494 VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK  572 (739)
Q Consensus       494 vKL~DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~  572 (739)
                      +||+|||++..............+..|+|||.+.+       ..++.++|||||||++|||++ |..||......+...+
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~  230 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-------SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK  230 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999864332211112223567999998863       457789999999999999997 9999988777666666


Q ss_pred             Hhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          573 VLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       573 i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      +... ...++..++.++.+||.+||..||.+||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         231 LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6543 345667789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.9e-40  Score=351.31  Aligned_cols=252  Identities=25%  Similarity=0.431  Sum_probs=207.5

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEE--EEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeec
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC--AIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~V--AIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~  426 (739)
                      .-++|++.+.||+|+||+||+|.++.++..+  |+|.+..    .........+.+|++++.++ +|+||+++++++..+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc----cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            3457999999999999999999998888654  6665442    12234456788899999999 899999999999999


Q ss_pred             ceEEEEEeecCCCCcchhhhhcc---------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC
Q 004660          427 DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS  491 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~---------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~  491 (739)
                      +.+|+||||+++|+|.+++.+..               ..+++.+++.++.||+.||+|||++||+||||||+||||+.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            99999999999999999996532               257899999999999999999999999999999999999999


Q ss_pred             CcEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHH
Q 004660          492 GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM  570 (739)
Q Consensus       492 g~vKL~DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~  570 (739)
                      +.+||+|||++.............++..|+|||.+.+       ..++.++|||||||++|||++ |..||......+..
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  233 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY  233 (303)
T ss_pred             CcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-------cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence            9999999999864322212222234678999998863       346789999999999999998 99999877666555


Q ss_pred             HHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          571 FKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       571 ~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ..+... ....+..++.++.+||.+||+.+|++||++.++|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         234 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            554433 234556678999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=344.78  Aligned_cols=252  Identities=29%  Similarity=0.547  Sum_probs=208.2

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      |++.+.||.|++|+||+|.++.+|..||+|++......   ......+.+|+++++.++|+||+++++++..++..|+||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc---ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            67889999999999999999999999999988743221   122345778999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-c
Q 004660          434 EYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-E  511 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~-~  511 (739)
                      ||+. ++|.+++.... ..+++..+..++.||+.||.|||+++++||||+|+|||++.++.+||+|||++........ .
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            9995 68999886643 3689999999999999999999999999999999999999999999999999976532221 1


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--------------
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--------------  577 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--------------  577 (739)
                      ....++..|+|||++.+      ...++.++||||||+++|+|++|+.||...+....+.+++...              
T Consensus       157 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         157 THEVVTLWYRAPEILLG------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             CccccccCCCCCceeec------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence            23356889999998753      2346778999999999999999999998766544444332210              


Q ss_pred             ---------------CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 ---------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 ---------------~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                                     ......++.++.++|.+||+.||.+|||+.|+++|+||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                           01123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.2e-40  Score=345.23  Aligned_cols=254  Identities=36%  Similarity=0.616  Sum_probs=216.3

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ..|...+.||+|++|.||++.++.+++.|++|+++..     .....+.+.+|+.+++.++|+||+++++++...+..|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence            4577788999999999999999999999999988632     12234567889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~  510 (739)
                      ||||+.|++|.+++..  ..+++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .
T Consensus        94 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          94 VMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             EEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            9999999999999876  468999999999999999999999999999999999999999999999999987654322 2


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCC---CccCCHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSE  587 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~i---P~~ls~e  587 (739)
                      .....|+..|+|||.+.+       ..++.++|||||||++|||++|+.||...+....+..+.......   +..++..
T Consensus       172 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (285)
T cd06648         172 RKSLVGTPYWMAPEVISR-------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPR  244 (285)
T ss_pred             cccccCCccccCHHHhcC-------CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHH
Confidence            223568999999999853       346779999999999999999999998776665555555442221   2337889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          588 GKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      +.+||.+||..||++||++.++|+|+||+...
T Consensus       245 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         245 LRSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             HHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence            99999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3e-40  Score=346.69  Aligned_cols=255  Identities=29%  Similarity=0.504  Sum_probs=206.0

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec----
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  426 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~----  426 (739)
                      ..+|++.++||+|+||.||+|.++.+++.||||++........   ....+.+|+++++.++|+||+++++++...    
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            5689999999999999999999999999999999864322111   123456899999999999999999987543    


Q ss_pred             ----ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccc
Q 004660          427 ----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA  502 (739)
Q Consensus       427 ----~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA  502 (739)
                          ..+|+||||+. ++|..++......+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          84 KRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             cccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence                34799999997 4677666555567999999999999999999999999999999999999999999999999999


Q ss_pred             hhccCccc------------ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHH
Q 004660          503 KHLTGLSY------------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM  570 (739)
Q Consensus       503 ~~~~~~~~------------~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~  570 (739)
                      ........            .....|++.|+|||.+.+      ...++.++|||||||++|||++|++||.+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG------ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhC------CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            76543221            112357889999999863      345677999999999999999999999876665544


Q ss_pred             HHHhhcCC-----------------------CC-------CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          571 FKVLNRTP-----------------------PI-------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       571 ~~i~~~~~-----------------------~i-------P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ..+.....                       ..       ...+..++.+||.+||..||++|||+.|+|.|+||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            44432100                       00       01245788999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.1e-40  Score=343.47  Aligned_cols=257  Identities=31%  Similarity=0.522  Sum_probs=210.4

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec--ceE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL  429 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~--~~l  429 (739)
                      ++|+..+.||.|++|.||+|.+..+++.||+|.+....    .......+.+|+++++.++|+||+++++++...  +.+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   76 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP----NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI   76 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC----chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence            36899999999999999999999999999999886421    123456788999999999999999999987654  468


Q ss_pred             EEEEeecCCCCcchhhhh---ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          430 YIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      |+||||++|++|.+++..   ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999999999888753   23568999999999999999999999999999999999999999999999999987654


Q ss_pred             CcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC-----chHHHHHHhhc-CCCC
Q 004660          507 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-----GPQAMFKVLNR-TPPI  580 (739)
Q Consensus       507 ~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~-----~~~~~~~i~~~-~~~i  580 (739)
                      .... ....++..|+|||.+.+       ..++.++|||||||++|+|++|+.||....     ..+....+... ...+
T Consensus       157 ~~~~-~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd06621         157 NSLA-GTFTGTSFYMAPERIQG-------KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL  228 (287)
T ss_pred             cccc-ccccCCccccCHHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence            3221 23467899999998863       456789999999999999999999997652     22333333321 1112


Q ss_pred             C------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          581 P------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       581 P------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      +      ..+++.+.+||.+||..||.+|||+.|+++|+||+....
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            1      234678999999999999999999999999999976544

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=343.38  Aligned_cols=252  Identities=29%  Similarity=0.510  Sum_probs=210.5

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec--ceEEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLYI  431 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~--~~l~L  431 (739)
                      |++.+.||.|+||.||+|.+..+|+.||+|++....   ........+.+|+.+++.++|+||+++++++...  +..|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            788999999999999999999999999999987532   1222335677899999999999999999999888  88999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~--  509 (739)
                      ||||+. ++|..++......+++..++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||++.......  
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          78 VFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             Eecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            999997 58888887654679999999999999999999999999999999999999999999999999998765432  


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-----------
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----------  578 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-----------  578 (739)
                      ......++..|+|||.+.+      ...++.++||||||+++|||++|+.||........+..+.....           
T Consensus       157 ~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         157 DYTNRVITLWYRPPELLLG------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             cccccccccccCCceeeEc------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence            1223457889999997753      23567899999999999999999999988776555554432110           


Q ss_pred             --------------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          579 --------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       579 --------------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                                          .+...++.++.++|++||..||.+||++.++++|+||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                                0011138899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-40  Score=341.45  Aligned_cols=249  Identities=26%  Similarity=0.474  Sum_probs=212.6

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...+|+++++||.|+||+||+|.++. +..+|+|++...     .......+.+|+.+|+.++|+||+++++++...+..
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD-----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc-----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence            34579999999999999999999988 899999987632     122345688899999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          430 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      ++||||+++++|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            9999999999999999763 346899999999999999999999999999999999999999999999999999776433


Q ss_pred             ccc-cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccCC
Q 004660          509 SYE-LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS  585 (739)
Q Consensus       509 ~~~-~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls  585 (739)
                      ... ....++..|+|||.+.+       ..++.++||||||+++|+|++ |+.||......+.+..+... ..+.+..++
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASH-------GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCP  230 (261)
T ss_pred             cccccCCCCceEecCHHHHcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCC
Confidence            221 12345678999998863       456779999999999999998 89999887766666666543 345567889


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ..+.++|.+||..||.+|||+.++++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         231 QEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.4e-40  Score=343.83  Aligned_cols=250  Identities=23%  Similarity=0.415  Sum_probs=208.8

Q ss_pred             CCceEeeEEeecCCeEEEEEEEC----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNR----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k----~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ..|++.+.||+|+||+||+|...    .++..||+|.+...    ...+....+.+|+.+++.++|+||+++++++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI----NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            56899999999999999999853    45678999987631    22344567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhc----------------cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC
Q 004660          428 HLYIYLEYVHPGSINRYVREH----------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS  491 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~----------------~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~  491 (739)
                      ..|+||||+.+++|.+++...                ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            999999999999999998532                1247888999999999999999999999999999999999999


Q ss_pred             CcEEEeecccchhccCcc---cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCch
Q 004660          492 GVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP  567 (739)
Q Consensus       492 g~vKL~DFGlA~~~~~~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~  567 (739)
                      +.+||+|||+++......   ......++..|+|||.+.+       ..++.++|||||||++|||++ |..||.+....
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ  233 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhcc-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999998664322   1223345778999998863       357789999999999999998 99999876655


Q ss_pred             HHHHHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          568 QAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       568 ~~~~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      .....+... ....+..++.++.++|.+||+.||++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            555554433 345667789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.3e-40  Score=346.25  Aligned_cols=261  Identities=28%  Similarity=0.484  Sum_probs=217.1

Q ss_pred             CceEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecce
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  428 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k---~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~  428 (739)
                      .|++.+.||.|+||.||+|++.   .+|..||+|++..... .......+.+.+|+.+|+.+ +|+||+.+++.+..+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            3889999999999999999875   4789999999864211 11223346678899999999 59999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      +|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          80 LHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            99999999999999999765 56899999999999999999999999999999999999999999999999999776432


Q ss_pred             c--cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc----hHHHHHHhhcCCCCCc
Q 004660          509 S--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPE  582 (739)
Q Consensus       509 ~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~----~~~~~~i~~~~~~iP~  582 (739)
                      .  ......|+..|+|||.+.+.     ...++.++||||||+++|+|++|..||.....    .+....+.....+++.
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGG-----DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  233 (290)
T ss_pred             cccccccccCCcccCChhhccCC-----CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc
Confidence            2  22245689999999998631     23456789999999999999999999964322    2333444455667788


Q ss_pred             cCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 004660          583 MLSSEGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRp-----Ta~elLqHpwf~~~~~  620 (739)
                      .++..+.+||.+||..||++|+     ++++++.|+||+...+
T Consensus       234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence            8999999999999999999997     8999999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.5e-40  Score=345.83  Aligned_cols=256  Identities=26%  Similarity=0.435  Sum_probs=209.3

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc--
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--  427 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~--  427 (739)
                      ...+|++.+.||+|+||+||+|.++.+|+.||||+++.....   ......+.+|+++++.++||||+++++++...+  
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc---cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            346799999999999999999999999999999998753221   112245678999999999999999999887654  


Q ss_pred             --------eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004660          428 --------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF  499 (739)
Q Consensus       428 --------~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DF  499 (739)
                              .+|+||||+.+ +|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence                    79999999985 677777655557999999999999999999999999999999999999999999999999


Q ss_pred             ccchhccCccc--ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-
Q 004660          500 GMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-  576 (739)
Q Consensus       500 GlA~~~~~~~~--~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-  576 (739)
                      |++..+.....  .....++..|+|||.+.+      ...++.++|||||||++|||++|++||...+..+.+..+... 
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~  234 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLG------EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC  234 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99987644321  122346888999998853      234677999999999999999999999876655544433221 


Q ss_pred             --CC---------------------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          577 --TP---------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       577 --~~---------------------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                        ..                           .....++..+.++|.+||..||.+||++.++|.|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence              10                           0122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-40  Score=347.54  Aligned_cols=260  Identities=29%  Similarity=0.492  Sum_probs=209.5

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecceEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~l~  430 (739)
                      .+|+..+.||+|+||.||++.++.+|+.||||.+.....    ......+.+|+.++.++. |+|||++++++..++..+
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~   79 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD----EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW   79 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC----hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence            357778899999999999999999999999998864221    134467888999999996 999999999999999999


Q ss_pred             EEEeecCCCCcchhh---hh-ccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          431 IYLEYVHPGSINRYV---RE-HCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       431 LVmEy~~gGsL~~~L---~~-~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                      ++|||+. ++|.++.   .. ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++..+
T Consensus        80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            9999986 4544433   22 23569999999999999999999997 49999999999999999999999999999876


Q ss_pred             cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch-HHHHHHhhcC-CCC---
Q 004660          506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRT-PPI---  580 (739)
Q Consensus       506 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~-~~~~~i~~~~-~~i---  580 (739)
                      ..........|+..|+|||++.+..    ...++.++|||||||++|||++|+.||...... +.+.++.... +.+   
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSA----RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNS  234 (288)
T ss_pred             ccCCccccccCccCccCHHHhcccc----ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCc
Confidence            5444444456899999999986411    135778999999999999999999999765421 2223332221 122   


Q ss_pred             -CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          581 -PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       581 -P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                       +..++.++.+||.+||..||++|||+.++++|+||+....
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence             2247889999999999999999999999999999976443

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.9e-40  Score=340.40  Aligned_cols=248  Identities=31%  Similarity=0.498  Sum_probs=209.1

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ..+|++++.||+|+||+||+|.++. +..||+|.++...   ..   ...+.+|+.+++.++||||+++++++...+.+|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---cc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence            3569999999999999999998764 4569999876321   11   245788999999999999999999999888999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~  510 (739)
                      +||||+.+|+|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.......
T Consensus        76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            99999999999999977555789999999999999999999999999999999999999999999999999876544322


Q ss_pred             cc--ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhcC-CCCCccCCH
Q 004660          511 EL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT-PPIPEMLSS  586 (739)
Q Consensus       511 ~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~  586 (739)
                      ..  ...++..|++||.+.+       ..++.++|||||||++|||++ |+.||......+....+.... ...+...+.
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLY-------SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASE  228 (256)
T ss_pred             eecCCCccChhhCCHHHHhc-------CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCH
Confidence            21  2235678999999863       346779999999999999998 999998877666666665543 344566789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      .++++|.+||..||.+||++.+++++
T Consensus       229 ~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         229 KVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=363.41  Aligned_cols=266  Identities=27%  Similarity=0.440  Sum_probs=233.3

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeec
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD  426 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~  426 (739)
                      .....+|..+.+||.|+||+|.+|..+.+.+.||||++++.-  -.+.+.++--..|-++|.... -|.+++++..|+.-
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDV--iiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm  422 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDV--IIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM  422 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccce--eeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence            455678999999999999999999999999999999986311  011111222344667777664 68999999999999


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc-
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-  505 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~-  505 (739)
                      +.+|+||||+.||+|.-.|++. +.+-|..+..|+..|+-||-|||++||++||||.+||||+.+|++||+|||+++.. 
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence            9999999999999999999775 67999999999999999999999999999999999999999999999999999864 


Q ss_pred             cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCC
Q 004660          506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLS  585 (739)
Q Consensus       506 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls  585 (739)
                      .+...+.+++||+.|+|||++.       ...|+.++|+||+||+|||||.|++||++.++.+.+..|+.....+|..++
T Consensus       502 ~~~~TTkTFCGTPdYiAPEIi~-------YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslS  574 (683)
T KOG0696|consen  502 FDGVTTKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLS  574 (683)
T ss_pred             cCCcceeeecCCCcccccceEE-------ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccccc
Confidence            3455667899999999999986       467899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----HHHHHcCccccccccCCC
Q 004660          586 SEGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL  623 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpT-----a~elLqHpwf~~~~~~~~  623 (739)
                      .++.++.+..|.+.|.+|..     -++|-.||||+..+|..+
T Consensus       575 kEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~  617 (683)
T KOG0696|consen  575 KEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL  617 (683)
T ss_pred             HHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence            99999999999999999975     368999999998877543

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-40  Score=339.64  Aligned_cols=249  Identities=24%  Similarity=0.406  Sum_probs=206.8

Q ss_pred             ceEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce--
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH--  428 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~t---g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~--  428 (739)
                      |++++.||+|+||.||+|....+   +..||||.++..   .........+.+|+++|+.++|+||+++++++...+.  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD---IHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC---cCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            67899999999999999987654   478999987632   2223445678899999999999999999997765443  


Q ss_pred             ----EEEEEeecCCCCcchhhhhc-----cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004660          429 ----LYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF  499 (739)
Q Consensus       429 ----l~LVmEy~~gGsL~~~L~~~-----~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DF  499 (739)
                          .++||||+.+|+|..++...     ...+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence                79999999999999988442     235899999999999999999999999999999999999999999999999


Q ss_pred             ccchhccCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh
Q 004660          500 GMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN  575 (739)
Q Consensus       500 GlA~~~~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~  575 (739)
                      |+++.+......   ....++..|+|||.+.       ...++.++|||||||++|||++ |..||.+....+.+..+..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-------DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcc-------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999866433211   1123567899999875       2456789999999999999999 9999988777666666554


Q ss_pred             c-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          576 R-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       576 ~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      . ....+..++.++.++|.+||+.||.+||++.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         231 GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3 455677889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-40  Score=340.10  Aligned_cols=252  Identities=24%  Similarity=0.415  Sum_probs=211.0

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  423 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~t-----g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~  423 (739)
                      ...++|++.+.||+|+||.||+|.++..     +..||+|.+...    ........+.+|+.+|+.++|+||+++++++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   78 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN----ASMRERIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc----cCHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence            4567899999999999999999988643     478999987521    1223345678899999999999999999999


Q ss_pred             eecceEEEEEeecCCCCcchhhhhcc---------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcE
Q 004660          424 VVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV  494 (739)
Q Consensus       424 ~~~~~l~LVmEy~~gGsL~~~L~~~~---------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~v  494 (739)
                      ...+..|+||||+.+|+|.+++....         ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence            99999999999999999999986431         236788999999999999999999999999999999999999999


Q ss_pred             EEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHH
Q 004660          495 KLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM  570 (739)
Q Consensus       495 KL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~  570 (739)
                      ||+|||+++.+.....   .....++..|+|||.+.+       ..++.++|||||||++|||++ |..||......+..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  231 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-------GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL  231 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhc-------CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH
Confidence            9999999986643321   123346789999998863       356779999999999999998 99999887766655


Q ss_pred             HHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          571 FKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       571 ~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ..+... ...+|..++.++.++|.+||+.+|++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         232 KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            555533 34567788999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6e-40  Score=333.90  Aligned_cols=252  Identities=31%  Similarity=0.524  Sum_probs=217.8

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|++.+.||+|+||.||++.++.+++.||+|.+.....   .......+.+|+++++.++|+||+++++++......|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM---SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc---cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence            58999999999999999999999999999998864221   223345677899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhc---cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          433 LEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~---~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      |||+++++|.+++...   ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999999998652   246899999999999999999999999999999999999999999999999999877554 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-CCCCccCCHHH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEG  588 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~el  588 (739)
                      ......|+..|++||.+.+       ..++.++|+||||+++|||++|+.||...+..+....+.... ..++..++.++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~-------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKG-------RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDL  229 (256)
T ss_pred             CcccccCCccccCHHHHCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHH
Confidence            3334568999999999863       456778999999999999999999998877665555554433 45666789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      +++|.+||..+|++||++.++|+||++
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         230 QNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.3e-40  Score=345.08  Aligned_cols=256  Identities=25%  Similarity=0.462  Sum_probs=213.3

Q ss_pred             CCCCCCCCceEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEee
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQY  419 (739)
Q Consensus       346 ~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~t-----g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl  419 (739)
                      .......+|++.+.||+|+||.||++..+..     ...||+|.+...    ........+.+|+.+++.+ +|+||+++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~   81 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINL   81 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC----CCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            4556677899999999999999999987643     367999987632    2233446688999999999 79999999


Q ss_pred             ccceeecceEEEEEeecCCCCcchhhhhc---------------cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCc
Q 004660          420 YGSEVVDDHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA  484 (739)
Q Consensus       420 ~~~~~~~~~l~LVmEy~~gGsL~~~L~~~---------------~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~  484 (739)
                      ++++..++.+|+||||+.+|+|..++...               ...+++..+..++.||+.||.|||++||+||||||+
T Consensus        82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~  161 (293)
T cd05053          82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR  161 (293)
T ss_pred             EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence            99999999999999999999999998642               346889999999999999999999999999999999


Q ss_pred             ceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCC
Q 004660          485 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP  560 (739)
Q Consensus       485 NILLd~~g~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~P  560 (739)
                      |||++.++.+||+|||+++.+.....   .....++..|+|||.+.+       ..++.++|||||||++|||++ |..|
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p  234 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLLWEIFTLGGSP  234 (293)
T ss_pred             eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-------CCcCcccceeehhhHHHHHhcCCCCC
Confidence            99999999999999999987644321   112234678999998753       457789999999999999997 9999


Q ss_pred             CCCCCchHHHHHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          561 WSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       561 F~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      |......+....+... ....+..++.++.+||.+||..||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         235 YPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            9887666655555433 335666788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.5e-40  Score=348.99  Aligned_cols=258  Identities=34%  Similarity=0.600  Sum_probs=215.9

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ...|++.+.||+|+||+||+|.+..+|+.||+|++...  .....+..+.+.+|+++++.++||||+++++++..++..|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecc--ccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            35699999999999999999999999999999988632  2223444567889999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~  510 (739)
                      +||||+. |+|.+++......+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++......  
T Consensus        92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9999997 5677776554467999999999999999999999999999999999999999999999999998765332  


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCC-CccCCHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPI-PEMLSSEG  588 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~i-P~~ls~el  588 (739)
                       ....|+..|+|||++.+.    ....++.++||||||+++|||++|+.||...+.......+... ...+ +..++.++
T Consensus       169 -~~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF  243 (307)
T ss_pred             -CCccCCccccCceeeecc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence             235688999999987531    1245778999999999999999999999877665555544432 2222 33478899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      +++|.+||..||++||++.+++.|+||...
T Consensus       244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            999999999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.4e-40  Score=348.81  Aligned_cols=255  Identities=38%  Similarity=0.634  Sum_probs=215.1

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ..+|.+.+.||+|+||+||++.+..++..||+|.+....     ....+.+.+|+.+++.++||||+++++.+...+..|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            468999999999999999999999999999999886321     112356788999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~  510 (739)
                      +||||+++++|.+++.+.  .+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        93 lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             EEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999999999999763  578999999999999999999999999999999999999999999999999876543322


Q ss_pred             -ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHh-hcCC--CCCccCCH
Q 004660          511 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRTP--PIPEMLSS  586 (739)
Q Consensus       511 -~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~-~~~~--~iP~~ls~  586 (739)
                       .....|++.|+|||.+.+       ..++.++|||||||++|+|++|+.||........+..+. ....  ..+..++.
T Consensus       171 ~~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  243 (293)
T ss_pred             ccccccCChhhcCchhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCH
Confidence             223468899999998863       346779999999999999999999998765544333332 2222  23445788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      .++++|.+||..+|++||++.+++.|+||+...
T Consensus       244 ~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-40  Score=340.65  Aligned_cols=247  Identities=29%  Similarity=0.483  Sum_probs=207.5

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      .+|++.+.||+|+||.||+|.++ ++..+|+|++....   ..   ...+.+|+++++.++|+||+++++++...+..|+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA---MS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI   76 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC---CC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence            46899999999999999999886 46789999875311   11   1356779999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      ||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            99999999999999775567899999999999999999999999999999999999999999999999999765432211


Q ss_pred             c--ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccCCHH
Q 004660          512 L--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE  587 (739)
Q Consensus       512 ~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~e  587 (739)
                      .  ...++..|+|||.+.+       ..++.++||||||+++|||++ |+.||......+....+... ....+..++.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDY-------SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTE  229 (256)
T ss_pred             ccCCCCCCccccCHHHhcc-------CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence            1  1123457999998863       356779999999999999999 89999877666666555443 34556678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          588 GKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      +.+++.+||..+|++|||+.|+++.
T Consensus       230 ~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         230 VYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.8e-40  Score=338.47  Aligned_cols=249  Identities=27%  Similarity=0.485  Sum_probs=208.9

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ...++|++.++||+|+||.||+|.+. ++..||+|.+...      ....+.+.+|+.+++.++|+||+++++.+...+.
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP   75 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45678999999999999999999865 5678999987531      1124578889999999999999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          429 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            99999999999999999653 35688899999999999999999999999999999999999999999999999987643


Q ss_pred             cccc--cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCcc
Q 004660          508 LSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM  583 (739)
Q Consensus       508 ~~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~  583 (739)
                      ....  ....++..|+|||.+.+       ..++.++|||||||++|+|++ |+.||...........+... ..+.+..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  228 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN  228 (261)
T ss_pred             CceeccCCCccceecCCHHHhcc-------CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            2221  12345678999998863       356778999999999999998 99999887666666555543 2334456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ++.++.++|.+||..||++||+++++++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         229 CPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            8899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.7e-40  Score=351.63  Aligned_cols=250  Identities=28%  Similarity=0.485  Sum_probs=207.7

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcE----EEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~----VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      ...+|++.+.||+|+||+||+|++..+|..    ||||+++..    ......+.+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~   80 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLT   80 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence            356799999999999999999998766664    888987521    223445678889999999999999999998876


Q ss_pred             cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                      . ..++|+||+.+|+|.+++.+....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus        81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence            4 578999999999999999876667899999999999999999999999999999999999999999999999999876


Q ss_pred             cCccccc---ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc--CCC
Q 004660          506 TGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPP  579 (739)
Q Consensus       506 ~~~~~~~---s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~--~~~  579 (739)
                      .......   ...++..|+|||.+.+       ..++.++|||||||++|||++ |+.||.+....+.. .++..  ..+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~  231 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLP  231 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhcc-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCC
Confidence            5433221   2234678999999863       456789999999999999997 99999876554433 33332  334


Q ss_pred             CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       580 iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      .+..++.++.++|.+||..||.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         232 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            556788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.8e-40  Score=356.01  Aligned_cols=257  Identities=28%  Similarity=0.501  Sum_probs=210.5

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee----cc
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DD  427 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~----~~  427 (739)
                      .+|.+.+.||+|+||.||+|.++.+|+.||+|++.....   .....+.+.+|+.+|+.++|+||+++++++..    ..
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD---VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc---cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence            679999999999999999999999999999998864221   22334667789999999999999999998763    34


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            6899999996 6898888654 5599999999999999999999999999999999999999999999999999976533


Q ss_pred             cc-----cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc------
Q 004660          508 LS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------  576 (739)
Q Consensus       508 ~~-----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~------  576 (739)
                      ..     ......|+..|+|||++.+      ...++.++|||||||++|||++|+.||...+....+..+...      
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~  233 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLS------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE  233 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcC------CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence            22     1123568999999999863      234678999999999999999999999876544333322210      


Q ss_pred             --------------------CCCC-----CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          577 --------------------TPPI-----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       577 --------------------~~~i-----P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                          ....     ...++.++.++|++||+.||++||++.++|+||||....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence                                0111     134688999999999999999999999999999997544

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-40  Score=341.41  Aligned_cols=252  Identities=30%  Similarity=0.529  Sum_probs=211.8

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      |++.+.||.|++|.||+|.+..+|+.+++|.+......   ......+.+|+.+|+.++|+||+++++++..++.+|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            67789999999999999999999999999988643221   233467888999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-ccc
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YEL  512 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~~~  512 (739)
                      ||+.+ +|.+++......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ...
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            99974 8888887755679999999999999999999999999999999999999999999999999997765433 222


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC--------------
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------------  578 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~--------------  578 (739)
                      ...++..|+|||.+.+      ...++.++||||||+++|+|++|+.||...+..+.+.++.....              
T Consensus       157 ~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         157 HYVVTRWYRAPELLLG------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CccCcccccCcHHHhc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            3458889999999863      23577899999999999999999999987766555444332100              


Q ss_pred             ----------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          579 ----------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       579 ----------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                                      .+...++.++++||.+||..||.+||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                            0112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.2e-40  Score=341.82  Aligned_cols=251  Identities=26%  Similarity=0.422  Sum_probs=209.0

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~-----tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      ...|++.+.||+|+||.||+|.++.     ++..||+|.+...    ........+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES----CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4579999999999999999999987     7788999977532    122333567889999999999999999999998


Q ss_pred             cceEEEEEeecCCCCcchhhhhcc------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC---cEEE
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHC------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKL  496 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g---~vKL  496 (739)
                      .+..|+||||+.|++|.+++....      ..+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence            899999999999999999996542      2488999999999999999999999999999999999998765   6999


Q ss_pred             eecccchhccCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHH
Q 004660          497 ADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK  572 (739)
Q Consensus       497 ~DFGlA~~~~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~  572 (739)
                      +|||+++.+......   .....+..|+|||++.+       ..++.++|||||||++|||++ |..||......+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~  233 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-------GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF  233 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhc-------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999876332211   11223567999999873       457889999999999999997 9999988766655554


Q ss_pred             Hhh-cCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          573 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       573 i~~-~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      +.. .....+..++..+.++|.+||+.||++||++.++|+|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         234 VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            443 2345567789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.8e-40  Score=352.90  Aligned_cols=262  Identities=30%  Similarity=0.451  Sum_probs=211.9

Q ss_pred             CCCce-EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccH---------HHHHHHHHHHHHHhhcCCCCeEeec
Q 004660          351 KSQWQ-KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------ECIKQLEQEIKVLGHLKHENIVQYY  420 (739)
Q Consensus       351 ~~~Y~-i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~---------~~~k~l~~Ei~iL~~L~HPNIVkl~  420 (739)
                      ..+|. +.+.||.|+||+||+|.++.+++.||||+++.........         .....+.+|+++|+.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            44565 5688999999999999999999999999986432221100         0112467899999999999999999


Q ss_pred             cceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecc
Q 004660          421 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG  500 (739)
Q Consensus       421 ~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFG  500 (739)
                      +++..++..|+||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence            99999999999999997 6898888654 568999999999999999999999999999999999999999999999999


Q ss_pred             cchhccCc---------------ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC
Q 004660          501 MAKHLTGL---------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE  565 (739)
Q Consensus       501 lA~~~~~~---------------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~  565 (739)
                      ++......               .......++..|+|||.+.+      ...++.++|||||||++|||++|+.||...+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG------AEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhccc------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99765411               11112346889999999863      3356789999999999999999999998877


Q ss_pred             chHHHHHHhhcCC----------------------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          566 GPQAMFKVLNRTP----------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       566 ~~~~~~~i~~~~~----------------------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                      ..+.+..+.....                            .+....+.++.++|.+||..||++||+++|+|.|+||+.
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~  318 (335)
T PTZ00024        239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS  318 (335)
T ss_pred             HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence            6655554432110                            011235788999999999999999999999999999986


Q ss_pred             ccc
Q 004660          618 ANY  620 (739)
Q Consensus       618 ~~~  620 (739)
                      ...
T Consensus       319 ~~~  321 (335)
T PTZ00024        319 DPL  321 (335)
T ss_pred             CCC
Confidence            543

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.3e-40  Score=353.93  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=210.6

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec----
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  426 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~----  426 (739)
                      ..+|.+.+.||+|+||+||+|++..+++.||||.+.....   .......+.+|+.+|+.++|+||+++++++...    
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence            4579999999999999999999999999999998864221   122235667899999999999999999987654    


Q ss_pred             -ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          427 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       427 -~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                       ..+||||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence             34899999996 7888888664 56999999999999999999999999999999999999999999999999999866


Q ss_pred             cCc-ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh---------
Q 004660          506 TGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---------  575 (739)
Q Consensus       506 ~~~-~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~---------  575 (739)
                      ... .......++..|+|||.+..      ...++.++|||||||++|+|++|+.||.+.+.......+..         
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLN------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED  232 (337)
T ss_pred             CCCcccccccccccCccChHHHhc------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence            433 22334568999999999863      23467899999999999999999999976543322221110         


Q ss_pred             --------------cC--------CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          576 --------------RT--------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       576 --------------~~--------~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                                    ..        ......++.++.+||++||+.||++|||+.++|+||||.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence                          00        0112357889999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.9e-40  Score=355.35  Aligned_cols=254  Identities=28%  Similarity=0.490  Sum_probs=207.4

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec----
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  426 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~----  426 (739)
                      ..+|++.+.||.|+||.||+|.++.+|+.||+|++.....     ...+.+.+|+++|+.++|+||+++++++...    
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence            4789999999999999999999999999999999864322     3346688899999999999999999876554    


Q ss_pred             ----------ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC-CCcEE
Q 004660          427 ----------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVK  495 (739)
Q Consensus       427 ----------~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~-~g~vK  495 (739)
                                ..+|+||||+. ++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEE
Confidence                      35899999997 588888754  35899999999999999999999999999999999999974 56799


Q ss_pred             EeecccchhccCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHH
Q 004660          496 LADFGMAKHLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF  571 (739)
Q Consensus       496 L~DFGlA~~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~  571 (739)
                      |+|||++..+.....    .....|+..|+|||.+.+      ...++.++|||||||++|||++|+.||......+...
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~  229 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ  229 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhC------ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999976532211    122357889999998763      2356779999999999999999999998765544444


Q ss_pred             HHhhcCC------------------------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          572 KVLNRTP------------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       572 ~i~~~~~------------------------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      .++...+                              .+...++.++.+||.+||+.||++|||+.|+|+|+||+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            3322110                              0112477899999999999999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-40  Score=333.88  Aligned_cols=246  Identities=33%  Similarity=0.552  Sum_probs=216.4

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecCCC
Q 004660          360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  439 (739)
Q Consensus       360 LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~gG  439 (739)
                      ||+|+||.||++.+..+++.||+|++....  .........+.+|+.+++.++|+||+++++.+..++..|+||||+.++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK--IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhh--hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            699999999999999899999999986432  122334567889999999999999999999999999999999999999


Q ss_pred             CcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-ccccccCCCC
Q 004660          440 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSLKGSP  518 (739)
Q Consensus       440 sL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~-~~~~s~~GT~  518 (739)
                      +|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++...... .......++.
T Consensus        79 ~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05123          79 ELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP  157 (250)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence            999999765 46899999999999999999999999999999999999999999999999999776543 2233456899


Q ss_pred             CCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHhccc
Q 004660          519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR  598 (739)
Q Consensus       519 ~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kcL~~  598 (739)
                      .|++||.+.+       ...+.++|+||||+++|+|++|+.||...+..+....+......++..++.++.++|++||..
T Consensus       158 ~~~~Pe~~~~-------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         158 EYLAPEVLLG-------KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQK  230 (250)
T ss_pred             cccChHHhCC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999863       346678999999999999999999998777666666776677788888999999999999999


Q ss_pred             CCCCCCCH---HHHHcCccc
Q 004660          599 NPVERPSA---VELLEHPFI  615 (739)
Q Consensus       599 DP~kRpTa---~elLqHpwf  615 (739)
                      ||++||++   +++++||||
T Consensus       231 ~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         231 DPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CHhhCCCcccHHHHHhCCCC
Confidence            99999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.8e-40  Score=338.63  Aligned_cols=249  Identities=24%  Similarity=0.396  Sum_probs=203.7

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCc--EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec-----
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-----  426 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~--~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~-----  426 (739)
                      |.++++||+|+||.||+|++..++.  .||+|.++...   ......+.+.+|+.+|+.++|+||+++++++...     
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   77 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG   77 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence            4578999999999999999987775  58999876421   2334457788899999999999999999865422     


Q ss_pred             -ceEEEEEeecCCCCcchhhhh-----ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecc
Q 004660          427 -DHLYIYLEYVHPGSINRYVRE-----HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG  500 (739)
Q Consensus       427 -~~l~LVmEy~~gGsL~~~L~~-----~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFG  500 (739)
                       ...++||||+.+|+|.+++..     ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence             247999999999999988742     22348899999999999999999999999999999999999999999999999


Q ss_pred             cchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc
Q 004660          501 MAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR  576 (739)
Q Consensus       501 lA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~  576 (739)
                      +++.+.....   .....++..|+|||.+.+       ..++.++|||||||++|||++ |+.||......+....+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-------RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccC-------CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9987643221   112245778999998863       457789999999999999999 89999887666655555543


Q ss_pred             C-CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          577 T-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       577 ~-~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      . ...+..++..+.++|.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         231 NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2 34566788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.4e-40  Score=341.97  Aligned_cols=249  Identities=26%  Similarity=0.430  Sum_probs=205.0

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcE----EEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  426 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~----VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~  426 (739)
                      ..+|++++.||+|+||+||+|.+..+|..    |++|.+.    ..........+..|+.++..+.|||||++++++. .
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~----~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~   80 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ----DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G   80 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecc----cccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence            46799999999999999999999887775    5566543    1222344567888999999999999999999765 4


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      ...+++|||+.+|+|.+++......+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            56789999999999999998766779999999999999999999999999999999999999999999999999998654


Q ss_pred             Cccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCC
Q 004660          507 GLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIP  581 (739)
Q Consensus       507 ~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP  581 (739)
                      ....   .....++..|+|||.+.+       ..++.++|||||||++|||++ |+.||.+.........+..+ ....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  233 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILF-------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP  233 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhcc-------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC
Confidence            3221   122346778999999863       357789999999999999998 99999876554443333322 33445


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ..++.++.+++.+||..||++|||+.|+++
T Consensus       234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         234 QICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            667889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.5e-40  Score=357.39  Aligned_cols=253  Identities=28%  Similarity=0.482  Sum_probs=206.1

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccc
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGS  422 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k-----~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~  422 (739)
                      ...++|+++++||+|+||.||+|.+.     .+++.||+|+++..    ......+.+.+|+.+++++ +|+||++++++
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG----ATASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC----CCHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            34568999999999999999999754     34578999987531    1233346678899999999 79999999998


Q ss_pred             eee-cceEEEEEeecCCCCcchhhhhcc----------------------------------------------------
Q 004660          423 EVV-DDHLYIYLEYVHPGSINRYVREHC----------------------------------------------------  449 (739)
Q Consensus       423 ~~~-~~~l~LVmEy~~gGsL~~~L~~~~----------------------------------------------------  449 (739)
                      +.. +..++++|||+.+|+|.++|....                                                    
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            765 456899999999999999885421                                                    


Q ss_pred             --------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc---ccccCCCC
Q 004660          450 --------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSP  518 (739)
Q Consensus       450 --------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~---~~s~~GT~  518 (739)
                              ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....   .....++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                    2578899999999999999999999999999999999999999999999999987643221   12234577


Q ss_pred             CCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc--CCCCCccCCHHHHHHHHHh
Q 004660          519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRC  595 (739)
Q Consensus       519 ~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~--~~~iP~~ls~el~dLI~kc  595 (739)
                      .|+|||++.+       ..++.++|||||||+||||++ |..||.+....+.+...+..  ....+..++.++.+++.+|
T Consensus       240 ~y~aPE~~~~-------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c  312 (337)
T cd05054         240 KWMAPESIFD-------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDC  312 (337)
T ss_pred             cccCcHHhcC-------CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHH
Confidence            8999999863       467889999999999999998 99999875544444444322  3345667889999999999


Q ss_pred             cccCCCCCCCHHHHHcC
Q 004660          596 FLRNPVERPSAVELLEH  612 (739)
Q Consensus       596 L~~DP~kRpTa~elLqH  612 (739)
                      |+.+|++||++.|+++|
T Consensus       313 l~~~p~~RPs~~ell~~  329 (337)
T cd05054         313 WHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ccCChhhCcCHHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.7e-40  Score=353.83  Aligned_cols=255  Identities=26%  Similarity=0.466  Sum_probs=205.8

Q ss_pred             eEEeec--CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEee
Q 004660          358 KLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY  435 (739)
Q Consensus       358 ~~LG~G--~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy  435 (739)
                      +.||+|  +||+||+|++..+|+.||||++....   ...+..+.+.+|+.+++.++|||||++++++..++.+|+||||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN---CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            456666  99999999999999999999886432   2234457889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc----
Q 004660          436 VHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY----  510 (739)
Q Consensus       436 ~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~----  510 (739)
                      +.+++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+........    
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999999998764 23589999999999999999999999999999999999999999999999986543321110    


Q ss_pred             ----ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC--------
Q 004660          511 ----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------  578 (739)
Q Consensus       511 ----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~--------  578 (739)
                          .....++..|+|||++.+.     ...++.++|||||||++|||++|+.||............+....        
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQD-----LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT  235 (328)
T ss_pred             cccccccccCccCccChhhhcCC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence                0112356679999998631     23467899999999999999999999987665544433332211        


Q ss_pred             ---------------------------------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          579 ---------------------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       579 ---------------------------------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                                             ..+..++..+++||.+||+.||++|||+.|+|+|+||....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                                   11123567889999999999999999999999999998654


Q ss_pred             c
Q 004660          620 Y  620 (739)
Q Consensus       620 ~  620 (739)
                      .
T Consensus       316 ~  316 (328)
T cd08226         316 E  316 (328)
T ss_pred             H
Confidence            3

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=384.26  Aligned_cols=254  Identities=27%  Similarity=0.448  Sum_probs=213.1

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccc-eee
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGS-EVV  425 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~-~~~  425 (739)
                      .+...++++.++|.+|||+.||+|++...|..||+|++..     .++..++.+.+||.+|++|+ |+|||.|++. ...
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~-----~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~  107 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV-----NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN  107 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec-----CCHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence            4455678999999999999999999999889999998864     24566788999999999997 9999999993 221


Q ss_pred             ------cceEEEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCC--eecccCCCcceEecCCCcEEE
Q 004660          426 ------DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKL  496 (739)
Q Consensus       426 ------~~~l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~G--IvHRDIKP~NILLd~~g~vKL  496 (739)
                            .-+++|.||||.||.|-+++.++ ...|+|.+|+.|+.|+++||.+||..+  |||||||-|||||+.+|.+||
T Consensus       108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence                  13589999999999999999643 245999999999999999999999887  999999999999999999999


Q ss_pred             eecccchhccCcc----------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc
Q 004660          497 ADFGMAKHLTGLS----------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG  566 (739)
Q Consensus       497 ~DFGlA~~~~~~~----------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~  566 (739)
                      ||||.|.......          ......-|+.|+|||++.-.    .+..++.|+|||+|||+||-|+....||++...
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly----sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY----SGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh----cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            9999986432111          11123369999999999742    246789999999999999999999999987643


Q ss_pred             hHHHHHHhhcCCCCCc--cCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 004660          567 PQAMFKVLNRTPPIPE--MLSSEGKDFLLRCFLRNPVERPSAVELLEHPF  614 (739)
Q Consensus       567 ~~~~~~i~~~~~~iP~--~ls~el~dLI~kcL~~DP~kRpTa~elLqHpw  614 (739)
                          .+|+++...+|.  .++..+++||+.||+.||.+||++.|++.+-+
T Consensus       264 ----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  264 ----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             ----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence                356777777775  68999999999999999999999999997643

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.4e-40  Score=337.81  Aligned_cols=255  Identities=28%  Similarity=0.523  Sum_probs=214.1

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|.+.+.||+|+||+||++.+..++..+++|+++..............+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58999999999999999999988888888887765443332233334577899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhh---ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-
Q 004660          433 LEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-  508 (739)
Q Consensus       433 mEy~~gGsL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~-  508 (739)
                      |||+.+++|.+++.+   ....+++.+++.++.||+.||.|||++||+|+||||+||+++. +.+||+|||++...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999998864   2356899999999999999999999999999999999999975 67999999998766432 


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCccCCHH
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE  587 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~e  587 (739)
                      .......|+..|+|||.+.+       ..++.++||||||+++|+|++|..||...........+... ...++..++.+
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKH-------QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQ  232 (260)
T ss_pred             ccccCCCCCcCccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHH
Confidence            22334568999999998753       34567899999999999999999999876666665555543 34456678899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          588 GKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      +.++|.+||..||++||++.|+++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.5e-40  Score=352.84  Aligned_cols=256  Identities=27%  Similarity=0.472  Sum_probs=212.2

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc--
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--  427 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~--  427 (739)
                      ...+|++.+.||+|+||+||+|.+..+|..||||++....   ........+.+|+.+|+.++|+||+++++++..+.  
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            4678999999999999999999999999999999875321   22333456788999999999999999999887653  


Q ss_pred             ----eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004660          428 ----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       428 ----~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                          .+++||||+ |++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence                469999999 7899888864  468999999999999999999999999999999999999999999999999997


Q ss_pred             hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-----
Q 004660          504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----  578 (739)
Q Consensus       504 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-----  578 (739)
                      .....  .....+++.|+|||.+.+      ...++.++|||||||++|+|++|+.||...+......+++....     
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         167 QTDSE--MTGYVVTRWYRAPEVILN------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             ccccC--ccccccCCcccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            65432  224567999999999863      23467799999999999999999999987655444443322111     


Q ss_pred             --------------------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          579 --------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       579 --------------------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                                .+...++.++.++|.+||..||++|||+.+++.|+||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence                                      11235678899999999999999999999999999998653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.2e-40  Score=340.23  Aligned_cols=250  Identities=27%  Similarity=0.432  Sum_probs=207.4

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~----~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      ...+|++.++||+|+||+||+|.+..+|.    .||+|+++..    ......+.+.+|+.+++.+.|+||+++++++..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC----CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            45689999999999999999999887776    4789987531    223445678899999999999999999998765


Q ss_pred             cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                       ...+++|||+++|+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence             4578999999999999999876567999999999999999999999999999999999999999999999999999876


Q ss_pred             cCccccc---ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCC
Q 004660          506 TGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPI  580 (739)
Q Consensus       506 ~~~~~~~---s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~i  580 (739)
                      .......   ...++..|+|||.+.+       ..++.++|||||||++|||++ |..||...........+... ..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILH-------RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ  232 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhcc-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence            4322211   2234678999999863       357789999999999999998 99999876555444433332 3445


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      +..++.++.++|.+||..||++||++.++++
T Consensus       233 ~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         233 PPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            6678899999999999999999999999995

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.3e-40  Score=343.35  Aligned_cols=250  Identities=22%  Similarity=0.383  Sum_probs=210.2

Q ss_pred             CCceEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  426 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~-----tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~  426 (739)
                      .+|++.+.||+|+||+||+|.+..     ++..||||+++..    ........+.+|+.++..++|||||++++++...
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK----AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            468899999999999999998754     3578999987632    1233456788999999999999999999999999


Q ss_pred             ceEEEEEeecCCCCcchhhhhc---------------cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC
Q 004660          427 DHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS  491 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~---------------~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~  491 (739)
                      +..++++||+.+++|.+++...               ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999998531               1347888899999999999999999999999999999999999


Q ss_pred             CcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCch
Q 004660          492 GVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP  567 (739)
Q Consensus       492 g~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~  567 (739)
                      +.+||+|||+++.......   .....+++.|+|||.+.+       ..++.++|||||||++|||++ |..||.+....
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  233 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-------GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  233 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhc-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999886643222   123345789999999863       346779999999999999998 88999887777


Q ss_pred             HHHHHHhhcC-CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          568 QAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       568 ~~~~~i~~~~-~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      +.+..+.... ..++..++.++.+||.+||+.+|++||++.++++.
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         234 DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            7777666543 35577899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-40  Score=351.85  Aligned_cols=257  Identities=30%  Similarity=0.492  Sum_probs=215.5

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc-----
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-----  427 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~-----  427 (739)
                      +|++.+.||+|+||.||+|++..+|+.||||++.....   .....+.+.+|+.+++.++|+||+++++++...+     
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            58999999999999999999999999999998864221   2334467889999999999999999999988775     


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        78 ~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          78 DVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             ceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            7999999997 5888888664 4799999999999999999999999999999999999999999999999999987654


Q ss_pred             cc----cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCC----
Q 004660          508 LS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP----  579 (739)
Q Consensus       508 ~~----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~----  579 (739)
                      ..    ......++..|+|||++.+      ...++.++||||||+++|+|++|+.||......+.+..++.....    
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLS------SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             cccccccccccccccCcCCceeeec------ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            32    2234568999999999874      225778999999999999999999999877665555544331110    


Q ss_pred             ---------------------------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          580 ---------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       580 ---------------------------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                                                 +...++.++.+||.+||++||.+||+++++|+||||+....
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                                       11236788999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-40  Score=338.39  Aligned_cols=251  Identities=29%  Similarity=0.470  Sum_probs=206.7

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc---CCCCeEeeccceeecce--
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVVDDH--  428 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L---~HPNIVkl~~~~~~~~~--  428 (739)
                      |++.+.||+|+||.||+|+++.+++.||+|+++.....   ......+.+|+.+++++   +|+||+++++++...+.  
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE---EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc---chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            78899999999999999999999999999998743322   12224456677777666   59999999999988776  


Q ss_pred             ---EEEEEeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          429 ---LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       429 ---l~LVmEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                         ++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus        78 ~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          78 ELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             CceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence               999999997 57888886532 3589999999999999999999999999999999999999999999999999977


Q ss_pred             ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-----C
Q 004660          505 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----P  579 (739)
Q Consensus       505 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-----~  579 (739)
                      ...........++..|+|||++.+       ..++.++|||||||++|||++|.+||......+.+.+++....     .
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQ-------SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             ccCCcccccccccccccChHHhcc-------CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence            654443344568899999999863       3467789999999999999999999988776666555543110     0


Q ss_pred             ----------------------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          580 ----------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       580 ----------------------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                                            ....++..+.++|.+||+.||.+||++.|+|+|+||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                                  001346788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.6e-40  Score=341.03  Aligned_cols=245  Identities=24%  Similarity=0.400  Sum_probs=200.7

Q ss_pred             CCceEeeEE--eecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecce
Q 004660          352 SQWQKGKLI--GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  428 (739)
Q Consensus       352 ~~Y~i~~~L--G~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~  428 (739)
                      +.|.+.+.+  |.|+||.||+++++.++..+|+|++......        .  .|+.++..+ +|+||+++++.+..++.
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------~--~e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--------A--IEPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--------h--hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            345666655  9999999999999999999999998642111        0  122222222 69999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC-cEEEeecccchhccC
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTG  507 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g-~vKL~DFGlA~~~~~  507 (739)
                      +|+||||+++++|.+++... ..+++.+++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            99999999999999999775 4799999999999999999999999999999999999999998 999999999876543


Q ss_pred             cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchH----HHHHHhhcCCCCCcc
Q 004660          508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ----AMFKVLNRTPPIPEM  583 (739)
Q Consensus       508 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~----~~~~i~~~~~~iP~~  583 (739)
                      .   ....|+..|+|||++.+       ..++.++|||||||++|||++|+.||.......    .+..........+..
T Consensus       163 ~---~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T PHA03390        163 P---SCYDGTLDYFSPEKIKG-------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKN  232 (267)
T ss_pred             C---ccCCCCCcccChhhhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccc
Confidence            2   23468999999999863       346778999999999999999999997543322    122222333455567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-HHHHHcCccccc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPS-AVELLEHPFIRN  617 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpT-a~elLqHpwf~~  617 (739)
                      ++..+++||.+||+.||.+|++ ++|+|+|+||.+
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        233 VSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             cCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            8999999999999999999996 699999999964

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.4e-40  Score=352.50  Aligned_cols=256  Identities=26%  Similarity=0.452  Sum_probs=214.0

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce-
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-  428 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~-  428 (739)
                      ..++|++.+.||+|+||+||+|++..+++.||||++....   ......+.+.+|+.+++.++|+||+++++++...+. 
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            4568999999999999999999999999999999875321   223344667789999999999999999998876654 


Q ss_pred             -----EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004660          429 -----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       429 -----l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                           +|+||||+ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence                 89999999 6799998865  469999999999999999999999999999999999999999999999999998


Q ss_pred             hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCC----
Q 004660          504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP----  579 (739)
Q Consensus       504 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~----  579 (739)
                      .....  .....++..|+|||.+.+      ...++.++|||||||++|||++|+.||......+.+..++.....    
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         167 HTDDE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             ccccc--ccCCcccccccCHHHHhC------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence            76433  234568899999999863      235677999999999999999999999877665555544332110    


Q ss_pred             ---------------------------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          580 ---------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       580 ---------------------------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                                 ....++.++.+||.+||..||++|||+.++|+||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~  305 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH  305 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence                                       1123588999999999999999999999999999998654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.9e-40  Score=345.89  Aligned_cols=256  Identities=25%  Similarity=0.450  Sum_probs=210.0

Q ss_pred             CCCCCCCCceEeeEEeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeE
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIV  417 (739)
Q Consensus       346 ~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~-------tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIV  417 (739)
                      .......+|.+++.||+|+||.||+|++..       ++..||+|.++..    ........+.+|+.+++.+ +|+||+
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~~h~~i~   87 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNII   87 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC----CChHHHHHHHHHHHHHHHhcCCCCEe
Confidence            445556789999999999999999998643       2356999987632    1233346788899999999 799999


Q ss_pred             eeccceeecceEEEEEeecCCCCcchhhhhcc---------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCC
Q 004660          418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK  482 (739)
Q Consensus       418 kl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~---------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIK  482 (739)
                      ++++++..++..|+||||+.+|+|.+++....               ..+++.+++.++.||+.||+|||++||+|||||
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk  167 (307)
T cd05098          88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA  167 (307)
T ss_pred             eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence            99999999999999999999999999997532               247889999999999999999999999999999


Q ss_pred             CcceEecCCCcEEEeecccchhccCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CC
Q 004660          483 GANLLVDASGVVKLADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK  558 (739)
Q Consensus       483 P~NILLd~~g~vKL~DFGlA~~~~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk  558 (739)
                      |+|||++.++.+||+|||++..+......   ....++..|+|||++.+       ..++.++|||||||++|||++ |.
T Consensus       168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~~g~  240 (307)
T cd05098         168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTLGG  240 (307)
T ss_pred             HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-------CCCCcHHHHHHHHHHHHHHHcCCC
Confidence            99999999999999999999766432211   11224578999998863       356789999999999999998 89


Q ss_pred             CCCCCCCchHHHHHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          559 PPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       559 ~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      .||......+....+... ....+..++.++.+||.+||..+|.+||++.+++++
T Consensus       241 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         241 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             CCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            999876655544444333 235667789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=334.18  Aligned_cols=250  Identities=28%  Similarity=0.504  Sum_probs=211.1

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      +...++|++.++||+|+||+||+|.++ ++..||||.+....   .   ..+.+.+|+.+++.++|+||+++++++..+.
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---M---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE   74 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---c---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence            345678999999999999999999976 45789999876321   1   1246788999999999999999999999889


Q ss_pred             eEEEEEeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          428 HLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      ..++||||+.+++|.+++.+.. ..+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.
T Consensus        75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence            9999999999999999997643 468999999999999999999999999999999999999999999999999987664


Q ss_pred             Ccccc--cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCc
Q 004660          507 GLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE  582 (739)
Q Consensus       507 ~~~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~  582 (739)
                      .....  ....++..|+|||.+.+       ..++.++|||||||++|||++ |+.||.+......+.++... ....+.
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  227 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANY-------GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPP  227 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhcc-------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            32211  12234678999998863       457789999999999999998 99999887766666666544 345566


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ..+.++.++|.+||..||++||++.++++
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         228 NCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            77899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1e-39  Score=335.59  Aligned_cols=241  Identities=24%  Similarity=0.421  Sum_probs=201.8

Q ss_pred             EEeecCCeEEEEEEE--CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeec
Q 004660          359 LIGRGTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       359 ~LG~G~fGtVy~a~~--k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      .||+|+||+||+|.+  +.++..||+|+++..   .......+.+.+|+.+|+.++|+||+++++++. .+..++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND---NNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCC---CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence            589999999999965  457889999987632   223445677889999999999999999999765 45679999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc----cc
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY----EL  512 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~----~~  512 (739)
                      .+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||++........    ..
T Consensus        78 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          78 ELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            999999999764 5689999999999999999999999999999999999999999999999999976643221    11


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccCCHHHHH
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD  590 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~d  590 (739)
                      ...++..|+|||.+..       ..++.++|||||||++|||++ |+.||......+....+... ...+|..++.++.+
T Consensus       157 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  229 (257)
T cd05116         157 HGKWPVKWYAPECMNY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYD  229 (257)
T ss_pred             CCCCCccccCHhHhcc-------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            2234678999998862       356779999999999999998 99999887666666655543 34677789999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHc
Q 004660          591 FLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       591 LI~kcL~~DP~kRpTa~elLq  611 (739)
                      ||.+||+.||++||++.+|.+
T Consensus       230 li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         230 LMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHHhccCchhCcCHHHHHH
Confidence            999999999999999998875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1e-39  Score=337.36  Aligned_cols=250  Identities=27%  Similarity=0.463  Sum_probs=209.5

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~---~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ..+|++++.||+|+||.||+|+++.++.   .||+|.++..    ......+.+.+|+.+|+.++||||+++++++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            3579999999999999999999875543   6899977532    12334567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      ..|+||||+++++|.+++......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99999999999999999987666789999999999999999999999999999999999999999999999999987643


Q ss_pred             cccc----cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCC
Q 004660          508 LSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIP  581 (739)
Q Consensus       508 ~~~~----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP  581 (739)
                      ....    ....++..|+|||.+.+       ..++.++|||||||++|||++ |..||......+....+... ..+.+
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAY-------RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP  231 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhcc-------CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC
Confidence            2211    11223568999999863       357789999999999999886 99999887666665555543 23445


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ..++..+.++|.+||+++|.+||++.++++
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         232 MDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-40  Score=336.31  Aligned_cols=249  Identities=27%  Similarity=0.482  Sum_probs=208.5

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ....+|++.+.||+|+||.||+|.+.. ++.||||.++...   .   ..+.+.+|+.+++.++|+||+++++++...+.
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~---~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT---M---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP   75 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc---c---cHHHHHHHHHHHHHCCCCCccceeEEEecCCC
Confidence            345679999999999999999999754 5789999876321   1   13457789999999999999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          429 LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            999999999999999997643 4689999999999999999999999999999999999999999999999999987653


Q ss_pred             ccccc--ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCcc
Q 004660          508 LSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM  583 (739)
Q Consensus       508 ~~~~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~  583 (739)
                      .....  ...++..|+|||.+.+       ..++.++||||||+++|||++ |+.||.+......+..+... ....+..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  228 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALY-------NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPG  228 (261)
T ss_pred             CcccccCCCcCceeccCcccccc-------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence            22211  1123457999998763       456789999999999999999 99999887766666655443 2345567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ++..+.++|.+||..||.+||++.++++
T Consensus       229 ~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         229 CPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            8899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.2e-39  Score=336.88  Aligned_cols=250  Identities=25%  Similarity=0.451  Sum_probs=209.9

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~---~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ...|++.+.||+|+||.||+|.++.++.   .||||.+...    ........+..|+.+++.++||||+++++++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   78 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR   78 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence            3468999999999999999999887765   5999987532    22444577899999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      ..++||||+.+|+|.+++....+.+++.+++.++.||+.||.|||++|++||||||+||||+.++.+||+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999999999999977656789999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccc----ccC--CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCC
Q 004660          508 LSYEL----SLK--GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPP  579 (739)
Q Consensus       508 ~~~~~----s~~--GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~  579 (739)
                      .....    ...  ++..|+|||.+.+       ..++.++|||||||++|||++ |..||......+....+... ..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~  231 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAY-------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP  231 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhcc-------CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            22111    111  2457999998863       456779999999999999886 99999887766665555432 334


Q ss_pred             CCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       580 iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .+..++..+.++|.+||..+|.+||++.+++.
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         232 PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            55678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.6e-39  Score=331.76  Aligned_cols=251  Identities=31%  Similarity=0.534  Sum_probs=209.5

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|.++....  ......+.+.+|++++++++|+||+++++++..++..++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM--MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            479999999999999999999999999999998874322  223335678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhh---ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          432 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      ||||+.+|+|..++..   ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+...
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999999998854   2345899999999999999999999999999999999999999999999999998765432


Q ss_pred             c-cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc--hHHHHHHhhc-CCCCCc-c
Q 004660          509 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLNR-TPPIPE-M  583 (739)
Q Consensus       509 ~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~--~~~~~~i~~~-~~~iP~-~  583 (739)
                      . ......|+..|+|||.+.+       ..++.++|||||||++|+|++|+.||.....  .+....+..+ ..+.+. .
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADH  232 (267)
T ss_pred             CcccceecCCccccCHHHhcc-------CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhh
Confidence            2 2223568999999999863       3567799999999999999999999965432  1222232222 233444 6


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ++.++.++|.+||..+|++||++.++++
T Consensus       233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         233 YSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            7889999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.8e-40  Score=336.02  Aligned_cols=251  Identities=32%  Similarity=0.532  Sum_probs=208.1

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      .+|++.+.||+|+||.||+|+++.+|..||||.+....  .........+.+|+.+++.++|+||+++++++..++..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD--LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh--hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence            46899999999999999999999999999999876432  1223345678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhh---ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          432 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      +|||+.+++|.+++..   ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999999998864   2345899999999999999999999999999999999999999999999999998766432


Q ss_pred             c-cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch--HHHHHHhhc-CCC-CCcc
Q 004660          509 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMFKVLNR-TPP-IPEM  583 (739)
Q Consensus       509 ~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~--~~~~~i~~~-~~~-iP~~  583 (739)
                      . ......|+..|+|||.+.+       ..++.++||||||+++|+|++|..||......  .....+... ..+ .+..
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH  232 (267)
T ss_pred             CcccccccCCcCccCHHHhcC-------CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccc
Confidence            2 2234568999999999863       35677899999999999999999999754332  222222221 122 2345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ++.+++++|.+||..||++|||+.++++
T Consensus       233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         233 YSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            7889999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1e-39  Score=335.66  Aligned_cols=248  Identities=27%  Similarity=0.517  Sum_probs=206.7

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|.+.....   .   ...+.+|+.+|+.++|+||+++++++. ++.
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~   74 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---S---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEP   74 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---C---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCC
Confidence            34568999999999999999999876 567799998763221   1   245788999999999999999999774 456


Q ss_pred             EEEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          429 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .|++|||+.+++|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            89999999999999999763 34589999999999999999999999999999999999999999999999999976644


Q ss_pred             cccc--cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCcc
Q 004660          508 LSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM  583 (739)
Q Consensus       508 ~~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~  583 (739)
                      ....  ....++..|+|||.+.+       ..++.++||||||+++|||++ |..||.+....+....+... ..+.+..
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQD  227 (260)
T ss_pred             cccccccCCCCCccccChHHHhc-------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence            3221  12335668999998863       356789999999999999999 99999887766666665543 3456677


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .+..+.+||.+||..||++|||+.++++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         228 CPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            8999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.5e-39  Score=340.20  Aligned_cols=251  Identities=26%  Similarity=0.434  Sum_probs=207.7

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCC----------------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETG----------------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH  413 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg----------------~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~H  413 (739)
                      ...+|++++.||+|+||.||+|.+..++                ..||+|.+...    ......+.+.+|+++|+.++|
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~~   78 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD----ASDNAREDFLKEVKILSRLSD   78 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhcCC
Confidence            3468999999999999999999876544                45799987632    223455778899999999999


Q ss_pred             CCeEeeccceeecceEEEEEeecCCCCcchhhhhcc----------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCC
Q 004660          414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG  483 (739)
Q Consensus       414 PNIVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~----------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP  483 (739)
                      +||+++++++..++..++||||+.+++|.+++....          ..+++..++.++.||+.||.|||++||+||||||
T Consensus        79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp  158 (296)
T cd05051          79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT  158 (296)
T ss_pred             CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence            999999999999999999999999999999996642          2589999999999999999999999999999999


Q ss_pred             cceEecCCCcEEEeecccchhccCcc---cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh--CC
Q 004660          484 ANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GK  558 (739)
Q Consensus       484 ~NILLd~~g~vKL~DFGlA~~~~~~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt--Gk  558 (739)
                      +|||++.++.++|+|||+++......   ......++..|+|||.+.+       ..++.++|||||||++|||++  |.
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~~~~~~  231 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-------GKFTTKSDVWAFGVTLWEILTLCRE  231 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-------CCCCccchhhhhHHHHHHHHhcCCC
Confidence            99999999999999999997654322   1223446788999999863       357789999999999999998  78


Q ss_pred             CCCCCCCchHHHHHHhhc--------CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          559 PPWSEFEGPQAMFKVLNR--------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       559 ~PF~~~~~~~~~~~i~~~--------~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .||......+.+..+...        ....+..++.++.+||.+||+.||++|||+.|+++
T Consensus       232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         232 QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            899876665555544321        12234457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-40  Score=339.28  Aligned_cols=251  Identities=31%  Similarity=0.511  Sum_probs=208.3

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecceEEEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~l~LV  432 (739)
                      |++.+.||+|+||+||+|.+..+++.||||.+......    .......+|+..++.++ |+||+++++++..++..|+|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            78899999999999999999999999999987632211    11223456899999999 99999999999999999999


Q ss_pred             EeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          433 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      |||+ +|+|.+++.... ..+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.........
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence            9999 789988887653 46899999999999999999999999999999999999999999999999999876544333


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-------------
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-------------  578 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-------------  578 (739)
                      ....|+..|+|||++.+      ...++.++||||||+++|||++|+.||......+.+.++.....             
T Consensus       156 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         156 TDYVSTRWYRAPEILLR------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             CCCCCcccccCceeeec------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence            44568999999998753      34467799999999999999999999987665554443321100             


Q ss_pred             -----------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          579 -----------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       579 -----------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                                       ......+.++.+||++||..||++|||+.|++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                             0011236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=367.68  Aligned_cols=255  Identities=29%  Similarity=0.482  Sum_probs=224.0

Q ss_pred             CceE--eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          353 QWQK--GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       353 ~Y~i--~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      -|++  .++||+|.||+||-|+++.+|+.||||+|++..-..+++   .++.+|+.||+.+.||.||.+.-.|+..+.++
T Consensus       563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe---sqlR~EVaILq~l~HPGiV~le~M~ET~ervF  639 (888)
T KOG4236|consen  563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE---SQLRNEVAILQNLHHPGIVNLECMFETPERVF  639 (888)
T ss_pred             HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchH---HHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence            3555  489999999999999999999999999998765444443   57889999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC---CcEEEeecccchhccC
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKHLTG  507 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~---g~vKL~DFGlA~~~~~  507 (739)
                      +|||.+.|.-|..+|....+.++|...+.++.||+.||.|||.++|+|.||||+|||+...   -.+||||||+|+.+..
T Consensus       640 VVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  640 VVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             EEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            9999999777887777666889999999999999999999999999999999999999654   3799999999999999


Q ss_pred             cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc----CCCCCcc
Q 004660          508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPEM  583 (739)
Q Consensus       508 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~----~~~iP~~  583 (739)
                      ..+..+.+||+.|+|||+|+       ++.|...-||||.|||+|--|.|..||.+.+.  +-.+|.+.    .+..+..
T Consensus       720 ksFRrsVVGTPAYLaPEVLr-------nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~e  790 (888)
T KOG4236|consen  720 KSFRRSVVGTPAYLAPEVLR-------NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSE  790 (888)
T ss_pred             hhhhhhhcCCccccCHHHHh-------hccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhh
Confidence            88888999999999999998       45677899999999999999999999976544  33334443    2334567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      ++++++|||..+|+..-.+|.++.+.|.|+|+++..
T Consensus       791 is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            999999999999999999999999999999998653

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.8e-40  Score=362.37  Aligned_cols=254  Identities=27%  Similarity=0.461  Sum_probs=207.6

Q ss_pred             CCCCCCCceEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeec
Q 004660          347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYY  420 (739)
Q Consensus       347 ~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~t-----g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~  420 (739)
                      ......+|+++++||+|+||+||+|.+...     +..||||+++..    ......+.+.+|+++|+.+. |||||+++
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~  107 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT----ARSSEKQALMSELKIMTHLGPHLNIVNLL  107 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC----CChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence            345567899999999999999999987533     357999988532    12233467889999999996 99999999


Q ss_pred             cceeecceEEEEEeecCCCCcchhhhhcc---------------------------------------------------
Q 004660          421 GSEVVDDHLYIYLEYVHPGSINRYVREHC---------------------------------------------------  449 (739)
Q Consensus       421 ~~~~~~~~l~LVmEy~~gGsL~~~L~~~~---------------------------------------------------  449 (739)
                      +++...+.+|||||||.+|+|.++|.+..                                                   
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            99999999999999999999999885421                                                   


Q ss_pred             --------------------------------------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcc
Q 004660          450 --------------------------------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN  485 (739)
Q Consensus       450 --------------------------------------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~N  485 (739)
                                                                  ..+++.++..++.||+.||+|||++||+||||||+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N  267 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN  267 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence                                                        237788889999999999999999999999999999


Q ss_pred             eEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCC
Q 004660          486 LLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW  561 (739)
Q Consensus       486 ILLd~~g~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF  561 (739)
                      ||++.++.+||+|||+++.......   .....++..|+|||.+.+       ..++.++|||||||++|||++ |..||
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ellt~g~~P~  340 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-------NLYTTLSDVWSYGILLWEIFSLGGTPY  340 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            9999999999999999976543221   122346788999999863       457789999999999999997 99999


Q ss_pred             CCCCchHHHHHHhhc--CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          562 SEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       562 ~~~~~~~~~~~i~~~--~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ........+...+..  ....+..++.++.++|.+||..||++||++.++.+
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         341 PGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             cccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            876544444333322  34456678999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-39  Score=340.19  Aligned_cols=250  Identities=28%  Similarity=0.496  Sum_probs=209.4

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeecccee
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  424 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k-----~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~  424 (739)
                      ...+|++.++||+|+||+||++...     .++..+|+|.+..     ........+.+|+++++.++|+||+++++++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTVLQHQHIVRFYGVCT   77 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe
Confidence            3467899999999999999999743     3567899997653     22344567899999999999999999999999


Q ss_pred             ecceEEEEEeecCCCCcchhhhhcc--------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC
Q 004660          425 VDDHLYIYLEYVHPGSINRYVREHC--------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA  490 (739)
Q Consensus       425 ~~~~l~LVmEy~~gGsL~~~L~~~~--------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~  490 (739)
                      ..+..+++|||+.+|+|.+++....              ..+++..+..++.||+.||+|||++||+||||||+|||+++
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~  157 (280)
T cd05092          78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ  157 (280)
T ss_pred             cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence            9999999999999999999987542              24788999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCc
Q 004660          491 SGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG  566 (739)
Q Consensus       491 ~g~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~  566 (739)
                      ++.+||+|||++........   .....++..|+|||.+.+       ..++.++|||||||++|||++ |.+||.....
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  230 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-------RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN  230 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-------CCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence            99999999999875533221   112335788999998863       457789999999999999998 9999987776


Q ss_pred             hHHHHHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          567 PQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       567 ~~~~~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .+....+... ....+..++..+.+||.+||+.||.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         231 TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6666655543 34556778999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.4e-39  Score=341.43  Aligned_cols=249  Identities=28%  Similarity=0.523  Sum_probs=208.6

Q ss_pred             CCCceEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k-----~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      ..+|.+.+.||+|+||.||+|++.     .++..+++|.+..     ......+.+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            457999999999999999999854     3456688887652     223344678899999999999999999999999


Q ss_pred             cceEEEEEeecCCCCcchhhhhcc---------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA  490 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~---------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~  490 (739)
                      .+..++||||+.+++|.+++..+.               ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            999999999999999999996532               34788999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCc
Q 004660          491 SGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG  566 (739)
Q Consensus       491 ~g~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~  566 (739)
                      ++.+||+|||++........   .....++..|+|||.+.+       ..++.++|||||||++|||++ |+.||.....
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999976543221   123446788999998863       457779999999999999998 9999988777


Q ss_pred             hHHHHHHhhcC-CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          567 PQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       567 ~~~~~~i~~~~-~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .+.+..+.... ...+..++.++.++|.+||..||++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         232 TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            66666555443 3445667899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.7e-40  Score=340.48  Aligned_cols=240  Identities=24%  Similarity=0.418  Sum_probs=198.8

Q ss_pred             eEEeecCCeEEEEEEECCCCcE-------EEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          358 KLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~-------VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      +.||.|+||+||+|.++.++..       ||+|.+..     ......+.+.+|+.+|+.++|||||++++++..++..+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            4699999999999998765543       77776542     22334467788999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCc--------EEEeecccc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--------VKLADFGMA  502 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~--------vKL~DFGlA  502 (739)
                      +||||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.        +||+|||++
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999999999876567899999999999999999999999999999999999987764        699999998


Q ss_pred             hhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCC-CCCCCCCchHHHHHHhhcCCCCC
Q 004660          503 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-PPWSEFEGPQAMFKVLNRTPPIP  581 (739)
Q Consensus       503 ~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk-~PF~~~~~~~~~~~i~~~~~~iP  581 (739)
                      ......   ....++..|+|||++.+      ...++.++|||||||++|||++|. .||...+... ...+......+|
T Consensus       156 ~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~  225 (258)
T cd05078         156 ITVLPK---EILLERIPWVPPECIEN------PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-KLQFYEDRHQLP  225 (258)
T ss_pred             cccCCc---hhccccCCccCchhccC------CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-HHHHHHccccCC
Confidence            665432   23568899999999863      234677999999999999999984 6665544433 333445556677


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ...+.++.+||.+||+.||++|||++++++.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         226 APKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            7788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.5e-39  Score=333.65  Aligned_cols=250  Identities=27%  Similarity=0.489  Sum_probs=208.9

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~---~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ...|+..+.||+|+||.||+|.++.++.   .+|||.++..    ........+.+|+++++.++|+||+++++++...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG----YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            4578999999999999999999887665   6889877532    12233467889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      ..|+||||+.+++|.+++......+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999999999999987666799999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccc----ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCC
Q 004660          508 LSYEL----SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIP  581 (739)
Q Consensus       508 ~~~~~----s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP  581 (739)
                      .....    ....+..|+|||.+..       ..++.++|||||||++|||++ |+.||......+....+... ..+.+
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~  232 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAY-------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP  232 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhc-------CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC
Confidence            22111    1123457999998863       356789999999999999997 99999877666666555443 23344


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ..++.++.++|.+||..+|++||++.++++
T Consensus       233 ~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         233 MDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.2e-39  Score=336.95  Aligned_cols=247  Identities=28%  Similarity=0.507  Sum_probs=205.1

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...+|++.++||+|+||+||+|.+..+ ..||+|+++...   ..   .+.+.+|+.+++.++|+||+++++.+. ++..
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~---~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI   75 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc---cC---HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCc
Confidence            456799999999999999999988765 469999876311   11   246788999999999999999998764 4568


Q ss_pred             EEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          430 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      |+||||+.+|+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            9999999999999999763 345889999999999999999999999999999999999999999999999999766433


Q ss_pred             ccc--cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccC
Q 004660          509 SYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML  584 (739)
Q Consensus       509 ~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~l  584 (739)
                      ...  ....++..|+|||.+.+       ..++.++|||||||++|||++ |..||.+....+....+... ....+..+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC  228 (262)
T ss_pred             ccccccCCcccceecCHhHhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCcccc
Confidence            221  12345678999998752       457889999999999999999 89999887666666655443 23445668


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      +..+.+||.+||+.||++||++.++++
T Consensus       229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         229 PESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=331.85  Aligned_cols=245  Identities=30%  Similarity=0.492  Sum_probs=208.7

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...+|++.+.||.|+||.||+|...  |+.||+|.++...      ...+++.+|+.+++.++|+||+++++++..++..
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL   75 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch------hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence            3457999999999999999999875  7899999886321      1456788999999999999999999999989999


Q ss_pred             EEEEeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          430 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      |+||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999999997643 26899999999999999999999999999999999999999999999999999876332


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccCCH
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSS  586 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~  586 (739)
                      ..  ...++..|+|||.+..       ..++.++||||||+++|||++ |..||......+....+... ....+..+++
T Consensus       156 ~~--~~~~~~~~~ape~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (256)
T cd05039         156 QD--SGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPP  226 (256)
T ss_pred             cc--cCCCcccccCchhhcC-------CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCH
Confidence            22  2345678999998863       356679999999999999997 99999887655555444433 3455667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ++.++|.+||..+|++||++.++++
T Consensus       227 ~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         227 EVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-40  Score=372.19  Aligned_cols=253  Identities=34%  Similarity=0.613  Sum_probs=217.7

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce--EEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH--LYI  431 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~--l~L  431 (739)
                      .+..++||+|+|-+||+|.+..+|..||.-.+++. +-....+.+.+|..|+.+|+.|+|+|||++|++|.+...  +.+
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~-d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~  120 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIR-DVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF  120 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHH-HhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence            35568999999999999999999999987655432 223456677899999999999999999999999987654  999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhC--CeecccCCCcceEecCC-CcEEEeecccchhccCc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--NTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGL  508 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~--GIvHRDIKP~NILLd~~-g~vKL~DFGlA~~~~~~  508 (739)
                      |+|++..|+|+.|++++ +.+....++.|++||++||.|||++  .|+|||||-+||||+.+ |.|||+|+|||......
T Consensus       121 iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            99999999999999887 6699999999999999999999987  49999999999999865 99999999999987664


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHH-HHHhhcCCC--CCccCC
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM-FKVLNRTPP--IPEMLS  585 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~-~~i~~~~~~--iP~~ls  585 (739)
                      ... ..+|||.|||||+..        ..|...+||||||++|.||+|+.+||........+ .++..+..+  +...-+
T Consensus       200 ~ak-svIGTPEFMAPEmYE--------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d  270 (632)
T KOG0584|consen  200 HAK-SVIGTPEFMAPEMYE--------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD  270 (632)
T ss_pred             ccc-eeccCccccChHHHh--------hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence            443 478999999999986        36778999999999999999999999987766554 455555432  334457


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      +++++||.+||.. ..+|+|+.|+|+|+||...
T Consensus       271 Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  271 PEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            8999999999999 8999999999999999875

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.2e-40  Score=339.27  Aligned_cols=246  Identities=31%  Similarity=0.562  Sum_probs=203.2

Q ss_pred             eEeeEEeecCCeEEEEEEEC----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          355 QKGKLIGRGTFGSVYIGTNR----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       355 ~i~~~LG~G~fGtVy~a~~k----~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .+.+.||.|.||.||+|.++    ..+..|+||.++.    ....+..+.+.+|+++|++++||||+++++++...+.++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc----ccccccceeeeeccccccccccccccccccccccccccc
Confidence            46789999999999999988    3467799998842    233444678899999999999999999999999888899


Q ss_pred             EEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          431 IYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      +||||+.+|+|.++|... ...+++..+..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++.......
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999876 5679999999999999999999999999999999999999999999999999997763211


Q ss_pred             ---cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccC
Q 004660          510 ---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML  584 (739)
Q Consensus       510 ---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~l  584 (739)
                         ......+...|+|||.+..       ..++.++||||||+++|||++ |+.||.+....+...++... ...++..+
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  230 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKD-------GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNC  230 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHH-------SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTS
T ss_pred             cccccccccccccccccccccc-------ccccccccccccccccccccccccccccccccccccccccccccceeccch
Confidence               1223346778999999985       347789999999999999999 78999988777766666443 34567778


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      +..+.++|.+||..||++||++.++++
T Consensus       231 ~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  231 PKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             BHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999999985

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.4e-39  Score=344.14  Aligned_cols=255  Identities=24%  Similarity=0.440  Sum_probs=209.6

Q ss_pred             CCCCCCCCceEeeEEeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeE
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIV  417 (739)
Q Consensus       346 ~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~-------tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIV  417 (739)
                      .+.....+|.+++.||+|+||.||+|+...       ....||+|.++..    ........+.+|+++++.+ +|+||+
T Consensus         6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv   81 (314)
T cd05099           6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN----ATDKDLADLISEMELMKLIGKHKNII   81 (314)
T ss_pred             cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC----CChHHHHHHHHHHHHHHhccCCCCee
Confidence            345556789999999999999999998642       3456899987532    2233456788899999999 599999


Q ss_pred             eeccceeecceEEEEEeecCCCCcchhhhhcc---------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCC
Q 004660          418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK  482 (739)
Q Consensus       418 kl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~---------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIK  482 (739)
                      ++++++..++.+|+||||+.+|+|.+++....               ..+++.++..++.||+.||.|||++||+|||||
T Consensus        82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk  161 (314)
T cd05099          82 NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA  161 (314)
T ss_pred             eEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence            99999999999999999999999999996531               347888999999999999999999999999999


Q ss_pred             CcceEecCCCcEEEeecccchhccCccc-c--cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CC
Q 004660          483 GANLLVDASGVVKLADFGMAKHLTGLSY-E--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK  558 (739)
Q Consensus       483 P~NILLd~~g~vKL~DFGlA~~~~~~~~-~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk  558 (739)
                      |+|||++.++.+||+|||+++....... .  ....++..|||||++.+       ..++.++|||||||++|||++ |.
T Consensus       162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~~g~  234 (314)
T cd05099         162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGILMWEIFTLGG  234 (314)
T ss_pred             ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-------CCcCccchhhHHHHHHHHHHhCCC
Confidence            9999999999999999999986643221 1  11224567999999863       457789999999999999999 89


Q ss_pred             CCCCCCCchHHHHHHhhcC-CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          559 PPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       559 ~PF~~~~~~~~~~~i~~~~-~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .||......+.+..+.... ...+..++.++++||.+||..||++||++.++++
T Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         235 SPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9998876655555554432 3556778899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-39  Score=338.54  Aligned_cols=257  Identities=42%  Similarity=0.719  Sum_probs=219.2

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ....|+..+.||.|+||.||+|.+..++..||+|+++....      ....+.+|+++++.++|+||+++++.+..++..
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence            45569999999999999999999998999999999874221      346688899999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      |+||||+.+++|.+++......+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            99999999999999998764479999999999999999999999999999999999999999999999999987654322


Q ss_pred             -cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-CCC--CccCC
Q 004660          510 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPI--PEMLS  585 (739)
Q Consensus       510 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~i--P~~ls  585 (739)
                       ......++..|++||.+.+       ..++.++|||||||++|+|++|+.||...........+.... ..+  +..++
T Consensus       171 ~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (286)
T cd06614         171 SKRNSVVGTPYWMAPEVIKR-------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWS  243 (286)
T ss_pred             hhhccccCCcccCCHhHhcC-------CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCC
Confidence             1223458899999998763       356789999999999999999999998776655555444322 222  23378


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      .++++||.+||+.+|.+||++.++|+|+||....
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence            8999999999999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-39  Score=342.67  Aligned_cols=257  Identities=26%  Similarity=0.474  Sum_probs=212.0

Q ss_pred             CCCCCCCCCceEeeEEeecCCeEEEEEEEC-------CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCe
Q 004660          345 PSASPKKSQWQKGKLIGRGTFGSVYIGTNR-------ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENI  416 (739)
Q Consensus       345 p~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k-------~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNI  416 (739)
                      +.+.....+|++++.||+|+||.||+|+..       .++..||+|.+...    ......+.+.+|+.+++.+ +|+||
T Consensus         8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i   83 (304)
T cd05101           8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNI   83 (304)
T ss_pred             CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCc
Confidence            345667788999999999999999999753       23457999977521    2233456788999999999 79999


Q ss_pred             EeeccceeecceEEEEEeecCCCCcchhhhhcc---------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccC
Q 004660          417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDI  481 (739)
Q Consensus       417 Vkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~---------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDI  481 (739)
                      +++++++...+..|+||||+.+|+|.+++....               ..++..++..++.||+.||.|||++||+||||
T Consensus        84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dl  163 (304)
T cd05101          84 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDL  163 (304)
T ss_pred             hheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence            999999999999999999999999999996531               24778889999999999999999999999999


Q ss_pred             CCcceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-C
Q 004660          482 KGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G  557 (739)
Q Consensus       482 KP~NILLd~~g~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-G  557 (739)
                      ||+|||++.++.+||+|||+++.+.....   .....++..|+|||++.+       ..++.++||||||+++|||++ |
T Consensus       164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g  236 (304)
T cd05101         164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFTLG  236 (304)
T ss_pred             ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-------CCCCchhhHHHHHHHHHHHHcCC
Confidence            99999999999999999999987643221   122345678999999863       457789999999999999998 8


Q ss_pred             CCCCCCCCchHHHHHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          558 KPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       558 k~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ..||......+....+... ....+..++.++++||.+||..+|.+||++.|+++.
T Consensus       237 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         237 GSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            8999877666665555433 234566788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.1e-39  Score=329.71  Aligned_cols=247  Identities=32%  Similarity=0.556  Sum_probs=210.6

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCC----cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg----~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      +++.+.||.|+||.||+|.+...+    ..||+|++....    ..+..+.+..|+.+|+.++|+||+++++++...+..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA----DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC----ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence            457889999999999999998766    889999885321    122456788999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhcccc-ccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          430 YIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~-lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      |++|||+.+++|.+++...... +++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999999999765444 999999999999999999999999999999999999999999999999999776543


Q ss_pred             cccc--ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccC
Q 004660          509 SYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML  584 (739)
Q Consensus       509 ~~~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~l  584 (739)
                      ....  ...++..|+|||.+.       ...++.++||||||+++|+|++ |..||...........+... ....+..+
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~-------~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLK-------DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENC  229 (258)
T ss_pred             cccccccCCCcccccChHHhc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcC
Confidence            2221  133678999999885       2456789999999999999998 89999887776666666543 34456678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      +.++.++|.+||..||++|||+.|+++
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      230 PPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=336.49  Aligned_cols=243  Identities=26%  Similarity=0.460  Sum_probs=199.9

Q ss_pred             eEEeecCCeEEEEEEECCCCcE--EEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecceEEEEEe
Q 004660          358 KLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLE  434 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~--VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~l~LVmE  434 (739)
                      ++||+|+||.||+|+++.++..  +|+|.++..    ........+.+|++++.++ +||||+++++++...+.+|+|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            4699999999999999888764  577766521    2233446788899999999 79999999999999999999999


Q ss_pred             ecCCCCcchhhhhcc---------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004660          435 YVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF  499 (739)
Q Consensus       435 y~~gGsL~~~L~~~~---------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DF  499 (739)
                      |+.+|+|.+++.+..               ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence            999999999996532               24788999999999999999999999999999999999999999999999


Q ss_pred             ccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-C
Q 004660          500 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-T  577 (739)
Q Consensus       500 GlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~  577 (739)
                      |++..............+..|+|||.+.       ...++.++|||||||++|||++ |..||......+....+... .
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~  229 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLN-------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  229 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHc-------cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC
Confidence            9986432211111223466799999885       2457789999999999999997 99999877665555555433 3


Q ss_pred             CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       578 ~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ...+..++.++.+||.+||..||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            3456678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.4e-39  Score=343.82  Aligned_cols=260  Identities=34%  Similarity=0.568  Sum_probs=218.6

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ....|...+.||+|+||+||+|++..+|..||+|++....  ....+....+.+|+++++.++|+|||++++++..++..
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  100 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA  100 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCC--CCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence            3445899999999999999999999999999999886432  22344556788999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      ||||||+. |+|.+++......+++.++..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....  
T Consensus       101 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         101 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             EEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            99999997 577777765556799999999999999999999999999999999999999999999999999865433  


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC--CCCccCCHH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSE  587 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~--~iP~~ls~e  587 (739)
                       .....|+..|+|||.+....    ...++.++|||||||++|||++|+.||...+.......+.....  .....++..
T Consensus       178 -~~~~~~~~~y~aPE~~~~~~----~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (317)
T cd06635         178 -ANSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY  252 (317)
T ss_pred             -cccccCCccccChhhhhcCC----CCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHH
Confidence             22356899999999985311    23467799999999999999999999988766666666554322  223457889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          588 GKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      +++||.+||+.+|.+||++.++++|+|+....
T Consensus       253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            99999999999999999999999999986544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-40  Score=337.61  Aligned_cols=252  Identities=32%  Similarity=0.562  Sum_probs=210.4

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      |++.+.||+|+||.||+|+...+++.||+|++.....   .....+.+..|+.+++.++|+||+++++++...+.+++||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc---cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            6788999999999999999999999999999875321   1222356678999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-ccc
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YEL  512 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~~~  512 (739)
                      ||+. ++|.+++......+++..++.++.||+.||.|||++||+||||+|+||+++.++.+||+|||++....... ...
T Consensus        78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence            9998 58999997754579999999999999999999999999999999999999999999999999997764432 222


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC---------------
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------------  577 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---------------  577 (739)
                      ...++..|+|||.+.+      ...++.++|||||||++|||++|+.||......+.+.++....               
T Consensus       157 ~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         157 HEVVTLWYRAPEILLG------SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             ccccCcCcCChHHhcC------CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            3456788999999863      2367789999999999999999999998876655544433210               


Q ss_pred             ---C-----------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          578 ---P-----------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       578 ---~-----------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                         .           .....++.++.++|.+||..||++||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence               0           0011247889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.2e-39  Score=333.68  Aligned_cols=247  Identities=26%  Similarity=0.499  Sum_probs=204.3

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ...+|++.+.||+|+||+||+|.+..+ ..+|+|.+...  . .   ..+.+.+|+.+++.++|+||+++++++. .+..
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~--~-~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPG--T-M---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI   75 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccC--C-c---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence            345799999999999999999988665 46999976531  1 1   1245778999999999999999998774 4568


Q ss_pred             EEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          430 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      |+||||+.+|+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||+++++.+||+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            9999999999999999764 234789999999999999999999999999999999999999999999999999765432


Q ss_pred             ccc--cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccC
Q 004660          509 SYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML  584 (739)
Q Consensus       509 ~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~l  584 (739)
                      ...  ....++..|+|||.+.+       ..++.++|||||||++|||++ |+.||.+....+....+... ....+..+
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC  228 (260)
T ss_pred             cccccCCCccchhhCCHHHhcc-------CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            221  12345678999998763       356789999999999999999 99999887666665555443 33456678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      +..+.++|.+||.+||++||+++++++
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         229 PESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-39  Score=335.78  Aligned_cols=250  Identities=28%  Similarity=0.458  Sum_probs=210.3

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~----~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      ...+|++++.||+|+||+||+|.++.+|.    .||+|.+...    ........+.+|+.+|+.++|+||+++++++..
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE----TSPKANKEILDEAYVMASVDHPHVVRLLGICLS   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            34679999999999999999999887765    5888876532    224445678899999999999999999998876


Q ss_pred             cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                       +..++||||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence             7899999999999999999876667999999999999999999999999999999999999999999999999999876


Q ss_pred             cCcccccc---cCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCC
Q 004660          506 TGLSYELS---LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPI  580 (739)
Q Consensus       506 ~~~~~~~s---~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~i  580 (739)
                      ........   ..++..|+|||.+..       ..++.++|||||||++|||++ |+.||......+....+... ....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILH-------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ  232 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhc-------CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence            53322111   223568999998862       356779999999999999998 99999887766655555543 3455


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      +...+.++.++|.+||..||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         233 PPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            6678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.8e-39  Score=339.13  Aligned_cols=261  Identities=30%  Similarity=0.488  Sum_probs=215.8

Q ss_pred             CceEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeecce
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  428 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k---~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~~~  428 (739)
                      +|++.+.||+|+||.||++++.   .++..||||+++.... .......+.+.+|+.++..+ +|+||+++++.+..++.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            4889999999999999999864   4678999998863211 12233446788999999999 59999999999999999


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      +|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||+.|++||||||.|||++.++.++|+|||++..+...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            99999999999999998764 56899999999999999999999999999999999999999999999999998765433


Q ss_pred             cc--ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc----hHHHHHHhhcCCCCCc
Q 004660          509 SY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPE  582 (739)
Q Consensus       509 ~~--~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~----~~~~~~i~~~~~~iP~  582 (739)
                      ..  .....|+..|+|||.+.+.     ....+.++||||||+++|||++|..||.....    .+....+.......+.
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGG-----SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK  233 (288)
T ss_pred             cccccccccCCccccCHHHhcCC-----CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc
Confidence            22  2234689999999998642     12356789999999999999999999964322    2333444555667788


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcccccccc
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANY  620 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpT---a~elLqHpwf~~~~~  620 (739)
                      .++.++.++|.+||+.||++|||   +.++|+|+||+...+
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            89999999999999999999998   578899999987654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.4e-39  Score=334.50  Aligned_cols=249  Identities=25%  Similarity=0.423  Sum_probs=196.6

Q ss_pred             eEEeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEee
Q 004660          358 KLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY  435 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~--tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy  435 (739)
                      +.||+|+||+||+|....  ....+|+|.+...    ........+.+|+.+++.++|+||+++++.+...+.+|+||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc----CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence            369999999999996543  3456777765421    2233446678899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhhcc----ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004660          436 VHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-  510 (739)
Q Consensus       436 ~~gGsL~~~L~~~~----~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~-  510 (739)
                      +.+|+|.+++....    ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            99999999997642    2346788899999999999999999999999999999999999999999999865432221 


Q ss_pred             --ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-C-----CCCC
Q 004660          511 --ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-T-----PPIP  581 (739)
Q Consensus       511 --~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~-----~~iP  581 (739)
                        .....++..|+|||++...........++.++|||||||++|||++ |..||......+.+..+... .     +.++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence              1223456789999998753221123456789999999999999999 88999887666655554432 2     2234


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ..++..+.+++..|| .||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            467889999999998 59999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.9e-39  Score=342.38  Aligned_cols=254  Identities=26%  Similarity=0.476  Sum_probs=210.4

Q ss_pred             CCCCCCCceEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeec
Q 004660          347 ASPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY  420 (739)
Q Consensus       347 ~~~~~~~Y~i~~~LG~G~fGtVy~a~~-----k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~  420 (739)
                      +....++|++.+.||+|+||.||+|.+     ..++..||+|.++..    ......+.+.+|+++++++ +|+||++++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~  105 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT----AHSSEREALMSELKIMSHLGNHENIVNLL  105 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc----CChHHHHHHHHHHHHHHhccCCCCcceEE
Confidence            345556899999999999999999975     335668999987632    1233446788999999999 799999999


Q ss_pred             cceeecceEEEEEeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004660          421 GSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF  499 (739)
Q Consensus       421 ~~~~~~~~l~LVmEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DF  499 (739)
                      +++...+..|+||||+.+|+|.+++.... ..+++.++..|+.||+.||.|||++||+|+||||+|||++.++.+||+||
T Consensus       106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCC
Confidence            99999999999999999999999997542 34899999999999999999999999999999999999999999999999


Q ss_pred             ccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh
Q 004660          500 GMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN  575 (739)
Q Consensus       500 GlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~  575 (739)
                      |+++.+.....   .....++..|+|||.+.+       ..++.++|||||||++|||++ |..||......+.+.+...
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~  258 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK  258 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhcc-------CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH
Confidence            99986643221   112346788999998863       356779999999999999998 9999987766555555443


Q ss_pred             c--CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          576 R--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       576 ~--~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .  ....+...+.++.+||.+||..+|++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            2  22345567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.5e-39  Score=332.01  Aligned_cols=244  Identities=28%  Similarity=0.502  Sum_probs=204.1

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeecccee-ecce
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV-VDDH  428 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~-~~~~  428 (739)
                      ...+|++.+.||+|+||.||++...  |..||+|.++.   +    ...+.+.+|+.+++.++|+||+++++++. .++.
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~---~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN---D----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   74 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCC---C----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence            3457999999999999999999765  78899998752   1    12356788999999999999999999754 4567


Q ss_pred             EEEEEeecCCCCcchhhhhccc-cccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          429 LYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~-~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .|+||||+++++|.+++.+... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            9999999999999999976433 488999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccCC
Q 004660          508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS  585 (739)
Q Consensus       508 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls  585 (739)
                      ..  ....++..|+|||++.+       ..++.++|||||||++|||++ |+.||......+....+... ....+..++
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP  225 (256)
T ss_pred             cC--CCCccceeecCHHHHcc-------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Confidence            22  22345678999998863       456789999999999999997 99999876665555555433 334566789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ..+.++|.+||..||++|||+.++++
T Consensus       226 ~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         226 PVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-40  Score=374.54  Aligned_cols=262  Identities=22%  Similarity=0.329  Sum_probs=196.8

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCC-CcEEEEEEeecC------------CCCcccHHHHHHHHHHHHHHhhcCCCCe
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDII------------PDDPKSAECIKQLEQEIKVLGHLKHENI  416 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~t-g~~VAIK~i~~~------------~~~~~~~~~~k~l~~Ei~iL~~L~HPNI  416 (739)
                      ...+|++++.||+|+||+||+|..+.. +..+++|.+...            +...........+++|+.+|+.++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            456899999999999999999986543 333333311100            0001122345678899999999999999


Q ss_pred             EeeccceeecceEEEEEeecCCCCcchhhhhc----cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC
Q 004660          417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG  492 (739)
Q Consensus       417 Vkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~----~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g  492 (739)
                      |++++++..++..|+|||++. ++|..++...    ........++.|+.||+.||.|||++||+||||||+||||+.++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            999999999999999999995 5676666432    12244677889999999999999999999999999999999999


Q ss_pred             cEEEeecccchhccCcc--cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCC-CCCC--ch
Q 004660          493 VVKLADFGMAKHLTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-SEFE--GP  567 (739)
Q Consensus       493 ~vKL~DFGlA~~~~~~~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF-~~~~--~~  567 (739)
                      .+||+|||+++.+....  ......||..|+|||++.+       ..++.++||||||||||||++|..++ ....  ..
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-------DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            99999999998765432  2234679999999999873       35778999999999999999988644 3221  12


Q ss_pred             HHHHHHhhcC----CCCC----------------------------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          568 QAMFKVLNRT----PPIP----------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       568 ~~~~~i~~~~----~~iP----------------------------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ..+.+++...    ..+|                            ..++.++.++|.+||..||.+|||+.|+|+||||
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            2222222110    0000                            1245678889999999999999999999999999


Q ss_pred             cccc
Q 004660          616 RNAN  619 (739)
Q Consensus       616 ~~~~  619 (739)
                      ....
T Consensus       458 ~~~~  461 (501)
T PHA03210        458 SAEE  461 (501)
T ss_pred             hcCC
Confidence            7643

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.3e-39  Score=333.02  Aligned_cols=248  Identities=27%  Similarity=0.490  Sum_probs=206.7

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ....+|+++++||+|+||.||+|..+ +++.||+|.+.....   .   ...+.+|+.+++.++|+||+++++++ ..+.
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~---~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   74 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---S---PEAFLAEANLMKQLQHPRLVRLYAVV-TQEP   74 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---c---HHHHHHHHHHHHhcCCcCeeeEEEEE-ccCC
Confidence            44568999999999999999999865 578899998763221   1   24678899999999999999999876 4567


Q ss_pred             EEEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          429 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .|++|||+.+++|.+++... ...+++.++..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            89999999999999998653 34689999999999999999999999999999999999999999999999999976653


Q ss_pred             cccc--cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCcc
Q 004660          508 LSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM  583 (739)
Q Consensus       508 ~~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~  583 (739)
                      ....  ....++..|+|||.+.+       ..++.++||||||+++|||++ |+.||.+....+....+... ..+.+..
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDN  227 (260)
T ss_pred             CCcccccCCcccccccCHHHhcc-------CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Confidence            2221  22345778999998863       356779999999999999998 99999887766655554433 3455677


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ++.++.++|.+||..+|++||++++++.
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         228 CPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            8899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.5e-39  Score=332.92  Aligned_cols=242  Identities=25%  Similarity=0.441  Sum_probs=200.6

Q ss_pred             EEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeec
Q 004660          359 LIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       359 ~LG~G~fGtVy~a~~k--~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      .||+|+||.||+|.++  .++..||+|++...    ......+.+.+|+.+|++++|+||+++++++. .+..++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc----cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            3899999999999875  44567999987532    22344567889999999999999999999875 45789999999


Q ss_pred             CCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc----cc
Q 004660          437 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY----EL  512 (739)
Q Consensus       437 ~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~----~~  512 (739)
                      .+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........    ..
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99999999976556799999999999999999999999999999999999999999999999999976533211    11


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh-cCCCCCccCCHHHHH
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKD  590 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~iP~~ls~el~d  590 (739)
                      ...++..|+|||.+..       ..++.++|||||||++|||++ |..||......+....+.. .....+...+.++.+
T Consensus       157 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  229 (257)
T cd05115         157 AGKWPLKWYAPECINF-------RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA  229 (257)
T ss_pred             CCCCCcccCCHHHHcc-------CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            1223578999999863       356779999999999999996 9999988776666555543 344567788999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcC
Q 004660          591 FLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       591 LI~kcL~~DP~kRpTa~elLqH  612 (739)
                      +|.+||..||++||++.++++.
T Consensus       230 li~~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         230 LMKDCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999998763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.7e-39  Score=328.61  Aligned_cols=243  Identities=28%  Similarity=0.465  Sum_probs=203.7

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecC
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  437 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~  437 (739)
                      ++||+|+||.||+|... ++..||+|.+...    ...+....+.+|+.+++.++|+||+++++++...+..++||||+.
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED----LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCc----CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence            47999999999999865 6889999987532    123334568889999999999999999999999999999999999


Q ss_pred             CCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc--ccC
Q 004660          438 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLK  515 (739)
Q Consensus       438 gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~--s~~  515 (739)
                      +++|.+++......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..........  ...
T Consensus        76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            999999997655668999999999999999999999999999999999999999999999999987543322111  123


Q ss_pred             CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccCCHHHHHHHH
Q 004660          516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLL  593 (739)
Q Consensus       516 GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~  593 (739)
                      ++..|+|||++.+       ..++.++||||||+++|||++ |..||...........+... ....+..++..+.++|.
T Consensus       156 ~~~~y~aPE~~~~-------~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  228 (250)
T cd05085         156 IPIKWTAPEALNY-------GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQ  228 (250)
T ss_pred             CcccccCHHHhcc-------CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            4667999999863       356779999999999999998 99999887666665555443 33456678899999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q 004660          594 RCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       594 kcL~~DP~kRpTa~elLqH  612 (739)
                      +||..+|++||++.++++.
T Consensus       229 ~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         229 RCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             HHcccCcccCCCHHHHHHH
Confidence            9999999999999999863

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.5e-39  Score=337.79  Aligned_cols=248  Identities=25%  Similarity=0.444  Sum_probs=204.1

Q ss_pred             CceEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~-----tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      +|++.+.||+|+||+||+|.+..     ....+|+|.+...    ........+.+|+.+|+.++||||+++++.+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC----CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            48899999999999999998753     2356888876521    22333567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhc-----------------------cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCc
Q 004660          428 HLYIYLEYVHPGSINRYVREH-----------------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA  484 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~-----------------------~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~  484 (739)
                      ..|+||||+.+|+|.+++...                       ...+++..++.++.||+.||.|||++||+||||||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~  156 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR  156 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence            999999999999999988542                       134788999999999999999999999999999999


Q ss_pred             ceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCC
Q 004660          485 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP  560 (739)
Q Consensus       485 NILLd~~g~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~P  560 (739)
                      ||||++++.+||+|||+++.......   .....++..|+|||.+.+       ..++.++||||||+++|||++ |..|
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p  229 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-------HIYTTQSDVWSFGVLLWEIVTLGGNP  229 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-------CCcchHhHHHHHHHHHHHHHhcCCCC
Confidence            99999999999999999976533221   122345778999998863       457789999999999999998 9999


Q ss_pred             CCCCCchHHHHHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          561 WSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       561 F~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      |.+....+....+... ....+..++.++.+||.+||+.||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         230 YPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            9876655544433322 33456778999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-39  Score=330.82  Aligned_cols=241  Identities=29%  Similarity=0.481  Sum_probs=200.6

Q ss_pred             eEEeecCCeEEEEEEECCCC---cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEe
Q 004660          358 KLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE  434 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg---~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmE  434 (739)
                      ++||+|+||.||+|.+...+   ..||+|.+.....    ....+.+.+|+.+|+.++|+|||++++++. .+..++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI----AAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            47999999999999876554   7899998763221    134467888999999999999999999765 456899999


Q ss_pred             ecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc--
Q 004660          435 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--  512 (739)
Q Consensus       435 y~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~--  512 (739)
                      |+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........  
T Consensus        76 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          76 LAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             eCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999999999775 479999999999999999999999999999999999999999999999999998664322211  


Q ss_pred             --ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccCCHHH
Q 004660          513 --SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG  588 (739)
Q Consensus       513 --s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el  588 (739)
                        ...++..|+|||.+.+       ..++.++|||||||++|||++ |..||...+..+....+... ....+..++..+
T Consensus       155 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  227 (257)
T cd05060         155 TTAGRWPLKWYAPECINY-------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEI  227 (257)
T ss_pred             ccCccccccccCHHHhcC-------CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence              1123567999998863       457789999999999999998 99999887766655555433 335667788999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      +++|.+||..||++||++.++++
T Consensus       228 ~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         228 YSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.6e-39  Score=343.71  Aligned_cols=255  Identities=27%  Similarity=0.436  Sum_probs=201.7

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      |.+++.+|.|  |.||+++.+.+++.||||++...   ....+..+.+.+|+.+|+.++|+||+++++++..++..|++|
T Consensus         4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   78 (314)
T cd08216           4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLD---SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVS   78 (314)
T ss_pred             hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEecc---ccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEE
Confidence            3444444444  55666666778999999998742   123345678999999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc--
Q 004660          434 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--  510 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~--  510 (739)
                      ||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+........  
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          79 PLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             eccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999999999999764 34589999999999999999999999999999999999999999999999999865532211  


Q ss_pred             ------ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-------
Q 004660          511 ------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------  577 (739)
Q Consensus       511 ------~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-------  577 (739)
                            .....++..|+|||++...     ...++.++|||||||++|||++|+.||..............+.       
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQN-----LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK  233 (314)
T ss_pred             cccccccccccccccccCHHHhcCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence                  1234578899999998631     1346779999999999999999999998765443332221110       


Q ss_pred             ---------------------------CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          578 ---------------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       578 ---------------------------~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                                                 ......++.++.+||.+||..||++|||+.|+|+||||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence                                       00111234688999999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.3e-39  Score=341.95  Aligned_cols=254  Identities=34%  Similarity=0.568  Sum_probs=213.3

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .|....+||+|+||.||++..+.+|+.||||++...     .......+.+|+.+++.++|+||+++++.+..++..|+|
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   95 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV   95 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence            455568899999999999999999999999987531     123346688999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE  511 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~-~~  511 (739)
                      |||+.+++|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ..
T Consensus        96 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657          96 MEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             EecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence            999999999998754  358999999999999999999999999999999999999999999999999987654322 22


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC---CCCccCCHHH
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEG  588 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~---~iP~~ls~el  588 (739)
                      ....|+..|+|||.+.+       ..++.++||||||+++|+|++|+.||......+....+.....   .....++..+
T Consensus       174 ~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (292)
T cd06657         174 KSLVGTPYWMAPELISR-------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSL  246 (292)
T ss_pred             cccccCccccCHHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHH
Confidence            23568999999998752       3467799999999999999999999987665554444432221   2234578899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      .++|.+||..||.+||++.++|+|+||.....
T Consensus       247 ~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         247 KGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            99999999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-39  Score=348.98  Aligned_cols=256  Identities=26%  Similarity=0.425  Sum_probs=208.4

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec---
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~---  426 (739)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+.+|+.+++.++|+||+++++++...   
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            4578999999999999999999999999999999886421   1222345677899999999999999999987543   


Q ss_pred             ---ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004660          427 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       427 ---~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                         ...|+++|++ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence               3478888887 7899888765  358999999999999999999999999999999999999999999999999987


Q ss_pred             hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC------
Q 004660          504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------  577 (739)
Q Consensus       504 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------  577 (739)
                      .....  .....|+..|+|||.+.+      ...++.++|||||||++|||++|+.||........+..++...      
T Consensus       169 ~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T cd07877         169 HTDDE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  240 (345)
T ss_pred             ccccc--ccccccCCCccCHHHHhC------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            65332  234568999999999863      2346778999999999999999999997665544333322110      


Q ss_pred             -----------------CCC--------CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          578 -----------------PPI--------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       578 -----------------~~i--------P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                       ..+        ....+.++++||.+||..||.+|+++.++|.|+||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence                             011        113578899999999999999999999999999998643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3e-39  Score=330.35  Aligned_cols=247  Identities=28%  Similarity=0.481  Sum_probs=207.8

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      .+|++.+.||+|+||.||+|.+.. +..+|+|.+....   ..   ...+.+|++++++++|+||+++++++......|+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~---~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA---MS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC---CC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence            479999999999999999998864 6789999875321   11   2357789999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~  511 (739)
                      ||||+.+++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            99999999999999776566899999999999999999999999999999999999999999999999998765432221


Q ss_pred             --cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccCCHH
Q 004660          512 --LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE  587 (739)
Q Consensus       512 --~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~e  587 (739)
                        ....++..|+|||.+.+       ..++.++||||||+++|||++ |+.||...........+... ....+...+.+
T Consensus       157 ~~~~~~~~~~~~aPe~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSF-------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS  229 (256)
T ss_pred             ccCCCccchhhcCHhHhcc-------CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence              12235678999998863       356779999999999999998 99999877666666555433 33445667899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          588 GKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      +.+|+.+||..+|++||++.++++.
T Consensus       230 ~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         230 VYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHHHcccChhhCCCHHHHHHh
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.9e-39  Score=330.64  Aligned_cols=242  Identities=30%  Similarity=0.531  Sum_probs=204.0

Q ss_pred             eEEeecCCeEEEEEEECC-CCc--EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEe
Q 004660          358 KLIGRGTFGSVYIGTNRE-TGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE  434 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~-tg~--~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmE  434 (739)
                      ++||+|+||+||+|.+.. .+.  .||||.+.....    ....+.+.+|+.++++++|+||+++++.+.. ...++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL----SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc----HHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            468999999999999865 333  589998764221    1556788999999999999999999999888 88999999


Q ss_pred             ecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc----
Q 004660          435 YVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS----  509 (739)
Q Consensus       435 y~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~----  509 (739)
                      |+.+|+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999999997754 468999999999999999999999999999999999999999999999999998764321    


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc--CCCCCccCCH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSS  586 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~--~~~iP~~ls~  586 (739)
                      ......++..|+|||.+.+       ..++.++|||||||++|||++ |+.||......+....+...  ....+..++.
T Consensus       156 ~~~~~~~~~~y~~pE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRT-------RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQ  228 (257)
T ss_pred             cccCCCCCceecCHHHhcc-------cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCH
Confidence            1112457789999998863       457789999999999999998 99999877776666655432  2344567889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .+.++|.+||..+|++||++.++++
T Consensus       229 ~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         229 DIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6.3e-39  Score=341.50  Aligned_cols=257  Identities=36%  Similarity=0.608  Sum_probs=215.0

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .|...+.||+|+||+||+|++..+|..||||++.....  ........+.+|+.+++.++|+||+++++++...+..|+|
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   99 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK--QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV   99 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc--CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            47778899999999999999999999999999864322  2334456788899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL  512 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~  512 (739)
                      |||+. |+|.+++......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   ..
T Consensus       100 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~  175 (313)
T cd06633         100 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---AN  175 (313)
T ss_pred             EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CC
Confidence            99996 677777766556789999999999999999999999999999999999999999999999999865432   22


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-CC-CCccCCHHHHH
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PP-IPEMLSSEGKD  590 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~-iP~~ls~el~d  590 (739)
                      ...|+..|+|||.+...    ....++.++|||||||++|||++|..||...+.......+.... .. ....++..+++
T Consensus       176 ~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  251 (313)
T cd06633         176 SFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG  251 (313)
T ss_pred             CccccccccChhhcccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence            45689999999998531    12346779999999999999999999998876666555554332 22 22356788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          591 FLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       591 LI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      ||.+||+.+|.+||++.++|.|+||+...
T Consensus       252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         252 FVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            99999999999999999999999998644

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-39  Score=328.51  Aligned_cols=242  Identities=29%  Similarity=0.518  Sum_probs=204.3

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecC
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  437 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~  437 (739)
                      ++||+|+||.||+|.+.. ++.||+|.+....    ..+....+.+|++++++++|+||+++++++...+..|+||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTL----PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence            479999999999999887 9999999876321    12345678899999999999999999999999999999999999


Q ss_pred             CCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc---cc
Q 004660          438 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SL  514 (739)
Q Consensus       438 gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~---s~  514 (739)
                      +++|.+++......+++..+..++.|++.||.|||++||+||||||+||||+.++.+||+|||++..........   ..
T Consensus        76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            999999997755678999999999999999999999999999999999999999999999999997654322111   12


Q ss_pred             CCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccCCHHHHHHH
Q 004660          515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFL  592 (739)
Q Consensus       515 ~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI  592 (739)
                      .++..|+|||.+.+       ..++.++|||||||++|||++ |..||...........+... ....+..++.++.++|
T Consensus       156 ~~~~~y~~PE~~~~-------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  228 (251)
T cd05041         156 QIPIKWTAPEALNY-------GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLM  228 (251)
T ss_pred             cceeccCChHhhcc-------CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence            23567999998863       356789999999999999998 89999877665555554433 3445677899999999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q 004660          593 LRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       593 ~kcL~~DP~kRpTa~elLq  611 (739)
                      .+||..+|++|||+.|+|+
T Consensus       229 ~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         229 LQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHhccChhhCcCHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.7e-39  Score=348.59  Aligned_cols=258  Identities=28%  Similarity=0.476  Sum_probs=209.6

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeec--
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD--  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~--  426 (739)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++.....   .......+.+|+.+++++ +|+||+++++++...  
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR---NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC---cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            45679999999999999999999999999999998753211   122234577899999999 999999999987654  


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      ..+|+||||+. ++|..++...  .+.+..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            36899999997 5898888664  68899999999999999999999999999999999999999999999999998664


Q ss_pred             Ccc------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC---
Q 004660          507 GLS------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---  577 (739)
Q Consensus       507 ~~~------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---  577 (739)
                      ...      ......||..|+|||++.+      ...++.++|||||||++|+|++|+.||......+...++....   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLG------STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             cccccccCcchhcccccccccCceeeec------cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            322      2223568999999998753      3456778999999999999999999997655444333221110   


Q ss_pred             ----------------------------CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          578 ----------------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       578 ----------------------------~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                                  ......++.++.+||.+||+.||.+|||+.++|+|+|++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~  302 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH  302 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence                                        011123688999999999999999999999999999998653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-39  Score=346.54  Aligned_cols=257  Identities=26%  Similarity=0.470  Sum_probs=211.9

Q ss_pred             CCCCCCCCCceEeeEEeecCCeEEEEEEECCC-------CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCe
Q 004660          345 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRET-------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENI  416 (739)
Q Consensus       345 p~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~t-------g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNI  416 (739)
                      +.+.....+|++++.||+|+||.||+|++...       +..||+|.++..    ......+.+.+|+.+++++ +|+||
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i   80 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNI   80 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCe
Confidence            35667777899999999999999999986432       236899976531    2233456788999999999 79999


Q ss_pred             EeeccceeecceEEEEEeecCCCCcchhhhhcc---------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccC
Q 004660          417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDI  481 (739)
Q Consensus       417 Vkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~---------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDI  481 (739)
                      +++++++..++.+|++|||+.+|+|.+++....               ..++..++..++.||+.||.|||++||+||||
T Consensus        81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dl  160 (334)
T cd05100          81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDL  160 (334)
T ss_pred             eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence            999999999999999999999999999986531               24677888999999999999999999999999


Q ss_pred             CCcceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-C
Q 004660          482 KGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G  557 (739)
Q Consensus       482 KP~NILLd~~g~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-G  557 (739)
                      ||+||||+.++.+||+|||+++.+.....   .....++..|+|||++.+       ..++.++|||||||+||||++ |
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g  233 (334)
T cd05100         161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLLWEIFTLG  233 (334)
T ss_pred             ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-------CCcCchhhhHHHHHHHHHHHhcC
Confidence            99999999999999999999976643221   112234567999999863       456779999999999999998 8


Q ss_pred             CCCCCCCCchHHHHHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          558 KPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       558 k~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ..||......+....+... ....+..++.++.+||.+||..+|++||++.|++++
T Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         234 GSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            9999887666665555443 335566788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.4e-39  Score=379.47  Aligned_cols=150  Identities=29%  Similarity=0.478  Sum_probs=136.5

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ..+|+++++||+|+||+||+|++..+++.||||+++...  .........+.+|+.++..++|+|||++++++...+.+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKAD--MINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhh--ccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            467999999999999999999999999999999986422  223445577889999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                      |||||+.|++|.+++... +.+++..++.|+.||+.||.|||.+||+||||||+||||+.++.+||+|||+++
T Consensus        81 lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999764 568999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-39  Score=339.71  Aligned_cols=251  Identities=27%  Similarity=0.434  Sum_probs=204.3

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCC--------------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCC
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETG--------------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN  415 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg--------------~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPN  415 (739)
                      ...+|++.+.||+|+||.||+|++..++              ..||+|.+...    ........+.+|+++|+.++|+|
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~   78 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD----VTKTARNDFLKEIKIMSRLKNPN   78 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCC
Confidence            3568999999999999999999875432              35899987532    22344567889999999999999


Q ss_pred             eEeeccceeecceEEEEEeecCCCCcchhhhhcc-----------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCc
Q 004660          416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA  484 (739)
Q Consensus       416 IVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~-----------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~  484 (739)
                      |+++++++..++..++||||+.+++|.+++....           ..+++..+..++.||+.||.|||++||+||||||+
T Consensus        79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~  158 (295)
T cd05097          79 IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR  158 (295)
T ss_pred             cCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence            9999999999999999999999999999985431           23678899999999999999999999999999999


Q ss_pred             ceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh--CCC
Q 004660          485 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP  559 (739)
Q Consensus       485 NILLd~~g~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt--Gk~  559 (739)
                      ||||+.++.+||+|||++..+.....   .....++..|+|||.+.+       ..++.++|||||||++|||++  |..
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~~l~el~~~~~~~  231 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-------GKFTTASDVWAFGVTLWEMFTLCKEQ  231 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-------CCcCchhhHHHHHHHHHHHHHcCCCC
Confidence            99999999999999999976543221   112345678999998863       357889999999999999988  778


Q ss_pred             CCCCCCchHHHHHHhh------c--CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          560 PWSEFEGPQAMFKVLN------R--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       560 PF~~~~~~~~~~~i~~------~--~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ||......+.+..+..      .  ....+..++..+.+||.+||..||++||++.++++
T Consensus       232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         232 PYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             CCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            8887666555444321      1  12234567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.4e-39  Score=336.27  Aligned_cols=251  Identities=24%  Similarity=0.446  Sum_probs=209.1

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeecccee
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  424 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k-----~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~  424 (739)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++...    ......+.+.+|+.+++.++|+||+++++++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~   78 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDHPNIVKLLGVCA   78 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC----cCHHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence            3567999999999999999999875     36788999987531    22344567889999999999999999999999


Q ss_pred             ecceEEEEEeecCCCCcchhhhhcc---------------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCC
Q 004660          425 VDDHLYIYLEYVHPGSINRYVREHC---------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG  483 (739)
Q Consensus       425 ~~~~l~LVmEy~~gGsL~~~L~~~~---------------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP  483 (739)
                      .++..|+||||+.+|+|.+++....                     ..+++.+++.++.||+.||.|||++||+||||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p  158 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT  158 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence            9999999999999999999996431                     2477888999999999999999999999999999


Q ss_pred             cceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCC
Q 004660          484 ANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP  559 (739)
Q Consensus       484 ~NILLd~~g~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~  559 (739)
                      +|||++.++.+||+|||++........   .....++..|+|||.+.+       ..++.++|||||||++|||++ |..
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~~~~~  231 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYGMQ  231 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-------CCCCchhHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999876533221   112234667999998863       457789999999999999997 888


Q ss_pred             CCCCCCchHHHHHHhhcC-CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          560 PWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       560 PF~~~~~~~~~~~i~~~~-~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ||.+....+....+.... ...+..++.++.+||.+||+.||.+|||+.|+++
T Consensus       232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         232 PYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            998777666666655443 3446678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.8e-39  Score=349.16  Aligned_cols=253  Identities=26%  Similarity=0.477  Sum_probs=204.4

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccc
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGS  422 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~-----k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~  422 (739)
                      ...++|++++.||+|+||+||+|++     ..+++.||||+++..    ........+.+|+.+|.++ +|+|||+++++
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC----CChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            3456899999999999999999985     346788999988632    1233346788899999999 68999999998


Q ss_pred             eeec-ceEEEEEeecCCCCcchhhhhcc----------------------------------------------------
Q 004660          423 EVVD-DHLYIYLEYVHPGSINRYVREHC----------------------------------------------------  449 (739)
Q Consensus       423 ~~~~-~~l~LVmEy~~gGsL~~~L~~~~----------------------------------------------------  449 (739)
                      +... ..+++||||+.+|+|.+++....                                                    
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            7654 56899999999999999986421                                                    


Q ss_pred             --------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc---cc
Q 004660          450 --------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---EL  512 (739)
Q Consensus       450 --------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~---~~  512 (739)
                                    ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....   ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                          2367778889999999999999999999999999999999999999999999976533221   11


Q ss_pred             ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHh-h-cCCCCCccCCHHHH
Q 004660          513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-N-RTPPIPEMLSSEGK  589 (739)
Q Consensus       513 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~-~-~~~~iP~~ls~el~  589 (739)
                      ...++..|+|||.+.+       ..++.++|||||||++|||++ |..||........+...+ . .....+..+++++.
T Consensus       240 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (343)
T cd05103         240 DARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY  312 (343)
T ss_pred             CCCCCcceECcHHhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHH
Confidence            2335678999999863       457789999999999999997 999998765443333333 2 23455677889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcC
Q 004660          590 DFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ++|.+||..||++||++.|+++|
T Consensus       313 ~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         313 QTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-39  Score=348.56  Aligned_cols=254  Identities=29%  Similarity=0.470  Sum_probs=206.9

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec----
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  426 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~----  426 (739)
                      ..+|.+.+.||+|+||.||+|+++.+|+.||||++....   ........+.+|+.+++.++|+||+++++++...    
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~   90 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD   90 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc---ccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence            468999999999999999999999999999999886421   1122335678899999999999999999988654    


Q ss_pred             --ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          427 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       427 --~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                        ..+|+||||+. .+|..++.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          91 EFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             CCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence              34699999996 46665542   3589999999999999999999999999999999999999999999999999876


Q ss_pred             ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-------
Q 004660          505 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------  577 (739)
Q Consensus       505 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-------  577 (739)
                      ....  .....++..|+|||++.+      ...++.++|||||||++|||++|+.||.+.+....+..++...       
T Consensus       167 ~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07879         167 ADAE--MTGYVVTRWYRAPEVILN------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF  238 (342)
T ss_pred             CCCC--CCCceeeecccChhhhcC------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            5332  223567899999999863      2346779999999999999999999998766554444333210       


Q ss_pred             ----------------CCC--------CccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          578 ----------------PPI--------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       578 ----------------~~i--------P~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                      ..+        ...++.++.+||.+||+.||++||++.++|.|+||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                            001        123677899999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.2e-39  Score=334.32  Aligned_cols=247  Identities=30%  Similarity=0.466  Sum_probs=198.0

Q ss_pred             CCc-eEeeEEeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec
Q 004660          352 SQW-QKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  426 (739)
Q Consensus       352 ~~Y-~i~~~LG~G~fGtVy~a~~----k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~  426 (739)
                      ++| ++.+.||+|+||+||++..    ..++..||+|.++..    ........+.+|+++|+.++||||+++++++...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE----CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ   78 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc----cChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            345 9999999999999988753    357889999988632    1123345678899999999999999999987653


Q ss_pred             --ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          427 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       427 --~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                        ..+|+||||+.+|+|.+++...  .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          79 GGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             CCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence              4689999999999999999763  599999999999999999999999999999999999999999999999999986


Q ss_pred             ccCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch-------------
Q 004660          505 LTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-------------  567 (739)
Q Consensus       505 ~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~-------------  567 (739)
                      ......    .....++..|+|||.+.+       ..++.++|||||||++|||++|..||......             
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKE-------NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT  229 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcc-------cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence            643221    112235677999998863       35678999999999999999999998643211             


Q ss_pred             -HHHHHHh--hcCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          568 -QAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       568 -~~~~~i~--~~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                       ..+....  ....+.+..++.++.+++.+||..||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             0011111  1122345677899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.1e-38  Score=341.99  Aligned_cols=255  Identities=30%  Similarity=0.511  Sum_probs=205.5

Q ss_pred             CceEeeEEeecCCeEEEEEEECCC--CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceeec---
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD---  426 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~t--g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~~---  426 (739)
                      +|.+.+.||+|+||.||++++..+  +..||||++....   ......+.+.+|+.+++.+ +|+||+++++.+...   
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc---ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            489999999999999999999988  8999999876322   1222345677899999999 599999999865432   


Q ss_pred             -ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          427 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       427 -~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                       ..+|++|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence             45889999986 6888888654 56999999999999999999999999999999999999999999999999999765


Q ss_pred             cCcc-----cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC---
Q 004660          506 TGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---  577 (739)
Q Consensus       506 ~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---  577 (739)
                      ....     ......||..|+|||.+.+      ...++.++|||||||++|+|++|+.||...+....+..++...   
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLS------FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP  229 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence            4321     1223568999999998863      3456789999999999999999999998765443333222110   


Q ss_pred             -------------------------CC---CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          578 -------------------------PP---IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       578 -------------------------~~---iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                                               ..   +...++..+.+||.+||+.||++|||+.++++|||++.-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence                                     00   112357899999999999999999999999999999743

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.2e-39  Score=337.34  Aligned_cols=264  Identities=31%  Similarity=0.525  Sum_probs=213.5

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeec
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD  426 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~  426 (739)
                      ....++|++.+.||+|+||+||+|.++.+++.||||.++....    ......+.+|+.++..+. |+||+++++++..+
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC----hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            4456789999999999999999999999999999999864321    222345666777666665 99999999999999


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                      ..+|+||||+. +.|..++......+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++..+
T Consensus        87 ~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          87 SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            99999999985 57777776645678999999999999999999997 69999999999999999999999999999876


Q ss_pred             cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc-hHHHHHHhhcC-CCCC--
Q 004660          506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLNRT-PPIP--  581 (739)
Q Consensus       506 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~-~~~~~~i~~~~-~~iP--  581 (739)
                      ..........++..|+|||.+.+..   ....++.++||||||+++|||++|+.||..... .+.+..++... ..++  
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPD---PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN  242 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCC---CccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence            5433333456888999999986311   023467899999999999999999999976433 33444444332 2222  


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      ..++.++.+||.+||..||.+||++.++++|+||+...
T Consensus       243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            24688999999999999999999999999999997543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.2e-39  Score=337.33  Aligned_cols=250  Identities=28%  Similarity=0.448  Sum_probs=202.8

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECC----------------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRE----------------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE  414 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~----------------tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HP  414 (739)
                      .++|++.+.||+|+||+||++.+..                ++..||+|++...    ........+.+|+.+|+.++|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~E~~~l~~l~~~   79 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----ANKNARNDFLKEIKIMSRLKDP   79 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCC
Confidence            4579999999999999999986432                3456899987632    1233456788999999999999


Q ss_pred             CeEeeccceeecceEEEEEeecCCCCcchhhhhcc----------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCc
Q 004660          415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA  484 (739)
Q Consensus       415 NIVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~----------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~  484 (739)
                      ||+++++++..++..|+||||+.+|+|.+++....          ..+++.++..++.||+.||+|||++||+||||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~  159 (296)
T cd05095          80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR  159 (296)
T ss_pred             CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence            99999999999999999999999999999986532          23677889999999999999999999999999999


Q ss_pred             ceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh--CCC
Q 004660          485 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP  559 (739)
Q Consensus       485 NILLd~~g~vKL~DFGlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt--Gk~  559 (739)
                      ||||+.++.+||+|||+++.+.....   .....++..|++||.+.+       ..++.++|||||||++|||++  |..
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~DiwSlG~~l~el~~~~~~~  232 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-------GKFTTASDVWAFGVTLWEILTLCKEQ  232 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-------CCccchhhhhHHHHHHHHHHHhCCCC
Confidence            99999999999999999976543221   112234678999998763       357789999999999999998  789


Q ss_pred             CCCCCCchHHHHHHhh--------cCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          560 PWSEFEGPQAMFKVLN--------RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       560 PF~~~~~~~~~~~i~~--------~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ||......+.+.....        ...+.+..++..+.+||.+||..||++||++.++++
T Consensus       233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         233 PYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             CccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9977655554433211        122345567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.3e-39  Score=339.87  Aligned_cols=258  Identities=33%  Similarity=0.573  Sum_probs=216.1

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ...|...+.||+|+||+||+|+++.++..||+|.+.....  .......++.+|+++++.++|+||+++++++..++..|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc--cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence            3458889999999999999999999999999998864221  22344567788999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~  510 (739)
                      +||||+. |+|.+++......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9999996 6787777655566899999999999999999999999999999999999999999999999998765432  


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-C-CCccCCHHH
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-P-IPEMLSSEG  588 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-~-iP~~ls~el  588 (739)
                       ....|+..|+|||.+.+..    ...++.++|||||||++|+|++|..||...+..+....+..... . ....++..+
T Consensus       169 -~~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (308)
T cd06634         169 -NXFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF  243 (308)
T ss_pred             -ccccCCccccCHHHHhhcc----cCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHH
Confidence             2356899999999986321    23466799999999999999999999987766555555543322 2 234678899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      .+||.+||..+|++||++.++++|+|+...
T Consensus       244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            999999999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.8e-39  Score=330.87  Aligned_cols=251  Identities=27%  Similarity=0.474  Sum_probs=208.7

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~t---g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~  426 (739)
                      ...+|++.++||+|+||.||+|.+...   ...||||.+...    ......+.+.+|+.+++.++|+||+++++++.. 
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-   78 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC----TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-   78 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc----CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence            456799999999999999999987654   346889976532    113445678899999999999999999998765 


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      +..|+||||+.+|+|.+++......+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++...
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            56789999999999999997755568999999999999999999999999999999999999999999999999997665


Q ss_pred             Cccccc--ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCc
Q 004660          507 GLSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE  582 (739)
Q Consensus       507 ~~~~~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~  582 (739)
                      ......  ...++..|+|||.+..       ..++.++|||||||++|||++ |..||......+....+... ....+.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP  231 (270)
T ss_pred             cccceecCCCCccccccChhhhcc-------CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            432211  2224568999998752       356789999999999999996 99999887766666555443 345677


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      .++.++.++|.+||..+|.+|||+.++++.
T Consensus       232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         232 NCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.6e-40  Score=342.77  Aligned_cols=261  Identities=28%  Similarity=0.476  Sum_probs=209.0

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee-
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-  425 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~----~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~-  425 (739)
                      ..+|++.+.||+|+||.||+|..+.+..    .+|||+++..++...   .-...-+||.+++.|+|+|||.+..+|.. 
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG---iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG---ISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC---cCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            3579999999999999999997665543    689998875433211   11345579999999999999999999987 


Q ss_pred             cceEEEEEeecCCCCcchhhhhc----cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC----CcEEEe
Q 004660          426 DDHLYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----GVVKLA  497 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~----~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~----g~vKL~  497 (739)
                      +..++|++||.+ -+|...|+-+    .+.++...++.|+.||+.||.|||++=|+||||||.||||..+    |.|||+
T Consensus       100 d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence            788999999997 6888888543    3568999999999999999999999999999999999999877    899999


Q ss_pred             ecccchhccCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc-------
Q 004660          498 DFGMAKHLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-------  566 (739)
Q Consensus       498 DFGlA~~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~-------  566 (739)
                      |||+++.+...-.    ....+.|.||+|||+|.|      ...|+.++|||++|||+.|||+-++.|.+.+.       
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG------a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~P  252 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG------ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNP  252 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcc------cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCC
Confidence            9999998865322    223567999999999996      46788999999999999999999999865322       


Q ss_pred             --hHHHHHH---hhcC--------CCCCcc--------------------------CCHHHHHHHHHhcccCCCCCCCHH
Q 004660          567 --PQAMFKV---LNRT--------PPIPEM--------------------------LSSEGKDFLLRCFLRNPVERPSAV  607 (739)
Q Consensus       567 --~~~~~~i---~~~~--------~~iP~~--------------------------ls~el~dLI~kcL~~DP~kRpTa~  607 (739)
                        .+.+.+|   ++-.        ..+|+.                          -++...+||.+||..||.+|+|++
T Consensus       253 fq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~  332 (438)
T KOG0666|consen  253 FQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAE  332 (438)
T ss_pred             chHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHH
Confidence              1223333   3211        012211                          245588999999999999999999


Q ss_pred             HHHcCccccccccC
Q 004660          608 ELLEHPFIRNANYQ  621 (739)
Q Consensus       608 elLqHpwf~~~~~~  621 (739)
                      |+|+|+||......
T Consensus       333 qAleh~yF~~d~lp  346 (438)
T KOG0666|consen  333 QALEHPYFTEDPLP  346 (438)
T ss_pred             HHhcccccccCCCC
Confidence            99999999976544

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-38  Score=331.34  Aligned_cols=252  Identities=23%  Similarity=0.389  Sum_probs=208.6

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECC----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeecccee
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRE----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  424 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~----tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~  424 (739)
                      ...++|++.++||+|+||.||+|.+..    ++..|++|.+..    .........+.+|+.+|+.++|+||+++++++.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   78 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILPILHVCI   78 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC----CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            356789999999999999999999876    357889997652    223444677889999999999999999999766


Q ss_pred             e-cceEEEEEeecCCCCcchhhhhcc-------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEE
Q 004660          425 V-DDHLYIYLEYVHPGSINRYVREHC-------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL  496 (739)
Q Consensus       425 ~-~~~l~LVmEy~~gGsL~~~L~~~~-------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL  496 (739)
                      . +...++++||+.+|+|.+++....       ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus        79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence            5 567899999999999999986532       45899999999999999999999999999999999999999999999


Q ss_pred             eecccchhccCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHH
Q 004660          497 ADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK  572 (739)
Q Consensus       497 ~DFGlA~~~~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~  572 (739)
                      +|||+++.+......   ....++..|+|||.+.+       ..++.++|||||||++|||++ |+.||...+..+....
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  231 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-------KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY  231 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-------CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence            999999866432221   12346778999999863       456789999999999999998 9999988766555544


Q ss_pred             Hhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          573 VLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       573 i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      +... ....+..+++++.++|.+||..||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         232 LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            4433 22345567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.7e-39  Score=332.54  Aligned_cols=249  Identities=29%  Similarity=0.488  Sum_probs=199.8

Q ss_pred             CCCceEeeEEeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee-
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-  425 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~----k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~-  425 (739)
                      ..+|++.+.||+|+||+||+|..    ..++..||||++...     .....+.+.+|+++|+.++|+||+++++++.. 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   77 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence            34799999999999999999984    457889999987632     23445678899999999999999999997643 


Q ss_pred             -cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          426 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 -~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                       ...+++||||+.+|+|.+++......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          78 GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             CCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence             3468999999999999999976555689999999999999999999999999999999999999999999999999987


Q ss_pred             ccCcccc----cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch-------------
Q 004660          505 LTGLSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-------------  567 (739)
Q Consensus       505 ~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~-------------  567 (739)
                      .......    ....++..|+|||.+.+       ..++.++|||||||++|||++|..++......             
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQM  230 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhcc-------CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccccc
Confidence            6432211    11223456999998863       35677999999999999999987765432111             


Q ss_pred             --HHHHHHhhc--CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          568 --QAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       568 --~~~~~i~~~--~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                        ..+..++..  ..+.+..++.++.+||.+||..+|++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence              011112221  22345668899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1e-38  Score=330.30  Aligned_cols=249  Identities=26%  Similarity=0.389  Sum_probs=194.6

Q ss_pred             eEEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEee
Q 004660          358 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY  435 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k--~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy  435 (739)
                      +.||+|+||.||+|...  .++..+|+|.++...    .......+.+|+.+++.++||||+++++++.....+++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            46999999999999865  355779999875321    122335688899999999999999999999988999999999


Q ss_pred             cCCCCcchhhhhcc----ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004660          436 VHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-  510 (739)
Q Consensus       436 ~~gGsL~~~L~~~~----~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~-  510 (739)
                      +.+|+|.+++....    ...++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            99999999996532    2356778889999999999999999999999999999999999999999999975433221 


Q ss_pred             --ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHh-hcCC-----CCC
Q 004660          511 --ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTP-----PIP  581 (739)
Q Consensus       511 --~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~-~~~~-----~iP  581 (739)
                        .....|+..|+|||++.+.........++.++|||||||++|||++ |+.||......+...... ....     .+.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence              1124578889999998632110001245779999999999999996 999998766555443332 2212     222


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ...+..+.++|.+|| .+|++|||++||++
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            346788999999999 68999999999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-41  Score=364.42  Aligned_cols=266  Identities=26%  Similarity=0.422  Sum_probs=240.4

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      .....+++++..||-|+||.|-++..+.....+|+|++++...  ......+.+..|-.||..++.|.||++|..|.++.
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI--VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI--VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK  493 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc--cchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence            3445667888899999999999999887666799998875332  22334567888999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+||+||-|-||+|+..++++ +.+++..++.|+..+++|++|||.+|||+|||||+|+||+.+|-+||.|||+|+.+..
T Consensus       494 yvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            999999999999999999887 6799999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC--CCCCccCC
Q 004660          508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPEMLS  585 (739)
Q Consensus       508 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~~ls  585 (739)
                      ...+-+++||+.|.|||++.       +...+.++|.||||+++||||+|.+||.+.+....+..|+.+.  ..+|..+.
T Consensus       573 g~KTwTFcGTpEYVAPEIIL-------nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~  645 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIIL-------NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRIT  645 (732)
T ss_pred             CCceeeecCCcccccchhhh-------ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccc
Confidence            88889999999999999998       4567789999999999999999999999999999999998764  56789999


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----HHHHHcCccccccccCCC
Q 004660          586 SEGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL  623 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpT-----a~elLqHpwf~~~~~~~~  623 (739)
                      ..+.+||+++...+|.+|..     +.+|-+|.||...+++.+
T Consensus       646 k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl  688 (732)
T KOG0614|consen  646 KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL  688 (732)
T ss_pred             hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence            99999999999999999976     899999999999887654

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.7e-39  Score=335.89  Aligned_cols=239  Identities=21%  Similarity=0.366  Sum_probs=194.9

Q ss_pred             EEeecCCeEEEEEEECCC------------------------CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC
Q 004660          359 LIGRGTFGSVYIGTNRET------------------------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE  414 (739)
Q Consensus       359 ~LG~G~fGtVy~a~~k~t------------------------g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HP  414 (739)
                      .||+|+||.||+|....+                        ...||+|++..     ........+.+|+.+++.++|+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP-----SHRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh-----HHHHHHHHHHHHHHHHhcCCCC
Confidence            699999999999975322                        13478887652     2233345678899999999999


Q ss_pred             CeEeeccceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC--
Q 004660          415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG--  492 (739)
Q Consensus       415 NIVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g--  492 (739)
                      ||+++++++..+...||||||+++|+|..++......+++..+..|+.||+.||+|||++||+||||||+||||+..+  
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999999999976556789999999999999999999999999999999999997654  


Q ss_pred             -----cEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHh-hCCCCCCCCCc
Q 004660          493 -----VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEFEG  566 (739)
Q Consensus       493 -----~vKL~DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELL-tGk~PF~~~~~  566 (739)
                           .+||+|||++......   ....++..|+|||.+.+      ...++.++|||||||++|||+ +|+.||.....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG------GNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             cCccceeeecCCccccccccc---cccccCCcccCchhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence                 4899999998654322   12357889999998863      245778999999999999995 69999987654


Q ss_pred             hHHHHHHhhcCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          567 PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       567 ~~~~~~i~~~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      .+. .........++.....++.++|.+||+.+|++||++.++|++
T Consensus       228 ~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         228 SEK-ERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHH-HHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            433 233344445566677899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-38  Score=327.43  Aligned_cols=244  Identities=28%  Similarity=0.530  Sum_probs=198.4

Q ss_pred             eEEeecCCeEEEEEEECC---CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeecccee-ecceEEEEE
Q 004660          358 KLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV-VDDHLYIYL  433 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~---tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~-~~~~l~LVm  433 (739)
                      ++||+|+||+||+|.+..   ++..||||.+...    ......+.+.+|+.+++.++||||+++++++. .++..++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc----CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            468999999999998653   3457999986421    22334567888999999999999999999765 456689999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc---
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---  510 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~---  510 (739)
                      ||+.+|+|.+++......+.+..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......   
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            99999999999977555677888899999999999999999999999999999999999999999999976543211   


Q ss_pred             --ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccCCH
Q 004660          511 --ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSS  586 (739)
Q Consensus       511 --~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~  586 (739)
                        .....++..|+|||.+.+       ..++.++|||||||++|||++ |.+||...+..+....+..+ ....+..++.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD  229 (262)
T ss_pred             cccccCcCCccccChhHhcc-------CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCH
Confidence              112345778999998863       356789999999999999999 56777776665555555443 3345666789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      .+.++|.+||..+|++||++.++++.
T Consensus       230 ~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         230 PLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.9e-39  Score=333.41  Aligned_cols=250  Identities=28%  Similarity=0.470  Sum_probs=202.2

Q ss_pred             CCceEeeEEeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec-
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-  426 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~----k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~-  426 (739)
                      .-|++++.||+|+||.||+|.+    +.++..||+|.++..    ........+.+|+.+|+.+.|+||+++++++... 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE----SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   79 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc----ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            4579999999999999999985    457889999987532    1233456789999999999999999999988765 


Q ss_pred             -ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          427 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       427 -~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                       ...++||||++|++|.+++.+....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence             5689999999999999999765556899999999999999999999999999999999999999999999999999876


Q ss_pred             cCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC--------------ch
Q 004660          506 TGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE--------------GP  567 (739)
Q Consensus       506 ~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~--------------~~  567 (739)
                      .....    .....++..|+|||.+.+       ..++.++|||||||++|||++++.|+....              ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQ-------SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV  232 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhcc-------CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH
Confidence            43221    123456778999998863       357779999999999999999876643210              01


Q ss_pred             HHHHHHhh--cCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          568 QAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       568 ~~~~~i~~--~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ......+.  ...+.+..++..+.+||.+||+.||++||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            11111121  2234566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.5e-39  Score=331.41  Aligned_cols=240  Identities=21%  Similarity=0.370  Sum_probs=194.5

Q ss_pred             eEEeecCCeEEEEEEECCC------------CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          358 KLIGRGTFGSVYIGTNRET------------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~t------------g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      +.||+|+||+||+|+....            ...||+|++..     ........+.+|+.+++.++|||||++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP-----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh-----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4699999999999985422            23578887643     223344567889999999999999999999999


Q ss_pred             cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCc-------EEEee
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV-------VKLAD  498 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~-------vKL~D  498 (739)
                      +...++||||+.+|+|..++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.       +||+|
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999999999998765567999999999999999999999999999999999999987664       89999


Q ss_pred             cccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHh-hCCCCCCCCCchHHHHHHhhcC
Q 004660          499 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEFEGPQAMFKVLNRT  577 (739)
Q Consensus       499 FGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELL-tGk~PF~~~~~~~~~~~i~~~~  577 (739)
                      ||++......   ....|+..|+|||.+..      ...++.++|||||||+||||+ .|..||......+. .......
T Consensus       156 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~  225 (262)
T cd05077         156 PGIPITVLSR---QECVERIPWIAPECVED------SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQ  225 (262)
T ss_pred             CCCCccccCc---ccccccccccChhhhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcC
Confidence            9998655322   23457889999998752      345778999999999999998 58888876543332 2333333


Q ss_pred             CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       578 ~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      .......+.++.+||.+||..||.+||++.+||++
T Consensus       226 ~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            33444456889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.7e-39  Score=355.00  Aligned_cols=255  Identities=26%  Similarity=0.445  Sum_probs=209.9

Q ss_pred             CCCCCCCceEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeec
Q 004660          347 ASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYY  420 (739)
Q Consensus       347 ~~~~~~~Y~i~~~LG~G~fGtVy~a~~k-----~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~  420 (739)
                      +....++|.++++||+|+||.||+|+++     .++..||||+++...    .......+.+|+++|..+. |+|||+++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~~H~niv~~~  107 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA----RSSEKQALMSELKIMSHLGPHLNIVNLL  107 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC----ChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            4555678999999999999999999864     345689999986421    1223356889999999997 99999999


Q ss_pred             cceeecceEEEEEeecCCCCcchhhhhcc---------------------------------------------------
Q 004660          421 GSEVVDDHLYIYLEYVHPGSINRYVREHC---------------------------------------------------  449 (739)
Q Consensus       421 ~~~~~~~~l~LVmEy~~gGsL~~~L~~~~---------------------------------------------------  449 (739)
                      +++..++.+||||||+.+|+|.+++....                                                   
T Consensus       108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            99999999999999999999999986431                                                   


Q ss_pred             ----------------------------------------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCC
Q 004660          450 ----------------------------------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG  483 (739)
Q Consensus       450 ----------------------------------------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP  483 (739)
                                                                    ..+++..++.|+.||+.||.|||++||+||||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp  267 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA  267 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence                                                          1356677889999999999999999999999999


Q ss_pred             cceEecCCCcEEEeecccchhccCcc---cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCC
Q 004660          484 ANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP  559 (739)
Q Consensus       484 ~NILLd~~g~vKL~DFGlA~~~~~~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~  559 (739)
                      +|||++.++.+||+|||+++......   ......++..|||||.+.+       ..++.++|||||||++|||++ |..
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGvil~e~l~~g~~  340 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-------NLYTTLSDVWSFGILLWEIFTLGGT  340 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-------CCCCcHhHHHHHHHHHHHHHHcCCC
Confidence            99999999999999999997653221   1123456789999999863       356789999999999999998 899


Q ss_pred             CCCCCCchHHHHHHhhc--CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          560 PWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       560 PF~~~~~~~~~~~i~~~--~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ||......+.....+..  ....|..++.++.+||.+||..+|.+||++.+|++.
T Consensus       341 P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         341 PYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99876665555444432  345667789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.3e-38  Score=326.10  Aligned_cols=249  Identities=27%  Similarity=0.504  Sum_probs=206.6

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      .....+|++.+.||+|+||.||++.+. .+..+|+|.+...      ......+.+|+.+++.++|+||+++++.+.. +
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~   73 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E   73 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C
Confidence            345678999999999999999999865 4567999977521      2234678889999999999999999998877 7


Q ss_pred             eEEEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          428 HLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      ..|++|||+.+++|.+++... ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++..+.
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            789999999999999999763 3457888999999999999999999999999999999999999999999999997664


Q ss_pred             Ccccc--cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCc
Q 004660          507 GLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE  582 (739)
Q Consensus       507 ~~~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~  582 (739)
                      .....  ....++..|+|||.+..       ..++.++|||||||++|+|++ |+.||...+.......+... ..+.+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  226 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE  226 (260)
T ss_pred             CCCcccccCCcccccccCHhHhcc-------CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcc
Confidence            32221  12335677999999863       356779999999999999998 99999887666655555443 234456


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ..+.++.++|.+||..||++||++.++++
T Consensus       227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         227 NCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            78899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-39  Score=374.95  Aligned_cols=250  Identities=27%  Similarity=0.479  Sum_probs=217.9

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeecccee
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  424 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~-----tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~  424 (739)
                      ...+.+..+.||+|.||+||+|+.-.     +...||||.++.    ........+|++|+++|..|+|||||+|+|++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd----~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD----KAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc----cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            34566788999999999999997542     346799998763    233446688999999999999999999999999


Q ss_pred             ecceEEEEEeecCCCCcchhhhhc---------ccc----ccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC
Q 004660          425 VDDHLYIYLEYVHPGSINRYVREH---------CRD----ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS  491 (739)
Q Consensus       425 ~~~~l~LVmEy~~gGsL~~~L~~~---------~~~----lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~  491 (739)
                      .++.+|||+|||..|||.+||+.+         +..    ++..+...|+.||+.||.||-++.+|||||..+|+||.++
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence            999999999999999999999643         122    8889999999999999999999999999999999999999


Q ss_pred             CcEEEeecccchhccCccccccc---CCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCch
Q 004660          492 GVVKLADFGMAKHLTGLSYELSL---KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP  567 (739)
Q Consensus       492 g~vKL~DFGlA~~~~~~~~~~s~---~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~  567 (739)
                      -.|||+||||++.+...++....   .--.+||+||.+.       ..+|+.++||||+||||||+++ |+.||.+....
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-------y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~  712 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-------YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ  712 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh-------cCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence            99999999999987654444322   1246899999998       4689999999999999999998 99999999999


Q ss_pred             HHHHHHhhcC-CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004660          568 QAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL  610 (739)
Q Consensus       568 ~~~~~i~~~~-~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elL  610 (739)
                      +.+..|.++. .+-|+.++.++.+||..||+.+|++||++.||-
T Consensus       713 EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  713 EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            9999998764 567899999999999999999999999999874

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9e-39  Score=326.34  Aligned_cols=238  Identities=24%  Similarity=0.443  Sum_probs=194.2

Q ss_pred             eEEeecCCeEEEEEEECCCC----------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          358 KLIGRGTFGSVYIGTNRETG----------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg----------~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      +.||+|+||.||+|.++.++          ..|++|.+....     .. ...+.+|+.+|+.++|+||+++++++.. +
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hh-HHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            47999999999999998776          347777654211     11 4678889999999999999999998877 7


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC-------cEEEeecc
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-------VVKLADFG  500 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g-------~vKL~DFG  500 (739)
                      ..++||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            78999999999999999987655789999999999999999999999999999999999999888       89999999


Q ss_pred             cchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhcCCC
Q 004660          501 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPP  579 (739)
Q Consensus       501 lA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~~~~  579 (739)
                      ++.....   .....++..|+|||.+.+.     ...++.++|||||||++|||++ |..||......+..... .....
T Consensus       154 ~a~~~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~~~~~  224 (259)
T cd05037         154 IPITVLS---REERVERIPWIAPECIRNG-----QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-QDQHR  224 (259)
T ss_pred             ccccccc---ccccccCCCccChhhhcCC-----CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-hcCCC
Confidence            9987644   2234577889999998741     1357789999999999999999 68888776543332222 22223


Q ss_pred             CCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       580 iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .+......+.++|.+||..+|.+|||+.++++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         225 LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            33334489999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-38  Score=330.23  Aligned_cols=251  Identities=24%  Similarity=0.440  Sum_probs=208.9

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~t-----g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      .+.|++.+.||+|+||+||+|+.+.+     .+.|++|.+...    ........+.+|+++|++++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   79 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT----KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE   79 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc----cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence            46799999999999999999997643     467889876531    223355678899999999999999999999999


Q ss_pred             cceEEEEEeecCCCCcchhhhhcc--------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEe
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHC--------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA  497 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~--------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~  497 (739)
                      .+..|+||||+.+|+|.+++....        ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence            899999999999999999997643        158999999999999999999999999999999999999999999999


Q ss_pred             ecccchhccCcc--cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHh
Q 004660          498 DFGMAKHLTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL  574 (739)
Q Consensus       498 DFGlA~~~~~~~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~  574 (739)
                      |||++.......  ......++..|+|||.+.+       ..++.++||||||+++|+|++ |..||........+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~  232 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-------DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ  232 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence            999987543221  1123346778999998863       345678999999999999998 889998776666666655


Q ss_pred             hcCC--CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          575 NRTP--PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       575 ~~~~--~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ....  ..+..++..+.++|.+||..||++||++.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         233 AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            4433  3356688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.1e-38  Score=376.89  Aligned_cols=252  Identities=22%  Similarity=0.353  Sum_probs=204.9

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|+++++||+|+||+||+|++..+|+.||||++....  .......+++.+|+++++.++|||||++++++.+++..|+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l--~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL--SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY   79 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc--ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence            57999999999999999999999999999999986322  1223445678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhc----------cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004660          432 YLEYVHPGSINRYVREH----------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM  501 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~----------~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGl  501 (739)
                      ||||++||+|.+++...          ...++...+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999999988542          12355677889999999999999999999999999999999999999999999


Q ss_pred             chhccCcc-------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCC
Q 004660          502 AKHLTGLS-------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS  562 (739)
Q Consensus       502 A~~~~~~~-------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~  562 (739)
                      ++......                   .....+||+.|||||++.+       ..++.++|||||||++|||++|+.||.
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-------~~~S~kSDIWSLGVILyELLTG~~PF~  232 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-------VPASESTDIYALGVILYQMLTLSFPYR  232 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-------CCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            97652110                   0112469999999999863       456789999999999999999999998


Q ss_pred             CCCchHHHHHHh-hcCCCC--CccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          563 EFEGPQAMFKVL-NRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       563 ~~~~~~~~~~i~-~~~~~i--P~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ............ ......  ...++..+.+++.+||..||++|++..+.|..
T Consensus       233 ~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        233 RKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             CcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            755443332211 111111  23578899999999999999999887665544

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2e-38  Score=340.74  Aligned_cols=256  Identities=28%  Similarity=0.495  Sum_probs=208.1

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee-cce
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDH  428 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~-~~~  428 (739)
                      ..++|++.+.||.|+||.||+|.++.+|+.||||++.....   .....+.+.+|+++++.++||||+++++++.. .+.
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS---TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            45689999999999999999999999999999998753211   12234567789999999999999999998865 567


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~  508 (739)
                      .|+||||+ +++|..++..  ..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++......
T Consensus        85 ~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            89999998 5788888764  35888999999999999999999999999999999999999999999999998755322


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh-------------
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-------------  575 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-------------  575 (739)
                        .....++..|+|||.+.+      ...++.++|||||||++|+|++|+.||...........+.+             
T Consensus       162 --~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         162 --MTGYVSTRYYRAPEIMLT------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             --cCCCcccccccCceeeec------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence              234567899999998753      24577899999999999999999999976554222111110             


Q ss_pred             -------------cCCCCC-----ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          576 -------------RTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       576 -------------~~~~iP-----~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                   .....+     ..++.++.++|.+||+.+|++||++.++|.|+||....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence                         000111     24678999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-40  Score=335.02  Aligned_cols=260  Identities=30%  Similarity=0.517  Sum_probs=222.7

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecceEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~l~  430 (739)
                      ++.+.+..||.|+.|+||+++.+.+|...|||.+...    ...+..+++...+.++.... .|+||+.+|+|..+..++
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt----~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~  167 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT----GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF  167 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc----CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence            4567778899999999999999999999999998753    33555678888888877665 899999999999999999


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHH-hCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLH-s~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      |.||.|. .-+..+++...+.++|..+-.+...++.||.||. ++||+|||+||.|||||+.|++||||||++..+.+..
T Consensus       168 IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  168 ICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            9999984 4455556555677999999999999999999998 5689999999999999999999999999998887766


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCC-CchHHHHHHhhcCCC-CC--ccCC
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVLNRTPP-IP--EMLS  585 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~-~~~~~~~~i~~~~~~-iP--~~ls  585 (739)
                      ......|-+.|||||.+.-    .....|+..+||||||++|+||.||+.||.+. .+.+.+.++++..++ ++  ..++
T Consensus       247 AhtrsAGC~~YMaPERidp----~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS  322 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDP----PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS  322 (391)
T ss_pred             ccccccCCccccCccccCC----CCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence            6666789999999998852    23578999999999999999999999999875 456777888875543 22  2489


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      +.+.+|+..||.+|+.+||...++|+|||+.....
T Consensus       323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             HHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence            99999999999999999999999999999986554

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-38  Score=327.49  Aligned_cols=243  Identities=28%  Similarity=0.500  Sum_probs=201.1

Q ss_pred             eEEeecCCeEEEEEEECCCC------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEE
Q 004660          358 KLIGRGTFGSVYIGTNRETG------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg------~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      +.||+|+||.||+|+.+...      ..||||.+...    ........+.+|+.+|+.++||||+++++++...+..|+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcc----cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            46999999999999986543      67999987531    112334568889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhhc------cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC-----cEEEeecc
Q 004660          432 YLEYVHPGSINRYVREH------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-----VVKLADFG  500 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~------~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g-----~vKL~DFG  500 (739)
                      ||||+.+++|.+++...      ...+++.++..++.||+.||.|||+++|+|+||||+|||++.++     .+||+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999999999652      23478899999999999999999999999999999999999887     89999999


Q ss_pred             cchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh-
Q 004660          501 MAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-  575 (739)
Q Consensus       501 lA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-  575 (739)
                      ++........   .....++..|+|||.+.+       ..++.++|||||||++|||++ |+.||......+....+.. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  229 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLD-------GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG  229 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHcc-------CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC
Confidence            9976543221   112345788999999863       356789999999999999998 9999987766665555443 


Q ss_pred             cCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          576 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       576 ~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .....+..++..+.+||.+||..+|.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            334566778999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.5e-38  Score=325.35  Aligned_cols=253  Identities=25%  Similarity=0.477  Sum_probs=210.9

Q ss_pred             CceEeeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCC-----cccHHHHHHHHHHHHHHhh-cCCCCeEeeccceee
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDD-----PKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVV  425 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~-tg~~VAIK~i~~~~~~-----~~~~~~~k~l~~Ei~iL~~-L~HPNIVkl~~~~~~  425 (739)
                      .|++.+.||+|+||.||+|.++. +++.+|+|.+......     ......+..+.+|+.++.. ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999999987 6889999988643211     1233455667789988865 789999999999999


Q ss_pred             cceEEEEEeecCCCCcchhhhh---ccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeeccc
Q 004660          426 DDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGM  501 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~---~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~vKL~DFGl  501 (739)
                      ++..|+||||+.|++|.+++..   ....+++..++.++.||+.||.|||+ .||+|+||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999988743   34568999999999999999999995 7899999999999999999999999999


Q ss_pred             chhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-CC
Q 004660          502 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PI  580 (739)
Q Consensus       502 A~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-~i  580 (739)
                      +.............|+..|++||.+.+       ..++.++||||||+++|||++|+.||...........+..... +.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  233 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKN-------EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL  233 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcC-------CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence            987655444445678999999999863       3467899999999999999999999987766655555554432 22


Q ss_pred             C-ccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          581 P-EMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       581 P-~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      + ..++.++.++|.+||..||++||++.|+..+
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            2 2578999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-39  Score=378.30  Aligned_cols=252  Identities=27%  Similarity=0.511  Sum_probs=220.1

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCC-Cc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccce
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRET-GA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  423 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~t-g~----~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~  423 (739)
                      ......++++.||+|.||.||.|..... |.    .||||.++..    ...+.+..|.+|..+|..++|||||+++|++
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~  764 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----SSEQEVSDFLKEALLMSKFDHPNIVSLIGVC  764 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence            4456788999999999999999988753 32    4899987643    2344567899999999999999999999999


Q ss_pred             eecceEEEEEeecCCCCcchhhhhc------cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEe
Q 004660          424 VVDDHLYIYLEYVHPGSINRYVREH------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA  497 (739)
Q Consensus       424 ~~~~~l~LVmEy~~gGsL~~~L~~~------~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~  497 (739)
                      .+.+..+|++|||+||+|..||++.      ...++..++..++.||++|++||+++++|||||..+|+||+....|||+
T Consensus       765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence            9999999999999999999999886      5679999999999999999999999999999999999999999999999


Q ss_pred             ecccchhccCccccc-ccCC--CCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHH
Q 004660          498 DFGMAKHLTGLSYEL-SLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV  573 (739)
Q Consensus       498 DFGlA~~~~~~~~~~-s~~G--T~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i  573 (739)
                      |||||+.+....+.. ...+  -..|||||.++.       ..++.++|||||||+|||+++ |..||.+.+..+++..+
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-------~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~  917 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-------GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV  917 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhh-------cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH
Confidence            999999664433322 2222  358999999983       578899999999999999999 99999999998888755


Q ss_pred             h-hcCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          574 L-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       574 ~-~~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      + +++.+.|.+++..+.++|.+||+.+|++||++..|++
T Consensus       918 ~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  918 LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            4 5678899999999999999999999999999999997

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.5e-38  Score=334.72  Aligned_cols=251  Identities=26%  Similarity=0.467  Sum_probs=204.6

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcE----EEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~----VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      ...+|++.+.||+|+||.||+|.+..+|..    ||+|.+...    ........+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET----TGPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            456799999999999999999999887764    677766421    223334467889999999999999999998765


Q ss_pred             cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                      . ..++++||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence            4 578999999999999999876667899999999999999999999999999999999999999999999999999876


Q ss_pred             cCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh-cCCCC
Q 004660          506 TGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPI  580 (739)
Q Consensus       506 ~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~i  580 (739)
                      ......   ....++..|+|||.+.+       ..++.++|||||||++|||++ |..||.+....+....+.. ...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHY-------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ  232 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhcc-------CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC
Confidence            433221   12335778999998863       457789999999999999997 9999987654433332222 22344


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      +..++..+.++|.+||..+|++||++.++++.
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         233 PPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            55678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-39  Score=359.35  Aligned_cols=263  Identities=30%  Similarity=0.475  Sum_probs=223.1

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      .++-|.+++.||-|+||.|.+++...|...||+|.+++  .+-.....+..++.|-.||...+.+-||+||..|++++.+
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrK--aDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRK--ADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHH--HHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            34568999999999999999999999999999998864  3333445567788999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc---
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT---  506 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~---  506 (739)
                      |+||+|++||++..+|.+. +-|.|..++.|+..|.+|+++.|+.|+|||||||+|||||.+|++||+||||+.-+.   
T Consensus       705 YFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             EEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence            9999999999999999886 569999999999999999999999999999999999999999999999999985431   


Q ss_pred             ------C------c----------------------------ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhH
Q 004660          507 ------G------L----------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS  546 (739)
Q Consensus       507 ------~------~----------------------------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWS  546 (739)
                            .      +                            ......+||+.|+|||+|.       ...|+..+|+||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-------r~g~~q~cdwws  856 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-------RTGYTQLCDWWS  856 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-------ccCccccchhhH
Confidence                  0      0                            0112367999999999997       356788999999


Q ss_pred             HHHHHHHHhhCCCCCCCCCchHHHHHHhh--cCCCCC--ccCCHHHHHHHHHhcccCCCCCCC---HHHHHcCccccccc
Q 004660          547 LGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIP--EMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNAN  619 (739)
Q Consensus       547 LGvVLyELLtGk~PF~~~~~~~~~~~i~~--~~~~iP--~~ls~el~dLI~kcL~~DP~kRpT---a~elLqHpwf~~~~  619 (739)
                      .|||||||+.|++||-+....+...++++  ....|+  ..++.++.+||.++ ..++++|..   ++|+-.||||+..+
T Consensus       857 ~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  857 VGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             hhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccc
Confidence            99999999999999988877776666654  233333  46899999999995 568889874   77899999999887


Q ss_pred             cCCC
Q 004660          620 YQNL  623 (739)
Q Consensus       620 ~~~~  623 (739)
                      +..+
T Consensus       936 fssl  939 (1034)
T KOG0608|consen  936 FSSL  939 (1034)
T ss_pred             hHhh
Confidence            6543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-39  Score=358.68  Aligned_cols=257  Identities=28%  Similarity=0.537  Sum_probs=220.7

Q ss_pred             CCCCCCCCceEeeEEeecCCeEEEEEEECCCCc---E-EEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeecc
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---S-CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG  421 (739)
Q Consensus       346 ~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~---~-VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~  421 (739)
                      .+...-++..+.++||+|.||.||+|..+..+.   . ||||..+.  ......+.++.+.+|+++|++++|||||++||
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~--~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG--SSELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc--cccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            455555666778999999999999999876432   3 89997763  22245677889999999999999999999999


Q ss_pred             ceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004660          422 SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM  501 (739)
Q Consensus       422 ~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGl  501 (739)
                      +...+..+|||||+|.||+|.++|++....++..+...++.+.++||+|||+++++||||..+|+|++.++.+||+||||
T Consensus       229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            99999999999999999999999999866799999999999999999999999999999999999999999999999999


Q ss_pred             chhccCccccccc-CCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh--cC
Q 004660          502 AKHLTGLSYELSL-KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RT  577 (739)
Q Consensus       502 A~~~~~~~~~~s~-~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~--~~  577 (739)
                      ++........... .--..|+|||.+..       ..|+.++|||||||++||+++ |..||.+....+...+|..  ..
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~-------~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r  381 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNT-------GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR  381 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhcc-------CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc
Confidence            8766422222111 24578999999984       478899999999999999999 8999999999888888843  34


Q ss_pred             CCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       578 ~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .++|...+.++..++.+||..||++|+++.++.+
T Consensus       382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            5677788899999999999999999999998875

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=329.61  Aligned_cols=256  Identities=26%  Similarity=0.388  Sum_probs=213.2

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      -...++|++.+.||+|||+-||+++...++..||+|+|...     ..+.++...+|++..++++||||++++++...+.
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~-----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH-----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc-----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            45678999999999999999999999999999999998752     2445677889999999999999999999765443


Q ss_pred             -----eEEEEEeecCCCCcchhhhhc---cccccHHHHHHHHHhHHHHHHHHHhCC--eecccCCCcceEecCCCcEEEe
Q 004660          428 -----HLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKLA  497 (739)
Q Consensus       428 -----~l~LVmEy~~gGsL~~~L~~~---~~~lse~~i~~i~~QLl~aL~yLHs~G--IvHRDIKP~NILLd~~g~vKL~  497 (739)
                           ..||++.|...|+|.+.|...   +..++|.++..|+.+|++||++||+..  ++||||||.|||+.+.+.++|+
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence                 499999999999999998642   447999999999999999999999998  9999999999999999999999


Q ss_pred             ecccchhccC----c------ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCC--C
Q 004660          498 DFGMAKHLTG----L------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF--E  565 (739)
Q Consensus       498 DFGlA~~~~~----~------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~--~  565 (739)
                      |||.++...-    .      ........|..|+|||.+.-    ..+...+.++|||||||+||+|+.|..||+..  .
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v----k~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV----KSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheec----ccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            9999875421    1      11123457999999999863    23457889999999999999999999999643  2


Q ss_pred             chHHHHHHhhcCCCCCc--cCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          566 GPQAMFKVLNRTPPIPE--MLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       566 ~~~~~~~i~~~~~~iP~--~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      +.....++.+....+|.  -+++.+.+||+.||+.||.+||++.++|.+
T Consensus       248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            22233344555555554  389999999999999999999999999864

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.6e-38  Score=326.13  Aligned_cols=249  Identities=22%  Similarity=0.351  Sum_probs=194.7

Q ss_pred             eEEeecCCeEEEEEEECCCC--cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEee
Q 004660          358 KLIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY  435 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg--~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy  435 (739)
                      +.||+|+||+||+|....++  ..+++|.+...    ......+.+.+|+.+++.++|||||++++.+......|+||||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY   76 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC----CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence            36999999999999754332  34556655421    1223356788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhhc---cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc---
Q 004660          436 VHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---  509 (739)
Q Consensus       436 ~~gGsL~~~L~~~---~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~---  509 (739)
                      +.+|+|.+++.+.   ...+.+..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......   
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            9999999999753   2346777888999999999999999999999999999999999999999999986432211   


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhcC------CCCCc
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT------PPIPE  582 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~~------~~iP~  582 (739)
                      ......|+..|+|||++...........++.++|||||||++|||++ |..||......+.+.+++...      +.++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence            12235688999999998532111112345679999999999999997 678998777666666554332      23444


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .+++.+.++|..|| .+|++||++.|+++
T Consensus       237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         237 PYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            57889999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.3e-38  Score=322.48  Aligned_cols=242  Identities=28%  Similarity=0.476  Sum_probs=201.3

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .++|++.+.||+|+||.||++.  .+++.||+|.++..       .....+.+|+.+++.++|+||+++++++..+ ..|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   74 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY   74 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence            3579999999999999999986  46889999987531       1124678899999999999999999988654 479


Q ss_pred             EEEeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          431 IYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      +||||+.+++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            9999999999999997643 358899999999999999999999999999999999999999999999999987543221


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CCCCCccCCHH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE  587 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~e  587 (739)
                        .....+..|+|||.+.+       ..++.++|||||||++|||++ |+.||......+....+... ....+..++.+
T Consensus       155 --~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (254)
T cd05083         155 --DNSKLPVKWTAPEALKH-------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPAD  225 (254)
T ss_pred             --CCCCCCceecCHHHhcc-------CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHH
Confidence              12334678999998863       356779999999999999997 99999887665555544433 23445668899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHc
Q 004660          588 GKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       588 l~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      +.++|.+||..+|++||++.++++
T Consensus       226 ~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         226 VYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-39  Score=357.99  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=216.1

Q ss_pred             cCCcccCCCCCCCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCC
Q 004660          337 VMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHEN  415 (739)
Q Consensus       337 ~~p~~~~~p~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPN  415 (739)
                      +.+.++..........+|.+...||.|+|+.|..+.+..+++.+++|++.....         +..+|+.++... +|||
T Consensus       307 va~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---------~~~~e~~~~~~~~~h~n  377 (612)
T KOG0603|consen  307 VAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---------DNQDEIPISLLVRDHPN  377 (612)
T ss_pred             cChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheecccccc---------ccccccchhhhhcCCCc
Confidence            334444444455567889999999999999999999999999999999875322         233477665555 6999


Q ss_pred             eEeeccceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEe-cCCCcE
Q 004660          416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV-DASGVV  494 (739)
Q Consensus       416 IVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILL-d~~g~v  494 (739)
                      |+++++++.+..++|+|||++.|+.|.+.|....  ....++..|+.||+.||.|||++|||||||||+|||+ +..|++
T Consensus       378 iv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~l  455 (612)
T KOG0603|consen  378 IVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHL  455 (612)
T ss_pred             ceeecceecCCceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcE
Confidence            9999999999999999999999999999887642  3337888999999999999999999999999999999 588999


Q ss_pred             EEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch-HHHHHH
Q 004660          495 KLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKV  573 (739)
Q Consensus       495 KL~DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~-~~~~~i  573 (739)
                      +|+|||.++.....  ..+.+-|..|.|||++.       ...|+.++||||||++||+||+|+.||...... ++...+
T Consensus       456 rltyFG~a~~~~~~--~~tp~~t~~y~APEvl~-------~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i  526 (612)
T KOG0603|consen  456 RLTYFGFWSELERS--CDTPALTLQYVAPEVLA-------IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI  526 (612)
T ss_pred             EEEEechhhhCchh--hcccchhhcccChhhhc-------cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence            99999999988665  34456789999999997       357899999999999999999999999866554 333333


Q ss_pred             hhcCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          574 LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       574 ~~~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      .  .+++...+|.++++||++||+.||.+|+++.+++.|+||
T Consensus       527 ~--~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  527 Q--MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             c--CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            2  234448899999999999999999999999999999999

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-39  Score=334.61  Aligned_cols=266  Identities=26%  Similarity=0.445  Sum_probs=231.7

Q ss_pred             CCCCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeecccee
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEV  424 (739)
Q Consensus       346 ~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~  424 (739)
                      .+.....+|.++.+||+|+|++|.+++.+.|.+.||||++++.-  ....+.+..++.|-.+..+. +||.+|-++.+|+
T Consensus       244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel--~nddedidwvqtek~vfe~asn~pflvglhscfq  321 (593)
T KOG0695|consen  244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ  321 (593)
T ss_pred             ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHh--cCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence            45566788999999999999999999999999999999987422  12234456677787777766 5999999999999


Q ss_pred             ecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          425 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       425 ~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      .+..+++|.||+.||+|...++.+ +.++|+.++.|...|+.||.|||++||+.||||.+|+|||.+|++||+|+|+++.
T Consensus       322 tesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  322 TESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             ccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence            999999999999999999998776 6799999999999999999999999999999999999999999999999999987


Q ss_pred             cc-CcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCC-------C-CchHHHHHHhh
Q 004660          505 LT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-------F-EGPQAMFKVLN  575 (739)
Q Consensus       505 ~~-~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~-------~-~~~~~~~~i~~  575 (739)
                      .. ....+.+++||+.|+|||++.+       ..|++.+|+|+||++|+||+.|+.||+-       . .+...++-|+.
T Consensus       401 ~l~~gd~tstfcgtpnyiapeilrg-------eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile  473 (593)
T KOG0695|consen  401 GLGPGDTTSTFCGTPNYIAPEILRG-------EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE  473 (593)
T ss_pred             CCCCCcccccccCCCcccchhhhcc-------cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh
Confidence            54 4556668999999999999984       6789999999999999999999999952       1 22334555678


Q ss_pred             cCCCCCccCCHHHHHHHHHhcccCCCCCC------CHHHHHcCccccccccC
Q 004660          576 RTPPIPEMLSSEGKDFLLRCFLRNPVERP------SAVELLEHPFIRNANYQ  621 (739)
Q Consensus       576 ~~~~iP~~ls~el~dLI~kcL~~DP~kRp------Ta~elLqHpwf~~~~~~  621 (739)
                      +...+|..++-.+..+|+..|.+||++|.      .+.++-.|+||+..++.
T Consensus       474 kqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd  525 (593)
T KOG0695|consen  474 KQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD  525 (593)
T ss_pred             hcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence            88999999999999999999999999995      47899999999977664

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.3e-38  Score=324.40  Aligned_cols=250  Identities=31%  Similarity=0.508  Sum_probs=203.7

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECC----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee-
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRE----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-  425 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~----tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~-  425 (739)
                      ..+|++.+.||+|+||.||+|....    ++..||||++.....    ....+.+.+|+++++.+.|+||+++++++.. 
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~   78 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE----EQHRSDFEREIEILRTLDHENIVKYKGVCEKP   78 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc----hHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence            3568889999999999999998653    478999998864221    1345778999999999999999999998877 


Q ss_pred             -cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          426 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 -~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                       ....++||||+.+++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence             5579999999999999999987655699999999999999999999999999999999999999999999999999987


Q ss_pred             ccCcccc----cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch-------------
Q 004660          505 LTGLSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-------------  567 (739)
Q Consensus       505 ~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~-------------  567 (739)
                      .......    ....++..|++||.+.+       ..++.++|||||||++|||++|..||......             
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRT-------SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI  231 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHcc-------CCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccccc
Confidence            6532211    11234567999998863       35677899999999999999999998653221             


Q ss_pred             -HHHHHHhhc--CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          568 -QAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       568 -~~~~~i~~~--~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                       ..+...+..  ....+..++.++.+||.+||..||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             112222222  22334567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.8e-38  Score=322.88  Aligned_cols=229  Identities=24%  Similarity=0.327  Sum_probs=190.8

Q ss_pred             cCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecCCCCcc
Q 004660          363 GTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSIN  442 (739)
Q Consensus       363 G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~gGsL~  442 (739)
                      |.||+||+|+++.+++.||+|.+....          ...+|...+....||||+++++++..++..|+||||+.||+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence            899999999999999999999886421          1233445555567999999999999999999999999999999


Q ss_pred             hhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCCCCCCC
Q 004660          443 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMA  522 (739)
Q Consensus       443 ~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s~~GT~~Y~A  522 (739)
                      +++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....  ....++..|+|
T Consensus        74 ~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~a  150 (237)
T cd05576          74 SHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCA  150 (237)
T ss_pred             HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccC
Confidence            999765 459999999999999999999999999999999999999999999999999886654322  23456788999


Q ss_pred             hHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHhcccCCCC
Q 004660          523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVE  602 (739)
Q Consensus       523 PEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kcL~~DP~k  602 (739)
                      ||.+.       ...++.++||||+||++|||++|+.||......  ..  ......+|..++..+++||.+||+.||++
T Consensus       151 PE~~~-------~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~  219 (237)
T cd05576         151 PEVGG-------ISEETEACDWWSLGAILFELLTGKTLVECHPSG--IN--THTTLNIPEWVSEEARSLLQQLLQFNPTE  219 (237)
T ss_pred             CcccC-------CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--cc--cccccCCcccCCHHHHHHHHHHccCCHHH
Confidence            99764       234677899999999999999999887643211  00  11123467778999999999999999999


Q ss_pred             CCCH-----HHHHcCccc
Q 004660          603 RPSA-----VELLEHPFI  615 (739)
Q Consensus       603 RpTa-----~elLqHpwf  615 (739)
                      |+++     +++++||||
T Consensus       220 R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         220 RLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             hcCCCccchHHHHcCCCC
Confidence            9985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.1e-37  Score=327.01  Aligned_cols=254  Identities=20%  Similarity=0.282  Sum_probs=190.1

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHH-H-----HHHHHHHHHHHhhcCCCCeEe
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAE-C-----IKQLEQEIKVLGHLKHENIVQ  418 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~t---g~~VAIK~i~~~~~~~~~~~-~-----~k~l~~Ei~iL~~L~HPNIVk  418 (739)
                      .....+|++.++||+|+||+||+|.+..+   +..+|+|+............ .     ......++..+..+.|+||++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            45567899999999999999999999887   66777776543221111110 0     011223444566778999999


Q ss_pred             eccceeecc----eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcE
Q 004660          419 YYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV  494 (739)
Q Consensus       419 l~~~~~~~~----~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~v  494 (739)
                      +++.+....    ..+++||++. ..+.+++... ...++..++.|+.||+.||.|||++||+||||||+|||++.++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            998765543    3577888874 4565555443 346788899999999999999999999999999999999999999


Q ss_pred             EEeecccchhccCcc--------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc
Q 004660          495 KLADFGMAKHLTGLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG  566 (739)
Q Consensus       495 KL~DFGlA~~~~~~~--------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~  566 (739)
                      ||+|||+|+.+....        ......||+.|+|||++.+       ..++.++|||||||+||||++|+.||.....
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-------~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-------ACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999998663211        1123469999999998863       4578899999999999999999999987633


Q ss_pred             h-HHH--------HHHhhcCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          567 P-QAM--------FKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       567 ~-~~~--------~~i~~~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      . ..+        ..+......+ ...+.++.++++.||..+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        239 NGNLIHAAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             chHHHHHhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            2 211        2222222222 346789999999999999999999999985

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.8e-37  Score=320.14  Aligned_cols=249  Identities=22%  Similarity=0.410  Sum_probs=201.8

Q ss_pred             ceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc---
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---  427 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~---tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~---  427 (739)
                      |.+.+.||+|+||.||+|.++.   ++..||||++...   .......+.+.+|+++|+.++||||+++++++...+   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD---IFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc---cCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            6788999999999999998654   5788999988632   222334567889999999999999999999876532   


Q ss_pred             ---eEEEEEeecCCCCcchhhhhc-----cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004660          428 ---HLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF  499 (739)
Q Consensus       428 ---~l~LVmEy~~gGsL~~~L~~~-----~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DF  499 (739)
                         ..++++||+.+|+|.+++...     ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               247899999999998887431     124788999999999999999999999999999999999999999999999


Q ss_pred             ccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh
Q 004660          500 GMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN  575 (739)
Q Consensus       500 GlA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~  575 (739)
                      |+++.......   .....++..|++||.+..       ..++.++|||||||++|||++ |+.||...+..+....+..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLAD-------NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhc-------CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Confidence            99986543221   112335678999998863       456779999999999999999 8999987766555555543


Q ss_pred             c-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          576 R-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       576 ~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      . ....+...+..+.+++.+||..+|++||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         231 GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3 334455678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=341.38  Aligned_cols=247  Identities=27%  Similarity=0.461  Sum_probs=197.3

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc-eEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-HLY  430 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~-~l~  430 (739)
                      +.|....+||+|+||+||+|.... |..||||++......   .  .++|.+|+.+|.+++|+|+|+|+|+|.+.+ +.+
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~---~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~  148 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQ---G--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL  148 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCc---c--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence            567778899999999999999765 489999976532211   1  345999999999999999999999999988 599


Q ss_pred             EEEeecCCCCcchhhhhccc-cccHHHHHHHHHhHHHHHHHHHhCC---eecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          431 IYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTN---TIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~-~lse~~i~~i~~QLl~aL~yLHs~G---IvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      ||+||+.+|+|.++|..... .++|.....|+.++++||+|||+..   |||||||+.|||||++.+.||+|||+|+...
T Consensus       149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~  228 (361)
T KOG1187|consen  149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP  228 (361)
T ss_pred             EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence            99999999999999987655 8999999999999999999999753   9999999999999999999999999997665


Q ss_pred             C-ccccccc-CCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC---c---hHHHHHHhhc--
Q 004660          507 G-LSYELSL-KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---G---PQAMFKVLNR--  576 (739)
Q Consensus       507 ~-~~~~~s~-~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~---~---~~~~~~i~~~--  576 (739)
                      . .....+. .||.+|+|||.+..       ...+.++||||||++|.||++|+.+.+...   .   .+.....+..  
T Consensus       229 ~~~~~~~~~~~gt~gY~~PEy~~~-------g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~  301 (361)
T KOG1187|consen  229 EGDTSVSTTVMGTFGYLAPEYAST-------GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK  301 (361)
T ss_pred             ccccceeeecCCCCccCChhhhcc-------CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence            4 3333333 89999999999863       467889999999999999999998876432   1   1111111111  


Q ss_pred             -----CCCCC-ccCC-----HHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          577 -----TPPIP-EMLS-----SEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       577 -----~~~iP-~~ls-----~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                           .+.+. ....     ..+..+..+|++.+|++||++.|+++
T Consensus       302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                 11111 1222     23457788999999999999999754

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.7e-38  Score=371.30  Aligned_cols=257  Identities=30%  Similarity=0.498  Sum_probs=203.7

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee---
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---  425 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~---  425 (739)
                      ....+|+.+++||+||||.||+++++-||..||||+|....    .......+.+|+++|.+|+|||||++|.+|.+   
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            34567899999999999999999999999999999987532    34445778999999999999999998843210   


Q ss_pred             --------------------------------------------------------------------------------
Q 004660          426 --------------------------------------------------------------------------------  425 (739)
Q Consensus       426 --------------------------------------------------------------------------------  425 (739)
                                                                                                      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------c--------ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHH
Q 004660          426 ----------------------------D--------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA  469 (739)
Q Consensus       426 ----------------------------~--------~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~  469 (739)
                                                  +        -.+||-||||+..+|.++|..+.-.-....+|++++||++||.
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence                                        0        1368889999988888888765221257889999999999999


Q ss_pred             HHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-------------------CcccccccCCCCCCCChHHHHHhh
Q 004660          470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-------------------GLSYELSLKGSPNWMAPEVIKAVM  530 (739)
Q Consensus       470 yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~-------------------~~~~~~s~~GT~~Y~APEvl~~~~  530 (739)
                      |+|++|||||||||.||||++++.|||+|||+|+...                   .....++.+||..|+|||++.+..
T Consensus       712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            9999999999999999999999999999999998621                   011334578999999999997521


Q ss_pred             hcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCC-CCchHHHHHHhhcCCCCCcc----CCHHHHHHHHHhcccCCCCCCC
Q 004660          531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGPQAMFKVLNRTPPIPEM----LSSEGKDFLLRCFLRNPVERPS  605 (739)
Q Consensus       531 ~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~-~~~~~~~~~i~~~~~~iP~~----ls~el~dLI~kcL~~DP~kRpT  605 (739)
                          ...|+.|+|||||||||+||+.   ||.. ++...++..+..+..+.+..    --+.-+.+|++||+.||.+|||
T Consensus       792 ----~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt  864 (1351)
T KOG1035|consen  792 ----SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT  864 (1351)
T ss_pred             ----cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC
Confidence                1368899999999999999986   4643 33333444444443343321    1245578999999999999999


Q ss_pred             HHHHHcCcccc
Q 004660          606 AVELLEHPFIR  616 (739)
Q Consensus       606 a~elLqHpwf~  616 (739)
                      |.|+|++.|+.
T Consensus       865 A~eLL~s~llp  875 (1351)
T KOG1035|consen  865 ATELLNSELLP  875 (1351)
T ss_pred             HHHHhhccCCC
Confidence            99999999997

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-39  Score=329.56  Aligned_cols=259  Identities=27%  Similarity=0.464  Sum_probs=213.6

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee----
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----  425 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~----  425 (739)
                      ..+.|....+||+|.||.||+|+.+.+|+.||+|++-........   -....+|+++|+.|+|+||+.+++.+..    
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGf---pitalreikiL~~lkHenv~nliEic~tk~Tp   91 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGF---PITALREIKILQLLKHENVVNLIEICRTKATP   91 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCC---cHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence            456799999999999999999999999999999976432222222   2345679999999999999999987753    


Q ss_pred             ----cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004660          426 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM  501 (739)
Q Consensus       426 ----~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGl  501 (739)
                          ...+||||.+|+ -+|..++......++..+++.++++++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+
T Consensus        92 ~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   92 TNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             cccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence                235999999997 788888877767899999999999999999999999999999999999999999999999999


Q ss_pred             chhccCcc-----cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh-
Q 004660          502 AKHLTGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-  575 (739)
Q Consensus       502 A~~~~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-  575 (739)
                      ++.+....     .....+.|.+|++||.+.|      +..|+.+.|||..||||.||++|.+.|.+..+.+.+..|-. 
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG------~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L  244 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG------DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL  244 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhc------ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence            98764321     1223456999999999995      67889999999999999999999999988777666554421 


Q ss_pred             -c--C------------------CCCCc-------------cCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          576 -R--T------------------PPIPE-------------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       576 -~--~------------------~~iP~-------------~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                       +  .                  .++|+             .-++++.|||.+||..||.+|+++.++|.|.||...
T Consensus       245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence             1  0                  01111             124688899999999999999999999999999754

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.8e-36  Score=300.71  Aligned_cols=240  Identities=38%  Similarity=0.650  Sum_probs=204.0

Q ss_pred             CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecCCCCcch
Q 004660          364 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINR  443 (739)
Q Consensus       364 ~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~gGsL~~  443 (739)
                      +||.||+|.+..+|+.||+|++.......    ..+.+.+|+++++.++|+||+++++.+......+++|||+.+++|..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK----KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccccc----HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            68999999999999999999986432211    14678899999999999999999999999999999999999999999


Q ss_pred             hhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCCCCCCCh
Q 004660          444 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP  523 (739)
Q Consensus       444 ~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s~~GT~~Y~AP  523 (739)
                      ++.... .+++..++.++.+|+.+|.|||+.||+|+||+|.||+++.++.++|+|||++.............++..|++|
T Consensus        77 ~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p  155 (244)
T smart00220       77 LLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAP  155 (244)
T ss_pred             HHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCH
Confidence            997643 3899999999999999999999999999999999999999999999999999877655444456789999999


Q ss_pred             HHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchH-HHHHHhhcCCCCCcc---CCHHHHHHHHHhcccC
Q 004660          524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKVLNRTPPIPEM---LSSEGKDFLLRCFLRN  599 (739)
Q Consensus       524 Evl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~-~~~~i~~~~~~iP~~---ls~el~dLI~kcL~~D  599 (739)
                      |.+.+       ..++.++|||+||+++|+|++|..||....... ....+..........   ++.++.+++.+||..|
T Consensus       156 E~~~~-------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  228 (244)
T smart00220      156 EVLLG-------KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKD  228 (244)
T ss_pred             HHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCC
Confidence            98862       456779999999999999999999998744433 333333333333222   8899999999999999


Q ss_pred             CCCCCCHHHHHcCccc
Q 004660          600 PVERPSAVELLEHPFI  615 (739)
Q Consensus       600 P~kRpTa~elLqHpwf  615 (739)
                      |++||++.++++|+||
T Consensus       229 p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      229 PEKRLTAEEALQHPFF  244 (244)
T ss_pred             chhccCHHHHhhCCCC
Confidence            9999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=351.98  Aligned_cols=243  Identities=31%  Similarity=0.546  Sum_probs=202.0

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc----
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD----  427 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~----  427 (739)
                      .-|...+.||+|+||.||+++++.+|+.||||.++...    ...-.+..-+|+++|++|+|+|||+++++.+...    
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            45888999999999999999999999999999887432    1222356678999999999999999999876544    


Q ss_pred             --eEEEEEeecCCCCcchhhhh--ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEec--CCC--cEEEeec
Q 004660          428 --HLYIYLEYVHPGSINRYVRE--HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASG--VVKLADF  499 (739)
Q Consensus       428 --~l~LVmEy~~gGsL~~~L~~--~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd--~~g--~vKL~DF  499 (739)
                        .-.+|||||.||+|+..+.+  +...++|.+++.++.++..||.|||++|||||||||.||++-  .+|  ..||+||
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence              57899999999999999965  456799999999999999999999999999999999999984  333  5899999


Q ss_pred             ccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchH----HHHHHhh
Q 004660          500 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ----AMFKVLN  575 (739)
Q Consensus       500 GlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~----~~~~i~~  575 (739)
                      |.|+.+.++....+++||..|.+||++..      ...|+..+|.|||||++|+++||..||....+..    .+..++.
T Consensus       169 G~Arel~d~s~~~S~vGT~~YLhPel~E~------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t  242 (732)
T KOG4250|consen  169 GAARELDDNSLFTSLVGTEEYLHPELYER------QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT  242 (732)
T ss_pred             cccccCCCCCeeeeecCchhhcChHHHhh------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence            99999999998899999999999999874      4678899999999999999999999997655542    3333322


Q ss_pred             c---------------------CCCCCccCCHHH----HHHHHHhcccCCCCCC
Q 004660          576 R---------------------TPPIPEMLSSEG----KDFLLRCFLRNPVERP  604 (739)
Q Consensus       576 ~---------------------~~~iP~~ls~el----~dLI~kcL~~DP~kRp  604 (739)
                      +                     ..++|..++..+    -..|..+|..+|++|.
T Consensus       243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            1                     123344445444    3567888999999998

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-38  Score=332.93  Aligned_cols=256  Identities=27%  Similarity=0.400  Sum_probs=210.6

Q ss_pred             CCCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC--C----CeEeec
Q 004660          347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--E----NIVQYY  420 (739)
Q Consensus       347 ~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~H--P----NIVkl~  420 (739)
                      ......+|.+.+.||+|+||.|..+.+++++..||||+++.+      ..+.+...-||++|++|.+  |    -+|++.
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            344578999999999999999999999999999999988732      3334556679999999942  2    378899


Q ss_pred             cceeecceEEEEEeecCCCCcchhhhh-ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC---------
Q 004660          421 GSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---------  490 (739)
Q Consensus       421 ~~~~~~~~l~LVmEy~~gGsL~~~L~~-~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~---------  490 (739)
                      ++|...+++|||+|.+ |-++++++.+ +...++...++.+..||+++|+|||+++++|.||||+|||+..         
T Consensus       158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence            9999999999999998 5699999977 4567999999999999999999999999999999999999831         


Q ss_pred             -----------CCcEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCC
Q 004660          491 -----------SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP  559 (739)
Q Consensus       491 -----------~g~vKL~DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~  559 (739)
                                 .-.|||+|||.|+......  .+.+.|+.|+|||++.+       -.++..+||||+||||+||.+|..
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg-------LGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG-------LGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec-------cCcCCccCceeeeeEEEEeeccce
Confidence                       2369999999997654433  46788999999999986       356779999999999999999999


Q ss_pred             CCCCCCchH---HHHHHhhcCC------------------CCCcc-------------------------CCHHHHHHHH
Q 004660          560 PWSEFEGPQ---AMFKVLNRTP------------------PIPEM-------------------------LSSEGKDFLL  593 (739)
Q Consensus       560 PF~~~~~~~---~~~~i~~~~~------------------~iP~~-------------------------ls~el~dLI~  593 (739)
                      .|...+..+   +++.|++..+                  .+++.                         -..++.|||+
T Consensus       308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~  387 (415)
T KOG0671|consen  308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR  387 (415)
T ss_pred             ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence            998776555   4455544211                  11111                         1146789999


Q ss_pred             HhcccCCCCCCCHHHHHcCcccccc
Q 004660          594 RCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       594 kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      +||..||.+|+|+.|+|+||||...
T Consensus       388 ~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  388 RMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             HHHccCccccccHHHHhcCHHhhcC
Confidence            9999999999999999999999754

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=352.81  Aligned_cols=261  Identities=36%  Similarity=0.645  Sum_probs=225.6

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceee--
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVV--  425 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~--  425 (739)
                      .....|.+.++||.|.+|.||+++.+.+|+.+|+|++....+.      .+.++.|.+||+.+. |||++.+|++|..  
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~------deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE------EEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc------cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            3445699999999999999999999999999999987643221      135667899998885 9999999998864  


Q ss_pred             ---cceEEEEEeecCCCCcchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004660          426 ---DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM  501 (739)
Q Consensus       426 ---~~~l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGl  501 (739)
                         ++++|||||||.||+.-++++.. +..+.|..+..|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||+
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence               47899999999999999999753 56799999999999999999999999999999999999999999999999999


Q ss_pred             chhccCc-ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCC-
Q 004660          502 AKHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-  579 (739)
Q Consensus       502 A~~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~-  579 (739)
                      +..+... ....+.+||++|||||++....+.  +..|+..+|+||||++..||--|.+|+.+.-....++.|-...++ 
T Consensus       170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~--d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk  247 (953)
T KOG0587|consen  170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESP--DATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK  247 (953)
T ss_pred             eeeeecccccccCcCCCcccccceeeecccCC--CCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence            9877543 234467899999999999764443  467888999999999999999999999998888887777544332 


Q ss_pred             --CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          580 --IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       580 --iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                        -|+.++.++.+||..||.+|-++||+..++|+|||++.
T Consensus       248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence              36778999999999999999999999999999999983

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=332.01  Aligned_cols=253  Identities=30%  Similarity=0.428  Sum_probs=211.8

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      +...+...+.++||+|-||.|.+|.... +.+||+|.++..    ......+.|.+||++|.+|+|||||++++++..++
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~----a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De  608 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPD----ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD  608 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcc----cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence            3445678899999999999999998654 799999988632    23344578999999999999999999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhhcccc-ccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~-lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      .++|||||+++|+|.+||.++... +.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+.
T Consensus       609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence            999999999999999999886332 3555666799999999999999999999999999999999999999999999765


Q ss_pred             Cccccc---ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh--CCCCCCCCCchHHHHHHhhc-----
Q 004660          507 GLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWSEFEGPQAMFKVLNR-----  576 (739)
Q Consensus       507 ~~~~~~---s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt--Gk~PF~~~~~~~~~~~i~~~-----  576 (739)
                      ...+..   ..+-..+|||+|.+.       ...++.++|||+||++|||+++  ...||.....++.+.+...-     
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsil-------lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~  761 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESIL-------LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG  761 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHH-------hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence            433322   233467999999987       3578899999999999999865  78899888777666654321     


Q ss_pred             ---CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          577 ---TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       577 ---~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                         ....|..++.++.+||.+||..|-++||+++++-.+
T Consensus       762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence               234577899999999999999999999999998643

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=334.98  Aligned_cols=265  Identities=28%  Similarity=0.465  Sum_probs=221.0

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCC--CCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  426 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~--~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~  426 (739)
                      ....+|.++.+||+|||+.||+|.+....+.||||+-.+.+  .+.+...+.+..-+|..|.+.|+||.||++|++|..+
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            34468999999999999999999999989999999865544  2345566778888999999999999999999999755


Q ss_pred             -ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhC--CeecccCCCcceEec---CCCcEEEeecc
Q 004660          427 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--NTIHRDIKGANLLVD---ASGVVKLADFG  500 (739)
Q Consensus       427 -~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~--GIvHRDIKP~NILLd---~~g~vKL~DFG  500 (739)
                       +.+|-|+|||+|.+|..||+.+ +.++|.+++.|+.||+.||.||.+.  .|||-||||.||||-   ..|.+||+|||
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence             5699999999999999999876 6799999999999999999999965  599999999999994   45899999999


Q ss_pred             cchhccCccccc--------ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHH-HH
Q 004660          501 MAKHLTGLSYEL--------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MF  571 (739)
Q Consensus       501 lA~~~~~~~~~~--------s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~-~~  571 (739)
                      |++.+.++.+..        ...||.||++||.+.-.   ..-+.++.++||||+|||+|..+.|+.||......+. +.
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg---kePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG---KEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecC---CCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            999987765442        35699999999988631   1135788899999999999999999999976543322 22


Q ss_pred             H--Hhh---cCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          572 K--VLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       572 ~--i~~---~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                      .  |++   -..+....++.++++||++||++--++|+...|+..||||..
T Consensus       696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            1  222   122333568999999999999999999999999999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.8e-36  Score=346.45  Aligned_cols=262  Identities=22%  Similarity=0.275  Sum_probs=182.2

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCC----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccc--
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRET----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS--  422 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~t----g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~--  422 (739)
                      ...++|+++++||+|+||+||+|++..+    +..||||++....    ..+   ....|  .++...+.+++.++..  
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e---~~~~e--~l~~~~~~~~~~~~~~~~  199 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVE---IWMNE--RVRRACPNSCADFVYGFL  199 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhH---HHHHH--HHHhhchhhHHHHHHhhh
Confidence            3457899999999999999999999998    9999999875311    111   01111  1122222233332222  


Q ss_pred             ----eeecceEEEEEeecCCCCcchhhhhcccc-------------------ccHHHHHHHHHhHHHHHHHHHhCCeecc
Q 004660          423 ----EVVDDHLYIYLEYVHPGSINRYVREHCRD-------------------ITESIVRNFTRHILNGLAYLHSTNTIHR  479 (739)
Q Consensus       423 ----~~~~~~l~LVmEy~~gGsL~~~L~~~~~~-------------------lse~~i~~i~~QLl~aL~yLHs~GIvHR  479 (739)
                          ...++.++|||||+.+++|.+++......                   ..+..+..|+.||+.||.|||++||+||
T Consensus       200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR  279 (566)
T PLN03225        200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR  279 (566)
T ss_pred             cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence                13456799999999999999988653211                   1234567899999999999999999999


Q ss_pred             cCCCcceEecC-CCcEEEeecccchhccCc--ccccccCCCCCCCChHHHHHhhhcCC---------------CCCCCcc
Q 004660          480 DIKGANLLVDA-SGVVKLADFGMAKHLTGL--SYELSLKGSPNWMAPEVIKAVMQKDG---------------NPKLALA  541 (739)
Q Consensus       480 DIKP~NILLd~-~g~vKL~DFGlA~~~~~~--~~~~s~~GT~~Y~APEvl~~~~~~~g---------------~~~~s~a  541 (739)
                      ||||+||||+. ++.+||+|||+|+.+...  .......||+.|||||.+....+...               ...++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999986 589999999999865432  22235678999999997753221100               0124457


Q ss_pred             hhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhc--------------C--------CCCCccCCHHHHHHHHHhcccC
Q 004660          542 VDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--------------T--------PPIPEMLSSEGKDFLLRCFLRN  599 (739)
Q Consensus       542 sDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--------------~--------~~iP~~ls~el~dLI~kcL~~D  599 (739)
                      +||||||||||||+++..++...  ...+..++..              .        ..+.......+.+||.+||++|
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            79999999999999987665431  1111111110              0        0011112345669999999999


Q ss_pred             CCCCCCHHHHHcCccccccccC
Q 004660          600 PVERPSAVELLEHPFIRNANYQ  621 (739)
Q Consensus       600 P~kRpTa~elLqHpwf~~~~~~  621 (739)
                      |++|||+.|+|+||||+.....
T Consensus       438 P~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        438 GRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             cccCCCHHHHhCCcCcCCCCcc
Confidence            9999999999999999876654

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-37  Score=341.70  Aligned_cols=255  Identities=25%  Similarity=0.437  Sum_probs=219.5

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCC-C--cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRET-G--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~t-g--~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      +...+..++|+||+|.||.|++|.+... |  -.||||.++....    ......|.+|+.+|.+|+|+|+|+|||+..+
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l----~~~mddflrEas~M~~L~H~hliRLyGvVl~  182 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL----NAIMDDFLREASHMLKLQHPHLIRLYGVVLD  182 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc----chhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence            3455688899999999999999998763 3  3589998874322    2256789999999999999999999998776


Q ss_pred             cceEEEEEeecCCCCcchhhhh-ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          426 DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~-~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                       ..+.||||++.+|+|.+.|++ ....|....+..|+.||+.||.||..++.|||||...||||-....|||+||||.+.
T Consensus       183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence             778999999999999999987 556788999999999999999999999999999999999999999999999999998


Q ss_pred             ccCcccccccC----CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh-cCC
Q 004660          505 LTGLSYELSLK----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTP  578 (739)
Q Consensus       505 ~~~~~~~~s~~----GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~  578 (739)
                      +..+.......    --..|+|||.|+       ...++.++|||++||+||||++ |..||.+....+++++|-. ...
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLr-------h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL  334 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLR-------HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL  334 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhc-------cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC
Confidence            87655443322    345799999997       4678899999999999999999 8999999999999888864 356


Q ss_pred             CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       579 ~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      +-|+.+++++.++++.||..+|++|||+..|.+.-+.
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            7789999999999999999999999999998654333

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-37  Score=346.15  Aligned_cols=254  Identities=26%  Similarity=0.469  Sum_probs=225.6

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeecccee
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  424 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~---~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~  424 (739)
                      +...+...|.++||.|.||.||+|+.+..|+   .||||.++.    +..+.....|..|+.||-+.+|||||+|.|+..
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~----GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT  700 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA----GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT  700 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc----CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence            3445667889999999999999999988774   599998873    345566788999999999999999999999999


Q ss_pred             ecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          425 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       425 ~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      ....++||+|||++|.|+.||+++.+.++..++..+++.|+.||+||-++|+|||||...||||+.+-.+|+.||||++.
T Consensus       701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence            99999999999999999999999989999999999999999999999999999999999999999999999999999998


Q ss_pred             ccCccc--ccccCC--CCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhhc-CC
Q 004660          505 LTGLSY--ELSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TP  578 (739)
Q Consensus       505 ~~~~~~--~~s~~G--T~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~  578 (739)
                      +.++..  ..+..|  -.+|.|||.+.       ...++.++||||+||||||.++ |..||.+....+.+..|..+ ..
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa-------~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL  853 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIA-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL  853 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhh-------hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCC
Confidence            765442  122223  46899999997       4688999999999999999877 99999999999999988754 56


Q ss_pred             CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       579 ~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      +.|-.++..+..|+..||++|-.+||.+.||+.+
T Consensus       854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            7778899999999999999999999999999864

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=337.44  Aligned_cols=247  Identities=27%  Similarity=0.514  Sum_probs=213.1

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCC--C--cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRET--G--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~t--g--~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      ....+.++||+|-||.||.|.+..-  |  --||||..+..    ...+..+.|..|..+|+.++|||||+++|++. +.
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d----~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~  463 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD----CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQ  463 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC----CChhhHHHHHHHHHHHHhCCCcchhheeeeee-cc
Confidence            3445567899999999999987643  3  34888877631    22333567889999999999999999999875 45


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      .+|||||+++.|.|..|++.+...++...+..|+.||+.||.|||+...|||||...|||+.....|||+||||++.+.+
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            68999999999999999998878899999999999999999999999999999999999999999999999999999987


Q ss_pred             cccccccCC--CCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh-cCCCCCcc
Q 004660          508 LSYELSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEM  583 (739)
Q Consensus       508 ~~~~~s~~G--T~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~iP~~  583 (739)
                      ..+.....|  ...|||||-++       ...++.++|||.|||+|||+|. |..||.+....+.+..+-+ .+.+.|+.
T Consensus       544 ~~yYkaS~~kLPIKWmaPESIN-------fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~n  616 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESIN-------FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPN  616 (974)
T ss_pred             cchhhccccccceeecCccccc-------hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCC
Confidence            766554444  45799999886       4578899999999999999987 9999999888887777765 46788999


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELL  610 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elL  610 (739)
                      +++.+..|+.+||+.+|.+||++.|+.
T Consensus       617 CPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  617 CPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             CChHHHHHHHHHhccCcccCCcHHHHH
Confidence            999999999999999999999987654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.5e-36  Score=303.61  Aligned_cols=252  Identities=24%  Similarity=0.442  Sum_probs=209.3

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeec--
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD--  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~--  426 (739)
                      ..++|++.+++|+|.|+.||.|....+.+.++||+++..        -.+.+.+|++||+.|. |||||+++++..+.  
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            567899999999999999999999999999999998742        2367899999999997 99999999987765  


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEeecccchhc
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHL  505 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~-g~vKL~DFGlA~~~  505 (739)
                      ...-||+||+.+.+...+.    ..++..+++.++.||+.||.|||++||+|||+||.|+|||.. ..++|+|+|||...
T Consensus       108 ktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             cCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence            4578999999988877665    458899999999999999999999999999999999999965 67999999999887


Q ss_pred             cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCC-CCCchHHHHHH---hh------
Q 004660          506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKV---LN------  575 (739)
Q Consensus       506 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~-~~~~~~~~~~i---~~------  575 (739)
                      -........+.+++|--||++..      ...|+..-|+|||||+|..|+..+-||- +.+..+.+.+|   ++      
T Consensus       184 Hp~~eYnVRVASRyfKGPELLVd------y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~  257 (338)
T KOG0668|consen  184 HPGKEYNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA  257 (338)
T ss_pred             CCCceeeeeeehhhcCCchheee------chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence            66555555678999999999975      3567778999999999999999988873 44444433332   11      


Q ss_pred             ---c-CCCCC------------------------ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          576 ---R-TPPIP------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       576 ---~-~~~iP------------------------~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                         + ...++                        ..+++++.|||.++|..|-.+|+||.|++.||||....
T Consensus       258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence               0 00000                        12469999999999999999999999999999997543

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-37  Score=314.05  Aligned_cols=262  Identities=28%  Similarity=0.450  Sum_probs=216.2

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHH-hhcCCCCeEeeccceeecc
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL-~~L~HPNIVkl~~~~~~~~  427 (739)
                      ......+-+..||.|+||+|++..++.+|+..|||.|+....    ....+++..|.+.. +.-+.||||++||+...++
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG  136 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG  136 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence            344567778899999999999999999999999999985433    22335677777654 4446899999999999999


Q ss_pred             eEEEEEeecCCCCcchhhhh----ccccccHHHHHHHHHhHHHHHHHHH-hCCeecccCCCcceEecCCCcEEEeecccc
Q 004660          428 HLYIYLEYVHPGSINRYVRE----HCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGMA  502 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~----~~~~lse~~i~~i~~QLl~aL~yLH-s~GIvHRDIKP~NILLd~~g~vKL~DFGlA  502 (739)
                      ..||.||+|+ .+|..+.+.    +...++|+.+-.|..-.+.||+||- +..||||||||+||||+..|.|||||||++
T Consensus       137 dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc  215 (361)
T KOG1006|consen  137 DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC  215 (361)
T ss_pred             ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence            9999999996 565554421    2356999999999999999999998 568999999999999999999999999999


Q ss_pred             hhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc-hHHHHHHhhcCCCCC
Q 004660          503 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLNRTPPIP  581 (739)
Q Consensus       503 ~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~-~~~~~~i~~~~~~iP  581 (739)
                      ..+.+........|-+.|||||.+...     +..|+.++||||||++|||+.||+.||...+. .+.+..+..+.+++-
T Consensus       216 GqLv~SiAkT~daGCrpYmAPERi~p~-----~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l  290 (361)
T KOG1006|consen  216 GQLVDSIAKTVDAGCRPYMAPERIDPS-----DKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPIL  290 (361)
T ss_pred             HhHHHHHHhhhccCCccccChhccCCc-----cCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCee
Confidence            888766555567799999999988631     33588999999999999999999999987544 456666666655532


Q ss_pred             ---c---cCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          582 ---E---MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       582 ---~---~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                         .   .++..++.+|..||.+|-..||...++++++|++....
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence               2   37889999999999999999999999999999986543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-34  Score=329.30  Aligned_cols=268  Identities=18%  Similarity=0.232  Sum_probs=190.2

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEEC----------------CCCcEEEEEEeecCCCCcccHHH----------HHHHH
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNR----------------ETGASCAIKEVDIIPDDPKSAEC----------IKQLE  402 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k----------------~tg~~VAIK~i~~~~~~~~~~~~----------~k~l~  402 (739)
                      ...++|++.++||+|+||+||+|.+.                ..++.||||.+...... ...+.          .+...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~-~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG-VRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh-hHHHHHhhhhhhhcccchhH
Confidence            34678999999999999999999752                24567999998642211 11111          11233


Q ss_pred             HHHHHHhhcCCCCe-----Eeeccceee--------cceEEEEEeecCCCCcchhhhhcc--------------------
Q 004660          403 QEIKVLGHLKHENI-----VQYYGSEVV--------DDHLYIYLEYVHPGSINRYVREHC--------------------  449 (739)
Q Consensus       403 ~Ei~iL~~L~HPNI-----Vkl~~~~~~--------~~~l~LVmEy~~gGsL~~~L~~~~--------------------  449 (739)
                      .|+.++.+++|.++     +++++++..        ++..||||||+.+++|.+++....                    
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            47777777776654     667776543        356899999999999999886421                    


Q ss_pred             ---ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccc--cCCCCCCCChH
Q 004660          450 ---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPE  524 (739)
Q Consensus       450 ---~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s--~~GT~~Y~APE  524 (739)
                         ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...........  ..+|+.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence               1235667889999999999999999999999999999999999999999999976543222222  23489999999


Q ss_pred             HHHHhhhcCCC-------------CCC--CcchhhhHHHHHHHHHhhCCC-CCCCCCchHH-----------HHHHhhcC
Q 004660          525 VIKAVMQKDGN-------------PKL--ALAVDIWSLGCTVIEMLTGKP-PWSEFEGPQA-----------MFKVLNRT  577 (739)
Q Consensus       525 vl~~~~~~~g~-------------~~~--s~asDIWSLGvVLyELLtGk~-PF~~~~~~~~-----------~~~i~~~~  577 (739)
                      ++.........             ..|  ....||||+|||||+|++|.. ||........           +..+....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            98632110000             001  124799999999999999886 7754221111           11111122


Q ss_pred             --CCCCccCCHHHHHHHHHhcccCC---CCCCCHHHHHcCccccc
Q 004660          578 --PPIPEMLSSEGKDFLLRCFLRNP---VERPSAVELLEHPFIRN  617 (739)
Q Consensus       578 --~~iP~~ls~el~dLI~kcL~~DP---~kRpTa~elLqHpwf~~  617 (739)
                        ..+....++.++|||.+||.++|   .+|+|+.|+|+||||..
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence              22334578999999999999876   68999999999999964

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=326.05  Aligned_cols=253  Identities=26%  Similarity=0.463  Sum_probs=219.4

Q ss_pred             CCCCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       346 ~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      .++....+..+-.+||-|.||.||.|.++.-.-.||||.++.      +...++.|..|+.+|+.++|||+|+|+++|..
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE------DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~  334 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH  334 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh------cchhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence            566677778888999999999999999999889999998762      22235678999999999999999999999999


Q ss_pred             cceEEEEEeecCCCCcchhhhhccc-cccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~-~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      +-.+|||+|||..|.|.+||++-.+ .++.-.+..++.||..||+||..+++|||||...|+|+.++..|||+||||++.
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            9999999999999999999987433 356666778889999999999999999999999999999999999999999999


Q ss_pred             ccCcccccc--cCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHhh-cCCCC
Q 004660          505 LTGLSYELS--LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPI  580 (739)
Q Consensus       505 ~~~~~~~~s--~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~i  580 (739)
                      +.++.++..  ..-...|.|||-|.       ...++.++|||+|||+|||+.| |-.||.+.+..+.+..+.+ ....-
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsLA-------yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~  487 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESLA-------YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG  487 (1157)
T ss_pred             hcCCceecccCccCcccccCccccc-------ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC
Confidence            988776543  22356899999886       3578889999999999999998 9999999887766555443 34567


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      |+.+++...+||+.||+++|.+||++.|+-+
T Consensus       488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             CCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence            8999999999999999999999999998754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.2e-35  Score=324.33  Aligned_cols=255  Identities=24%  Similarity=0.386  Sum_probs=213.2

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC------CCeEeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH------ENIVQYYG  421 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~H------PNIVkl~~  421 (739)
                      +..-.+|.+....|.|-|++|.+|.+..-|..||||+|..      ....-+.=..|++||++|..      -|+|+|+.
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn------NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN------NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec------chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            3444678888889999999999999999999999999873      23333555679999999952      48999999


Q ss_pred             ceeecceEEEEEeecCCCCcchhhhhcc--ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEee
Q 004660          422 SEVVDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLAD  498 (739)
Q Consensus       422 ~~~~~~~l~LVmEy~~gGsL~~~L~~~~--~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~-g~vKL~D  498 (739)
                      .|...+++|||+|-+. ..|.+.|++.+  ..|....++.|+.||+.||..|-..||+|.||||+||||++. ..+||||
T Consensus       502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD  580 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD  580 (752)
T ss_pred             HhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence            9999999999999985 78999998754  357888999999999999999999999999999999999876 5799999


Q ss_pred             cccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC
Q 004660          499 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP  578 (739)
Q Consensus       499 FGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~  578 (739)
                      ||.|.....+..+ .+..+..|.|||++.|       ..|+...|+||.||+||||.||+..|.+....+++...+....
T Consensus       581 fGSA~~~~eneit-PYLVSRFYRaPEIiLG-------~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG  652 (752)
T KOG0670|consen  581 FGSASFASENEIT-PYLVSRFYRAPEIILG-------LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG  652 (752)
T ss_pred             Ccccccccccccc-HHHHHHhccCcceeec-------CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence            9999877655433 3456889999999985       4678899999999999999999999999888777765554333


Q ss_pred             CCCcc------------------------------------------------------------CCHHHHHHHHHhccc
Q 004660          579 PIPEM------------------------------------------------------------LSSEGKDFLLRCFLR  598 (739)
Q Consensus       579 ~iP~~------------------------------------------------------------ls~el~dLI~kcL~~  598 (739)
                      ++|..                                                            +-..+++||.+||..
T Consensus       653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L  732 (752)
T KOG0670|consen  653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL  732 (752)
T ss_pred             CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence            33211                                                            115778999999999


Q ss_pred             CCCCCCCHHHHHcCccccc
Q 004660          599 NPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       599 DP~kRpTa~elLqHpwf~~  617 (739)
                      ||++|+|+.|+|+||||+.
T Consensus       733 dP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  733 DPEKRITVNQALKHPFITE  751 (752)
T ss_pred             ChhhcCCHHHHhcCCcccC
Confidence            9999999999999999964

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-35  Score=304.46  Aligned_cols=252  Identities=24%  Similarity=0.398  Sum_probs=209.1

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec---
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~---  426 (739)
                      ...+|.-++.+|.|.- .|..|.+.-.++.||+|++-.....   ....++..+|+.++..+.|+|||+++.+|.-.   
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n---~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN---QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc---CccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence            4467999999999999 8888999999999999987543222   22346788999999999999999999998654   


Q ss_pred             ---ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004660          427 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       427 ---~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                         ..+|+||||+. .+|...+.-   .++-..+..|+.|+++|++|||+.||+||||||+||++..++.+||.|||+|+
T Consensus        91 ~~~~e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   91 EEFQEVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHhHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence               35899999997 788887763   47888999999999999999999999999999999999999999999999998


Q ss_pred             hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCC-----
Q 004660          504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----  578 (739)
Q Consensus       504 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-----  578 (739)
                      .....-.....+.|++|.|||++.+.       .|...+||||+||++.||++|+..|.+.+..+.+.++.....     
T Consensus       167 ~e~~~~~mtpyVvtRyyrapevil~~-------~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  167 TEDTDFMMTPYVVTRYYRAPEVILGM-------GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             ccCcccccCchhheeeccCchheecc-------CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence            76555455567899999999999863       377799999999999999999999988766655554432100     


Q ss_pred             --------------------------CCCc-----------cCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 004660          579 --------------------------PIPE-----------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR  616 (739)
Q Consensus       579 --------------------------~iP~-----------~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~  616 (739)
                                                -+|.           .-...+++|+.+||..||++|++++++|+|||++
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                      0111           1235678999999999999999999999999997

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=304.26  Aligned_cols=257  Identities=27%  Similarity=0.464  Sum_probs=209.3

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec-----c
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-----D  427 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~-----~  427 (739)
                      +.+-.+-||.|+||.||.+.+-.+|+.||+|++....   ..-..-+++.+|+++|.-.+|.||+..++..+-.     .
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf---q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF---QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH---HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            3455678999999999999999999999999775322   2223347889999999999999999998876543     3


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      ++|+++|++. .+|..+|..- ..++.+.++-++.||++||+|||+.||+||||||.|+|++.+..+||||||+|+....
T Consensus       131 EiYV~TELmQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  131 ELYVLTELMQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHHHHH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence            5899999996 7888888664 6799999999999999999999999999999999999999999999999999987654


Q ss_pred             ccc--ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhh----------
Q 004660          508 LSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN----------  575 (739)
Q Consensus       508 ~~~--~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~----------  575 (739)
                      ...  ....+.|.+|+|||++.|.      ..|+.++||||.|||+.|||..+..|......+.+..|.+          
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGa------RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM  282 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGA------RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM  282 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcc------hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence            322  2234579999999999974      5677799999999999999999999987766665554432          


Q ss_pred             -------------cCCCCCc-----------cCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          576 -------------RTPPIPE-----------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       576 -------------~~~~iP~-----------~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                                   +..+.|.           ....+..+++.+||..||++|++.++.+.|++.....+
T Consensus       283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL  351 (449)
T ss_pred             HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence                         1111111           23357789999999999999999999999999876543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-34  Score=309.97  Aligned_cols=257  Identities=24%  Similarity=0.386  Sum_probs=199.1

Q ss_pred             CCCC-CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-----C---CCeEe
Q 004660          348 SPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----H---ENIVQ  418 (739)
Q Consensus       348 ~~~~-~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-----H---PNIVk  418 (739)
                      ..+. .+|.+.++||+|-|+|||+|.+..+.+.||+|+++      ....+.+....||++|++++     |   ..||+
T Consensus        73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK------SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~  146 (590)
T KOG1290|consen   73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK------SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ  146 (590)
T ss_pred             ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe------hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence            4455 89999999999999999999999999999999987      33445566788999999884     2   37999


Q ss_pred             eccceeec----ceEEEEEeecCCCCcchhhhh-ccccccHHHHHHHHHhHHHHHHHHH-hCCeecccCCCcceEecC--
Q 004660          419 YYGSEVVD----DHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDA--  490 (739)
Q Consensus       419 l~~~~~~~----~~l~LVmEy~~gGsL~~~L~~-~~~~lse~~i~~i~~QLl~aL~yLH-s~GIvHRDIKP~NILLd~--  490 (739)
                      |++.|...    .++|||+|++ |..|..+|+. ..+.++...++.|++|||.||.||| +.||||.||||+||||..  
T Consensus       147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e  225 (590)
T KOG1290|consen  147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTE  225 (590)
T ss_pred             eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccc
Confidence            99999864    4799999999 5677777754 5678999999999999999999999 569999999999999810  


Q ss_pred             --------------------------------------------------------------------------------
Q 004660          491 --------------------------------------------------------------------------------  490 (739)
Q Consensus       491 --------------------------------------------------------------------------------  490 (739)
                                                                                                      
T Consensus       226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~  305 (590)
T KOG1290|consen  226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN  305 (590)
T ss_pred             cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------C-----------------------------------------------
Q 004660          491 --------------------------------S-----------------------------------------------  491 (739)
Q Consensus       491 --------------------------------~-----------------------------------------------  491 (739)
                                                      .                                               
T Consensus       306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~  385 (590)
T KOG1290|consen  306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP  385 (590)
T ss_pred             ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence                                            0                                               


Q ss_pred             -----CcEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc
Q 004660          492 -----GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG  566 (739)
Q Consensus       492 -----g~vKL~DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~  566 (739)
                           -.|||+|||-|+-+..  ..+..+.|+.|+|||++.|       ..|+..+||||++|++|||+||...|+..++
T Consensus       386 ~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllG-------sgY~~~ADiWS~AC~~FELaTGDyLFePhsG  456 (590)
T KOG1290|consen  386 LPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLG-------SGYSTSADIWSTACMAFELATGDYLFEPHSG  456 (590)
T ss_pred             CCccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeec-------CCCCCchhHHHHHHHHHHhhcCceeecCCCC
Confidence                 0256666666654321  1122347889999999985       4688899999999999999999999964221


Q ss_pred             ------hHHHHHHhhcCCC------------------------------------------CCccCCHHHHHHHHHhccc
Q 004660          567 ------PQAMFKVLNRTPP------------------------------------------IPEMLSSEGKDFLLRCFLR  598 (739)
Q Consensus       567 ------~~~~~~i~~~~~~------------------------------------------iP~~ls~el~dLI~kcL~~  598 (739)
                            ++.+..|+.....                                          ++..-..++.+||.-||+.
T Consensus       457 ~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef  536 (590)
T KOG1290|consen  457 ENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEF  536 (590)
T ss_pred             CCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhc
Confidence                  2222222221111                                          1112235778999999999


Q ss_pred             CCCCCCCHHHHHcCcccccccc
Q 004660          599 NPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       599 DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      +|++|+||.++|+|||+.....
T Consensus       537 ~PeKR~tA~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  537 DPEKRPTAAQCLKHPWLNPVAG  558 (590)
T ss_pred             CccccccHHHHhcCccccCCCC
Confidence            9999999999999999986543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.6e-34  Score=348.56  Aligned_cols=236  Identities=23%  Similarity=0.372  Sum_probs=185.9

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .|...++||+|+||+||+|+++.+|..||||+++....         ....|+++|++++|||||++++++..++..|+|
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence            35566789999999999999999999999998763211         112468899999999999999999999999999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHH---hCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH---STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLH---s~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~  509 (739)
                      |||+++|+|.++++.    +++..+..|+.||+.||+|||   +.+|+||||||+|||++.++..++. ||........ 
T Consensus       762 ~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        762 HEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             EeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            999999999999953    788999999999999999999   6799999999999999998888775 6665443221 


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch--HH--HHHH-h---------h
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QA--MFKV-L---------N  575 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~--~~--~~~i-~---------~  575 (739)
                        ....||..|||||++.       ...++.++|||||||++|||++|+.||......  ..  ..+. .         .
T Consensus       836 --~~~~~t~~y~aPE~~~-------~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  906 (968)
T PLN00113        836 --TKCFISSAYVAPETRE-------TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID  906 (968)
T ss_pred             --CCccccccccCccccc-------CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC
Confidence              2346899999999876       345788999999999999999999999542211  11  1110 0         0


Q ss_pred             c----CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          576 R----TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       576 ~----~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      .    ....+.....++.+++.+||+.||++|||+.|+++.
T Consensus       907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0    001111122356789999999999999999999865

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-35  Score=326.54  Aligned_cols=259  Identities=35%  Similarity=0.599  Sum_probs=222.4

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      .+.+|.++.++|.|+||.||+|+++.+++..|+|+|+..+.+.     ++-+..||-+++.++|+|||.+++.+...+.+
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-----~~~iqqei~~~~dc~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-----FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-----ccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence            4568999999999999999999999999999999999766543     34567899999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-c
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-L  508 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~-~  508 (739)
                      ||+||||.||+|.+...-. +.++|.++....+..++||+|||++|-+|||||-.|||+++.|.|||+|||.+..+.. -
T Consensus        88 wicMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             EEEEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence            9999999999999977554 6799999999999999999999999999999999999999999999999999876643 2


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCC-----Ccc
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI-----PEM  583 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~i-----P~~  583 (739)
                      ....++.||++|||||+..-..    ...|...+|||++|++..||-.-++|..+.-....++......+..     +..
T Consensus       167 ~KrksfiGtpywmapEvaaver----kggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~k  242 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVER----KGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTK  242 (829)
T ss_pred             hhhhcccCCccccchhHHHHHh----cccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCcc
Confidence            3344688999999999976322    3457789999999999999999888877666665555544333222     345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      +++.+-+|++.+|.++|++||+++.+|+|+|+...
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            78999999999999999999999999999998653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-33  Score=323.23  Aligned_cols=255  Identities=29%  Similarity=0.482  Sum_probs=211.3

Q ss_pred             CCCCCCCCceEeeEEeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeE
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIV  417 (739)
Q Consensus       346 ~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~-------tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIV  417 (739)
                      .++.......+.+.||+|.||.|++|..+.       ....||||.++....    ....+.+..|+++|+.+. |+|||
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~----~~~~~~~~~El~~m~~~g~H~niv  365 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS----SSEKKDLMSELNVLKELGKHPNIV  365 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC----cHHHHHHHHHHHHHHHhcCCcchh
Confidence            344555556788899999999999997431       135699998763222    244578899999999995 99999


Q ss_pred             eeccceeecceEEEEEeecCCCCcchhhhhcc---------------ccccHHHHHHHHHhHHHHHHHHHhCCeecccCC
Q 004660          418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK  482 (739)
Q Consensus       418 kl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~---------------~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIK  482 (739)
                      .+++++..++.+++|+||+..|+|..+++...               ..++..++..++.||+.||+||++.++|||||.
T Consensus       366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA  445 (609)
T KOG0200|consen  366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA  445 (609)
T ss_pred             hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence            99999999999999999999999999998764               248899999999999999999999999999999


Q ss_pred             CcceEecCCCcEEEeecccchhccCccccc--ccCCC--CCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-C
Q 004660          483 GANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G  557 (739)
Q Consensus       483 P~NILLd~~g~vKL~DFGlA~~~~~~~~~~--s~~GT--~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-G  557 (739)
                      .+||||..+..+||+|||+|+.........  ...|+  ..|||||.+.       ...|+.++||||+||+||||++ |
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-------~~~ft~kSDVWSfGI~L~EifsLG  518 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-------DRVFTSKSDVWSFGILLWEIFTLG  518 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc-------cCcccccchhhHHHHHHHHHhhCC
Confidence            999999999999999999998765433332  12232  3499999997       3578899999999999999999 9


Q ss_pred             CCCCCCCC-chHHHHHHhh-cCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          558 KPPWSEFE-GPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       558 k~PF~~~~-~~~~~~~i~~-~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ..||.+.. ..+.+..+.. .....|..++.++.++|+.||..+|++||++.|+.+
T Consensus       519 ~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  519 GTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             CCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            99999866 3444443443 356889999999999999999999999999999885

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-34  Score=308.29  Aligned_cols=246  Identities=24%  Similarity=0.391  Sum_probs=192.9

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHh--hcCCCCeEeeccceeecc-
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG--HLKHENIVQYYGSEVVDD-  427 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~--~L~HPNIVkl~~~~~~~~-  427 (739)
                      ....++.++||+|.||.||+|+..  ++.||||++..        +....+.+|-+|..  .|+|+||++++++..... 
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            334778899999999999999876  59999998763        22345555655554  458999999999877655 


Q ss_pred             ---eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh---------CCeecccCCCcceEecCCCcEE
Q 004660          428 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS---------TNTIHRDIKGANLLVDASGVVK  495 (739)
Q Consensus       428 ---~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs---------~GIvHRDIKP~NILLd~~g~vK  495 (739)
                         .++||+||.+.|+|.+||..+  .+++....+++.-|++||+|||+         ..|+|||||.+||||..|+...
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc  356 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC  356 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence               799999999999999999875  58999999999999999999995         3699999999999999999999


Q ss_pred             EeecccchhccC---cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCC------------C
Q 004660          496 LADFGMAKHLTG---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------------P  560 (739)
Q Consensus       496 L~DFGlA~~~~~---~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~------------P  560 (739)
                      |+|||||..+..   .......+||.+|||||+|.++.+... ...-.+.||||+|.|||||++...            |
T Consensus       357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d-~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp  435 (534)
T KOG3653|consen  357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD-RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP  435 (534)
T ss_pred             eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc-HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence            999999987753   233445789999999999999877652 333357999999999999998543            3


Q ss_pred             CCCC----CchHHHHHH-h--hcCCCCCccC-----CHHHHHHHHHhcccCCCCCCCHHHH
Q 004660          561 WSEF----EGPQAMFKV-L--NRTPPIPEML-----SSEGKDFLLRCFLRNPVERPSAVEL  609 (739)
Q Consensus       561 F~~~----~~~~~~~~i-~--~~~~~iP~~l-----s~el~dLI~kcL~~DP~kRpTa~el  609 (739)
                      |...    -..+.++.. +  ..++.+|..+     -.-+++.|+.||..|++.|.|+.=+
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            3210    111222222 2  3455666532     3567899999999999999998643

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-34  Score=325.32  Aligned_cols=242  Identities=31%  Similarity=0.503  Sum_probs=194.5

Q ss_pred             eeEEeecCCeE-EEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecceEEEEEe
Q 004660          357 GKLIGRGTFGS-VYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLE  434 (739)
Q Consensus       357 ~~~LG~G~fGt-Vy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~l~LVmE  434 (739)
                      -+++|.|+-|+ ||+|...  |+.||||.+-        .+......+||.+|+.-+ |||||++|+...+...+||.+|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            36789999986 7999876  7899999764        455567889999999985 9999999999999999999999


Q ss_pred             ecCCCCcchhhhhccc--c-ccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC---C--CcEEEeecccchhcc
Q 004660          435 YVHPGSINRYVREHCR--D-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---S--GVVKLADFGMAKHLT  506 (739)
Q Consensus       435 y~~gGsL~~~L~~~~~--~-lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~---~--g~vKL~DFGlA~~~~  506 (739)
                      +|. .+|.+++.....  . ....+.+.++.|++.||++||+.+||||||||.||||+.   +  ..++|.|||+++.+.
T Consensus       584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            996 899999976311  1 111456788999999999999999999999999999976   3  479999999999886


Q ss_pred             Cccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhC-CCCCCCCCchHHHHHHhhcCCCCC
Q 004660          507 GLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNRTPPIP  581 (739)
Q Consensus       507 ~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtG-k~PF~~~~~~~~~~~i~~~~~~iP  581 (739)
                      .+..    ..+..||-+|+|||++....       -..++||||||||+|+.++| ..||.+.-.  ...+|+.+...+-
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-------~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~  733 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-------KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLV  733 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-------cCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCcccee
Confidence            5433    23456999999999998532       23489999999999999995 999976432  2334555443322


Q ss_pred             ---ccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          582 ---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       582 ---~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                         .....+++|||.+||..+|..||+|.++|.||||-..
T Consensus       734 ~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  734 HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence               1122289999999999999999999999999999654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-33  Score=314.85  Aligned_cols=249  Identities=29%  Similarity=0.468  Sum_probs=211.5

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeec
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  426 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~----~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~  426 (739)
                      ..+.+.+++||.|+||+||+|.+--.|+    +||||++....    ..+.-..+.+|+-+|..|+|||+++|++++...
T Consensus       695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t----~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s  770 (1177)
T KOG1025|consen  695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT----SPKASIELLDEALRMASLDHPNLLRLLGVCMLS  770 (1177)
T ss_pred             hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC----CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence            3457788999999999999998866554    57888765322    233345678899999999999999999998876


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      . +.||++|+++|.|.+|++.+...+...+...|..||++||.|||++++|||||-.+||||..-..|||.|||+|+.+.
T Consensus       771 ~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  771 T-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             h-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            6 889999999999999999988899999999999999999999999999999999999999999999999999999887


Q ss_pred             CcccccccC---CCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHHHHHh-hcCCCCC
Q 004660          507 GLSYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIP  581 (739)
Q Consensus       507 ~~~~~~s~~---GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~-~~~~~iP  581 (739)
                      .+.......   --+.|||-|.+.       ...|+.++||||+||++|||+| |..|+.+....++-..+. +.+..-|
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~-------~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqP  922 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIR-------IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQP  922 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhh-------ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCC
Confidence            655443332   245688888876       4688999999999999999999 999999887665544433 3346778


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      ..++.++..+|.+||..|++.||+++++..
T Consensus       923 piCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  923 PICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            899999999999999999999999998775

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=2.9e-31  Score=256.57  Aligned_cols=213  Identities=39%  Similarity=0.681  Sum_probs=186.0

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecCCC
Q 004660          360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  439 (739)
Q Consensus       360 LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~gG  439 (739)
                      ||+|.+|.||++....+++.+++|++.......    ....+.+|+.+++.+.|++|+++++++......+++|||+.|+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            689999999999998889999999887432211    3467889999999999999999999999999999999999999


Q ss_pred             CcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC-CCcEEEeecccchhccCcc-cccccCCC
Q 004660          440 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-YELSLKGS  517 (739)
Q Consensus       440 sL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~-~g~vKL~DFGlA~~~~~~~-~~~s~~GT  517 (739)
                      +|.+++......+++..++.++.+++.+|.|||+.|++|+||+|.||+++. ++.++|+|||++....... ......+.
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            999999764346899999999999999999999999999999999999999 8999999999997664432 12335578


Q ss_pred             CCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHhcc
Q 004660          518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL  597 (739)
Q Consensus       518 ~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kcL~  597 (739)
                      ..|++||.+...      ..++.+.|+|+||+++|+|                               ..+.++|.+||.
T Consensus       157 ~~~~~pe~~~~~------~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         157 PAYMAPEVLLGK------GYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             CCccChhHhccc------CCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhh
Confidence            899999998641      2566789999999999999                               678999999999


Q ss_pred             cCCCCCCCHHHHHcCc
Q 004660          598 RNPVERPSAVELLEHP  613 (739)
Q Consensus       598 ~DP~kRpTa~elLqHp  613 (739)
                      .||++||++.++++++
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-32  Score=291.21  Aligned_cols=249  Identities=27%  Similarity=0.441  Sum_probs=193.5

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHh--hcCCCCeEeeccceeec-
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG--HLKHENIVQYYGSEVVD-  426 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~--~L~HPNIVkl~~~~~~~-  426 (739)
                      ...+.++.+.||+|.||.||+|.++  |+.||||++...  +      .+...+|.+|.+  .|+|+||+.++++...+ 
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr--d------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~  278 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR--D------ERSWFRETEIYQTVMLRHENILGFIAADNKDN  278 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEeccc--c------hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence            4567899999999999999999998  899999998631  1      133445655554  56999999999987644 


Q ss_pred             ---ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh--------CCeecccCCCcceEecCCCcEE
Q 004660          427 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS--------TNTIHRDIKGANLLVDASGVVK  495 (739)
Q Consensus       427 ---~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs--------~GIvHRDIKP~NILLd~~g~vK  495 (739)
                         .++|||++|.+.|+|+|||..  ..++.+...+++.-++.||++||-        -.|+|||||..||||..+|..-
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence               369999999999999999977  468999999999999999999993        2499999999999999999999


Q ss_pred             EeecccchhccCcc-----cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhC----------CCC
Q 004660          496 LADFGMAKHLTGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPP  560 (739)
Q Consensus       496 L~DFGlA~~~~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtG----------k~P  560 (739)
                      |+|+|||.......     .....+||.+|||||+|...++..--..| ..+||||||.||||++..          ++|
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy-k~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESY-KRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhh-hHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            99999997665432     22346799999999999876554321122 368999999999999752          578


Q ss_pred             CCCC----CchHHHHHHh---hcCCCCCccCC-----HHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          561 WSEF----EGPQAMFKVL---NRTPPIPEMLS-----SEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       561 F~~~----~~~~~~~~i~---~~~~~iP~~ls-----~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      |.+.    -..+.+.+++   ...+.+|..+.     ..+..+|+.||..||..|.||-.+-+
T Consensus       436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            8643    2334555543   23455555432     24467899999999999999876653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-33  Score=306.73  Aligned_cols=204  Identities=26%  Similarity=0.423  Sum_probs=175.8

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC--Cc-ccHHHHHHHHHHHHHHhhcC---CCCeEeeccceee
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DP-KSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVV  425 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~--~~-~~~~~~k~l~~Ei~iL~~L~---HPNIVkl~~~~~~  425 (739)
                      ..|..++.||+|+||.|++|.+++....|+||.|.+.+.  +. ....-+-.+-.||.||..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            469999999999999999999999999999999864221  10 11111223557999999997   9999999999999


Q ss_pred             cceEEEEEeecC-CCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          426 DDHLYIYLEYVH-PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 ~~~l~LVmEy~~-gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      ++.+||+||-.. |-+|+++|.-+ ..++|.+++.|++|++.|+++||++||||||||-+|+.++.+|.+||+|||.|..
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            999999999764 56899999765 6799999999999999999999999999999999999999999999999999977


Q ss_pred             ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCC
Q 004660          505 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE  563 (739)
Q Consensus       505 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~  563 (739)
                      ...... ..++||..|.|||++.|      ..+.+..-|||+||++||-++...-||.+
T Consensus       720 ~ksgpf-d~f~gtv~~aapevl~g------~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 TKSGPF-DVFVGTVDYAAPEVLGG------EKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hcCCCc-ceeeeeccccchhhhCC------CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            655444 35889999999999974      67778889999999999999999999865

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-32  Score=269.34  Aligned_cols=223  Identities=25%  Similarity=0.444  Sum_probs=185.2

Q ss_pred             CCCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceee
Q 004660          347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV  425 (739)
Q Consensus       347 ~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~  425 (739)
                      .+...+....++.||+|+||.|-+.++..+|...|+|.+...-.    ....+++.+|+.+.... ..|.+|.+||.+..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            45566778888999999999999999999999999999874322    33346778888876555 69999999999999


Q ss_pred             cceEEEEEeecCCCCcchhhh---hccccccHHHHHHHHHhHHHHHHHHHhC-CeecccCCCcceEecCCCcEEEeeccc
Q 004660          426 DDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGM  501 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~---~~~~~lse~~i~~i~~QLl~aL~yLHs~-GIvHRDIKP~NILLd~~g~vKL~DFGl  501 (739)
                      +..++|.||.|+ .+|..+.+   ++++.++|..+-.|+..++.||+|||++ .|+|||+||.||||+.+|.|||||||+
T Consensus       117 egdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI  195 (282)
T KOG0984|consen  117 EGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI  195 (282)
T ss_pred             cccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence            999999999996 67766654   3567899999999999999999999965 899999999999999999999999999


Q ss_pred             chhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCC-CchHHHHHHhhcC
Q 004660          502 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVLNRT  577 (739)
Q Consensus       502 A~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~-~~~~~~~~i~~~~  577 (739)
                      +..+.+.-......|-..|||||.+....+   ...|+.++||||||++++||.+++.||+.. ...+.+.++....
T Consensus       196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n---~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  196 SGYLVDSIAKTMDAGCKPYMAPERINPELN---QKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             ceeehhhhHHHHhcCCCccCChhhcCcccC---cccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            987765444444678899999999975433   336899999999999999999999999865 4456666666543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=7.4e-32  Score=290.67  Aligned_cols=253  Identities=28%  Similarity=0.499  Sum_probs=200.7

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceee
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVV  425 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~---tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~  425 (739)
                      ....|.+.++||+|+|++||+|.+..   ....||+|.|.....       ..++.+|+++|..+. +.||+++.+++..
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-------p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-------PSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-------chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            34569999999999999999999887   788999999875322       246889999999996 8999999999999


Q ss_pred             cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEeecccchh
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKH  504 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~-g~vKL~DFGlA~~  504 (739)
                      +++..+||||++..+..+++..    ++..+++.+++.++.||.++|.+|||||||||.|+|.+.. +.-.|+|||||..
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence            9999999999998888888744    7789999999999999999999999999999999999854 7788999999962


Q ss_pred             ccC----------------------------------ccc-----------ccccCCCCCCCChHHHHHhhhcCCCCCCC
Q 004660          505 LTG----------------------------------LSY-----------ELSLKGSPNWMAPEVIKAVMQKDGNPKLA  539 (739)
Q Consensus       505 ~~~----------------------------------~~~-----------~~s~~GT~~Y~APEvl~~~~~~~g~~~~s  539 (739)
                      ...                                  ..+           .....||++|+|||++...      +.-+
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~------~~Qt  256 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC------PRQT  256 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc------cCcC
Confidence            100                                  000           0013599999999999863      4556


Q ss_pred             cchhhhHHHHHHHHHhhCCCCCCCC-CchHHHHH---Hhh-----------cC---------CC----------------
Q 004660          540 LAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFK---VLN-----------RT---------PP----------------  579 (739)
Q Consensus       540 ~asDIWSLGvVLyELLtGk~PF~~~-~~~~~~~~---i~~-----------~~---------~~----------------  579 (739)
                      .++||||.|+|+.-+++++.||-.. +....+.+   |++           +.         +.                
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~  336 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI  336 (418)
T ss_pred             CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence            7999999999999999999998421 11111111   000           00         00                


Q ss_pred             ------------CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          580 ------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       580 ------------iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                                  .-+..+..+.||+.+||..||.+|+||+++|+||||....
T Consensus       337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence                        0112456889999999999999999999999999998543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.6e-30  Score=258.05  Aligned_cols=214  Identities=36%  Similarity=0.589  Sum_probs=181.1

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      |.+++.||.|++|+||++....+++.+|+|.+......    ...+.+.+|++.++.++|+||+++++.+...+..++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            67889999999999999999988999999988742211    24578889999999999999999999999889999999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--cc
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YE  511 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~--~~  511 (739)
                      ||+.+++|.+++......+++..+..++.|++.+|.|||++|++|+||++.||+++.++.++|+|||++.......  ..
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            9999999999997753338999999999999999999999999999999999999999999999999998775543  23


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCC-CCch-HHHHHHhhcC
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGP-QAMFKVLNRT  577 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~-~~~~-~~~~~i~~~~  577 (739)
                      ....++..|++||.+.      ....++.++|||+||+++|||++|+.||.. .+.. .+...+..+.
T Consensus       157 ~~~~~~~~~~~pe~~~------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      157 KTVKGTPFYLAPEVLL------GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cceeccCCcCCHhHhc------CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            3456888999999884      134566699999999999999999999977 4444 4444455544

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=3e-30  Score=309.06  Aligned_cols=199  Identities=21%  Similarity=0.277  Sum_probs=147.8

Q ss_pred             hcCC-CCeEeeccce-------eecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccC
Q 004660          410 HLKH-ENIVQYYGSE-------VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI  481 (739)
Q Consensus       410 ~L~H-PNIVkl~~~~-------~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDI  481 (739)
                      .+.| .||++++++|       ...+.++++|||+ +++|.++|......+++.+++.|++||++||+|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3445 5788888876       2334678889987 57999999765567999999999999999999999999999999


Q ss_pred             CCcceEecCC-------------------CcEEEeecccchhccCcc-----------------cccccCCCCCCCChHH
Q 004660          482 KGANLLVDAS-------------------GVVKLADFGMAKHLTGLS-----------------YELSLKGSPNWMAPEV  525 (739)
Q Consensus       482 KP~NILLd~~-------------------g~vKL~DFGlA~~~~~~~-----------------~~~s~~GT~~Y~APEv  525 (739)
                      ||+||||+..                   +.+||+|||+++......                 ......||++|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            9999999653                   456666666665321100                 0012458999999999


Q ss_pred             HHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcC-CCCCccCCHHHHHHHHHhcccCCCCCC
Q 004660          526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERP  604 (739)
Q Consensus       526 l~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~el~dLI~kcL~~DP~kRp  604 (739)
                      +.+       ..|+.++||||||||||||++|..||.....  .+..+.... ++..........+++.+||..||.+||
T Consensus       187 ~~~-------~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rp  257 (793)
T PLN00181        187 DNG-------SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRP  257 (793)
T ss_pred             hcc-------CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCc
Confidence            873       3578899999999999999999988754321  222221111 111111245678999999999999999


Q ss_pred             CHHHHHcCcccccc
Q 004660          605 SAVELLEHPFIRNA  618 (739)
Q Consensus       605 Ta~elLqHpwf~~~  618 (739)
                      ++.|+|+||||...
T Consensus       258 s~~eil~h~~~~~~  271 (793)
T PLN00181        258 SMSELLQSEFINEP  271 (793)
T ss_pred             ChHHHhhchhhhhh
Confidence            99999999999763

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-30  Score=263.43  Aligned_cols=256  Identities=22%  Similarity=0.368  Sum_probs=204.3

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeecc-ceeecc
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYG-SEVVDD  427 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~-~~~~~~  427 (739)
                      ..++|.+.+.||+|.||.+.+|+++.+...+++|.+..      ....++.|.+|...--.|. |.|||..|+ +|+..+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d   95 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD   95 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence            45689999999999999999999999999999998753      2334578899998776775 899999988 588889


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEec--CCCcEEEeecccchhc
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASGVVKLADFGMAKHL  505 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd--~~g~vKL~DFGlA~~~  505 (739)
                      .++++|||++.|+|..-+...  .+.|...+.++.||++||.|||++++||||||.+||||-  +...|||||||+.+..
T Consensus        96 ~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen   96 AYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            999999999999999988663  588999999999999999999999999999999999994  3358999999998654


Q ss_pred             cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch----HHHHHHhh-cCCCC
Q 004660          506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----QAMFKVLN-RTPPI  580 (739)
Q Consensus       506 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~----~~~~~i~~-~~~~i  580 (739)
                      ...  -....-+..|.+||+....  ..+.-.....+|||.||+|+|.+|+|++||......    ..+.+..+ ..+..
T Consensus       174 g~t--V~~~~~~~~y~~pe~~~~~--~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  174 GTT--VKYLEYVNNYHAPELCDTV--VNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL  249 (378)
T ss_pred             Cce--ehhhhhhcccCCcHHHhhc--cccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence            321  1123356789999998754  333445667899999999999999999999743221    12222332 23334


Q ss_pred             C---ccCCHHHHHHHHHhcccCCCCC---CCHHHHHcCccccc
Q 004660          581 P---EMLSSEGKDFLLRCFLRNPVER---PSAVELLEHPFIRN  617 (739)
Q Consensus       581 P---~~ls~el~dLI~kcL~~DP~kR---pTa~elLqHpwf~~  617 (739)
                      |   .-+++.+..+.++-|..++++|   .++.......|...
T Consensus       250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            4   3478999999999999999999   77777777777653

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-28  Score=261.86  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=208.7

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCC-----cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS  422 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg-----~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~  422 (739)
                      ...+.++++..++-+|+||.||.|.+++..     +.|-+|.++.    ...+-.+..+..|..+|..+.|||+..+.++
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            345567888899999999999999876532     3455665441    1233445678889999999999999999998


Q ss_pred             eeec-ceEEEEEeecCCCCcchhhh-----h--ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcE
Q 004660          423 EVVD-DHLYIYLEYVHPGSINRYVR-----E--HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV  494 (739)
Q Consensus       423 ~~~~-~~l~LVmEy~~gGsL~~~L~-----~--~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~v  494 (739)
                      ..++ +..++++.+..-|.|..++.     +  ..+.++..++..++.||+.||+|||++||||.||...|++|++.-.|
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV  435 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV  435 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence            7655 45778888998899999997     2  23457888889999999999999999999999999999999999999


Q ss_pred             EEeecccchhccCccccc---ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCchHHH
Q 004660          495 KLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM  570 (739)
Q Consensus       495 KL~DFGlA~~~~~~~~~~---s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~~~~  570 (739)
                      ||+|=.+++.+...++.-   ...-...||++|.+.       +..|+.++||||||++||||++ |+.||.+.+..++.
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~-------n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~  508 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-------NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME  508 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHh-------hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence            999999998775544432   112345799999998       4678889999999999999999 99999999998887


Q ss_pred             HHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          571 FKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       571 ~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .-+.++ +...|-.+++++..++..||+.+|++||+++|+..
T Consensus       509 ~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  509 HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            777654 45678899999999999999999999999999864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=5.9e-27  Score=236.39  Aligned_cols=256  Identities=34%  Similarity=0.558  Sum_probs=206.8

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC-CeEeeccceeecceEEEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE-NIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HP-NIVkl~~~~~~~~~l~LV  432 (739)
                      |.+.+.||.|+||.||++.+.   ..+++|.+......  .......+.+|+.+++.+.|+ +|+++++.+......+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLES--KSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhcc--chhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence            788999999999999999988   78899988643222  123457788999999999988 799999999877889999


Q ss_pred             EeecCCCCcchhhhhcc--ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC-cEEEeecccchhccCcc
Q 004660          433 LEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLS  509 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~--~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g-~vKL~DFGlA~~~~~~~  509 (739)
                      +||+.+++|.+++....  ..+.+..+..++.|++.+|.|+|+.|++||||||+|||++..+ .++|+|||++..+....
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999999997776543  2699999999999999999999999999999999999999988 79999999998654432


Q ss_pred             -------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCc----hHHHHHHhhcCC
Q 004660          510 -------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTP  578 (739)
Q Consensus       510 -------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~----~~~~~~i~~~~~  578 (739)
                             ......||..|++||.+.+..    ...+....|+|++|+++++++.|..||.....    ......+.....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLS----LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCC----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence                   235677999999999987410    13567799999999999999999999877654    333333333322


Q ss_pred             C-CCccC--------CHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          579 P-IPEML--------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       579 ~-iP~~l--------s~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      . .....        ...+.+++..++..+|..|.+..+...+.|....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            2 11111        1578999999999999999999999988666543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=8.3e-28  Score=233.73  Aligned_cols=160  Identities=29%  Similarity=0.331  Sum_probs=130.5

Q ss_pred             CCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCCC
Q 004660          439 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP  518 (739)
Q Consensus       439 GsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s~~GT~  518 (739)
                      |+|.+++......+++.+++.|+.||+.||.|||+++      ||+|||++.++.+|+  ||+++......    ..||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            7899999876667999999999999999999999999      999999999999999  99987664422    26899


Q ss_pred             CCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch-HHHHHHhhcCCC-------CCccCCH--HH
Q 004660          519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPP-------IPEMLSS--EG  588 (739)
Q Consensus       519 ~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~-~~~~~i~~~~~~-------iP~~ls~--el  588 (739)
                      .|||||++.+       ..++.++|||||||++|||++|+.||...... ..+..+......       .+..++.  ++
T Consensus        69 ~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (176)
T smart00750       69 YFMAPEVIQG-------QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF  141 (176)
T ss_pred             cccChHHhcC-------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence            9999999973       45778999999999999999999999765432 233333322211       1223334  69


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                      +++|.+||..||++||++.|+++|+|+..
T Consensus       142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      142 ADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=6.8e-29  Score=287.90  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=207.1

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCC-CCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       355 ~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~-~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      ...+++|.|.+|.|+.+......+.++.|.+.... ......+....+..|+.+-..|.|+||+..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            56788999999999999888877777777654210 12222333344777888889999999999888777777666679


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-----
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-----  508 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~-----  508 (739)
                      |||++ +|+.++... ..+...++..+++||+.||+|||+.||.|||||++|||++.+|.+||+|||.+..+...     
T Consensus       401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence            99999 999999764 46999999999999999999999999999999999999999999999999999876432     


Q ss_pred             ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHH--H-------HHhhcCCC
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM--F-------KVLNRTPP  579 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~--~-------~i~~~~~~  579 (739)
                      .....++|+..|+|||++.+      ..+....+||||.|+|++.|++|+.||......+..  .       ++..+...
T Consensus       479 ~~~~g~~gS~pY~apE~~~~------~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~  552 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTG------KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR  552 (601)
T ss_pred             hhhcCcccCCcCcCcccccc------cccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence            23346789999999999875      345556899999999999999999999754433222  1       11122223


Q ss_pred             CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 004660          580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       580 iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~  620 (739)
                      +...++.+.+.+|.+||+.||.+|+|+++||+.+||+....
T Consensus       553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            44567889999999999999999999999999999987543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=3.2e-26  Score=251.19  Aligned_cols=185  Identities=17%  Similarity=0.183  Sum_probs=138.7

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEe-eccceee
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ-YYGSEVV  425 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~-tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVk-l~~~~~~  425 (739)
                      .....+|+++++||+|+||+||+|+++. +++.||||++.............+.+.+|+++|++|+|+|||. +++.   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            3455679999999999999999999886 6788899986521110012334567899999999999999984 5542   


Q ss_pred             cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccC-CCcceEecCCCcEEEeecccchh
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI-KGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDI-KP~NILLd~~g~vKL~DFGlA~~  504 (739)
                       +..||||||++|++|... ...    .   ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence             458999999999999632 111    1   1468899999999999999999999 99999999999999999999986


Q ss_pred             ccCcc---------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhh
Q 004660          505 LTGLS---------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIW  545 (739)
Q Consensus       505 ~~~~~---------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIW  545 (739)
                      +....         ......++..|+|||.+..... ......+...|-|
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~-~~~~~~~~~~dgW  210 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRER-KILARKSLPSRIW  210 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCChhhh-ccccccccccCcE
Confidence            54321         1134568899999999864322 1223333456777

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2e-27  Score=267.23  Aligned_cols=243  Identities=26%  Similarity=0.428  Sum_probs=210.9

Q ss_pred             EEeecCCeEEEEEE---ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecceEEEEEe
Q 004660          359 LIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLE  434 (739)
Q Consensus       359 ~LG~G~fGtVy~a~---~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~l~LVmE  434 (739)
                      ++|.|+||.|++++   ....|..+|+|+.+..........   ....|..++..++ ||.+|+++..++.+..++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            47999999999875   334578899998875433222221   4456778888887 9999999999999999999999


Q ss_pred             ecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccccc
Q 004660          435 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL  514 (739)
Q Consensus       435 y~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s~  514 (739)
                      |..||+|...+.+. ..+++..++.+...++.+++++|+.||+|||+|++||+++.+|++|+.|||+.+........   
T Consensus        78 ~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---  153 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---  153 (612)
T ss_pred             hcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence            99999999999765 67899999999999999999999999999999999999999999999999999987654443   


Q ss_pred             CCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHH
Q 004660          515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLR  594 (739)
Q Consensus       515 ~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~k  594 (739)
                      +||..|||||++++         ...++|.||+|++++||++|..||..    +....|+.....+|..++.++.+++..
T Consensus       154 cgt~eymApEI~~g---------h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~  220 (612)
T KOG0603|consen  154 CGTYEYRAPEIING---------HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQ  220 (612)
T ss_pred             ccchhhhhhHhhhc---------cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHH
Confidence            89999999999973         34589999999999999999999988    777788888889999999999999999


Q ss_pred             hcccCCCCCCC-----HHHHHcCccccccccC
Q 004660          595 CFLRNPVERPS-----AVELLEHPFIRNANYQ  621 (739)
Q Consensus       595 cL~~DP~kRpT-----a~elLqHpwf~~~~~~  621 (739)
                      ++.++|..|.-     +.|+++|+||+...+.
T Consensus       221 l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  221 LFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            99999999964     5799999999987765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.3e-25  Score=238.26  Aligned_cols=247  Identities=24%  Similarity=0.313  Sum_probs=191.9

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCC-cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC----CCeEeeccce-eec
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH----ENIVQYYGSE-VVD  426 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg-~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~H----PNIVkl~~~~-~~~  426 (739)
                      +|.+.+.||+|+||.||+|.+..++ ..+|+|+.........     ..+..|+.+|..+..    .++..+++.. ..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            8999999999999999999998775 6788887664322111     145668888888762    5888998888 477


Q ss_pred             ceEEEEEeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC-----CcEEEeecc
Q 004660          427 DHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-----GVVKLADFG  500 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~-----g~vKL~DFG  500 (739)
                      ...||||+++ |.+|.++..... +.++..++..++.|++.+|++||+.|++||||||+|+++...     ..+.|+|||
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            7899999998 789999886554 789999999999999999999999999999999999999765     469999999


Q ss_pred             cch--hccCcc--------c-ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHH
Q 004660          501 MAK--HLTGLS--------Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA  569 (739)
Q Consensus       501 lA~--~~~~~~--------~-~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~  569 (739)
                      +++  .+....        . ...+.||..|+++.+..+       ...+.+.|+||++.++.||+.|.+||........
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-------~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~  245 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-------IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL  245 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-------CccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence            998  322111        1 123569999999998874       4556789999999999999999999977654333


Q ss_pred             HHHHhh---cC-CC-CCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          570 MFKVLN---RT-PP-IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       570 ~~~i~~---~~-~~-iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ..++..   .. .. .....+.++.+++..+-..+...+|....+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  246 KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            322221   11 11 233456778888888877899999998877654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.6e-23  Score=212.91  Aligned_cols=245  Identities=24%  Similarity=0.329  Sum_probs=196.3

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC-CCeEeeccceeec
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVD  426 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~H-PNIVkl~~~~~~~  426 (739)
                      ......|.+++.||.|+||.+|+|....+|+.||||+-....   ..    -++..|.++.+.|++ ..|..+.-+..++
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~   83 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KH----PQLLYESKVYRILQGGVGIPHIRHYGTEK   83 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CC----cchhHHHHHHHHhccCCCCchhhhhcccc
Confidence            345678999999999999999999999999999999754221   11    246678899888874 6777788788888


Q ss_pred             ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC---CCcEEEeecccch
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAK  503 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~---~g~vKL~DFGlA~  503 (739)
                      +.-.|||+++ |.+|.+++.--.+.++..++.-++.||+.-|+|+|.++++||||||+|+|+.-   ...+.|+|||||+
T Consensus        84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence            8999999998 68888888654567999999999999999999999999999999999999964   3579999999998


Q ss_pred             hccCcc--------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch---HHHHH
Q 004660          504 HLTGLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFK  572 (739)
Q Consensus       504 ~~~~~~--------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~---~~~~~  572 (739)
                      .+.+..        ......||.+|.+--.+.+..+.       ...|+-|+|.||.++.-|.+||.+....   +...+
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqS-------RRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk  235 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQS-------RRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK  235 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhh-------hhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence            875432        12246699999998888765544       3679999999999999999999876443   34445


Q ss_pred             HhhcCCCCC-----ccCCHHHHHHHHHhcccCCCCCCCHH
Q 004660          573 VLNRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAV  607 (739)
Q Consensus       573 i~~~~~~iP-----~~ls~el~dLI~kcL~~DP~kRpTa~  607 (739)
                      |.+.....+     ..++.++...|.-|-..--++-|...
T Consensus       236 I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  236 ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            555544433     35788899999988887777777643

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.4e-23  Score=221.14  Aligned_cols=243  Identities=24%  Similarity=0.341  Sum_probs=189.7

Q ss_pred             CCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecc
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD  427 (739)
Q Consensus       349 ~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~  427 (739)
                      ...-.|.++++||+|+||.+++|.+.-+++.||||.-..   ....    -++..|.+..+.|. .++|..+|.+....-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr---kS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~   97 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR---KSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGK   97 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccc---cCCc----chHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence            345579999999999999999999999999999996432   2222    24667888888775 689999998888888


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC-----CCcEEEeecccc
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-----SGVVKLADFGMA  502 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~-----~g~vKL~DFGlA  502 (739)
                      +-.||||++ |.+|+|+..--++.++..++..++.||+.-|+|+|++.+|.|||||+|+||..     ...|.|+|||+|
T Consensus        98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            899999998 68888888665678999999999999999999999999999999999999964     347999999999


Q ss_pred             hhccCccc--------ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCC---chHHHH
Q 004660          503 KHLTGLSY--------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---GPQAMF  571 (739)
Q Consensus       503 ~~~~~~~~--------~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~---~~~~~~  571 (739)
                      +...+...        ..+..||.+||+-....|..+       +...|+-|||-|+++.|-|.+||.+..   ..+..+
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-------SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe  249 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-------SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE  249 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchh-------hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence            98765432        235679999999988876444       447899999999999999999998654   344445


Q ss_pred             HHhhcCCCCC-----ccCCHHHHHHHHHhcccCCCCCCCH
Q 004660          572 KVLNRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSA  606 (739)
Q Consensus       572 ~i~~~~~~iP-----~~ls~el~dLI~kcL~~DP~kRpTa  606 (739)
                      +|-......|     +.++.++...|+-.-..+-.+-|..
T Consensus       250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence            5533222221     2355666666665555555555553

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.3e-23  Score=222.02  Aligned_cols=260  Identities=23%  Similarity=0.361  Sum_probs=188.9

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCc-----------------------------------EEEEEEeecCCCCccc
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGA-----------------------------------SCAIKEVDIIPDDPKS  394 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~-----------------------------------~VAIK~i~~~~~~~~~  394 (739)
                      ..++|++++.||+|.-+.||.|+...+|.                                   +.|||.+-.+..+...
T Consensus       155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~  234 (598)
T KOG4158|consen  155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD  234 (598)
T ss_pred             chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence            34679999999999999999987655322                                   3566766544444444


Q ss_pred             HHHHHHHHHHHH------HH--------h-------h-cCCCCeEeeccceee---------------------------
Q 004660          395 AECIKQLEQEIK------VL--------G-------H-LKHENIVQYYGSEVV---------------------------  425 (739)
Q Consensus       395 ~~~~k~l~~Ei~------iL--------~-------~-L~HPNIVkl~~~~~~---------------------------  425 (739)
                      ...++...+|+.      .+        +       + -+|||||++.++|.+                           
T Consensus       235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~  314 (598)
T KOG4158|consen  235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE  314 (598)
T ss_pred             HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence            555555555531      11        1       1 269999999988754                           


Q ss_pred             cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEec--CCC--cEEEeeccc
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASG--VVKLADFGM  501 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd--~~g--~vKL~DFGl  501 (739)
                      ...+|+||..++ .+|..|+-.+  ..+....+-++.||++|+.|||++||.|||+|.+||||.  +|+  .+.|+|||+
T Consensus       315 ~~tlylvMkrY~-~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC  391 (598)
T KOG4158|consen  315 PKTLYLVMKRYR-QTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC  391 (598)
T ss_pred             CceEEEehhcch-hhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence            125899998775 7888888663  467788889999999999999999999999999999983  444  588999998


Q ss_pred             chhc-------cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHH--HHH
Q 004660          502 AKHL-------TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA--MFK  572 (739)
Q Consensus       502 A~~~-------~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~--~~~  572 (739)
                      +-.-       ...+......|.-.-||||+....-....--.| .++|.|+.|.+.||+++..-||..-.+...  ..-
T Consensus       392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny-~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y  470 (598)
T KOG4158|consen  392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNY-EKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY  470 (598)
T ss_pred             eeeccccccccccccccccCCCcceecchhhhhcCCCCceeecc-chhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence            7322       223344456688899999998754222111122 389999999999999999999987322211  111


Q ss_pred             HhhcCCCCCccCCHHHHHHHHHhcccCCCCCCC---HHHHHcCc
Q 004660          573 VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPS---AVELLEHP  613 (739)
Q Consensus       573 i~~~~~~iP~~ls~el~dLI~kcL~~DP~kRpT---a~elLqHp  613 (739)
                      .....+.+|+.+++.+++|+..+|+.||.+|++   +..+|+--
T Consensus       471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~Ls  514 (598)
T KOG4158|consen  471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLS  514 (598)
T ss_pred             hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHH
Confidence            223467789999999999999999999999987   44566533

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=2e-23  Score=244.41  Aligned_cols=224  Identities=28%  Similarity=0.475  Sum_probs=176.6

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  427 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~  427 (739)
                      .+...+|..++.|-.|+||.||+++++.+.+.+|+|+ .+  +    ..    +.+  .||.....|.+|          
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nk--q----~l----ilR--nilt~a~npfvv----------  135 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NK--Q----NL----ILR--NILTFAGNPFVV----------  135 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhcc-cc--c----ch----hhh--ccccccCCccee----------
Confidence            3445689999999999999999999999999999953 21  1    11    111  033333444444          


Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                                 ||-..+++.. +.++.+        ++.+++|||+.||+|||+||+|+||+.-|++|++|||+.+....
T Consensus       136 -----------gDc~tllk~~-g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 -----------GDCATLLKNI-GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             -----------chhhhhcccC-CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                       5555555443 334432        38899999999999999999999999999999999999875321


Q ss_pred             ----------------cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHH
Q 004660          508 ----------------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF  571 (739)
Q Consensus       508 ----------------~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~  571 (739)
                                      .-.....+||+.|+|||++..       ..|+..+|+|+||+|+||.+.|..||.+...++.+.
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-------qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg  268 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG  268 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhh-------hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh
Confidence                            001123579999999999973       467889999999999999999999999999988888


Q ss_pred             HHhhcCCCCCc---cCCHHHHHHHHHhcccCCCCCC---CHHHHHcCccccccccC
Q 004660          572 KVLNRTPPIPE---MLSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRNANYQ  621 (739)
Q Consensus       572 ~i~~~~~~iP~---~ls~el~dLI~kcL~~DP~kRp---Ta~elLqHpwf~~~~~~  621 (739)
                      .++.....+|+   .+.++++++|.++|..+|..|.   .+-++.+|.||+..++.
T Consensus       269 ~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  269 QVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             hhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            88887766665   4789999999999999999994   57789999999988775

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=6.2e-23  Score=206.15  Aligned_cols=144  Identities=19%  Similarity=0.169  Sum_probs=111.8

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccH---------------------HHHHHHHHHHHHHhhcCCCC
Q 004660          357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------------------ECIKQLEQEIKVLGHLKHEN  415 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~---------------------~~~k~l~~Ei~iL~~L~HPN  415 (739)
                      .+.||+|+||.||+|.+. +|+.||||+++.........                     .......+|+++|..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999987 89999999997532111110                     01234456999999998877


Q ss_pred             eEeeccceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHH-HhCCeecccCCCcceEecCCCcE
Q 004660          416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGANLLVDASGVV  494 (739)
Q Consensus       416 IVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yL-Hs~GIvHRDIKP~NILLd~~g~v  494 (739)
                      |...+... .. ..+|||||+.|++|...+... ..+++.++..++.||+.+|.|| |+.||+||||||+|||++ ++.+
T Consensus        81 v~~p~~~~-~~-~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          81 IPCPEPIL-LK-SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCCCcEEE-ec-CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence            64433222 22 238999999998776654332 5689999999999999999999 799999999999999998 5789


Q ss_pred             EEeecccchhc
Q 004660          495 KLADFGMAKHL  505 (739)
Q Consensus       495 KL~DFGlA~~~  505 (739)
                      +|+|||+|...
T Consensus       157 ~LiDFG~a~~~  167 (190)
T cd05147         157 YIIDVSQSVEH  167 (190)
T ss_pred             EEEEccccccC
Confidence            99999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=7.3e-24  Score=248.00  Aligned_cols=248  Identities=23%  Similarity=0.293  Sum_probs=186.5

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      +|...+.||++.|=+|.+|++.+ | .|+||++-+. ++...-.-.++...|++ ...+++||++.+..+.+.+...|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~-~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQ-DPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEecc-CCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            68889999999999999998775 3 4999988643 32333333344445566 5667899999999988888889999


Q ss_pred             EeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc--cCcc-
Q 004660          433 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLS-  509 (739)
Q Consensus       433 mEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~--~~~~-  509 (739)
                      -+|+. .+|+|.|..+ ..+.+.+.++|+.||+.||..||+.||+|||||.+||||+..+-+.|+||..-+..  ..+. 
T Consensus       100 Rqyvk-hnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  100 RQYVK-HNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHHHh-hhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            99996 7899998664 66889999999999999999999999999999999999999999999999876432  1111 


Q ss_pred             -cccccCC----CCCCCChHHHHHhh----hcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCc-------hHHHHH
Q 004660          510 -YELSLKG----SPNWMAPEVIKAVM----QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG-------PQAMFK  572 (739)
Q Consensus       510 -~~~s~~G----T~~Y~APEvl~~~~----~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~-------~~~~~~  572 (739)
                       ....+-.    -..|+|||.+....    ........+.+-||||+|||++||++ |+++|.-...       ......
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~  257 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ  257 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence             1111112    23699999998633    11122337889999999999999988 8999852110       111111


Q ss_pred             HhhcCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          573 VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       573 i~~~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      ++++      .-+..++.||..|+++||.+|.+|++.|+.
T Consensus       258 ~Le~------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  258 LLEK------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHh------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1111      123478999999999999999999999985

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=2.7e-22  Score=200.62  Aligned_cols=147  Identities=16%  Similarity=0.144  Sum_probs=114.4

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc---------------------HHHHHHHHHHHHHHhhcCCC
Q 004660          356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---------------------AECIKQLEQEIKVLGHLKHE  414 (739)
Q Consensus       356 i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~---------------------~~~~k~l~~Ei~iL~~L~HP  414 (739)
                      +.+.||+|+||.||+|.+. +|+.||||+++........                     ......+.+|+..+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 8999999998754221100                     11123456899999999999


Q ss_pred             CeEeeccceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCc
Q 004660          415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGV  493 (739)
Q Consensus       415 NIVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~  493 (739)
                      +|.....+...  ..||||||+.|+++...+... ..+++.++..++.||+.+|.+||. +||+||||||+|||++ ++.
T Consensus        80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCCCceEEEec--CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence            87544333322  248999999988654443222 457888999999999999999999 9999999999999998 899


Q ss_pred             EEEeecccchhccC
Q 004660          494 VKLADFGMAKHLTG  507 (739)
Q Consensus       494 vKL~DFGlA~~~~~  507 (739)
                      ++|+|||++.....
T Consensus       156 ~~liDFG~a~~~~~  169 (190)
T cd05145         156 PYIIDVSQAVELDH  169 (190)
T ss_pred             EEEEEcccceecCC
Confidence            99999999977643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=2.7e-22  Score=213.08  Aligned_cols=242  Identities=23%  Similarity=0.295  Sum_probs=155.1

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC----------CC------e
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH----------EN------I  416 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~H----------PN------I  416 (739)
                      .+.+++.||.|+++.||.+++.+||+.+|+|++.... + .....++.+++|.-....+.+          -.      +
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~-~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-D-ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-T-THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-c-cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            5788999999999999999999999999999987644 2 223335666666644443222          12      2


Q ss_pred             Eeecc---ceeec---c-----eEEEEEeecCCCCcchhhhh---ccc---cccHHHHHHHHHhHHHHHHHHHhCCeecc
Q 004660          417 VQYYG---SEVVD---D-----HLYIYLEYVHPGSINRYVRE---HCR---DITESIVRNFTRHILNGLAYLHSTNTIHR  479 (739)
Q Consensus       417 Vkl~~---~~~~~---~-----~l~LVmEy~~gGsL~~~L~~---~~~---~lse~~i~~i~~QLl~aL~yLHs~GIvHR  479 (739)
                      +++-+   ++...   .     ..+++|+-+. ++|.+++..   ...   .+.......+..|+++.+++||..||||+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            33322   11111   1     2366777774 788777642   111   12223334566999999999999999999


Q ss_pred             cCCCcceEecCCCcEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhc-CCCCCCCcchhhhHHHHHHHHHhhCC
Q 004660          480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK-DGNPKLALAVDIWSLGCTVIEMLTGK  558 (739)
Q Consensus       480 DIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~-~g~~~~s~asDIWSLGvVLyELLtGk  558 (739)
                      ||||+|+|++.+|.++|+||+...........  ...+..|.+||.......+ .....++.+.|.|+||+++|.|.+|.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            99999999999999999999987654332221  3456889999987653110 02345788999999999999999999


Q ss_pred             CCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHhcccCCCCC
Q 004660          559 PPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVER  603 (739)
Q Consensus       559 ~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kcL~~DP~kR  603 (739)
                      .||............+..-   . .+++.+++||+++|++||++|
T Consensus       248 lPf~~~~~~~~~~~~f~~C---~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEWDFSRC---R-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGGGGTTS---S----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccccchhc---C-CcCHHHHHHHHHHccCCcccC
Confidence            9998654322211122211   1 578889999999999999988

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=2.9e-22  Score=207.08  Aligned_cols=175  Identities=13%  Similarity=0.154  Sum_probs=133.3

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHH------HHHHHHHHhhcCCCCeEeeccce
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------LEQEIKVLGHLKHENIVQYYGSE  423 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~------l~~Ei~iL~~L~HPNIVkl~~~~  423 (739)
                      ...+|++.++||.|+||.||++..  ++..||||++.....  ........      +++|+..+.+|.|++|..+.+++
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~--~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVK--RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcC--chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            357899999999999999999765  467899998863221  22333333      68999999999999999998876


Q ss_pred             eec--------ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEE
Q 004660          424 VVD--------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK  495 (739)
Q Consensus       424 ~~~--------~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vK  495 (739)
                      ...        +..+|||||++|.+|.++..     +++    ..+.+|+.+|..||+.||+||||||.|||++.+| ++
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence            643        35899999999999987631     333    2466999999999999999999999999999999 99


Q ss_pred             EeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh
Q 004660          496 LADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT  556 (739)
Q Consensus       496 L~DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt  556 (739)
                      |+|||............           ..+..       ..|..++|||+||++|..+..
T Consensus       175 liDfg~~~~~~e~~a~d-----------~~vle-------r~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKD-----------RIDLE-------RHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEECCCcccccchhhHH-----------HHHHH-------hHhcccccccceeEeehHHHH
Confidence            99999886653221110           02221       234468999999999877643

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.3e-21  Score=199.29  Aligned_cols=189  Identities=16%  Similarity=0.123  Sum_probs=141.3

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecceEEEEE
Q 004660          355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       355 ~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      .+...|++|+||+||++..  .+.+++.+.+...+.- ...-....+.+|+++|++|. |++|.+++++    +..|++|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~-~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWW-LRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhh-hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            4578899999999997765  5788887766532211 01111235789999999996 5889998875    3469999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccC-CCcceEecCCCcEEEeecccchhccCccc--
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI-KGANLLVDASGVVKLADFGMAKHLTGLSY--  510 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDI-KP~NILLd~~g~vKL~DFGlA~~~~~~~~--  510 (739)
                      ||+.|.+|.+.+..       . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|........  
T Consensus        78 eyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             eeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            99999998754421       1 1357889999999999999999999 79999999999999999999985543221  


Q ss_pred             ------------ccccCCCCCCCChHHHHHhhhcCCCCCCC-cchhhhHHHHHHHHHhhCCCCCCCC
Q 004660          511 ------------ELSLKGSPNWMAPEVIKAVMQKDGNPKLA-LAVDIWSLGCTVIEMLTGKPPWSEF  564 (739)
Q Consensus       511 ------------~~s~~GT~~Y~APEvl~~~~~~~g~~~~s-~asDIWSLGvVLyELLtGk~PF~~~  564 (739)
                                  ..-...++.|+.|+...-..      ..+ .+.++++.|+-+|.++|+..++..+
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~------~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLK------RTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc------cchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                        01123689999999765321      112 4678889999999999999886544

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=2.2e-20  Score=191.00  Aligned_cols=136  Identities=21%  Similarity=0.286  Sum_probs=106.7

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-----CCCCeEeeccceeecc--
Q 004660          355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-----KHENIVQYYGSEVVDD--  427 (739)
Q Consensus       355 ~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-----~HPNIVkl~~~~~~~~--  427 (739)
                      .-.++||+|+||.||.  +..++.. +||++.....     ...+.+.+|+++++.|     .||||+++|++++++.  
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~   76 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT   76 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence            3457899999999995  6666665 6888764211     1235688999999999     5799999999998873  


Q ss_pred             -e-EEEEEee--cCCCCcchhhhhccccccHHHHHHHHHhHHHHH-HHHHhCCeecccCCCcceEecCC----CcEEEee
Q 004660          428 -H-LYIYLEY--VHPGSINRYVREHCRDITESIVRNFTRHILNGL-AYLHSTNTIHRDIKGANLLVDAS----GVVKLAD  498 (739)
Q Consensus       428 -~-l~LVmEy--~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL-~yLHs~GIvHRDIKP~NILLd~~----g~vKL~D  498 (739)
                       . +.+||||  +.+|+|.+++++.  .+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+|
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence             4 3478999  5579999999663  36655  36688888887 99999999999999999999743    3799999


Q ss_pred             cccc
Q 004660          499 FGMA  502 (739)
Q Consensus       499 FGlA  502 (739)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.83  E-value=5e-21  Score=197.21  Aligned_cols=245  Identities=20%  Similarity=0.323  Sum_probs=194.6

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEE
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .++..+.-+|.+.-.|..|+|+++  |..+++|++.+.   ......-+.|..|.-.|+-..||||+.+++.+.....+.
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr---~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVR---EVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             hhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhh---hcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            345667778999999999999987  455666766542   223334467888999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCC--eecccCCCcceEecCCCcEEEe--ecccchhc
Q 004660          431 IYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKLA--DFGMAKHL  505 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~G--IvHRDIKP~NILLd~~g~vKL~--DFGlA~~~  505 (739)
                      +|..|++.|+|+..+.+.. .-++..++..++.+|++|++|||+..  |.---|....++||++-..+|.  |--++.. 
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-  342 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-  342 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence            9999999999999997752 34678899999999999999999875  4444688899999999877664  3222111 


Q ss_pred             cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHh--hcCCCCCcc
Q 004660          506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEM  583 (739)
Q Consensus       506 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~--~~~~~iP~~  583 (739)
                           .......+.||+||.++....    ...-.++|+|||+++||||.|...||.+....+.-.+|.  +....+|..
T Consensus       343 -----e~gr~y~pawmspealqrkpe----d~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippg  413 (448)
T KOG0195|consen  343 -----EVGRAYSPAWMSPEALQRKPE----DLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPG  413 (448)
T ss_pred             -----ccccccCcccCCHHHHhcCch----hcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCC
Confidence                 112334789999999985322    122358999999999999999999999988887766653  456789999


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELL  610 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elL  610 (739)
                      ++.....||..|+..||.+||.+..++
T Consensus       414 is~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  414 ISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999999999887664

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=5.4e-20  Score=191.18  Aligned_cols=152  Identities=18%  Similarity=0.126  Sum_probs=116.8

Q ss_pred             CCCceEeeEEeecCCeEEEEEE-ECCCCcEEEEEEeecCCCCcc-------------------cHHHHHHHHHHHHHHhh
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPK-------------------SAECIKQLEQEIKVLGH  410 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~-~k~tg~~VAIK~i~~~~~~~~-------------------~~~~~k~l~~Ei~iL~~  410 (739)
                      ...|.+.+.||+|+||.||+|. +..+|+.||||+++.......                   .......+.+|+.++.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458999999999999999999 667899999999874321100                   01122456789999999


Q ss_pred             cCCCCeEeeccceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCC-eecccCCCcceEec
Q 004660          411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN-TIHRDIKGANLLVD  489 (739)
Q Consensus       411 L~HPNIVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~G-IvHRDIKP~NILLd  489 (739)
                      +.+. ++.+...+.. ...+|||||+.|++|..+.... ..+.+.++..++.||+.+|.+||++| |+||||||+|||++
T Consensus       107 L~~~-~i~~p~~~~~-~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      107 LYEA-GVPVPKPIAW-RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             HHhc-CCCCCeeeEe-cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            9753 2222222222 2358999999998887765332 34667778899999999999999999 99999999999999


Q ss_pred             CCCcEEEeecccchhcc
Q 004660          490 ASGVVKLADFGMAKHLT  506 (739)
Q Consensus       490 ~~g~vKL~DFGlA~~~~  506 (739)
                       ++.++|+|||++....
T Consensus       184 -~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 -DGKVVIIDVSQSVELD  199 (237)
T ss_pred             -CCCEEEEEChhhhccC
Confidence             8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=4.1e-19  Score=178.36  Aligned_cols=140  Identities=21%  Similarity=0.290  Sum_probs=114.7

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc---cHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~---~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      ++.||+|++|.||+|.+  +|..|++|+.........   .......+.+|+.++..+.|++|.....++...+..+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999987  678899997642211111   1112346788999999999999877777777778899999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      ||++|++|.+++....    . ....++.+|+.+|.+||..||+||||+|.|||++ ++.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999986531    2 7889999999999999999999999999999999 78999999999865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=6.5e-21  Score=221.56  Aligned_cols=258  Identities=29%  Similarity=0.436  Sum_probs=210.4

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecce
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH  428 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~-tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~  428 (739)
                      ...|.+.+.||+|+|+.|-++.... ....+|+|.+....   ......++...|..+-..+. |.|++.+++.....+.
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~   95 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS   95 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCcc
Confidence            3457888889999999999888754 34557777665433   33444566777888888887 9999999999999999


Q ss_pred             EEEEEeecCCCCcchhh-hhccccccHHHHHHHHHhHHHHHHHHH-hCCeecccCCCcceEecCCC-cEEEeecccchhc
Q 004660          429 LYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASG-VVKLADFGMAKHL  505 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L-~~~~~~lse~~i~~i~~QLl~aL~yLH-s~GIvHRDIKP~NILLd~~g-~vKL~DFGlA~~~  505 (739)
                      .++++||..|+++++.+ .......+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+|++|||+|..+
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            99999999999999999 554436888999999999999999999 99999999999999999999 9999999999876


Q ss_pred             cC-cc---cccccCC-CCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHH-HHHhhc---
Q 004660          506 TG-LS---YELSLKG-SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM-FKVLNR---  576 (739)
Q Consensus       506 ~~-~~---~~~s~~G-T~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~-~~i~~~---  576 (739)
                      .. ..   .....+| ++.|+|||.+.+.      .+.+...|+||+|+++.-|++|..||......... ......   
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~------~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  249 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGK------AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR  249 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccch------hhcCCCcccccccccccccccCCCCccccccccccceeecccccc
Confidence            54 21   2234568 9999999998752      34566899999999999999999999765443322 122221   


Q ss_pred             -CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          577 -TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       577 -~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                       ....+..++....+++.++|..+|.+|.+.+++-.++|+..
T Consensus       250 ~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  250 FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence             23455678899999999999999999999999999999987

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=9.1e-19  Score=174.54  Aligned_cols=136  Identities=22%  Similarity=0.299  Sum_probs=108.4

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc---cHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEee
Q 004660          359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY  435 (739)
Q Consensus       359 ~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~---~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy  435 (739)
                      .||+|+||+||+|..  +|..|++|+.........   ......++.+|+++++.+.|++|.....++...+..+|||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  578899998643221111   112246778999999999988765555455566778999999


Q ss_pred             cCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          436 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       436 ~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                      ++|++|.+++....  .      .++.||+.+|.+||+.||+||||||+|||++ ++.++|+|||++...
T Consensus        79 ~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999998875531  1      7899999999999999999999999999999 899999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=8e-19  Score=209.37  Aligned_cols=197  Identities=24%  Similarity=0.315  Sum_probs=156.5

Q ss_pred             CCCCCCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC---CCCeEeeccc
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQYYGS  422 (739)
Q Consensus       346 ~~~~~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~---HPNIVkl~~~  422 (739)
                      ...+....|.|-+.||+|+||+||+|.... |+.||+|+-+.  .....      |.--.+++.+|+   -+-|+.+..+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P--~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a  762 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKP--PNPWE------FYICLQVMERLKPQMLPSIMHISSA  762 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecC--CCcee------eeehHHHHHhhchhhhcchHHHHHH
Confidence            445566789999999999999999999877 99999997542  11111      000112233333   3456777777


Q ss_pred             eeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC-------CCcEE
Q 004660          423 EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-------SGVVK  495 (739)
Q Consensus       423 ~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~-------~g~vK  495 (739)
                      +...+.-+||+||.+.|+|.+++.. .+.+++..+..|+.||+..|+.||..||||+||||+|+||..       .--++
T Consensus       763 ~~~~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  763 HVFQNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             HccCCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceE
Confidence            7778888999999999999999974 477999999999999999999999999999999999999942       23599


Q ss_pred             Eeecccchhc---cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCC
Q 004660          496 LADFGMAKHL---TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP  559 (739)
Q Consensus       496 L~DFGlA~~~---~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~  559 (739)
                      |||||.+-.+   .+.......++|-.+--+|++.       +..++..+|.|.|+.++|-||.|+.
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~-------grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE-------GRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhc-------CCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9999998544   3343444567899999999987       4678889999999999999999974

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=1e-18  Score=175.23  Aligned_cols=143  Identities=18%  Similarity=0.176  Sum_probs=111.1

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc-----------------HHHHHHHHHHHHHHhhcCCCC
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-----------------AECIKQLEQEIKVLGHLKHEN  415 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~-----------------~~~~k~l~~Ei~iL~~L~HPN  415 (739)
                      .|.+.+.||+|+||.||+|... +|+.||||++.........                 ........+|+.++..+.|.+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3888999999999999999875 7999999987642211000                 011224678999999998774


Q ss_pred             --eEeeccceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCc
Q 004660          416 --IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV  493 (739)
Q Consensus       416 --IVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~  493 (739)
                        +...++    ....++||||++|++|..+...       .....++.+|+.+|.++|+.||+||||||+||||+.++.
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence              344433    3456899999999998765431       345678899999999999999999999999999999999


Q ss_pred             EEEeecccchhccC
Q 004660          494 VKLADFGMAKHLTG  507 (739)
Q Consensus       494 vKL~DFGlA~~~~~  507 (739)
                      ++|+|||++..+..
T Consensus       164 ~~liDfg~~~~~~~  177 (198)
T cd05144         164 IYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEEECCccccCCC
Confidence            99999999966544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=1.5e-19  Score=200.71  Aligned_cols=243  Identities=23%  Similarity=0.312  Sum_probs=165.3

Q ss_pred             CceEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeecc-------c
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG-------S  422 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~t---g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~-------~  422 (739)
                      .+.+.+..++++++.++..+....   .+.++.+..+.     ..........+++-.+....|-+..-+.+       .
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~-----d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~  319 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV-----DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES  319 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhc-----cchhhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence            345556666677776665543332   22233332221     12122334445555555554433333322       1


Q ss_pred             ee-----ecceEEEEEeecCCCCcchhhhh--ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEE
Q 004660          423 EV-----VDDHLYIYLEYVHPGSINRYVRE--HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK  495 (739)
Q Consensus       423 ~~-----~~~~l~LVmEy~~gGsL~~~L~~--~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vK  495 (739)
                      +.     ....+||.|++|.-.+|.++|..  .....+......|+.|++.|++|   +|.+|||+||.||++..++.+|
T Consensus       320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k  396 (516)
T KOG1033|consen  320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK  396 (516)
T ss_pred             ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence            11     12358999999999999999953  34457778889999999999999   9999999999999999999999


Q ss_pred             EeecccchhccCcc-------cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhh-CCCCCCCCCch
Q 004660          496 LADFGMAKHLTGLS-------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP  567 (739)
Q Consensus       496 L~DFGlA~~~~~~~-------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLt-Gk~PF~~~~~~  567 (739)
                      |+|||+........       ......||.+||+||.+.+       ..|+.++||||||+||+||+. -...|.   ..
T Consensus       397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-------~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~  466 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-------QQYSEKVDIYALGLILAELLIQFSTQFE---RI  466 (516)
T ss_pred             hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh-------hhhhhhcchhhHHHHHHHHHHHhccHHH---HH
Confidence            99999997765544       4445789999999999985       578889999999999999998 222221   11


Q ss_pred             HHHHHHhhcCCCCCc---cCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          568 QAMFKVLNRTPPIPE---MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       568 ~~~~~i~~~~~~iP~---~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ..+..+.++  .+|+   .-.++-.+|+.+||...|.+||++.+.--|.|.
T Consensus       467 ~t~~d~r~g--~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  467 ATLTDIRDG--IIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             HhhhhhhcC--CCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            222222333  2331   112445789999999999999988777767664

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=4.1e-18  Score=196.37  Aligned_cols=142  Identities=19%  Similarity=0.227  Sum_probs=113.2

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc---ccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecce
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~---~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ..|...++||+|+||+||++.+..  ..+++|+........   ......+++.+|+++|+.++|++|+..+.++...+.
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345678999999999999998753  345555432111111   111234568899999999999999887777777778


Q ss_pred             EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                      .++||||++|++|.+++.         ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            899999999999998875         346789999999999999999999999999999 6789999999999764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=3.1e-18  Score=192.70  Aligned_cols=204  Identities=26%  Similarity=0.449  Sum_probs=162.0

Q ss_pred             HhhcCCCCeEeeccceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCe-ecccCCCcce
Q 004660          408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT-IHRDIKGANL  486 (739)
Q Consensus       408 L~~L~HPNIVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GI-vHRDIKP~NI  486 (739)
                      |+.+.|.|+.+++|...++..+++|.+||..|+|.+.+......++.-....++++|+.||.|||.-.| .|+.++..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            467899999999999999999999999999999999998877789999999999999999999998776 8999999999


Q ss_pred             EecCCCcEEEeecccchhccCc---ccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCC
Q 004660          487 LVDASGVVKLADFGMAKHLTGL---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE  563 (739)
Q Consensus       487 LLd~~g~vKL~DFGlA~~~~~~---~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~  563 (739)
                      +++....+||.|||+.......   .......-..-|.|||++.+..........+.+.||||+|+++||+++.+.||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998766421   1111112345699999998642222112256689999999999999999999975


Q ss_pred             C----CchHHHHHHhh-cCC----CCC--ccCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004660          564 F----EGPQAMFKVLN-RTP----PIP--EMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       564 ~----~~~~~~~~i~~-~~~----~iP--~~ls~el~dLI~kcL~~DP~kRpTa~elLq  611 (739)
                      .    +..+++..+.+ +..    .+.  ..+.+++..+++.||..+|++||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            2    22345555555 221    111  134567899999999999999999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=1.8e-17  Score=163.45  Aligned_cols=143  Identities=21%  Similarity=0.257  Sum_probs=101.6

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHH-------------------HHHHHHHHHHHhhcCCCC-
Q 004660          356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC-------------------IKQLEQEIKVLGHLKHEN-  415 (739)
Q Consensus       356 i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~-------------------~k~l~~Ei~iL~~L~HPN-  415 (739)
                      +++.||+|+||+||+|.+. +|+.||||++............                   ......|...+..+.+.. 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999976 8999999988642211111100                   011245666666665432 


Q ss_pred             -eEeeccceeecceEEEEEeecCCCCcchh-hhhccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCC
Q 004660          416 -IVQYYGSEVVDDHLYIYLEYVHPGSINRY-VREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASG  492 (739)
Q Consensus       416 -IVkl~~~~~~~~~l~LVmEy~~gGsL~~~-L~~~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g  492 (739)
                       +.++++.    ...++||||+.|+.+... +... . . ..+++.++.+++.++.+||. .||+||||||+|||++ ++
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhh-h-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence             3344432    246899999999655422 2221 1 1 16778999999999999999 9999999999999999 99


Q ss_pred             cEEEeecccchhccC
Q 004660          493 VVKLADFGMAKHLTG  507 (739)
Q Consensus       493 ~vKL~DFGlA~~~~~  507 (739)
                      .++|+|||.+.....
T Consensus       152 ~~~liDfg~a~~~~~  166 (187)
T cd05119         152 KVYIIDVPQAVEIDH  166 (187)
T ss_pred             cEEEEECcccccccC
Confidence            999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=8.2e-17  Score=167.59  Aligned_cols=141  Identities=18%  Similarity=0.242  Sum_probs=106.4

Q ss_pred             eeEEe-ecCCeEEEEEEECCCCcEEEEEEeecCC-------CC-cccHHHHHHHHHHHHHHhhcCCCCe--Eeeccceee
Q 004660          357 GKLIG-RGTFGSVYIGTNRETGASCAIKEVDIIP-------DD-PKSAECIKQLEQEIKVLGHLKHENI--VQYYGSEVV  425 (739)
Q Consensus       357 ~~~LG-~G~fGtVy~a~~k~tg~~VAIK~i~~~~-------~~-~~~~~~~k~l~~Ei~iL~~L~HPNI--Vkl~~~~~~  425 (739)
                      +.+|| .||.|+||.+...  +..++||.+....       .+ ........++.+|+.++..|.|++|  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45677 7888888888764  7889999885311       11 0112234568889999999998775  666665443


Q ss_pred             cc----eEEEEEeecCC-CCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecc
Q 004660          426 DD----HLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG  500 (739)
Q Consensus       426 ~~----~l~LVmEy~~g-GsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFG  500 (739)
                      +.    ..+|||||++| .+|.+++.+  ..+++.    .+.||+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg  187 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD  187 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence            32    23599999997 689888865  235544    36789999999999999999999999999999999999999


Q ss_pred             cchhc
Q 004660          501 MAKHL  505 (739)
Q Consensus       501 lA~~~  505 (739)
                      .+...
T Consensus       188 ~~~~~  192 (239)
T PRK01723        188 RGELR  192 (239)
T ss_pred             CcccC
Confidence            88653

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=2.2e-16  Score=146.31  Aligned_cols=132  Identities=20%  Similarity=0.288  Sum_probs=110.5

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC--CCeEeeccceeecceEEEEE
Q 004660          356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       356 i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~H--PNIVkl~~~~~~~~~l~LVm  433 (739)
                      +.+.||.|.++.||++....  ..+++|.+.....       ...+.+|+.+++.+.|  .++.+++.++...+..+++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence            45789999999999999754  7899998753211       3467889999999976  58889888888778899999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhC---CeecccCCCcceEecCCCcEEEeecccchh
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST---NTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~---GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      ||+.|+.+..+        +......++.+++.+|++||..   +++|+||+|+|||++..+.++|+|||++..
T Consensus        73 e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          73 EWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99998887765        4455667889999999999984   799999999999999999999999998854

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=9e-17  Score=181.35  Aligned_cols=265  Identities=23%  Similarity=0.258  Sum_probs=205.8

Q ss_pred             CCCCCCCCceEeeEEee--cCCeEEEEEEE--CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeec
Q 004660          346 SASPKKSQWQKGKLIGR--GTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYY  420 (739)
Q Consensus       346 ~~~~~~~~Y~i~~~LG~--G~fGtVy~a~~--k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~  420 (739)
                      ........+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-++.......   -.+-.+|+.....++ |+|.|+.+
T Consensus       108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~---~~~k~~~~~s~~~i~~~~~~v~~~  184 (524)
T KOG0601|consen  108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD---SKRKLREFLSHHKIDSHENPVRDS  184 (524)
T ss_pred             ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc---cccccchhhcccccCccccccccC
Confidence            44555667888999999  99999999998  889999999974432221111   123345666666675 99999999


Q ss_pred             cceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHH----HHHHHHhCCeecccCCCcceEecCC-CcEE
Q 004660          421 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN----GLAYLHSTNTIHRDIKGANLLVDAS-GVVK  495 (739)
Q Consensus       421 ~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~----aL~yLHs~GIvHRDIKP~NILLd~~-g~vK  495 (739)
                      ..++..+.+||-+|+|. .+|..+....+..+++..++.++.+..+    ||.++|..+|+|-|+||+||++..+ ...+
T Consensus       185 ~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  185 PAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             cccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceee
Confidence            99999999999999995 8899988887777999999999999999    9999999999999999999999999 8999


Q ss_pred             EeecccchhccCccccc------ccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCC--Cch
Q 004660          496 LADFGMAKHLTGLSYEL------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF--EGP  567 (739)
Q Consensus       496 L~DFGlA~~~~~~~~~~------s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~--~~~  567 (739)
                      ++|||+...+.......      ...|...|++||.+++        -++.+.|||+||.|+.+..+|...+...  ...
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--------l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W  335 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--------LATFASDIFSLGEVILEAILGSHLPSVGKNSSW  335 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--------ccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence            99999998776544222      1257888999999974        5677899999999999999887665332  221


Q ss_pred             HHHHHHhhcCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccccccCCC
Q 004660          568 QAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL  623 (739)
Q Consensus       568 ~~~~~i~~~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~~~~~  623 (739)
                      ..+.... ...++-...+.++...+.+||..+|..|++++.++.|.++.......+
T Consensus       336 ~~~r~~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~  390 (524)
T KOG0601|consen  336 SQLRQGY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHL  390 (524)
T ss_pred             ccccccc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcc
Confidence            1111111 111222334667777999999999999999999999999986544333

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=2.7e-16  Score=185.25  Aligned_cols=267  Identities=24%  Similarity=0.379  Sum_probs=213.9

Q ss_pred             CCCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceE
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ....+.+.+-+-+|.++.++.+.-..+|...++|+....+.-..  ...+.+..+-.++-...+|.++...-.+......
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~--~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT--NDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhcc--ccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            34567788889999999999999888888888886653221111  1122233344444445678888877777778889


Q ss_pred             EEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc---
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT---  506 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~---  506 (739)
                      +|+|+|+.|++|...++.- +..+++-++.++..+.++++|||...+.|||++|.|+|+..+|..++.|||......   
T Consensus       880 ~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             chhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            9999999999999999775 467888889999999999999999999999999999999999999999998442210   


Q ss_pred             ---C--------------------------cccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhC
Q 004660          507 ---G--------------------------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG  557 (739)
Q Consensus       507 ---~--------------------------~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtG  557 (739)
                         +                          ........||+.|.+||++.+.       ..+.++|+|++|++++|.++|
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-------~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-------RHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-------cCCCcchhhhhhhhhhhhhcC
Confidence               0                          0112345689999999999863       445689999999999999999


Q ss_pred             CCCCCCCCchHHHHHHhhcCCCCC---ccCCHHHHHHHHHhcccCCCCCCCHH---HHHcCccccccccCCCCCc
Q 004660          558 KPPWSEFEGPQAMFKVLNRTPPIP---EMLSSEGKDFLLRCFLRNPVERPSAV---ELLEHPFIRNANYQNLSVP  626 (739)
Q Consensus       558 k~PF~~~~~~~~~~~i~~~~~~iP---~~ls~el~dLI~kcL~~DP~kRpTa~---elLqHpwf~~~~~~~~~~~  626 (739)
                      .+||......+.+..|.++..++|   ...+.++.+++.+.|..++.+|..+.   ++-.|+||+..++.++...
T Consensus      1032 ~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q 1106 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQ 1106 (1205)
T ss_pred             CCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccc
Confidence            999999999899988988877665   46789999999999999999999877   9999999999988777543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=7e-14  Score=157.75  Aligned_cols=146  Identities=16%  Similarity=0.151  Sum_probs=98.8

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc-----------------------------HHHHH------HHH
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-----------------------------AECIK------QLE  402 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~-----------------------------~~~~k------~l~  402 (739)
                      +.||.|++|.||+|+.+ +|+.||||+.+..-.....                             .+..+      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            67999999999999975 6899999997531100000                             01111      133


Q ss_pred             HHHHHHhhc----CCCCeEeeccce-eecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHH-HHHHHHhCCe
Q 004660          403 QEIKVLGHL----KHENIVQYYGSE-VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN-GLAYLHSTNT  476 (739)
Q Consensus       403 ~Ei~iL~~L----~HPNIVkl~~~~-~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~-aL~yLHs~GI  476 (739)
                      +|+..+.++    +|.+-|.+-.++ ......+|||||++|++|.++.......+   ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            455544444    233333333322 22345799999999999998765321112   23456666665 4788999999


Q ss_pred             ecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          477 IHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       477 vHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      +|+|+||.|||++.+|.++|+|||++..+..
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999977653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.52  E-value=1.7e-14  Score=165.82  Aligned_cols=145  Identities=17%  Similarity=0.175  Sum_probs=100.9

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC-----------------------------cccHHHHHHHHH
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----------------------------PKSAECIKQLEQ  403 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~-----------------------------~~~~~~~k~l~~  403 (739)
                      .|.. +.||+|++|.||+|+.+.+|+.||||+++..-..                             ..-.+..+.+.+
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 7899999999999999988999999998632100                             001133344555


Q ss_pred             HHHHHhhcCCCCeEeeccceee-------------cceEEEEEeecCCCCcchhh--hhcc---ccccHHHHHHHHHhHH
Q 004660          404 EIKVLGHLKHENIVQYYGSEVV-------------DDHLYIYLEYVHPGSINRYV--REHC---RDITESIVRNFTRHIL  465 (739)
Q Consensus       404 Ei~iL~~L~HPNIVkl~~~~~~-------------~~~l~LVmEy~~gGsL~~~L--~~~~---~~lse~~i~~i~~QLl  465 (739)
                      |+.+++..  .|+.++...|..             ....+|||||+.|+.|.++.  ...+   ..+.+..+..++.||+
T Consensus       200 ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        200 ELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             hhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            55555444  244444333332             23457999999999998742  2221   1356666667777765


Q ss_pred             HHHHHHHhCCeecccCCCcceEecCCC----cEEEeecccchhccC
Q 004660          466 NGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKHLTG  507 (739)
Q Consensus       466 ~aL~yLHs~GIvHRDIKP~NILLd~~g----~vKL~DFGlA~~~~~  507 (739)
                             ..|++|+|+||.|||++.+|    .++++|||++..+..
T Consensus       278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   59999999999999999888    999999999876643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.49  E-value=2.7e-13  Score=154.91  Aligned_cols=183  Identities=22%  Similarity=0.355  Sum_probs=139.7

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      |.+ +..+-++.+.+-.|..+.++.+|.|++++....     +......+-++-|+.|+||||+++++.++.++.+|||+
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvT   88 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVT   88 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEe
Confidence            444 444444444333577788999999998875322     34455677888999999999999999999999999999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHH-hCCeecccCCCcceEecCCCcEEEeecccchhccCccc-c
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-E  511 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLH-s~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~-~  511 (739)
                      |-+.  -|..++++    +....+...+.||+.||.||| +.+++|++|.-.-|+|+..|.+||++|.++....+... .
T Consensus        89 ErV~--Pl~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~  162 (690)
T KOG1243|consen   89 ERVR--PLETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA  162 (690)
T ss_pred             eccc--cHHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc
Confidence            9986  56667755    447888899999999999998 67899999999999999999999999999876544332 1


Q ss_pred             cccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhC
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG  557 (739)
Q Consensus       512 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtG  557 (739)
                      ....--..|..|+.+..         -+...|.|-|||+++|++.|
T Consensus       163 ~~~~~~~s~~~P~~~~~---------s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  163 KSLYLIESFDDPEEIDP---------SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccchhhhcccChhhcCc---------cccchhhhhHHHHHHHHhCc
Confidence            11122334677775531         11357999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=4.1e-14  Score=159.97  Aligned_cols=253  Identities=26%  Similarity=0.202  Sum_probs=188.5

Q ss_pred             CCCCCCceEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEeeccceee
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV  425 (739)
Q Consensus       348 ~~~~~~Y~i~~~LG~G~fGtVy~a~~k-~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVkl~~~~~~  425 (739)
                      .-...+|..+..||.|.|+.|+.+..+ .++..|++|.+...-.  ...+.+ .-..|+.+...+ .|.+++.++..|..
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~  337 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQ  337 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhh-cchhhhhHhhHhhcccccCCCCCCccc
Confidence            344567999999999999999998866 6788999998753211  111111 123455555555 49999999999999


Q ss_pred             cceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEeecccchh
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKH  504 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~-g~vKL~DFGlA~~  504 (739)
                      .+..||-.|||.++++...+.- ...+.+...+.++.|++.++.++|++.++|+|+||.||++..+ +..++.|||++..
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             cccccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence            9999999999999998877733 2568899999999999999999999999999999999999876 8899999999875


Q ss_pred             ccCcccccccCCCCCCC-ChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCcc
Q 004660          505 LTGLSYELSLKGSPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM  583 (739)
Q Consensus       505 ~~~~~~~~s~~GT~~Y~-APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~  583 (739)
                      +.  .......+.-+++ ..|++..      +..+..++|+++||..++|.++|...=....   ....+..+..+....
T Consensus       417 ~~--~~~~~~~~~~r~~p~~~~~~e------~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p~~~~  485 (524)
T KOG0601|consen  417 LA--FSSGVFHHIDRLYPIAEILLE------DYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTPNLPG  485 (524)
T ss_pred             cc--eecccccccccccccchhhcc------ccccccccccccccccccccccCcccCcccc---cceeeecccccCCCc
Confidence            32  1122233444555 3565553      3456679999999999999999875422222   223344443343344


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf  615 (739)
                      ...++..+.+.++..++..|+.+.++..|.=|
T Consensus       486 ~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  486 LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            44888999999999999999999998887644

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=2.9e-13  Score=130.79  Aligned_cols=128  Identities=16%  Similarity=0.118  Sum_probs=95.3

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeE-eeccceeecceEEEEEee
Q 004660          357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-QYYGSEVVDDHLYIYLEY  435 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIV-kl~~~~~~~~~l~LVmEy  435 (739)
                      .+.|+.|.++.||++...  +..|++|+......      ....+++|+++++.+.+.+++ +++...  .+..++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEe
Confidence            467899999999999865  78899997642111      112456799999988654443 444432  3345899999


Q ss_pred             cCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCe-----ecccCCCcceEecCCCcEEEeecccchh
Q 004660          436 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT-----IHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       436 ~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GI-----vHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      ++|.++...  .       .....++.+|+.+|..||..++     +|+|++|.|||++ ++.++|+|||.+..
T Consensus        73 i~G~~l~~~--~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          73 IEGSELLTE--D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cCCCccccc--c-------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            999888653  1       1123467899999999999885     9999999999998 67899999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.42  E-value=1.1e-12  Score=133.08  Aligned_cols=143  Identities=16%  Similarity=0.201  Sum_probs=103.1

Q ss_pred             eeEEeecCCeEEEEEEECC------CCcEEEEEEeecCCCCcc---------------------cHHHHHHHHHHHHHHh
Q 004660          357 GKLIGRGTFGSVYIGTNRE------TGASCAIKEVDIIPDDPK---------------------SAECIKQLEQEIKVLG  409 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~------tg~~VAIK~i~~~~~~~~---------------------~~~~~k~l~~Ei~iL~  409 (739)
                      ...||.|--+.||.|....      .+..+|||+++......+                     ........++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998653      357899999864221100                     0111223448999999


Q ss_pred             hcCC--CCeEeeccceeecceEEEEEeecCCCCcch-hhhhccccccHHHHHHHHHhHHHHHHHH-HhCCeecccCCCcc
Q 004660          410 HLKH--ENIVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGAN  485 (739)
Q Consensus       410 ~L~H--PNIVkl~~~~~~~~~l~LVmEy~~gGsL~~-~L~~~~~~lse~~i~~i~~QLl~aL~yL-Hs~GIvHRDIKP~N  485 (739)
                      +|..  -++.+++++    ..-+|||||+.++.+.. .+++  ..+++.++..++.|++.+|..| |+.||||+||++.|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            9853  345555543    45689999998764432 2322  2355667778899999999999 89999999999999


Q ss_pred             eEecCCCcEEEeecccchhcc
Q 004660          486 LLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       486 ILLd~~g~vKL~DFGlA~~~~  506 (739)
                      ||++ ++.+.|+|||.+....
T Consensus       156 IL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEE-CCcEEEEECCCceeCC
Confidence            9996 5789999999886553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=4.7e-13  Score=142.07  Aligned_cols=240  Identities=20%  Similarity=0.328  Sum_probs=156.4

Q ss_pred             EEEEEEECCCCcEEEEEEeecC--CCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecc-----eEEEEEeecCCC
Q 004660          367 SVYIGTNRETGASCAIKEVDII--PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-----HLYIYLEYVHPG  439 (739)
Q Consensus       367 tVy~a~~k~tg~~VAIK~i~~~--~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~-----~l~LVmEy~~gG  439 (739)
                      .||++-++..|..|+.-.+...  ++-..+.+.++.   -..-|-++-|.|||+++.++.+..     ...+++||+.-|
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~---vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssg  157 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRA---VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSG  157 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHH---HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccch
Confidence            4677777777766554433210  011111222222   223344567999999999886543     488999999999


Q ss_pred             Ccchhhhhc---cccccHHHHHHHHHhHHHHHHHHHhC--CeecccCCCcceEecCCCcEEEeecccchh---cc--Ccc
Q 004660          440 SINRYVREH---CRDITESIVRNFTRHILNGLAYLHST--NTIHRDIKGANLLVDASGVVKLADFGMAKH---LT--GLS  509 (739)
Q Consensus       440 sL~~~L~~~---~~~lse~~i~~i~~QLl~aL~yLHs~--GIvHRDIKP~NILLd~~g~vKL~DFGlA~~---~~--~~~  509 (739)
                      +|..+|++.   ...+.....++|+.||+.||.|||+.  -|+|+.+..+-|++..+|-+||+--.-...   +.  ...
T Consensus       158 s~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~  237 (458)
T KOG1266|consen  158 SLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREA  237 (458)
T ss_pred             hHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHh
Confidence            999999753   35688888999999999999999976  599999999999999999998862111000   00  000


Q ss_pred             cccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCch-HHHHHHhhcCCCCCccCCHHH
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPIPEMLSSEG  588 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~-~~~~~i~~~~~~iP~~ls~el  588 (739)
                      ......+-++|.+||.-.       -...+-++|||++|....||..|..--.+.+.. +.-..+.+-...+   -..--
T Consensus       238 Ek~~~~~~~g~~a~~sg~-------~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l---en~lq  307 (458)
T KOG1266|consen  238 EKSVNTSLPGFSAPESGT-------TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL---ENGLQ  307 (458)
T ss_pred             hhhccccCCccccCCcCc-------ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec---cCccc
Confidence            111123678899998432       233455899999999999998876532221111 1111111111111   11223


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 004660          589 KDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~elLqHpwf~~~~  619 (739)
                      +++|.+||.-.|..||++.++|.||..-+..
T Consensus       308 r~~i~kcl~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  308 RGSITKCLEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             cCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence            6789999999999999999999999765544

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=4e-11  Score=120.16  Aligned_cols=141  Identities=18%  Similarity=0.202  Sum_probs=104.7

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC--CeEeeccceeec---ceEEE
Q 004660          357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGSEVVD---DHLYI  431 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HP--NIVkl~~~~~~~---~~l~L  431 (739)
                      .+.||.|.++.||++.... |..+++|+.......    .....+.+|+++++.+.+.  ++.+++.+....   +..++
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~   77 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY   77 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence            3678999999999998753 688999976532111    1234678899999998753  345566555443   36789


Q ss_pred             EEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHh--------------------------------------
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS--------------------------------------  473 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs--------------------------------------  473 (739)
                      ||||++|.+|...+..  ..+++.+...++.+++++|.+||+                                      
T Consensus        78 v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          78 VMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            9999999988876632  346666777777788887777773                                      


Q ss_pred             ------------------CCeecccCCCcceEecC--CCcEEEeecccchh
Q 004660          474 ------------------TNTIHRDIKGANLLVDA--SGVVKLADFGMAKH  504 (739)
Q Consensus       474 ------------------~GIvHRDIKP~NILLd~--~g~vKL~DFGlA~~  504 (739)
                                        ..++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                              34699999999999998  67789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.15  E-value=1.3e-10  Score=116.02  Aligned_cols=135  Identities=19%  Similarity=0.306  Sum_probs=99.8

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC---c-ccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEE
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---P-KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  433 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~---~-~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVm  433 (739)
                      ..+++|+-+.||.+...  |..+++|. ++.+.-   . ...-...+-.+|+++|.+++--.|.-.+=++.+.+...|+|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence            46789999999999664  44566664 222211   1 11122355678999999887555544444456677788999


Q ss_pred             eecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          434 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       434 Ey~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      ||++|..|.+++...        ...+++.+-.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus        79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999998888664        146778888889999999999999999999997665 99999999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.15  E-value=1.8e-10  Score=114.78  Aligned_cols=147  Identities=22%  Similarity=0.261  Sum_probs=109.9

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC---CcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEE
Q 004660          356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       356 i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~---~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LV  432 (739)
                      .+.+|-+|+-+.|+++...  |+.+.||.-....-   .....-..++..+|+++|.++.--.|.-..=++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            6788999999999999765  88888885321110   112233456788899999988654554333345666667899


Q ss_pred             EeecCC-CCcchhhhhccccccHHHH-HHHHHhHHHHHHHHHhCCeecccCCCcceEecCCC---cEEEeecccchh
Q 004660          433 LEYVHP-GSINRYVREHCRDITESIV-RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKH  504 (739)
Q Consensus       433 mEy~~g-GsL~~~L~~~~~~lse~~i-~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g---~vKL~DFGlA~~  504 (739)
                      |||++| -++.+++......-.++.. ..++++|-+.|.-||.++|+|+||..+||||..+|   .+.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999987 4788888776444444444 78999999999999999999999999999997665   358999999854

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=3.8e-11  Score=138.04  Aligned_cols=195  Identities=23%  Similarity=0.321  Sum_probs=139.4

Q ss_pred             HhHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCcccc--------c--ccCCCCCCCChHHHHHhh
Q 004660          462 RHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--------L--SLKGSPNWMAPEVIKAVM  530 (739)
Q Consensus       462 ~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~--------~--s~~GT~~Y~APEvl~~~~  530 (739)
                      .+++.||.|+|. .++||+.|.|++|.++..|.+||+.|+++....+....        .  ...-...|.|||.+.+  
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--  183 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--
Confidence            344589999995 58999999999999999999999999998665442111        0  1123567999999874  


Q ss_pred             hcCCCCCCCcchhhhHHHHHHHHHh-hCCCCCCCCCchHHHHHHhh----cCCCCCccCCHHHHHHHHHhcccCCCCCCC
Q 004660          531 QKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEFEGPQAMFKVLN----RTPPIPEMLSSEGKDFLLRCFLRNPVERPS  605 (739)
Q Consensus       531 ~~~g~~~~s~asDIWSLGvVLyELL-tGk~PF~~~~~~~~~~~i~~----~~~~iP~~ls~el~dLI~kcL~~DP~kRpT  605 (739)
                           ...+.++|+|||||++|-+. .|+..+.............+    ....+...++.++++-|.++|..+...||+
T Consensus       184 -----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~  258 (700)
T KOG2137|consen  184 -----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT  258 (700)
T ss_pred             -----ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence                 45667999999999999999 57776665543333222211    123455779999999999999999999999


Q ss_pred             HHHHHcCccccccccCCCCCcccccccccCCCCChhHHHHHhhhcCCCCCCchhhhccCCCCC
Q 004660          606 AVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPC  668 (739)
Q Consensus       606 a~elLqHpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~l~~~~~~~~r~r~l~~  668 (739)
                      +.+++..+||.+.....+.......++     ...+..+-.......++..+..-+.++-+|+
T Consensus       259 ~~~l~~~~ff~D~~~~aLrfLD~l~~k-----dn~qKs~Flk~Ls~~ip~fp~rv~~~kiLP~  316 (700)
T KOG2137|consen  259 LDLLLSIPFFSDPGLKALRFLDDLPQK-----DNSQKSSFLKGLSKLIPTFPARVLFQKILPT  316 (700)
T ss_pred             hhhhhcccccCCchhhhhhhccccccc-----CcHHHHHHHHHHHHhhccCCHHHHHHhhhhH
Confidence            999999999998766555433322221     2223333334455667778877777776654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.06  E-value=4.3e-09  Score=117.95  Aligned_cols=213  Identities=15%  Similarity=0.174  Sum_probs=156.3

Q ss_pred             CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceee----cceEEEEEeecCC-
Q 004660          364 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHLYIYLEYVHP-  438 (739)
Q Consensus       364 ~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~----~~~l~LVmEy~~g-  438 (739)
                      --.+.|+|....||..|++|.+...+....     .....-+++++++.|.|||++.++|..    +..+++|++|.++ 
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc-----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence            345789999999999999999853322211     112235678899999999999999873    3469999999986 


Q ss_pred             CCcchhhhh--------------ccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          439 GSINRYVRE--------------HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       439 GsL~~~L~~--------------~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      ++|.++.-.              .+...+|..+|.|+.||..||.++|+.|+.-+-|.+.+||++.+-.++|...|+...
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceee
Confidence            466655411              234588999999999999999999999999999999999999888899988887765


Q ss_pred             ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCC-CCCCCchHH-HHHHhhcCCCCCc
Q 004660          505 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQA-MFKVLNRTPPIPE  582 (739)
Q Consensus       505 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~P-F~~~~~~~~-~~~i~~~~~~iP~  582 (739)
                      +..+..             |.+.+.          .+-|.=.||.++..|.+|..- |......+. +.       .+-.
T Consensus       443 l~~d~~-------------~~le~~----------Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~-------~I~~  492 (655)
T KOG3741|consen  443 LQEDPT-------------EPLESQ----------QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT-------RITT  492 (655)
T ss_pred             ecCCCC-------------cchhHH----------hhhhHHHHHHHHHHHhhcccccccccchHHHHHH-------Hhhh
Confidence            544331             112211          146888999999999999632 111111111 11       2234


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~elLqH  612 (739)
                      .++.+++++|.-+...++++ -++.++|.+
T Consensus       493 ~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  493 TYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            57889999999999999987 678888865

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=1.9e-09  Score=108.81  Aligned_cols=131  Identities=22%  Similarity=0.299  Sum_probs=86.6

Q ss_pred             EEEEEEECCCCcEEEEEEeecCCCC---------------------cccHHHHHHHHHHHHHHhhcCCC--CeEeeccce
Q 004660          367 SVYIGTNRETGASCAIKEVDIIPDD---------------------PKSAECIKQLEQEIKVLGHLKHE--NIVQYYGSE  423 (739)
Q Consensus       367 tVy~a~~k~tg~~VAIK~i~~~~~~---------------------~~~~~~~k~l~~Ei~iL~~L~HP--NIVkl~~~~  423 (739)
                      .||.|.. .+|..+|||+.+.....                     ..........++|++.|..+..-  ++.+++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899987 45789999998632111                     11222345678999999999755  455665432


Q ss_pred             eecceEEEEEeecC--CCCcchhhhhccccccHHHHHHHHHhHHHHHHH-HHhCCeecccCCCcceEecCCCcEEEeecc
Q 004660          424 VVDDHLYIYLEYVH--PGSINRYVREHCRDITESIVRNFTRHILNGLAY-LHSTNTIHRDIKGANLLVDASGVVKLADFG  500 (739)
Q Consensus       424 ~~~~~l~LVmEy~~--gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~y-LHs~GIvHRDIKP~NILLd~~g~vKL~DFG  500 (739)
                          .-+|||||++  |..+..+. +.  .++..+...++.+++..+.. +|+.||+|+||.+.|||++++ .+.|+|||
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~-~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLK-DV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHH-HC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred             ----CCEEEEEecCCCccchhhHH-hc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence                3479999998  55554433 32  23356677888899986655 579999999999999999877 89999999


Q ss_pred             cchhcc
Q 004660          501 MAKHLT  506 (739)
Q Consensus       501 lA~~~~  506 (739)
                      .+....
T Consensus       152 qav~~~  157 (188)
T PF01163_consen  152 QAVDSS  157 (188)
T ss_dssp             TEEETT
T ss_pred             cceecC
Confidence            886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.97  E-value=8.1e-09  Score=109.76  Aligned_cols=142  Identities=15%  Similarity=0.123  Sum_probs=97.5

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHH----------HHHHHHHHHhhcCCCCe--Eeecccee
Q 004660          357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK----------QLEQEIKVLGHLKHENI--VQYYGSEV  424 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k----------~l~~Ei~iL~~L~HPNI--Vkl~~~~~  424 (739)
                      ++.+-......|+++..  .|+.|.||.....    ...+..+          .+.+|...+..|..-+|  ..++++.+
T Consensus        27 ~e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~----~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e  100 (268)
T PRK15123         27 GEVFRELEGRRTLRFEL--AGKSYFLKWHRGT----GWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGE  100 (268)
T ss_pred             CcEEecCCCceEEEEEE--CCEEEEEEEecCC----cHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEE
Confidence            34444444445666544  4778999966321    1111112          36788888877743332  33333333


Q ss_pred             e-----cceEEEEEeecCCC-Ccchhhhhc-cccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecC-------
Q 004660          425 V-----DDHLYIYLEYVHPG-SINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-------  490 (739)
Q Consensus       425 ~-----~~~l~LVmEy~~gG-sL~~~L~~~-~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~-------  490 (739)
                      .     ....+||||++++. +|.+++... .....+.....++.+|+..+.-||..||+|+|+++.||||+.       
T Consensus       101 ~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        101 RGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             ecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCC
Confidence            2     23578999999986 788888532 234566777899999999999999999999999999999975       


Q ss_pred             CCcEEEeecccchh
Q 004660          491 SGVVKLADFGMAKH  504 (739)
Q Consensus       491 ~g~vKL~DFGlA~~  504 (739)
                      ++.+.||||+.+..
T Consensus       181 ~~~~~LIDl~r~~~  194 (268)
T PRK15123        181 DLKLSVIDLHRAQI  194 (268)
T ss_pred             CceEEEEECCcccc
Confidence            46899999998753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.82  E-value=1.3e-08  Score=107.06  Aligned_cols=141  Identities=19%  Similarity=0.219  Sum_probs=104.4

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC--------------Cc---ccHHHHHHHHHHHHHHhhcCCC--
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--------------DP---KSAECIKQLEQEIKVLGHLKHE--  414 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~--------------~~---~~~~~~k~l~~Ei~iL~~L~HP--  414 (739)
                      +.++..||.|--+.||.|.+. .|.++|||.=+.-..              ..   .........++|.++|+.|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            567899999999999999976 589999996432110              00   1112234567899999998644  


Q ss_pred             CeEeeccceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcE
Q 004660          415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV  494 (739)
Q Consensus       415 NIVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~v  494 (739)
                      .|.+.+++    +.-.+||||++|-.|...-      ++...+..++..|++-+.-+-..||||+|+.+-|||++++|.+
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence            56666653    4568999999997776543      2344555667777777777779999999999999999999999


Q ss_pred             EEeecccchhc
Q 004660          495 KLADFGMAKHL  505 (739)
Q Consensus       495 KL~DFGlA~~~  505 (739)
                      .|+||--+...
T Consensus       242 ~vIDwPQ~v~~  252 (304)
T COG0478         242 VVIDWPQAVPI  252 (304)
T ss_pred             EEEeCcccccC
Confidence            99999765443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.77  E-value=1.8e-07  Score=102.99  Aligned_cols=242  Identities=17%  Similarity=0.214  Sum_probs=155.0

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeEe--------eccceee
Q 004660          355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ--------YYGSEVV  425 (739)
Q Consensus       355 ~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L-~HPNIVk--------l~~~~~~  425 (739)
                      ..++-||+|+-+.+|-.-.-  +. .+.|++..-+.. ..    .+   .+..|... .||-+-.        ++|-- .
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa-~~----aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~-~   81 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPA-AQ----AQ---KVAELAATPDAPLLNYRVAWPQATLHGGR-R   81 (637)
T ss_pred             CCCccccCCccceeeecchh--hc-hhheeecCCCch-HH----HH---HHHHhccCCCCcchhhhhcccHHHhhCCC-c
Confidence            34677999999999965322  22 334666532211 11    11   12233333 4664322        22211 1


Q ss_pred             cceEEEEEeecCCCC-cchhh-----hhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004660          426 DDHLYIYLEYVHPGS-INRYV-----REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF  499 (739)
Q Consensus       426 ~~~l~LVmEy~~gGs-L~~~L-----~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DF  499 (739)
                      ...+-+.|..+.|.. +.+++     ++.+....+..+.+..+.|+.+.+.||+.|.+-+|+.++|||+.+++.|.|+|=
T Consensus        82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcc
Confidence            223778888888753 33333     223455788899999999999999999999999999999999999999999985


Q ss_pred             ccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhC-CCCCCCCCch----HHHH-HH
Q 004660          500 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGP----QAMF-KV  573 (739)
Q Consensus       500 GlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtG-k~PF~~~~~~----~~~~-~i  573 (739)
                      ..-.....+......+|...|.+||.-.-. ... +..-+...|.|.||+++++||.| +.||.+....    .-.. .|
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~-sf~-g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLP-SFV-GFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccc-ccc-ccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            433333344444556799999999975411 111 12334578999999999999986 9999764211    0001 11


Q ss_pred             hh---------c--CCC----C-CccCCHHHHHHHHHhccc--CCCCCCCHHHHH
Q 004660          574 LN---------R--TPP----I-PEMLSSEGKDFLLRCFLR--NPVERPSAVELL  610 (739)
Q Consensus       574 ~~---------~--~~~----i-P~~ls~el~dLI~kcL~~--DP~kRpTa~elL  610 (739)
                      ..         +  ..+    + ...+++++..|..+|+..  ++.-|||++..+
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~  294 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV  294 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence            11         1  111    1 145789999999999985  467899987533

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=4.1e-08  Score=100.01  Aligned_cols=105  Identities=18%  Similarity=0.245  Sum_probs=81.6

Q ss_pred             HHHHHHHHHHhhcCCCC--eEeeccceeec----ceEEEEEeecCCC-CcchhhhhccccccHHHHHHHHHhHHHHHHHH
Q 004660          399 KQLEQEIKVLGHLKHEN--IVQYYGSEVVD----DHLYIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYL  471 (739)
Q Consensus       399 k~l~~Ei~iL~~L~HPN--IVkl~~~~~~~----~~l~LVmEy~~gG-sL~~~L~~~~~~lse~~i~~i~~QLl~aL~yL  471 (739)
                      .+..+|...+..|..-+  +.+.+++.+..    ...+||||++++. +|.+++..... ++......++.+|+..+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            35677888777774322  33444443332    3468999999984 79998876422 67777889999999999999


Q ss_pred             HhCCeecccCCCcceEecCCC---cEEEeecccchh
Q 004660          472 HSTNTIHRDIKGANLLVDASG---VVKLADFGMAKH  504 (739)
Q Consensus       472 Hs~GIvHRDIKP~NILLd~~g---~vKL~DFGlA~~  504 (739)
                      |++||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999887   899999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.58  E-value=9.7e-09  Score=117.47  Aligned_cols=239  Identities=23%  Similarity=0.209  Sum_probs=169.6

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCC-eEeeccceeecceEEE
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDDHLYI  431 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPN-IVkl~~~~~~~~~l~L  431 (739)
                      -|....-+++|+++++++.+...+...+ .+++...          ....-++++|.+++||| .+..++.++.++..++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            3566677899999999999877665555 6665421          22345788999999999 8888888888999999


Q ss_pred             EEeecCCC-CcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004660          432 YLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       432 VmEy~~gG-sL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~~~~  510 (739)
                      +|+|+.++ +-..........+.+-+...+.+.-+++|+|||+.--+|||    |||..+ +..|++||+....+.....
T Consensus       312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~  386 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK  386 (829)
T ss_pred             hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccc
Confidence            99999988 22222211123355566667778888999999998889999    887755 7899999999988766555


Q ss_pred             ccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCc-----cCC
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-----MLS  585 (739)
Q Consensus       511 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~-----~ls  585 (739)
                      ..+..+|+.++|||+..+       ..+....|+|++|+-..+|--|.+|-...  ......+-++ +..+.     ..+
T Consensus       387 ~~t~~~~~~~~~pev~~~-------~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~-p~s~~L~~~~aw~  456 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQE-------NTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNG-PNSPMLTDKSAWS  456 (829)
T ss_pred             cccCCCCCCCCCchhhcc-------cccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCC-CCccccchhhhcC
Confidence            567889999999998873       45666899999999888888887775431  0010000000 00110     011


Q ss_pred             -HHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 004660          586 -SEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       586 -~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~  617 (739)
                       ..-.++...|+..-|..|+....++.|.+|..
T Consensus       457 ~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  457 PVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             cccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence             11125778889999999999988888877754

>PRK09902 hypothetical protein; Provisional

Probab=98.58  E-value=3.3e-07  Score=94.15  Aligned_cols=143  Identities=14%  Similarity=0.165  Sum_probs=100.2

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeec-CCCCcccHHHHHHHHHHHHHHhhcCCCC--eEeeccceee----cceEEEE
Q 004660          360 IGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVLGHLKHEN--IVQYYGSEVV----DDHLYIY  432 (739)
Q Consensus       360 LG~G~fGtVy~a~~k~tg~~VAIK~i~~-~~~~~~~~~~~k~l~~Ei~iL~~L~HPN--IVkl~~~~~~----~~~l~LV  432 (739)
                      -|+||.+.|+.....  |+.+-+|.-.. ......-..-...|.+|+..|+.|..-+  +.++......    .-..+||
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            367899999987654  44688886541 1100000112356888999998885322  4444421111    1247999


Q ss_pred             EeecCC-CCcchhhhhcc-ccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCc--EEEeecccchh
Q 004660          433 LEYVHP-GSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--VKLADFGMAKH  504 (739)
Q Consensus       433 mEy~~g-GsL~~~L~~~~-~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~--vKL~DFGlA~~  504 (739)
                      +|-+.| -+|.+++.+.. ...++.....++.+|+..|.-||+.|+.|+|+-+.|||++.+|.  |+++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998765 57888876532 24577777899999999999999999999999999999987777  99999987654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.48  E-value=1.3e-06  Score=87.60  Aligned_cols=139  Identities=19%  Similarity=0.305  Sum_probs=82.2

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC--CeEeeccce---eecceEEE
Q 004660          357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGSE---VVDDHLYI  431 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HP--NIVkl~~~~---~~~~~l~L  431 (739)
                      ++.|+.|..+.||++....  ..+++|....       ......+.+|+.+++.|...  .+.+++...   ......++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~-------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~   72 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP-------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL   72 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESS-------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCC-------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence            5789999999999998765  4899997542       13456778899998888532  345555533   23345799


Q ss_pred             EEeecCCCCcch----------------hhhh---c---cccccH------HHHHHH---------------HHhHHH-H
Q 004660          432 YLEYVHPGSINR----------------YVRE---H---CRDITE------SIVRNF---------------TRHILN-G  467 (739)
Q Consensus       432 VmEy~~gGsL~~----------------~L~~---~---~~~lse------~~i~~i---------------~~QLl~-a  467 (739)
                      +|++++|..+..                .+..   .   ...+..      .....+               ...+.. .
T Consensus        73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (239)
T PF01636_consen   73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL  152 (239)
T ss_dssp             EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence            999999987777                1111   0   000000      000000               011222 3


Q ss_pred             HHHHH-------hCCeecccCCCcceEec-CCCcEEEeecccchh
Q 004660          468 LAYLH-------STNTIHRDIKGANLLVD-ASGVVKLADFGMAKH  504 (739)
Q Consensus       468 L~yLH-------s~GIvHRDIKP~NILLd-~~g~vKL~DFGlA~~  504 (739)
                      +..++       ...++|+|+.+.|||++ .++.+-|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            33333       24699999999999999 667778999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.47  E-value=4.7e-07  Score=104.27  Aligned_cols=142  Identities=20%  Similarity=0.218  Sum_probs=91.2

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCC----------------------CC-------cccHHHHHHHH------
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----------------------DD-------PKSAECIKQLE------  402 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~----------------------~~-------~~~~~~~k~l~------  402 (739)
                      +-|+.++-|.||+|+.+. |+.||||+.+..-                      ..       ..-.+..+.+.      
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            568999999999999876 9999999875210                      00       00112222333      


Q ss_pred             HHHHHHhhc----C-CCCeEeeccceeecceEEEEEeecCCCCcchhhhhcccccc-----HHHHHHHHHhHHHHHHHHH
Q 004660          403 QEIKVLGHL----K-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT-----ESIVRNFTRHILNGLAYLH  472 (739)
Q Consensus       403 ~Ei~iL~~L----~-HPNIVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~ls-----e~~i~~i~~QLl~aL~yLH  472 (739)
                      +|..-+.++    + .++|.--.=+++....-+|+|||++|-.+.+...-....++     +.-+..++.|+       =
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~-------~  282 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQL-------L  282 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            333333333    2 23332222223334567899999999999888532222344     23333333333       3


Q ss_pred             hCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004660          473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       473 s~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~~  507 (739)
                      ..|++|.|..|.||+++.+|.+.+.|||+...+..
T Consensus       283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            58999999999999999999999999999876543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.45  E-value=1.6e-06  Score=90.68  Aligned_cols=141  Identities=14%  Similarity=0.174  Sum_probs=96.9

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc-------------------cHHHHHHHHHHHHHHhhcC--CCCe
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------------------SAECIKQLEQEIKVLGHLK--HENI  416 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~-------------------~~~~~k~l~~Ei~iL~~L~--HPNI  416 (739)
                      ..|..|--++||+|.. .++..||+|+++.......                   .........+|+.-|+++.  +-.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3667788889999986 4689999999864322211                   1112234556777777764  3334


Q ss_pred             EeeccceeecceEEEEEeecCCC-CcchhhhhccccccHHHHHHHHHhHHHHHHHHHh-CCeecccCCCcceEecCCCcE
Q 004660          417 VQYYGSEVVDDHLYIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVV  494 (739)
Q Consensus       417 Vkl~~~~~~~~~l~LVmEy~~gG-sL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs-~GIvHRDIKP~NILLd~~g~v  494 (739)
                      .+-+.+.    .-.|||||+... .-.-.|++  ..+...++..+..++++.|.-|-. .|+||+||..-|||+. ++.+
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            4444433    357999999643 11122222  223444788889999999998876 9999999999999998 8899


Q ss_pred             EEeecccchhcc
Q 004660          495 KLADFGMAKHLT  506 (739)
Q Consensus       495 KL~DFGlA~~~~  506 (739)
                      .|||||-|....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999886554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.40  E-value=1.8e-06  Score=89.51  Aligned_cols=135  Identities=15%  Similarity=0.186  Sum_probs=81.4

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCC--eEeeccceeecceEEEEEee
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN--IVQYYGSEVVDDHLYIYLEY  435 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPN--IVkl~~~~~~~~~l~LVmEy  435 (739)
                      ..||.|..+.||+.    .|..+++|....   . ...   ..+.+|.++|+.+..-+  +.+.+++....+...+|||+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~---~-~~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~   75 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNP---G-FDK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYEL   75 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCC---C-CCH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeee
Confidence            57899999999984    255677886542   1 111   34577999998886433  35666666677778899999


Q ss_pred             cCCCC-cchhh--------------hh-----cc---ccccHHH-HHHHHH----------hHHH-HHHHHH----hCCe
Q 004660          436 VHPGS-INRYV--------------RE-----HC---RDITESI-VRNFTR----------HILN-GLAYLH----STNT  476 (739)
Q Consensus       436 ~~gGs-L~~~L--------------~~-----~~---~~lse~~-i~~i~~----------QLl~-aL~yLH----s~GI  476 (739)
                      ++|.+ +...+              .+     +.   ....... ...+..          .+.. ...+|.    ...+
T Consensus        76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~  155 (226)
T TIGR02172        76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC  155 (226)
T ss_pred             cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence            99863 11111              00     00   0001000 001100          0111 122222    2247


Q ss_pred             ecccCCCcceEecCCCcEEEeecccchh
Q 004660          477 IHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       477 vHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      +|+|+.|.||++++++ +.|+||+.+..
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            8999999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.39  E-value=3.8e-06  Score=86.86  Aligned_cols=140  Identities=17%  Similarity=0.236  Sum_probs=87.6

Q ss_pred             CCCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHH------HHHHHHHHhhcCCC---CeEeecc
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------LEQEIKVLGHLKHE---NIVQYYG  421 (739)
Q Consensus       351 ~~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~------l~~Ei~iL~~L~HP---NIVkl~~  421 (739)
                      ..+|.+.+++-....-.|.+..  -+|+.+++|..+...  ......+..      ..+++..+..+...   .+..++-
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~--~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREEN--RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhh--hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            4567777887777666666554  457889999764211  111111111      22334433333322   2222222


Q ss_pred             ce-----eecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCcEEE
Q 004660          422 SE-----VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL  496 (739)
Q Consensus       422 ~~-----~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~vKL  496 (739)
                      +.     ..-...+|+|||++|..|.++..     +++    .+...|.++|.-||+.|++|+|+.|.|++++.++ +++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~i  175 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRI  175 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEE
Confidence            22     12244678999999998877642     222    2446677889999999999999999999998555 999


Q ss_pred             eecccchh
Q 004660          497 ADFGMAKH  504 (739)
Q Consensus       497 ~DFGlA~~  504 (739)
                      +||+..+.
T Consensus       176 ID~~~k~~  183 (229)
T PF06176_consen  176 IDTQGKRM  183 (229)
T ss_pred             EECccccc
Confidence            99987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.34  E-value=1.3e-06  Score=105.90  Aligned_cols=207  Identities=27%  Similarity=0.363  Sum_probs=151.1

Q ss_pred             HHHHHHHHHHHHhhcCCCCeEeeccceeecce----EEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHH
Q 004660          397 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH  472 (739)
Q Consensus       397 ~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~----l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLH  472 (739)
                      .+...+-|+..+..+.|+|++.++.+...+..    +.+..|+|.+.++...++.. ..++...++.+..++++||.|+|
T Consensus       225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHH
Confidence            34556678888899999999999987654432    34557889999999888765 67899999999999999999999


Q ss_pred             hCCeecccCCCc---ceEecCCCcEEEe--ecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHH
Q 004660          473 STNTIHRDIKGA---NLLVDASGVVKLA--DFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL  547 (739)
Q Consensus       473 s~GIvHRDIKP~---NILLd~~g~vKL~--DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSL  547 (739)
                      +....|.-+-..   +--++.++.+.+.  ||+..+.+..........-...|.++|.....     ........|+|.+
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~-----~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKEN-----TAKKSRLTDLWCL  378 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccc-----cchhhhhhHHHHH
Confidence            986555544443   4444566777777  99998887776666666667788888877521     1223345799999


Q ss_pred             HHHHHHHhhCCCCCCCCCchHHHHHHhhcCCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          548 GCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       548 GvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      |..+..+..|..+-....   ....++.      ........+++.+|+..+.++|+.+.++|.|+|.+..
T Consensus       379 gll~~~~~~~~~i~~~~~---~~~~~l~------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSA---VPVSLLD------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             HHHHhhhhhcCccccccc---chhhhhc------cccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence            999999998865422111   1111111      1122267899999999999999999999999998754

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.15  E-value=1.1e-05  Score=83.40  Aligned_cols=136  Identities=16%  Similarity=0.108  Sum_probs=81.7

Q ss_pred             EEeecCC-eEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeEeeccceeecceEEEEEeec
Q 004660          359 LIGRGTF-GSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEYV  436 (739)
Q Consensus       359 ~LG~G~f-GtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~l~LVmEy~  436 (739)
                      .|-.|.. ..||++...  +..+.+|.....   .     ...+.+|+++++.+. +--+.+++++...++..++|||++
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~---~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   74 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSG---P-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV   74 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCC---c-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence            4555665 789998653  467888865421   1     234667998888884 334556777666666789999999


Q ss_pred             CCCCcchhhh----------------h-ccc-----cccH---HHHHH---HH----------------HhHHHHHHHH-
Q 004660          437 HPGSINRYVR----------------E-HCR-----DITE---SIVRN---FT----------------RHILNGLAYL-  471 (739)
Q Consensus       437 ~gGsL~~~L~----------------~-~~~-----~lse---~~i~~---i~----------------~QLl~aL~yL-  471 (739)
                      +|..|.....                . +..     .+..   ..+..   .+                ..+...+..| 
T Consensus        75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  154 (244)
T cd05150          75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE  154 (244)
T ss_pred             CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence            9877653310                0 000     0000   00000   00                0011112222 


Q ss_pred             ------HhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          472 ------HSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       472 ------Hs~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                            ....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence                  123589999999999999988889999998743

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.09  E-value=1.2e-05  Score=92.73  Aligned_cols=145  Identities=21%  Similarity=0.197  Sum_probs=90.7

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC--------------------------cccHHHHHHHHHHHHHH---
Q 004660          358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--------------------------PKSAECIKQLEQEIKVL---  408 (739)
Q Consensus       358 ~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~--------------------------~~~~~~~k~l~~Ei~iL---  408 (739)
                      +-||.-+.|.||+|+.+. |+.||||+-+..-.+                          ....+..+.+..|+..+   
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            568999999999999887 999999986421100                          01112223333333332   


Q ss_pred             -------hhcCCCC------eEeeccceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCC
Q 004660          409 -------GHLKHEN------IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN  475 (739)
Q Consensus       409 -------~~L~HPN------IVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~G  475 (739)
                             +.+.|-+      |.++|-  .....-+|+||||+|.-+.++-.-....++...+..-+.+..  +.-|=..|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence                   2233444      333332  223457899999999988766422223455554443333322  22233678


Q ss_pred             eecccCCCcceEecC----CCcEEEeecccchhccC
Q 004660          476 TIHRDIKGANLLVDA----SGVVKLADFGMAKHLTG  507 (739)
Q Consensus       476 IvHRDIKP~NILLd~----~g~vKL~DFGlA~~~~~  507 (739)
                      ++|.|-.|.||+++.    ++.+.|.|||+...+..
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            999999999999983    67899999999876644

>PLN02876 acyl-CoA dehydrogenase

Probab=98.06  E-value=2.3e-05  Score=95.68  Aligned_cols=145  Identities=17%  Similarity=0.296  Sum_probs=88.6

Q ss_pred             EeeEEeecCCeEEEEEEECCCC--cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCe--Eeeccceeec---c
Q 004660          356 KGKLIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI--VQYYGSEVVD---D  427 (739)
Q Consensus       356 i~~~LG~G~fGtVy~a~~k~tg--~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-HPNI--Vkl~~~~~~~---~  427 (739)
                      ..+.|+.|.+..+|+......+  ..+++|+...   ... ......+.+|+++|+.|. |.+|  .+++.++.+.   +
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~---~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G  117 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPP---GKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG  117 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCC---Ccc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC
Confidence            4677899999999998765433  3577775421   111 011235778999999995 6654  6666665543   4


Q ss_pred             eEEEEEeecCCCCcchh--------------------hhh-cc---c-----------cccHHHHHHHHHh---------
Q 004660          428 HLYIYLEYVHPGSINRY--------------------VRE-HC---R-----------DITESIVRNFTRH---------  463 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~--------------------L~~-~~---~-----------~lse~~i~~i~~Q---------  463 (739)
                      ..|+||||++|..+.+.                    +.. +.   .           ...+.++..|..|         
T Consensus       118 ~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~  197 (822)
T PLN02876        118 TAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGK  197 (822)
T ss_pred             CceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccC
Confidence            67999999998654321                    100 00   0           0111233332222         


Q ss_pred             ------HHHHHHHHHh-----------CCeecccCCCcceEecCC--CcEEEeecccchh
Q 004660          464 ------ILNGLAYLHS-----------TNTIHRDIKGANLLVDAS--GVVKLADFGMAKH  504 (739)
Q Consensus       464 ------Ll~aL~yLHs-----------~GIvHRDIKP~NILLd~~--g~vKL~DFGlA~~  504 (739)
                            +...+.+|..           ..+||+|+++.|||++.+  ..+-|+||+++..
T Consensus       198 ~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        198 PPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             CCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence                  2234556631           359999999999999853  3467999999864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.02  E-value=7.1e-07  Score=109.74  Aligned_cols=210  Identities=18%  Similarity=0.079  Sum_probs=150.7

Q ss_pred             HHHHHHHHHhhcCCCCeEeeccceee--cceEEEEEeecCCCCcchhhhhc---cccccHHHHHHHHHhHHHHHHHHHhC
Q 004660          400 QLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHST  474 (739)
Q Consensus       400 ~l~~Ei~iL~~L~HPNIVkl~~~~~~--~~~l~LVmEy~~gGsL~~~L~~~---~~~lse~~i~~i~~QLl~aL~yLHs~  474 (739)
                      .+..|...++...|++++..+.-...  ....|+.++|+.+|.++..|-+.   ...+.+.-+....++.+.+..-+|..
T Consensus      1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            34445556667789999887765433  34579999999999999999653   34456666666677768888888853


Q ss_pred             -----CeecccCCCcceEecCCCcEEEeecccchh-ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHH
Q 004660          475 -----NTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLG  548 (739)
Q Consensus       475 -----GIvHRDIKP~NILLd~~g~vKL~DFGlA~~-~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLG  548 (739)
                           -.+|+++|+-|.||..+..+|++++|+.+. ...........+++.|+.+++.+..       .++.++|+|..|
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~i-------k~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEI-------KFTKRSDILRRS 1427 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHH-------hhhhHHHHHHHH
Confidence                 278999999999999999999999999993 3333344456789999999998853       344569999999


Q ss_pred             HHHHHHhhCCCCCCCCCchHHHHHHhhc-CCCCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 004660          549 CTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR  616 (739)
Q Consensus       549 vVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~  616 (739)
                      +-+|++..|..+|...........+.++ ...++...+.++......+|-..-..||.-...+..+.|.
T Consensus      1428 ~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            9999999998877543333332223222 2344555566666666666666777888887777766553

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.02  E-value=2.4e-05  Score=80.90  Aligned_cols=31  Identities=29%  Similarity=0.389  Sum_probs=26.5

Q ss_pred             CCeecccCCCcceEecCCCcEEEeecccchh
Q 004660          474 TNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       474 ~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      .+++|+|+.+.|||++.++..-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4589999999999998776678999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.94  E-value=2.8e-05  Score=77.89  Aligned_cols=133  Identities=23%  Similarity=0.273  Sum_probs=92.4

Q ss_pred             CCceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCe-EeeccceeecceEE
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLY  430 (739)
Q Consensus       352 ~~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNI-Vkl~~~~~~~~~l~  430 (739)
                      ...+..+.||+|++|.||++.++  |..+|+|+-+.   +.    -...++.|+++|..+.--++ -++|.+.    ..+
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~---ds----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~   88 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR---DS----PRRNLEKEAKILEILAGEGVTPEVYFYG----EDF   88 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeecc--CceEEEEEecC---Cc----chhhHHHHHHHHHHhhhcCCCceEEEec----hhh
Confidence            34566788999999999999887  56899997542   11    12568889999998876655 2344332    234


Q ss_pred             EEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCC-CcceEecCCCcEEEeecccchhc
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK-GANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIK-P~NILLd~~g~vKL~DFGlA~~~  505 (739)
                      +.|||+.|-.|.+.....    +    +.-+..+++.-.-|-..||-|+.|. |..++|..++.+.|+||.-|+..
T Consensus        89 i~me~i~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          89 IRMEYIDGRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhhcCcchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            559999988887665321    1    2233445555555667899999984 56556656669999999998744

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.85  E-value=0.00034  Score=71.74  Aligned_cols=130  Identities=22%  Similarity=0.290  Sum_probs=90.3

Q ss_pred             CCceEeeEEeecCC-eEEEEEEECCCCcEEEEEEeecCC---CCc-----c--c------HHHHHHHHHHHHHHhhc---
Q 004660          352 SQWQKGKLIGRGTF-GSVYIGTNRETGASCAIKEVDIIP---DDP-----K--S------AECIKQLEQEIKVLGHL---  411 (739)
Q Consensus       352 ~~Y~i~~~LG~G~f-GtVy~a~~k~tg~~VAIK~i~~~~---~~~-----~--~------~~~~k~l~~Ei~iL~~L---  411 (739)
                      ..++.++.||.|.- |.||+++..  |..||+|+.+...   .+.     .  .      .....-|..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67999999999999 999999865  7899999943211   100     0  0      12334577787766655   


Q ss_pred             CCCCe--Eeeccceeecc------------------eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHH
Q 004660          412 KHENI--VQYYGSEVVDD------------------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL  471 (739)
Q Consensus       412 ~HPNI--Vkl~~~~~~~~------------------~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yL  471 (739)
                      .+.++  |+++|+.....                  ..-||.||+....          .+.    ..=+.+|++-|..+
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~~  180 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKIL  180 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHHH
Confidence            45566  89998764321                  1456777665332          122    23356788889999


Q ss_pred             HhCCeecccCCCcceEecCCCcEEEeecccc
Q 004660          472 HSTNTIHRDIKGANLLVDASGVVKLADFGMA  502 (739)
Q Consensus       472 Hs~GIvHRDIKP~NILLd~~g~vKL~DFGlA  502 (739)
                      |..||+-+|+|+.|..     .-||+|||.+
T Consensus       181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHCCeeeccCcccccc-----CCEEEecccC
Confidence            9999999999999986     2379999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.84  E-value=0.0001  Score=75.70  Aligned_cols=75  Identities=13%  Similarity=0.151  Sum_probs=47.1

Q ss_pred             eeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCC-eEeeccceeecceEEEEEe
Q 004660          357 GKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDDHLYIYLE  434 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~-tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPN-IVkl~~~~~~~~~l~LVmE  434 (739)
                      ++.|..|-...||++.... +++.|++|+......      ..-..++|+.+++.+...+ +.+++..+.    -.+|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEE
Confidence            4677888888999987543 357888996542111      1112346888888885333 344443322    247999


Q ss_pred             ecCCCCc
Q 004660          435 YVHPGSI  441 (739)
Q Consensus       435 y~~gGsL  441 (739)
                      |++|.++
T Consensus        73 ~i~G~~l   79 (235)
T cd05157          73 FIPGRTL   79 (235)
T ss_pred             eeCCCcC
Confidence            9998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.72  E-value=0.00025  Score=72.49  Aligned_cols=136  Identities=21%  Similarity=0.335  Sum_probs=91.8

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc-----------ccHHHHHHHHHHHHHHhhcC------CCCeEee
Q 004660          357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----------KSAECIKQLEQEIKVLGHLK------HENIVQY  419 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~-----------~~~~~~k~l~~Ei~iL~~L~------HPNIVkl  419 (739)
                      ...||+|+.=.||.--   ......||++.......           ......++..+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4579999999999643   34456778776432000           00112345566666555554      7889999


Q ss_pred             ccceeecceEEEEEeecCCC------CcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCC--
Q 004660          420 YGSEVVDDHLYIYLEYVHPG------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--  491 (739)
Q Consensus       420 ~~~~~~~~~l~LVmEy~~gG------sL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~--  491 (739)
                      ||..+++.-.-+|+|.+...      +|.+++++.  .+++    .+...|-.-..||-+++|+.+||+|.||++...  
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            99999988889999987643      577777543  3554    333444556678889999999999999999633  


Q ss_pred             C--cEEEee-ccc
Q 004660          492 G--VVKLAD-FGM  501 (739)
Q Consensus       492 g--~vKL~D-FGl  501 (739)
                      +  .+.|+| ||.
T Consensus       157 ~~~~lvlIDG~G~  169 (199)
T PF10707_consen  157 GEFRLVLIDGLGE  169 (199)
T ss_pred             CceEEEEEeCCCC
Confidence            2  577887 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.64  E-value=0.00021  Score=76.08  Aligned_cols=138  Identities=17%  Similarity=0.203  Sum_probs=82.6

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC--CeEeeccc------eeecc
Q 004660          356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGS------EVVDD  427 (739)
Q Consensus       356 i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HP--NIVkl~~~------~~~~~  427 (739)
                      -.+.|..|....+|+...  ++..+++|+...     ..   ...+..|+++++.|.+-  .+.+++..      ...++
T Consensus        18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             heecccCccccceEEEEe--CCCcEEEEEcCC-----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            356778888889999864  345788887642     11   13466688888877432  24444432      23345


Q ss_pred             eEEEEEeecCCCCcch----hhh----------hccccccH--------HHHH------------HHHHhHHHHHHHHHh
Q 004660          428 HLYIYLEYVHPGSINR----YVR----------EHCRDITE--------SIVR------------NFTRHILNGLAYLHS  473 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~----~L~----------~~~~~lse--------~~i~------------~i~~QLl~aL~yLHs  473 (739)
                      ..++||||++|..+..    .+.          .....+..        ....            .....+..++.++-.
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999999876532    010          00000000        0000            011112334444443


Q ss_pred             -------CCeecccCCCcceEecCCCcEEEeecccch
Q 004660          474 -------TNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       474 -------~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                             .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                   479999999999999998888999999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.61  E-value=0.00014  Score=76.05  Aligned_cols=134  Identities=16%  Similarity=0.224  Sum_probs=74.6

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCe-EeeccceeecceEEEEEeecCC
Q 004660          360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLYIYLEYVHP  438 (739)
Q Consensus       360 LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNI-Vkl~~~~~~~~~l~LVmEy~~g  438 (739)
                      +..|-...+|+..  .++..+++|......     ....-...+|.++|+.+..-++ .+++...  +  -++||||++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~-----~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVC-----KALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCccc-----ccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccC
Confidence            4557777899886  456778888543210     0000124668888888854322 2233222  2  3689999998


Q ss_pred             CCcchh-------h-------hh-cc-----cccc-HHHHHHHHHhH---------HHHHHHHHh--------CCeeccc
Q 004660          439 GSINRY-------V-------RE-HC-----RDIT-ESIVRNFTRHI---------LNGLAYLHS--------TNTIHRD  480 (739)
Q Consensus       439 GsL~~~-------L-------~~-~~-----~~ls-e~~i~~i~~QL---------l~aL~yLHs--------~GIvHRD  480 (739)
                      ..+...       +       .+ +.     ..++ ...+..+..++         ...+..+-.        ..++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            765421       1       10 00     0111 11222222222         111222211        2589999


Q ss_pred             CCCcceEecCCCcEEEeecccchhc
Q 004660          481 IKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       481 IKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                      +.+.|||++.++ +.|+||+.|...
T Consensus       153 l~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       153 VHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             CCcCcEEEeCCC-CEEEeccccCcC
Confidence            999999999877 789999988543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.61  E-value=0.00061  Score=73.58  Aligned_cols=79  Identities=13%  Similarity=0.083  Sum_probs=53.4

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC---CCeEeecccee---ecc
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH---ENIVQYYGSEV---VDD  427 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~H---PNIVkl~~~~~---~~~  427 (739)
                      ..-.+.||.|..+.||+.....  ..+.+|..+..    ..   ...+..|.+.|+.|.-   -.|.++++++.   ..+
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~--~~~~~k~~~~~----~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g   86 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQ--GNPMPLMARSF----ST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG   86 (297)
T ss_pred             hheeeecCCccceeEEEEEcCC--CCEEEEEeccc----cc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence            4456789999999999986432  35677764320    01   1357789888887742   24566665543   346


Q ss_pred             eEEEEEeecCCCCc
Q 004660          428 HLYIYLEYVHPGSI  441 (739)
Q Consensus       428 ~l~LVmEy~~gGsL  441 (739)
                      ..+||||+++|+++
T Consensus        87 ~~~LVmE~i~G~~~  100 (297)
T PRK10593         87 PDVLLLERLRGVSV  100 (297)
T ss_pred             CeEEEEeccCCEec
Confidence            78999999998765

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.61  E-value=0.00045  Score=74.40  Aligned_cols=141  Identities=20%  Similarity=0.193  Sum_probs=81.7

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC--CeEeeccc------eee
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGS------EVV  425 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HP--NIVkl~~~------~~~  425 (739)
                      ...++.|+.|-...||++...  +..+++|+....    ...   ..+..|++++..|..-  .|.+++..      ...
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~----~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~   94 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKR----VKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL   94 (307)
T ss_pred             ceeccccCCccccceEEEEeC--CCcEEEEEecCC----CCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence            344667788888899988642  346778876431    111   2344567777776421  23343331      123


Q ss_pred             cceEEEEEeecCCCCcchh-----------h---hhccccc----------cH-HH--HH----------HHHHhHHHHH
Q 004660          426 DDHLYIYLEYVHPGSINRY-----------V---REHCRDI----------TE-SI--VR----------NFTRHILNGL  468 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~-----------L---~~~~~~l----------se-~~--i~----------~i~~QLl~aL  468 (739)
                      ++..+++|||++|..+...           +   +.....+          .. ..  ..          .....+...+
T Consensus        95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~  174 (307)
T TIGR00938        95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL  174 (307)
T ss_pred             CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence            5678999999998654211           1   0000001          00 00  00          0011233455


Q ss_pred             HHHH-------hCCeecccCCCcceEecCCCcEEEeecccch
Q 004660          469 AYLH-------STNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       469 ~yLH-------s~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                      +++.       ..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            5554       3689999999999999998878999999873

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.58  E-value=0.00061  Score=75.14  Aligned_cols=145  Identities=19%  Similarity=0.243  Sum_probs=97.9

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecC----CCC----------------cc-cHHHHHHHHHHHHHHhhcCC
Q 004660          355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII----PDD----------------PK-SAECIKQLEQEIKVLGHLKH  413 (739)
Q Consensus       355 ~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~----~~~----------------~~-~~~~~k~l~~Ei~iL~~L~H  413 (739)
                      .+-.+|..|--+.||.|.. .+|..+|||+++..    ++.                .. .....-+.+.|++-|.+|..
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            3445788899999999874 56888999998521    110                01 11223456778888888765


Q ss_pred             CCeEeeccceeecceEEEEEeecCCCCc-chhhhhccccccHHHHHHHHHhHHHHHHHHH-hCCeecccCCCcceEecCC
Q 004660          414 ENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDAS  491 (739)
Q Consensus       414 PNIVkl~~~~~~~~~l~LVmEy~~gGsL-~~~L~~~~~~lse~~i~~i~~QLl~aL~yLH-s~GIvHRDIKP~NILLd~~  491 (739)
                      -.|. +-.-.... .-+|||+|+..... .-.|+.  ..++...+..+..|++.-|.-|- ..++||.||.--|+|+ .+
T Consensus       226 aGIP-~PePIlLk-~hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hd  300 (520)
T KOG2270|consen  226 AGIP-CPEPILLK-NHVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HD  300 (520)
T ss_pred             cCCC-CCCceeee-cceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-EC
Confidence            4432 11111111 24789999963322 222222  45788889999999999888884 6799999999999999 67


Q ss_pred             CcEEEeecccchhc
Q 004660          492 GVVKLADFGMAKHL  505 (739)
Q Consensus       492 g~vKL~DFGlA~~~  505 (739)
                      |.+.|||-+-+...
T Consensus       301 G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEH  314 (520)
T ss_pred             CEEEEEEccccccC
Confidence            89999998876543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.54  E-value=7.4e-05  Score=81.02  Aligned_cols=141  Identities=13%  Similarity=0.176  Sum_probs=98.2

Q ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCC-------C------Cc-ccHH-HHH--HHHHHHHHHhhcC-CC
Q 004660          353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-------D------DP-KSAE-CIK--QLEQEIKVLGHLK-HE  414 (739)
Q Consensus       353 ~Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~-------~------~~-~~~~-~~k--~l~~Ei~iL~~L~-HP  414 (739)
                      -+-+++.||-|.-+.||.+-+. .|.+.++|.-++-.       .      .. ...+ .+.  ...+|...|+.|. |-
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            4678899999999999999875 47888888532110       0      00 1111 111  2357888888885 32


Q ss_pred             -CeEeeccceeecceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecccCCCcceEecCCCc
Q 004660          415 -NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV  493 (739)
Q Consensus       415 -NIVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHRDIKP~NILLd~~g~  493 (739)
                       -|.+.++    -+.-++|||++.|..|.+.-+-       ..+..+...|+.-+.-|-.+|+||+|..--||||++++.
T Consensus       172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             CCCCCccc----ccceeeHHHhhcccceeeeeec-------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence             2334443    3456899999999888765422       223455666777777888999999999999999999999


Q ss_pred             EEEeecccchhc
Q 004660          494 VKLADFGMAKHL  505 (739)
Q Consensus       494 vKL~DFGlA~~~  505 (739)
                      +++|||--....
T Consensus       241 i~vIDFPQmvS~  252 (465)
T KOG2268|consen  241 IVVIDFPQMVST  252 (465)
T ss_pred             EEEeechHhhcc
Confidence            999999865433

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.47  E-value=0.0003  Score=71.18  Aligned_cols=99  Identities=21%  Similarity=0.171  Sum_probs=79.2

Q ss_pred             HHHHHHHhhcCC-CCeEeeccceeecceEEEEEeecCCCCcchh---hhhccccccHHHHHHHHHhHHHHHHHHHh---C
Q 004660          402 EQEIKVLGHLKH-ENIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHS---T  474 (739)
Q Consensus       402 ~~Ei~iL~~L~H-PNIVkl~~~~~~~~~l~LVmEy~~gGsL~~~---L~~~~~~lse~~i~~i~~QLl~aL~yLHs---~  474 (739)
                      ..|.-+|+.+.+ +++.+++|++-    -++|+||+..+++...   +.+ ...-++.....|+.+++..+++|+.   .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            358888898875 69999999872    2678999987766432   111 1246788899999999999999987   4


Q ss_pred             CeecccCCCcceEecCCCcEEEeecccchhc
Q 004660          475 NTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       475 GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~  505 (739)
                      .+.-.|++++|+-|+++|.+|++|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            5888999999999999999999999977543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.47  E-value=0.00099  Score=75.00  Aligned_cols=82  Identities=16%  Similarity=0.159  Sum_probs=53.8

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC-Cccc-HHHHHHHHHHHHHHhhcC---CCCeEeeccceeecceEEE
Q 004660          357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKS-AECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~-~~~~-~~~~k~l~~Ei~iL~~L~---HPNIVkl~~~~~~~~~l~L  431 (739)
                      .+.||.|.+..||++.....++.|+||.-...-. .+.. .-...+...|.+.|+.+.   -.++.++|.+  +++..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4679999999999999864446899997431100 0010 112356677888887763   2456777755  4466889


Q ss_pred             EEeecCCCC
Q 004660          432 YLEYVHPGS  440 (739)
Q Consensus       432 VmEy~~gGs  440 (739)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.39  E-value=0.00055  Score=73.20  Aligned_cols=76  Identities=17%  Similarity=0.179  Sum_probs=45.9

Q ss_pred             eeEEeecCCeEEEEEEECC------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCe-EeeccceeecceE
Q 004660          357 GKLIGRGTFGSVYIGTNRE------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHL  429 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~------tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNI-Vkl~~~~~~~~~l  429 (739)
                      ++.|..|-.-.||++....      .++.|++|+.....      .......+|++++..+...++ .++++.+.    -
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~------~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~   72 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV------ELLIDRERELVVFARLSERNLGPKLYGIFP----N   72 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC------cceechHHHHHHHHHHHhCCCCCceEEEeC----C
Confidence            3456666667899887543      25789999754311      112245678888888753332 34444332    2


Q ss_pred             EEEEeecCCCCcc
Q 004660          430 YIYLEYVHPGSIN  442 (739)
Q Consensus       430 ~LVmEy~~gGsL~  442 (739)
                      .+||||++|..+.
T Consensus        73 ~~v~e~i~G~~l~   85 (302)
T cd05156          73 GRIEEFIPSRTLT   85 (302)
T ss_pred             CchhheeCCCcCC
Confidence            3689999987664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.35  E-value=0.0024  Score=68.80  Aligned_cols=137  Identities=17%  Similarity=0.142  Sum_probs=75.2

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-----CCCeEeecc---ceeecce
Q 004660          357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----HENIVQYYG---SEVVDDH  428 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~-----HPNIVkl~~---~~~~~~~  428 (739)
                      .+.|+.|....+|+....  +..+++|++..  .   ..   ..+..|+.+++.|.     -|.++...+   +....+.
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~--~---~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~   96 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFER--L---TA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGK   96 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEecc--C---Ch---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCE
Confidence            456777888899998753  34688887641  1   11   22334555555553     334343211   1234567


Q ss_pred             EEEEEeecCCCCcch-----------hhhh---ccccc----------cH-HH-HH-----------HHHHh-HHHHHHH
Q 004660          429 LYIYLEYVHPGSINR-----------YVRE---HCRDI----------TE-SI-VR-----------NFTRH-ILNGLAY  470 (739)
Q Consensus       429 l~LVmEy~~gGsL~~-----------~L~~---~~~~l----------se-~~-i~-----------~i~~Q-Ll~aL~y  470 (739)
                      .+++|||++|..+..           .+.+   ....+          .. .. +.           ..+.+ +...++.
T Consensus        97 ~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  176 (319)
T PRK05231         97 PAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAF  176 (319)
T ss_pred             EEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHh
Confidence            899999999875421           1110   00000          00 00 00           01111 1111222


Q ss_pred             HH-------hCCeecccCCCcceEecCCCcEEEeecccch
Q 004660          471 LH-------STNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       471 LH-------s~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                      +-       ..|+||+|+.+.|||++.+...-|+||+.+.
T Consensus       177 ~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        177 LASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             hhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            22       2489999999999999877667899999874

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.04  E-value=0.0034  Score=67.19  Aligned_cols=31  Identities=26%  Similarity=0.355  Sum_probs=25.9

Q ss_pred             CeecccCCCcceEecCCCc-EEEeecccchhc
Q 004660          475 NTIHRDIKGANLLVDASGV-VKLADFGMAKHL  505 (739)
Q Consensus       475 GIvHRDIKP~NILLd~~g~-vKL~DFGlA~~~  505 (739)
                      .++|+|+++.|||++.++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997554 579999988654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.85  E-value=0.0087  Score=65.53  Aligned_cols=145  Identities=13%  Similarity=0.190  Sum_probs=80.1

Q ss_pred             eEeeEEeecCCe-EEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC--CeEeeccceeecc--eE
Q 004660          355 QKGKLIGRGTFG-SVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGSEVVDD--HL  429 (739)
Q Consensus       355 ~i~~~LG~G~fG-tVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HP--NIVkl~~~~~~~~--~l  429 (739)
                      .+.+.+ .||+. .+|.....  ++.+++. .   +.............+|+.+|+.+.--  -+-..++.+.++.  ..
T Consensus        28 ~~v~~~-~~G~sn~t~~~~~~--~~~~vlR-~---P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p  100 (321)
T COG3173          28 LIVEEI-SGGWSNDTFRLGDT--GQKYVLR-K---PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP  100 (321)
T ss_pred             ceeeec-cCCcccceEEEecC--CceEEEe-c---CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence            334444 34433 34444433  6677776 2   11122233445677888888877432  2334445554444  67


Q ss_pred             EEEEeecCCCCcchhhhhcc-------------------------------ccccHHHHHHHHHhH--------------
Q 004660          430 YIYLEYVHPGSINRYVREHC-------------------------------RDITESIVRNFTRHI--------------  464 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~-------------------------------~~lse~~i~~i~~QL--------------  464 (739)
                      |.||+|++|..+...+....                               ......++..+..+.              
T Consensus       101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            99999999853322221100                               000111112222221              


Q ss_pred             HHHHHHHHh--------CCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004660          465 LNGLAYLHS--------TNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       465 l~aL~yLHs--------~GIvHRDIKP~NILLd~~g~vKL~DFGlA~~~~  506 (739)
                      ..-..||+.        ..++|+|+.+.||+|+.++.+-|+||+++....
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            223444432        358999999999999999999999999987543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.81  E-value=0.017  Score=61.78  Aligned_cols=29  Identities=24%  Similarity=0.332  Sum_probs=25.6

Q ss_pred             CCeecccCCCcceEecCCCcEEEeecccch
Q 004660          474 TNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       474 ~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                      .+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57999999999999987 678999999663

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.59  E-value=0.0059  Score=67.91  Aligned_cols=77  Identities=10%  Similarity=0.124  Sum_probs=48.7

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEee----cCCCCcccHHHHHHHHHHHHHHhhcC--CC-CeEeeccceeecceEEE
Q 004660          359 LIGRGTFGSVYIGTNRETGASCAIKEVD----IIPDDPKSAECIKQLEQEIKVLGHLK--HE-NIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       359 ~LG~G~fGtVy~a~~k~tg~~VAIK~i~----~~~~~~~~~~~~k~l~~Ei~iL~~L~--HP-NIVkl~~~~~~~~~l~L  431 (739)
                      .||-|....||++.+...++.|+||.-.    .....  -.-.+.+..-|...|+...  -| .+.++|  +.+++...+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~--wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGES--WPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCC--CCCCccHHHHHHHHHHHhhccCccccCeEE--EEcccccee
Confidence            5799999999999976444689999642    11111  1112344556777776653  23 455565  345666789


Q ss_pred             EEeecCCC
Q 004660          432 YLEYVHPG  439 (739)
Q Consensus       432 VmEy~~gG  439 (739)
                      |||++...
T Consensus        78 vMEdL~~~   85 (370)
T TIGR01767        78 VMEDLSHH   85 (370)
T ss_pred             hHhhCccc
Confidence            99999643

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.40  E-value=0.019  Score=63.00  Aligned_cols=140  Identities=15%  Similarity=0.198  Sum_probs=76.7

Q ss_pred             eEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCe-EeeccceeecceEE
Q 004660          355 QKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLY  430 (739)
Q Consensus       355 ~i~~~LG~G~fGtVy~a~~k~t---g~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNI-Vkl~~~~~~~~~l~  430 (739)
                      ...+.|..|=.-.+|++.....   +..|++|+......      ..-.-.+|+.+++.+..-++ .++++++. ++   
T Consensus        17 i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~------~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---   86 (330)
T PLN02421         17 FSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD------YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---   86 (330)
T ss_pred             eEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC------eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence            3445555577778898875432   34788886542111      11123568888888864443 34454442 22   


Q ss_pred             EEEeecCCCCcch-------hh-------hh-cccc------c-cHHHHHHHHHhH----------------------HH
Q 004660          431 IYLEYVHPGSINR-------YV-------RE-HCRD------I-TESIVRNFTRHI----------------------LN  466 (739)
Q Consensus       431 LVmEy~~gGsL~~-------~L-------~~-~~~~------l-se~~i~~i~~QL----------------------l~  466 (739)
                      +|.||++|..|..       .+       ++ +...      . -...+..++.++                      ..
T Consensus        87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~  166 (330)
T PLN02421         87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD  166 (330)
T ss_pred             EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence            5899998766532       01       00 1101      1 112222232222                      11


Q ss_pred             HHHHH----HhC----CeecccCCCcceEecC-CCcEEEeecccchh
Q 004660          467 GLAYL----HST----NTIHRDIKGANLLVDA-SGVVKLADFGMAKH  504 (739)
Q Consensus       467 aL~yL----Hs~----GIvHRDIKP~NILLd~-~g~vKL~DFGlA~~  504 (739)
                      -+..+    ...    -.+|.|+.+.|||+++ ++.++|+||+.|..
T Consensus       167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            12221    112    2689999999999975 57899999998743

>PLN02236 choline kinase

Probab=96.37  E-value=0.018  Score=63.62  Aligned_cols=141  Identities=11%  Similarity=0.138  Sum_probs=78.9

Q ss_pred             ceEeeEEeecCCeEEEEEEECC----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCe-Eeeccceeecce
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRE----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDH  428 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~----tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNI-Vkl~~~~~~~~~  428 (739)
                      ..-.+.|-.|-.-.+|++....    .++.|++|+.....     ...+. ..+|+.+++.+..-++ .++++.+.. + 
T Consensus        38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-----~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g-  109 (344)
T PLN02236         38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-----ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G-  109 (344)
T ss_pred             cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-----Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c-
Confidence            3444556557778899986432    24678888654211     11122 3568888888754333 244444422 2 


Q ss_pred             EEEEEeecCCCCcchh----------h-------hhcc---c--cccHHHHHHHHHhH-----------------HHHHH
Q 004660          429 LYIYLEYVHPGSINRY----------V-------REHC---R--DITESIVRNFTRHI-----------------LNGLA  469 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~----------L-------~~~~---~--~lse~~i~~i~~QL-----------------l~aL~  469 (739)
                        .|+||++|.+|...          +       +...   .  ......+..|+.++                 ...+.
T Consensus       110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~  187 (344)
T PLN02236        110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN  187 (344)
T ss_pred             --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence              58999987766421          0       0000   0  11122333333222                 11111


Q ss_pred             HH--------HhCCeecccCCCcceEecC-CCcEEEeecccchh
Q 004660          470 YL--------HSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKH  504 (739)
Q Consensus       470 yL--------Hs~GIvHRDIKP~NILLd~-~g~vKL~DFGlA~~  504 (739)
                      .|        +...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            12        1236899999999999986 47899999998753

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.24  E-value=0.034  Score=60.04  Aligned_cols=30  Identities=17%  Similarity=0.201  Sum_probs=27.6

Q ss_pred             CeecccCCCcceEecCCCcEEEeecccchh
Q 004660          475 NTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       475 GIvHRDIKP~NILLd~~g~vKL~DFGlA~~  504 (739)
                      +++|+|+.+.|||++.++.+.|+||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.23  E-value=0.01  Score=68.16  Aligned_cols=159  Identities=19%  Similarity=0.359  Sum_probs=101.5

Q ss_pred             HHHHHHHHhhcCCCCeEeeccceeec-ceEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHHhCCeecc
Q 004660          401 LEQEIKVLGHLKHENIVQYYGSEVVD-DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  479 (739)
Q Consensus       401 l~~Ei~iL~~L~HPNIVkl~~~~~~~-~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLHs~GIvHR  479 (739)
                      +.--..+++.+.|+|...++++-... ....+|||++ +.+|++++..+.  +-...       ++       .+|+.|-
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s-------~~-------~~~~~~~   91 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDES-------LL-------AHGVLHL   91 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhh-------hc-------cccccee
Confidence            33456778899999999999876543 4588899999 488888886642  11111       00       2222221


Q ss_pred             cCCCcceEecCCCcEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCcchhhhHHHHHHHHHhhCCC
Q 004660          480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP  559 (739)
Q Consensus       480 DIKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDIWSLGvVLyELLtGk~  559 (739)
                           ||       ++++|     .+....             |            ...++++|||++|.++.|+..|..
T Consensus        92 -----~~-------~~~td-----~~~t~~-------------~------------~~~~pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   92 -----NI-------IYITD-----HFLTKY-------------P------------SPIGPKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             -----hh-------hhccc-----cccccC-------------C------------CCCCcchhhhhHHHHHHHHHHhhH
Confidence                 22       23344     010000             0            111238999999999999999988


Q ss_pred             CCCCCCchHHHHHHhhcCC------------CCCccCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 004660          560 PWSEFEGPQAMFKVLNRTP------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       560 PF~~~~~~~~~~~i~~~~~------------~iP~~ls~el~dLI~kcL~~DP~kRpTa~elLqHpwf~~~  618 (739)
                      .|......+....+..-..            .+-..++....+++.+|+-..|..||...++++++-|...
T Consensus       130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  130 LEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            8766555444433322110            1112356777889999999999999999999999988765

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.95  E-value=0.014  Score=65.65  Aligned_cols=81  Identities=15%  Similarity=0.071  Sum_probs=52.1

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecC-CCCcccHHHHHHHHHHHHHHhhcC--CC-CeEeeccceeecceEEEE
Q 004660          357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDII-PDDPKSAECIKQLEQEIKVLGHLK--HE-NIVQYYGSEVVDDHLYIY  432 (739)
Q Consensus       357 ~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~-~~~~~~~~~~k~l~~Ei~iL~~L~--HP-NIVkl~~~~~~~~~l~LV  432 (739)
                      .+.||-|.-.-||++.+...++.|+||.-... .....-.-...+..-|.++|+.+.  -| .+.++|  +.+++...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHH
Confidence            67889999999999998544577999864211 111111122355666778887663  23 456666  3456677899


Q ss_pred             EeecCCC
Q 004660          433 LEYVHPG  439 (739)
Q Consensus       433 mEy~~gG  439 (739)
                      ||+++..
T Consensus       112 MEdL~~~  118 (409)
T PRK12396        112 MEDLSDH  118 (409)
T ss_pred             HHhCccc
Confidence            9998643

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.90  E-value=0.075  Score=60.21  Aligned_cols=79  Identities=20%  Similarity=0.191  Sum_probs=49.3

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc--HHHHHHHHHHHHHHhhcC---CCCeEeeccceeecceEE
Q 004660          356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--AECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       356 i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~--~~~~k~l~~Ei~iL~~L~---HPNIVkl~~~~~~~~~l~  430 (739)
                      ..+.||-|..-.||+..+.  +..|+||.-.....-...  .....+...|+..|+.+.   -.++.++|.+..  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            4678899999999998863  456888864311110000  012234445666666553   246777776554  5578


Q ss_pred             EEEeecCC
Q 004660          431 IYLEYVHP  438 (739)
Q Consensus       431 LVmEy~~g  438 (739)
                      ++|||+++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            89999987

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.81  E-value=0.036  Score=59.95  Aligned_cols=76  Identities=18%  Similarity=0.185  Sum_probs=46.8

Q ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC---CCCeEeeccceeecceEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~---HPNIVkl~~~~~~~~~l~  430 (739)
                      .+..+.|+-|....+|+..  .+++.+.||+-...        ....++.|.+-|+.|.   --.+.+++++...++.-|
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~--------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f   88 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES--------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF   88 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG--------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChh--------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence            4566789999999999987  67889999976521        1134667887777773   345778888877777789


Q ss_pred             EEEeecCCC
Q 004660          431 IYLEYVHPG  439 (739)
Q Consensus       431 LVmEy~~gG  439 (739)
                      |||||++.+
T Consensus        89 Llle~l~~~   97 (288)
T PF03881_consen   89 LLLEFLEMG   97 (288)
T ss_dssp             EEEE-----
T ss_pred             EEEEeecCC
Confidence            999999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.74  E-value=0.02  Score=58.13  Aligned_cols=30  Identities=37%  Similarity=0.537  Sum_probs=21.3

Q ss_pred             CeecccCCCcceEe-cCCCcEEEeecccchh
Q 004660          475 NTIHRDIKGANLLV-DASGVVKLADFGMAKH  504 (739)
Q Consensus       475 GIvHRDIKP~NILL-d~~g~vKL~DFGlA~~  504 (739)
                      .++|.||.+.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            57899999999999 8889999999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PTZ00384 choline kinase; Provisional

Probab=95.45  E-value=0.065  Score=60.24  Aligned_cols=83  Identities=14%  Similarity=0.127  Sum_probs=46.7

Q ss_pred             ceEeeEEeecCCeEEEEEEECCC-CcEEEEEE-eecCCCCcccHHHHHHHHHHHHHHhhcCCCCe-EeeccceeecceEE
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRET-GASCAIKE-VDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLY  430 (739)
Q Consensus       354 Y~i~~~LG~G~fGtVy~a~~k~t-g~~VAIK~-i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNI-Vkl~~~~~~~~~l~  430 (739)
                      ....+.|..|-...+|++..... +..+.+|. +......  ..+..-.-.+|+++++.|..-++ .++++.+.    -+
T Consensus        52 ~i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~--~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g  125 (383)
T PTZ00384         52 FIEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST--YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DF  125 (383)
T ss_pred             cEEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC--CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CE
Confidence            34455666688889999975433 22332332 1111111  11111223568899998865444 45666553    26


Q ss_pred             EEEeecCCCCcc
Q 004660          431 IYLEYVHPGSIN  442 (739)
Q Consensus       431 LVmEy~~gGsL~  442 (739)
                      +|.||++|..|.
T Consensus       126 ~l~efIeGr~l~  137 (383)
T PTZ00384        126 TIQEWVEGNTMG  137 (383)
T ss_pred             EEEEEeccccCC
Confidence            999999987664

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.32  E-value=0.06  Score=59.38  Aligned_cols=134  Identities=19%  Similarity=0.217  Sum_probs=77.2

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCe------Eeeccc--eeecc--eE
Q 004660          360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI------VQYYGS--EVVDD--HL  429 (739)
Q Consensus       360 LG~G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNI------Vkl~~~--~~~~~--~l  429 (739)
                      |.+ .--.||+.....  ..+++|+....    ..   ...+..|+.+|+.|.-.+|      ..+=|.  ....+  ..
T Consensus        34 l~s-~eN~~f~~~~~~--g~~iLki~~~~----~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~  103 (331)
T COG2334          34 LNS-EENSNFRVQTED--GRYILKIYRPG----WT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP  103 (331)
T ss_pred             ccc-ccCceEEEEecC--CCeEEEEecCC----CC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence            444 445688887543  33488877632    11   2456668888888742222      222221  12334  78


Q ss_pred             EEEEeecCCCCcch-hhhh--------------ccccc-----------cHH----HH---------HHHHHhHHHHHHH
Q 004660          430 YIYLEYVHPGSINR-YVRE--------------HCRDI-----------TES----IV---------RNFTRHILNGLAY  470 (739)
Q Consensus       430 ~LVmEy~~gGsL~~-~L~~--------------~~~~l-----------se~----~i---------~~i~~QLl~aL~y  470 (739)
                      +-+++|++|..+.. ....              ..+.+           .+.    ..         .....++...++.
T Consensus       104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~  183 (331)
T COG2334         104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR  183 (331)
T ss_pred             EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence            88999999988772 1100              00111           111    00         0122334445555


Q ss_pred             HHh--------CC--eecccCCCcceEecCCCc-EEEeecccch
Q 004660          471 LHS--------TN--TIHRDIKGANLLVDASGV-VKLADFGMAK  503 (739)
Q Consensus       471 LHs--------~G--IvHRDIKP~NILLd~~g~-vKL~DFGlA~  503 (739)
                      +.+        .+  |||+|+.+.|||++.+.. +.++|||-+.
T Consensus       184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            542        24  999999999999998884 9999999774

>PRK06148 hypothetical protein; Provisional

Probab=95.20  E-value=0.18  Score=63.53  Aligned_cols=31  Identities=45%  Similarity=0.670  Sum_probs=26.3

Q ss_pred             CCeecccCCCcceEecCCC--cEE-Eeecccchh
Q 004660          474 TNTIHRDIKGANLLVDASG--VVK-LADFGMAKH  504 (739)
Q Consensus       474 ~GIvHRDIKP~NILLd~~g--~vK-L~DFGlA~~  504 (739)
                      .+|||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999875  454 999998754

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.13  E-value=0.096  Score=55.80  Aligned_cols=30  Identities=33%  Similarity=0.374  Sum_probs=25.2

Q ss_pred             eecccCCCcceEecCC--C---cEEEeecccchhc
Q 004660          476 TIHRDIKGANLLVDAS--G---VVKLADFGMAKHL  505 (739)
Q Consensus       476 IvHRDIKP~NILLd~~--g---~vKL~DFGlA~~~  505 (739)
                      |+|||++.+|||+..+  |   .++++||-+++..
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~g  251 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARYG  251 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeeccccccCC
Confidence            8999999999999655  3   6999999987543

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.71  E-value=0.25  Score=54.02  Aligned_cols=28  Identities=21%  Similarity=0.253  Sum_probs=23.9

Q ss_pred             CCeecccCCCcceEecCCCcEEEeecccch
Q 004660          474 TNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       474 ~GIvHRDIKP~NILLd~~g~vKL~DFGlA~  503 (739)
                      .++||+|+.+.|||++ + .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4789999999999995 4 57899999774

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.34  E-value=0.15  Score=53.42  Aligned_cols=116  Identities=17%  Similarity=0.189  Sum_probs=71.1

Q ss_pred             cCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeEeeccceeecceEEEEEeecCCCCcc
Q 004660          363 GTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSIN  442 (739)
Q Consensus       363 G~fGtVy~a~~k~tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy~~gGsL~  442 (739)
                      |+-++.-.+..+-  ....+|++...+-.-.    ...+..+..++.++.  .|+++..-  ..-.+-+|+|+|-...  
T Consensus        73 ~gNsTl~~~kt~i--G~L~lKKi~slp~~~~----~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~--  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKI--GPLFLKKIRSLPCCIN----DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK--  140 (308)
T ss_pred             CCceEEEEecccc--chhhhhhccCCCcccc----hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc--
Confidence            4444444433322  3445666553332211    234567888888764  57888742  4445889999984211  


Q ss_pred             hhhhhccccccHHHHHHHHHhHHHHHHHHH--hCCeecccCCCcceEecCCCcEEEeecccc
Q 004660          443 RYVREHCRDITESIVRNFTRHILNGLAYLH--STNTIHRDIKGANLLVDASGVVKLADFGMA  502 (739)
Q Consensus       443 ~~L~~~~~~lse~~i~~i~~QLl~aL~yLH--s~GIvHRDIKP~NILLd~~g~vKL~DFGlA  502 (739)
                              -..-    .++..=+.+|.-.|  ..+.+|+|-.|+|||-|..|.+||.|=+..
T Consensus       141 --------i~~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  141 --------INFS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             --------cchh----HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence                    1111    11222245677778  357999999999999999999999997754

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=93.77  E-value=0.098  Score=58.96  Aligned_cols=61  Identities=23%  Similarity=0.335  Sum_probs=44.9

Q ss_pred             eEEEEEeecCCCCcchhhhhccccccHHHHHHHHHhHHHHHHHHH-hCCeecccCCCcceEecC
Q 004660          428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDA  490 (739)
Q Consensus       428 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~i~~QLl~aL~yLH-s~GIvHRDIKP~NILLd~  490 (739)
                      ...|+-+|..|..+..+++..  ..+|+..+.++.-.+.||--|- -.+.+|.|+.|.||++..
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            356777899999999998764  3556666666666666654443 568999999999999953

>PTZ00296 choline kinase; Provisional

Probab=93.77  E-value=0.41  Score=54.95  Aligned_cols=76  Identities=12%  Similarity=0.008  Sum_probs=43.9

Q ss_pred             EeeEEeecCCeEEEEEEECC--------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeE-eeccceeec
Q 004660          356 KGKLIGRGTFGSVYIGTNRE--------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-QYYGSEVVD  426 (739)
Q Consensus       356 i~~~LG~G~fGtVy~a~~k~--------tg~~VAIK~i~~~~~~~~~~~~~k~l~~Ei~iL~~L~HPNIV-kl~~~~~~~  426 (739)
                      .++.|..|=.-.+|++....        .++.|.+++.-..     ....+ .-..|..+++.+..-+|- ++++.+.  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~-----te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~--  180 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKD-----VDELY-NPISEFEVYKTMSKYRIAPQLLNTFS--  180 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCC-----cccee-CHHHHHHHHHHHHHCCCCCceEEEeC--
Confidence            56667667777888887542        1467888765321     11111 234577777777543332 3444432  


Q ss_pred             ceEEEEEeecCCCCc
Q 004660          427 DHLYIYLEYVHPGSI  441 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL  441 (739)
                        -+.|.||++|-.|
T Consensus       181 --gg~I~efi~g~~l  193 (442)
T PTZ00296        181 --GGRIEEWLYGDPL  193 (442)
T ss_pred             --CCEEEEeeCCccC
Confidence              3567899987744

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	739
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-46
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-46
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-45
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-42
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-42
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-40
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-40
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-40
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-40
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-40
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-40
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-40
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-39
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-39
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-39
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-39
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-39
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-39
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-38
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-38
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-38
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-37
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-36
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-36
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-35
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-35
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-35
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-35
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-35
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-35
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-35
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-35
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-34
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-34
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-34
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-34
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-34
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-34
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-34
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-34
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-34
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-34
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-34
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-34
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-34
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-34
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-33
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-33
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-33
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-33
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-33
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-33
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-33
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-33
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-33
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-33
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-33
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-33
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-33
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-33
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-33
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-33
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-33
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-33
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-32
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-32
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-29
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-28
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-28
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-28
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-28
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-28
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-28
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-27
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-27
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-27
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-27
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-27
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-27
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-26
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-26
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-26
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-26
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-26
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-26
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-26
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-26
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-26
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-26
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-26
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-26
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-26
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-26
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-26
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-26
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-26
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-26
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-26
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-26
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-26
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-26
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-26
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-26
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-26
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-26
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-26
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-26
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-26
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-26
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-26
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-26
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-26
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-26
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-26
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-26
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-26
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-26
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-26
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-26
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-25
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-25
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-25
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-25
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-25
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-25
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-25
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-25
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-25
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-25
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-25
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-25
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-25
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-25
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-25
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-25
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-25
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-25
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-25
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-25
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-25
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-25
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-25
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-25
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-25
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-25
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-25
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-25
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-25
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-25
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-25
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-25
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-25
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-25
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-25
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-25
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-25
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-25
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-25
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-25
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-25
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-25
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-25
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-25
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-25
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-25
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-25
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-25
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-25
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-25
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-25
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-25
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-25
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-25
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-25
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-25
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-24
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-24
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-24
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-24
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-24
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-24
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-24
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-24
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-24
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-24
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-24
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-24
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-24
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-24
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-24
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-24
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-24
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-24
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-24
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-24
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-24
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-24
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-24
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-24
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-24
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-24
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-24
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-24
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-24
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-24
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-24
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-24
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-24
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-24
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-24
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-24
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-24
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-24
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-24
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-24
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-24
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-24
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-24
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-24
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-24
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-24
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-24
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-23
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-23
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-23
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-23
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-23
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-23
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-23
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-23
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-23
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-23
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-23
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-23
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-23
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-23
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-23
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-23
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-23
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-23
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-23
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-23
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-23
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-23
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-23
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-23
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-23
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-23
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-23
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-23
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-23
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-23
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-23
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-23
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-23
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-23
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-23
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-23
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-23
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-23
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-23
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-23
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-23
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-23
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-23
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-23
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-23
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-23
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-22
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-22
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-22
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-22
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-22
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-22
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-22
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-22
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-22
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-22
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-22
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-22
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-22
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-22
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-22
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-22
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-22
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-22
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-22
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-22
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-22
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-22
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-22
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-22
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-22
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-22
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-22
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-22
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-22
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-22
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-22
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-22
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-22
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-22
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-22
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-22
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-22
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-22
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-22
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-22
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-22
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-22
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-21
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-21
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-21
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-21
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-21
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-21
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-21
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-21
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-21
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-21
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-21
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-21
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-21
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-21
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-21
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-21
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-21
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-21
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-21
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-21
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-21
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-21
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-21
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-21
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-21
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-21
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-21
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-21
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-21
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-21
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-21
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-21
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-21
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-21
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-21
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-21
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-21
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-21
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-21
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-21
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-21
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-21
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-21
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-21
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-21
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-21
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-21
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-21
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-21
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-21
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-21
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-20
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-20
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-20
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-20
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-20
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-20
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-20
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-20
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-20
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-20
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-20
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-20
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-20
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-20
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-20
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-20
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-20
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-20
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-20
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-20
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-20
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-20
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-20
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-20
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-20
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-20
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-20
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-20
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-20
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-20
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-20
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-20
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-20
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-20
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-20
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-20
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-20
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-20
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-20
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-20
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-20
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-20
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-20
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-20
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-20
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-20
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-20
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-20
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-20
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-20
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-20
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-20
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-20
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-20
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-20
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-20
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-20
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-20
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-20
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-20
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-20
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-20
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-20
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-20
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-20
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-20
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-20
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-20
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-20
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-20
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-20
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-20
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-20
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-20
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-19
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-19
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-19
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-19
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-19
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-19
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-19
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-19
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-19
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-19
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-19
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-19
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-19
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-19
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-19
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-19
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-19
3soa_A	444	Full-Length Human Camkii Length = 444		3e-19
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-19
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-19
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-19
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-19
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-19
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-19
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-19
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-19
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-19
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-19
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-19
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-19
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-19
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-19
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-19
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-19
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-19
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-19
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-19
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		9e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-18
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-18
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-18
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-18
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-18
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-18
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-18
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-18
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-18
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-18
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-18
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-18
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-18
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-18
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-18
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-18
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-18
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-18
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-18
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-18
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-18
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-18
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-18
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-18
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-18
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-18
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-18
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-18
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-18
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-18
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-18
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-18
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-18
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-18
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-18
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-18
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-18
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-18
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-18
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-18
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-18
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-18
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-18
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-18
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-17
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-17
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-17
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-17
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-17
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-17
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-17
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-17
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-17
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-17
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-17
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-17
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-17
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-17
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-17
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-17
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-17
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-17
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-17
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-17
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-17
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-17
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-17
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-17
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-17
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-16
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-16
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-16
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-16
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-16
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-16
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-16
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-16
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-16
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-16
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-16
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-16
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-16
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-16
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-16
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		6e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-16
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-16
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-16
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-16
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-16
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-16
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-16
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-16
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-15
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-15
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-15
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-15
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-15
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-15
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-15
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-15
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-15
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-15
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-15
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-15
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-15
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-15
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-15
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-15
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-15
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-15
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-15
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-15
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-15
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-15
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-15
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-15
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-15
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-15
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-15
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-15
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		9e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-15
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-14
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-14
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-14
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-14
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-14
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-14
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-14
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-14
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-14
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-14
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-14
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-14
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-14
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-14
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		7e-14
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-13
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-13
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-13
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-13
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-13
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-13
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-13
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-13
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-13
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-13
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-13
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-13
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-13
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-13
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-12
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-12
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-12
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		9e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-11
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-11
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-10

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  184 bits (467), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 97/263 (36%), Positives = 152/263 (57%), Gaps = 18/263 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G++GSVY   ++ETG   AIK+V +  D       ++++ +EI ++      ++V+Y
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDSPHVVKY 89
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           YGS   +  L+I +EY   GS++  +R   + +TE  +    +  L GL YLH    IHR
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK  N+L++  G  KLADFG+A  LT  ++    + G+P WMAPEVI+ +         
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEI-------GY 202
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKDFLLRC 595
               DIWSLG T IEM  GKPP+++    +A+F +    PP    PE+ S    DF+ +C
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC 262
Query: 596 FLRNPVERPSAVELLEHPFIRNA 618
            +++P +R +A +LL+HPF+R+A
Sbjct: 263 LVKSPEQRATATQLLQHPFVRSA 285

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  183 bits (464), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 111/276 (40%), Positives = 164/276 (59%), Gaps = 19/276 (6%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           ++G+GT+G VY G +       AIKE   IP+  + +   + L +EI +  HLKH+NIVQ
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKE---IPE--RDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNT 476
           Y GS   +  + I++E V  GS++  +R     +   E  +  +T+ IL GL YLH    
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 477 IHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDG 534
           +HRDIKG N+L++  SGV+K++DFG +K L G++    +  G+  +MAPE+I      D 
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII------DK 197
Query: 535 NPK-LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKV--LNRTPPIPEMLSSEGKD 590
            P+    A DIWSLGCT+IEM TGKPP+ E   PQ AMFKV      P IPE +S+E K 
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257
Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
           F+L+CF  +P +R  A +LL   F++ ++ +  + P
Sbjct: 258 FILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  181 bits (460), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 110/266 (41%), Positives = 159/266 (59%), Gaps = 19/266 (7%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           ++G+GT+G VY G +       AIKE   IP+  + +   + L +EI +  HLKH+NIVQ
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKE---IPE--RDSRYSQPLHEEIALHKHLKHKNIVQ 69
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNT 476
           Y GS   +  + I++E V  GS++  +R     +   E  +  +T+ IL GL YLH    
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 477 IHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDG 534
           +HRDIKG N+L++  SGV+K++DFG +K L G++    +  G+  +MAPE+I      D 
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII------DK 183
Query: 535 NPK-LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKV--LNRTPPIPEMLSSEGKD 590
            P+    A DIWSLGCT+IEM TGKPP+ E   PQ AMFKV      P IPE +S+E K 
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 243
Query: 591 FLLRCFLRNPVERPSAVELLEHPFIR 616
           F+L+CF  +P +R  A +LL   F++
Sbjct: 244 FILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  169 bits (428), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 142/266 (53%), Gaps = 11/266 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W+    +G G FG VY   N+ETGA  A K ++      KS E ++    EI++L    H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 75
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             IV+  G+   D  L+I +E+   G+++  + E  R +TE  ++   R +L  L +LHS
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
              IHRD+K  N+L+   G ++LADFG+ AK+L  L    S  G+P WMAPEV+     K
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGK 589
           D         DIWSLG T+IEM   +PP  E    + + K+    PP    P   S E +
Sbjct: 196 D--TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253
Query: 590 DFLLRCFLRNPVERPSAVELLEHPFI 615
           DFL     +NP  RPSA +LLEHPF+
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  169 bits (427), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 142/266 (53%), Gaps = 11/266 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W+    +G G FG VY   N+ETGA  A K ++      KS E ++    EI++L    H
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 67
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             IV+  G+   D  L+I +E+   G+++  + E  R +TE  ++   R +L  L +LHS
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
              IHRD+K  N+L+   G ++LADFG+ AK+L  L    S  G+P WMAPEV+     K
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGK 589
           D         DIWSLG T+IEM   +PP  E    + + K+    PP    P   S E +
Sbjct: 188 D--TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 245
Query: 590 DFLLRCFLRNPVERPSAVELLEHPFI 615
           DFL     +NP  RPSA +LLEHPF+
Sbjct: 246 DFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  164 bits (416), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 109/287 (37%), Positives = 154/287 (53%), Gaps = 22/287 (7%)
Query: 340 HIMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 395
            I+EK     S    K ++ + + IG+G  G+VY   +  TG   AI+++++    PK  
Sbjct: 4   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKE 62
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 455
             I     EI V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E 
Sbjct: 63  LIIN----EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EG 116
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSL 514
            +    R  L  L +LHS   IHRDIK  N+L+   G VKL DFG    +T   S   ++
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176
Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV- 573
            G+P WMAPEV   V +K   PK    VDIWSLG   IEM+ G+PP+      +A++ + 
Sbjct: 177 VGTPYWMAPEV---VTRKAYGPK----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 574 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            N TP +  PE LS+  +DFL RC   +  +R SA ELL+H F++ A
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  164 bits (415), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 109/287 (37%), Positives = 153/287 (53%), Gaps = 22/287 (7%)
Query: 340 HIMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 395
            I+EK     S    K ++ + + IG+G  G+VY   +  TG   AI+++++    PK  
Sbjct: 4   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKE 62
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 455
             I     EI V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E 
Sbjct: 63  LII----NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EG 116
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSL 514
            +    R  L  L +LHS   IHRDIK  N+L+   G VKL DFG    +T   S    +
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM 176
Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV- 573
            G+P WMAPEV   V +K   PK    VDIWSLG   IEM+ G+PP+      +A++ + 
Sbjct: 177 VGTPYWMAPEV---VTRKAYGPK----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 574 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            N TP +  PE LS+  +DFL RC   +  +R SA ELL+H F++ A
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 109/287 (37%), Positives = 153/287 (53%), Gaps = 22/287 (7%)
Query: 340 HIMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 395
            I+EK     S    K ++ + + IG+G  G+VY   +  TG   AI+++++    PK  
Sbjct: 4   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKE 62
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 455
             I     EI V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E 
Sbjct: 63  LIIN----EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EG 116
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSL 514
            +    R  L  L +LHS   IHRDIK  N+L+   G VKL DFG    +T   S    +
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEM 176
Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV- 573
            G+P WMAPEV   V +K   PK    VDIWSLG   IEM+ G+PP+      +A++ + 
Sbjct: 177 VGTPYWMAPEV---VTRKAYGPK----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 574 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            N TP +  PE LS+  +DFL RC   +  +R SA ELL+H F++ A
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  163 bits (412), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 108/287 (37%), Positives = 153/287 (53%), Gaps = 22/287 (7%)
Query: 340 HIMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 395
            I+EK     S    K ++ + + IG+G  G+VY   +  TG   AI+++++    PK  
Sbjct: 5   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKE 63
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 455
             I     EI V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E 
Sbjct: 64  LIIN----EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EG 117
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSL 514
            +    R  L  L +LHS   IHRDIK  N+L+   G VKL DFG    +T   S    +
Sbjct: 118 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM 177
Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV- 573
            G+P WMAPEV   V +K   PK    VDIWSLG   IEM+ G+PP+      +A++ + 
Sbjct: 178 VGTPYWMAPEV---VTRKAYGPK----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 230
Query: 574 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            N TP +  PE LS+  +DFL RC   +  +R SA EL++H F++ A
Sbjct: 231 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIA 277

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  162 bits (411), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 111/281 (39%), Positives = 154/281 (54%), Gaps = 17/281 (6%)
Query: 342 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           M+   A P++  + K + IG+G+FG V+ G +  T    AIK +D+     ++ + I+ +
Sbjct: 13  MQNLKADPEE-LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDI 67
Query: 402 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 461
           +QEI VL       + +YYGS + D  L+I +EY+  GS    +     D  E+ +    
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATIL 125
Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNW 520
           R IL GL YLHS   IHRDIK AN+L+   G VKLADFG+A  LT    + +   G+P W
Sbjct: 126 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFW 185
Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI 580
           MAPEVIK   Q   + K     DIWSLG T IE+  G+PP SE    + +F +    PP 
Sbjct: 186 MAPEVIK---QSAYDSK----ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT 238
Query: 581 PE-MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI-RNAN 619
            E   S   K+F+  C  + P  RP+A ELL+H FI RNA 
Sbjct: 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  162 bits (409), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 107/263 (40%), Positives = 145/263 (55%), Gaps = 16/263 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG+G+FG V+ G +  T    AIK +D+     ++ + I+ ++QEI VL       + +Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           YGS + D  L+I +EY+  GS    +     D  E+ +    R IL GL YLHS   IHR
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHR 128
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK AN+L+   G VKLADFG+A  LT    +  +  G+P WMAPEVIK   Q   + K 
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDSK- 184
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-MLSSEGKDFLLRCFL 597
               DIWSLG T IE+  G+PP SE    + +F +    PP  E   S   K+F+  C  
Sbjct: 185 ---ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 241
Query: 598 RNPVERPSAVELLEHPFI-RNAN 619
           + P  RP+A ELL+H FI RNA 
Sbjct: 242 KEPSFRPTAKELLKHKFILRNAK 264

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  162 bits (409), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 107/262 (40%), Positives = 145/262 (55%), Gaps = 16/262 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG+G+FG V+ G +  T    AIK +D+     ++ + I+ ++QEI VL       + +Y
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 90
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           YGS + D  L+I +EY+  GS    +     D  E+ +    R IL GL YLHS   IHR
Sbjct: 91  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHR 148
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK AN+L+   G VKLADFG+A  LT    +  +  G+P WMAPEVIK   Q   + K 
Sbjct: 149 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDSK- 204
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-MLSSEGKDFLLRCFL 597
               DIWSLG T IE+  G+PP SE    + +F +    PP  E   S   K+F+  C  
Sbjct: 205 ---ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 261
Query: 598 RNPVERPSAVELLEHPFI-RNA 618
           + P  RP+A ELL+H FI RNA
Sbjct: 262 KEPSFRPTAKELLKHKFILRNA 283

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  161 bits (408), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 107/287 (37%), Positives = 154/287 (53%), Gaps = 22/287 (7%)
Query: 340 HIMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 395
            I+EK     S    K ++ + + IG+G  G+VY   +  TG   AI+++++    PK  
Sbjct: 5   EILEKLRIIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKE 63
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 455
             I     EI V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E 
Sbjct: 64  LIIN----EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EG 117
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSL 514
            +    R  L  L +LHS   IHR+IK  N+L+   G VKL DFG    +T   S   ++
Sbjct: 118 QIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 177
Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV- 573
            G+P WMAPEV   V +K   PK    VDIWSLG   IEM+ G+PP+      +A++ + 
Sbjct: 178 VGTPYWMAPEV---VTRKAYGPK----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 230
Query: 574 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            N TP +  PE LS+  +DFL RC   +  +R SA EL++H F++ A
Sbjct: 231 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIA 277

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  161 bits (408), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 107/263 (40%), Positives = 145/263 (55%), Gaps = 16/263 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG+G+FG V+ G +  T    AIK +D+     ++ + I+ ++QEI VL       + +Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           YGS + D  L+I +EY+  GS    +     D  E+ +    R IL GL YLHS   IHR
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHR 128
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK AN+L+   G VKLADFG+A  LT    + +   G+P WMAPEVIK   Q   + K 
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIK---QSAYDSK- 184
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-MLSSEGKDFLLRCFL 597
               DIWSLG T IE+  G+PP SE    + +F +    PP  E   S   K+F+  C  
Sbjct: 185 ---ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 241
Query: 598 RNPVERPSAVELLEHPFI-RNAN 619
           + P  RP+A ELL+H FI RNA 
Sbjct: 242 KEPSFRPTAKELLKHKFILRNAK 264

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  160 bits (406), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 91/272 (33%), Positives = 151/272 (55%), Gaps = 13/272 (4%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++ G L+G+G+F  VY   +  TG   AIK +D        A  +++++ E+K+  
Sbjct: 9   KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMID--KKAMYKAGMVQRVQNEVKIHC 66
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            LKH +I++ Y      +++Y+ LE  H G +NRY++   +  +E+  R+F   I+ G+ 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIK 527
           YLHS   +HRD+  +NLL+  +  +K+ADFG+A  L  + +E   +L G+PN+++PE+  
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK-MPHEKHYTLCGTPNYISPEI-- 183
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
           A     G     L  D+WSLGC    +L G+PP+        + KV+     +P  LS E
Sbjct: 184 ATRSAHG-----LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIE 238
Query: 588 GKDFLLRCFLRNPVERPSAVELLEHPFI-RNA 618
            KD + +   RNP +R S   +L+HPF+ RN+
Sbjct: 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  159 bits (403), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 95/266 (35%), Positives = 139/266 (52%), Gaps = 11/266 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W+    +G G FG VY   N+ET    A K +D      KS E ++    EI +L    H
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 93
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+   +   +++L+I +E+   G+++  + E  R +TES ++   +  L+ L YLH 
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
              IHRD+K  N+L    G +KLADFG+ AK+   +    S  G+P WMAPEV+     K
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGK 589
           D  P      D+WSLG T+IEM   +PP  E    + + K+    PP    P   SS  K
Sbjct: 214 D-RP-YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 271
Query: 590 DFLLRCFLRNPVERPSAVELLEHPFI 615
           DFL +C  +N   R +  +LL+HPF+
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  159 bits (403), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 95/266 (35%), Positives = 139/266 (52%), Gaps = 11/266 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W+    +G G FG VY   N+ET    A K +D      KS E ++    EI +L    H
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 93
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+   +   +++L+I +E+   G+++  + E  R +TES ++   +  L+ L YLH 
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
              IHRD+K  N+L    G +KLADFG+ AK+   +    S  G+P WMAPEV+     K
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGK 589
           D  P      D+WSLG T+IEM   +PP  E    + + K+    PP    P   SS  K
Sbjct: 214 D-RP-YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 271
Query: 590 DFLLRCFLRNPVERPSAVELLEHPFI 615
           DFL +C  +N   R +  +LL+HPF+
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  158 bits (400), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 100/258 (38%), Positives = 142/258 (55%), Gaps = 15/258 (5%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG+G+FG VY G +  T    AIK +D+     ++ + I+ ++QEI VL       I +Y
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYITRY 82
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           +GS +    L+I +EY+  GS    ++     + E+ +    R IL GL YLHS   IHR
Sbjct: 83  FGSYLKSTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERKIHR 140
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK AN+L+   G VKLADFG+A  LT    + +   G+P WMAPEVIK           
Sbjct: 141 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIK-------QSAY 193
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE-GKDFLLRCFL 597
               DIWSLG T IE+  G+PP S+    + +F +   +PP  E   S+  K+F+  C  
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLN 253
Query: 598 RNPVERPSAVELLEHPFI 615
           ++P  RP+A ELL+H FI
Sbjct: 254 KDPRFRPTAKELLKHKFI 271

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  158 bits (400), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 149/273 (54%), Gaps = 23/273 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG-HLKHENI 416
           +L+G GT+G VY G + +TG   AIK +D+  D+ +      +++QEI +L  +  H NI
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE------EIKQEINMLKKYSHHRNI 83
Query: 417 VQYYGSEV------VDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLA 469
             YYG+ +      +DD L++ +E+   GS+   ++      + E  +    R IL GL+
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKA 528
           +LH    IHRDIKG N+L+  +  VKL DFG++  L   +    +  G+P WMAPEVI  
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 529 VMQKDGNPKLA--LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPIP-EML 584
               D NP        D+WSLG T IEM  G PP  +    +A+F +  N  P +  +  
Sbjct: 204 ----DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 259
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           S + + F+  C ++N  +RP+  +L++HPFIR+
Sbjct: 260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 138/266 (51%), Gaps = 11/266 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W+    +G G FG VY   N+ET    A K +D      KS E ++    EI +L    H
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 93
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+   +   +++L+I +E+   G+++  + E  R +TES ++   +  L+ L YLH 
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
              IHRD+K  N+L    G +KLADFG+ AK+   +       G+P WMAPEV+     K
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSK 213
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGK 589
           D  P      D+WSLG T+IEM   +PP  E    + + K+    PP    P   SS  K
Sbjct: 214 D-RP-YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 271
Query: 590 DFLLRCFLRNPVERPSAVELLEHPFI 615
           DFL +C  +N   R +  +LL+HPF+
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  156 bits (395), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 99/258 (38%), Positives = 142/258 (55%), Gaps = 15/258 (5%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG+G+FG V+ G +  T    AIK +D+     ++ + I+ ++QEI VL       + +Y
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSSYVTKY 86
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           YGS +    L+I +EY+  GS    +R    D  E  +    + IL GL YLHS   IHR
Sbjct: 87  YGSYLKGSKLWIIMEYLGGGSALDLLRAGPFD--EFQIATMLKEILKGLDYLHSEKKIHR 144
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK AN+L+   G VKLADFG+A  LT    +  +  G+P WMAPEVI+   Q   + K 
Sbjct: 145 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ---QSAYDSK- 200
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IPEMLSSEGKDFLLRCFL 597
               DIWSLG T IE+  G+PP S+    + +F +    PP +    +   K+F+  C  
Sbjct: 201 ---ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLN 257
Query: 598 RNPVERPSAVELLEHPFI 615
           ++P  RP+A ELL+H FI
Sbjct: 258 KDPSFRPTAKELLKHKFI 275

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  150 bits (379), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 145/272 (53%), Gaps = 18/272 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+ G V I T R +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 213
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHR 271
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK  ++L+   G VKL+DFG    ++  +     L G+P WMAPE+I  +         
Sbjct: 272 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL-------PY 324
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML---SSEGKDFLLRC 595
              VDIWSLG  VIEM+ G+PP+      +AM  + +  PP  + L   S   K FL R 
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384
Query: 596 FLRNPVERPSAVELLEHPFIRNANYQNLSVPM 627
            +R+P +R +A ELL+HPF+  A      VP+
Sbjct: 385 LVRDPAQRATAAELLKHPFLAKAGPPASIVPL 416

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  149 bits (375), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 146/274 (53%), Gaps = 22/274 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+ G V +   + +G   A+K +D+     +  +  + L  E+ ++   +H N+V+ 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y S +V + L++ +E++  G++   V +    + E  +      +L  LAYLH+   IHR
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK  ++L+   G VKL+DFG    ++  +     L G+P WMAPEVI   +        
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSL-------Y 218
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG-----KDFLL 593
           A  VDIWSLG  VIEM+ G+PP+      QAM K L  +PP P++ +S       +DFL 
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-KRLRDSPP-PKLKNSHKVSPVLRDFLE 276
Query: 594 RCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 627
           R  +R+P ER +A ELL+HPF+         VP+
Sbjct: 277 RMLVRDPQERATAQELLDHPFLLQTGLPECLVPL 310

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  148 bits (373), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 146/272 (53%), Gaps = 18/272 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+ G V I T + TG   A+K++D+     +  +  + L  E+ ++    H+N+V  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHDNVVDM 107
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+YLH+   IHR
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLSVLRALSYLHNQGVIHR 165
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK  ++L+ + G +KL+DFG    ++  +     L G+P WMAPEVI  +         
Sbjct: 166 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRL-------PY 218
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML---SSEGKDFLLRC 595
              VDIWSLG  VIEM+ G+PP+      QAM ++ +  PP  + L   SS  + FL   
Sbjct: 219 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLM 278
Query: 596 FLRNPVERPSAVELLEHPFIRNANYQNLSVPM 627
            +R P +R +A ELL HPF++ A   +  VP+
Sbjct: 279 LVREPSQRATAQELLGHPFLKLAGPPSCIVPL 310

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  147 bits (372), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 91/264 (34%), Positives = 142/264 (53%), Gaps = 18/264 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+ G V I T R +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 136
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHR 194
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK  ++L+   G VKL+DFG    ++  +     L G+P WMAPE+I  +         
Sbjct: 195 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL-------PY 247
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML---SSEGKDFLLRC 595
              VDIWSLG  VIEM+ G+PP+      +AM  + +  PP  + L   S   K FL R 
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307
Query: 596 FLRNPVERPSAVELLEHPFIRNAN 619
            +R+P +R +A ELL+HPF+  A 
Sbjct: 308 LVRDPAQRATAAELLKHPFLAKAG 331

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 91/264 (34%), Positives = 142/264 (53%), Gaps = 18/264 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+ G V I T R +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 93
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHR 151
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK  ++L+   G VKL+DFG    ++  +     L G+P WMAPE+I  +         
Sbjct: 152 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL-------PY 204
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML---SSEGKDFLLRC 595
              VDIWSLG  VIEM+ G+PP+      +AM  + +  PP  + L   S   K FL R 
Sbjct: 205 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 264
Query: 596 FLRNPVERPSAVELLEHPFIRNAN 619
            +R+P +R +A ELL+HPF+  A 
Sbjct: 265 LVRDPAQRATAAELLKHPFLAKAG 288

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  147 bits (370), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 144/264 (54%), Gaps = 18/264 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+ G V I T R +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 91
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHR 149
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK  ++L+   G VKL+DFG    ++  +     L G+P WMAPE+I  +      P+ 
Sbjct: 150 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL---PYGPE- 205
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML---SSEGKDFLLRC 595
              VDIWSLG  VIEM+ G+PP+      +AM  + +  PP  + L   S   K FL R 
Sbjct: 206 ---VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 262
Query: 596 FLRNPVERPSAVELLEHPFIRNAN 619
            +R+P +R +A ELL+HPF+  A 
Sbjct: 263 LVRDPAQRATAAELLKHPFLAKAG 286

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 144/264 (54%), Gaps = 18/264 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+ G V I T R +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHR 140
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK  ++L+   G VKL+DFG    ++  +     L G+P WMAPE+I  +      P+ 
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL---PYGPE- 196
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML---SSEGKDFLLRC 595
              VDIWSLG  VIEM+ G+PP+      +AM  + +  PP  + L   S   K FL R 
Sbjct: 197 ---VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 253
Query: 596 FLRNPVERPSAVELLEHPFIRNAN 619
            +R+P +R +A ELL+HPF+  A 
Sbjct: 254 LVRDPAQRATAAELLKHPFLAKAG 277

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 145/272 (53%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 84
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 143
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE
Sbjct: 144 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 202
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 203 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 254
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 255 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  146 bits (368), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 144/264 (54%), Gaps = 18/264 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+ G V I T R +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 86
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHR 144
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           DIK  ++L+   G VKL+DFG    ++  +     L G+P WMAPE+I  +      P+ 
Sbjct: 145 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL---PYGPE- 200
Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML---SSEGKDFLLRC 595
              VDIWSLG  VIEM+ G+PP+      +AM  + +  PP  + L   S   K FL R 
Sbjct: 201 ---VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 257
Query: 596 FLRNPVERPSAVELLEHPFIRNAN 619
            +R+P +R +A ELL+HPF+  A 
Sbjct: 258 LVRDPAQRATAAELLKHPFLAKAG 281

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  145 bits (366), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 145/272 (53%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 59
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 118
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPS-SRRTTLSGTLDYLPPE 177
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 178 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 229
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  145 bits (365), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 145/272 (53%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 18  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 75
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 76  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 134
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE
Sbjct: 135 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 193
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 194 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 245
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 246 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  144 bits (364), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 145/272 (53%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 63
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 122
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 181
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 182 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 233
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 234 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 145/272 (53%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 61
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 179
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 180 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 231
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 232 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 144/272 (52%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 84
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 143
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE
Sbjct: 144 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRDDLCGTLDYLPPE 202
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 203 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 254
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 255 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 144/272 (52%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 60
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 119
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE
Sbjct: 120 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPE 178
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 179 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 230
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 231 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  143 bits (361), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 144/272 (52%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 63
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 122
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 181
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 182 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 233
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 234 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  143 bits (361), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 144/272 (52%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 59
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 118
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 177
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 178 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 229
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  143 bits (360), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 145/272 (53%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 59
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 118
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRDTLCGTLDYLPPE 177
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 178 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 229
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  143 bits (360), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 144/272 (52%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 58
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 176
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 177 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 228
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 229 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  143 bits (360), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 87/272 (31%), Positives = 143/272 (52%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 63
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G + + +++  +   E     +   +
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITEL 122
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLXGTLDYLPPE 181
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 182 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 233
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 234 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  143 bits (360), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 145/272 (53%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 61
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 179
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 180 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 231
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 232 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 87/272 (31%), Positives = 145/272 (53%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 60
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 119
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+A+FG + H    S   +L G+ +++ PE
Sbjct: 120 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS-SRRTTLCGTLDYLPPE 178
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 179 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 230
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 231 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 87/272 (31%), Positives = 144/272 (52%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 63
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G + + +++  +   E     +   +
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITEL 122
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 181
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 182 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 233
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 234 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  142 bits (358), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 144/272 (52%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 61
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPE 179
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 180 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 231
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 232 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  142 bits (357), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 145/275 (52%), Gaps = 18/275 (6%)
Query: 347 ASPKKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           A   K QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL
Sbjct: 2   AMGSKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQL 59
Query: 402 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 461
            +E+++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     + 
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYI 118
Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             + N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYL 177
Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PI 580
            PE+I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     
Sbjct: 178 PPEMIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTF 229
Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           P+ ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 230 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/272 (31%), Positives = 145/272 (53%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 61
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+A+FG + H    S   +L G+ +++ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS-SRRTTLCGTLDYLPPE 179
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
           +I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 180 MIEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 231
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 232 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 144/271 (53%), Gaps = 18/271 (6%)
Query: 351 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREV 59
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELA 118
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
           N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE+
Sbjct: 119 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPPEM 177
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEML 584
           I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ +
Sbjct: 178 IEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFV 229
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           +   +D + R    NP +RP   E+LEHP+I
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/272 (31%), Positives = 143/272 (52%), Gaps = 18/272 (6%)
Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 63
Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 122
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 181
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEM 583
            I+     +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ 
Sbjct: 182 XIEGRXHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDF 233
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++   +D + R    NP +RP   E+LEHP+I
Sbjct: 234 VTEGARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 144/271 (53%), Gaps = 18/271 (6%)
Query: 351 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREV 58
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + 
Sbjct: 59  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELA 117
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
           N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE+
Sbjct: 118 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEM 176
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEML 584
           I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ +
Sbjct: 177 IEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFV 228
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           +   +D + R    NP +RP   E+LEHP+I
Sbjct: 229 TEGARDLISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 143/271 (52%), Gaps = 18/271 (6%)
Query: 351 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREV 59
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELA 118
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
           N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE+
Sbjct: 119 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPEM 177
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEML 584
           I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ +
Sbjct: 178 IEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFV 229
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           +   +D + R    NP +RP   E+LEHP+I
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 13/263 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++ G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+++  HL+H
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + N L+Y HS
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS 126
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
              IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE+I+  M  +
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMHDE 185
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEMLSSEGKDFL 592
                   VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ ++   +D +
Sbjct: 186 -------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGARDLI 237
Query: 593 LRCFLRNPVERPSAVELLEHPFI 615
            R    NP +RP   E+LEHP+I
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  141 bits (355), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 142/263 (53%), Gaps = 13/263 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++ G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+++  HL+H
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + N L+Y HS
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS 129
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
              IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE+I+  M  +
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPPEMIEGRMHDE 188
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEMLSSEGKDFL 592
                   VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ ++   +D +
Sbjct: 189 -------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 593 LRCFLRNPVERPSAVELLEHPFI 615
            R    NP +RP   E+LEHP+I
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  141 bits (355), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 139/295 (47%), Gaps = 33/295 (11%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
           S  +  ++  ++IG G    V            AIK +++     K    + +L +EI+ 
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDELLKEIQA 66
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------EHCRDIT-ESIVRNF 460
           +    H NIV YY S VV D L++ ++ +  GS+   ++      EH   +  ES +   
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL------TGLSYELSL 514
            R +L GL YLH    IHRD+K  N+L+   G V++ADFG++  L      T      + 
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            G+P WMAPEV++ V   D         DIWS G T IE+ TG  P+ ++   + +   L
Sbjct: 187 VGTPCWMAPEVMEQVRGYD------FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240
Query: 575 NRTPPI-------PEMLSSEGKDF---LLRCFLRNPVERPSAVELLEHPFIRNAN 619
              PP         EML   GK F   +  C  ++P +RP+A ELL H F + A 
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 143/271 (52%), Gaps = 18/271 (6%)
Query: 351 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K QW     + G+ +G+G FG+VY+   + +    A+K   +     + A    QL +E+
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKV--LFKAQLEKAGVEHQLRREV 59
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELA 118
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
           N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE+
Sbjct: 119 NALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPPEM 177
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEML 584
           I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ +
Sbjct: 178 IEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQDTYKRISRVEFTFPDFV 229
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           +   +D + R    NP +RP   E+LEHP+I
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 141/263 (53%), Gaps = 13/263 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++ G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+++  HL+H
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + N L+Y HS
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS 126
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
              IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE+I+  M  +
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTELCGTLDYLPPEMIEGRMHDE 185
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEMLSSEGKDFL 592
                   VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ ++   +D +
Sbjct: 186 -------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGARDLI 237
Query: 593 LRCFLRNPVERPSAVELLEHPFI 615
            R    NP +RP   E+LEHP+I
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 139/295 (47%), Gaps = 33/295 (11%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
           S  +  ++  ++IG G    V            AIK +++     K    + +L +EI+ 
Sbjct: 6   SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDELLKEIQA 61
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------EHCRDIT-ESIVRNF 460
           +    H NIV YY S VV D L++ ++ +  GS+   ++      EH   +  ES +   
Sbjct: 62  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL------TGLSYELSL 514
            R +L GL YLH    IHRD+K  N+L+   G V++ADFG++  L      T      + 
Sbjct: 122 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            G+P WMAPEV++ V   D         DIWS G T IE+ TG  P+ ++   + +   L
Sbjct: 182 VGTPCWMAPEVMEQVRGYD------FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 235
Query: 575 NRTPPI-------PEMLSSEGKDF---LLRCFLRNPVERPSAVELLEHPFIRNAN 619
              PP         EML   GK F   +  C  ++P +RP+A ELL H F + A 
Sbjct: 236 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 290

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 143/271 (52%), Gaps = 18/271 (6%)
Query: 351 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREV 59
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELA 118
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
           N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE+
Sbjct: 119 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPEM 177
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEML 584
           I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ +
Sbjct: 178 IEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFV 229
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           +   +D + R    NP +RP   E+LEHP+I
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 143/271 (52%), Gaps = 18/271 (6%)
Query: 351 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREV 59
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELA 118
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
           N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE+
Sbjct: 119 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTXLCGTLDYLPPEM 177
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEML 584
           I+  M  +        VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ +
Sbjct: 178 IEGRMHDE-------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFV 229
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           +   +D + R    NP +RP   E+LEHP+I
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  140 bits (353), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 90/260 (34%), Positives = 137/260 (52%), Gaps = 16/260 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+FG+VY   +       AIK++       +S E  + + +E++ L  L+H N +QY
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
            G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAYLHS N IHR
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 537
           D+K  N+L+   G+VKL DFG A  +   +      G+P WMAPEVI A+   Q DG   
Sbjct: 179 DVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGK-- 233
Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEG-KDFLLRC 595
               VD+WSLG T IE+   KPP        A++ +  N +P +     SE  ++F+  C
Sbjct: 234 ----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 289
Query: 596 FLRNPVERPSAVELLEHPFI 615
             + P +RP++  LL+H F+
Sbjct: 290 LQKIPQDRPTSEVLLKHRFV 309

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  139 bits (351), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 90/260 (34%), Positives = 137/260 (52%), Gaps = 16/260 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+FG+VY   +       AIK++       +S E  + + +E++ L  L+H N +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
            G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAYLHS N IHR
Sbjct: 81  RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 537
           D+K  N+L+   G+VKL DFG A  +   +      G+P WMAPEVI A+   Q DG   
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGK-- 194
Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEG-KDFLLRC 595
               VD+WSLG T IE+   KPP        A++ +  N +P +     SE  ++F+  C
Sbjct: 195 ----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250
Query: 596 FLRNPVERPSAVELLEHPFI 615
             + P +RP++  LL+H F+
Sbjct: 251 LQKIPQDRPTSEVLLKHRFV 270

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  138 bits (348), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 141/263 (53%), Gaps = 13/263 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++ G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+++  HL+H
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + N L+Y HS
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS 129
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
              IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE+I+  M  +
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRDDLCGTLDYLPPEMIEGRMHDE 188
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEMLSSEGKDFL 592
                   VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ ++   +D +
Sbjct: 189 -------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 593 LRCFLRNPVERPSAVELLEHPFI 615
            R    NP +RP   E+LEHP+I
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  138 bits (348), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 141/263 (53%), Gaps = 13/263 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++ G+ +G+G FG+VY+   ++     A+K   +     + A    QL +E+++  HL+H
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 64
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + N L+Y HS
Sbjct: 65  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS 123
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
              IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE+I+  M  +
Sbjct: 124 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMHDE 182
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEMLSSEGKDFL 592
                   VD+WSLG    E L GKPP+ E    Q  +K ++R     P+ ++   +D +
Sbjct: 183 -------KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGARDLI 234
Query: 593 LRCFLRNPVERPSAVELLEHPFI 615
            R    NP +RP   E+LEHP+I
Sbjct: 235 SRLLKHNPSQRPMLREVLEHPWI 257

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  136 bits (343), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 142/272 (52%), Gaps = 18/272 (6%)
Query: 351 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K QW       G+ +G+G FG+VY+   R++    A+K   +     + A    QL +E+
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKV--LFKTQLEKAGVEHQLRREV 63
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  R   E     +   + 
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELA 122
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
           N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE+
Sbjct: 123 NALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEM 181
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEML 584
           I+  M  +        VD+WSLG    E L G PP+ E    Q  ++ ++R     P+ +
Sbjct: 182 IEGRMHDE-------KVDLWSLGVLCYEFLVGMPPF-EAHTYQETYRRISRVEFTFPDFV 233
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
           +   +D + R    N  +R +  E+LEHP+I+
Sbjct: 234 TEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  135 bits (340), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 142/272 (52%), Gaps = 18/272 (6%)
Query: 351 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K QW       G+ +G+G FG+VY+   R++    A+K   +     + A    QL +E+
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKV--LFKTQLEKAGVEHQLRREV 63
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  R   E     +   + 
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELA 122
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
           N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE+
Sbjct: 123 NALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPS-SRRDTLCGTLDYLPPEM 181
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEML 584
           I+  M  +        VD+WSLG    E L G PP+ E    Q  ++ ++R     P+ +
Sbjct: 182 IEGRMHDE-------KVDLWSLGVLCYEFLVGMPPF-EAHTYQETYRRISRVEFTFPDFV 233
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
           +   +D + R    N  +R +  E+LEHP+I+
Sbjct: 234 TEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  126 bits (317), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 147/290 (50%), Gaps = 21/290 (7%)
Query: 343 EKPSASPKK--SQWQKGKLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAE 396
           E+PS   K     ++  K++G+G+FG V++   ++T    AIK    +V ++ DD    E
Sbjct: 7   ERPSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VE 63
Query: 397 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 456
           C   +E+ +  L   +H  +   + +    ++L+  +EY++ G +  ++ + C     S 
Sbjct: 64  CT-MVEKRVLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSR 120
Query: 457 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLK 515
              +   I+ GL +LHS   ++RD+K  N+L+D  G +K+ADFGM K ++ G +      
Sbjct: 121 ATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC 180
Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 575
           G+P+++APE++          K   +VD WS G  + EML G+ P+   +  +    +  
Sbjct: 181 GTPDYIAPEILLG-------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 233
Query: 576 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV-ELLEHPFIRNANYQNLS 624
             P  P  L  E KD L++ F+R P +R     ++ +HP  R  N++ L 
Sbjct: 234 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELE 283

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  125 bits (313), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 140/273 (51%), Gaps = 19/273 (6%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           K++G+G+FG V++   ++T    AIK    +V ++ DD    EC   +E+ +  L   +H
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECT-MVEKRVLSLA-WEH 77
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             +   + +    ++L+  +EY++ G +  ++ + C     S    +   I+ GL +LHS
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
              ++RD+K  N+L+D  G +K+ADFGM K ++ G +      G+P+++APE++      
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG---- 192
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 592
               K   +VD WS G  + EML G+ P+   +  +    +    P  P  L  E KD L
Sbjct: 193 ---QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249
Query: 593 LRCFLRNPVERPSAV-ELLEHPFIRNANYQNLS 624
           ++ F+R P +R     ++ +HP  R  N++ L 
Sbjct: 250 VKLFVREPEKRLGVRGDIRQHPLFREINWEELE 282

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 132/267 (49%), Gaps = 27/267 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           K IGRG F  VY       G   A+K+V I  + D    A+CIK    EI +L  L H N
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLLKQLNHPN 93
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLH 472
           +++YY S + D+ L I LE    G ++R ++   +  R I E  V  +   + + L ++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQ 531
           S   +HRDIK AN+ + A+GVVKL D G+ +  +  +    SL G+P +M+PE I     
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI----H 209
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------PPIP-EML 584
           ++G        DIWSLGC + EM   + P   F G +     L +       PP+P +  
Sbjct: 210 ENG---YNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQCDYPPLPSDHY 263
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLE 611
           S E +  +  C   +P +RP    + +
Sbjct: 264 SEELRQLVNMCINPDPEKRPDVTYVYD 290

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 143/274 (52%), Gaps = 11/274 (4%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
            P    ++  K IG+G F  V +  +  TG   AIK +D    +P S   +++L +E+++
Sbjct: 8   QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---LQKLFREVRI 64
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R+  R I++ 
Sbjct: 65  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSA 123
Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           + Y H    +HRD+K  NLL+DA   +K+ADFG +   T      +  GSP + APE+ +
Sbjct: 124 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQ 183
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
              +K   P+    VD+WSLG  +  +++G  P+      +   +VL     IP  +S++
Sbjct: 184 G--KKYDGPE----VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 237
Query: 588 GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 621
            ++ L R  + NP++R +  ++++  +I NA ++
Sbjct: 238 CENLLKRFLVLNPIKRGTLEQIMKDRWI-NAGHE 270

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  122 bits (307), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 136/274 (49%), Gaps = 9/274 (3%)
Query: 344 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 403
           K     K   +  G  +G GTFG V IG ++ TG   A+K ++      +S + + ++++
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKR 60
Query: 404 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
           EI+ L   +H +I++ Y         ++ +EYV  G +  Y+ +H R + E   R   + 
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQ 119
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 523
           IL+ + Y H    +HRD+K  N+L+DA    K+ADFG++  ++   +  +  GSPN+ AP
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM 583
           EVI   +     P+    VDIWS G  +  +L G  P+ +   P    K+      IPE 
Sbjct: 180 EVISGRLY--AGPE----VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY 233
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           L+      L+     +P++R +  ++ EH + + 
Sbjct: 234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 143/274 (52%), Gaps = 11/274 (4%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
            P    ++  K IG+G F  V +  +  TG   AIK +D    +P S   +++L +E+++
Sbjct: 11  QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---LQKLFREVRI 67
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R+  R I++ 
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSA 126
Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           + Y H    +HRD+K  NLL+DA   +K+ADFG +   T      +  G+P + APE+ +
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ 186
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
              +K   P+    VD+WSLG  +  +++G  P+      +   +VL     IP  +S++
Sbjct: 187 G--KKYDGPE----VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 240
Query: 588 GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 621
            ++ L R  + NP++R +  ++++  +I NA ++
Sbjct: 241 CENLLKRFLVLNPIKRGTLEQIMKDRWI-NAGHE 273

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  122 bits (305), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 135/274 (49%), Gaps = 9/274 (3%)
Query: 344 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 403
           K     K   +  G  +G GTFG V IG ++ TG   A+K ++      +S + + ++++
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKR 60
Query: 404 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
           EI+ L   +H +I++ Y         ++ +EYV  G +  Y+ +H R + E   R   + 
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQ 119
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 523
           IL+ + Y H    +HRD+K  N+L+DA    K+ADFG++  ++   +     GSPN+ AP
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAP 179
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM 583
           EVI   +     P+    VDIWS G  +  +L G  P+ +   P    K+      IPE 
Sbjct: 180 EVISGRLY--AGPE----VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY 233
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           L+      L+     +P++R +  ++ EH + + 
Sbjct: 234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 156/293 (53%), Gaps = 20/293 (6%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G  G V+  +++ +G   A K   +I  + K A    Q+ +E++VL 
Sbjct: 23  KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK---LIHLEIKPA-IRNQIIRELQVLH 78
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 79  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 137
Query: 470 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL   + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++M+PE ++ 
Sbjct: 138 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 196
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPE- 582
                     ++  DIWS+G +++EM  G+ P     G  A+F++L+       P +P  
Sbjct: 197 T-------HYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSG 249
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINL 635
           + S E +DF+ +C ++NP ER    +L+ H FI+ ++ + +     + S I L
Sbjct: 250 VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 302

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 138/282 (48%), Gaps = 26/282 (9%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI----KQLEQEIKVL 408
           ++ +G+ +G+G F   Y  T+ +T    A K V      PKS        +++  EI + 
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV------PKSMLLKPHQKEKMSTEIAIH 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             L + ++V ++G    DD +Y+ LE     S+   + +  + +TE   R F R  + G+
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGV 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPE 524
            YLH+   IHRD+K  NL ++    VK+ DFG+A   T + ++     +L G+PN++APE
Sbjct: 156 QYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA---TKIEFDGERKKTLCGTPNYIAPE 212
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 584
               V+ K G+   +  VDIWSLGC +  +L GKPP+      +   ++      +P  +
Sbjct: 213 ----VLCKKGH---SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHI 265
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
           +      + R    +P  RPS  ELL   F   + Y  + +P
Sbjct: 266 NPVASALIRRMLHADPTLRPSVAELLTDEFF-TSGYAPMRLP 306

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  120 bits (300), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 137/282 (48%), Gaps = 26/282 (9%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI----KQLEQEIKVL 408
           ++ +G+ +G+G F   Y  T+ +T    A K V      PKS        +++  EI + 
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV------PKSMLLKPHQKEKMSTEIAIH 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             L + ++V ++G    DD +Y+ LE     S+   + +  + +TE   R F R  + G+
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGV 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPE 524
            YLH+   IHRD+K  NL ++    VK+ DFG+A   T + ++      L G+PN++APE
Sbjct: 156 QYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA---TKIEFDGERKKDLCGTPNYIAPE 212
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 584
               V+ K G+   +  VDIWSLGC +  +L GKPP+      +   ++      +P  +
Sbjct: 213 ----VLCKKGH---SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHI 265
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
           +      + R    +P  RPS  ELL   F   + Y  + +P
Sbjct: 266 NPVASALIRRMLHADPTLRPSVAELLTDEFF-TSGYAPMRLP 306

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  119 bits (299), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 137/282 (48%), Gaps = 26/282 (9%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI----KQLEQEIKVL 408
           ++ +G+ +G+G F   Y  T+ +T    A K V      PKS        +++  EI + 
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV------PKSMLLKPHQKEKMSTEIAIH 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             L + ++V ++G    DD +Y+ LE     S+   + +  + +TE   R F R  + G+
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGV 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPE 524
            YLH+   IHRD+K  NL ++    VK+ DFG+A   T + ++      L G+PN++APE
Sbjct: 156 QYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA---TKIEFDGERKKXLCGTPNYIAPE 212
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 584
               V+ K G+   +  VDIWSLGC +  +L GKPP+      +   ++      +P  +
Sbjct: 213 ----VLCKKGH---SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHI 265
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
           +      + R    +P  RPS  ELL   F   + Y  + +P
Sbjct: 266 NPVASALIRRMLHADPTLRPSVAELLTDEFF-TSGYAPMRLP 306

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K IG G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +K+ADFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 142/297 (47%), Gaps = 29/297 (9%)
Query: 338 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 397
           +P ++  P       ++ +G+ +G+G F   Y  T+ +T    A K V      PKS   
Sbjct: 15  IPDVLVDPRTM---KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV------PKSMLL 65
Query: 398 I----KQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 453
                +++  EI +   L + ++V ++G    DD +Y+ LE     S+   + +  + +T
Sbjct: 66  KPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVT 124
Query: 454 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-- 511
           E   R F R  + G+ YLH+   IHRD+K  NL ++    VK+ DFG+A   T + ++  
Sbjct: 125 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA---TKIEFDGE 181
Query: 512 --LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA 569
               L G+PN++APE    V+ K G+   +  VDIWSLGC +  +L GKPP+      + 
Sbjct: 182 RKKDLCGTPNYIAPE----VLCKKGH---SFEVDIWSLGCILYTLLVGKPPFETSCLKET 234
Query: 570 MFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
             ++      +P  ++      + R    +P  RPS  ELL   F   + Y  + +P
Sbjct: 235 YIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFF-TSGYAPMRLP 290

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K IG G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EY+  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +K+ADFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 116/214 (54%), Gaps = 17/214 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           SQ+++ + +G GT+ +VY G N+ TG   A+KEV +  ++   +  I+    EI ++  L
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKEL 60
Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-----RDITESIVRNFTRHILN 466
           KHENIV+ Y     ++ L +  E++    + +Y+         R +  ++V+ F   +L 
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEV 525
           GLA+ H    +HRD+K  NLL++  G +KL DFG+A+         S +    W  AP+V
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
           +       G+   + ++DIWS GC + EM+TGKP
Sbjct: 180 LM------GSRTYSTSIDIWSCGCILAEMITGKP 207

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K IG G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EY+  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +K+ADFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 138/278 (49%), Gaps = 28/278 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           KL+G+GTFG V +   + TG   A+K    EV I  D+      +     E +VL + +H
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 67
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             +     +    D L   +EY + G +  ++    R  TE   R +   I++ L YLHS
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS 126
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 530
            + ++RDIK  NL++D  G +K+ DFG+ K   G+S   ++K   G+P ++APEV++   
Sbjct: 127 RDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLE--- 181
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
               +     AVD W LG  + EM+ G+ P+   +  +    +L      P  LS E K 
Sbjct: 182 ----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 237
Query: 591 FLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNL 623
            L     ++P +R    PS A E++EH F  + N+Q++
Sbjct: 238 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 275

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 140/279 (50%), Gaps = 30/279 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           KL+G+GTFG V +   + TG   A+K    EV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 472
             +     +    D L   +EY + G +  ++ RE  R  TE   R +   I++ L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAV 529
           S + ++RDIK  NL++D  G +K+ DFG+ K   G+S   ++K   G+P ++APEV++  
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLE-- 178
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 589
                +     AVD W LG  + EM+ G+ P+   +  +    +L      P  LS E K
Sbjct: 179 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 590 DFLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNL 623
             L     ++P +R    PS A E++EH F  + N+Q++
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+FG   +  + E G    IKE++I     K  E   +  +E+ VL ++KH NIVQY
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE---ESRREVAVLANMKHPNIVQY 88
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
             S   +  LYI ++Y   G + + +  +      E  + ++   I   L ++H    +H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK--GSPNWMAPEVIKAVMQKDGNP 536
           RDIK  N+ +   G V+L DFG+A+ L   + EL+    G+P +++PE+ +    K  N 
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVELARACIGTPYYLSPEICE---NKPYNN 204
Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRC 595
           K     DIW+LGC + E+ T K  +        + K+++ + PP+    S + +  + + 
Sbjct: 205 K----SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 596 FLRNPVERPSAVELLEHPFI 615
           F RNP +RPS   +LE  FI
Sbjct: 261 FKRNPRDRPSVNSILEKGFI 280

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  117 bits (293), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 140/279 (50%), Gaps = 30/279 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           KL+G+GTFG V +   + TG   A+K    EV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 472
             +     +    D L   +EY + G +  ++ RE  R  TE   R +   I++ L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAV 529
           S + ++RDIK  NL++D  G +K+ DFG+ K   G+S   ++K   G+P ++APEV++  
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKXFCGTPEYLAPEVLE-- 178
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 589
                +     AVD W LG  + EM+ G+ P+   +  +    +L      P  LS E K
Sbjct: 179 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 590 DFLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNL 623
             L     ++P +R    PS A E++EH F  + N+Q++
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 138/278 (49%), Gaps = 28/278 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           KL+G+GTFG V +   + TG   A+K    EV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             +     +    D L   +EY + G +  ++    R  TE   R +   I++ L YLHS
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS 123
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 530
            + ++RDIK  NL++D  G +K+ DFG+ K   G+S   ++K   G+P ++APEV++   
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLE--- 178
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
               +     AVD W LG  + EM+ G+ P+   +  +    +L      P  LS E K 
Sbjct: 179 ----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 591 FLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNL 623
            L     ++P +R    PS A E++EH F  + N+Q++
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  ++ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 88
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 89  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 147
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 203
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 204 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 258
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 259 KD-LLRNLLQ 267

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 140/279 (50%), Gaps = 30/279 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           KL+G+GTFG V +   + TG   A+K    EV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 472
             +     +    D L   +EY + G +  ++ RE  R  TE   R +   I++ L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAV 529
           S + ++RDIK  NL++D  G +K+ DFG+ K   G+S   ++K   G+P ++APEV++  
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKXFCGTPEYLAPEVLE-- 178
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 589
                +     AVD W LG  + EM+ G+ P+   +  +    +L      P  LS E K
Sbjct: 179 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 590 DFLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNL 623
             L     ++P +R    PS A E++EH F  + N+Q++
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 138/301 (45%), Gaps = 42/301 (13%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            +++   L+G G++G V    N++TG   AIK+  +  DD K  + I    +EIK+L  L
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAM--REIKLLKQL 81
Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           +HEN+V            Y+  E+V    ++  +      +   +V+ +   I+NG+ + 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDD-LELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVM 530
           HS N IHRDIK  N+LV  SGVVKL DFG A+ L         + +  W  APE++    
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV--- 197
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--------------NR 576
              G+ K   AVD+W++GC V EM  G+P +        ++ ++              N+
Sbjct: 198 ---GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 577 TPP-----IPEM------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
            P      +PE+            LS    D   +C   +P +RP   ELL H F +   
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314
Query: 620 Y 620
           +
Sbjct: 315 F 315

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G  G V+  +++ +G   A K + +   + K A    Q+ +E++VL 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPA-IRNQIIRELQVLH 59
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 118
Query: 470 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL   + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++M+PE ++ 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 177
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGK----PPWSEFEG--PQAMFKVL----NRTP 578
                     ++  DIWS+G +++EM  G+    PP ++ +   P A+F++L    N  P
Sbjct: 178 T-------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPP 230
Query: 579 P-IPE-MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINL 635
           P +P  + S E +DF+ +C ++NP ER    +L+ H FI+ ++ + +     + S I L
Sbjct: 231 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 289

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  ++ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  ++ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 138/260 (53%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   E  Q   K+++   
Sbjct: 203 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 138/260 (53%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K +D      +    +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L+  G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 134/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  ++ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 212 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 267 KD-LLRNLLQ 275

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  ++ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 212 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 267 KD-LLRNLLQ 275

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  ++ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  ++ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 212 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 267 KD-LLRNLLQ 275

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  ++ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 116
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 117 QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 175
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 231
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 232 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 286
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 287 KD-LLRNLLQ 295

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 130/276 (47%), Gaps = 11/276 (3%)
Query: 341 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 400
           + E P        +  G+ +G+G FG+VY+   ++     A+K +     + +  E   Q
Sbjct: 4   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQ 61
Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           L +EI++  HL+H NI++ Y        +Y+ LE+   G + + +++H R   E     F
Sbjct: 62  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATF 120
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 520
              + + L Y H    IHRDIK  NLL+   G +K+ADFG + H   L     + G+ ++
Sbjct: 121 MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-XMCGTLDY 179
Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI 580
           + PE+I+     +        VD+W  G    E L G PP+      +   +++N     
Sbjct: 180 LPPEMIEGKTHDE-------KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF 232
Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
           P  LS   KD + +    +P +R     ++EHP+++
Sbjct: 233 PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 268

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 132/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  ++ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 88
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R +   I+   
Sbjct: 89  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHARFYAAQIVLTF 147
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 203
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 204 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 258
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 259 KD-LLRNLLQ 267

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 138/278 (49%), Gaps = 28/278 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           KL+G+GTFG V +   + TG   A+K    EV I  D+      +     E +VL + +H
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 69
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             +     +    D L   +EY + G +  ++    R  TE   R +   I++ L YLHS
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS 128
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 530
            + ++RDIK  NL++D  G +K+ DFG+ K   G+S   ++K   G+P ++APEV++   
Sbjct: 129 RDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKXFCGTPEYLAPEVLE--- 183
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
               +     AVD W LG  + EM+ G+ P+   +  +    +L      P  LS E K 
Sbjct: 184 ----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 239
Query: 591 FLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNL 623
            L     ++P +R    PS A E++EH F  + N+Q++
Sbjct: 240 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 277

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 138/278 (49%), Gaps = 28/278 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           KL+G+GTFG V +   + TG   A+K    EV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             +     +    D L   +EY + G +  ++    R  TE   R +   I++ L YLHS
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS 123
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 530
            + ++RDIK  NL++D  G +K+ DFG+ K   G+S   ++K   G+P ++APEV++   
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKXFCGTPEYLAPEVLE--- 178
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
               +     AVD W LG  + EM+ G+ P+   +  +    +L      P  LS E K 
Sbjct: 179 ----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 591 FLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNL 623
            L     ++P +R    PS A E++EH F  + N+Q++
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 135/264 (51%), Gaps = 10/264 (3%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
            P    ++  K IG+G F  V +  +  TG   A+K   II     ++  +++L +E+++
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRI 66
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R   R I++ 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVSA 125
Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           + Y H    +HRD+K  NLL+DA   +K+ADFG +   T  +   +  GSP + APE+ +
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQ 185
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
              +K   P+    VD+WSLG  +  +++G  P+      +   +VL     IP  +S++
Sbjct: 186 G--KKYDGPE----VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 588 GKDFLLRCFLRNPVERPSAVELLE 611
            ++ L +  + NP +R +  ++++
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMK 263

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  116 bits (290), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 137/260 (52%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K +D      +    +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++   L G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLXGTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 135/264 (51%), Gaps = 10/264 (3%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
            P    ++  K IG+G F  V +  +  TG   A+K   II     ++  +++L +E+++
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRI 66
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R   R I++ 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVSA 125
Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           + Y H    +HRD+K  NLL+DA   +K+ADFG +   T  +   +  GSP + APE+ +
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQ 185
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
              +K   P+    VD+WSLG  +  +++G  P+      +   +VL     IP  +S++
Sbjct: 186 G--KKYDGPE----VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 588 GKDFLLRCFLRNPVERPSAVELLE 611
            ++ L +  + NP +R +  ++++
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMK 263

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 135/275 (49%), Gaps = 9/275 (3%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE 402
           +K     K   +  G  +G GTFG V +G +  TG   A+K ++      +S + + ++ 
Sbjct: 7   QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIR 64
Query: 403 QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 462
           +EI+ L   +H +I++ Y        +++ +EYV  G +  Y+ ++ R + E   R   +
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-LDEKESRRLFQ 123
Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
            IL+G+ Y H    +HRD+K  N+L+DA    K+ADFG++  ++   +     GSPN+ A
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAA 183
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PEVI   +     P+    VDIWS G  +  +L G  P+ +   P    K+ +     P+
Sbjct: 184 PEVISGRLY--AGPE----VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ 237
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
            L+      L      +P++R +  ++ EH + + 
Sbjct: 238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  115 bits (289), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 139/260 (53%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 52  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 106
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 107 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 165
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++  +L G+P
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATW--TLCGTP 223
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 224 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 277 RFPSHFSSDLKD-LLRNLLQ 295

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  115 bits (289), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 137/260 (52%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K +D      +    +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 138/260 (53%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 138/260 (53%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 138/260 (53%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 138/260 (53%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 32  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 86
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 87  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 145
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 203
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 204 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 257 RFPSHFSSDLKD-LLRNLLQ 275

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 80/250 (32%), Positives = 132/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  ++ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NL++D  G +K+ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 212 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 267 KD-LLRNLLQ 275

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  115 bits (288), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 132/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  115 bits (288), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++  +L G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEYLAPEII-- 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 212 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 267 KD-LLRNLLQ 275

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  115 bits (288), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 137/260 (52%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K +D      +    +KQ+
Sbjct: 18  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQI 72
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 73  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 131
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 132 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC--GTP 189
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 190 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 242
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 243 RFPSHFSSDLKD-LLRNLLQ 261

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  115 bits (288), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 132/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 132/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 132/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 212 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 267 KD-LLRNLLQ 275

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 132/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ + +G G+FG V +  ++ETG   A+K +D      +    +KQ+E    E ++ 
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIQ 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ LEY   G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +K+ADFG AK + G ++ L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEII-- 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 212 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 267 KD-LLRNLLQ 275

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 135/264 (51%), Gaps = 10/264 (3%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
            P    ++  K IG+G F  V +  +  TG   A++   II     ++  +++L +E+++
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVR---IIDKTQLNSSSLQKLFREVRI 66
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R   R I++ 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVSA 125
Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           + Y H    +HRD+K  NLL+DA   +K+ADFG +   T  +   +  GSP + APE+ +
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQ 185
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
              +K   P+    VD+WSLG  +  +++G  P+      +   +VL     IP  +S++
Sbjct: 186 G--KKYDGPE----VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 588 GKDFLLRCFLRNPVERPSAVELLE 611
            ++ L +  + NP +R +  ++++
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMK 263

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 137/260 (52%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FAEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 137/260 (52%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 52  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 106
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R
Sbjct: 107 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR 165
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 223
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 224 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 277 RFPSHFSSDLKD-LLRNLLQ 295

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 137/260 (52%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 135/264 (51%), Gaps = 10/264 (3%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
            P    ++  K IG+G F  V +  +  TG   A+K   II     ++  +++L +E+++
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRI 66
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R   R I++ 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVSA 125
Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           + Y H    +HRD+K  NLL+DA   +K+ADFG +   T  +   +  G+P + APE+ +
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQ 185
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
              +K   P+    VD+WSLG  +  +++G  P+      +   +VL     IP  +S++
Sbjct: 186 G--KKYDGPE----VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 588 GKDFLLRCFLRNPVERPSAVELLE 611
            ++ L +  + NP +R +  ++++
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMK 263

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 137/260 (52%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 133/250 (53%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 81
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 82  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 140
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++  +L G+P ++APE+I  
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEYLAPEII-- 196
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 197 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 251
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 252 KD-LLRNLLQ 260

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 137/260 (52%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 137/260 (52%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 26  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 80
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R
Sbjct: 81  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR 139
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 140 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 197
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 198 EYLAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 250
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 251 RFPSHFSSDLKD-LLRNLLQ 269

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVL 408
            +++K + IG GT+G+V+   NRET    A+K V +  DD   P SA       +EI +L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLL 55
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             LKH+NIV+ +     D  L +  E+     + +Y      D+   IV++F   +L GL
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            + HS N +HRD+K  NLL++ +G +KLADFG+A+         S +    W  P  +  
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEM----------------------LTGKPPWSEFEG 566
                G    + ++D+WS GC   E+                      L G P   ++  
Sbjct: 175 -----GAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 567 --------PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
                   P  M+        +   L++ G+D L      NPV+R SA E L+HP+  +
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 131/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  114 bits (286), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 154/293 (52%), Gaps = 24/293 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G  G V+  +++ +G   A K + +   + K A    Q+ +E++VL 
Sbjct: 7   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPA-IRNQIIRELQVLH 62
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 63  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 121
Query: 470 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL   + I HRD+K +N+LV++ G +KL DFG++  L          G+ ++M+PE ++ 
Sbjct: 122 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-EMANEFVGTRSYMSPERLQG 180
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPE- 582
                     ++  DIWS+G +++EM  G+ P      P A+F++L+       P +P  
Sbjct: 181 T-------HYSVQSDIWSMGLSLVEMAVGRYP----RPPMAIFELLDYIVNEPPPKLPSA 229
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINL 635
           + S E +DF+ +C ++NP ER    +L+ H FI+ ++ + +     + S I L
Sbjct: 230 VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 282

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  114 bits (286), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 132/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  114 bits (286), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 140/306 (45%), Gaps = 40/306 (13%)
Query: 345 PSASPKKSQ-WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 403
           P  SP+  + +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +
Sbjct: 2   PLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIR 58
Query: 404 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
           EI +L  L H NIV+       ++ LY+  E++H              I   +++++   
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-A 522
           +L GLA+ HS   +HRD+K  NLL++  G +KLADFG+A+         + +    W  A
Sbjct: 119 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 178
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL----- 574
           PE++       G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L     
Sbjct: 179 PEILL------GXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 232
Query: 575 ----------NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHP 613
                     +  P  P+            L  +G+  L +    +P +R SA   L HP
Sbjct: 233 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 292
Query: 614 FIRNAN 619
           F ++  
Sbjct: 293 FFQDVT 298

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  114 bits (286), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 131/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R +   I+   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHARFYAAQIVLTF 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 212 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 267 KD-LLRNLLQ 275

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 124/257 (48%), Gaps = 11/257 (4%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG+VY+   ++     A+K +     + +  E   QL +EI++  HL+H NI++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHLRHPNILRM 79
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y        +Y+ LE+   G + + +++H R   E     F   + + L Y H    IHR
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCHERKVIHR 138
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 539
           DIK  NLL+   G +K+ADFG + H   L     + G+ +++ PE+I+     +      
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVHAPSLRRR-XMCGTLDYLPPEMIEGKTHDE------ 191
Query: 540 LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRN 599
             VD+W  G    E L G PP+      +   +++N     P  LS   KD + +    +
Sbjct: 192 -KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYH 250
Query: 600 PVERPSAVELLEHPFIR 616
           P +R     ++EHP+++
Sbjct: 251 PPQRLPLKGVMEHPWVK 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 134/264 (50%), Gaps = 10/264 (3%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
            P    ++  K IG+G F  V +  +  TG   A++   II     ++  +++L +E+++
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVR---IIDKTQLNSSSLQKLFREVRI 66
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R   R I++ 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVSA 125
Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           + Y H    +HRD+K  NLL+DA   +K+ADFG +   T  +      GSP + APE+ +
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQ 185
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
              +K   P+    VD+WSLG  +  +++G  P+      +   +VL     IP  +S++
Sbjct: 186 G--KKYDGPE----VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 588 GKDFLLRCFLRNPVERPSAVELLE 611
            ++ L +  + NP +R +  ++++
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMK 263

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/260 (32%), Positives = 138/260 (53%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + +M  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPEII---LSKGYNK----AVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 136/268 (50%), Gaps = 11/268 (4%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G+FG V + T+ +T    A+K +       K ++   ++E+EI  L  L+H +I++ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFIS--RQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           Y        + + +EY   G +  Y+ E  R +TE   R F + I+  + Y H    +HR
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRHKIVHR 132
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 539
           D+K  NLL+D +  VK+ADFG++  +T  ++  +  GSPN+ APEVI      +G     
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI------NGKLYAG 186
Query: 540 LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRN 599
             VD+WS G  +  ML G+ P+ +   P    KV +    +P+ LS   +  + R  + +
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVAD 246
Query: 600 PVERPSAVELLEHPFIRNANYQNLSVPM 627
           P++R +  E+   P+  N N  +   PM
Sbjct: 247 PMQRITIQEIRRDPWF-NVNLPDYLRPM 273

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/260 (32%), Positives = 138/260 (53%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NL++D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPEII---ISKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/250 (32%), Positives = 131/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NL++D  G +K+ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 139/278 (50%), Gaps = 24/278 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +++G+G+FG V +   +ETG   A+K +  D+I  D    EC    E+ I  L    H  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD-DDVEC-TMTEKRILSLAR-NHPF 85
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           + Q +      D L+  +E+V+ G +  ++++  R   E+  R +   I++ L +LH   
Sbjct: 86  LTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKG 144
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
            I+RD+K  N+L+D  G  KLADFGM K     G++   +  G+P+++APE+++ ++   
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TATFCGTPDYIAPEILQEML--- 200
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFL 592
                  AVD W++G  + EML G  P+ E E    +F+ +LN     P  L  +    L
Sbjct: 201 ----YGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLHEDATGIL 255
Query: 593 LRCFLRNPVERPSAV------ELLEHPFIRNANYQNLS 624
                +NP  R  ++       +L HPF +  ++  L+
Sbjct: 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLN 293

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 140/306 (45%), Gaps = 40/306 (13%)
Query: 345 PSASPKKSQ-WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 403
           P  SP+  + +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +
Sbjct: 2   PLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIR 58
Query: 404 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
           EI +L  L H NIV+       ++ LY+  E++H              I   +++++   
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-A 522
           +L GLA+ HS   +HRD+K  NLL++  G +KLADFG+A+         + +    W  A
Sbjct: 119 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 178
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL----- 574
           PE++       G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L     
Sbjct: 179 PEILL------GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 232
Query: 575 ----------NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHP 613
                     +  P  P+            L  +G+  L +    +P +R SA   L HP
Sbjct: 233 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 292
Query: 614 FIRNAN 619
           F ++  
Sbjct: 293 FFQDVT 298

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 80/250 (32%), Positives = 130/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EY   G +  ++R   R   E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NL++D  G +K+ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  113 bits (283), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 132/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +K++E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKEIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NL++D  G +K+ DFG+AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  113 bits (283), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 137/260 (52%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
             +APE+I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EALAPEII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 176
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 177 -GXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/260 (32%), Positives = 137/260 (52%), Gaps = 20/260 (7%)
Query: 343 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 402 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            +   I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++ L   G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTP 202
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 578
            ++AP +I   + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++   
Sbjct: 203 EYLAPAII---LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 579 PIPEMLSSEGKDFLLRCFLR 598
             P   SS+ KD LLR  L+
Sbjct: 256 RFPSHFSSDLKD-LLRNLLQ 274

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 139/299 (46%), Gaps = 44/299 (14%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGH 410
            +++K   IG G++G V+   NR+TG   AIK+     DDP     IK++  +EI++L  
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP----VIKKIALREIRMLKQ 58
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           LKH N+V           L++  EY     ++   R + R + E +V++ T   L  + +
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNF 117
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAV 529
            H  N IHRD+K  N+L+    V+KL DFG A+ LTG S     + +  W  +PE++   
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV-- 175
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPPIPEMLSS 586
               G+ +    VD+W++GC   E+L+G P W   S+ +    + K L    P  + + S
Sbjct: 176 ----GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231
Query: 587 EGKDF---------------------------LLR-CFLRNPVERPSAVELLEHPFIRN 617
             + F                           LL+ C   +P ER +  +LL HP+  N
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 65
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE++      
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 180
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 181 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 239
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 240 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 295

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E+VH              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 175
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 176 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 131/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NL++D  G +++ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE++      
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 177
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 178 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 175
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 176 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 176
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 177 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 175
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 176 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H    +         I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 176
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 177 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 176
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 177 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVL 408
            +++K + IG GT+G+V+   NRET    A+K V +  DD   P SA       +EI +L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLL 55
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             LKH+NIV+ +     D  L +  E+     + +Y      D+   IV++F   +L GL
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            + HS N +HRD+K  NLL++ +G +KLA+FG+A+         S +    W  P  +  
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEM----------------------LTGKPPWSEFEG 566
                G    + ++D+WS GC   E+                      L G P   ++  
Sbjct: 175 -----GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 567 --------PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
                   P  M+        +   L++ G+D L      NPV+R SA E L+HP+  +
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 130/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    + +   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NL++D  G +K+ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 212 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 267 KD-LLRNLLQ 275

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 138/280 (49%), Gaps = 25/280 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++  ++IG+G F  V    NRETG   A+K VD+           + L++E  +   LKH
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAY 470
            +IV+   +   D  LY+  E++    +   + +        +E++  ++ R IL  L Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 471 LHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEV 525
            H  N IHRD+K  N+L+   + S  VKL DFG+A  L  +GL     + G+P++MAPEV
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV-GTPHFMAPEV 204
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-----FEG-PQAMFKVLNRTPP 579
           +K   +  G P     VD+W  G  +  +L+G  P+       FEG  +  +K+    P 
Sbjct: 205 VKR--EPYGKP-----VDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKM---NPR 254
Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
               +S   KD + R  + +P ER +  E L HP+++  +
Sbjct: 255 QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 178
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 179 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 237
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 179
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 180 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 178
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 179 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 237
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 176
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 177 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 178
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 179 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 237
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 130/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    + +   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NL++D  G +K+ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 212 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 267 KD-LLRNLLQ 275

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 179
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 180 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 176
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 177 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 132/250 (52%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +K++E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKEIEHTLNEKRIL 95
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    +V+   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NL++D  G +++ DFG+AK + G ++ L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC--GTPEYLAPEII-- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 211 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 266 KD-LLRNLLQ 274

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 179
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 180 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 176
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 177 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 65
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 180
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 181 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 239
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 240 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 295

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 177
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 178 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 175
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 176 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 177
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 178 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 177
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 178 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 131/270 (48%), Gaps = 25/270 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G FG V++   R +G    IK ++      +S   ++Q+E EI+VL  L H NI++ 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTIN----KDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 420 YGSEVVDDH--LYIYLEYVHPGSI-NRYVREHCRD--ITESIVRNFTRHILNGLAYLHST 474
           +  EV +D+  +YI +E    G +  R V    R   ++E  V    + ++N LAY HS 
Sbjct: 86  F--EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 475 NTIHRDIKGANLLVDAS---GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           + +H+D+K  N+L   +     +K+ DFG+A+      +  +  G+  +MAPEV K    
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR--- 200
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM---LSSEG 588
                 +    DIWS G  +  +LTG  P++     +   K   + P        L+ + 
Sbjct: 201 -----DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 589 KDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            D L +   ++P  RPSA ++L H + + A
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 175
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 176 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GL++ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 176
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 177 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 129/250 (51%), Gaps = 19/250 (7%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 408
            Q+++ K +G G+FG V +  + ETG   A+K +D      +    +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIL 96
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             +    + +   S   + +LY+ +EY   G +  ++R   R   E   R +   I+   
Sbjct: 97  QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHARFYAAQIVLTF 155
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            YLHS + I+RD+K  NL++D  G +K+ DFG AK + G ++ L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEII-- 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 588
            + K  N     AVD W+LG  + EM  G PP+   +  Q   K+++     P   SS+ 
Sbjct: 212 -LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 589 KDFLLRCFLR 598
           KD LLR  L+
Sbjct: 267 KD-LLRNLLQ 275

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 134/294 (45%), Gaps = 39/294 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 176
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 177 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 144/283 (50%), Gaps = 22/283 (7%)
Query: 331 SSVTSAV--MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII 388
           +S+TSA    PHI            ++  K IG+G F  V +  +  TG   A+K +D  
Sbjct: 2   NSITSATDEQPHI----------GNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKT 51
Query: 389 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 448
             +P S   +++L +E++++  L H NIV+ +     +  LY+ +EY   G +  Y+  H
Sbjct: 52  QLNPTS---LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH 108
Query: 449 CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 508
            R + E   R   R I++ + Y H    +HRD+K  NLL+D    +K+ADFG +   T  
Sbjct: 109 GR-MKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG 167
Query: 509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ 568
           +   +  GSP + APE+ +   +K   P+    VD+WSLG  +  +++G  P+      +
Sbjct: 168 NKLDTFCGSPPYAAPELFQG--KKYDGPE----VDVWSLGVILYTLVSGSLPFDGQNLKE 221
Query: 569 AMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
              +VL     IP  +S++ ++ L +  + NP++R S  ++++
Sbjct: 222 LRERVLRGKYRIPFYMSTDCENLLKKLLVLNPIKRGSLEQIMK 264

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 131/254 (51%), Gaps = 10/254 (3%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K IG+G F  V +  +  TG   A+K   II     ++  +++L +E++++  L H NIV
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 69
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           + +     +  LY+ +EY   G +  Y+  H   + E   R   R I++ + Y H    +
Sbjct: 70  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGW-MKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           HRD+K  NLL+DA   +K+ADFG +   T  +   +  GSP + APE+ +   +K   P+
Sbjct: 129 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQG--KKYDGPE 186
Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 597
               VD+WSLG  +  +++G  P+      +   +VL     IP  +S++ ++ L +  +
Sbjct: 187 ----VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLI 242
Query: 598 RNPVERPSAVELLE 611
            NP +R +  ++++
Sbjct: 243 LNPSKRGTLEQIMK 256

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 149/286 (52%), Gaps = 30/286 (10%)
Query: 358 KLIGRGTFGSVYIG---TNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           K++G G +G V++    +  +TG   A   +K+  I+    + A+  +    E +VL H+
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV----QKAKTTEHTRTERQVLEHI 115
Query: 412 KHE-NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           +    +V  + +   +  L++ L+Y++ G +  ++ +  R  TE  V+ +   I+  L +
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEH 174
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK--GSPNWMAPEVIKA 528
           LH    I+RDIK  N+L+D++G V L DFG++K       E +    G+  +MAP++++ 
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMF--KVLNRTPPIPEM 583
                G+     AVD WSLG  + E+LTG  P++  +G    QA    ++L   PP P+ 
Sbjct: 235 -----GDSGHDKAVDWWSLGVLMYELLTGASPFT-VDGEKNSQAEISRRILKSEPPYPQE 288
Query: 584 LSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLS 624
           +S+  KD + R  +++P +R       A E+ EH F +  N+ +L+
Sbjct: 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLA 334

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 136/286 (47%), Gaps = 18/286 (6%)
Query: 338 MPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 390
           M  +ME  S +P           ++ G+ +G+G FG+VY+   +++    A+K +     
Sbjct: 2   MQKVMENSSGTPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQI 61
Query: 391 DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR 450
           + +  E   QL +EI++  HL H NI++ Y        +Y+ LEY   G + + +++ C 
Sbjct: 62  EKEGVE--HQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC- 118
Query: 451 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 510
              E         + + L Y H    IHRDIK  NLL+   G +K+ADFG + H   L  
Sbjct: 119 TFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR 178
Query: 511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM 570
           + ++ G+ +++ PE+I+  M  +        VD+W +G    E+L G PP+      +  
Sbjct: 179 K-TMCGTLDYLPPEMIEGRMHNE-------KVDLWCIGVLCYELLVGNPPFESASHNETY 230
Query: 571 FKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
            +++      P  + +  +D + +    NP ER    ++  HP++R
Sbjct: 231 RRIVKVDLKFPASVPTGAQDLISKLLRHNPSERLPLAQVSAHPWVR 276

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 177 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIX 56
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIX 56
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIX 57
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 177 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+ ++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE++      
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 176
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 177 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+ ++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 175
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 176 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 177 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 139/284 (48%), Gaps = 13/284 (4%)
Query: 343 EKPSASPKKSQWQK---GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAEC 397
           E P  +  K  +QK     +IGRG    V    +R TG   A+K +++  +   P+  E 
Sbjct: 82  ELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE 141
Query: 398 IKQ-LEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 455
           +++   +E  +L  +  H +I+    S      +++  + +  G +  Y+ E    ++E 
Sbjct: 142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA-LSEK 200
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
             R+  R +L  +++LH+ N +HRD+K  N+L+D +  ++L+DFG + HL        L 
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC 260
Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL- 574
           G+P ++APE++K  M  + +P     VD+W+ G  +  +L G PP+        +  ++ 
Sbjct: 261 GTPGYLAPEILKCSMD-ETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319
Query: 575 ---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
                + P  +  SS  KD + R    +P  R +A + L+HPF 
Sbjct: 320 GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 177 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 177 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 177 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 132/264 (50%), Gaps = 12/264 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +Q  K +G G+FG V +  +  TG   A+K ++        ++   ++E+EI  L  L+H
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIIN--KKVLAKSDMQGRIEREISYLRLLRH 72
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLH 472
            +I++ Y      D + + +EY      +  V+   RD ++E   R F + I++ + Y H
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH 129
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
               +HRD+K  NLL+D    VK+ADFG++  +T  ++  +  GSPN+ APEVI   +  
Sbjct: 130 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY- 188
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 592
              P+    VD+WS G  +  ML  + P+ +   P     + N    +P+ LS      +
Sbjct: 189 -AGPE----VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 243
Query: 593 LRCFLRNPVERPSAVELLEHPFIR 616
            R  + NP+ R S  E+++  + +
Sbjct: 244 KRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 177 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 132/264 (50%), Gaps = 12/264 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +Q  K +G G+FG V +  +  TG   A+K ++        ++   ++E+EI  L  L+H
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIIN--KKVLAKSDMQGRIEREISYLRLLRH 73
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLH 472
            +I++ Y      D + + +EY      +  V+   RD ++E   R F + I++ + Y H
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH 130
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
               +HRD+K  NLL+D    VK+ADFG++  +T  ++  +  GSPN+ APEVI   +  
Sbjct: 131 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY- 189
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 592
              P+    VD+WS G  +  ML  + P+ +   P     + N    +P+ LS      +
Sbjct: 190 -AGPE----VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 244
Query: 593 LRCFLRNPVERPSAVELLEHPFIR 616
            R  + NP+ R S  E+++  + +
Sbjct: 245 KRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 132/264 (50%), Gaps = 12/264 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +Q  K +G G+FG V +  +  TG   A+K ++        ++   ++E+EI  L  L+H
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIIN--KKVLAKSDMQGRIEREISYLRLLRH 63
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLH 472
            +I++ Y      D + + +EY      +  V+   RD ++E   R F + I++ + Y H
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH 120
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
               +HRD+K  NLL+D    VK+ADFG++  +T  ++  +  GSPN+ APEVI   +  
Sbjct: 121 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY- 179
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 592
              P+    VD+WS G  +  ML  + P+ +   P     + N    +P+ LS      +
Sbjct: 180 -AGPE----VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 234
Query: 593 LRCFLRNPVERPSAVELLEHPFIR 616
            R  + NP+ R S  E+++  + +
Sbjct: 235 KRMLIVNPLNRISIHEIMQDDWFK 258

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 126/256 (49%), Gaps = 10/256 (3%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
            P    ++  K IG+G F  V +  +  TG   A+K   II     ++  +++L +E+++
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRI 66
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
              L H NIV+ +     +  LY+  EY   G +  Y+  H R   E   R   R I++ 
Sbjct: 67  XKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGR-XKEKEARAKFRQIVSA 125
Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           + Y H    +HRD+K  NLL+DA   +K+ADFG +   T  +   +  G+P + APE+ +
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQ 185
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
              +K   P+    VD+WSLG  +  +++G  P+      +   +VL     IP   S++
Sbjct: 186 G--KKYDGPE----VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTD 239
Query: 588 GKDFLLRCFLRNPVER 603
            ++ L +  + NP +R
Sbjct: 240 CENLLKKFLILNPSKR 255

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 83/268 (30%), Positives = 133/268 (49%), Gaps = 26/268 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           ++IG G FG VY       G   A+K     PD+  S + I+ + QE K+   LKH NI+
Sbjct: 13  EIIGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLKHPNII 69
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN-- 475
              G  + + +L + +E+   G +NR +    + I   I+ N+   I  G+ YLH     
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 476 -TIHRDIKGANLLV-------DASG-VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
             IHRD+K +N+L+       D S  ++K+ DFG+A+     + ++S  G+  WMAPEVI
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAYAWMAPEVI 186
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTP-PIPEML 584
           +A M   G+       D+WS G  + E+LTG+ P+   +G    + V +N+   PIP   
Sbjct: 187 RASMFSKGS-------DVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEH 612
                  +  C+  +P  RPS   +L+ 
Sbjct: 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 177 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 132/264 (50%), Gaps = 12/264 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +Q  K +G G+FG V +  +  TG   A+K ++        ++   ++E+EI  L  L+H
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIIN--KKVLAKSDMQGRIEREISYLRLLRH 67
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLH 472
            +I++ Y      D + + +EY      +  V+   RD ++E   R F + I++ + Y H
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH 124
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
               +HRD+K  NLL+D    VK+ADFG++  +T  ++  +  GSPN+ APEVI   +  
Sbjct: 125 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY- 183
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 592
              P+    VD+WS G  +  ML  + P+ +   P     + N    +P+ LS      +
Sbjct: 184 -AGPE----VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 238
Query: 593 LRCFLRNPVERPSAVELLEHPFIR 616
            R  + NP+ R S  E+++  + +
Sbjct: 239 KRMLIVNPLNRISIHEIMQDDWFK 262

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 142/288 (49%), Gaps = 31/288 (10%)
Query: 349 PKKS--QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ--- 403
           PK S   +Q  + +G G+FG V++  +R  G   A+K +          E + +L+Q   
Sbjct: 1   PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL--------KKEIVVRLKQVEH 52
Query: 404 ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
              E  +L  + H  I++ +G+      +++ ++Y+  G +   +R+  R     + + +
Sbjct: 53  TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFY 111
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 520
              +   L YLHS + I+RD+K  N+L+D +G +K+ DFG AK++  ++Y L   G+P++
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC--GTPDY 169
Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI 580
           +APEV+     K  N     ++D WS G  + EML G  P+ +    +   K+LN     
Sbjct: 170 IAPEVVST---KPYNK----SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF 222
Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVE-----LLEHPFIRNANYQNL 623
           P   + + KD L R   R+  +R   ++     +  HP+ +   ++ L
Sbjct: 223 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 270

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 114/219 (52%), Gaps = 14/219 (6%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
           +P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI +
Sbjct: 1   APFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 56
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
              L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ G
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAG 115
Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPE 524
           + YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++APE
Sbjct: 116 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           ++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 LLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 133/296 (44%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E+V               I   +++++   +L GLA+ HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 179
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 180 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++     +         I   +++++   +L GLA+ HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 179
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 180 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  108 bits (271), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++     +         I   +++++   +L GLA+ HS
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 178
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 179 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 237
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/331 (26%), Positives = 160/331 (48%), Gaps = 58/331 (17%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G  G V+  +++ +G   A K + +   + K A    Q+ +E++VL 
Sbjct: 66  KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPA-IRNQIIRELQVLH 121
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 122 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 180
Query: 470 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL   + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++M+PE ++ 
Sbjct: 181 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 239
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-------------SEFEG--------- 566
                     ++  DIWS+G +++EM  G+ P               + EG         
Sbjct: 240 T-------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 292
Query: 567 ----------------PQAMFKVL----NRTPP-IPE-MLSSEGKDFLLRCFLRNPVERP 604
                           P A+F++L    N  PP +P  + S E +DF+ +C ++NP ER 
Sbjct: 293 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERA 352
Query: 605 SAVELLEHPFIRNANYQNLSVPMRVFSRINL 635
              +L+ H FI+ ++ + +     + S I L
Sbjct: 353 DLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 383

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 133/296 (44%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++               I   +++++   +L GLA+ HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 179
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 180 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 136/282 (48%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 88
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +    S  G+  +++PE++ 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 206
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
              +K  +     + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 207 --TEKSASK----SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 260
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 133/296 (44%), Gaps = 39/296 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++               I   +++++   +L GLA+ HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+           +    W  APE++      
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL----- 177
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVL--------------- 574
            G    + AVDIWSLGC   EM+T +   P  SE +    +F+ L               
Sbjct: 178 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 575 NRTPPIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +  P  P+            L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/221 (35%), Positives = 118/221 (53%), Gaps = 26/221 (11%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            ++Q  ++ G+GTFG+V +G  + TG S AIK+V     DP+      Q+ Q++ V   L
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAV---L 76
Query: 412 KHENIVQ---YYGS----EVVDDHLYIYLEYVHPGSINRYVREHCRDITE---SIVRNFT 461
            H NIVQ   Y+ +    +  D +L + +EYV P +++R  R + R        +++ F 
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 462 RHILNGLAYLH--STNTIHRDIKGANLLV-DASGVVKLADFGMAKHLTGLSYELSLKGSP 518
             ++  +  LH  S N  HRDIK  N+LV +A G +KL DFG AK L+     ++   S 
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
            + APE+I       GN     AVDIWS+GC   EM+ G+P
Sbjct: 196 YYRAPELIF------GNQHYTTAVDIWSVGCIFAEMMLGEP 230

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 143/302 (47%), Gaps = 18/302 (5%)
Query: 330 KSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 389
           + S+    + H +++       SQ++  K++G+G+FG V++        +  +  + ++ 
Sbjct: 2   EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61
Query: 390 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 449
                     + + E  +L  + H  IV+ + +   +  LY+ L+++  G +   + +  
Sbjct: 62  KATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV 121
Query: 450 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
              TE  V+ +   +   L +LHS   I+RD+K  N+L+D  G +KL DFG++K    + 
Sbjct: 122 M-FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SID 178
Query: 510 YE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 566
           +E    S  G+  +MAPEV+     + G+ + A   D WS G  + EMLTG  P+   + 
Sbjct: 179 HEKKAYSFCGTVEYMAPEVV----NRRGHTQSA---DWWSFGVLMFEMLTGTLPFQGKDR 231
Query: 567 PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVER----PSAVELLE-HPFIRNANYQ 621
            + M  +L     +P+ LS E +  L   F RNP  R    P  VE ++ H F    ++ 
Sbjct: 232 KETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291
Query: 622 NL 623
            L
Sbjct: 292 KL 293

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 142/275 (51%), Gaps = 22/275 (8%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            +++  K IG G FG   +  +++     A+K ++      +  +  + +++EI     L
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIE------RGEKIDENVKREIINHRSL 72
Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           +H NIV++    +   HL I +EY   G +   +    R  +E   R F + +++G++Y 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYA 131
Query: 472 HSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           H+    HRD+K  N L+D S    +K+ADFG +K     S   S  G+P ++APEV+   
Sbjct: 132 HAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVL--- 188
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----QAMFKVLNRTPPIPEM-- 583
           ++K+ + K+A   D+WS G T+  ML G  P+ + E P    + + ++LN    IP+   
Sbjct: 189 LKKEYDGKVA---DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVH 245
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHP-FIRN 617
           +S E +  + R F+ +P +R S  E+  H  F++N
Sbjct: 246 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 133/282 (47%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 89
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 148
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +    S  G+  +++PE++ 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 209 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 261
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 262 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 303

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 25/265 (9%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLEQEIKVLGHLKHE 414
            +G+G F   +  ++ +T    A K   I+P      P   E   ++  EI +   L H+
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGK---IVPKSLLLKPHQRE---KMSMEISIHRSLAHQ 81
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           ++V ++G    +D +++ LE     S+   + +  + +TE   R + R I+ G  YLH  
Sbjct: 82  HVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN 140
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPEVIKAVM 530
             IHRD+K  NL ++    VK+ DFG+A   T + Y+     +L G+PN++APE    V+
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKTLCGTPNYIAPE----VL 193
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
            K G+   +  VD+WS+GC +  +L GKPP+      +   ++      IP+ ++     
Sbjct: 194 SKKGH---SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 250
Query: 591 FLLRCFLRNPVERPSAVELLEHPFI 615
            + +    +P  RP+  ELL   F 
Sbjct: 251 LIQKMLQTDPTARPTINELLNDEFF 275

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 113/220 (51%), Gaps = 14/220 (6%)
Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G  G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAP 523
           G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           E++K   +++ +   A  VD+WS G  +  ML G+ PW +
Sbjct: 176 ELLK---RREFH---AEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 147/285 (51%), Gaps = 16/285 (5%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +GRG +G V    +  +G   A+K +    +  +    +  L+  ++ +        V +
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV---DCPFTVTF 115
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHS-TN 475
           YG+   +  ++I +E +   S++++   V +  + I E I+      I+  L +LHS  +
Sbjct: 116 YGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 174
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
            IHRD+K +N+L++A G VK+ DFG++ +L     +    G   +MAPE I   + + G 
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG- 233
Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR-TPPIP-EMLSSEGKDFL 592
              ++  DIWSLG T+IE+   + P+  +  P Q + +V+   +P +P +  S+E  DF 
Sbjct: 234 --YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 291
Query: 593 LRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGD 637
            +C  +N  ERP+  EL++HPF     +++    +  F ++ LGD
Sbjct: 292 SQCLKKNSKERPTYPELMQHPFF--TLHESKGTDVASFVKLILGD 334

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 25/265 (9%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLEQEIKVLGHLKHE 414
            +G+G F   +  ++ +T    A K   I+P      P   E   ++  EI +   L H+
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGK---IVPKSLLLKPHQRE---KMSMEISIHRSLAHQ 77
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           ++V ++G    +D +++ LE     S+   + +  + +TE   R + R I+ G  YLH  
Sbjct: 78  HVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPEVIKAVM 530
             IHRD+K  NL ++    VK+ DFG+A   T + Y+     +L G+PN++APE    V+
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKTLCGTPNYIAPE----VL 189
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
            K G+   +  VD+WS+GC +  +L GKPP+      +   ++      IP+ ++     
Sbjct: 190 SKKGH---SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 246
Query: 591 FLLRCFLRNPVERPSAVELLEHPFI 615
            + +    +P  RP+  ELL   F 
Sbjct: 247 LIQKMLQTDPTARPTINELLNDEFF 271

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 25/265 (9%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLEQEIKVLGHLKHE 414
            +G+G F   +  ++ +T    A K   I+P      P   E   ++  EI +   L H+
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGK---IVPKSLLLKPHQRE---KMSMEISIHRSLAHQ 77
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           ++V ++G    +D +++ LE     S+   + +  + +TE   R + R I+ G  YLH  
Sbjct: 78  HVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPEVIKAVM 530
             IHRD+K  NL ++    VK+ DFG+A   T + Y+     +L G+PN++APE    V+
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKTLCGTPNYIAPE----VL 189
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
            K G+   +  VD+WS+GC +  +L GKPP+      +   ++      IP+ ++     
Sbjct: 190 SKKGH---SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 246
Query: 591 FLLRCFLRNPVERPSAVELLEHPFI 615
            + +    +P  RP+  ELL   F 
Sbjct: 247 LIQKMLQTDPTARPTINELLNDEFF 271

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 143/302 (47%), Gaps = 20/302 (6%)
Query: 331 SSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 390
            S+    + H +++       SQ++  K++G+G+FG V++        +  +  + ++  
Sbjct: 3   GSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK 62
Query: 391 DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHC 449
                    + + E  +L  + H  IV+ + +   +  LY+ L+++  G +  R  +E  
Sbjct: 63  ATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122
Query: 450 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
              TE  V+ +   +   L +LHS   I+RD+K  N+L+D  G +KL DFG++K    + 
Sbjct: 123 --FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SID 178
Query: 510 YE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 566
           +E    S  G+  +MAPEV+     + G+ + A   D WS G  + EMLTG  P+   + 
Sbjct: 179 HEKKAYSFCGTVEYMAPEVV----NRRGHTQSA---DWWSFGVLMFEMLTGTLPFQGKDR 231
Query: 567 PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVER----PSAVELLE-HPFIRNANYQ 621
            + M  +L     +P+ LS E +  L   F RNP  R    P  VE ++ H F    ++ 
Sbjct: 232 KETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291
Query: 622 NL 623
            L
Sbjct: 292 KL 293

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 142/292 (48%), Gaps = 28/292 (9%)
Query: 345 PSASP--KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE 402
           PS++P  K S +   K+IG+G+FG V +  ++      A+K +       K A   K+ E
Sbjct: 29  PSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ------KKAILKKKEE 82
Query: 403 QEIK-----VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESI 456
           + I      +L ++KH  +V  + S    D LY  L+Y++ G +  ++ RE C    E  
Sbjct: 83  KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPR 140
Query: 457 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLK 515
            R +   I + L YLHS N ++RD+K  N+L+D+ G + L DFG+ K ++   S   +  
Sbjct: 141 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC 200
Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 575
           G+P ++APE    V+ K    +    VD W LG  + EML G PP+      +    +LN
Sbjct: 201 GTPEYLAPE----VLHKQPYDR---TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253
Query: 576 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSA----VELLEHPFIRNANYQNL 623
           +   +   +++  +  L     ++  +R  A    +E+  H F    N+ +L
Sbjct: 254 KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL 305

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 143/302 (47%), Gaps = 20/302 (6%)
Query: 331 SSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 390
            S+    + H +++       SQ++  K++G+G+FG V++        +  +  + ++  
Sbjct: 4   GSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK 63
Query: 391 DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHC 449
                    + + E  +L  + H  IV+ + +   +  LY+ L+++  G +  R  +E  
Sbjct: 64  ATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 123
Query: 450 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
              TE  V+ +   +   L +LHS   I+RD+K  N+L+D  G +KL DFG++K    + 
Sbjct: 124 --FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SID 179
Query: 510 YE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 566
           +E    S  G+  +MAPEV+     + G+ + A   D WS G  + EMLTG  P+   + 
Sbjct: 180 HEKKAYSFCGTVEYMAPEVV----NRRGHTQSA---DWWSFGVLMFEMLTGTLPFQGKDR 232
Query: 567 PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVER----PSAVELLE-HPFIRNANYQ 621
            + M  +L     +P+ LS E +  L   F RNP  R    P  VE ++ H F    ++ 
Sbjct: 233 KETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 292
Query: 622 NL 623
            L
Sbjct: 293 KL 294

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 141/275 (51%), Gaps = 22/275 (8%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            +++  K IG G FG   +  ++++    A+K ++      +  +    +++EI     L
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE------RGEKIAANVKREIINHRSL 72
Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           +H NIV++    +   HL I +EY   G +   +    R  +E   R F + +++G++Y 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYC 131
Query: 472 HSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           H+    HRD+K  N L+D S    +K+ DFG +K     S   S  G+P ++APEV+   
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL--- 188
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----QAMFKVLNRTPPIPEM-- 583
           ++K+ + K+A   D+WS G T+  ML G  P+ + E P    + + ++LN    IP+   
Sbjct: 189 LKKEYDGKVA---DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVH 245
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHP-FIRN 617
           +S E +  + R F+ +P +R S  E+  H  F++N
Sbjct: 246 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 43/291 (14%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG GT+G VY   N   G + A+K++ +  +D        +   EI +L  LKH NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV-RNFTRHILNGLAYLHSTNTIH 478
           Y  +V+     + L + H     + + + C    ES+  ++F   +LNG+AY H    +H
Sbjct: 66  Y--DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGNPK 537
           RD+K  NLL++  G +K+ADFG+A+       + + +    W  AP+V+       G+ K
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLM------GSKK 177
Query: 538 LALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL-----NRTPPIPEM------ 583
            +  +DIWS+GC   EM+ G P +   SE +    +F++L        P + E+      
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 584 ---------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
                          L   G D L +    +P +R +A + LEH + +  N
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 43/291 (14%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG GT+G VY   N   G + A+K++ +  +D        +   EI +L  LKH NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV-RNFTRHILNGLAYLHSTNTIH 478
           Y  +V+     + L + H     + + + C    ES+  ++F   +LNG+AY H    +H
Sbjct: 66  Y--DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGNPK 537
           RD+K  NLL++  G +K+ADFG+A+       + + +    W  AP+V+       G+ K
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLM------GSKK 177
Query: 538 LALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL-----NRTPPIPEM------ 583
            +  +DIWS+GC   EM+ G P +   SE +    +F++L        P + E+      
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 584 ---------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
                          L   G D L +    +P +R +A + LEH + +  N
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 12/205 (5%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G   +VY+  +       AIK + I P + +  E +K+ E+E+     L H+NIV  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE--ETLKRFEREVHNSSQLSHQNIVSM 76
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
              +  DD  Y+ +EY+   +++ Y+  H     ++ + NFT  IL+G+ + H    +HR
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI-NFTNQILDGIKHAHDMRIVHR 135
Query: 480 DIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           DIK  N+L+D++  +K+ DFG+AK L  T L+    + G+  + +PE  K     +    
Sbjct: 136 DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE---- 191
Query: 538 LALAVDIWSLGCTVIEMLTGKPPWS 562
                DI+S+G  + EML G+PP++
Sbjct: 192 ---CTDIYSIGIVLYEMLVGEPPFN 213

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 132/274 (48%), Gaps = 13/274 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVLG 409
           ++  +++GRG    V    ++ T    A+K +D+      SAE +++L +    E+ +L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 410 HLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
            +  H NI+Q   +   +   ++  + +  G +  Y+ E    ++E   R   R +L  +
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVI 137
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
             LH  N +HRD+K  N+L+D    +KL DFG +  L       S+ G+P+++APE+I+ 
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIEC 197
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NRTPPIPEM-- 583
            M  D +P     VD+WS G  +  +L G PP+        M +++   N     PE   
Sbjct: 198 SMN-DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
            S   KD + R  +  P +R +A E L HPF + 
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 133/282 (47%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 86
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 145
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +    +  G+  +++PE++ 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 206 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 258
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 259 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 128/265 (48%), Gaps = 25/265 (9%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLEQEIKVLGHLKHE 414
            +G+G F   +  ++ +T    A K   I+P      P   E   ++  EI +   L H+
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGK---IVPKSLLLKPHQRE---KMSMEISIHRSLAHQ 99
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           ++V ++G    +D +++ LE     S+   + +  + +TE   R + R I+ G  YLH  
Sbjct: 100 HVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN 158
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK----GSPNWMAPEVIKAVM 530
             IHRD+K  NL ++    VK+ DFG+A   T + Y+   K    G+PN++APE    V+
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPE----VL 211
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
            K G+   +  VD+WS+GC +  +L GKPP+      +   ++      IP+ ++     
Sbjct: 212 SKKGH---SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 268
Query: 591 FLLRCFLRNPVERPSAVELLEHPFI 615
            + +    +P  RP+  ELL   F 
Sbjct: 269 LIQKMLQTDPTARPTINELLNDEFF 293

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 138/294 (46%), Gaps = 18/294 (6%)
Query: 338 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 397
           + H ++  S     S ++  K++G+G+FG V++        S  +  + ++         
Sbjct: 14  ITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRD 73
Query: 398 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 457
             + + E  +L  + H  +V+ + +   +  LY+ L+++  G +   + +     TE  V
Sbjct: 74  RVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-FTEEDV 132
Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE---LSL 514
           + +   +  GL +LHS   I+RD+K  N+L+D  G +KL DFG++K    + +E    S 
Sbjct: 133 KFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--AIDHEKKAYSF 190
Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            G+  +MAPEV+     + G+   A   D WS G  + EMLTG  P+   +  + M  +L
Sbjct: 191 CGTVEYMAPEVV----NRQGHSHSA---DWWSYGVLMFEMLTGSLPFQGKDRKETMTLIL 243
Query: 575 NRTPPIPEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
                +P+ LS+E +  L   F RNP  R       A E+  H F    ++  L
Sbjct: 244 KAKLGMPQFLSTEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKL 297

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 43/291 (14%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG GT+G VY   N   G + A+K++ +  +D        +   EI +L  LKH NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV-RNFTRHILNGLAYLHSTNTIH 478
           Y  +V+     + L + H     + + + C    ES+  ++F   +LNG+AY H    +H
Sbjct: 66  Y--DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGNPK 537
           RD+K  NLL++  G +K+ADFG+A+       + + +    W  AP+V+       G+ K
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM------GSKK 177
Query: 538 LALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL-----NRTPPIPEM------ 583
            +  +DIWS+GC   EM+ G P +   SE +    +F++L        P + E+      
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 584 ---------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
                          L   G D L +    +P +R +A + LEH + +  N
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/331 (25%), Positives = 159/331 (48%), Gaps = 58/331 (17%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G  G V+  +++ +G   A K + +   + K A    Q+ +E++VL 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPA-IRNQIIRELQVLH 59
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 118
Query: 470 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL   + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++M+PE ++ 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 177
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-------------SEFEG--------- 566
                     ++  DIWS+G +++EM  G+ P               + EG         
Sbjct: 178 T-------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 567 ----------------PQAMFKVLNRT-----PPIPE-MLSSEGKDFLLRCFLRNPVERP 604
                           P A+F++L+       P +P  + S E +DF+ +C ++NP ER 
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 605 SAVELLEHPFIRNANYQNLSVPMRVFSRINL 635
              +L+ H FI+ ++ + +     + S I L
Sbjct: 291 DLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 321

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 142/275 (51%), Gaps = 22/275 (8%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            +++  K IG G FG   +  ++++    A+K ++      +  +  + +++EI     L
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE------RGEKIDENVKREIINHRSL 71
Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           +H NIV++    +   HL I +EY   G +   +    R  +E   R F + +++G++Y 
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYC 130
Query: 472 HSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           H+    HRD+K  N L+D S    +K+ DFG +K     S   S  G+P ++APEV+   
Sbjct: 131 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL--- 187
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----QAMFKVLNRTPPIPEM-- 583
           ++K+ + K+A   D+WS G T+  ML G  P+ + E P    + + ++LN    IP+   
Sbjct: 188 LKKEYDGKVA---DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVH 244
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHP-FIRN 617
           +S E +  + R F+ +P +R S  E+  H  F++N
Sbjct: 245 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 279

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 87/331 (26%), Positives = 159/331 (48%), Gaps = 58/331 (17%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G  G V+  +++ +G   A K   +I  + K A    Q+ +E++VL 
Sbjct: 31  KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK---LIHLEIKPA-IRNQIIRELQVLH 86
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 145
Query: 470 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL   + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++M+PE ++ 
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 204
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-------------SEFEG--------- 566
                     ++  DIWS+G +++EM  G+ P               + EG         
Sbjct: 205 T-------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 567 ----------------PQAMFKVLNRT-----PPIPE-MLSSEGKDFLLRCFLRNPVERP 604
                           P A+F++L+       P +P  + S E +DF+ +C ++NP ER 
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317
Query: 605 SAVELLEHPFIRNANYQNLSVPMRVFSRINL 635
              +L+ H FI+ ++ + +     + S I L
Sbjct: 318 DLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 348

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 134/282 (47%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 88
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
              +K        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 207 --TEKSAXK----SSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK 260
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/331 (25%), Positives = 159/331 (48%), Gaps = 58/331 (17%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G  G V+  +++ +G   A K + +   + K A    Q+ +E++VL 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPA-IRNQIIRELQVLH 59
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 118
Query: 470 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL   + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++M+PE ++ 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 177
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-------------SEFEG--------- 566
                     ++  DIWS+G +++EM  G+ P               + EG         
Sbjct: 178 T-------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 567 ----------------PQAMFKVLNRT-----PPIPE-MLSSEGKDFLLRCFLRNPVERP 604
                           P A+F++L+       P +P  + S E +DF+ +C ++NP ER 
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 605 SAVELLEHPFIRNANYQNLSVPMRVFSRINL 635
              +L+ H FI+ ++ + +     + S I L
Sbjct: 291 DLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 321

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 88
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 208 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK 260
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 139/295 (47%), Gaps = 29/295 (9%)
Query: 342 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAEC 397
           + KP      ++++  KL+G+GTFG V +   + TG   A+K    EV +  D+      
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------ 191
Query: 398 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 457
           +     E +VL + +H  +     S    D L   +EY + G +  ++    R  +E   
Sbjct: 192 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRA 250
Query: 458 RNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK- 515
           R +   I++ L YLHS  N ++RD+K  NL++D  G +K+ DFG+ K   G+    ++K 
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKT 308
Query: 516 --GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV 573
             G+P ++APEV++       +     AVD W LG  + EM+ G+ P+   +  +    +
Sbjct: 309 FCGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361
Query: 574 LNRTPPIPEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
           L      P  L  E K  L     ++P +R       A E+++H F     +Q++
Sbjct: 362 LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 416

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 128/265 (48%), Gaps = 25/265 (9%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLEQEIKVLGHLKHE 414
            +G+G F   +  ++ +T    A K   I+P      P   E   ++  EI +   L H+
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGK---IVPKSLLLKPHQRE---KMSMEISIHRSLAHQ 101
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           ++V ++G    +D +++ LE     S+   + +  + +TE   R + R I+ G  YLH  
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK----GSPNWMAPEVIKAVM 530
             IHRD+K  NL ++    VK+ DFG+A   T + Y+   K    G+PN++APE    V+
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPE----VL 213
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
            K G+   +  VD+WS+GC +  +L GKPP+      +   ++      IP+ ++     
Sbjct: 214 SKKGH---SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 270
Query: 591 FLLRCFLRNPVERPSAVELLEHPFI 615
            + +    +P  RP+  ELL   F 
Sbjct: 271 LIQKMLQTDPTARPTINELLNDEFF 295

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 133/282 (47%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 85
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 144
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +    S  G+  +++PE++ 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 205 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 257
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 258 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 299

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 89
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 148
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 209 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 261
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 262 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 303

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 139/295 (47%), Gaps = 29/295 (9%)
Query: 342 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAEC 397
           + KP      ++++  KL+G+GTFG V +   + TG   A+K    EV +  D+      
Sbjct: 141 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------ 194
Query: 398 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 457
           +     E +VL + +H  +     S    D L   +EY + G +  ++    R  +E   
Sbjct: 195 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRA 253
Query: 458 RNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK- 515
           R +   I++ L YLHS  N ++RD+K  NL++D  G +K+ DFG+ K   G+    ++K 
Sbjct: 254 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKT 311
Query: 516 --GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV 573
             G+P ++APEV++       +     AVD W LG  + EM+ G+ P+   +  +    +
Sbjct: 312 FCGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 364
Query: 574 LNRTPPIPEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
           L      P  L  E K  L     ++P +R       A E+++H F     +Q++
Sbjct: 365 LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 419

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 86
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 145
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 206 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 258
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 259 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 66
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 125
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 126 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 186 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 238
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 239 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 280

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 136/280 (48%), Gaps = 25/280 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++  ++IG+G F  V    NRETG   A+K VD+           + L++E  +   LKH
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAY 470
            +IV+   +   D  LY+  E++    +   + +        +E++  ++ R IL  L Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 471 LHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEV 525
            H  N IHRD+K   +L+   + S  VKL  FG+A  L  +GL     + G+P++MAPEV
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEV 206
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-----FEG-PQAMFKVLNRTPP 579
           +K   +  G P     VD+W  G  +  +L+G  P+       FEG  +  +K+    P 
Sbjct: 207 VKR--EPYGKP-----VDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKM---NPR 256
Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
               +S   KD + R  + +P ER +  E L HP+++  +
Sbjct: 257 QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 296

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 65
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 124
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 125 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 185 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 237
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 238 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 279

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 88
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 208 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 260
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 88
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 208 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 260
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 88
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 208 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 260
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 86
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 145
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 206 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 258
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 259 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 86/331 (25%), Positives = 159/331 (48%), Gaps = 58/331 (17%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G  G V+  +++ +G   A K + +   + K A    Q+ +E++VL 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPA-IRNQIIRELQVLH 59
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 118
Query: 470 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL   + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++M+PE ++ 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 177
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-------------SEFEG--------- 566
                     ++  DIWS+G +++EM  G+ P               + EG         
Sbjct: 178 T-------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 567 ----------------PQAMFKVLNRT-----PPIPE-MLSSEGKDFLLRCFLRNPVERP 604
                           P A+F++L+       P +P  + S E +DF+ +C ++NP ER 
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 605 SAVELLEHPFIRNANYQNLSVPMRVFSRINL 635
              +L+ H FI+ ++ + +     + S I L
Sbjct: 291 DLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 321

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 86/331 (25%), Positives = 159/331 (48%), Gaps = 58/331 (17%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G  G V+  +++ +G   A K + +   + K A    Q+ +E++VL 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPA-IRNQIIRELQVLH 59
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 118
Query: 470 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL   + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++M+PE ++ 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 177
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-------------SEFEG--------- 566
                     ++  DIWS+G +++EM  G+ P               + EG         
Sbjct: 178 T-------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 567 ----------------PQAMFKVLNRT-----PPIPE-MLSSEGKDFLLRCFLRNPVERP 604
                           P A+F++L+       P +P  + S E +DF+ +C ++NP ER 
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 605 SAVELLEHPFIRNANYQNLSVPMRVFSRINL 635
              +L+ H FI+ ++ + +     + S I L
Sbjct: 291 DLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 321

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 63
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 64  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 122
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 123 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 183 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 235
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 236 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 277

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 128/265 (48%), Gaps = 25/265 (9%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLEQEIKVLGHLKHE 414
            +G+G F   +  ++ +T    A K   I+P      P   E   ++  EI +   L H+
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGK---IVPKSLLLKPHQRE---KMSMEISIHRSLAHQ 75
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           ++V ++G    +D +++ LE     S+   + +  + +TE   R + R I+ G  YLH  
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK----GSPNWMAPEVIKAVM 530
             IHRD+K  NL ++    VK+ DFG+A   T + Y+   K    G+PN++APE    V+
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPE----VL 187
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 590
            K G+   +  VD+WS+GC +  +L GKPP+      +   ++      IP+ ++     
Sbjct: 188 SKKGH---SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 244
Query: 591 FLLRCFLRNPVERPSAVELLEHPFI 615
            + +    +P  RP+  ELL   F 
Sbjct: 245 LIQKMLQTDPTARPTINELLNDEFF 269

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 64
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 123
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 184 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 236
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 131/274 (47%), Gaps = 13/274 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVLG 409
           ++  +++GRG    V    ++ T    A+K +D+      SAE +++L +    E+ +L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 410 HLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
            +  H NI+Q   +   +   ++  + +  G +  Y+ E    ++E   R   R +L  +
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVI 137
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
             LH  N +HRD+K  N+L+D    +KL DFG +  L        + G+P+++APE+I+ 
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 197
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NRTPPIPEM-- 583
            M  D +P     VD+WS G  +  +L G PP+        M +++   N     PE   
Sbjct: 198 SMN-DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
            S   KD + R  +  P +R +A E L HPF + 
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 131/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 93
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y     D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 94  LDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 152
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 213 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 265
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 266 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 307

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 136/280 (48%), Gaps = 25/280 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++  ++IG+G F  V    NRETG   A+K VD+           + L++E  +   LKH
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAY 470
            +IV+   +   D  LY+  E++    +   + +        +E++  ++ R IL  L Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 471 LHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEV 525
            H  N IHRD+K   +L+   + S  VKL  FG+A  L  +GL     + G+P++MAPEV
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEV 204
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-----FEG-PQAMFKVLNRTPP 579
           +K   +  G P     VD+W  G  +  +L+G  P+       FEG  +  +K+    P 
Sbjct: 205 VKR--EPYGKP-----VDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKM---NPR 254
Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
               +S   KD + R  + +P ER +  E L HP+++  +
Sbjct: 255 QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 142/295 (48%), Gaps = 23/295 (7%)
Query: 346 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 400
           S  PK  + ++   K +G G  G V +   R+T    AIK +          + A+    
Sbjct: 8   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 67
Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           +E EI++L  L H  I++       +D+ YI LE +  G +   V  + R + E+  + +
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLY 125
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGS 517
              +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L   S   +L G+
Sbjct: 126 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 185
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--- 574
           P ++APEV+ +V    G      AVD WSLG  +   L+G PP+SE     ++   +   
Sbjct: 186 PTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 241
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN----YQNL 623
             N  P +   +S +  D + +  + +P  R +  E L HP++++ +    +Q+L
Sbjct: 242 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 296

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 142/295 (48%), Gaps = 23/295 (7%)
Query: 346 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 400
           S  PK  + ++   K +G G  G V +   R+T    AIK +          + A+    
Sbjct: 2   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           +E EI++L  L H  I++       +D+ YI LE +  G +   V  + R + E+  + +
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLY 119
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGS 517
              +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L   S   +L G+
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--- 574
           P ++APEV+ +V    G      AVD WSLG  +   L+G PP+SE     ++   +   
Sbjct: 180 PTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN----YQNL 623
             N  P +   +S +  D + +  + +P  R +  E L HP++++ +    +Q+L
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 290

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 142/295 (48%), Gaps = 23/295 (7%)
Query: 346 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 400
           S  PK  + ++   K +G G  G V +   R+T    AIK +          + A+    
Sbjct: 2   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           +E EI++L  L H  I++       +D+ YI LE +  G +   V  + R + E+  + +
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLY 119
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGS 517
              +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L   S   +L G+
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--- 574
           P ++APEV+ +V    G      AVD WSLG  +   L+G PP+SE     ++   +   
Sbjct: 180 PTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN----YQNL 623
             N  P +   +S +  D + +  + +P  R +  E L HP++++ +    +Q+L
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 290

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 142/295 (48%), Gaps = 23/295 (7%)
Query: 346 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 400
           S  PK  + ++   K +G G  G V +   R+T    AIK +          + A+    
Sbjct: 1   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 60
Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           +E EI++L  L H  I++       +D+ YI LE +  G +   V  + R + E+  + +
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLY 118
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGS 517
              +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L   S   +L G+
Sbjct: 119 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 178
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--- 574
           P ++APEV+ +V    G      AVD WSLG  +   L+G PP+SE     ++   +   
Sbjct: 179 PTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 234
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN----YQNL 623
             N  P +   +S +  D + +  + +P  R +  E L HP++++ +    +Q+L
Sbjct: 235 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 289

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 70
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 71  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 129
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 130 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 190 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 242
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 243 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 284

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 141/302 (46%), Gaps = 29/302 (9%)
Query: 344 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--L 401
           K  A   K  ++  + +G G F  V +   + TG   A+K +      PK A   K+  +
Sbjct: 14  KKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCI------PKKALKGKESSI 67
Query: 402 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNF 460
           E EI VL  +KHENIV         +HLY+ ++ V  G + +R V +     TE      
Sbjct: 68  ENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF--YTEKDASTL 125
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK-G 516
            R +L+ + YLH    +HRD+K  NLL    D    + ++DFG++K + G    +S   G
Sbjct: 126 IRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACG 184
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR 576
           +P ++APEV+            + AVD WS+G     +L G PP+ + E    +F+ + +
Sbjct: 185 TPGYVAPEVL-------AQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDSKLFEQILK 236
Query: 577 TP-----PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFS 631
                  P  + +S   KDF+     ++P +R +  +   HP+I      N ++   V +
Sbjct: 237 AEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHESVSA 296
Query: 632 RI 633
           +I
Sbjct: 297 QI 298

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 142/295 (48%), Gaps = 23/295 (7%)
Query: 346 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 400
           S  PK  + ++   K +G G  G V +   R+T    AIK +          + A+    
Sbjct: 2   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           +E EI++L  L H  I++       +D+ YI LE +  G +   V  + R + E+  + +
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLY 119
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGS 517
              +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L   S   +L G+
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--- 574
           P ++APEV+ +V    G      AVD WSLG  +   L+G PP+SE     ++   +   
Sbjct: 180 PTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN----YQNL 623
             N  P +   +S +  D + +  + +P  R +  E L HP++++ +    +Q+L
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 290

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 138/286 (48%), Gaps = 31/286 (10%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKV 407
           ++++  KL+G+GTFG V +   + TG   A+K    EV +  D+      +     E +V
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRV 62
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILN 466
           L + +H  +     S    D L   +EY + G +  ++ RE  R  +E   R +   I++
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVS 120
Query: 467 GLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMA 522
            L YLHS  N ++RD+K  NL++D  G +K+ DFG+ K   G+    ++K   G+P ++A
Sbjct: 121 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKXFCGTPEYLA 178
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PEV++       +     AVD W LG  + EM+ G+ P+   +  +    +L      P 
Sbjct: 179 PEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 231
Query: 583 MLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
            L  E K  L     ++P +R       A E+++H F     +Q++
Sbjct: 232 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 277

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 138/286 (48%), Gaps = 31/286 (10%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKV 407
           ++++  KL+G+GTFG V +   + TG   A+K    EV +  D+      +     E +V
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRV 63
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILN 466
           L + +H  +     S    D L   +EY + G +  ++ RE  R  +E   R +   I++
Sbjct: 64  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVS 121
Query: 467 GLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMA 522
            L YLHS  N ++RD+K  NL++D  G +K+ DFG+ K   G+    ++K   G+P ++A
Sbjct: 122 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKXFCGTPEYLA 179
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PEV++       +     AVD W LG  + EM+ G+ P+   +  +    +L      P 
Sbjct: 180 PEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 232
Query: 583 MLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
            L  E K  L     ++P +R       A E+++H F     +Q++
Sbjct: 233 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 278

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 138/286 (48%), Gaps = 31/286 (10%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKV 407
           ++++  KL+G+GTFG V +   + TG   A+K    EV +  D+      +     E +V
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRV 61
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILN 466
           L + +H  +     S    D L   +EY + G +  ++ RE  R  +E   R +   I++
Sbjct: 62  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVS 119
Query: 467 GLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMA 522
            L YLHS  N ++RD+K  NL++D  G +K+ DFG+ K   G+    ++K   G+P ++A
Sbjct: 120 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKXFCGTPEYLA 177
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PEV++       +     AVD W LG  + EM+ G+ P+   +  +    +L      P 
Sbjct: 178 PEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 230
Query: 583 MLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
            L  E K  L     ++P +R       A E+++H F     +Q++
Sbjct: 231 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 276

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 131/274 (47%), Gaps = 13/274 (4%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVLG 409
           ++  +++GRG    V    ++ T    A+K +D+      SAE +++L +    E+ +L 
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 410 HLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
            +  H NI+Q   +   +   ++  + +  G +  Y+ E    ++E   R   R +L  +
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVI 124
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
             LH  N +HRD+K  N+L+D    +KL DFG +  L        + G+P+++APE+I+ 
Sbjct: 125 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 184
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NRTPPIPEM-- 583
            M  D +P     VD+WS G  +  +L G PP+        M +++   N     PE   
Sbjct: 185 SMN-DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDD 242
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
            S   KD + R  +  P +R +A E L HPF + 
Sbjct: 243 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +  +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 86
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 145
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 206 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 258
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 259 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 85
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 144
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      PE    +
Sbjct: 205 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 257
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 258 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 299

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 140/277 (50%), Gaps = 25/277 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIV 417
           +G GT G V+    R+TG   A+K++    +  ++   +  L+  +K      H+   IV
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLK-----SHDCPYIV 87
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN- 475
           Q +G+ + +  ++I +E +  G+    +++  +  I E I+   T  I+  L YL   + 
Sbjct: 88  QCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
            IHRD+K +N+L+D  G +KL DFG++  L     +    G   +MAPE I         
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP--PDPTK 203
Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNRTPP-IPEMLSSEG-- 588
           P   +  D+WSLG +++E+ TG+ P+    ++FE    + KVL   PP +P  +   G  
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---VLTKVLQEEPPLLPGHMGFSGDF 260
Query: 589 KDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSV 625
           + F+  C  ++  +RP   +LLEH FI+   Y+ L V
Sbjct: 261 QSFVKDCLTKDHRKRPKYNKLLEHSFIK--RYETLEV 295

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 141/275 (51%), Gaps = 22/275 (8%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            +++  K IG G FG   +  ++++    A+K ++      +  +  + +++EI     L
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE------RGEKIDENVKREIINHRSL 72
Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           +H NIV++    +   HL I +EY   G +   +    R  +E   R F + +++G++Y 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYC 131
Query: 472 HSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           H+    HRD+K  N L+D S    +K+  FG +K     S   S  G+P ++APEV+   
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVL--- 188
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----QAMFKVLNRTPPIPEM-- 583
           ++K+ + K+A   D+WS G T+  ML G  P+ + E P    + + ++LN    IP+   
Sbjct: 189 LKKEYDGKVA---DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVH 245
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHP-FIRN 617
           +S E +  + R F+ +P +R S  E+  H  F++N
Sbjct: 246 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 141/293 (48%), Gaps = 19/293 (6%)
Query: 342 MEKPSASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAE 396
           ++  S  PK  + ++   K +G G  G V +   R+T    AI+ +          + A+
Sbjct: 123 VDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREAD 182
Query: 397 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 456
               +E EI++L  L H  I++       +D+ YI LE +  G +   V  + R + E+ 
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEAT 240
Query: 457 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELS 513
            + +   +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L   S   +
Sbjct: 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300
Query: 514 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV 573
           L G+P ++APEV+ +V    G      AVD WSLG  +   L+G PP+SE     ++   
Sbjct: 301 LCGTPTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 356
Query: 574 L-----NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 621
           +     N  P +   +S +  D + +  + +P  R +  E L HP++++ + +
Sbjct: 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 25/282 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 410
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 91
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 92  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 150
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 527
           LH    IHRD+K  N+L++    +++ DFG AK L+  S +       G+  +++PE++ 
Sbjct: 151 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                        + D+W+LGC + +++ G PP+          K++      P     +
Sbjct: 211 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPK 263
Query: 588 GKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
            +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 264 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 305

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 134/269 (49%), Gaps = 23/269 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+FG+V+       G+  A+K   I+ +    AE + +  +E+ ++  L+H NIV +
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTN-- 475
            G+     +L I  EY+  GS+ R + +      + E    +    +  G+ YLH+ N  
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMA--KHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
            +HR++K  NLLVD    VK+ DFG++  K  T LS + S  G+P WMAPEV++    + 
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK-SAAGTPEWMAPEVLR---DEP 215
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGKDF 591
            N K     D++S G  + E+ T + PW      Q +  V  +     IP  L+ +    
Sbjct: 216 SNEK----SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI 271
Query: 592 LLRCFLRNPVERPSAVELLE--HPFIRNA 618
           +  C+   P +RPS   +++   P I++A
Sbjct: 272 IEGCWTNEPWKRPSFATIMDLLRPLIKSA 300

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 152/314 (48%), Gaps = 61/314 (19%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S +Q   L+G G +G V   T++ TG   AIK+++  P D K    ++ L +EIK+L H 
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PFD-KPLFALRTL-REIKILKHF 66
Query: 412 KHENIVQYYGSEVVD-----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           KHENI+  +  +  D     + +YI  E +    ++R +      +++  ++ F    L 
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM--LSDDHIQYFIYQTLR 123
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----------TGLSYELSLKG 516
            +  LH +N IHRD+K +NLL++++  +K+ DFG+A+ +          TG    ++   
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYV 183
Query: 517 SPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP---------------- 559
           +  W  APEV+        + K + A+D+WS GC + E+   +P                
Sbjct: 184 ATRWYRAPEVMLT------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 560 ----PWSE-----FEGPQA--MFKVLNRTP--PIPEM---LSSEGKDFLLRCFLRNPVER 603
               P S+      E P+A    K L   P  P+ +M   ++ +G D L R  + +P +R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 604 PSAVELLEHPFIRN 617
            +A E LEHP+++ 
Sbjct: 298 ITAKEALEHPYLQT 311

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 152/314 (48%), Gaps = 61/314 (19%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S +Q   L+G G +G V   T++ TG   AIK+++  P D K    ++ L +EIK+L H 
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PFD-KPLFALRTL-REIKILKHF 66
Query: 412 KHENIVQYYGSEVVD-----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           KHENI+  +  +  D     + +YI  E +    ++R +      +++  ++ F    L 
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM--LSDDHIQYFIYQTLR 123
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----------TGLSYELSLKG 516
            +  LH +N IHRD+K +NLL++++  +K+ DFG+A+ +          TG    ++   
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 517 SPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP---------------- 559
           +  W  APEV+        + K + A+D+WS GC + E+   +P                
Sbjct: 184 ATRWYRAPEVMLT------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 560 ----PWSE-----FEGPQA--MFKVLNRTP--PIPEM---LSSEGKDFLLRCFLRNPVER 603
               P S+      E P+A    K L   P  P+ +M   ++ +G D L R  + +P +R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 604 PSAVELLEHPFIRN 617
            +A E LEHP+++ 
Sbjct: 298 ITAKEALEHPYLQT 311

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 134/279 (48%), Gaps = 26/279 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCA-------IKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           +++G+G +G V+    + TGA+         +K+  I+    ++A+     + E  +L  
Sbjct: 23  RVLGKGGYGKVF-QVRKVTGANTGKIFAMKVLKKAMIV----RNAKDTAHTKAERNILEE 77
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           +KH  IV    +      LY+ LEY+  G +   + E      E     +   I   L +
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACFYLAEISMALGH 136
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAV 529
           LH    I+RD+K  N++++  G VKL DFG+ K  +   +   +  G+  +MAPE+    
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI---- 192
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 589
           + + G+ +   AVD WSLG  + +MLTG PP++     + + K+L     +P  L+ E +
Sbjct: 193 LMRSGHNR---AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249
Query: 590 DFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
           D L +   RN   R       A E+  HPF R+ N++ L
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL 288

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 141/293 (48%), Gaps = 19/293 (6%)
Query: 342 MEKPSASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAE 396
           ++  S  PK  + ++   K +G G  G V +   R+T    AI+ +          + A+
Sbjct: 137 VDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREAD 196
Query: 397 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 456
               +E EI++L  L H  I++       +D+ YI LE +  G +   V  + R + E+ 
Sbjct: 197 PALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEAT 254
Query: 457 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELS 513
            + +   +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L   S   +
Sbjct: 255 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 314
Query: 514 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV 573
           L G+P ++APEV+ +V    G      AVD WSLG  +   L+G PP+SE     ++   
Sbjct: 315 LCGTPTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 370
Query: 574 L-----NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 621
           +     N  P +   +S +  D + +  + +P  R +  E L HP++++ + +
Sbjct: 371 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 423

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 134/269 (49%), Gaps = 22/269 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K IG G FG   +  ++ T    A+K ++      + A   + +++EI     L+H NIV
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIE------RGAAIDENVQREIINHRSLRHPNIV 79
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           ++    +   HL I +EY   G +   +    R  +E   R F + +L+G++Y HS    
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCHSMQIC 138
Query: 478 HRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
           HRD+K  N L+D S    +K+ DFG +K     S   S  G+P ++APEV+   ++++ +
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---LRQEYD 195
Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----PIPE--MLSSEGK 589
            K+A   D+WS G T+  ML G  P+ + E P+   K + R       IP+   +S E  
Sbjct: 196 GKIA---DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252
Query: 590 DFLLRCFLRNPVERPSAVELLEHP-FIRN 617
             + R F+ +P  R S  E+  H  F++N
Sbjct: 253 HLISRIFVADPATRISIPEIKTHSWFLKN 281

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 147/285 (51%), Gaps = 16/285 (5%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +GRG +G V    +  +G   A+K +    +  +    +  L+  ++ +        V +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV---DCPFTVTF 71
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHS-TN 475
           YG+   +  ++I +E +   S++++   V +  + I E I+      I+  L +LHS  +
Sbjct: 72  YGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
            IHRD+K +N+L++A G VK+ DFG++ +L     +    G   +MAPE I   + + G 
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKG- 189
Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR-TPPIP-EMLSSEGKDFL 592
              ++  DIWSLG T+IE+   + P+  +  P Q + +V+   +P +P +  S+E  DF 
Sbjct: 190 --YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247
Query: 593 LRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGD 637
            +C  +N  ERP+  EL++HPF     +++    +  F ++ LGD
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFF--TLHESKGTDVASFVKLILGD 290

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 135/281 (48%), Gaps = 30/281 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCA-------IKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           +++G+G +G V+    + TGA+         +K+  I+    ++A+     + E  +L  
Sbjct: 23  RVLGKGGYGKVF-QVRKVTGANTGKIFAMKVLKKAMIV----RNAKDTAHTKAERNILEE 77
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           +KH  IV    +      LY+ LEY+  G +   + E      E     +   I   L +
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACFYLAEISMALGH 136
Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAK---HLTGLSYELSLKGSPNWMAPEVIK 527
           LH    I+RD+K  N++++  G VKL DFG+ K   H   +++     G+  +MAPE+  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC--GTIEYMAPEI-- 192
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
             + + G+ +   AVD WSLG  + +MLTG PP++     + + K+L     +P  L+ E
Sbjct: 193 --LMRSGHNR---AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE 247
Query: 588 GKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
            +D L +   RN   R       A E+  HPF R+ N++ L
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL 288

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 101
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 221 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 133/275 (48%), Gaps = 37/275 (13%)
Query: 350 KKSQWQKGKL-IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           ++  W   +L +GRG+FG V+   +++TG  CA+K+V +        E  +   +E+   
Sbjct: 71  EEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRL--------EVFRA--EELMAC 120
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNG 467
             L    IV  YG+      + I++E +  GS+ + V+E  C  + E     +    L G
Sbjct: 121 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALEG 178
Query: 468 LAYLHSTNTIHRDIKGANLLVDASGV-VKLADFGMAKHLT--GLSYEL----SLKGSPNW 520
           L YLHS   +H D+K  N+L+ + G    L DFG A  L   GL  +L     + G+   
Sbjct: 179 LEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETH 238
Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI 580
           MAPEV   V+ +  + K    VD+WS  C ++ ML G  PW++F       K+ +  PP+
Sbjct: 239 MAPEV---VLGRSCDAK----VDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPV 291
Query: 581 PEM------LSSEGKDFLLRCFLRNPVERPSAVEL 609
            E+      L+++     LR   + P+ R SA EL
Sbjct: 292 REIPPSCAPLTAQAIQEGLR---KEPIHRVSAAEL 323

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 124/268 (46%), Gaps = 26/268 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+FG+VY G      A   +K VD  P      E  +    E+ VL   +H NI+ +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTP------EQFQAFRNEVAVLRKTRHVNILLF 97
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
            G  +  D+L I  ++    S+ +++           + +  R    G+ YLH+ N IHR
Sbjct: 98  MGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHR 156
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDGNP 536
           D+K  N+ +     VK+ DFG+A   +  S    ++   GS  WMAPEVI+    +D NP
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM---QDNNP 213
Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLS------SEGKD 590
             +   D++S G  + E++TG+ P+S       +  ++ R    P++           K 
Sbjct: 214 -FSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKR 272
Query: 591 FLLRCFLRNPVERP------SAVELLEH 612
            +  C  +   ERP      S++ELL+H
Sbjct: 273 LVADCVKKVKEERPLFPQILSSIELLQH 300

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 53  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 103
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 104 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 162
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 163 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 222
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 223 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 272

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 55  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 105
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 106 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 164
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 165 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 224
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 225 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 274

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 117/236 (49%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V          +  K   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQGKAFKN--RELQIM 67
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PATVYRVARHYSRAKQTLPVIYVKL 126
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 187 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 101
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 220
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 221 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 45  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 95
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 96  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 154
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 155 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 214
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 215 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 264

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 96  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 146
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 147 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 205
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 206 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 265
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 266 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 315

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 132/269 (49%), Gaps = 23/269 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G+FG+V+       G+  A+K   I+ +    AE + +  +E+ ++  L+H NIV +
Sbjct: 45  IGAGSFGTVH--RAEWHGSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTN-- 475
            G+     +L I  EY+  GS+ R + +      + E    +    +  G+ YLH+ N  
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKD 533
            +HRD+K  NLLVD    VK+ DFG+++ L    +  S    G+P WMAPEV++    + 
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLR---DEP 215
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGKDF 591
            N K     D++S G  + E+ T + PW      Q +  V  +     IP  L+ +    
Sbjct: 216 SNEK----SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI 271
Query: 592 LLRCFLRNPVERPSAVELLE--HPFIRNA 618
           +  C+   P +RPS   +++   P I++A
Sbjct: 272 IEGCWTNEPWKRPSFATIMDLLRPLIKSA 300

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 143/308 (46%), Gaps = 42/308 (13%)
Query: 339 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI 398
           P +  + S +    +++  +++G+G+FG V +  ++ TG  CA+K +        S   +
Sbjct: 36  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI--------SKRQV 87
Query: 399 KQ------LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR 450
           KQ      L +E+++L  L H NI++ Y  E  +D  Y YL  E    G +   +    R
Sbjct: 88  KQKTDKESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR 145
Query: 451 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTG 507
             +E       R +L+G+ Y+H    +HRD+K  NLL+++      +++ DFG++ H   
Sbjct: 146 -FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 204
Query: 508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 567
                   G+  ++APEV+     +          D+WS G  +  +L+G PP   F G 
Sbjct: 205 SKKMKDKIGTAYYIAPEVLHGTYDE--------KCDVWSTGVILYILLSGCPP---FNGA 253
Query: 568 QAMFKVLNR------TPPIPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
              + +L +      T  +P+   +S   KD + +     P  R SA + L+H +I+   
Sbjct: 254 NE-YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 312
Query: 620 YQNLSVPM 627
            + +SV +
Sbjct: 313 KEQISVDV 320

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 120/250 (48%), Gaps = 25/250 (10%)
Query: 346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII----PDDPKSAECIKQL 401
           S S     W    ++G+G   +V+ G +++TG   AIK  + I    P D +        
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM------- 55
Query: 402 EQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVRE--HCRDITESIV 457
            +E +VL  L H+NIV+ +    E    H  + +E+   GS+   + E  +   + ES  
Sbjct: 56  -REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLL----VDASGVVKLADFGMAKHLTGLSYELS 513
               R ++ G+ +L     +HR+IK  N++     D   V KL DFG A+ L      +S
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174
Query: 514 LKGSPNWMAPEVI-KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----Q 568
           L G+  ++ P++  +AV++KD   K    VD+WS+G T     TG  P+  FEGP    +
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 569 AMFKVLNRTP 578
            M+K++   P
Sbjct: 235 VMYKIITGKP 244

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 132/275 (48%), Gaps = 37/275 (13%)
Query: 350 KKSQWQKGKL-IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           ++  W   +L +GRG+FG V+   +++TG  CA+K+V +        E  +   +E+   
Sbjct: 90  EEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRL--------EVFRA--EELMAC 139
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNG 467
             L    IV  YG+      + I++E +  GS+ + V+E  C  + E     +    L G
Sbjct: 140 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALEG 197
Query: 468 LAYLHSTNTIHRDIKGANLLVDASGV-VKLADFGMAKHLT--GLSYEL----SLKGSPNW 520
           L YLHS   +H D+K  N+L+ + G    L DFG A  L   GL   L     + G+   
Sbjct: 198 LEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETH 257
Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI 580
           MAPEV   V+ +  + K    VD+WS  C ++ ML G  PW++F       K+ +  PP+
Sbjct: 258 MAPEV---VLGRSCDAK----VDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPV 310
Query: 581 PEM------LSSEGKDFLLRCFLRNPVERPSAVEL 609
            E+      L+++     LR   + P+ R SA EL
Sbjct: 311 REIPPSCAPLTAQAIQEGLR---KEPIHRVSAAEL 342

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 143/308 (46%), Gaps = 42/308 (13%)
Query: 339 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI 398
           P +  + S +    +++  +++G+G+FG V +  ++ TG  CA+K +        S   +
Sbjct: 37  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI--------SKRQV 88
Query: 399 KQ------LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR 450
           KQ      L +E+++L  L H NI++ Y  E  +D  Y YL  E    G +   +    R
Sbjct: 89  KQKTDKESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR 146
Query: 451 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTG 507
             +E       R +L+G+ Y+H    +HRD+K  NLL+++      +++ DFG++ H   
Sbjct: 147 -FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 205
Query: 508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 567
                   G+  ++APEV+     +          D+WS G  +  +L+G PP   F G 
Sbjct: 206 SKKMKDKIGTAYYIAPEVLHGTYDE--------KCDVWSTGVILYILLSGCPP---FNGA 254
Query: 568 QAMFKVLNR------TPPIPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
              + +L +      T  +P+   +S   KD + +     P  R SA + L+H +I+   
Sbjct: 255 NE-YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 313
Query: 620 YQNLSVPM 627
            + +SV +
Sbjct: 314 KEQISVDV 321

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 140/275 (50%), Gaps = 22/275 (8%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            +++  K IG G FG   +  ++++    A+K ++      +  +  + +++EI     L
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE------RGEKIDENVKREIINHRSL 72
Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           +H NIV++    +   HL I +EY   G +   +    R  +E   R F + +++G++Y 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYC 131
Query: 472 HSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           H+    HRD+K  N L+D S    +K+  FG +K     S      G+P ++APEV+   
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVL--- 188
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----QAMFKVLNRTPPIPEM-- 583
           ++K+ + K+A   D+WS G T+  ML G  P+ + E P    + + ++LN    IP+   
Sbjct: 189 LKKEYDGKVA---DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVH 245
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHP-FIRN 617
           +S E +  + R F+ +P +R S  E+  H  F++N
Sbjct: 246 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 22  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 72
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 73  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 131
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 132 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 191
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 192 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 241

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 143/308 (46%), Gaps = 42/308 (13%)
Query: 339 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI 398
           P +  + S +    +++  +++G+G+FG V +  ++ TG  CA+K +        S   +
Sbjct: 13  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI--------SKRQV 64
Query: 399 KQ------LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR 450
           KQ      L +E+++L  L H NI++ Y  E  +D  Y YL  E    G +   +    R
Sbjct: 65  KQKTDKESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR 122
Query: 451 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTG 507
             +E       R +L+G+ Y+H    +HRD+K  NLL+++      +++ DFG++ H   
Sbjct: 123 -FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181
Query: 508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 567
                   G+  ++APEV+     +          D+WS G  +  +L+G PP   F G 
Sbjct: 182 SKKMKDKIGTAYYIAPEVLHGTYDE--------KCDVWSTGVILYILLSGCPP---FNGA 230
Query: 568 QAMFKVLNR------TPPIPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
              + +L +      T  +P+   +S   KD + +     P  R SA + L+H +I+   
Sbjct: 231 NE-YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289
Query: 620 YQNLSVPM 627
            + +SV +
Sbjct: 290 KEQISVDV 297

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 140/303 (46%), Gaps = 48/303 (15%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 409
           ++QK + +G GT+G VY   + + G   A+K + +  +D   P +A       +EI +L 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAI------REISLLK 74
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            L H NIV        +  L +  E++    + + + E+   + +S ++ +   +L G+A
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKA 528
           + H    +HRD+K  NLL+++ G +KLADFG+A+         + +    W  AP+V+  
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM- 192
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------------------------PWSEF 564
                G+ K + +VDIWS+GC   EM+TGKP                         W + 
Sbjct: 193 -----GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 565 E----GPQAMFKVLNRTP--PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           +      Q  F+V  + P   I      EG D L      +P +R SA + + HP+ ++ 
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
Query: 619 NYQ 621
           + Q
Sbjct: 308 DPQ 310

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 119/225 (52%), Gaps = 15/225 (6%)
Query: 398 IKQLEQEIKVLGHLKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDIT 453
           I+Q+ QEI +L  L H N+V+    EV+DD    HLY+  E V+ G +        + ++
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEV--PTLKPLS 135
Query: 454 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 513
           E   R + + ++ G+ YLH    IHRDIK +NLLV   G +K+ADFG++    G    LS
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195
Query: 514 -LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK 572
              G+P +MAPE +    +K  + K   A+D+W++G T+   + G+ P+ +        K
Sbjct: 196 NTVGTPAFMAPESLSET-RKIFSGK---ALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251
Query: 573 VLNRTPPIPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           + ++    P+   ++ + KD + R   +NP  R    E+  HP++
Sbjct: 252 IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 30  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 80
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 81  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 139
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 140 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 199
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 200 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 249

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 117/237 (49%), Gaps = 26/237 (10%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V          +  K   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQGKAFKN--RELQIM 67
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 575
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++ 
Sbjct: 187 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 117/237 (49%), Gaps = 26/237 (10%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V          +  K   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQGKAFKN--RELQIM 67
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 575
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++ 
Sbjct: 187 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 130/267 (48%), Gaps = 18/267 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IGRG +GSV    ++ +G   A+K +    D+ +  + +  L+    V+       IVQ+
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQF 86
Query: 420 YGSEVVDDHLYIYLEYVHPG--SINRYVREHCRDIT-ESIVRNFTRHILNGLAYL-HSTN 475
           YG+   +   +I +E +        +YV     D+  E I+   T   +  L +L  +  
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
            IHRDIK +N+L+D SG +KL DFG++  L     +    G   +MAPE I     + G 
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG- 205
Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD----- 590
               +  D+WSLG T+ E+ TG+ P+ ++         + +  P P++ +SE ++     
Sbjct: 206 --YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP-PQLSNSEEREFSPSF 262
Query: 591 --FLLRCFLRNPVERPSAVELLEHPFI 615
             F+  C  ++  +RP   ELL+HPFI
Sbjct: 263 INFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 151/314 (48%), Gaps = 61/314 (19%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S +Q   L+G G +G V   T++ TG   AIK+++  P D K    ++ L +EIK+L H 
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PFD-KPLFALRTL-REIKILKHF 66
Query: 412 KHENIVQYYGSEVVD-----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           KHENI+  +  +  D     + +YI  E +    ++R +      +++  ++ F    L 
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM--LSDDHIQYFIYQTLR 123
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----------TGLSYELSLKG 516
            +  LH +N IHRD+K +NLL++++  +K+ DFG+A+ +          TG    +    
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 517 SPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP---------------- 559
           +  W  APEV+        + K + A+D+WS GC + E+   +P                
Sbjct: 184 ATRWYRAPEVMLT------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 560 ----PWSE-----FEGPQA--MFKVLNRTP--PIPEM---LSSEGKDFLLRCFLRNPVER 603
               P S+      E P+A    K L   P  P+ +M   ++ +G D L R  + +P +R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 604 PSAVELLEHPFIRN 617
            +A E LEHP+++ 
Sbjct: 298 ITAKEALEHPYLQT 311

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 79
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 80  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 138
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 198
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 199 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 248

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 140/303 (46%), Gaps = 48/303 (15%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 409
           ++QK + +G GT+G VY   + + G   A+K + +  +D   P +A       +EI +L 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAI------REISLLK 74
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            L H NIV        +  L +  E++    + + + E+   + +S ++ +   +L G+A
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKA 528
           + H    +HRD+K  NLL+++ G +KLADFG+A+         + +    W  AP+V+  
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM- 192
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------------------------PWSEF 564
                G+ K + +VDIWS+GC   EM+TGKP                         W + 
Sbjct: 193 -----GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 565 E----GPQAMFKVLNRTP--PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           +      Q  F+V  + P   I      EG D L      +P +R SA + + HP+ ++ 
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
Query: 619 NYQ 621
           + Q
Sbjct: 308 DPQ 310

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 36  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 86
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 87  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 145
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 146 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 205
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 206 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 255

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 25  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 75
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 76  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 134
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 135 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 194
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 195 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 244

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 79
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 80  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 138
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 198
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 199 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 248

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 127/268 (47%), Gaps = 44/268 (16%)
Query: 360 IGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           +G G FG V++         +     A+K +    D+ +     K   +E ++L +L+HE
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR-----KDFHREAELLTNLQHE 75
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------------ITESIVRNFTR 462
           +IV++YG  V  D L +  EY+  G +N+++R H  D            +T+S + +  +
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---- 518
            I  G+ YL S + +HRD+   N LV  + +VK+ DFGM++ +    Y   + G      
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPI 194
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM-----FK 572
            WM PE   ++M +    K     D+WSLG  + E+ T GK PW +    + +      +
Sbjct: 195 RWMPPE---SIMYR----KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247
Query: 573 VLNRTPPIPEMLSSEGKDFLLRCFLRNP 600
           VL R    P+    E  + +L C+ R P
Sbjct: 248 VLQRPRTCPQ----EVYELMLGCWQREP 271

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 118/237 (49%), Gaps = 26/237 (10%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 67
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 575
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++ 
Sbjct: 187 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 118/237 (49%), Gaps = 26/237 (10%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 67
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 575
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++ 
Sbjct: 187 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 118/237 (49%), Gaps = 26/237 (10%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 18  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 68
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 69  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 127
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 128 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 187
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 575
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++ 
Sbjct: 188 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 238

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 118/237 (49%), Gaps = 26/237 (10%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 67
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 575
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++ 
Sbjct: 187 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 130/276 (47%), Gaps = 23/276 (8%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHL-KHE 414
           ++G+G+FG V +   + T    AIK +    +I DD    EC      E +VL  L K  
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDD--DVECTMV---EKRVLALLDKPP 80
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            + Q +      D LY  +EYV+ G +  ++++  +   E     +   I  GL +LH  
Sbjct: 81  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISIGLFFLHKR 139
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
             I+RD+K  N+++D+ G +K+ADFGM K H+          G+P+++APE+I    Q  
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII--AYQPY 197
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 593
           G      +VD W+ G  + EML G+PP+   +  +    ++      P+ LS E      
Sbjct: 198 GK-----SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICK 252
Query: 594 RCFLRNPVER-----PSAVELLEHPFIRNANYQNLS 624
               ++P +R         ++ EH F R  +++ L 
Sbjct: 253 GLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLE 288

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 118/237 (49%), Gaps = 26/237 (10%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 21  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 71
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 72  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 130
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 131 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 190
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 575
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++ 
Sbjct: 191 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 241

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 22/264 (8%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 29  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 82
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + + G       L I  ++    S+  ++           + +  R    G+ YLH+ + 
Sbjct: 83  LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQK 532
           IHRD+K  N+ +     VK+ DFG+A   +  S    +E  L GS  WMAPEVI+    +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE-QLSGSILWMAPEVIR---MQ 197
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS--- 586
           D NP  +   D+++ G  + E++TG+ P+S       + +++ R   +P + ++ S+   
Sbjct: 198 DSNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256
Query: 587 EGKDFLLRCFLRNPVERPSAVELL 610
             K  +  C  +   ERPS   +L
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRIL 280

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 22/264 (8%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 29  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 82
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + + G       L I  ++    S+  ++           + +  R    G+ YLH+ + 
Sbjct: 83  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQK 532
           IHRD+K  N+ +     VK+ DFG+A   +  S    +E  L GS  WMAPEVI+    +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE-QLSGSILWMAPEVIR---MQ 197
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS--- 586
           D NP  +   D+++ G  + E++TG+ P+S       + +++ R   +P + ++ S+   
Sbjct: 198 DSNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256
Query: 587 EGKDFLLRCFLRNPVERPSAVELL 610
             K  +  C  +   ERPS   +L
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRIL 280

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 137/299 (45%), Gaps = 13/299 (4%)
Query: 339 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI 398
           P ++       ++  ++  K+IGRG F  V +   ++TG   A+K ++   D  K  E +
Sbjct: 48  PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW-DMLKRGE-V 105
Query: 399 KQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 458
               +E  VL +     I Q + +   +++LY+ +EY   G +   + +    I   + R
Sbjct: 106 SCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR 165
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKG 516
            +   I+  +  +H    +HRDIK  N+L+D  G ++LADFG    L   G    L   G
Sbjct: 166 FYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG 225
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-----SEFEGPQAMF 571
           +P++++PE+++AV    G        D W+LG    EM  G+ P+     +E  G    +
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285
Query: 572 KVLNRTPPIPEMLSSEGKDFLLR--CFLRNPVERPSAVELLEHPFIRNANYQNL--SVP 626
           K     P + E +  E +DF+ R  C     + R  A +   HPF    ++  L  SVP
Sbjct: 286 KEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVP 344

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 113/222 (50%), Gaps = 20/222 (9%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G  +G G FG VY G    T  + A+K++  + D   + E  +Q +QEIKV+   +HEN+
Sbjct: 36  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENL 92
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL----NGLAYLH 472
           V+  G     D L +   Y+  GS+    R  C D T  +  +    I     NG+ +LH
Sbjct: 93  VELLGFSSDGDDLCLVYVYMPNGSL--LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAV 529
             + IHRDIK AN+L+D +   K++DFG+A+     +  +    + G+  +MAPE ++  
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGE 210
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 571
           +     PK     DI+S G  ++E++TG P   E   PQ + 
Sbjct: 211 I----TPK----SDIYSFGVVLLEIITGLPAVDEHREPQLLL 244

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 124/263 (47%), Gaps = 20/263 (7%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 17  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 70
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + + G       L I  ++    S+  ++           + +  R    G+ YLH+ + 
Sbjct: 71  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 129
Query: 477 IHRDIKGANLLVDASGVVKLADFGMA---KHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
           IHRD+K  N+ +     VK+ DFG+A      +G      L GS  WMAPEVI+    +D
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR---MQD 186
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS---E 587
            NP  +   D+++ G  + E++TG+ P+S       + +++ R   +P + ++ S+    
Sbjct: 187 SNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 245
Query: 588 GKDFLLRCFLRNPVERPSAVELL 610
            K  +  C  +   ERPS   +L
Sbjct: 246 MKRLMAECLKKKRDERPSFPRIL 268

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 113/222 (50%), Gaps = 20/222 (9%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G  +G G FG VY G    T  + A+K++  + D   + E  +Q +QEIKV+   +HEN+
Sbjct: 36  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENL 92
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL----NGLAYLH 472
           V+  G     D L +   Y+  GS+    R  C D T  +  +    I     NG+ +LH
Sbjct: 93  VELLGFSSDGDDLCLVYVYMPNGSL--LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAV 529
             + IHRDIK AN+L+D +   K++DFG+A+     +  +    + G+  +MAPE ++  
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGE 210
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 571
           +     PK     DI+S G  ++E++TG P   E   PQ + 
Sbjct: 211 I----TPK----SDIYSFGVVLLEIITGLPAVDEHREPQLLL 244

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 135/290 (46%), Gaps = 34/290 (11%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------LEQEIK 406
           +++  +++G+G+FG V +  ++ TG  CA+K +        S   +KQ      L +E++
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVI--------SKRQVKQKTDKESLLREVQ 78
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +L  L H NI + Y  E  +D  Y YL  E    G +   +    R  +E       R +
Sbjct: 79  LLKQLDHPNIXKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQV 135
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
           L+G+ Y H    +HRD+K  NLL+++      +++ DFG++ H           G+  ++
Sbjct: 136 LSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYI 195
Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPP 579
           APEV+     +          D+WS G  +  +L+G PP++       + KV     T  
Sbjct: 196 APEVLHGTYDE--------KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE 247
Query: 580 IPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 627
           +P+   +S   KD + +     P  R SA + L+H +I+    + +SV +
Sbjct: 248 LPQWKKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQTYTKEQISVDV 297

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 113/222 (50%), Gaps = 20/222 (9%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G  +G G FG VY G    T  + A+K++  + D   + E  +Q +QEIKV+   +HEN+
Sbjct: 30  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENL 86
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL----NGLAYLH 472
           V+  G     D L +   Y+  GS+    R  C D T  +  +    I     NG+ +LH
Sbjct: 87  VELLGFSSDGDDLCLVYVYMPNGSL--LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 144
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAV 529
             + IHRDIK AN+L+D +   K++DFG+A+     +  +    + G+  +MAPE ++  
Sbjct: 145 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGE 204
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 571
           +     PK     DI+S G  ++E++TG P   E   PQ + 
Sbjct: 205 I----TPK----SDIYSFGVVLLEIITGLPAVDEHREPQLLL 238

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 135/280 (48%), Gaps = 17/280 (6%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++  K+IGRG FG V +  ++ T    A+K +       +S       E++I    
Sbjct: 67  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
           +     +VQ + +   D +LY+ +EY+  G +   +  +  D+ E   R +T  ++  L 
Sbjct: 127 NSPW--VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALD 182
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIK 527
            +HS   IHRD+K  N+L+D SG +KLADFG  M  +  G+    +  G+P++++PEV+K
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPEM 583
           +   + G+       D WS+G  + EML G  P+          K++N     T P    
Sbjct: 243 S---QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299
Query: 584 LSSEGKDFLLRCFLRN---PVERPSAVELLEHPFIRNANY 620
           +S E K+ L+  FL +    + R    E+  H F +N  +
Sbjct: 300 ISKEAKN-LICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 135/280 (48%), Gaps = 17/280 (6%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++  K+IGRG FG V +  ++ T    A+K +       +S       E++I    
Sbjct: 72  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 131
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
           +     +VQ + +   D +LY+ +EY+  G +   +  +  D+ E   R +T  ++  L 
Sbjct: 132 NSPW--VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALD 187
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIK 527
            +HS   IHRD+K  N+L+D SG +KLADFG  M  +  G+    +  G+P++++PEV+K
Sbjct: 188 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 247
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPEM 583
           +   + G+       D WS+G  + EML G  P+          K++N     T P    
Sbjct: 248 S---QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 304
Query: 584 LSSEGKDFLLRCFLRN---PVERPSAVELLEHPFIRNANY 620
           +S E K+ L+  FL +    + R    E+  H F +N  +
Sbjct: 305 ISKEAKN-LICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 343

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 119/250 (47%), Gaps = 25/250 (10%)
Query: 346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII----PDDPKSAECIKQL 401
           S S     W    ++G+G   +V+ G +++TG   AIK  + I    P D +        
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM------- 55
Query: 402 EQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVRE--HCRDITESIV 457
            +E +VL  L H+NIV+ +    E    H  + +E+   GS+   + E  +   + ES  
Sbjct: 56  -REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLL----VDASGVVKLADFGMAKHLTGLSYELS 513
               R ++ G+ +L     +HR+IK  N++     D   V KL DFG A+ L      + 
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX 174
Query: 514 LKGSPNWMAPEVI-KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----Q 568
           L G+  ++ P++  +AV++KD   K    VD+WS+G T     TG  P+  FEGP    +
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 569 AMFKVLNRTP 578
            M+K++   P
Sbjct: 235 VMYKIITGKP 244

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 116/232 (50%), Gaps = 34/232 (14%)
Query: 342 MEKPSASPK---KSQWQKGKLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKS 394
           M  P++ P    K   +K + +G G FG V    Y  TN  TG   A+K +         
Sbjct: 1   MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------K 52
Query: 395 AECIKQ----LEQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREH 448
           A+C  Q     +QEI +L  L HE+I++Y G   +  +  L + +EYV  GS+  Y+  H
Sbjct: 53  ADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH 112
Query: 449 CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TG 507
              + + ++  F + I  G+AYLHS + IHR++   N+L+D   +VK+ DFG+AK +  G
Sbjct: 113 SIGLAQLLL--FAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEG 170
Query: 508 LSYELSLKGSPN---WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
             Y    +   +   W APE +K         K   A D+WS G T+ E+LT
Sbjct: 171 HEYYRVREDGDSPVFWYAPECLKEY-------KFYYASDVWSFGVTLYELLT 215

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 141/279 (50%), Gaps = 33/279 (11%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ- 418
           +G G +GSV    + ++G   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 115
Query: 419 ---YYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 116 LDVFTPATSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 173
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 174 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 230
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKP--PWSEFEGPQAMFKVLNRTPP---IPEMLSSEG 588
                 + VDIWS+GC + E+LTG+   P ++          L  TPP   I  M S E 
Sbjct: 231 ------MTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEA 284
Query: 589 KDFL-------LRCFLRNPV-ERPSAVELLEHPFIRNAN 619
           ++++        R F    +   P AV+LLE   + + +
Sbjct: 285 RNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTD 323

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 67
Query: 409 GHLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+   L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L      +S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
            + APE+I       G      ++D+WS GC + E+L G+P +    G   + +++
Sbjct: 187 YYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 125/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 327
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y + V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 328 Y-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-------G 439
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 498
Query: 594 RCFLRNPVERPS 605
           +C+ + P ERP+
Sbjct: 499 QCWRKEPEERPT 510

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 103
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 221
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 222 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 137/283 (48%), Gaps = 33/283 (11%)
Query: 338 MPHIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIP 389
           +P +  KP    +K  W+         K +G G FG V++ T N+ T    A+K +    
Sbjct: 167 VPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTMK--- 221
Query: 390 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--E 447
             P S   ++    E  V+  L+H+ +V+ +   V  + +YI  E++  GS+  +++  E
Sbjct: 222 --PGSM-SVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDE 277
Query: 448 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 507
             +     ++ +F+  I  G+A++   N IHRD++ AN+LV AS V K+ADFG+A+ +  
Sbjct: 278 GSKQPLPKLI-DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336
Query: 508 LSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 564
             Y      K    W APE I             +  D+WS G  ++E++T G+ P+   
Sbjct: 337 NEYTAREGAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389
Query: 565 EGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPS 605
             P+ + + L R    P PE    E  + ++RC+   P ERP+
Sbjct: 390 SNPEVI-RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 431

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 137/297 (46%), Gaps = 44/297 (14%)
Query: 345 PSASPKKSQWQKGKL-----IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSA 395
           P  S   +Q+++  L     +G+G FGSV    Y      TG   A+K++        + 
Sbjct: 16  PRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTE 70
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 453
           E ++  E+EI++L  L+H+NIV+Y G        +L + +EY+  GS+  Y+++H   I 
Sbjct: 71  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 130
Query: 454 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 513
              +  +T  I  G+ YL +   IHRD+   N+LV+    VK+ DFG+ K L        
Sbjct: 131 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 190
Query: 514 LK---GSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF- 564
           +K    SP  W APE +          K ++A D+WS G  + E+ T     K P +EF 
Sbjct: 191 VKEPGESPIFWYAPESLT-------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM 243
Query: 565 -------EGPQAMFKVL-----NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
                  +G   +F ++     N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 244 RMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 34/279 (12%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            ++Q+ K +G G +G V +  ++ TGA  AIK +        +      L  E+ VL  L
Sbjct: 4   DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIK--KSSVTTTSNSGALLDEVAVLKQL 61
Query: 412 KHENIVQYYGSEVVDD--HLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNG 467
            H NI++ Y  E  +D  + Y+ +E    G +     +R+   ++  +++    + +L+G
Sbjct: 62  DHPNIMKLY--EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLSG 116
Query: 468 LAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
             YLH  N +HRD+K  NLL+++     ++K+ DFG++ H           G+  ++APE
Sbjct: 117 TTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE 176
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------- 577
           V++         K     D+WS G  +  +L G PP+    G Q   ++L R        
Sbjct: 177 VLR--------KKYDEKCDVWSCGVILYILLCGYPPF----GGQTDQEILKRVEKGKFSF 224
Query: 578 -PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
            PP    +S E K  +       P +R SA E L HP+I
Sbjct: 225 DPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 130/278 (46%), Gaps = 34/278 (12%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q+ K +G G +G V +  ++ TGA  AIK +        +      L  E+ VL  L 
Sbjct: 22  RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIK--KSSVTTTSNSGALLDEVAVLKQLD 79
Query: 413 HENIVQYYGSEVVDD--HLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGL 468
           H NI++ Y  E  +D  + Y+ +E    G +     +R+   ++  +++    + +L+G 
Sbjct: 80  HPNIMKLY--EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLSGT 134
Query: 469 AYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
            YLH  N +HRD+K  NLL+++     ++K+ DFG++ H           G+  ++APEV
Sbjct: 135 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEV 194
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------- 577
           ++         K     D+WS G  +  +L G PP+    G Q   ++L R         
Sbjct: 195 LR--------KKYDEKCDVWSCGVILYILLCGYPPF----GGQTDQEILKRVEKGKFSFD 242
Query: 578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           PP    +S E K  +       P +R SA E L HP+I
Sbjct: 243 PPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 128/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y++ H   I    +  +T  I  G+ YL +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 193
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 194 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 248
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 249 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 77
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 195
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 196 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 250
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 251 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 287

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 79
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 197
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 198 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 252
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 253 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 289

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 135/280 (48%), Gaps = 17/280 (6%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++  K+IGRG FG V +  ++ T    A+K +       +S       E++I    
Sbjct: 72  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 131
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
           +     +VQ + +   D +LY+ +EY+  G +   +  +  D+ E   R +T  ++  L 
Sbjct: 132 N--SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALD 187
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIK 527
            +HS   IHRD+K  N+L+D SG +KLADFG  M  +  G+    +  G+P++++PEV+K
Sbjct: 188 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 247
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPEM 583
           +   + G+       D WS+G  + EML G  P+          K++N     T P    
Sbjct: 248 S---QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 304
Query: 584 LSSEGKDFLLRCFLRN---PVERPSAVELLEHPFIRNANY 620
           +S E K+ L+  FL +    + R    E+  H F +N  +
Sbjct: 305 ISKEAKN-LICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 343

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 71
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 189
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 190 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 244
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 245 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 281

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 193
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 194 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 248
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 249 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +++G G F  V++   R TG   A+K +   P    S+     LE EI VL  +KHENIV
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS-----LENEIAVLKKIKHENIV 69
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHSTNT 476
                     H Y+ ++ V  G +   + E  R + TE       + +L+ + YLH    
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 477 IHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
           +HRD+K  NLL    + +  + + DFG++K +       +  G+P ++APEV+       
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVL------- 179
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-----TPPIPEMLSSEG 588
                + AVD WS+G     +L G PP+ E E    +F+ +         P  + +S   
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESA 238
Query: 589 KDFLLRCFLRNPVERPSAVELLEHPFI 615
           KDF+     ++P ER +  + L HP+I
Sbjct: 239 KDFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 133/276 (48%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI +E++  G++  Y+RE  R +++  ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 175 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 226
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 190
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 191 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 137/297 (46%), Gaps = 44/297 (14%)
Query: 345 PSASPKKSQWQKGKL-----IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSA 395
           P  S   +Q+++  L     +G+G FGSV    Y      TG   A+K++        + 
Sbjct: 16  PRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTE 70
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 453
           E ++  E+EI++L  L+H+NIV+Y G        +L + +EY+  GS+  Y+++H   I 
Sbjct: 71  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 130
Query: 454 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 513
              +  +T  I  G+ YL +   IHRD+   N+LV+    VK+ DFG+ K L        
Sbjct: 131 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 190
Query: 514 LK---GSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF- 564
           +K    SP  W APE +          K ++A D+WS G  + E+ T     K P +EF 
Sbjct: 191 VKEPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM 243
Query: 565 -------EGPQAMFKVL-----NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
                  +G   +F ++     N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 244 RMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 78
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 196
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 197 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 251
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 252 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 288

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 76
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 194
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 195 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 249
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 250 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 286

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 70
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 188
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 189 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 243
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 244 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 280

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 133/276 (48%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI +E++  G++  Y+RE  R +++  ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 175 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 226
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 190
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 191 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 133/276 (48%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
           +SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 59
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI +E++  G++  Y+RE  R ++   ++ 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 180 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 231
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 232 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 116/232 (50%), Gaps = 34/232 (14%)
Query: 342 MEKPSASPK---KSQWQKGKLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKS 394
           M  P++ P    K   +K + +G G FG V    Y  TN  TG   A+K +         
Sbjct: 1   MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------K 52
Query: 395 AECIKQ----LEQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREH 448
           A+C  Q     +QEI +L  L HE+I++Y G   +  +  L + +EYV  GS+  Y+  H
Sbjct: 53  ADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH 112
Query: 449 CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TG 507
              + + ++  F + I  G+AYLH+ + IHR++   N+L+D   +VK+ DFG+AK +  G
Sbjct: 113 SIGLAQLLL--FAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEG 170
Query: 508 LSYELSLKGSPN---WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
             Y    +   +   W APE +K         K   A D+WS G T+ E+LT
Sbjct: 171 HEYYRVREDGDSPVFWYAPECLKEY-------KFYYASDVWSFGVTLYELLT 215

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 206
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 207 QT------VDIWSVGCIMAELLTGR 225

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT-- 190
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 191 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 39/281 (13%)
Query: 338 MPHIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIP 389
           +P +  KP    +K  W+         K +G G FG V++ T N+ T    A+K +    
Sbjct: 161 VPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTMK--- 215
Query: 390 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--E 447
             P S   ++    E  V+  L+H+ +V+ +   V  + +YI  E++  GS+  +++  E
Sbjct: 216 --PGSM-SVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDE 271
Query: 448 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 507
             +     ++ +F+  I  G+A++   N IHRD++ AN+LV AS V K+ADFG+A+    
Sbjct: 272 GSKQPLPKLI-DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR---- 326
Query: 508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 566
               +  K    W APE I             +  D+WS G  ++E++T G+ P+     
Sbjct: 327 ----VGAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 375
Query: 567 PQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPS 605
           P+ + + L R    P PE    E  + ++RC+   P ERP+
Sbjct: 376 PEVI-RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 415

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 147 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 203
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 204 QT------VDIWSVGCIMAELLTGR 222

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNAMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 116/229 (50%), Gaps = 39/229 (17%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S+++K   IG+GTFG V+   +R+TG   A+K+V  + ++ K    I  L +EIK+L  L
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQLL 74
Query: 412 KHENIVQYY--------------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 457
           KHEN+V                 GS  +   ++ + E+   G ++  + +     T S +
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYL---VFDFCEHDLAGLLSNVLVK----FTLSEI 127
Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 517
           +   + +LNGL Y+H    +HRD+K AN+L+   GV+KLADFG+A+     ++ L+    
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-----AFSLAKNSQ 182
Query: 518 PNWMAPEVIKAVMQKDGNPKLALA-------VDIWSLGCTVIEMLTGKP 559
           PN     V+    +    P+L L        +D+W  GC + EM T  P
Sbjct: 183 PNRYXNRVVTLWYRP---PELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 126/252 (50%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI +EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-------YG 190
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 249
Query: 594 RCFLRNPVERPS 605
           +C+ ++P ERP+
Sbjct: 250 QCWRKDPEERPT 261

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLGHLKHENIVQ 418
           IG G++G       +  G     KE+D         E  KQ L  E+ +L  LKH NIV+
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDY----GSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 419 YYGSEVVD---DHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLH 472
           YY   ++D     LYI +EY   G +   + +  ++   + E  V      +   L   H
Sbjct: 70  YY-DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 473 STN-----TIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVI 526
             +      +HRD+K AN+ +D    VKL DFG+A+ L    S+  +  G+P +M+PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLS 585
             +   + +       DIWSLGC + E+    PP++ F   +   K+   +   IP   S
Sbjct: 189 NRMSYNEKS-------DIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 586 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
            E  + + R        RPS  E+LE+P I
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 151 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 207
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 208 QT------VDIWSVGCIMAELLTGR 226

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 93/323 (28%), Positives = 143/323 (44%), Gaps = 83/323 (25%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S++   K +G G  G V+   + +     AIK+  I+  DP+S   +K   +EIK++  L
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQS---VKHALREIKIIRRL 65
Query: 412 KHENIVQYY------GSEVVDD--------HLYIYLEYVHPGSINRYVREHCRDITESIV 457
            H+NIV+ +      GS++ DD         +YI  EY+     N  V E    + E   
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN--VLEQG-PLLEEHA 122
Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV-KLADFGMAK-------HLTGLS 509
           R F   +L GL Y+HS N +HRD+K ANL ++   +V K+ DFG+A+       H   LS
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKPPWS 562
             L  K    W              +P+L L       A+D+W+ GC   EMLTGK  ++
Sbjct: 183 EGLVTK----WYR------------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226
Query: 563 EFEGPQAMFKVLNRTP---------------------------PIPEML---SSEGKDFL 592
                + M  +L   P                           P+ ++L   S E  DFL
Sbjct: 227 GAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFL 286
Query: 593 LRCFLRNPVERPSAVELLEHPFI 615
            +    +P++R +A E L HP++
Sbjct: 287 EQILTFSPMDRLTAEEALSHPYM 309

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLGHLKHENIVQ 418
           IG G++G       +  G     KE+D         E  KQ L  E+ +L  LKH NIV+
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDY----GSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 419 YYGSEVVD---DHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLH 472
           YY   ++D     LYI +EY   G +   + +  ++   + E  V      +   L   H
Sbjct: 70  YY-DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 473 STN-----TIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVI 526
             +      +HRD+K AN+ +D    VKL DFG+A+ L    S+  +  G+P +M+PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 188
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLS 585
             +   + +       DIWSLGC + E+    PP++ F   +   K+   +   IP   S
Sbjct: 189 NRMSYNEKS-------DIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 586 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
            E  + + R        RPS  E+LE+P I
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 338 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 397
           MPH + +PS          G+++G+G FG     T+RETG    +KE  +I  D ++   
Sbjct: 2   MPHRIFRPS------DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQ-- 51
Query: 398 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 457
            +   +E+KV+  L+H N++++ G    D  L    EY+  G++   ++        S  
Sbjct: 52  -RTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQR 110
Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-------GL-- 508
            +F + I +G+AYLHS N IHRD+   N LV  +  V +ADFG+A+ +        GL  
Sbjct: 111 VSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 509 ------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 555
                     ++ G+P WMAPE+I      +        VD++S G  + E++
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDE-------KVDVFSFGIVLCEII 216

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 125/255 (49%), Gaps = 20/255 (7%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G +G VY+G  ++   + A+K    + +D    E   +  +E  V+  +KH N+VQ 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 93
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIH 478
            G   ++   YI  EY+  G++  Y+RE  R+ +T  ++      I + + YL   N IH
Sbjct: 94  LGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIH 153
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD+   N LV  + VVK+ADFG+++ +TG +Y      K    W APE +          
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-------AYN 206
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLL 593
             ++  D+W+ G  + E+ T G  P+   +  Q ++ +L +   +  PE    +  + + 
Sbjct: 207 TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYDLLEKGYRMEQPEGCPPKVYELMR 265
Query: 594 RCFLRNPVERPSAVE 608
            C+  +P +RPS  E
Sbjct: 266 ACWKWSPADRPSFAE 280

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 23/264 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQEIKVLGHLKHENIVQ 418
           IGRG++G V I   + T    A K++      PK   E + + +QEI+++  L H NI++
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKI------PKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
            Y +   +  +Y+ +E    G +   V  H R   ES      + +L+ +AY H  N  H
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCHKLNVAH 129
Query: 479 RDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
           RD+K  N L         +KL DFG+A          +  G+P +++P+V++ +   +  
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPE-- 187
Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM----LSSEGKDF 591
                  D WS G  +  +L G PP+S     + M K+   T   PE     +S + +  
Sbjct: 188 ------CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 592 LLRCFLRNPVERPSAVELLEHPFI 615
           + R   ++P +R ++++ LEH + 
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWF 265

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYN 208
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 209 QT------VDIWSVGCIMAELLTGR 227

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 136/278 (48%), Gaps = 29/278 (10%)
Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           +S +Q  + +G+G F  V        G   A K   II     SA   ++LE+E ++   
Sbjct: 21  QSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAK---IINTKKLSARDHQKLEREARICRL 77
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGL 468
           LKH NIV+ + S   + H Y+  + V  G +  +   RE+    +E+   +  + IL  +
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAV 134
Query: 469 AYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYE-LSLKGSPNWMAPE 524
            + H    +HRD+K  NLL+ +      VKLADFG+A  + G         G+P +++PE
Sbjct: 135 LHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 194
Query: 525 VIKAVMQKD--GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---P 579
           V++    KD  G P     VD+W+ G  +  +L G PP+ + E    +++ +       P
Sbjct: 195 VLR----KDPYGKP-----VDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFP 244
Query: 580 IPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
            PE   ++ E KD + +    NP +R +A E L+HP+I
Sbjct: 245 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 128/256 (50%), Gaps = 26/256 (10%)
Query: 358 KLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           K +G G FG V++ T N+ T    A+K +      P S   ++    E  V+  L+H+ +
Sbjct: 21  KKLGAGQFGEVWMATYNKHT--KVAVKTMK-----PGSM-SVEAFLAEANVMKTLQHDKL 72
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHST 474
           V+ +   V  + +YI  E++  GS+  +++  E  +     ++ +F+  I  G+A++   
Sbjct: 73  VKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-DFSAQIAEGMAFIEQR 130
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQK 532
           N IHRD++ AN+LV AS V K+ADFG+A+ +    Y      K    W APE I      
Sbjct: 131 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF---- 186
Query: 533 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGK 589
                  +  D+WS G  ++E++T G+ P+     P+ + + L R    P PE    E  
Sbjct: 187 ---GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMPRPENCPEELY 242
Query: 590 DFLLRCFLRNPVERPS 605
           + ++RC+   P ERP+
Sbjct: 243 NIMMRCWKNRPEERPT 258

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 39/282 (13%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENIVQ 418
           +G G +G+V    +  TGA  AIK++      P  +E   K+  +E+++L H++HEN++ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 419 ----YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
               +   E +DD    YL     G+    + +H + + E  ++     +L GL Y+H+ 
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIHAA 147
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
             IHRD+K  NL V+    +K+ DFG+A+       E+       W  APEVI   M   
Sbjct: 148 GIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMXGXVVTRWYRAPEVILNWM--- 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP---IPEMLSSE 587
              +    VDIWS+GC + EM+TGK  +      +  + + KV   TPP   +  + S E
Sbjct: 202 ---RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG-TPPAEFVQRLQSDE 257
Query: 588 GKDFL----------LRCFLRNPVERPSAVELLEHPFIRNAN 619
            K+++              L N    P AV LLE   + +A 
Sbjct: 258 AKNYMKGLPELEKKDFASILTNA--SPLAVNLLEKMLVLDAE 297

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 127/273 (46%), Gaps = 33/273 (12%)
Query: 360 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++    N        +  V  + D   +A   K  ++E ++L +L+HE+IV
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 80
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------------ITESIVRNFTR 462
           ++YG     D L +  EY+  G +N+++R H  D               +  S + +   
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---- 518
            I +G+ YL S + +HRD+   N LV A+ +VK+ DFGM++ +    Y   + G      
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPI 199
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-R 576
            WM PE   ++M +    K     D+WS G  + E+ T GK PW +    + +  +   R
Sbjct: 200 RWMPPE---SIMYR----KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
Query: 577 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
               P +   E  D +L C+ R P +R +  E+
Sbjct: 253 VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 23/264 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQEIKVLGHLKHENIVQ 418
           IGRG++G V I   + T    A K++      PK   E + + +QEI+++  L H NI++
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKI------PKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
            Y +   +  +Y+ +E    G +   V  H R   ES      + +L+ +AY H  N  H
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCHKLNVAH 146
Query: 479 RDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
           RD+K  N L         +KL DFG+A          +  G+P +++P+V++ +   +  
Sbjct: 147 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPE-- 204
Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM----LSSEGKDF 591
                  D WS G  +  +L G PP+S     + M K+   T   PE     +S + +  
Sbjct: 205 ------CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 258
Query: 592 LLRCFLRNPVERPSAVELLEHPFI 615
           + R   ++P +R ++++ LEH + 
Sbjct: 259 IRRLLTKSPKQRITSLQALEHEWF 282

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKK---LSKPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 213
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 214 QT------VDIWSVGCIMAELLTGR 232

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 115/226 (50%), Gaps = 33/226 (14%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S+++K   IG+GTFG V+   +R+TG   A+K+V  + ++ K    I  L +EIK+L  L
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQLL 74
Query: 412 KHENIVQ-----------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           KHEN+V            Y   +     ++ + E+   G ++  + +     T S ++  
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRV 130
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 520
            + +LNGL Y+H    +HRD+K AN+L+   GV+KLADFG+A+     ++ L+    PN 
Sbjct: 131 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-----AFSLAKNSQPNR 185
Query: 521 MAPEVIKAVMQKDGNPKLALA-------VDIWSLGCTVIEMLTGKP 559
               V+    +    P+L L        +D+W  GC + EM T  P
Sbjct: 186 YXNRVVTLWYRP---PELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 133/276 (48%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
           +SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 59
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R +++  ++ 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 119
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 180 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 231
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 232 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 206
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 207 QT------VDIWSVGCIMAELLTGR 225

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYN 208
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 209 QT------VDIWSVGCIMAELLTGR 227

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/325 (26%), Positives = 135/325 (41%), Gaps = 72/325 (22%)
Query: 342 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS-CAIKEVDI-IPDDPKSAECIK 399
           MEK        Q++    IG G +G V+   + + G    A+K V +   ++      I+
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 400 QLEQEIKVLGHLK---HENIVQYYGS----------------EVVDDHLYIYLEYV-HPG 439
               E+ VL HL+   H N+V+ +                  E VD  L  YL+ V  PG
Sbjct: 61  ----EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG 116
Query: 440 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 499
                       +    +++    +L GL +LHS   +HRD+K  N+LV +SG +KLADF
Sbjct: 117 ------------VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164
Query: 500 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
           G+A+  +      S+  +  + APEV+            A  VD+WS+GC   EM   KP
Sbjct: 165 GLARIYSFQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKP 217
Query: 560 PWSEFEGPQAMFKVLN-----------RTPPIPEM----------------LSSEGKDFL 592
            +        + K+L+           R   +P                  +   GKD L
Sbjct: 218 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 277
Query: 593 LRCFLRNPVERPSAVELLEHPFIRN 617
           L+C   NP +R SA   L HP+ ++
Sbjct: 278 LKCLTFNPAKRISAYSALSHPYFQD 302

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 140/301 (46%), Gaps = 35/301 (11%)
Query: 344 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQL 401
           K S+S     +   ++IGRG++  V +   ++T    A++ V  +++ DD    E I  +
Sbjct: 44  KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD----EDIDWV 99
Query: 402 EQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           + E  V      H  +V  +     +  L+  +EYV+ G +  +++   R + E   R +
Sbjct: 100 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFY 158
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELSLKGS 517
           +  I   L YLH    I+RD+K  N+L+D+ G +KL D+GM K   GL       +  G+
Sbjct: 159 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGT 216
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS--------EFEGPQA 569
           PN++APE+++             +VD W+LG  + EM+ G+ P+         +      
Sbjct: 217 PNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269
Query: 570 MFKV-LNRTPPIPEMLSSEGKDFLLRCFLRNPVER------PSAVELLEHPFIRNANYQN 622
           +F+V L +   IP  LS +    L     ++P ER          ++  HPF RN ++  
Sbjct: 270 LFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 329
Query: 623 L 623
           +
Sbjct: 330 M 330

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 97
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 155
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 156 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 212
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 213 QT------VDIWSVGCIMAELLTGR 231

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYN 208
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 209 QT------VDIWSVGCIMAELLTGR 227

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGXVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +E++  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP-NWMAPEVIKAV 529
              IHRD+   N+LV+    VK+ DFG+ K L        +K    SP  W APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 193
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 194 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 248
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 249 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 140/301 (46%), Gaps = 35/301 (11%)
Query: 344 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQL 401
           K S+S     +   ++IGRG++  V +   ++T    A+K V  +++ DD    E I  +
Sbjct: 12  KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWV 67
Query: 402 EQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           + E  V      H  +V  +     +  L+  +EYV+ G +  +++   R + E   R +
Sbjct: 68  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFY 126
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELSLKGS 517
           +  I   L YLH    I+RD+K  N+L+D+ G +KL D+GM K   GL          G+
Sbjct: 127 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXFCGT 184
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS--------EFEGPQA 569
           PN++APE+++             +VD W+LG  + EM+ G+ P+         +      
Sbjct: 185 PNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 237
Query: 570 MFKV-LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV------ELLEHPFIRNANYQN 622
           +F+V L +   IP  +S +    L     ++P ER   +      ++  HPF RN ++  
Sbjct: 238 LFQVILEKQIRIPRSMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDM 297
Query: 623 L 623
           +
Sbjct: 298 M 298

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 203
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 204 QT------VDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 203
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 204 QT------VDIWSVGCIMAELLTGR 222

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 207
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 208 QT------VDIWSVGCIMAELLTGR 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 203
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 204 QT------VDIWSVGCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 206
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 207 QT------VDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 85
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 86  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 143
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 144 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 200
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 201 QT------VDIWSVGCIMAELLTGR 219

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 132/276 (47%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R +++  ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 175 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 226
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 208
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 209 QT------VDIWSVGCIMAELLTGR 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 86/329 (26%), Positives = 156/329 (47%), Gaps = 23/329 (6%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   +   K+IGRG FG V +  ++ +    A+K +       +S       E++I    
Sbjct: 73  KAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 132
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
           +     +VQ + +   D +LY+ +EY+  G +   +  +  D+ E   + +T  ++  L 
Sbjct: 133 N--SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALD 188
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIK 527
            +HS   IHRD+K  N+L+D  G +KLADFG  M    TG+ +  +  G+P++++PEV+K
Sbjct: 189 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLK 248
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--PE--M 583
           +   + G+       D WS+G  + EML G  P+          K+++    +  PE   
Sbjct: 249 S---QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAE 305
Query: 584 LSSEGKDFLLRCFLRN---PVERPSAVELLEHPFIRNA--NYQNL---SVPMRVFSRINL 635
           +S   K+ L+  FL +    + R    E+ +HPF +N   N+ N+   + P+      ++
Sbjct: 306 ISKHAKN-LICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDI 364
Query: 636 GDKSHDQVERATRKTESLPDSPETRVRNR 664
              + D +E      E+ P  P+  V N+
Sbjct: 365 DSSNFDDIEDDKGDVETFP-IPKAFVGNQ 392

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 132/276 (47%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
           +SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 59
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 180 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 231
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 232 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 109
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 224
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 225 QT------VDIWSVGCIMAELLTGR 243

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 126/252 (50%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 75
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY++ GS+  +++ E  + +    + + +  I +G+AY+   N +H
Sbjct: 76  YAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVH 134
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-------YG 187
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 246
Query: 594 RCFLRNPVERPS 605
           +C+ + P ERP+
Sbjct: 247 QCWRKEPEERPT 258

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 213
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 214 QT------VDIWSVGCIMAELLTGR 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 207
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 208 QT------VDIWSVGCIMAELLTGR 226

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 213
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 214 QT------VDIWSVGCIMAELLTGR 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 97
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 155
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 156 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 212
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 213 QT------VDIWSVGCIMAELLTGR 231

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 83
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 141
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 198
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 199 QT------VDIWSVGCIMAELLTGR 217

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 125/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-------YG 190
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 249
Query: 594 RCFLRNPVERPS 605
           +C+ ++P ERP+
Sbjct: 250 QCWRKDPEERPT 261

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 132/276 (47%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 208 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 261
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R +++  ++ 
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 321
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
                I + + YL   N IHR++   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 322 YMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 382 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 433
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 31/220 (14%)
Query: 351 KSQWQKGKLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQL----E 402
           K   +K + +G G FG V    Y  TN  TG   A+K +           C  QL    +
Sbjct: 8   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------KEGCGPQLRSGWQ 59
Query: 403 QEIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           +EI++L  L HE+IV+Y G   +  +  + + +EYV  GS+  Y+  HC  + + ++  F
Sbjct: 60  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--F 117
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPN 519
            + I  G+AYLH+ + IHR +   N+L+D   +VK+ DFG+AK +  G  Y    +   +
Sbjct: 118 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 177
Query: 520 ---WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
              W APE +K         K   A D+WS G T+ E+LT
Sbjct: 178 PVFWYAPECLKEC-------KFYYASDVWSFGVTLYELLT 210

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 132/276 (47%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R +++  ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 175 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 226
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 84
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 85  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 142
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 143 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 199
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 200 QT------VDIWSVGCIMAELLTGR 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 197
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 198 QT------VDIWSVGCIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 207
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 208 QT------VDIWSVGCIMAELLTGR 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 105
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 106 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 220
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 221 QT------VDIWSVGCIMAELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 221
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 222 QT------VDIWSVGCIMAELLTGR 240

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 132/276 (47%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
           +SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 59
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 180 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 231
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 232 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 206
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 207 QT------VDIWSVGCIMAELLTGR 225

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G FG VY G  ++   + A+K    + +D    E   +  +E  V+  +KH N+VQ 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 72
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIH 478
            G    +   YI  E++  G++  Y+RE  R +++  ++      I + + YL   N IH
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD+   N LV  + +VK+ADFG+++ +TG   +     K    W APE +          
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-------AYN 185
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLL 593
           K ++  D+W+ G  + E+ T G  P+   + P  ++++L +   +  PE    +  + + 
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGID-PSQVYELLEKDYRMERPEGCPEKVYELMR 244
Query: 594 RCFLRNPVERPSAVEL 609
            C+  NP +RPS  E+
Sbjct: 245 ACWQWNPSDRPSFAEI 260

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 125/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-------YG 190
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 249
Query: 594 RCFLRNPVERPS 605
           +C+ ++P ERP+
Sbjct: 250 QCWRKDPEERPT 261

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 83
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 141
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 198
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 199 QT------VDIWSVGCIMAELLTGR 217

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 31/220 (14%)
Query: 351 KSQWQKGKLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQL----E 402
           K   +K + +G G FG V    Y  TN  TG   A+K +           C  QL    +
Sbjct: 7   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------KEGCGPQLRSGWQ 58
Query: 403 QEIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           +EI++L  L HE+IV+Y G   +  +  + + +EYV  GS+  Y+  HC  + + ++  F
Sbjct: 59  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--F 116
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPN 519
            + I  G+AYLH+ + IHR +   N+L+D   +VK+ DFG+AK +  G  Y    +   +
Sbjct: 117 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 176
Query: 520 ---WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
              W APE +K         K   A D+WS G T+ E+LT
Sbjct: 177 PVFWYAPECLKEC-------KFYYASDVWSFGVTLYELLT 209

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 96
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 97  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 154
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 155 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 211
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 212 QT------VDIWSVGCIMAELLTGR 230

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 116/229 (50%), Gaps = 39/229 (17%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S+++K   IG+GTFG V+   +R+TG   A+K+V  + ++ K    I  L +EIK+L  L
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQLL 73
Query: 412 KHENIVQYY--------------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 457
           KHEN+V                 GS  +   ++ + E+   G ++  + +     T S +
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYL---VFDFCEHDLAGLLSNVLVK----FTLSEI 126
Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 517
           +   + +LNGL Y+H    +HRD+K AN+L+   GV+KLADFG+A+     ++ L+    
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-----AFSLAKNSQ 181
Query: 518 PNWMAPEVIKAVMQKDGNPKLALA-------VDIWSLGCTVIEMLTGKP 559
           PN     V+    +    P+L L        +D+W  GC + EM T  P
Sbjct: 182 PNRYXNRVVTLWYRP---PELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G +G VY G  ++   + A+K    + +D    E   +  +E  V+  +KH N+VQ 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 72
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIH 478
            G    +   YI +E++  G++  Y+RE  R +++  ++      I + + YL   N IH
Sbjct: 73  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD+   N LV  + +VK+ADFG+++ +TG   +     K    W APE +          
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-------AYN 185
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLL 593
           K ++  D+W+ G  + E+ T G  P+   + P  ++++L +   +  PE    +  + + 
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGID-PSQVYELLEKDYRMERPEGCPEKVYELMR 244
Query: 594 RCFLRNPVERPSAVEL 609
            C+  NP +RPS  E+
Sbjct: 245 ACWQWNPSDRPSFAEI 260

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 221
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 222 QT------VDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ- 418
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 105
Query: 419 ---YYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 106 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 220
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 221 QT------VDIWSVGCIMAELLTGR 239

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 247 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 300
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 459
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R    ++V  
Sbjct: 301 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 360
Query: 460 F-TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
           +    I + + YL   N IHR++   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 361 YMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 420
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 421 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 472
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 473 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G +G VY G  ++   + A+K    + +D    E   +  +E  V+  +KH N+VQ 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 72
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIH 478
            G    +   YI  E++  G++  Y+RE  R +++  ++      I + + YL   N IH
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD+   N LV  + +VK+ADFG+++ +TG ++      K    W APE +          
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESL-------AYN 185
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLL 593
           K ++  D+W+ G  + E+ T G  P+   + P  ++++L +   +  PE    +  + + 
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGID-PSQVYELLEKDYRMERPEGCPEKVYELMR 244
Query: 594 RCFLRNPVERPSAVEL 609
            C+  NP +RPS  E+
Sbjct: 245 ACWQWNPSDRPSFAEI 260

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 348 SPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 400
           SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   +
Sbjct: 6   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---E 59
Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRN 459
             +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++  
Sbjct: 60  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 119
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGS 517
               I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K  
Sbjct: 120 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR 576
             W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L +
Sbjct: 180 IKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEK 231
Query: 577 TPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
              +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 131/277 (47%), Gaps = 39/277 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 73
Query: 416 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKG-SP-NWMAPEVIKAV 529
              IHR++   N+LV+    VK+ DFG+ K L      Y++   G SP  W APE +   
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE- 192
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL--- 574
                  K ++A D+WS G  + E+ T     K P +EF        +G   +F ++   
Sbjct: 193 ------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 246
Query: 575 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
             N   P P+    E    +  C+  N  +RPS  +L
Sbjct: 247 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 283

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 125/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 17  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 69
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 70  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 128
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-------YG 181
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 182 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 240
Query: 594 RCFLRNPVERPS 605
           +C+ ++P ERP+
Sbjct: 241 QCWRKDPEERPT 252

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 125/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI +EY+  G +  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-------YG 190
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 249
Query: 594 RCFLRNPVERPS 605
           +C+ ++P ERP+
Sbjct: 250 QCWRKDPEERPT 261

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 114
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 175 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 226
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 124/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 244
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 245 YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-------G 356
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 415
Query: 594 RCFLRNPVERPS 605
           +C+ + P ERP+
Sbjct: 416 QCWRKEPEERPT 427

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/325 (26%), Positives = 135/325 (41%), Gaps = 72/325 (22%)
Query: 342 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS-CAIKEVDI-IPDDPKSAECIK 399
           MEK        Q++    IG G +G V+   + + G    A+K V +   ++      I+
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 400 QLEQEIKVLGHLK---HENIVQYYGS----------------EVVDDHLYIYLEYV-HPG 439
               E+ VL HL+   H N+V+ +                  E VD  L  YL+ V  PG
Sbjct: 61  ----EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG 116
Query: 440 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 499
                       +    +++    +L GL +LHS   +HRD+K  N+LV +SG +KLADF
Sbjct: 117 ------------VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164
Query: 500 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
           G+A+  +      S+  +  + APEV+            A  VD+WS+GC   EM   KP
Sbjct: 165 GLARIYSFQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKP 217
Query: 560 PWSEFEGPQAMFKVLN-----------RTPPIPEM----------------LSSEGKDFL 592
            +        + K+L+           R   +P                  +   GKD L
Sbjct: 218 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 277
Query: 593 LRCFLRNPVERPSAVELLEHPFIRN 617
           L+C   NP +R SA   L HP+ ++
Sbjct: 278 LKCLTFNPAKRISAYSALSHPYFQD 302

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 348 SPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 400
           SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   +
Sbjct: 4   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---E 57
Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRN 459
             +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++  
Sbjct: 58  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 117
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGS 517
               I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K  
Sbjct: 118 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFP 177
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR 576
             W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L +
Sbjct: 178 IKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEK 229
Query: 577 TPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
              +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 230 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 124/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 244
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 245 YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-------G 356
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 415
Query: 594 RCFLRNPVERPS 605
           +C+ + P ERP+
Sbjct: 416 QCWRKEPEERPT 427

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 125/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 15  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 67
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 68  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 126
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-------YG 179
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 180 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 238
Query: 594 RCFLRNPVERPS 605
           +C+ ++P ERP+
Sbjct: 239 QCWRKDPEERPT 250

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 197
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 198 QT------VDIWSVGCIMAELLTGR 216

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 348 SPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 400
           SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   +
Sbjct: 3   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---E 56
Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRN 459
             +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++  
Sbjct: 57  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 116
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGS 517
               I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K  
Sbjct: 117 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFP 176
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR 576
             W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L +
Sbjct: 177 IKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEK 228
Query: 577 TPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
              +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 229 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 109
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E+    +  W  APE++   M  +
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMXGYVATRWYRAPEIMLNWMHYN 224
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 225 Q------TVDIWSVGCIMAELLTGR 243

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMAGFVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 348 SPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 400
           SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   +
Sbjct: 4   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---E 57
Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRN 459
             +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++  
Sbjct: 58  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 117
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGS 517
               I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K  
Sbjct: 118 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 177
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR 576
             W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L +
Sbjct: 178 IKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEK 229
Query: 577 TPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
              +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 230 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMAGFVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ- 418
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 419 ---YYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E+    +  W  APE++   M  +
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMXGXVATRWYRAPEIMLNWMHYN 221
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 222 QT------VDIWSVGCIMAELLTGR 240

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 126/252 (50%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI +EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +     +     K    W APE            
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL-------YG 190
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 249
Query: 594 RCFLRNPVERPS 605
           +C+ ++P ERP+
Sbjct: 250 QCWRKDPEERPT 261

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 116/229 (50%), Gaps = 39/229 (17%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S+++K   IG+GTFG V+   +R+TG   A+K+V  + ++ K    I  L +EIK+L  L
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQLL 74
Query: 412 KHENIVQYY--------------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 457
           KHEN+V                 GS  +   ++ + E+   G ++  + +     T S +
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYL---VFDFCEHDLAGLLSNVLVK----FTLSEI 127
Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 517
           +   + +LNGL Y+H    +HRD+K AN+L+   GV+KLADFG+A+     ++ L+    
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-----AFSLAKNSQ 182
Query: 518 PNWMAPEVIKAVMQKDGNPKLALA-------VDIWSLGCTVIEMLTGKP 559
           PN     V+    +    P+L L        +D+W  GC + EM T  P
Sbjct: 183 PNRYXNRVVTLWYRP---PELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 114
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 175 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 226
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 138/292 (47%), Gaps = 30/292 (10%)
Query: 339 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI 398
           P +  + S +    +++  +++G+G+FG V +  ++ TG  CA+K +       K+ +  
Sbjct: 19  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK-- 76
Query: 399 KQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESI 456
           + L +E+++L  L H NI++ Y  E  +D  Y YL  E    G +   +    R  +E  
Sbjct: 77  ESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVD 133
Query: 457 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELS 513
                R +L+G+ Y+H    +HRD+K  NLL+++      +++ DFG++ H         
Sbjct: 134 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 193
Query: 514 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV 573
             G+  ++APEV+     +          D+WS G  +  +L+G PP   F G    + +
Sbjct: 194 KIGTAYYIAPEVLHGTYDE--------KCDVWSTGVILYILLSGCPP---FNGANE-YDI 241
Query: 574 LNR------TPPIPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           L +      T  +P+   +S   KD + +     P  R SA + L+H +I+ 
Sbjct: 242 LKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 293

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 128/267 (47%), Gaps = 22/267 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G F  V    ++ TG   A K   II     SA   ++LE+E ++   L+H NIV+ 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 420 YGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           + S   +   Y+  + V  G +  +   RE     +E+   +  + IL  +AY HS   +
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 150
Query: 478 HRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           HR++K  NLL+ +      VKLADFG+A  +          G+P +++PEV+K    KD 
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK----KDP 206
Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGP-QAMFKVLNRTPPIPEM--LSSEGKD 590
             K    VDIW+ G  +  +L G PP W E +    A  K      P PE   ++ E K 
Sbjct: 207 YSK---PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263
Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRN 617
            +      NP +R +A + L+ P+I N
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICN 290

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 14  GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 67
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 68  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 127
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKG 516
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K 
Sbjct: 128 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 187
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 188 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 239
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 240 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 134/288 (46%), Gaps = 35/288 (12%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHL-KHE 414
           ++IGRG++  V +   ++T    A+K V  +++ DD    E I  ++ E  V      H 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 66
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +V  +     +  L+  +EYV+ G +  +++   R + E   R ++  I   L YLH  
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER 125
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELSLKGSPNWMAPEVIKAVMQ 531
             I+RD+K  N+L+D+ G +KL D+GM K   GL          G+PN++APE+++    
Sbjct: 126 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXFCGTPNYIAPEILRG--- 180
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWS--------EFEGPQAMFKV-LNRTPPIPE 582
                    +VD W+LG  + EM+ G+ P+         +      +F+V L +   IP 
Sbjct: 181 ----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 236
Query: 583 MLSSEGKDFLLRCFLRNPVER------PSAVELLEHPFIRNANYQNLS 624
            LS +    L     ++P ER          ++  HPF RN ++  + 
Sbjct: 237 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 284

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMAGFVATRWYRAPEIMLNWMHYN 197
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 198 QT------VDIWSVGCIMAELLTGR 216

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 24/289 (8%)
Query: 338 MPHIMEKP---SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS 394
           MP  +E P    A   +  +    ++G G F  V +  ++ T    AIK +     + K 
Sbjct: 1   MPGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE 60
Query: 395 AECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE 454
                 +E EI VL  +KH NIV          HLY+ ++ V  G +   + E     TE
Sbjct: 61  G----SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTE 115
Query: 455 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL---VDASGVVKLADFGMAKHLTGLSYE 511
                    +L+ + YLH    +HRD+K  NLL   +D    + ++DFG++K     S  
Sbjct: 116 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 175
Query: 512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 571
            +  G+P ++APEV+            + AVD WS+G     +L G PP+ + E    +F
Sbjct: 176 STACGTPGYVAPEVL-------AQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLF 227
Query: 572 KVLNRTP-----PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           + + +       P  + +S   KDF+     ++P +R +  + L+HP+I
Sbjct: 228 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 133/286 (46%), Gaps = 31/286 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHL-KHE 414
           ++IGRG++  V +   ++T    A+K V  +++ DD    E I  ++ E  V      H 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 70
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +V  +     +  L+  +EYV+ G +  +++   R + E   R ++  I   L YLH  
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER 129
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
             I+RD+K  N+L+D+ G +KL D+GM K  L          G+PN++APE+++      
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG----- 184
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWS--------EFEGPQAMFKV-LNRTPPIPEML 584
                  +VD W+LG  + EM+ G+ P+         +      +F+V L +   IP  L
Sbjct: 185 --EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242
Query: 585 SSEGKDFLLRCFLRNPVER------PSAVELLEHPFIRNANYQNLS 624
           S +    L     ++P ER          ++  HPF RN ++  + 
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 288

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 125/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  ++HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKIRHEKLVQL 78
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-------YG 190
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 249
Query: 594 RCFLRNPVERPS 605
           +C+ ++P ERP+
Sbjct: 250 QCWRKDPEERPT 261

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 134/324 (41%), Gaps = 72/324 (22%)
Query: 342 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS-CAIKEVDI-IPDDPKSAECIK 399
           MEK        Q++    IG G +G V+   + + G    A+K V +   ++      I+
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 400 QLEQEIKVLGHLK---HENIVQYYGS----------------EVVDDHLYIYLEYV-HPG 439
               E+ VL HL+   H N+V+ +                  E VD  L  YL+ V  PG
Sbjct: 61  ----EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG 116
Query: 440 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 499
                       +    +++    +L GL +LHS   +HRD+K  N+LV +SG +KLADF
Sbjct: 117 ------------VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164
Query: 500 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
           G+A+  +      S+  +  + APEV+            A  VD+WS+GC   EM   KP
Sbjct: 165 GLARIYSFQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKP 217
Query: 560 PWSEFEGPQAMFKVLN-----------RTPPIPEM----------------LSSEGKDFL 592
            +        + K+L+           R   +P                  +   GKD L
Sbjct: 218 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 277
Query: 593 LRCFLRNPVERPSAVELLEHPFIR 616
           L+C   NP +R SA   L HP+ +
Sbjct: 278 LKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 112/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ D+G+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDYGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 124/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 19  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 71
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 72  YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 130
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-------YG 183
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 184 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 242
Query: 594 RCFLRNPVERPS 605
           +C+ + P ERP+
Sbjct: 243 QCWRKEPEERPT 254

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G +G VY G  ++   + A+K    + +D    E   +  +E  V+  +KH N+VQ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 76
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIH 478
            G    +   YI  E++  G++  Y+RE  R ++   ++      I + + YL   N IH
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD+   N LV  + +VK+ADFG+++ +TG +Y      K    W APE +          
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-------AYN 189
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLL 593
           K ++  D+W+ G  + E+ T G  P+   +  Q ++++L +   +  PE    +  + + 
Sbjct: 190 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEKVYELMR 248
Query: 594 RCFLRNPVERPSAVEL 609
            C+  NP +RPS  E+
Sbjct: 249 ACWQWNPSDRPSFAEI 264

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 126/252 (50%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 75
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY++ GS+  +++ E  + +    + + +  I +G+AY+   N +H
Sbjct: 76  YAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVH 134
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    +      K    W APE            
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAAL-------YG 187
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 246
Query: 594 RCFLRNPVERPS 605
           +C+ + P ERP+
Sbjct: 247 QCWRKEPEERPT 258

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 124/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 244
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 245 YAV-VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-------G 356
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 415
Query: 594 RCFLRNPVERPS 605
           +C+ + P ERP+
Sbjct: 416 QCWRKEPEERPT 427

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 134/276 (48%), Gaps = 25/276 (9%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           ++G+G+FG V +   + T    A+K +    +I DD    EC    ++ + + G  K   
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALPG--KPPF 403
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           + Q +      D LY  +EYV+ G +  ++++  R   E     +   I  GL +L S  
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
            I+RD+K  N+++D+ G +K+ADFGM K     G++ +    G+P+++APE+I    Q  
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-XFCGTPDYIAPEII--AYQPY 519
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFL 592
           G      +VD W+ G  + EML G+ P+ E E    +F+ ++      P+ +S E     
Sbjct: 520 GK-----SVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 573
Query: 593 LRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
                ++P +R         ++ EH F R  +++ L
Sbjct: 574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 127/286 (44%), Gaps = 40/286 (13%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G GT+ +VY G ++ T    A+KE+ +  ++      I+    E+ +L  LKH NIV  
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 65
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           +     +  L +  EY+    + +Y+ +    I    V+ F   +L GLAY H    +HR
Sbjct: 66  HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 539
           D+K  NLL++  G +KLADFG+A+  +  +     +    W  P  I       G+   +
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL-----GSTDYS 179
Query: 540 LAVDIWSLGCTVIEMLTGKP--PWSEFEGP-QAMFKVLN----------------RTPPI 580
             +D+W +GC   EM TG+P  P S  E     +F++L                 +T   
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239
Query: 581 PEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           P+            L S+G D L +        R SA + ++HPF 
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+HS 
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CAKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 197
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 198 QT------VDIWSVGCIMAELLTGR 216

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 124/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNP 536
           RD+  AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-------YG 190
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 249
Query: 594 RCFLRNPVERPS 605
           +C+ ++P ERP+
Sbjct: 250 QCWRKDPEERPT 261

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 124/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 193 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGNMSPEA------FLQEAQVMKKLRHEKLVQL 245
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 246 YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 304
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+ + +    Y      K    W APE            
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALY-------G 357
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 358 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 416
Query: 594 RCFLRNPVERPS 605
           +C+ ++P ERP+
Sbjct: 417 QCWRKDPEERPT 428

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/218 (33%), Positives = 109/218 (50%), Gaps = 27/218 (12%)
Query: 351 KSQWQKGKLIGRGTFGSV----YIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQE 404
           K   +K + +G G FG V    Y  TN  TG   A+K +  D  P            +QE
Sbjct: 30  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG------WKQE 83
Query: 405 IKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 462
           I +L  L HE+I++Y G   +     L + +EYV  GS+  Y+  H   + + ++  F +
Sbjct: 84  IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQ 141
Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKG-SP- 518
            I  G+AYLH+ + IHRD+   N+L+D   +VK+ DFG+AK +      Y +   G SP 
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV 201
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
            W APE +K         K   A D+WS G T+ E+LT
Sbjct: 202 FWYAPECLKEY-------KFYYASDVWSFGVTLYELLT 232

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 20/282 (7%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G FG V+  T R TG + A K V + P +       + + +EI+ +  L+H  +V  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDK----ETVRKEIQTMSVLRHPTLVNL 113
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           + +   D+ + +  E++  G +   V +    ++E     + R +  GL ++H  N +H 
Sbjct: 114 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 173
Query: 480 DIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           D+K  N++     S  +KL DFG+  HL          G+  + APEV       +G P 
Sbjct: 174 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV------AEGKP- 226
Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV----LNRTPPIPEMLSSEGKDFLL 593
           +    D+WS+G     +L+G  P+      + +  V     N        +S +GKDF+ 
Sbjct: 227 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 286
Query: 594 RCFLRNPVERPSAVELLEHPFIR--NANYQNLSVPMRVFSRI 633
           +  L +P  R +  + LEHP++   NA  ++  +P   +++I
Sbjct: 287 KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 328

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 348 SPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 400
           SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   +
Sbjct: 3   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---E 56
Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRN 459
             +E  V+  +KH N+VQ  G    +   YI +E++  G++  Y+RE  R ++   ++  
Sbjct: 57  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLY 116
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGS 517
               I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG   +     K  
Sbjct: 117 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 176
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR 576
             W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L +
Sbjct: 177 IKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEK 228
Query: 577 TPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
              +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 229 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 133/275 (48%), Gaps = 13/275 (4%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K+IGRG FG V +   + T    A+K ++      ++     + E+++ V G  +    +
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
            Y   +  ++HLY+ ++Y   G +   + +    + E + R +   ++  +  +H  + +
Sbjct: 156 HYAFQD--ENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYV 213
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
           HRDIK  N+L+D +G ++LADFG    +   G        G+P++++PE+++A+  +DG 
Sbjct: 214 HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM--EDGM 271
Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-----RTPPIPEMLSSEGKD 590
            K     D WSLG  + EML G+ P+      +   K++N     + P     +S E KD
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 331
Query: 591 FLLR--CFLRNPVERPSAVELLEHPFIRNANYQNL 623
            + R  C     + +    +  +H F    N++N+
Sbjct: 332 LIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENI 366

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 128/267 (47%), Gaps = 22/267 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G F  V    ++ TG   A K   II     SA   ++LE+E ++   L+H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 420 YGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           + S   +   Y+  + V  G +  +   RE     +E+   +  + IL  +AY HS   +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 127
Query: 478 HRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           HR++K  NLL+ +      VKLADFG+A  +          G+P +++PEV+K    KD 
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK----KDP 183
Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGP-QAMFKVLNRTPPIPEM--LSSEGKD 590
             K    VDIW+ G  +  +L G PP W E +    A  K      P PE   ++ E K 
Sbjct: 184 YSK---PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRN 617
            +      NP +R +A + L+ P+I N
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICN 267

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 21/263 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHLKHE 414
           K+IG G FG VY G  +    S   KEV +     K+    KQ      E  ++G   H 
Sbjct: 50  KVIGAGEFGEVYKGMLK---TSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NI++  G       + I  EY+  G++++++RE   + +   +    R I  G+ YL + 
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG---LSYELSLKGSP-NWMAPEVIKAVM 530
           N +HRD+   N+LV+++ V K++DFG+++ L      +Y  S    P  W APE I    
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-- 224
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSE 587
                 K   A D+WS G  + E++T G+ P+ E    + M K +N     P P    S 
Sbjct: 225 -----RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-KAINDGFRLPTPMDCPSA 278
Query: 588 GKDFLLRCFLRNPVERPSAVELL 610
               +++C+ +    RP   +++
Sbjct: 279 IYQLMMQCWQQERARRPKFADIV 301

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 128/267 (47%), Gaps = 22/267 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G F  V    ++ TG   A K   II     SA   ++LE+E ++   L+H NIV+ 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 420 YGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           + S   +   Y+  + V  G +  +   RE     +E+   +  + IL  +AY HS   +
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 126
Query: 478 HRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           HR++K  NLL+ +      VKLADFG+A  +          G+P +++PEV+K    KD 
Sbjct: 127 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK----KDP 182
Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGP-QAMFKVLNRTPPIPEM--LSSEGKD 590
             K    VDIW+ G  +  +L G PP W E +    A  K      P PE   ++ E K 
Sbjct: 183 YSK---PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 239
Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRN 617
            +      NP +R +A + L+ P+I N
Sbjct: 240 LIDSMLTVNPKKRITADQALKVPWICN 266

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 124/252 (49%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ +YI  EY+  G +  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE            
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-------YG 190
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 249
Query: 594 RCFLRNPVERPS 605
           +C+ ++P ERP+
Sbjct: 250 QCWRKDPEERPT 261

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 134/274 (48%), Gaps = 35/274 (12%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLGHLKHENIVQ 418
           IGRG+F +VY G + ET    A  E+     D K  +  +Q  ++E + L  L+H NIV+
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCEL----QDRKLTKSERQRFKEEAEXLKGLQHPNIVR 89
Query: 419 YYGS--EVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           +Y S    V     I L  E    G++  Y++   +     ++R++ R IL GL +LH+ 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRF-KVXKIKVLRSWCRQILKGLQFLHTR 148
Query: 475 N--TIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
               IHRD+K  N+ +   +G VK+ D G+A  L   S+  ++ G+P + APE  +    
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFXAPEXYE---- 203
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPP-------IPEM 583
                K   +VD+++ G   +E  T + P+SE +    ++ +V +   P       IPE+
Sbjct: 204 ----EKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
                K+ +  C  +N  ER S  +LL H F + 
Sbjct: 260 -----KEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 20/282 (7%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G FG V+  T R TG + A K V + P +       + + +EI+ +  L+H  +V  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDK----ETVRKEIQTMSVLRHPTLVNL 219
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           + +   D+ + +  E++  G +   V +    ++E     + R +  GL ++H  N +H 
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 279
Query: 480 DIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           D+K  N++     S  +KL DFG+  HL          G+  + APEV       +G P 
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV------AEGKP- 332
Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV----LNRTPPIPEMLSSEGKDFLL 593
           +    D+WS+G     +L+G  P+      + +  V     N        +S +GKDF+ 
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392
Query: 594 RCFLRNPVERPSAVELLEHPFIR--NANYQNLSVPMRVFSRI 633
           +  L +P  R +  + LEHP++   NA  ++  +P   +++I
Sbjct: 393 KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 434

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 121/270 (44%), Gaps = 26/270 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLGHLKHENIVQ 418
           IG G++G       +  G     KE+D         E  KQ L  E+ +L  LKH NIV+
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDY----GSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 419 YYGSEVVD---DHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLH 472
           YY   ++D     LYI +EY   G +   + +  ++   + E  V      +   L   H
Sbjct: 70  YY-DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 473 STN-----TIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVI 526
             +      +HRD+K AN+ +D    VKL DFG+A+ L     +     G+P +M+PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM 188
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLS 585
             +   + +       DIWSLGC + E+    PP++ F   +   K+   +   IP   S
Sbjct: 189 NRMSYNEKS-------DIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 586 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
            E  + + R        RPS  E+LE+P I
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 128/267 (47%), Gaps = 22/267 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G F  V    ++ TG   A K   II     SA   ++LE+E ++   L+H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 420 YGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           + S   +   Y+  + V  G +  +   RE     +E+   +  + IL  +AY HS   +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 127
Query: 478 HRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           HR++K  NLL+ +      VKLADFG+A  +          G+P +++PEV+K    KD 
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK----KDP 183
Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGP-QAMFKVLNRTPPIPEM--LSSEGKD 590
             K    VDIW+ G  +  +L G PP W E +    A  K      P PE   ++ E K 
Sbjct: 184 YSK---PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRN 617
            +      NP +R +A + L+ P+I N
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICN 267

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 58/308 (18%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           +  +++K   +G G F +VY   ++ T    AIK++ +           +   +EIK+L 
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            L H NI+    +     ++ +  +++    +   ++++   +T S ++ +    L GL 
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---------- 519
           YLH    +HRD+K  NLL+D +GV+KLADFG+AK            GSPN          
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF----------GSPNRAYXHQVVTR 176
Query: 520 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLN 575
            + APE++       G     + VD+W++GC + E+L   P     S+ +    +F+ L 
Sbjct: 177 WYRAPELLF------GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230
Query: 576 RTP-----------------------PIPEMLSSEGKDFL---LRCFLRNPVERPSAVEL 609
            TP                       P+  + S+ G D L      FL NP  R +A + 
Sbjct: 231 -TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289
Query: 610 LEHPFIRN 617
           L+  +  N
Sbjct: 290 LKMKYFSN 297

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 32/272 (11%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 33  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 86
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 474
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 87  LLFMGYST-KPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 143
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS----YELSLKGSPNWMAPEVIKAVM 530
           + IHRD+K  N+ +     VK+ DFG+A   +  S    +E  L GS  WMAPEVI+   
Sbjct: 144 SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE-QLSGSILWMAPEVIRM-- 200
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS- 586
            +D NP  +   D+++ G  + E++TG+ P+S       +  ++ R   +P + ++ S+ 
Sbjct: 201 -QDKNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 258
Query: 587 --EGKDFLLRCFLRNPVERP------SAVELL 610
               K  +  C  +   ERP      +++ELL
Sbjct: 259 PKAMKRLMAECLKKKRDERPLFPQILASIELL 290

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 32/272 (11%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 41  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 94
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 474
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 95  LLFMGYST-KPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS----YELSLKGSPNWMAPEVIKAVM 530
           + IHRD+K  N+ +     VK+ DFG+A   +  S    +E  L GS  WMAPEVI+   
Sbjct: 152 SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE-QLSGSILWMAPEVIRM-- 208
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS- 586
            +D NP  +   D+++ G  + E++TG+ P+S       +  ++ R   +P + ++ S+ 
Sbjct: 209 -QDKNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 266
Query: 587 --EGKDFLLRCFLRNPVERP------SAVELL 610
               K  +  C  +   ERP      +++ELL
Sbjct: 267 PKAMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 133/275 (48%), Gaps = 13/275 (4%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K+IGRG FG V +   + T    A+K ++      ++     + E+++ V G  +    +
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
            Y   +  ++HLY+ ++Y   G +   + +    + E + R +   ++  +  +H  + +
Sbjct: 140 HYAFQD--ENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYV 197
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
           HRDIK  N+L+D +G ++LADFG    +   G        G+P++++PE+++A+  +DG 
Sbjct: 198 HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM--EDGM 255
Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-----RTPPIPEMLSSEGKD 590
            K     D WSLG  + EML G+ P+      +   K++N     + P     +S E KD
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 315
Query: 591 FLLR--CFLRNPVERPSAVELLEHPFIRNANYQNL 623
            + R  C     + +    +  +H F    N++N+
Sbjct: 316 LIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENI 350

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 132/263 (50%), Gaps = 29/263 (11%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +++GRG FG V     R      AIK+++       S    K    E++ L  + H NIV
Sbjct: 15  EVVGRGAFGVVCKAKWR--AKDVAIKQIE-------SESERKAFIVELRQLSRVNHPNIV 65
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTN 475
           + YG+ +  + + + +EY   GS+   +   E     T +   ++      G+AYLHS  
Sbjct: 66  KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 476 ---TIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
               IHRD+K  NLL+ A G V+K+ DFG A  +   ++  + KGS  WMAPEV +    
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEGSNY 181
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMFKVLNRT-PPIPEMLSSEG 588
            +         D++S G  + E++T + P+ E  GP  + M+ V N T PP+ + L    
Sbjct: 182 SE-------KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 234
Query: 589 KDFLLRCFLRNPVERPSAVELLE 611
           +  + RC+ ++P +RPS  E+++
Sbjct: 235 ESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 40  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 93
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 474
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 94  LLFMGYST-KPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 150
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           + IHRD+K  N+ +     VK+ DFG+A      +G      L GS  WMAPEVI+    
Sbjct: 151 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM--- 207
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS-- 586
           +D NP  +   D+++ G  + E++TG+ P+S       +  ++ R   +P + ++ S+  
Sbjct: 208 QDKNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 266
Query: 587 -EGKDFLLRCFLRNPVERP------SAVELL 610
              K  +  C  +   ERP      +++ELL
Sbjct: 267 KAMKRLMAECLKKKRDERPLFPQILASIELL 297

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  + +G+G F  V       TG   A K   II     SA   ++LE+E ++   LK
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAK---IINTKKLSARDHQKLEREARICRLLK 61
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAY 470
           H NIV+ + S   +   Y+  + V  G +  +   RE+    +E+   +  + IL  + +
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY---YSEADASHCIQQILESVNH 118
Query: 471 LHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYE-LSLKGSPNWMAPEVI 526
            H    +HRD+K  NLL+ +      VKLADFG+A  + G         G+P +++PEV+
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 527 KAVMQKD--GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIP 581
           +    KD  G P     VD+W+ G  +  +L G PP+ + E    +++ +       P P
Sbjct: 179 R----KDPYGKP-----VDMWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSP 228
Query: 582 EM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           E   ++ E KD + +    NP +R +A E L+HP+I
Sbjct: 229 EWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 41  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 94
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 474
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 95  LLFMGYST-KPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           + IHRD+K  N+ +     VK+ DFG+A      +G      L GS  WMAPEVI+    
Sbjct: 152 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR---M 208
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS-- 586
           +D NP  +   D+++ G  + E++TG+ P+S       +  ++ R   +P + ++ S+  
Sbjct: 209 QDKNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 267
Query: 587 -EGKDFLLRCFLRNPVERP------SAVELL 610
              K  +  C  +   ERP      +++ELL
Sbjct: 268 KAMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 132/263 (50%), Gaps = 29/263 (11%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +++GRG FG V     R      AIK+++       S    K    E++ L  + H NIV
Sbjct: 14  EVVGRGAFGVVCKAKWR--AKDVAIKQIE-------SESERKAFIVELRQLSRVNHPNIV 64
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTN 475
           + YG+ +  + + + +EY   GS+   +   E     T +   ++      G+AYLHS  
Sbjct: 65  KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 476 ---TIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
               IHRD+K  NLL+ A G V+K+ DFG A  +   ++  + KGS  WMAPEV +    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEGSNY 180
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMFKVLNRT-PPIPEMLSSEG 588
            +         D++S G  + E++T + P+ E  GP  + M+ V N T PP+ + L    
Sbjct: 181 SE-------KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 589 KDFLLRCFLRNPVERPSAVELLE 611
           +  + RC+ ++P +RPS  E+++
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 126/268 (47%), Gaps = 27/268 (10%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--LEQEIKVLGHLKHENI 416
           ++G G F  V +  ++ T    AIK +       K A   K+  +E EI VL  +KH NI
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI------AKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           V          HLY+ ++ V  G + +R V +     TE         +L+ + YLH   
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDAVKYLHDLG 136
Query: 476 TIHRDIKGANLL---VDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
            +HRD+K  NLL   +D    + ++DFG++K     S   +  G+P ++APEV+      
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL------ 190
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----PIPEMLSSE 587
                 + AVD WS+G     +L G PP+ + E    +F+ + +       P  + +S  
Sbjct: 191 -AQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 588 GKDFLLRCFLRNPVERPSAVELLEHPFI 615
            KDF+     ++P +R +  + L+HP+I
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 126/268 (47%), Gaps = 27/268 (10%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--LEQEIKVLGHLKHENI 416
           ++G G F  V +  ++ T    AIK +       K A   K+  +E EI VL  +KH NI
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI------AKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           V          HLY+ ++ V  G + +R V +     TE         +L+ + YLH   
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDAVKYLHDLG 136
Query: 476 TIHRDIKGANLL---VDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
            +HRD+K  NLL   +D    + ++DFG++K     S   +  G+P ++APEV+      
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL------ 190
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----PIPEMLSSE 587
                 + AVD WS+G     +L G PP+ + E    +F+ + +       P  + +S  
Sbjct: 191 -AQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 588 GKDFLLRCFLRNPVERPSAVELLEHPFI 615
            KDF+     ++P +R +  + L+HP+I
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 131/276 (47%), Gaps = 27/276 (9%)
Query: 347 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
           +SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 59
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKG 516
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG   +     K 
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF 179
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
              W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q ++++L 
Sbjct: 180 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 231
Query: 576 RTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           +   +  PE    +  + +  C+  NP +RPS  E+
Sbjct: 232 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 134/274 (48%), Gaps = 25/274 (9%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  + IG+G F  V       TG   A K   II     SA   ++LE+E ++   LK
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAK---IINTKKLSARDHQKLEREARICRLLK 61
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAY 470
           H NIV+ + S   +   Y+  + V  G +  +   RE+    +E+   +  + IL  + +
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLH 118
Query: 471 LHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVI 526
            H    +HRD+K  NLL+ +      VKLADFG+A  + G         G+P +++PEV+
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEM 583
           +   +  G P     VDIW+ G  +  +L G PP+ + E    +++ +       P PE 
Sbjct: 179 RK--EAYGKP-----VDIWACGVILYILLVGYPPFWD-EDQHKLYQQIKAGAYDFPSPEW 230
Query: 584 --LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
             ++ E K+ + +    NP +R +A E L+HP++
Sbjct: 231 DTVTPEAKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 150/323 (46%), Gaps = 62/323 (19%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   +++   +G G  G V    +R +G   A K + +   + K A    Q+ +E++VL 
Sbjct: 14  KDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHL---EIKPA-IRNQIIRELQVLH 69
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ ++E  R I E I+   +  +L GLA
Sbjct: 70  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLA 128
Query: 470 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL   + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++MAPE ++ 
Sbjct: 129 YLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMAPERLQG 187
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGK-----PPWSEFEG----------------- 566
                     ++  DIWS+G +++E+  G+     P   E E                  
Sbjct: 188 T-------HYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSI 240
Query: 567 --------------------PQAMFKVL----NRTPP-IPE-MLSSEGKDFLLRCFLRNP 600
                                 A+F++L    N  PP +P  + + + ++F+ +C ++NP
Sbjct: 241 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNP 300
Query: 601 VERPSAVELLEHPFIRNANYQNL 623
            ER     L  H FI+ +  + +
Sbjct: 301 AERADLKMLTNHTFIKRSEVEEV 323

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+  FG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILGFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 15  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 68
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 474
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 69  LLFMGYST-KPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 125
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           + IHRD+K  N+ +     VK+ DFG+A      +G      L GS  WMAPEVI+    
Sbjct: 126 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR---M 182
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS-- 586
           +D NP  +   D+++ G  + E++TG+ P+S       +  ++ R   +P + ++ S+  
Sbjct: 183 QDKNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 241
Query: 587 -EGKDFLLRCFLRNPVERP------SAVELL 610
              K  +  C  +   ERP      +++ELL
Sbjct: 242 KAMKRLMAECLKKKRDERPLFPQILASIELL 272

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/317 (24%), Positives = 132/317 (41%), Gaps = 22/317 (6%)
Query: 360 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           RD+   NLL+    +VK+ DFG+ + L         +   K    W APE +K       
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK------- 191
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGKDF 591
               + A D W  G T+ EM T G+ PW    G Q + K+       P PE    +  + 
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 251
Query: 592 LLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTE 651
           +++C+   P +RP+ V L      R+   +     MR        DK H Q+       E
Sbjct: 252 MVQCWAHKPEDRPTFVAL------RDFLLEAQPTDMRALQDFEEPDKLHIQMNDVITVIE 305
Query: 652 SLPDSPETRVRNRKLPC 668
              ++   R +N +  C
Sbjct: 306 GRAENYWWRGQNTRTLC 322

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 18  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 71
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 474
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 72  LLFMGYST-KPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           + IHRD+K  N+ +     VK+ DFG+A      +G      L GS  WMAPEVI+    
Sbjct: 129 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR---M 185
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS-- 586
           +D NP  +   D+++ G  + E++TG+ P+S       +  ++ R   +P + ++ S+  
Sbjct: 186 QDKNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 244
Query: 587 -EGKDFLLRCFLRNPVERP------SAVELL 610
              K  +  C  +   ERP      +++ELL
Sbjct: 245 KAMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 18  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 71
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 474
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 72  LLFMGYST-KPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           + IHRD+K  N+ +     VK+ DFG+A      +G      L GS  WMAPEVI+    
Sbjct: 129 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR---M 185
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS-- 586
           +D NP  +   D+++ G  + E++TG+ P+S       +  ++ R   +P + ++ S+  
Sbjct: 186 QDKNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 244
Query: 587 -EGKDFLLRCFLRNPVERP------SAVELL 610
              K  +  C  +   ERP      +++ELL
Sbjct: 245 KAMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 126/268 (47%), Gaps = 27/268 (10%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--LEQEIKVLGHLKHENI 416
           ++G G F  V +  ++ T    AIK +       K A   K+  +E EI VL  +KH NI
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI------AKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           V          HLY+ ++ V  G + +R V +     TE         +L+ + YLH   
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDAVKYLHDLG 136
Query: 476 TIHRDIKGANLL---VDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
            +HRD+K  NLL   +D    + ++DFG++K     S   +  G+P ++APEV+      
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL------ 190
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----PIPEMLSSE 587
                 + AVD WS+G     +L G PP+ + E    +F+ + +       P  + +S  
Sbjct: 191 -AQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 588 GKDFLLRCFLRNPVERPSAVELLEHPFI 615
            KDF+     ++P +R +  + L+HP+I
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DF +A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFYLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 32/272 (11%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 66
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 474
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 67  LLFMGYST-KPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS----YELSLKGSPNWMAPEVIKAVM 530
           + IHRD+K  N+ +     VK+ DFG+A   +  S    +E  L GS  WMAPEVI+   
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE-QLSGSILWMAPEVIR--- 179
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS- 586
            +D NP  +   D+++ G  + E++TG+ P+S       +  ++ R   +P + ++ S+ 
Sbjct: 180 MQDKNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 587 --EGKDFLLRCFLRNPVERP------SAVELL 610
               K  +  C  +   ERP      +++ELL
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 20/222 (9%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G   G G FG VY G    T  + A+K++  + D   + E  +Q +QEIKV    +HEN+
Sbjct: 27  GNKXGEGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQEIKVXAKCQHENL 83
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN----FTRHILNGLAYLH 472
           V+  G     D L +   Y   GS+    R  C D T  +  +      +   NG+ +LH
Sbjct: 84  VELLGFSSDGDDLCLVYVYXPNGSL--LDRLSCLDGTPPLSWHXRCKIAQGAANGINFLH 141
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS---LKGSPNWMAPEVIKAV 529
             + IHRDIK AN+L+D +   K++DFG+A+     +  +    + G+  + APE ++  
Sbjct: 142 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGE 201
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 571
           +     PK     DI+S G  ++E++TG P   E   PQ + 
Sbjct: 202 I----TPK----SDIYSFGVVLLEIITGLPAVDEHREPQLLL 235

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ D G+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDAGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  + +G+G F  V       TG   A K   II     SA   ++LE+E ++   LK
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAK---IINTKKLSARDHQKLEREARICRLLK 61
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAY 470
           H NIV+ + S   +   Y+  + V  G +  +   RE+    +E+   +  + IL  + +
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY---YSEADASHCIQQILESVNH 118
Query: 471 LHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYE-LSLKGSPNWMAPEVI 526
            H    +HRD+K  NLL+ +      VKLADFG+A  + G         G+P +++PEV+
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 527 KAVMQKD--GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIP 581
           +    KD  G P     VD+W+ G  +  +L G PP+ + E    +++ +       P P
Sbjct: 179 R----KDPYGKP-----VDMWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSP 228
Query: 582 EM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           E   ++ E KD + +    NP +R +A E L+HP+I
Sbjct: 229 EWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 134/311 (43%), Gaps = 65/311 (20%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           IG+G++G V +    +T A  AIK ++   I   +PK  E IK    E++++  L H NI
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT---EVRLMKKLHHPNI 90
Query: 417 VQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDIT--------------------- 453
            + Y  EV +D  YI L  E  H G +   +     D T                     
Sbjct: 91  ARLY--EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 454 ------------------ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL--VDASGV 493
                             E ++ N  R I + L YLH+    HRDIK  N L   + S  
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208
Query: 494 VKLADFGMAKHLTGLS----YELSLK-GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLG 548
           +KL DFG++K    L+    Y ++ K G+P ++APEV+    +  G PK     D WS G
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG-PK----CDAWSAG 263
Query: 549 CTVIEMLTGKPPWSEFEGPQAMFKVLNRT----PPIPEMLSSEGKDFLLRCFLRNPVERP 604
             +  +L G  P+        + +VLN+      P   +LS   +D L     RN  ER 
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323
Query: 605 SAVELLEHPFI 615
            A+  L+HP+I
Sbjct: 324 DAMRALQHPWI 334

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+   + +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--XQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ D G+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDRGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 66
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 474
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 67  LLFMGYSTAP-QLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           + IHRD+K  N+ +     VK+ DFG+A      +G      L GS  WMAPEVI+    
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR---M 180
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS-- 586
           +D NP  +   D+++ G  + E++TG+ P+S       +  ++ R   +P + ++ S+  
Sbjct: 181 QDKNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 587 -EGKDFLLRCFLRNPVERP------SAVELL 610
              K  +  C  +   ERP      +++ELL
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 66
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 474
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 67  LLFMGYST-KPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           + IHRD+K  N+ +     VK+ DFG+A      +G      L GS  WMAPEVI+    
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR---M 180
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS-- 586
           +D NP  +   D+++ G  + E++TG+ P+S       +  ++ R   +P + ++ S+  
Sbjct: 181 QDKNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 587 -EGKDFLLRCFLRNPVERP------SAVELL 610
              K  +  C  +   ERP      +++ELL
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ D G+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDGGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENIVQ 418
           +G G +GSV    ++ +G   AIK++      P  +E   K+  +E+ +L H++HEN++ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS----RPFQSEIFAKRAYRELLLLKHMQHENVIG 105
Query: 419 YYGSEVVDDHLYIYLEY--VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
                     L  + ++  V P       +    + +E  ++     +L GL Y+HS   
Sbjct: 106 LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGV 165
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGN 535
           +HRD+K  NL V+    +K+ DFG+A+H      E++      W  APEVI + M  +  
Sbjct: 166 VHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQT 222
Query: 536 PKLALAVDIWSLGCTVIEMLTGK 558
                 VDIWS+GC + EMLTGK
Sbjct: 223 ------VDIWSVGCIMAEMLTGK 239

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 130/276 (47%), Gaps = 31/276 (11%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +Q+ K +G G +G V +  ++ T    AIK   II     S     +L +E+ VL  L H
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIK---IIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYL 471
            NI++ Y       + Y+ +E    G +   +  R    ++  +++    + +L+G+ YL
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI---IKQVLSGVTYL 152
Query: 472 HSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           H  N +HRD+K  NLL+++     ++K+ DFG++             G+  ++APEV++ 
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR- 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------TPPIPE 582
                   K     D+WS+G  +  +L G PP+    G Q   ++L +      T   PE
Sbjct: 212 -------KKYDEKCDVWSIGVILFILLAGYPPF----GGQTDQEILRKVEKGKYTFDSPE 260
Query: 583 M--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
              +S   KD + +    +   R SA + LEHP+I+
Sbjct: 261 WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 131/263 (49%), Gaps = 14/263 (5%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +GRG +G V    +  +G   A+K +    +  +    +  L+   + +        V +
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTV---DCPFTVTF 98
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHS-TN 475
           YG+   +  ++I  E +   S++++   V +  + I E I+      I+  L +LHS  +
Sbjct: 99  YGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 157
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
            IHRD+K +N+L++A G VK  DFG++ +L     +    G   + APE I   + + G 
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKG- 216
Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR-TPPIP-EMLSSEGKDFL 592
              ++  DIWSLG T IE+   + P+  +  P Q + +V+   +P +P +  S+E  DF 
Sbjct: 217 --YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 274
Query: 593 LRCFLRNPVERPSAVELLEHPFI 615
            +C  +N  ERP+  EL +HPF 
Sbjct: 275 SQCLKKNSKERPTYPELXQHPFF 297

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 135/312 (43%), Gaps = 70/312 (22%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           ++  +   K+IG G+FG V+     E+    AIK+V          +  +   +E++++ 
Sbjct: 38  REIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKV---------LQDKRFKNRELQIMR 87
Query: 410 HLKHENIVQ----YYGSEVVDDHLYI--YLEYVHPGSINRYVREHCR---DITESIVRNF 460
            +KH N+V     +Y +    D +++   LEYV P ++ R  R + +    +   +++ +
Sbjct: 88  IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLY 146
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSPN 519
              +L  LAY+HS    HRDIK  NLL+D  SGV+KL DFG AK L      +S   S  
Sbjct: 147 MYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY 206
Query: 520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---- 575
           + APE+I        N      +DIWS GC + E++ G+P +    G   + +++     
Sbjct: 207 YRAPELIFGATNYTTN------IDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260
Query: 576 --------------------------------RTPPIPEMLSSEGKDFLLRCFLRNPVER 603
                                           RTPP       +  D + R     P  R
Sbjct: 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPP-------DAIDLISRLLEYTPSAR 313
Query: 604 PSAVELLEHPFI 615
            +A+E L HPF 
Sbjct: 314 LTAIEALCHPFF 325

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+   + +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX--QKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 QT------VDIWSVGCIMAELLTGR 220

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 134/276 (48%), Gaps = 29/276 (10%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  + +G+G F  V        G   A     II     SA   ++LE+E ++   LK
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAM---IINTKKLSARDHQKLEREARICRLLK 68
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAY 470
           H NIV+ + S   + H Y+  + V  G +  +   RE+    +E+   +  + IL  + +
Sbjct: 69  HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLH 125
Query: 471 LHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYE-LSLKGSPNWMAPEVI 526
            H    +HR++K  NLL+ +      VKLADFG+A  + G         G+P +++PEV+
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 527 KAVMQKD--GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIP 581
           +    KD  G P     VD+W+ G  +  +L G PP+ + E    +++ +       P P
Sbjct: 186 R----KDPYGKP-----VDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSP 235
Query: 582 EM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           E   ++ E KD + +    NP +R +A E L+HP+I
Sbjct: 236 EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 134/277 (48%), Gaps = 25/277 (9%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           ++G+G+FG V +   + T    A+K +    +I DD    EC    ++ + + G  K   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALPG--KPPF 82
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           + Q +      D LY  +EYV+ G +  ++++  R   E     +   I  GL +L S  
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKG 141
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
            I+RD+K  N+++D+ G +K+ADFGM K     G++ +    G+P+++APE+I    Q  
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-XFCGTPDYIAPEII--AYQPY 198
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFL 592
           G      +VD W+ G  + EML G+ P+ E E    +F+ ++      P+ +S E     
Sbjct: 199 GK-----SVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252
Query: 593 LRCFLRNPVER-----PSAVELLEHPFIRNANYQNLS 624
                ++P +R         ++ EH F R  +++ L 
Sbjct: 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE 289

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++  + IG G +G V     R TG   AIK+   IP+        K+  +E+K+L H K
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKK---IPNAFDVVTNAKRTLRELKILKHFK 112
Query: 413 HENIVQY---------YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
           H+NI+           YG       +Y+ L+ +   S    +    + +T   VR F   
Sbjct: 113 HDNIIAIKDILRPTVPYGEF---KSVYVVLDLME--SDLHQIIHSSQPLTLEHVRYFLYQ 167
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPN 519
           +L GL Y+HS   IHRD+K +NLLV+ +  +K+ DFGMA+ L        Y ++   +  
Sbjct: 168 LLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 520 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
           W  APE++ ++ +         A+D+WS+GC   EML 
Sbjct: 228 WYRAPELMLSLHE------YTQAIDLWSVGCIFGEMLA 259

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 137/298 (45%), Gaps = 41/298 (13%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKSAECI 398
           E P     + +   GK +G G FG V     +G +++         V ++ DD  + E +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEEDL 84
Query: 399 KQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EHCR 450
             L  E++++  + KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+  
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 451 DI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 502
           DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG+A
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 503 KHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
           + +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+ T
Sbjct: 205 RDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEIFT 254
Query: 557 -GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 255 LGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 134/273 (49%), Gaps = 23/273 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--EN 415
           K IG G    V+   N E     AIK V++   D ++ +  +    EI  L  L+   + 
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 117
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           I++ Y  E+ D ++Y+ +E    G+I  N ++++  + I     +++ +++L  +  +H 
Sbjct: 118 IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIKAVM 530
              +H D+K AN L+   G++KL DFG+A  +   T    + S  G+ N+M PE IK + 
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 531 QKDGN----PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NRTPPIPEM 583
               N     K++   D+WSLGC +  M  GK P+ +     +    +   N     P++
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
              + +D L  C  R+P +R S  ELL HP+++
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 72  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 131
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 132 DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 188
Query: 449 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 248
Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 249 LARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 298
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 299 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 134/273 (49%), Gaps = 23/273 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--EN 415
           K IG G    V+   N E     AIK V++   D ++ +  +    EI  L  L+   + 
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 117
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           I++ Y  E+ D ++Y+ +E    G+I  N ++++  + I     +++ +++L  +  +H 
Sbjct: 118 IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIKAVM 530
              +H D+K AN L+   G++KL DFG+A  +   T    + S  G+ N+M PE IK + 
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 531 QKDGN----PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NRTPPIPEM 583
               N     K++   D+WSLGC +  M  GK P+ +     +    +   N     P++
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
              + +D L  C  R+P +R S  ELL HP+++
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 126/269 (46%), Gaps = 20/269 (7%)
Query: 356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           K +++G G FG V+      TG   A K +       +  +  ++++ EI V+  L H N
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGMKDKEEVKNEISVMNQLDHAN 147
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           ++Q Y +    + + + +EYV  G +   + +   ++TE     F + I  G+ ++H   
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 476 TIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
            +H D+K  N+L    DA   +K+ DFG+A+            G+P ++APEV+      
Sbjct: 208 ILHLDLKPENILCVNRDAKQ-IKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDF-- 264
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM----LSSEG 588
                ++   D+WS+G     +L+G  P+      + +  +L     + +     +S E 
Sbjct: 265 -----VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319
Query: 589 KDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           K+F+ +  ++    R SA E L+HP++ +
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 449 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 202
Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 203 LARDINNIDY---YKNTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 252
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 253 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 110/205 (53%), Gaps = 20/205 (9%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 418 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  +++   +YL  ++    +N  V+   + +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--SQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
           + IHRD+K +NL V+    +K+ DFG+ +H      E++   +  W  APE++   M  +
Sbjct: 145 DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD---EMTGYVATRWYRAPEIMLNWMHYN 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGK 558
                   VDIWS+GC + E+LTG+
Sbjct: 202 Q------TVDIWSVGCIMAELLTGR 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENIVQ 418
           +G G +GSV    ++ +G   AIK++      P  +E   K+  +E+ +L H++HEN++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS----RPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 419 YYGSEVVDDHLYIYLEY--VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
                     L  + ++  V P       +      +E  ++     +L GL Y+HS   
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGV 147
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGN 535
           +HRD+K  NL V+    +K+ DFG+A+H      E++      W  APEVI + M  +  
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQT 204
Query: 536 PKLALAVDIWSLGCTVIEMLTGK 558
                 VDIWS+GC + EMLTGK
Sbjct: 205 ------VDIWSVGCIMAEMLTGK 221

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++  + IG G +G V     R TG   AIK+   IP+        K+  +E+K+L H K
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKK---IPNAFDVVTNAKRTLRELKILKHFK 111
Query: 413 HENIVQY---------YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
           H+NI+           YG       +Y+ L+ +   S    +    + +T   VR F   
Sbjct: 112 HDNIIAIKDILRPTVPYGEF---KSVYVVLDLME--SDLHQIIHSSQPLTLEHVRYFLYQ 166
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPN 519
           +L GL Y+HS   IHRD+K +NLLV+ +  +K+ DFGMA+ L        Y ++   +  
Sbjct: 167 LLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 520 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 558
           W  APE++ ++ +         A+D+WS+GC   EML  +
Sbjct: 227 WYRAPELMLSLHE------YTQAIDLWSVGCIFGEMLARR 260

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 134/273 (49%), Gaps = 23/273 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--EN 415
           K IG G    V+   N E     AIK V++   D ++ +  +    EI  L  L+   + 
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 117
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           I++ Y  E+ D ++Y+ +E    G+I  N ++++  + I     +++ +++L  +  +H 
Sbjct: 118 IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIKAVM 530
              +H D+K AN L+   G++KL DFG+A  +   T    + S  G+ N+M PE IK + 
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 531 QKDGN----PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NRTPPIPEM 583
               N     K++   D+WSLGC +  M  GK P+ +     +    +   N     P++
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
              + +D L  C  R+P +R S  ELL HP+++
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 145/308 (47%), Gaps = 31/308 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH---- 413
           K +GRG F  V    ++ TG   A K    +    +  +C  ++  EI VL   K     
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 414 ENIVQYY--GSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAY 470
            N+ + Y   SE++     + LEY   G I +  + E    ++E+ V    + IL G+ Y
Sbjct: 92  INLHEVYENTSEII-----LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 471 LHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVI 526
           LH  N +H D+K  N+L+ +    G +K+ DFGM++ + G + EL  + G+P ++APE++
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMGTPEYLAPEIL 205
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV----LNRTPPIPE 582
                 + +P +  A D+W++G     +LT   P+   +  +    +    ++ +     
Sbjct: 206 ------NYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQ 642
            +S    DF+    ++NP +RP+A   L H +++  +++NL  P    S     D S   
Sbjct: 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRS 318
Query: 643 VERATRKT 650
            E  T K+
Sbjct: 319 SEDKTSKS 326

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 449 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 202
Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 203 LARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 252
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 253 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/321 (25%), Positives = 144/321 (44%), Gaps = 50/321 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 449 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 202
Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  +      K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 203 LARDINNID---XXKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 252
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 253 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 612 H-----PFIRNANYQNLSVPM 627
                     N  Y +LS P+
Sbjct: 312 DLDRILTLTTNEEYLDLSQPL 332

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 15  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 74
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 75  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 131
Query: 449 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG
Sbjct: 132 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 191
Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 192 LARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 241
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 242 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 118/263 (44%), Gaps = 30/263 (11%)
Query: 358 KLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           K +G G FG V +G    +   A   IKE  +  D         +  QE + +  L H  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---------EFFQEAQTMMKLSHPK 64
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           +V++YG    +  +YI  EY+  G +  Y+R H + +  S +      +  G+A+L S  
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVMQKD 533
            IHRD+   N LVD    VK++DFGM +++    Y  S+  K    W APEV        
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF---- 180
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEMLSSE 587
              K +   D+W+ G  + E+ + GK P+  +   + + KV     L R    P + S  
Sbjct: 181 ---KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR----PHLASDT 233
Query: 588 GKDFLLRCFLRNPVERPSAVELL 610
               +  C+   P +RP+  +LL
Sbjct: 234 IYQIMYSCWHELPEKRPTFQQLL 256

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 449 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 202
Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 203 LARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 252
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 253 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 18  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 77
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 78  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 134
Query: 449 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG
Sbjct: 135 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 194
Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 195 LARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 244
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 245 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 13  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 72
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 73  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 129
Query: 449 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG
Sbjct: 130 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFG 189
Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 190 LARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 239
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 240 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 134/273 (49%), Gaps = 23/273 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--EN 415
           K IG G    V+   N E     AIK V++   D ++ +  +    EI  L  L+   + 
Sbjct: 15  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 70
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           I++ Y  E+ D ++Y+ +E    G+I  N ++++  + I     +++ +++L  +  +H 
Sbjct: 71  IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIKAVM 530
              +H D+K AN L+   G++KL DFG+A  +   T    + S  G+ N+M PE IK + 
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 531 QKDGN----PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NRTPPIPEM 583
               N     K++   D+WSLGC +  M  GK P+ +     +    +   N     P++
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
              + +D L  C  R+P +R S  ELL HP+++
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 122/253 (48%), Gaps = 20/253 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V++GT        AIK +      P+S        +E +++  LKH+ +V
Sbjct: 15  KRLGNGQFGEVWMGT-WNGNTKVAIKTLKPGTMSPES------FLEEAQIMKKLKHDKLV 67
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           Q Y   V ++ +YI  EY++ GS+  ++++   R +    + +    +  G+AY+   N 
Sbjct: 68  QLYAV-VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 126
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV    + K+ADFG+A+ +     +     K    W APE          
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALY------ 180
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKDFL 592
             +  +  D+WS G  + E++T G+ P+      + + +V      P P+       + +
Sbjct: 181 -GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 239
Query: 593 LRCFLRNPVERPS 605
           + C+ ++P ERP+
Sbjct: 240 IHCWKKDPEERPT 252

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 123/252 (48%), Gaps = 22/252 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 16  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 68
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y   V ++ + I  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 69  YAV-VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 127
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           RD++ AN+LV  + V K+ADFG+A+ +     +     K    W APE            
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL-------YG 180
Query: 537 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 593
           +  +  D+WS G  + E+ T G+ P+      + + +V    R P  PE   S   D + 
Sbjct: 181 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 239
Query: 594 RCFLRNPVERPS 605
           +C+ + P ERP+
Sbjct: 240 QCWRKEPEERPT 251

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 449 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+++ADFG
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFG 202
Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 203 LARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 252
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 253 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 131/275 (47%), Gaps = 13/275 (4%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K+IGRG FG V +   +      A+K ++      ++     + E+++ V G  K    +
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
            Y   +  D++LY+ ++Y   G +   + +    + E + R +   ++  +  +H  + +
Sbjct: 140 HYAFQD--DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
           HRDIK  N+L+D +G ++LADFG    L   G        G+P++++PE+++A+  + G 
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM--EGGK 255
Query: 536 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-----RTPPIPEMLSSEGKD 590
            +     D WSLG  + EML G+ P+      +   K++N     + P     +S   KD
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315
Query: 591 FLLR--CFLRNPVERPSAVELLEHPFIRNANYQNL 623
            + R  C   + + +    +  +HPF    ++ N+
Sbjct: 316 LIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 44/268 (16%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +GRG+FG V+   +++TG  CA+K+V +          + ++E+ +   G L    IV  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE---------VFRVEELVACAG-LSSPRIVPL 115
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           YG+      + I++E +  GS+ + +++  C  + E     +    L GL YLH+   +H
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 479 RDIKGANLLVDASGV-VKLADFGMAKHLT--GLSYEL----SLKGSPNWMAPEVIKAVMQ 531
            D+K  N+L+ + G    L DFG A  L   GL   L     + G+   MAPEV   VM 
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV---VMG 230
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGPQAM---------FKVLNRTPPIP 581
           K  + K    VDIWS  C ++ ML G  PW++ F GP  +          ++     P+ 
Sbjct: 231 KPCDAK----VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286
Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVEL 609
                EG    LR   + PV R SA+EL
Sbjct: 287 AQAIQEG----LR---KEPVHRASAMEL 307

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 134/273 (49%), Gaps = 23/273 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--EN 415
           K IG G    V+   N E     AIK V++   D ++ +  +    EI  L  L+   + 
Sbjct: 34  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 89
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           I++ Y  E+ D ++Y+ +E    G+I  N ++++  + I     +++ +++L  +  +H 
Sbjct: 90  IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIKAVM 530
              +H D+K AN L+   G++KL DFG+A  +   T    + S  G+ N+M PE IK + 
Sbjct: 146 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 531 QKDGN----PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NRTPPIPEM 583
               N     K++   D+WSLGC +  M  GK P+ +     +    +   N     P++
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
              + +D L  C  R+P +R S  ELL HP+++
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 132/283 (46%), Gaps = 27/283 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 410
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                 +  P L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 190 ------NYEP-LGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 239
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 622
                S+  KDF+ R  +++P +R +  + L+HP+I+  + Q 
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/321 (25%), Positives = 143/321 (44%), Gaps = 50/321 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E 
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEX 142
Query: 449 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 202
Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  +      K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 203 LARDINNID---XXKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 252
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 253 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 612 H-----PFIRNANYQNLSVPM 627
                     N  Y +LS P+
Sbjct: 312 DLDRILTLTTNEEYLDLSQPL 332

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 134/273 (49%), Gaps = 23/273 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--EN 415
           K IG G    V+   N E     AIK V++   D ++ +  +    EI  L  L+   + 
Sbjct: 18  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 73
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           I++ Y  E+ D ++Y+ +E    G+I  N ++++  + I     +++ +++L  +  +H 
Sbjct: 74  IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIKAVM 530
              +H D+K AN L+   G++KL DFG+A  +   T    + S  G+ N+M PE IK + 
Sbjct: 130 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 531 QKDGN----PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NRTPPIPEM 583
               N     K++   D+WSLGC +  M  GK P+ +     +    +   N     P++
Sbjct: 189 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 248
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
              + +D L  C  R+P +R S  ELL HP+++
Sbjct: 249 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 44/268 (16%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +GRG+FG V+   +++TG  CA+K+V +          + ++E+ +   G L    IV  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE---------VFRVEELVACAG-LSSPRIVPL 131
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           YG+      + I++E +  GS+ + +++  C  + E     +    L GL YLH+   +H
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILH 189
Query: 479 RDIKGANLLVDASGV-VKLADFGMAKHLT--GLSYEL----SLKGSPNWMAPEVIKAVMQ 531
            D+K  N+L+ + G    L DFG A  L   GL   L     + G+   MAPEV   VM 
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV---VMG 246
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGPQAM---------FKVLNRTPPIP 581
           K  + K    VDIWS  C ++ ML G  PW++ F GP  +          ++     P+ 
Sbjct: 247 KPCDAK----VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 302
Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVEL 609
                EG    LR   + PV R SA+EL
Sbjct: 303 AQAIQEG----LR---KEPVHRASAMEL 323

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 114/258 (44%), Gaps = 16/258 (6%)
Query: 360 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           RD+   NLL+    +VK+ DFG+ + L         +   K    W APE +K       
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK------- 197
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGKDF 591
               + A D W  G T+ EM T G+ PW    G Q + K+       P PE    +  + 
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 257
Query: 592 LLRCFLRNPVERPSAVEL 609
           +++C+   P +RP+ V L
Sbjct: 258 MVQCWAHKPEDRPTFVAL 275

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 114/258 (44%), Gaps = 16/258 (6%)
Query: 360 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           RD+   NLL+    +VK+ DFG+ + L         +   K    W APE +K       
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK------- 197
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGKDF 591
               + A D W  G T+ EM T G+ PW    G Q + K+       P PE    +  + 
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 257
Query: 592 LLRCFLRNPVERPSAVEL 609
           +++C+   P +RP+ V L
Sbjct: 258 MVQCWAHKPEDRPTFVAL 275

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 131/287 (45%), Gaps = 19/287 (6%)
Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           K+ +++ +++G+G FG V     R TG   A K+++      +  E +   E++I  L  
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEK 240
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLA 469
           +    +V    +    D L + L  ++ G +  ++    +    E+    +   I  GL 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
            LH    ++RD+K  N+L+D  G ++++D G+A H+          G+  +MAPEV+K  
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-- 358
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLS 585
                N +   + D W+LGC + EM+ G+ P+ + +      +V      +P    E  S
Sbjct: 359 -----NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS 413
Query: 586 SEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 627
            + +    +   ++P ER      SA E+ EHP  +  N++ L   M
Sbjct: 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGM 460

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 44/268 (16%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +GRG+FG V+   +++TG  CA+K+V +          + ++E+ +   G L    IV  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLE---------VFRVEELVACAG-LSSPRIVPL 129
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           YG+      + I++E +  GS+ + +++  C  + E     +    L GL YLH+   +H
Sbjct: 130 YGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILH 187
Query: 479 RDIKGANLLVDASGV-VKLADFGMAKHLT--GLSYEL----SLKGSPNWMAPEVIKAVMQ 531
            D+K  N+L+ + G    L DFG A  L   GL   L     + G+   MAPEV   VM 
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV---VMG 244
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGPQAM---------FKVLNRTPPIP 581
           K  + K    VDIWS  C ++ ML G  PW++ F GP  +          ++     P+ 
Sbjct: 245 KPCDAK----VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 300
Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVEL 609
                EG    LR   + PV R SA+EL
Sbjct: 301 AQAIQEG----LR---KEPVHRASAMEL 321

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 132/283 (46%), Gaps = 27/283 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 410
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIV 189
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                 +  P L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 190 ------NYEP-LGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 239
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 622
                S+  KDF+ R  +++P +R +  + L+HP+I+  + Q 
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 131/287 (45%), Gaps = 19/287 (6%)
Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           K+ +++ +++G+G FG V     R TG   A K+++      +  E +   E++I  L  
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEK 240
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLA 469
           +    +V    +    D L + L  ++ G +  ++    +    E+    +   I  GL 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
            LH    ++RD+K  N+L+D  G ++++D G+A H+          G+  +MAPEV+K  
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-- 358
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLS 585
                N +   + D W+LGC + EM+ G+ P+ + +      +V      +P    E  S
Sbjct: 359 -----NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS 413
Query: 586 SEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 627
            + +    +   ++P ER      SA E+ EHP  +  N++ L   M
Sbjct: 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGM 460

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 27/283 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 410
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                      L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 190 -------NYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 239
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 622
                S+  KDF+ R  +++P +R +  + L+HP+I+  + Q 
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 134/273 (49%), Gaps = 23/273 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--EN 415
           K IG G    V+   N E     AIK V++   D ++ +  +    EI  L  L+   + 
Sbjct: 14  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 69
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           I++ Y  E+ D ++Y+ +E    G+I  N ++++  + I     +++ +++L  +  +H 
Sbjct: 70  IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIKAVM 530
              +H D+K AN L+   G++KL DFG+A  +   T    + S  G+ N+M PE IK + 
Sbjct: 126 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 184
Query: 531 QKDGN----PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NRTPPIPEM 583
               N     K++   D+WSLGC +  M  GK P+ +     +    +   N     P++
Sbjct: 185 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 244
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
              + +D L  C  R+P +R S  ELL HP+++
Sbjct: 245 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 114/258 (44%), Gaps = 16/258 (6%)
Query: 360 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           RD+   NLL+    +VK+ DFG+ + L         +   K    W APE +K       
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK------- 191
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGKDF 591
               + A D W  G T+ EM T G+ PW    G Q + K+       P PE    +  + 
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 251
Query: 592 LLRCFLRNPVERPSAVEL 609
           +++C+   P +RP+ V L
Sbjct: 252 MVQCWAHKPEDRPTFVAL 269

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 27/283 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 410
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                      L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 190 -------NYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 239
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 622
                S+  KDF+ R  +++P +R +  + L+HP+I+  + Q 
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 114/258 (44%), Gaps = 16/258 (6%)
Query: 360 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           RD+   NLL+    +VK+ DFG+ + L         +   K    W APE +K       
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK------- 187
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGKDF 591
               + A D W  G T+ EM T G+ PW    G Q + K+       P PE    +  + 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 592 LLRCFLRNPVERPSAVEL 609
           +++C+   P +RP+ V L
Sbjct: 248 MVQCWAHKPEDRPTFVAL 265

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 27/283 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 410
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                      L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 190 -------NYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 239
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 622
                S+  KDF+ R  +++P +R +  + L+HP+I+  + Q 
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 114/258 (44%), Gaps = 16/258 (6%)
Query: 360 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           RD+   NLL+    +VK+ DFG+ + L         +   K    W APE +K       
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK------- 187
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGKDF 591
               + A D W  G T+ EM T G+ PW    G Q + K+       P PE    +  + 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 592 LLRCFLRNPVERPSAVEL 609
           +++C+   P +RP+ V L
Sbjct: 248 MVQCWAHKPEDRPTFVAL 265

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 33/289 (11%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +GRG    VY    + T    A+K +    D        K +  EI VL  L H NI++ 
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-------KIVRTEIGVLLRLSHPNIIKL 113
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTN 475
                    + + LE V  G +   + E      RD  +++     + IL  +AYLH   
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV-----KQILEAVAYLHENG 168
Query: 476 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
            +HRD+K  NLL         +K+ADFG++K +       ++ G+P + APE+++     
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY- 227
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLN----RTPPIPEMLSSE 587
              P+    VD+WS+G     +L G  P+ +  G Q MF ++LN       P  + +S  
Sbjct: 228 --GPE----VDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281
Query: 588 GKDFLLRCFLRNPVERPSAVELLEHPFI--RNANYQNLSVPMRVFSRIN 634
            KD + +  + +P +R +  + L+HP++  + AN+ ++    +     N
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFN 330

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 137/300 (45%), Gaps = 45/300 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ + Y   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEY 142
Query: 449 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 202
Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 203 LARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 252
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 253 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 27/283 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 410
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 69
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 128
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                      L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 189 -------NYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 238
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 622
                S+  KDF+ R  +++P +R +  + L+HP+I+  + Q 
Sbjct: 239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 27/283 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 410
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 69
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 128
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                      L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 189 -------NYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 238
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 622
                S+  KDF+ R  +++P +R +  + L+HP+I+  + Q 
Sbjct: 239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 114/258 (44%), Gaps = 16/258 (6%)
Query: 360 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 479 RDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           RD+   NLL+    +VK+ DFG+ + L         +   K    W APE +K       
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK------- 187
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGKDF 591
               + A D W  G T+ EM T G+ PW    G Q + K+       P PE    +  + 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 592 LLRCFLRNPVERPSAVEL 609
           +++C+   P +RP+ V L
Sbjct: 248 MVQCWAHKPEDRPTFVAL 265

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 132/283 (46%), Gaps = 27/283 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 410
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                 +  P L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 190 ------NYEP-LGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 239
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 622
                S+  KDF+ R  +++P +R +  + L+HP+I+  + Q 
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 126/275 (45%), Gaps = 23/275 (8%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII-PDDPKSAECIKQLEQEIKVLGHLK 412
           +  G+ +G G F  V     + TG   A K +        +     + +E+E+ +L  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH 131
Query: 473 STNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           S    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM----- 583
                    L L  D+WS+G     +L+G  P   F G      + N +    E      
Sbjct: 192 -------EPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDEYF 241
Query: 584 --LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
              S+  KDF+ R  +++P +R +  + L+HP+I+
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 107/255 (41%), Gaps = 18/255 (7%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           G+ IGRG FG V+ G  R      A+K   + +P D K+     +  QE ++L    H N
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-----KFLQEARILKQYSHPN 173
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           IV+  G       +YI +E V  G    ++R     +    +         G+ YL S  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQK 532
            IHRD+   N LV    V+K++DFGM++      Y  S  L+  P  W APE +      
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN----- 288
Query: 533 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM-FKVLNRTPPIPEMLSSEGKD 590
               + +   D+WS G  + E  + G  P+      Q   F       P PE+       
Sbjct: 289 --YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346
Query: 591 FLLRCFLRNPVERPS 605
            + +C+   P +RPS
Sbjct: 347 LMEQCWAYEPGQRPS 361

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSA-ECIKQLEQEIKVLGHLKHE 414
           +G G FG V    Y      TG   A+K +      P+S    I  L++EI++L +L HE
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 83
Query: 415 NIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           NIV+Y G  +E   + + + +E++  GS+  Y+ ++   I       +   I  G+ YL 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----WMAPEVIKA 528
           S   +HRD+   N+LV++   VK+ DFG+ K +       ++K   +    W APE +  
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL-- 201
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT 556
            MQ     K  +A D+WS G T+ E+LT
Sbjct: 202 -MQ----SKFYIASDVWSFGVTLHELLT 224

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 132/283 (46%), Gaps = 27/283 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 410
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                 +  P L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 190 ------NYEP-LGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 239
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 622
                S+  KDF+ R  +++P +R +  + L+HP+I+  + Q 
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/323 (25%), Positives = 144/323 (44%), Gaps = 54/323 (16%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 393
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 76
Query: 394 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 446
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 77  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 447 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 498
           E+C +        ++   + +    +  G+ YL S   IHRD+   N+LV    V+K+AD
Sbjct: 134 EYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 193
Query: 499 FGMAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 552
           FG+A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + 
Sbjct: 194 FGLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 243
Query: 553 EMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           E+ T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L
Sbjct: 244 EIFTLGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302
Query: 610 LEH-----PFIRNANYQNLSVPM 627
           +E          N  Y +LS+P+
Sbjct: 303 VEDLDRIVALTSNQEYLDLSMPL 325

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 138/301 (45%), Gaps = 45/301 (14%)
Query: 334 TSAVMPHIMEKPSASPK---KSQW----QKGKL---IGRGTFGSVYIGTNRETGASCAIK 383
           T  + P +ME   A+     +S W    ++ KL   IG+G FG V +G  R  G   A+K
Sbjct: 165 TRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVK 222
Query: 384 EVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-LYIYLEYVHPGSIN 442
               I +D  +    +    E  V+  L+H N+VQ  G  V +   LYI  EY+  GS+ 
Sbjct: 223 ---CIKNDATA----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 443 RYVREHCRDITES-IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 501
            Y+R   R +     +  F+  +   + YL   N +HRD+   N+LV    V K++DFG+
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 502 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 560
            K  +  S + + K    W APE ++         K +   D+WS G  + E+ + G+ P
Sbjct: 336 TKEAS--STQDTGKLPVKWTAPEALR-------EKKFSTKSDVWSFGILLWEIYSFGRVP 386
Query: 561 WSEFEGPQAMFK-VLNRTPPIPEMLSSEG-----KDFLLRCFLRNPVERPSAVEL---LE 611
           +     P+   K V+ R     +M + +G      D +  C+  +   RP+ ++L   LE
Sbjct: 387 Y-----PRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441
Query: 612 H 612
           H
Sbjct: 442 H 442

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 128/282 (45%), Gaps = 17/282 (6%)
Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLG 409
           +  ++ G+ +G G F  V     + TG   A K +        +     +++E+E+ +L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            ++H NI+  +        + + LE V  G +  ++ E    +TE     F + IL+G+ 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVH 122
Query: 470 YLHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
           YLHS    H D+K  N+++    V    +KL DFG+A  +   +   ++ G+P ++APE+
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLS 585
           +           L L  D+WS+G     +L+G  P+      + +  +        E   
Sbjct: 183 VNY-------EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 235
Query: 586 SE----GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 623
           S      KDF+ R  +++P  R +  + LEH +I+    +N+
Sbjct: 236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 137/300 (45%), Gaps = 45/300 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 395
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ + Y   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEY 142
Query: 449 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             DI        T   + + T  +  G+ YL S   IHRD+   N+LV  + V+K+ADFG
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 202
Query: 501 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           +A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + E+
Sbjct: 203 LARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 252
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 253 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 133/273 (48%), Gaps = 23/273 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--EN 415
           K IG G    V+   N E     AIK V++   D ++ +  +    EI  L  L+   + 
Sbjct: 34  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 89
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           I++ Y  E+ D ++Y+ +E    G+I  N ++++  + I     +++ +++L  +  +H 
Sbjct: 90  IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIKAVM 530
              +H D+K AN L+   G++KL DFG+A  +        + S  G+ N+M PE IK + 
Sbjct: 146 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMS 204
Query: 531 QKDGN----PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NRTPPIPEM 583
               N     K++   D+WSLGC +  M  GK P+ +     +    +   N     P++
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
              + +D L  C  R+P +R S  ELL HP+++
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 127/271 (46%), Gaps = 31/271 (11%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           ++G+G+FG V    +R T    A+K ++      K    I +   E+++L  L H NI++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIMK 85
Query: 419 YYGSEVVDDH--LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
            +  E+++D    YI  E    G +   + +  R  +E       + + +G+ Y+H  N 
Sbjct: 86  LF--EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNI 142
Query: 477 IHRDIKGANLLVDASGV---VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
           +HRD+K  N+L+++      +K+ DFG++      +      G+  ++APEV++    + 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE- 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------PIPEMLS 585
                    D+WS G  +  +L+G PP   F G    + +L R          P    +S
Sbjct: 202 -------KCDVWSAGVILYILLSGTPP---FYGKNE-YDILKRVETGKYAFDLPQWRTIS 250
Query: 586 SEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
            + KD + +    +P  R +A + LEHP+I+
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 143/314 (45%), Gaps = 21/314 (6%)
Query: 342 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQ 400
           ME       +  +  G+ +G G F  V     + TG   A K +        +   C ++
Sbjct: 2   METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           +E+E+ +L  + H NI+  +        + + LE V  G +  ++ +    ++E    +F
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSF 120
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLT-GLSYELSLK 515
            + IL+G+ YLH+    H D+K  N+++    +    +KL DFG+A  +  G+ ++ ++ 
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK-NIF 179
Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 575
           G+P ++APE++      +  P L L  D+WS+G     +L+G  P+      + +  +  
Sbjct: 180 GTPEFVAPEIV------NYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232
Query: 576 RTPPIPEMLSSE----GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFS 631
            +    E   S+     KDF+ +  ++   +R +  E L HP+I   + Q   V  R  S
Sbjct: 233 VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMV--RRES 290
Query: 632 RINLGDKSHDQVER 645
            +NL +     V R
Sbjct: 291 VVNLENFKKQYVRR 304

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 27/283 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 410
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                      L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 190 -------NYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 239
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 622
                S+  KDF+ R  +++P +R +  + L+HP+I+  + Q 
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSA-ECIKQLEQEIKVLGHLKHE 414
           +G G FG V    Y      TG   A+K +      P+S    I  L++EI++L +L HE
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 71
Query: 415 NIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           NIV+Y G  +E   + + + +E++  GS+  Y+ ++   I       +   I  G+ YL 
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 131
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----WMAPEVIKA 528
           S   +HRD+   N+LV++   VK+ DFG+ K +       ++K   +    W APE    
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE---C 188
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT 556
           +MQ     K  +A D+WS G T+ E+LT
Sbjct: 189 LMQ----SKFYIASDVWSFGVTLHELLT 212

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 134/275 (48%), Gaps = 29/275 (10%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +Q  + +G+G F  V     +      A K   II     SA   ++LE+E ++   LKH
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAK---IINTKKLSARDHQKLEREARICRLLKH 89
Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYL 471
            NIV+ + S   +   Y+  + V  G +  +   RE+    +E+   +    IL  + ++
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY---YSEADASHCIHQILESVNHI 146
Query: 472 HSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYE-LSLKGSPNWMAPEVIK 527
           H  + +HRD+K  NLL+ +      VKLADFG+A  + G         G+P +++PEV++
Sbjct: 147 HQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLR 206
Query: 528 AVMQKD--GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPE 582
               KD  G P     VDIW+ G  +  +L G PP+ + E    +++ +       P PE
Sbjct: 207 ----KDPYGKP-----VDIWACGVILYILLVGYPPFWD-EDQHKLYQQIKAGAYDFPSPE 256
Query: 583 M--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
              ++ E K+ + +    NP +R +A + L+HP++
Sbjct: 257 WDTVTPEAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 131/270 (48%), Gaps = 21/270 (7%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLKHE 414
           IG+G+FG V I    +T    A+K ++         +C+++ E     +E++++  L+H 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMN-------KQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +V  + S   ++ +++ ++ +  G +  +++++     E  V+ F   ++  L YL + 
Sbjct: 76  FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH-FKEETVKLFICELVMALDYLQNQ 134
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
             IHRD+K  N+L+D  G V + DF +A  L   +   ++ G+  +MAPE+  +   + G
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS---RKG 191
Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 591
               + AVD WSLG T  E+L G+ P+   S     + +          P   S E    
Sbjct: 192 -AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL 250
Query: 592 LLRCFLRNPVERPSAV-ELLEHPFIRNANY 620
           L +    NP +R S + ++   P++ + N+
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 138/293 (47%), Gaps = 51/293 (17%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ- 418
           +G G +GSV    +       A+K+   +    +S    ++  +E+++L HLKHEN++  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKK---LSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 419 ---YYGSEVVDDHLYIYLEYVHPGS-INRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  ++D   +YL     G+ +N  V+  C+ +++  V+     +L GL Y+HS 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVK--CQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
             IHRD+K +N+ V+    +++ DFG+A+       E++   +  W  APE++   M  +
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQADE---EMTGYVATRWYRAPEIMLNWMHYN 207
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKP--PWSEF-------------EGPQAMFKV----- 573
                   VDIWS+GC + E+L GK   P S++               P+ + K+     
Sbjct: 208 QT------VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHA 261
Query: 574 ---LNRTPPIPEM-LSSEGK-------DFLLRCFLRNPVERPSAVELLEHPFI 615
              +   PP+P+  LSS  +       D L R  + +  +R SA E L H + 
Sbjct: 262 RTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 27/277 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 410
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                      L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 190 NY-------EPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 239
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
                S+  KDF+ R  +++P +R +  + L+HP+I+
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 27/277 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 410
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                      L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 190 NY-------EPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 239
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
                S+  KDF+ R  +++P +R +  + L+HP+I+
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 113/225 (50%), Gaps = 39/225 (17%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           LIGRG++G VY+  ++ T  + AIK+V+ + +D    +C K++ +EI +L  LK + I++
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED--LIDC-KRILREITILNRLKSDYIIR 89
Query: 419 YYGSEVVDD-----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            Y   + DD      LYI LE +    + +  +     +TE  ++    ++L G  ++H 
Sbjct: 90  LYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIF-LTEEHIKTILYNLLLGENFIHE 147
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAK----------------------HLTGLSYE 511
           +  IHRD+K AN L++    VK+ DFG+A+                      H   L  +
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 512 LSLKGSPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 555
           L+      W  APE+I  ++Q++       ++DIWS GC   E+L
Sbjct: 208 LTSHVVTRWYRAPELI--LLQENYTK----SIDIWSTGCIFAELL 246

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 134/296 (45%), Gaps = 25/296 (8%)
Query: 347 ASPKKSQW-QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           A P    W    +++GRG FG V+    + TG   A K+++      +       +E+  
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK-- 236
Query: 406 KVLGHLKHENIVQY-YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFT 461
           K+L  +    IV   Y  E   D L + +  ++ G I  ++     D     E     +T
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNW 520
             I++GL +LH  N I+RD+K  N+L+D  G V+++D G+A  L  G +      G+P +
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNR 576
           MAPE++          +   +VD ++LG T+ EM+  + P+     + E  +   +VL +
Sbjct: 356 MAPELLL-------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 577 TPPIPEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 627
               P+  S   KDF      ++P +R      S   L  HP  R+ +++ L   M
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGM 464

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 135/313 (43%), Gaps = 56/313 (17%)
Query: 345 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           P  S   S+++    IG G +G+VY   +  +G   A+K V +               +E
Sbjct: 2   PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE 61
Query: 405 IKVLGHLK---HENIVQYY---GSEVVDDHLYIYLEYVHPGSINRYVREHCRD-----IT 453
           + +L  L+   H N+V+      +   D  + + L + H   +++ +R +        + 
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH---VDQDLRTYLDKAPPPGLP 118
Query: 454 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 513
              +++  R  L GL +LH+   +HRD+K  N+LV + G VKLADFG+A+     SY+++
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMA 175
Query: 514 LK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGP 567
           L     +  + APEV+            A  VD+WS+GC   EM   KP +   SE +  
Sbjct: 176 LTPVVVTLWYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 228
Query: 568 QAMFKVLNRTPP-------------------------IPEMLSSEGKDFLLRCFLRNPVE 602
             +F ++   P                          +PEM  S G   LL     NP +
Sbjct: 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEES-GAQLLLEMLTFNPHK 287
Query: 603 RPSAVELLEHPFI 615
           R SA   L+H ++
Sbjct: 288 RISAFRALQHSYL 300

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 134/296 (45%), Gaps = 25/296 (8%)
Query: 347 ASPKKSQW-QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           A P    W    +++GRG FG V+    + TG   A K+++      +       +E+  
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK-- 236
Query: 406 KVLGHLKHENIVQY-YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFT 461
           K+L  +    IV   Y  E   D L + +  ++ G I  ++     D     E     +T
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNW 520
             I++GL +LH  N I+RD+K  N+L+D  G V+++D G+A  L  G +      G+P +
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNR 576
           MAPE++          +   +VD ++LG T+ EM+  + P+     + E  +   +VL +
Sbjct: 356 MAPELLL-------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 577 TPPIPEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 627
               P+  S   KDF      ++P +R      S   L  HP  R+ +++ L   M
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGM 464

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 134/296 (45%), Gaps = 25/296 (8%)
Query: 347 ASPKKSQW-QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           A P    W    +++GRG FG V+    + TG   A K+++      +       +E+  
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK-- 236
Query: 406 KVLGHLKHENIVQY-YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFT 461
           K+L  +    IV   Y  E   D L + +  ++ G I  ++     D     E     +T
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNW 520
             I++GL +LH  N I+RD+K  N+L+D  G V+++D G+A  L  G +      G+P +
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNR 576
           MAPE++          +   +VD ++LG T+ EM+  + P+     + E  +   +VL +
Sbjct: 356 MAPELLL-------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 577 TPPIPEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 627
               P+  S   KDF      ++P +R      S   L  HP  R+ +++ L   M
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGM 464

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 127/271 (46%), Gaps = 31/271 (11%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           ++G+G+FG V    +R T    A+K ++      K    I +   E+++L  L H NI++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIMK 85
Query: 419 YYGSEVVDDH--LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
            +  E+++D    YI  E    G +   + +  R  +E       + + +G+ Y+H  N 
Sbjct: 86  LF--EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNI 142
Query: 477 IHRDIKGANLLVDASGV---VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
           +HRD+K  N+L+++      +K+ DFG++      +      G+  ++APEV++    + 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE- 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------PIPEMLS 585
                    D+WS G  +  +L+G PP   F G    + +L R          P    +S
Sbjct: 202 -------KCDVWSAGVILYILLSGTPP---FYGKNE-YDILKRVETGKYAFDLPQWRTIS 250
Query: 586 SEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
            + KD + +    +P  R +A + LEHP+I+
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 121/267 (45%), Gaps = 17/267 (6%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K+++ ++ K++G G FG+VY G     G +  I     I ++    +   +   E  ++ 
Sbjct: 36  KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 95
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            + H ++V+  G   +   + +  + +  G +  YV EH  +I   ++ N+   I  G+ 
Sbjct: 96  SMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMM 154
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 526
           YL     +HRD+   N+LV +   VK+ DFG+A+ L G   E +  G      WMA E I
Sbjct: 155 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF---EGPQAMFKVLNRTPPIPE 582
                     K     D+WS G T+ E++T G  P+      E P  + K      P P 
Sbjct: 215 HY-------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK--GERLPQPP 265
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + + +    +++C++ +   RP   EL
Sbjct: 266 ICTIDVYMVMVKCWMIDADSRPKFKEL 292

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 134/296 (45%), Gaps = 25/296 (8%)
Query: 347 ASPKKSQW-QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           A P    W    +++GRG FG V+    + TG   A K+++      +       +E+  
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK-- 236
Query: 406 KVLGHLKHENIVQY-YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFT 461
           K+L  +    IV   Y  E   D L + +  ++ G I  ++     D     E     +T
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNW 520
             I++GL +LH  N I+RD+K  N+L+D  G V+++D G+A  L  G +      G+P +
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNR 576
           MAPE++          +   +VD ++LG T+ EM+  + P+     + E  +   +VL +
Sbjct: 356 MAPELLL-------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 577 TPPIPEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 627
               P+  S   KDF      ++P +R      S   L  HP  R+ +++ L   M
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGM 464

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 121/267 (45%), Gaps = 17/267 (6%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K+++ ++ K++G G FG+VY G     G +  I     I ++    +   +   E  ++ 
Sbjct: 13  KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 72
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            + H ++V+  G   +   + +  + +  G +  YV EH  +I   ++ N+   I  G+ 
Sbjct: 73  SMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMM 131
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 526
           YL     +HRD+   N+LV +   VK+ DFG+A+ L G   E +  G      WMA E I
Sbjct: 132 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF---EGPQAMFKVLNRTPPIPE 582
                     K     D+WS G T+ E++T G  P+      E P  + K      P P 
Sbjct: 192 HY-------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK--GERLPQPP 242
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + + +    +++C++ +   RP   EL
Sbjct: 243 ICTIDVYMVMVKCWMIDADSRPKFKEL 269

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 127/271 (46%), Gaps = 31/271 (11%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           ++G+G+FG V    +R T    A+K ++      K    I +   E+++L  L H NI++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIMK 85
Query: 419 YYGSEVVDDH--LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
            +  E+++D    YI  E    G +   + +  R  +E       + + +G+ Y+H  N 
Sbjct: 86  LF--EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNI 142
Query: 477 IHRDIKGANLLVDASGV---VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
           +HRD+K  N+L+++      +K+ DFG++      +      G+  ++APEV++    + 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE- 201
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------PIPEMLS 585
                    D+WS G  +  +L+G PP   F G    + +L R          P    +S
Sbjct: 202 -------KCDVWSAGVILYILLSGTPP---FYGKNE-YDILKRVETGKYAFDLPQWRTIS 250
Query: 586 SEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
            + KD + +    +P  R +A + LEHP+I+
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 138/293 (47%), Gaps = 51/293 (17%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ- 418
           +G G +GSV    +       A+K+   +    +S    ++  +E+++L HLKHEN++  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKK---LSRPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 419 ---YYGSEVVDDHLYIYLEYVHPGS-INRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  ++D   +YL     G+ +N  V+  C+ +++  V+     +L GL Y+HS 
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVK--CQALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
             IHRD+K +N+ V+    +++ DFG+A+       E++   +  W  APE++   M  +
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLARQADE---EMTGYVATRWYRAPEIMLNWMHYN 199
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKP--PWSEF-------------EGPQAMFKV----- 573
                   VDIWS+GC + E+L GK   P S++               P+ + K+     
Sbjct: 200 QT------VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHA 253
Query: 574 ---LNRTPPIPEM-LSSEGK-------DFLLRCFLRNPVERPSAVELLEHPFI 615
              +   PP+P+  LSS  +       D L R  + +  +R SA E L H + 
Sbjct: 254 RTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 306

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 27/283 (9%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII-PDDPKSAECIKQLEQEIKVLGHLK 412
           +  G+ +G G F  V     + TG   A K +        +     + +E+E+ +L  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 413 HENIVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           H N++  +  EV ++   + L  E V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 73  HPNVITLH--EVYENKTDVILIGELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 471 LHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LHS    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--- 583
                      L L  D+WS+G     +L+G  P   F G      + N +    E    
Sbjct: 190 -------NYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDE 239
Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 622
                S+  KDF+ R  +++P +R +  + L+HP+I+  + Q 
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 128/285 (44%), Gaps = 17/285 (5%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIK 406
           S  +  ++ G+ +G G F  V     + TG   A K +        +     +++E+E+ 
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +L  ++H NI+  +        + + LE V  G +  ++ E    +TE     F + IL+
Sbjct: 82  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILD 140
Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           G+ YLHS    H D+K  N+++    V    +KL DFG+A  +   +   ++ G+P ++A
Sbjct: 141 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 200
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE++           L L  D+WS+G     +L+G  P+      + +  +        E
Sbjct: 201 PEIVNY-------EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 253
Query: 583 MLSSE----GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 623
              S      KDF+ R  +++P  R    + LEH +I+    +N+
Sbjct: 254 EYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRNV 298

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 136/290 (46%), Gaps = 43/290 (14%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI 416
           K++G G+ G+V    + + G   A+K + I         C   L  EIK+L     H N+
Sbjct: 21  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIAL-MEIKLLTESDDHPNV 71
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT-----RHILNGLAYL 471
           ++YY SE  D  LYI LE  +    +    ++  D    + + +      R I +G+A+L
Sbjct: 72  IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 472 HSTNTIHRDIKGANLLVDASG-------------VVKLADFGMAKHLTG--LSYELSLK- 515
           HS   IHRD+K  N+LV  S               + ++DFG+ K L     S+  +L  
Sbjct: 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 516 --GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
             G+  W APE+++         +L  ++DI+S+GC    +L+ GK P+ +    ++   
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--N 249
Query: 573 VLNRTPPIPEM-------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++     + EM       L +E  D + +    +P++RP+A+++L HP  
Sbjct: 250 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 124/275 (45%), Gaps = 17/275 (6%)
Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLG 409
           +  ++ G+ +G G F  V     + TG   A K +        +     +++E+E+ +L 
Sbjct: 11  EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 70
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            ++H NI+  +        + + LE V  G +  ++ E    +TE     F + IL+G+ 
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVH 129
Query: 470 YLHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
           YLHS    H D+K  N+++    V    +KL DFG+A  +   +   ++ G+P ++APE+
Sbjct: 130 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 189
Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLS 585
           +           L L  D+WS+G     +L+G  P+      + +  +        E   
Sbjct: 190 VNY-------EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 242
Query: 586 SE----GKDFLLRCFLRNPVERPSAVELLEHPFIR 616
           S      KDF+ R  +++P  R    + LEH +I+
Sbjct: 243 SNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 136/307 (44%), Gaps = 61/307 (19%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK-QLEQEIKVLGH 410
           S+++    IG G +G+VY   +  +G   A+K V +    P   E +     +E+ +L  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV----PNGEEGLPISTVREVALLRR 59
Query: 411 LK---HENIVQYY---GSEVVDDHLYIYLEYVHPGSINRYVREHCRD-----ITESIVRN 459
           L+   H N+V+      +   D  + + L + H   +++ +R +        +    +++
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH---VDQDLRTYLDKAPPPGLPAETIKD 116
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---G 516
             R  L GL +LH+   +HRD+K  N+LV + G VKLADFG+A+     SY+++L     
Sbjct: 117 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVV 173
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKV 573
           +  + APEV+            A  VD+WS+GC   EM   KP +   SE +    +F +
Sbjct: 174 TLWYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 574 LNRTPP-------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVE 608
           +   P                          +PEM  S G   LL     NP +R SA  
Sbjct: 227 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEES-GAQLLLEMLTFNPHKRISAFR 285
Query: 609 LLEHPFI 615
            L+H ++
Sbjct: 286 ALQHSYL 292

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 41/278 (14%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---------- 399
           ++ + + G+ IG G FG V+ G             + + P++P  A  IK          
Sbjct: 8   QRERIELGRCIGEGQFGDVHQG-------------IYMSPENPAMAVAIKTCKNCTSDSV 54
Query: 400 --QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHCRDITES 455
             +  QE   +    H +IV+  G  + ++ ++I +E    G +  +  VR+   D+   
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASL 113
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           I+  +   +   LAYL S   +HRDI   N+LV A+  VKL DFG+++++   +Y  + K
Sbjct: 114 IL--YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 516 GS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
           G     WMAPE I          +   A D+W  G  + E+L  G  P+   +    + +
Sbjct: 172 GKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 224
Query: 573 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + N    P+P          + +C+  +P  RP   EL
Sbjct: 225 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/317 (25%), Positives = 136/317 (42%), Gaps = 44/317 (13%)
Query: 340 HIMEKPSASPKKSQWQK-------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP 392
           ++   P+  P   +W+        GK +G G FG V   T      S A   V +    P
Sbjct: 27  YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 86
Query: 393 KSAECIKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-- 448
            +    ++ L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R    
Sbjct: 87  SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 146
Query: 449 ---CRDITESIVR------------NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 493
              C   + +I+             +F+  +  G+A+L S N IHRD+   N+L+    +
Sbjct: 147 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 206
Query: 494 VKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGC 549
            K+ DFG+A+H+   S    +KG+      WMAPE I        N       D+WS G 
Sbjct: 207 TKICDFGLARHIKNDS-NYVVKGNARLPVKWMAPESI-------FNCVYTFESDVWSYGI 258
Query: 550 TVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS- 605
            + E+ + G  P+         +K++     +  PE   +E  D +  C+  +P++RP+ 
Sbjct: 259 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 318
Query: 606 --AVELLEHPFIRNANY 620
              V+L+E     + N+
Sbjct: 319 KQIVQLIEKQISESTNH 335

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 41/278 (14%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---------- 399
           ++ + + G+ IG G FG V+ G             + + P++P  A  IK          
Sbjct: 388 QRERIELGRCIGEGQFGDVHQG-------------IYMSPENPAMAVAIKTCKNCTSDSV 434
Query: 400 --QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHCRDITES 455
             +  QE   +    H +IV+  G  + ++ ++I +E    G +  +  VR+   D+   
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASL 493
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           I+  +   +   LAYL S   +HRDI   N+LV A+  VKL DFG+++++   +Y  + K
Sbjct: 494 IL--YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK 551
Query: 516 GS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
           G     WMAPE I          +   A D+W  G  + E+L  G  P+   +    + +
Sbjct: 552 GKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604
Query: 573 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + N    P+P          + +C+  +P  RP   EL
Sbjct: 605 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 136/307 (44%), Gaps = 61/307 (19%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK-QLEQEIKVLGH 410
           S+++    IG G +G+VY   +  +G   A+K V +    P   E +     +E+ +L  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV----PNGEEGLPISTVREVALLRR 59
Query: 411 LK---HENIVQYY---GSEVVDDHLYIYLEYVHPGSINRYVREHCRD-----ITESIVRN 459
           L+   H N+V+      +   D  + + L + H   +++ +R +        +    +++
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH---VDQDLRTYLDKAPPPGLPAETIKD 116
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---G 516
             R  L GL +LH+   +HRD+K  N+LV + G VKLADFG+A+     SY+++L     
Sbjct: 117 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVV 173
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKV 573
           +  + APEV+            A  VD+WS+GC   EM   KP +   SE +    +F +
Sbjct: 174 TLWYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 574 LNRTPP-------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVE 608
           +   P                          +PEM  S G   LL     NP +R SA  
Sbjct: 227 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEES-GAQLLLEMLTFNPHKRISAFR 285
Query: 609 LLEHPFI 615
            L+H ++
Sbjct: 286 ALQHSYL 292

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 18/257 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 30  KELGTGQFGVVKYGKWRGQ-YDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 82
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVMQKDGN 535
           HRD+   N LV+  GVVK++DFG+++++    Y  S+  K    W  PEV+         
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY------- 195
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI-PEMLSSEGKDFLL 593
            K +   DIW+ G  + E+ + GK P+  F   +    +        P + S +    + 
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 255
Query: 594 RCFLRNPVERPSAVELL 610
            C+     ERP+   LL
Sbjct: 256 SCWHEKADERPTFKILL 272

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 135/290 (46%), Gaps = 43/290 (14%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI 416
           K++G G+ G+V    + + G   A+K + I         C   L  EIK+L     H N+
Sbjct: 21  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIAL-MEIKLLTESDDHPNV 71
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT-----RHILNGLAYL 471
           ++YY SE  D  LYI LE  +    +    ++  D    + + +      R I +G+A+L
Sbjct: 72  IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 472 HSTNTIHRDIKGANLLVDASG-------------VVKLADFGMAKHLTG--LSYELSLK- 515
           HS   IHRD+K  N+LV  S               + ++DFG+ K L      +  +L  
Sbjct: 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 516 --GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
             G+  W APE+++         +L  ++DI+S+GC    +L+ GK P+ +    ++   
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--N 249
Query: 573 VLNRTPPIPEM-------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++     + EM       L +E  D + +    +P++RP+A+++L HP  
Sbjct: 250 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 123/265 (46%), Gaps = 35/265 (13%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG+G FG V +G  R  G   A+K    I +D  +   +     E  V+  L+H N+VQ 
Sbjct: 29  IGKGEFGDVMLGDYR--GNKVAVK---CIKNDATAQAFL----AEASVMTQLRHSNLVQL 79
Query: 420 YGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITES-IVRNFTRHILNGLAYLHSTNTI 477
            G  V +   LYI  EY+  GS+  Y+R   R +     +  F+  +   + YL   N +
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           HRD+   N+LV    V K++DFG+ K  +  S + + K    W APE ++         K
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALR-------EKK 190
Query: 538 LALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEG-----KD 590
            +   D+WS G  + E+ + G+ P+     P+   K V+ R     +M + +G      +
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPY-----PRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 245
Query: 591 FLLRCFLRNPVERPSAVEL---LEH 612
            +  C+  +   RPS ++L   LEH
Sbjct: 246 VMKNCWHLDAAMRPSFLQLREQLEH 270

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 106/255 (41%), Gaps = 18/255 (7%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           G+ IGRG FG V+ G  R      A+K   + +P D K+     +  QE ++L    H N
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-----KFLQEARILKQYSHPN 173
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           IV+  G       +YI +E V  G    ++R     +    +         G+ YL S  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQK 532
            IHRD+   N LV    V+K++DFGM++         S  L+  P  W APE +      
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALN----- 288
Query: 533 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM-FKVLNRTPPIPEMLSSEGKD 590
               + +   D+WS G  + E  + G  P+      Q   F       P PE+       
Sbjct: 289 --YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346
Query: 591 FLLRCFLRNPVERPS 605
            + +C+   P +RPS
Sbjct: 347 LMEQCWAYEPGQRPS 361

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 136/307 (44%), Gaps = 61/307 (19%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK-QLEQEIKVLGH 410
           S+++    IG G +G+VY   +  +G   A+K V +    P   E +     +E+ +L  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV----PNGEEGLPISTVREVALLRR 59
Query: 411 LK---HENIVQYY---GSEVVDDHLYIYLEYVHPGSINRYVREHCRD-----ITESIVRN 459
           L+   H N+V+      +   D  + + L + H   +++ +R +        +    +++
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH---VDQDLRTYLDKAPPPGLPAETIKD 116
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL---KG 516
             R  L GL +LH+   +HRD+K  N+LV + G VKLADFG+A+     SY+++L     
Sbjct: 117 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVV 173
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKV 573
           +  + APEV+            A  VD+WS+GC   EM   KP +   SE +    +F +
Sbjct: 174 TLWYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 574 LNRTPP-------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVE 608
           +   P                          +PEM  S G   LL     NP +R SA  
Sbjct: 227 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEES-GAQLLLEMLTFNPHKRISAFR 285
Query: 609 LLEHPFI 615
            L+H ++
Sbjct: 286 ALQHSYL 292

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---------- 399
           ++ + + G+ IG G FG V+ G             + + P++P  A  IK          
Sbjct: 36  QRERIELGRCIGEGQFGDVHQG-------------IYMSPENPALAVAIKTCKNCTSDSV 82
Query: 400 --QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHCRDITES 455
             +  QE   +    H +IV+  G  + ++ ++I +E    G +  +  VR++  D+   
Sbjct: 83  REKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASL 141
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           I+  +   +   LAYL S   +HRDI   N+LV ++  VKL DFG+++++   +Y  + K
Sbjct: 142 IL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 199
Query: 516 GS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
           G     WMAPE I          +   A D+W  G  + E+L  G  P+   +    + +
Sbjct: 200 GKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 252
Query: 573 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + N    P+P          + +C+  +P  RP   EL
Sbjct: 253 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 290

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---------- 399
           ++ + + G+ IG G FG V+ G             + + P++P  A  IK          
Sbjct: 10  QRERIELGRCIGEGQFGDVHQG-------------IYMSPENPALAVAIKTCKNCTSDSV 56
Query: 400 --QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHCRDITES 455
             +  QE   +    H +IV+  G  + ++ ++I +E    G +  +  VR++  D+   
Sbjct: 57  REKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASL 115
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           I+  +   +   LAYL S   +HRDI   N+LV ++  VKL DFG+++++   +Y  + K
Sbjct: 116 IL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 173
Query: 516 GS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
           G     WMAPE I          +   A D+W  G  + E+L  G  P+   +    + +
Sbjct: 174 GKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 226
Query: 573 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + N    P+P          + +C+  +P  RP   EL
Sbjct: 227 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 264

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---------- 399
           ++ + + G+ IG G FG V+ G             + + P++P  A  IK          
Sbjct: 11  QRERIELGRCIGEGQFGDVHQG-------------IYMSPENPALAVAIKTCKNCTSDSV 57
Query: 400 --QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHCRDITES 455
             +  QE   +    H +IV+  G  + ++ ++I +E    G +  +  VR++  D+   
Sbjct: 58  REKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASL 116
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           I+  +   +   LAYL S   +HRDI   N+LV ++  VKL DFG+++++   +Y  + K
Sbjct: 117 IL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 174
Query: 516 GS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
           G     WMAPE I          +   A D+W  G  + E+L  G  P+   +    + +
Sbjct: 175 GKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 227
Query: 573 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + N    P+P          + +C+  +P  RP   EL
Sbjct: 228 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 265

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---------- 399
           ++ + + G+ IG G FG V+ G             + + P++P  A  IK          
Sbjct: 13  QRERIELGRCIGEGQFGDVHQG-------------IYMSPENPALAVAIKTCKNCTSDSV 59
Query: 400 --QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHCRDITES 455
             +  QE   +    H +IV+  G  + ++ ++I +E    G +  +  VR++  D+   
Sbjct: 60  REKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASL 118
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           I+  +   +   LAYL S   +HRDI   N+LV ++  VKL DFG+++++   +Y  + K
Sbjct: 119 IL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 516 GS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
           G     WMAPE I          +   A D+W  G  + E+L  G  P+   +    + +
Sbjct: 177 GKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229
Query: 573 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + N    P+P          + +C+  +P  RP   EL
Sbjct: 230 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 267

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---------- 399
           ++ + + G+ IG G FG V+ G             + + P++P  A  IK          
Sbjct: 8   QRERIELGRCIGEGQFGDVHQG-------------IYMSPENPAMAVAIKTCKNCTSDSV 54
Query: 400 --QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHCRDITES 455
             +  QE   +    H +IV+  G  + ++ ++I +E    G +  +  VR++  D+   
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASL 113
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           I+  +   +   LAYL S   +HRDI   N+LV ++  VKL DFG+++++   +Y  + K
Sbjct: 114 IL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 516 GS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
           G     WMAPE I          +   A D+W  G  + E+L  G  P+   +    + +
Sbjct: 172 GKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 224
Query: 573 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + N    P+P          + +C+  +P  RP   EL
Sbjct: 225 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 18/257 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 14  KELGTGQFGVVKYGKWR-GQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 66
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 126
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVMQKDGN 535
           HRD+   N LV+  GVVK++DFG+++++    Y  S+  K    W  PEV+         
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY------- 179
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI-PEMLSSEGKDFLL 593
            K +   DIW+ G  + E+ + GK P+  F   +    +        P + S +    + 
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 239
Query: 594 RCFLRNPVERPSAVELL 610
            C+     ERP+   LL
Sbjct: 240 SCWHEKADERPTFKILL 256

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 18/257 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 10  KELGTGQFGVVKYGKWR-GQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 62
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVMQKDGN 535
           HRD+   N LV+  GVVK++DFG+++++    Y  S+  K    W  PEV+         
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY------- 175
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI-PEMLSSEGKDFLL 593
            K +   DIW+ G  + E+ + GK P+  F   +    +        P + S +    + 
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235
Query: 594 RCFLRNPVERPSAVELL 610
            C+     ERP+   LL
Sbjct: 236 SCWHEKADERPTFKILL 252

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG+G FG V +G  R  G   A+K    I +D  +   +     E  V+  L+H N+VQ 
Sbjct: 14  IGKGEFGDVMLGDYR--GNKVAVK---CIKNDATAQAFL----AEASVMTQLRHSNLVQL 64
Query: 420 YGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITES-IVRNFTRHILNGLAYLHSTNTI 477
            G  V +   LYI  EY+  GS+  Y+R   R +     +  F+  +   + YL   N +
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 124
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           HRD+   N+LV    V K++DFG+ K  +  S + + K    W APE ++         K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALR-------EKK 175
Query: 538 LALAVDIWSLGCTVIEMLT-GKPPW 561
            +   D+WS G  + E+ + G+ P+
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 115/258 (44%), Gaps = 20/258 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 15  KELGTGQFGVVKYGKWR-GQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 67
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQKDG 534
           HRD+   N LV+  GVVK++DFG+++++    Y  S +GS     W  PEV+        
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSRGSKFPVRWSPPEVLMY------ 180
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI-PEMLSSEGKDFL 592
             K +   DIW+ G  + E+ + GK P+  F   +    +        P + S +    +
Sbjct: 181 -SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 239
Query: 593 LRCFLRNPVERPSAVELL 610
             C+     ERP+   LL
Sbjct: 240 YSCWHEKADERPTFKILL 257

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 109
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 110 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 169
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    Y     +   K    WMA E ++ 
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 228
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 229 ------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 282
Query: 587 EGKDFLLRCFLRNPVERPSAVELL 610
              + +L+C+      RPS  EL+
Sbjct: 283 PLYEVMLKCWHPKAEMRPSFSELV 306

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 139/305 (45%), Gaps = 42/305 (13%)
Query: 336 AVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-------I 388
           A+ P +  +         + K + +G G +G V +   +   +  AIK +          
Sbjct: 20  AINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRY 79
Query: 389 PDDPKSAECI-KQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVHPGS----- 440
            DD K+ E   +++  EI +L  L H NI++ +  +V +D  Y YL  E+   G      
Sbjct: 80  SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF--DVFEDKKYFYLVTEFYEGGELFEQI 137
Query: 441 INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV---VKLA 497
           INR+  + C         N  + IL+G+ YLH  N +HRDIK  N+L++       +K+ 
Sbjct: 138 INRHKFDECD------AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191
Query: 498 DFGMAKHLTGLSYELSLK-GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
           DFG++   +   Y+L  + G+  ++APEV+K    K  N K     D+WS G  +  +L 
Sbjct: 192 DFGLSSFFSK-DYKLRDRLGTAYYIAPEVLK----KKYNEK----CDVWSCGVIMYILLC 242
Query: 557 GKPPWSEFEGPQAMFKVLNRTPPIPEM-----LSSEGKDFLLRCFLRNPVERPSAVELLE 611
           G PP+   +  Q + K + +     +      +S E K+ +      +  +R +A E L 
Sbjct: 243 GYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
Query: 612 HPFIR 616
             +I+
Sbjct: 302 SRWIK 306

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---------- 399
           ++ + + G+ IG G FG V+ G             + + P++P  A  IK          
Sbjct: 8   QRERIELGRCIGEGQFGDVHQG-------------IYMSPENPALAVAIKTCKNCTSDSV 54
Query: 400 --QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHCRDITES 455
             +  QE   +    H +IV+  G  + ++ ++I +E    G +  +  VR++  D+   
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASL 113
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           I+  +   +   LAYL S   +HRDI   N+LV ++  VKL DFG+++++   +Y  + K
Sbjct: 114 IL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 516 GS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
           G     WMAPE I          +   A D+W  G  + E+L  G  P+   +    + +
Sbjct: 172 GKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 224
Query: 573 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + N    P+P          + +C+  +P  RP   EL
Sbjct: 225 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 89
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 149
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    Y     +   K    WMA E ++ 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 208
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 209 ------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 262
Query: 587 EGKDFLLRCFLRNPVERPSAVELL 610
              + +L+C+      RPS  EL+
Sbjct: 263 PLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 137/290 (47%), Gaps = 47/290 (16%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI 416
           K++G G+ G+V    + + G   A+K + I         C   L  EIK+L     H N+
Sbjct: 39  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIAL-MEIKLLTESDDHPNV 89
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT-----RHILNGLAYL 471
           ++YY SE  D  LYI LE  +    +    ++  D    + + +      R I +G+A+L
Sbjct: 90  IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 149
Query: 472 HSTNTIHRDIKGANLLVDASG-------------VVKLADFGMAKHLTG--LSYELSLK- 515
           HS   IHRD+K  N+LV  S               + ++DFG+ K L      +  +L  
Sbjct: 150 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 516 --GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
             G+  W APE+++   ++    +L  ++DI+S+GC    +L+ GK P+ +    ++   
Sbjct: 210 PSGTSGWRAPELLEESTKR----RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--N 263
Query: 573 VLNRTPPIPEM-------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++     + EM       L +E  D + +    +P++RP+A+++L HP  
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 91
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    Y     +   K    WMA E ++ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 211 ------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 264
Query: 587 EGKDFLLRCFLRNPVERPSAVELL 610
              + +L+C+      RPS  EL+
Sbjct: 265 PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---------- 399
           ++ + + G+ IG G FG V+ G             + + P++P  A  IK          
Sbjct: 5   QRERIELGRCIGEGQFGDVHQG-------------IYMSPENPALAVAIKTCKNCTSDSV 51
Query: 400 --QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHCRDITES 455
             +  QE   +    H +IV+  G  + ++ ++I +E    G +  +  VR++  D+   
Sbjct: 52  REKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASL 110
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           I+  +   +   LAYL S   +HRDI   N+LV ++  VKL DFG+++++   +Y  + K
Sbjct: 111 IL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 168
Query: 516 GS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
           G     WMAPE I          +   A D+W  G  + E+L  G  P+   +    + +
Sbjct: 169 GKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 221
Query: 573 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + N    P+P          + +C+  +P  RP   EL
Sbjct: 222 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 259

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 110
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 111 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 170
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    Y     +   K    WMA E ++ 
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 229
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 230 ------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 283
Query: 587 EGKDFLLRCFLRNPVERPSAVELL 610
              + +L+C+      RPS  EL+
Sbjct: 284 PLYEVMLKCWHPKAEMRPSFSELV 307

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 137/290 (47%), Gaps = 47/290 (16%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI 416
           K++G G+ G+V    + + G   A+K + I         C   L  EIK+L     H N+
Sbjct: 39  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIAL-MEIKLLTESDDHPNV 89
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT-----RHILNGLAYL 471
           ++YY SE  D  LYI LE  +    +    ++  D    + + +      R I +G+A+L
Sbjct: 90  IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 149
Query: 472 HSTNTIHRDIKGANLLVDASG-------------VVKLADFGMAKHLTG--LSYELSLK- 515
           HS   IHRD+K  N+LV  S               + ++DFG+ K L      +  +L  
Sbjct: 150 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 516 --GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
             G+  W APE+++   ++    +L  ++DI+S+GC    +L+ GK P+ +    ++   
Sbjct: 210 PSGTSGWRAPELLEESTKR----RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--N 263
Query: 573 VLNRTPPIPEM-------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           ++     + EM       L +E  D + +    +P++RP+A+++L HP  
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 18/257 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 21  KELGTGQFGVVKYGKWRGQ-YDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 73
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 74  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 133
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVMQKDGN 535
           HRD+   N LV+  GVVK++DFG+++++    Y  S+  K    W  PEV+         
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY------- 186
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI-PEMLSSEGKDFLL 593
            K +   DIW+ G  + E+ + GK P+  F   +    +        P + S +    + 
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 246
Query: 594 RCFLRNPVERPSAVELL 610
            C+     ERP+   LL
Sbjct: 247 SCWHEKADERPTFKILL 263

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 18/257 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 15  KELGTGQFGVVKYGKWR-GQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 67
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVMQKDGN 535
           HRD+   N LV+  GVVK++DFG+++++    Y  S+  K    W  PEV+         
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY------- 180
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI-PEMLSSEGKDFLL 593
            K +   DIW+ G  + E+ + GK P+  F   +    +        P + S +    + 
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 240
Query: 594 RCFLRNPVERPSAVELL 610
            C+     ERP+   LL
Sbjct: 241 SCWHEKADERPTFKILL 257

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 86
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    Y     +   K    WMA E ++ 
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 205
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 206 ------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259
Query: 587 EGKDFLLRCFLRNPVERPSAVELL 610
              + +L+C+      RPS  EL+
Sbjct: 260 PLYEVMLKCWHPKAEMRPSFSELV 283

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 120/255 (47%), Gaps = 23/255 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V++G    +    A+K +      P +   ++   +E  ++  L+H+ +V
Sbjct: 19  KRLGAGQFGEVWMGYYNNS-TKVAVKTLK-----PGTM-SVQAFLEEANLMKTLQHDKLV 71
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTN 475
           + Y     ++ +YI  EY+  GS+  +++  E  + +   ++ +F+  I  G+AY+   N
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKN 130
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKD 533
            IHRD++ AN+LV  S + K+ADFG+A+ +    Y      K    W APE I       
Sbjct: 131 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF----- 185
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 590
                 +  D+WS G  + E++T GK P+        M  +    R P + E    E  D
Sbjct: 186 --GCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV-ENCPDELYD 242
Query: 591 FLLRCFLRNPVERPS 605
            +  C+     ERP+
Sbjct: 243 IMKMCWKEKAEERPT 257

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 83
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 84  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 143
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    Y     +   K    WMA E ++ 
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 202
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 203 ------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 256
Query: 587 EGKDFLLRCFLRNPVERPSAVELL 610
              + +L+C+      RPS  EL+
Sbjct: 257 PLYEVMLKCWHPKAEMRPSFSELV 280

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 136/302 (45%), Gaps = 49/302 (16%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 393
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 4   EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 61
Query: 394 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 446
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 62  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 447 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 498
           E+C +        ++   + +    +  G+ YL S   IHRD+   N+LV    V+K+AD
Sbjct: 119 EYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178
Query: 499 FGMAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 552
           FG+A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + 
Sbjct: 179 FGLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 228
Query: 553 EMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           E+ T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L
Sbjct: 229 EIFTLGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287
Query: 610 LE 611
           +E
Sbjct: 288 VE 289

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 88
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 148
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    Y     +   K    WMA E ++ 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 207
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 208 ------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 261
Query: 587 EGKDFLLRCFLRNPVERPSAVELL 610
              + +L+C+      RPS  EL+
Sbjct: 262 PLYEVMLKCWHPKAEMRPSFSELV 285

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 90
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    Y     +   K    WMA E ++ 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 209
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 210 ------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 263
Query: 587 EGKDFLLRCFLRNPVERPSAVELL 610
              + +L+C+      RPS  EL+
Sbjct: 264 PLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 91
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    Y     +   K    WMA E ++ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ- 210
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 211 ------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 264
Query: 587 EGKDFLLRCFLRNPVERPSAVELL 610
              + +L+C+      RPS  EL+
Sbjct: 265 PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 26/284 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHLKHE 414
           ++IG G FG V  G  +  G     +E+ +     KS    KQ      E  ++G   H 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 94
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           N++   G       + I  E++  GS++ ++R++    T   +    R I  G+ YL   
Sbjct: 95  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 154
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGS--PNWMAPEVIKA 528
           N +HRD+   N+LV+++ V K++DFG+++ L    +  +Y  +L G     W APE I+ 
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 585
                   K   A D+WS G  + E+++ G+ P+ +      +  +    R PP P    
Sbjct: 215 -------RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP-PMDCP 266
Query: 586 SEGKDFLLRCFLRNPVERPSAVELLE--HPFIRNANYQNLSVPM 627
           S     +L C+ ++   RP   +++      IRN N      P+
Sbjct: 267 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPL 310

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 122/278 (43%), Gaps = 41/278 (14%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---------- 399
           ++ + + G+ IG G FG V+ G             + + P++P  A  IK          
Sbjct: 388 QRERIELGRCIGEGQFGDVHQG-------------IYMSPENPAMAVAIKTCKNCTSDSV 434
Query: 400 --QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHCRDITES 455
             +  QE   +    H +IV+  G  + ++ ++I +E    G +  +  VR+   D+   
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASL 493
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           I+  +   +   LAYL S   +HRDI   N+LV ++  VKL DFG+++++   +Y  + K
Sbjct: 494 IL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 551
Query: 516 GS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
           G     WMAPE I          +   A D+W  G  + E+L  G  P+   +    + +
Sbjct: 552 GKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604
Query: 573 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + N    P+P          + +C+  +P  RP   EL
Sbjct: 605 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 136/293 (46%), Gaps = 51/293 (17%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ- 418
           +G G +GSV    +       A+K+   +    +S    ++  +E+++L HLKHEN++  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKK---LSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 419 ---YYGSEVVDDHLYIYLEYVHPGS-INRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
              +  +  ++D   +YL     G+ +N  V+     +++  V+     +L GL Y+HS 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQA--LSDEHVQFLVYQLLRGLKYIHSA 150
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 533
             IHRD+K +N+ V+    +++ DFG+A+       E++   +  W  APE++   M  +
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQADE---EMTGYVATRWYRAPEIMLNWMHYN 207
Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKP--PWSEF-------------EGPQAMFKV----- 573
                   VDIWS+GC + E+L GK   P S++               P+ + K+     
Sbjct: 208 QT------VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHA 261
Query: 574 ---LNRTPPIPEM-LSSEGK-------DFLLRCFLRNPVERPSAVELLEHPFI 615
              +   PP+P+  LSS  +       D L R  + +  +R SA E L H + 
Sbjct: 262 RTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 120/270 (44%), Gaps = 37/270 (13%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +LIG G FG V+   +R  G +  IK V    +         + E+E+K L  L H NIV
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHVNIV 67
Query: 418 QYYGSEVVDDH----------------LYIYLEYVHPGSINRYV-REHCRDITESIVRNF 460
            Y G     D+                L+I +E+   G++ +++ +     + + +    
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 520
              I  G+ Y+HS   I+RD+K +N+ +  +  VK+ DFG+   L         KG+  +
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRY 187
Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI 580
           M+PE I +  Q  G       VD+++LG  + E+L      + FE  +    +  R   I
Sbjct: 188 MSPEQISS--QDYGKE-----VDLYALGLILAELL--HVCDTAFETSKFFTDL--RDGII 236
Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            ++   + K  L +   + P +RP+  E+L
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 121/283 (42%), Gaps = 50/283 (17%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +LIG G FG V+   +R  G +  I+ V    +         + E+E+K L  L H NIV
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNE---------KAEREVKALAKLDHVNIV 68
Query: 418 QY--------YGSEVVDDHL---------------------YIYLEYVHPGSINRYV-RE 447
            Y        Y  E  DD L                     +I +E+   G++ +++ + 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 448 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 507
               + + +       I  G+ Y+HS   IHRD+K +N+ +  +  VK+ DFG+   L  
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 188
Query: 508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 567
                  KG+  +M+PE I +  Q  G       VD+++LG  + E+L      + FE  
Sbjct: 189 DGKRTRSKGTLRYMSPEQISS--QDYGKE-----VDLYALGLILAELL--HVCDTAFETS 239
Query: 568 QAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +    +  R   I ++   + K  L +   + P +RP+  E+L
Sbjct: 240 KFFTDL--RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 34/289 (11%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 150
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-----LSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    ++        K    WMA E ++ 
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ- 269
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 270 ------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 323
Query: 587 EGKDFLLRCFLRNPVERPSAVELL------------EHPFIRNANYQNL 623
              + +L+C+      RPS  EL+            EH    NA Y N+
Sbjct: 324 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNV 372

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 122/273 (44%), Gaps = 40/273 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TGA  A+K++     D +     +  ++EI++L  L  + 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDF 72
Query: 416 IVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G         L + +EY+  G +  +++ H   +  S +  ++  I  G+ YL S
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKA 528
              +HRD+   N+LV++   VK+ADFG+AK L  L  +  +   P      W APE +  
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPESLS- 190
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF---EGPQAMFKVLNRTP--- 578
                 +   +   D+WS G  + E+ T       P +EF    G +     L+R     
Sbjct: 191 ------DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELL 244
Query: 579 ------PIPEMLSSEGKDFLLRCFLRNPVERPS 605
                 P P    +E  + +  C+  +P +RPS
Sbjct: 245 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS 277

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 34/289 (11%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 96
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 97  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 156
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-----LSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    ++        K    WMA E ++ 
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 217 -------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 269
Query: 587 EGKDFLLRCFLRNPVERPSAVELL------------EHPFIRNANYQNL 623
              + +L+C+      RPS  EL+            EH    NA Y N+
Sbjct: 270 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNV 318

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 114/258 (44%), Gaps = 20/258 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 30  KELGTGQFGVVKYGKWRGQ-YDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 82
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQKDG 534
           HRD+   N LV+  GVVK++DFG+++++     E S  GS     W  PEV+        
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEETSSVGSKFPVRWSPPEVLMY------ 195
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI-PEMLSSEGKDFL 592
             K +   DIW+ G  + E+ + GK P+  F   +    +        P + S +    +
Sbjct: 196 -SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 254
Query: 593 LRCFLRNPVERPSAVELL 610
             C+     ERP+   LL
Sbjct: 255 YSCWHEKADERPTFKILL 272

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 34/289 (11%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 91
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-----LSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    ++        K    WMA E ++ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 212 -------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 264
Query: 587 EGKDFLLRCFLRNPVERPSAVELL------------EHPFIRNANYQNL 623
              + +L+C+      RPS  EL+            EH    NA Y N+
Sbjct: 265 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNV 313

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 50/277 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-----------EQEIKVL 408
           +G G FG V++       A C     +++P+  K    +K L           ++E ++L
Sbjct: 49  LGEGAFGKVFL-------AECH----NLLPEQDKMLVAVKALKEASESARQDFQREAELL 97
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--------------ITE 454
             L+H++IV+++G       L +  EY+  G +NR++R H  D              +  
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 455 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 514
             +      +  G+ YL   + +HRD+   N LV    VVK+ DFGM++ +    Y   +
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-YRV 216
Query: 515 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 569
            G       WM PE I          K     D+WS G  + E+ T GK PW +    +A
Sbjct: 217 GGRTMLPIRWMPPESIL-------YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269
Query: 570 MFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPS 605
           +  +   R    P     E    +  C+ R P +R S
Sbjct: 270 IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHS 306

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 128/269 (47%), Gaps = 17/269 (6%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           Q + G+LIG+G FG VY G  R  G   AI+ +DI  D+      +K  ++E+      +
Sbjct: 34  QLEIGELIGKGRFGQVYHG--RWHG-EVAIRLIDIERDNEDQ---LKAFKREVMAYRQTR 87
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           HEN+V + G+ +   HL I        ++   VR+    +  +  R   + I+ G+ YLH
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGM---AKHLTGLSYELSLKGSPNW---MAPEVI 526
           +   +H+D+K  N+  D +G V + DFG+   +  L     E  L+    W   +APE+I
Sbjct: 148 AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 527 KAVMQKDGNPKLALA--VDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPIPEM 583
           + +       KL  +   D+++LG    E+   + P+        ++++     P + ++
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI 266
Query: 584 -LSSEGKDFLLRCFLRNPVERPSAVELLE 611
            +  E  D LL C+     ERP+  +L++
Sbjct: 267 GMGKEISDILLFCWAFEQEERPTFTKLMD 295

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 34/289 (11%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 92
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-----LSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    ++        K    WMA E ++ 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 213 -------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 265
Query: 587 EGKDFLLRCFLRNPVERPSAVELL------------EHPFIRNANYQNL 623
              + +L+C+      RPS  EL+            EH    NA Y N+
Sbjct: 266 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNV 314

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/328 (22%), Positives = 134/328 (40%), Gaps = 71/328 (21%)
Query: 349 PKKSQWQKGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           P+   ++   +IG+G     +V +   + TG    ++ +++   +  S E +  L+ E+ 
Sbjct: 6   PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL---EACSNEMVTFLQGELH 62
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHIL 465
           V     H NIV Y  + + D+ L++   ++  GS    +  H  D + E  +    + +L
Sbjct: 63  VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 122
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-----------ELSL 514
             L Y+H    +HR +K +++L+   G V L+  G+  +L+ +S+           + S+
Sbjct: 123 KALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSV 180
Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
           K  P W++PEV++  +Q           DI+S+G T  E+  G  P+ +    Q + + L
Sbjct: 181 KVLP-WLSPEVLQQNLQGYDAKS-----DIYSVGITACELANGHVPFKDMPATQMLLEKL 234
Query: 575 NRTPP-------IP---------------------------------------EMLSSEG 588
           N T P       IP                                          S   
Sbjct: 235 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 294
Query: 589 KDFLLRCFLRNPVERPSAVELLEHPFIR 616
             F+ +C  RNP  RPSA  LL H F +
Sbjct: 295 HHFVEQCLQRNPDARPSASTLLNHSFFK 322

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 34/289 (11%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 89
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 149
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-----LSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    ++        K    WMA E ++ 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 210 -------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 262
Query: 587 EGKDFLLRCFLRNPVERPSAVELL------------EHPFIRNANYQNL 623
              + +L+C+      RPS  EL+            EH    NA Y N+
Sbjct: 263 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNV 311

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 121/243 (49%), Gaps = 27/243 (11%)
Query: 346 SASPKKS---QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIK 399
           SA+P  +   ++++   +G GT+G VY   +  T  + AIK + +  ++   P +A    
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI--- 81
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 459
              +E+ +L  L+H NI++       +  L++  EY     + +Y+ ++  D++  ++++
Sbjct: 82  ---REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP-DVSMRVIKS 136
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-----VVKLADFGMAKHLTGLSYELSL 514
           F   ++NG+ + HS   +HRD+K  NLL+  S      V+K+ DFG+A+       + + 
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF 571
           +    W  P  I       G+   + +VDIWS+ C   EML   P +   SE +    +F
Sbjct: 197 EIITLWYRPPEILL-----GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251
Query: 572 KVL 574
           +VL
Sbjct: 252 EVL 254

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 34/289 (11%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 91
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-----LSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    ++        K    WMA E ++ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 212 -------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 264
Query: 587 EGKDFLLRCFLRNPVERPSAVELL------------EHPFIRNANYQNL 623
              + +L+C+      RPS  EL+            EH    NA Y N+
Sbjct: 265 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNV 313

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 135/301 (44%), Gaps = 33/301 (10%)
Query: 337 VMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVD 386
           V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 387 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 446
           +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ ++R
Sbjct: 83  VGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
           +H    T   +    R I +G+ YL     +HRD+   N+L++++ V K++DFG+A+ L 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLE 198
Query: 507 G---LSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 561
                +Y       P  W +PE I          K   A D+WS G  + E+++ G+ P+
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAI-------AYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 562 SEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPFIR 616
            E    Q + K ++   R PP P    +     +L C+ ++   RP   +++      IR
Sbjct: 252 WEMSN-QDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 617 N 617
           N
Sbjct: 310 N 310

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 34/289 (11%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 92
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-----LSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +    ++        K    WMA E ++ 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 213 -------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 265
Query: 587 EGKDFLLRCFLRNPVERPSAVELL------------EHPFIRNANYQNL 623
              + +L+C+      RPS  EL+            EH    NA Y N+
Sbjct: 266 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNV 314

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 128/271 (47%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 17  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 72
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 73  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 131
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 132 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 192 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 243
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 244 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 50/277 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-----------EQEIKVL 408
           +G G FG V++       A C     +++P+  K    +K L           ++E ++L
Sbjct: 20  LGEGAFGKVFL-------AECH----NLLPEQDKMLVAVKALKEASESARQDFQREAELL 68
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--------------ITE 454
             L+H++IV+++G       L +  EY+  G +NR++R H  D              +  
Sbjct: 69  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 128
Query: 455 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 514
             +      +  G+ YL   + +HRD+   N LV    VVK+ DFGM++ +    Y   +
Sbjct: 129 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-YRV 187
Query: 515 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 569
            G       WM PE I          K     D+WS G  + E+ T GK PW +    +A
Sbjct: 188 GGRTMLPIRWMPPESIL-------YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 240
Query: 570 MFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPS 605
           +  +   R    P     E    +  C+ R P +R S
Sbjct: 241 IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHS 277

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 122/265 (46%), Gaps = 35/265 (13%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG+G FG V +G  R  G   A+K    I +D  +    +    E  V+  L+H N+VQ 
Sbjct: 20  IGKGEFGDVMLGDYR--GNKVAVK---CIKNDATA----QAFLAEASVMTQLRHSNLVQL 70
Query: 420 YGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITES-IVRNFTRHILNGLAYLHSTNTI 477
            G  V +   LYI  EY+  GS+  Y+R   R +     +  F+  +   + YL   N +
Sbjct: 71  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 130
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           HRD+   N+LV    V K++DFG+ K  +  S + + K    W APE ++          
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALR-------EAA 181
Query: 538 LALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEG-----KD 590
            +   D+WS G  + E+ + G+ P+     P+   K V+ R     +M + +G      +
Sbjct: 182 FSTKSDVWSFGILLWEIYSFGRVPY-----PRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 236
Query: 591 FLLRCFLRNPVERPSAVEL---LEH 612
            +  C+  +   RPS ++L   LEH
Sbjct: 237 VMKNCWHLDAAMRPSFLQLREQLEH 261

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/317 (24%), Positives = 135/317 (42%), Gaps = 44/317 (13%)
Query: 340 HIMEKPSASPKKSQWQK-------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP 392
           ++   P+  P   +W+        GK +G G FG V   T      S A   V +    P
Sbjct: 4   YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 393 KSAECIKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-- 448
            +    ++ L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R    
Sbjct: 64  SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 449 ---CRDITESIVR------------NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 493
              C   + +I+             +F+  +  G+A+L S N IHRD+   N+L+    +
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183
Query: 494 VKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGC 549
            K+ DFG+A+ +   S    +KG+      WMAPE I        N       D+WS G 
Sbjct: 184 TKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESI-------FNCVYTFESDVWSYGI 235
Query: 550 TVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS- 605
            + E+ + G  P+         +K++     +  PE   +E  D +  C+  +P++RP+ 
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295
Query: 606 --AVELLEHPFIRNANY 620
              V+L+E     + N+
Sbjct: 296 KQIVQLIEKQISESTNH 312

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/328 (22%), Positives = 134/328 (40%), Gaps = 71/328 (21%)
Query: 349 PKKSQWQKGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           P+   ++   +IG+G     +V +   + TG    ++ +++   +  S E +  L+ E+ 
Sbjct: 22  PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL---EACSNEMVTFLQGELH 78
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHIL 465
           V     H NIV Y  + + D+ L++   ++  GS    +  H  D + E  +    + +L
Sbjct: 79  VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-----------ELSL 514
             L Y+H    +HR +K +++L+   G V L+  G+  +L+ +S+           + S+
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
           K  P W++PEV++  +Q           DI+S+G T  E+  G  P+ +    Q + + L
Sbjct: 197 KVLP-WLSPEVLQQNLQGYDAKS-----DIYSVGITACELANGHVPFKDMPATQMLLEKL 250
Query: 575 NRTPP-------IP---------------------------------------EMLSSEG 588
           N T P       IP                                          S   
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310
Query: 589 KDFLLRCFLRNPVERPSAVELLEHPFIR 616
             F+ +C  RNP  RPSA  LL H F +
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFFK 338

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 50/277 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-----------EQEIKVL 408
           +G G FG V++       A C     +++P+  K    +K L           ++E ++L
Sbjct: 26  LGEGAFGKVFL-------AECH----NLLPEQDKMLVAVKALKEASESARQDFQREAELL 74
Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--------------ITE 454
             L+H++IV+++G       L +  EY+  G +NR++R H  D              +  
Sbjct: 75  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 134
Query: 455 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 514
             +      +  G+ YL   + +HRD+   N LV    VVK+ DFGM++ +    Y   +
Sbjct: 135 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-YRV 193
Query: 515 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 569
            G       WM PE I          K     D+WS G  + E+ T GK PW +    +A
Sbjct: 194 GGRTMLPIRWMPPESIL-------YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 246
Query: 570 MFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPS 605
           +  +   R    P     E    +  C+ R P +R S
Sbjct: 247 IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHS 283

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/309 (29%), Positives = 143/309 (46%), Gaps = 46/309 (14%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE------IKVLGHL 411
           +++G G  G V    +R TG  CA+K   ++ D PK+ + +    Q       + +L   
Sbjct: 16  QVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASGGPHIVCILD-- 70
Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAY 470
            +EN+  ++G       L I +E +  G +   ++E   +  TE       R I   + +
Sbjct: 71  VYENM--HHGKRC----LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 124
Query: 471 LHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           LHS N  HRD+K  NLL    +   V+KL DFG AK  T  + +     +P ++APEV+ 
Sbjct: 125 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-TPYYVAPEVL- 182
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-------PI 580
                 G  K   + D+WSLG  +  +L G PP+    G QA+   + R         P 
Sbjct: 183 ------GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG-QAISPGMKRRIRLGQYGFPN 235
Query: 581 PEMLS-SEGKDFLLRCFLR-NPVERPSAVELLEHPFIRNANYQNLSVPMRVF--SRINLG 636
           PE    SE    L+R  L+ +P ER +  + + HP+I     Q++ VP      +R+   
Sbjct: 236 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN----QSMVVPQTPLHTARVLQE 291
Query: 637 DKSH-DQVE 644
           DK H D+V+
Sbjct: 292 DKDHWDEVK 300

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 122/273 (44%), Gaps = 40/273 (14%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TGA  A+K++     D +     +  ++EI++L  L  + 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDF 85
Query: 416 IVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G         L + +EY+  G +  +++ H   +  S +  ++  I  G+ YL S
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKA 528
              +HRD+   N+LV++   VK+ADFG+AK L  L  +  +   P      W APE +  
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPESLS- 203
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF---EGPQAMFKVLNRTP--- 578
                 +   +   D+WS G  + E+ T       P +EF    G +     L+R     
Sbjct: 204 ------DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 579 ------PIPEMLSSEGKDFLLRCFLRNPVERPS 605
                 P P    +E  + +  C+  +P +RPS
Sbjct: 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS 290

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/309 (29%), Positives = 143/309 (46%), Gaps = 46/309 (14%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE------IKVLGHL 411
           +++G G  G V    +R TG  CA+K   ++ D PK+ + +    Q       + +L   
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASGGPHIVCILD-- 89
Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAY 470
            +EN+  ++G       L I +E +  G +   ++E   +  TE       R I   + +
Sbjct: 90  VYENM--HHGKRC----LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 471 LHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           LHS N  HRD+K  NLL    +   V+KL DFG AK  T  + +     +P ++APEV+ 
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-TPYYVAPEVL- 201
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-------PI 580
                 G  K   + D+WSLG  +  +L G PP+    G QA+   + R         P 
Sbjct: 202 ------GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG-QAISPGMKRRIRLGQYGFPN 254
Query: 581 PEMLS-SEGKDFLLRCFLR-NPVERPSAVELLEHPFIRNANYQNLSVPMRVF--SRINLG 636
           PE    SE    L+R  L+ +P ER +  + + HP+I     Q++ VP      +R+   
Sbjct: 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN----QSMVVPQTPLHTARVLQE 310
Query: 637 DKSH-DQVE 644
           DK H D+V+
Sbjct: 311 DKDHWDEVK 319

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 128/271 (47%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 14  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 69
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 70  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 128
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 129 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 189 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 240
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 241 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 122/255 (47%), Gaps = 23/255 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG V++G    +    A+K +      P +   ++   +E  ++  L+H+ +V
Sbjct: 18  KKLGAGQFGEVWMGYYNNS-TKVAVKTLK-----PGTM-SVQAFLEEANLMKTLQHDKLV 70
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTN 475
           + Y     ++ +YI  E++  GS+  +++  E  + +   ++ +F+  I  G+AY+   N
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKN 129
Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKD 533
            IHRD++ AN+LV  S + K+ADFG+A+ +    Y      K    W APE I       
Sbjct: 130 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF----- 184
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLS--SEGKD 590
                 +  ++WS G  + E++T GK P+        M   L++   +P M +   E  D
Sbjct: 185 --GCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVM-SALSQGYRMPRMENCPDELYD 241
Query: 591 FLLRCFLRNPVERPS 605
            +  C+     ERP+
Sbjct: 242 IMKMCWKEKAEERPT 256

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 90
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL-----TGLSYELSLKGSPNWMAPEVIKA 528
              +HRD+   N ++D    VK+ADFG+A+ +       +  +   K    WMA E ++ 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ- 209
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 586
                   K     D+WS G  + E++T G PP+ +         +L  R    PE    
Sbjct: 210 ------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 263
Query: 587 EGKDFLLRCFLRNPVERPSAVELL 610
              + +L+C+      RPS  EL+
Sbjct: 264 PLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 128/271 (47%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 15  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 70
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 71  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 190 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 241
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 242 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 128/271 (47%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 16  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 71
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 72  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 191 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 242
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 243 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 128/271 (47%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 68
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 188 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 239
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 128/271 (47%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 14  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 69
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 70  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIA 128
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 129 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 189 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 240
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 241 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TGA  A+K++     D +     +  ++EI++L  L  + 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDF 73
Query: 416 IVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G         L + +EY+  G +  +++ H   +  S +  ++  I  G+ YL S
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 133
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKA 528
              +HRD+   N+LV++   VK+ADFG+AK L  L  +  +   P      W APE +  
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPESLS- 191
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT 556
                 +   +   D+WS G  + E+ T
Sbjct: 192 ------DNIFSRQSDVWSFGVVLYELFT 213

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 21/265 (7%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +GRG FG V+      +  +   K V +   D         +++EI +L   +H NI+  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVKKEISILNIARHRNILHL 66
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
           + S    + L +  E++    I   +     ++ E  + ++   +   L +LHS N  H 
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126
Query: 480 DIKGANLLVDA--SGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           DI+  N++     S  +K+ +FG A+ L  G ++ L L  +P + APEV         + 
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEV-------HQHD 178
Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE----MLSSEGKDFL 592
            ++ A D+WSLG  V  +L+G  P+      Q +  ++N      E     +S E  DF+
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238
Query: 593 LRCFLRNPVERPSAVELLEHPFIRN 617
            R  ++    R +A E L+HP+++ 
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 360 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G+G FGSV    Y      TGA  A+K++     D +     +  ++EI++L  L  + 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDF 69
Query: 416 IVQYYGSEVVDD--HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           IV+Y G         L + +EY+  G +  +++ H   +  S +  ++  I  G+ YL S
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKA 528
              +HRD+   N+LV++   VK+ADFG+AK L  L  +  +   P      W APE +  
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAK-LLPLDKDXXVVREPGQSPIFWYAPESLS- 187
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT 556
                 +   +   D+WS G  + E+ T
Sbjct: 188 ------DNIFSRQSDVWSFGVVLYELFT 209

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHL 411
           W+  + +G G FG V    +++TG   AIK+   ++ P + +   C+     EI+++  L
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN-RERWCL-----EIQIMKKL 70
Query: 412 KHENIVQYYGSEVVD--------DHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFT 461
            H N+V     EV D        D   + +EY   G + +Y+   E+C  + E  +R   
Sbjct: 71  NHPNVVS--AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 128
Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKHLTGLSYELSLKGSP 518
             I + L YLH    IHRD+K  N+++       + K+ D G AK L          G+ 
Sbjct: 129 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL 188
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 561
            ++APE+++         K  + VD WS G    E +TG  P+
Sbjct: 189 QYLAPELLE-------QKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/317 (24%), Positives = 135/317 (42%), Gaps = 44/317 (13%)
Query: 340 HIMEKPSASPKKSQWQK-------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP 392
           ++   P+  P   +W+        GK +G G FG V   T      S A   V +    P
Sbjct: 27  YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 86
Query: 393 KSAECIKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-- 448
            +    ++ L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R    
Sbjct: 87  SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 146
Query: 449 ---CRDITESIVR------------NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 493
              C   + +I+             +F+  +  G+A+L S N IHRD+   N+L+    +
Sbjct: 147 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 206
Query: 494 VKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGC 549
            K+ DFG+A+ +   S    +KG+      WMAPE I        N       D+WS G 
Sbjct: 207 TKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESI-------FNCVYTFESDVWSYGI 258
Query: 550 TVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS- 605
            + E+ + G  P+         +K++     +  PE   +E  D +  C+  +P++RP+ 
Sbjct: 259 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 318
Query: 606 --AVELLEHPFIRNANY 620
              V+L+E     + N+
Sbjct: 319 KQIVQLIEKQISESTNH 335

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHL 411
           W+  + +G G FG V    +++TG   AIK+   ++ P + +   C+     EI+++  L
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN-RERWCL-----EIQIMKKL 69
Query: 412 KHENIVQYYGSEVVD--------DHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFT 461
            H N+V     EV D        D   + +EY   G + +Y+   E+C  + E  +R   
Sbjct: 70  NHPNVVS--AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKHLTGLSYELSLKGSP 518
             I + L YLH    IHRD+K  N+++       + K+ D G AK L          G+ 
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL 187
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 561
            ++APE+++         K  + VD WS G    E +TG  P+
Sbjct: 188 QYLAPELLE-------QKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/317 (24%), Positives = 135/317 (42%), Gaps = 44/317 (13%)
Query: 340 HIMEKPSASPKKSQWQK-------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP 392
           ++   P+  P   +W+        GK +G G FG V   T      S A   V +    P
Sbjct: 22  YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 81
Query: 393 KSAECIKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-- 448
            +    ++ L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R    
Sbjct: 82  SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 141
Query: 449 ---CRDITESIVR------------NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 493
              C   + +I+             +F+  +  G+A+L S N IHRD+   N+L+    +
Sbjct: 142 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 201
Query: 494 VKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGC 549
            K+ DFG+A+ +   S    +KG+      WMAPE I        N       D+WS G 
Sbjct: 202 TKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESI-------FNCVYTFESDVWSYGI 253
Query: 550 TVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS- 605
            + E+ + G  P+         +K++     +  PE   +E  D +  C+  +P++RP+ 
Sbjct: 254 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 313
Query: 606 --AVELLEHPFIRNANY 620
              V+L+E     + N+
Sbjct: 314 KQIVQLIEKQISESTNH 330

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 133/312 (42%), Gaps = 44/312 (14%)
Query: 345 PSASPKKSQWQK-------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 397
           P+  P   +W+        GK +G G FG V   T      S A   V +    P +   
Sbjct: 25  PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 84
Query: 398 IKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-----CR 450
            ++ L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R       C 
Sbjct: 85  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 144
Query: 451 DITESIVR------------NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 498
             + +I+             +F+  +  G+A+L S N IHRD+   N+L+    + K+ D
Sbjct: 145 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 204
Query: 499 FGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           FG+A+ +   S    +KG+      WMAPE I        N       D+WS G  + E+
Sbjct: 205 FGLARDIKNDS-NYVVKGNARLPVKWMAPESI-------FNCVYTFESDVWSYGIFLWEL 256
Query: 555 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS---AVE 608
            + G  P+         +K++     +  PE   +E  D +  C+  +P++RP+    V+
Sbjct: 257 FSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316
Query: 609 LLEHPFIRNANY 620
           L+E     + N+
Sbjct: 317 LIEKQISESTNH 328

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 135/301 (44%), Gaps = 33/301 (10%)
Query: 337 VMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVD 386
           V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 387 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 446
           +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ ++R
Sbjct: 83  VGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
           +H    T   +    R I +G+ YL     +HRD+   N+L++++ V K++DFG+++ L 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 507 G---LSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 561
                +Y       P  W +PE I          K   A D+WS G  + E+++ G+ P+
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAI-------AYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 562 SEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPFIR 616
            E    Q + K ++   R PP P    +     +L C+ ++   RP   +++      IR
Sbjct: 252 WEMSN-QDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 617 N 617
           N
Sbjct: 310 N 310

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 135/301 (44%), Gaps = 33/301 (10%)
Query: 337 VMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVD 386
           V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 387 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 446
           +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ ++R
Sbjct: 83  VGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
           +H    T   +    R I +G+ YL     +HRD+   N+L++++ V K++DFG+++ L 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 507 G---LSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 561
                +Y       P  W +PE I          K   A D+WS G  + E+++ G+ P+
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAI-------AYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 562 SEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPFIR 616
            E    Q + K ++   R PP P    +     +L C+ ++   RP   +++      IR
Sbjct: 252 WEMSN-QDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 617 N 617
           N
Sbjct: 310 N 310

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 133/274 (48%), Gaps = 19/274 (6%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-EIKVLGHLKHENI 416
           ++IGRG FG VY     +TG   A+K +D      K  E +   E+  + ++       I
Sbjct: 194 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 253
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V    +    D L   L+ ++ G ++ ++ +H    +E+ +R +   I+ GL ++H+   
Sbjct: 254 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMHNRFV 312
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           ++RD+K AN+L+D  G V+++D G+A   +      S+ G+  +MAPEV++  +  D   
Sbjct: 313 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDS-- 369
Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVLNRTPPIPEMLSSEGKDFLL 593
               + D +SLGC + ++L G  P+ + +     +     L     +P+  S E +  LL
Sbjct: 370 ----SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS-LL 424
Query: 594 RCFLRNPVER------PSAVELLEHPFIRNANYQ 621
              L+  V R        A E+ E PF R+ ++Q
Sbjct: 425 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 458

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 141/305 (46%), Gaps = 21/305 (6%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLK 412
           +  G+ +G G F  V     + TG   A K +        +     +++E+E+ +L  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H N++  +        + + LE V  G +  ++ +    ++E    +F + IL+G+ YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH 132
Query: 473 STNTIHRDIKGANLLVDASGV----VKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIK 527
           +    H D+K  N+++    +    +KL DFG+A  +  G+ ++ ++ G+P ++APE++ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK-NIFGTPEFVAPEIV- 190
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                +  P L L  D+WS+G     +L+G  P+      + +  +   +    E   S+
Sbjct: 191 -----NYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 588 ----GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQV 643
                KDF+ +  ++   +R +  E L HP+I   + Q   V  R  S +NL +     V
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV--RRESVVNLENFRKQYV 302
Query: 644 ERATR 648
            R ++
Sbjct: 303 RRRSK 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 136/303 (44%), Gaps = 33/303 (10%)
Query: 335 SAVMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKE 384
           + V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK 
Sbjct: 21  TYVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 385 VDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY 444
           + +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ +
Sbjct: 81  LKVGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 445 VREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 504
           +R+H    T   +    R I +G+ YL     +HRD+   N+L++++ V K++DFG+++ 
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 505 LTG---LSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP 559
           L      +Y       P  W +PE I          K   A D+WS G  + E+++ G+ 
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAI-------AYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 560 PWSEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPF 614
           P+ E    Q + K ++   R PP P    +     +L C+ ++   RP   +++      
Sbjct: 250 PYWEMSN-QDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
Query: 615 IRN 617
           IRN
Sbjct: 308 IRN 310

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 134/301 (44%), Gaps = 33/301 (10%)
Query: 337 VMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVD 386
           V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 387 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 446
           +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ ++R
Sbjct: 83  VGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
           +H    T   +    R I +G+ YL     +HRD+   N+L++++ V K++DFG+ + L 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 507 G---LSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 561
                +Y       P  W +PE I          K   A D+WS G  + E+++ G+ P+
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAI-------AYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 562 SEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPFIR 616
            E    Q + K ++   R PP P    +     +L C+ ++   RP   +++      IR
Sbjct: 252 WEMSN-QDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 617 N 617
           N
Sbjct: 310 N 310

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 133/274 (48%), Gaps = 19/274 (6%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-EIKVLGHLKHENI 416
           ++IGRG FG VY     +TG   A+K +D      K  E +   E+  + ++       I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V    +    D L   L+ ++ G ++ ++ +H    +E+ +R +   I+ GL ++H+   
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMHNRFV 313
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           ++RD+K AN+L+D  G V+++D G+A   +      S+ G+  +MAPEV++  +  D   
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDS-- 370
Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVLNRTPPIPEMLSSEGKDFLL 593
               + D +SLGC + ++L G  P+ + +     +     L     +P+  S E +  LL
Sbjct: 371 ----SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS-LL 425
Query: 594 RCFLRNPVER------PSAVELLEHPFIRNANYQ 621
              L+  V R        A E+ E PF R+ ++Q
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 459

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 124/267 (46%), Gaps = 15/267 (5%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K+++++K K++G G FG+VY G     G    I    +   +  S +  K++  E  V+ 
Sbjct: 47  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMA 106
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I  G+ 
Sbjct: 107 SVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 165
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 526
           YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA E I
Sbjct: 166 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 225
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPE--M 583
              +    +       D+WS G TV E++T G  P+      + +  +L +   +P+  +
Sbjct: 226 LHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPI 277
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELL 610
            + +    +++C++ +   RP   EL+
Sbjct: 278 CTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 41/278 (14%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---------- 399
           ++ + + G+ IG G FG V+ G             + + P++P  A  IK          
Sbjct: 8   QRERIELGRCIGEGQFGDVHQG-------------IYMSPENPAMAVAIKTCKNCTSDSV 54
Query: 400 --QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHCRDITES 455
             +  QE   +    H +IV+  G  + ++ ++I +E    G +  +  VR+   D+   
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASL 113
Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           I+  +   +   LAYL S   +HRDI   N+LV ++  VKL DFG+++++   +   + K
Sbjct: 114 IL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASK 171
Query: 516 GS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
           G     WMAPE I          +   A D+W  G  + E+L  G  P+   +    + +
Sbjct: 172 GKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 224
Query: 573 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           + N    P+P          + +C+  +P  RP   EL
Sbjct: 225 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 345 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAE 396
           P+  P   +W       Q GK +G G FG V   T    G   A+ +V + +      A+
Sbjct: 24  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 83
Query: 397 CIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--------- 446
             + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R         
Sbjct: 84  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK 143
Query: 447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
           E  R +    + +F+  +  G+A+L S N IHRD+   N+L+    V K+ DFG+A+ + 
Sbjct: 144 EDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 203
Query: 507 GLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
             S  + +KG+      WMAPE I   +         +  D+WS G  + E+ +
Sbjct: 204 NDSNYI-VKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 249

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 141/305 (46%), Gaps = 21/305 (6%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLK 412
           +  G+ +G G F  V     + TG   A K +        +     +++E+E+ +L  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H N++  +        + + LE V  G +  ++ +    ++E    +F + IL+G+ YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH 132
Query: 473 STNTIHRDIKGANLLVDASGV----VKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIK 527
           +    H D+K  N+++    +    +KL DFG+A  +  G+ ++ ++ G+P ++APE++ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK-NIFGTPEFVAPEIV- 190
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                +  P L L  D+WS+G     +L+G  P+      + +  + + +    E   S 
Sbjct: 191 -----NYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 588 ----GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQV 643
                KDF+ +  ++   +R +  E L HP+I   + Q   V  R  S +NL +     V
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV--RRESVVNLENFRKQYV 302
Query: 644 ERATR 648
            R ++
Sbjct: 303 RRRSK 307

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 20  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 75
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 76  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 195 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 246
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 247 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 15  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 70
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 71  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 190 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 241
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 242 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 19  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 74
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 75  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 133
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 134 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 194 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 245
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 246 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 136/303 (44%), Gaps = 33/303 (10%)
Query: 335 SAVMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKE 384
           + V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK 
Sbjct: 19  TYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 78
Query: 385 VDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY 444
           + +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ +
Sbjct: 79  LKVGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 134
Query: 445 VREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 504
           +R+H    T   +    R I +G+ YL     +HRD+   N+L++++ V K++DFG+++ 
Sbjct: 135 LRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 194
Query: 505 LTG---LSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP 559
           L      +Y       P  W +PE I          K   A D+WS G  + E+++ G+ 
Sbjct: 195 LEDDPEAAYTTRGGKIPIRWTSPEAI-------AYRKFTSASDVWSYGIVLWEVMSYGER 247
Query: 560 PWSEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPF 614
           P+ E    Q + K ++   R PP P    +     +L C+ ++   RP   +++      
Sbjct: 248 PYWEMSN-QDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305
Query: 615 IRN 617
           IRN
Sbjct: 306 IRN 308

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 135/301 (44%), Gaps = 33/301 (10%)
Query: 337 VMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVD 386
           V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK + 
Sbjct: 23  VDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 387 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 446
           +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ ++R
Sbjct: 83  VGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
           +H    T   +    R I +G+ YL     +HRD+   N+L++++ V K++DFG+++ L 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 507 G---LSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 561
                +Y       P  W +PE I          K   A D+WS G  + E+++ G+ P+
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAI-------AYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 562 SEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPFIR 616
            E    Q + K ++   R PP P    +     +L C+ ++   RP   +++      IR
Sbjct: 252 WEMSN-QDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 617 N 617
           N
Sbjct: 310 N 310

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 68
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 188 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 239
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 68
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 188 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 239
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 136/303 (44%), Gaps = 33/303 (10%)
Query: 335 SAVMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKE 384
           + V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK 
Sbjct: 21  TYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 385 VDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY 444
           + +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ +
Sbjct: 81  LKVGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 445 VREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 504
           +R+H    T   +    R I +G+ YL     +HRD+   N+L++++ V K++DFG+++ 
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 505 LTG---LSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP 559
           L      +Y       P  W +PE I          K   A D+WS G  + E+++ G+ 
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAI-------AYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 560 PWSEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPF 614
           P+ E    Q + K ++   R PP P    +     +L C+ ++   RP   +++      
Sbjct: 250 PYWEMSN-QDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
Query: 615 IRN 617
           IRN
Sbjct: 308 IRN 310

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 136/317 (42%), Gaps = 43/317 (13%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEV-------DIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +G G FG V+   ++E      +K +       D   +DPK    + ++  EI +L  ++
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPK----LGKVTLEIAILSRVE 87
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGS---INRYVREHCRDITESIVRNFTRHILNGLA 469
           H NI++    ++ ++  +  L     GS   +  ++  H R + E +     R +++ + 
Sbjct: 88  HANIIKVL--DIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVG 144
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           YL   + IHRDIK  N+++     +KL DFG A +L       +  G+  + APEV+   
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM-- 202
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 589
               GNP     +++WSLG T+  ++  + P+ E E      + +      P ++S E  
Sbjct: 203 ----GNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELM 252
Query: 590 DFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRK 649
             +       P  R +  +L+  P++                 +NL D + ++V R  + 
Sbjct: 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQP--------------VNLADYTWEEVFRVNKP 298
Query: 650 TESLPDSPETRVRNRKL 666
              +  +    + NR L
Sbjct: 299 ESGVLSAASLEMGNRSL 315

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 135/300 (45%), Gaps = 55/300 (18%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEI---KV 407
           +++ + + IG G FGSV+    R  G   AIK        P +    +Q   +E+    V
Sbjct: 7   TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR----SKKPLAGSVDEQNALREVYAHAV 62
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT---ESIVRNFTRHI 464
           LG  +H ++V+Y+ +   DDH+ I  EY + GS+   + E+ R ++   E+ +++    +
Sbjct: 63  LG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 120
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGV-------------------VKLADFGMAKHL 505
             GL Y+HS + +H DIK +N+ +  + +                    K+ D G   H+
Sbjct: 121 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HV 177
Query: 506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------ 559
           T +S     +G   ++A EV++       N       DI++L  TV+     +P      
Sbjct: 178 TRISSPQVEEGDSRFLANEVLQE------NYTHLPKADIFALALTVVXAAGAEPLPRNGD 231
Query: 560 PWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
            W E            R P IP++LS E  + L      +P  RPSA+ L++H  + +A+
Sbjct: 232 QWHEIRQ--------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 283

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 15  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 70
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 71  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG AK L     E   +G      WMA
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 190 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 241
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 242 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 345 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAE 396
           P+  P   +W       Q GK +G G FG V   T    G   A+ +V + +      A+
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 397 CIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--------- 446
             + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R         
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK 151
Query: 447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
           E  R +    + +F+  +  G+A+L S N IHRD+   N+L+    V K+ DFG+A+ + 
Sbjct: 152 EDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 211
Query: 507 GLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
             S  + +KG+      WMAPE I   +         +  D+WS G  + E+ +
Sbjct: 212 NDSNYI-VKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 257

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 38  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 93
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 94  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 152
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 153 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 213 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 264
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 265 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 16  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 71
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 72  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 191 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 242
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 243 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 16  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 71
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 72  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 191 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 242
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 243 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 40/218 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 90
Query: 418 ----------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
                     Q     +V D +            + Y    C+ ++   +  F   IL G
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM----------ETDLYKLLKCQHLSNDHICYFLYQILRG 140
Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGSPNWM 521
           L Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +  + 
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--ATRWYR 198
Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
           APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 199 APEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 230

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 126/284 (44%), Gaps = 26/284 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHLKHE 414
           ++IG G FG V  G  +  G     +E+ +     KS    KQ      E  ++G   H 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 68
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           N++   G       + I  E++  GS++ ++R++    T   +    R I  G+ YL   
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 128
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGS--PNWMAPEVIKA 528
           N +HR +   N+LV+++ V K++DFG+++ L    +  +Y  +L G     W APE I+ 
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 585
                   K   A D+WS G  + E+++ G+ P+ +      +  +    R PP P    
Sbjct: 189 -------RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP-PMDCP 240
Query: 586 SEGKDFLLRCFLRNPVERPSAVELLE--HPFIRNANYQNLSVPM 627
           S     +L C+ ++   RP   +++      IRN N      P+
Sbjct: 241 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPL 284

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 17  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 72
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 73  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 131
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG AK L     E   +G      WMA
Sbjct: 132 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 192 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 243
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 244 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 133/274 (48%), Gaps = 19/274 (6%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-EIKVLGHLKHENI 416
           ++IGRG FG VY     +TG   A+K +D      K  E +   E+  + ++       I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V    +    D L   L+ ++ G ++ ++ +H    +E+ +R +   I+ GL ++H+   
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMHNRFV 313
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           ++RD+K AN+L+D  G V+++D G+A   +      S+ G+  +MAPEV++  +  D   
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDS-- 370
Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVLNRTPPIPEMLSSEGKDFLL 593
               + D +SLGC + ++L G  P+ + +     +     L     +P+  S E +  LL
Sbjct: 371 ----SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS-LL 425
Query: 594 RCFLRNPVER------PSAVELLEHPFIRNANYQ 621
              L+  V R        A E+ E PF R+ ++Q
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 459

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 133/274 (48%), Gaps = 19/274 (6%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-EIKVLGHLKHENI 416
           ++IGRG FG VY     +TG   A+K +D      K  E +   E+  + ++       I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V    +    D L   L+ ++ G ++ ++ +H    +E+ +R +   I+ GL ++H+   
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMHNRFV 313
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           ++RD+K AN+L+D  G V+++D G+A   +      S+ G+  +MAPEV++  +  D   
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDS-- 370
Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVLNRTPPIPEMLSSEGKDFLL 593
               + D +SLGC + ++L G  P+ + +     +     L     +P+  S E +  LL
Sbjct: 371 ----SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS-LL 425
Query: 594 RCFLRNPVER------PSAVELLEHPFIRNANYQ 621
              L+  V R        A E+ E PF R+ ++Q
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 459

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 126/273 (46%), Gaps = 26/273 (9%)
Query: 358 KLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           K++G G FG V  G  +   +   S AIK + +   + +  + +     E  ++G   H 
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHP 77
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NI++  G       + I  EY+  GS++ ++R+H    T   +    R I +G+ YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG---LSYELSLKGSP-NWMAPEVIKAVM 530
             +HRD+   N+L++++ V K++DFG+++ L      +Y       P  W +PE I    
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI---- 193
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RTPPIPEMLSS 586
                 K   A D+WS G  + E+++ G+ P+ E    Q + K ++   R PP P    +
Sbjct: 194 ---AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPP-PMDCPA 248
Query: 587 EGKDFLLRCFLRNPVERPSAVELLE--HPFIRN 617
                +L C+ ++   RP   +++      IRN
Sbjct: 249 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 106
Query: 418 -QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
                +  ++    +YL   H    + Y     + ++   +  F   IL GL Y+HS N 
Sbjct: 107 NDIIRAPTIEQMKDVYL-VTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGSPNWMAPEVIKAVM 530
           +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +  + APE++   +
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV--ATRWYRAPEIM---L 220
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
              G  K   ++DIWS+GC + EML+ +P
Sbjct: 221 NSKGYTK---SIDIWSVGCILAEMLSNRP 246

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 126/273 (46%), Gaps = 26/273 (9%)
Query: 358 KLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           K++G G FG V  G  +   +   S AIK + +   + +  + +     E  ++G   H 
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHP 94
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NI++  G       + I  EY+  GS++ ++R+H    T   +    R I +G+ YL   
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG---LSYELSLKGSP-NWMAPEVIKAVM 530
             +HRD+   N+L++++ V K++DFG+++ L      +Y       P  W +PE I    
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI---- 210
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RTPPIPEMLSS 586
                 K   A D+WS G  + E+++ G+ P+ E    Q + K ++   R PP P    +
Sbjct: 211 ---AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPP-PMDCPA 265
Query: 587 EGKDFLLRCFLRNPVERPSAVELLE--HPFIRN 617
                +L C+ ++   RP   +++      IRN
Sbjct: 266 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 298

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 114/233 (48%), Gaps = 42/233 (18%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++   LIGRG++G VY+  ++    + AIK+V+ + +D    +C K++ +EI +L  LK 
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFED--LIDC-KRILREITILNRLKS 86
Query: 414 ENIVQYYGSEVVDD-----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
           + I++ +   + +D      LYI LE +    + +  +     +TE  V+    ++L G 
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIF-LTEQHVKTILYNLLLGE 144
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------------------------- 503
            ++H +  IHRD+K AN L++    VK+ DFG+A+                         
Sbjct: 145 KFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 504 HLTGLSYELSLKGSPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 555
           H   L  +L+      W  APE+I  ++Q++       ++DIWS GC   E+L
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELI--LLQENYTN----SIDIWSTGCIFAELL 251

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 139/302 (46%), Gaps = 21/302 (6%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLK 412
           +  G+ +G G F  V     + TG   A K +        +     +++E+E+ +L  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H N++  +        + + LE V  G +  ++ +    ++E    +F + IL+G+ YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH 132
Query: 473 STNTIHRDIKGANLLVDASGV----VKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIK 527
           +    H D+K  N+++    +    +KL DFG+A  +  G+ ++ ++ G+P ++APE++ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK-NIFGTPEFVAPEIV- 190
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                +  P L L  D+WS+G     +L+G  P+      + +  + + +    E   S 
Sbjct: 191 -----NYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 588 ----GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQV 643
                KDF+ +  ++   +R +  E L HP+I   + Q   V  R  S +NL +     V
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV--RRESVVNLENFRKQYV 302
Query: 644 ER 645
            R
Sbjct: 303 RR 304

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 138/299 (46%), Gaps = 21/299 (7%)
Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLKHEN 415
           G+ +G G F  V     + TG   A K +        +     +++E+E+ +L  + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           ++  +        + + LE V  G +  ++ +    ++E    +F + IL+G+ YLH+  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 476 TIHRDIKGANLLVDASGV----VKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVM 530
             H D+K  N+++    +    +KL DFG+A  +  G+ ++ ++ G+P ++APE++    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK-NIFGTPEFVAPEIV---- 190
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE--- 587
             +  P L L  D+WS+G     +L+G  P+      + +  +   +    E   S+   
Sbjct: 191 --NYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 588 -GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVER 645
             KDF+ +  ++   +R +  E L HP+I   + Q   V  R  S +NL +     V R
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV--RRESVVNLENFRKQYVRR 304

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 34/238 (14%)
Query: 345 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAE 396
           P+  P   +W       Q GK +G G FG V   T    G   A+ +V + +      A+
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 397 CIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR----- 450
             + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R   R     
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 451 --------DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 502
                    ++   + +F+  +  G+A+L S N IHRD+   N+L+    V K+ DFG+A
Sbjct: 152 PAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 503 KHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
           + +   S  + +KG+      WMAPE I   +         +  D+WS G  + E+ +
Sbjct: 212 RDIMNDSNYI-VKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 261

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 10  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 65
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 66  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 124
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 125 EGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 185 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 236
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 237 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 267

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 7   KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 62
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 63  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 182 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 233
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 264

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 27/279 (9%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 34  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 92
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 151
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 210
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP 579
           PE I+       +     +  +WSLG  + +M+ G  P+    E  G Q  F+       
Sbjct: 211 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR------- 257
Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
             + +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 258 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 27/279 (9%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 34  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 92
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 151
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 210
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP 579
           PE I+       +     +  +WSLG  + +M+ G  P+    E  G Q  F+       
Sbjct: 211 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR------- 257
Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
             + +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 258 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 131/288 (45%), Gaps = 49/288 (17%)
Query: 357 GKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
           GK +G G FG V +           NR T  +  + + D    D   ++ I ++E  +K+
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEM-MKM 81
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EHCRD--------I 452
           +G  KH+NI+   G+   D  LY+ +EY   G++  Y++       E+  +        +
Sbjct: 82  IG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 453 TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 512
           +   + +    +  G+ YL S   IHRD+   N+LV    V+K+ADFG+A+ +  + Y  
Sbjct: 140 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY-- 197
Query: 513 SLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 565
             K + N      WMAPE +   +    +       D+WS G  + E+ T G  P+    
Sbjct: 198 -YKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLWEIFTLGGSPYPGVP 249
Query: 566 GPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
             + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 250 -VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 27/279 (9%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 33  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 91
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 150
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 151 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 209
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP 579
           PE I+       +     +  +WSLG  + +M+ G  P+    E  G Q  F+       
Sbjct: 210 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR------- 256
Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
             + +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 257 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 128/276 (46%), Gaps = 18/276 (6%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K+++ +K K++G G FG+V+ G     G S  I     + +D    +  + +   +  +G
Sbjct: 29  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 88
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            L H +IV+  G       L +  +Y+  GS+  +VR+H   +   ++ N+   I  G+ 
Sbjct: 89  SLDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 147
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVI 526
           YL     +HR++   N+L+ +   V++ADFG+A  L     +L     K    WMA E I
Sbjct: 148 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 207
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF---EGPQAMFKVLNRTPPIPE 582
                     K     D+WS G TV E++T G  P++     E P  + K        P+
Sbjct: 208 HF-------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK--GERLAQPQ 258
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           + + +    +++C++ +   RP+  E L + F R A
Sbjct: 259 ICTIDVYMVMVKCWMIDENIRPTFKE-LANEFTRMA 293

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 81
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 82  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 140
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +    Y      K    W APE I        
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY------ 194
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 195 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 252
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 253 MRLCWKERPEDRPT 266

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 27/279 (9%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 33  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 91
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 150
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 151 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 209
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP 579
           PE I+       +     +  +WSLG  + +M+ G  P+    E  G Q  F+       
Sbjct: 210 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR------- 256
Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
             + +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 257 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 131/288 (45%), Gaps = 49/288 (17%)
Query: 357 GKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
           GK +G G FG V +           NR T  +  + + D    D   ++ I ++E  +K+
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEM-MKM 78
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EHCRD--------I 452
           +G  KH+NI+   G+   D  LY+ +EY   G++  Y++       E+  +        +
Sbjct: 79  IG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 453 TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 512
           +   + +    +  G+ YL S   IHRD+   N+LV    V+K+ADFG+A+ +  + Y  
Sbjct: 137 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY-- 194
Query: 513 SLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 565
             K + N      WMAPE +   +    +       D+WS G  + E+ T G  P+    
Sbjct: 195 -YKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLWEIFTLGGSPYPGVP 246
Query: 566 GPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
             + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 247 -VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 135/300 (45%), Gaps = 55/300 (18%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEI---KV 407
           +++ + + IG G FGSV+    R  G   AIK        P +    +Q   +E+    V
Sbjct: 9   TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR----SKKPLAGSVDEQNALREVYAHAV 64
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT---ESIVRNFTRHI 464
           LG  +H ++V+Y+ +   DDH+ I  EY + GS+   + E+ R ++   E+ +++    +
Sbjct: 65  LG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGV-------------------VKLADFGMAKHL 505
             GL Y+HS + +H DIK +N+ +  + +                    K+ D G   H+
Sbjct: 123 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HV 179
Query: 506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------ 559
           T +S     +G   ++A EV++       N       DI++L  TV+     +P      
Sbjct: 180 TRISSPQVEEGDSRFLANEVLQE------NYTHLPKADIFALALTVVCAAGAEPLPRNGD 233
Query: 560 PWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
            W E            R P IP++LS E  + L      +P  RPSA+ L++H  + +A+
Sbjct: 234 QWHEIRQ--------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 285

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 135/300 (45%), Gaps = 55/300 (18%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEI---KV 407
           +++ + + IG G FGSV+    R  G   AIK        P +    +Q   +E+    V
Sbjct: 9   TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR----SKKPLAGSVDEQNALREVYAHAV 64
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT---ESIVRNFTRHI 464
           LG  +H ++V+Y+ +   DDH+ I  EY + GS+   + E+ R ++   E+ +++    +
Sbjct: 65  LG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGV-------------------VKLADFGMAKHL 505
             GL Y+HS + +H DIK +N+ +  + +                    K+ D G   H+
Sbjct: 123 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HV 179
Query: 506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------ 559
           T +S     +G   ++A EV++       N       DI++L  TV+     +P      
Sbjct: 180 TRISSPQVEEGDSRFLANEVLQE------NYTHLPKADIFALALTVVCAAGAEPLPRNGD 233
Query: 560 PWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
            W E            R P IP++LS E  + L      +P  RPSA+ L++H  + +A+
Sbjct: 234 QWHEIRQ--------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 285

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 124/263 (47%), Gaps = 42/263 (15%)
Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-------REHCRDI 452
             + E++++  +K+E  +   G     D +YI  EY+   SI ++        + +   I
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 453 TESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 511
              +++   + +LN  +Y+H+  N  HRD+K +N+L+D +G VKL+DFG ++++     +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 571
            S +G+  +M PE        +G       VDIWSLG  +  M     P+S       +F
Sbjct: 209 GS-RGTYEFMPPEFFSNESSYNG-----AKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 572 KVLNRTPPIP---------------------EMLSSEGKDFLLRCFLR-NPVERPSAVEL 609
             + RT  I                        LS+E  DF L+ FLR NP ER ++ + 
Sbjct: 263 NNI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF-LKLFLRKNPAERITSEDA 320
Query: 610 LEHPFIRNANYQNLSVPMRVFSR 632
           L+H ++ + N ++L    R FS+
Sbjct: 321 LKHEWLADTNIEDL----REFSK 339

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 49/302 (16%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 393
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 12  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 69
Query: 394 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 446
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 70  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 126
Query: 447 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 498
           E+  +        ++   + +    +  G+ YL S   IHRD+   N+LV    V+K+AD
Sbjct: 127 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 186
Query: 499 FGMAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 552
           FG+A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + 
Sbjct: 187 FGLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 236
Query: 553 EMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           E+ T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L
Sbjct: 237 EIFTLGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 295
Query: 610 LE 611
           +E
Sbjct: 296 VE 297

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 34/238 (14%)
Query: 345 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAE 396
           P+  P   +W       Q GK +G G FG V   T    G   A+ +V + +      A+
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 397 CIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--- 452
             + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R   R +   
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 453 --------TESI--VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 502
                   T S   + +F+  +  G+A+L S N IHRD+   N+L+    V K+ DFG+A
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 503 KHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
           + +   S  + +KG+      WMAPE I   +         +  D+WS G  + E+ +
Sbjct: 212 RDIMNDSNYI-VKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 261

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 111/262 (42%), Gaps = 32/262 (12%)
Query: 360 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           IG G FG V++G   N++  A   IKE  +  DD           +E +V+  L H  +V
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD---------FIEEAEVMMKLSHPKLV 85
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG  +    + +  E++  G ++ Y+R          +      +  G+AYL     I
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 145
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGN 535
           HRD+   N LV  + V+K++DFGM + +    Y  S   K    W +PEV          
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF------- 198
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSE------FEGPQAMFKVLNRTPPIPEMLSSEG 588
            + +   D+WS G  + E+ + GK P+         E     F++       P + S+  
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTHV 253
Query: 589 KDFLLRCFLRNPVERPSAVELL 610
              +  C+   P +RP+   LL
Sbjct: 254 YQIMNHCWKERPEDRPAFSRLL 275

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 49/302 (16%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 393
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 76
Query: 394 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 446
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 77  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 447 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 498
           E+  +        ++   + +    +  G+ YL S   IHRD+   N+LV    V+K+AD
Sbjct: 134 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 193
Query: 499 FGMAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 552
           FG+A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + 
Sbjct: 194 FGLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 243
Query: 553 EMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           E+ T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L
Sbjct: 244 EIFTLGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302
Query: 610 LE 611
           +E
Sbjct: 303 VE 304

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 126/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 23  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 78
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 79  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 137
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 138 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 198 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 249
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    + +C++ +   RP   EL+
Sbjct: 250 QPPICTIDVYMIMRKCWMIDADSRPKFRELI 280

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 28/276 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHLKHE 414
           K+IG G FG V  G  +  G     +E+ +     K+    KQ      E  ++G   H 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGK----REICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 90
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NI+   G       + I  EY+  GS++ ++R++    T   +    R I +G+ YL   
Sbjct: 91  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG---LSYELSLKGSP-NWMAPEVIKAVM 530
           + +HRD+   N+LV+++ V K++DFGM++ L      +Y       P  W APE I    
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI---- 206
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RTPPIPEMLSS 586
                 K   A D+WS G  + E+++ G+ P+ +    Q + K +    R PP P     
Sbjct: 207 ---AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPP-PMDCPI 261
Query: 587 EGKDFLLRCFLRNPVERP---SAVELLEHPFIRNAN 619
                +L C+ +   +RP     V +L+   IRN N
Sbjct: 262 ALHQLMLDCWQKERSDRPKFGQIVNMLDK-LIRNPN 296

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++  G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 20  KETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 75
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 76  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 195 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 246
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 247 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 135/300 (45%), Gaps = 55/300 (18%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEI---KV 407
           +++ + + IG G FGSV+    R  G   AIK        P +    +Q   +E+    V
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR----SKKPLAGSVDEQNALREVYAHAV 66
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT---ESIVRNFTRHI 464
           LG  +H ++V+Y+ +   DDH+ I  EY + GS+   + E+ R ++   E+ +++    +
Sbjct: 67  LG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGV-------------------VKLADFGMAKHL 505
             GL Y+HS + +H DIK +N+ +  + +                    K+ D G   H+
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HV 181
Query: 506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------ 559
           T +S     +G   ++A EV++       N       DI++L  TV+     +P      
Sbjct: 182 TRISSPQVEEGDSRFLANEVLQE------NYTHLPKADIFALALTVVCAAGAEPLPRNGD 235
Query: 560 PWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
            W E            R P IP++LS E  + L      +P  RPSA+ L++H  + +A+
Sbjct: 236 QWHEIRQ--------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 126/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 15  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 70
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 71  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG AK L     E   +G      WMA
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 190 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 241
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    + +C++ +   RP   EL+
Sbjct: 242 QPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 126/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 16  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 71
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 72  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 191 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 242
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    + +C++ +   RP   EL+
Sbjct: 243 QPPICTIDVYMIMRKCWMIDADSRPKFRELI 273

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 129/282 (45%), Gaps = 19/282 (6%)
Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLK 412
           +  G+ +G G F  V     + TG   A K +        +     +++E+E+ +L  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H N++  +        + + LE V  G +  ++ +    ++E    +F + IL+G+ YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH 132
Query: 473 STNTIHRDIKGANLLVDASGV----VKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIK 527
           +    H D+K  N+++    +    +KL DFG+A  +  G+ ++ ++ G+P ++APE++ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK-NIFGTPEFVAPEIV- 190
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                     L L  D+WS+G     +L+G  P+      + +  + + +    E   S 
Sbjct: 191 ------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 588 ----GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSV 625
                KDF+ +  ++   +R +  E L HP+I   + Q   V
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 131/288 (45%), Gaps = 49/288 (17%)
Query: 357 GKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 407
           GK +G G FG V +           NR T  +  + + D    D   ++ I ++E  +K+
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEM-MKM 89
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EHCRD--------I 452
           +G  KH+NI+   G+   D  LY+ +EY   G++  Y++       E+  +        +
Sbjct: 90  IG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 453 TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 512
           +   + +    +  G+ YL S   IHRD+   N+LV    V+K+ADFG+A+ +  + Y  
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY-- 205
Query: 513 SLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 565
             K + N      WMAPE +   +    +       D+WS G  + E+ T G  P+    
Sbjct: 206 -YKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLWEIFTLGGSPYPGVP 257
Query: 566 GPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
             + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E
Sbjct: 258 -VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 125/280 (44%), Gaps = 24/280 (8%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++ G+++G G    V++  +       A+K +    D  +      +  +E +    L 
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALN 70
Query: 413 HENIVQYYGSEVVDDHL----YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
           H  IV  Y +   +       YI +EYV  G   R +      +T              L
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT----GLSYELSLKGSPNWMAPE 524
            + H    IHRD+K AN+++ A+  VK+ DFG+A+ +      ++   ++ G+  +++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 581
                 Q  G+   A + D++SLGC + E+LTG+PP++  + P ++     R  PIP   
Sbjct: 190 ------QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSA 241
Query: 582 --EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
             E LS++    +L+   +NP  R      +    +R  N
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 125/280 (44%), Gaps = 24/280 (8%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++ G+++G G    V++  +       A+K   +  D  +      +  +E +    L 
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKV--LRADLARDPSFYLRFRREAQNAAALN 70
Query: 413 HENIVQYYGSEVVDDHL----YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
           H  IV  Y +   +       YI +EYV  G   R +      +T              L
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT----GLSYELSLKGSPNWMAPE 524
            + H    IHRD+K AN+++ A+  VK+ DFG+A+ +      ++   ++ G+  +++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 581
                 Q  G+   A + D++SLGC + E+LTG+PP++  + P ++     R  PIP   
Sbjct: 190 ------QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTG-DSPDSVAYQHVREDPIPPSA 241
Query: 582 --EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
             E LS++    +L+   +NP  R      +    +R  N
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 77
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 78  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 136
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +    Y      K    W APE I        
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY------ 190
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 191 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 248
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 249 MRLCWKERPEDRPT 262

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 126/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 20  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 75
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 76  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG AK L     E   +G      WMA
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 195 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 246
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 247 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 49/302 (16%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 393
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 60  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 117
Query: 394 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 446
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 118 LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174
Query: 447 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 498
           E+  +        ++   + +    +  G+ YL S   IHRD+   N+LV    V+K+AD
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 499 FGMAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 552
           FG+A+ +  + Y    K + N      WMAPE +   +    +       D+WS G  + 
Sbjct: 235 FGLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 284
Query: 553 EMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           E+ T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L
Sbjct: 285 EIFTLGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 343
Query: 610 LE 611
           +E
Sbjct: 344 VE 345

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 76
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 77  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 135
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +    Y      K    W APE I        
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY------ 189
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 190 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 247
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 248 MRLCWKERPEDRPT 261

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 142/296 (47%), Gaps = 46/296 (15%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++  K +G+G +G V+   +R TG   A+K+   I D  +++   ++  +EI +L  L 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKK---IFDAFQNSTDAQRTFREIMILTELS 66
Query: 413 -HENIVQYYGSEVVDDHLYIYLEYVH-PGSINRYVREHCRDITESIVRNFTRH-ILNGLA 469
            HENIV        D+   +YL + +    ++  +R    +I E + + +  + ++  + 
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA---NILEPVHKQYVVYQLIKVIK 123
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELSLKGSPN------- 519
           YLHS   +HRD+K +N+L++A   VK+ADFG+++    +   +  + L  + N       
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 520 ------------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 567
                       + APE++       G+ K    +D+WSLGC + E+L GKP    F G 
Sbjct: 184 QPILTDYVATRWYRAPEILL------GSTKYTKGIDMWSLGCILGEILCGKPI---FPGS 234
Query: 568 QAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 623
             M + L R   + +  S+E  + +   F +  +E      L E   IR +N +++
Sbjct: 235 STMNQ-LERIIGVIDFPSNEDVESIQSPFAKTMIE-----SLKEKVEIRQSNKRDI 284

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 126/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 68
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG AK L     E   +G      WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 188 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 239
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 128/276 (46%), Gaps = 18/276 (6%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K+++ +K K++G G FG+V+ G     G S  I     + +D    +  + +   +  +G
Sbjct: 11  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            L H +IV+  G       L +  +Y+  GS+  +VR+H   +   ++ N+   I  G+ 
Sbjct: 71  SLDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVI 526
           YL     +HR++   N+L+ +   V++ADFG+A  L     +L     K    WMA E I
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF---EGPQAMFKVLNRTPPIPE 582
                     K     D+WS G TV E++T G  P++     E P  + K        P+
Sbjct: 190 HF-------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK--GERLAQPQ 240
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           + + +    +++C++ +   RP+  E L + F R A
Sbjct: 241 ICTIDVYMVMVKCWMIDENIRPTFKE-LANEFTRMA 275

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 12/254 (4%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IG+G FG VY G      +    CAIK +  I +     + ++   +E  ++  L H 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE----MQQVEAFLREGLLMRGLNHP 82
Query: 415 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           N++   G  +  + L ++ L Y+  G + +++R   R+ T   + +F   +  G+ YL  
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
              +HRD+   N ++D S  VK+ADFG+A+ +    Y  S++   +   P V    ++  
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY-YSVQQHRHARLP-VKWTALESL 200
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE-GPQAMFKVLNRTPPIPEMLSSEGKDF 591
              +     D+WS G  + E+LT G PP+   +      F    R  P PE         
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQV 260
Query: 592 LLRCFLRNPVERPS 605
           + +C+  +P  RP+
Sbjct: 261 MQQCWEADPAVRPT 274

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 124/280 (44%), Gaps = 24/280 (8%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++ G+++G G    V++  +       A+K +    D  +      +  +E +    L 
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALN 70
Query: 413 HENIVQYYGSEVVDDHL----YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
           H  IV  Y +   +       YI +EYV  G   R +      +T              L
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT----GLSYELSLKGSPNWMAPE 524
            + H    IHRD+K AN+L+ A+  VK+ DFG+A+ +      +    ++ G+  +++PE
Sbjct: 130 NFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 581
                 Q  G+   A + D++SLGC + E+LTG+PP++  + P ++     R  PIP   
Sbjct: 190 ------QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSA 241
Query: 582 --EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
             E LS++    +L+   +NP  R      +    +R  N
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 125/280 (44%), Gaps = 24/280 (8%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++ G+++G G    V++  +       A+K +    D  +      +  +E +    L 
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALN 70
Query: 413 HENIVQYYGSEVVDDHL----YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
           H  IV  Y +   +       YI +EYV  G   R +      +T              L
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT----GLSYELSLKGSPNWMAPE 524
            + H    IHRD+K AN+++ A+  VK+ DFG+A+ +      ++   ++ G+  +++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 581
                 Q  G+   A + D++SLGC + E+LTG+PP++  + P ++     R  PIP   
Sbjct: 190 ------QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSA 241
Query: 582 --EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
             E LS++    +L+   +NP  R      +    +R  N
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/320 (24%), Positives = 137/320 (42%), Gaps = 48/320 (15%)
Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 393
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 76
Query: 394 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---- 449
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 77  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 450 -----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 498
                        ++   + +    +  G+ YL S   IHRD+   N+LV    V+K+AD
Sbjct: 134 EFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 193
Query: 499 FGMAK---HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 555
           FG+A+   H+       + +    WMAPE +   +    +       D+WS G  + E+ 
Sbjct: 194 FGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLWEIF 246
Query: 556 T-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           T G  P+      + +FK+L     +  P   ++E    +  C+   P +RP+  +L+E 
Sbjct: 247 TLGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 305
Query: 613 -----PFIRNANYQNLSVPM 627
                    N    +LS+P+
Sbjct: 306 LDRIVALTSNQEXLDLSMPL 325

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 125/280 (44%), Gaps = 24/280 (8%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++ G+++G G    V++  +       A+K   +  D  +      +  +E +    L 
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKV--LRADLARDPSFYLRFRREAQNAAALN 70
Query: 413 HENIVQYYGSEVVDDHL----YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
           H  IV  Y +   +       YI +EYV  G   R +      +T              L
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT----GLSYELSLKGSPNWMAPE 524
            + H    IHRD+K AN+++ A+  VK+ DFG+A+ +      ++   ++ G+  +++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 581
                 Q  G+   A + D++SLGC + E+LTG+PP++  + P ++     R  PIP   
Sbjct: 190 ------QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSA 241
Query: 582 --EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
             E LS++    +L+   +NP  R      +    +R  N
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 71
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +    Y      K    W APE I        
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY------ 184
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 185 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 242
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 243 MRLCWKERPEDRPT 256

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 66
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 67  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 125
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +    Y      K    W APE I        
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY------ 179
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 180 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 237
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 238 MRLCWKERPEDRPT 251

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 134/301 (44%), Gaps = 33/301 (10%)
Query: 337 VMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVD 386
           V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 387 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 446
           +   + +  + +     E  ++G   H NI++  G       + I  E +  GS++ ++R
Sbjct: 83  VGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR 138
Query: 447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
           +H    T   +    R I +G+ YL     +HRD+   N+L++++ V K++DFG+++ L 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 507 G---LSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 561
                +Y       P  W +PE I          K   A D+WS G  + E+++ G+ P+
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAI-------AYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 562 SEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPFIR 616
            E    Q + K ++   R PP P    +     +L C+ ++   RP   +++      IR
Sbjct: 252 WEMSN-QDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 617 N 617
           N
Sbjct: 310 N 310

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 27/279 (9%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 59
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 118
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 177
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP 579
           PE I+       +     +  +WSLG  + +M+ G  P+    E  G Q  F+       
Sbjct: 178 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR------- 224
Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
             + +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 225 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 132/278 (47%), Gaps = 48/278 (17%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENIVQ 418
           IG G++       ++ T    A+K +D    DP          +EI++L  + +H NI+ 
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDP---------SEEIEILLRYGQHPNIIT 85
Query: 419 YYGSEVVDD--HLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNG-LAYLHST 474
               +V DD  H+Y+  E +  G + ++ +R+      E+   +F  H +   + YLHS 
Sbjct: 86  L--KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREA---SFVLHTIGKTVEYLHSQ 140
Query: 475 NTIHRDIKGANLL-VDASG---VVKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVI 526
             +HRD+K +N+L VD SG    +++ DFG AK L     E  L  +P    N++APEV+
Sbjct: 141 GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRA---ENGLLMTPCYTANFVAPEVL 197
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM-FKVLNRTPPIPEMLS 585
           K     +G        DIWSLG  +  ML G  P++   GP     ++L R       LS
Sbjct: 198 KRQGYDEG-------CDIWSLGILLYTMLAGYTPFA--NGPSDTPEEILTRIGSGKFTLS 248
Query: 586 S--------EGKDFLLRCFLRNPVERPSAVELLEHPFI 615
                      KD + +    +P +R +A ++L+HP++
Sbjct: 249 GGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 127/283 (44%), Gaps = 38/283 (13%)
Query: 357 GKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           GK +GRG FG V      G ++   A+C    V ++ +    +E  + L  E+K+L H+ 
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSE-HRALMSELKILIHIG 89
Query: 413 HE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDIT-----ESIVRNF----- 460
           H  N+V   G+       L + +E+   G+++ Y+R    +       E + ++F     
Sbjct: 90  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEH 149
Query: 461 ----TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG 516
               +  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +     +   KG
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK-DPDXVRKG 208
Query: 517 SP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WMAPE I        +    +  D+WS G  + E+ + G  P+   +  +   
Sbjct: 209 DARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 572 KVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           + L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 28/276 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHLKHE 414
           K+IG G FG V  G  +  G     +E+ +     K+    KQ      E  ++G   H 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGK----REICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NI+   G       + I  EY+  GS++ ++R++    T   +    R I +G+ YL   
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG---LSYELSLKGSP-NWMAPEVIKAVM 530
           + +HRD+   N+LV+++ V K++DFGM++ L      +Y       P  W APE I    
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI---- 191
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RTPPIPEMLSS 586
                 K   A D+WS G  + E+++ G+ P+ +    Q + K +    R PP P     
Sbjct: 192 ---AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPP-PMDCPI 246
Query: 587 EGKDFLLRCFLRNPVERP---SAVELLEHPFIRNAN 619
                +L C+ +   +RP     V +L+   IRN N
Sbjct: 247 ALHQLMLDCWQKERSDRPKFGQIVNMLDK-LIRNPN 281

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 126/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++  G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 13  KETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 68
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 188 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 239
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 126/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 68
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 188 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 239
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    + +C++ +   RP   EL+
Sbjct: 240 QPPICTIDVYMIMRKCWMIDADSRPKFRELI 270

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 123/279 (44%), Gaps = 27/279 (9%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 34  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 92
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 151
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 210
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP 579
           PE I+       +     +  +WSLG  + +M+ G  P+    E  G Q  F+       
Sbjct: 211 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR------- 257
Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
             + +S E +  +  C    P +RP+  E+  HP++++ 
Sbjct: 258 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 113/227 (49%), Gaps = 33/227 (14%)
Query: 346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
              P+ +Q Q    IG G +G V    +       AIK++   P + ++  C + L +EI
Sbjct: 40  DVGPRYTQLQ---YIGEGAYGMVSSAYDHVRKTRVAIKKIS--PFEHQTY-CQRTL-REI 92
Query: 406 KVLGHLKHENIV------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 459
           ++L   +HEN++      +    E + D +YI  + +     + Y     + ++   +  
Sbjct: 93  QILLRFRHENVIGIRDILRASTLEAMRD-VYIVQDLM---ETDLYKLLKSQQLSNDHICY 148
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELS 513
           F   IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG    L+
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGF---LT 205
Query: 514 LKGSPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
              +  W  APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 206 EXVATRWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 246

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 123/279 (44%), Gaps = 27/279 (9%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 34  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 92
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 151
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 210
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP 579
           PE I+       +     +  +WSLG  + +M+ G  P+    E  G Q  F+       
Sbjct: 211 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR------- 257
Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
             + +S E +  +  C    P +RP+  E+  HP++++ 
Sbjct: 258 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 126/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++  G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 20  KETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 75
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 76  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G      WMA
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 195 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 246
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    +++C++ +   RP   EL+
Sbjct: 247 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 28/276 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHLKHE 414
           K+IG G FG V  G  +  G     +E+ +     K+    KQ      E  ++G   H 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGK----REICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NI+   G       + I  EY+  GS++ ++R++    T   +    R I +G+ YL   
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG---LSYELSLKGSP-NWMAPEVIKAVM 530
           + +HRD+   N+LV+++ V K++DFGM++ L      +Y       P  W APE I    
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI---- 185
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RTPPIPEMLSS 586
                 K   A D+WS G  + E+++ G+ P+ +    Q + K +    R PP P     
Sbjct: 186 ---AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPP-PMDCPI 240
Query: 587 EGKDFLLRCFLRNPVERP---SAVELLEHPFIRNAN 619
                +L C+ +   +RP     V +L+   IRN N
Sbjct: 241 ALHQLMLDCWQKERSDRPKFGQIVNMLDK-LIRNPN 275

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 133/303 (43%), Gaps = 44/303 (14%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIV 417
           ++G G    V    N  T    A+K ++  P   +S     ++ +E+++L   + H N++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-----RVFREVEMLYQCQGHRNVL 74
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYLHSTN 475
           +       +D  Y+  E +  GSI  ++  R H  ++  S+V    + + + L +LH+  
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVASALDFLHNKG 131
Query: 476 TIHRDIKGANLLVD---ASGVVKLADFGMAK--HLTGLSYELSLK------GSPNWMAPE 524
             HRD+K  N+L +       VK+ DFG+     L G    +S        GS  +MAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 584
           V++A  ++          D+WSLG  +  +L+G PP+    G    +      P    ML
Sbjct: 192 VVEAFSEE--ASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 585 -------------------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN-LS 624
                              S   KD + +  +R+  +R SA ++L+HP+++    +N L 
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309
Query: 625 VPM 627
            PM
Sbjct: 310 TPM 312

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 133/282 (47%), Gaps = 48/282 (17%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENIVQ 418
           IG G++       ++ T    A+K +D    DP          +EI++L  + +H NI+ 
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS---------EEIEILLRYGQHPNIIT 85
Query: 419 YYGSEVVDD--HLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILN-GLAYLHST 474
               +V DD  H+Y+  E +  G + ++ +R+      E+   +F  H +   + YLHS 
Sbjct: 86  L--KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREA---SFVLHTIGKTVEYLHSQ 140
Query: 475 NTIHRDIKGANLL-VDASG---VVKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVI 526
             +HRD+K +N+L VD SG    +++ DFG AK L     E  L  +P    N++APEV+
Sbjct: 141 GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRA---ENGLLMTPCYTANFVAPEVL 197
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM-FKVLNRTPPIPEMLS 585
           K     +G        DIWSLG  +  ML G  P++   GP     ++L R       LS
Sbjct: 198 KRQGYDEG-------CDIWSLGILLYTMLAGYTPFA--NGPSDTPEEILTRIGSGKFTLS 248
Query: 586 S--------EGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
                      KD + +    +P +R +A ++L+HP++   +
Sbjct: 249 GGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKD 290

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 123/263 (46%), Gaps = 25/263 (9%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++G G FG VY G    ++    + A+K    D   D+ +      +   E  ++ +L 
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE------KFMSEAVIMKNLD 83
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H +IV+  G  + ++  +I +E    G +  Y+  +   +    +  ++  I   +AYL 
Sbjct: 84  HPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 142
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGSP-NWMAPEVIKAVM 530
           S N +HRDI   N+LV +   VKL DFG+++++     Y+ S+   P  WM+PE I    
Sbjct: 143 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-- 200
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPP--WSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                 +   A D+W     + E+L+ GK P  W E +    + +  +R P  P++    
Sbjct: 201 -----RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPV 254
Query: 588 GKDFLLRCFLRNPVERPSAVELL 610
               + RC+  +P +RP   EL+
Sbjct: 255 LYTLMTRCWDYDPSDRPRFTELV 277

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 130/290 (44%), Gaps = 39/290 (13%)
Query: 351 KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           + + + GK +GRG FG V      G ++   A+C    V ++ +    +E  + L  E+K
Sbjct: 26  RDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSE-HRALMSELK 82
Query: 407 VLGHLKHE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDIT------ESIVR 458
           +L H+ H  N+V   G+       L + +E+   G+++ Y+R    +        E + +
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 459 NF---------TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
           +F         +  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +    
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-D 201
Query: 510 YELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 564
            +   KG       WMAPE I        +    +  D+WS G  + E+ + G  P+   
Sbjct: 202 PDYVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 565 EGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +  +   + L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 130/290 (44%), Gaps = 39/290 (13%)
Query: 351 KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           + + + GK +GRG FG V      G ++   A+C    V ++ +    +E  + L  E+K
Sbjct: 17  RDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSEH-RALMSELK 73
Query: 407 VLGHLKHE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDIT------ESIVR 458
           +L H+ H  N+V   G+       L + +E+   G+++ Y+R    +        E + +
Sbjct: 74  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 459 NF---------TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
           +F         +  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +    
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK-D 192
Query: 510 YELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 564
            +   KG       WMAPE I        +    +  D+WS G  + E+ + G  P+   
Sbjct: 193 PDXVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 245
Query: 565 EGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +  +   + L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIKE+     +  S +  K++  E 
Sbjct: 15  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 70
Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 71  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG AK L     E   +G      WMA
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 581
            E I   +    +       D+WS G TV E++T G  P+      + +  +L +   +P
Sbjct: 190 LESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP 241
Query: 582 E--MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           +  + + +    + +C++ +   RP   EL+
Sbjct: 242 QPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 131/290 (45%), Gaps = 39/290 (13%)
Query: 351 KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           + + + GK +GRG FG V      G ++   A+C    V ++ +    +E  + L  E+K
Sbjct: 28  RDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSE-HRALMSELK 84
Query: 407 VLGHLKHE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREH------CRDITESIVR 458
           +L H+ H  N+V   G+       L + +E+   G+++ Y+R         ++  E + +
Sbjct: 85  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYK 144
Query: 459 NF---------TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
           +F         +  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +    
Sbjct: 145 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-D 203
Query: 510 YELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 564
            +   KG       WMAPE I        +    +  D+WS G  + E+ + G  P+   
Sbjct: 204 PDYVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 256
Query: 565 EGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +  +   + L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 257 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 123/279 (44%), Gaps = 27/279 (9%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 33  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 91
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 150
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 151 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 209
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP 579
           PE I+       +     +  +WSLG  + +M+ G  P+    E  G Q  F+       
Sbjct: 210 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR------- 256
Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
             + +S E +  +  C    P +RP+  E+  HP++++ 
Sbjct: 257 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 130/290 (44%), Gaps = 39/290 (13%)
Query: 351 KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           + + + GK +GRG FG V      G ++   A+C    V ++ +    +E  + L  E+K
Sbjct: 26  RDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSE-HRALMSELK 82
Query: 407 VLGHLKHE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDIT------ESIVR 458
           +L H+ H  N+V   G+       L + +E+   G+++ Y+R    +        E + +
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 459 NF---------TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
           +F         +  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +    
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK-D 201
Query: 510 YELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 564
            +   KG       WMAPE I        +    +  D+WS G  + E+ + G  P+   
Sbjct: 202 PDXVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 565 EGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +  +   + L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 86
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 132
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV--AT 190
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 191 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 226

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 124/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 5   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 63
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE + P   +  ++ E    + E + R+F   
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGA-LQEELARSFFWQ 122
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 181
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 182 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 229
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 230 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 86
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 132
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV--AT 190
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 191 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 226

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 127/286 (44%), Gaps = 24/286 (8%)
Query: 339 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAE 396
           PH+ EK    P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +   
Sbjct: 21  PHMKEK---EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 77
Query: 397 CIKQLEQEIKVLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDIT 453
             + +  E+ +L  +      +++        D   + LE   P   +  ++ E    + 
Sbjct: 78  GTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQ 135
Query: 454 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYEL 512
           E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y  
Sbjct: 136 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT- 194
Query: 513 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK 572
              G+  +  PE I+       +     +  +WSLG  + +M+ G  P+   E      +
Sbjct: 195 DFDGTRVYSPPEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E 242
Query: 573 VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           ++       + +S E +  +  C    P +RP+  E+  HP++++ 
Sbjct: 243 IIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 288

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 79
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 80  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 138
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +     +     K    W APE I        
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY------ 192
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 193 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 250
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 251 MRLCWKERPEDRPT 264

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 130/290 (44%), Gaps = 39/290 (13%)
Query: 351 KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           + + + GK +GRG FG V      G ++   A+C    V ++ +    +E  + L  E+K
Sbjct: 26  RDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSE-HRALMSELK 82
Query: 407 VLGHLKHE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDIT------ESIVR 458
           +L H+ H  N+V   G+       L + +E+   G+++ Y+R    +        E + +
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 459 NF---------TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
           +F         +  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +    
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-D 201
Query: 510 YELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 564
            +   KG       WMAPE I        +    +  D+WS G  + E+ + G  P+   
Sbjct: 202 PDXVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 565 EGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +  +   + L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLAFRHENIIGI 88
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 134
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYV--AT 192
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 193 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 228

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 50/223 (22%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 86
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 132
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG    L+   +
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGF---LTEYVA 189
Query: 518 PNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             W  APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 190 TRWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 226

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 90
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 136
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV--AT 194
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 195 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 88
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 134
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 192
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 193 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 228

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 86
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 132
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 190
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 191 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 226

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 90
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 136
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV--AT 194
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 195 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 230

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 77
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 78  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 136
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +     +     K    W APE I        
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY------ 190
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 191 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 248
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 249 MRLCWKERPEDRPT 262

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 91
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 137
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV--AT 195
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 196 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 231

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 24/274 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IG G FG V  G  +  G    + AIK + +   + +  + +     E  ++G   H 
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFL----CEASIMGQFDHP 104
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           N+V   G       + I +E++  G+++ ++R+H    T   +    R I  G+ YL   
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPNWMAPEVIKAVM 530
             +HRD+   N+LV+++ V K++DFG+++ +      +      K    W APE I+   
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ--- 221
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 589
                 K   A D+WS G  + E+++ G+ P+ +    Q + K +     +P  +     
Sbjct: 222 ----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPAPMDCPAG 276
Query: 590 --DFLLRCFLRNPVERPSAVEL--LEHPFIRNAN 619
               +L C+ +   ERP   ++  +    IRN N
Sbjct: 277 LHQLMLDCWQKERAERPKFEQIVGILDKMIRNPN 310

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 123/263 (46%), Gaps = 25/263 (9%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++G G FG VY G    ++    + A+K    D   D+ +      +   E  ++ +L 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE------KFMSEAVIMKNLD 67
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H +IV+  G  + ++  +I +E    G +  Y+  +   +    +  ++  I   +AYL 
Sbjct: 68  HPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 126
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGSP-NWMAPEVIKAVM 530
           S N +HRDI   N+LV +   VKL DFG+++++     Y+ S+   P  WM+PE I    
Sbjct: 127 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-- 184
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPP--WSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                 +   A D+W     + E+L+ GK P  W E +    + +  +R P  P++    
Sbjct: 185 -----RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPV 238
Query: 588 GKDFLLRCFLRNPVERPSAVELL 610
               + RC+  +P +RP   EL+
Sbjct: 239 LYTLMTRCWDYDPSDRPRFTELV 261

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 42/233 (18%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S +++  ++G+G FG V    N       AIK++        + E +  +  E+ +L  L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI------RHTEEKLSTILSEVMLLASL 59
Query: 412 KHENIVQYYGSEVVDDH-------------LYIYLEYVHPGSINRYVR-EHCRDITESIV 457
            H+ +V+YY + +   +             L+I +EY   G++   +  E+     +   
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------------- 503
           R F R IL  L+Y+HS   IHRD+K  N+ +D S  VK+ DFG+AK              
Sbjct: 120 RLF-RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 504 HLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 555
           +L G S  L S  G+  ++A EV+      DG       +D++SLG    EM+
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVL------DGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 130/290 (44%), Gaps = 39/290 (13%)
Query: 351 KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           + + + GK +GRG FG V      G ++   A+C    V ++ +    +E  + L  E+K
Sbjct: 63  RDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSEH-RALMSELK 119
Query: 407 VLGHLKHE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDIT------ESIVR 458
           +L H+ H  N+V   G+       L + +E+   G+++ Y+R    +        E + +
Sbjct: 120 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 179
Query: 459 NF---------TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
           +F         +  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +    
Sbjct: 180 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-D 238
Query: 510 YELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 564
            +   KG       WMAPE I        +    +  D+WS G  + E+ + G  P+   
Sbjct: 239 PDYVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291
Query: 565 EGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +  +   + L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 292 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 91
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 137
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 195
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 196 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 231

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 80
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 81  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 139
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +     +     K    W APE I        
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY------ 193
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 194 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 251
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 252 MRLCWKERPEDRPT 265

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 92
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 93  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 138
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 139 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 196
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 197 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 83
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 84  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 129
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 130 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 187
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 188 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 90
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 136
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 194
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 195 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 230

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 84
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 130
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 188
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 189 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 224

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 123/263 (46%), Gaps = 25/263 (9%)
Query: 358 KLIGRGTFGSVYIGT---NRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++G G FG VY G    ++    + A+K    D   D+ +      +   E  ++ +L 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE------KFMSEAVIMKNLD 71
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H +IV+  G  + ++  +I +E    G +  Y+  +   +    +  ++  I   +AYL 
Sbjct: 72  HPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGSP-NWMAPEVIKAVM 530
           S N +HRDI   N+LV +   VKL DFG+++++     Y+ S+   P  WM+PE I    
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-- 188
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPP--WSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                 +   A D+W     + E+L+ GK P  W E +    + +  +R P  P++    
Sbjct: 189 -----RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPV 242
Query: 588 GKDFLLRCFLRNPVERPSAVELL 610
               + RC+  +P +RP   EL+
Sbjct: 243 LYTLMTRCWDYDPSDRPRFTELV 265

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ- 418
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 106
Query: 419 ---------------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 107 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 152
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 210
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 211 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 246

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 36/240 (15%)
Query: 345 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAE 396
           P+  P   +W       Q GK +G G FG V   T    G   A+ +V + +      A+
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 397 CIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 448
             + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R       E+
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEY 151
Query: 449 CRD--------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
             +        ++   + +F+  +  G+A+L S N IHRD+   N+L+    V K+ DFG
Sbjct: 152 SYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 211
Query: 501 MAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
           +A+ +   S  + +KG+      WMAPE I   +         +  D+WS G  + E+ +
Sbjct: 212 LARDIMNDSNYI-VKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 263

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 112/262 (42%), Gaps = 32/262 (12%)
Query: 360 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           IG G FG V++G   N++  A   I+E  +  +D           +E +V+  L H  +V
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAEVMMKLSHPKLV 65
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG  +    + +  E++  G ++ Y+R          +      +  G+AYL   + I
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVI 125
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGN 535
           HRD+   N LV  + V+K++DFGM + +    Y  S   K    W +PEV          
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF------- 178
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSE------FEGPQAMFKVLNRTPPIPEMLSSEG 588
            + +   D+WS G  + E+ + GK P+         E     F++       P + S+  
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTHV 233
Query: 589 KDFLLRCFLRNPVERPSAVELL 610
              +  C+   P +RP+   LL
Sbjct: 234 YQIMNHCWKERPEDRPAFSRLL 255

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 127/261 (48%), Gaps = 24/261 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI---KQLEQEIKVLGHLKHE 414
           K IG+G FG V+ G   +  +  AIK + I+ D     E I   ++ ++E+ ++ +L H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NIV+ YG  ++ +   + +E+V  G +   + +    I  S+       I  G+ Y+ + 
Sbjct: 84  NIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 475 N--TIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           N   +HRD++  N+ +     +A    K+ADFG+++    +     L G+  WMAPE I 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--SVHSVSGLLGNFQWMAPETIG 199
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----PPIPEM 583
           A  +++   + A   D +S    +  +LTG+ P+ E+   +  F  + R     P IPE 
Sbjct: 200 A--EEESYTEKA---DTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 584 LSSEGKDFLLRCFLRNPVERP 604
                ++ +  C+  +P +RP
Sbjct: 255 CPPRLRNVIELCWSGDPKKRP 275

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/313 (23%), Positives = 136/313 (43%), Gaps = 70/313 (22%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +GRG FG V+   N+    + AIK + +    P      +++ +E+K L  L+H  IV+Y
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 420 YGSEVVDD------------HLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHIL 465
           + + +  +            +LYI ++     ++  ++   C   +   S+  +    I 
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL----------- 514
             + +LHS   +HRD+K +N+      VVK+ DFG+   +     E ++           
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 515 --KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK 572
              G+  +M+PE      Q  GN   +  VDI+SLG  + E+L   P  ++ E  + +  
Sbjct: 189 GQVGTKLYMSPE------QIHGN-SYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTD 239
Query: 573 VLN-RTPP------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           V N + PP            + +MLS             +P+ERP A+ ++E     NA 
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQDMLSP------------SPMERPEAINIIE-----NAV 282
Query: 620 YQNLSVPMRVFSR 632
           +++L  P +   R
Sbjct: 283 FEDLDFPGKTVLR 295

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 84
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 130
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 188
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 189 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 224

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 135/303 (44%), Gaps = 33/303 (10%)
Query: 335 SAVMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKE 384
           + V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK 
Sbjct: 21  TYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 385 VDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY 444
           + +   + +  + +     E  ++G   H NI++  G       + I  E +  GS++ +
Sbjct: 81  LKVGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 445 VREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 504
           +R+H    T   +    R I +G+ YL     +HRD+   N+L++++ V K++DFG+++ 
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 505 LTG---LSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP 559
           L      +Y       P  W +PE I          K   A D+WS G  + E+++ G+ 
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAI-------AYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 560 PWSEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPF 614
           P+ E    Q + K ++   R PP P    +     +L C+ ++   RP   +++      
Sbjct: 250 PYWEMSN-QDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
Query: 615 IRN 617
           IRN
Sbjct: 308 IRN 310

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 94
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 95  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 140
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 141 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 198
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 199 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 86
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 132
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 190
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 191 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 226

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 125/280 (44%), Gaps = 24/280 (8%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++ G+++G G    V++  +       A+K +    D  +      +  +E +    L 
Sbjct: 30  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALN 87
Query: 413 HENIVQYYGSEVVDDHL----YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
           H  IV  Y +   +       YI +EYV  G   R +      +T              L
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQAL 146
Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT----GLSYELSLKGSPNWMAPE 524
            + H    IHRD+K AN+++ A+  VK+ DFG+A+ +      ++   ++ G+  +++PE
Sbjct: 147 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 581
                 Q  G+   A + D++SLGC + E+LTG+PP++  + P ++     R  PIP   
Sbjct: 207 ------QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSA 258
Query: 582 --EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
             E LS++    +L+   +NP  R      +    +R  N
Sbjct: 259 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 298

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 129/290 (44%), Gaps = 39/290 (13%)
Query: 351 KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           + + + GK +GRG FG V      G ++   A+C    V ++ +    +E  + L  E+K
Sbjct: 17  RDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSEH-RALMSELK 73
Query: 407 VLGHLKHE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDIT------ESIVR 458
           +L H+ H  N+V   G+       L +  E+   G+++ Y+R    +        E + +
Sbjct: 74  ILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 459 NF---------TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
           +F         +  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +    
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK-D 192
Query: 510 YELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 564
            +   KG       WMAPE I        +    +  D+WS G  + E+ + G  P+   
Sbjct: 193 PDXVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 245
Query: 565 EGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +  +   + L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 129/290 (44%), Gaps = 39/290 (13%)
Query: 351 KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           + + + GK +GRG FG V      G ++   A+C    V ++ +    +E  + L  E+K
Sbjct: 17  RDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSE-HRALMSELK 73
Query: 407 VLGHLKHE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDIT------ESIVR 458
           +L H+ H  N+V   G+       L +  E+   G+++ Y+R    +        E + +
Sbjct: 74  ILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 459 NF---------TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
           +F         +  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +    
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-D 192
Query: 510 YELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 564
            +   KG       WMAPE I        +    +  D+WS G  + E+ + G  P+   
Sbjct: 193 PDYVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 245
Query: 565 EGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +  +   + L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 20  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 78
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 137
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 138 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 196
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 197 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 244
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 245 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLAFRHENIIGI 88
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 134
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 192
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 193 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 228

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 129/290 (44%), Gaps = 39/290 (13%)
Query: 351 KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           + + + GK +GRG FG V      G ++   A+C    V ++ +    +E  + L  E+K
Sbjct: 17  RDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSEH-RALMSELK 73
Query: 407 VLGHLKHE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDIT------ESIVR 458
           +L H+ H  N+V   G+       L +  E+   G+++ Y+R    +        E + +
Sbjct: 74  ILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 459 NF---------TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 509
           +F         +  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +    
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-D 192
Query: 510 YELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 564
            +   KG       WMAPE I        +    +  D+WS G  + E+ + G  P+   
Sbjct: 193 PDYVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 245
Query: 565 EGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +  +   + L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 40  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 98
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 99  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 157
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 216
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 217 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 264
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 26/273 (9%)
Query: 358 KLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           K++G G FG V  G  +   +   S AIK + +   + +  + +     E  ++G   H 
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHP 77
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NI++  G       + I  E +  GS++ ++R+H    T   +    R I +G+ YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG---LSYELSLKGSP-NWMAPEVIKAVM 530
             +HRD+   N+L++++ V K++DFG+++ L      +Y       P  W +PE I    
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI---- 193
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RTPPIPEMLSS 586
                 K   A D+WS G  + E+++ G+ P+ E    Q + K ++   R PP P    +
Sbjct: 194 ---AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPP-PMDCPA 248
Query: 587 EGKDFLLRCFLRNPVERPSAVELLE--HPFIRN 617
                +L C+ ++   RP   +++      IRN
Sbjct: 249 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 71
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +     +     K    W APE I        
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY------ 184
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 185 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 242
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 243 MRLCWKERPEDRPT 256

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 117/257 (45%), Gaps = 52/257 (20%)
Query: 340 HIMEKPSASPKK--SQWQK------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD 391
           H   KP+AS  +  S WQ         LIG G++G V    ++      AIK++  + +D
Sbjct: 33  HHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED 92
Query: 392 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-----HLYIYLEYVHPGSINRYVR 446
               +C K++ +EI +L  L H+++V+     +  D      LY+ LE +      +  R
Sbjct: 93  --LIDC-KRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFR 148
Query: 447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK--- 503
                +TE  ++    ++L G+ Y+HS   +HRD+K AN LV+    VK+ DFG+A+   
Sbjct: 149 TPVY-LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207
Query: 504 ------------------------HLTGLSYELSLKGSPNWM-APEVIKAVMQKDGNPKL 538
                                   H   L  +L+      W  APE+I  ++Q++     
Sbjct: 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI--LLQENYTE-- 263
Query: 539 ALAVDIWSLGCTVIEML 555
             A+D+WS+GC   E+L
Sbjct: 264 --AIDVWSIGCIFAELL 278

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 21  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 79
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 138
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 139 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 197
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 198 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 245
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 246 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 128/272 (47%), Gaps = 36/272 (13%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           IG G++       ++ T    A+K +D    DP         E EI +L + +H NI+  
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-------EIEI-LLRYGQHPNIITL 81
Query: 420 YGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
              +V DD  Y+Y+  E +  G + ++ +R+      E+    FT  I   + YLH+   
Sbjct: 82  --KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT--ITKTVEYLHAQGV 137
Query: 477 IHRDIKGANLL-VDASG---VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
           +HRD+K +N+L VD SG    +++ DFG AK L     E  L  +P + A  V   V+++
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA---ENGLLMTPCYTANFVAPEVLER 194
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM-FKVLNR--------TPPIPEM 583
            G      A DIWSLG  +  MLTG  P++   GP     ++L R        +      
Sbjct: 195 QGYDA---ACDIWSLGVLLYTMLTGYTPFA--NGPDDTPEEILARIGSGKFSLSGGYWNS 249
Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           +S   KD + +    +P +R +A  +L HP+I
Sbjct: 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 48  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 106
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 165
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 166 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 224
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 225 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 272
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 273 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 33  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 91
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 150
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 151 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 209
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 210 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 257
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 258 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 67
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 68  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 126
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDG 534
           IHR+++ AN+LV  +   K+ADFG+A+ +    Y      K    W APE I        
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY------ 180
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 181 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 238
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 239 MRLCWKERPEDRPT 252

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 6   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 64
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 123
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 182
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 183 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 230
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 231 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AI+++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 90
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 136
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 194
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 195 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 230

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 73
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 74  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 132
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +     +     K    W APE I        
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY------ 186
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 187 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 244
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 245 MRLCWKERPEDRPT 258

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 139/301 (46%), Gaps = 47/301 (15%)
Query: 341 IMEKPSASPKK--SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI 398
           I+ K S  PK       +G ++ RG F +  +   R            I+P      EC 
Sbjct: 20  IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR------------ILP------ECF 61
Query: 399 KQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 457
              ++E+++L    +H N+++Y+ +E      YI +E     ++  YV +  +D     +
Sbjct: 62  SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQ--KDFAHLGL 118
Query: 458 RNFT--RHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVK--LADFGMAKHLTGLSY 510
              T  +   +GLA+LHS N +HRD+K  N+L+   +A G +K  ++DFG+ K L    +
Sbjct: 119 EPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 511 ELSLK----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 565
             S +    G+  W+APE    ++ +D        VDI+S GC    +++ G  P+ +  
Sbjct: 179 SFSRRSGVPGTEGWIAPE----MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 566 GPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR-----NPVERPSAVELLEHPFIRNANY 620
             QA   +L     +  +   + +D + R  +      +P +RPSA  +L+HPF  +   
Sbjct: 235 QRQA--NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292
Query: 621 Q 621
           Q
Sbjct: 293 Q 293

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 123/259 (47%), Gaps = 24/259 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGA--SC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IG G FG V  G  +  G   SC AIK +     + +  E +     E  ++G  +H 
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFL----SEASIMGQFEHP 75
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NI++  G       + I  E++  G+++ ++R +    T   +    R I +G+ YL   
Sbjct: 76  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEM 135
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGS--PNWMAPEVIKA 528
           + +HRD+   N+LV+++ V K++DFG+++ L    +  +Y  SL G     W APE I  
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI-- 193
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 585
                   K   A D WS G  + E+++ G+ P+ +      +  +    R PP P+  +
Sbjct: 194 -----AFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPT 248
Query: 586 SEGKDFLLRCFLRNPVERP 604
           S  +  +L C+ ++   RP
Sbjct: 249 SLHQ-LMLDCWQKDRNARP 266

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 72
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 73  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 131
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +     +     K    W APE I        
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY------ 185
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 186 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 243
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 244 MRLCWKERPEDRPT 257

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 107/247 (43%), Gaps = 43/247 (17%)
Query: 345 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAE 396
           P+  P   +W       Q GK +G G FG V   T    G   A+ +V + +      A+
Sbjct: 17  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 76
Query: 397 CIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--------- 446
             + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R         
Sbjct: 77  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGP 136
Query: 447 -------------EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 493
                        E  R +    + +F+  +  G+A+L S N IHRD+   N+L+    V
Sbjct: 137 SLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 196
Query: 494 VKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGC 549
            K+ DFG+A+ +   S  + +KG+      WMAPE I   +         +  D+WS G 
Sbjct: 197 AKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGI 248
Query: 550 TVIEMLT 556
            + E+ +
Sbjct: 249 LLWEIFS 255

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 48/222 (21%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 417
           IG G +G V    +       AIK++            ++    EIK+L   +HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR----EIKILLRFRHENIIGI 90
Query: 418 --------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
                          Y   ++++  LY  L+  H              ++   +  F   
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 136
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGLSYELSLKGS 517
           IL GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+        TG   E     +
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV--AT 194
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             + APE++   +   G  K   ++DIWS+GC + EML+ +P
Sbjct: 195 RWYRAPEIM---LNSKGYTK---SIDIWSVGCILAEMLSNRP 230

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 129/283 (45%), Gaps = 23/283 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           +G G FG V+    + TG     K ++   P D  +      ++ EI ++  L H  ++ 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT------VKNEISIMNQLHHPKLIN 112
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
            + +      + + LE++  G +   +      ++E+ V N+ R    GL ++H  + +H
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172
Query: 479 RDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
            DIK  N++ +   +  VK+ DFG+A  L           +  + APE++      D  P
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV------DREP 226
Query: 537 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE----MLSSEGKDFL 592
            +    D+W++G     +L+G  P++  +  + +  V        E     +S E KDF+
Sbjct: 227 -VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285
Query: 593 LRCFLRNPVERPSAVELLEHPFIRNANYQNLS--VPMRVFSRI 633
                + P +R +  + LEHP+++  ++ NL+  +P   +++I
Sbjct: 286 KNLLQKEPRKRLTVHDALEHPWLK-GDHSNLTSRIPSSRYNKI 327

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 118/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FG V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 71
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +     +     K    W APE I        
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY------ 184
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 185 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 242
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 243 MRLCWKERPEDRPT 256

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 111/262 (42%), Gaps = 32/262 (12%)
Query: 360 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           IG G FG V++G   N++  A   I+E  +  +D           +E +V+  L H  +V
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAEVMMKLSHPKLV 65
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG  +    + +  E++  G ++ Y+R          +      +  G+AYL     I
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 125
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGN 535
           HRD+   N LV  + V+K++DFGM + +    Y  S   K    W +PEV          
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF------- 178
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSE------FEGPQAMFKVLNRTPPIPEMLSSEG 588
            + +   D+WS G  + E+ + GK P+         E     F++       P + S+  
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTHV 233
Query: 589 KDFLLRCFLRNPVERPSAVELL 610
              +  C+   P +RP+   LL
Sbjct: 234 YQIMNHCWKERPEDRPAFSRLL 255

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 126/261 (48%), Gaps = 24/261 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI---KQLEQEIKVLGHLKHE 414
           K IG+G FG V+ G   +  +  AIK + I+ D     E I   ++ ++E+ ++ +L H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NIV+ YG  ++ +   + +E+V  G +   + +    I  S+       I  G+ Y+ + 
Sbjct: 84  NIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 475 N--TIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           N   +HRD++  N+ +     +A    K+ADFG ++    +     L G+  WMAPE I 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ--SVHSVSGLLGNFQWMAPETIG 199
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----PPIPEM 583
           A  +++   + A   D +S    +  +LTG+ P+ E+   +  F  + R     P IPE 
Sbjct: 200 A--EEESYTEKA---DTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 584 LSSEGKDFLLRCFLRNPVERP 604
                ++ +  C+  +P +RP
Sbjct: 255 CPPRLRNVIELCWSGDPKKRP 275

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 111/262 (42%), Gaps = 32/262 (12%)
Query: 360 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           IG G FG V++G   N++  A   I+E  +  +D           +E +V+  L H  +V
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAEVMMKLSHPKLV 63
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG  +    + +  E++  G ++ Y+R          +      +  G+AYL     I
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGN 535
           HRD+   N LV  + V+K++DFGM + +    Y  S   K    W +PEV          
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF------- 176
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSE------FEGPQAMFKVLNRTPPIPEMLSSEG 588
            + +   D+WS G  + E+ + GK P+         E     F++       P + S+  
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTHV 231
Query: 589 KDFLLRCFLRNPVERPSAVELL 610
              +  C+   P +RP+   LL
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLL 253

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 111/262 (42%), Gaps = 32/262 (12%)
Query: 360 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           IG G FG V++G   N++  A   I+E  +  +D           +E +V+  L H  +V
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAEVMMKLSHPKLV 68
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG  +    + +  E++  G ++ Y+R          +      +  G+AYL     I
Sbjct: 69  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 128
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGN 535
           HRD+   N LV  + V+K++DFGM + +    Y  S   K    W +PEV          
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF------- 181
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSE------FEGPQAMFKVLNRTPPIPEMLSSEG 588
            + +   D+WS G  + E+ + GK P+         E     F++       P + S+  
Sbjct: 182 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTHV 236
Query: 589 KDFLLRCFLRNPVERPSAVELL 610
              +  C+   P +RP+   LL
Sbjct: 237 YQIMNHCWRERPEDRPAFSRLL 258

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 6   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 64
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 123
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 182
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 183 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 230
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 231 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 107/241 (44%), Gaps = 58/241 (24%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S +++  ++G+G FG V    N       AIK++        + E +  +  E+ +L  L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI------RHTEEKLSTILSEVMLLASL 59
Query: 412 KHENIVQYYGSEVVDDH-------------LYIYLEY---------VHPGSINRYVREHC 449
            H+ +V+YY + +   +             L+I +EY         +H  ++N+   E+ 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 450 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------ 503
           R           R IL  L+Y+HS   IHRD+K  N+ +D S  VK+ DFG+AK      
Sbjct: 120 R---------LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 504 --------HLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
                   +L G S  L S  G+  ++A EV+      DG       +D++SLG    EM
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVL------DGTGHYNEKIDMYSLGIIFFEM 224
Query: 555 L 555
           +
Sbjct: 225 I 225

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 5   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 63
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 122
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 181
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 182 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 229
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 230 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 6   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 64
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 123
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 182
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 183 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 230
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 231 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 32/262 (12%)
Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI------KQLEQE 404
           +S +   + I  G++G+V  G + E G   AIK V     D ++   +      K++ +E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 405 IKVLGHLKHENI-----VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 459
           I++L H  H NI     +  +  E     LY+  E +    + + + +    I+   ++ 
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY 138
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN 519
           F  HIL GL  LH    +HRD+   N+L+  +  + + DF +A+  T  + +        
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--- 576
           + APE+   VMQ  G  KL   VD+WS GC + EM   K   + F G    +  LN+   
Sbjct: 199 YRAPEL---VMQFKGFTKL---VDMWSAGCVMAEMFNRK---ALFRG-STFYNQLNKIVE 248
Query: 577 ---TPPIPE--MLSS-EGKDFL 592
              TP I +  M SS   +D+L
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYL 270

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 104/240 (43%), Gaps = 27/240 (11%)
Query: 339 PHIMEKPSASPK-------KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD 391
           PH  E+P  + +        S+    K+IG G  G V  G  R  G     ++V +    
Sbjct: 29  PHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ----RDVPVAIKA 84
Query: 392 PKSAECIKQ---LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 448
            K+    +Q      E  ++G   H NI++  G         I  EY+  GS++ ++R H
Sbjct: 85  LKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH 144
Query: 449 CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-- 506
               T   +    R +  G+ YL     +HRD+   N+LVD++ V K++DFG+++ L   
Sbjct: 145 DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 507 -GLSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWS 562
              +Y  +    P  W APE I            + A D+WS G  + E+L    +P W+
Sbjct: 205 PDAAYTTTGGKIPIRWTAPEAI-------AFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 132/303 (43%), Gaps = 44/303 (14%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIV 417
           ++G G    V    N  T    A+K ++  P   +S     ++ +E+++L   + H N++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-----RVFREVEMLYQCQGHRNVL 74
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYLHSTN 475
           +       +D  Y+  E +  GSI  ++  R H  ++  S+V    + + + L +LH+  
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVASALDFLHNKG 131
Query: 476 TIHRDIKGANLLVD---ASGVVKLADF--GMAKHLTGLSYELSLK------GSPNWMAPE 524
             HRD+K  N+L +       VK+ DF  G    L G    +S        GS  +MAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 584
           V++A  ++          D+WSLG  +  +L+G PP+    G    +      P    ML
Sbjct: 192 VVEAFSEE--ASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 585 -------------------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN-LS 624
                              S   KD + +  +R+  +R SA ++L+HP+++    +N L 
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309
Query: 625 VPM 627
            PM
Sbjct: 310 TPM 312

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 21/277 (7%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEI 405
            P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEV 78
Query: 406 KVLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTR 462
            +L  +      +++        D   + LE   P   +  ++ E    + E + R+F  
Sbjct: 79  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFW 137
Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
            +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  + 
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYS 196
Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP 581
            PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       
Sbjct: 197 PPEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR 244
Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           + +S E +  +  C    P +RP+  E+  HP++++ 
Sbjct: 245 QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDV 281

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 32/262 (12%)
Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI------KQLEQE 404
           +S +   + I  G++G+V  G + E G   AIK V     D ++   +      K++ +E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 405 IKVLGHLKHENI-----VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 459
           I++L H  H NI     +  +  E     LY+  E +    + + + +    I+   ++ 
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY 138
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN 519
           F  HIL GL  LH    +HRD+   N+L+  +  + + DF +A+  T  + +        
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--- 576
           + APE+   VMQ  G  KL   VD+WS GC + EM   K   + F G    +  LN+   
Sbjct: 199 YRAPEL---VMQFKGFTKL---VDMWSAGCVMAEMFNRK---ALFRG-STFYNQLNKIVE 248
Query: 577 ---TPPIPE--MLSS-EGKDFL 592
              TP I +  M SS   +D+L
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYL 270

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 21  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 79
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 138
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 139 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 197
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 198 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 245
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +S E +  +  C    P +RP+  E+  HP++++ 
Sbjct: 246 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 21/277 (7%)
Query: 348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEI 405
            P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+
Sbjct: 3   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEV 61
Query: 406 KVLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTR 462
            +L  +      +++        D   + LE   P   +  ++ E    + E + R+F  
Sbjct: 62  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFW 120
Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
            +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  + 
Sbjct: 121 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYS 179
Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP 581
            PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       
Sbjct: 180 PPEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR 227
Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           + +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 228 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 264

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 111/262 (42%), Gaps = 32/262 (12%)
Query: 360 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           IG G FG V++G   N++  A   I+E  +  +D           +E +V+  L H  +V
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAEVMMKLSHPKLV 66
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           Q YG  +    + +  E++  G ++ Y+R          +      +  G+AYL     I
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGN 535
           HRD+   N LV  + V+K++DFGM + +    Y  S   K    W +PEV          
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF------- 179
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSE------FEGPQAMFKVLNRTPPIPEMLSSEG 588
            + +   D+WS G  + E+ + GK P+         E     F++       P + S+  
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTHV 234
Query: 589 KDFLLRCFLRNPVERPSAVELL 610
              +  C+   P +RP+   LL
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLL 256

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 59
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 118
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 177
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 178 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 225
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 20  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 78
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 137
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 138 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 196
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 197 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 244
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +S E +  +  C    P +RP+  E+  HP++++ 
Sbjct: 245 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 53  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 111
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 112 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 170
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 171 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 229
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 230 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 277
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +S E +  +  C    P +RP+  E+  HP++++ 
Sbjct: 278 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 313

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 35/283 (12%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLG 409
            ++  G L+G G++G V    + ET    A+K +        P     +K+   EI++L 
Sbjct: 5   GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK---EIQLLR 61
Query: 410 HLKHENIVQY----YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES-----IVRNF 460
            L+H+N++Q     Y  E     +Y+ +EY   G     ++E    + E          +
Sbjct: 62  RLRHKNVIQLVDVLYNEE--KQKMYMVMEYCVCG-----MQEMLDSVPEKRFPVCQAHGY 114
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GS 517
              +++GL YLHS   +H+DIK  NLL+   G +K++  G+A+ L   + + + +   GS
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA--MFKVLN 575
           P +  PE+   +    G       VDIWS G T+  + TG  P   FEG     +F+ + 
Sbjct: 175 PAFQPPEIANGLDTFSG-----FKVDIWSAGVTLYNITTGLYP---FEGDNIYKLFENIG 226
Query: 576 R-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           + +  IP        D L       P +R S  ++ +H + R 
Sbjct: 227 KGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 126/261 (48%), Gaps = 24/261 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI---KQLEQEIKVLGHLKHE 414
           K IG+G FG V+ G   +  +  AIK + I+ D     E I   ++ ++E+ ++ +L H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NIV+ YG  ++ +   + +E+V  G +   + +    I  S+       I  G+ Y+ + 
Sbjct: 84  NIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 475 N--TIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           N   +HRD++  N+ +     +A    K+ADF +++    +     L G+  WMAPE I 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ--SVHSVSGLLGNFQWMAPETIG 199
Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----PPIPEM 583
           A  +++   + A   D +S    +  +LTG+ P+ E+   +  F  + R     P IPE 
Sbjct: 200 A--EEESYTEKA---DTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 584 LSSEGKDFLLRCFLRNPVERP 604
                ++ +  C+  +P +RP
Sbjct: 255 CPPRLRNVIELCWSGDPKKRP 275

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 118/269 (43%), Gaps = 16/269 (5%)
Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQEIKVLG 409
           +  +Q+   +G G++G V+   ++E G   A+K        PK  A  + ++    KV  
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
           H     + Q +    +   LY+  E   P S+ ++       + E+ V  + R  L  LA
Sbjct: 116 HPCCVRLEQAWEEGGI---LYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           +LHS   +H D+K AN+ +   G  KL DFG+   L         +G P +MAPE+++  
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG- 230
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IPEMLSSEG 588
                      A D++SLG T++E+          EG Q + +     PP     LSSE 
Sbjct: 231 -------SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ--GYLPPEFTAGLSSEL 281
Query: 589 KDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           +  L+     +P  R +A  LL  P +R 
Sbjct: 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 48  PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 106
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 165
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 166 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 224
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 225 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 272
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +S E +  +  C    P +RP+  E+  HP++++ 
Sbjct: 273 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 24/259 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGA--SC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IG G FG V  G  +  G   SC AIK +     + +  E +     E  ++G  +H 
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLS----EASIMGQFEHP 77
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           NI++  G       + I  E++  G+++ ++R +    T   +    R I +G+ YL   
Sbjct: 78  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE------LSLKGSPNWMAPEVIKA 528
           + +HRD+   N+LV+++ V K++DFG+++ L   S +      L  K    W APE I  
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI-- 195
Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 585
                   K   A D WS G  + E+++ G+ P+ +      +  +    R PP P+  +
Sbjct: 196 -----AFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPT 250
Query: 586 SEGKDFLLRCFLRNPVERP 604
           S  +  +L C+ ++   RP
Sbjct: 251 SLHQ-LMLDCWQKDRNARP 268

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 131/289 (45%), Gaps = 39/289 (13%)
Query: 351 KSQWQKGKLIGRGTFGSVY----IGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           + + + GK +GRG FG V      G ++  T  + A+K   ++ +    +E  + L  E+
Sbjct: 28  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK---MLKEGATHSEH-RALMSEL 83
Query: 406 KVLGHLKHE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDIT----ESIVRN 459
           K+L H+ H  N+V   G+       L + +E+   G+++ Y+R    +      E + ++
Sbjct: 84  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKD 143
Query: 460 F---------TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 510
           F         +  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +     
Sbjct: 144 FLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXK-DP 202
Query: 511 ELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 565
           +   KG       WMAPE I        +    +  D+WS G  + E+ + G  P+   +
Sbjct: 203 DXVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 566 GPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
             +   + L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 126/293 (43%), Gaps = 43/293 (14%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +L+G G +  V    + + G   A+K ++      +S    +++E   +  G+     ++
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRS-RVFREVETLYQCQGNKNILELI 77
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +++     D   Y+  E +  GSI  ++++  +   E       R +   L +LH+    
Sbjct: 78  EFFED---DTRFYLVFEKLQGGSILAHIQKQ-KHFNEREASRVVRDVAAALDFLHTKGIA 133
Query: 478 HRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLK-----------GSPNWMAP 523
           HRD+K  N+L ++      VK+ DF +    +G+    S             GS  +MAP
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLG---SGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-------------- 569
           EV++     D         D+WSLG  +  ML+G PP+    G                 
Sbjct: 191 EVVEVFT--DQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 248
Query: 570 MFKVLNRTP-PIPEM----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           +F+ +       P+     +SSE KD + +  +R+  +R SA ++L+HP+++ 
Sbjct: 249 LFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 27/240 (11%)
Query: 339 PHIMEKPSASPK-------KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD 391
           PH  E+P  + +        S+    K+IG G  G V  G  R  G     ++V +    
Sbjct: 29  PHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ----RDVPVAIKA 84
Query: 392 PKSAECIKQ---LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 448
            K+    +Q      E  ++G   H NI++  G         I  EY+  GS++ ++R H
Sbjct: 85  LKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH 144
Query: 449 CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--- 505
               T   +    R +  G+ YL     +HRD+   N+LVD++ V K++DFG+++ L   
Sbjct: 145 DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 506 -TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWS 562
                     K    W APE I            + A D+WS G  + E+L    +P W+
Sbjct: 205 PDAAXTTTGGKIPIRWTAPEAI-------AFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 127/273 (46%), Gaps = 38/273 (13%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENIVQ 418
           IG G++       ++ T    A+K +D    DP          +EI++L  + +H NI+ 
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPT---------EEIEILLRYGQHPNIIT 80
Query: 419 YYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
               +V DD  Y+Y+  E    G + ++ +R+      E+    FT  I   + YLH+  
Sbjct: 81  L--KDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFT--ITKTVEYLHAQG 136
Query: 476 TIHRDIKGANLL-VDASG---VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
            +HRD+K +N+L VD SG    +++ DFG AK L     E  L  +P + A  V   V++
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA---ENGLLXTPCYTANFVAPEVLE 193
Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM-FKVLNR--------TPPIPE 582
           + G      A DIWSLG  +   LTG  P++   GP     ++L R        +     
Sbjct: 194 RQGYDA---ACDIWSLGVLLYTXLTGYTPFA--NGPDDTPEEILARIGSGKFSLSGGYWN 248
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
            +S   KD + +    +P +R +A  +L HP+I
Sbjct: 249 SVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 114/250 (45%), Gaps = 54/250 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI-KVLGHL 411
           ++  GK +G G+FG V    + E+G   A+K+V     DP+     K  E +I KVL H+
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---LQDPRY----KNRELDIMKVLDHV 60
Query: 412 KHENIVQYYGS---------EVVDDH--------------------------LYIYLEYV 436
               +V Y+ +         +  DDH                          L + +EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 437 HPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SG 492
            P ++++ ++      R I  +++  +   +   + ++HS    HRDIK  NLLV++   
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 493 VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 552
            +KL DFG AK L      ++   S  + APE++       G  +   ++D+WS+GC   
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELML------GATEYTPSIDLWSIGCVFG 233
Query: 553 EMLTGKPPWS 562
           E++ GKP +S
Sbjct: 234 ELILGKPLFS 243

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 21/276 (7%)
Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIK 406
           P +SQ+Q G L+G G FGSVY G         AIK V  D I D  +     + +  E+ 
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVV 59
Query: 407 VLGHLK--HENIVQYYGSEVVDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRH 463
           +L  +      +++        D   + LE   P   +  ++ E    + E + R+F   
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 118
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y     G+  +  
Sbjct: 119 VLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSP 177
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE I+       +     +  +WSLG  + +M+ G  P+   E      +++       +
Sbjct: 178 PEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 225
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
            +S E +  +  C    P +RP+  E+  HP++++ 
Sbjct: 226 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 128/281 (45%), Gaps = 37/281 (13%)
Query: 357 GKLIGRGTFGSVY----IGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           GK +GRG FG V      G ++  T  + A+K   ++ +    +E  + L  E+K+L H+
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVK---MLKEGATHSEH-RALMSELKILIHI 87
Query: 412 KHE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREH------CRDITESIVR----- 458
            H  N+V   G+       L + +E+   G+++ Y+R         +D+ +  +      
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
            ++  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +     +   KG  
Sbjct: 148 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYK-DPDYVRKGDA 206
Query: 519 ----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 573
                WMAPE I        +    +  D+WS G  + E+ + G  P+   +  +   + 
Sbjct: 207 RLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRR 259
Query: 574 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 260 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 117/254 (46%), Gaps = 26/254 (10%)
Query: 360 IGRGTFGSVYIGT-NRETGASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G  G V++G  N  T  +  ++K+  + PD             E  ++  L+H+ +V
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 71
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N 
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLKGSPNWMAPEVIKAVMQKDG 534
           IHRD++ AN+LV  +   K+ADFG+A+ +     +     K    W APE I        
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINY------ 184
Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDF 591
                +  D+WS G  + E++T G+ P+     P+ + + L R   +  P+    E    
Sbjct: 185 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELYQL 242
Query: 592 LLRCFLRNPVERPS 605
           +  C+   P +RP+
Sbjct: 243 MRLCWKERPEDRPT 256

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 129/300 (43%), Gaps = 40/300 (13%)
Query: 341 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECI 398
           I+E P     +     GK +G G FG V   T  + +  A      V ++ ++   +E +
Sbjct: 12  ILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-L 70
Query: 399 KQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE----------- 447
           + L  E  VL  + H ++++ YG+   D  L + +EY   GS+  ++RE           
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 448 ------------HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 495
                         R +T   + +F   I  G+ YL     +HRD+   N+LV     +K
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMK 190
Query: 496 LADFGMAKHLTGL-SYELSLKGS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 552
           ++DFG+++ +    SY    +G     WMA E +        +       D+WS G  + 
Sbjct: 191 ISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL-------FDHIYTTQSDVWSFGVLLW 243
Query: 553 EMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           E++T G  P+     P+ +F +L     +  P+  S E    +L+C+ + P +RP   ++
Sbjct: 244 EIVTLGGNPYPGIP-PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 26/275 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI 416
           +++G G  G V    N+ T    A+K +   P   +  E   +  Q   ++  +  +EN+
Sbjct: 30  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL 89
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTN 475
             Y G +     L I +E +  G +   +++   +  TE       + I   + YLHS N
Sbjct: 90  --YAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 143
Query: 476 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
             HRD+K  NLL  +   + ++KL DFG AK  T  +   +   +P ++APEV+      
Sbjct: 144 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL------ 197
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEMLS- 585
            G  K   + D+WSLG  +  +L G PP+          G +   ++     P PE    
Sbjct: 198 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 256
Query: 586 SEGKDFLLRCFLRN-PVERPSAVELLEHPFIRNAN 619
           SE    L+R  L+  P +R +  E + HP+I  + 
Sbjct: 257 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 291

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 30/277 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQEIKVLGHLKHE 414
           +++G G  G V    N+ T    A+K +   P   +  E      Q    ++++    +E
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD--VYE 95
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHS 473
           N+  Y G +     L I +E +  G +   +++   +  TE       + I   + YLHS
Sbjct: 96  NL--YAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 149
Query: 474 TNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
            N  HRD+K  NLL  +   + ++KL DFG AK  T  +   +   +P ++APEV+    
Sbjct: 150 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL---- 205
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEML 584
              G  K   + D+WSLG  +  +L G PP+          G +   ++     P PE  
Sbjct: 206 ---GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 262
Query: 585 S-SEGKDFLLRCFLRN-PVERPSAVELLEHPFIRNAN 619
             SE    L+R  L+  P +R +  E + HP+I  + 
Sbjct: 263 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 299

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 30/273 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQEIKVLGHLKHE 414
           +++G G  G V    N+ T    A+K +   P   +  E      Q    ++++    +E
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD--VYE 125
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHS 473
           N+  Y G +     L I +E +  G +   +++   +  TE       + I   + YLHS
Sbjct: 126 NL--YAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 474 TNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
            N  HRD+K  NLL  +   + ++KL DFG AK  T  +   +   +P ++APEV+    
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL---- 235
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEML 584
              G  K   + D+WSLG  +  +L G PP+          G +   ++     P PE  
Sbjct: 236 ---GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292
Query: 585 S-SEGKDFLLRCFLRN-PVERPSAVELLEHPFI 615
             SE    L+R  L+  P +R +  E + HP+I
Sbjct: 293 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 128/281 (45%), Gaps = 37/281 (13%)
Query: 357 GKLIGRGTFGSVY----IGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           GK +GRG FG V      G ++  T  + A+K   ++ +    +E  + L  E+K+L H+
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVK---MLKEGATHSEH-RALMSELKILIHI 87
Query: 412 KHE-NIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDIT--ESIVRNF------- 460
            H  N+V   G+       L + +E+   G+++ Y+R    +    + + ++F       
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 461 --TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
             +  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +     +   KG  
Sbjct: 148 CYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKGDA 206
Query: 519 ----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 573
                WMAPE I        +    +  D+WS G  + E+ + G  P+   +  +   + 
Sbjct: 207 RLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 259
Query: 574 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           L     +  P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 260 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 30/277 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQEIKVLGHLKHE 414
           +++G G  G V    N+ T    A+K +   P   +  E      Q    ++++    +E
Sbjct: 28  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD--VYE 85
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHS 473
           N+  Y G +     L I +E +  G +   +++   +  TE       + I   + YLHS
Sbjct: 86  NL--YAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 139
Query: 474 TNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
            N  HRD+K  NLL  +   + ++KL DFG AK  T  +   +   +P ++APEV+    
Sbjct: 140 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL---- 195
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEML 584
              G  K   + D+WSLG  +  +L G PP+          G +   ++     P PE  
Sbjct: 196 ---GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 252
Query: 585 S-SEGKDFLLRCFLRN-PVERPSAVELLEHPFIRNAN 619
             SE    L+R  L+  P +R +  E + HP+I  + 
Sbjct: 253 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 289

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 30/277 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQEIKVLGHLKHE 414
           +++G G  G V    N+ T    A+K +   P   +  E      Q    ++++    +E
Sbjct: 29  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD--VYE 86
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHS 473
           N+  Y G +     L I +E +  G +   +++   +  TE       + I   + YLHS
Sbjct: 87  NL--YAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 140
Query: 474 TNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
            N  HRD+K  NLL  +   + ++KL DFG AK  T  +   +   +P ++APEV+    
Sbjct: 141 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL---- 196
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEML 584
              G  K   + D+WSLG  +  +L G PP+          G +   ++     P PE  
Sbjct: 197 ---GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 253
Query: 585 S-SEGKDFLLRCFLRN-PVERPSAVELLEHPFIRNAN 619
             SE    L+R  L+  P +R +  E + HP+I  + 
Sbjct: 254 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 290

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 30/273 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQEIKVLGHLKHE 414
           +++G G  G V    N+ T    A+K +   P   +  E      Q    ++++    +E
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD--VYE 79
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHS 473
           N+  Y G +     L I +E +  G +   +++   +  TE       + I   + YLHS
Sbjct: 80  NL--YAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 133
Query: 474 TNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
            N  HRD+K  NLL  +   + ++KL DFG AK  T  +   +   +P ++APEV+    
Sbjct: 134 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL---- 189
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEML 584
              G  K   + D+WSLG  +  +L G PP+          G +   ++     P PE  
Sbjct: 190 ---GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 246
Query: 585 S-SEGKDFLLRCFLRN-PVERPSAVELLEHPFI 615
             SE    L+R  L+  P +R +  E + HP+I
Sbjct: 247 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 414
           K+IG+G+FG V    + +     A+K V             +Q  +EI++L HL+ +   
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 415 ---NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
              N++    +    +H+ +  E +         +   +  +  +VR F   IL  L  L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 472 HSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           H    IH D+K  N+L+   G   +K+ DFG + +     Y  +   S  + APEVI   
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--TXIQSRFYRAPEVILGA 274
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-SEFEGPQ 568
                  +  + +D+WSLGC + E+LTG P    E EG Q
Sbjct: 275 -------RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 30/273 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQEIKVLGHLKHE 414
           +++G G  G V    N+ T    A+K +   P   +  E      Q    ++++    +E
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD--VYE 81
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHS 473
           N+  Y G +     L I +E +  G +   +++   +  TE       + I   + YLHS
Sbjct: 82  NL--YAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 474 TNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
            N  HRD+K  NLL  +   + ++KL DFG AK  T  +   +   +P ++APEV+    
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL---- 191
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEML 584
              G  K   + D+WSLG  +  +L G PP+          G +   ++     P PE  
Sbjct: 192 ---GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 248
Query: 585 S-SEGKDFLLRCFLRN-PVERPSAVELLEHPFI 615
             SE    L+R  L+  P +R +  E + HP+I
Sbjct: 249 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 30/273 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQEIKVLGHLKHE 414
           +++G G  G V    N+ T    A+K +   P   +  E      Q    ++++    +E
Sbjct: 74  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD--VYE 131
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHS 473
           N+  Y G +     L I +E +  G +   +++   +  TE       + I   + YLHS
Sbjct: 132 NL--YAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 185
Query: 474 TNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
            N  HRD+K  NLL  +   + ++KL DFG AK  T  +   +   +P ++APEV+    
Sbjct: 186 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL---- 241
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEML 584
              G  K   + D+WSLG  +  +L G PP+          G +   ++     P PE  
Sbjct: 242 ---GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 298
Query: 585 S-SEGKDFLLRCFLRN-PVERPSAVELLEHPFI 615
             SE    L+R  L+  P +R +  E + HP+I
Sbjct: 299 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 30/273 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQEIKVLGHLKHE 414
           +++G G  G V    N+ T    A+K +   P   +  E      Q    ++++    +E
Sbjct: 23  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD--VYE 80
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHS 473
           N+  Y G +     L I +E +  G +   +++   +  TE       + I   + YLHS
Sbjct: 81  NL--YAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 134
Query: 474 TNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
            N  HRD+K  NLL  +   + ++KL DFG AK  T  +   +   +P ++APEV+    
Sbjct: 135 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL---- 190
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEML 584
              G  K   + D+WSLG  +  +L G PP+          G +   ++     P PE  
Sbjct: 191 ---GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 247
Query: 585 S-SEGKDFLLRCFLRN-PVERPSAVELLEHPFI 615
             SE    L+R  L+  P +R +  E + HP+I
Sbjct: 248 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 128/299 (42%), Gaps = 31/299 (10%)
Query: 338 MPHIMEKPSASP-------KKSQWQKGKLIGRGTFGSVYIGTNRETGAS---CAIKEVDI 387
           MPH  E P+ +        + S     ++IG G FG V  G  +  G      AIK + +
Sbjct: 1   MPHTYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKV 60
Query: 388 IPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE 447
              + +  + +     E  ++G   H NI+   G       + I  EY+  GS++ ++++
Sbjct: 61  GYTEKQRRDFLG----EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKK 116
Query: 448 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 507
           +    T   +    R I  G+ YL     +HRD+   N+L++++ V K++DFG+++ L  
Sbjct: 117 NDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 176
Query: 508 ---LSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 562
               +Y       P  W APE I          K   A D+WS G  + E+++ G+ P+ 
Sbjct: 177 DPEAAYTTRGGKIPIRWTAPEAI-------AFRKFTSASDVWSYGIVMWEVVSYGERPYW 229
Query: 563 EFEGPQAMFKVLNRTPPIPEMLSSEGK--DFLLRCFLRNPVERPSAVELLE--HPFIRN 617
           E    Q + K +     +P  +         +L C+ +    RP   E++      IRN
Sbjct: 230 EMTN-QDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRN 287

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 27/277 (9%)
Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--------PKSAECIKQLE 402
           +++++ G L+G+G FG+V+ G         AIK   +IP +          S  C  ++ 
Sbjct: 30  EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIK---VIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 403 QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG-SINRYVREHCRDITESIVRNFT 461
              KV     H  +++        +   + LE   P   +  Y+ E    + E   R F 
Sbjct: 87  LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFF 145
Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNW 520
             ++  + + HS   +HRDIK  N+L+D   G  KL DFG    L    Y     G+  +
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT-DFDGTRVY 204
Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI 580
             PE I            AL   +WSLG  + +M+ G  P   FE  Q   ++L      
Sbjct: 205 SPPEWISRHQYH------ALPATVWSLGILLYDMVCGDIP---FERDQ---EILEAELHF 252
Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           P  +S +    + RC    P  RPS  E+L  P+++ 
Sbjct: 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 30/277 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQEIKVLGHLKHE 414
           +++G G  G V    N+ T    A+K +   P   +  E      Q    ++++    +E
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD--VYE 81
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHS 473
           N+  Y G +     L I +E +  G +   +++   +  TE       + I   + YLHS
Sbjct: 82  NL--YAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 474 TNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
            N  HRD+K  NLL  +   + ++KL DFG AK  T  +   +   +P ++APEV+    
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL---- 191
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEML 584
              G  K   + D+WSLG  +  +L G PP+          G +   ++     P PE  
Sbjct: 192 ---GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 248
Query: 585 S-SEGKDFLLRCFLRN-PVERPSAVELLEHPFIRNAN 619
             SE    L+R  L+  P +R +  E + HP+I  + 
Sbjct: 249 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 285

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 414
           K+IG+G+FG V    + +     A+K V             +Q  +EI++L HL+ +   
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 415 ---NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
              N++    +    +H+ +  E +         +   +  +  +VR F   IL  L  L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 472 HSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           H    IH D+K  N+L+   G   +K+ DFG + +     Y  +   S  + APEVI   
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--TXIQSRFYRAPEVILGA 274
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-SEFEGPQ 568
                  +  + +D+WSLGC + E+LTG P    E EG Q
Sbjct: 275 -------RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 26/246 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 414
           K+IG+G FG V    + +     A+K V             +Q  +EI++L HL+ +   
Sbjct: 103 KVIGKGXFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 415 ---NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
              N++    +    +H+ +  E +         +   +  +  +VR F   IL  L  L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 472 HSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           H    IH D+K  N+L+   G   +K+ DFG + +     Y      S  + APEVI   
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXI--QSRFYRAPEVILGA 274
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-SEFEGPQAMFKVLNRTPPIPEML--SS 586
                  +  + +D+WSLGC + E+LTG P    E EG Q    +     P  ++L  S 
Sbjct: 275 -------RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASK 327
Query: 587 EGKDFL 592
             K+F+
Sbjct: 328 RAKNFV 333

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 131/302 (43%), Gaps = 44/302 (14%)
Query: 341 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECI 398
           I+E P     +     GK +G G FG V   T  + +  A      V ++ ++   +E +
Sbjct: 12  ILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-L 70
Query: 399 KQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE----------- 447
           + L  E  VL  + H ++++ YG+   D  L + +EY   GS+  ++RE           
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 448 ------------HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 495
                         R +T   + +F   I  G+ YL   + +HRD+   N+LV     +K
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMK 190
Query: 496 LADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 550
           ++DFG+++ +     +  +K S       WMA E +   +    +       D+WS G  
Sbjct: 191 ISDFGLSRDVY--EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVL 241
Query: 551 VIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAV 607
           + E++T G  P+     P+ +F +L     +  P+  S E    +L+C+ + P +RP   
Sbjct: 242 LWEIVTLGGNPYPGIP-PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300
Query: 608 EL 609
           ++
Sbjct: 301 DI 302

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 120/273 (43%), Gaps = 30/273 (10%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQEIKVLGHLKHE 414
           +++G G  G V    N+ T    A+K +   P   +  E      Q    ++++    +E
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD--VYE 79
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHS 473
           N+  Y G +     L I +E +  G +   +++   +  TE       + I   + YLHS
Sbjct: 80  NL--YAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 133
Query: 474 TNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
            N  HRD+K  NLL  +   + ++KL DFG AK  T  +       +P ++APEV+    
Sbjct: 134 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVL---- 189
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEML 584
              G  K   + D+WSLG  +  +L G PP+          G +   ++     P PE  
Sbjct: 190 ---GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 246
Query: 585 S-SEGKDFLLRCFLRN-PVERPSAVELLEHPFI 615
             SE    L+R  L+  P +R +  E + HP+I
Sbjct: 247 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 130/302 (43%), Gaps = 44/302 (14%)
Query: 341 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECI 398
           I+E P     +     GK +G G FG V   T  + +  A      V ++ ++   +E +
Sbjct: 12  ILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-L 70
Query: 399 KQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE----------- 447
           + L  E  VL  + H ++++ YG+   D  L + +EY   GS+  ++RE           
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 448 ------------HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 495
                         R +T   + +F   I  G+ YL     +HRD+   N+LV     +K
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMK 190
Query: 496 LADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 550
           ++DFG+++ +     +  +K S       WMA E +   +    +       D+WS G  
Sbjct: 191 ISDFGLSRDVY--EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVL 241
Query: 551 VIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAV 607
           + E++T G  P+     P+ +F +L     +  P+  S E    +L+C+ + P +RP   
Sbjct: 242 LWEIVTLGGNPYPGIP-PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300
Query: 608 EL 609
           ++
Sbjct: 301 DI 302

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 124/268 (46%), Gaps = 17/268 (6%)
Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K+++ +K K++G G FG+VY G     G +  I     +  +  S +  K++  E  V+ 
Sbjct: 15  KETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMA 74
Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            +    + +  G   +   + +  + +  G +  +VRE+   +    + N+   I  G++
Sbjct: 75  GVGSPYVSRLLGI-CLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 526
           YL     +HRD+   N+LV +   VK+ DFG+A+ L     E    G      WMA   +
Sbjct: 134 YLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA---L 190
Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF---EGPQAMFKVLNRTPPIPE 582
           ++++++    +     D+WS G TV E++T G  P+      E P  + K      P P 
Sbjct: 191 ESILRR----RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK--GERLPQPP 244
Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELL 610
           + + +    +++C++ +   RP   EL+
Sbjct: 245 ICTIDVYMIMVKCWMIDSECRPRFRELV 272

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 52/290 (17%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G +G V+ G+ +  G + A+K       D KS       E E+     L+HENI+ +
Sbjct: 45  VGKGRYGEVWRGSWQ--GENVAVKIFS--SRDEKSWF----RETELYNTVMLRHENILGF 96
Query: 420 YGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST- 474
             S++   H    L++   Y   GS+  Y++    D T S +R     I +GLA+LH   
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-TVSCLR-IVLSIASGLAHLHIEI 154
Query: 475 -------NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMA 522
                     HRD+K  N+LV  +G   +AD G+A   +  + +L +      G+  +MA
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIE----MLTG------KPPWSE-------FE 565
           PEV+   +Q D        VDIW+ G  + E    M++       KPP+ +       FE
Sbjct: 215 PEVLDETIQVDCFDSYK-RVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 273
Query: 566 GPQAMFKVLNRTPPIPE------MLSSEGKDFLLRCFLRNPVERPSAVEL 609
             + +  V  + P IP        L+S  K  +  C+ +NP  R +A+ +
Sbjct: 274 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSARLTALRI 322

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 40/230 (17%)
Query: 357 GKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-K 412
           GK++G G FG V   T     +TG S  +  V ++ +   S+E  + L  E+K++  L  
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVA-VKMLKEKADSSE-REALMSELKMMTQLGS 107
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------- 459
           HENIV   G+  +   +Y+  EY   G +  Y+R      +E  +               
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 460 ---------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 510
                    F   +  G+ +L   + +HRD+   N+LV    VVK+ DFG+A+ +   S 
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS- 226
Query: 511 ELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
              ++G+      WMAPE +   +         +  D+WS G  + E+ +
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGI-------YTIKSDVWSYGILLWEIFS 269

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 52/290 (17%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G +G V+ G+ +  G + A+K       D KS       E E+     L+HENI+ +
Sbjct: 16  VGKGRYGEVWRGSWQ--GENVAVKIFS--SRDEKSWF----RETELYNTVMLRHENILGF 67
Query: 420 YGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST- 474
             S++   H    L++   Y   GS+  Y++    D T S +R     I +GLA+LH   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-TVSCLR-IVLSIASGLAHLHIEI 125
Query: 475 -------NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMA 522
                     HRD+K  N+LV  +G   +AD G+A   +  + +L +      G+  +MA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIE----MLTG------KPPWSE-------FE 565
           PEV+   +Q D        VDIW+ G  + E    M++       KPP+ +       FE
Sbjct: 186 PEVLDETIQVDCFDSYK-RVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 566 GPQAMFKVLNRTPPIPE------MLSSEGKDFLLRCFLRNPVERPSAVEL 609
             + +  V  + P IP        L+S  K  +  C+ +NP  R +A+ +
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSARLTALRI 293

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 52/290 (17%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G+G +G V+ G+ +  G + A+K       D KS       E E+     L+HENI+ +
Sbjct: 16  VGKGRYGEVWRGSWQ--GENVAVKIFS--SRDEKSWF----RETELYNTVMLRHENILGF 67
Query: 420 YGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST- 474
             S++   H    L++   Y   GS+  Y++    D T S +R     I +GLA+LH   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-TVSCLR-IVLSIASGLAHLHIEI 125
Query: 475 -------NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMA 522
                     HRD+K  N+LV  +G   +AD G+A   +  + +L +      G+  +MA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIE----MLTG------KPPWSE-------FE 565
           PEV+   +Q D        VDIW+ G  + E    M++       KPP+ +       FE
Sbjct: 186 PEVLDETIQVDCFDSYK-RVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 566 GPQAMFKVLNRTPPIPE------MLSSEGKDFLLRCFLRNPVERPSAVEL 609
             + +  V  + P IP        L+S  K  +  C+ +NP  R +A+ +
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSARLTALRI 293

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 58/241 (24%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S +++  ++G+G FG V    N       AIK++        + E +  +  E+ +L  L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI------RHTEEKLSTILSEVXLLASL 59
Query: 412 KHENIVQYYGSEVVDDH-------------LYIYLEY---------VHPGSINRYVREHC 449
            H+ +V+YY + +   +             L+I  EY         +H  ++N+   E+ 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 450 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK------ 503
           R           R IL  L+Y+HS   IHR++K  N+ +D S  VK+ DFG+AK      
Sbjct: 120 R---------LFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 504 --------HLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
                   +L G S  L S  G+  ++A EV+      DG       +D +SLG    E 
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAXYVATEVL------DGTGHYNEKIDXYSLGIIFFEX 224
Query: 555 L 555
           +
Sbjct: 225 I 225

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 114/271 (42%), Gaps = 26/271 (9%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI 416
           +++G G  G V    N+ T    A+K +   P   +  E   +  Q   ++  +  +EN+
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQCPHIVRIVDVYENL 127
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTN 475
             Y G +     L I  E +  G +   +++   +  TE       + I   + YLHS N
Sbjct: 128 --YAGRKC----LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSIN 181
Query: 476 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
             HRD+K  NLL  +   + ++KL DFG AK  T  +   +   +P ++APEV+      
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL------ 235
Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEM--L 584
            G  K   + D WSLG     +L G PP+          G +   +      P PE   +
Sbjct: 236 -GPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEV 294
Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           S E K  +       P +R +  E   HP+I
Sbjct: 295 SEEVKXLIRNLLKTEPTQRXTITEFXNHPWI 325

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 123/272 (45%), Gaps = 25/272 (9%)
Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           + Q+  G+++G+G FGSV     ++   S     V ++  D  ++  I++  +E   +  
Sbjct: 22  EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKE 81
Query: 411 LKHENIVQYYGSEV---VDDHL---YIYLEYVHPGSINRY-----VREHCRDITESIVRN 459
             H ++ +  G  +       L    + L ++  G ++ +     + E+  ++    +  
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE---LSLKG 516
           F   I  G+ YL S N IHRD+   N ++     V +ADFG+++ +    Y     + K 
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL- 574
              W+A E +        +    +  D+W+ G T+ E++T G+ P++  E  +    ++ 
Sbjct: 202 PVKWLALESL-------ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
Query: 575 -NRTPPIPEMLSSEGKDFLLRCFLRNPVERPS 605
            NR    PE +  E  D + +C+  +P +RPS
Sbjct: 255 GNRLKQPPECM-EEVYDLMYQCWSADPKQRPS 285

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 56/283 (19%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------EIKV 407
           +G+G+FG VY G  +            ++ D+P++   IK + +            E  V
Sbjct: 33  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE---------SIVR 458
           +      ++V+  G         + +E +  G +  Y+R    ++           S + 
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
                I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG  
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGK 199
Query: 519 N-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  
Sbjct: 200 GLLPVRWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252
Query: 573 V-----LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           V     L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 253 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 291

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 56/283 (19%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------EIKV 407
           +G+G+FG VY G  +            ++ D+P++   IK + +            E  V
Sbjct: 24  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE---------SIVR 458
           +      ++V+  G         + +E +  G +  Y+R    ++           S + 
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
                I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG  
Sbjct: 133 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGK 190
Query: 519 N-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  
Sbjct: 191 GLLPVRWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 243
Query: 573 V-----LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           V     L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 244 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 282

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 56/283 (19%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------EIKV 407
           +G+G+FG VY G  +            ++ D+P++   IK + +            E  V
Sbjct: 20  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE---------SIVR 458
           +      ++V+  G         + +E +  G +  Y+R    ++           S + 
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
                I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG  
Sbjct: 129 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGK 186
Query: 519 N-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  
Sbjct: 187 GLLPVRWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 239
Query: 573 V-----LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           V     L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 240 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 278

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 56/283 (19%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------EIKV 407
           +G+G+FG VY G  +            ++ D+P++   IK + +            E  V
Sbjct: 27  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE---------SIVR 458
           +      ++V+  G         + +E +  G +  Y+R    ++           S + 
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
                I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG  
Sbjct: 136 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGK 193
Query: 519 N-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  
Sbjct: 194 GLLPVRWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 246
Query: 573 V-----LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           V     L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 247 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 285

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 56/283 (19%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------EIKV 407
           +G+G+FG VY G  +            ++ D+P++   IK + +            E  V
Sbjct: 26  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE---------SIVR 458
           +      ++V+  G         + +E +  G +  Y+R    ++           S + 
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
                I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG  
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGK 192
Query: 519 N-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  
Sbjct: 193 GLLPVRWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 245
Query: 573 V-----LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           V     L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 246 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 284

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 56/283 (19%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------EIKV 407
           +G+G+FG VY G  +            ++ D+P++   IK + +            E  V
Sbjct: 26  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE---------SIVR 458
           +      ++V+  G         + +E +  G +  Y+R    ++           S + 
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
                I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG  
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGK 192
Query: 519 N-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  
Sbjct: 193 GLLPVRWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 245
Query: 573 V-----LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           V     L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 246 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 284

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 56/283 (19%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------EIKV 407
           +G+G+FG VY G  +            ++ D+P++   IK + +            E  V
Sbjct: 55  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE---------SIVR 458
           +      ++V+  G         + +E +  G +  Y+R    ++           S + 
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
                I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG  
Sbjct: 164 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGK 221
Query: 519 N-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  
Sbjct: 222 GLLPVRWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 274
Query: 573 V-----LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           V     L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 275 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 313

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 24/272 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG+V  G   +         V I+ ++        +L  E  V+  L +  IV
Sbjct: 375 KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +  G    +  + + +E    G +N+Y++++ R + +  +      +  G+ YL  +N +
Sbjct: 434 RMIGICEAESWMLV-MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFV 491
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS--PNWMAPEVIKAVMQKD 533
           HRD+   N+L+      K++DFG++K L      Y+    G     W APE I       
Sbjct: 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---- 547
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKD 590
              K +   D+WS G  + E  + G+ P+   +G +  AM +   R    P     E  D
Sbjct: 548 ---KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GCPAGCPREMYD 603
Query: 591 FLLRCFLRNPVERP--SAVELLEHPFIRNANY 620
            +  C+  +   RP  +AVEL     +RN  Y
Sbjct: 604 LMNLCWTYDVENRPGFAAVELR----LRNYYY 631

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 115/283 (40%), Gaps = 56/283 (19%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------EIKV 407
           +G+G+FG VY G  +            ++ D+P++   IK + +            E  V
Sbjct: 33  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE---------SIVR 458
           +      ++V+  G         + +E +  G +  Y+R     +           S + 
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
                I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG  
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGK 199
Query: 519 N-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  
Sbjct: 200 GLLPVRWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252
Query: 573 V-----LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           V     L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 253 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 291

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G FGSV  G  R       +  + ++    + A+  +++ +E +++  L +  IV+ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVA-IKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRL 401
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
            G     + L + +E    G +++++     +I  S V      +  G+ YL   N +HR
Sbjct: 402 IGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGN 535
           ++   N+L+      K++DFG++K L       + + +      W APE I         
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF------- 513
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 570
            K +   D+WS G T+ E L+ G+ P+ + +GP+ M
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 24/272 (8%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG+V  G   +         V I+ ++        +L  E  V+  L +  IV
Sbjct: 376 KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +  G    +  + + +E    G +N+Y++++ R + +  +      +  G+ YL  +N +
Sbjct: 435 RMIGICEAESWMLV-MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFV 492
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS--PNWMAPEVIKAVMQKD 533
           HRD+   N+L+      K++DFG++K L      Y+    G     W APE I       
Sbjct: 493 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---- 548
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKD 590
              K +   D+WS G  + E  + G+ P+   +G +  AM +   R    P     E  D
Sbjct: 549 ---KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GCPAGCPREMYD 604
Query: 591 FLLRCFLRNPVERP--SAVELLEHPFIRNANY 620
            +  C+  +   RP  +AVEL     +RN  Y
Sbjct: 605 LMNLCWTYDVENRPGFAAVELR----LRNYYY 632

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 115/283 (40%), Gaps = 56/283 (19%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------EIKV 407
           +G+G+FG VY G  +            ++ D+P++   IK + +            E  V
Sbjct: 23  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE---------SIVR 458
           +      ++V+  G         + +E +  G +  Y+R     +           S + 
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
                I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG  
Sbjct: 132 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGK 189
Query: 519 N-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  
Sbjct: 190 GLLPVRWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 242
Query: 573 V-----LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           V     L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 243 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 281

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 116/283 (40%), Gaps = 56/283 (19%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------EIKV 407
           +G+G+FG VY G  +            ++ D+P++   IK + +            E  V
Sbjct: 27  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE---------SIVR 458
           +      ++V+  G         + +E +  G +  Y+R    ++           S + 
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
                I +G+AYL++   +HRD+   N +V     VK+ DFGM + +     +   KG  
Sbjct: 136 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX--ETDXXRKGGK 193
Query: 519 N-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  
Sbjct: 194 GLLPVRWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 246
Query: 573 V-----LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           V     L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 247 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 285

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 46/278 (16%)
Query: 360 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 412
           +G+G+FG VY G  R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 78
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI---------TESIVRNFTRH 463
             ++V+  G         + +E +  G +  Y+R    +          T   +      
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 519
           I +G+AYL++   +HRD+   N +V     VK+ DFGM + +   +Y    KG       
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAY--YRKGGKGLLPV 196
Query: 520 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 573
            WMAPE +     KDG      + D+WS G  + E+ +  + P+      Q +  V    
Sbjct: 197 RWMAPESL-----KDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 574 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            L++    PE ++    D +  C+  NP  RP+ +E++
Sbjct: 250 YLDQPDNCPERVT----DLMRMCWQFNPKMRPTFLEIV 283

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 116/283 (40%), Gaps = 56/283 (19%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------EIKV 407
           +G+G+FG VY G  +            ++ D+P++   IK + +            E  V
Sbjct: 18  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE---------SIVR 458
           +      ++V+  G         + +E +  G +  Y+R    ++           S + 
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
                I +G+AYL++   +HRD+   N +V     VK+ DFGM + +     +   KG  
Sbjct: 127 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX--ETDXXRKGGK 184
Query: 519 N-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  
Sbjct: 185 GLLPVRWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 237
Query: 573 V-----LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           V     L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 238 VMEGGLLDKPDNCPDMLL----ELMRMCWQYNPKMRPSFLEII 276

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 28/221 (12%)
Query: 356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           +G  +GRGT+G VY    ++           I       + C     +EI +L  LKH N
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLRELKHPN 79
Query: 416 IV--QYYGSEVVDDHLYIYLEYV-----HPGSINRYVREHCRDIT--ESIVRNFTRHILN 466
           ++  Q       D  +++  +Y      H    +R  + + + +     +V++    IL+
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 467 GLAYLHSTNTIHRDIKGANLLVDAS----GVVKLADFGMAKH----LTGLSYELSLKGSP 518
           G+ YLH+   +HRD+K AN+LV       G VK+AD G A+     L  L+    +  + 
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
            + APE++       G      A+DIW++GC   E+LT +P
Sbjct: 200 WYRAPELLL------GARHYTKAIDIWAIGCIFAELLTSEP 234

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 25/221 (11%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            +++   LIG+G+FG V    +R      AIK    I  + K+   + Q + E+++L  +
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK----IIKNKKAF--LNQAQIEVRLLELM 107
Query: 412 -KHENIVQYYGSEV-----VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            KH+  ++YY   +       +HL +  E +     +     + R ++ ++ R F + + 
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 466 NGLAYLHS--TNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             L +L +   + IH D+K  N+L+       +K+ DFG +  L    Y+     S  + 
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXI--QSRFYR 225
Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 562
           +PEV+       G P   LA+D+WSLGC ++EM TG+P +S
Sbjct: 226 SPEVLL------GMP-YDLAIDMWSLGCILVEMHTGEPLFS 259

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 25/221 (11%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            +++   LIG+G+FG V    +R      AIK    I  + K+   + Q + E+++L  +
Sbjct: 35  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK----IIKNKKA--FLNQAQIEVRLLELM 88
Query: 412 -KHENIVQYYGSEV-----VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            KH+  ++YY   +       +HL +  E +     +     + R ++ ++ R F + + 
Sbjct: 89  NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 148
Query: 466 NGLAYLHS--TNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             L +L +   + IH D+K  N+L+       +K+ DFG +  L    Y+     S  + 
Sbjct: 149 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXI--QSRFYR 206
Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 562
           +PEV+       G P   LA+D+WSLGC ++EM TG+P +S
Sbjct: 207 SPEVLL------GMP-YDLAIDMWSLGCILVEMHTGEPLFS 240

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 419
           +G G FGSV  G  R       +  + ++    + A+  +++ +E +++  L +  IV+ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVA-IKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRL 75
Query: 420 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 479
            G     + L + +E    G +++++     +I  S V      +  G+ YL   N +HR
Sbjct: 76  IGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGN 535
           D+   N+L+      K++DFG++K L       + + +      W APE I         
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF------- 187
Query: 536 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 570
            K +   D+WS G T+ E L+ G+ P+ + +GP+ M
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 223

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 118/278 (42%), Gaps = 46/278 (16%)
Query: 360 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 412
           +G+G+FG VY G  R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 78
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI---------TESIVRNFTRH 463
             ++V+  G         + +E +  G +  Y+R    +          T   +      
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 519
           I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG       
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPV 196
Query: 520 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 573
            WMAPE +     KDG      + D+WS G  + E+ +  + P+      Q +  V    
Sbjct: 197 RWMAPESL-----KDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 574 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            L++    PE ++    D +  C+  NP  RP+ +E++
Sbjct: 250 YLDQPDNCPERVT----DLMRMCWQFNPKMRPTFLEIV 283

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 118/278 (42%), Gaps = 46/278 (16%)
Query: 360 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 412
           +G+G+FG VY G  R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 77
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR---------NFTRH 463
             ++V+  G         + +E +  G +  Y+R    +   +  R              
Sbjct: 78  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 519
           I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y    KG       
Sbjct: 138 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPV 195
Query: 520 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 573
            WMAPE +     KDG      + D+WS G  + E+ +  + P+      Q +  V    
Sbjct: 196 RWMAPESL-----KDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 248
Query: 574 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            L++    PE ++    D +  C+  NP  RP+ +E++
Sbjct: 249 YLDQPDNCPERVT----DLMRMCWQFNPKMRPTFLEIV 282

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 25/221 (11%)
Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            +++   LIG+G+FG V    +R      AIK    I  + K+   + Q + E+++L  +
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK----IIKNKKAF--LNQAQIEVRLLELM 107
Query: 412 -KHENIVQYYGSEV-----VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            KH+  ++YY   +       +HL +  E +     +     + R ++ ++ R F + + 
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 466 NGLAYLHS--TNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             L +L +   + IH D+K  N+L+       +K+ DFG +  L    Y+     S  + 
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXI--QSRFYR 225
Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 562
           +PEV+       G P   LA+D+WSLGC ++EM TG+P +S
Sbjct: 226 SPEVLL------GMP-YDLAIDMWSLGCILVEMHTGEPLFS 259

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 115/283 (40%), Gaps = 56/283 (19%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------EIKV 407
           +G+G+FG VY G  +            ++ D+P++   IK + +            E  V
Sbjct: 20  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE---------SIVR 458
           +      ++V+  G         + +E +  G +  Y+R    ++           S + 
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 518
                I +G+AYL++   +HRD+   N  V     VK+ DFGM + +    Y    KG  
Sbjct: 129 QMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDY--YRKGGK 186
Query: 519 N-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
                 WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  
Sbjct: 187 GLLPVRWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 239
Query: 573 V-----LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           V     L++    P+ML     + +  C+  NP  RPS +E++
Sbjct: 240 VMEGGLLDKPDNCPDMLL----ELMRMCWQYNPKMRPSFLEII 278

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 112/282 (39%), Gaps = 50/282 (17%)
Query: 360 IGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           IG G FG V+          E     A+K +     +  SA+     ++E  ++    + 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK----EEASADMQADFQREAALMAEFDNP 110
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE----------HCRDITESIVRN----- 459
           NIV+  G   V   + +  EY+  G +N ++R           H    T + V +     
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 460 --------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 511
                     R +  G+AYL     +HRD+   N LV  + VVK+ADFG+++++    Y 
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY- 229
Query: 512 LSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 564
              K   N      WM PE I          +     D+W+ G  + E+ + G  P+   
Sbjct: 230 --YKADGNDAIPIRWMPPESIF-------YNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280
Query: 565 EGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPS 605
              + ++ V +      PE    E  + +  C+ + P +RPS
Sbjct: 281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPS 322

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 114/282 (40%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 39  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++  L H+NIV+  G  +     +I LE +  G +  ++RE          +    + + 
Sbjct: 87  IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG 
Sbjct: 147 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGG 204
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 205 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 257
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 258 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 46/278 (16%)
Query: 360 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 412
           +G+G+FG VY G  R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 78
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI---------TESIVRNFTRH 463
             ++V+  G         + +E +  G +  Y+R    +          T   +      
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 519
           I +G+AYL++   +HRD+   N +V     VK+ DFGM + +     +   KG       
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX--ETDXXRKGGKGLLPV 196
Query: 520 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 573
            WMAPE +     KDG      + D+WS G  + E+ +  + P+      Q +  V    
Sbjct: 197 RWMAPESL-----KDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 574 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            L++    PE ++    D +  C+  NP  RP+ +E++
Sbjct: 250 YLDQPDNCPERVT----DLMRMCWQFNPKMRPTFLEIV 283

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           LIG G FG VY G  R+ GA  A+K        P+S++ I++ E EI+ L   +H ++V 
Sbjct: 46  LIGHGVFGKVYKGVLRD-GAKVALKR-----RTPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHIL----NGLAYLHS 473
             G     + + +  +Y+  G++ R++  +  D+ T S+       I      GL YLH+
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYLHT 157
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPE-VIKAV 529
              IHRD+K  N+L+D + V K+ DFG++K  T L        +KG+  ++ PE  IK  
Sbjct: 158 RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKG- 216
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGK 558
                  +L    D++S G  + E+L  +
Sbjct: 217 -------RLTEKSDVYSFGVVLFEVLCAR 238

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 46/278 (16%)
Query: 360 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 412
           +G+G+FG VY G  R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 75
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI---------TESIVRNFTRH 463
             ++V+  G         + +E +  G +  Y+R    +          T   +      
Sbjct: 76  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 519
           I +G+AYL++   +HRD+   N +V     VK+ DFGM + +     +   KG       
Sbjct: 136 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX--ETDXXRKGGKGLLPV 193
Query: 520 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 573
            WMAPE +     KDG      + D+WS G  + E+ +  + P+      Q +  V    
Sbjct: 194 RWMAPESL-----KDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 246
Query: 574 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            L++    PE ++    D +  C+  NP  RP+ +E++
Sbjct: 247 YLDQPDNCPERVT----DLMRMCWQFNPKMRPTFLEIV 280

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           LIG G FG VY G  R+ GA  A+K        P+S++ I++ E EI+ L   +H ++V 
Sbjct: 46  LIGHGVFGKVYKGVLRD-GAKVALKR-----RTPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHIL----NGLAYLHS 473
             G     + + +  +Y+  G++ R++  +  D+ T S+       I      GL YLH+
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYLHT 157
Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPE-VIKAV 529
              IHRD+K  N+L+D + V K+ DFG++K  T L        +KG+  ++ PE  IK  
Sbjct: 158 RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKG- 216
Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGK 558
                  +L    D++S G  + E+L  +
Sbjct: 217 -------RLTEKSDVYSFGVVLFEVLCAR 238

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 114/282 (40%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 53  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++  L H+NIV+  G  +     +I LE +  G +  ++RE          +    + + 
Sbjct: 101 IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG 
Sbjct: 161 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGG 218
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 219 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 271
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 272 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/272 (23%), Positives = 118/272 (43%), Gaps = 31/272 (11%)
Query: 359 LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           +IG G FG V     ++ G     AIK +          +   +LE   K LGH  H NI
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LGH--HPNI 88
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFT 461
           +   G+     +LY+ +EY   G++  ++R+                   ++   + +F 
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             +  G+ YL     IHRD+   N+LV  + V K+ADFG+++       +   +    WM
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 208
Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI 580
           A E +   +    +       D+WS G  + E+++ G  P+      + +++ L +   +
Sbjct: 209 AIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRL 260
Query: 581 PEMLS--SEGKDFLLRCFLRNPVERPSAVELL 610
            + L+   E  D + +C+   P ERPS  ++L
Sbjct: 261 EKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 46/278 (16%)
Query: 360 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 412
           +G+G+FG VY G  R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 78
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI---------TESIVRNFTRH 463
             ++V+  G         + +E +  G +  Y+R    +          T   +      
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 519
           I +G+AYL++   +HRD+   N +V     VK+ DFGM + +     +   KG       
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX--ETDXXRKGGKGLLPV 196
Query: 520 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 573
            WMAPE +     KDG      + D+WS G  + E+ +  + P+      Q +  V    
Sbjct: 197 RWMAPESL-----KDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 574 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            L++    PE ++    D +  C+  NP  RP+ +E++
Sbjct: 250 YLDQPDNCPERVT----DLMRMCWQFNPNMRPTFLEIV 283

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/272 (23%), Positives = 118/272 (43%), Gaps = 31/272 (11%)
Query: 359 LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           +IG G FG V     ++ G     AIK +          +   +LE   K LGH  H NI
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LGH--HPNI 78
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFT 461
           +   G+     +LY+ +EY   G++  ++R+                   ++   + +F 
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             +  G+ YL     IHRD+   N+LV  + V K+ADFG+++       +   +    WM
Sbjct: 139 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 198
Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI 580
           A E +   +    +       D+WS G  + E+++ G  P+      + +++ L +   +
Sbjct: 199 AIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRL 250
Query: 581 PEMLS--SEGKDFLLRCFLRNPVERPSAVELL 610
            + L+   E  D + +C+   P ERPS  ++L
Sbjct: 251 EKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 113/282 (40%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 39  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++    H+NIV+  G  +     +I LE +  G +  ++RE          +    + + 
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG 
Sbjct: 147 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGG 204
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 205 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 257
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 258 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 113/282 (40%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 65  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 112
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++    H+NIV+  G  +     +I LE +  G +  ++RE          +    + + 
Sbjct: 113 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 172
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG 
Sbjct: 173 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGG 230
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 231 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 283
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 284 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 324

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 113/282 (40%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 30  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 77
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++    H+NIV+  G  +     +I LE +  G +  ++RE          +    + + 
Sbjct: 78  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 137
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG 
Sbjct: 138 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGG 195
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 196 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 248
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 249 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 289

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 113/282 (40%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 38  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++    H+NIV+  G  +     +I LE +  G +  ++RE          +    + + 
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG 
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGG 203
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 204 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 257 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 113/282 (40%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 39  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++    H+NIV+  G  +     +I LE +  G +  ++RE          +    + + 
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG 
Sbjct: 147 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASY--YRKGG 204
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 205 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 257
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 258 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 113/282 (40%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 45  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 92
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++    H+NIV+  G  +     +I LE +  G +  ++RE          +    + + 
Sbjct: 93  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 152
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG 
Sbjct: 153 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGG 210
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 211 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 263
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 264 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 304

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +LIGRG +G+VY G+  E   +  +               I   E+ I  +  ++H+NI 
Sbjct: 19  ELIGRGRYGAVYKGSLDERPVAVKVFSF------ANRQNFIN--EKNIYRVPLMEHDNIA 70
Query: 418 QYY-GSE-VVDDHLYIYL---EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           ++  G E V  D    YL   EY   GS+ +Y+  H  D   S        +  GLAYLH
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC--RLAHSVTRGLAYLH 128
Query: 473 ST---------NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG---------LSYELSL 514
           +             HRD+   N+LV   G   ++DFG++  LTG          +  +S 
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 515 KGSPNWMAPEVIK-AVMQKDGNPKLALAVDIWSLGCTVIEML 555
            G+  +MAPEV++ AV  +D    L   VD+++LG    E+ 
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALK-QVDMYALGLIYWEIF 229

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 20/261 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG+V  G   +         V I+ ++        +L  E  V+  L +  IV
Sbjct: 31  KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +  G    +  + + +E    G +N+Y++++ R + +  +      +  G+ YL  +N +
Sbjct: 90  RMIGICEAESWMLV-MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFV 147
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS--PNWMAPEVIKAVMQKD 533
           HRD+   N+L+      K++DFG++K L      Y+    G     W APE I       
Sbjct: 148 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---- 203
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKD 590
              K +   D+WS G  + E  + G+ P+   +G +  AM +   R    P     E  D
Sbjct: 204 ---KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GCPAGCPREMYD 259
Query: 591 FLLRCFLRNPVERP--SAVEL 609
            +  C+  +   RP  +AVEL
Sbjct: 260 LMNLCWTYDVENRPGFAAVEL 280

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 113/282 (40%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 55  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 102
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++    H+NIV+  G  +     +I LE +  G +  ++RE          +    + + 
Sbjct: 103 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 162
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG 
Sbjct: 163 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGG 220
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 221 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 273
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 274 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 314

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 46/278 (16%)
Query: 360 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 412
           +G+G+FG VY G  R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 78
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI---------TESIVRNFTRH 463
             ++V+  G         + +E +  G +  Y+R    +          T   +      
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 519
           I +G+AYL++   +HR++   N +V     VK+ DFGM + +    Y    KG       
Sbjct: 139 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPV 196
Query: 520 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 573
            WMAPE +     KDG      + D+WS G  + E+ +  + P+      Q +  V    
Sbjct: 197 RWMAPESL-----KDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 574 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            L++    PE ++    D +  C+  NP  RP+ +E++
Sbjct: 250 YLDQPDNCPERVT----DLMRMCWQFNPNMRPTFLEIV 283

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 46/278 (16%)
Query: 360 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 412
           +G+G+FG VY G  R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 79
Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI---------TESIVRNFTRH 463
             ++V+  G         + +E +  G +  Y+R    +          T   +      
Sbjct: 80  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 519
           I +G+AYL++   +HR++   N +V     VK+ DFGM + +    Y    KG       
Sbjct: 140 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPV 197
Query: 520 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 573
            WMAPE +     KDG      + D+WS G  + E+ +  + P+      Q +  V    
Sbjct: 198 RWMAPESL-----KDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 250
Query: 574 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            L++    PE ++    D +  C+  NP  RP+ +E++
Sbjct: 251 YLDQPDNCPERVT----DLMRMCWQFNPNMRPTFLEIV 284

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 115/258 (44%), Gaps = 23/258 (8%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G+GTF  ++ G  RE G    + E +++    D       +   +   ++  L H+++V
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
             YG  V  D   +  E+V  GS++ Y++++   I         + +   + +L     I
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLI 135
Query: 478 HRDIKGANLLV-----DASG---VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           H ++   N+L+       +G    +KL+D G++  +T L  ++  +  P W+ PE I+  
Sbjct: 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--ITVLPKDILQERIP-WVPPECIE-- 190
Query: 530 MQKDGNPK-LALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 587
                NPK L LA D WS G T+ E+ + G  P S  +  Q   +       +P   ++E
Sbjct: 191 -----NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYEDRHQLPAPKAAE 244
Query: 588 GKDFLLRCFLRNPVERPS 605
             + +  C    P  RPS
Sbjct: 245 LANLINNCMDYEPDHRPS 262

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  + 
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVN 119
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   + +   +H R      +      +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQM 173
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + AP
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 232
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI  +  K+        VDIWS+GC + EM+  K  +   +      KV+ +   P PE
Sbjct: 233 EVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285
Query: 583 ML-----------------------------------------SSEGKDFLLRCFLRNPV 601
            +                                         +S+ +D L +  + +P 
Sbjct: 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345
Query: 602 ERPSAVELLEHPFI 615
           +R S  + L+HP+I
Sbjct: 346 KRISVDDALQHPYI 359

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 20/261 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG+V  G   +         V I+ ++        +L  E  V+  L +  IV
Sbjct: 33  KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +  G    +  + + +E    G +N+Y++++ R + +  +      +  G+ YL  +N +
Sbjct: 92  RMIGICEAESWMLV-MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFV 149
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS--PNWMAPEVIKAVMQKD 533
           HRD+   N+L+      K++DFG++K L      Y+    G     W APE I       
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---- 205
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKD 590
              K +   D+WS G  + E  + G+ P+   +G +  AM +   R    P     E  D
Sbjct: 206 ---KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GCPAGCPREMYD 261
Query: 591 FLLRCFLRNPVERP--SAVEL 609
            +  C+  +   RP  +AVEL
Sbjct: 262 LMNLCWTYDVENRPGFAAVEL 282

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 20/261 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG+V  G   +         V I+ ++        +L  E  V+  L +  IV
Sbjct: 33  KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +  G    +  + + +E    G +N+Y++++ R + +  +      +  G+ YL  +N +
Sbjct: 92  RMIGICEAESWMLV-MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFV 149
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS--PNWMAPEVIKAVMQKD 533
           HRD+   N+L+      K++DFG++K L      Y+    G     W APE I       
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---- 205
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKD 590
              K +   D+WS G  + E  + G+ P+   +G +  AM +   R    P     E  D
Sbjct: 206 ---KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GCPAGCPREMYD 261
Query: 591 FLLRCFLRNPVERP--SAVEL 609
            +  C+  +   RP  +AVEL
Sbjct: 262 LMNLCWTYDVENRPGFAAVEL 282

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 113/282 (40%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 38  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++    H+NIV+  G  +     +I +E +  G +  ++RE          +    + + 
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG 
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGG 203
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 204 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 257 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 20/261 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG+V  G   +         V I+ ++        +L  E  V+  L +  IV
Sbjct: 17  KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +  G    +  + + +E    G +N+Y++++ R + +  +      +  G+ YL  +N +
Sbjct: 76  RMIGICEAESWMLV-MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFV 133
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS--PNWMAPEVIKAVMQKD 533
           HRD+   N+L+      K++DFG++K L      Y+    G     W APE I       
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY---- 189
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKD 590
              K +   D+WS G  + E  + G+ P+   +G +  AM +   R    P     E  D
Sbjct: 190 ---KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GCPAGCPREMYD 245
Query: 591 FLLRCFLRNPVERP--SAVEL 609
            +  C+  +   RP  +AVEL
Sbjct: 246 LMNLCWTYDVENRPGFAAVEL 266

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 111/273 (40%), Gaps = 51/273 (18%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQEIKVLGHLKHE 414
           +++G G  G V    N+ T    A+K +   P   +  E      Q    ++++    +E
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD--VYE 81
Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHS 473
           N+  Y G +     L I +E +  G +   +++   +  TE       + I   + YLHS
Sbjct: 82  NL--YAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 474 TNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
            N  HRD+K  NLL  +   + ++KL DFG AK  TG  Y+ S                 
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKS----------------- 178
Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE------GPQAMFKVLNRTPPIPEML 584
                       D+WSLG  +  +L G PP+          G +   ++     P PE  
Sbjct: 179 -----------CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227
Query: 585 S-SEGKDFLLRCFLRN-PVERPSAVELLEHPFI 615
             SE    L+R  L+  P +R +  E + HP+I
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKXVN 81
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   + +   +H R      +      +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHER------MSYLLYQM 135
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + AP
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 194
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI  +  K+        VDIWS+GC + EM+  K  +   +      KV+ +   P PE
Sbjct: 195 EVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 583 ML-----------------------------------------SSEGKDFLLRCFLRNPV 601
            +                                         +S+ +D L +  + +P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 602 ERPSAVELLEHPFI 615
           +R S  + L+HP+I
Sbjct: 308 KRISVDDALQHPYI 321

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 452 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSY 510
           + E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L    Y
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 213
Query: 511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGP 567
                G+  +  PE I+       +     +  +WSLG  + +M+ G  P+    E    
Sbjct: 214 T-DFDGTRVYSPPEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 266
Query: 568 QAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           Q  F+         + +SSE +  +  C    P +RP+  E+  HP++++ 
Sbjct: 267 QVFFR---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 20/261 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG+V  G   +         V I+ ++        +L  E  V+  L +  IV
Sbjct: 17  KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +  G    +  + + +E    G +N+Y++++ R + +  +      +  G+ YL  +N +
Sbjct: 76  RMIGICEAESWMLV-MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFV 133
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS--PNWMAPEVIKAVMQKD 533
           HRD+   N+L+      K++DFG++K L      Y+    G     W APE I       
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---- 189
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKD 590
              K +   D+WS G  + E  + G+ P+   +G +  AM +   R    P     E  D
Sbjct: 190 ---KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GCPAGCPREMYD 245
Query: 591 FLLRCFLRNPVERP--SAVEL 609
            +  C+  +   RP  +AVEL
Sbjct: 246 LMNLCWTYDVENRPGFAAVEL 266

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 118/272 (43%), Gaps = 31/272 (11%)
Query: 359 LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           +IG G FG V     ++ G     AIK +          +   +LE   K LGH  H NI
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LGH--HPNI 85
Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFT 461
           +   G+     +LY+ +EY   G++  ++R+                   ++   + +F 
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             +  G+ YL     IHR++   N+LV  + V K+ADFG+++       +   +    WM
Sbjct: 146 ADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 205
Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI 580
           A E +   +    +       D+WS G  + E+++ G  P+      + +++ L +   +
Sbjct: 206 AIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRL 257
Query: 581 PEMLS--SEGKDFLLRCFLRNPVERPSAVELL 610
            + L+   E  D + +C+   P ERPS  ++L
Sbjct: 258 EKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 113/282 (40%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 53  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++    H+NIV+  G  +     +I +E +  G +  ++RE          +    + + 
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG 
Sbjct: 161 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGG 218
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 219 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 271
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 272 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 20/261 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG+V  G   +         V I+ ++        +L  E  V+  L +  IV
Sbjct: 11  KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +  G    +  + + +E    G +N+Y++++ R + +  +      +  G+ YL  +N +
Sbjct: 70  RMIGICEAESWMLV-MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFV 127
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS--PNWMAPEVIKAVMQKD 533
           HRD+   N+L+      K++DFG++K L      Y+    G     W APE I       
Sbjct: 128 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---- 183
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKD 590
              K +   D+WS G  + E  + G+ P+   +G +  AM +   R    P     E  D
Sbjct: 184 ---KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GCPAGCPREMYD 239
Query: 591 FLLRCFLRNPVERP--SAVEL 609
            +  C+  +   RP  +AVEL
Sbjct: 240 LMNLCWTYDVENRPGFAAVEL 260

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 112/282 (39%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 79  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++    H+NIV+  G  +     +I LE +  G +  ++RE          +    + + 
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +    Y    KG 
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY--YRKGG 244
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 245 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 298 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 338

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 112/282 (39%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE----QEIK 406
           +G G FG VY G            +V  +P+DP   +         C +Q E     E  
Sbjct: 56  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 103
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++    H+NIV+  G  +     +I LE +  G +  ++RE          +    + + 
Sbjct: 104 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 163
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +    Y    KG 
Sbjct: 164 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY--YRKGG 221
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 222 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 274
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 275 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 315

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 20/261 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG+V  G   +         V I+ ++        +L  E  V+  L +  IV
Sbjct: 23  KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +  G    +  + + +E    G +N+Y++++ R + +  +      +  G+ YL  +N +
Sbjct: 82  RMIGICEAESWMLV-MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS--PNWMAPEVIKAVMQKD 533
           HRD+   N+L+      K++DFG++K L      Y+    G     W APE I       
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---- 195
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKD 590
              K +   D+WS G  + E  + G+ P+   +G +  AM +   R    P     E  D
Sbjct: 196 ---KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GCPAGCPREMYD 251
Query: 591 FLLRCFLRNPVERP--SAVEL 609
            +  C+  +   RP  +AVEL
Sbjct: 252 LMNLCWTYDVENRPGFAAVEL 272

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  + 
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVN 119
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   + +   +H R      +      +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQM 173
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + AP
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 232
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI  +  K+        VDIWS+GC + EM+  K  +   +      KV+ +   P PE
Sbjct: 233 EVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285
Query: 583 ML-----------------------------------------SSEGKDFLLRCFLRNPV 601
            +                                         +S+ +D L +  + +P 
Sbjct: 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345
Query: 602 ERPSAVELLEHPFI 615
           +R S  + L+HP+I
Sbjct: 346 KRISVDDALQHPYI 359

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVN 81
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   + +   +H R      +      +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHER------MSYLLYQM 135
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + AP
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 194
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI  +  K+        VDIWS+GC + EM+  K  +   +      KV+ +   P PE
Sbjct: 195 EVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 583 ML-----------------------------------------SSEGKDFLLRCFLRNPV 601
            +                                         +S+ +D L +  + +P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 602 ERPSAVELLEHPFI 615
           +R S  + L+HP+I
Sbjct: 308 KRISVDDALQHPYI 321

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKXVN 81
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   + +   +H R      +      +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHER------MSYLLYQM 135
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + AP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 194
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI  +  K+        VDIWS+GC + EM+  K  +   +      KV+ +   P PE
Sbjct: 195 EVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 583 ML-----------------------------------------SSEGKDFLLRCFLRNPV 601
            +                                         +S+ +D L +  + +P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 602 ERPSAVELLEHPFI 615
           +R S  + L+HP+I
Sbjct: 308 KRISVDDALQHPYI 321

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 20/261 (7%)
Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           K +G G FG+V  G   +         V I+ ++        +L  E  V+  L +  IV
Sbjct: 13  KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +  G    +  + + +E    G +N+Y++++ R + +  +      +  G+ YL  +N +
Sbjct: 72  RMIGICEAESWMLV-MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS--PNWMAPEVIKAVMQKD 533
           HRD+   N+L+      K++DFG++K L      Y+    G     W APE I       
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---- 185
Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKD 590
              K +   D+WS G  + E  + G+ P+   +G +  AM +   R    P     E  D
Sbjct: 186 ---KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GCPAGCPREMYD 241
Query: 591 FLLRCFLRNPVERP--SAVEL 609
            +  C+  +   RP  +AVEL
Sbjct: 242 LMNLCWTYDVENRPGFAAVEL 262

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 113/282 (40%), Gaps = 52/282 (18%)
Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQ------------EIK 406
           +G G FG VY G            +V  +P+DP   +  +K L +            E  
Sbjct: 53  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEAL 100
Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNF 460
           ++    H+NIV+  G  +     +I LE +  G +  ++RE          +    + + 
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGS 517
            R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG 
Sbjct: 161 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGG 218
Query: 518 -----PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 571
                  WM PE   A M+     K     D WS G  + E+ + G  P+      + + 
Sbjct: 219 CAMLPVKWMPPE---AFMEGIFTSK----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 271
Query: 572 KVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            V +  R  P P+         + +C+   P +RP+   +LE
Sbjct: 272 FVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 15/167 (8%)
Query: 452 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 511
           IT   + +++  +  G+ +L S   IHRD+   N+L+  + VVK+ DFG+A+ +   + +
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-NPD 254
Query: 512 LSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 566
              KG       WMAPE I        +   +   D+WS G  + E+ + G  P+   + 
Sbjct: 255 YVRKGDTRLPLKWMAPESI-------FDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQM 307
Query: 567 PQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            +     L     +  PE  + E    +L C+ R+P ERP   EL+E
Sbjct: 308 DEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVE 354

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           Q Q  K IG+G +G V++G  R  G   A+K    +    + A   ++ E    VL  ++
Sbjct: 38  QIQMVKQIGKGRYGEVWMGKWR--GEKVAVK----VFFTTEEASWFRETEIYQTVL--MR 89
Query: 413 HENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
           HENI+ +  +++        LY+  +Y   GS+  Y++    D    +   ++   ++GL
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS--VSGL 147
Query: 469 AYLHST--------NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL-----K 515
            +LH+            HRD+K  N+LV  +G   +AD G+A      + E+ +      
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           G+  +M PEV+   + ++      +A D++S G  + E+
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMA-DMYSFGLILWEV 245

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 130/314 (41%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q+ K IG G  G V    +   G + A+K++     +   A   K+  +E+ +L  + 
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLKCVN 79
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   +     +H R      +      +
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHER------MSYLLYQM 133
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+  +          +  + APE
Sbjct: 134 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPE 193
Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK--------------------PPWSEF 564
           VI  +  K+        VDIWS+GC + E++ G                      P +EF
Sbjct: 194 VILGMGYKEN-------VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 246
Query: 565 EG---PQAMFKVLNRTPPIP--------------------EMLSSEGKDFLLRCFLRNPV 601
                P     V NR P  P                    ++ +S+ +D L +  + +P 
Sbjct: 247 MAALQPTVRNYVENR-PAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPD 305
Query: 602 ERPSAVELLEHPFI 615
           +R S  E L HP+I
Sbjct: 306 KRISVDEALRHPYI 319

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  + 
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVN 74
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   + +   +H R      +      +
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHER------MSYLLYQM 128
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + AP
Sbjct: 129 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 187
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI  +  K+        VDIWS+GC + EM+  K  +   +      KV+ +   P PE
Sbjct: 188 EVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 583 ML-----------------------------------------SSEGKDFLLRCFLRNPV 601
            +                                         +S+ +D L +  + +P 
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300
Query: 602 ERPSAVELLEHPFI 615
           +R S  + L+HP+I
Sbjct: 301 KRISVDDALQHPYI 314

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  + 
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVN 82
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   + +   +H R      +      +
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQM 136
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + AP
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 195
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI  +  K+        VDIWS+GC + EM+  K  +   +      KV+ +   P PE
Sbjct: 196 EVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 248
Query: 583 ML-----------------------------------------SSEGKDFLLRCFLRNPV 601
            +                                         +S+ +D L +  + +P 
Sbjct: 249 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 308
Query: 602 ERPSAVELLEHPFI 615
           +R S  + L+HP+I
Sbjct: 309 KRISVDDALQHPYI 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVN 81
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   + +   +H R      +      +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQM 135
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + AP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 194
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI  +  K+        VDIWS+GC + EM+  K  +   +      KV+ +   P PE
Sbjct: 195 EVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 583 ML-----------------------------------------SSEGKDFLLRCFLRNPV 601
            +                                         +S+ +D L +  + +P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 602 ERPSAVELLEHPFI 615
           +R S  + L+HP+I
Sbjct: 308 KRISVDDALQHPYI 321

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKXVN 81
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   + +   +H R      +      +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQM 135
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + AP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 194
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI  +  K+        VDIWS+GC + EM+  K  +   +      KV+ +   P PE
Sbjct: 195 EVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 583 ML-----------------------------------------SSEGKDFLLRCFLRNPV 601
            +                                         +S+ +D L +  + +P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 602 ERPSAVELLEHPFI 615
           +R S  + L+HP+I
Sbjct: 308 KRISVDDALQHPYI 321

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  + 
Sbjct: 24  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVN 80
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   + +   +H R      +      +
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQM 134
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + AP
Sbjct: 135 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 193
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI  +  K+        VDIWS+GC + EM+  K  +   +      KV+ +   P PE
Sbjct: 194 EVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 246
Query: 583 ML-----------------------------------------SSEGKDFLLRCFLRNPV 601
            +                                         +S+ +D L +  + +P 
Sbjct: 247 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 306
Query: 602 ERPSAVELLEHPFI 615
           +R S  + L+HP+I
Sbjct: 307 KRISVDDALQHPYI 320

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVN 81
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   + +   +H R      +      +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQM 135
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + AP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 194
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI  +  K+        VDIWS+GC + EM+  K  +   +      KV+ +   P PE
Sbjct: 195 EVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 583 ML-----------------------------------------SSEGKDFLLRCFLRNPV 601
            +                                         +S+ +D L +  + +P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 602 ERPSAVELLEHPFI 615
           +R S  + L+HP+I
Sbjct: 308 KRISVDDALQHPYI 321

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 57/96 (59%), Gaps = 9/96 (9%)
Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWM 521
            +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + 
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYR 192
Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 557
           APEVI  +  K+        VDIWS+GC + EM+ G
Sbjct: 193 APEVILGMGYKEN-------VDIWSVGCIMGEMIKG 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  + 
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVN 82
Query: 413 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           H+NI+        Q    E  D +L + L   +   + +   +H R      +      +
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQM 136
Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++    +  + AP
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 195
Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 582
           EVI  +  K+        VDIWS+GC + EM+  K  +   +      KV+ +   P PE
Sbjct: 196 EVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 248
Query: 583 ML-----------------------------------------SSEGKDFLLRCFLRNPV 601
            +                                         +S+ +D L +  + +P 
Sbjct: 249 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 308
Query: 602 ERPSAVELLEHPFI 615
           +R S  + L+HP+I
Sbjct: 309 KRISVDDALQHPYI 322
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	739
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-141
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-128
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-118
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-102
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-98
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-94
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-89
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-88
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-86
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-86
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-85
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-85
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-84
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-84
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-83
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-77
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-76
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-76
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-75
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-75
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-74
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-73
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-73
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-72
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-71
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-70
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-67
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-66
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-66
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-66
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-65
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-65
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-63
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-62
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-62
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-59
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-57
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-57
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-57
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-57
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-56
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-56
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-56
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-55
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-55
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-55
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-55
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-55
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-54
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-54
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-54
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-54
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-54
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-53
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-53
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-53
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-53
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-53
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-53
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-53
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-53
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-53
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-52
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-52
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-52
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-52
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-52
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-52
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-52
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-52
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-52
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-52
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-52
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-52
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-52
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-51
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-51
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-50
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-50
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-50
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-50
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-50
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-50
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-50
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-50
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-49
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-49
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-48
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-48
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-48
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-48
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-48
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-48
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-48
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-47
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-47
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-47
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-47
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-47
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-47
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-47
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-46
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-46
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-46
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-46
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-46
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-46
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-46
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-45
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-45
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-45
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-44
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-44
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-44
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-43
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-43
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-43
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-43
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-43
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-43
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-42
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-42
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-42
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-42
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-42
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-42
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-42
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-42
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-42
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-41
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-41
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-41
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-40
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-40
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-40
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-40
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-40
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-40
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-39
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-39
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-39
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-39
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-38
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-38
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-38
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-37
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-37
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-37
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-36
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-36
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-36
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-36
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-36
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-35
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-35
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-35
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-34
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-29
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-29
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-29
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-28
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-24
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-23
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-23
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-23
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-23
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-20
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-20
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-18
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-17
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-17
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-14
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  414 bits (1066), Expect = e-141
 Identities = 107/292 (36%), Positives = 161/292 (55%), Gaps = 17/292 (5%)

Query: 343 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE 402
           +      +  +     ++G+GT+G VY G +       AIKE+       + +   + L 
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE-----RDSRYSQPLH 67

Query: 403 QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNF 460
           +EI +  HLKH+NIVQY GS   +  + I++E V  GS++  +R     +   E  +  +
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127

Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGL-SYELSLKGSP 518
           T+ IL GL YLH    +HRDIKG N+L++  SGV+K++DFG +K L G+     +  G+ 
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 187

Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKV--LN 575
            +MAPE+I       G      A DIWSLGCT+IEM TGKPP+ E   P  AMFKV    
Sbjct: 188 QYMAPEIID--KGPRG---YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK 242

Query: 576 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 627
             P IPE +S+E K F+L+CF  +P +R  A +LL   F++ ++ +  + P 
Sbjct: 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  383 bits (985), Expect = e-128
 Identities = 80/339 (23%), Positives = 132/339 (38%), Gaps = 31/339 (9%)

Query: 301 PQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLI 360
             +   L ++ +  +A    L P         +T  + P          +         +
Sbjct: 10  AHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKP---VDYEYREEVHWMTHQPRV 66

Query: 361 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 420
           GRG+FG V+   +++TG  CA+K+V +               +E+     L    IV  Y
Sbjct: 67  GRGSFGEVHRMKDKQTGFQCAVKKVRLE----------VFRVEELVACAGLSSPRIVPLY 116

Query: 421 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 480
           G+      + I++E +  GS+ + ++     + E     +    L GL YLH+   +H D
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175

Query: 481 IKGANLLVDASGV-VKLADFGMAKHLTGLSYEL------SLKGSPNWMAPEVIKAVMQKD 533
           +K  N+L+ + G    L DFG A  L              + G+   MAPEV+     K 
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM---GKP 232

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGKD 590
            + K    VDIWS  C ++ ML G  PW+++       K+ +  PP   IP   +     
Sbjct: 233 CDAK----VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288

Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRV 629
            +     + PV R SA+EL             L  P + 
Sbjct: 289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKG 327

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  357 bits (917), Expect = e-118
 Identities = 76/301 (25%), Positives = 141/301 (46%), Gaps = 26/301 (8%)

Query: 327 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 386
              +      +    +     S      +    IGRG+F +VY G + ET    A  E+ 
Sbjct: 4   RNQQQDDIEELETKAVGM---SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60

Query: 387 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHLYIYLEYVHPGSIN 442
              D   +    ++ ++E ++L  L+H NIV++Y S          + +  E +  G++ 
Sbjct: 61  ---DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117

Query: 443 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNT--IHRDIKGANLLVDA-SGVVKLADF 499
            Y++     +   ++R++ R IL GL +LH+     IHRD+K  N+ +   +G VK+ D 
Sbjct: 118 TYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176

Query: 500 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 559
           G+A      S+  ++ G+P +MAPE+ +         K   +VD+++ G  ++EM T + 
Sbjct: 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEE--------KYDESVDVYAFGMCMLEMATSEY 227

Query: 560 PWSEFEGPQAMFK-VLNRTPP--IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
           P+SE +    +++ V +   P    ++   E K+ +  C  +N  ER S  +LL H F +
Sbjct: 228 PYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

Query: 617 N 617
            
Sbjct: 288 E 288

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  313 bits (804), Expect = e-102
 Identities = 70/296 (23%), Positives = 127/296 (42%), Gaps = 37/296 (12%)

Query: 346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
             S   +++ + + IG G FGSV+    R  G   AIK               +   +E+
Sbjct: 5   MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD---EQNALREV 61

Query: 406 KVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFT 461
                L +H ++V+Y+ +   DDH+ I  EY + GS+   + E+ R      E+ +++  
Sbjct: 62  YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGV-------------------VKLADFGMA 502
             +  GL Y+HS + +H DIK +N+ +  + +                    K+ D G  
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181

Query: 503 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 562
             ++        +G   ++A EV++        PK     DI++L  TV+     +P   
Sbjct: 182 TRISSPQ---VEEGDSRFLANEVLQ--ENYTHLPK----ADIFALALTVVCAAGAEPLPR 232

Query: 563 EFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
             +    + +   R P IP++LS E  + L      +P  RPSA+ L++H  + +A
Sbjct: 233 NGDQWHEIRQ--GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  305 bits (783), Expect = 6e-98
 Identities = 73/280 (26%), Positives = 134/280 (47%), Gaps = 19/280 (6%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   +   K IG G    V+   N E     AIK V++   D ++   +     EI  L 
Sbjct: 7   KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLN 62

Query: 410 HLKH--ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
            L+   + I++ Y  E+ D ++Y+ +E  +   +N ++++  + I     +++ +++L  
Sbjct: 63  KLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKSYWKNMLEA 120

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPE 524
           +  +H    +H D+K AN L+   G++KL DFG+A  +   T    + S  G+ N+M PE
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 525 VIK----AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR--T 577
            IK    +        K++   D+WSLGC +  M  GK P+ +       +  +++    
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239

Query: 578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
              P++   + +D L  C  R+P +R S  ELL HP+++ 
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  303 bits (778), Expect = 1e-97
 Identities = 75/309 (24%), Positives = 125/309 (40%), Gaps = 12/309 (3%)

Query: 308 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 367
           L + N        L P  +S    +  +   P        S  +  +Q+   +G G++G 
Sbjct: 13  LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72

Query: 368 VYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 427
           V+   ++E G   A+K        PK  +  ++L +        +H   V+   +     
Sbjct: 73  VFKVRSKEDGRLYAVKRSMSPFRGPK--DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130

Query: 428 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 487
            LY+  E     S+ ++       + E+ V  + R  L  LA+LHS   +H D+K AN+ 
Sbjct: 131 ILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189

Query: 488 VDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 547
           +   G  KL DFG+   L         +G P +MAPE++    Q           D++SL
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL----QGSYGTA----ADVFSL 241

Query: 548 GCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 607
           G T++E+          EG Q + +     P     LSSE +  L+     +P  R +A 
Sbjct: 242 GLTILEVACNMELPHGGEGWQQLRQ-GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAE 300

Query: 608 ELLEHPFIR 616
            LL  P +R
Sbjct: 301 ALLALPVLR 309

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  304 bits (781), Expect = 5e-97
 Identities = 77/334 (23%), Positives = 138/334 (41%), Gaps = 21/334 (6%)

Query: 296 RHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQ 355
            H                  A         +  P                  S K   + 
Sbjct: 2   HHHHHSSGLVPRGSGMKETAAAKFE--RQHMDSPDLGTDDDDKASSSANECISVKGRIYS 59

Query: 356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-- 413
             K IG G    V+   N E     AIK V++   D ++   +     EI  L  L+   
Sbjct: 60  ILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQQHS 115

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           + I++ Y  E+ D ++Y+ +E  +   +N ++++    I     +++ +++L  +  +H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQ 173

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIK--- 527
              +H D+K AN L+   G++KL DFG+A  +   T    + S  G+ N+M PE IK   
Sbjct: 174 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 528 -AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR--TPPIPEM 583
            +        K++   D+WSLGC +  M  GK P+ +       +  +++       P++
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
              + +D L  C  R+P +R S  ELL HP+++ 
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  301 bits (774), Expect = 6e-97
 Identities = 74/288 (25%), Positives = 136/288 (47%), Gaps = 19/288 (6%)

Query: 342 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           +   S S K   +   K IG G    V+   N E     AIK V++   +    + +   
Sbjct: 18  LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSY 73

Query: 402 EQEIKVLGHLKH--ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 459
             EI  L  L+   + I++ Y  E+ D ++Y+ +E  +   +N ++++  + I     ++
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKS 131

Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKG 516
           + +++L  +  +H    +H D+K AN L+   G++KL DFG+A  +   T    + S  G
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 190

Query: 517 SPNWMAPEVIK----AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMF 571
           + N+M PE IK    +        K++   D+WSLGC +  M  GK P+ +       + 
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250

Query: 572 KVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
            +++       P++   + +D L  C  R+P +R S  ELL HP+++ 
Sbjct: 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  294 bits (754), Expect = 5e-94
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 17/300 (5%)

Query: 327 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 386
                 V        +         + ++  K IGRG F  VY       G   A+K+V 
Sbjct: 7   GMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ 66

Query: 387 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 446
           I   D   A+      +EI +L  L H N+++YY S + D+ L I LE    G ++R ++
Sbjct: 67  I--FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124

Query: 447 EHCRD---ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 503
              +    I E  V  +   + + L ++HS   +HRDIK AN+ + A+GVVKL D G+ +
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184

Query: 504 HLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW- 561
             +   +   SL G+P +M+PE I    +   N K     DIWSLGC + EM   + P+ 
Sbjct: 185 FFSSKTTAAHSLVGTPYYMSPERIH---ENGYNFK----SDIWSLGCLLYEMAALQSPFY 237

Query: 562 -SEFEGPQAMFKVLN-RTPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
             +        K+     PP+P +  S E +  +  C   +P +RP    + +     +A
Sbjct: 238 GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  281 bits (720), Expect = 3e-89
 Identities = 96/274 (35%), Positives = 141/274 (51%), Gaps = 15/274 (5%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
              W+    +G G FG VY   N+ETGA  A K ++   ++      ++    EI++L  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYIVEIEILAT 72

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
             H  IV+  G+   D  L+I +E+   G+++  + E  R +TE  ++   R +L  L +
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAV 529
           LHS   IHRD+K  N+L+   G ++LADFG++      L    S  G+P WMAPEV+   
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192

Query: 530 MQKDG--NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEML 584
             KD   + K     DIWSLG T+IEM   +PP  E    + + K+    PP    P   
Sbjct: 193 TMKDTPYDYK----ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           S E +DFL     +NP  RPSA +LLEHPF+ + 
Sbjct: 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  281 bits (720), Expect = 1e-88
 Identities = 94/322 (29%), Positives = 152/322 (47%), Gaps = 21/322 (6%)

Query: 308 LESNNHLNAHPLPLP-------PGALSPPKSSVTSAVM--PHIMEKPSASPKKSQWQKGK 358
           +   +H + H   +P        GA+ P  +   +  +  P + E       +  +   +
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLR 60

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
            IG G+FG+VY   +       AIK++          E  + + +E++ L  L+H N +Q
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQ 118

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
           Y G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAYLHS N IH
Sbjct: 119 YRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           RD+K  N+L+   G+VKL DFG A  +   +   S  G+P WMAPEVI A+ +   + K 
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQYDGK- 233

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCF 596
              VD+WSLG T IE+   KPP        A++ +     P       S   ++F+  C 
Sbjct: 234 ---VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 290

Query: 597 LRNPVERPSAVELLEHPFIRNA 618
            + P +RP++  LL+H F+   
Sbjct: 291 QKIPQDRPTSEVLLKHRFVLRE 312

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  274 bits (703), Expect = 2e-86
 Identities = 98/269 (36%), Positives = 156/269 (57%), Gaps = 18/269 (6%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +   + +G G++GSVY   ++ETG   AIK+V +  D       ++++ +EI ++     
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDS 83

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            ++V+YYGS   +  L+I +EY   GS++  +R   + +TE  +    +  L GL YLH 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQK 532
              IHRDIK  N+L++  G  KLADFG+A  LT  ++   ++ G+P WMAPEVI+   + 
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EI 200

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGK 589
             N       DIWSLG T IEM  GKPP+++    +A+F +    PP    PE+ S    
Sbjct: 201 GYNCV----ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT 256

Query: 590 DFLLRCFLRNPVERPSAVELLEHPFIRNA 618
           DF+ +C +++P +R +A +LL+HPF+R+A
Sbjct: 257 DFVKQCLVKSPEQRATATQLLQHPFVRSA 285

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  271 bits (696), Expect = 9e-86
 Identities = 99/272 (36%), Positives = 145/272 (53%), Gaps = 18/272 (6%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           K ++ + + IG+G  G+VY   +  TG   AI+++++     K       +  EI V+  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVMRE 73

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
            K+ NIV Y  S +V D L++ +EY+  GS+   V E C  + E  +    R  L  L +
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 131

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAV 529
           LHS   IHRDIK  N+L+   G VKL DFG    +T   S   ++ G+P WMAPEV+   
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-- 189

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSS 586
            +K   PK    VDIWSLG   IEM+ G+PP+      +A++ +     P    PE LS+
Sbjct: 190 -RKAYGPK----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244

Query: 587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
             +DFL RC   +  +R SA ELL+H F++ A
Sbjct: 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  271 bits (696), Expect = 1e-85
 Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 35/305 (11%)

Query: 338 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 397
           M         S  +  ++  ++IG G    V            AIK +++          
Sbjct: 1   MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---- 56

Query: 398 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------ 451
           + +L +EI+ +    H NIV YY S VV D L++ ++ +  GS+   ++           
Sbjct: 57  MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116

Query: 452 -ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 510
            + ES +    R +L GL YLH    IHRD+K  N+L+   G V++ADFG++  L     
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176

Query: 511 ELSLK------GSPNWMAPEVIKAVMQKDG-NPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
               K      G+P WMAPEV++   Q  G + K     DIWS G T IE+ TG  P+ +
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVME---QVRGYDFK----ADIWSFGITAIELATGAAPYHK 229

Query: 564 FEGPQAMFKVLNRTPP----------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHP 613
           +   + +   L   PP          + +      +  +  C  ++P +RP+A ELL H 
Sbjct: 230 YPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289

Query: 614 FIRNA 618
           F + A
Sbjct: 290 FFQKA 294

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  270 bits (693), Expect = 4e-85
 Identities = 106/277 (38%), Positives = 149/277 (53%), Gaps = 16/277 (5%)

Query: 342 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           M+   A P++  + K + IG+G+FG V+ G +  T    AIK +D+   + +    I+ +
Sbjct: 13  MQNLKADPEE-LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE----IEDI 67

Query: 402 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 461
           +QEI VL       + +YYGS + D  L+I +EY+  GS    +      + E+ +    
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATIL 125

Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNW 520
           R IL GL YLHS   IHRDIK AN+L+   G VKLADFG+A  LT       +  G+P W
Sbjct: 126 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 185

Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP- 579
           MAPEVIK   Q   + K     DIWSLG T IE+  G+PP SE    + +F +    PP 
Sbjct: 186 MAPEVIK---QSAYDSK----ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT 238

Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
           +    S   K+F+  C  + P  RP+A ELL+H FI 
Sbjct: 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  269 bits (690), Expect = 1e-84
 Identities = 93/313 (29%), Positives = 153/313 (48%), Gaps = 19/313 (6%)

Query: 311 NNHLNAHPLPLPPGALSPPKSSVTSA-VMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVY 369
           ++H ++  + L    L      VT       +         +        IG G+ G V 
Sbjct: 3   HHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVC 62

Query: 370 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 429
           +   + +G   A+K +D+     +  +  + L  E+ ++   +H N+V+ Y S +V + L
Sbjct: 63  LAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117

Query: 430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 489
           ++ +E++  G++   V +    + E  +      +L  LAYLH+   IHRDIK  ++L+ 
Sbjct: 118 WVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175

Query: 490 ASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLG 548
             G VKL+DFG    ++  +    SL G+P WMAPEVI    +     +    VDIWSLG
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS---RSLYATE----VDIWSLG 228

Query: 549 CTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKDFLLRCFLRNPVERPS 605
             VIEM+ G+PP+      QAM ++ +  PP       +S   +DFL R  +R+P ER +
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288

Query: 606 AVELLEHPFIRNA 618
           A ELL+HPF+   
Sbjct: 289 AQELLDHPFLLQT 301

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  268 bits (688), Expect = 3e-84
 Identities = 93/281 (33%), Positives = 147/281 (52%), Gaps = 23/281 (8%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
              ++  +L+G GT+G VY G + +TG   AIK +D+  D+       ++++QEI +L  
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKK 76

Query: 411 L-KHENIVQYYGS------EVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTR 462
              H NI  YYG+        +DD L++ +E+   GS+   ++      + E  +    R
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWM 521
            IL GL++LH    IHRDIKG N+L+  +  VKL DFG++  L   +    +  G+P WM
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196

Query: 522 APEVIKAVMQKDG--NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP 579
           APEVI      D   + K     D+WSLG T IEM  G PP  +    +A+F +     P
Sbjct: 197 APEVIACDENPDATYDFK----SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252

Query: 580 I--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
               +  S + + F+  C ++N  +RP+  +L++HPFIR+ 
Sbjct: 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  267 bits (685), Expect = 2e-83
 Identities = 82/318 (25%), Positives = 148/318 (46%), Gaps = 14/318 (4%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++ + + IG G+FG   +  + E G    IKE++I      S++  ++  +E+ VL ++K
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI---SRMSSKEREESRREVAVLANMK 81

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYL 471
           H NIVQY  S   +  LYI ++Y   G + + +         E  + ++   I   L ++
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVM 530
           H    +HRDIK  N+ +   G V+L DFG+A+ L   +    +  G+P +++PE+ +   
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE--- 198

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGK 589
            K  N K     DIW+LGC + E+ T K  +        + K+++   PP+    S + +
Sbjct: 199 NKPYNNK----SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLR 254

Query: 590 DFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRK 649
             + + F RNP +RPS   +LE  FI     +    P  +     L   S    +    K
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAK-RIEKFLSPQLIAEEFCLKTFSKFGSQPIPAK 313

Query: 650 TESLPDSPETRVRNRKLP 667
             +   +  + +  +K+ 
Sbjct: 314 RPASGQNSISVMPAQKIT 331

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  251 bits (642), Expect = 1e-76
 Identities = 71/372 (19%), Positives = 130/372 (34%), Gaps = 69/372 (18%)

Query: 346 SASPKKSQWQKGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 403
           S  P+   ++   +IG+G     +V +   + TG    ++ +++   +  S E +  L+ 
Sbjct: 19  SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL---EACSNEMVTFLQG 75

Query: 404 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTR 462
           E+ V     H NIV Y  + + D+ L++   ++  GS    +  H  D + E  +    +
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG--------MAKHLTGLSYELSL 514
            +L  L Y+H    +HR +K +++L+   G V L+             +      +    
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 515 KGSPNWMAPEVIKAVMQKDG--NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK 572
                W++PEV++   Q     + K     DI+S+G T  E+  G  P+ +    Q + +
Sbjct: 196 VKVLPWLSPEVLQ---QNLQGYDAK----SDIYSVGITACELANGHVPFKDMPATQMLLE 248

Query: 573 VLNRTPP----------------------------------------------IPEMLSS 586
            LN T P                                                   S 
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308

Query: 587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERA 646
               F+ +C  RNP  RPSA  LL H F +    +       +   +           + 
Sbjct: 309 HFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQD 368

Query: 647 TRKTESLPDSPE 658
                 L  + E
Sbjct: 369 HSGIFGLVTNLE 380

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  247 bits (632), Expect = 2e-76
 Identities = 79/294 (26%), Positives = 141/294 (47%), Gaps = 18/294 (6%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
              +    +GRG +G V    +  +G   A+K +    +  +     K+L  ++ +    
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE----QKRLLMDLDISMRT 62

Query: 412 -KHENIVQYYGSEVVDDHLYIYLEYVHPGS---INRYVREHCRDITESIVRNFTRHILNG 467
                 V +YG+   +  ++I +E +   S     + V +  + I E I+      I+  
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 468 LAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           L +LHS  + IHRD+K +N+L++A G VK+ DFG++ +L     +    G   +MAPE I
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI--PEM 583
              + + G    +   DIWSLG T+IE+   + P+  +  P Q + +V+    P    + 
Sbjct: 182 NPELNQKGYSVKS---DIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGD 637
            S+E  DF  +C  +N  ERP+  EL++HPF     +++    +  F ++ LGD
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT--LHESKGTDVASFVKLILGD 290

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  244 bits (625), Expect = 1e-75
 Identities = 80/292 (27%), Positives = 126/292 (43%), Gaps = 31/292 (10%)

Query: 338 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 397
           MP   E          ++    IG G++G       +  G     KE+D       +   
Sbjct: 1   MPSRAED---------YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAE 48

Query: 398 IKQLEQEIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRD---I 452
            + L  E+ +L  LKH NIV+YY    +  +  LYI +EY   G +   + +  ++   +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108

Query: 453 TESIVRNFTRHILNGLAYLHSTNT-----IHRDIKGANLLVDASGVVKLADFGMAKHLT- 506
            E  V      +   L   H  +      +HRD+K AN+ +D    VKL DFG+A+ L  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168

Query: 507 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 566
             S+  +  G+P +M+PE +    +   N K     DIWSLGC + E+    PP++ F  
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMN---RMSYNEK----SDIWSLGCLLYELCALMPPFTAFSQ 221

Query: 567 PQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
            +   K+   +   IP   S E  + + R        RPS  E+LE+P I  
Sbjct: 222 KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  244 bits (624), Expect = 2e-75
 Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 37/280 (13%)

Query: 355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++ +LIG G FG V+   +R  G +  IK V        + E   + E+E+K L  L H 
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNE---KAEREVKALAKLDHV 64

Query: 415 NIVQYYGS----------------EVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIV 457
           NIV Y G                       L+I +E+   G++ +++ +   + + + + 
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 517
                 I  G+ Y+HS   I+RD+K +N+ +  +  VK+ DFG+   L         KG+
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184

Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 577
             +M+PE I     +D   +    VD+++LG  + E+L        FE  +    +  R 
Sbjct: 185 LRYMSPEQIS---SQDYGKE----VDLYALGLILAELLHVCDT--AFETSKFFTDL--RD 233

Query: 578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
             I ++   + K  L +   + P +RP+  E+L    +  
Sbjct: 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  241 bits (617), Expect = 4e-74
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 48/302 (15%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
            S +++  ++G+G FG V    N       AIK++        + E +  +  E+ +L  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLAS 58

Query: 411 LKHENIVQYYGSEVVDDH-------------LYIYLEYVHPGSINRYVREHCRDITESIV 457
           L H+ +V+YY + +   +             L+I +EY   G++   +     +      
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-- 515
               R IL  L+Y+HS   IHRD+K  N+ +D S  VK+ DFG+AK++      L L   
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 516 -------------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 562
                        G+  ++A EV+        N K    +D++SLG    EM+       
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDG--TGHYNEK----IDMYSLGIIFFEMIYPFSTGM 232

Query: 563 EFEGPQAMFKVLNR-----TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           E      + K L        P   +      K  +      +P +RP A  LL   ++  
Sbjct: 233 E---RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289

Query: 618 AN 619
            +
Sbjct: 290 KH 291

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  240 bits (615), Expect = 1e-73
 Identities = 81/292 (27%), Positives = 132/292 (45%), Gaps = 30/292 (10%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ 418
           IGRG +GSV    ++ +G   A+K +    D+ +     KQL  ++ V+        IVQ
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE----QKQLLMDLDVVMRSSDCPYIVQ 85

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHST- 474
           +YG+   +   +I +E +       Y          I E I+   T   +  L +L    
Sbjct: 86  FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMAPEVIKAV 529
             IHRDIK +N+L+D SG +KL DFG++  L       S+      G   +MAPE I   
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-----SIAKTRDAGCRPYMAPERIDPS 200

Query: 530 MQKDG-NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI-----PE 582
             + G + +     D+WSLG T+ E+ TG+ P+ ++      + +V+   PP        
Sbjct: 201 ASRQGYDVR----SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 634
             S    +F+  C  ++  +RP   ELL+HPFI     + + V   V   ++
Sbjct: 257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILD 308

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  243 bits (623), Expect = 2e-73
 Identities = 65/317 (20%), Positives = 128/317 (40%), Gaps = 39/317 (12%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           K  +    ++G G  G++            A+K +          EC    ++E+++L  
Sbjct: 23  KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--------ECFSFADREVQLLRE 73

Query: 411 L-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
             +H N+++Y+ +E      YI +E     ++  YV +              +   +GLA
Sbjct: 74  SDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132

Query: 470 YLHSTNTIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGLSYELS----LKGSPNW 520
           +LHS N +HRD+K  N+L+            ++DFG+ K L    +  S    + G+  W
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---R 576
           +APE++     +D        VDI+S GC    +++ G  P+ +    QA   +      
Sbjct: 193 IAPEMLS----EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD 248

Query: 577 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLG 636
                +      ++ + +    +P +RPSA  +L+HPF  +              ++   
Sbjct: 249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE-----------KQLQFF 297

Query: 637 DKSHDQVERATRKTESL 653
               D++E+ +     +
Sbjct: 298 QDVSDRIEKESLDGPIV 314

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  238 bits (609), Expect = 1e-72
 Identities = 77/277 (27%), Positives = 133/277 (48%), Gaps = 15/277 (5%)

Query: 360 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ 418
           +G GT G V+    R+TG   A+K++    +  +     K++  ++ V+        IVQ
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE----NKRILMDLDVVLKSHDCPYIVQ 88

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTI 477
            +G+ + +  ++I +E +   +     R     I E I+   T  I+  L YL      I
Sbjct: 89  CFGTFITNTDVFIAMELMGTCAEKLKKRMQGP-IPERILGKMTVAIVKALYYLKEKHGVI 147

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           HRD+K +N+L+D  G +KL DFG++  L     +    G   +MAPE I         P 
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP--PDPTKPD 205

Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI---PEMLSSEGKDFLL 593
             +  D+WSLG +++E+ TG+ P+   +   + + KVL   PP+       S + + F+ 
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265

Query: 594 RCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVF 630
            C  ++  +RP   +LLEH FI+   Y+ L V +  +
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFIK--RYETLEVDVASW 300

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  233 bits (596), Expect = 5e-71
 Identities = 68/306 (22%), Positives = 129/306 (42%), Gaps = 42/306 (13%)

Query: 355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           +  + +GRG FG V+   N+    + AIK + +    P      +++ +E+K L  L+H 
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHP 63

Query: 415 NIVQYYGS------------EVVDDHLYIYLEYVHPGSINRYVREHCR--DITESIVRNF 460
            IV+Y+ +                 +LYI ++     ++  ++   C   +   S+  + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-------------G 507
              I   + +LHS   +HRD+K +N+      VVK+ DFG+   +               
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 567
            +      G+  +M+PE I        + K    VDI+SLG  + E+L   P  ++ E  
Sbjct: 184 YARHTGQVGTKLYMSPEQIH---GNSYSHK----VDIFSLGLILFELLY--PFSTQMERV 234

Query: 568 QAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
           + +  V N + PP+           +      +P+ERP A+ ++E+    + ++      
Sbjct: 235 RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG-KTV 293

Query: 627 MRVFSR 632
           +R  SR
Sbjct: 294 LRQRSR 299

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  231 bits (592), Expect = 1e-70
 Identities = 87/281 (30%), Positives = 146/281 (51%), Gaps = 24/281 (8%)

Query: 346 SASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLE 402
           +    +    ++ G L+G+G+F  VY   +  TG   AIK   +I       A  +++++
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQ 59

Query: 403 QEIKVLGHLKHENIVQYYGSEVVDDHLYIY--LEYVHPGSINRYVREHCRDITESIVRNF 460
            E+K+   LKH +I++ Y     +D  Y+Y  LE  H G +NRY++   +  +E+  R+F
Sbjct: 60  NEVKIHCQLKHPSILELY--NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF 117

Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPN 519
              I+ G+ YLHS   +HRD+  +NLL+  +  +K+ADFG+A  L     +   L G+PN
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177

Query: 520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNR 576
           +++PE+     +     +     D+WSLGC    +L G+PP   F+    +    KV+  
Sbjct: 178 YISPEIA---TRSAHGLE----SDVWSLGCMFYTLLIGRPP---FDTDTVKNTLNKVVLA 227

Query: 577 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
              +P  LS E KD + +   RNP +R S   +L+HPF+  
Sbjct: 228 DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  222 bits (567), Expect = 7e-67
 Identities = 77/300 (25%), Positives = 142/300 (47%), Gaps = 33/300 (11%)

Query: 339 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAEC 397
           P ++  P     + ++ +G+ +G+G F   +  ++ +T    A K   I+P         
Sbjct: 5   PEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK---IVPKSLLLKPHQ 58

Query: 398 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY--LEYVHPGSINRYVREHCRDITES 455
            +++  EI +   L H+++V ++     +D+ +++  LE     S+    +     +TE 
Sbjct: 59  REKMSMEISIHRSLAHQHVVGFH--GFFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEP 115

Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
             R + R I+ G  YLH    IHRD+K  NL ++    VK+ DFG+A   T + Y+   K
Sbjct: 116 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERK 172

Query: 516 ----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QA 569
               G+PN++APEV+    +K  + +    VD+WS+GC +  +L GKPP   FE    + 
Sbjct: 173 KVLCGTPNYIAPEVL---SKKGHSFE----VDVWSIGCIMYTLLVGKPP---FETSCLKE 222

Query: 570 MF-KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMR 628
            + ++      IP+ ++      + +    +P  RP+  ELL   F  +  Y    +P+ 
Sbjct: 223 TYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS-GYIPARLPIT 281

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  222 bits (567), Expect = 1e-66
 Identities = 70/310 (22%), Positives = 126/310 (40%), Gaps = 47/310 (15%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
              W    ++G+G   +V+ G +++TG   AIK   +  ++      +    +E +VL  
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VF-NNISFLRPVDVQMREFEVLKK 63

Query: 411 LKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHI 464
           L H+NIV+ +   + ++    H  + +E+   GS+   + E      + ES      R +
Sbjct: 64  LNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 465 LNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNW 520
           + G+ +L     +HR+IK  N++     D   V KL DFG A+ L      +SL G+  +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 521 MAPEVIK-AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA----MFKVLN 575
           + P++ + AV++KD   K    VD+WS+G T     TG  P+  FEGP+     M+K++ 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 576 RTPP-------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
             P                          +   L       L      +  +     +  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 611 EHP-FIRNAN 619
                I +  
Sbjct: 302 AETSDILHRG 311

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  222 bits (568), Expect = 2e-66
 Identities = 82/331 (24%), Positives = 152/331 (45%), Gaps = 58/331 (17%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G  G V+  +++ +G   A K + +            Q+ +E++VL 
Sbjct: 31  KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI----RNQIIRELQVLH 86

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 145

Query: 470 YLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL      +HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++M+PE ++ 
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ- 203

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW--------------------------- 561
                     ++  DIWS+G +++EM  G+ P                            
Sbjct: 204 ------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257

Query: 562 -----------SEFEGPQAMFKVL----NRTPPI--PEMLSSEGKDFLLRCFLRNPVERP 604
                       +   P A+F++L    N  PP     + S E +DF+ +C ++NP ER 
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317

Query: 605 SAVELLEHPFIRNANYQNLSVPMRVFSRINL 635
              +L+ H FI+ ++ + +     + S I L
Sbjct: 318 DLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 348

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  221 bits (565), Expect = 3e-66
 Identities = 84/347 (24%), Positives = 156/347 (44%), Gaps = 35/347 (10%)

Query: 318 PLPLPPGA-----LSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT 372
           P P  PG      ++ P +   +     I E       + ++ +G+ +G+G F   +  +
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61

Query: 373 NRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 431
           + +T    A K   I+P          +++  EI +   L H+++V ++     +D+ ++
Sbjct: 62  DADTKEVFAGK---IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH--GFFEDNDFV 116

Query: 432 Y--LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 489
           +  LE     S+    +     +TE   R + R I+ G  YLH    IHRD+K  NL ++
Sbjct: 117 FVVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175

Query: 490 ASGVVKLADFGMAKHLTGLSYELSLK----GSPNWMAPEVIKAVMQKDGNPKLALAVDIW 545
               VK+ DFG+A   T + Y+   K    G+PN++APEV+    +K  + +    VD+W
Sbjct: 176 EDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVL---SKKGHSFE----VDVW 225

Query: 546 SLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVE 602
           S+GC +  +L GKPP   FE    +  + ++      IP+ ++      + +    +P  
Sbjct: 226 SIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTA 282

Query: 603 RPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRK 649
           RP+  ELL   F   + Y    +P+   +       +   ++ + RK
Sbjct: 283 RPTINELLNDEFF-TSGYIPARLPITCLTIPPRFSIAPSSLDPSNRK 328

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  218 bits (557), Expect = 1e-65
 Identities = 87/276 (31%), Positives = 143/276 (51%), Gaps = 22/276 (7%)

Query: 350 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
           KK QW     + G+ +G+G FG+VY+   +++    A+K +       + A    QL +E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK--AQLEKAGVEHQLRRE 59

Query: 405 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 118

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            N L+Y HS   IHRDIK  NLL+ ++G +K+ADFG + H    S    L G+ +++ PE
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 177

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMF-KVLNRTPPIP 581
           +I+    +  + K    VD+WSLG    E L GKPP   FE    Q  + ++       P
Sbjct: 178 MIE---GRMHDEK----VDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFP 227

Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           + ++   +D + R    NP +RP   E+LEHP+I  
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  221 bits (565), Expect = 4e-65
 Identities = 80/314 (25%), Positives = 139/314 (44%), Gaps = 42/314 (13%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           K+     K++G G+ G+V        G   A+K + I        +       EIK+L  
Sbjct: 14  KNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLI--------DFCDIALMEIKLLTE 64

Query: 411 LK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV------REHCRDITESIVRNFTRH 463
              H N+++YY SE  D  LYI LE     ++   V       E+ +   E    +  R 
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGV-------------VKLADFGMAKHLTG--L 508
           I +G+A+LHS   IHRD+K  N+LV  S               + ++DFG+ K L     
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 509 SYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP-WSE 563
           S+  +L    G+  W APE+++         +L  ++DI+S+GC    +L+ GK P   +
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243

Query: 564 FEGPQAMFK----VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +     + +    +          L +E  D + +    +P++RP+A+++L HP     +
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS 303

Query: 620 YQNLSVPMRVFSRI 633
            + L   ++V  R+
Sbjct: 304 -KKLEFLLKVSDRL 316

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  210 bits (537), Expect = 9e-63
 Identities = 78/288 (27%), Positives = 135/288 (46%), Gaps = 23/288 (7%)

Query: 347 ASPKKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           A   K ++       G+ +G+G FG+VY+   ++     A+K +       +      QL
Sbjct: 4   AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQL 61

Query: 402 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 461
            +EI++  HL+H NI++ Y        +Y+ LE+   G + + +++H R   E     F 
Sbjct: 62  RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFM 120

Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             + + L Y H    IHRDIK  NLL+   G +K+ADFG + H        ++ G+ +++
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRTMCGTLDYL 179

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMF-KVLNRTP 578
            PE+I+    K  + K    VD+W  G    E L G PP   F+         +++N   
Sbjct: 180 PPEMIE---GKTHDEK----VDLWCAGVLCYEFLVGMPP---FDSPSHTETHRRIVNVDL 229

Query: 579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
             P  LS   KD + +    +P +R     ++EHP+++ AN + +  P
Sbjct: 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK-ANSRRVLPP 276

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  213 bits (543), Expect = 2e-62
 Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 46/302 (15%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
              W    ++G+G   +V+ G +++TG   AIK   +  ++      +    +E +VL  
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VF-NNISFLRPVDVQMREFEVLKK 63

Query: 411 LKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHI 464
           L H+NIV+ +   + ++    H  + +E+   GS+   + E      + ES      R +
Sbjct: 64  LNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 465 LNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNW 520
           + G+ +L     +HR+IK  N++     D   V KL DFG A+ L      +SL G+  +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 521 MAPEVIK-AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA----MFKVLN 575
           + P++ + AV++KD   K    VD+WS+G T     TG  P+  FEGP+     M+K++ 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 576 RTPP-------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
             P                          +   L       L      +  +     +  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 611 EH 612
             
Sbjct: 302 AE 303

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  209 bits (533), Expect = 8e-62
 Identities = 53/287 (18%), Positives = 99/287 (34%), Gaps = 37/287 (12%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
            +   + +G G F  V +      G   A+K +          +  ++ ++E  +     
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQREADMHRLFN 84

Query: 413 HENIVQYYGSEVVDD----HLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHI 464
           H NI++     + +       ++ L +   G+    I R   +    +TE  +      I
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGI 143

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT----------GLSYELSL 514
             GL  +H+    HRD+K  N+L+   G   L D G                 L    + 
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203

Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 574
           + + ++ APE+         + +     D+WSLGC +  M+ G+ P   ++        +
Sbjct: 204 RCTISYRAPELFSVQSHCVIDER----TDVWSLGCVLYAMMFGEGP---YDMVFQKGDSV 256

Query: 575 NR------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
                   + P     SS     L      +P +RP    LL     
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  204 bits (521), Expect = 1e-59
 Identities = 69/345 (20%), Positives = 144/345 (41%), Gaps = 55/345 (15%)

Query: 322 PPGALSPPKSSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASC 380
           P G++    S+ ++ +  ++ +      K  + ++  + + +G F  + +    +     
Sbjct: 2   PLGSMKDILSNYSNLI--YLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFY 57

Query: 381 AIKEVD------------IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD- 427
           A+K+ +               D           + E++++  +K+E  +      ++ + 
Sbjct: 58  ALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE--GIITNY 115

Query: 428 -HLYIYLEYVHPGSINRYVREHCR-------DITESIVRNFTRHILNGLAYLHSTNTI-H 478
             +YI  EY+   SI ++              I   +++   + +LN  +Y+H+   I H
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
           RD+K +N+L+D +G VKL+DFG ++++     +   +G+  +M PE        +G    
Sbjct: 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GSRGTYEFMPPEFFSNESSYNG---- 230

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEM-------------- 583
              VDIWSLG  +  M     P+S       +F  +  +    P                
Sbjct: 231 -AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKST 289

Query: 584 -----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 623
                LS+E  DFL     +NP ER ++ + L+H ++ + N ++L
Sbjct: 290 CSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL 334

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  200 bits (510), Expect = 1e-58
 Identities = 80/294 (27%), Positives = 135/294 (45%), Gaps = 40/294 (13%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---------------------IIPDD 391
           Q+     IG+G++G V +  N       A+K +                           
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 392 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVRE 447
            +    I+Q+ QEI +L  L H N+V+    EV+D    DHLY+  E V+ G +      
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVMEVP-T 130

Query: 448 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 507
               ++E   R + + ++ G+ YLH    IHRDIK +NLLV   G +K+ADFG++    G
Sbjct: 131 LKP-LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 508 LSYELSLK-GSPNWMAPEVIKAVMQK-DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 565
               LS   G+P +MAPE +    +   G      A+D+W++G T+   + G+ P+ + E
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSG-----KALDVWAMGVTLYCFVFGQCPFMD-E 243

Query: 566 GPQAMF-KVLNRTPPIPE--MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
               +  K+ ++    P+   ++ + KD + R   +NP  R    E+  HP++ 
Sbjct: 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  196 bits (501), Expect = 1e-57
 Identities = 64/274 (23%), Positives = 128/274 (46%), Gaps = 22/274 (8%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--AECIKQLEQEIKVLG 409
           ++ +  K IG+G FG V+ G   +  +  AIK + +   + ++   E  ++ ++E+ ++ 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
           +L H NIV+ YG  ++ +   + +E+V  G +   + +    I  S+       I  G+ 
Sbjct: 79  NLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136

Query: 470 YLHSTNT--IHRDIKGANLLVDASG-----VVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
           Y+ + N   +HRD++  N+ + +         K+ADFG+++          L G+  WMA
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS--GLLGNFQWMA 194

Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL----NRTP 578
           PE I A  ++    K     D +S    +  +LTG+ P+ E+   +  F  +       P
Sbjct: 195 PETIGA-EEESYTEK----ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249

Query: 579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
            IPE      ++ +  C+  +P +RP    +++ 
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  195 bits (499), Expect = 1e-57
 Identities = 78/271 (28%), Positives = 126/271 (46%), Gaps = 30/271 (11%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
            ++IG G FG VY       G   A+K     PD+  S + I+ + QE K+   LKH NI
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLKHPNI 68

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           +   G  + + +L + +E+   G +NR +    + I   I+ N+   I  G+ YLH    
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 477 ---IHRDIKGANLLVDASG--------VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
              IHRD+K +N+L+            ++K+ DFG+A+     + ++S  G+  WMAPEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAYAWMAPEV 185

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVI--EMLTGKPPWSEFEGPQAMFKVL--NRTPPIP 581
           I+       +       D+WS G  V+  E+LTG+ P+   +G    + V       PIP
Sbjct: 186 IR---ASMFSKG----SDVWSYG--VLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236

Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
                     +  C+  +P  RPS   +L+ 
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  200 bits (510), Expect = 2e-57
 Identities = 74/278 (26%), Positives = 131/278 (47%), Gaps = 19/278 (6%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKH 413
            K +G G  G V +   R+T    AI+ +          + A+    +E EI++L  L H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 414 ENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
             I++       D    YI LE +  G +   V  + R + E+  + +   +L  + YLH
Sbjct: 200 PCIIKIK--NFFDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH 256

Query: 473 STNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
               IHRD+K  N+L+   +   ++K+ DFG +K L   S   +L G+P ++APEV+ +V
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV 316

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNR----TPPIPEML 584
                N      VD WSLG  +   L+G PP+SE     ++  ++ +      P +   +
Sbjct: 317 GTAGYNRA----VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 622
           S +  D + +  + +P  R +  E L HP++++ + + 
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  194 bits (495), Expect = 7e-57
 Identities = 71/278 (25%), Positives = 126/278 (45%), Gaps = 21/278 (7%)

Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K   I+ D  ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IV-DMKRAVDCPENIKKEIC 57

Query: 407 VLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +   L HEN+V++Y        +  Y++LEY   G +   +      + E   + F   +
Sbjct: 58  INKMLNHENVVKFY--GHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQL 114

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWM 521
           + G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPI 580
           APE++K           A  VD+WS G  +  ML G+ PW +       +     +   +
Sbjct: 175 APELLK------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228

Query: 581 P--EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
              + + S     L +  + NP  R +  ++ +  +  
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  195 bits (499), Expect = 7e-57
 Identities = 84/330 (25%), Positives = 145/330 (43%), Gaps = 27/330 (8%)

Query: 346 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQ 400
           S  PK  + ++   K +G G  G V +   R+T    AIK +          + A+    
Sbjct: 2   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61

Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVREHCRDITESIVRN 459
           +E EI++L  L H  I++       D    YI LE +  G +   V  + R + E+  + 
Sbjct: 62  VETEIEILKKLNHPCIIKIK--NFFDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKL 118

Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKG 516
           +   +L  + YLH    IHRD+K  N+L+ +     ++K+ DFG +K L   S   +L G
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 178

Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPPWSEFEGPQAMFK-- 572
           +P ++APEV+ +V     N      VD WSLG  VI    L+G PP+SE     ++    
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRA----VDCWSLG--VILFICLSGYPPFSEHRTQVSLKDQI 232

Query: 573 ---VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN-YQNLSVPMR 628
                N  P +   +S +  D + +  + +P  R +  E L HP++++ +  +     + 
Sbjct: 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLS 292

Query: 629 VFSRINLGDKSHDQVERATRKTESLPDSPE 658
             +      +   Q    +RK     ++  
Sbjct: 293 EENESTALPQVLAQP-STSRKRPREGEAEG 321

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  194 bits (495), Expect = 3e-56
 Identities = 79/277 (28%), Positives = 140/277 (50%), Gaps = 20/277 (7%)

Query: 345 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 404
               P    ++  K IG+G F  V +  +  TG   AIK   II     +   +++L +E
Sbjct: 8   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFRE 64

Query: 405 IKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 462
           ++++  L H NIV+ +  EV++    LY+ +EY   G +  Y+  H R + E   R+  R
Sbjct: 65  VRIMKILNHPNIVKLF--EVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFR 121

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMA 522
            I++ + Y H    +HRD+K  NLL+DA   +K+ADFG +   T      +  G+P + A
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181

Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPP 579
           PE+ +      G       VD+WSLG  +  +++G  P   F+G   + +  +VL     
Sbjct: 182 PELFQ------GKKYDGPEVDVWSLGVILYTLVSGSLP---FDGQNLKELRERVLRGKYR 232

Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
           IP  +S++ ++ L R  + NP++R +  ++++  +I 
Sbjct: 233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  203 bits (517), Expect = 3e-56
 Identities = 66/290 (22%), Positives = 114/290 (39%), Gaps = 29/290 (10%)

Query: 344 KPSASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           +  + P ++   W+  + +G G FG V    +++TG   AIK+         S +  ++ 
Sbjct: 4   RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERW 59

Query: 402 EQEIKVLGHLKHENIVQYYGSEVVD--------DHLYIYLEYVHPGSINRYV--REHCRD 451
             EI+++  L H N+V     EV D        D   + +EY   G + +Y+   E+C  
Sbjct: 60  CLEIQIMKKLNHPNVVSAR--EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG 117

Query: 452 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGL 508
           + E  +R     I + L YLH    IHRD+K  N+++       + K+ D G AK L   
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177

Query: 509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ 568
                  G+  ++APE++    QK         VD WS G    E +TG  P+     P 
Sbjct: 178 ELCTEFVGTLQYLAPELL---EQKKYTVT----VDYWSFGTLAFECITGFRPFLPNWQPV 230

Query: 569 AMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
                +  ++     +             L  P      +      +++ 
Sbjct: 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQC 280

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  193 bits (493), Expect = 6e-56
 Identities = 67/312 (21%), Positives = 117/312 (37%), Gaps = 41/312 (13%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           + +  +++  G F  VY   +  +G   A+K +          E  + + QE+  +  L 
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAIIQEVCFMKKLS 83

Query: 413 -HENIVQYYGSEVVD-------DHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTR 462
            H NIVQ+  +  +           ++ L  +  G +  ++   E    ++   V     
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143

Query: 463 HILNGLAYLHSTNT--IHRDIKGANLLVDASGVVKLADFGMAKHLT-------------G 507
                + ++H      IHRD+K  NLL+   G +KL DFG A  ++              
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203

Query: 508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 567
           +  E++   +P +  PE+I          K     DIW+LGC +  +   + P   FE  
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEK----QDIWALGCILYLLCFRQHP---FED- 255

Query: 568 QAMFKVLNRTPPIPEML--SSEGKDFLLRCFLRNPVERPSAVELLEHPF-IRNANYQNLS 624
            A  +++N    IP      +     +      NP ER S  E++     I  A   N  
Sbjct: 256 GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315

Query: 625 VPMRVFSRINLG 636
            P+      N G
Sbjct: 316 SPITELLEQNGG 327

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  191 bits (487), Expect = 1e-55
 Identities = 80/277 (28%), Positives = 130/277 (46%), Gaps = 33/277 (11%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
            + +G G FG V++   R +G    IK    I  D +S   ++Q+E EI+VL  L H NI
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIK---TINKD-RSQVPMEQIEAEIEVLKSLDHPNI 82

Query: 417 VQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRD--ITESIVRNFTRHILNGLAYL 471
           ++ +  EV +D+  +Y+  E    G +  R V    R   ++E  V    + ++N LAY 
Sbjct: 83  IKIF--EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 472 HSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           HS + +H+D+K  N+L         +K+ DFG+A+      +  +  G+  +MAPEV K 
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK- 199

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN---RTPPIP 581
              +D   K     DIWS G  V+   +LTG  P        + +  K            
Sbjct: 200 ---RDVTFK----CDIWSAG--VVMYFLLTGCLPFTGTSL--EEVQQKATYKEPNYAVEC 248

Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 618
             L+ +  D L +   ++P  RPSA ++L H + + A
Sbjct: 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  192 bits (489), Expect = 1e-55
 Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 25/266 (9%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
            + IG G+FG+V+       G+  A+K   I+ +    AE + +  +E+ ++  L+H NI
Sbjct: 42  KEKIGAGSFGTVHRAEWH--GSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHST 474
           V + G+     +L I  EY+  GS+ R + +      + E    +    +  G+ YLH+ 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 475 NT--IHRDIKGANLLVDASGVVKLADFGMA--KHLTGLSYELSLKGSPNWMAPEVIKAVM 530
           N   +HR++K  NLLVD    VK+ DFG++  K  T LS + S  G+P WMAPEV++   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK-SAAGTPEWMAPEVLR--- 212

Query: 531 QKDGNPKLALAVDIWSLGCTVI--EMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEMLSS 586
            +  N K     D++S G  VI  E+ T + PW      Q +  V    +   IP  L+ 
Sbjct: 213 DEPSNEK----SDVYSFG--VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266

Query: 587 EGKDFLLRCFLRNPVERPSAVELLEH 612
           +    +  C+   P +RPS   +++ 
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDL 292

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  192 bits (490), Expect = 2e-55
 Identities = 73/314 (23%), Positives = 122/314 (38%), Gaps = 61/314 (19%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
              IG+G++G V +    +T A  AIK ++       + + +++++ E++++  L H NI
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSI----------------------------------- 441
            + Y     + ++ + +E  H G +                                   
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 442 ----NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVK 495
               + +         E ++ N  R I + L YLH+    HRDIK  N L   + S  +K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210

Query: 496 LADFGMAKHLTGLSYELSLK-----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 550
           L DFG++K    L+           G+P ++APEV+    +  G        D WS G  
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP-----KCDAWSAGVL 265

Query: 551 VIEMLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVER 603
           +  +L G  P     +       +VLN       P     LS   +D L     RN  ER
Sbjct: 266 LHLLLMGAVPFPGVND--ADTISQVLNKKLCFENPNYNV-LSPLARDLLSNLLNRNVDER 322

Query: 604 PSAVELLEHPFIRN 617
             A+  L+HP+I  
Sbjct: 323 FDAMRALQHPWISQ 336

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  191 bits (487), Expect = 3e-55
 Identities = 75/322 (23%), Positives = 134/322 (41%), Gaps = 31/322 (9%)

Query: 308 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 367
           + S++H + H   L P        +   A    +       P +SQ+Q G L+G G FGS
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMAPCNDLHA--TKLAPGKEKEPLESQYQVGPLLGSGGFGS 58

Query: 368 VYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYG 421
           VY G         AIK    +      D        ++  E+ +L  +      +++   
Sbjct: 59  VYSGIRVSDNLPVAIK---HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL- 114

Query: 422 SEVVD--DHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
            +  +  D   + LE   P   +  ++ E    + E + R+F   +L  + + H+   +H
Sbjct: 115 -DWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLH 172

Query: 479 RDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 537
           RDIK  N+L+D   G +KL DFG    L    Y     G+  +  PE I+       +  
Sbjct: 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIR------YHRY 225

Query: 538 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 597
              +  +WSLG  + +M+ G  P   FE  +   +++       + +SSE +  +  C  
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIP---FEHDE---EIIRGQVFFRQRVSSECQHLIRWCLA 279

Query: 598 RNPVERPSAVELLEHPFIRNAN 619
             P +RP+  E+  HP++++  
Sbjct: 280 LRPSDRPTFEEIQNHPWMQDVL 301

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  190 bits (486), Expect = 4e-55
 Identities = 72/279 (25%), Positives = 125/279 (44%), Gaps = 23/279 (8%)

Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           A P    W   + +G G +G V +  NR T  + A+K   I+ D  ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IV-DMKRAVDCPENIKKEIC 57

Query: 407 VLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
           +   L HEN+V++Y        +  Y++LEY   G +   +      + E   + F   +
Sbjct: 58  INKMLNHENVVKFY--GHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQL 114

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWM 521
           + G+ YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM-FKVLNR---T 577
           APE++K           A  VD+WS G  +  ML G+ PW +             +    
Sbjct: 175 APELLK------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228

Query: 578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
            P  ++  S     L +  + NP  R +  ++ +  +  
Sbjct: 229 NPWKKI-DSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  189 bits (483), Expect = 5e-55
 Identities = 65/265 (24%), Positives = 116/265 (43%), Gaps = 20/265 (7%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IG G+FG+VY G         A+K   ++     + + ++  + E+ VL   +H NI
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           + + G       L I  ++    S+  ++           + +  R    G+ YLH+ + 
Sbjct: 83  LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 477 IHRDIKGANLLVDASGVVKLADFGMA--KHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKD 533
           IHRD+K  N+ +     VK+ DFG+A  K     S++   L GS  WMAPEVI+      
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------TPPIPEMLSSE 587
            + +     D+++ G  + E++TG+ P+S       + +++ R         +       
Sbjct: 202 YSFQ----SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257

Query: 588 GKDFLLRCFLRNPVERPSAVELLEH 612
            K  +  C  +   ERPS   +L  
Sbjct: 258 MKRLMAECLKKKRDERPSFPRILAE 282

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  191 bits (487), Expect = 1e-54
 Identities = 46/340 (13%), Positives = 102/340 (30%), Gaps = 50/340 (14%)

Query: 318 PLPLPPGALSPPKSSVTSAVMPH---IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR 374
                    S   S V++++         +     +     +G ++G+    +    T++
Sbjct: 36  VRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQ 95

Query: 375 ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---------------------- 412
           ETG S  +        +   +  IKQ+++E+  L  L+                      
Sbjct: 96  ETGESFEVHVPYF--TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153

Query: 413 ---HENIVQYYGSEVVDDHLYIYLEYVHP--------GSINRYVREHCRDITESIVRNFT 461
               + +++    E     L  +  Y             +  +   H + +        T
Sbjct: 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLT 212

Query: 462 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 521
             ++  LA LH    +H  ++  ++++D  G V L  F                 S  + 
Sbjct: 213 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV---VSSVSRGFE 269

Query: 522 APEVIKAVM----QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 577
            PE+          +D    +  + D W+LG  +  +     P ++         +    
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC 329

Query: 578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
             IP+      +  L         +R   ++ +E P    
Sbjct: 330 KNIPQ----PVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  194 bits (495), Expect = 1e-54
 Identities = 79/332 (23%), Positives = 132/332 (39%), Gaps = 36/332 (10%)

Query: 320 PLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS 379
                              P +            +Q+ K +G G +G V +  ++ T   
Sbjct: 5   HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64

Query: 380 CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVH 437
            AIK   II     S     +L +E+ VL  L H NI++ Y  +  +D    YL  E   
Sbjct: 65  RAIK---IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY--DFFEDKRNYYLVMECYK 119

Query: 438 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVV 494
            G +   +    +   E       + +L+G+ YLH  N +HRD+K  NLL+   +   ++
Sbjct: 120 GGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALI 178

Query: 495 KLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           K+ DFG++             G+  ++APEV++    K  + K     D+WS+G  +  +
Sbjct: 179 KIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR----KKYDEK----CDVWSIGVILFIL 230

Query: 555 LTGKPPWSEFEGP--QAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSA 606
           L G PP   F G   Q +  KV        +P     +S   KD + +    +   R SA
Sbjct: 231 LAGYPP---FGGQTDQEILRKVEKGKYTFDSPEWKN-VSEGAKDLIKQMLQFDSQRRISA 286

Query: 607 VELLEHPFIRN---ANYQNLSVPMR--VFSRI 633
            + LEHP+I+         + +P        +
Sbjct: 287 QQALEHPWIKEMCSKKESGIELPSLANAIENM 318

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  194 bits (494), Expect = 2e-54
 Identities = 75/290 (25%), Positives = 129/290 (44%), Gaps = 30/290 (10%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHEN 415
            +++G+G+FG V +  ++ TG  CA+K   +I     K     + L +E+++L  L H N
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVK---VISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 416 IVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           I++ Y  E  +D  Y YL  E    G +   +    R  +E       R +L+G+ Y+H 
Sbjct: 88  IMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHK 144

Query: 474 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
              +HRD+K  NLL+        +++ DFG++ H           G+  ++APEV+    
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH--- 201

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEM 583
               + K     D+WS G  +  +L+G PP     E    +  KV         P   + 
Sbjct: 202 -GTYDEK----CDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYTFELPQWKK- 253

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRI 633
           +S   KD + +     P  R SA + L+H +I+    + +SV +      
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNA 303

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  193 bits (493), Expect = 2e-54
 Identities = 65/282 (23%), Positives = 131/282 (46%), Gaps = 29/282 (10%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
             ++G+G+FG V    +R T    A+K   +I       +    + +E+++L  L H NI
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 417 VQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           ++ +  E+++D    Y+  E    G +   + +  R  +E       + + +G+ Y+H  
Sbjct: 84  MKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKH 140

Query: 475 NTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           N +HRD+K  N+L+   +    +K+ DFG++      +      G+  ++APEV++    
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR---- 196

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEML 584
              + K     D+WS G  +  +L+G PP + + E    +  +V         P     +
Sbjct: 197 GTYDEK----CDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQWRT-I 249

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
           S + KD + +    +P  R +A + LEHP+I+  + +  ++ 
Sbjct: 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTIS 291

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  187 bits (478), Expect = 3e-54
 Identities = 79/270 (29%), Positives = 130/270 (48%), Gaps = 29/270 (10%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            + +  +++GRG FG V     R      AIK++       +S    K    E++ L  +
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQI-------ESESERKAFIVELRQLSRV 58

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLA 469
            H NIV+ YG     + + + +EY   GS+   +   E     T +   ++      G+A
Sbjct: 59  NHPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116

Query: 470 YLHSTNT---IHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
           YLHS      IHRD+K  NLL+ A G V+K+ DFG A  +       + KGS  WMAPEV
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEV 174

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMFKVL-NRTPPIPE 582
            +     + + K     D++S G  + E++T + P+ E  GP  + M+ V     PP+ +
Sbjct: 175 FE---GSNYSEK----CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK 227

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
            L    +  + RC+ ++P +RPS  E+++ 
Sbjct: 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  187 bits (476), Expect = 8e-54
 Identities = 75/302 (24%), Positives = 133/302 (44%), Gaps = 30/302 (9%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLGH 410
           ++  G L+G G++G V    + ET    A+K   I+      +       +++EI++L  
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 411 LKHENIVQYYGSEVVDD----HLYIYLEYVHPGSIN--RYVREHCRDITESIVRNFTRHI 464
           L+H+N++Q    +V+ +     +Y+ +EY   G       V E  R         +   +
Sbjct: 63  LRHKNVIQLV--DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-R-FPVCQAHGYFCQL 118

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWM 521
           ++GL YLHS   +H+DIK  NLL+   G +K++  G+A+ L   + + + +   GSP + 
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTP 578
            PE+   +    G       VDIWS G T+  + TG  P   FEG     +F  +   + 
Sbjct: 179 PPEIANGLDTFSG-----FKVDIWSAGVTLYNITTGLYP---FEGDNIYKLFENIGKGSY 230

Query: 579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDK 638
            IP        D L       P +R S  ++ +H + R   +     P+ +    +  D+
Sbjct: 231 AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR-KKHPPAEAPVPIPPSPDTKDR 289

Query: 639 SH 640
             
Sbjct: 290 WR 291

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  187 bits (476), Expect = 1e-53
 Identities = 63/266 (23%), Positives = 116/266 (43%), Gaps = 17/266 (6%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+LIG+G FG VY G         AI+   +I  +  + + +K  ++E+      +HEN+
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIR---LIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V + G+ +   HL I        ++   VR+    +  +  R   + I+ G+ YLH+   
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL------SLKGSPNWMAPEVIKAVM 530
           +H+D+K  N+  D +G V + DFG+      L             G    +APE+I+ + 
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 531 QKDGNPKLAL--AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSS 586
                 KL      D+++LG    E+   + P+        ++++    +       +  
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270

Query: 587 EGKDFLLRCFLRNPVERPSAVELLEH 612
           E  D LL C+     ERP+  +L++ 
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMDM 296

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  185 bits (472), Expect = 1e-53
 Identities = 82/282 (29%), Positives = 139/282 (49%), Gaps = 27/282 (9%)

Query: 344 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLE 402
           K     K   +  G  +G GTFG V IG ++ TG   A+K   I+     +S + + +++
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIK 59

Query: 403 QEIKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           +EI+ L   +H +I++ Y  +V+      ++ +EYV  G +  Y+ +H R + E   R  
Sbjct: 60  REIQNLKLFRHPHIIKLY--QVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRL 116

Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GS 517
            + IL+ + Y H    +HRD+K  N+L+DA    K+ADFG++  ++   +   L+   GS
Sbjct: 117 FQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGS 173

Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVL 574
           PN+ APEVI       G       VDIWS G  +  +L G  P   F+      +F K+ 
Sbjct: 174 PNYAAPEVIS------GRLYAGPEVDIWSCGVILYALLCGTLP---FDDEHVPTLFKKIR 224

Query: 575 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
                IPE L+      L+     +P++R +  ++ EH + +
Sbjct: 225 GGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  185 bits (473), Expect = 4e-53
 Identities = 98/335 (29%), Positives = 140/335 (41%), Gaps = 81/335 (24%)

Query: 327 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 386
           S      T  +    MEK         ++   L+G G++G V    N++TG   AIK+  
Sbjct: 9   SSGVDLGTENLYFQSMEK---------YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59

Query: 387 IIPDD---PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIYLEYVHPGSI 441
              DD    K A  ++    EIK+L  L+HEN+V     EV       Y+  E+V   +I
Sbjct: 60  ESDDDKMVKKIA--MR----EIKLLKQLRHENLVNLL--EVCKKKKRWYLVFEFVD-HTI 110

Query: 442 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 501
              +      +   +V+ +   I+NG+ + HS N IHRDIK  N+LV  SGVVKL DFG 
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 170

Query: 502 AKHLTGLSYELSLKGSPN----------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCT 550
           A+ L           +P           W  APE++       G+ K   AVD+W++GC 
Sbjct: 171 ARTL----------AAPGEVYDDEVATRWYRAPELLV------GDVKYGKAVDVWAIGCL 214

Query: 551 VIEMLTGKPPW---SEFEGPQAMFKVL-------------------NRTPPIPEM----- 583
           V EM  G+P +   S+ +    +   L                    R P I E      
Sbjct: 215 VTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLER 274

Query: 584 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
               LS    D   +C   +P +RP   ELL H F
Sbjct: 275 RYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  184 bits (470), Expect = 4e-53
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 29/279 (10%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK----QLEQEIKVLGHLK 412
            +++GRG    V    ++ T    A+K +D+      SAE ++       +E+ +L  + 
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 413 -HENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNG 467
            H NI+Q    +  + + + +L  + +  G + +    +     ++E   R   R +L  
Sbjct: 82  GHPNIIQLK--DTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEV 136

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           +  LH  N +HRD+K  N+L+D    +KL DFG +  L        + G+P+++APE+I+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 196

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTP 578
             M  +        VD+WS G  VI   +L G PP W   +    M   +++      +P
Sbjct: 197 CSMNDNHPG-YGKEVDMWSTG--VIMYTLLAGSPPFWHRKQ--MLMLRMIMSGNYQFGSP 251

Query: 579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
              +  S   KD + R  +  P +R +A E L HPF + 
Sbjct: 252 EWDD-YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  183 bits (467), Expect = 5e-53
 Identities = 45/265 (16%), Positives = 98/265 (36%), Gaps = 24/265 (9%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
              +     G ++ G  +  G    +K   ++     S    +   +E   L    H N+
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVK---VLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 417 VQYYG--SEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHS 473
           +   G        H  +   ++  GS+   + E     + +S    F   +  G+A+LH+
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 474 TNT--IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
                    +   ++++D     +++   +               +P W+APE ++    
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQK-KP 184

Query: 532 KDGNPKLALAVDIWSLGCTVI--EMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSE 587
           +D N +   + D+WS    V+  E++T + P+++    +   KV      P IP  +S  
Sbjct: 185 EDTNRR---SADMWSFA--VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239

Query: 588 GKDFLLRCFLRNPVERPSAVELLEH 612
               +  C   +P +RP    ++  
Sbjct: 240 VSKLMKICMNEDPAKRPKFDMIVPI 264

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  183 bits (468), Expect = 5e-53
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 33/276 (11%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
              IGRG++G V I   + T    A K    IP      E + + +QEI+++  L H NI
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAK---KIPK--YFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 417 VQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
           ++ Y  E  +D+  IYL  E    G +   V        ES      + +L+ +AY H  
Sbjct: 69  IRLY--ETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHKL 125

Query: 475 NTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           N  HRD+K  N L         +KL DFG+A          +  G+P +++P+V++    
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE---- 181

Query: 532 KDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLNRTPPIPE----M 583
               P+     D WS G  V+   +L G PP  +  +    +  K+   T   PE     
Sbjct: 182 GLYGPE----CDEWSAG--VMMYVLLCGYPPFSAPTD--SEVMLKIREGTFTFPEKDWLN 233

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           +S + +  + R   ++P +R ++++ LEH +     
Sbjct: 234 VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  185 bits (471), Expect = 8e-53
 Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 33/287 (11%)

Query: 356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-E 414
             K +GRG F  V    ++ TG   A K    +    +  +C  ++  EI VL   K   
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCP 89

Query: 415 NIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYL 471
            ++  +  EV ++   I L  EY   G I +  + E    ++E+ V    + IL G+ YL
Sbjct: 90  RVINLH--EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 472 HSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           H  N +H D+K  N+L+      G +K+ DFGM++ +        + G+P ++APE++  
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN- 206

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPP 579
                 +P +  A D+W++G  +I   +LT   P   E    Q  +  +           
Sbjct: 207 -----YDP-ITTATDMWNIG--IIAYMLLTHTSPFVGEDN--QETYLNISQVNVDYSEET 256

Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
               +S    DF+    ++NP +RP+A   L H +++  +++NL  P
Sbjct: 257 FSS-VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHP 302

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  184 bits (468), Expect = 9e-53
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 36/276 (13%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+++G+G FG     T+RETG    +KE+          E  +   +E+KV+  L+H N+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELI-----RFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           +++ G    D  L    EY+  G++   ++        S   +F + I +G+AYLHS N 
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE---------------LSLKGSPNWM 521
           IHRD+   N LV  +  V +ADFG+A+ +     +                ++ G+P WM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 522 APEVIKAVMQKDGNP---KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---N 575
           APE+I       G     K    VD++S G  + E++       ++      F +     
Sbjct: 190 APEMIN------GRSYDEK----VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239

Query: 576 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
                P           +RC   +P +RPS V+L  
Sbjct: 240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  189 bits (482), Expect = 1e-52
 Identities = 76/344 (22%), Positives = 137/344 (39%), Gaps = 50/344 (14%)

Query: 320 PLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS 379
                +          A+ P +  +         + K + +G G +G V +   +   + 
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63

Query: 380 CAIK--------EVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 431
            AIK        +     D+    +  +++  EI +L  L H NI++ +  +V +D  Y 
Sbjct: 64  KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF--DVFEDKKYF 121

Query: 432 YL--EYVHPG-------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 482
           YL  E+   G       + +++         E    N  + IL+G+ YLH  N +HRDIK
Sbjct: 122 YLVTEFYEGGELFEQIINRHKF--------DECDAANIMKQILSGICYLHKHNIVHRDIK 173

Query: 483 GANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 539
             N+L+   ++   +K+ DFG++   +         G+  ++APEV+K    K  N K  
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK----KKYNEK-- 227

Query: 540 LAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMF-KVLNRTPPIPE----MLSSEGKDFLL 593
              D+WS G  +  +L G PP   + +  Q +  KV              +S E K+ + 
Sbjct: 228 --CDVWSCGVIMYILLCGYPPFGGQND--QDIIKKVEKGKYYFDFNDWKNISDEAKELIK 283

Query: 594 RCFLRNPVERPSAVELLEHPFIR----NANYQNLSVPMRVFSRI 633
                +  +R +A E L   +I+    N N  +        S +
Sbjct: 284 LMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNM 327

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  183 bits (468), Expect = 1e-52
 Identities = 83/322 (25%), Positives = 130/322 (40%), Gaps = 83/322 (25%)

Query: 341 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAEC 397
           +MEK         ++K   IG G++G V+   NR+TG   AIK+     DD    K A  
Sbjct: 1   MMEK---------YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA-- 49

Query: 398 IKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITES 455
           ++    EI++L  LKH N+V     EV      L++  EY    ++   +  + R + E 
Sbjct: 50  LR----EIRMLKQLKHPNLVNLL--EVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEH 102

Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 515
           +V++ T   L  + + H  N IHRD+K  N+L+    V+KL DFG A+ L          
Sbjct: 103 LVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL---------- 152

Query: 516 GSPN----------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----- 559
             P+          W  +PE++       G+ +    VD+W++GC   E+L+G P     
Sbjct: 153 TGPSDYYDDEVATRWYRSPELLV------GDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206

Query: 560 ---------------P----WSEFEGPQAMFKVLNRTPPIPE--------MLSSEGKDFL 592
                                  F   Q  F  +    P            +S      L
Sbjct: 207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQY-FSGVKIPDPEDMEPLELKFPNISYPALGLL 265

Query: 593 LRCFLRNPVERPSAVELLEHPF 614
             C   +P ER +  +LL HP+
Sbjct: 266 KGCLHMDPTERLTCEQLLHHPY 287

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  182 bits (465), Expect = 1e-52
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 32/285 (11%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
            + +G+G F  V    ++ TG   A K   II     SA   ++LE+E ++   L+H NI
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHST 474
           V+ + S   +   Y+  + V  G +    V RE     +E+   +  + IL  +AY HS 
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSN 124

Query: 475 NTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
             +HR++K  NLL+        VKLADFG+A  +          G+P +++PEV+K    
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK---- 180

Query: 532 KDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPE 582
              +P  +  VDIW+ G  VI   +L G PP W E +    ++ ++        +P    
Sbjct: 181 --KDP-YSKPVDIWACG--VILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDT 233

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 627
            ++ E K  +      NP +R +A + L+ P+I N      ++  
Sbjct: 234 -VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHR 277

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  184 bits (468), Expect = 2e-52
 Identities = 65/335 (19%), Positives = 132/335 (39%), Gaps = 32/335 (9%)

Query: 339 PHIMEKPSASPKKSQ----WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDD 391
           P  +E    +  + +    +     +G G FG V+   ++E      +K +    ++ D 
Sbjct: 7   PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66

Query: 392 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE---YVHPGSINRYVREH 448
                 + ++  EI +L  ++H NI++    ++ ++  +  L    +     +  ++  H
Sbjct: 67  WIEDPKLGKVTLEIAILSRVEHANIIKVL--DIFENQGFFQLVMEKHGSGLDLFAFIDRH 124

Query: 449 CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 508
            R + E +     R +++ + YL   + IHRDIK  N+++     +KL DFG A +L   
Sbjct: 125 PR-LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183

Query: 509 SYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 565
                     G+  + APEV+       GNP     +++WSLG T+  ++  + P+ E E
Sbjct: 184 KL---FYTFCGTIEYCAPEVLM------GNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234

Query: 566 GPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSV 625
                 + +      P ++S E    +       P  R +  +L+  P++          
Sbjct: 235 ------ETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV-TQPVNLADY 287

Query: 626 PMRVFSRINLGDKSHDQVERATRKTESLPDSPETR 660
                 R+N  +              SL D  + +
Sbjct: 288 TWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQ 322

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  184 bits (468), Expect = 2e-52
 Identities = 85/300 (28%), Positives = 145/300 (48%), Gaps = 29/300 (9%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHL 411
            +   + +G G+FG V + T+ +T    A+K    I     K ++   ++E+EI  L  L
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLL 66

Query: 412 KHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
           +H +I++ Y  +V+     + + +EY   G +  Y+ E  R +TE   R F + I+  + 
Sbjct: 67  RHPHIIKLY--DVITTPTDIVMVIEYAG-GELFDYIVEKKR-MTEDEGRRFFQQIICAIE 122

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVI 526
           Y H    +HRD+K  NLL+D +  VK+ADFG++  +T  ++   LK   GSPN+ APEVI
Sbjct: 123 YCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVI 179

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEM 583
                  G       VD+WS G  +  ML G+ P   F+      +F KV +    +P+ 
Sbjct: 180 N------GKLYAGPEVDVWSCGIVLYVMLVGRLP---FDDEFIPNLFKKVNSCVYVMPDF 230

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQV 643
           LS   +  + R  + +P++R +  E+   P+  N N  +   PM          +   ++
Sbjct: 231 LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF-NVNLPDYLRPMEEVQGSYADSRIVSKL 289

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  181 bits (462), Expect = 4e-52
 Identities = 72/288 (25%), Positives = 130/288 (45%), Gaps = 41/288 (14%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 412
           G+ +G G F  V     + TG   A K    I        +     +++E+E+ +L  ++
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAK---FIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 413 HENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGL 468
           H NI+  +  ++ ++   + L  E V  G + +    +E    +TE     F + IL+G+
Sbjct: 67  HPNIITLH--DIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGV 121

Query: 469 AYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            YLHS    H D+K  N+++      +  +KL DFG+A  +   +   ++ G+P ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN----- 575
           ++         P L L  D+WS+G  VI   +L+G  P   E +  Q     +       
Sbjct: 182 IVN------YEP-LGLEADMWSIG--VITYILLSGASPFLGETK--QETLTNISAVNYDF 230

Query: 576 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 623
                    S   KDF+ R  +++P  R +  + LEH +I+    +N+
Sbjct: 231 DEEYFSN-TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  184 bits (468), Expect = 4e-52
 Identities = 79/279 (28%), Positives = 128/279 (45%), Gaps = 29/279 (10%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
            ++IG+G F  V    NRETG   A+K VD+           + L++E  +   LKH +I
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDI-TESIVRNFTRHILNGLAYLHS 473
           V+   +   D  LY+  E++    +    V R     + +E++  ++ R IL  L Y H 
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 474 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAPEVIKAV 529
            N IHRD+K   +L+   + S  VKL  FG+A  L         + G+P++MAPEV+K  
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK-- 206

Query: 530 MQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPI 580
                 P     VD+W  G  VI   +L+G  P +      + +F  ++           
Sbjct: 207 ----REP-YGKPVDVWGCG--VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQW 256

Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
              +S   KD + R  + +P ER +  E L HP+++  +
Sbjct: 257 SH-ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  182 bits (465), Expect = 5e-52
 Identities = 73/299 (24%), Positives = 131/299 (43%), Gaps = 41/299 (13%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 412
           G+ +G G F  V     + TG   A K    I        +     + +E+E+ +L  ++
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAK---FIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 413 HENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGL 468
           H N++  +  EV ++   + L  E V  G + +    +E    +TE     F + ILNG+
Sbjct: 73  HPNVITLH--EVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 127

Query: 469 AYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            YLHS    H D+K  N+++         +K+ DFG+A  +   +   ++ G+P ++APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN----- 575
           ++         P L L  D+WS+G  VI   +L+G  P   + +  Q     V       
Sbjct: 188 IVN------YEP-LGLEADMWSIG--VITYILLSGASPFLGDTK--QETLANVSAVNYEF 236

Query: 576 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 634
                    S+  KDF+ R  +++P +R +  + L+HP+I+  + Q           + 
Sbjct: 237 EDEYFSN-TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNME 294

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  183 bits (465), Expect = 5e-52
 Identities = 62/344 (18%), Positives = 116/344 (33%), Gaps = 86/344 (25%)

Query: 347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK----------------EVDIIP- 389
           AS   + ++  + +GRG FG V+   N+    + AIK                EV  +  
Sbjct: 1   ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK 60

Query: 390 ------------------------------------DDPKSAECIKQLEQEIKVLGHLKH 413
                                                   S   +     +I+ +     
Sbjct: 61  LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFST 120

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYL 471
           +N V          +LYI ++     ++  ++  R    D    +  +    I   + +L
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-------------GSP 518
           HS   +HRD+K +N+      VVK+ DFG+   +     E ++              G+ 
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--- 575
            +M+PE I      + + K    VDI+SLG  + E+L       E        +++    
Sbjct: 241 LYMSPEQIH---GNNYSHK----VDIFSLGLILFELLYSFSTQME------RVRIITDVR 287

Query: 576 --RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
             + P +      +    +      +P ERP A +++E+    N
Sbjct: 288 NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  183 bits (467), Expect = 5e-52
 Identities = 82/379 (21%), Positives = 150/379 (39%), Gaps = 45/379 (11%)

Query: 259 SPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHP 318
           S    N ++ +        R     N R  R+ +         Q++  L E+    +A P
Sbjct: 8   SSGVDNKFNKERRRARREIRHLPNLN-REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66

Query: 319 LPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGA 378
                                 + +  +A     ++    +IGRG    V    +R TG 
Sbjct: 67  KGTENLYFQSMGPE------DELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120

Query: 379 SCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYL- 433
             A+K ++         +  E  +   +E  +L  +  H +I+     +  +   +++L 
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI--DSYESSSFMFLV 178

Query: 434 -EYVHPG-------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN 485
            + +  G                    +E   R+  R +L  +++LH+ N +HRD+K  N
Sbjct: 179 FDLMRKGELFDYLTEKVAL--------SEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230

Query: 486 LLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIW 545
           +L+D +  ++L+DFG + HL        L G+P ++APE++K  M +         VD+W
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG-YGKEVDLW 289

Query: 546 SLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCF 596
           + G  VI   +L G PP W   +    M   ++       +P   +  SS  KD + R  
Sbjct: 290 ACG--VILFTLLAGSPPFWHRRQ--ILMLRMIMEGQYQFSSPEWDD-RSSTVKDLISRLL 344

Query: 597 LRNPVERPSAVELLEHPFI 615
             +P  R +A + L+HPF 
Sbjct: 345 QVDPEARLTAEQALQHPFF 363

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  181 bits (461), Expect = 6e-52
 Identities = 66/278 (23%), Positives = 129/278 (46%), Gaps = 35/278 (12%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
             ++G+G+FG V    +R T    A+K   +I       +    + +E+++L  L H NI
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 417 VQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           ++ +  E+++D    Y+  E    G + +  ++      +E       + + +G+ Y+H 
Sbjct: 84  MKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHK 139

Query: 474 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
            N +HRD+K  N+L+   +    +K+ DFG++      +      G+  ++APEV++   
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR--- 196

Query: 531 QKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIP 581
               + K     D+WS G  VI   +L+G PP + + E    +  +V         P   
Sbjct: 197 -GTYDEK----CDVWSAG--VILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQWR 247

Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
             +S + KD + +    +P  R +A + LEHP+I+  +
Sbjct: 248 T-ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  183 bits (466), Expect = 8e-52
 Identities = 48/356 (13%), Positives = 95/356 (26%), Gaps = 52/356 (14%)

Query: 305 KELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPH---IMEKPSASPKKSQWQKGKLIG 361
           ++LL+    L  +         +    +VT+ V P           S  + + +  + + 
Sbjct: 12  RDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLR 71

Query: 362 RGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG 421
            G    V++  + E     A+K          S   +++L +       L  E+  +   
Sbjct: 72  VGDRSVVFLVRDVERLEDFALKV--FTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 422 SE--------------------------VVDDHLYIYLEYVH-----PGSINRYVREHCR 450
                                           +  + +           S   +V     
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 451 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 510
           D     +   T  ++   A L S   +H      NL +   G + L D      +     
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP 249

Query: 511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQA 569
                  P   AP                 A++ W LG ++  +     P+     G + 
Sbjct: 250 AS---SVPVTYAPR----EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302

Query: 570 MFKVLNRTPPIPEML--------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
            +K  +   P  + L            K  + R    +   R   +E +E P    
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  181 bits (461), Expect = 1e-51
 Identities = 74/304 (24%), Positives = 122/304 (40%), Gaps = 38/304 (12%)

Query: 327 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 386
            PP    T    P   ++      +++++ G L+G+G FG+V+ G         AIK   
Sbjct: 9   GPPAPPGTPTPPPGGKDR---EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIK--- 62

Query: 387 IIP----DDPKSAECIKQLEQEIKVL----GHLKHENIVQYYGSEVVD--DHLYIYLEYV 436
           +IP                  E+ +L        H  +++    +  +  +   + LE  
Sbjct: 63  VIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL--DWFETQEGFMLVLERP 120

Query: 437 HPGS-INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVV 494
            P   +  Y+ E    + E   R F   ++  + + HS   +HRDIK  N+L+D   G  
Sbjct: 121 LPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179

Query: 495 KLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI-- 552
           KL DFG    L    Y     G+  +  PE I        +   AL   +WSLG  ++  
Sbjct: 180 KLIDFGSGALLHDEPYTDFD-GTRVYSPPEWIS------RHQYHALPATVWSLG--ILLY 230

Query: 553 EMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +M+ G  P   FE  Q   ++L      P  +S +    + RC    P  RPS  E+L  
Sbjct: 231 DMVCGDIP---FERDQ---EILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284

Query: 613 PFIR 616
           P+++
Sbjct: 285 PWMQ 288

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  180 bits (460), Expect = 2e-51
 Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 31/275 (11%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
            + +GRG FG V+      +  +   K    +            +++EI +L   +H NI
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAK---FVK---VKGTDQVLVKKEISILNIARHRNI 63

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           +  + S    + L +  E++    I  R        + E  + ++   +   L +LHS N
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSHN 122

Query: 476 TIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
             H DI+  N++     S  +K+ +FG A+ L        L  +P + APEV +      
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ------ 176

Query: 534 GNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEML 584
            +  ++ A D+WSLG   +   +L+G  P  +E    Q +   ++N           E +
Sbjct: 177 HDV-VSTATDMWSLG--TLVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFKE-I 230

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
           S E  DF+ R  ++    R +A E L+HP+++   
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  179 bits (457), Expect = 1e-50
 Identities = 79/310 (25%), Positives = 135/310 (43%), Gaps = 32/310 (10%)

Query: 324 GALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK 383
           G      +              +++     +   + +G+G F  V    ++ TG   A K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60

Query: 384 EVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-N 442
              II     SA   ++LE+E ++   L+H NIV+ + S   +   Y+  + V  G +  
Sbjct: 61  ---IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 117

Query: 443 RYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLAD 498
             V RE     +E+   +  + IL  +AY HS   +HR++K  NLL+        VKLAD
Sbjct: 118 DIVAREF---YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 174

Query: 499 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLT 556
           FG+A  +          G+P +++PEV+K   +   +      VDIW+ G  VI   +L 
Sbjct: 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLK---KDPYSKP----VDIWACG--VILYILLV 225

Query: 557 GKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
           G PP W E +    ++ ++        +P     ++ E K  +      NP +R +A + 
Sbjct: 226 GYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDT-VTPEAKSLIDSMLTVNPKKRITADQA 282

Query: 610 LEHPFIRNAN 619
           L+ P+I N  
Sbjct: 283 LKVPWICNRE 292

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  177 bits (452), Expect = 2e-50
 Identities = 80/295 (27%), Positives = 131/295 (44%), Gaps = 31/295 (10%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           +  +   +++G G F  V++   R TG   A+K    I   P   +    LE EI VL  
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK---CIKKSPAFRD--SSLENEIAVLKK 62

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGL 468
           +KHENIV          H Y+ ++ V  G + +R + R      TE       + +L+ +
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAV 119

Query: 469 AYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 525
            YLH    +HRD+K  NLL    + +  + + DFG++K         +  G+P ++APEV
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-TACGTPGYVAPEV 178

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMF-KVLN-----RTP 578
           +            + AVD WS+G     +L G PP + E E    +F K+        +P
Sbjct: 179 LA-------QKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKEGYYEFESP 229

Query: 579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRI 633
              + +S   KDF+     ++P ER +  + L HP+I      +  +   V  +I
Sbjct: 230 FWDD-ISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQI 283

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  177 bits (452), Expect = 2e-50
 Identities = 79/316 (25%), Positives = 142/316 (44%), Gaps = 32/316 (10%)

Query: 323 PGALSPPKSSVTSAVMPHIMEKPSASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASC 380
            G  + P+    S       + P    KK    ++ GK++G G+F +V +     T    
Sbjct: 2   DGTAAEPRPGAGS---LQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREY 58

Query: 381 AIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 437
           AIK ++   II +       + +   E  V+  L H   V+ Y +   D+ LY  L Y  
Sbjct: 59  AIKILEKRHIIKE--NKVPYVTR---ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113

Query: 438 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 497
            G + +Y+R       E+  R +T  I++ L YLH    IHRD+K  N+L++    +++ 
Sbjct: 114 NGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQIT 172

Query: 498 DFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 554
           DFG AK L+  S +    S  G+  +++PE++     +    K   + D+W+LGC + ++
Sbjct: 173 DFGTAKVLSPESKQARANSFVGTAQYVSPELL----TEKSACK---SSDLWALGCIIYQL 225

Query: 555 LTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERP------SAV 607
           + G PP+        +F K++      PE    + +D + +  + +  +R          
Sbjct: 226 VAGLPPFRA-GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 284

Query: 608 ELLEHPFIRNANYQNL 623
            L  HPF  +  ++NL
Sbjct: 285 PLKAHPFFESVTWENL 300

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  178 bits (453), Expect = 4e-50
 Identities = 82/294 (27%), Positives = 128/294 (43%), Gaps = 34/294 (11%)

Query: 339 PHIMEKPSASPKKS---QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 395
             +   P   P      ++   K IG G FG   +  ++ T    A+K    I       
Sbjct: 4   APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YIERGAAID 60

Query: 396 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDIT 453
           E    +++EI     L+H NIV++   EV+    HL I +EY   G +   +    R  +
Sbjct: 61  E---NVQREIINHRSLRHPNIVRFK--EVILTPTHLAIIMEYASGGELYERICNAGR-FS 114

Query: 454 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYE 511
           E   R F + +L+G++Y HS    HRD+K  N L+D S    +K+ DFG +K     S  
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174

Query: 512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ--A 569
            S  G+P ++APEV+                D+WS G T+  ML G  P   FE P+   
Sbjct: 175 KSTVGTPAYIAPEVLL------RQEYDGKIADVWSCGVTLYVMLVGAYP---FEDPEEPR 225

Query: 570 MFK-----VLNRTPPIPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
            ++     +L+    IP+   +S E    + R F+ +P  R S  E+  H +  
Sbjct: 226 DYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  180 bits (459), Expect = 5e-50
 Identities = 78/297 (26%), Positives = 133/297 (44%), Gaps = 41/297 (13%)

Query: 342 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 401
           M   + +    ++Q  + +G+G F  V        G   A     II     SA   ++L
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM---IINTKKLSARDHQKL 57

Query: 402 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI------TES 455
           E+E ++   LKH NIV+ + S   + H Y+  + V  G       E   DI      +E+
Sbjct: 58  EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG-------ELFEDIVAREYYSEA 110

Query: 456 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL 512
              +  + IL  + + H    +HR++K  NLL+        VKLADFG+A  + G     
Sbjct: 111 DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170

Query: 513 S-LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQ 568
               G+P +++PEV++   +          VD+W+ G  VI   +L G PP W E +   
Sbjct: 171 FGFAGTPGYLSPEVLR---KDPYGKP----VDLWACG--VILYILLVGYPPFWDEDQ--H 219

Query: 569 AMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
            ++ ++        +P     ++ E KD + +    NP +R +A E L+HP+I + +
Sbjct: 220 RLYQQIKAGAYDFPSPEWDT-VTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 275

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  177 bits (450), Expect = 5e-50
 Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 37/297 (12%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 412
           G+ +G G F  V     + TG   A K    I        +     +++E+E+ +L  + 
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAK---FIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAY 470
           H N++  +        + + LE V  G + +    +E    ++E    +F + IL+G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130

Query: 471 LHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LH+    H D+K  N+++         +KL DFG+A  +       ++ G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RT 577
                    P L L  D+WS+G  VI   +L+G  P   + +  Q     + +       
Sbjct: 191 N------YEP-LGLEADMWSIG--VITYILLSGASPFLGDTK--QETLANITSVSYDFDE 239

Query: 578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 634
                  S   KDF+ +  ++   +R +  E L HP+I   + Q   V       + 
Sbjct: 240 EFFSH-TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  177 bits (451), Expect = 6e-50
 Identities = 82/331 (24%), Positives = 142/331 (42%), Gaps = 46/331 (13%)

Query: 312 NHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPK-----------KSQWQKGKLI 360
           +H + H   +  G  +    S++S          S  P               ++    +
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61

Query: 361 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 420
           GRG    VY    + T    A+K +       K+ +  K +  EI VL  L H NI++  
Sbjct: 62  GRGATSIVYRCKQKGTQKPYALKVLK------KTVD-KKIVRTEIGVLLRLSHPNIIKLK 114

Query: 421 GSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
                   + + LE V  G + +R V + +    +E    +  + IL  +AYLH    +H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHENGIVH 171

Query: 479 RDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 535
           RD+K  NLL         +K+ADFG++K +       ++ G+P + APE+++        
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR----GCAY 227

Query: 536 PKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSS 586
                 VD+WS+G  +I   +L G  P + E  G Q MF ++LN      +P   E +S 
Sbjct: 228 GP---EVDMWSVG--IITYILLCGFEPFYDE-RGDQFMFRRILNCEYYFISPWWDE-VSL 280

Query: 587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
             KD + +  + +P +R +  + L+HP++  
Sbjct: 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  178 bits (453), Expect = 8e-50
 Identities = 78/384 (20%), Positives = 154/384 (40%), Gaps = 36/384 (9%)

Query: 267 SADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGAL 326
             D        +    S  +  R  +   +      +  E +   +   +      P   
Sbjct: 11  GVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPP 70

Query: 327 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 386
           +P    +       +  K  A        K +++G G FG V+      TG   A K + 
Sbjct: 71  APFDHRI-------VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK 123

Query: 387 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV 445
                 +  +  ++++ EI V+  L H N++Q Y +    + + + +EYV  G + +R +
Sbjct: 124 T-----RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178

Query: 446 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAK 503
            E    +TE     F + I  G+ ++H    +H D+K  N+L     +  +K+ DFG+A+
Sbjct: 179 DESYN-LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

Query: 504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP- 560
                       G+P ++APEV+        +  ++   D+WS+G  VI   +L+G  P 
Sbjct: 238 RYKPREKLKVNFGTPEFLAPEVVN------YDF-VSFPTDMWSVG--VIAYMLLSGLSPF 288

Query: 561 WSEFEGPQAMFKVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
             + +  + +  +L            + +S E K+F+ +  ++    R SA E L+HP++
Sbjct: 289 LGDND-AETLNNILACRWDLEDEEFQD-ISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

Query: 616 RNAN-YQNLSVPMRVFSRINLGDK 638
            +   +  LS   +     +  D 
Sbjct: 347 SDHKLHSRLSAQKKKNRGSDAQDF 370

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  179 bits (456), Expect = 2e-49
 Identities = 92/422 (21%), Positives = 171/422 (40%), Gaps = 56/422 (13%)

Query: 339 PHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAE 396
           P   ++      K   +  G  +G GTFG V +G +  TG   A+K   I+     +S +
Sbjct: 2   PMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSLD 58

Query: 397 CIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITE 454
            + ++ +EI+ L   +H +I++ Y  +V+     +++ +EYV  G +  Y+ ++ R + E
Sbjct: 59  VVGKIRREIQNLKLFRHPHIIKLY--QVISTPSDIFMVMEYVSGGELFDYICKNGR-LDE 115

Query: 455 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 514
              R   + IL+G+ Y H    +HRD+K  N+L+DA    K+ADFG++  ++   +   L
Sbjct: 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---L 172

Query: 515 K---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QA 569
           +   GSPN+ APEVI       G       VDIWS G  +  +L G  P   F+      
Sbjct: 173 RTSCGSPNYAAPEVIS------GRLYAGPEVDIWSSGVILYALLCGTLP---FDDDHVPT 223

Query: 570 MF-KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN--ANYQNLSVP 626
           +F K+ +     P+ L+      L      +P++R +  ++ EH + +     Y     P
Sbjct: 224 LFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDP 283

Query: 627 MRVFSRIN---------LGDKSHDQVERATRKTESLPDSPETR-----VRNRKLPCNSEV 672
               + I+           + S ++V             P        + NR++   ++ 
Sbjct: 284 SYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRN--HQDPLAVAYHLIIDNRRIMNEAK- 340

Query: 673 CPQCHAGTFNCATASRHSSCSTFGVHISLSTSNSHNFSPSSRNMPLGAVNNHPCAPLRSQ 732
                    +   A+          H++        F  +        ++       + Q
Sbjct: 341 ---------DFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQ 391

Query: 733 GQ 734
           G 
Sbjct: 392 GV 393

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  175 bits (446), Expect = 5e-49
 Identities = 70/297 (23%), Positives = 126/297 (42%), Gaps = 37/297 (12%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 412
           G+ +G G F  V     + TG   A K    I        +   C +++E+E+ +L  + 
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAK---FIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAY 470
           H NI+  +        + + LE V  G + +    +E    ++E    +F + IL+G+ Y
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130

Query: 471 LHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           LH+    H D+K  N+++         +KL DFG+A  +       ++ G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RT 577
                    P L L  D+WS+G  VI   +L+G  P   + +  Q     +         
Sbjct: 191 N------YEP-LGLEADMWSIG--VITYILLSGASPFLGDTK--QETLANITAVSYDFDE 239

Query: 578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 634
               +  S   KDF+ +  ++   +R +  E L HP+I   + Q   V       + 
Sbjct: 240 EFFSQ-TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLE 295

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  173 bits (440), Expect = 2e-48
 Identities = 87/354 (24%), Positives = 147/354 (41%), Gaps = 83/354 (23%)

Query: 316 AHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKS--QWQKGKLIGRGTFGSVYIGTN 373
           AH      G L            P  M   +A    S  ++++   +G GT+G VY   +
Sbjct: 2   AHHHHHHMGTLEAQTQG------PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAID 55

Query: 374 RETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 430
             T  + AIK + +  ++   P +A  I+    E+ +L  L+H NI++       +  L+
Sbjct: 56  TVTNETVAIKRIRLEHEEEGVPGTA--IR----EVSLLKELQHRNIIELKSVIHHNHRLH 109

Query: 431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 490
           +  EY     + +Y+ +   D++  ++++F   ++NG+ + HS   +HRD+K  NLL+  
Sbjct: 110 LIFEYAE-NDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167

Query: 491 S-----GVVKLADFGMAKHLTGLSYELSLKGSPN----------WM-APEVIKAVMQKDG 534
           S      V+K+ DFG+A+            G P           W   PE++       G
Sbjct: 168 SDASETPVLKIGDFGLAR----------AFGIPIRQFTHEIITLWYRPPEILL------G 211

Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP------------- 578
           +   + +VDIWS+ C   EML   P +   SE +    +F+VL   P             
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-GLPDDTTWPGVTALPD 270

Query: 579 ---------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
                           +  +L  EG D L      +PV+R SA   LEHP+  +
Sbjct: 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  174 bits (443), Expect = 2e-48
 Identities = 66/275 (24%), Positives = 124/275 (45%), Gaps = 21/275 (7%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLK 412
           + IG+G+FG V I    +T    A+K +          +C+++ E     +E++++  L+
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKCVERNEVRNVFKELQIMQGLE 73

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H  +V  + S   ++ +++ ++ +  G + RY  +      E  V+ F   ++  L YL 
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLFICELVMALDYLQ 132

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
           +   IHRD+K  N+L+D  G V + DF +A  L   +   ++ G+  +MAPE+       
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF----SS 188

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPW--SEFEGPQAMF-KVLNRTPPIPEMLSSEGK 589
                 + AVD WSLG T  E+L G+ P+        + +           P   S E  
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV 248

Query: 590 DFLLRCFLRNPVER-PSAVELLEHPFIRNANYQNL 623
             L +    NP +R     ++   P++ + N+  +
Sbjct: 249 SLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV 283

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  171 bits (435), Expect = 2e-48
 Identities = 82/310 (26%), Positives = 136/310 (43%), Gaps = 67/310 (21%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 409
           ++   + IG GT+G VY   N   G + A+K++ +  +D   P +   I+    EI +L 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTT--IR----EISILK 55

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            LKH NIV+ Y        L +  E++    + + +      +     ++F   +LNG+A
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---------- 519
           Y H    +HRD+K  NLL++  G +K+ADFG+A+            G P           
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR----------AFGIPVRKYTHEIVTL 164

Query: 520 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL- 574
           W  AP+V+       G+ K +  +DIWS+GC   EM+ G P +   SE +    +F++L 
Sbjct: 165 WYRAPDVLM------GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218

Query: 575 --------------------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVEL 609
                                   P+P     + L   G D L +    +P +R +A + 
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

Query: 610 LEHPFIRNAN 619
           LEH + +  N
Sbjct: 279 LEHAYFKENN 288

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  174 bits (443), Expect = 2e-48
 Identities = 61/274 (22%), Positives = 118/274 (43%), Gaps = 32/274 (11%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
            + +G G FG V+    + TG     K ++              ++ EI ++  L H  +
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFINT-----PYPLDKYTVKNEISIMNQLHHPKL 110

Query: 417 VQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           +  +  +  +D   + L  E++  G + +R   E  + ++E+ V N+ R    GL ++H 
Sbjct: 111 INLH--DAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE 167

Query: 474 TNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
            + +H DIK  N++     +  VK+ DFG+A  L           +  + APE++     
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD---- 223

Query: 532 KDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMFKVLN-----RTPPIPEM 583
               P +    D+W++G  V+   +L+G  P   E +  + +  V               
Sbjct: 224 --REP-VGFYTDMWAIG--VLGYVLLSGLSPFAGEDD-LETLQNVKRCDWEFDEDAFSS- 276

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           +S E KDF+     + P +R +  + LEHP+++ 
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  171 bits (436), Expect = 3e-48
 Identities = 85/309 (27%), Positives = 137/309 (44%), Gaps = 67/309 (21%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 409
           +++K + IG GT+G+V+   NRET    A+K V +  DD   P SA  ++    EI +L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LR----EICLLK 56

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            LKH+NIV+ +     D  L +  E+     + +Y      D+   IV++F   +L GL 
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---------- 519
           + HS N +HRD+K  NLL++ +G +KLA+FG+A+            G P           
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR----------AFGIPVRCYSAEVVTL 165

Query: 520 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVL 574
           W   P+V+       G    + ++D+WS GC   E+     P        +  + +F++L
Sbjct: 166 WYRPPDVLF------GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219

Query: 575 ---------------------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVE 608
                                              L++ G+D L      NPV+R SA E
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279

Query: 609 LLEHPFIRN 617
            L+HP+  +
Sbjct: 280 ALQHPYFSD 288

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  171 bits (435), Expect = 5e-48
 Identities = 82/329 (24%), Positives = 145/329 (44%), Gaps = 76/329 (23%)

Query: 343 EKPSASPKKSQWQKGKL--------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--- 391
               +S +++ + +G +        +G GT+G VY   +   G   A+K + +  +D   
Sbjct: 4   HHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI 62

Query: 392 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD 451
           P +A  I+    EI +L  L H NIV        +  L +  E++    + + + E+   
Sbjct: 63  PSTA--IR----EISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTG 115

Query: 452 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 511
           + +S ++ +   +L G+A+ H    +HRD+K  NLL+++ G +KLADFG+A+        
Sbjct: 116 LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-------- 167

Query: 512 LSLKGSPN----------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 560
               G P           W  AP+V+       G+ K + +VDIWS+GC   EM+TGKP 
Sbjct: 168 --AFGIPVRSYTHEVVTLWYRAPDVLM------GSKKYSTSVDIWSIGCIFAEMITGKPL 219

Query: 561 W---SEFEGPQAMFKVL------------------NRTPPIPE---------MLSSEGKD 590
           +   ++ +    +F +L                   RT  + E             EG D
Sbjct: 220 FPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGID 279

Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRNAN 619
            L      +P +R SA + + HP+ ++ +
Sbjct: 280 LLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  170 bits (434), Expect = 1e-47
 Identities = 80/317 (25%), Positives = 134/317 (42%), Gaps = 66/317 (20%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLGH 410
            + K   +G GT+ +VY G ++ T    A+KE+ +  ++  P +A  I+    E+ +L  
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA--IR----EVSLLKD 56

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           LKH NIV  +     +  L +  EY+    + +Y+ +    I    V+ F   +L GLAY
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----------W 520
            H    +HRD+K  NLL++  G +KLADFG+A+           K  P           W
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLAR----------AKSIPTKTYDNEVVTLW 165

Query: 521 M-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL-- 574
              P+++       G+   +  +D+W +GC   EM TG+P +   +  E    +F++L  
Sbjct: 166 YRPPDILL------GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219

Query: 575 ----------------NRTPPIPE---------MLSSEGKDFLLRCFLRNPVERPSAVEL 609
                               P             L S+G D L +        R SA + 
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279

Query: 610 LEHPFIRNANYQNLSVP 626
           ++HPF  +   +   +P
Sbjct: 280 MKHPFFLSLGERIHKLP 296

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  170 bits (433), Expect = 2e-47
 Identities = 80/367 (21%), Positives = 146/367 (39%), Gaps = 61/367 (16%)

Query: 342 MEKPSASPKKSQWQK-----------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 390
           M+         Q  +            + IG G++       ++ T    A+K   II  
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IID- 56

Query: 391 DPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV- 445
             KS     +   EI++L    +H NI+     +V DD  Y+Y+  E +  G + ++ + 
Sbjct: 57  --KSKRDPTE---EIEILLRYGQHPNIITLK--DVYDDGKYVYVVTELMKGGELLDKILR 109

Query: 446 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGM 501
           ++     +E         I   + YLH+   +HRD+K +N+L          +++ DFG 
Sbjct: 110 QKF---FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166

Query: 502 AKHLTGLSYELSLK-GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGK 558
           AK L   +  L     + N++APEV++   Q         A DIWSLG  V+   MLTG 
Sbjct: 167 AKQLRAENGLLMTPCYTANFVAPEVLER--QGYD-----AACDIWSLG--VLLYTMLTGY 217

Query: 559 PP-WSEF-EGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
            P  +   + P+ +  ++ +             +S   KD + +    +P +R +A  +L
Sbjct: 218 TPFANGPDDTPEEILARIGSGKFSLSGGYWNS-VSDTAKDLVSKMLHVDPHQRLTAALVL 276

Query: 611 EHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESL-----PDSPETRVRNRK 665
            HP+I + + Q     +      +L   +      A  + +S        S   + R  K
Sbjct: 277 RHPWIVHWD-QLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRGIK 335

Query: 666 LPCNSEV 672
              ++ +
Sbjct: 336 KITSTAL 342

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  170 bits (432), Expect = 3e-47
 Identities = 82/362 (22%), Positives = 146/362 (40%), Gaps = 70/362 (19%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSAECIKQLEQ 403
           +  +++K   +G G F +VY   ++ T    AIK++ +           ++A  ++    
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA--LR---- 61

Query: 404 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
           EIK+L  L H NI+    +     ++ +  +++    +   ++++   +T S ++ +   
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 519
            L GL YLH    +HRD+K  NLL+D +GV+KLADFG+AK            GSPN    
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS----------FGSPNRAYT 170

Query: 520 ------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQA 569
                 W  APE++       G     + VD+W++GC + E+L   P     S+ +    
Sbjct: 171 HQVVTRWYRAPELLF------GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 224

Query: 570 MFKVL--------------------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERP 604
           +F+ L                       P IP          +  D +   FL NP  R 
Sbjct: 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284

Query: 605 SAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNR 664
           +A + L+  +  N         +   +      K       A ++     ++ E     +
Sbjct: 285 TATQALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKR--KRTEALEQGGLPK 342

Query: 665 KL 666
           KL
Sbjct: 343 KL 344

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  170 bits (434), Expect = 5e-47
 Identities = 92/353 (26%), Positives = 144/353 (40%), Gaps = 78/353 (22%)

Query: 310 SNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVY 369
           S    NA    +    L  P   +            +   ++  +   K+IG G+FG V+
Sbjct: 2   SFTMSNAPLNGVKLNPLDDPNKVIKVLASDG----KTGEQREIAYTNCKVIGNGSFGVVF 57

Query: 370 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ----YYGSEVV 425
                E+    AIK+   +  D +         +E++++  +KH N+V     +Y +   
Sbjct: 58  QAKLVESD-EVAIKK---VLQDKRFKN------RELQIMRIVKHPNVVDLKAFFYSNGDK 107

Query: 426 DDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAYLHSTNTIHRD 480
            D +++ L  EYV P ++ R  R + +    +   +++ +   +L  LAY+HS    HRD
Sbjct: 108 KDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRD 166

Query: 481 IKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPN-------WM-APEVIKAVMQ 531
           IK  NLL+D  SGV+KL DFG AK L          G PN       +  APE+I     
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILI--------AGEPNVSYICSRYYRAPELIF---- 214

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP---IPEM-- 583
             G       +DIWS GC + E++ G+P +   S  +    + KVL  TP    I  M  
Sbjct: 215 --GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG-TPSREQIKTMNP 271

Query: 584 ----------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
                                    +  D + R     P  R +A+E L HPF
Sbjct: 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  168 bits (428), Expect = 6e-47
 Identities = 65/314 (20%), Positives = 132/314 (42%), Gaps = 42/314 (13%)

Query: 356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HE 414
           K K +G G+F       ++++  + A+K   II    K  E     ++EI  L   + H 
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVK---IIS---KRME--ANTQKEITALKLCEGHP 66

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
           NIV+ +       H ++ +E ++ G +  R  ++     +E+      R +++ ++++H 
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHD 124

Query: 474 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAPEVIKAV 529
              +HRD+K  NLL    + +  +K+ DFG A+     +  L     + ++ APE++   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN-- 182

Query: 530 MQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEG-----PQAMFK-----VLNR 576
             ++G  +   + D+WSLG  VI   ML+G+ P  S            + K       + 
Sbjct: 183 --QNGYDE---SCDLWSLG--VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235

Query: 577 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLG 636
                + +S E KD +      +P +R     L  + ++++ +     +        ++ 
Sbjct: 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS----QLSSNPLMTPDIL 291

Query: 637 DKSHDQVERATRKT 650
             S   V    + T
Sbjct: 292 GSSGAAVHTCVKAT 305

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  168 bits (428), Expect = 6e-47
 Identities = 91/331 (27%), Positives = 146/331 (44%), Gaps = 75/331 (22%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLG 409
           SQ+++ + +G GT+ +VY G N+ TG   A+KEV +  ++  P +A  I+    EI ++ 
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IR----EISLMK 58

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVH---PGSI-NRYVREHCRDITESIVRNFTRHIL 465
            LKHENIV+ Y     ++ L +  E++       + +R V    R +  ++V+ F   +L
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------ 519
            GLA+ H    +HRD+K  NLL++  G +KL DFG+A+            G P       
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR----------AFGIPVNTFSSE 168

Query: 520 ----WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF 571
               W  AP+V+       G+   + ++DIWS GC + EM+TGKP +   ++ E  + +F
Sbjct: 169 VVTLWYRAPDVLM------GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222

Query: 572 KVLNRTP--------------------------------PIPEMLSSEGKDFLLRCFLRN 599
            ++  TP                                   E L     DFL      N
Sbjct: 223 DIM-GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281

Query: 600 PVERPSAVELLEHPFIRNANYQNLSVPMRVF 630
           P  R SA + L HP+     +       R  
Sbjct: 282 PDMRLSAKQALHHPWFAEYYHHASMGGSRSH 312

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  171 bits (433), Expect = 6e-47
 Identities = 44/336 (13%), Positives = 103/336 (30%), Gaps = 47/336 (13%)

Query: 320 PLPPGALSPPKSSVTSAVMP---HIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRET 376
                  S   S V++++         +     +     +G ++G+    +    T++ET
Sbjct: 43  TTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET 102

Query: 377 GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL----------------------KHE 414
           G S  +        +   +  IKQ+++E+  L  L                      K  
Sbjct: 103 GESFEVHV--PYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160

Query: 415 NIVQYYGSEVVDDHLYIYLEYV-----------HPGSINRYVREHCRDITESIVRNFTRH 463
              +     + +  +++   +                +  +   H + +        T  
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQ 219

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWM 521
           ++  LA LH    +H  ++  ++++D  G V L  F        + +S        P   
Sbjct: 220 VIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETT 279

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP 581
           A  ++     +     +  A D W+LG  +  +     P ++         +      IP
Sbjct: 280 AERMLP--FGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIP 337

Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           + +    +  L         +R   ++ +E P    
Sbjct: 338 QPV----RALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  169 bits (429), Expect = 1e-46
 Identities = 60/353 (16%), Positives = 114/353 (32%), Gaps = 59/353 (16%)

Query: 318 PLPLPPGALSPPKSSVTSAVMPHIMEK--------PSASPKKSQWQK------------- 356
           P     G +  P   V +     ++ K         S+ P   +WQ              
Sbjct: 3   PQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQL 62

Query: 357 -------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
                    L+G G F  VY  T  +   +   ++  +    P +        Q ++ L 
Sbjct: 63  GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHIL 465
                  +++Y + +  +   +  E    G+    IN Y     + + + +V +F   +L
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 466 NGLAYLHSTNTIHRDIKGANLLV-----------DASGVVKLADFGMAKHLTGLSYELSL 514
             +  +H    IH DIK  N ++           D S  + L D G +  +         
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 515 K---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 571
                +  +   E++     K  N +    +D + +  TV  ML G     + EG +   
Sbjct: 243 TAKCETSGFQCVEMLS---NKPWNYQ----IDYFGVAATVYCMLFGTYMKVKNEGGECKP 295

Query: 572 KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN--ANYQN 622
           + L R  P  +M      +F              +++LL     +    +Y N
Sbjct: 296 EGLFRRLPHLDMW----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  167 bits (424), Expect = 1e-46
 Identities = 70/296 (23%), Positives = 124/296 (41%), Gaps = 50/296 (16%)

Query: 355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
              + +G+G +G V+ G+ +  G + A+K   I     + +      E E+     L+HE
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ--GENVAVK---IFSSRDEKSW---FRETELYNTVMLRHE 62

Query: 415 NIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           NI+ +  S++   H    L++   Y   GS+  Y++    D    +       I +GLA+
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL--RIVLSIASGLAH 120

Query: 471 LHSTNT--------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GS 517
           LH             HRD+K  N+LV  +G   +AD G+A   +  + +L +      G+
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPPWSEFEGP 567
             +MAPEV+   +Q D        VDIW+ G  + E+             KPP+ +    
Sbjct: 181 KRYMAPEVLDETIQVD-CFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239

Query: 568 QAMFKVL-------NRTPPIPEMLSSEG-----KDFLLRCFLRNPVERPSAVELLE 611
              F+ +        + P IP    S+         +  C+ +NP  R +A+ + +
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  167 bits (425), Expect = 1e-46
 Identities = 70/314 (22%), Positives = 121/314 (38%), Gaps = 51/314 (16%)

Query: 356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HE 414
           +  ++G G    V    N  T    A+K   II   P       ++ +E+++L   + H 
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVK---IIEKQPG--HIRSRVFREVEMLYQCQGHR 71

Query: 415 NIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYL 471
           N+++    E  ++    YL  E +  GSI +   +       E       + + + L +L
Sbjct: 72  NVLELI--EFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFL 127

Query: 472 HSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK--------GSPNW 520
           H+    HRD+K  N+L    +    VK+ DF +   +        +         GS  +
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMFKVLNRT 577
           MAPEV++A    +         D+WSLG  VI   +L+G PP            +     
Sbjct: 188 MAPEVVEA--FSEEASIYDKRCDLWSLG--VILYILLSGYPPFVGRCGSDCGWDRGEACP 243

Query: 578 PPIPEML------------------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN-A 618
                +                   S   KD + +  +R+  +R SA ++L+HP+++  A
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303

Query: 619 NYQNLSVPMRVFSR 632
               L  PM V  R
Sbjct: 304 PENTLPTPM-VLQR 316

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  170 bits (432), Expect = 2e-46
 Identities = 88/314 (28%), Positives = 133/314 (42%), Gaps = 73/314 (23%)

Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P++  +   K+IG G+FG VY     ++G   AIK+   +  D +         +E++++
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKN------RELQIM 101

Query: 409 GHLKHENIVQ----YYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRN 459
             L H NIV+    +Y S    D +Y+ L  +YV P ++ R  R + R    +    V+ 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160

Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 518
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L         +G P
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--------RGEP 212

Query: 519 N-------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGP 567
           N       +  APE+I       G      ++D+WS GC + E+L G+P +   S  +  
Sbjct: 213 NVSYICSRYYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266

Query: 568 QAMFKVLNRTPP---IPEM------------------------LSSEGKDFLLRCFLRNP 600
             + KVL  TP    I EM                           E      R     P
Sbjct: 267 VEIIKVLG-TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325

Query: 601 VERPSAVELLEHPF 614
             R + +E   H F
Sbjct: 326 TARLTPLEACAHSF 339

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  173 bits (440), Expect = 2e-46
 Identities = 76/377 (20%), Positives = 140/377 (37%), Gaps = 47/377 (12%)

Query: 263 RNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLP 322
            N +       P+ P        +  R      + K +          +N++        
Sbjct: 85  ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144

Query: 323 PGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAI 382
           P  +      V                    +   + +G G FG V+  T R TG + A 
Sbjct: 145 PQPVEIKHDHV-----------------LDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187

Query: 383 KEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI- 441
           K V             + + +EI+ +  L+H  +V  + +   D+ + +  E++  G + 
Sbjct: 188 KFVMT-----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242

Query: 442 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADF 499
            +   EH + ++E     + R +  GL ++H  N +H D+K  N++     S  +KL DF
Sbjct: 243 EKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 301

Query: 500 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTG 557
           G+  HL          G+  + APEV +          +    D+WS+G  V+   +L+G
Sbjct: 302 GLTAHLDPKQSVKVTTGTAEFAAPEVAE-------GKPVGYYTDMWSVG--VLSYILLSG 352

Query: 558 KPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
             P   E +        V +             +S +GKDF+ +  L +P  R +  + L
Sbjct: 353 LSPFGGEND--DETLRNVKSCDWNMDDSAFSG-ISEDGKDFIRKLLLADPNTRMTIHQAL 409

Query: 611 EHPFIRNANYQNLSVPM 627
           EHP++   N       +
Sbjct: 410 EHPWLTPGNAPGRDSQI 426

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  166 bits (423), Expect = 3e-46
 Identities = 61/296 (20%), Positives = 120/296 (40%), Gaps = 50/296 (16%)

Query: 355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           Q  K IG+G +G V++G  R  G   A+K   +     +++      E EI     ++HE
Sbjct: 40  QMVKQIGKGRYGEVWMGKWR--GEKVAVK---VFFTTEEASW---FRETEIYQTVLMRHE 91

Query: 415 NIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           NI+ +  +++        LY+  +Y   GS+  Y++     +    +       ++GL +
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCH 149

Query: 471 LHSTNT--------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GS 517
           LH+            HRD+K  N+LV  +G   +AD G+A      + E+ +      G+
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209

Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPPWSEFEGP 567
             +M PEV+   + ++      +  D++S G  + E+             + P+ +    
Sbjct: 210 KRYMPPEVLDESLNRNHFQSY-IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268

Query: 568 QAMFKVL-------NRTPPIPEMLSSEGKDFLL-----RCFLRNPVERPSAVELLE 611
              ++ +          P  P   SS+     +      C+  NP  R +A+ + +
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  168 bits (427), Expect = 5e-46
 Identities = 81/329 (24%), Positives = 128/329 (38%), Gaps = 47/329 (14%)

Query: 315 NAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQK-----GKLIGRGTFGSVY 369
               LP PP    PP         P    K     KK+          +++G G  G V 
Sbjct: 24  PTPALPHPPAQPPPPPPQQ----FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVL 79

Query: 370 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG----SEV 424
              N+ T    A+K   ++ D         +  +E+++     +  +IV+          
Sbjct: 80  QIFNKRTQEKFALK---MLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA 129

Query: 425 VDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 483
               L I +E +  G + +R      +  TE       + I   + YLHS N  HRD+K 
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 189

Query: 484 ANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 540
            NLL      + ++KL DFG AK  T  +   +   +P ++APEV+    +K        
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYD-----K 242

Query: 541 AVDIWSLGCTVIE--MLTGKPP-WSE--FEGPQAMF-KVLNRTP--PIPE--MLSSEGKD 590
           + D+WSLG  VI   +L G PP +S         M  ++       P PE   +S E K 
Sbjct: 243 SCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 300

Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRNAN 619
            +       P +R +  E + HP+I  + 
Sbjct: 301 LIRNLLKTEPTQRMTITEFMNHPWIMQST 329

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  168 bits (427), Expect = 6e-46
 Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 21/280 (7%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           K+IGRG F  V +   ++TG   A+K +   D++        C ++   E  VL +    
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG--EVSCFRE---ERDVLVNGDRR 121

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            I Q + +   +++LY+ +EY   G +   + +    I   + R +   I+  +  +H  
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQK 532
             +HRDIK  N+L+D  G ++LADFG    L   G    L   G+P++++PE+++AV   
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLN-----RTPPIPEMLSS 586
            G        D W+LG    EM  G+ P+   +     + K+++       P + E +  
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPE 300

Query: 587 EGKDFLLRCFLRNPVER---PSAVELLEHPFIRNANYQNL 623
           E +D  ++  L  P  R     A +   HPF    ++  L
Sbjct: 301 EARD-FIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL 339

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  164 bits (418), Expect = 2e-45
 Identities = 80/319 (25%), Positives = 126/319 (39%), Gaps = 61/319 (19%)

Query: 338 MPHIMEKPSAS----PKKSQWQKG----------KLIGRGTFGSVYIGTNRETGASCAIK 383
           M H     S+      +  + +K           +++G G  G V    +R TG  CA+K
Sbjct: 1   MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60

Query: 384 EVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG----SEVVDDHLYIYLEYVHP 438
              ++ D PK         QE+          +IV               L I +E +  
Sbjct: 61  ---LLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110

Query: 439 GSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVV 494
           G + +R      +  TE       R I   + +LHS N  HRD+K  NLL    +   V+
Sbjct: 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170

Query: 495 KLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 551
           KL DFG AK  T    + +L+    +P ++APEV+    +K        + D+WSLG  V
Sbjct: 171 KLTDFGFAKETT----QNALQTPCYTPYYVAPEVLGP--EKYD-----KSCDMWSLG--V 217

Query: 552 IE--MLTGKPP-WSE--FEGPQAMFKVLNR------TPPIPEMLSSEGKDFLLRCFLRNP 600
           I   +L G PP +S         M + +         P   E +S + K  +      +P
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE-VSEDAKQLIRLLLKTDP 276

Query: 601 VERPSAVELLEHPFIRNAN 619
            ER +  + + HP+I  + 
Sbjct: 277 TERLTITQFMNHPWINQSM 295

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  164 bits (417), Expect = 3e-45
 Identities = 83/278 (29%), Positives = 137/278 (49%), Gaps = 28/278 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           KL+G+GTFG V +   + TG   A+K +    II  D            E +VL + +H 
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVT---ESRVLQNTRHP 65

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +     +    D L   +EY + G +  ++    R  TE   R +   I++ L YLHS 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSR 124

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQ 531
           + ++RDIK  NL++D  G +K+ DFG+ K   G+S   ++K   G+P ++APEV+    +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVL----E 178

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKD 590
            +   +   AVD W LG  + EM+ G+ P+   +  + +F  +L      P  LS E K 
Sbjct: 179 DNDYGR---AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKS 234

Query: 591 FLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
            L     ++P +R       A E++EH F  + N+Q++
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  164 bits (416), Expect = 7e-45
 Identities = 88/316 (27%), Positives = 132/316 (41%), Gaps = 74/316 (23%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            ++Q  ++ G+GTFG+V +G  + TG S AIK+   +  DP+     ++L Q ++ L  L
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQDPR--FRNREL-QIMQDLAVL 76

Query: 412 KHENIVQ-----YYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRNFT 461
            H NIVQ     Y   E     +Y+ +  EYV P +++R  R + R        +++ F 
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 462 RHILNGLAYLH--STNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSP 518
             ++  +  LH  S N  HRDIK  N+LV+ A G +KL DFG AK L+           P
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS--------PSEP 187

Query: 519 N-------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----------- 559
           N       +  APE+I       GN     AVDIWS+GC   EM+ G+P           
Sbjct: 188 NVAYICSRYYRAPELIF------GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241

Query: 560 --------------------PWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLR 598
                                 ++ +   +     +          + E  D L      
Sbjct: 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQY 301

Query: 599 NPVERPSAVELLEHPF 614
            P ER    E L HP+
Sbjct: 302 LPEERMKPYEALCHPY 317

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  161 bits (410), Expect = 2e-44
 Identities = 69/275 (25%), Positives = 133/275 (48%), Gaps = 25/275 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           + +G G+FG V++  +R  G   A+K   +  ++    K  E       E  +L  + H 
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL--KQVEHTND---ERLMLSIVTHP 66

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            I++ +G+      +++ ++Y+  G +   +R   +     + + +   +   L YLHS 
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSK 125

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           + I+RD+K  N+L+D +G +K+ DFG AK++  ++Y  +L G+P+++APEV+        
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVV----STKP 179

Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLL 593
             K   ++D WS G  + EML G  P+ +       + K+LN     P   + + KD L 
Sbjct: 180 YNK---SIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELRFPPFFNEDVKDLLS 235

Query: 594 RCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
           R   R+  +R         ++  HP+ +   ++ L
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 270

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  162 bits (412), Expect = 7e-44
 Identities = 83/323 (25%), Positives = 146/323 (45%), Gaps = 38/323 (11%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           K+IGRG FG V +  ++ T    A+K   + ++I      +    +   E  ++      
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR--SDSAFFWE---ERDIMAFANSP 129

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +VQ + +   D +LY+ +EY+  G +   +     D+ E   R +T  ++  L  +HS 
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM 187

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQK 532
             IHRD+K  N+L+D SG +KLADFG    +   G+    +  G+P++++PEV+K+   +
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS---Q 244

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIP----EMLSSE 587
            G+       D WS+G  + EML G  P+   +     + K++N    +       +S E
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKE 303

Query: 588 GKDFLLRCFLRNPVER---PSAVELLEHPFIRNANYQNLS--------VPMRVFSRINLG 636
            K+ L+  FL +   R       E+  H F +N  +   +        VP  + S     
Sbjct: 304 AKN-LICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP-DLSSD---I 358

Query: 637 DKSH-DQVERATRKTESLPDSPE 658
           D S+ D +E    + E+ P    
Sbjct: 359 DTSNFDDLEEDKGEEETFPIPKA 381

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  160 bits (406), Expect = 8e-44
 Identities = 81/284 (28%), Positives = 128/284 (45%), Gaps = 36/284 (12%)

Query: 358 KLIGRGTFGSVYI---GTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++G+G +G V+     T   TG   A+K +   +I  + K     K    E  +L  +K
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERNILEEVK 79

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGL 468
           H  IV    +      LY+ LEY+  G     + R          E     +   I   L
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMAL 134

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEV 525
            +LH    I+RD+K  N++++  G VKL DFG+ K    +          G+  +MAPE+
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEI 192

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEML 584
           +     + G+ +   AVD WSLG  + +MLTG PP++  E  +    K+L     +P  L
Sbjct: 193 L----MRSGHNR---AVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKLNLPPYL 244

Query: 585 SSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
           + E +D L +   RN   R       A E+  HPF R+ N++ L
Sbjct: 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL 288

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  158 bits (401), Expect = 2e-43
 Identities = 77/327 (23%), Positives = 131/327 (40%), Gaps = 80/327 (24%)

Query: 345 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSAECI 398
           P  S   S+++    IG G +G+VY   +  +G   A+K V +          P S   +
Sbjct: 2   PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST--V 59

Query: 399 KQLEQEIKVLGHLK---HENIVQYYGSEVV-------DDHLYIYLEYVHPGSINRYVREH 448
           +    E+ +L  L+   H N+V+    +V        +  + +  E+V    +  Y+ + 
Sbjct: 60  R----EVALLRRLEAFEHPNVVRLM--DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA 112

Query: 449 -CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 507
               +    +++  R  L GL +LH+   +HRD+K  N+LV + G VKLADFG+A+    
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR---- 168

Query: 508 LSYELSLKGSPNWMAPEVI----KAVMQKDGNPKLAL------AVDIWSLGCTVIEMLTG 557
                 +      + P V+    +A       P++ L       VD+WS+GC   EM   
Sbjct: 169 ------IYSYQMALTPVVVTLWYRA-------PEVLLQSTYATPVDMWSVGCIFAEMFRR 215

Query: 558 KPPW---SEFEGPQAMFKVL-------------------NRTPPIP-----EMLSSEGKD 590
           KP +   SE +    +F ++                       P P       +   G  
Sbjct: 216 KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQ 275

Query: 591 FLLRCFLRNPVERPSAVELLEHPFIRN 617
            LL     NP +R SA   L+H ++  
Sbjct: 276 LLLEMLTFNPHKRISAFRALQHSYLHK 302

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  159 bits (404), Expect = 2e-43
 Identities = 75/275 (27%), Positives = 132/275 (48%), Gaps = 25/275 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           K +G G+FG V +  ++E+G   A+K +    ++    K  E       E ++L  +   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV--KLKQIEHTLN---EKRILQAVNFP 101

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +V+   S   + +LY+ +EYV  G +  ++R      +E   R +   I+    YLHS 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           + I+RD+K  NLL+D  G +++ DFG AK + G ++  +L G+P  +APE+I       G
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEII----LSKG 214

Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLL 593
             K   AVD W+LG  + EM  G PP+   + P  ++ K+++     P   SS+ KD L 
Sbjct: 215 YNK---AVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270

Query: 594 RCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
                +  +R         ++  H +    ++  +
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  163 bits (415), Expect = 3e-43
 Identities = 69/285 (24%), Positives = 126/285 (44%), Gaps = 34/285 (11%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           +++GRG FG V+    + TG   A K+++   +        +       E K+L  +   
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK--GYQGAMV---EKKILAKVHSR 245

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGLAY 470
            IV    +      L + +  ++ G     I     ++     E     +T  I++GL +
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEH 304

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIK 527
           LH  N I+RD+K  N+L+D  G V+++D G+A      + +   K   G+P +MAPE++ 
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYAGTPGFMAPELLL 362

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF-KVLNRTPPIPEM 583
                    +   +VD ++LG T+ EM+  + P+    E    + +  +VL +    P+ 
Sbjct: 363 -------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415

Query: 584 LSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
            S   KDF      ++P +R      S   L  HP  R+ +++ L
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  157 bits (399), Expect = 3e-43
 Identities = 72/306 (23%), Positives = 113/306 (36%), Gaps = 68/306 (22%)

Query: 339 PHIMEKPSASPKKSQWQK-----GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK 393
           PH+  K     KK+          +++G G  G V    N+ T    A+K   ++ D   
Sbjct: 2   PHV--KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD--- 53

Query: 394 SAECIKQLEQEIKVLGHL-KHENIVQYYG----SEVVDDHLYIYLEYVHPGSI-NRYVRE 447
                 +  +E+++     +  +IV+              L I +E +  G + +R    
Sbjct: 54  ----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 109

Query: 448 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKH 504
             +  TE       + I   + YLHS N  HRD+K  NLL      + ++KL DFG AK 
Sbjct: 110 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169

Query: 505 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-W 561
            TG  Y+ S                             D+WSLG  VI   +L G PP +
Sbjct: 170 TTGEKYDKS----------------------------CDMWSLG--VIMYILLCGYPPFY 199

Query: 562 SE--FEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHP 613
           S         M  ++         P   E +S E K  +       P +R +  E + HP
Sbjct: 200 SNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258

Query: 614 FIRNAN 619
           +I  + 
Sbjct: 259 WIMQST 264

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  159 bits (404), Expect = 4e-43
 Identities = 70/261 (26%), Positives = 107/261 (40%), Gaps = 18/261 (6%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+ IGRG FG V+ G  R      A+K      +     +   +  QE ++L    H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVK---SCRET-LPPDLKAKFLQEARILKQYSHPNI 174

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V+  G       +YI +E V  G    ++R     +    +         G+ YL S   
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQKD 533
           IHRD+   N LV    V+K++DFGM++      Y  S  L+  P  W APE +       
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL-----NY 289

Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 590
           G  + +   D+WS G  + E  + G  P+      Q    V    R P  PE+       
Sbjct: 290 G--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC-PELCPDAVFR 346

Query: 591 FLLRCFLRNPVERPSAVELLE 611
            + +C+   P +RPS   + +
Sbjct: 347 LMEQCWAYEPGQRPSFSTIYQ 367

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  158 bits (401), Expect = 4e-43
 Identities = 66/311 (21%), Positives = 115/311 (36%), Gaps = 56/311 (18%)

Query: 346 SASPKKSQW------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
           S  P   Q          + IG+G FG V+ G  R  G   A+K   I     + +    
Sbjct: 30  SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVK---IFSSREERSW--- 81

Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITES 455
             E EI     L+HENI+ +  ++  D+     L++  +Y   GS+  Y+  +   +   
Sbjct: 82  FREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM 141

Query: 456 IVRNFTRHILNGLAYLHSTNT--------IHRDIKGANLLVDASGVVKLADFGMAKHLTG 507
           I         +GLA+LH             HRD+K  N+LV  +G   +AD G+A     
Sbjct: 142 I--KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199

Query: 508 LSYELSLK-----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----- 557
            +  + +      G+  +MAPEV+   +            DI+++G    E+        
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGG 258

Query: 558 -----KPPWSEFEGPQAMFKVL-------NRTPPIPEMLSSEGKDFLL-----RCFLRNP 600
                + P+ +        + +          P IP    S     ++      C+  N 
Sbjct: 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318

Query: 601 VERPSAVELLE 611
             R +A+ + +
Sbjct: 319 AARLTALRIKK 329

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  163 bits (415), Expect = 4e-43
 Identities = 66/279 (23%), Positives = 120/279 (43%), Gaps = 25/279 (8%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           +++G+G FG V     R TG   A K+++   I                E ++L  +   
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMALN---EKQILEKVNSR 244

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHS 473
            +V    +    D L + L  ++ G +  ++    +    E+    +   I  GL  LH 
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 533
              ++RD+K  N+L+D  G ++++D G+A H+          G+  +MAPEV+K      
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK------ 358

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF-KVLNRTPPIPEMLSSEGK 589
            N +   + D W+LGC + EM+ G+ P+    +    + +   V        E  S + +
Sbjct: 359 -NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR 417

Query: 590 DFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
               +   ++P ER      SA E+ EHP  +  N++ L
Sbjct: 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL 456

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  159 bits (405), Expect = 1e-42
 Identities = 79/279 (28%), Positives = 132/279 (47%), Gaps = 29/279 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           KL+G+GTFG V +   + TG   A+K +    I+  D            E +VL + +H 
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--EVAHTLT---ENRVLQNSRHP 208

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            +     S    D L   +EY + G +  ++    R  +E   R +   I++ L YLHS 
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSE 267

Query: 475 -NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 530
            N ++RD+K  NL++D  G +K+ DFG+ K   G+    ++K   G+P ++APEV++   
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLE--- 322

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGK 589
             D       AVD W LG  + EM+ G+ P+   +  + +F  +L      P  L  E K
Sbjct: 323 DNDYGR----AVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAK 377

Query: 590 DFLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNL 623
             L     ++P +R       A E+++H F     +Q++
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 416

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  156 bits (396), Expect = 1e-42
 Identities = 84/329 (25%), Positives = 136/329 (41%), Gaps = 80/329 (24%)

Query: 342 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTN-RETGASCAIKEVDIIPDD---PKSAEC 397
           MEK        Q++    IG G +G V+   + +  G   A+K V +   +   P S   
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-- 58

Query: 398 IKQLEQEIKVLGHLK---HENIVQYYGSEVV-------DDHLYIYLEYVHPGSINRYVRE 447
           I+    E+ VL HL+   H N+V+ +  +V        +  L +  E+V    +  Y+ +
Sbjct: 59  IR----EVAVLRHLETFEHPNVVRLF--DVCTVSRTDRETKLTLVFEHVD-QDLTTYL-D 110

Query: 448 HCRD--ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 505
              +  +    +++    +L GL +LHS   +HRD+K  N+LV +SG +KLADFG+A+  
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-- 168

Query: 506 TGLSYELSLKGSPNWMAPEVI----KAVMQKDGNPKLAL------AVDIWSLGCTVIEML 555
                   +      +   V+    +A       P++ L       VD+WS+GC   EM 
Sbjct: 169 --------IYSFQMALTSVVVTLWYRA-------PEVLLQSSYATPVDLWSVGCIFAEMF 213

Query: 556 TGKP--------------------P----WSEFEG-PQAMFKVLNRTP--PIPEMLSSEG 588
             KP                    P    W      P+  F   +  P       +   G
Sbjct: 214 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 273

Query: 589 KDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           KD LL+C   NP +R SA   L HP+ ++
Sbjct: 274 KDLLLKCLTFNPAKRISAYSALSHPYFQD 302

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  158 bits (402), Expect = 2e-42
 Identities = 69/280 (24%), Positives = 130/280 (46%), Gaps = 23/280 (8%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           K+IGRG FG V +   +      A+K +   +++        C ++   E  VL +   +
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR--AETACFRE---ERDVLVNGDSK 134

Query: 415 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 474
            I   + +   D++LY+ ++Y   G +   + +    + E + R +   ++  +  +H  
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQK 532
           + +HRDIK  N+L+D +G ++LADFG    L   G        G+P++++PE+++A   +
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA--ME 252

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRT-----PPIPEMLSS 586
            G  +     D WSLG  + EML G+ P+   E     + K++N       P     +S 
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVSE 311

Query: 587 EGKDFLLRCFLRNPVER---PSAVELLEHPFIRNANYQNL 623
             KD L+R  + +   R       +  +HPF    ++ N+
Sbjct: 312 NAKD-LIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  156 bits (396), Expect = 3e-42
 Identities = 76/323 (23%), Positives = 132/323 (40%), Gaps = 79/323 (24%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVL 408
           S+++K   IG+GTFG V+   +R+TG   A+K+V +  +    P +A       +EIK+L
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL------REIKIL 70

Query: 409 GHLKHENIVQYYGSEVV----------DDHLYIYLEYV-HPGSINRYVREHCRDITESIV 457
             LKHEN+V     E+              +Y+  ++  H   +   +       T S +
Sbjct: 71  QLLKHENVVNLI--EICRTKASPYNRCKGSIYLVFDFCEH--DLAGLLSNVLVKFTLSEI 126

Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 517
           +   + +LNGL Y+H    +HRD+K AN+L+   GV+KLADFG+A+      + L+    
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-----FSLAKNSQ 181

Query: 518 PNWMAPEVI----KAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKPPW---SE 563
           PN     V+    +        P+L L        +D+W  GC + EM T  P     +E
Sbjct: 182 PNRYTNRVVTLWYRP-------PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234

Query: 564 FEGPQAMFKVL------------------NRTPPIPE-----------MLSSEGKDFLLR 594
                 + ++                          +           +      D + +
Sbjct: 235 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 294

Query: 595 CFLRNPVERPSAVELLEHPFIRN 617
             + +P +R  + + L H F  +
Sbjct: 295 LLVLDPAQRIDSDDALNHDFFWS 317

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  156 bits (396), Expect = 3e-42
 Identities = 73/288 (25%), Positives = 131/288 (45%), Gaps = 37/288 (12%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 413
           ++IGRG++  V +   ++T    A+K V    +  D+    + ++    E  V      H
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE--DIDWVQT---EKHVFEQASNH 69

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             +V  +     +  L+  +EYV+ G +  +++   R + E   R ++  I   L YLH 
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE 128

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 530
              I+RD+K  N+L+D+ G +KL D+GM K   GL    +     G+PN++APE++    
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL---- 182

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA--------MF-KVLNRTPPIP 581
           + +       +VD W+LG  + EM+ G+ P+                +F  +L +   IP
Sbjct: 183 RGEDYGF---SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239

Query: 582 EMLSSEGKDFLLRCFLRNPVER------PSAVELLEHPFIRNANYQNL 623
             LS +    L     ++P ER          ++  HPF RN ++  +
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 287

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  155 bits (395), Expect = 4e-42
 Identities = 76/275 (27%), Positives = 137/275 (49%), Gaps = 25/275 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 413
           K++G+G+FG V++   ++T    AIK +    ++ DD    EC      E +VL    +H
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVECTMV---EKRVLSLAWEH 77

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             +   + +    ++L+  +EY++ G +  +++  C     S    +   I+ GL +LHS
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS 136

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 530
              ++RD+K  N+L+D  G +K+ADFGM K    +  +       G+P+++APE++    
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEIL---- 190

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGK 589
                     +VD WS G  + EML G+ P+   +  + +F  +    P  P  L  E K
Sbjct: 191 LGQKYNH---SVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYPRWLEKEAK 246

Query: 590 DFLLRCFLRNPVER-PSAVELLEHPFIRNANYQNL 623
           D L++ F+R P +R     ++ +HP  R  N++ L
Sbjct: 247 DLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 281

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  157 bits (398), Expect = 4e-42
 Identities = 78/345 (22%), Positives = 147/345 (42%), Gaps = 44/345 (12%)

Query: 308 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKG-------KLI 360
           +   +H + H   +P       + ++ S +        +    K+    G       ++I
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVI 60

Query: 361 GRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKHENI 416
           GRG++  V +   ++T    A++ V    +  D+    + ++    E  V      H  +
Sbjct: 61  GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE--DIDWVQT---EKHVFEQASNHPFL 115

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V  +     +  L+  +EYV+ G +  +++   R + E   R ++  I   L YLH    
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGI 174

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKD 533
           I+RD+K  N+L+D+ G +KL D+GM K   GL    +     G+PN++APE++    + +
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL----RGE 228

Query: 534 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA--------MF-KVLNRTPPIPEML 584
                  +VD W+LG  + EM+ G+ P+                +F  +L +   IP  L
Sbjct: 229 DYGF---SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285

Query: 585 SSEGKDFLLRCFLRNPVER------PSAVELLEHPFIRNANYQNL 623
           S +    L     ++P ER          ++  HPF RN ++  +
Sbjct: 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 330

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  154 bits (392), Expect = 5e-42
 Identities = 69/274 (25%), Positives = 118/274 (43%), Gaps = 25/274 (9%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIK    + +        + L  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREATSPKANKEIL-DEA 68

Query: 406 KVLGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
            V+  + + ++ +  G  +     + +  + +  G +  YVREH  +I    + N+   I
Sbjct: 69  YVMASVDNPHVCRLLG--ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWM 521
             G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G   P  WM
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTP 578
           A E I                D+WS G TV E++T G  P+      +    +    R P
Sbjct: 187 ALESI-----LHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239

Query: 579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
             P + + +    + +C++ +   RP   EL+  
Sbjct: 240 Q-PPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  155 bits (394), Expect = 6e-42
 Identities = 80/285 (28%), Positives = 144/285 (50%), Gaps = 30/285 (10%)

Query: 358 KLIGRGTFGSVYI---GTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 412
           K++G G +G V++    +  +TG   A+K +    I    K+ E  +    E +VL H++
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT---ERQVLEHIR 116

Query: 413 HEN-IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
               +V  + +   +  L++ L+Y++ G +  ++       TE  V+ +   I+  L +L
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHL 175

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL----SLKGSPNWMAPEVIK 527
           H    I+RDIK  N+L+D++G V L DFG++K    ++ E        G+  +MAP++++
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEYMAPDIVR 233

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF-KVLNRTPPIPEM 583
                 G+ K   AVD WSLG  + E+LTG  P+    E      +  ++L   PP P+ 
Sbjct: 234 G--GDSGHDK---AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288

Query: 584 LSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
           +S+  KD + R  +++P +R       A E+ EH F +  N+ +L
Sbjct: 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 333

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  155 bits (393), Expect = 1e-41
 Identities = 71/342 (20%), Positives = 123/342 (35%), Gaps = 103/342 (30%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            ++  GK +G G+FG V    + E+G   A+K+   +  DP+         +E+ ++  L
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK---VLQDPRYKN------RELDIMKVL 57

Query: 412 KHENIVQ--------------------------------------YYGSEVVDDHLYIYL 433
            H NI++                                         +   + +L + +
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 434 EYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 490
           EYV P ++++ ++   R    I  +++  +   +   + ++HS    HRDIK  NLLV++
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 491 -SGVVKLADFGMAKHLTGLSYELSLKGSPN-------WM-APEVIKAVMQKDGNPKLALA 541
               +KL DFG AK L            P+       +  APE++       G  +   +
Sbjct: 177 KDNTLKLCDFGSAKKLI--------PSEPSVAYICSRFYRAPELML------GATEYTPS 222

Query: 542 VDIWSLGCTVIEMLTGKP--------------------PWSE---FEGPQAMFKVLNRTP 578
           +D+WS+GC   E++ GKP                    P  E      P           
Sbjct: 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282

Query: 579 PIP------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
                    E   S   D L +     P  R +  E + HPF
Sbjct: 283 AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  154 bits (391), Expect = 2e-41
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 29/279 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 413
            ++G+G+FG V +   + T    A+K +    +I DD    EC      E +VL    K 
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMV---EKRVLALPGKP 80

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             + Q +      D LY  +EYV+ G +  ++ +      E     +   I  GL +L S
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQS 139

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 530
              I+RD+K  N+++D+ G +K+ADFGM K    +   ++ K   G+P+++APE+I    
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEII---- 193

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGK 589
                 K   +VD W+ G  + EML G+ P+   E    +F  ++      P+ +S E  
Sbjct: 194 AYQPYGK---SVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAV 249

Query: 590 DFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
                   ++P +R         ++ EH F R  +++ L
Sbjct: 250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 288

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  153 bits (390), Expect = 2e-41
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 30/280 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 413
           +++G+G+FG V +   +ETG   A+K +    I+ DD    EC      E ++L     H
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD--DVECTMT---EKRILSLARNH 83

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             + Q +      D L+  +E+V+ G +  +++   R   E+  R +   I++ L +LH 
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEIISALMFLHD 142

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 530
              I+RD+K  N+L+D  G  KLADFGM K   G+   ++     G+P+++APE++    
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEIL---- 196

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGK 589
           Q+        AVD W++G  + EML G  P+   E    +F  +LN     P  L  +  
Sbjct: 197 QEMLYGP---AVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLHEDAT 252

Query: 590 DFLLRCFLRNPVER------PSAVELLEHPFIRNANYQNL 623
             L     +NP  R           +L HPF +  ++  L
Sbjct: 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  151 bits (383), Expect = 1e-40
 Identities = 73/285 (25%), Positives = 128/285 (44%), Gaps = 40/285 (14%)

Query: 358 KLIGRGTFGSVYI---GTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHL 411
           K++G+G+FG V++    +  +     A+K +    +   D            E  +L  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD--RVRTK----MERDILVEV 83

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNG 467
            H  IV+ + +   +  LY+ L+++  G     +++ V       TE  V+ +   +   
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-----FTEEDVKFYLAELALA 138

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPE 524
           L +LHS   I+RD+K  N+L+D  G +KL DFG++K    + +E       G+  +MAPE
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPE 196

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEM 583
           V+     + G+ +   + D WS G  + EMLTG  P+   +  +     +L     +P+ 
Sbjct: 197 VV----NRRGHTQ---SADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLGMPQF 248

Query: 584 LSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
           LS E +  L   F RNP  R         E+  H F    ++  L
Sbjct: 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL 293

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  152 bits (386), Expect = 1e-40
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 28/278 (10%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLG-HLKH 413
           K+IG+G+FG V +  ++      A+K +    I+       + I     E  VL  ++KH
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK--EEKHIMS---ERNVLLKNVKH 98

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             +V  + S    D LY  L+Y++ G +  +++   R   E   R +   I + L YLHS
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHS 157

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 530
            N ++RD+K  N+L+D+ G + L DFG+ K    + +  +     G+P ++APEV+    
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVL---- 211

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGK 589
            K    +    VD W LG  + EML G PP+        M+  +LN+   +   +++  +
Sbjct: 212 HKQPYDR---TVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQLKPNITNSAR 267

Query: 590 DFLLRCFLRNPVER----PSAVELLEHPFIRNANYQNL 623
             L     ++  +R       +E+  H F    N+ +L
Sbjct: 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL 305

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  149 bits (378), Expect = 1e-40
 Identities = 66/264 (25%), Positives = 118/264 (44%), Gaps = 23/264 (8%)

Query: 357 GKLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
            +++G G FG VY G    ++    + A+K       D       K +  E  ++ +L H
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVK---TCKKDCTLDNKEKFM-SEAVIMKNLDH 72

Query: 414 ENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
            +IV+  G  ++++   +I +E    G +  Y+  +   +    +  ++  I   +AYL 
Sbjct: 73  PHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVM 530
           S N +HRDI   N+LV +   VKL DFG+++++    Y  +     P  WM+PE I    
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI---- 186

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSE 587
                 +   A D+W     + E+L+ GK P+   E    +  +    R P  P++    
Sbjct: 187 -NFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPV 242

Query: 588 GKDFLLRCFLRNPVERPSAVELLE 611
               + RC+  +P +RP   EL+ 
Sbjct: 243 LYTLMTRCWDYDPSDRPRFTELVC 266

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  157 bits (398), Expect = 2e-40
 Identities = 85/473 (17%), Positives = 169/473 (35%), Gaps = 34/473 (7%)

Query: 169 PTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVF 228
            T     +     +     ++ I     +     +  +  +  +    + P         
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212

Query: 229 SSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSP 288
           +         +W+      L                  ++ +  + S     S+      
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272

Query: 289 RKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSAS 348
              +  L  +     +  +    +  N         A     +        + + K   +
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332

Query: 349 PKKSQWQKG-----KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 400
             + + +        ++G+G+FG V +   + T    A+K +    +I DD    EC   
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMV 390

Query: 401 LEQEIKVLGH-LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 459
              E +VL    K   + Q +      D LY  +EYV+ G +  ++ +      E     
Sbjct: 391 ---EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVF 446

Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---G 516
           +   I  GL +L S   I+RD+K  N+++D+ G +K+ADFGM K    +   ++ K   G
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCG 504

Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLN 575
           +P+++APE+I          K   +VD W+ G  + EML G+ P+   E    +F  ++ 
Sbjct: 505 TPDYIAPEII----AYQPYGK---SVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIME 556

Query: 576 RTPPIPEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
                P+ +S E          ++P +R         ++ EH F R  +++ L
Sbjct: 557 HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  149 bits (379), Expect = 2e-40
 Identities = 74/311 (23%), Positives = 123/311 (39%), Gaps = 54/311 (17%)

Query: 340 HIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGT----NRETGASCAIKEVDII 388
            I+ +   + +            + + +G G FG V +         TG   A+K +   
Sbjct: 2   DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-- 59

Query: 389 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVR 446
                    I  L++EI++L +L HENIV+Y G  +E   + + + +E++  GS+  Y+ 
Sbjct: 60  --PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP 117

Query: 447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
           ++   I       +   I  G+ YL S   +HRD+   N+LV++   VK+ DFG+ K + 
Sbjct: 118 KNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177

Query: 507 GLS--YELSLKG-SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 561
                Y +     SP  W APE +          K  +A D+WS G T+ E+LT      
Sbjct: 178 TDKEYYTVKDDRDSPVFWYAPECL-----MQS--KFYIASDVWSFGVTLHELLTYCDSDS 230

Query: 562 SEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL--------------------LRCFLRNPV 601
           S       M       P   +M  +   + L                     +C+   P 
Sbjct: 231 SPMALFLKMIG-----PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPS 285

Query: 602 ERPSAVELLEH 612
            R S   L+E 
Sbjct: 286 NRTSFQNLIEG 296

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  148 bits (377), Expect = 2e-40
 Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 24/274 (8%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGT-NRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIK 406
            +   +  + +G G+FG V  G  +  +G +   A+K   + PD     E +    +E+ 
Sbjct: 16  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC--LKPDVLSQPEAMDDFIREVN 73

Query: 407 VLGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            +  L H N+++ YG  VV    + +  E    GS+   +R+H        +  +   + 
Sbjct: 74  AMHSLDHRNLIRLYG--VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWM 521
            G+ YL S   IHRD+   NLL+    +VK+ DFG+ + L      Y +      P  W 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RT 577
           APE +K           + A D W  G T+ EM T G+ PW    G Q + K+     R 
Sbjct: 192 APESLK-------TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244

Query: 578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
           P  PE    +  + +++C+   P +RP+ V L +
Sbjct: 245 PR-PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  149 bits (378), Expect = 4e-40
 Identities = 72/300 (24%), Positives = 123/300 (41%), Gaps = 40/300 (13%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           ++   +    +G+G FGSV +         TGA  A+K++          +  +  ++EI
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-----HSGPDQQRDFQREI 75

Query: 406 KVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
           ++L  L  + IV+Y G         L + +EY+  G +  +++ H   +  S +  ++  
Sbjct: 76  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKG-SP-N 519
           I  G+ YL S   +HRD+   N+LV++   VK+ADFG+AK L      Y +   G SP  
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195

Query: 520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP 578
           W APE +      D     +   D+WS G  + E+ T      S       M       P
Sbjct: 196 WYAPESL-----SDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248

Query: 579 PIPEMLSS--EGK-------------DFLLRCFLRNPVERPSAVELLEH--PFIRNANYQ 621
            +  +L    EG+             + +  C+  +P +RPS   L          +   
Sbjct: 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  148 bits (375), Expect = 5e-40
 Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 41/291 (14%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           ++   +  + +G+G FGSV +         TG   A+K++        + E ++  E+EI
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREI 62

Query: 406 KVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
           ++L  L+H+NIV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKG-SP-N 519
           I  G+ YL +   IHRD+   N+LV+    VK+ DFG+ K L      +++   G SP  
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182

Query: 520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT----------------GKPPWSE 563
           W APE +      +   K ++A D+WS G  + E+ T                G     +
Sbjct: 183 WYAPESL-----TES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235

Query: 564 FEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
                 +  + N  R P  P+    E    +  C+  N  +RPS  +L   
Sbjct: 236 MIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  149 bits (379), Expect = 6e-40
 Identities = 79/306 (25%), Positives = 136/306 (44%), Gaps = 61/306 (19%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
            L+G G +G V   T++ TG   AIK+++   D P  A    +  +EIK+L H KHENI+
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFA---LRTLREIKILKHFKHENII 72

Query: 418 QYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
             +      S    + +YI  E +    ++R +    + +++  ++ F    L  +  LH
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLH 129

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------- 521
            +N IHRD+K +NLL++++  +K+ DFG+A+ +   + + S                   
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PW 561
           APEV+    +         A+D+WS GC + E+   +P                    P 
Sbjct: 190 APEVMLTSAKYSR------AMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243

Query: 562 SEF-------EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVEL 609
           S+           +   K L   P  P  +M    + +G D L R  + +P +R +A E 
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303

Query: 610 LEHPFI 615
           LEHP++
Sbjct: 304 LEHPYL 309

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  148 bits (376), Expect = 6e-40
 Identities = 62/300 (20%), Positives = 118/300 (39%), Gaps = 52/300 (17%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
              Q  ++  RG FG V+           A+K        P   +   Q E E+  L  +
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIF------PIQDKQSWQNEYEVYSLPGM 75

Query: 412 KHENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
           KHENI+Q+ G+E         L++   +   GS++ +++ +   ++ + + +    +  G
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARG 133

Query: 468 LAYLHSTNT----------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-- 515
           LAYLH               HRDIK  N+L+  +    +ADFG+A               
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193

Query: 516 -GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS----EFEGP--- 567
            G+  +MAPEV++  +  +      L +D++++G  + E+ +          E+  P   
Sbjct: 194 VGTRRYMAPEVLEGAI--NFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251

Query: 568 --------QAMFKVL---NRTPPIPEMLSSEG-----KDFLLRCFLRNPVERPSAVELLE 611
                   + M +V+    + P + +            + +  C+  +   R SA  + E
Sbjct: 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  146 bits (372), Expect = 8e-40
 Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 22/261 (8%)

Query: 357 GKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
            K +G G FG V +G    +     A+K   +I +   S +   +  QE + +  L H  
Sbjct: 13  LKELGSGQFGVVKLGKWKGQY--DVAVK---MIKEGSMSED---EFFQEAQTMMKLSHPK 64

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           +V++YG    +  +YI  EY+  G +  Y+R H + +  S +      +  G+A+L S  
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKD 533
            IHRD+   N LVD    VK++DFGM +++    Y  S+    P  W APEV        
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF-----HY 179

Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 590
              K +   D+W+ G  + E+ + GK P+  +   + + KV    R    P + S     
Sbjct: 180 F--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-PHLASDTIYQ 236

Query: 591 FLLRCFLRNPVERPSAVELLE 611
            +  C+   P +RP+  +LL 
Sbjct: 237 IMYSCWHELPEKRPTFQQLLS 257

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  146 bits (371), Expect = 1e-39
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 27/266 (10%)

Query: 357 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           G+ IG G FG V+ G      N     + AIK      +    +   K L QE   +   
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPAL--AVAIK---TCKNCTSDSVREKFL-QEALTMRQF 73

Query: 412 KHENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
            H +IV+  G  V+ ++ ++I +E    G +  +++     +  + +  +   +   LAY
Sbjct: 74  DHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SP-NWMAPEVIKA 528
           L S   +HRDI   N+LV ++  VKL DFG+++++   +Y  + KG  P  WMAPE I  
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-- 189

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 585
                   +   A D+W  G  + E+L  G  P+   +    + ++ N  R P  P    
Sbjct: 190 ---NFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-PPNCP 243

Query: 586 SEGKDFLLRCFLRNPVERPSAVELLE 611
                 + +C+  +P  RP   EL  
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTELKA 269

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  145 bits (369), Expect = 2e-39
 Identities = 66/269 (24%), Positives = 110/269 (40%), Gaps = 22/269 (8%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
            + IG G FG V++G         AIK    I +   S E      +E +V+  L H  +
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKD-KVAIK---TIREGAMSEE---DFIEEAEVMMKLSHPKL 65

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           VQ YG  +    + +  E++  G ++ Y+R          +      +  G+AYL     
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKDG 534
           IHRD+   N LV  + V+K++DFGM + +    Y  S     P  W +PEV         
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-----SFS 180

Query: 535 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDF 591
             + +   D+WS G  + E+ + GK P+      + +  +    R    P + S+     
Sbjct: 181 --RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQI 237

Query: 592 LLRCFLRNPVERPSAVELLEH--PFIRNA 618
           +  C+   P +RP+   LL        + 
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAESG 266

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  146 bits (370), Expect = 2e-39
 Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 29/291 (9%)

Query: 347 ASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
            SP   +W            +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54

Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVR 458
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R  ++  ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 114

Query: 459 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS- 517
                I + + YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y        
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174

Query: 518 P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 575
           P  W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q    +  
Sbjct: 175 PIKWTAPESL-----AYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

Query: 576 --RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQN 622
             R    PE    +  + +  C+  NP +RPS  E+ +      + ++  +
Sbjct: 228 DYRMER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  153 bits (388), Expect = 3e-39
 Identities = 76/351 (21%), Positives = 137/351 (39%), Gaps = 28/351 (7%)

Query: 285 LRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEK 344
           L +     F +R +   + +   +    +     +     ++S                 
Sbjct: 320 LVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTM 379

Query: 345 PSASPK---KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECI 398
           PS       + + + G+ IG G FG V+ G          + AIK      +    +   
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVRE 436

Query: 399 KQLEQEIKVLGHLKHENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIV 457
           K L QE   +    H +IV+  G  V+ ++ ++I +E    G +  +++     +  + +
Sbjct: 437 KFL-QEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASL 493

Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG- 516
             +   +   LAYL S   +HRDI   N+LV ++  VKL DFG+++++   +Y  + KG 
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553

Query: 517 SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 574
            P  WMAPE I          +   A D+W  G  + E+L  G  P+   +    + ++ 
Sbjct: 554 LPIKWMAPESI-----NFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

Query: 575 N--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQ 621
           N  R P  P          + +C+  +P  RP   EL       +     Q
Sbjct: 607 NGERLPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  147 bits (372), Expect = 5e-39
 Identities = 74/302 (24%), Positives = 129/302 (42%), Gaps = 54/302 (17%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
             +     +G G +GSV    ++ +G   AIK++         A   K+  +E+ +L H+
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA---KRAYRELLLLKHM 80

Query: 412 KHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
           +HEN++          S       Y+ + ++    + + +       +E  ++     +L
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL---KFSEEKIQYLVYQML 136

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPE 524
            GL Y+HS   +HRD+K  NL V+    +K+ DFG+A+       E++      W  APE
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPE 193

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF 564
           VI + M  +        VDIWS+GC + EMLTGK                     P +EF
Sbjct: 194 VILSWMHYNQ------TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247

Query: 565 ------EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHP 613
                 +  ++  + L +TP     ++    S +  D L +    +  +R +A + L HP
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307

Query: 614 FI 615
           F 
Sbjct: 308 FF 309

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  153 bits (387), Expect = 6e-39
 Identities = 68/280 (24%), Positives = 125/280 (44%), Gaps = 27/280 (9%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           ++IGRG FG VY     +TG   A+K +D   I                E  +L  +   
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALN---ERIMLSLVSTG 249

Query: 415 N---IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           +   IV    +    D L   L+ ++ G ++ ++       +E+ +R +   I+ GL ++
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHM 308

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           H+   ++RD+K AN+L+D  G V+++D G+A   +      +  G+  +MAPEV+    +
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVL---QK 364

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEMLSSEG 588
                    + D +SLGC + ++L G  P+ + +      +    L     +P+  S E 
Sbjct: 365 GVAYDS---SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421

Query: 589 KDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
           +  L     R+   R       A E+ E PF R+ ++Q +
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (369), Expect = 6e-39
 Identities = 79/302 (26%), Positives = 131/302 (43%), Gaps = 48/302 (15%)

Query: 345 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPK 393
            SA   +          +  + +G+G FGSV +         TG   A+K++        
Sbjct: 27  GSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HS 81

Query: 394 SAECIKQLEQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRD 451
           + E ++  E+EI++L  L+H+NIV+Y G        +L + +EY+  GS+  Y+++H   
Sbjct: 82  TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 141

Query: 452 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLS 509
           I    +  +T  I  G+ YL +   IHRD+   N+LV+    VK+ DFG+ K L      
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201

Query: 510 YELSLKG-SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT----------- 556
           Y++   G SP  W APE +      +   K ++A D+WS G  + E+ T           
Sbjct: 202 YKVKEPGESPIFWYAPESL-----TES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAE 254

Query: 557 -----GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 609
                G     +      +  + N  R P  P+    E    +  C+  N  +RPS  +L
Sbjct: 255 FMRMIGNDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 313

Query: 610 LE 611
             
Sbjct: 314 AL 315

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  145 bits (369), Expect = 8e-39
 Identities = 76/322 (23%), Positives = 137/322 (42%), Gaps = 27/322 (8%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++++K K++G G FG+VY G       +     AIK    + +   S +  K++  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREAT-SPKANKEILDEA 68

Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWMA 522
            G+ YL     +HRD+   N+LV     VK+ DFG+AK L     E   +G   P  WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPP 579
            E I                D+WS G TV E++T G  P+      +    +    R P 
Sbjct: 188 LESI-----LHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240

Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRN-ANYQNLSVPMRVFSRINLG 636
            P + + +    +++C++ +   RP   EL+       R+   Y  +    R+    +  
Sbjct: 241 -PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP-SPT 298

Query: 637 DKSHDQVERATRKTESLPDSPE 658
           D +  +        + + D+ E
Sbjct: 299 DSNFYRALMDEEDMDDVVDADE 320

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  143 bits (364), Expect = 1e-38
 Identities = 74/293 (25%), Positives = 120/293 (40%), Gaps = 30/293 (10%)

Query: 342 MEKPS-ASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK 393
              PS A      W          K +G G FG V  G  R      AIK +       +
Sbjct: 6   KNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMI------KE 58

Query: 394 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 453
            +    +  +E KV+ +L HE +VQ YG       ++I  EY+  G +  Y+RE      
Sbjct: 59  GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118

Query: 454 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 513
              +    + +   + YL S   +HRD+   N LV+  GVVK++DFG+++++    Y  S
Sbjct: 119 TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178

Query: 514 LKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 570
           +    P  W  PEV+          K +   DIW+ G  + E+ + GK P+  F   +  
Sbjct: 179 VGSKFPVRWSPPEVL-----MYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 231

Query: 571 FKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNAN 619
             +    R    P + S +    +  C+     ERP+   LL +    +   +
Sbjct: 232 EHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  144 bits (365), Expect = 1e-38
 Identities = 61/266 (22%), Positives = 113/266 (42%), Gaps = 24/266 (9%)

Query: 356 KGKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           + K +G G FG+V  G    ++   + A+K   I+ ++        +L  E  V+  L +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDN 77

Query: 414 ENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
             IV+  G  + +     + +E    G +N+Y++++ R + +  +      +  G+ YL 
Sbjct: 78  PYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE 134

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWMAPEVIKA 528
            +N +HRD+   N+L+      K++DFG++K L      Y+    G  P  W APE I  
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI-- 192

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 585
                   K +   D+WS G  + E  + G+ P+   +G +    +    R    P    
Sbjct: 193 ---NYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-PAGCP 246

Query: 586 SEGKDFLLRCFLRNPVERPSAVELLE 611
            E  D +  C+  +   RP    +  
Sbjct: 247 REMYDLMNLCWTYDVENRPGFAAVEL 272

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  145 bits (367), Expect = 1e-38
 Identities = 68/274 (24%), Positives = 124/274 (45%), Gaps = 25/274 (9%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           K+++ +K K++G G FG+V+ G              IK   +I D        + +   +
Sbjct: 11  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK---VIEDKSGRQS-FQAVTDHM 66

Query: 406 KVLGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
             +G L H +IV+  G  +     L +  +Y+  GS+  +VR+H   +   ++ N+   I
Sbjct: 67  LAIGSLDHAHIVRLLG--LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWM 521
             G+ YL     +HR++   N+L+ +   V++ADFG+A  L     +L    +  P  WM
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184

Query: 522 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTP 578
           A E I       G  K     D+WS G TV E++T G  P++     +    +    R  
Sbjct: 185 ALESI-----HFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA 237

Query: 579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
             P++ + +    +++C++ +   RP+  EL   
Sbjct: 238 Q-PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  145 bits (367), Expect = 1e-38
 Identities = 70/296 (23%), Positives = 116/296 (39%), Gaps = 37/296 (12%)

Query: 337 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVD 386
             PH  E+P  + +              K+IG G  G V  G  R  G      AIK   
Sbjct: 27  AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK--- 83

Query: 387 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 446
            +       +    L  E  ++G   H NI++  G         I  EY+  GS++ ++R
Sbjct: 84  ALKAGYTERQRRDFL-SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142

Query: 447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
            H    T   +    R +  G+ YL     +HRD+   N+LVD++ V K++DFG+++ L 
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202

Query: 507 GLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 557
                        + ++    W APE I            + A D+WS G  + E+L  G
Sbjct: 203 DDPDAAYTTTGGKIPIR----WTAPEAI-----AFR--TFSSASDVWSFGVVMWEVLAYG 251

Query: 558 KPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
           + P+        +  V    R P  P          +L C+ ++  +RP   +++ 
Sbjct: 252 ERPYWNMTNRDVISSVEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  146 bits (370), Expect = 1e-38
 Identities = 75/303 (24%), Positives = 135/303 (44%), Gaps = 53/303 (17%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            ++Q    +G G +GSV    + +TG   A+K++         A   K+  +E+++L H+
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHM 85

Query: 412 KHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
           KHEN++          S    + +Y+    +    +N  V+  C+ +T+  V+     IL
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQIL 142

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPE 524
            GL Y+HS + IHRD+K +NL V+    +K+ DFG+A+H      E++   +  W  APE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPE 199

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF 564
           ++   M  +        VDIWS+GC + E+LTG+                     P +E 
Sbjct: 200 IMLNWMHYNQ------TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253

Query: 565 ------EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHP 613
                 E  +   + L + P +    +    +    D L +  + +  +R +A + L H 
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313

Query: 614 FIR 616
           +  
Sbjct: 314 YFA 316

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  148 bits (375), Expect = 1e-38
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 31/303 (10%)

Query: 339 PHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD 391
           P +  KP    +K  W       +  K +G G FG V++ T  +     A+K   + P  
Sbjct: 168 PCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKT--MKPGS 224

Query: 392 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CR 450
                       E  V+  L+H+ +V+ +   V  + +YI  E++  GS+  +++     
Sbjct: 225 MSVEA----FLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGS 279

Query: 451 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 510
                 + +F+  I  G+A++   N IHRD++ AN+LV AS V K+ADFG+A+ +    Y
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339

Query: 511 ELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP 567
                   P  W APE I       G     +  D+WS G  ++E++T G+ P+     P
Sbjct: 340 TAREGAKFPIKWTAPEAI-----NFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392

Query: 568 QAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQNL 623
           + +  +    R P  PE    E  + ++RC+   P ERP+   +      F      Q  
Sbjct: 393 EVIRALERGYRMPR-PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYE 451

Query: 624 SVP 626
            +P
Sbjct: 452 EIP 454

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  147 bits (373), Expect = 2e-38
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 29/288 (10%)

Query: 337 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 389
            +    +  +    K  W       +    +G+G FG V++GT   T    AIK   + P
Sbjct: 162 TVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKT--LKP 218

Query: 390 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 449
                   +    QE +V+  L+HE +VQ Y   V ++ +YI  EY+  GS+  +++   
Sbjct: 219 GTMSPEAFL----QEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET 273

Query: 450 RD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 508
              +    + +    I +G+AY+   N +HRD++ AN+LV  + V K+ADFG+A+ +   
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333

Query: 509 SYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 565
            Y        P  W APE            +  +  D+WS G  + E+ T G+ P+    
Sbjct: 334 EYTARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386

Query: 566 GPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
             + + +V    R P  P        D + +C+ + P ERP+   L  
Sbjct: 387 NREVLDQVERGYRMPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQA 433

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  143 bits (363), Expect = 4e-38
 Identities = 69/321 (21%), Positives = 120/321 (37%), Gaps = 61/321 (19%)

Query: 342 MEKPSASPKK--SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
           ME  ++ P       +  +LIGRG +G+VY G+  E     A+K   +     +      
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER--PVAVK---VFSFANRQNF--- 52

Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDD-----HLYIYLEYVHPGSINRYVREHCRDITE 454
             E+ I  +  ++H+NI ++   +            + +EY   GS+ +Y+  H  D   
Sbjct: 53  INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVS 112

Query: 455 SIVRNFTRHILNGLAYLHSTNT---------IHRDIKGANLLVDASGVVKLADFGMAKHL 505
           S        +  GLAYLH+             HRD+   N+LV   G   ++DFG++  L
Sbjct: 113 SC--RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170

Query: 506 TGLSYEL---------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
           TG              S  G+  +MAPEV++  +           VD+++LG    E+  
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

Query: 557 G-------------KPPWSEFEGPQAMFKVL-------NRTPPIPEMLSSEG------KD 590
                         +  +    G    F+ +        + P  PE            K+
Sbjct: 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290

Query: 591 FLLRCFLRNPVERPSAVELLE 611
            +  C+ ++   R +A    E
Sbjct: 291 TIEDCWDQDAEARLTAQXAEE 311

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  143 bits (362), Expect = 1e-37
 Identities = 65/310 (20%), Positives = 120/310 (38%), Gaps = 65/310 (20%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            ++     IG G +G V    +       AIK++    +        ++  +EIK+L   
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYC---QRTLREIKILLRF 82

Query: 412 KHENIVQYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +HENI+         +      +YI  + +    + + ++   + ++   +  F   IL 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLK--TQHLSNDHICYFLYQILR 139

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----- 521
           GL Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+                ++     
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD------PDHDHTGFLTEYVA 193

Query: 522 -----APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----------------- 559
                APE++              ++DIWS+GC + EML+ +P                 
Sbjct: 194 TRWYRAPEIMLNSKGYTK------SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247

Query: 560 ---PWSEF------EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPS 605
              P  E          +     L     +P   +     S+  D L +    NP +R  
Sbjct: 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307

Query: 606 AVELLEHPFI 615
             + L HP++
Sbjct: 308 VEQALAHPYL 317

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  145 bits (368), Expect = 2e-37
 Identities = 72/293 (24%), Positives = 128/293 (43%), Gaps = 29/293 (9%)

Query: 345 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 397
              SP   +W            +G G +G VY G  ++   + A+K   +  D  +  E 
Sbjct: 206 YGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE- 262

Query: 398 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESI 456
                +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R  ++  +
Sbjct: 263 ---FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 319

Query: 457 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG 516
           +      I + + YL   N IHR++   N LV  + +VK+ADFG+++ +TG +Y      
Sbjct: 320 LLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 379

Query: 517 S-PN-WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 573
             P  W APE +          K ++  D+W+ G  + E+ T G  P+   +  Q    +
Sbjct: 380 KFPIKWTAPESLA-------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432

Query: 574 LN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQN 622
               R    PE    +  + +  C+  NP +RPS  E+ +      + ++  +
Sbjct: 433 EKDYRMER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 484

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  142 bits (360), Expect = 3e-37
 Identities = 68/314 (21%), Positives = 127/314 (40%), Gaps = 66/314 (21%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  +
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYRELVLMKCV 81

Query: 412 KHENIVQ-------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 464
            H+NI+            E   D +YI +E +   ++ + ++    ++    +      +
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQD-VYIVMELM-DANLCQVIQ---MELDHERMSYLLYQM 136

Query: 465 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-AP 523
           L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+   G S+ ++      +  AP
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAP 195

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSE 563
           EVI               VDIWS+GC + EM+ G                      P  E
Sbjct: 196 EVI-------LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248

Query: 564 F-----EGPQAMFKVLNRTPPIP-----------------EMLSSEGKDFLLRCFLRNPV 601
           F        +   +   +                      ++ +S+ +D L +  + +  
Sbjct: 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308

Query: 602 ERPSAVELLEHPFI 615
           +R S  E L+HP+I
Sbjct: 309 KRISVDEALQHPYI 322

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  142 bits (360), Expect = 5e-37
 Identities = 74/417 (17%), Positives = 140/417 (33%), Gaps = 108/417 (25%)

Query: 343 EKPSASPKKSQWQKGKL---IGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAEC 397
            K S+  ++ +         +GRGT+G VY    ++       A+K+++       SA  
Sbjct: 9   VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSACR 67

Query: 398 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDH----LYIYLEYV----------HPGSINR 443
                 EI +L  LKH N++     +V   H    +++  +Y           H  S   
Sbjct: 68  ------EIALLRELKHPNVISLQ--KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119

Query: 444 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----GVVKLADF 499
                   +   +V++    IL+G+ YLH+   +HRD+K AN+LV       G VK+AD 
Sbjct: 120 KKPVQ---LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176

Query: 500 GMAKHLTGLSYELSLKGSPNWM---------APEVIKAVMQKDGNPKLALAVDIWSLGCT 550
           G A+      +   LK   +           APE++       G      A+DIW++GC 
Sbjct: 177 GFAR-----LFNSPLKPLADLDPVVVTFWYRAPELLL------GARHYTKAIDIWAIGCI 225

Query: 551 VIEMLTGKP-----------------------------------------PWSEFEGPQA 569
             E+LT +P                                         P         
Sbjct: 226 FAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 285

Query: 570 MFKVLNRTPPIPEM------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA----- 618
                     I  M        S+    L +    +P++R ++ + ++ P+         
Sbjct: 286 RRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTS 345

Query: 619 -NYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEVCP 674
             +    +P      +   +      ++  ++ +    +  T     +   +++  P
Sbjct: 346 DVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPP 402

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  139 bits (352), Expect = 5e-37
 Identities = 68/275 (24%), Positives = 118/275 (42%), Gaps = 26/275 (9%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
            + +G G FG V++G         A+K    +     S +       E  ++  L+H+ +
Sbjct: 18  VERLGAGQFGEVWMGYYNGHT-KVAVK---SLKQGSMSPD---AFLAEANLMKQLQHQRL 70

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN 475
           V+ Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N
Sbjct: 71  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKD 533
            IHRD++ AN+LV  +   K+ADFG+A+ +    Y        P  W APE I       
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-----NY 184

Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 590
           G     +  D+WS G  + E++T G+ P+     P+ +  +    R    P+    E   
Sbjct: 185 G--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQ 241

Query: 591 FLLRCFLRNPVERPSAVELLEH--PFIRN--ANYQ 621
            +  C+   P +RP+   L      F       YQ
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  140 bits (355), Expect = 5e-37
 Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 38/297 (12%)

Query: 337 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT----NRETGASCAIKEV 385
               +   P+ +  K           + K+IG G FG VY G     + +     AIK  
Sbjct: 22  FQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK-- 79

Query: 386 DIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV 445
             +       + +  L  E  ++G   H NI++  G       + I  EY+  G++++++
Sbjct: 80  -TLKAGYTEKQRVDFL-GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137

Query: 446 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 505
           RE   + +   +    R I  G+ YL + N +HRD+   N+LV+++ V K++DFG+++ L
Sbjct: 138 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197

Query: 506 TGLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT- 556
                         + ++    W APE I          K   A D+WS G  + E++T 
Sbjct: 198 EDDPEATYTTSGGKIPIR----WTAPEAI-----SYR--KFTSASDVWSFGIVMWEVMTY 246

Query: 557 GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
           G+ P+ E    + M  + +  R P  P    S     +++C+ +    RP   +++ 
Sbjct: 247 GERPYWELSNHEVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVS 302

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  139 bits (352), Expect = 6e-37
 Identities = 65/262 (24%), Positives = 113/262 (43%), Gaps = 24/262 (9%)

Query: 360 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FGSV  G    R+     AIK   ++          +++ +E +++  L +  IV
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQG-TEKADTEEMMREAQIMHQLDNPYIV 73

Query: 418 QYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           +  G  V     L + +E    G +++++     +I  S V      +  G+ YL   N 
Sbjct: 74  RLIG--VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWMAPEVIKAVMQK 532
           +HRD+   N+L+      K++DFG++K L      Y     G  P  W APE I      
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-----N 186

Query: 533 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGK 589
               K +   D+WS G T+ E L+ G+ P+ + +GP+ M  +    R    P     E  
Sbjct: 187 FR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELY 243

Query: 590 DFLLRCFLRNPVERPSAVELLE 611
             +  C++    +RP  + + +
Sbjct: 244 ALMSDCWIYKWEDRPDFLTVEQ 265

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  141 bits (358), Expect = 7e-37
 Identities = 72/307 (23%), Positives = 128/307 (41%), Gaps = 39/307 (12%)

Query: 337 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVD 386
           V PH  E P+ +  +             K++G G FG V  G  +       S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82

Query: 387 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 446
           +   + +  +       E  ++G   H NI++  G       + I  EY+  GS++ ++R
Sbjct: 83  VGYTEKQRRD----FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138

Query: 447 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
           +H    T   +    R I +G+ YL     +HRD+   N+L++++ V K++DFG+ + L 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198

Query: 507 GLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 557
                        + ++    W +PE I          K   A D+WS G  + E+++ G
Sbjct: 199 DDPEAAYTTRGGKIPIR----WTSPEAI-----AYR--KFTSASDVWSYGIVLWEVMSYG 247

Query: 558 KPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HP 613
           + P+ E      +  V    R PP P    +     +L C+ ++   RP   +++     
Sbjct: 248 ERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306

Query: 614 FIRNANY 620
            IRN   
Sbjct: 307 LIRNPGS 313

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  138 bits (350), Expect = 1e-36
 Identities = 71/266 (26%), Positives = 124/266 (46%), Gaps = 24/266 (9%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
              +G G   +VY+  +       AIK +       +  E +K+ E+E+     L H+NI
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIF--IPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V     +  DD  Y+ +EY+   +++ Y+  H   ++     NFT  IL+G+ + H    
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMRI 132

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
           +HRDIK  N+L+D++  +K+ DFG+AK L  T L+    + G+  + +PE      Q  G
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE------QAKG 186

Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM---FKVLNRTPPIP-----EMLSS 586
                   DI+S+G  + EML G+PP   F G  A+    K +  + P       + +  
Sbjct: 187 EATDE-CTDIYSIGIVLYEMLVGEPP---FNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242

Query: 587 EGKDFLLRCFLRNPVERP-SAVELLE 611
              + +LR   ++   R  +  E+ +
Sbjct: 243 SLSNVILRATEKDKANRYKTIQEMKD 268

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  139 bits (352), Expect = 1e-36
 Identities = 79/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIG----TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
            K   +K + +G G FG V +     TN  TG   A+K +          +     +QEI
Sbjct: 29  HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----ADAGPQHRSGWKQEI 84

Query: 406 KVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
            +L  L HE+I++Y G   +     L + +EYV  GS+  Y+  H   I  + +  F + 
Sbjct: 85  DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQ 142

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKG-SP-N 519
           I  G+AYLH+ + IHRD+   N+L+D   +VK+ DFG+AK +      Y +   G SP  
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202

Query: 520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP 578
           W APE +     K+   K   A D+WS G T+ E+LT      S       +        
Sbjct: 203 WYAPECL-----KEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-----IGI 250

Query: 579 PIPEMLSSEGKDFL--------------------LRCFLRNPVERPSAVELLE 611
              +M      + L                      C+      RP+   L+ 
Sbjct: 251 AQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  138 bits (351), Expect = 2e-36
 Identities = 79/319 (24%), Positives = 127/319 (39%), Gaps = 75/319 (23%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S++   K +G G  G V+   + +     AIK+  I+  DP+S    K   +EIK++  L
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQSV---KHALREIKIIRRL 65

Query: 412 KHENIV--------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 457
            H+NIV                 GS    + +YI  EY+    +   +      + E   
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE--QGPLLEEHA 122

Query: 458 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKG 516
           R F   +L GL Y+HS N +HRD+K ANL ++    V+K+ DFG+A+ +           
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------PHYS 176

Query: 517 SPNWM----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------- 559
               +          +P ++ +            A+D+W+ GC   EMLTGK        
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTK------AIDMWAAGCIFAEMLTGKTLFAGAHE 230

Query: 560 -------------PWSEF-----EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCF 596
                           E             +     P  P  ++L   S E  DFL +  
Sbjct: 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQIL 290

Query: 597 LRNPVERPSAVELLEHPFI 615
             +P++R +A E L HP++
Sbjct: 291 TFSPMDRLTAEEALSHPYM 309

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  138 bits (350), Expect = 2e-36
 Identities = 60/264 (22%), Positives = 106/264 (40%), Gaps = 22/264 (8%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
            +L+GRG  G VY   +       A+K +              ++++E +  G L+  ++
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMS--ETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 476
           V  +    +D  LY+ +  ++   +   +R     +         R I + L   H+   
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 477 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKDG 534
            HRD+K  N+LV A     L DFG+A       L+   +  G+  +MAPE      +   
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE------RFSE 209

Query: 535 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLNRTPPIPEM----LSSEG 588
           +       DI++L C + E LTG PP   ++G     M   +N+  P P      +    
Sbjct: 210 SHATY-RADIYALTCVLYECLTGSPP---YQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265

Query: 589 KDFLLRCFLRNPVER-PSAVELLE 611
              + R   +NP +R  +  +L  
Sbjct: 266 DAVIARGMAKNPEDRYVTCGDLSA 289

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  137 bits (348), Expect = 2e-36
 Identities = 63/272 (23%), Positives = 117/272 (43%), Gaps = 28/272 (10%)

Query: 355 QKGKLIGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
              ++IG+G FG VY G   +   +   CAIK    +    +  + ++   +E  ++  L
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK---SLSRITEMQQ-VEAFLREGLLMRGL 79

Query: 412 KHENIVQYYGSEVV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
            H N++   G  ++   +   ++ L Y+  G + +++R   R+ T   + +F   +  G+
Sbjct: 80  NHPNVLALIG--IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAP 523
            YL     +HRD+   N ++D S  VK+ADFG+A+ +    Y    +         W A 
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPI 580
           E +     +    +     D+WS G  + E+LT G PP+   +       +    R P  
Sbjct: 198 ESL-----QTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ- 249

Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           PE         + +C+  +P  RP+   L+  
Sbjct: 250 PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  138 bits (350), Expect = 3e-36
 Identities = 68/316 (21%), Positives = 119/316 (37%), Gaps = 82/316 (25%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
             +Q  + +GRG +  V+   N        +K   + P   K  +      +EIK+L +L
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--LKPVKKKKIK------REIKILENL 87

Query: 412 K-HENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +   NI+     ++V D       +  E+V+     +  +     +T+  +R +   IL 
Sbjct: 88  RGGPNIITLA--DIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILK 141

Query: 467 GLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMA------KHLTGLSYELSLKGSPN 519
            L Y HS   +HRD+K  N+++D     ++L D+G+A      +         S      
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--RVASR----- 194

Query: 520 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP------QAMFK 572
           +   PE++      D       ++D+WSLGC +  M+  K P+  F G         + K
Sbjct: 195 YFKGPELLVDYQMYD------YSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVRIAK 246

Query: 573 VL------------------------NRTPPIP----------EMLSSEGKDFLLRCFLR 598
           VL                         R                ++S E  DFL +    
Sbjct: 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 306

Query: 599 NPVERPSAVELLEHPF 614
           +   R +A E +EHP+
Sbjct: 307 DHQSRLTAREAMEHPY 322

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  139 bits (352), Expect = 3e-36
 Identities = 72/296 (24%), Positives = 126/296 (42%), Gaps = 53/296 (17%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           + +G G +G+V    +  TGA  AIK++         A   K+  +E+++L H++HEN++
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA---KRAYRELRLLKHMRHENVI 87

Query: 418 QYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
                     +       Y+ + ++    + + ++     + E  ++     +L GL Y+
Sbjct: 88  GLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYI 144

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVM 530
           H+   IHRD+K  NL V+    +K+ DFG+A+       E++      W  APEVI   M
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPEVILNWM 201

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF------ 564
           +          VDIWS+GC + EM+TGK                     P +EF      
Sbjct: 202 RYTQ------TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255

Query: 565 EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
           +  +   K L          +L   S    + L +  + +  +R +A E L HP+ 
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  136 bits (345), Expect = 6e-36
 Identities = 56/282 (19%), Positives = 108/282 (38%), Gaps = 39/282 (13%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKSAECIKQLE 402
           +       + +G+GTF  ++ G  RE G           +K +D            +   
Sbjct: 6   RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-----KAHRNYSESFF 60

Query: 403 QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 462
           +   ++  L H+++V  YG  V  D   +  E+V  GS++ Y++++   I         +
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASG--------VVKLADFGMAKHLTGLSYELSL 514
            +   + +L     IH ++   N+L+             +KL+D G++  +         
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--- 177

Query: 515 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 573
           +    W+ PE I     ++    L LA D WS G T+ E+ + G  P S  +  + +   
Sbjct: 178 QERIPWVPPECI-----ENPK-NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

Query: 574 LNR----TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            +R     P   E+      + +  C    P  RPS   ++ 
Sbjct: 232 EDRHQLPAPKAAELA-----NLINNCMDYEPDHRPSFRAIIR 268

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  138 bits (350), Expect = 6e-36
 Identities = 68/317 (21%), Positives = 114/317 (35%), Gaps = 71/317 (22%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI------KQLEQEI 405
           S +   + I  G++G+V  G +   G   AIK V     D ++   +      K++ +EI
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 406 KVLGHLKHENIVQYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
           ++L H  H NI+          E     LY+  E +    + + + +    I+   ++ F
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139

Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 520
             HIL GL  LH    +HRD+   N+L+  +  + + DF +A+  T          +   
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT----------ADAN 189

Query: 521 M----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----------- 559
                      APE++               VD+WS GC + EM   K            
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTK------LVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243

Query: 560 ---------PWSEF----EGPQA---MFKVLNRTPPIP--EML---SSEGKDFLLRCFLR 598
                    P  E       P A   +   L+  P      ++        D + +    
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303

Query: 599 NPVERPSAVELLEHPFI 615
           NP  R S  + L HP+ 
Sbjct: 304 NPQRRISTEQALRHPYF 320

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  138 bits (349), Expect = 9e-36
 Identities = 78/372 (20%), Positives = 137/372 (36%), Gaps = 39/372 (10%)

Query: 256 SPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLN 315
           SP+ P   + +   H    +           SP         +      K+    N +  
Sbjct: 2   SPIDPMGHHHHH--HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQ 59

Query: 316 -AHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR 374
            A+ + +   AL+P        V+                   ++IGRG FG VY GT  
Sbjct: 60  GANTVHIDLSALNPELVQAVQHVVIGP--------SSLIVHFNEVIGRGHFGCVYHGTLL 111

Query: 375 ETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---DDH 428
           +       CA+K    +       E + Q   E  ++    H N++   G  +    +  
Sbjct: 112 DNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSHPNVLSLLG--ICLRSEGS 165

Query: 429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 488
             + L Y+  G +  ++R    + T   +  F   +  G+ +L S   +HRD+   N ++
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 225

Query: 489 DASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKAVMQKDGNPKLALAVD 543
           D    VK+ADFG+A+ +    ++     +       WMA E +     +    K     D
Sbjct: 226 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL-----QTQ--KFTTKSD 278

Query: 544 IWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNP 600
           +WS G  + E++T G PP+ +         +L   R    PE       + +L+C+    
Sbjct: 279 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLKCWHPKA 337

Query: 601 VERPSAVELLEH 612
             RPS  EL+  
Sbjct: 338 EMRPSFSELVSR 349

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  139 bits (352), Expect = 2e-35
 Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 42/298 (14%)

Query: 333 VTSAVMPHIMEKPSASPK---KSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAI 382
            T  + P +ME   A+     +S W       +  + IG+G FG V +G  R  G   A+
Sbjct: 164 CTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAV 221

Query: 383 KEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---DDHLYIYLEYVHPG 439
           K +       K+    +    E  V+  L+H N+VQ  G  V+      LYI  EY+  G
Sbjct: 222 KCI-------KNDATAQAFLAEASVMTQLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKG 272

Query: 440 SINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 498
           S+  Y+R   R  +    +  F+  +   + YL   N +HRD+   N+LV    V K++D
Sbjct: 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332

Query: 499 FGMAKHLTGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
           FG+ K  +       L +K    W APE +     ++   K +   D+WS G  + E+ +
Sbjct: 333 FGLTKEASSTQDTGKLPVK----WTAPEAL-----REK--KFSTKSDVWSFGILLWEIYS 381

Query: 557 -GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            G+ P+        + +V    +    P+       D +  C+  +   RP+ ++L E
Sbjct: 382 FGRVPYPRIPLKDVVPRVEKGYKMDA-PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  139 bits (352), Expect = 2e-35
 Identities = 71/352 (20%), Positives = 121/352 (34%), Gaps = 94/352 (26%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            +++   LIG G++G V    ++      AIK++  + +D       K++ +EI +L  L
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC---KRILREIAILNRL 109

Query: 412 KHENIVQYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
            H+++V+             D LY+ LE        +  R     +TE  ++    ++L 
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLV 167

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           G+ Y+HS   +HRD+K AN LV+    VK+ DFG+A+ +       S            +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227

Query: 527 KAVMQKDGN---------------PKLAL-------AVDIWSLGCTVIEM---------- 554
                                   P+L L       A+D+WS+GC   E+          
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287

Query: 555 ------------------------------------------LTGKPP---WSEFEGPQA 569
                                                     + G P        E   A
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA 347

Query: 570 --MFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHPF 614
               ++  +       E     S++    L R  + NP +R +  E L HPF
Sbjct: 348 KRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  134 bits (340), Expect = 2e-35
 Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 39/285 (13%)

Query: 344 KPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 396
                  +S W       +  + IG+G FG V +G  R      A+K +       K+  
Sbjct: 6   AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCI-------KNDA 56

Query: 397 CIKQLEQEIKVLGHLKHENIVQYYGSEVV---DDHLYIYLEYVHPGSINRYVREHCRD-I 452
             +    E  V+  L+H N+VQ  G  V+      LYI  EY+  GS+  Y+R   R  +
Sbjct: 57  TAQAFLAEASVMTQLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 114

Query: 453 TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 512
               +  F+  +   + YL   N +HRD+   N+LV    V K++DFG+ K         
Sbjct: 115 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SST 170

Query: 513 SLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 569
              G  P  W APE +     ++   K +   D+WS G  + E+ + G+ P+        
Sbjct: 171 QDTGKLPVKWTAPEAL-----REK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 223

Query: 570 MFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           + +V    +    P+       + +  C+  +   RPS ++L E 
Sbjct: 224 VPRVEKGYKMDA-PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 267

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  135 bits (341), Expect = 2e-35
 Identities = 67/270 (24%), Positives = 111/270 (41%), Gaps = 28/270 (10%)

Query: 357 GKLIGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
            ++IGRG FG VY GT  +       CA+K    +       E + Q   E  ++    H
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 85

Query: 414 ENIVQYYGSEVV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
            N++   G  +    +    + L Y+  G +  ++R    + T   +  F   +  G+ Y
Sbjct: 86  PNVLSLLG--ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 143

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEV 525
           L S   +HRD+   N ++D    VK+ADFG+A+ +    Y      +       WMA E 
Sbjct: 144 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPE 582
           +     +    K     D+WS G  + E++T G PP+ +         +L   R    PE
Sbjct: 204 L-----QTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PE 255

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
                  + +L+C+      RPS  EL+  
Sbjct: 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  141 bits (356), Expect = 2e-35
 Identities = 77/358 (21%), Positives = 133/358 (37%), Gaps = 31/358 (8%)

Query: 271 SPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPK 330
             L      SS SN         P    +L    + +   N+               P  
Sbjct: 248 YCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRP 307

Query: 331 SSVTSAVMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNRETGASC--A 381
             + ++V       P     K       +       +G G FGSV  G  R        A
Sbjct: 308 MPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVA 367

Query: 382 IKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-LYIYLEYVHPGS 440
           IK   +     K+    +++ +E +++  L +  IV+  G  V     L + +E    G 
Sbjct: 368 IKV--LKQGTEKADT--EEMMREAQIMHQLDNPYIVRLIG--VCQAEALMLVMEMAGGGP 421

Query: 441 INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 500
           +++++     +I  S V      +  G+ YL   N +HR++   N+L+      K++DFG
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481

Query: 501 MAKHLTGLS--YELSLKG-SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 556
           ++K L      Y     G  P  W APE I          K +   D+WS G T+ E L+
Sbjct: 482 LSKALGADDSYYTARSAGKWPLKWYAPECIN-------FRKFSSRSDVWSYGVTMWEALS 534

Query: 557 -GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            G+ P+ + +GP+ M  +    R    P     E    +  C++    +RP  + + +
Sbjct: 535 YGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  136 bits (345), Expect = 3e-35
 Identities = 81/369 (21%), Positives = 132/369 (35%), Gaps = 47/369 (12%)

Query: 291 VYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSS-VTSAVMPHIMEKPSASP 349
            Y    H      + E L          L  P   LS  ++S + +   P+       S 
Sbjct: 3   YYHHHHHHDYDIPTTENL-YFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSS 61

Query: 350 KKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAEC 397
                          + +G G FG VY G      N  +    A+K +   P+     + 
Sbjct: 62  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQD- 117

Query: 398 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------ 451
                 E  ++    H+NIV+  G  +     +I LE +  G +  ++RE          
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177

Query: 452 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGL 508
           +    + +  R I  G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237

Query: 509 SYELSLKGSPN-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 562
            Y    KG        WM PE        +G        D WS G  + E+ + G  P+ 
Sbjct: 238 GYY--RKGGCAMLPVKWMPPEAF-----MEG--IFTSKTDTWSFGVLLWEIFSLGYMPYP 288

Query: 563 EFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNA 618
                + +  V    R  P P+         + +C+   P +RP+   +LE      ++ 
Sbjct: 289 SKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347

Query: 619 NYQNLSVPM 627
           +  N ++P+
Sbjct: 348 DVINTALPI 356

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  136 bits (344), Expect = 6e-35
 Identities = 73/333 (21%), Positives = 128/333 (38%), Gaps = 88/333 (26%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI 416
           K +G+G +G V+   +R TG   A+K++     +   A   ++  +EI +L  L  HENI
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA---QRTFREIMILTELSGHENI 71

Query: 417 VQYYGSEVV----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           V      V+    D  +Y+  +Y+    ++  +R     +     +     ++  + YLH
Sbjct: 72  VNLL--NVLRADNDRDVYLVFDYM-ETDLHAVIR--ANILEPVHKQYVVYQLIKVIKYLH 126

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------- 521
           S   +HRD+K +N+L++A   VK+ADFG+++    +    +                   
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186

Query: 522 -----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----------- 559
                      APE++    +          +D+WSLGC + E+L GKP           
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTK------GIDMWSLGCILGEILCGKPIFPGSSTMNQL 240

Query: 560 ---------PWSEF------EGPQAMFKVLNRTPPIPEM--------------------- 583
                    P +E          + M + L     I +                      
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
            + E  D L +    NP +R SA + L+HPF+ 
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (350), Expect = 6e-35
 Identities = 72/261 (27%), Positives = 120/261 (45%), Gaps = 22/261 (8%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
              +G+G FG V++GT   T    AIK   + P        +    QE +V+  L+HE +
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKT--LKPGTMSPEAFL----QEAQVMKKLRHEKL 324

Query: 417 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 475
           VQ Y   V ++ +YI  EY+  GS+  +++      +    + +    I +G+AY+   N
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKD 533
            +HRD++ AN+LV  + V K+ADFG+A+ +    Y        P  W APE         
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL------ 437

Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 590
              +  +  D+WS G  + E+ T G+ P+      + + +V    R P  P        D
Sbjct: 438 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHD 495

Query: 591 FLLRCFLRNPVERPSAVELLE 611
            + +C+ + P ERP+   L  
Sbjct: 496 LMCQCWRKEPEERPTFEYLQA 516

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  134 bits (339), Expect = 8e-35
 Identities = 73/322 (22%), Positives = 119/322 (36%), Gaps = 47/322 (14%)

Query: 324 GALSPPKSSVTSAVMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT---- 372
           G+   P     S +  HI+E P                     +G G FG V++      
Sbjct: 6   GSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65

Query: 373 -NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 431
              +     A+K +        S    +  ++E ++L  L+H++IV+++G       L +
Sbjct: 66  LPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120

Query: 432 YLEYVHPGSINRYVREHCRDITESIVRN--------------FTRHILNGLAYLHSTNTI 477
             EY+  G +NR++R H  D                          +  G+ YL   + +
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFV 180

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKAVMQK 532
           HRD+   N LV    VVK+ DFGM++ +    Y     G        WM PE I      
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESI-----L 233

Query: 533 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD 590
               K     D+WS G  + E+ T GK PW +    +A+  +        P     E   
Sbjct: 234 YR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYA 291

Query: 591 FLLRCFLRNPVERPSAVELLEH 612
            +  C+ R P +R S  ++   
Sbjct: 292 IMRGCWQREPQQRHSIKDVHAR 313

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  135 bits (342), Expect = 3e-34
 Identities = 65/322 (20%), Positives = 125/322 (38%), Gaps = 82/322 (25%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  +
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCV 118

Query: 412 KHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            H+NI+          +      +Y+ +E +   ++ + ++    ++    +      +L
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM---ELDHERMSYLLYQML 174

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM---- 521
            G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+            G+   M    
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----------GTSFMMTPYV 224

Query: 522 ------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP---------------- 559
                 APEVI               VDIWS+GC + EM+  K                 
Sbjct: 225 VTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277

Query: 560 ----PWSEF-----EGPQAMFKVLNRTPPIP-----------------EMLSSEGKDFLL 593
               P  EF        +   +   +   +                  ++ +S+ +D L 
Sbjct: 278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 337

Query: 594 RCFLRNPVERPSAVELLEHPFI 615
           +  + +P +R S  + L+HP+I
Sbjct: 338 KMLVIDPAKRISVDDALQHPYI 359

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  131 bits (331), Expect = 7e-34
 Identities = 66/271 (24%), Positives = 116/271 (42%), Gaps = 29/271 (10%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
           G+++G G    V++  +       A+K +    D  +      +  +E +    L H  I
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 417 VQYY--GSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           V  Y  G          Y+  EYV   ++   V      +T              L + H
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH 133

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL----SLKGSPNWMAPEVIKA 528
               IHRD+K AN+++ A+  VK+ DFG+A+ +      +    ++ G+  +++PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE---- 189

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM---FKVLNRTPPIP---- 581
             Q  G+   A   D++SLGC + E+LTG+PP   F G   +   ++ +   P  P    
Sbjct: 190 --QARGDSVDA-RSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPSARH 243

Query: 582 EMLSSEGKDFLLRCFLRNPVERP-SAVELLE 611
           E LS++    +L+   +NP  R  +A E+  
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRA 274

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  134 bits (338), Expect = 8e-34
 Identities = 75/347 (21%), Positives = 128/347 (36%), Gaps = 98/347 (28%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
            LIGRG++G VY+  ++ T  + AIK+V+ + +D       K++ +EI +L  LK + I+
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILREITILNRLKSDYII 88

Query: 418 QYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           + Y        +  D LYI LE      + +  +     +TE  ++    ++L G  ++H
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH 146

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMA-------------KHLTGLSYELSLKGSPN 519
            +  IHRD+K AN L++    VK+ DFG+A                         K    
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206

Query: 520 WM----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE------ 563
            +          APE+I              ++DIWS GC   E+L              
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTK------SIDIWSTGCIFAELLNMLQSHINDPTNRF 260

Query: 564 --FEGPQAMFKV----------------LNR------TPPIPEMLS-------------- 585
             F G                       LN       TP   ++ +              
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP 320

Query: 586 -SEGKDF-------------LLRCFLR-NPVERPSAVELLEHPFIRN 617
             +  +              LL   L+ NP +R +  + L+HP++++
Sbjct: 321 HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  130 bits (330), Expect = 1e-33
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 38/295 (12%)

Query: 357 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            + +G G FG VY G      N  +    A+K +   P+     +       E  ++   
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQD-ELDFLMEALIISKF 90

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------ITESIVRNFTRHIL 465
            H+NIV+  G  +     +I +E +  G +  ++RE          +    + +  R I 
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGSPN--- 519
            G  YL   + IHRDI   N L+   G   V K+ DFGMA+ +   SY    KG      
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY--RKGGCAMLP 208

Query: 520 --WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-- 574
             WM PE        +G        D WS G  + E+ + G  P+      + +  V   
Sbjct: 209 VKWMPPEAF-----MEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261

Query: 575 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQNLSVPM 627
            R  P P+         + +C+   P +RP+   +LE      ++ +  N ++P+
Sbjct: 262 GRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPI 315

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  130 bits (329), Expect = 1e-33
 Identities = 70/324 (21%), Positives = 127/324 (39%), Gaps = 41/324 (12%)

Query: 308 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 367
           + S++H + H   L P      ++ +   V+             +    GK++G G FGS
Sbjct: 1   MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDR-----------NLLILGKILGEGEFGS 49

Query: 368 VYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG--- 421
           V  G       T    A+K +     D  S   I++   E   +    H N+++  G   
Sbjct: 50  VMEGNLKQEDGTSLKVAVKTM---KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106

Query: 422 --SEVVDDHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHST 474
             S        + L ++  G ++ Y+         + I    +  F   I  G+ YL + 
Sbjct: 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR 166

Query: 475 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWMAPEVIKAVMQ 531
           N +HRD+   N ++     V +ADFG++K +    Y    + +  P  W+A E +     
Sbjct: 167 NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL----- 221

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEG 588
            D         D+W+ G T+ E+ T G  P+   +  +    +L+  R    PE    E 
Sbjct: 222 ADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ-PEDCLDEL 278

Query: 589 KDFLLRCFLRNPVERPSAVELLEH 612
            + +  C+  +P++RP+   L   
Sbjct: 279 YEIMYSCWRTDPLDRPTFSVLRLQ 302

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  130 bits (328), Expect = 2e-33
 Identities = 59/275 (21%), Positives = 116/275 (42%), Gaps = 29/275 (10%)

Query: 357 GKLIGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           G+++G+G FGSV     ++   S    A+K +     D  ++  I++  +E   +    H
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML---KADIIASSDIEEFLREAACMKEFDH 84

Query: 414 ENIVQYYG------SEVVDDHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTR 462
            ++ +  G      ++       + L ++  G ++ ++          ++    +  F  
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-N 519
            I  G+ YL S N IHRD+   N ++     V +ADFG+++ +    Y      S  P  
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RT 577
           W+A E +      D      +  D+W+ G T+ E++T G+ P++  E  +    ++    
Sbjct: 205 WLALESL-----ADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257

Query: 578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
              P     E  D + +C+  +P +RPS   L   
Sbjct: 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  127 bits (321), Expect = 2e-32
 Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 30/275 (10%)

Query: 357 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            + +G+G+FG VY G        E     AIK    + +     E   +   E  V+   
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRE-RIEFLNEASVMKEF 85

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN---------FTR 462
              ++V+  G         + +E +  G +  Y+R     +  + V              
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 463 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-N 519
            I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y         P  
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-T 577
           WM+PE +     KDG        D+WS G  + E+ T  + P+      Q +  V+    
Sbjct: 206 WMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258

Query: 578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
              P+       + +  C+  NP  RPS +E++  
Sbjct: 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  125 bits (317), Expect = 3e-32
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 45/284 (15%)

Query: 357 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            + +G G FG V++         +     A+K    + D   +A   K  ++E ++L +L
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVK---ALKDPTLAAR--KDFQREAELLTNL 74

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 459
           +HE+IV++YG     D L +  EY+  G +N+++R H  D    +               
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 460 ---FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY------ 510
                  I +G+ YL S + +HRD+   N LV A+ +VK+ DFGM++ +    Y      
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 511 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ 568
             L ++    WM PE I          K     D+WS G  + E+ T GK PW +    +
Sbjct: 195 TMLPIR----WMPPESI-----MYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243

Query: 569 AMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
            +  +   R    P +   E  D +L C+ R P +R +  E+ +
Sbjct: 244 VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  123 bits (312), Expect = 2e-31
 Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 49/305 (16%)

Query: 345 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDP 392
           P+  P   +W         GK +G G FG V   T       +   + A+K   ++    
Sbjct: 9   PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSA 65

Query: 393 KSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD 451
              E  + L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R     
Sbjct: 66  HLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124

Query: 452 ITESIVRN-----------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 494
              S                     F+  +  G+A+L S N IHRD+   N+L+    + 
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184

Query: 495 KLADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 551
           K+ DFG+A+ +    +Y +      P  WMAPE I      +         D+WS G  +
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-----FNC--VYTFESDVWSYGIFL 237

Query: 552 IEMLT-GKPPWSEFEGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 607
            E+ + G  P+         +K++    R    PE   +E  D +  C+  +P++RP+  
Sbjct: 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKRPTFK 296

Query: 608 ELLEH 612
           ++++ 
Sbjct: 297 QIVQL 301

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  122 bits (308), Expect = 5e-31
 Identities = 61/282 (21%), Positives = 104/282 (36%), Gaps = 38/282 (13%)

Query: 357 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            + +G   FG VY G        E   + AIK    + D  +     +    E  +   L
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPLREE-FRHEAMLRARL 69

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 459
           +H N+V   G    D  L +   Y   G ++ ++             +            
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 460 ---FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK 515
                  I  G+ YL S + +H+D+   N+LV     VK++D G+ + +     Y+L   
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 516 GS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
              P  WMAPE I       G  K ++  DIWS G  + E+ + G  P+  +     +  
Sbjct: 190 SLLPIRWMAPEAI-----MYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242

Query: 573 VLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           + N    P  P+   +     ++ C+   P  RP   ++   
Sbjct: 243 IRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  121 bits (307), Expect = 1e-30
 Identities = 69/305 (22%), Positives = 124/305 (40%), Gaps = 53/305 (17%)

Query: 349 PKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAE 396
            +  +W         GK +G G FG V   T      R    + A+K   ++ ++   +E
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSE 69

Query: 397 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 456
            ++ L  E  VL  + H ++++ YG+   D  L + +EY   GS+  ++RE  +     +
Sbjct: 70  -LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128

Query: 457 VRN-----------------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 493
                                     F   I  G+ YL     +HRD+   N+LV     
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188

Query: 494 VKLADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 550
           +K++DFG+++ +    SY    +G  P  WMA E +      D         D+WS G  
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL-----FDH--IYTTQSDVWSFGVL 241

Query: 551 VIEMLT-GKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 607
           + E++T G  P+      +    +   +R    P+  S E    +L+C+ + P +RP   
Sbjct: 242 LWEIVTLGGNPYPGIPPERLFNLLKTGHRMER-PDNCSEEMYRLMLQCWKQEPDKRPVFA 300

Query: 608 ELLEH 612
           ++ + 
Sbjct: 301 DISKD 305

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  121 bits (306), Expect = 2e-30
 Identities = 78/319 (24%), Positives = 131/319 (41%), Gaps = 51/319 (15%)

Query: 349 PKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDDPKS 394
           P+  +W         GK +G G FG V +           +   + A+K   ++ DD   
Sbjct: 25  PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATE 81

Query: 395 AECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 453
            + +  L  E++++  + KH+NI+   G+   D  LY+ +EY   G++  Y+R       
Sbjct: 82  KD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140

Query: 454 ESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 498
           E                     T  +  G+ YL S   IHRD+   N+LV  + V+K+AD
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200

Query: 499 FGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 555
           FG+A+ +     Y+ +  G  P  WMAPE +      D         D+WS G  + E+ 
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEAL-----FDR--VYTHQSDVWSFGVLMWEIF 253

Query: 556 T-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH- 612
           T G  P+      +    +        P   ++E    +  C+   P +RP+  +L+E  
Sbjct: 254 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

Query: 613 ----PFIRNANYQNLSVPM 627
                   N  Y +LS P+
Sbjct: 314 DRILTLTTNEEYLDLSQPL 332

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  121 bits (305), Expect = 3e-30
 Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 53/305 (17%)

Query: 345 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDP 392
           P+  P   +W       Q GK +G G FG V   T       +     A+K   ++    
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTA 88

Query: 393 KSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD 451
            + E  + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R   R 
Sbjct: 89  HADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147

Query: 452 ITESIVRNFTRHILN-------------GLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 498
           +             +             G+A+L S N IHRD+   N+L+    V K+ D
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207

Query: 499 FGMAKHLTGLSY-------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 551
           FG+A+ +   S         L +K    WMAPE I      D      +  D+WS G  +
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVK----WMAPESI-----FDC--VYTVQSDVWSYGILL 256

Query: 552 IEMLT-GKPPWSEFEGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 607
            E+ + G  P+         +K++    +    P          +  C+   P  RP+  
Sbjct: 257 WEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACWALEPTHRPTFQ 315

Query: 608 ELLEH 612
           ++   
Sbjct: 316 QICSF 320

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  120 bits (303), Expect = 4e-30
 Identities = 76/314 (24%), Positives = 126/314 (40%), Gaps = 55/314 (17%)

Query: 337 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKE 384
           +  H    P      S+W       + GK +GRG FG V            T  + A+K 
Sbjct: 8   LDEHCERLP---YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 64

Query: 385 VDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV---DDHLYIYLEYVHPGS 440
           +    +    +E  + L  E+K+L H+  H N+V   G          L + +E+   G+
Sbjct: 65  L---KEGATHSE-HRALMSELKILIHIGHHLNVVNLLG--ACTKPGGPLMVIVEFCKFGN 118

Query: 441 INRYVREHCRDITESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGAN 485
           ++ Y+R    +     V                 ++  +  G+ +L S   IHRD+   N
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178

Query: 486 LLVDASGVVKLADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAV 542
           +L+    VVK+ DFG+A+ +     Y        P  WMAPE I      D      +  
Sbjct: 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-----FDR--VYTIQS 231

Query: 543 DIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLR 598
           D+WS G  + E+ + G  P+   +  +   + L    R    P+  + E    +L C+  
Sbjct: 232 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHG 290

Query: 599 NPVERPSAVELLEH 612
            P +RP+  EL+EH
Sbjct: 291 EPSQRPTFSELVEH 304

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  125 bits (315), Expect = 6e-30
 Identities = 58/260 (22%), Positives = 94/260 (36%), Gaps = 32/260 (12%)

Query: 359 LIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
            I  G  G +Y+       G    +K           AE       E + L  + H +IV
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLK----GLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 418 QYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           Q +          D   YI +EYV   S+ R   +    +  +    +   IL  L+YLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH 199

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
           S   ++ D+K  N+++     +KL D G    +        L G+P + APE        
Sbjct: 200 SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFG---YLYGTPGFQAPE------IV 249

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 592
              P   +A DI+++G T+  +    P      G       L    P+ +         L
Sbjct: 250 RTGP--TVATDIYTVGRTLAALTLDLPT---RNGRYV--DGLPEDDPVLK-TYDSYGRLL 301

Query: 593 LRCFLRNPVERP-SAVELLE 611
            R    +P +R  +A E+  
Sbjct: 302 RRAIDPDPRQRFTTAEEMSA 321

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  120 bits (303), Expect = 1e-29
 Identities = 82/362 (22%), Positives = 144/362 (39%), Gaps = 50/362 (13%)

Query: 286 RSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKP 345
           + P  V+   +   L +      ES++ +N+   PL         ++ T  +        
Sbjct: 12  QDPPAVHKLTKRIPLRRQVTVSAESSSSMNS-NTPLVRITTRLSSTADTPMLAG---VSE 67

Query: 346 SASPKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDD 391
              P+  +W         GK +G G FG V +           +   + A+K   ++ DD
Sbjct: 68  YELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDD 124

Query: 392 PKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR 450
               + +  L  E++++  + KH+NI+   G+   D  LY+ +EY   G++  Y+R    
Sbjct: 125 ATEKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183

Query: 451 DITESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 495
              E                     T  +  G+ YL S   IHRD+   N+LV  + V+K
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 243

Query: 496 LADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 552
           +ADFG+A+ +     Y+ +  G  P  WMAPE +      D         D+WS G  + 
Sbjct: 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-----FDR--VYTHQSDVWSFGVLMW 296

Query: 553 EMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 610
           E+ T G  P+      +    +        P   ++E    +  C+   P +RP+  +L+
Sbjct: 297 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356

Query: 611 EH 612
           E 
Sbjct: 357 ED 358

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  118 bits (299), Expect = 2e-29
 Identities = 71/307 (23%), Positives = 120/307 (39%), Gaps = 52/307 (16%)

Query: 357 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           GK++G G FG V   T             A+K +    +   S+E  + L  E+K++  L
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSE-REALMSELKMMTQL 105

Query: 412 -KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR------------ 458
             HENIV   G+  +   +Y+  EY   G +  Y+R      +E  +             
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 459 ----------NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 508
                      F   +  G+ +L   + +HRD+   N+LV    VVK+ DFG+A+ +   
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 509 SYELSLKGSP---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 564
           S  +    +     WMAPE +      +G     +  D+WS G  + E+ + G  P+   
Sbjct: 226 SNYVVRGNARLPVKWMAPESL-----FEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGI 278

Query: 565 EGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH-----PFIR 616
                 +K++    +    P   + E    +  C+  +  +RPS   L            
Sbjct: 279 PVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337

Query: 617 NANYQNL 623
            A YQN+
Sbjct: 338 EAMYQNV 344

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  118 bits (298), Expect = 2e-29
 Identities = 70/296 (23%), Positives = 114/296 (38%), Gaps = 40/296 (13%)

Query: 357 GKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KH 413
             +IG G FG V     ++ G     AIK    + +     +  +    E++VL  L  H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDD-HRDFAGELEVLCKLGHH 85

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN-------------- 459
            NI+   G+     +LY+ +EY   G++  ++R+     T+                   
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 460 -FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS- 517
            F   +  G+ YL     IHRD+   N+LV  + V K+ADFG+++      Y     G  
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203

Query: 518 P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL- 574
           P  WMA E +                D+WS G  + E+++ G  P+      +   K+  
Sbjct: 204 PVRWMAIESL-----NYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256

Query: 575 -NRTPPIPEMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANYQNLSVP 626
             R    P     E  D + +C+   P ERPS    +  L         Y N ++ 
Sbjct: 257 GYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 311

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  118 bits (298), Expect = 5e-29
 Identities = 68/361 (18%), Positives = 122/361 (33%), Gaps = 124/361 (34%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK----- 412
           + +G G F +V++  +       A+K   I+  D    E     E EIK+L  +      
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTE---AAEDEIKLLQRVNDADNT 78

Query: 413 ------HENIVQYYGS---------------EVVDDHLYIYLEYVHPGSINRYVREHCRD 451
                   +I++                   EV+ ++L   ++         +       
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK------YEHRG----- 127

Query: 452 ITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDAS------GVVKLADFGMAKH 504
           I    V+  ++ +L GL Y+H     IH DIK  N+L++          +K+AD G A  
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187

Query: 505 LTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLTGKP 559
                +  +    +  + +PEV+           L        DIWS  C + E++TG  
Sbjct: 188 YDEHYTNSIQ---TREYRSPEVL-----------LGAPWGCGADIWSTACLIFELITGDF 233

Query: 560 PWSEFEG-----------------------PQAMFKVLNRT------------------P 578
               FE                        P  + +    T                   
Sbjct: 234 L---FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290

Query: 579 PIPEMLSSEGK----------DFLLRCFLRNPVERPSAVELLEHPFIRNA-NYQNLSVPM 627
           P+ ++L+ + K          DFL      +P +R  A  L+ HP++++    + + VP 
Sbjct: 291 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 350

Query: 628 R 628
           R
Sbjct: 351 R 351

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  118 bits (297), Expect = 8e-29
 Identities = 71/300 (23%), Positives = 121/300 (40%), Gaps = 48/300 (16%)

Query: 349 PKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDDPKS 394
           P+  +W         GK +G G FG V +                 A+K   ++  D   
Sbjct: 59  PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATE 115

Query: 395 AECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 453
            + +  L  E++++  + KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 116 KD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174

Query: 454 ESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 498
           E                        +  G+ YL S   IHRD+   N+LV    V+K+AD
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234

Query: 499 FGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 555
           FG+A+ +     Y+ +  G  P  WMAPE +      D         D+WS G  + E+ 
Sbjct: 235 FGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDR--IYTHQSDVWSFGVLLWEIF 287

Query: 556 T-GKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           T G  P+      +    +   +R    P   ++E    +  C+   P +RP+  +L+E 
Sbjct: 288 TLGGSPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  117 bits (295), Expect = 8e-29
 Identities = 60/293 (20%), Positives = 113/293 (38%), Gaps = 52/293 (17%)

Query: 357 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            + IG G FG V+          E     A+K   ++ ++  +       ++E  ++   
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADM-QADFQREAALMAEF 107

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 459
            + NIV+  G   V   + +  EY+  G +N ++R        S+  +            
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 460 -----------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 508
                        R +  G+AYL     +HRD+   N LV  + VVK+ADFG+++++   
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 509 SY-------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 560
            Y        + ++    WM PE I          +     D+W+ G  + E+ + G  P
Sbjct: 228 DYYKADGNDAIPIR----WMPPESI-----FYN--RYTTESDVWAYGVVLWEIFSYGLQP 276

Query: 561 WSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +      + ++ V +      PE    E  + +  C+ + P +RPS   +   
Sbjct: 277 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  115 bits (291), Expect = 9e-28
 Identities = 69/334 (20%), Positives = 122/334 (36%), Gaps = 98/334 (29%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 414
           K+IG+G+FG V    + +     A+K   ++ ++ +     +Q  +EI++L HL+ +   
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK---MVRNEKRFH---RQAAEEIRILEHLRKQDKD 156

Query: 415 ---NIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 468
              N++    +    +H+ +  E +   S+N Y    +   +  +  +VR F   IL  L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213

Query: 469 AYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEV 525
             LH    IH D+K  N+L+       +K+ DFG + +    +   +    S  + APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ---SRFYRAPEV 270

Query: 526 IKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLTG---------------------KPP 560
           I           L       +D+WSLGC + E+LTG                      P 
Sbjct: 271 I-----------LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319

Query: 561 WS----------EFEGPQAMFKVLNRTPPIPEMLSSEGK--------------------- 589
                                     T     ++ + G+                     
Sbjct: 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379

Query: 590 -------DFLLRCFLRNPVERPSAVELLEHPFIR 616
                  DFL +C   +P  R +  + L HP++R
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  108 bits (271), Expect = 1e-25
 Identities = 74/346 (21%), Positives = 109/346 (31%), Gaps = 119/346 (34%)

Query: 358 KLIGRGTFGSVYIGTNRETGA-SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE-- 414
             +G G FG V    + + G    A+K   I+ +  +  E       EI+VL HL     
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVK---IVKNVDRYCE---AARSEIQVLEHLNTTDP 73

Query: 415 ----NIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHC-RDITESIVRNFTRHILNG 467
                 VQ         H+ I  E +    ++ Y  ++E+         +R     I   
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130

Query: 468 LAYLHSTNTIHRDIKGAN-LLVDASGV------------------VKLADFGMA-----K 503
           + +LHS    H D+K  N L V +                     +K+ DFG A      
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190

Query: 504 HLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLT 556
           H T +S   Y           APEVI           LAL      D+WS+GC +IE   
Sbjct: 191 HSTLVSTRHYR----------APEVI-----------LALGWSQPCDVWSIGCILIEYYL 229

Query: 557 GKP----------------------------------------PWSEFEGPQAMFKVLNR 576
           G                                           W E     A   V   
Sbjct: 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDE--HSSAGRYVSRA 287

Query: 577 TPPIPEMLSSEGK------DFLLRCFLRNPVERPSAVELLEHPFIR 616
             P+ E + S+        D + +    +P +R +  E L+HPF  
Sbjct: 288 CKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  108 bits (271), Expect = 1e-25
 Identities = 73/357 (20%), Positives = 114/357 (31%), Gaps = 137/357 (38%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 414
           + +G GTFG V +  + +     A+K   ++ +  K        + E  +L  ++++   
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVK---VVRNIKKYTR---SAKIEADILKKIQNDDIN 94

Query: 415 --NIVQYYGS-----------EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 461
             NIV+Y+G            E +   LY  +        N Y            ++ + 
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR------NNYNG-----FHIEDIKLYC 143

Query: 462 RHILNGLAYLHSTNTIHRDIKGAN-LLVDASGV------------------------VKL 496
             IL  L YL   +  H D+K  N LL D                            +KL
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 497 ADFGMA-----KHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDI 544
            DFG A      H + ++   Y           APEVI           L L    + D+
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYR----------APEVI-----------LNLGWDVSSDM 242

Query: 545 WSLGCTVIEMLTGKP--------------------------------------------- 559
           WS GC + E+ TG                                               
Sbjct: 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKL 302

Query: 560 PWSEFEGPQAMFKVLNRTPPIPEMLSSEG-KDFLLRCFLRNPVERPSAVELLEHPFI 615
            W E        K + +  P+ +++  E   DFL      +P  RPS  ELL+H F+
Sbjct: 303 AWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  102 bits (255), Expect = 4e-24
 Identities = 26/255 (10%), Positives = 56/255 (21%), Gaps = 45/255 (17%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
             G       +   +       A+  VD  P      + +++       L  +    + +
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVD--PQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 419 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 478
                       +  E++  GS+           +        + +       H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVAL 152

Query: 479 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 538
                + + V   G V LA                                         
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMPDANPQD----------------------------- 183

Query: 539 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD-------F 591
               DI  +G ++  +L  + P  E      +      T   P   +   +D        
Sbjct: 184 ----DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239

Query: 592 LLRCFLRNPVERPSA 606
             R    +   R ++
Sbjct: 240 AARSVQGDGGIRSAS 254

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  102 bits (255), Expect = 1e-23
 Identities = 70/345 (20%), Positives = 108/345 (31%), Gaps = 115/345 (33%)

Query: 358 KLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE-- 414
             +G GTFG V    +   G +  A+K   II +  K     +    EI VL  +K +  
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALK---IIRNVGKYR---EAARLEINVLKKIKEKDK 78

Query: 415 ----NIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHC-RDITESIVRNFTRHILNG 467
                 V          H+ I  E +     N +  ++E+  +      VR+    + + 
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135

Query: 468 LAYLHSTNTIHRDIKGAN-LLVDASGV------------------VKLADFGMA-----K 503
           L +LH     H D+K  N L V++                     +++ADFG A      
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195

Query: 504 HLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLT 556
           H T ++   Y            PEVI           L L      D+WS+GC + E   
Sbjct: 196 HTTIVATRHYR----------PPEVI-----------LELGWAQPCDVWSIGCILFEYYR 234

Query: 557 GKPPW---SEFE---------G--PQAMFK------------------------VLNRTP 578
           G   +      E         G  P  M                          V     
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294

Query: 579 PIPEMLSSEGK------DFLLRCFLRNPVERPSAVELLEHPFIRN 617
           P+   +  +        D + R    +P +R +  E L HPF   
Sbjct: 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  102 bits (255), Expect = 2e-23
 Identities = 68/340 (20%), Positives = 112/340 (32%), Gaps = 103/340 (30%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 414
            LIG+G+FG V    +R      AIK   II +         Q + E+++L  +      
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAFL---NQAQIEVRLLELMNKHDTE 113

Query: 415 ---NIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 468
               IV      +  +HL +  E +   S N Y      + R ++ ++ R F + +   L
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170

Query: 469 AYLHST--NTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
            +L +   + IH D+K  N+L+       +K+ DFG +  L    Y      S  + +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQSRFYRSPE 228

Query: 525 VIKAVMQKDGNPKLAL----AVDIWSLGCTV---------------------IEMLTGKP 559
           V+           L +    A+D+WSLGC +                     I  + G P
Sbjct: 229 VL-----------LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

Query: 560 P---------------------WSEFEGPQ-------------AMFKVLNRTPPIPEMLS 585
           P                     W+  +                     +    P      
Sbjct: 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337

Query: 586 SEGK---------DFLLRCFLRNPVERPSAVELLEHPFIR 616
             G          D +LR    +P  R      L+H F +
Sbjct: 338 ESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =   99 bits (250), Expect = 4e-23
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 45/221 (20%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           LIG G FG VY G  R+ GA  A+K        P+S++ I++ E EI+ L   +H ++V 
Sbjct: 46  LIGHGVFGKVYKGVLRD-GAKVALKRRT-----PESSQGIEEFETEIETLSFCRHPHLVS 99

Query: 419 YYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN----------- 466
             G     +  + IY +Y+  G+    ++ H          +     ++           
Sbjct: 100 LIGFCDERNEMILIY-KYMENGN----LKRHLYG------SDLPTMSMSWEQRLEICIGA 148

Query: 467 --GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-----LKGSPN 519
             GL YLH+   IHRD+K  N+L+D + V K+ DFG++K   G   + +     +KG+  
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLSTVVKGTLG 206

Query: 520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 560
           ++ PE            +L    D++S G  + E+L  +  
Sbjct: 207 YIDPEYFI-------KGRLTEKSDVYSFGVVLFEVLCARSA 240

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 99.2 bits (248), Expect = 7e-23
 Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 48/292 (16%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           +     G  +G G FG VY G    T  + A+K++     D  + E  +Q +QEIKV+  
Sbjct: 30  RPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAA-MVDITTEELKQQFDQEIKVMAK 86

Query: 411 LKHENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRN-FTRH----- 463
            +HEN+V+  G     D    +Y  Y+  GS    + +    +  +   +   R      
Sbjct: 87  CQHENLVELLGFSSDGDDLCLVY-VYMPNGS----LLDRLSCLDGTPPLSWHMRCKIAQG 141

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-----LKGSP 518
             NG+ +LH  + IHRDIK AN+L+D +   K++DFG+A+      +  +     + G+ 
Sbjct: 142 AANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQTVMTSRIVGTT 199

Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF----KVL 574
            +MAPE ++      G  ++    DI+S G  ++E++TG P   E   PQ +     ++ 
Sbjct: 200 AYMAPEALR------G--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251

Query: 575 NRTPPIPEMLSSEGKDFL-----------LRCFLRNPVERPS---AVELLEH 612
           +    I + +  +  D              +C      +RP      +LL+ 
Sbjct: 252 DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 35/225 (15%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++ G+ IG G+FG +Y+GT+   G   AIK       +    +   QL  E K+   ++
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK------LECVKTKH-PQLHIESKIYKMMQ 62

Query: 413 H-ENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
               I  +++ G+E   D+  + +E + P S+        R  +   V      +++ + 
Sbjct: 63  GGVGIPTIRWCGAE--GDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIE 119

Query: 470 YLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL--------SLKGSP 518
           Y+HS N IHRD+K  N L+       +V + DFG+AK                 +L G+ 
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179

Query: 519 NWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 561
            + +      + Q  +D         D+ SLG  ++    G  PW
Sbjct: 180 RYASINTHLGIEQSRRD---------DLESLGYVLMYFNLGSLPW 215

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 89.3 bits (222), Expect = 9e-20
 Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 37/227 (16%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
            ++ G+ IG G+FG ++ GTN       AIK       +P+ ++   QL  E +    L 
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK------FEPRRSDA-PQLRDEYRTYKLLA 63

Query: 413 H-ENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
               I  V Y+G E    H  + ++ + P S+   +    R  +   V    + +L  + 
Sbjct: 64  GCTGIPNVYYFGQE--GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120

Query: 470 YLHSTNTIHRDIKGANLLVDASG-----VVKLADFGMAK----HLTG--LSYE--LSLKG 516
            +H  + ++RDIK  N L+         ++ + DFGM K     +T   + Y    +L G
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180

Query: 517 SPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 561
           +  +M+        Q  +D         D+ +LG   +  L G  PW
Sbjct: 181 TARYMSINTHLGREQSRRD---------DLEALGHVFMYFLRGSLPW 218

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 39/228 (17%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIK-EVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            ++ GK IG G FG + +G N  T    AIK E       P  +    QL  E +    L
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE-------PMKSRA-PQLHLEYRFYKQL 61

Query: 412 KH-ENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
              + I  V Y+G      +  + LE + P S+        R  +   V      +++ +
Sbjct: 62  GSGDGIPQVYYFGPC--GKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRM 118

Query: 469 AYLHSTNTIHRDIKGANLLVDASG-----VVKLADFGMAK----HLTGLSYE----LSLK 515
            Y+HS N I+RD+K  N L+   G     V+ + DF +AK      T          SL 
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178

Query: 516 GSPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 561
           G+  +M+        Q  +D         D+ +LG   +  L G  PW
Sbjct: 179 GTARYMSINTHLGKEQSRRD---------DLEALGHMFMYFLRGSLPW 217

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 52/300 (17%), Positives = 89/300 (29%), Gaps = 86/300 (28%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
            +QW  GK IG G FG +Y+          A     ++  + +       L  E+K    
Sbjct: 36  GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH---VVKVEYQEN---GPLFSELKFYQR 89

Query: 411 LKHENIVQYYGSEVVDDHLYI-YLEY--VHPGSINRY--------------VREHCRDIT 453
           +  ++ ++ +      D+L I       +       Y              +        
Sbjct: 90  VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFK 149

Query: 454 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAKH------- 504
           +S V      +L+ L Y+H    +H DIK ANLL+       V LAD+G++         
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

Query: 505 ----------LTG----------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 544
                       G              LS +                           D+
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRS--------------------------DV 243

Query: 545 WSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRN--PVE 602
             LG  ++  L GK PW +        +   +T  + E+        +L+         E
Sbjct: 244 EILGYCMLRWLCGKLPWEQNLKDPVAVQTA-KTNLLDEL-----PQSVLKWAPSGSSCCE 297

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 26/213 (12%)

Query: 359 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 418
           ++GRG FG VY G     G   A+K +     + ++     Q + E++++    H N+++
Sbjct: 37  ILGRGGFGKVYKGR-LADGTLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLLR 91

Query: 419 YYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH-----ILNGLAYLH 472
             G  +     L +Y  Y+  GS+   +RE      +  +    R         GLAYLH
Sbjct: 92  LRGFCMTPTERLLVY-PYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLH 148

Query: 473 ---STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIK 527
                  IHRD+K AN+L+D      + DFG+AK +      ++  ++G+   +APE + 
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 208

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 560
                 G  K +   D++  G  ++E++TG+  
Sbjct: 209 T-----G--KSSEKTDVFGYGVMLLELITGQRA 234

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 83.9 bits (207), Expect = 4e-17
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 35/225 (15%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++ G+ IG G+FG +Y+GTN +T    AIK  ++    P       QL  E K+   L+
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRILQ 60

Query: 413 -HENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
               I  V+++G E   D+  + ++ + P S+        R ++   V      ++N + 
Sbjct: 61  GGTGIPNVRWFGVE--GDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVE 117

Query: 470 YLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL--------SLKGSP 518
           ++HS + +HRDIK  N L+     +  V + DFG+AK     S           +L G+ 
Sbjct: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177

Query: 519 NWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 561
            + +      + Q  +D         D+ SLG  ++  L G  PW
Sbjct: 178 RYASVNTHLGIEQSRRD---------DLESLGYVLMYFLRGSLPW 213

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 82.3 bits (203), Expect = 6e-17
 Identities = 43/185 (23%), Positives = 77/185 (41%), Gaps = 15/185 (8%)

Query: 435 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 494
                        +   +T   +  ++  +  G+ +L S   IHRD+   N+L+    VV
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232

Query: 495 KLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 551
           K+ DFG+A+ +      +    +     WMAPE I        +    +  D+WS G  +
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLL 285

Query: 552 IEMLT-GKPPWSEFEGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 607
            E+ + G  P+   +  +   + L    R    P+  + E    +L C+   P +RP+  
Sbjct: 286 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFS 344

Query: 608 ELLEH 612
           EL+EH
Sbjct: 345 ELVEH 349

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 16/162 (9%)

Query: 357 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           GK +GRG FG V            T  + A+K +    +    +E  + L  E+K+L H+
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSE-HRALMSELKILIHI 82

Query: 412 -KHENIVQYYG-SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
             H N+V   G        L + +E+   G+++ Y+R    +      +        G  
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGA--RFRQGKD 140

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 511
           Y+     I  D+K     + +S     + F   K L+ +  E
Sbjct: 141 YV---GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 46/242 (19%), Positives = 85/242 (35%), Gaps = 45/242 (18%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
            + W+ G  IG+G FG +Y+  +  +  S       ++  +P        L  E+K    
Sbjct: 34  AAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQR 89

Query: 411 LKHENIVQ-----------------YYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRD 451
                 +Q                   G    +   Y ++  +      + +    + + 
Sbjct: 90  AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKR 148

Query: 452 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAK----HL 505
            +   V   +  IL+ L Y+H    +H DIK +NLL++      V L D+G+A       
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

Query: 506 TGLSYEL----SLKGSPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKP 559
              +Y         G+  + + +    V    +          D+  LG  +I+ LTG  
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRG---------DLEILGYCMIQWLTGHL 259

Query: 560 PW 561
           PW
Sbjct: 260 PW 261

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 79.6 bits (196), Expect = 7e-16
 Identities = 56/362 (15%), Positives = 108/362 (29%), Gaps = 109/362 (30%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK----- 412
           + +G G F +V++  + +     A+K   ++       E       EI++L  ++     
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTE---TALDEIRLLKSVRNSDPN 96

Query: 413 ---HENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHI 464
               E +VQ      +      H+ +  E +    + +++ + + + +    V+   + +
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 465 LNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADF-------GMAKHLTGLSYELSLKG 516
           L GL YLH+    IH DIK  N+L+  +                        S   +   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 517 SPNWMAPEVIKAVMQKDGNPKLA---------------------------------LAVD 543
           +        ++    +    K+A                                    D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275

Query: 544 IWSLGCTVIEMLTGKPPWSEFEG------------------------------------- 566
           IWS  C   E+ TG   +    G                                     
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335

Query: 567 -----------PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
                      P  +F+VL       +  ++   DFLL      P +R +A E L HP++
Sbjct: 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395

Query: 616 RN 617
            +
Sbjct: 396 NS 397

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 74.5 bits (182), Expect = 2e-14
 Identities = 59/334 (17%), Positives = 102/334 (30%), Gaps = 77/334 (23%)

Query: 346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-- 403
           S      + Q+ + IG G FG V+      T    AIK + I   D  +    K  E+  
Sbjct: 14  SHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPV--AIKIIAIEGPDLVNGSHQKTFEEIL 71

Query: 404 -EIKVLGHL---------KHENIVQYYGSEVV---------------------------- 425
            EI +   L         + E  +       V                            
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 426 --DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIK 482
             DD L+I LE+   G     +R     +     ++    +   LA   ++    HRD+ 
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAEASLRFEHRDLH 189

Query: 483 GANLLVDASGVVKLADFGMAKHLT----GLSYEL--------SLKGSPNWMAPEVIKAVM 530
             N+L+  + + KL      K  T    GL   +           G   +    + + + 
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-------KVLNRTPPIPEM 583
             DG+ +     DI+ L             W E+     +        K+L +     + 
Sbjct: 250 TGDGDYQF----DIYRLMKKENNN-----RWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300

Query: 584 LSSEGKDFL--LRCFLRNPVERPSAVELLEHPFI 615
            +   K     ++ F R  +   SA +LL    +
Sbjct: 301 NTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSL 334

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 72.5 bits (178), Expect = 7e-14
 Identities = 42/242 (17%), Positives = 79/242 (32%), Gaps = 45/242 (18%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETG--------ASCAIKEVDIIPDDPKSAECIKQLE 402
             QW+      R   G +Y      T            ++K   +   D +        +
Sbjct: 41  GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK---LDAKDGRLFNEQNFFQ 97

Query: 403 QEIKV--------LGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHC--RD 451
           +  K         L       I    G  V  D + ++ L  +   S+     +      
Sbjct: 98  RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPKHV 155

Query: 452 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--GVVKLADFGMAKH----L 505
           ++E  V      +L+ L +LH    +H ++   N+ VD      V LA +G A       
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

Query: 506 TGLSY----ELSLKGSPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKP 559
             ++Y        +G   +++ ++ K      +          D+ SLG  +++ L G  
Sbjct: 216 KHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRS---------DLQSLGYCMLKWLYGFL 266

Query: 560 PW 561
           PW
Sbjct: 267 PW 268

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.0 bits (108), Expect = 4e-05
 Identities = 53/398 (13%), Positives = 110/398 (27%), Gaps = 121/398 (30%)

Query: 329 PKSSVTSAVMPHIMEKPSASPKKSQ-----W---QKGKLIGRGTFGSV------------ 368
           PKS ++   + HI+    A    S      W    K + + +     V            
Sbjct: 42  PKSILSKEEIDHIIMSKDA---VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI 98

Query: 369 ---YIGTNRETGASCAIKEVDIIPDDPKS--------AECIKQLEQEIKVLGHLKHENIV 417
                  +  T     I++ D + +D +          +   +L    + L  L+    V
Sbjct: 99  KTEQRQPSMMT--RMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR---QALLELRPAKNV 153

Query: 418 QYYGSEVVDDHLYIYLEYVHPG---SINRYVREHCRDITESIVRNFTRHI--LNGLAYLH 472
              G                 G   +      + C      +       I  LN L   +
Sbjct: 154 LIDGV---------------LGSGKTW--VALDVCLS--YKVQCKMDFKIFWLN-LKNCN 193

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
           S  T+   ++   LL                  +   +  ++K   + +  E+ + +  K
Sbjct: 194 SPETVLEMLQ--KLLYQIDP----------NWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241

Query: 533 DGNPKLALAV--DIWS--------LGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
               +  L V  ++ +        L C ++ + T     ++F        +         
Sbjct: 242 PY--ENCLLVLLNVQNAKAWNAFNLSCKIL-LTTRFKQVTDFLSAATTTHI--SLDHHSM 296

Query: 583 MLS-SEGKDFLLRCFLRNPVERPSAV------------ELLEHPFIRNANYQNLSVPMRV 629
            L+  E K  LL+     P + P  V            E +        N++++      
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV------ 350

Query: 630 FSRINLGDKSHDQVERATRKT-ESLPDSPETRVRNRKL 666
                    + D++      +   L +  E R    +L
Sbjct: 351 ---------NCDKLTTIIESSLNVL-EPAEYRKMFDRL 378

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 1e-04
 Identities = 81/626 (12%), Positives = 166/626 (26%), Gaps = 199/626 (31%)

Query: 110 NQTAKGSAGFLSHFHKGDSQVLNIESVKNDLR-PSVPVRSTPTSLSSSHAVSPQRSNLQN 168
           ++  +    F+    + + + L +  +K + R PS+  R              QR  L N
Sbjct: 73  SKQEEMVQKFVEEVLRINYKFL-MSPIKTEQRQPSMMTRM----------YIEQRDRLYN 121

Query: 169 PTPLHNPKSISTRRRGFSHDLNIECANYSSR-ADIIP--------KSAPTSVFSSPAVSP 219
              +    ++ +R + +   L +  A    R A  +         K+      +      
Sbjct: 122 DNQVFAKYNV-SRLQPY---LKLRQALLELRPAKNVLIDGVLGSGKT----WVALDVCLS 173

Query: 220 QSSKTGNVFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKR--NVYSADHSPLPSPP 277
              +    F  FW              +L     C SP +  +    +         S  
Sbjct: 174 YKVQCKMDFKIFWL-------------NLKN---CNSPETVLEMLQKLLYQIDPNWTSRS 217

Query: 278 RQSSQSNLRS----PRKVYFPLRHKSLPQNSKELL-----ESNNHLNAHPLP---LPPGA 325
             SS   LR            L+ K    N   LL     ++    NA  L    L    
Sbjct: 218 DHSSNIKLRIHSIQAELRRL-LKSKPYE-NC--LLVLLNVQNAKAWNAFNLSCKIL---- 269

Query: 326 LSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV 385
           L+     VT  +        S                 T       T  E  +    K +
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHH-----------SMTL------TPDEVKSLLL-KYL 311

Query: 386 DIIPDD-PKSAECIKQLEQEIKVLGHLKHENIV-----QYYGSEVVDDHLYIYLEYVHPG 439
           D  P D P+           + ++     + +      ++   + +   +   L  + P 
Sbjct: 312 DCRPQDLPREVLTTNPRR--LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369

Query: 440 SI-NRYV-----REHCRDITESI--------VRNFTRHILNGLA--------------YL 471
                +            I   +        +++    ++N L                +
Sbjct: 370 EYRKMFDRLSVFPPSA-HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428

Query: 472 HSTNTIHRDIKG-----ANL---LVDA---------SGVVKLADFG-----MAKHLTGLS 509
            S   I+ ++K        L   +VD            ++           +  HL  + 
Sbjct: 429 PS---IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIE 485

Query: 510 YELSLKGSP------NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 563
           +   +           +     ++  ++ D           W+   +++  L     +  
Sbjct: 486 HPERMTLFRMVFLDFRF-----LEQKIRHDSTA--------WNASGSILNTLQQLKFYKP 532

Query: 564 FEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF---IRNANY 620
           +         +    P  E L +   DFL +              L+   +   +R A  
Sbjct: 533 Y---------ICDNDPKYERLVNAILDFLPKI----------EENLICSKYTDLLRIA-- 571

Query: 621 QNLSVPMR-VFSRINLGDKSHDQVER 645
             L      +F      +++H QV+R
Sbjct: 572 --LMAEDEAIF------EEAHKQVQR 589

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	739
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-81
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-77
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-75
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-75
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-73
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-73
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-72
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-71
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-71
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-70
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-70
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-70
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-70
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-69
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-69
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-67
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-66
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-66
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-63
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-62
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-62
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-60
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-60
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-60
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-60
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-60
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-59
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-59
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-58
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-57
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-57
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-56
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-56
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-55
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-55
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-55
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-54
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-53
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-53
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-53
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-51
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-51
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-49
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-48
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-48
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-47
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-37
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-27

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (663), Expect = 2e-81
 Identities = 93/274 (33%), Positives = 139/274 (50%), Gaps = 11/274 (4%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           W+    +G G FG VY   N+ET    A K +D      KS E ++    EI +L    H
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 68

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+   +   +++L+I +E+   G+++  + E  R +TES ++   +  L+ L YLH 
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQK 532
              IHRD+K  N+L    G +KLADFG++   T       S  G+P WMAPEV+     K
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGK 589
           D         D+WSLG T+IEM   +PP  E    + + K+    PP    P   SS  K
Sbjct: 189 DR--PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246

Query: 590 DFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 623
           DFL +C  +N   R +  +LL+HPF+   + + +
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (634), Expect = 1e-77
 Identities = 79/265 (29%), Positives = 134/265 (50%), Gaps = 11/265 (4%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
             ++ G+ +G+G FG+VY+   +++    A+K +       + A    QL +E+++  HL
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 63

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
           +H NI++ YG       +Y+ LEY   G++ R ++       E     +   + N L+Y 
Sbjct: 64  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYC 122

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           HS   IHRDIK  NLL+ ++G +K+ADFG + H    S   +L G+ +++ PE+I+    
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIE---- 177

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 591
                     VD+WSLG    E L GKPP+      +   ++       P+ ++   +D 
Sbjct: 178 ---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234

Query: 592 LLRCFLRNPVERPSAVELLEHPFIR 616
           + R    NP +RP   E+LEHP+I 
Sbjct: 235 ISRLLKHNPSQRPMLREVLEHPWIT 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  244 bits (624), Expect = 1e-75
 Identities = 90/297 (30%), Positives = 146/297 (49%), Gaps = 14/297 (4%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           +  +   + IG G+FG+VY   +       AIK++       +S E  + + +E++ L  
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQK 71

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L+H N +QY G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAY
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 530
           LHS N IHRD+K  N+L+   G+VKL DFG A  +   +   S  G+P WMAPEVI A+ 
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMD 187

Query: 531 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEG 588
           +   + K    VD+WSLG T IE+   KPP        A++ +             S   
Sbjct: 188 EGQYDGK----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243

Query: 589 KDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVER 645
           ++F+  C  + P +RP++  LL+H F+     +  +V M +  R     +  D ++ 
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVL--RERPPTVIMDLIQRTKDAVRELDNLQY 298

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (619), Expect = 2e-75
 Identities = 71/274 (25%), Positives = 124/274 (45%), Gaps = 17/274 (6%)

Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 408
           P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI + 
Sbjct: 2   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 57

Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
             L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ G+
Sbjct: 58  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGV 116

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEV 525
            YLH     HRDIK  NLL+D    +K++DFG+A      + E  L    G+  ++APE+
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 526 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPE 582
           +K           A  VD+WS G  +  ML G+ PW +       +             +
Sbjct: 177 LK------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
            + S     L +  + NP  R +  ++ +  +  
Sbjct: 231 KIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (604), Expect = 6e-73
 Identities = 101/300 (33%), Positives = 152/300 (50%), Gaps = 22/300 (7%)

Query: 341 IMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 396
           I+EK     S    K ++ + + IG+G  G+VY   +  TG   AI+++++     +   
Sbjct: 5   ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQP 59

Query: 397 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 456
             + +  EI V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E  
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQ 117

Query: 457 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LK 515
           +    R  L  L +LHS   IHRDIK  N+L+   G VKL DFG    +T    + S + 
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177

Query: 516 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 575
           G+P WMAPEV+               VDIWSLG   IEM+ G+PP+      +A++ +  
Sbjct: 178 GTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230

Query: 576 RTPP---IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSR 632
              P    PE LS+  +DFL RC   +  +R SA ELL+H F++ A   +   P+   ++
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAK 290

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  236 bits (602), Expect = 8e-73
 Identities = 71/273 (26%), Positives = 130/273 (47%), Gaps = 11/273 (4%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVL 408
            ++  +++GRG    V    ++ T    A+K +D+      SAE +++L +    E+ +L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 409 GHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
             +  H NI+Q   +   +   ++  + +  G +  Y+ E    ++E   R   R +L  
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEV 122

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           +  LH  N +HRD+K  N+L+D    +KL DFG +  L        + G+P+++APE+I+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----PPIPEM 583
                D +P     VD+WS G  +  +L G PP+   +    +  +++       P  + 
Sbjct: 183 C-SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
            S   KD + R  +  P +R +A E L HPF +
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  237 bits (605), Expect = 3e-72
 Identities = 69/334 (20%), Positives = 133/334 (39%), Gaps = 27/334 (8%)

Query: 340 HIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 399
           H+++          +   + +G G FG V+  T R TG + A K V             +
Sbjct: 23  HVLDH---------YDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKE 68

Query: 400 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 459
            + +EI+ +  L+H  +V  + +   D+ + +  E++  G +   V +    ++E     
Sbjct: 69  TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 128

Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGS 517
           + R +  GL ++H  N +H D+K  N++     S  +KL DFG+  HL          G+
Sbjct: 129 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188

Query: 518 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 577
             + APEV +          +    D+WS+G     +L+G  P+      + +  V +  
Sbjct: 189 AEFAAPEVAE-------GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 241

Query: 578 PPIPE----MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRI 633
             + +     +S +GKDF+ +  L +P  R +  + LEHP++   N       +      
Sbjct: 242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYT 301

Query: 634 NLGDKSHDQVERATRKTESLPDSPETRVRNRKLP 667
            + D    + +        L          +  P
Sbjct: 302 KIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRP 335

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 4e-71
 Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 22/274 (8%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++    IG G++G       +  G     K    +     +    + L  E+ +L  LKH
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWK---ELDYGSMTEAEKQMLVSEVNLLRELKH 62

Query: 414 ENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGL 468
            NIV+YY    +  +  LYI +EY   G +   + +  ++   + E  V      +   L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 469 AYLHSTNT-----IHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMA 522
              H  +      +HRD+K AN+ +D    VKL DFG+A+ L    S+  +  G+P +M+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIP 581
           PE +                DIWSLGC + E+    PP++ F   +   K+   +   IP
Sbjct: 183 PEQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 235

Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
              S E  + + R        RPS  E+LE+P I
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 8e-71
 Identities = 72/287 (25%), Positives = 131/287 (45%), Gaps = 22/287 (7%)

Query: 349 PKK---SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 405
           P+K     ++ GK++G G+F +V +     T    AIK ++           +  + +E 
Sbjct: 2   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRER 59

Query: 406 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
            V+  L H   V+ Y +   D+ LY  L Y   G + +Y+R       E+  R +T  I+
Sbjct: 60  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIV 118

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMA 522
           + L YLH    IHRD+K  N+L++    +++ DFG AK L+  S +    S  G+  +++
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 523 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 582
           PE++              + D+W+LGC + +++ G PP+          K++      PE
Sbjct: 179 PELLT-------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 623
               + +D + +  + +  +R    E      L  HPF  +  ++NL
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 3e-70
 Identities = 72/270 (26%), Positives = 134/270 (49%), Gaps = 23/270 (8%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
              IGRG+F +VY G + ET    A      + D   +    ++ ++E ++L  L+H NI
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWC---ELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 417 VQYYGS----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           V++Y S          + +  E +  G++  Y++     +   ++R++ R IL GL +LH
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH 129

Query: 473 STNT--IHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           +     IHRD+K  N+ +   +G VK+ D G+A      S+  ++ G+P +MAPE+ +  
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE- 187

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---RTPPIPEMLSS 586
                  K   +VD+++ G  ++EM T + P+SE +    +++ +    +     ++   
Sbjct: 188 -------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240

Query: 587 EGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
           E K+ +  C  +N  ER S  +LL H F +
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 5e-70
 Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 20/272 (7%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
              Q   G+ IG G+FG+VY G         A+K   ++     + + ++  + E+ VL 
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLR 59

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
             +H NI+ + G       L I  ++    S+  ++           + +  R    G+ 
Sbjct: 60  KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVI 526
           YLH+ + IHRD+K  N+ +     VK+ DFG+A   +  S       L GS  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------TPPI 580
           +   +   + +     D+++ G  + E++TG+ P+S       +  ++ R         +
Sbjct: 179 RMQDKNPYSFQ----SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234

Query: 581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
                   K  +  C  +   ERP   ++L  
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 8e-70
 Identities = 82/331 (24%), Positives = 154/331 (46%), Gaps = 58/331 (17%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K   ++K   +G G  G V+  +++ +G   A K + +            Q+ +E++VL 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLH 59

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 118

Query: 470 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           YL   + I HRD+K +N+LV++ G +KL DFG++  L   S   S  G+ ++M+PE ++ 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ- 176

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW--------------------------- 561
                     ++  DIWS+G +++EM  G+ P                            
Sbjct: 177 ------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230

Query: 562 -----------SEFEGPQAMFKVLNRT-----PPIPE-MLSSEGKDFLLRCFLRNPVERP 604
                       +   P A+F++L+       P +P  + S E +DF+ +C ++NP ER 
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290

Query: 605 SAVELLEHPFIRNANYQNLSVPMRVFSRINL 635
              +L+ H FI+ ++ + +     + S I L
Sbjct: 291 DLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 321

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 9e-70
 Identities = 67/313 (21%), Positives = 127/313 (40%), Gaps = 19/313 (6%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +   + +GRG FG V+      +  +   K V +   D         +++EI +L   +H
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVKKEISILNIARH 60

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NI+  + S    + L +  E++    I   +     ++ E  + ++   +   L +LHS
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 474 TNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
            N  H DI+  N++     S  +K+ +FG A+ L        L  +P + APEV +    
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ---- 176

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM----LSSE 587
              +  ++ A D+WSLG  V  +L+G  P+      Q +  ++N      E     +S E
Sbjct: 177 ---HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 588 GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERAT 647
             DF+ R  ++    R +A E L+HP+++    +  +  +R             +     
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMV 293

Query: 648 RKTESLPDSPETR 660
                +      R
Sbjct: 294 VSAARISCGGAIR 306

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  227 bits (579), Expect = 4e-69
 Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 19/290 (6%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           +  +    ++G G F  V +  ++ T    AIK +     + K       +E EI VL  
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE----GSMENEIAVLHK 63

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           +KH NIV          HLY+ ++ V  G +   + E     TE         +L+ + Y
Sbjct: 64  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKY 122

Query: 471 LHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           LH    +HRD+K  NLL    D    + ++DFG++K     S   +  G+P ++APEV+ 
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPEM 583
                      + AVD WS+G     +L G PP+ +    +   ++L        P  + 
Sbjct: 183 -------QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRI 633
           +S   KDF+     ++P +R +  + L+HP+I      + ++   V  +I
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  228 bits (582), Expect = 6e-69
 Identities = 64/318 (20%), Positives = 132/318 (41%), Gaps = 28/318 (8%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +   + +G G FG V+    + TG     K ++              ++ EI ++  L H
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHH 85

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
             ++  + +      + + LE++  G +   +      ++E+ V N+ R    GL ++H 
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 474 TNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
            + +H DIK  N++ +   +  VK+ DFG+A  L           +  + APE++     
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD---- 201

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM----LSSE 587
                 +    D+W++G     +L+G  P++  +  + +  V        E     +S E
Sbjct: 202 ---REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258

Query: 588 GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLS--VPMRVFSRINLGDKSHDQVER 645
            KDF+     + P +R +  + LEHP+++  ++ NL+  +P   +++I        Q  +
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKG-DHSNLTSRIPSSRYNKI-------RQKIK 310

Query: 646 ATRKTESLPDSPETRVRN 663
                   P     R+ N
Sbjct: 311 EKYADWPAPQPAIGRIAN 328

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 3e-67
 Identities = 73/273 (26%), Positives = 136/273 (49%), Gaps = 13/273 (4%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LK 412
           +   K++G+G+FG V++   ++T    AIK +    D     + ++    E +VL    +
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H  +   + +    ++L+  +EY++ G +  +++   +    S    +   I+ GL +LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQ 531
           S   ++RD+K  N+L+D  G +K+ADFGM K    G +   +  G+P+++APE++     
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL---- 176

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 591
                K   +VD WS G  + EML G+ P+   +  +    +    P  P  L  E KD 
Sbjct: 177 ---GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233

Query: 592 LLRCFLRNPVERPSAV-ELLEHPFIRNANYQNL 623
           L++ F+R P +R     ++ +HP  R  N++ L
Sbjct: 234 LVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 266

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  220 bits (562), Expect = 1e-66
 Identities = 66/277 (23%), Positives = 132/277 (47%), Gaps = 17/277 (6%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
             +Q  + +G G+FG V++  +R  G   A+K +    +     + ++    E  +L  +
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK--KEIVVRLKQVEHTNDERLMLSIV 61

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
            H  I++ +G+      +++ ++Y+  G     +    +     + + +   +   L YL
Sbjct: 62  THPFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
           HS + I+RD+K  N+L+D +G +K+ DFG AK++  ++Y  +L G+P+++APEV+     
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVS---- 174

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 591
                    ++D WS G  + EML G  P+ +    +   K+LN     P   + + KD 
Sbjct: 175 ---TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231

Query: 592 LLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
           L R   R+  +R         ++  HP+ +   ++ L
Sbjct: 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 4e-66
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 17/273 (6%)

Query: 349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKV 407
           P +SQ+Q G L+G G FGSVY G         AIK V+     D        ++  E+ +
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60

Query: 408 LGHLK--HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 465
           L  +      +++        D   + LE   P             + E + R+F   +L
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120

Query: 466 NGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 524
             + + H+   +HRDIK  N+L+D + G +KL DFG    L   +      G+  +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPE 179

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 584
            I+       +     +  +WSLG  + +M+ G  P+   E      +++       + +
Sbjct: 180 WIR------YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRV 227

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
           SSE +  +  C    P +RP+  E+  HP++++
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-63
 Identities = 67/279 (24%), Positives = 126/279 (45%), Gaps = 17/279 (6%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLK 412
           +  G+ +G G F  V     + TG   A K +        +     + +E+E+ +L  ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ YLH
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLH 130

Query: 473 STNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
           S    H D+K  N+++    V    +K+ DFG+A  +   +   ++ G+P ++APE++  
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 189

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPEML 584
                    L L  D+WS+G     +L+G  P+      + +  V               
Sbjct: 190 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 623
           S+  KDF+ R  +++P +R +  + L+HP+I+  + Q  
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  213 bits (542), Expect = 4e-63
 Identities = 69/279 (24%), Positives = 126/279 (45%), Gaps = 17/279 (6%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGHLK 412
           +   ++IGRG FG VY     +TG   A+K +D      K  E +   E   + ++    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
              IV    +    D L   L+ ++ G ++ ++ +H     E+ +R +   I+ GL ++H
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAAEIILGLEHMH 124

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
           +   ++RD+K AN+L+D  G V+++D G+A   +      +  G+  +MAPEV+      
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVL------ 177

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF---KVLNRTPPIPEMLSSEGK 589
                   + D +SLGC + ++L G  P+ + +           L     +P+  S E +
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237

Query: 590 DFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL 623
             L     R+   R       A E+ E PF R+ ++Q +
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 276

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 1e-62
 Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 22/265 (8%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            + +  + IG+G FG V +G  R  G   A+K +       K+    +    E  V+  L
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQL 57

Query: 412 KHENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLA 469
           +H N+VQ  G  V +   LYI  EY+  GS+  Y+R   R  +    +  F+  +   + 
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           YL   N +HRD+   N+LV    V K++DFG+ K  +  S + + K    W APE ++  
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALR-- 173

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSE 587
                  K +   D+WS G  + E+ + G+ P+        + +V        P+     
Sbjct: 174 -----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228

Query: 588 GKDFLLRCFLRNPVERPSAVELLEH 612
             + +  C+  +   RPS ++L E 
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 2e-62
 Identities = 62/265 (23%), Positives = 109/265 (41%), Gaps = 18/265 (6%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S+    + IG G FG V++G         AIK +       + A   +   +E +V+  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR------EGAMSEEDFIEEAEVMMKL 57

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
            H  +VQ YG  +    + +  E++  G ++ Y+R          +      +  G+AYL
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAV 529
                IHRD+   N LV  + V+K++DFGM + +     +     K    W +PEV    
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS-- 175

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSE 587
                  + +   D+WS G  + E+ + GK P+      + +  +        P + S+ 
Sbjct: 176 -----FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230

Query: 588 GKDFLLRCFLRNPVERPSAVELLEH 612
               +  C+   P +RP+   LL  
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 2e-62
 Identities = 75/277 (27%), Positives = 130/277 (46%), Gaps = 16/277 (5%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
            +   KL+G+GTFG V +   + TG   A+K +    +   + + +     E +VL + +
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQNTR 63

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H  +     +    D L   +EY + G +  ++       TE   R +   I++ L YLH
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH 122

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQ 531
           S + ++RDIK  NL++D  G +K+ DFG+ K        +    G+P ++APEV++    
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---- 178

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 591
              +     AVD W LG  + EM+ G+ P+   +  +    +L      P  LS E K  
Sbjct: 179 ---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235

Query: 592 LLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL 623
           L     ++P +R       A E++EH F  + N+Q++
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 1e-61
 Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 23/273 (8%)

Query: 358 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 415
           K +G G FG+V  G  +  +   + A+K   I+ ++        +L  E  V+  L +  
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPY 69

Query: 416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 475
           IV+  G     +   + +E    G +N+Y++++   + +  +      +  G+ YL  +N
Sbjct: 70  IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN 127

Query: 476 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG----LSYELSLKGSPNWMAPEVIKAVMQ 531
            +HRD+   N+L+      K++DFG++K L         +   K    W APE I     
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN---- 183

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGK 589
                K +   D+WS G  + E  + G+ P+   +G +    +        P     E  
Sbjct: 184 ---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 240

Query: 590 DFLLRCFLRNPVERPSA---VELLEHPFIRNAN 619
           D +  C+  +   RP        L + +    N
Sbjct: 241 DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  205 bits (522), Expect = 4e-61
 Identities = 60/272 (22%), Positives = 117/272 (43%), Gaps = 6/272 (2%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S  +  ++IG G FG V  G  +  G       +  +     + +  +    E  ++G  
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQF 84

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
            H N++   G       + I  E++  GS++ ++R++    T   +    R I  G+ YL
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 531
              N +HRD+   N+LV+++ V K++DFG+++ L   + + +   +     P    A   
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEGK 589
                K   A D+WS G  + E+++ G+ P+ +      +  +  +   P P    S   
Sbjct: 205 IQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263

Query: 590 DFLLRCFLRNPVERPSAVELLEH--PFIRNAN 619
             +L C+ ++   RP   +++      IRN N
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-60
 Identities = 69/265 (26%), Positives = 112/265 (42%), Gaps = 18/265 (6%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
                 K +G G FG V  G  R      AIK +       + +    +  +E KV+ +L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIK------EGSMSEDEFIEEAKVMMNL 56

Query: 412 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
            HE +VQ YG       ++I  EY+  G +  Y+RE         +    + +   + YL
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116

Query: 472 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAV 529
            S   +HRD+   N LV+  GVVK++DFG+++++    Y  S   K    W  PEV+   
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM-- 174

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSE 587
                  K +   DIW+ G  + E+ + GK P+  F   +    +        P + S +
Sbjct: 175 -----YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 229

Query: 588 GKDFLLRCFLRNPVERPSAVELLEH 612
               +  C+     ERP+   LL +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSN 254

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-60
 Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 19/270 (7%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 406
           ++ + + G+ IG G FG V+ G          + AIK       D       ++  QE  
Sbjct: 5   QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD----SVREKFLQEAL 60

Query: 407 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
            +    H +IV+  G  + ++ ++I +E    G +  +++     +  + +  +   +  
Sbjct: 61  TMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPE 524
            LAYL S   +HRDI   N+LV ++  VKL DFG+++++   +Y  +   K    WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPE 582
            I          +   A D+W  G  + E+L  G  P+   +    + ++ N    P+P 
Sbjct: 180 SIN-------FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 232

Query: 583 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
                    + +C+  +P  RP   EL   
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  203 bits (516), Expect = 2e-60
 Identities = 61/279 (21%), Positives = 119/279 (42%), Gaps = 22/279 (7%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++ G+++G G    V++  +       A+K +    D  +      +  +E +    L 
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALN 65

Query: 413 HENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
           H  IV  Y +   +       YI +EYV   ++   V      +T              L
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQAL 124

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPNWMAPE 524
            + H    IHRD+K AN+++ A+  VK+ DFG+A+ +      ++   ++ G+  +++PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 525 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 581
             +          +    D++SLGC + E+LTG+PP++        ++ +   P  P   
Sbjct: 185 QAR-------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237

Query: 582 -EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
            E LS++    +L+   +NP  R      +    +R  N
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 2e-60
 Identities = 69/327 (21%), Positives = 127/327 (38%), Gaps = 35/327 (10%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHEN 415
            +++G G  G V    N+ T    A+K +              +  +E+++     +  +
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPH 66

Query: 416 IVQYYG----SEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAY 470
           IV+              L I +E +  G +   +++      TE       + I   + Y
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 471 LHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 527
           LHS N  HRD+K  NLL  +   + ++KL DFG AK  T  +   +   +P ++APEV+ 
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL- 185

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--------TPP 579
                 G  K   + D+WSLG  +  +L G PP+    G      +  R          P
Sbjct: 186 ------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239

Query: 580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKS 639
               +S E K  +       P +R +  E + HP+I   + +    P+     +    + 
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ-STKVPQTPLHTSRVLKEDKER 298

Query: 640 HDQVERATRKTESLPDSPETRVRNRKL 666
            + V+       +       +++ +K+
Sbjct: 299 WEDVKEEMTSALATMRVDYEQIKIKKI 325

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 3e-60
 Identities = 70/269 (26%), Positives = 115/269 (42%), Gaps = 20/269 (7%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
            +  + +G G+FG V  G          S A+K +   PD     E +    +E+  +  
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQPEAMDDFIREVNAMHS 67

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
           L H N+++ YG  V+   + +  E    GS+   +R+H        +  +   +  G+ Y
Sbjct: 68  LDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 471 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL----KGSPNWMAPEVI 526
           L S   IHRD+   NLL+    +VK+ DFG+ + L        +    K    W APE +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEM 583
           K           + A D W  G T+ EM T G+ PW    G Q + K+       P PE 
Sbjct: 187 K-------TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEH 612
              +  + +++C+   P +RP+ V L + 
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 1e-59
 Identities = 79/296 (26%), Positives = 128/296 (43%), Gaps = 39/296 (13%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +QK + IG GT+G VY   N+ TG   A+K    I  D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKELNH 60

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 474 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQK 532
              +HRD+K  NLL++  G +KLADFG+A+     +        +  + APE++      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 175

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--------- 583
            G    + AVDIWSLGC   EM+T +  +        +F++        E+         
Sbjct: 176 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 584 --------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 619
                               L  +G+  L +    +P +R SA   L HPF ++  
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 2e-59
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 13/268 (4%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           K+++++K K++G G FG+VY G     G    I        +  S +  K++  E  V+ 
Sbjct: 7   KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
            + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I  G+ 
Sbjct: 67  SVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL---KGSPNWMAPEVI 526
           YL     +HRD+   N+LV     VK+ DFG+AK L     E      K    WMA E I
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEML 584
                   +       D+WS G TV E++T G  P+      +    +      P P + 
Sbjct: 186 L-------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 238

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLEH 612
           + +    +++C++ +   RP   EL+  
Sbjct: 239 TIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 3e-59
 Identities = 61/267 (22%), Positives = 111/267 (41%), Gaps = 23/267 (8%)

Query: 360 IGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
           +G G FGSV  G  R        AIK +             +++ +E +++  L +  IV
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLK----QGTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
           +  G     + L + +E    G +++++     +I  S V      +  G+ YL   N +
Sbjct: 73  RLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHLTG----LSYELSLKGSPNWMAPEVIKAVMQKD 533
           HRD+   N+L+      K++DFG++K L       +   + K    W APE I       
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN------ 185

Query: 534 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEGKDF 591
              K +   D+WS G T+ E L+ G+ P+ + +GP+ M  +   +    P     E    
Sbjct: 186 -FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244

Query: 592 LLRCFLRNPVERPSA---VELLEHPFI 615
           +  C++    +RP      + +   + 
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-59
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 36/289 (12%)

Query: 358 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 417
             +G G F +VY   ++ T    AIK++ +           +   +EIK+L  L H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 418 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 477
               +     ++ +  +++    +   ++++   +T S ++ +    L GL YLH    +
Sbjct: 64  GLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122

Query: 478 HRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 536
           HRD+K  NLL+D +GV+KLADFG+AK   +          +  + APE++          
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG--- 179

Query: 537 KLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP-------------- 579
              + VD+W++GC + E+L   P     S+ +    +F+ L                   
Sbjct: 180 ---VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 580 -----------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
                      I      +  D +   FL NP  R +A + L+  +  N
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 1e-58
 Identities = 64/272 (23%), Positives = 118/272 (43%), Gaps = 23/272 (8%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           +   +  + +G G FG V++G         A+K +       + +        E  ++  
Sbjct: 12  RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK------QGSMSPDAFLAEANLMKQ 64

Query: 411 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLA 469
           L+H+ +V+ Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A
Sbjct: 65  LQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIK 527
           ++   N IHRD++ AN+LV  +   K+ADFG+A+ +    Y      K    W APE I 
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 528 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLS 585
                       +  D+WS G  + E++T G+ P+     P+ +  +        P+   
Sbjct: 184 -------YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236

Query: 586 SEGKDFLLRCFLRNPVERPSA---VELLEHPF 614
            E    +  C+   P +RP+      +LE  F
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 8e-58
 Identities = 63/292 (21%), Positives = 114/292 (39%), Gaps = 37/292 (12%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVLG 409
           +   + GK++G G FG V   T      +    +V + +  +   +   + L  E+K++ 
Sbjct: 36  RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95

Query: 410 HL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD----------------- 451
            L  HENIV   G+  +   +Y+  EY   G +  Y+R                      
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 452 -----ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 506
                +T   +  F   +  G+ +L   + +HRD+   N+LV    VVK+ DFG+A+ + 
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 507 GLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 562
             S  +   + +    WMAPE +             +  D+WS G  + E+ + G  P+ 
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLF-------EGIYTIKSDVWSYGILLWEIFSLGVNPYP 268

Query: 563 EFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
                   +K++        P   + E    +  C+  +  +RPS   L   
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-57
 Identities = 76/286 (26%), Positives = 143/286 (50%), Gaps = 22/286 (7%)

Query: 353 QWQKGKLIGRGTFGSVYIG---TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
            ++  K++G G +G V++    +  +TG   A+K +       + A+  +    E +VL 
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK-ATIVQKAKTTEHTRTERQVLE 83

Query: 410 HLKHE-NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
           H++    +V  + +   +  L++ L+Y++ G +  ++ +  R  TE  V+ +   I+  L
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLAL 142

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVI 526
            +LH    I+RDIK  N+L+D++G V L DFG++K       E +    G+  +MAP+++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPE 582
           +             AVD WSLG  + E+LTG  P++      +  ++  R     PP P+
Sbjct: 203 RGGDSGHDK-----AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257

Query: 583 MLSSEGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL 623
            +S+  KD + R  +++P +R       A E+ EH F +  N+ +L
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 303

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 3e-57
 Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 40/298 (13%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           Q++    IG G +G V+   + +  G   A+K V +   +        +    ++ L   
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 412 KHENIVQYYGSEVV-----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           +H N+V+ +    V     +  L +  E+V         +     +    +++    +L 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           GL +LHS   +HRD+K  N+LV +SG +KLADFG+A+  +      S+  +  + APEV+
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 187

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN----------- 575
                       A  VD+WS+GC   EM   KP +        + K+L+           
Sbjct: 188 L-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240

Query: 576 ----------------RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
                                   +   GKD LL+C   NP +R SA   L HP+ ++
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  194 bits (493), Expect = 5e-57
 Identities = 65/280 (23%), Positives = 128/280 (45%), Gaps = 20/280 (7%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           +++       +G G +G VY G  ++   + A+K +       +    +++  +E  V+ 
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMK 68

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGL 468
            +KH N+VQ  G    +   YI  E++  G++  Y+RE  R +++  ++      I + +
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVI 526
            YL   N IHRD+   N LV  + +VK+ADFG+++ +TG +Y      K    W APE +
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEML 584
                     K ++  D+W+ G  + E+ T             ++++L +      PE  
Sbjct: 189 A-------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 241

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLE--HPFIRNANYQN 622
             +  + +  C+  NP +RPS  E+ +      + ++  +
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  194 bits (494), Expect = 2e-56
 Identities = 78/288 (27%), Positives = 138/288 (47%), Gaps = 18/288 (6%)

Query: 342 MEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 400
            E PS +  +  Q+ + K +G G+FG V +  ++E+G   A+K +D         + I+ 
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD--KQKVVKLKQIEH 87

Query: 401 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 460
              E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFY 146

Query: 461 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 520
              I+    YLHS + I+RD+K  NLL+D  G +++ DFG AK + G ++  +L G+P  
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEA 204

Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI 580
           +APE+I        +     AVD W+LG  + EM  G PP+   +  Q   K+++     
Sbjct: 205 LAPEIIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257

Query: 581 PEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 623
           P   SS+ KD L      +  +R         ++  H +    ++  +
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 3e-56
 Identities = 78/315 (24%), Positives = 129/315 (40%), Gaps = 37/315 (11%)

Query: 335 SAVMPHIMEKPSA---SPKKSQWQKGKLIGRGTFGSVYIGT---NRETGASCAIKEVDII 388
           SA+ P +++        P        ++IGRG FG VY GT   N      CA+K ++ I
Sbjct: 7   SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 66

Query: 389 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVRE 447
            D       + Q   E  ++    H N++   G  +  +    + L Y+  G +  ++R 
Sbjct: 67  TDI----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 122

Query: 448 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 507
              + T   +  F   +  G+ +L S   +HRD+   N ++D    VK+ADFG+A+ +  
Sbjct: 123 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182

Query: 508 LSYEL-----SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 561
             ++        K    WMA E ++         K     D+WS G  + E++T G PP+
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPY 235

Query: 562 SEFEGPQAMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH------PF 614
            +         +L  R    PE       + +L+C+      RPS  EL+         F
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295

Query: 615 IR------NANYQNL 623
           I       NA Y N+
Sbjct: 296 IGEHYVHVNATYVNV 310

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  191 bits (486), Expect = 3e-56
 Identities = 74/294 (25%), Positives = 124/294 (42%), Gaps = 41/294 (13%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           ++   + IG GT+G VY   N   G + A+K    I  + +         +EI +L  LK
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALK---KIRLEKEDEGIPSTTIREISILKELK 58

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H NIV+ Y        L +  E++               +     ++F   +LNG+AY H
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH 117

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQ 531
               +HRD+K  NLL++  G +K+ADFG+A+     +        +  + AP+V+     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM---- 173

Query: 532 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP--------- 579
             G+ K +  +DIWS+GC   EM+ G P +   SE +    +F++L              
Sbjct: 174 --GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231

Query: 580 -----------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
                              + L   G D L +    +P +R +A + LEH + +
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-56
 Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 22/275 (8%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
            +   +    +G+G FG V++GT   T    AIK +             +   QE +V+ 
Sbjct: 15  PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK------PGTMSPEAFLQEAQVMK 67

Query: 410 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGL 468
            L+HE +VQ Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+
Sbjct: 68  KLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVI 526
           AY+   N +HRD++ AN+LV  + V K+ADFG+A+ +    Y      K    W APE  
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEML 584
                     +  +  D+WS G  + E+ T G+ P+      + + +V      P P   
Sbjct: 187 L-------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 239

Query: 585 SSEGKDFLLRCFLRNPVERPSAVELLE--HPFIRN 617
                D + +C+ + P ERP+   L      +  +
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 4e-56
 Identities = 65/270 (24%), Positives = 114/270 (42%), Gaps = 21/270 (7%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKV 407
           S   + K+IG G FG VY G  + +        AIK +     +    +       E  +
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE----KQRVDFLGEAGI 62

Query: 408 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
           +G   H NI++  G       + I  EY+  G++++++RE   + +   +    R I  G
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL----SLKGSPNWMAP 523
           + YL + N +HRD+   N+LV+++ V K++DFG+++ L             K    W AP
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIP 581
           E I          K   A D+WS G  + E++T             + K +N     P P
Sbjct: 183 EAIS-------YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235

Query: 582 EMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
               S     +++C+ +    RP   +++ 
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (482), Expect = 2e-55
 Identities = 59/288 (20%), Positives = 105/288 (36%), Gaps = 38/288 (13%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++ G+ IG G+FG +Y+GT+   G   AIK   +    P       QL  E K+   ++
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQ 60

Query: 413 HEN-IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 471
               I          D+  + +E +   S+        R  +   V      +++ + Y+
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 472 HSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL--------SLKGSPNW 520
           HS N IHRD+K  N L+       +V + DFG+AK                 +L G+  +
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--- 577
            +              + +   D+ SLG  ++    G  PW   +      K    +   
Sbjct: 180 ASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232

Query: 578 -----PPIPEMLSSEGKDFLLRCFLRNPVERPSA---VELLEHPFIRN 617
                  + +   SE   +L  C      ++P      +L  + F R 
Sbjct: 233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 6e-55
 Identities = 62/305 (20%), Positives = 120/305 (39%), Gaps = 51/305 (16%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
            ++     IG G +G V    +       AIK++             ++  +EIK+L   
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ----TYCQRTLREIKILLRF 63

Query: 412 KHENIVQYYG---SEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNG 467
           +HENI+       +  ++    +YL  ++    + + ++   + ++   +  F   IL G
Sbjct: 64  RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRG 121

Query: 468 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK----GSPNWMAP 523
           L Y+HS N +HRD+K +NLL++ +  +K+ DFG+A+                 +  + AP
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM 583
           E++        +     ++DIWS+GC + EML+ +P +        +  +L       + 
Sbjct: 182 EIM------LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235

Query: 584 -------------------------------LSSEGKDFLLRCFLRNPVERPSAVELLEH 612
                                            S+  D L +    NP +R    + L H
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295

Query: 613 PFIRN 617
           P++  
Sbjct: 296 PYLEQ 300

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 8e-55
 Identities = 68/311 (21%), Positives = 122/311 (39%), Gaps = 55/311 (17%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 411
           S+++K   IG+GTFG V+   +R+TG   A+K    +  + +         +EIK+L  L
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITALREIKILQLL 66

Query: 412 KHENIVQYYGS--------EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
           KHEN+V                   +Y+  ++         +       T S ++   + 
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQM 125

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-----TGLSYELSLKGSP 518
           +LNGL Y+H    +HRD+K AN+L+   GV+KLADFG+A+       +  +   +   + 
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 519 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLN 575
            +  PE++       G       +D+W  GC + EM T  P     +E      + ++  
Sbjct: 186 WYRPPELLL------GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239

Query: 576 RTPP-----------------------------IPEMLSSEGKDFLLRCFLRNPVERPSA 606
              P                                +      D + +  + +P +R  +
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

Query: 607 VELLEHPFIRN 617
            + L H F  +
Sbjct: 300 DDALNHDFFWS 310

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (470), Expect = 9e-54
 Identities = 63/303 (20%), Positives = 117/303 (38%), Gaps = 49/303 (16%)

Query: 342 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAE 396
           +E P     ++  +  + IG G FG V+          E     A+K +     +  SA+
Sbjct: 8   LEYP-----RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK----EEASAD 58

Query: 397 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD----- 451
                ++E  ++    + NIV+  G   V   + +  EY+  G +N ++R          
Sbjct: 59  MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 452 ------------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 493
                             ++ +      R +  G+AYL     +HRD+   N LV  + V
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV 178

Query: 494 VKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 550
           VK+ADFG+++++    Y     +      WM PE I          +     D+W+ G  
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-------YNRYTTESDVWAYGVV 231

Query: 551 VIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVE 608
           + E+ + G  P+      + ++ V +      PE    E  + +  C+ + P +RPS   
Sbjct: 232 LWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 291

Query: 609 LLE 611
           +  
Sbjct: 292 IHR 294

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-53
 Identities = 83/335 (24%), Positives = 133/335 (39%), Gaps = 57/335 (17%)

Query: 331 SSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 390
           S VT+ V      +    P++  +   K+IG G+FG VY     ++G   AIK    +  
Sbjct: 1   SKVTTVVA--TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KVLQ 55

Query: 391 DPKSAECIKQLEQEIKVLGHLKHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRY 444
           D +         +E++++  L H NIV+        G +  + +L + L+YV P ++ R 
Sbjct: 56  DKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRV 108

Query: 445 VREHCRD---ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFG 500
            R + R    +    V+ +   +   LAY+HS    HRDIK  NLL+D    V+KL DFG
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 168

Query: 501 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 560
            AK L      +S   S  + APE+I       G      ++D+WS GC + E+L G+P 
Sbjct: 169 SAKQLVRGEPNVSYICSRYYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPI 222

Query: 561 WSEFEGPQAMFKVLNRTPPIPEM-----------------------------LSSEGKDF 591
           +    G   + +++                                         E    
Sbjct: 223 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282

Query: 592 LLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 626
             R     P  R + +E   H F       N+ +P
Sbjct: 283 CSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 317

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-53
 Identities = 78/330 (23%), Positives = 138/330 (41%), Gaps = 53/330 (16%)

Query: 351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 410
           ++ ++  + +G G +G+V    +  TGA  AIK    +    +S    K+  +E+++L H
Sbjct: 17  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKH 73

Query: 411 LKHENIVQYYGS----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 466
           ++HEN++         E +DD    YL     G+    + +H + + E  ++     +L 
Sbjct: 74  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLK 132

Query: 467 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 526
           GL Y+H+   IHRD+K  NL V+    +K+ DFG+A+             +  + APEVI
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--GYVVTRWYRAPEVI 190

Query: 527 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP---- 579
                     +    VDIWS+GC + EM+TGK  +      +  + + KV    P     
Sbjct: 191 L------NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244

Query: 580 ------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 615
                                   I    S    + L +  + +  +R +A E L HP+ 
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304

Query: 616 RNANYQNLSVPMRVFSRINLGDKSHDQVER 645
            + +       ++ +      D S D V+R
Sbjct: 305 ESLHDTEDEPQVQKY------DDSFDDVDR 328

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 3e-53
 Identities = 64/281 (22%), Positives = 114/281 (40%), Gaps = 31/281 (11%)

Query: 352 SQWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLG 409
           +  +   +IG G FG V     ++ G     AIK +     +  S +  +    E++VL 
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFAGELEVLC 65

Query: 410 HL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------------IT 453
            L  H NI+   G+     +LY+ +EY   G++  ++R+                   ++
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 454 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 513
              + +F   +  G+ YL     IHRD+   N+LV  + V K+ADFG+++       +  
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185

Query: 514 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 572
            +    WMA E +                D+WS G  + E+++ G  P+      +   K
Sbjct: 186 GRLPVRWMAIESLN-------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238

Query: 573 VL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +        P     E  D + +C+   P ERPS  ++L  
Sbjct: 239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 3e-53
 Identities = 77/295 (26%), Positives = 129/295 (43%), Gaps = 39/295 (13%)

Query: 353 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 412
           +++K + IG GT+G+V+   NRET    A+K    +  D           +EI +L  LK
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELK 59

Query: 413 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           H+NIV+ +     D  L +  E+     + +Y      D+   IV++F   +L GL + H
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 473 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 532
           S N +HRD+K  NLL++ +G +KLA+FG+A+         S +    W  P  +    + 
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 533 DGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNRTPP--------- 579
                   ++D+WS GC   E+     P        +  + +F++L              
Sbjct: 179 YST-----SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 580 -----------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 617
                            +   L++ G+D L      NPV+R SA E L+HP+  +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  178 bits (452), Expect = 3e-51
 Identities = 55/288 (19%), Positives = 105/288 (36%), Gaps = 38/288 (13%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           ++ G+ IG G+FG ++ GTN       AIK     P     A  ++   +  K+L     
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRR-SDAPQLRDEYRTYKLLAGCTG 62

Query: 414 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 473
              V Y+G E    H  + ++ + P S+   +    R  +   V    + +L  +  +H 
Sbjct: 63  IPNVYYFGQE--GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 474 TNTIHRDIKGANLLVDA-----SGVVKLADFGMAKHL--------TGLSYELSLKGSPNW 520
            + ++RDIK  N L+       + ++ + DFGM K               + +L G+  +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 521 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-----LN 575
           M+       + ++ + +     D+ +LG   +  L G  PW   +      K        
Sbjct: 180 MSINTH---LGREQSRR----DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232

Query: 576 RTPPIPEM---LSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRN 617
           ++ P+ E+      E   ++           P       L      R 
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 4e-51
 Identities = 69/308 (22%), Positives = 123/308 (39%), Gaps = 47/308 (15%)

Query: 340 HIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDI 387
           ++   P+  P   +W         GK +G G FG V   T       +   + A+K +  
Sbjct: 4   YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK- 62

Query: 388 IPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 446
                      + L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R
Sbjct: 63  ---PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119

Query: 447 EHCRD-----------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 489
                                 +    + +F+  +  G+A+L S N IHRD+   N+L+ 
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179

Query: 490 ASGVVKLADFGMAKHLTGLSYELS---LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 546
              + K+ DFG+A+ +   S  +     +    WMAPE I        N       D+WS
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-------NCVYTFESDVWS 232

Query: 547 LGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVER 603
            G  + E+ + G  P+         +K++        PE   +E  D +  C+  +P++R
Sbjct: 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 604 PSAVELLE 611
           P+  ++++
Sbjct: 293 PTFKQIVQ 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  175 bits (444), Expect = 1e-49
 Identities = 62/308 (20%), Positives = 115/308 (37%), Gaps = 60/308 (19%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK- 412
           +Q  + +GRG +  V+   N        +K +             K++++EIK+L +L+ 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENLRG 88

Query: 413 HENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 470
             NI+       + V     +  E+V+        ++  + +T+  +R +   IL  L Y
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDF----KQLYQTLTDYDIRFYMYEILKALDY 144

Query: 471 LHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
            HS   +HRD+K  N+++D     ++L D+G+A+             S  +  PE     
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE----- 199

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNR--------- 576
                      ++D+WSLGC +  M+  K P+      ++    + KVL           
Sbjct: 200 -LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258

Query: 577 -------------------------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 611
                                          ++S E  DFL +    +   R +A E +E
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

Query: 612 HPFIRNAN 619
           HP+     
Sbjct: 319 HPYFYTVV 326

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-49
 Identities = 60/292 (20%), Positives = 110/292 (37%), Gaps = 28/292 (9%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVL 408
            + +    + +G+G+FG VY G  +          V I   ++  S     +   E  V+
Sbjct: 18  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77

Query: 409 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------ITESIVRN 459
                 ++V+  G         + +E +  G +  Y+R               + S +  
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 460 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKG 516
               I +G+AYL++   +HRD+   N +V     VK+ DFGM + +    Y         
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 517 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLN 575
              WM+PE +K       +       D+WS G  + E+ T  + P+      Q +  V+ 
Sbjct: 198 PVRWMSPESLK-------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250

Query: 576 -RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE------HPFIRNANY 620
                 P+       + +  C+  NP  RPS +E++        P  R  ++
Sbjct: 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 1e-48
 Identities = 64/294 (21%), Positives = 111/294 (37%), Gaps = 50/294 (17%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 416
            + IG+G FG V+ G  +  G   A+K            E     E EI     L+HENI
Sbjct: 8   QESIGKGRFGEVWRG--KWRGEEVAVKIFS------SREERSWFREAEIYQTVMLRHENI 59

Query: 417 VQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 472
           + +  ++  D+     L++  +Y   GS+  Y+  +   +T   +        +GLA+LH
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH 117

Query: 473 S--------TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPN 519
                        HRD+K  N+LV  +G   +AD G+A      +  + +      G+  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 520 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-- 577
           +MAPEV+   +    + +     DI+++G    E+          E  Q  +  L  +  
Sbjct: 178 YMAPEVLDDSINM-KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 578 ---------------PPIPEMLSSEG-----KDFLLRCFLRNPVERPSAVELLE 611
                          P IP    S          +  C+  N   R +A+ + +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 2e-48
 Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 46/299 (15%)

Query: 349 PKKSQW-------QKGKLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKS 394
           P+  +W         GK +G G FG V +                 A+K +        +
Sbjct: 3   PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK----SDAT 58

Query: 395 AECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-- 451
            + +  L  E++++  + KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118

Query: 452 -------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 498
                        ++   + +    +  G+ YL S   IHRD+   N+LV    V+K+AD
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178

Query: 499 FGMAKHLTGLSYELSL---KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 555
           FG+A+ +  + Y       +    WMAPE +        +       D+WS G  + E+ 
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-------DRIYTHQSDVWSFGVLLWEIF 231

Query: 556 TGKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           T           + +FK+L        P   ++E    +  C+   P +RP+  +L+E 
Sbjct: 232 TLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 8e-48
 Identities = 64/311 (20%), Positives = 116/311 (37%), Gaps = 62/311 (19%)

Query: 355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           Q  K IG G  G V    +     + AIK    +    ++    K+  +E+ ++  + H+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 415 NIVQYYGSEVVDD------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 468
           NI+                 +Y+ +E +         +    ++    +      +L G+
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGI 132

Query: 469 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 528
            +LHS   IHRD+K +N++V +   +K+ DFG+A+             +  + APEVI  
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL- 191

Query: 529 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEML--- 584
                        VDIWS+GC + EM+  K  +   +      KV+     P PE +   
Sbjct: 192 ------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 585 --------------------------------------SSEGKDFLLRCFLRNPVERPSA 606
                                                 +S+ +D L +  + +P +R S 
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 607 VELLEHPFIRN 617
            + L+HP+I  
Sbjct: 306 DDALQHPYINV 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-47
 Identities = 67/298 (22%), Positives = 123/298 (41%), Gaps = 49/298 (16%)

Query: 355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 414
           Q    +G G +GSV    + +TG   A+K    +    +S    K+  +E+++L H+KHE
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 415 NIVQYYGS-----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 469
           N++           + + +    + ++    +N  V+  C+ +T+  V+     IL GL 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLK 135

Query: 470 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 529
           Y+HS + IHRD+K +NL V+    +K+ DFG+A+H            +  + APE++   
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML-- 191

Query: 530 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML----- 584
                       VDIWS+GC + E+LTG+  +   +    +  +L         L     
Sbjct: 192 ----NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 585 --------------------------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 616
                                     +    D L +  + +  +R +A + L H +  
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 4e-47
 Identities = 62/287 (21%), Positives = 117/287 (40%), Gaps = 31/287 (10%)

Query: 350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVL 408
            + + + GK +GRG FG V          +   + V + +  +  +    + L  E+K+L
Sbjct: 11  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70

Query: 409 GHLKHENIVQYYGSEVVDD--HLYIYLEYVHPGSINRYVREHCRD--------------- 451
            H+ H   V             L + +E+   G+++ Y+R    +               
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 452 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 511
           +T   +  ++  +  G+ +L S   IHRD+   N+L+    VVK+ DFG+A+ +      
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 512 L---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGP 567
           +     +    WMAPE I        +    +  D+WS G  + E+ +    P+   +  
Sbjct: 191 VRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243

Query: 568 QAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 612
           +   + L        P+  + E    +L C+   P +RP+  EL+EH
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  141 bits (356), Expect = 2e-37
 Identities = 61/346 (17%), Positives = 117/346 (33%), Gaps = 86/346 (24%)

Query: 354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 413
           +   + +G G F +V++  +       A+K V             +  E EIK+L  +  
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAEDEIKLLQRVND 68

Query: 414 ENIVQ-------------YYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVR 458
            +  +              + +    + +++ + +   G     +  +   R I    V+
Sbjct: 69  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128

Query: 459 NFTRHILNGLAYL-HSTNTIHRDIKGANLLVDASGV------VKLADFGMAKHLTGLSYE 511
             ++ +L GL Y+      IH DIK  N+L++          +K+AD G A       + 
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHY 186

Query: 512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----- 566
            +   +  + +PEV+                DIWS  C + E++TG   +   EG     
Sbjct: 187 TNSIQTREYRSPEVLL-------GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239

Query: 567 ---------------PQAMFK----------------------------VLNRTPPIPEM 583
                          P  + +                            VL       + 
Sbjct: 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 299

Query: 584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA-NYQNLSVPMR 628
            + E  DFL      +P +R  A  L+ HP++++    + + VP R
Sbjct: 300 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDR 345

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  105 bits (263), Expect = 9e-27
 Identities = 35/210 (16%), Positives = 71/210 (33%), Gaps = 36/210 (17%)

Query: 357 GKLIGRGTFGSVYIGTNRETGASCAIKEVDI-------------IPDDPKSAECIKQLEQ 403
           GKL+G G   +V+   + E    C +K   +               D   S   I+    
Sbjct: 5   GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 404 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 463
           E + L  L+   + + Y     + +  + +E +    + R   E+  ++           
Sbjct: 64  EFRALQKLQGLAVPKVYA---WEGN-AVLMELIDAKELYRVRVENPDEVL--------DM 111

Query: 464 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 523
           IL  +A  +    +H D+   N+LV   G + + DF  +  +    +   L+        
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILE-----RDV 165

Query: 524 EVIKAVMQKDGNPKLALAVDIWSLGCTVIE 553
             I     +    +     DI S    +++
Sbjct: 166 RNIITYFSRTYRTE----KDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	739
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.95
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.94
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.64
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.53
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	98.03
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.88
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.83

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=439.14  Aligned_cols=259  Identities=25%  Similarity=0.420  Sum_probs=231.1

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEE
Q ss_conf             99906813881249769999999799947999996318999550999999999999994169987575146212155589
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .++|++++.||+|+||+||+|+++.+|..||||++...     .....+.+.+|+.+|+.|+|||||++++++.+++.+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-----CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf             65758988984076819999998899989999998452-----4316999999999998679979992999999899999


Q ss_pred             EEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECC--CCCEEEEECCCCHHCCCC
Q ss_conf             999522798700243201466307889887775799999977299240447776648668--993899302630101375
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~--~g~vKL~DFGLA~~~~~~  508 (739)
                      ||||||.||+|.+++....+.+++..++.|+.||+.||.|||++||+||||||+|||++.  ++.+||+|||+|+.+...
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             EEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf             99985799889999976237899999999999999999999756976000154673641688986999545210442565


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC----CCC
Q ss_conf             5333457999998769999853039999899310356778999999619999999983689999860599999----559
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EML  584 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~iP----~~l  584 (739)
                      ....+..||+.|||||++.+       ..|+.++|||||||++|||++|+.||.+.+..+.+..+......++    ..+
T Consensus       180 ~~~~~~~gT~~Y~aPEv~~~-------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  252 (350)
T d1koaa2         180 QSVKVTTGTAEFAAPEVAEG-------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI  252 (350)
T ss_dssp             SCEEEECSCTTTCCHHHHHT-------CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGC
T ss_pred             CCCCEECCCCCCCCHHHHCC-------CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf             43200068624218899758-------99872676554659999998598998997999999999847889894223589


Q ss_pred             CHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCC
Q ss_conf             9999999999400199999999999809354345557
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ  621 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~~~~  621 (739)
                      ++++++||.+||..||.+|||+.|+|+||||+.....
T Consensus       253 s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             CHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCCC
T ss_conf             9999999999756896679089998629132889888

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=439.82  Aligned_cols=256  Identities=21%  Similarity=0.381  Sum_probs=230.3

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEE
Q ss_conf             99906813881249769999999799947999996318999550999999999999994169987575146212155589
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .++|++++.||+|+||+||+|+++.+|+.||||++...     .......+.+|+.+|+.|+|||||++++++.+++.+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-----CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf             40359989993177829999999899979999998872-----6467999999999998679979891999999899999


Q ss_pred             EEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEEC--CCCCEEEEECCCCHHCCCC
Q ss_conf             99952279870024320146630788988777579999997729924044777664866--8993899302630101375
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASGVVKLADFGMAKHLTGL  508 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId--~~g~vKL~DFGLA~~~~~~  508 (739)
                      ||||||+||+|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||++  .++.+||+|||+|+.+...
T Consensus       103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf             99982899808888986389989999999999999999999977926513144553113467884899525630343788


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC----CCC
Q ss_conf             5333457999998769999853039999899310356778999999619999999983689999860599999----559
Q 004660          509 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EML  584 (739)
Q Consensus       509 ~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~iP----~~l  584 (739)
                      .......||+.|+|||++.       +..|+.++|||||||+||||++|+.||.+.+..+.+..+......++    ..+
T Consensus       183 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  255 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVD-------REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV  255 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHT-------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTS
T ss_pred             CCEEECCCCCCCCCHHHHC-------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf             7201004764534899974-------799897633389899999999688998997999999999847889893002479


Q ss_pred             CHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             9999999999400199999999999809354345
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~  618 (739)
                      ++++++||.+||..||.+|||+.|+|+||||+..
T Consensus       256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             9999999999756996689189999609734888

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=438.21  Aligned_cols=254  Identities=37%  Similarity=0.607  Sum_probs=224.7

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEE
Q ss_conf             99906813881249769999999799947999996318999550999999999999994169987575146212155589
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++......  .   .+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--K---KELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--C---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH--H---HHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
T ss_conf             10538878981285829999999899989999998430172--7---999999999998679998805857798899989


Q ss_pred             EEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCC-C
Q ss_conf             999522798700243201466307889887775799999977299240447776648668993899302630101375-5
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~-~  509 (739)
                      ||||||.||+|.+++.+  ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+... .
T Consensus        94 ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             EEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEECCCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf             99970379808988641--5999999999999999999999987972267768886887899686425156413213666


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC---CCCCCCCCCH
Q ss_conf             3334579999987699998530399998993103567789999996199999999836899998605---9999955999
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS  586 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~---~~~iP~~ls~  586 (739)
                      .....+||+.|+|||++.       +..|+.++|||||||++|||++|+.||.+.+....+..+...   ....+..+++
T Consensus       172 ~~~~~~gt~~Y~aPE~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  244 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  244 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHS-------SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCH
T ss_pred             CCCCCCCCCCCCCHHHHC-------CCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCH
T ss_conf             444444477736826644-------7998801203137299999804889989979999999998579998888553799


Q ss_pred             HHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             99999999400199999999999809354345
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~  618 (739)
                      ++++||.+||..||.+|||+.|+|+||||+..
T Consensus       245 ~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             99999999866996689099999649965778

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=436.22  Aligned_cols=258  Identities=26%  Similarity=0.475  Sum_probs=221.0

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEE
Q ss_conf             89990681388124976999999979994799999631899955099999999999999416998757514621215558
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++....    ..+..+.+.+|+++|+.++|||||++++++.+++.+
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~   78 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   78 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH----CCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEE
T ss_conf             8746089989721748099999999999799999984566----412799999999999857998884696540467436


Q ss_pred             EEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC
Q ss_conf             99995227987002432014663078898877757999999772992404477766486689938993026301013755
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~  509 (739)
                      |||||||.||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus        79 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf             7988645898089997537-999999999999999999999997598357546899788789987983231422404688


Q ss_pred             ---CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHCC--CCCCCC
Q ss_conf             ---3334579999987699998530399998993103567789999996199999999836899-9986059--999955
Q 004660          510 ---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM-FKVLNRT--PPIPEM  583 (739)
Q Consensus       510 ---~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~-~~i~~~~--~~iP~~  583 (739)
                         .....+||+.|||||++.+      ..+++.++|||||||+||||++|+.||......... ..+....  ...+..
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~------~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  231 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKR------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK  231 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHC------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGG
T ss_pred             CCCCCCCEEECCCCCCHHHHCC------CCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf             6531113255747428728618------9999971016173799999982997888898599999998638887886446


Q ss_pred             CCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             99999999999400199999999999809354345
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~  618 (739)
                      +++++++||.+||..||++|||+.|+|+||||+..
T Consensus       232 ~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         232 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             99999999999767996689099999619845859

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=440.78  Aligned_cols=262  Identities=29%  Similarity=0.464  Sum_probs=234.2

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEE
Q ss_conf             99906813881249769999999799947999996318999550999999999999994169987575146212155589
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++....  ......+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCC
T ss_conf             4742898898317684999999989998999999815654--49799999999999998679998877876403564211


Q ss_pred             EEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCC-CC
Q ss_conf             99952279870024320146630788988777579999997729924044777664866899389930263010137-55
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LS  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~-~~  509 (739)
                      +|||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus        82 iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             CCEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCCC
T ss_conf             100035798605555325-6775999999999996521134315962246477784765899888820565200356786


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf             33345799999876999985303999989931035677899999961999999998368999986059999955999999
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK  589 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~  589 (739)
                      ...+.+||+.|+|||++.       +..|+.++|||||||++|||++|+.||.+.+..+.+..+......+|..++++++
T Consensus       161 ~~~~~~GT~~Y~aPE~~~-------~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  233 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK  233 (337)
T ss_dssp             CBCCCEECGGGCCGGGGS-------SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             CCCCCEECHHHHHHHHCC-------CCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHH
T ss_conf             205510088996666504-------8988833310223067889987899999969999999985289989866899999


Q ss_pred             HHHHHHCCCCCCCCC-----CHHHHHCCCCCCCCCCCC
Q ss_conf             999994001999999-----999998093543455578
Q 004660          590 DFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQN  622 (739)
Q Consensus       590 dLI~kcL~~DP~kRp-----Ta~eiLqHpff~~~~~~~  622 (739)
                      +||.+||++||.+|+     ++.|+++||||+..+|..
T Consensus       234 dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~  271 (337)
T d1o6la_         234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD  271 (337)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCHHH
T ss_conf             99986663893442256523499997291503699999

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=439.88  Aligned_cols=263  Identities=27%  Similarity=0.502  Sum_probs=233.5

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEEE
Q ss_conf             99068138812497699999997999479999963189995509999999999999941699875751462121555899
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++++.||+|+||+||+|+++.+++.||||++.....  ........+.+|+++|+.++|||||++++++.+++.+|+
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf             877898898508790999999989997999999865775--577789999999999987688886179999998998899


Q ss_pred             EEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC--
Q ss_conf             995227987002432014663078898877757999999772992404477766486689938993026301013755--
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--  509 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~--  509 (739)
                      |||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+....  
T Consensus        86 vmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCC
T ss_conf             99704898777765315-99999999999999999997621650884767741236688853886032102422567764


Q ss_pred             -CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf             -3334579999987699998530399998993103567789999996199999999836899998605999995599999
Q 004660          510 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG  588 (739)
Q Consensus       510 -~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el  588 (739)
                       ...+.+||+.|+|||++.+       ..|+.++|||||||+||||++|+.||.+.+..+.+.++......+|..+++++
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  237 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTE-------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA  237 (288)
T ss_dssp             -----CCCCGGGCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHH
T ss_pred             CCCCCCCCCCCCCCCEEECC-------CCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHH
T ss_conf             33355567755258440026-------89896662304569999980388998995999999999718999985479999


Q ss_pred             HHHHHHHCCCCCCCCCCHHH------HHCCCCCCCCCCCCCC
Q ss_conf             99999940019999999999------9809354345557888
Q 004660          589 KDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNLS  624 (739)
Q Consensus       589 ~dLI~kcL~~DP~kRpTa~e------iLqHpff~~~~~~~~~  624 (739)
                      ++||.+||..||.+|+|+.|      +++||||+..+|..+.
T Consensus       238 ~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~  279 (288)
T d1uu3a_         238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  279 (288)
T ss_dssp             HHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             HHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCCHHHHH
T ss_conf             999999855797689197897377898769764789988961

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=438.72  Aligned_cols=256  Identities=30%  Similarity=0.558  Sum_probs=230.0

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEE
Q ss_conf             99906813881249769999999799947999996318999550999999999999994169987575146212155589
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.....  ........+.+|+.+|+.++|||||++++++.+++.+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC--CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf             5376998898517785899999989994999999816885--67689999999999998568888885999999899989


Q ss_pred             EEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCC
Q ss_conf             99952279870024320146630788988777579999997729924044777664866899389930263010137553
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~~  510 (739)
                      ||||||+||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus        83 ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             EEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC-
T ss_conf             998504798589887504-899999999999999999999998894652202344146689987115556335448885-


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf             33457999998769999853039999899310356778999999619999999983689999860599999559999999
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD  590 (739)
Q Consensus       511 ~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~d  590 (739)
                      .....||+.|||||++.+       ..|+.++|||||||+||||++|+.||.+.+..+.+..+......+|..+++++++
T Consensus       161 ~~~~~Gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  233 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEG-------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD  233 (263)
T ss_dssp             CEETTEEGGGCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred             CCCCCCCCCCCCHHHHCC-------CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHH
T ss_conf             235578876349999758-------9989314404675999998329999888999999999971899998668999999


Q ss_pred             HHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf             999940019999999999980935434
Q 004660          591 FLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       591 LI~kcL~~DP~kRpTa~eiLqHpff~~  617 (739)
                      ||.+||..||++|||+.|+|+||||+.
T Consensus       234 li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         234 LISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             999976479768909999971907078

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=435.93  Aligned_cols=260  Identities=34%  Similarity=0.576  Sum_probs=227.9

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEE
Q ss_conf             99906813881249769999999799947999996318999550999999999999994169987575146212155589
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .+.|++++.||+|+||+||+|+++.++..||+|+++....     ...+.+.+|+++|+.++|||||++++++.+++.+|
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-----GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCH-----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf             0375984799307781999999999993999999872899-----99999999999998679999884988980099589


Q ss_pred             EEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCC-C
Q ss_conf             999522798700243201466307889887775799999977299240447776648668993899302630101375-5
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~-~  509 (739)
                      ||||||+||+|.+++.+..+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus        86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             EEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCCC
T ss_conf             99962799818899986289999999999999999999999988988714070031487899989971612303577864


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC---CCCCCCCH
Q ss_conf             333457999998769999853039999899310356778999999619999999983689999860599---99955999
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSS  586 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~---~iP~~ls~  586 (739)
                      ...+..||+.|+|||++.+...  ....|+.++|||||||++|||++|+.||.+.+..+.+.++.....   ..+..+++
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~--~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~  243 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETS--KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS  243 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCST--TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred             CCCCCCCCCCCCCHHHHHHCCC--CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCH
T ss_conf             1001025626479999832025--78888806657878999999820889999989999999997079987776566999


Q ss_pred             HHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf             9999999940019999999999980935434
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~eiLqHpff~~  617 (739)
                      ++++||.+||+.||.+|||+.|+|+||||+.
T Consensus       244 ~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             9999999976699668919999962923188

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=433.87  Aligned_cols=258  Identities=27%  Similarity=0.422  Sum_probs=228.6

Q ss_pred             CCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCE
Q ss_conf             78999068138812497699999997999479999963189995509999999999999941699875751462121555
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ...+.|++++.||+|+||+||+|+++.+++.||||++......    .....+.+|+.+|+.++|||||++++++.+++.
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGH   81 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf             7766669988994065839999999999989999998157731----289999999999986799899919899998998


Q ss_pred             EEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEEC---CCCCEEEEECCCCHHC
Q ss_conf             8999952279870024320146630788988777579999997729924044777664866---8993899302630101
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKHL  505 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId---~~g~vKL~DFGLA~~~  505 (739)
                      +|||||||+||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+|||+.   .++.+||+|||+|+..
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EEEEEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf             88988526898488865303-67887899999999999987524130556870463001104688824998315435872


Q ss_pred             CCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC----C
Q ss_conf             375533345799999876999985303999989931035677899999961999999998368999986059999----9
Q 004660          506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI----P  581 (739)
Q Consensus       506 ~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~i----P  581 (739)
                      .......+.+||+.|||||++.+       ..|+.++|||||||+||||++|+.||.+....+....+......+    +
T Consensus       161 ~~~~~~~~~~GT~~y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  233 (307)
T d1a06a_         161 DPGSVLSTACGTPGYVAPEVLAQ-------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW  233 (307)
T ss_dssp             ------------CTTSCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTT
T ss_pred             CCCCEEEEEEECCCCCCCHHHCC-------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
T ss_conf             58970440032842259188737-------99980787345159999998597999998999999998616877787666


Q ss_pred             CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             5599999999999400199999999999809354345
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~  618 (739)
                      ..+++++++||.+||..||.+|||+.|+|+||||+..
T Consensus       234 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             6789999999999760897579189998629844799

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=438.90  Aligned_cols=263  Identities=28%  Similarity=0.537  Sum_probs=221.2

Q ss_pred             CCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCE
Q ss_conf             78999068138812497699999997999479999963189995509999999999999941699875751462121555
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       349 ~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ...++|++++.||+|+||+||+|+++.+|+.||+|+++....    ......+.+|+.+|+.++|||||++++++.+++.
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   78 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   78 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE
T ss_pred             CCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC----HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf             875688897897127780999999989996999999875409----7899999999999986799999949999998999


Q ss_pred             EEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCCCCEEECCCCCEEEEECCCCHHCCC
Q ss_conf             899995227987002432014663078898877757999999772-9924044777664866899389930263010137
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  507 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs-~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~  507 (739)
                      +|||||||.||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.+..
T Consensus        79 ~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf             99999767998689987424-99999999999999999999999859997144577994687899899954877625678


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----------------
Q ss_conf             5533345799999876999985303999989931035677899999961999999998368999----------------
Q 004660          508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF----------------  571 (739)
Q Consensus       508 ~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~----------------  571 (739)
                      . ...+.+||++|||||++.+       ..|+.++||||+||++|||++|+.||.+.+......                
T Consensus       158 ~-~~~~~~GT~~Y~APEvl~~-------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (322)
T d1s9ja_         158 S-MANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  229 (322)
T ss_dssp             H-TC---CCSSCCCCHHHHHC-------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred             C-CCCCCCCCCCCCCCHHHCC-------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf             8-6211137714119468758-------9989488899899999999988899899887899999988751775457742


Q ss_pred             --------------------------HHHHC-CCCCC-CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCCCC
Q ss_conf             --------------------------98605-99999-559999999999940019999999999980935434555788
Q 004660          572 --------------------------KVLNR-TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL  623 (739)
Q Consensus       572 --------------------------~i~~~-~~~iP-~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~~~~~~  623 (739)
                                                .+... .+..+ ..++.++++||.+||..||.+|||+.|+|+||||+...+..+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~  309 (322)
T d1s9ja_         230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV  309 (322)
T ss_dssp             ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCCCCCC
T ss_conf             12333221111222354134778876650268766764448999999999986899467908999960986476982313


Q ss_pred             C
Q ss_conf             8
Q 004660          624 S  624 (739)
Q Consensus       624 ~  624 (739)
                      .
T Consensus       310 d  310 (322)
T d1s9ja_         310 D  310 (322)
T ss_dssp             C
T ss_pred             C
T ss_conf             4

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=432.50  Aligned_cols=259  Identities=29%  Similarity=0.449  Sum_probs=232.4

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEE
Q ss_conf             99906813881249769999999799947999996318999550999999999999994169987575146212155589
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.....  ........+.+|+++|+.++|||||++++++...+.+|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC--CCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCC
T ss_conf             2370898896117680899999989998999999826774--58899999999999999748772740344443222223


Q ss_pred             EEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCC
Q ss_conf             99952279870024320146630788988777579999997729924044777664866899389930263010137553
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~~  510 (739)
                      +||||+.||+|..++... +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+...  
T Consensus       118 ~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             CCCCCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC--
T ss_conf             222233466226667515-89899999999999999899998599861767999936077897886101033322566--


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf             33457999998769999853039999899310356778999999619999999983689999860599999559999999
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD  590 (739)
Q Consensus       511 ~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~d  590 (739)
                      ..+..||+.|||||++.+       ..|+.++|||||||++|||++|+.||.+.+....+..+......+|..+++++.+
T Consensus       195 ~~~~~Gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  267 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILS-------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD  267 (350)
T ss_dssp             BCCCEECGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHH
T ss_pred             CCCCCCCCCCCCHHHHCC-------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHH
T ss_conf             643367635678899717-------9988533114500789999758899899599999999861798897668999999


Q ss_pred             HHHHHCCCCCCCCC-----CHHHHHCCCCCCCCCCC
Q ss_conf             99994001999999-----99999809354345557
Q 004660          591 FLLRCFLRNPVERP-----SAVELLEHPFIRNANYQ  621 (739)
Q Consensus       591 LI~kcL~~DP~kRp-----Ta~eiLqHpff~~~~~~  621 (739)
                      ||.+||..||.+|+     |+.++++||||+..+|.
T Consensus       268 li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf             999983409986065534549999719051589989

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=433.51  Aligned_cols=259  Identities=25%  Similarity=0.497  Sum_probs=232.2

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEEE
Q ss_conf             99068138812497699999997999479999963189995509999999999999941699875751462121555899
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.....  ......+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC--CCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEE
T ss_conf             470888897207680899999989997999999845775--488999999999999986369675330356852880056


Q ss_pred             EEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCC
Q ss_conf             99522798700243201466307889887775799999977299240447776648668993899302630101375533
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~~~  511 (739)
                      |||||.||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....  .
T Consensus        82 vmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~  158 (316)
T d1fota_          82 IMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--T  158 (316)
T ss_dssp             EECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--B
T ss_pred             EEEECCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEECCC--C
T ss_conf             76503786322343222-21110079999999987655412476770556810503868998898317521671245--6


Q ss_pred             CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf             34579999987699998530399998993103567789999996199999999836899998605999995599999999
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF  591 (739)
Q Consensus       512 ~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dL  591 (739)
                      .+.+||+.|||||++.+       ..|+.++|||||||++|||++|+.||.+.+..+.+.++......+|..++++++++
T Consensus       159 ~~~~Gt~~Y~APE~l~~-------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  231 (316)
T d1fota_         159 YTLCGTPDYIAPEVVST-------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL  231 (316)
T ss_dssp             CCCCSCTTTCCHHHHTT-------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             CCCCCCCCCCCHHHHCC-------CCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHH
T ss_conf             43457634359999838-------99980430465333689997598999996999999999708988997789999999


Q ss_pred             HHHHCCCCCCCCC-----CHHHHHCCCCCCCCCCCC
Q ss_conf             9994001999999-----999998093543455578
Q 004660          592 LLRCFLRNPVERP-----SAVELLEHPFIRNANYQN  622 (739)
Q Consensus       592 I~kcL~~DP~kRp-----Ta~eiLqHpff~~~~~~~  622 (739)
                      |.+||.+||.+|+     |++++|+||||+..+|+.
T Consensus       232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~  267 (316)
T d1fota_         232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  267 (316)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             HHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCHHH
T ss_conf             999954499766643102199998193514679899

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=429.62  Aligned_cols=265  Identities=25%  Similarity=0.437  Sum_probs=233.5

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCC-CHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCE
Q ss_conf             89990681388124976999999979994799999631899955-09999999999999941699875751462121555
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  428 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~-~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~  428 (739)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++........ .....+.+.+|+.+|+.++|||||++++++.+++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf             55677982798117895999999999998999999875663213406899999999999986799899938899997998


Q ss_pred             EEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCC----CEEEEECCCCHH
Q ss_conf             8999952279870024320146630788988777579999997729924044777664866899----389930263010
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKH  504 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g----~vKL~DFGLA~~  504 (739)
                      +|||||||+||+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++    .+||+|||+|..
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCCCCCHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHH
T ss_conf             99999867786431001035-64215578999999999987666254221133301279825898666469643344210


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC---
Q ss_conf             13755333457999998769999853039999899310356778999999619999999983689999860599999---
Q 004660          505 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP---  581 (739)
Q Consensus       505 ~~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~iP---  581 (739)
                      +.......+..||+.|+|||++.       ...++.++|||||||++|||++|+.||.+.+..+.+..+......++   
T Consensus       167 ~~~~~~~~~~~~t~~y~APE~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1jksa_         167 IDFGNEFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY  239 (293)
T ss_dssp             CTTSCBCSCCCCCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHC-------CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCHH
T ss_conf             57776312247777430999981-------89999766522140999999708899889999999999981688887010


Q ss_pred             -CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCCC
Q ss_conf             -55999999999994001999999999998093543455578
Q 004660          582 -EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN  622 (739)
Q Consensus       582 -~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~~~~~  622 (739)
                       ..++.++++||.+||..||.+|||+.|+|+||||+..+++.
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCHHH
T ss_conf             478899999999998638966891999996190418887057

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=429.12  Aligned_cols=264  Identities=25%  Similarity=0.388  Sum_probs=223.7

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCC-CCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEE
Q ss_conf             99906813881249769999999799947999996318999-55099999999999999416998757514621215558
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~-~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      .++|+++++||+|+||+||+|+++.+|+.||||++...... ............|+.+++.++|||||++++++.+++.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf             77685101884288909999999999979999998458754266799999999999998508998588999999989988


Q ss_pred             EEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC
Q ss_conf             99995227987002432014663078898877757999999772992404477766486689938993026301013755
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~  509 (739)
                      |||||||.||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECCCC-
T ss_conf             9999914898389998732-55327899999999999999999779622044422167858896798220102333788-


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHCCCCCCCCCCH
Q ss_conf             3334579999987699998530399998993103567789999996199999999836---8999986059999955999
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVLNRTPPIPEMLSS  586 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~---~~~~~i~~~~~~iP~~ls~  586 (739)
                      ......||+.|+|||++..      +..|+.++|||||||+||||++|+.||.+....   .....+......+|..+++
T Consensus       161 ~~~~~~GT~~y~APE~~~~------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  234 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP  234 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHST------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred             CCCCCCCCCCCCHHHHHHC------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCH
T ss_conf             6433113455421687603------8999844104677899999985999888899899999998604688878877899


Q ss_pred             HHHHHHHHHCCCCCCCCCC-----HHHHHCCCCCCCCCCCC
Q ss_conf             9999999940019999999-----99998093543455578
Q 004660          587 EGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQN  622 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpT-----a~eiLqHpff~~~~~~~  622 (739)
                      ++++||.+||..||.+|+|     |+|+++||||+..+|..
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~  275 (364)
T d1omwa3         235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM  275 (364)
T ss_dssp             HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHHH
T ss_conf             99999999856698880887435799997491023789879

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=425.71  Aligned_cols=257  Identities=32%  Similarity=0.554  Sum_probs=225.1

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEEE
Q ss_conf             99068138812497699999997999479999963189995509999999999999941699875751462121555899
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ..|++++.||+|+||+||+|+++.++..||||++....  ....+..+.+.+|+++|+.++|||||++++++.+++.+|+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS--SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf             85676279701888099999998999399999984444--3588999999999999997789998238999998998899


Q ss_pred             EEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCC
Q ss_conf             99522798700243201466307889887775799999977299240447776648668993899302630101375533
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE  511 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~~~  511 (739)
                      |||||.+|+|..++... +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....   .
T Consensus        93 v~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~  168 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---A  168 (309)
T ss_dssp             EEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---B
T ss_pred             EEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCCC---C
T ss_conf             99806999457899737-9999999999999999999999868976667884217987999789844365334677---8


Q ss_pred             CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC--CCCCCCCHHHH
Q ss_conf             3457999998769999853039999899310356778999999619999999983689999860599--99955999999
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGK  589 (739)
Q Consensus       512 ~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~--~iP~~ls~el~  589 (739)
                      ....||+.|||||++.+.    ....|+.++|||||||++|||++|+.||.+....+.+..+.....  ..+..++++++
T Consensus       169 ~~~~GT~~Y~APE~~~~~----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~  244 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR  244 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTT----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHH
T ss_pred             CCCCCCCCCCCHHHHHCC----CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHH
T ss_conf             731347663688998346----7888672145455899999998788999997999999999828999888788899999


Q ss_pred             HHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             99999400199999999999809354345
Q 004660          590 DFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~eiLqHpff~~~  618 (739)
                      +||.+||..||.+|||+.|+|+||||...
T Consensus       245 ~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf             99999773796579189999719975378

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=426.09  Aligned_cols=256  Identities=25%  Similarity=0.385  Sum_probs=229.5

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEE
Q ss_conf             89990681388124976999999979994799999631899955099999999999999416998757514621215558
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ..++|++++.||+|+||+||+|+++.+++.||+|+++..      ......+.+|+++|+.++|||||++++++.+++.+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC------CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
T ss_conf             701058878983177839999999899969999997578------66599999999999857997989098999889988


Q ss_pred             EEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCC--CCEEEEECCCCHHCCC
Q ss_conf             99995227987002432014663078898877757999999772992404477766486689--9389930263010137
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--GVVKLADFGMAKHLTG  507 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~--g~vKL~DFGLA~~~~~  507 (739)
                      |||||||.||+|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||++.+  ..+||+|||+++....
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC
T ss_conf             99995389980889987538999999999999999999999987699751355444344378851899764411100346


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC----C
Q ss_conf             553334579999987699998530399998993103567789999996199999999836899998605999995----5
Q 004660          508 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE----M  583 (739)
Q Consensus       508 ~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~----~  583 (739)
                      ........||+.|+|||++.       +..|+.++|||||||++|+|++|+.||.+.+..+.+..+......++.    .
T Consensus       157 ~~~~~~~~~t~~y~ape~~~-------~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  229 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQ-------HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE  229 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHT-------TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             CCCCCCCCCCCCCCCCHHCC-------CCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHCCC
T ss_conf             77532122332223402104-------87778401130279999999828999999899999999983899988022367


Q ss_pred             CCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             99999999999400199999999999809354345
Q 004660          584 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       584 ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~  618 (739)
                      ++.++++||.+||..||.+|||+.|+|+||||+..
T Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             89999999999866996689099999639965667

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=425.79  Aligned_cols=255  Identities=29%  Similarity=0.478  Sum_probs=225.0

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEE--CCE
Q ss_conf             999068138812497699999997999479999963189995509999999999999941699875751462121--555
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDH  428 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~--~~~  428 (739)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++....   ......+.+.+|+++|++++|||||++++++.+  ++.
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT---SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred             CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
T ss_conf             333799679830889199999999999799999987465---79799999999999999778999824899999178998


Q ss_pred             EEEEEEECCCCCCCHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCCCCCEEECCCCCEEEEECC
Q ss_conf             89999522798700243201---466307889887775799999977299-----2404477766486689938993026
Q 004660          429 LYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTN-----TIHRDIKGANLLVDASGVVKLADFG  500 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~gL~yLHs~G-----IvHRDIKPeNILId~~g~vKL~DFG  500 (739)
                      +|||||||+||+|.+++.+.   ...+++..++.|+.||+.||.|||+.+     |+||||||+|||++.++.+||+|||
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECC
T ss_conf             99999568999389999851545789999999999999999999999716778878858676542574788857980010


Q ss_pred             CCHHCCCCC-CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC-C
Q ss_conf             301013755-33345799999876999985303999989931035677899999961999999998368999986059-9
Q 004660          501 MAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-P  578 (739)
Q Consensus       501 LA~~~~~~~-~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~-~  578 (739)
                      +|+.+.... ......||+.|||||++.       ...|+.++|||||||++|||++|+.||.+.+..+...++.... .
T Consensus       160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~  232 (269)
T d2java1         160 LARILNHDTSFAKAFVGTPYYMSPEQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR  232 (269)
T ss_dssp             HHHHC-----------CCCSCCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred             CEEECCCCCCCCCCCCCCCCCCCHHHHC-------CCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf             0032245777556677882327999983-------999993898875278999980188998998999999999718998


Q ss_pred             CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCC
Q ss_conf             9995599999999999400199999999999809354
Q 004660          579 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI  615 (739)
Q Consensus       579 ~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff  615 (739)
                      .+|..+++++++||.+||..||.+|||+.|+|+|||+
T Consensus       233 ~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf             8974359999999999767995579189999729819

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=418.82  Aligned_cols=265  Identities=26%  Similarity=0.446  Sum_probs=234.4

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCC----HHHHHHHHHHHHHHHHCC-CCCEEEECCCEEE
Q ss_conf             99906813881249769999999799947999996318999550----999999999999994169-9875751462121
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQEIKVLGHLK-HENIVQYYGSEVV  425 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~----~~~~~~l~~Ei~iL~~L~-HPNIVkl~~~~~~  425 (739)
                      .++|++++.||+|+||+||+|+++.+++.||||++.........    ......+.+|+.+|+.++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf             66388852884176849999999999989999999624464114788899999999999999985079974799762146


Q ss_pred             CCEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf             55589999522798700243201466307889887775799999977299240447776648668993899302630101
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~  505 (739)
                      ++.+|||||||+||+|.+++... +.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCEEEEEECCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEEC
T ss_conf             76059999768986689999865-99999999999999999999998759943234625489868998387124031672


Q ss_pred             CCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC----C
Q ss_conf             375533345799999876999985303999989931035677899999961999999998368999986059999----9
Q 004660          506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI----P  581 (739)
Q Consensus       506 ~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~i----P  581 (739)
                      ..........||+.|+|||++.+.... ....++.++||||+||++|||++|+.||.+.+.......+..+...+    .
T Consensus       161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~-~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (277)
T d1phka_         161 DPGEKLREVCGTPSYLAPEIIECSMND-NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW  239 (277)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCT-TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred             CCCCCEEEEECCCCCCCHHHHHCCCCC-CCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf             688721345246788898886053445-6788992331856560231032288898899999999999818988898543


Q ss_pred             CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf             559999999999940019999999999980935434
Q 004660          582 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       582 ~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~  617 (739)
                      ..+++++++||.+||..||.+||++.|+|+||||+.
T Consensus       240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf             468999999999976589668919999973978797

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=417.94  Aligned_cols=253  Identities=29%  Similarity=0.521  Sum_probs=215.6

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEE----C
Q ss_conf             999068138812497699999997999479999963189995509999999999999941699875751462121----5
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----D  426 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~----~  426 (739)
                      ...|+..++||+|+||+||+|+++.++..||+|++.....   .....+.+.+|+++|++++|||||++++++..    +
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             CCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHC---CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCC
T ss_conf             8778851697008284999999999995999999851227---9899999999999998579998506999984033458


Q ss_pred             CEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCCCCEEEC-CCCCEEEEECCCCH
Q ss_conf             5589999522798700243201466307889887775799999977299--24044777664866-89938993026301
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVD-ASGVVKLADFGMAK  503 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~G--IvHRDIKPeNILId-~~g~vKL~DFGLA~  503 (739)
                      ..+|||||||++|+|.+++.+. ..+++..++.|+.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+|+
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             CEEEEEEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCE
T ss_conf             8899999578989489997513-554699999999999999999997899799687674351166799988980057654


Q ss_pred             HCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHCCC--CC
Q ss_conf             01375533345799999876999985303999989931035677899999961999999998368999-9860599--99
Q 004660          504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTP--PI  580 (739)
Q Consensus       504 ~~~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~-~i~~~~~--~i  580 (739)
                      .... ....+.+||+.|||||++.+        .|+.++|||||||++|||++|+.||.+......+. .+..+..  .+
T Consensus       164 ~~~~-~~~~~~~GT~~Y~aPE~~~~--------~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~  234 (270)
T d1t4ha_         164 LKRA-SFAKAVIGTPEFMAPEMYEE--------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF  234 (270)
T ss_dssp             GCCT-TSBEESCSSCCCCCGGGGGT--------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred             ECCC-CCCCCCCCCCCCCCHHHHCC--------CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC
T ss_conf             2368-76677553813008988478--------99986711007999999987889998765599999999738998656


Q ss_pred             CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCC
Q ss_conf             955999999999994001999999999998093543
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR  616 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~  616 (739)
                      +..+++++++||.+||..||++|||+.|+|+||||+
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf             755789999999997637975892999996775409

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=422.27  Aligned_cols=259  Identities=27%  Similarity=0.495  Sum_probs=227.3

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHH-HCCCCCEEEECCCEEECCEEE
Q ss_conf             9906813881249769999999799947999996318999550999999999999994-169987575146212155589
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG-HLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       352 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~-~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      ++|++++.||+|+||+||+|+++.+++.||||+++....  ........+..|+.++. .++|||||++++++.+++.+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEE
T ss_conf             971886589408782899999999998999999805553--384899999999999998479996878988970498316


Q ss_pred             EEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCC-C
Q ss_conf             999522798700243201466307889887775799999977299240447776648668993899302630101375-5
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S  509 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~-~  509 (739)
                      ||||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus        80 ivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEEEECCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCCC
T ss_conf             777503798089986404-7899999999999999999999868934034765404444899630155530232356653


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf             33345799999876999985303999989931035677899999961999999998368999986059999955999999
Q 004660          510 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK  589 (739)
Q Consensus       510 ~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~  589 (739)
                      ......||+.|+|||++.       +..|+.++|||||||++|||++|+.||.+.+..+.+.++....+.+|..++++++
T Consensus       159 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~  231 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILL-------GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK  231 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             CCCCCCCCCCCCCHHHHC-------CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHH
T ss_conf             345457877768999982-------7998832320112278989873889999989999999997189989756799999


Q ss_pred             HHHHHHCCCCCCCCCCHH-HHHCCCCCCCCCC
Q ss_conf             999994001999999999-9980935434555
Q 004660          590 DFLLRCFLRNPVERPSAV-ELLEHPFIRNANY  620 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~-eiLqHpff~~~~~  620 (739)
                      +||.+||..||.+||++. ++++||||+..++
T Consensus       232 dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         232 DLLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             HHHHHHCCCCCCCCCCHHHHHHHCCHHCCCCH
T ss_conf             99999654489878388999980901315899

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=418.58  Aligned_cols=258  Identities=26%  Similarity=0.403  Sum_probs=218.9

Q ss_pred             EEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEEEEEE
Q ss_conf             68138812497699999997999479999963189995509999999999999941699875751462121555899995
Q 004660          355 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE  434 (739)
Q Consensus       355 ~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmE  434 (739)
                      +.+++||+|+||+||+|+++.+|+.||||+++............+.+.+|+.+|+.++|||||++++++..++.+|||||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHH
T ss_conf             95638512728299999999999699999984202124567999999999999986799998689854225874022045


Q ss_pred             ECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC-CCCC
Q ss_conf             227987002432014663078898877757999999772992404477766486689938993026301013755-3334
Q 004660          435 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS  513 (739)
Q Consensus       435 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~-~~~s  513 (739)
                      |+.++++..++.. ...+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.... ....
T Consensus        81 ~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          81 FMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             CCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred             HHCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             5345077655412-667789999999999999998863163550357762588537784114657610005787554330


Q ss_pred             CCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC--C-------------
Q ss_conf             5799999876999985303999989931035677899999961999999998368999986059--9-------------
Q 004660          514 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--P-------------  578 (739)
Q Consensus       514 ~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~--~-------------  578 (739)
                      .+||+.|+|||++.+      ...|+.++|||||||++|||++|++||.+....+.+.++....  +             
T Consensus       160 ~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         160 QVVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             SCCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             EECCHHHCCHHHHCC------CCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCH
T ss_conf             204733363999726------77888056436304289999859699999999999999998518997254521000213


Q ss_pred             --------C-----CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf             --------9-----9955999999999994001999999999998093543455
Q 004660          579 --------P-----IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       579 --------~-----iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~~  619 (739)
                              .     +...+++++++||.+||..||++|||+.|+|+||||++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             HHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             443034789886785656899999999997638945690899996799657899

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=407.84  Aligned_cols=259  Identities=29%  Similarity=0.490  Sum_probs=219.0

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEEE
Q ss_conf             99068138812497699999997999479999963189995509999999999999941699875751462121555899
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++....   .......+.+|+++|++++|||||++++++.+++.+|+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC---CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEE
T ss_conf             997765177237680999999999997999999802225---75899999999999986799838874453322432037


Q ss_pred             EEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCC-CC
Q ss_conf             99522798700243201466307889887775799999977299240447776648668993899302630101375-53
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SY  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~-~~  510 (739)
                      ||||+.++.+..........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... ..
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             EEEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCCCC
T ss_conf             88623774455544202568888999999999999999865288992135711401134676210357861343688641


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC------------
Q ss_conf             33457999998769999853039999899310356778999999619999999983689999860599------------
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------------  578 (739)
Q Consensus       511 ~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~------------  578 (739)
                      .....||+.|+|||++..      ..+++.++|||||||++|+|++|+.||.+.+..+.+..+.....            
T Consensus       159 ~~~~~gt~~y~apE~~~~------~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CEEECCCCEEEEHHHHCC------CCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCC
T ss_conf             001036521541122136------65777422103333134279668799898899999999998328983331444222


Q ss_pred             ------CC-----------CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf             ------99-----------955999999999994001999999999998093543455
Q 004660          579 ------PI-----------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       579 ------~i-----------P~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~~  619 (739)
                            .+           ...++.++++||.+||..||.+|||+.|+|+||||++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             4212434543222204441667899999999997639955791899996787014699

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=409.65  Aligned_cols=255  Identities=26%  Similarity=0.450  Sum_probs=217.4

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCC-CCHHHHHHHHHHHHHHHHCC--CCCEEEECCCEEEC
Q ss_conf             8999068138812497699999997999479999963189995-50999999999999994169--98757514621215
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLK--HENIVQYYGSEVVD  426 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~-~~~~~~~~l~~Ei~iL~~L~--HPNIVkl~~~~~~~  426 (739)
                      ..++|+++++||+|+||+||+|+++.+|+.||||++....... .......++.+|+.+|++++  |||||++++++.++
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
T ss_conf             78837996798408783999999999997999999856884433455679999999999997435898812799998309


Q ss_pred             CEEEEEEEECCC-CCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCC-CCEEEEECCCCHH
Q ss_conf             558999952279-87002432014663078898877757999999772992404477766486689-9389930263010
Q 004660          427 DHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKH  504 (739)
Q Consensus       427 ~~l~LVmEy~~g-GsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~-g~vKL~DFGLA~~  504 (739)
                      +.+|+||||+.+ +++.+++... ..+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CEEEEEEEECCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEE
T ss_conf             96899998336862289998615-89999999999999999999998779755667611147744788489775465353


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf             13755333457999998769999853039999899310356778999999619999999983689999860599999559
Q 004660          505 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML  584 (739)
Q Consensus       505 ~~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~l  584 (739)
                      .... ...+..||+.|+|||++.+      ...++.++|||||||++|||++|+.||...+      .+......++..+
T Consensus       161 ~~~~-~~~~~~GT~~y~aPE~~~~------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~  227 (273)
T d1xwsa_         161 LKDT-VYTDFDGTRVYSPPEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRV  227 (273)
T ss_dssp             CCSS-CBCCCCSCGGGSCHHHHHH------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCC
T ss_pred             CCCC-CCCCCCCCCCCCCHHHHCC------CCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH------HHHHCCCCCCCCC
T ss_conf             2444-5566565877479999848------9978865332554034536756889988736------7761544778779


Q ss_pred             CHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             9999999999400199999999999809354345
Q 004660          585 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       585 s~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~  618 (739)
                      ++++++||.+||..||++|||+.|+|+||||++.
T Consensus       228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             9999999999760897589399998539866788

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=409.95  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=213.2

Q ss_pred             CCCCEEE-EEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHH-CCCCCEEEECCCEEE---
Q ss_conf             9990681-38812497699999997999479999963189995509999999999999941-699875751462121---
Q 004660          351 KSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVV---  425 (739)
Q Consensus       351 ~~~Y~i~-k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~-L~HPNIVkl~~~~~~---  425 (739)
                      .++|.+. ++||+|+||+||+|+++.+++.||||+++.      .    ..+.+|+.++.+ ++|||||+++++|.+   
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------C----PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------S----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC------C----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
T ss_conf             14879810796545486999999889998999999897------4----7799999999986699997829899950346


Q ss_pred             -CCEEEEEEEECCCCCCCHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECC---CCCEEEEECC
Q ss_conf             -55589999522798700243201-466307889887775799999977299240447776648668---9938993026
Q 004660          426 -DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFG  500 (739)
Q Consensus       426 -~~~l~LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~---~g~vKL~DFG  500 (739)
                       +..+|||||||+||+|.+++.+. ...+++.+++.|+.||+.||+|||++||+||||||+|||++.   .+.+||+|||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             89789999977899849999986278775799999999999999999997698644410022011355556631135455


Q ss_pred             CCHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HC
Q ss_conf             30101375533345799999876999985303999989931035677899999961999999998368999986----05
Q 004660          501 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL----NR  576 (739)
Q Consensus       501 LA~~~~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~----~~  576 (739)
                      +|+............||+.|||||++.+       ..|+.++|||||||+||+|++|+.||.+.+.......+.    ..
T Consensus       160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~  232 (335)
T d2ozaa1         160 FAKETTSHNSLTTPCYTPYYVAPEVLGP-------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG  232 (335)
T ss_dssp             TCEECCCCCCCCCCSCCCSSCCCCCCCG-------GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC
T ss_pred             EEEECCCCCCCCCCCCCCCCCCCHHHCC-------CCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCC
T ss_conf             1233368886432267756379277748-------988888888764516778865889988988778899999998538


Q ss_pred             CCCCC----CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf             99999----55999999999994001999999999998093543455
Q 004660          577 TPPIP----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       577 ~~~iP----~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~~  619 (739)
                      ...+|    ..+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus       233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCCC
T ss_conf             88889854346999999999997569965790999997098761788

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=402.56  Aligned_cols=261  Identities=29%  Similarity=0.478  Sum_probs=216.2

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCC-CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHC---CCCCEEEECCCEEE
Q ss_conf             899906813881249769999999799-94799999631899955099999999999999416---99875751462121
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV  425 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~t-g~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HPNIVkl~~~~~~  425 (739)
                      ..++|++++.||+|+||+||+|++..+ ++.||||+++.........   ..+.+|+.+|+.|   +|||||++++++..
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~---~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~   81 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTV   81 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHH---HHHHHHHHHHHHHHHCCCCCCCEEEEEECC
T ss_conf             75897988899215586999999988899899999980232451679---999999999998742589880236632214


Q ss_pred             -----CCEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECC
Q ss_conf             -----555899995227987002432014663078898877757999999772992404477766486689938993026
Q 004660          426 -----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG  500 (739)
Q Consensus       426 -----~~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFG  500 (739)
                           ...+|++|||+.++.+..........+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHH
T ss_conf             66666746999997405871444443037899989999999999999999975889835798627898589975421000


Q ss_pred             CCHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC---
Q ss_conf             30101375533345799999876999985303999989931035677899999961999999998368999986059---
Q 004660          501 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---  577 (739)
Q Consensus       501 LA~~~~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~---  577 (739)
                      +++............||+.|+|||++.       +..|+.++|||||||++|||++|+.||.+.+..+.+..++...   
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~-------~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  234 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             HHHHHCCCCCCCCCCCCHHHCCCCHHC-------CCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCC
T ss_conf             101100234577765485114831001-------7988811100032899999987879989989899999999840799


Q ss_pred             ------------------------CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             ------------------------9999559999999999940019999999999980935434555
Q 004660          578 ------------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       578 ------------------------~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~~~  620 (739)
                                              ..++..+++++++||.+||..||++|||+.|+|+||||+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCHH
T ss_conf             6110532111103330223456454404458999999999987489667918999966963407521

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=399.52  Aligned_cols=258  Identities=28%  Similarity=0.401  Sum_probs=213.8

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEEC----
Q ss_conf             9990681388124976999999979994799999631899955099999999999999416998757514621215----
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  426 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~----  426 (739)
                      ..+|..+++||+|+||+||+|+++.+|+.||||++.....         ...+|+.+|++++|+|||++++++...    
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~   89 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK   89 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH---------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
T ss_conf             6776751698217683999999999997999999881606---------8999999998668989873878997447657


Q ss_pred             --CEEEEEEEECCCCCCCHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCC-CEEEEECCC
Q ss_conf             --55899995227987002432--0146630788988777579999997729924044777664866899-389930263
Q 004660          427 --DHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGM  501 (739)
Q Consensus       427 --~~l~LVmEy~~gGsL~~~L~--~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g-~vKL~DFGL  501 (739)
                        ..+|||||||+++.+..+..  .....+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus        90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             CCEEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCC
T ss_conf             73189999841688607888863103689999999999999999999998668764578860378735897116733660


Q ss_pred             CHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-----
Q ss_conf             010137553334579999987699998530399998993103567789999996199999999836899998605-----
Q 004660          502 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-----  576 (739)
Q Consensus       502 A~~~~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~-----  576 (739)
                      ++.+.......+..|++.|+|||++.+      ...|+.++||||+||++|||++|+.||...+..+.+..+...     
T Consensus       170 a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~  243 (350)
T d1q5ka_         170 AKQLVRGEPNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  243 (350)
T ss_dssp             CEECCTTSCCCSCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             HHHCCCCCCCCCCCCCCCCCCHHHHHC------CCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCH
T ss_conf             544047765320025555568277640------46888210002465277855028799898799999999999748981


Q ss_pred             ------------CCC------------CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCCCC
Q ss_conf             ------------999------------99559999999999940019999999999980935434555788
Q 004660          577 ------------TPP------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL  623 (739)
Q Consensus       577 ------------~~~------------iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~~~~~~  623 (739)
                                  ...            ....+++++.+||.+||..||++|||+.|+|+||||+.....+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~  314 (350)
T d1q5ka_         244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV  314 (350)
T ss_dssp             HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred             HHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCC
T ss_conf             77654306210110355445674444315689999999999976589557929999966984524667777

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=403.84  Aligned_cols=254  Identities=25%  Similarity=0.429  Sum_probs=217.0

Q ss_pred             CCCCCCCEEEEEEEECCCEEEEEEEECCCCC-----EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEECC
Q ss_conf             9789990681388124976999999979994-----799999631899955099999999999999416-9987575146
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG  421 (739)
Q Consensus       348 ~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~-----~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HPNIVkl~~  421 (739)
                      +...++|+++++||+|+||+||+|+++.+++     .||+|.+....    .......+.+|+.+|.++ +|||||++++
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC----CHHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf             57789939701983078819999998578855420499999966335----87899999999999997158996868778


Q ss_pred             CEEECCEEEEEEEECCCCCCCHHHHHCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEECC
Q ss_conf             2121555899995227987002432014----------------------663078898877757999999772992404
Q 004660          422 SEVVDDHLYIYLEYVHPGSINRYVREHC----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  479 (739)
Q Consensus       422 ~~~~~~~l~LVmEy~~gGsL~~~L~~~~----------------------~~Lse~~i~~i~~QIl~gL~yLHs~GIvHR  479 (739)
                      ++.+.+.+|+|||||++|+|.++++...                      ..+++..++.|+.||+.||.|||+++|+||
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEC
T ss_conf             88629958999972799959999986257775102210000122200125778999999999999999999973990505


Q ss_pred             CCCCCCEEECCCCCEEEEECCCCHHCCCCCCC---CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf             47776648668993899302630101375533---345799999876999985303999989931035677899999961
Q 004660          480 DIKGANLLVDASGVVKLADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT  556 (739)
Q Consensus       480 DIKPeNILId~~g~vKL~DFGLA~~~~~~~~~---~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLt  556 (739)
                      ||||+|||++.++.+||+|||+|+........   .+..||+.|||||++.+       ..|+.++|||||||+||||++
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwS~Gvil~emlt  261 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-------GIYTIKSDVWSYGILLWEIFS  261 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTT
T ss_pred             CCCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCC-------CCCCCCEECCCHHHHHHHHHH
T ss_conf             2703214434598289851422220457786156234357876578388727-------999963303000399999983


Q ss_pred             -CCCCCCCCCCHHHHHHHHHC--CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             -99999999836899998605--999995599999999999400199999999999809
Q 004660          557 -GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       557 -Gk~PF~~~~~~~~~~~i~~~--~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqH  612 (739)
                       |+.||.+......+.+++..  .++.|..+++++++||.+||..||++|||+.|+++|
T Consensus       262 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         262 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             89999999898999999985699899887678999999999758896689399999999

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=399.66  Aligned_cols=253  Identities=25%  Similarity=0.453  Sum_probs=219.6

Q ss_pred             CCCCCCEEEEEEEECCCEEEEEEEECCCCC---EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEE
Q ss_conf             789990681388124976999999979994---79999963189995509999999999999941699875751462121
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       349 ~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~---~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      ...++|++.++||+|+||+||+|+++.+++   .||||.+..    .......+.+.+|+.+|++++|||||++++++..
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   98 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK   98 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS----SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC----CCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
T ss_conf             080042785698027882999999957997889999999784----4598999999999999985799888618999962


Q ss_pred             CCEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf             55589999522798700243201466307889887775799999977299240447776648668993899302630101
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~  505 (739)
                      ++.+|+|||||++|+|.+++....+.+++.++..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf             88779999722798530021045679999999999999999889885279835761504489889991998884431575


Q ss_pred             CCCCCC------CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHC-C
Q ss_conf             375533------345799999876999985303999989931035677899999961-99999999836899998605-9
Q 004660          506 TGLSYE------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-T  577 (739)
Q Consensus       506 ~~~~~~------~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLt-Gk~PF~~~~~~~~~~~i~~~-~  577 (739)
                      ......      ....||+.|||||++.       ...++.++|||||||+||||++ |+.||.+....+.+..+..+ .
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~  251 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQ-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR  251 (299)
T ss_dssp             -----------------CGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred             CCCCCCCEEEECCCCCCCCCCCCHHHHH-------CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf             6777765365025666883003878883-------699786121445357899998679999999999999999973788


Q ss_pred             CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             99995599999999999400199999999999809
Q 004660          578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       578 ~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqH  612 (739)
                      ++.|..++.++.+||.+||..||++|||+.|++++
T Consensus       252 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         252 LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             99974226999999999758797689299999999

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=395.20  Aligned_cols=256  Identities=26%  Similarity=0.461  Sum_probs=217.4

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECC--
Q ss_conf             899906813881249769999999799947999996318999550999999999999994169987575146212155--
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--  427 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~--  427 (739)
                      ..++|++++.||+|+||+||+|+++.+|+.||||+++.   ........+.+.+|+++|+.++|||||++++++...+  
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~---~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSS---TTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECH---HHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCC
T ss_conf             47718998898017781999999999998999999852---225969999999999999866898754799986357655


Q ss_pred             ----EEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCH
Q ss_conf             ----5899995227987002432014663078898877757999999772992404477766486689938993026301
Q 004660          428 ----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       428 ----~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~  503 (739)
                          .+|+||||+ +++|..+++.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCCEEEEEEECC-CCCHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEE
T ss_conf             5541599998405-5218999874--022699999999999999999873787645668511112100122113431022


Q ss_pred             HCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC------
Q ss_conf             01375533345799999876999985303999989931035677899999961999999998368999986059------
Q 004660          504 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------  577 (739)
Q Consensus       504 ~~~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~------  577 (739)
                      .....  .....||+.|+|||++.+      ...++.++||||+||++|||++|+.||.+.+....+..+....      
T Consensus       170 ~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (346)
T d1cm8a_         170 QADSE--MTGYVVTRWYRAPEVILN------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE  241 (346)
T ss_dssp             ECCSS--CCSSCSCGGGCCTHHHHT------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             CCCCC--CCCCCCCCCCCCHHHHCC------CCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHH
T ss_conf             06876--310245533358899817------8789965010300389999997869988897689999998503788488


Q ss_pred             -------------------------CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf             -------------------------999955999999999994001999999999998093543455
Q 004660          578 -------------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       578 -------------------------~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~~  619 (739)
                                               ......+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             8865300034433115786665566775568999999999997729955792999996396237587

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=395.12  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=217.3

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEEE
Q ss_conf             99068138812497699999997999479999963189995509999999999999941699875751462121555899
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++.++||+|+||+||+|+++ +|+.||||++......   ....+.+.+|+.+|+.++|||||++++++..++..|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             CCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCC---HHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEE
T ss_conf             99634318722778189999968-9999999998123268---5899999999999986799868766012046773158


Q ss_pred             EEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCC-
Q ss_conf             9952279870024320146630788988777579999997729924044777664866899389930263010137553-
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~~-  510 (739)
                      +|||+.++.+..+.... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|........ 
T Consensus        78 ~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEEEHHHHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCCC
T ss_conf             99740045678998604-77514456899999999999860574882678775056868997873236643011467654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC-------------
Q ss_conf             3345799999876999985303999989931035677899999961999999998368999986059-------------
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------------  577 (739)
Q Consensus       511 ~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~-------------  577 (739)
                      .....|++.|+|||++.+      ...++.++|||||||++|||++|+.||.+.+..+.+..+....             
T Consensus       157 ~~~~~~~~~y~~pE~~~~------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             -----CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCEECCCCHHHHHHHHHC------CCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf             101024311013788717------88888410021117589999779799898898999999998638997110421233


Q ss_pred             ----------------CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf             ----------------9999559999999999940019999999999980935434
Q 004660          578 ----------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN  617 (739)
Q Consensus       578 ----------------~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~  617 (739)
                                      ......+++++++||.+||..||++|||+.|+|+||||+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             32214333335676466651258999999999986689668909999856922074

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=399.85  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=215.5

Q ss_pred             CCCCCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEE
Q ss_conf             99978999068138812497699999997999479999963189995509999999999999941699875751462121
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       346 ~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      .++...++|++++.||+|+||+||+|+++.++..||||+++..   ...   .+.+.+|+.+|+.++|||||++++++.+
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR   84 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC---CCH---HHHHHHHHHHHHHCCCCCEECCCCCEEE
T ss_conf             5174579939865982088808999999999969999997776---103---9999999999986799988267752745


Q ss_pred             CCEEEEEEEECCCCCCCHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf             55589999522798700243201-46630788988777579999997729924044777664866899389930263010
Q 004660          426 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~  504 (739)
                      ++.+|||||||.+|+|.+++... ...+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf             78547876314676067775303554157999999999999978889878930576045768998999289832445465


Q ss_pred             CCCCCCC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHH-CCCCC
Q ss_conf             1375533--345799999876999985303999989931035677899999961999999-9983689999860-59999
Q 004660          505 LTGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKVLN-RTPPI  580 (739)
Q Consensus       505 ~~~~~~~--~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~-~~~~~~~~~~i~~-~~~~i  580 (739)
                      .......  ....|+..|+|||++.+       ..|+.++|||||||++|||++|..||. +.+.......+.. ..+++
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~  237 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER  237 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             CCCCCCEEECCCCCCCCCCCHHHHCC-------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC
T ss_conf             37887221035566546669278727-------99981043021789999998679988774259999999855888888


Q ss_pred             CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             9559999999999940019999999999980
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~eiLq  611 (739)
                      |..+++++++||.+||..||++|||+.|+++
T Consensus       238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             7433099999999975779768939999999

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=395.28  Aligned_cols=256  Identities=24%  Similarity=0.416  Sum_probs=218.5

Q ss_pred             CCCCCCEEEEE-EEECCCEEEEEEEECC--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEE
Q ss_conf             78999068138-8124976999999979--99479999963189995509999999999999941699875751462121
Q 004660          349 PKKSQWQKGKL-IGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       349 ~~~~~Y~i~k~-LG~GsfG~Vy~a~~k~--tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      ...++|.+.+. ||+|+||+||+|.++.  ++..||||+++..    ......+.+.+|+++|++++|||||++++++..
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~   80 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA   80 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             ECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC
T ss_conf             5444718878487306080999999960897689999998820----397899999999999986799888068656036


Q ss_pred             CCEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf             55589999522798700243201466307889887775799999977299240447776648668993899302630101
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~  505 (739)
                       +.+|||||||++|+|.+++......+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus        81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             -CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf             -8079999807899689975212569999999999999999878998688105767646604546885420331342115


Q ss_pred             CCCCC----CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHC-CCC
Q ss_conf             37553----3345799999876999985303999989931035677899999961-99999999836899998605-999
Q 004660          506 TGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPP  579 (739)
Q Consensus       506 ~~~~~----~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~  579 (739)
                      .....    .....||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.+....+....+..+ .++
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~  232 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME  232 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCHHHHHC-------CCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf             543432113562113743358688727-------9999541232201789999938999999979999999998189999


Q ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCHHHH---HCCCCCC
Q ss_conf             995599999999999400199999999999---8093543
Q 004660          580 IPEMLSSEGKDFLLRCFLRNPVERPSAVEL---LEHPFIR  616 (739)
Q Consensus       580 iP~~ls~el~dLI~kcL~~DP~kRpTa~ei---LqHpff~  616 (739)
                      +|..+++++.+||.+||..||++|||+.++   |+|.|+.
T Consensus       233 ~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             9976789999999997577976890999999999999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=396.78  Aligned_cols=256  Identities=25%  Similarity=0.439  Sum_probs=215.2

Q ss_pred             CCCCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEEC
Q ss_conf             99789990681388124976999999979994799999631899955099999999999999416998757514621215
Q 004660          347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  426 (739)
Q Consensus       347 ~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~  426 (739)
                      ++...++|++++.||+|+||+||+|+.+   ..||||+++.....   ....+.+.+|+.+|++++|||||++++++. +
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~   75 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT---PQQLQAFKNEVGVLRKTRHVNILLFMGYST-A   75 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             CCCCCCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-C
T ss_conf             1315451899889830788589999999---98999999734699---899999999999998479987864567971-5


Q ss_pred             CEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCC
Q ss_conf             55899995227987002432014663078898877757999999772992404477766486689938993026301013
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~  506 (739)
                      +.+|||||||+||+|.+++......+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus        76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             CEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECC
T ss_conf             58999996589988899985235789999999999999999888750999516147899798189978875002213335


Q ss_pred             CCC---CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC------
Q ss_conf             755---33345799999876999985303999989931035677899999961999999998368999986059------
Q 004660          507 GLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------  577 (739)
Q Consensus       507 ~~~---~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~------  577 (739)
                      ...   ......||+.|||||++.+.    ....|+.++|||||||+||||++|+.||.+......+..+....      
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~  231 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQ----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL  231 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHCC----CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf             56776312566557431799999505----68999953151635999999997889989989699999999658889860


Q ss_pred             CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCC
Q ss_conf             999955999999999994001999999999998093
Q 004660          578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHP  613 (739)
Q Consensus       578 ~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHp  613 (739)
                      ..++..+++++.+||.+||..||.+|||+.|++++-
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L  267 (276)
T d1uwha_         232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI  267 (276)
T ss_dssp             GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf             003655549999999997588976892999999999

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=392.93  Aligned_cols=258  Identities=22%  Similarity=0.417  Sum_probs=220.4

Q ss_pred             CCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECC-
Q ss_conf             7899906813881249769999999799947999996318999550999999999999994169987575146212155-
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-  427 (739)
Q Consensus       349 ~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~-  427 (739)
                      ...++|++.+.||+|+||+||+|+++.+|+.||||++....  .........+.+|+.+|+.++|||||++++++..++ 
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             CCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHH--CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCC
T ss_conf             70620698689960899299999999999899999985566--4698999999999999985699988731143543268


Q ss_pred             ---EEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf             ---58999952279870024320146630788988777579999997729924044777664866899389930263010
Q 004660          428 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       428 ---~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~  504 (739)
                         .+|||||||+||+|.+++... +.+++.+++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             CCCEEEEEEECCCCCEEHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHH
T ss_conf             876699999778898710112035-8999999999999999999999857952763467556657543201003444322


Q ss_pred             CCCC----CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf             1375----533345799999876999985303999989931035677899999961999999998368999986059999
Q 004660          505 LTGL----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI  580 (739)
Q Consensus       505 ~~~~----~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~i  580 (739)
                      ....    .......||+.|+|||++.       +..++.++|||||||++|||++|+.||.+.+..+...++....+..
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~  233 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQAR-------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP  233 (277)
T ss_dssp             CC----------------TTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred             HCCCCCCCCCCCCCCCCCCCCCHHHHC-------CCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf             123544333346425762436999983-------9999966320265289999976979989969999999998469999


Q ss_pred             ----CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCC
Q ss_conf             ----955999999999994001999999999998093543
Q 004660          581 ----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR  616 (739)
Q Consensus       581 ----P~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~  616 (739)
                          ...+++++.+||.+||..||.+||+..+.|.|+|.+
T Consensus       234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf             7100347899999999998667976777399999999999

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=391.23  Aligned_cols=253  Identities=23%  Similarity=0.387  Sum_probs=211.2

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEECCCEEE--C
Q ss_conf             899906813881249769999999799947999996318999550999999999999994169-9875751462121--5
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVV--D  426 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HPNIVkl~~~~~~--~  426 (739)
                      ..++|+++++||+|+||+||+|+++.+++.||||+++..     .   .+++.+|+.+|+.+. ||||+++++++..  .
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~  104 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----K---KKKIKREIKILENLRGGPNIITLADIVKDPVS  104 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----C---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-----H---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCC
T ss_conf             986718978983174819999998899979999998889-----9---99999999999851579987679999981687


Q ss_pred             CEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCC-CEEEEECCCCHHC
Q ss_conf             558999952279870024320146630788988777579999997729924044777664866899-3899302630101
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHL  505 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g-~vKL~DFGLA~~~  505 (739)
                      ..+++|||||.+++|..+.    +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus       105 ~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         105 RTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             CSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             CCEEEEEEECCCCCHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEEC
T ss_conf             7126888631798589974----689999999999999999988764334434564412377489983664156542664


Q ss_pred             CCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHH---HH------
Q ss_conf             375533345799999876999985303999989931035677899999961999999998368-99998---60------
Q 004660          506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKV---LN------  575 (739)
Q Consensus       506 ~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~-~~~~i---~~------  575 (739)
                      ..........||+.|+|||++.+      ...++.++||||+||++|||++|+.||....... ....+   .+      
T Consensus       181 ~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~  254 (328)
T d3bqca1         181 HPGQEYNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD  254 (328)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHH
T ss_conf             68874443224864247610268------888884523233545558760488999887601899999999878841555


Q ss_pred             ----C------------------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf             ----5------------------------99999559999999999940019999999999980935434555
Q 004660          576 ----R------------------------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY  620 (739)
Q Consensus       576 ----~------------------------~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~~~  620 (739)
                          .                        .......+++++++||.+||..||.+|+|++|+|+||||+...+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             HHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf             5542254447430000033343311211552112448999999999986699568908999964935588797

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=389.89  Aligned_cols=258  Identities=23%  Similarity=0.396  Sum_probs=212.8

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECC--
Q ss_conf             899906813881249769999999799947999996318999550999999999999994169987575146212155--
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--  427 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~--  427 (739)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++...    ......+.+.+|+.+|+.|+|||||++++++....  
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHH----CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC
T ss_conf             389859978994064809999999999949999998031----0958999999999999976898988588899505645


Q ss_pred             --EEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf             --589999522798700243201466307889887775799999977299240447776648668993899302630101
Q 004660          428 --HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       428 --~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~  505 (739)
                        ..+++|||+.+|+|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        82 ~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          82 QMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             TCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCEEEEEEEECCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf             5414999996259865664405--89999999999999999999999789867778764378879997787545705650


Q ss_pred             CCCC----CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-----
Q ss_conf             3755----3334579999987699998530399998993103567789999996199999999836899998605-----
Q 004660          506 TGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-----  576 (739)
Q Consensus       506 ~~~~----~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~-----  576 (739)
                      ....    .....+||+.|+|||++..      ...++.++||||+||++|||++|+.||.+.+...........     
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~  233 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS  233 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTT------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CCCCCCCEEECCCCCCCEECHHHHHHC------CCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf             477764101011026520003878604------78887410100467013377669799788888999998765206997


Q ss_pred             ------------------C---C-----CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf             ------------------9---9-----99955999999999994001999999999998093543455
Q 004660          577 ------------------T---P-----PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       577 ------------------~---~-----~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~~  619 (739)
                                        .   .     .....+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             566423433222202446775577877783789999999999997648956790899986198655588

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=390.65  Aligned_cols=259  Identities=26%  Similarity=0.417  Sum_probs=212.8

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEE----
Q ss_conf             8999068138812497699999997999479999963189995509999999999999941699875751462121----
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----  425 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~----  425 (739)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++......   ......+.+|+++|+.++|+||+++++++..    
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~   84 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASP   84 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT---TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC---HHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf             627988999972274829999999899979999998422246---37899999999999983599966067654024654


Q ss_pred             ----CCEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCC
Q ss_conf             ----5558999952279870024320146630788988777579999997729924044777664866899389930263
Q 004660          426 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM  501 (739)
Q Consensus       426 ----~~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGL  501 (739)
                          ++.+|+||||+.++.+..+. .....+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          85 YNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             ------CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCCCCCEEEEEEECCCCCCCCHHH-HCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCE
T ss_conf             444576389998535787410122-2034433089999999999999885229988567672220366899687631350


Q ss_pred             CHHCCCC-----CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC
Q ss_conf             0101375-----53334579999987699998530399998993103567789999996199999999836899998605
Q 004660          502 AKHLTGL-----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR  576 (739)
Q Consensus       502 A~~~~~~-----~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~  576 (739)
                      ++.+...     ....+.+||+.|+|||++.+      ...|+.++|||||||++|||++|+.||.+.+.......+...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~------~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~  237 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL  237 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             EEECCCCCCCCCCCCCCEECCHHHHHHHHHCC------CCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf             02235544432113566024978742899707------999891787006786466174487998998999999999984


Q ss_pred             CCCCC--------------------------------CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             99999--------------------------------5599999999999400199999999999809354345
Q 004660          577 TPPIP--------------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       577 ~~~iP--------------------------------~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~  618 (739)
                      ....+                                ...++++++||.+||..||++|+|+.|+|+||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             CCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             18998255344320344433201334455503340444599899999999873896589099999749501569

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=392.14  Aligned_cols=249  Identities=25%  Similarity=0.442  Sum_probs=215.9

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEE
Q ss_conf             89990681388124976999999979994799999631899955099999999999999416998757514621215558
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  429 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l  429 (739)
                      ..++|++++.||+|+||+||+|.++ ++..||||+++..   ...   .+.+.+|+++++.++|||||++++++..++.+
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~---~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~   75 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG---AMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   75 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS---SSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             CHHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCC---CCC---HHHHHHHHHHHHHCCCCCCCCCCCEECCCCCE
T ss_conf             9699588889820888299999988-9999999998788---676---89999999999966899756535243159933


Q ss_pred             EEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC
Q ss_conf             99995227987002432014663078898877757999999772992404477766486689938993026301013755
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~  509 (739)
                      |+||||+.+|+|.+++......+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+....
T Consensus        76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC
T ss_conf             79998369991899752013478899999999999998776531643104431532666688776865532100236887


Q ss_pred             CC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHC-CCCCCCCCC
Q ss_conf             33--345799999876999985303999989931035677899999961-99999999836899998605-999995599
Q 004660          510 YE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS  585 (739)
Q Consensus       510 ~~--~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls  585 (739)
                      ..  ....||..|+|||++.       ...|+.++|||||||++|||++ |++||......+.+..+..+ ....|..++
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~-------~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~  228 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFS-------FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS  228 (263)
T ss_dssp             ---------CTTSCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred             CEEECCEECCCCCCCHHHHC-------CCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf             33504300176667857860-------79998403321059999999878988877899999999998068889954367


Q ss_pred             HHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             999999999400199999999999809
Q 004660          586 SEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       586 ~el~dLI~kcL~~DP~kRpTa~eiLqH  612 (739)
                      +++.+||.+||..||++|||+.|+++|
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             999999999765797689199999999

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=391.26  Aligned_cols=257  Identities=24%  Similarity=0.450  Sum_probs=215.9

Q ss_pred             CCCCCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEE
Q ss_conf             99978999068138812497699999997999479999963189995509999999999999941699875751462121
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       346 ~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      .++...++|++++.||+|+||+||+|.++ ++..||||+++...   ..   .+.+.+|+.+|++++|||||++++++. 
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~-   78 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MS---PDAFLAEANLMKQLQHQRLVRLYAVVT-   78 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             CEECCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCC---CC---HHHHHHHHHHHHHCCCCCEEEEEEEEC-
T ss_conf             70038899388679810798289999999-99999999986476---88---899999999998679998857873104-


Q ss_pred             CCEEEEEEEECCCCCCCHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf             55589999522798700243201-46630788988777579999997729924044777664866899389930263010
Q 004660          426 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~  504 (739)
                      ++.+|+||||+++|+|.+++... ...+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.
T Consensus        79 ~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEEE
T ss_conf             59769999957898288887514789887889999999999999999748954675642251562024404234101477


Q ss_pred             CCCCCC--CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHC-CCCC
Q ss_conf             137553--33457999998769999853039999899310356778999999619-9999999836899998605-9999
Q 004660          505 LTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNR-TPPI  580 (739)
Q Consensus       505 ~~~~~~--~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtG-k~PF~~~~~~~~~~~i~~~-~~~i  580 (739)
                      +.....  .....||+.|||||++.+       ..++.++|||||||++|||++| .+||......+.+..+..+ .+..
T Consensus       159 ~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~  231 (272)
T d1qpca_         159 IEDNEYTAREGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR  231 (272)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHC-------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf             35886442035677444458289837-------99982456452579999999689888888899999999970688889


Q ss_pred             CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC--CCCCCC
Q ss_conf             9559999999999940019999999999980--935434
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPFIRN  617 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~eiLq--Hpff~~  617 (739)
                      |..+++++.+||.+||..||++|||+.++++  ++||..
T Consensus       232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             655719999999997588976893999999986113213

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=388.84  Aligned_cols=252  Identities=28%  Similarity=0.453  Sum_probs=216.2

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCC----EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEE
Q ss_conf             89990681388124976999999979994----79999963189995509999999999999941699875751462121
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~----~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      ...+|+++++||+|+||+||+|.++.+|+    .||+|+++..    ......+.+.+|+++|++++|||||++++++.+
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   82 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLT   82 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf             8899978319820899299999995899889899999996513----497999999999999986799888158999961


Q ss_pred             CCEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf             55589999522798700243201466307889887775799999977299240447776648668993899302630101
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~  505 (739)
                       +..+++|||+.+|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus        83 -~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          83 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             -CCEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEEC
T ss_conf             -9836999842687401011133457999999999999999999998769504762120311679987586025522233


Q ss_pred             CCCCCC---CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHC-CCCC
Q ss_conf             375533---345799999876999985303999989931035677899999961-99999999836899998605-9999
Q 004660          506 TGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPI  580 (739)
Q Consensus       506 ~~~~~~---~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~i  580 (739)
                      ......   ....||+.|+|||++.+       ..|+.++|||||||++|||+| |.+||.+....+....+..+ .++.
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~  234 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ  234 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHC-------CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC
T ss_conf             54445322365105864467088746-------99983565440799999999779999999998999999975998999


Q ss_pred             CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCC
Q ss_conf             955999999999994001999999999998093
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHP  613 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHp  613 (739)
                      |..++.++.+||.+||..||.+|||+.|+++|.
T Consensus       235 p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf             855689999999984789934691999999999

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=390.13  Aligned_cols=247  Identities=23%  Similarity=0.418  Sum_probs=210.5

Q ss_pred             EEEEECCCEEEEEEEECC--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEEEEEEE
Q ss_conf             388124976999999979--994799999631899955099999999999999416998757514621215558999952
Q 004660          358 KLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY  435 (739)
Q Consensus       358 k~LG~GsfG~Vy~a~~k~--tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~LVmEy  435 (739)
                      ++||+|+||+||+|.++.  +++.||||+++...   ......+.+.+|+++|++++|||||++++++.. +..||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH---CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEEC
T ss_conf             7834587829999998169738599999988010---898999999999999986799898527777505-977999974


Q ss_pred             CCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCC----C
Q ss_conf             279870024320146630788988777579999997729924044777664866899389930263010137553----3
Q 004660          436 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY----E  511 (739)
Q Consensus       436 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~~----~  511 (739)
                      |++|+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+.....    .
T Consensus        89 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          89 AELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             CTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCCC
T ss_conf             7889689997522-578999999999999999766874795567776113102356751234134533134323443224


Q ss_pred             CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHH-CCCCCCCCCCHHHH
Q ss_conf             345799999876999985303999989931035677899999961-9999999983689999860-59999955999999
Q 004660          512 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGK  589 (739)
Q Consensus       512 ~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~iP~~ls~el~  589 (739)
                      ....||+.|||||++.+       ..++.++|||||||++|||++ |+.||.+....+....+.. ..+++|..+++++.
T Consensus       168 ~~~~gt~~y~APE~l~~-------~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~  240 (277)
T d1xbba_         168 THGKWPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY  240 (277)
T ss_dssp             ---CCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CCCCCCCEECCCHHHCC-------CCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
T ss_conf             45677842039166537-------99984344303403132896589999999899999999982899999865679999


Q ss_pred             HHHHHHCCCCCCCCCCHHHH---HCCCCCC
Q ss_conf             99999400199999999999---8093543
Q 004660          590 DFLLRCFLRNPVERPSAVEL---LEHPFIR  616 (739)
Q Consensus       590 dLI~kcL~~DP~kRpTa~ei---LqHpff~  616 (739)
                      +||.+||..||++|||+.++   |+|.|+.
T Consensus       241 ~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         241 DLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHCCCCHHHCCCHHHHHHHHHCHHHH
T ss_conf             999997588976890989999985288750

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=386.43  Aligned_cols=254  Identities=24%  Similarity=0.372  Sum_probs=213.3

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEE-----
Q ss_conf             999068138812497699999997999479999963189995509999999999999941699875751462121-----
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-----  425 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~-----  425 (739)
                      .++|+++++||+|+||+||+|+++.+|+.||||++....   .......++.+|+.+|+.++|||||+++++|..     
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCC
T ss_conf             377599889621758599999999999899999988233---69799999999999998648987648998970256434


Q ss_pred             -CCEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf             -5558999952279870024320146630788988777579999997729924044777664866899389930263010
Q 004660          426 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 -~~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~  504 (739)
                       ...+|+|||||.++.+. .+.   ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~~~~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          93 EFQDVYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             TCCEEEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CCCEEEEEEECCCHHHHH-HHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHC
T ss_conf             576269998414467787-650---3899999999999999999886522112456776321136544313201023211


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--------
Q ss_conf             137553334579999987699998530399998993103567789999996199999999836899998605--------
Q 004660          505 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--------  576 (739)
Q Consensus       505 ~~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~--------  576 (739)
                      ...........||+.|+|||++.+       ..++.++||||+||++|||++|+.||.+.+......+++..        
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~-------~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             ------------CCTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHCC-------CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf             466655332214655558133147-------7778774333566257898659899888977889999997205898799


Q ss_pred             --------------CCCC--------------------CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             --------------9999--------------------95599999999999400199999999999809354345
Q 004660          577 --------------TPPI--------------------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       577 --------------~~~i--------------------P~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~  618 (739)
                                    ....                    ....++++++||.+||..||++||||+|+|+||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf             9876566777764175435666421264333543210133379999999999876994579089999669420878

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=382.15  Aligned_cols=253  Identities=26%  Similarity=0.450  Sum_probs=214.7

Q ss_pred             CCCCCCCEEEEEEEECCCEEEEEEEECCCC----CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCE
Q ss_conf             978999068138812497699999997999----4799999631899955099999999999999416998757514621
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  423 (739)
Q Consensus       348 ~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg----~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~  423 (739)
                      +...++|.+.++||+|+||+||+|.++.++    ..||||++...    ........+.+|+.+|++++|||||++++++
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~   78 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI   78 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCC----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf             578899686159811779099999996899878799999998844----5968999999999999856898783236778


Q ss_pred             EECCEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCH
Q ss_conf             21555899995227987002432014663078898877757999999772992404477766486689938993026301
Q 004660          424 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       424 ~~~~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~  503 (739)
                      ...+.+++||||+.+|+|.+++......+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus        79 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          79 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ECCCCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHH
T ss_conf             33880389997213574022210234542089999999999985412121234257656442788899849984551030


Q ss_pred             HCCCCCC----CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHC-C
Q ss_conf             0137553----33457999998769999853039999899310356778999999619-9999999836899998605-9
Q 004660          504 HLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNR-T  577 (739)
Q Consensus       504 ~~~~~~~----~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtG-k~PF~~~~~~~~~~~i~~~-~  577 (739)
                      .+.....    .....||+.|||||++.       +..++.++|||||||++|||+++ .++|......+.+..+..+ .
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~  231 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAIS-------YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR  231 (283)
T ss_dssp             ---------------CCCGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred             CCCCCCCCCEEECCCCCCCCCCCHHHHC-------CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf             0357876526742677773434888870-------499997355634489899999679886556899999999863578


Q ss_pred             CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             9999559999999999940019999999999980
Q 004660          578 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       578 ~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLq  611 (739)
                      ++.|..++.++.+||.+||..||++|||+.|+++
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             9985045799999999977679768939999999

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=388.03  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=215.6

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEEC----
Q ss_conf             9990681388124976999999979994799999631899955099999999999999416998757514621215----
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  426 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~----  426 (739)
                      .++|++++.||+|+||+||+|+++.+|+.||||++...   .......+++.+|+.+|+.++|+|||++++++...    
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCH---HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCC
T ss_conf             98718888983178839999999999979999998820---028689999999999998668987425999996346456


Q ss_pred             -CEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf             -5589999522798700243201466307889887775799999977299240447776648668993899302630101
Q 004660          427 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL  505 (739)
Q Consensus       427 -~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~  505 (739)
                       ...+++|||+.||+|.+++..  +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             CCCEEEEEEEECCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC
T ss_conf             6864999996258862320022--45309999999999999999997388765166776334554322001321000125


Q ss_pred             CCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC------
Q ss_conf             37553334579999987699998530399998993103567789999996199999999836899998605999------
Q 004660          506 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP------  579 (739)
Q Consensus       506 ~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i~~~~~~------  579 (739)
                      ...  ..+..|++.|+|||++.+      ...++.++|||||||++|+|++|+.||.+.+.......+......      
T Consensus       172 ~~~--~~~~~g~~~y~apE~~~~------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         172 DDE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             TGG--GSSSCHHHHTSCHHHHTT------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CCC--CCCCCCCCCCCCCHHHCC------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf             754--444345435558355337------756785512432058999997688997889889999999973079975773


Q ss_pred             -----------------C--------CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf             -----------------9--------955999999999994001999999999998093543455
Q 004660          580 -----------------I--------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN  619 (739)
Q Consensus       580 -----------------i--------P~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~~  619 (739)
                                       .        ...+++++++||.+||..||.+|+|+.|+|+||||+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             20010244544430355787555662678999999999997758834593899985599548799

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=387.13  Aligned_cols=254  Identities=25%  Similarity=0.448  Sum_probs=219.6

Q ss_pred             CCCCCCCCEEEEEEEECCCEEEEEEEECCCC---CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCE
Q ss_conf             9978999068138812497699999997999---4799999631899955099999999999999416998757514621
Q 004660          347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  423 (739)
Q Consensus       347 ~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg---~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~  423 (739)
                      ++...++|++++.||+|+||+||+|++..++   ..||||.++.    .........+.+|+.+|+.++|||||++++++
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~   77 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI   77 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT----TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECC----CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf             97688996987799307882999999936996449999999365----66879999999999999868999985698899


Q ss_pred             EECCEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCH
Q ss_conf             21555899995227987002432014663078898877757999999772992404477766486689938993026301
Q 004660          424 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       424 ~~~~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~  503 (739)
                      . ++.+|+||||+.+|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus        78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          78 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             E-CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHE
T ss_conf             5-374799998406980776542247899999999999999877523022674414102655320678967876503421


Q ss_pred             HCCCCCC--CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHC-CCC
Q ss_conf             0137553--3345799999876999985303999989931035677899999961-99999999836899998605-999
Q 004660          504 HLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPP  579 (739)
Q Consensus       504 ~~~~~~~--~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~  579 (739)
                      .+.....  .....||+.|+|||++.+       ..++.++|||||||++|||++ |.+||.+....+.+..+..+ ..+
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~-------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~  229 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP  229 (273)
T ss_dssp             --------------CCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred             ECCCCCCEECCCEECCCCCCHHHHHCC-------CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf             336776233054005831032667516-------9988745244424789999826999988899999999998189998


Q ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             995599999999999400199999999999809
Q 004660          580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       580 iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqH  612 (739)
                      +|..+++++.+||.+||..||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             987779999999999768797689299999999

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=386.30  Aligned_cols=248  Identities=28%  Similarity=0.463  Sum_probs=219.6

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEE
Q ss_conf             99906813881249769999999799947999996318999550999999999999994169987575146212155589
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~  430 (739)
                      .++|++++.||+|+||+||+|+++ ++..||||+++....   .   ...+.+|+++++.++|||||++++++.+++.++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~   75 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---S---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---C---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC---C---HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEE
T ss_conf             699799689820788399999988-998999999874757---7---899999999999668986015889985078169


Q ss_pred             EEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCC
Q ss_conf             99952279870024320146630788988777579999997729924044777664866899389930263010137553
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY  510 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~~  510 (739)
                      +||||+.+|+|.+++......+++..+..|+.||++||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus        76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             EEEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC
T ss_conf             99970489938886410246776899999999999999987546843466541358876998479886144202357872


Q ss_pred             C--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHC-CCCCCCCCCH
Q ss_conf             3--345799999876999985303999989931035677899999961-99999999836899998605-9999955999
Q 004660          511 E--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSS  586 (739)
Q Consensus       511 ~--~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~  586 (739)
                      .  ....||..|+|||++.+       ..++.++||||||+++|||++ |+.||.+....+...++..+ ....|..++.
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~-------~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~  228 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMY-------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE  228 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             EEECCCCCCCCCCCCHHHCC-------CCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCH
T ss_conf             25246578877578078637-------99885210336432467397559999889999999999980797899654659


Q ss_pred             HHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             99999999400199999999999809
Q 004660          587 EGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       587 el~dLI~kcL~~DP~kRpTa~eiLqH  612 (739)
                      ++.+||.+||..||++|||+.++|+|
T Consensus       229 ~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         229 KVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             99999999766897689399999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=389.99  Aligned_cols=263  Identities=28%  Similarity=0.478  Sum_probs=220.9

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEE---CCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCC-CCEEEECCCEEEC
Q ss_conf             99906813881249769999999---7999479999963189995509999999999999941699-8757514621215
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTN---RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVD  426 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~---k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-PNIVkl~~~~~~~  426 (739)
                      .++|++++.||+|+||+||+|++   +.+|+.||||+++..... ......+.+.+|+++|++++| |||+++++++.+.
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf             10259998983287839999998765887948999998367721-01689999999999998646798399962000248


Q ss_pred             CEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCC
Q ss_conf             55899995227987002432014663078898877757999999772992404477766486689938993026301013
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~  506 (739)
                      ..+|++|||+.+|+|.+++... +.+.+..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CCEEEEEECCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHHHC
T ss_conf             7300123123411799998730-454378888889999999988514998965477320124699988874132022203


Q ss_pred             CC--CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHHCCCCC
Q ss_conf             75--5333457999998769999853039999899310356778999999619999999983689----99986059999
Q 004660          507 GL--SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA----MFKVLNRTPPI  580 (739)
Q Consensus       507 ~~--~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~----~~~i~~~~~~i  580 (739)
                      ..  ....+..|++.|++||.+.+.     ...++.++|||||||+||||++|+.||.+......    ........+++
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~-----~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~  255 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGG-----DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY  255 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTC-----C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred             CCCCCCCCCCCCCCCCCHHHHHHCC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCCCC
T ss_conf             4444322122233333106876057-----76887132517777999999768999888877779999998335689988


Q ss_pred             CCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCCCCC
Q ss_conf             955999999999994001999999-----9999980935434555
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANY  620 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRp-----Ta~eiLqHpff~~~~~  620 (739)
                      |..+++++++||.+||..||.+|+     |++|+|+||||+..++
T Consensus       256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCH
T ss_conf             654799999999997445898819997450999974972348998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=380.05  Aligned_cols=257  Identities=29%  Similarity=0.455  Sum_probs=216.5

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECCEEEE
Q ss_conf             99068138812497699999997999479999963189995509999999999999941699875751462121555899
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  431 (739)
Q Consensus       352 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~~l~L  431 (739)
                      ++|++++.||+|+||+||+|+++.+++.||||+++....   ......++.+|+.+|+.++|+|||++++++...+..++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC---CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEE
T ss_conf             997862697128681999999999996999999803217---86899999999999985675788821354444431158


Q ss_pred             EEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC-C
Q ss_conf             995227987002432014663078898877757999999772992404477766486689938993026301013755-3
Q 004660          432 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y  510 (739)
Q Consensus       432 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~-~  510 (739)
                      +||++.+++|..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+...... .
T Consensus        79 v~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             EEEECCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCCC
T ss_conf             86302332221121235-65403678999999999987743399860014676121133782665204601104688751


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHC-------------
Q ss_conf             334579999987699998530399998993103567789999996199999999-836899998605-------------
Q 004660          511 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVLNR-------------  576 (739)
Q Consensus       511 ~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~-~~~~~~~~i~~~-------------  576 (739)
                      .....++..|+|||++..      ...++.++|||||||++|||++|+.||... +..+.+.++...             
T Consensus       158 ~~~~~~~~~~~~pe~~~~------~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CEEECCCCCHHHHHHHCC------CCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHH
T ss_conf             001034431014667506------98888044402654188998518999988999999999998611899735513443


Q ss_pred             ----------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             ----------------999995599999999999400199999999999809354345
Q 004660          577 ----------------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA  618 (739)
Q Consensus       577 ----------------~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqHpff~~~  618 (739)
                                      .......+++++++||.+||..||.+||||.|+|+||||++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             HCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             2221133444544310433065689999999999864996689099999649534079

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=380.11  Aligned_cols=259  Identities=26%  Similarity=0.464  Sum_probs=216.0

Q ss_pred             CCCCCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEE
Q ss_conf             99978999068138812497699999997999479999963189995509999999999999941699875751462121
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  425 (739)
Q Consensus       346 ~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~  425 (739)
                      .++...++|++++.||+|+||+||+|+++.+ ..||||+++...   ...   +.+.+|+.+|++++|+|||++++++. 
T Consensus        11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~-   82 (285)
T d1fmka3          11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-   82 (285)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             CEECCHHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCC---CCH---HHHHHHHHHHHHCCCCCEEEEEEEEE-
T ss_conf             6074779979846993079809999999999-999999988044---888---99999999998666678868999982-


Q ss_pred             CCEEEEEEEECCCCCCCHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf             55589999522798700243201-46630788988777579999997729924044777664866899389930263010
Q 004660          426 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~  504 (739)
                      ++.+|+||||+.+|+|..++... ...+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus        83 ~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3          83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHH
T ss_conf             39759999944799435420000355305999999999999999987541143353123079998999299844255542


Q ss_pred             CCCCC--CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHC-CCCC
Q ss_conf             13755--3334579999987699998530399998993103567789999996199-999999836899998605-9999
Q 004660          505 LTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-PPWSEFEGPQAMFKVLNR-TPPI  580 (739)
Q Consensus       505 ~~~~~--~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk-~PF~~~~~~~~~~~i~~~-~~~i  580 (739)
                      +....  ......||+.|+|||++..       ..++.++|||||||++|||++|. ++|......+.+..+..+ ..++
T Consensus       163 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~  235 (285)
T d1fmka3         163 IEDNEYTARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC  235 (285)
T ss_dssp             -------------CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             CCCCCCEEECCCCCCCCCCCHHHHHC-------CCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf             56887335245455665458089837-------99891774132358999998689999988889999999982689999


Q ss_pred             CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC--CCCCCCCC
Q ss_conf             9559999999999940019999999999980--93543455
Q 004660          581 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPFIRNAN  619 (739)
Q Consensus       581 P~~ls~el~dLI~kcL~~DP~kRpTa~eiLq--Hpff~~~~  619 (739)
                      +..++.++++||.+||..||++||++.++++  ++||....
T Consensus       236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCC
T ss_conf             83237999999999756697589199999998766623899

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=379.42  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=219.2

Q ss_pred             CCCCCCEEEEEEEECCCEEEEEEEECCCCCE--EEEEEEECCCCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEECCCEEE
Q ss_conf             7899906813881249769999999799947--99999631899955099999999999999416-99875751462121
Q 004660          349 PKKSQWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV  425 (739)
Q Consensus       349 ~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~--vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HPNIVkl~~~~~~  425 (739)
                      +..++|+++++||+|+||+||+|+++.++..  ||||.+....    ..+..+.+.+|+++|..+ +|||||++++++.+
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   82 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   82 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             CCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC----CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC
T ss_conf             6879968877982078828999999899969999999978233----857999999999999862289988367888841


Q ss_pred             CCEEEEEEEECCCCCCCHHHHHC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECC
Q ss_conf             55589999522798700243201---------------466307889887775799999977299240447776648668
Q 004660          426 DDHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA  490 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~---------------~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~  490 (739)
                      ++.+|+||||+++|+|.++++..               ...+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  162 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
T ss_conf             87369999802898699998640355555123101234578999999999999999987663089545550520489868


Q ss_pred             CCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCHHH
Q ss_conf             99389930263010137553334579999987699998530399998993103567789999996199-99999983689
Q 004660          491 SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-PPWSEFEGPQA  569 (739)
Q Consensus       491 ~g~vKL~DFGLA~~~~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk-~PF~~~~~~~~  569 (739)
                      ++.+||+|||+|+............||..|+|||.+.+       ..++.++||||||+++|||++|. +||.+.+..+.
T Consensus       163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~  235 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL  235 (309)
T ss_dssp             GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             CCCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCC-------CCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf             87638743443224442234553013775555387526-------99996221531388999998368999999999999


Q ss_pred             HHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             9998605-999995599999999999400199999999999809
Q 004660          570 MFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       570 ~~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqH  612 (739)
                      +..+..+ .+++|..+++++++||.+||..||++|||+.+++++
T Consensus       236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             99998268888876678999999999767896689499999999

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=378.07  Aligned_cols=254  Identities=26%  Similarity=0.451  Sum_probs=210.3

Q ss_pred             CCCCCCCEEEEEEEECCCEEEEEEEECC-----CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEECC
Q ss_conf             9789990681388124976999999979-----994799999631899955099999999999999416-9987575146
Q 004660          348 SPKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG  421 (739)
Q Consensus       348 ~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~-----tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HPNIVkl~~  421 (739)
                      +...++|++++.||+|+||.||+|.+..     +++.||||+++..    ......+.+.+|+.++.++ +|+|||.+++
T Consensus         9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCC----CCCHHHHHHHHHHHHHHHHCCCCEEEEEEE
T ss_conf             6167997984498416783999999867775557839999998600----171789999999999886149984997411


Q ss_pred             CEEEC-CEEEEEEEECCCCCCCHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCC
Q ss_conf             21215-55899995227987002432014---------------663078898877757999999772992404477766
Q 004660          422 SEVVD-DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN  485 (739)
Q Consensus       422 ~~~~~-~~l~LVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeN  485 (739)
                      ++... +.+++|||||++|+|.+++....               ..+++..+..|+.||+.||.|||+++|+||||||+|
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N  164 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  164 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             EECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf             54047975799998458992999998536666653222023321468999999999999999998873797178677310


Q ss_pred             EEECCCCCEEEEECCCCHHCCCCC---CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCC
Q ss_conf             486689938993026301013755---333457999998769999853039999899310356778999999619-9999
Q 004660          486 LLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPW  561 (739)
Q Consensus       486 ILId~~g~vKL~DFGLA~~~~~~~---~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtG-k~PF  561 (739)
                      ||++.++.+||+|||+|+......   ......||+.|+|||++.+       ..++.++|||||||++|||++| .+||
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDiwS~Gvil~ellt~~~~p~  237 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPY  237 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             EEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHC-------CCCCCCCCEEEHHHHHHHHHHCCCCCC
T ss_conf             6577998289845752001135665222475166721020368646-------889966322136789999986889999


Q ss_pred             CCCCCHHHHHHHH--HCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             9998368999986--05999995599999999999400199999999999809
Q 004660          562 SEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       562 ~~~~~~~~~~~i~--~~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqH  612 (739)
                      .+....+.+..++  +..+++|..+++++++||.+||..||++|||+.|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         238 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             TTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             89998999999996389888886578999999999767796679199999999

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=375.41  Aligned_cols=257  Identities=25%  Similarity=0.468  Sum_probs=219.7

Q ss_pred             CCCCCCCCCCCEEEEEEEECCCEEEEEEEECCCC-------CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHC-CCCC
Q ss_conf             9999978999068138812497699999997999-------4799999631899955099999999999999416-9987
Q 004660          344 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETG-------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHEN  415 (739)
Q Consensus       344 ~~~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg-------~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HPN  415 (739)
                      .+.+....++|++++.||+|+||.||+|++..++       ..||||+++.   + ........+.+|+..+.++ +|||
T Consensus         5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~---~-~~~~~~~~~~~e~~~l~~~~~Hpn   80 (299)
T d1fgka_           5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---D-ATEKDLSDLISEMEMMKMIGKHKN   80 (299)
T ss_dssp             CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT---T-CCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CCCCCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECC---C-CCHHHHHHHHHHHHHHHHHCCCCE
T ss_conf             976722589969700985167828999998578755566754999999881---1-286889999999999998139996


Q ss_pred             EEEECCCEEECCEEEEEEEECCCCCCCHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCEECCC
Q ss_conf             5751462121555899995227987002432014---------------6630788988777579999997729924044
Q 004660          416 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRD  480 (739)
Q Consensus       416 IVkl~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRD  480 (739)
                      ||++++++.+++.+|+|||||.+|+|.+++....               ..+++..+..|+.||+.||+|||+++|+|||
T Consensus        81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD  160 (299)
T d1fgka_          81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD  160 (299)
T ss_dssp             BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             EEECCCCCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEE
T ss_conf             97346522018868999973699909999986067764322233457434679999999999999999876637978630


Q ss_pred             CCCCCEEECCCCCEEEEECCCCHHCCCCC---CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH-
Q ss_conf             77766486689938993026301013755---33345799999876999985303999989931035677899999961-
Q 004660          481 IKGANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-  556 (739)
Q Consensus       481 IKPeNILId~~g~vKL~DFGLA~~~~~~~---~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLt-  556 (739)
                      |||+|||++.++.+||+|||+++......   ......|++.|+|||++.+       ..|+.++||||||+++|||++ 
T Consensus       161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-------~~y~~k~DiwS~Gvvl~ell~~  233 (299)
T d1fgka_         161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTL  233 (299)
T ss_dssp             CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTT
T ss_pred             ECCCCEEECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCC-------CCCCCHHHHHHHHHHHHHHCCC
T ss_conf             221022454789767622111011355555431466788846632667517-------9888255547758888874017


Q ss_pred             CCCCCCCCCCHHHHHHHHH-CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             9999999983689999860-599999559999999999940019999999999980
Q 004660          557 GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       557 Gk~PF~~~~~~~~~~~i~~-~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLq  611 (739)
                      |.+||.+....+.+..+.. ..++.|..+++++++||.+||..||.+|||+.|+++
T Consensus       234 g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         234 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             SCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             98989999999999999728888987435299999999976679767939999999

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=374.74  Aligned_cols=251  Identities=24%  Similarity=0.426  Sum_probs=217.0

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECC-----CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEE
Q ss_conf             89990681388124976999999979-----9947999996318999550999999999999994169987575146212
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  424 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~-----tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~  424 (739)
                      ..++|++++.||+|+||+||+|+.+.     ++..||||+++.    ....+..+++.+|+.+|+.++||||+++++++.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~----~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECH----HCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf             9889388679820788399999988876577882999999882----108579999999999999668997655246660


Q ss_pred             ECCEEEEEEEECCCCCCCHHHHHCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCC
Q ss_conf             1555899995227987002432014-----------------------66307889887775799999977299240447
Q 004660          425 VDDHLYIYLEYVHPGSINRYVREHC-----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDI  481 (739)
Q Consensus       425 ~~~~l~LVmEy~~gGsL~~~L~~~~-----------------------~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDI  481 (739)
                      ..+.++++|||+.+|+|.+++....                       ..+++..+..|+.||+.||+|||+++|+||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl  166 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  166 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf             59803899981589929999985275542100001110012103467889899999999999999855413578685488


Q ss_pred             CCCCEEECCCCCEEEEECCCCHHCCCCCC---CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCC
Q ss_conf             77664866899389930263010137553---334579999987699998530399998993103567789999996199
Q 004660          482 KGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK  558 (739)
Q Consensus       482 KPeNILId~~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk  558 (739)
                      ||+|||++.++.+||+|||+|+.+.....   ..+..|++.|+|||++.+       ..|+.++|||||||++|||++|.
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCC-------CCCCHHHHHCCCHHHHHHHHCCC
T ss_conf             40116898999289833144211367764111577776767679899726-------88980563025236299998068


Q ss_pred             -CCCCCCCCHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             -999999836899998605-99999559999999999940019999999999980
Q 004660          559 -PPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       559 -~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLq  611 (739)
                       +||.+....+....+..+ .+++|..+++++.+||.+||..||++|||+.|+++
T Consensus       240 ~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         240 LQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             CCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             9999998999999999739978887325299999999974889657939999999

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.89  Aligned_cols=255  Identities=25%  Similarity=0.446  Sum_probs=215.9

Q ss_pred             CCCCCCCCCEEEEEEEECCCEEEEEEEEC-----CCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEE
Q ss_conf             99978999068138812497699999997-----9994799999631899955099999999999999416-99875751
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQY  419 (739)
Q Consensus       346 ~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k-----~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HPNIVkl  419 (739)
                      .++...++|+++++||+|+||.||+|+.+     .++..||||+++..    ........+.+|+.++..+ +|||||++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~E~~~~~~l~~HpnIv~~   92 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIVNL   92 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCC----CCHHHHHHHHHHHHHHHHCCCCCCEEEE
T ss_conf             263778996985498206882999999806644778869999998742----4877999999999998762699988789


Q ss_pred             CCCEEECCEEEEEEEECCCCCCCHHHHHCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCC
Q ss_conf             462121555899995227987002432014-----------------663078898877757999999772992404477
Q 004660          420 YGSEVVDDHLYIYLEYVHPGSINRYVREHC-----------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK  482 (739)
Q Consensus       420 ~~~~~~~~~l~LVmEy~~gGsL~~~L~~~~-----------------~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIK  482 (739)
                      ++++..++.+|+|||||++|+|.++++...                 ..+++..+..|+.||+.||+|||+++|+|||||
T Consensus        93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK  172 (311)
T d1t46a_          93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA  172 (311)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCC
T ss_conf             98983199789999737998799999853566544444533222334588999999999999999998875792666241


Q ss_pred             CCCEEECCCCCEEEEECCCCHHCCCCCC---CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH-CC
Q ss_conf             7664866899389930263010137553---3345799999876999985303999989931035677899999961-99
Q 004660          483 GANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK  558 (739)
Q Consensus       483 PeNILId~~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLt-Gk  558 (739)
                      |+|||++.++.+||+|||+++.......   .....||+.|+|||++.+       ..++.++||||||+++|||++ |.
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DIwS~G~~l~ellt~g~  245 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGIFLWELFSLGS  245 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCCCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCC-------CCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf             0210000257521023401023367886158620135968767788617-------999974001025899999985899


Q ss_pred             CCCCCCCCHHHHHHHHH--CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             99999983689999860--599999559999999999940019999999999980
Q 004660          559 PPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       559 ~PF~~~~~~~~~~~i~~--~~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLq  611 (739)
                      ++|........+.+++.  ..+..+..++.++.+||.+||..||++|||+.|+++
T Consensus       246 p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             8877899899999998668988985436599999999975779657929999999

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=371.04  Aligned_cols=256  Identities=23%  Similarity=0.392  Sum_probs=219.3

Q ss_pred             CCCCCCCCCEEEEEEEECCCEEEEEEEECC-----CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEC
Q ss_conf             999789990681388124976999999979-----994799999631899955099999999999999416998757514
Q 004660          346 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY  420 (739)
Q Consensus       346 ~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~-----tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~  420 (739)
                      .++...++|++++.||+|+||+||+|.++.     ++..||||+++..    ........+.+|+.++++++|||||+++
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~----~~~~~~~~~~~E~~il~~l~h~nIv~~~   89 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLL   89 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             CEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC----CCHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf             004268991883598207881899999878644778968999998701----2868999999999999976999884125


Q ss_pred             CCEEECCEEEEEEEECCCCCCCHHHHHCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCC
Q ss_conf             62121555899995227987002432014---------663078898877757999999772992404477766486689
Q 004660          421 GSEVVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS  491 (739)
Q Consensus       421 ~~~~~~~~l~LVmEy~~gGsL~~~L~~~~---------~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~  491 (739)
                      +++..++.+++||||+.+|+|.+++....         ..+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus        90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED  169 (308)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred             EEEECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCC
T ss_conf             47842881067776048998899987503321134446887999999999999999998764796543286775403599


Q ss_pred             CCEEEEECCCCHHCCCCCC---CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCH
Q ss_conf             9389930263010137553---33457999998769999853039999899310356778999999619-9999999836
Q 004660          492 GVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGP  567 (739)
Q Consensus       492 g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtG-k~PF~~~~~~  567 (739)
                      +.+||+|||+|+.+.....   .....||+.|+|||.+.+       ..++.++||||||+++|||++| ++||.+....
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-------~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~  242 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE  242 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred             CEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCC-------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf             6499942454202357763031340231632378888736-------998833344437899999996899999998999


Q ss_pred             HHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             899998605-999995599999999999400199999999999809
Q 004660          568 QAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       568 ~~~~~i~~~-~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLqH  612 (739)
                      +.+..+..+ .+++|..++..+.+||.+||..||.+|||+.+++++
T Consensus       243 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             9999998088888863353999999999757796589399999999

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=374.74  Aligned_cols=252  Identities=27%  Similarity=0.490  Sum_probs=215.3

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECC-CC--CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEEC
Q ss_conf             89990681388124976999999979-99--4799999631899955099999999999999416998757514621215
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRE-TG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  426 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~-tg--~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~  426 (739)
                      ..++|++.+.||+|+||+||+|++.. ++  ..||||+++...  ....+..+.+.+|+++|+.++|||||++++++.+ 
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~--~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-   82 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-   82 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHH--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-
T ss_conf             6489199789803888399999998899907999999998355--5798999999999999986899998789877740-


Q ss_pred             CEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCC
Q ss_conf             55899995227987002432014663078898877757999999772992404477766486689938993026301013
Q 004660          427 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT  506 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~  506 (739)
                      +.+++||||+.+|+|.+++....+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CCHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf             10011465423861254442126899999999999999999987521787520566888156556543325611555303


Q ss_pred             CCCC----CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHC--CCC
Q ss_conf             7553----3345799999876999985303999989931035677899999961-99999999836899998605--999
Q 004660          507 GLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPP  579 (739)
Q Consensus       507 ~~~~----~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLt-Gk~PF~~~~~~~~~~~i~~~--~~~  579 (739)
                      ....    .....|+..|+|||++.+       ..++.++||||||+++|||++ |+.||.+.+..+.+..+...  .++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~  235 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKT-------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP  235 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred             CCCCCCEECCCCCCCCCCCCHHHHHC-------CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf             58875265476325731079999837-------99994215661489999999689999999699999999984799999


Q ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             99559999999999940019999999999980
Q 004660          580 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       580 iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLq  611 (739)
                      .+..++.++++||.+||..||++|||+.++++
T Consensus       236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             85445399999999976889667929999999

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=369.12  Aligned_cols=248  Identities=27%  Similarity=0.479  Sum_probs=216.1

Q ss_pred             CCCCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEE-
Q ss_conf             9978999068138812497699999997999479999963189995509999999999999941699875751462121-
Q 004660          347 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-  425 (739)
Q Consensus       347 ~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~-  425 (739)
                      ++...++|++++.||+|+||.||+|..+  |..||||+++.   +.    ..+.+.+|+++|++++|||||++++++.+ 
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~---~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN---DA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   72 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCC---CC------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             CCCCHHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECC---HH----HHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf             9557899488579820798089999999--90999999885---77----799999999999867898985498788723


Q ss_pred             CCEEEEEEEECCCCCCCHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf             555899995227987002432014-6630788988777579999997729924044777664866899389930263010
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~  504 (739)
                      ++.+|+||||+.+|+|.+++.+.. ..+++..++.|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             CCCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEE
T ss_conf             89289999636999899998745788889999999999998523211337655366656760146899776324560034


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHH-CCCCCCC
Q ss_conf             1375533345799999876999985303999989931035677899999961-9999999983689999860-5999995
Q 004660          505 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPE  582 (739)
Q Consensus       505 ~~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~iP~  582 (739)
                      ....  .....++..|+|||++.+       ..++.++||||||+++|||++ |++||......+....+.. ..+++|.
T Consensus       153 ~~~~--~~~~~~~~~y~aPE~l~~-------~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~  223 (262)
T d1byga_         153 ASST--QDTGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD  223 (262)
T ss_dssp             -----------CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT
T ss_pred             CCCC--CCCCCCCCCCCCHHHHHC-------CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCC
T ss_conf             4787--765566646778178727-------9888588777579999999978999999999999999998089999976


Q ss_pred             CCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             599999999999400199999999999809
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~eiLqH  612 (739)
                      .+++++++||.+||..||.+|||+.+++++
T Consensus       224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             579999999999756697689399999999

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.50  Aligned_cols=248  Identities=26%  Similarity=0.442  Sum_probs=208.1

Q ss_pred             CEEEEEEEECCCEEEEEEEECCCC---CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEE-CCEE
Q ss_conf             068138812497699999997999---479999963189995509999999999999941699875751462121-5558
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDHL  429 (739)
Q Consensus       354 Y~i~k~LG~GsfG~Vy~a~~k~tg---~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~-~~~l  429 (739)
                      +...++||+|+||+||+|++..++   ..||||+++..    ......+.+.+|+++|++++|||||++++++.. ++.+
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC----CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred             ECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
T ss_conf             52666981368809999999779987999999998843----69789999999999998678999867867898069943


Q ss_pred             EEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC
Q ss_conf             99995227987002432014663078898877757999999772992404477766486689938993026301013755
Q 004660          430 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS  509 (739)
Q Consensus       430 ~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFGLA~~~~~~~  509 (739)
                      ++|||||.+|+|.+++......+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf             89998740674144210134540489999999998876520033676257766875767799988991065232255665


Q ss_pred             -----CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHH-HCCCCCCC
Q ss_conf             -----3334579999987699998530399998993103567789999996199999999-8368999986-05999995
Q 004660          510 -----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVL-NRTPPIPE  582 (739)
Q Consensus       510 -----~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~-~~~~~~~~i~-~~~~~iP~  582 (739)
                           ......||..|+|||++..       ..++.++||||||+++|||++|..||... +..+....+. +..+..|.
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~  257 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE  257 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCT
T ss_pred             CCCCEECCCCCCCCCCCCHHHHHC-------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCC
T ss_conf             553100256555645567688743-------7999745746619999999978999988899999999998089889964


Q ss_pred             CCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             599999999999400199999999999809
Q 004660          583 MLSSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       583 ~ls~el~dLI~kcL~~DP~kRpTa~eiLqH  612 (739)
                      .+++++.+||.+||..||++||++.|+++|
T Consensus       258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             475999999999768897689399999999

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=351.63  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=201.5

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCE-EEECCCEEECCE
Q ss_conf             8999068138812497699999997999479999963189995509999999999999941699875-751462121555
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDH  428 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNI-Vkl~~~~~~~~~  428 (739)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++......       ..+..|+++++.++|+++ +.+.+.+...+.
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             ECCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC-------HHHHHHHHHHHHCCCCCCCCEEEEEEECCCE
T ss_conf             888899968985078809999999889989999997210058-------8899999999970389960179999951987


Q ss_pred             EEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECC---CCCEEEEECCCCHHC
Q ss_conf             89999522798700243201466307889887775799999977299240447776648668---993899302630101
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHL  505 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~---~g~vKL~DFGLA~~~  505 (739)
                      .++||||+. ++|.+.+....+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+.+
T Consensus        78 ~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          78 NVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEECC-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEEC
T ss_conf             789998738-7133324430688768999999999999999999799442667876606433577761565046751342


Q ss_pred             CCCC--------CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---H
Q ss_conf             3755--------3334579999987699998530399998993103567789999996199999999836899998---6
Q 004660          506 TGLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV---L  574 (739)
Q Consensus       506 ~~~~--------~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~~~~~~i---~  574 (739)
                      ....        ......||+.|||||++.+       ..++.++|||||||++|||++|+.||...........+   .
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~  229 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLG-------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  229 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-------BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred             CCCCCCCCEECCCCCCCCCCCCCCCHHHHHC-------CCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf             5544554100013577678735329999918-------998983218861778999984987665530577999999852


Q ss_pred             HC-----CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH---HHHCCCCCC
Q ss_conf             05-----9999955999999999994001999999999---998093543
Q 004660          575 NR-----TPPIPEMLSSEGKDFLLRCFLRNPVERPSAV---ELLEHPFIR  616 (739)
Q Consensus       575 ~~-----~~~iP~~ls~el~dLI~kcL~~DP~kRpTa~---eiLqHpff~  616 (739)
                      ..     .......+++++.+||.+||..||++||++.   ++|++.|.+
T Consensus       230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             35678983575347889999999998439955791999999999999997

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=344.94  Aligned_cols=247  Identities=20%  Similarity=0.268  Sum_probs=204.1

Q ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCC-CCEEEECCCEEECCE
Q ss_conf             8999068138812497699999997999479999963189995509999999999999941699-875751462121555
Q 004660          350 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVDDH  428 (739)
Q Consensus       350 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-PNIVkl~~~~~~~~~  428 (739)
                      ..++|++++.||+|+||+||+|++..+|+.||||++......       ..+.+|+++++.|.| +||+.+++++..+..
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   75 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   75 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC-------HHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
T ss_conf             898069979984178829999999889979999997502582-------9999999999996489998779999601881


Q ss_pred             EEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECC-----CCCEEEEECCCCH
Q ss_conf             89999522798700243201466307889887775799999977299240447776648668-----9938993026301
Q 004660          429 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-----SGVVKLADFGMAK  503 (739)
Q Consensus       429 l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~-----~g~vKL~DFGLA~  503 (739)
                      .|+||||+ +++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.     .+.+||+|||+|+
T Consensus        76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             CEEEEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf             17999964-88879999752031106899999999999999999779662667713152347543447956872366057


Q ss_pred             HCCCC--------CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHH
Q ss_conf             01375--------53334579999987699998530399998993103567789999996199999999836---89999
Q 004660          504 HLTGL--------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFK  572 (739)
Q Consensus       504 ~~~~~--------~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~---~~~~~  572 (739)
                      .+...        .......||+.|||||++.       +..++.++||||||+++|||++|+.||.+....   .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~-------~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~  227 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHL-------GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  227 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             ECCCCCCCCCEEECCCCCEEECHHHCCHHHHC-------CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf             71467665411102467627751026798964-------88888699989831999999869876788530219999999


Q ss_pred             HHHCC-----CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf             86059-----9999559999999999940019999999999980
Q 004660          573 VLNRT-----PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE  611 (739)
Q Consensus       573 i~~~~-----~~iP~~ls~el~dLI~kcL~~DP~kRpTa~eiLq  611 (739)
                      +....     ..+...+++++.+++..|+..+|++||++..+.+
T Consensus       228 i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf             97056799958965799899999999984399300859999999

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.02  Aligned_cols=251  Identities=25%  Similarity=0.353  Sum_probs=193.7

Q ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCCEEECC---
Q ss_conf             99906813881249769999999799947999996318999550999999999999994169987575146212155---
Q 004660          351 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---  427 (739)
Q Consensus       351 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~~~~~~~~---  427 (739)
                      ..+|.+.++||+|+||.||+|+.  +|..||||+++..     . ......+.|+..+..++|||||++++++..++   
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~   73 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----E-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----G-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             CCEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCC-----C-HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
T ss_conf             86899988982078819999999--9989999998720-----0-46799999999996279986832688998379860


Q ss_pred             -EEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCEECCCCCCCCEEECCCCCEEEEE
Q ss_conf             -5899995227987002432014663078898877757999999772--------9924044777664866899389930
Q 004660          428 -HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS--------TNTIHRDIKGANLLVDASGVVKLAD  498 (739)
Q Consensus       428 -~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs--------~GIvHRDIKPeNILId~~g~vKL~D  498 (739)
                       .+|+|||||.+|+|.+++++.  .+++..+..++.|++.||.|||.        +||+||||||+|||++.++.+||+|
T Consensus        74 ~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEEEECCCCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEE
T ss_conf             4899999646698989998658--99989999999999999999887665204689866153173135786887768876


Q ss_pred             CCCCHHCCCCCC-----CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC--------
Q ss_conf             263010137553-----3345799999876999985303999989931035677899999961999999998--------
Q 004660          499 FGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE--------  565 (739)
Q Consensus       499 FGLA~~~~~~~~-----~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~--------  565 (739)
                      ||+++.......     .....||+.|+|||++.+..... ...++.++|||||||+||||++|..||....        
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK-HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTT-CHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             CCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHH
T ss_conf             3866234677762001355250354767822105654546-777675012201599999996289988766311241012


Q ss_pred             ------CHHHHHHHH-H--CCCCCCCCC-----CHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf             ------368999986-0--599999559-----9999999999400199999999999809
Q 004660          566 ------GPQAMFKVL-N--RTPPIPEML-----SSEGKDFLLRCFLRNPVERPSAVELLEH  612 (739)
Q Consensus       566 ------~~~~~~~i~-~--~~~~iP~~l-----s~el~dLI~kcL~~DP~kRpTa~eiLqH  612 (739)
                            ....+.... .  ..+.++..+     ...+.+||.+||..||++|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             2556430999999875024688877655776899999999999760698589599999999

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=345.22  Aligned_cols=252  Identities=23%  Similarity=0.374  Sum_probs=196.8

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCC-----------CCCEEEEC
Q ss_conf             9906813881249769999999799947999996318999550999999999999994169-----------98757514
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----------HENIVQYY  420 (739)
Q Consensus       352 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-----------HPNIVkl~  420 (739)
                      .+|+++++||+|+||+||+|+++.+|+.||||+++.      .......+.+|+++++.+.           |+|||+++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~------~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEC------CCCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEE
T ss_conf             857998997507781899999999997999999834------31336899999999998401455555422767647899


Q ss_pred             CCEEEC--CEEEEEEEECCCCCCCHHH--HHCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCCCCEEECCCC---
Q ss_conf             621215--5589999522798700243--2014663078898877757999999772-9924044777664866899---
Q 004660          421 GSEVVD--DHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASG---  492 (739)
Q Consensus       421 ~~~~~~--~~l~LVmEy~~gGsL~~~L--~~~~~~Lse~~i~~i~~QIl~gL~yLHs-~GIvHRDIKPeNILId~~g---  492 (739)
                      +++...  ...+++|+++..+......  ......+++..++.++.||+.||.|||+ .||+||||||+|||++.++   
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCCC
T ss_conf             87631256520234320003542000001223467868999999999999988876405864656770570563057656


Q ss_pred             ---CEEEEECCCCHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH--
Q ss_conf             ---389930263010137553334579999987699998530399998993103567789999996199999999836--
Q 004660          493 ---VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--  567 (739)
Q Consensus       493 ---~vKL~DFGLA~~~~~~~~~~s~~GT~~Y~APEiL~~~~~~~g~~~~t~asDVWSLGvILyELLtGk~PF~~~~~~--  567 (739)
                         .+||+|||.+......  .....||+.|+|||++.+       ..++.++||||+||++++|++|+.||...+..  
T Consensus       167 ~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~  237 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-------APWGCGADIWSTACLIFELITGDFLFEPDEGHSY  237 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-------CCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCCEEEEEECCCCCCCCCC--CCCCCCCCCCCCHHHCCC-------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf             4430567531442123445--422366521057132146-------6777643201237899999878899898755432


Q ss_pred             ----HHHHH---HHHC---------------------------------------CCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf             ----89999---8605---------------------------------------9999955999999999994001999
Q 004660          568 ----QAMFK---VLNR---------------------------------------TPPIPEMLSSEGKDFLLRCFLRNPV  601 (739)
Q Consensus       568 ----~~~~~---i~~~---------------------------------------~~~iP~~ls~el~dLI~kcL~~DP~  601 (739)
                          ..+..   +++.                                       ....+...++++++||.+||..||.
T Consensus       238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~  317 (362)
T d1q8ya_         238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  317 (362)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             CCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHH
T ss_conf             10268999999983799878862453220001320122024323577644421000156743589999999998779945


Q ss_pred             CCCCHHHHHCCCCCCCC
Q ss_conf             99999999809354345
Q 004660          602 ERPSAVELLEHPFIRNA  618 (739)
Q Consensus       602 kRpTa~eiLqHpff~~~  618 (739)
                      +|||+.|+|+||||++.
T Consensus       318 ~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         318 KRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             TCBCHHHHHTCGGGTTC
T ss_pred             HCCCHHHHHCCCCCCCC
T ss_conf             79089999669340789

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.95  E-value=2.2e-28  Score=186.40  Aligned_cols=174  Identities=18%  Similarity=0.209  Sum_probs=122.2

Q ss_pred             CEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCC-------------CCCHHHHHHHHHHHHHHHHCCCCCEEEEC
Q ss_conf             06813881249769999999799947999996318999-------------55099999999999999416998757514
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------------PKSAECIKQLEQEIKVLGHLKHENIVQYY  420 (739)
Q Consensus       354 Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~-------------~~~~~~~~~l~~Ei~iL~~L~HPNIVkl~  420 (739)
                      +.++++||+|+||+||+|++. +|+.||||+++.....             ...........+|+..+..+.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf             022778024856599999979-9999999998604434666556563000888999999778999999981699914499


Q ss_pred             CCEEECCEEEEEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECC
Q ss_conf             62121555899995227987002432014663078898877757999999772992404477766486689938993026
Q 004660          421 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG  500 (739)
Q Consensus       421 ~~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs~GIvHRDIKPeNILId~~g~vKL~DFG  500 (739)
                      +..    ..+++|||++++.+.+        +.+..+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|||
T Consensus        81 ~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          81 AWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             EEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             EEC----CCEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-CEEEEECC
T ss_conf             862----8889999504565420--------0157899999999999999826888983689036114289-89998778


Q ss_pred             CCHHCCCCCCCCCCCCCCCCCCH--HHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             30101375533345799999876--99998530399998993103567789999
Q 004660          501 MAKHLTGLSYELSLKGSPNWMAP--EVIKAVMQKDGNPKLALAVDIWSLGCTVI  552 (739)
Q Consensus       501 LA~~~~~~~~~~s~~GT~~Y~AP--EiL~~~~~~~g~~~~t~asDVWSLGvILy  552 (739)
                      +|.........       .|...  +.+....    ...|+..+|+||+.--+.
T Consensus       148 ~a~~~~~~~~~-------~~l~rd~~~~~~~f----~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         148 QSVEVGEEGWR-------EILERDVRNIITYF----SRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             TCEETTSTTHH-------HHHHHHHHHHHHHH----HHHHCCCCCHHHHHHHHH
T ss_pred             CCCCCCCCCCH-------HHHHHHHHHHHHHH----CCCCCCCCCHHHHHHHHH
T ss_conf             84308998709-------99987799999997----578998446899999874

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.94  E-value=1.6e-09  Score=72.27  Aligned_cols=140  Identities=14%  Similarity=0.088  Sum_probs=86.1

Q ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEECCCEEECCEEE
Q ss_conf             9906813881249769999999799947999996318999550999999999999994169-987575146212155589
Q 004660          352 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY  430 (739)
Q Consensus       352 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HPNIVkl~~~~~~~~~l~  430 (739)
                      ..|+..+..+-++.+.||++.  .++..+.+|.........     ...+.+|...++.|. +-.+.+++.+...++..|
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HCEEEEECCCCCCCCCEEEEE--ECCCEEEEEECCCCCCCC-----HHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf             352799767899877189999--089869999848876532-----5569999999998760699872899975089649


Q ss_pred             EEEEECCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q ss_conf             9995227987002432014663078898877757999999772-------------------------------------
Q 004660          431 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-------------------------------------  473 (739)
Q Consensus       431 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~gL~yLHs-------------------------------------  473 (739)
                      +|||+++|..+.......      .....+..++...+..||+                                     
T Consensus        87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEECCCCCCCCCCCCC------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf             999860433435433440------26999999899999998556842143576446565557789987765555430332


Q ss_pred             ----------------------CCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf             ----------------------9924044777664866899389930263010
Q 004660          474 ----------------------TNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       474 ----------------------~GIvHRDIKPeNILId~~g~vKL~DFGLA~~  504 (739)
                                            ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf             32005799999999844986781789860047642364996599960231441

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.64  E-value=4.9e-08  Score=63.20  Aligned_cols=82  Identities=16%  Similarity=0.115  Sum_probs=50.9

Q ss_pred             EEEEEEECCCEEEEEEEECCCCCEEEEEEEEC----CCCCCCCHHHHHHHHHHHHHHHHCC-C--CCEEEECCCEEECCE
Q ss_conf             81388124976999999979994799999631----8999550999999999999994169-9--875751462121555
Q 004660          356 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDI----IPDDPKSAECIKQLEQEIKVLGHLK-H--ENIVQYYGSEVVDDH  428 (739)
Q Consensus       356 i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~----~~~~~~~~~~~~~l~~Ei~iL~~L~-H--PNIVkl~~~~~~~~~  428 (739)
                      ..+.||.|..-.||++.+..++..+++|.-..    .... . .....+...|.+.|+.+. +  ..+.+++.  .+++.
T Consensus        30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~-~-~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~  105 (392)
T d2pula1          30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES-W-PLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM  105 (392)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CC-C-CCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT
T ss_pred             EEEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCC-C-CCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECCCC
T ss_conf             6998079852768999957998489996177130346777-8-887789999999999865057988552899--85988


Q ss_pred             EEEEEEECCCCCC
Q ss_conf             8999952279870
Q 004660          429 LYIYLEYVHPGSI  441 (739)
Q Consensus       429 l~LVmEy~~gGsL  441 (739)
                      .++|||++.+..+
T Consensus       106 ~~lvmE~L~~~~~  118 (392)
T d2pula1         106 AVTVMEDLSHLKI  118 (392)
T ss_dssp             TEEEECCCTTSEE
T ss_pred             CEEEEECCCCCCC
T ss_conf             7798713577653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.53  E-value=4.2e-07  Score=57.57  Aligned_cols=138  Identities=13%  Similarity=0.014  Sum_probs=78.9

Q ss_pred             EEEEECC-CEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCC--CCEEEECCCEEECCEEEEEEE
Q ss_conf             3881249-7699999997999479999963189995509999999999999941699--875751462121555899995
Q 004660          358 KLIGRGT-FGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVDDHLYIYLE  434 (739)
Q Consensus       358 k~LG~Gs-fG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H--PNIVkl~~~~~~~~~l~LVmE  434 (739)
                      +.+..|. .+.||++.. ..+..+.+|.....  ..      ..+..|...|+.|..  -.+.+++.+..+.+..++|||
T Consensus        16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~--~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~   86 (255)
T d1nd4a_          16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--AL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   86 (255)
T ss_dssp             EECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             EECCCCCCCCEEEEEEE-CCCCEEEEEECCCC--CH------HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEE
T ss_conf             87678654775899993-89878999958966--77------68999999999998659998861322245661599987


Q ss_pred             ECCCCCCCHHHH--------------H-C-----CCCCCHH-------HHHHH---------------HHHHHHHHHHHH
Q ss_conf             227987002432--------------0-1-----4663078-------89887---------------775799999977
Q 004660          435 YVHPGSINRYVR--------------E-H-----CRDITES-------IVRNF---------------TRHILNGLAYLH  472 (739)
Q Consensus       435 y~~gGsL~~~L~--------------~-~-----~~~Lse~-------~i~~i---------------~~QIl~gL~yLH  472 (739)
                      +++|.++.....              + +     ...+...       ....+               .......+..+.
T Consensus        87 ~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  166 (255)
T d1nd4a_          87 EVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  166 (255)
T ss_dssp             CCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             EEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
T ss_conf             44135543221268999999999999873688544887554124688999999875411011340112137999999998


Q ss_pred             H-------CCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf             2-------9924044777664866899389930263010
Q 004660          473 S-------TNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       473 s-------~GIvHRDIKPeNILId~~g~vKL~DFGLA~~  504 (739)
                      .       ..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             718765795678678887635773796589998533265

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=98.03  E-value=2.9e-05  Score=46.45  Aligned_cols=131  Identities=15%  Similarity=0.136  Sum_probs=71.2

Q ss_pred             CEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCC-----CCEEEECC--CEEECCEEEEEEEECC
Q ss_conf             7699999997999479999963189995509999999999999941699-----87575146--2121555899995227
Q 004660          365 FGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-----ENIVQYYG--SEVVDDHLYIYLEYVH  437 (739)
Q Consensus       365 fG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-----PNIVkl~~--~~~~~~~l~LVmEy~~  437 (739)
                      .-.||++.. .+|..|++|+.+..  . ..   ..++..|+..|..|..     +..+..-+  .+..++..+.+++++.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~--~-~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPE--R-WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTT--T-SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             CCEEEEEEC-CCCCEEEEEEECCC--C-CC---HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECC
T ss_conf             202699983-89997999984787--7-88---99999999999999855998787520689805665347999986527


Q ss_pred             CCCCCHH----HH----------H----C----CCC-------------------CCHHH---HHHHHHHHHHHHHHHH-
Q ss_conf             9870024----32----------0----1----466-------------------30788---9887775799999977-
Q 004660          438 PGSINRY----VR----------E----H----CRD-------------------ITESI---VRNFTRHILNGLAYLH-  472 (739)
Q Consensus       438 gGsL~~~----L~----------~----~----~~~-------------------Lse~~---i~~i~~QIl~gL~yLH-  472 (739)
                      |..+...    +.          .    .    ...                   ++...   ....+.+++..+.-+- 
T Consensus       108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~  187 (325)
T d1zyla1         108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  187 (325)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf             76889999999999899999988630357865567789788766568999874769988989999999999999998454


Q ss_pred             ---HCCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf             ---29924044777664866899389930263010
Q 004660          473 ---STNTIHRDIKGANLLVDASGVVKLADFGMAKH  504 (739)
Q Consensus       473 ---s~GIvHRDIKPeNILId~~g~vKL~DFGLA~~  504 (739)
                         ..++||+|+.+.|||++. + ..++||+.+..
T Consensus       188 ~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         188 EDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             SCSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             CCCCCEEECCCCCCCCEEEEC-C-CEEEECHHCCC
T ss_conf             568712024788804287838-9-35886520146

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.88  E-value=0.00017  Score=41.79  Aligned_cols=141  Identities=16%  Similarity=0.125  Sum_probs=75.3

Q ss_pred             CEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCC-----CCCEEEECC---CEEE
Q ss_conf             06813881249769999999799947999996318999550999999999999994169-----987575146---2121
Q 004660          354 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----HENIVQYYG---SEVV  425 (739)
Q Consensus       354 Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-----HPNIVkl~~---~~~~  425 (739)
                      ..-.+.|..|---+.|++...  +..+++|++... .+      ...+..|+++|..|.     .|..+...+   ....
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~-~~------~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~   90 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR-VE------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   90 (316)
T ss_dssp             EEEEEEECC---EEEEEEEES--SCCEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             CEEEECCCCCCCCCEEEEEEC--CCCEEEEECCCC-CC------HHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEE
T ss_conf             568523788852673899978--972899980789-99------889999999987543025554556410489762134


Q ss_pred             CCEEEEEEEECCCCCCCHHHHHCC----------------------C------------------CCCHHHHHHHHHHHH
Q ss_conf             555899995227987002432014----------------------6------------------630788988777579
Q 004660          426 DDHLYIYLEYVHPGSINRYVREHC----------------------R------------------DITESIVRNFTRHIL  465 (739)
Q Consensus       426 ~~~l~LVmEy~~gGsL~~~L~~~~----------------------~------------------~Lse~~i~~i~~QIl  465 (739)
                      .+....++.++.|...........                      .                  ..........+..+.
T Consensus        91 ~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  170 (316)
T d2ppqa1          91 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  170 (316)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             ECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_conf             12550245311465533320467888889987645444320245310111012002456777765311412799999998


Q ss_pred             HHHHHHH----HCCEECCCCCCCCEEECCCCCEEEEECCCCH
Q ss_conf             9999977----2992404477766486689938993026301
Q 004660          466 NGLAYLH----STNTIHRDIKGANLLVDASGVVKLADFGMAK  503 (739)
Q Consensus       466 ~gL~yLH----s~GIvHRDIKPeNILId~~g~vKL~DFGLA~  503 (739)
                      ..+....    ..|+||+|+.++|||++.+...-|+||+.+.
T Consensus       171 ~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         171 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf             764204855454503337863656402045412674222123

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.83  E-value=7.2e-05  Score=44.04  Aligned_cols=77  Identities=13%  Similarity=0.154  Sum_probs=46.2

Q ss_pred             EEEEEEEECCCEEEEEEEECC-------CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCE-EEECCCEEEC
Q ss_conf             681388124976999999979-------99479999963189995509999999999999941699875-7514621215
Q 004660          355 QKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVD  426 (739)
Q Consensus       355 ~i~k~LG~GsfG~Vy~a~~k~-------tg~~vAIK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HPNI-Vkl~~~~~~~  426 (739)
                      ...+.|+-|-.=.+|++....       .+..|.+++.-   .. ...   ....+|..+++.+.-.++ .++++.+.  
T Consensus        45 l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g---~~-~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~--  115 (395)
T d1nw1a_          45 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF---NP-ETE---SHLVAESVIFTLLSERHLGPKLYGIFS--  115 (395)
T ss_dssp             EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC---SC-CCH---HHHHHHHHHHHHHHHTTSSSCEEEEET--
T ss_pred             EEEEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC---CC-CHH---HHHHHHHHHHHHHHHCCCCCEEEEECC--
T ss_conf             699991785334348999688775445789817999659---96-116---589999999999975799980899818--


Q ss_pred             CEEEEEEEECCCCCCC
Q ss_conf             5589999522798700
Q 004660          427 DHLYIYLEYVHPGSIN  442 (739)
Q Consensus       427 ~~l~LVmEy~~gGsL~  442 (739)
                      +  .+||||++|..|.
T Consensus       116 ~--g~I~efi~g~~l~  129 (395)
T d1nw1a_         116 G--GRLEEYIPSRPLS  129 (395)
T ss_dssp             T--EEEECCCCEEECC
T ss_pred             C--CEEEEEECCCCCC
T ss_conf             9--5699973455488